PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Sowell, ER; Peterson, BS; Thompson, PM; Welcome, SE; Henkenius, AL; Toga, AW				Sowell, ER; Peterson, BS; Thompson, PM; Welcome, SE; Henkenius, AL; Toga, AW			Mapping cortical change across the human life span	NATURE NEUROSCIENCE			English	Article							AGE-RELATED-CHANGES; IN-VIVO; HUMAN BRAIN; REGIONAL BRAIN; ADOLESCENCE; MATURATION; CHILDHOOD; VOLUMES; MRI; MYELINATION	We used magnetic resonance imaging and cortical matching algorithms to map gray matter density (GMD) in 176 normal individuals ranging in age from 7 to 87 years. We found a significant, nonlinear decline in GMD with age, which was most rapid between 7 and about 60 years, over dorsal frontal and parietal association cortices on both the lateral and interhemispheric surfaces. Age effects were inverted in the left posterior temporal region, where GMD gain continued up to age 30 and then rapidly declined. The trajectory of maturational and aging effects varied considerably over the cortex. Visual, auditory and limbic cortices, which are known to myelinate early, showed a more linear pattern of aging than the frontal and parietal neocortices, which continue myelination into adulthood. Our findings also indicate that the posterior temporal cortices, primarily in the left hemisphere, which typically support language functions, have a more protracted course of maturation than any other cortical region.	Univ Calif Los Angeles, Lab Neuro Imaging, Dept Neurol, Los Angeles, CA 90095 USA; Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, New York, NY 10032 USA	University of California System; University of California Los Angeles; Columbia University; New York State Psychiatry Institute	Sowell, ER (corresponding author), Univ Calif Los Angeles, Lab Neuro Imaging, Dept Neurol, 710 Westwood Plaza, Los Angeles, CA 90095 USA.		Thompson, Paul M/C-4194-2018	Thompson, Paul M/0000-0002-4720-8867	NCRR NIH HHS [P41 RR13642] Funding Source: Medline; NIMH NIH HHS [5T32 MH16381, MH01232, MH01733, MH59139, P20 MH/DA52176] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR013642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH016381, R01MH059139, P20MH052176, K08MH001232] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bartzokis G, 2001, ARCH GEN PSYCHIAT, V58, P461, DOI 10.1001/archpsyc.58.5.461; BENES FM, 1994, ARCH GEN PSYCHIAT, V51, P477; BENES FM, 1989, SCHIZOPHRENIA BULL, V15, P585, DOI 10.1093/schbul/15.4.585; Burke DM, 1997, PHILOS T R SOC B, V352, P1845, DOI 10.1098/rstb.1997.0170; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Courchesne E, 2000, RADIOLOGY, V216, P672, DOI 10.1148/radiology.216.3.r00au37672; DEKABAN AS, 1978, ANN NEUROL, V4, P345, DOI 10.1002/ana.410040410; Duvernoy H. M., 1991, HUMAN BRAIN SURFACE; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Jernigan TL, 2001, NEUROBIOL AGING, V22, P581, DOI 10.1016/S0197-4580(01)00217-2; MacDonald D, 1994, P SOC PHOTO-OPT INS, V2359, P160; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Morrison JH, 1997, SCIENCE, V278, P412, DOI 10.1126/science.278.5337.412; Ono M, 1990, ATLAS CEREBRAL SULCI; Paus T, 1999, SCIENCE, V283, P1908, DOI 10.1126/science.283.5409.1908; Peterson BS, 2000, ARCH GEN PSYCHIAT, V57, P364, DOI 10.1001/archpsyc.57.4.364; Peterson BS, 2001, ARCH GEN PSYCHIAT, V58, P427, DOI 10.1001/archpsyc.58.5.427; Ravid D, 2002, J CHILD LANG, V29, P417, DOI 10.1017/S0305000902005111; SALM, 2002, NEUROIMAGE, V17, P1027; Sowell ER, 1999, NEUROIMAGE, V9, P587, DOI 10.1006/nimg.1999.0436; Sowell ER, 2001, J NEUROSCI, V21, P8819, DOI 10.1523/JNEUROSCI.21-22-08819.2001; Sowell ER, 2002, CEREB CORTEX, V12, P856, DOI 10.1093/cercor/12.8.856; Sowell ER, 1999, NAT NEUROSCI, V2, P859, DOI 10.1038/13154; Sowell ER, 2002, DEV MED CHILD NEUROL, V44, P4, DOI 10.1017/S0012162201001591; Sowell ER, 2002, CEREB CORTEX, V12, P17, DOI 10.1093/cercor/12.1.17; TERRY RD, 1987, ANN NEUROL, V21, P530, DOI 10.1002/ana.410210603; Thompson PM, 2000, NATURE, V404, P190, DOI 10.1038/35004593; Thompson PM, 2000, HUM BRAIN MAPP, V9, P81, DOI 10.1002/(SICI)1097-0193(200002)9:2<81::AID-HBM3>3.0.CO;2-8; Thompson PM, 2001, CEREB CORTEX, V11, P1, DOI 10.1093/cercor/11.1.1; THOMPSON PM, 2002, COMPUTING VISUALIZAT, V5, P1; THOMPSON PM, INPRESS J NEUROSCI; WOODS RP, 1993, J COMPUT ASSIST TOMO, V17, P536, DOI 10.1097/00004728-199307000-00004; Yakovlev P. I., 1967, REGIONAL DEV BRAIN E, P3	35	1611	1630	3	152	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2003	6	3					309	315		10.1038/nn1008	http://dx.doi.org/10.1038/nn1008			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	648YB	12548289				2022-12-24	WOS:000181178300020
J	Eger, E; Sterzer, P; Russ, MO; Giraud, AL; Kleinschmidt, A				Eger, E; Sterzer, P; Russ, MO; Giraud, AL; Kleinschmidt, A			A supramodal number representation in human intraparietal cortex	NEURON			English	Article							BRAIN; FMRI	The triple-code theory of numerical processing postulates an abstract-semantic "number sense." Neuropsychology points to intraparietal cortex as a potential substrate, but previous functional neuroimaging studies did not dissociate the representation of numerical magnitude from task-driven effects on intraparietal activation. In an event-related fMRI study, we presented numbers, letters, and colors in the visual and auditory modality, asking subjects to respond to target items within each category. In the absence of explicit magnitude processing, numbers compared with letters and colors across modalities activated a bilateral region in the horizontal intraparietal sulcus. This stimulus-driven number-specific intraparietal response supports the idea of a supramodal number representation that is automatically accessed by presentation of numbers and may code magnitude information.	Univ Frankfurt, Dept Neurol, Cognit Neurol Unit, D-6000 Frankfurt, Germany	Goethe University Frankfurt	Eger, E (corresponding author), Univ Frankfurt, Dept Neurol, Cognit Neurol Unit, D-6000 Frankfurt, Germany.		Eger, Evelyn/B-1393-2019	Eger, Evelyn/0000-0002-7164-2356				Chochon F, 1999, J COGNITIVE NEUROSCI, V11, P617, DOI 10.1162/089892999563689; Dehaene S, 1999, SCIENCE, V284, P970, DOI 10.1126/science.284.5416.970; DEHAENE S, 1995, J EXP PSYCHOL LEARN, V21, P314, DOI 10.1037/0278-7393.21.2.314; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; DEHAENE S, 1992, COGNITION, V44, P1, DOI 10.1016/0010-0277(92)90049-N; Dehaene S, 1998, TRENDS NEUROSCI, V21, P355, DOI 10.1016/S0166-2236(98)01263-6; DEHAENE S, 2003, CEREB CORTEX, V11, P350; Dehaene S., 1995, MATH COGNITION, V1, P83, DOI DOI 10.1155/2014/461647; Hauser MD, 1996, P NATL ACAD SCI USA, V93, P1514, DOI 10.1073/pnas.93.4.1514; Menon V, 2000, COGNITIVE BRAIN RES, V9, P343, DOI 10.1016/S0926-6410(00)00010-0; Naccache L, 2001, CEREB CORTEX, V11, P966, DOI 10.1093/cercor/11.10.966; Nieder A, 2002, SCIENCE, V297, P1708, DOI 10.1126/science.1072493; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Orlov T, 2000, NATURE, V404, P77, DOI 10.1038/35003571; Pesenti M, 2000, J COGNITIVE NEUROSCI, V12, P461, DOI 10.1162/089892900562273; Piazza M, 2002, NEUROIMAGE, V15, P435, DOI 10.1006/nimg.2001.0980; Pinel P, 1999, NEUROREPORT, V10, P1473, DOI 10.1097/00001756-199905140-00015; Pinel P, 2001, NEUROIMAGE, V14, P1013, DOI 10.1006/nimg.2001.0913; Rickard TC, 2000, NEUROPSYCHOLOGIA, V38, P325, DOI 10.1016/S0028-3932(99)00068-8; Sawamura H, 2002, NATURE, V415, P918, DOI 10.1038/415918a; Simon O, 2002, NEURON, V33, P475, DOI 10.1016/S0896-6273(02)00575-5; TAYLOR DA, 1984, J EXP PSYCHOL LEARN, V10, P61; Zilles K, 2001, NEUROIMAGE, V14, pS8, DOI 10.1006/nimg.2001.0823	23	334	340	1	19	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 20	2003	37	4					719	725		10.1016/S0896-6273(03)00036-9	http://dx.doi.org/10.1016/S0896-6273(03)00036-9			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	648EH	12597867	Bronze			2022-12-24	WOS:000181136500018
J	Wang, ZR; Xu, NL; Wu, CP; Duan, SM; Poo, MM				Wang, ZR; Xu, NL; Wu, CP; Duan, SM; Poo, MM			Bidirectional changes in spatial dendritic integration accompanying long-term synaptic modifications	NEURON			English	Article							RAT HIPPOCAMPAL SLICES; CA1 PYRAMIDAL NEURONS; EPSP-SPIKE POTENTIATION; E-S COMPONENT; INTRINSIC EXCITABILITY; SUPRALINEAR SUMMATION; LASTING POTENTIATION; PERFORANT PATH; K+ CURRENT; IN-VITRO	Information processing in the neuron requires spatial summation of synaptic inputs at the dendrite. In CA1 pyramidal neurons of the hippocampus, a brief period of correlated pre- and postsynaptic activity, which induces long-term potentiation (LTP) or long-term depression (LTD), results in a persistent increase or decrease in the linearity of spatial summation, respectively. Such bidirectional modification of the summation property is specific to the modified input and reflects localized dendritic changes involving I-h channels and NMDA receptors. Thus, correlated pre- and postsynaptic activity alters not only the strength of the activated input but also its dendritic integration with other inputs.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai, Peoples R China; Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of California System; University of California Berkeley	Duan, SM (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai, Peoples R China.		Xu, Ning-long/U-8665-2019; Xu, Ninglong/F-8768-2011	Xu, Ning-long/0000-0002-1651-401X; 	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036999] Funding Source: NIH RePORTER; NINDS NIH HHS [NS36999] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABRAHAM WC, 1987, J PHYSIOL-LONDON, V394, P367, DOI 10.1113/jphysiol.1987.sp016875; Aizenman CD, 2000, NAT NEUROSCI, V3, P109, DOI 10.1038/72049; ANDERSEN P, 1980, J PHYSIOL-LONDON, V302, P463; Armano S, 2000, J NEUROSCI, V20, P5208, DOI 10.1523/JNEUROSCI.20-14-05208.2000; ASZTELY F, 1994, HIPPOCAMPUS, V4, P148, DOI 10.1002/hipo.450040205; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Cash S, 1998, J NEUROSCI, V18, P10; Cash S, 1999, NEURON, V22, P383, DOI 10.1016/S0896-6273(00)81098-3; CHAVEZNORIEGA LE, 1990, EXP BRAIN RES, V79, P633; CHAVEZNORIEGA LE, 1989, NEUROSCI LETT, V104, P58, DOI 10.1016/0304-3940(89)90329-7; Christie BR, 1997, J NEUROPHYSIOL, V77, P1651, DOI 10.1152/jn.1997.77.3.1651; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Ganguly K, 2000, NAT NEUROSCI, V3, P1018, DOI 10.1038/79838; HESS G, 1990, NEUROSCIENCE, V37, P61, DOI 10.1016/0306-4522(90)90192-7; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Hoffman DA, 1998, J NEUROSCI, V18, P3521; Ingram SL, 1996, J PHYSIOL-LONDON, V492, P97, DOI 10.1113/jphysiol.1996.sp021292; JESTER JM, 1995, J PHYSIOL-LONDON, V484, P689, DOI 10.1113/jphysiol.1995.sp020696; KATO K, 1993, NEUROSCIENCE, V53, P39, DOI 10.1016/0306-4522(93)90282-K; Kullmann DM, 1996, NEURON, V17, P461, DOI 10.1016/S0896-6273(00)80178-6; Lu YM, 2000, NEURON, V26, P197, DOI 10.1016/S0896-6273(00)81150-2; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Magee JC, 1998, J NEUROSCI, V18, P7613; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MALENKA RC, 1994, CELL, V78, P535, DOI 10.1016/0092-8674(94)90517-7; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Mellor J, 2002, SCIENCE, V295, P143, DOI 10.1126/science.1064285; Nettleton JS, 2000, J NEUROPHYSIOL, V83, P3310, DOI 10.1152/jn.2000.83.6.3310; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; PUGLIESE AM, 1994, NEUROSCIENCE, V62, P1021, DOI 10.1016/0306-4522(94)90340-9; Rall W, 1964, NEURAL THEORY MODELI, P73; SPRUSTON N, 2001, DENDRITES, P231; Stuart G, 1998, J NEUROSCI, V18, P3501; Tessier S, 1999, CIRC RES, V85, P810, DOI 10.1161/01.RES.85.9.810; TOMASULO RA, 1993, J NEUROPHYSIOL, V69, P165, DOI 10.1152/jn.1993.69.1.165; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; TURRIGIANO G, 1994, SCIENCE, V264, P974, DOI 10.1126/science.8178157; Wessel R, 1999, J NEUROSCI, V19, P5875, DOI 10.1523/JNEUROSCI.19-14-05875.1999; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071	50	105	106	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 6	2003	37	3					463	472		10.1016/S0896-6273(02)01189-3	http://dx.doi.org/10.1016/S0896-6273(02)01189-3			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	647FF	12575953	Bronze			2022-12-24	WOS:000181081600011
J	Murai, KK; Nguyen, LN; Irie, F; Yamaguchi, Y; Pasquale, EB				Murai, KK; Nguyen, LN; Irie, F; Yamaguchi, Y; Pasquale, EB			Control of hippocampal dendritic spine morphology through ephrin-A3/EphA4 signaling	NATURE NEUROSCIENCE			English	Article							EPH RECEPTORS; GLIA; INTERMEDIATE; EXPRESSION; VARIANTS; SYNAPSES; MOTILITY; NEURONS; MICE	Communication between glial cells and neurons is emerging as a critical parameter of synaptic function. However, the molecular mechanisms underlying the ability of glial cells to modify synaptic structure and physiology are poorly understood. Here we describe a repulsive interaction that regulates postsynaptic morphology through the EphA4 receptor tyrosine kinase and its ligand ephrin-A3. EphA4 is enriched on dendritic spines of pyramidal neurons in the adult mouse hippocampus, and ephrin-A3 is localized on astrocytic processes that envelop spines. Activation of EphA4 by ephrin-A3 was found to induce spine retraction, whereas inhibiting ephrin/EphA4 interactions distorted spine shape and organization in hippocampal slices. Furthermore, spine irregularities in pyramidal neurons from EphA4 knockout mice and in slices transfected with kinase-inactive EphA4 indicated that ephrin/EphA4 signaling is critical for spine morphology. Thus, our data support a model in which transient interactions between the ephrin-A3 ligand and the EphA4 receptor regulate the structure of excitatory synaptic connections through neuroglial cross-talk.	Burnham Inst, Neurobiol Program, La Jolla, CA 92037 USA; Univ Calif San Diego, Mol Pathol Program, La Jolla, CA 92093 USA	Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego	Pasquale, EB (corresponding author), Burnham Inst, Neurobiol Program, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	elenap@burnham.org			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD025938] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY010576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS043029] Funding Source: NIH RePORTER; NEI NIH HHS [EY10576] Funding Source: Medline; NICHD NIH HHS [HD25938] Funding Source: Medline; NINDS NIH HHS [NS43029] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Chelly J, 1999, HUM MOL GENET, V8, P1833, DOI 10.1093/hmg/8.10.1833; Contractor A, 2002, SCIENCE, V296, P1864, DOI 10.1126/science.1069081; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Davenport RW, 1998, J NEUROSCI, V18, P975; Dodelet VC, 1999, J BIOL CHEM, V274, P31941, DOI 10.1074/jbc.274.45.31941; Dunaevsky A, 2001, NAT NEUROSCI, V4, P685, DOI 10.1038/89460; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Ethell IM, 2001, NEURON, V31, P1001, DOI 10.1016/S0896-6273(01)00440-8; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Gerlai R, 2000, BEHAV BRAIN RES, V108, P133, DOI 10.1016/S0166-4328(99)00139-4; Gerlai R, 2001, NAT REV NEUROSCI, V2, P205, DOI 10.1038/35058582; Glantz LA, 2000, ARCH GEN PSYCHIAT, V57, P65, DOI 10.1001/archpsyc.57.1.65; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Irie F, 2002, NAT NEUROSCI, V5, P1117, DOI 10.1038/nn964; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Korkotian E, 2000, HIPPOCAMPUS, V10, P587, DOI 10.1002/1098-1063(2000)10:5<587::AID-HIPO9>3.0.CO;2-C; Lai KO, 1999, FEBS LETT, V458, P265, DOI 10.1016/S0014-5793(99)01159-X; Mann F, 2002, NEURON, V35, P461, DOI 10.1016/S0896-6273(02)00786-9; Martone ME, 1997, BRAIN RES, V771, P238, DOI 10.1016/S0006-8993(97)00792-0; McCall MA, 1996, P NATL ACAD SCI USA, V93, P6361, DOI 10.1073/pnas.93.13.6361; Murai KK, 2002, CURR BIOL, V12, P181, DOI 10.1016/S0960-9822(02)00680-2; Murai KK, 2002, NEURON, V33, P159, DOI 10.1016/S0896-6273(02)00565-2; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Pasini A, 2002, BIOESSAYS, V24, P427, DOI 10.1002/bies.10085; Pasquale EB, 1997, CURR OPIN CELL BIOL, V9, P608, DOI 10.1016/S0955-0674(97)80113-5; Salzer JL, 1997, NEURON, V18, P843, DOI 10.1016/S0896-6273(00)80323-2; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Stein C A, 1993, Antisense Res Dev, V3, P19; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999; Yue Y, 2002, P NATL ACAD SCI USA, V99, P10777, DOI 10.1073/pnas.162354599; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zhang JH, 1996, J NEUROSCI, V16, P7182	41	370	404	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2003	6	2					153	160		10.1038/nn994	http://dx.doi.org/10.1038/nn994			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	640CL	12496762				2022-12-24	WOS:000180669100015
J	Hippenmeyer, S; Shneider, NA; Birchmeier, C; Burden, SJ; Jessell, TM; Arber, S				Hippenmeyer, S; Shneider, NA; Birchmeier, C; Burden, SJ; Jessell, TM; Arber, S			A role for Neuregulin1 signaling in muscle spindle differentiation	NEURON			English	Article							ETS TRANSCRIPTION FACTOR; PERIPHERAL NERVOUS-SYSTEM; NICOTINIC ACETYLCHOLINE-RECEPTOR; LIM HOMEOBOX GENES; PROPRIOCEPTIVE AFFERENTS; NEUROMUSCULAR SYNAPSE; SELECTIVE EXPRESSION; MOTOR INNERVATION; SENSORY NEURONS; MICE LACKING	The maturation of synaptic structures depends on inductive interactions between axons and their prospective targets. One example of such an interaction is the influence of proprioceptive sensory axons on the differentiation of muscle spindles. We have monitored the expression of three transcription factors, Egr3, Pea3, and Erm, that delineate early muscle spindle development in an assay of muscle spindle-inducing signals. We provide genetic evidence that Neuregulin1 (Nrg1) is required for proprioceptive afferent-evoked induction of muscle spindle differentiation in the mouse. Ig-Nrg1 isoforms are preferentially expressed by proprioceptive sensory neurons and are sufficient to induce muscle spindle differentiation in vivo, whereas CRD-Nrg1 isoforms are broadly expressed in sensory and motor neurons but are not required for muscle spindle induction.	Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland; Columbia Univ, Dept Neurol, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; Columbia Univ, Dept Biochem & Mol Biophys, Ctr Neurobiol & Behav, New York, NY 10032 USA; Max Delbruck Ctr Mol Med, Dept Med Genet, D-13122 Berlin, Germany; Skirball Inst, Mol Neurobiol Program, New York, NY 10011 USA; Friedrich Miescher Inst, CH-4058 Basel, Switzerland	University of Basel; Columbia University; Columbia University; Howard Hughes Medical Institute; Columbia University; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Friedrich Miescher Institute for Biomedical Research	Arber, S (corresponding author), Univ Basel, Biozentrum, Dept Cell Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.		Shneider, Neil/ABF-5751-2020	Shneider, Neil/0000-0002-3223-7366; Arber, Silvia/0000-0002-6261-250X; Burden, Steven/0000-0002-3550-6891; Hippenmeyer, Simon/0000-0003-2279-1061	NINDS NIH HHS [R01 NS029071-15, R01 NS029071-16, R01 NS029071-13S1, R01 NS027963-13, NS29071, R01 NS029071-13, R01 NS029071-14] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029071, R01NS027963] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Andrechek ER, 2002, MOL CELL BIOL, V22, P4714, DOI 10.1128/MCB.22.13.4714-4722.2002; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Arber S, 2002, CURR OPIN NEUROBIOL, V12, P100, DOI 10.1016/S0959-4388(02)00296-9; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Bosc DG, 2001, ONCOGENE, V20, P6215, DOI 10.1038/sj.onc.1204820; Briguet A, 2000, J NEUROSCI, V20, P5989, DOI 10.1523/JNEUROSCI.20-16-05989.2000; Buonanno A, 2001, CURR OPIN NEUROBIOL, V11, P287, DOI 10.1016/S0959-4388(00)00210-5; Burden S, 1997, NEURON, V18, P847, DOI 10.1016/S0896-6273(00)80324-4; Chen HH, 2002, J NEUROSCI, V22, P3512; COPRAY JCVM, 1994, NEUROSCIENCE, V63, P1125, DOI 10.1016/0306-4522(94)90578-9; Ernfors P, 2001, CELL MOL LIFE SCI, V58, P1036, DOI 10.1007/PL00000918; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; Farinas I, 1999, MICROSC RES TECHNIQ, V45, P233, DOI 10.1002/(SICI)1097-0029(19990515/01)45:4/5<233::AID-JEMT7>3.0.CO;2-Y; FARINAS I, 1994, NATURE, V369, P658, DOI 10.1038/369658a0; Fischbach GD, 1997, ANNU REV NEUROSCI, V20, P429, DOI 10.1146/annurev.neuro.20.1.429; Fromm L, 1998, J PHYSIOLOGY-PARIS, V92, P173, DOI 10.1016/S0928-4257(98)80005-3; Garratt AN, 2000, BIOESSAYS, V22, P987, DOI 10.1002/1521-1878(200011)22:11<987::AID-BIES5>3.0.CO;2-5; Hidalgo A, 2001, DEV CELL, V1, P679, DOI 10.1016/S1534-5807(01)00074-0; Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0; HONDA CN, 1995, NEUROSCIENCE, V68, P883, DOI 10.1016/0306-4522(95)00180-Q; Huang Z, 1998, CELL, V95, P693, DOI 10.1016/S0092-8674(00)81639-6; Huang Z, 1998, DEVELOPMENT, V125, P3753; HUNT CC, 1990, PHYSIOL REV, V70, P643, DOI 10.1152/physrev.1990.70.3.643; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; KATZ WS, 1995, CELL, V82, P297, DOI 10.1016/0092-8674(95)90317-8; KLEIN R, 1994, NATURE, V368, P249, DOI 10.1038/368249a0; Kopp DM, 1997, J NEUROSCI, V17, P6697; KOZEKA K, 1981, DEV BIOL, V87, P133, DOI 10.1016/0012-1606(81)90067-1; Kramer R, 1996, P NATL ACAD SCI USA, V93, P4833, DOI 10.1073/pnas.93.10.4833; KUCERA J, 1993, ANAT EMBRYOL, V187, P397; KUCERA J, 1994, ANAT EMBRYOL, V190, P273; Kucera J, 2002, DEV DYNAM, V223, P389, DOI 10.1002/dvdy.10066; KUCERA J, 1992, ANAT EMBRYOL, V186, P301; Liebl DJ, 1997, J NEUROSCI, V17, P9113; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2; Loeb JA, 1999, DEVELOPMENT, V126, P781; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; Maier A, 1997, INT J DEV BIOL, V41, P1; Matsuo S, 2000, NEUROSCIENCE, V95, P209; Mendell LM, 2001, J PHYSIOL-LONDON, V533, P91, DOI 10.1111/j.1469-7793.2001.0091b.x; Meyer D, 1997, DEVELOPMENT, V124, P3575; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; O'Donovan KJ, 1999, TRENDS NEUROSCI, V22, P167, DOI 10.1016/S0166-2236(98)01343-5; O'Hagan RC, 1998, ONCOGENE, V16, P301, DOI 10.1038/sj.onc.1201547; Ozaki M, 1997, NATURE, V390, P691, DOI 10.1038/37795; Parkinson DB, 2002, MOL CELL NEUROSCI, V20, P154, DOI 10.1006/mcne.2002.1109; Sandrock AW, 1997, SCIENCE, V276, P599, DOI 10.1126/science.276.5312.599; SANES JR, 1991, DEVELOPMENT, V113, P1181; Sapru MK, 1998, P NATL ACAD SCI USA, V95, P1289, DOI 10.1073/pnas.95.3.1289; Schaeffer L, 2001, NEURON, V31, P15, DOI 10.1016/S0896-6273(01)00353-1; Schaeffer L, 1998, EMBO J, V17, P3078, DOI 10.1093/emboj/17.11.3078; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Shepherd TG, 2001, CURR BIOL, V11, P1739, DOI 10.1016/S0960-9822(01)00536-X; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sweeney C, 2001, J BIOL CHEM, V276, P22685, DOI 10.1074/jbc.M100602200; Tan PB, 1998, CELL, V93, P569, DOI 10.1016/S0092-8674(00)81186-1; Tourtellotte WG, 1998, NAT GENET, V20, P87, DOI 10.1038/1757; Tourtellotte WG, 2001, DEV BIOL, V232, P388, DOI 10.1006/dbio.2001.0202; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Verdi JM, 1996, NEURON, V16, P515, DOI 10.1016/S0896-6273(00)80071-9; Volk T, 1999, TRENDS GENET, V15, P448, DOI 10.1016/S0168-9525(99)01862-4; Walro JM, 1999, TRENDS NEUROSCI, V22, P180, DOI 10.1016/S0166-2236(98)01339-3; Wolpowitz D, 2000, NEURON, V25, P79, DOI 10.1016/S0896-6273(00)80873-9; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; Yang X, 1998, NEURON, V20, P255, DOI 10.1016/S0896-6273(00)80454-7; ZELENA J, 1994, NERVES MECHANORECEPT, P1; ZHU XJ, 1995, EMBO J, V14, P5842, DOI 10.1002/j.1460-2075.1995.tb00272.x	70	121	123	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 19	2002	36	6					1035	1049		10.1016/S0896-6273(02)01101-7	http://dx.doi.org/10.1016/S0896-6273(02)01101-7			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	628TA	12495620	Bronze			2022-12-24	WOS:000180011600008
J	Rose, M; Haider, H; Weiller, C; Buchel, C				Rose, M; Haider, H; Weiller, C; Buchel, C			The role of medial temporal lobe structures in implicit learning: An event-related fMRI study	NEURON			English	Article							SEQUENTIAL COGNITIVE SKILLS; ANTERIOR CINGULATE CORTEX; HUMAN BRAIN; DECLARATIVE MEMORY; VISUAL-ATTENTION; FUNCTIONAL MRI; HIPPOCAMPUS; SYSTEMS; PET; ACQUISITION	The medial temporal lobe (MTL) has been associated with declarative learning of flexible relational rules and the basal ganglia with implicit learning of stimulus-response mappings. It remains an open question of whether MTL or basal ganglia are involved when learning flexible relational contingencies without awareness. We studied learning of an explicit stimulus-response association with fMRI. Embedded in this explicit task was a hidden structure that was learnt implicitly. Implicit learning of the sequential regularities of the "hidden rule" activated the ventral perirhinal cortex, within the MTL, whereas learning the fixed stimulus-response associations activated the basal ganglia, indicating that the function of the MTL and the basal ganglia depends on the learned material and not necessarily on the participants' awareness.	Univ Hamburg, Sch Med, Dept Neurol, Cognit Neurosci Lab, D-20246 Hamburg, Germany; Univ Cologne, D-50931 Cologne, Germany	University of Hamburg; University of Cologne	Rose, M (corresponding author), Univ Hamburg, Sch Med, Dept Neurol, Cognit Neurosci Lab, Martinistr 52, D-20246 Hamburg, Germany.	rose@uke.uni-hamburg.de						Blazquez PM, 2002, NEURON, V33, P973, DOI 10.1016/S0896-6273(02)00627-X; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Buchel C, 1998, BRAIN, V121, P1281, DOI 10.1093/brain/121.7.1281; Chun MM, 1999, NAT NEUROSCI, V2, P844, DOI 10.1038/12222; Clark RE, 1998, SCIENCE, V280, P77, DOI 10.1126/science.280.5360.77; Cohen NJ, 1997, MEMORY, V5, P131, DOI 10.1080/741941149; Doane SM, 1999, J EXP PSYCHOL HUMAN, V25, P1390, DOI 10.1037/0096-1523.25.5.1390; Dusek JA, 1997, P NATL ACAD SCI USA, V94, P7109, DOI 10.1073/pnas.94.13.7109; Eichenbaum H, 1997, SCIENCE, V277, P330, DOI 10.1126/science.277.5324.330; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Eichenbaum H, 1999, NAT NEUROSCI, V2, P775, DOI 10.1038/12137; Eichenbaum H, 2001, BEHAV BRAIN RES, V127, P199, DOI 10.1016/S0166-4328(01)00365-5; Eldridge LL, 2000, NAT NEUROSCI, V3, P1149, DOI 10.1038/80671; Eliassen JC, 2001, EXP BRAIN RES, V141, P269, DOI 10.1007/s002210100822; Fletcher PC, 2001, NAT NEUROSCI, V4, P1043, DOI 10.1038/nn733; FRENSCH P, 2002, IN PRESS ATTENTION I; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; GRAFTON ST, 1995, J COGNITIVE NEUROSCI, V7, P497, DOI 10.1162/jocn.1995.7.4.497; Hazeltine E, 1997, BRAIN, V120, P123, DOI 10.1093/brain/120.1.123; Hazeltine E, 2000, J COGNITIVE NEUROSCI, V12, P118, DOI 10.1162/089892900563984; Honda M, 1998, BRAIN, V121, P2159, DOI 10.1093/brain/121.11.2159; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Knowlton BJ, 1996, SCIENCE, V273, P1399, DOI 10.1126/science.273.5280.1399; Konishi S, 1999, BRAIN, V122, P981, DOI 10.1093/brain/122.5.981; Krams M, 1998, EXP BRAIN RES, V120, P386, DOI 10.1007/s002210050412; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Manns JR, 2001, COGN AFFECT BEHAV NE, V1, P192, DOI 10.3758/CABN.1.2.192; Manns JR, 2001, HIPPOCAMPUS, V11, P776, DOI 10.1002/hipo.1093; McGlincheyBerroth R, 1997, BEHAV NEUROSCI, V111, P873, DOI 10.1037/0735-7044.111.5.873; Nadel L, 1998, NEUROPHARMACOLOGY, V37, P431, DOI 10.1016/S0028-3908(98)00057-4; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; Nobre AC, 1999, NAT NEUROSCI, V2, P11, DOI 10.1038/4513; Platt ML, 2002, NEURON, V33, P316, DOI 10.1016/S0896-6273(02)00579-2; Poldrack RA, 2001, NATURE, V414, P546, DOI 10.1038/35107080; Rauch SL, 1995, HUM BRAIN MAPP, V3, P271, DOI 10.1002/hbm.460030403; Reber A.S., 1993, IMPLICIT LEARNING TA; Rose M, 2001, NEUROIMAGE, V13, pS732; SEGER CA, 1994, PSYCHOL BULL, V115, P163, DOI 10.1037/0033-2909.115.2.163; SHANKS DR, 1994, BEHAV BRAIN SCI, V17, P367, DOI 10.1017/S0140525X00035032; SOLOMON PR, 1986, BEHAV NEUROSCI, V100, P729, DOI 10.1037/0735-7044.100.5.729; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; THURSTONE LL, 1941, PSYCHOMETRIC MONOGRA, V294; Wallenstein GV, 1998, TRENDS NEUROSCI, V21, P317, DOI 10.1016/S0166-2236(97)01220-4; Willingham DB, 2000, MEM COGNITION, V28, P366, DOI 10.3758/BF03198552; Woltz DJ, 1996, J EXP PSYCHOL LEARN, V22, P438, DOI 10.1037/0278-7393.22.2.438; Woltz DJ, 2000, J EXP PSYCHOL LEARN, V26, P601, DOI 10.1037/0278-7393.26.3.601	47	80	83	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 19	2002	36	6					1221	1231		10.1016/S0896-6273(02)01105-4	http://dx.doi.org/10.1016/S0896-6273(02)01105-4			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	628TA	12495634	Bronze			2022-12-24	WOS:000180011600022
J	Davis, KD; Pope, GE; Crawley, AP; Mikulis, DJ				Davis, KD; Pope, GE; Crawley, AP; Mikulis, DJ			Neural correlates of prickle sensation: a percept-related fMRI study	NATURE NEUROSCIENCE			English	Article							PAIN; CORTEX; HUMANS		Univ Toronto, Dept Surg, Toronto, ON, Canada; Toronto Western Hosp, Univ Hlth Network MP14 306, Toronto Western Res Inst, Toronto, ON M5T 2S8, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Davis, KD (corresponding author), Univ Toronto, Dept Surg, Toronto, ON, Canada.		Mikulis, David J/H-5167-2019	Mikulis, David/0000-0003-3956-0892				BURTON H, 1993, SOMATOSENS MOT RES, V10, P297, DOI 10.3109/08990229309028839; Chen CC, 1996, PAIN, V68, P33, DOI 10.1016/S0304-3959(96)03180-6; Davis KD, 2002, PAIN, V98, P179, DOI 10.1016/S0304-3959(02)00043-X; Davis KD, 1998, NEUROREPORT, V9, P3019, DOI 10.1097/00001756-199809140-00018; Davis KD, 1998, PAIN, V75, P47, DOI 10.1016/S0304-3959(97)00203-0; Downar J, 2002, J NEUROPHYSIOL, V87, P615, DOI 10.1152/jn.00636.2001; GARNSWORTHY RK, 1988, J NEUROPHYSIOL, V59, P1083, DOI 10.1152/jn.1988.59.4.1083; GARNSWORTHY RK, 1988, J NEUROPHYSIOL, V59, P1116, DOI 10.1152/jn.1988.59.4.1116; HSIEH JC, 1994, J NEUROPHYSIOL, V72, P3004, DOI 10.1152/jn.1994.72.6.3004; MELZACK R, 1968, P423; Penfield W, 1954, EPILEPSY FUNCTIONAL; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Porro CA, 1998, J NEUROPHYSIOL, V80, P3312, DOI 10.1152/jn.1998.80.6.3312; TOLAIRACH J, 1988, COPLANAR STEREOTAXIC; Treede RD, 1999, PAIN, V79, P105, DOI 10.1016/S0304-3959(98)00184-5	15	84	85	1	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1121	1122		10.1038/nn955	http://dx.doi.org/10.1038/nn955			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	609CG	12368810				2022-12-24	WOS:000178884600013
J	Schoppa, NE; Westbrook, GL				Schoppa, NE; Westbrook, GL			AMPA autoreceptors drive correlated spiking in olfactory bulb glomeruli	NATURE NEUROSCIENCE			English	Article							RETINAL GANGLION-CELLS; MITRAL CELLS; GAP-JUNCTIONS; TEMPORAL INFORMATION; RAT-BRAIN; NEURONS; EXPRESSION; SYNCHRONY; SYNAPSES; EXCITATION	Information processing in the brain may rely on temporal correlations in spike activity between neurons. Within the olfactory bulb, correlated spiking in output mitral cells could affect the odor code by either binding or amplifying signals from individual odorant receptors. We examined the timing of spike trains in mitral cells of rat olfactory bulb slices. Depolarization of mitral cell pairs elicited spikes that were correlated on a rapid timescale (less than or equal to10 ms) for cells whose primary dendrites projected to the same glomerulus. Correlated spiking was driven by a novel mechanism that depended on electrical coupling at mitral cell primary dendrites; the specific synchronizing signal was a coupled depolarization (similar to20 ms) that was mediated by dendritic AMPA autoreceptors. We suggest that glomerulus-specific correlated spiking in mitral cells helps to preserve the fidelity of odor signals that are delivered to the olfactory cortex.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA	Oregon Health & Science University	Schoppa, NE (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.	schoppan@hotmail.com			NINDS NIH HHS [NS26494] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS026494, R01NS026494] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADRIAN ED, 1950, ELECTROEN CLIN NEURO, V2, P377, DOI 10.1016/0013-4694(50)90075-7; Aroniadou-Anderjaska V, 1999, J NEUROPHYSIOL, V82, P489, DOI 10.1152/jn.1999.82.1.489; Belluardo N, 2000, BRAIN RES, V865, P121, DOI 10.1016/S0006-8993(00)02300-3; Bozza TC, 2001, CURR BIOL, V11, pR687, DOI 10.1016/S0960-9822(01)00409-2; Brivanlou IH, 1998, NEURON, V20, P527, DOI 10.1016/S0896-6273(00)80992-7; Carlson GC, 2000, J NEUROSCI, V20, P2011; CARR CE, 1993, ANNU REV NEUROSCI, V16, P223, DOI 10.1146/annurev.ne.16.030193.001255; Desmaisons D, 1999, J NEUROSCI, V19, P10727, DOI 10.1523/JNEUROSCI.19-24-10727.1999; Didier A, 2001, P NATL ACAD SCI USA, V98, P6441, DOI 10.1073/pnas.101126398; DildyMayfield JE, 1996, J PHARMACOL EXP THER, V276, P1058; FREEMAN WJ, 1972, J NEUROPHYSIOL, V35, P762, DOI 10.1152/jn.1972.35.6.762; Friedman D, 2000, J NEUROPHYSIOL, V84, P39, DOI 10.1152/jn.2000.84.1.39; Friedrich RW, 2001, CURR OPIN NEUROBIOL, V11, P468, DOI 10.1016/S0959-4388(00)00236-1; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Isaacson JS, 1999, NEURON, V23, P377, DOI 10.1016/S0896-6273(00)80787-4; Isaacson JS, 1998, NEURON, V20, P749, DOI 10.1016/S0896-6273(00)81013-2; Kashiwadani H, 1999, J NEUROPHYSIOL, V82, P1786, DOI 10.1152/jn.1999.82.4.1786; Kay LM, 1999, NAT NEUROSCI, V2, P1003, DOI 10.1038/14801; Kirson ED, 1998, BRIT J PHARMACOL, V124, P1607, DOI 10.1038/sj.bjp.0701996; Laurent G, 2001, ANNU REV NEUROSCI, V24, P263, DOI 10.1146/annurev.neuro.24.1.263; Lei H, 2002, NAT NEUROSCI, V5, P557, DOI 10.1038/nn859; MacLeod K, 1998, NATURE, V395, P693, DOI 10.1038/27201; MEISTER M, 1995, SCIENCE, V270, P1207, DOI 10.1126/science.270.5239.1207; Miragall F, 1996, NEUROSCI LETT, V216, P199, DOI 10.1016/0304-3940(96)13042-1; Montague AA, 1999, J COMP NEUROL, V405, P233, DOI 10.1002/(SICI)1096-9861(19990308)405:2<233::AID-CNE7>3.0.CO;2-A; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; NICOLL RA, 1982, NATURE, V296, P441, DOI 10.1038/296441a0; PATERNOSTRO MA, 1995, DEV BRAIN RES, V84, P1; RALL W, 1968, J NEUROPHYSIOL, V31, P884, DOI 10.1152/jn.1968.31.6.884; Salin PA, 2001, J NEUROPHYSIOL, V85, P1275, DOI 10.1152/jn.2001.85.3.1275; Schmitz D, 2001, NEURON, V31, P831, DOI 10.1016/S0896-6273(01)00410-X; Schoppa NE, 2001, NEURON, V31, P639, DOI 10.1016/S0896-6273(01)00389-0; Schoppa NE, 1998, J NEUROSCI, V18, P6790; Schoppa NE, 1999, NAT NEUROSCI, V2, P1106, DOI 10.1038/16033; Shadlen M.N., 1999, NEURON, V24.1, P111, DOI DOI 10.1016/S0896-627380822-3; Shadlen MN, 1999, NEURON, V24, P67, DOI 10.1016/S0896-6273(00)80822-3; Shen GYY, 1999, J NEUROPHYSIOL, V82, P3006, DOI 10.1152/jn.1999.82.6.3006; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Srinivas M, 1999, J NEUROSCI, V19, P9848; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Teubner B, 2000, J MEMBRANE BIOL, V176, P249, DOI 10.1007/s002320001094; Urban NN, 2002, J PHYSIOL-LONDON, V542, P355, DOI 10.1113/jphysiol.2001.013491; Usrey WM, 2000, J NEUROSCI, V20, P5461, DOI 10.1523/JNEUROSCI.20-14-05461.2000; Veenstra RD, 1996, J BIOENERG BIOMEMBR, V28, P327, DOI 10.1007/BF02110109; Velazquez JLP, 2000, TRENDS NEUROSCI, V23, P68; Venance L, 2000, P NATL ACAD SCI USA, V97, P10260, DOI 10.1073/pnas.160037097; Williams SR, 2002, SCIENCE, V295, P1907, DOI 10.1126/science.1067903; Zhang CB, 2002, BRAIN RES, V929, P37, DOI 10.1016/S0006-8993(01)03372-8; Zou ZH, 2001, NATURE, V414, P173, DOI 10.1038/35102506	51	121	123	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1194	1202		10.1038/nn953	http://dx.doi.org/10.1038/nn953			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	609CG	12379859				2022-12-24	WOS:000178884600023
J	Sweeney, ST; Davis, GW				Sweeney, ST; Davis, GW			Unrestricted synaptic growth in spinster - A late endosomal protein implicated in TGF-beta-mediated synaptic growth regulation	NEURON			English	Article							PROGRAMMED CELL-DEATH; NEUROMUSCULAR-JUNCTIONS; ENDOCYTIC PATHWAYS; II RECEPTOR; DROSOPHILA; MUTATIONS; MEMBRANE; SYSTEM; DPP; IDENTIFICATION	In a genetic screen for genes that control synapse development, we have identified spinster (spin), which encodes a multipass transmembrane protein. spin mutant synapses reveal a 200% increase in bouton number and a deficit in presynaptic release. We demonstrate that spin is expressed in both nerve and muscle and is required both pre- and postsynaptically for normal synaptic growth. We have localized Spin to a late endosomal compartment and present evidence for altered enclosomal/lysosomal function in spin. We also present evidence that synaptic overgrowth in spin is caused by enhanced/misregulated TGF-beta signaling. TGF-beta receptor mutants show dose-dependent suppression of synaptic overgrowth in spin. Furthermore, mutations in Dad, an inhibitory Smad, cause synapse overgrowth. We present a model for synaptic growth control with implications for the etiology of lysosomal storage and neurodegenerative disease.	Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Davis, GW (corresponding author), Univ Calif San Francisco, Dept Biochem, 513 Parnassus Ave,HSE 901, San Francisco, CA 94143 USA.	gdavis@biochem.ucsf.edu		Sweeney, Sean/0000-0003-2673-9578	PHS HHS [44908-32374] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; BALICEGORDON RJ, 1990, J NEUROSCI, V10, P2660; Barbosa MDFS, 1996, NATURE, V382, P262, DOI 10.1038/382262a0; Blott EJ, 2002, NAT REV MOL CELL BIO, V3, P122, DOI 10.1038/nrm732; BROADWELL RD, 1984, J COMP NEUROL, V230, P231, DOI 10.1002/cne.902300208; BRUMMEL TJ, 1994, CELL, V78, P251, DOI 10.1016/0092-8674(94)90295-X; Cataldo AM, 1996, J NEUROSCI, V16, P186; Cohen-Cory S, 1999, J NEUROSCI, V19, P9996; Davis GW, 1998, CURR OPIN NEUROBIOL, V8, P149, DOI 10.1016/S0959-4388(98)80018-4; Davis GW, 1998, NATURE, V392, P82, DOI 10.1038/32176; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Dubois L, 2001, CELL, V105, P613, DOI 10.1016/S0092-8674(01)00375-0; Eaton BA, 2002, NEURON, V34, P729, DOI 10.1016/S0896-6273(02)00721-3; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; GATINSKY KP, 1990, J NEUROCYTOL, V19, P989; HOLLENBECK PJ, 1987, J CELL BIOL, V105, P2827, DOI 10.1083/jcb.105.6.2827; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Inoue H, 1998, MOL BIOL CELL, V9, P2145, DOI 10.1091/mbc.9.8.2145; Isosomppi J, 2002, HUM MOL GENET, V11, P885, DOI 10.1093/hmg/11.8.885; Kaisto T, 1999, EXP CELL RES, V253, P551, DOI 10.1006/excr.1999.4659; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Komada M, 1999, GENE DEV, V13, P1475, DOI 10.1101/gad.13.11.1475; Kramer H, 1996, J CELL BIOL, V133, P1205, DOI 10.1083/jcb.133.6.1205; Liscum L, 2000, TRAFFIC, V1, P218, DOI 10.1034/j.1600-0854.2000.010304.x; Lloyd TE, 2002, CELL, V108, P261, DOI 10.1016/S0092-8674(02)00611-6; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; McPherson PS, 2001, TRAFFIC, V2, P375, DOI 10.1034/j.1600-0854.2001.002006375.x; Mitchison HM, 2001, CURR OPIN NEUROL, V14, P795, DOI 10.1097/00019052-200112000-00019; Nakano Y, 2001, MOL CELL BIOL, V21, P3775, DOI 10.1128/MCB.21.11.3775-3788.2001; Narayanan R, 2000, J NEUROBIOL, V45, P105, DOI 10.1002/1097-4695(20001105)45:2<105::AID-NEU5>3.0.CO;2-X; NELLEN D, 1994, CELL, V78, P225, DOI 10.1016/0092-8674(94)90293-3; NIXON RA, 1995, TRENDS NEUROSCI, V18, P489, DOI 10.1016/0166-2236(95)92772-I; Overly CC, 1996, J NEUROSCI, V16, P6056; PARTON RG, 1992, J CELL BIOL, V119, P123, DOI 10.1083/jcb.119.1.123; Pennetta G, 2002, NEURON, V35, P291, DOI 10.1016/S0896-6273(02)00769-9; PENTON A, 1994, CELL, V78, P239, DOI 10.1016/0092-8674(94)90294-1; Preston CR, 1996, GENETICS, V144, P1623; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Sanyal S, 2002, NATURE, V416, P870, DOI 10.1038/416870a; SAXTON WM, 1991, CELL, V64, P1093, DOI 10.1016/0092-8674(91)90264-Y; SchultzEhrenburg U, 1996, PHLEBOLOGY, V11, P17; Stewart BA, 2002, J NEUROBIOL, V51, P261, DOI 10.1002/neu.10059; Stewart BA, 1996, J NEUROSCI, V16, P3877; Tanaka H, 2000, NEURON, V25, P93, DOI 10.1016/S0896-6273(00)80874-0; Tsuneizumi K, 1997, NATURE, V389, P627, DOI 10.1038/39362; Usui-Aoki K, 2002, ARCH INSECT BIOCHEM, V49, P94, DOI 10.1002/arch.10011; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Young RM, 2002, DEV DYNAM, V223, P298, DOI 10.1002/dvdy.10060	50	199	206	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 24	2002	36	3					403	416		10.1016/S0896-6273(02)01014-0	http://dx.doi.org/10.1016/S0896-6273(02)01014-0			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	608ZE	12408844	Bronze			2022-12-24	WOS:000178877700010
J	Katsuno, M; Adachi, H; Kume, A; Li, M; Nakagomi, Y; Niwa, H; Sang, C; Kobayashi, Y; Doyu, M; Sobue, G				Katsuno, M; Adachi, H; Kume, A; Li, M; Nakagomi, Y; Niwa, H; Sang, C; Kobayashi, Y; Doyu, M; Sobue, G			Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy	NEURON			English	Article							ANDROGEN RECEPTOR-GENE; RECESSIVE BULBOSPINAL NEURONOPATHY; CAG-REPEAT EXPANSION; CREB-BINDING PROTEIN; HUNTINGTONS-DISEASE; TRINUCLEOTIDE REPEAT; POLYGLUTAMINE TRACT; EXPANDED POLYGLUTAMINE; AGGREGATE FORMATION; TRANSCRIPTIONAL ACTIVATION	Spinal and bulbar muscular atrophy (SBMA) is a polyglutamine disease caused by the expansion of a CAG repeat in the androgen receptor (AR) gene. We generated a transgenic mouse model carrying a full-length AR containing 97 CAGs. Three of the five lines showed progressive muscular atrophy and weakness as well as diffuse nuclear staining and nuclear inclusions consisting of the mutant AR. These phenotypes were markedly pronounced in male transgenic mice, and dramatically rescued by castration. Female transgenic mice showed only a few manifestations that markedly deteriorated with testosterone administration. Nuclear translocation of the mutant AR by testosterone contributed to the phenotypic difference with gender and the effects of hormonal interventions. These results suggest the therapeutic potential of hormonal intervention for SBMA.	Nagoya Univ, Grad Sch Med, Dept Neurol, Showa Ku, Nagoya, Aichi 4668550, Japan; Aichi Med Univ, Electron Microscopy Lab, Nagakute, Aichi 4801195, Japan	Nagoya University; Aichi Medical University	Sobue, G (corresponding author), Nagoya Univ, Grad Sch Med, Dept Neurol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	sobueg@med.nagoya-u.ac.jp	Adachi, Hiroaki/AAM-7812-2020; KATSUNO, MASAHISA/I-7502-2014	Adachi, Hiroaki/0000-0002-9302-4663; KATSUNO, MASAHISA/0000-0001-9453-9311				Abel A, 2001, HUM MOL GENET, V10, P107, DOI 10.1093/hmg/10.2.107; Adachi H, 2001, HUM MOL GENET, V10, P1039, DOI 10.1093/hmg/10.10.1039; Andreassen OA, 2001, NEUROBIOL DIS, V8, P479, DOI 10.1006/nbdi.2001.0406; BINGHAM PM, 1995, NAT GENET, V9, P191, DOI 10.1038/ng0295-191; CHAMBERLAIN NL, 1994, NUCLEIC ACIDS RES, V22, P3181, DOI 10.1093/nar/22.15.3181; Cummings CJ, 1999, NEURON, V24, P879, DOI 10.1016/S0896-6273(00)81035-1; Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; DANEK A, 1994, CLIN INVESTIGATOR, V72, P892; DOYU M, 1992, ANN NEUROL, V32, P707, DOI 10.1002/ana.410320517; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; Goldenberg JN, 1996, J NEUROL SCI, V135, P158, DOI 10.1016/0022-510X(95)00285-A; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Heiser V, 2000, P NATL ACAD SCI USA, V97, P6739, DOI 10.1073/pnas.110138997; IGARASHI S, 1992, NEUROLOGY, V42, P2300, DOI 10.1212/WNL.42.12.2300; Igarashi S, 1998, NAT GENET, V18, P111, DOI 10.1038/ng0298-111; Karpuj MV, 2002, NAT MED, V8, P143, DOI 10.1038/nm0202-143; KAZEMIESFARJANI P, 1995, HUM MOL GENET, V4, P523, DOI 10.1093/hmg/4.4.523; KEMPPAINEN JA, 1992, J BIOL CHEM, V267, P968; KENNEDY WR, 1968, NEUROLOGY, V18, P671, DOI 10.1212/WNL.18.7.671; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Kobayashi Y, 2000, J BIOL CHEM, V275, P8772, DOI 10.1074/jbc.275.12.8772; Kobayashi Y, 1998, BIOCHEM BIOPH RES CO, V252, P145, DOI 10.1006/bbrc.1998.9624; La Spada AR, 1998, HUM MOL GENET, V7, P959, DOI 10.1093/hmg/7.6.959; LASPADA AR, 1992, NAT GENET, V2, P301, DOI 10.1038/ng1292-301; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Li I, 1998, AM J PATHOL, V153, P695, DOI 10.1016/S0002-9440(10)65612-X; Li M, 1998, ANN NEUROL, V44, P249, DOI 10.1002/ana.410440216; MACLEAN HE, 1995, MOL CELL ENDOCRINOL, V112, P133, DOI 10.1016/0303-7207(95)03608-A; Mariotti C, 2000, NEUROMUSCULAR DISORD, V10, P391, DOI 10.1016/S0960-8966(99)00132-7; McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197; MCPHAUL MJ, 1993, J CLIN ENDOCR METAB, V76, P17, DOI 10.1210/jc.76.1.17; Mende-Mueller LM, 2001, J NEUROSCI, V21, P1830, DOI 10.1523/JNEUROSCI.21-06-01830.2001; Merry D. E., 1996, American Journal of Human Genetics, V59, pA271; MHATRE AN, 1993, NAT GENET, V5, P184, DOI 10.1038/ng1093-184; Morrison JR, 2000, AM J HUM GENET, V67, P51; Nakajima H, 1996, J NEUROL SCI, V142, P12, DOI 10.1016/0022-510X(96)00142-6; NeuschmidKaspar F, 1996, MOL CELL ENDOCRINOL, V117, P149, DOI 10.1016/0303-7207(95)03741-1; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Ona VO, 1999, NATURE, V399, P263, DOI 10.1038/20446; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Paulson HL, 2000, BRAIN PATHOL, V10, P293, DOI 10.1111/j.1750-3639.2000.tb00263.x; Peters MF, 1999, MOL CELL NEUROSCI, V14, P121, DOI 10.1006/mcne.1999.0773; Rubinsztein DC, 2002, TRENDS GENET, V18, P202, DOI 10.1016/S0168-9525(01)02625-7; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Simeoni S, 2000, HUM MOL GENET, V9, P133, DOI 10.1093/hmg/9.1.133; SOBUE G, 1993, J NEUROL SCI, V117, P74, DOI 10.1016/0022-510X(93)90157-T; SOBUE G, 1989, BRAIN, V112, P209, DOI 10.1093/brain/112.1.209; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Stenoien DL, 1999, HUM MOL GENET, V8, P731, DOI 10.1093/hmg/8.5.731; SYMS AJ, 1985, J BIOL CHEM, V260, P455; Tanaka F, 1999, AM J HUM GENET, V65, P966, DOI 10.1086/302578; Terao S, 1996, ACTA NEUROPATHOL, V92, P109, DOI 10.1007/s004010050497; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Wellington CL, 1998, J BIOL CHEM, V273, P9158, DOI 10.1074/jbc.273.15.9158; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; ZHOU ZX, 1994, RECENT PROG HORM RES, V49, P249; ZHOU ZX, 1995, MOL ENDOCRINOL, V9, P208, DOI 10.1210/me.9.2.208; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	62	349	365	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 29	2002	35	5					843	854		10.1016/S0896-6273(02)00834-6	http://dx.doi.org/10.1016/S0896-6273(02)00834-6			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	589UY	12372280	Bronze			2022-12-24	WOS:000177779800008
J	Field, GD; Rieke, F				Field, GD; Rieke, F			Mechanisms regulating variability of the single photon responses of mammalian rod photoreceptors	NEURON			English	Article							OUTER SEGMENTS; RETINAL RODS; PHOSPHORYLATION SITES; GUANYLATE-CYCLASE; RHODOPSIN KINASE; DARK NOISE; ARRESTIN; PROTEIN; CALCIUM; MEMBRANE	Variability in the single photon responses of rod photoreceptors limits the accuracy with which the number and timing of photon absorptions are encoded. We investigated how much single photon responses of mammalian rods fluctuate and what mechanisms control these fluctuations. Mammalian rods, like those of toads, generated responses to single photons with trial-to-trial fluctuations 3-4 times smaller than other familiar signals produced by single molecules. We used the properties of the measured fluctuations to constrain models for how the single photon responses are regulated. Neither feedback control of rhodopsin's activity nor saturation within the transduction cascade were consistent with experiment. The measured responses, however, could be explained by multistep shutoff of rhodopsin or a combination of multistep shutoff and saturation.	Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Rieke, F (corresponding author), Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA.		Field, Greg/AAI-1428-2021	Field, Greg/0000-0001-5942-2679	NATIONAL EYE INSTITUTE [R01EY011850] Funding Source: NIH RePORTER; NEI NIH HHS [EY-11850] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P589; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; BAYLOR DA, 1980, J PHYSIOL-LONDON, V309, P591, DOI 10.1113/jphysiol.1980.sp013529; BENNETT N, 1988, BIOCHEMISTRY-US, V27, P1710, DOI 10.1021/bi00405a049; BERG HC, 1977, BIOPHYS J, V20, P193, DOI 10.1016/S0006-3495(77)85544-6; BIALEK W, 1987, ANNU REV BIOPHYS BIO, V16, P455; BOHM SK, 1997, BIOCHEM J, V15, P1; BURNS ME, 2002, IN PRESS NEURON; Calvert PD, 2001, NATURE, V411, P90, DOI 10.1038/35075083; CERVETTO L, 1989, NATURE, V337, P740, DOI 10.1038/337740a0; CHEN J, 1995, SCIENCE, V267, P374, DOI 10.1126/science.7824934; Detwiler PB, 2000, BIOPHYS J, V79, P2801, DOI 10.1016/S0006-3495(00)76519-2; DEVRIES H, 1961, PRINCIPLES SENSORY C, P159; Dohlman HG, 2002, ANNU REV PHYSIOL, V64, P129, DOI 10.1146/annurev.physiol.64.081701.133448; Felber S, 1996, BIOPHYS J, V71, P3051, DOI 10.1016/S0006-3495(96)79499-7; Field GD, 2002, NEURON, V34, P773, DOI 10.1016/S0896-6273(02)00700-6; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Gibson SK, 2000, BIOCHEMISTRY-US, V39, P5738, DOI 10.1021/bi991857f; Hecht S, 1942, J GEN PHYSIOL, V25, P819, DOI 10.1085/jgp.25.6.819; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Leskov IB, 2000, NEURON, V27, P525, DOI 10.1016/S0896-6273(00)00063-5; MATTHEWS HR, 1991, J PHYSIOL-LONDON, V436, P93, DOI 10.1113/jphysiol.1991.sp018541; Mendez A, 2000, NEURON, V28, P153, DOI 10.1016/S0896-6273(00)00093-3; Mendez A, 2001, P NATL ACAD SCI USA, V98, P9948, DOI 10.1073/pnas.171308998; MENINI A, 1995, NATURE, V373, P435, DOI 10.1038/373435a0; NAKATANI K, 1988, J PHYSIOL-LONDON, V395, P695, DOI 10.1113/jphysiol.1988.sp016942; Nikonov S, 1998, J GEN PHYSIOL, V111, P7, DOI 10.1085/jgp.111.1.7; PALCZEWSKI K, 1992, NEURON, V8, P117, DOI 10.1016/0896-6273(92)90113-R; Rieke F, 1996, BIOPHYS J, V71, P2553, DOI 10.1016/S0006-3495(96)79448-1; Rieke F, 1998, REV MOD PHYS, V70, P1027, DOI 10.1103/RevModPhys.70.1027; Rieke F, 1998, BIOPHYS J, V75, P1836, DOI 10.1016/S0006-3495(98)77625-8; SAKITT B, 1972, J PHYSIOL-LONDON, V223, P131, DOI 10.1113/jphysiol.1972.sp009838; Whitlock GG, 1999, NEURON, V23, P337, DOI 10.1016/S0896-6273(00)80784-9; WILDEN U, 1982, BIOCHEMISTRY-US, V21, P3014, DOI 10.1021/bi00541a032; Xu J, 1997, NATURE, V389, P505, DOI 10.1038/39068	39	96	98	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 15	2002	35	4					733	747		10.1016/S0896-6273(02)00822-X	http://dx.doi.org/10.1016/S0896-6273(02)00822-X			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	585JE	12194872	Bronze			2022-12-24	WOS:000177521000013
J	Henze, DA; Wittner, L; Buzsaki, G				Henze, DA; Wittner, L; Buzsaki, G			Single granule cells reliably discharge targets in the hippocampal CA3 network in vivo	NATURE NEUROSCIENCE			English	Article							MOSSY FIBER SYNAPSE; DENTATE GYRUS; SPIKE TRANSMISSION; UNIT-ACTIVITY; RAT; PLASTICITY; NEURONS; MEMORY; INTERNEURONS; INFORMATION	Processing of neuronal information depends on interactions between the anatomical connectivity and cellular properties of single cells. We examined how these computational building blocks work together in the intact rat hippocampus. Single spikes in dentate granule cells, controlled intracellularly, generally failed to discharge either interneurons or CA3 pyramidal cells. In contrast, trains of spikes effectively discharged both CA3 cell types. Increasing the discharge rate of the granule cell increased the discharge probability of its target neuron and decreased the delay between the onset of a granule cell train and evoked firing in postsynaptic targets. Thus, we conclude that the granule cell to CA3 synapses are 'conditional detonators,' dependent on granule cell firing pattern. In addition, we suggest that information in single granule cells is converted into a temporal delay code in target CA3 pyramidal cells and interneurons. These data demonstrate how a neural circuit of the CNS may process information.	Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick	Buzsaki, G (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, 197 Univ Ave, Newark, NJ 07102 USA.	buzsaki@axon.rutgers.edu	Wittner, Lucia/C-9386-2013	Wittner, Lucia/0000-0001-6800-0953; Buzsaki, Gyorgy/0000-0002-3100-4800	NCRR NIH HHS [5P41RR009754] Funding Source: Medline; NIMH NIH HHS [MH54671, MH12403] Funding Source: Medline; NINDS NIH HHS [NS34994, NS43157] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR009754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043157, R01NS034994] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Acsady L, 1998, J NEUROSCI, V18, P3386; Alle H, 2001, P NATL ACAD SCI USA, V98, P14708, DOI 10.1073/pnas.251610898; AMARAL DG, 1990, PROG BRAIN RES, V83, P1; AMARAL DG, 1981, J COMP NEUROL, V195, P51, DOI 10.1002/cne.901950106; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BOSS BD, 1985, BRAIN RES, V338, P144, DOI 10.1016/0006-8993(85)90257-4; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; CHATTARJI S, 1989, BRAIN RES, V495, P145, DOI 10.1016/0006-8993(89)91228-6; COLLIER TJ, 1982, BEHAV NEURAL BIOL, V34, P227, DOI 10.1016/S0163-1047(82)91623-5; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; Doherty J, 2001, J NEUROSCI, V21, P2048, DOI 10.1523/JNEUROSCI.21-06-02048.2001; FROTSCHER M, 1994, SYNAPSE, V16, P148, DOI 10.1002/syn.890160208; Galarreta M, 2001, SCIENCE, V292, P2295, DOI 10.1126/science.1061395; Hara K, 2002, ANESTH ANALG, V94, P313, DOI 10.1097/00000539-200202000-00015; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; HARRIS KD, IN PRESS NATURE; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; Henze DA, 2000, NEUROSCIENCE, V98, P407, DOI 10.1016/S0306-4522(00)00146-9; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; Lorincz A, 2000, ANN NY ACAD SCI, V911, P83; LOTHMAN EW, 1992, DENTATE GYRUS ITS RO, P301; Maccaferri G, 1998, SCIENCE, V279, P1368, DOI 10.1126/science.279.5355.1368; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Marshall L, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-02-j0001.2002; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; MODY I, 1987, J NEUROPHYSIOL, V57, P869, DOI 10.1152/jn.1987.57.3.869; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Paulsen O, 2000, CURR OPIN NEUROBIOL, V10, P172, DOI 10.1016/S0959-4388(00)00076-3; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; ROLLS E, 1989, COMP NEUR S, P125; Rolls E.T., 1989, NEURAL MODELS PLASTI, P240; Salin PA, 1996, P NATL ACAD SCI USA, V93, P13304, DOI 10.1073/pnas.93.23.13304; SCHARFMAN HE, 1990, NEUROSCIENCE, V37, P693, DOI 10.1016/0306-4522(90)90100-I; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; SLOVITER RS, 1994, ANN NEUROL, V35, P640, DOI 10.1002/ana.410350604; TANK DW, 1987, P NATL ACAD SCI USA, V84, P1896, DOI 10.1073/pnas.84.7.1896; Toth K, 2000, J NEUROSCI, V20, P8279, DOI 10.1523/JNEUROSCI.20-22-08279.2000; Urban NN, 2001, HIPPOCAMPUS, V11, P408, DOI 10.1002/hipo.1055.abs; VANDERWOLF CH, 1988, INT REV NEUROBIOL, V30, P225; YLINEN A, 1995, J NEUROSCI, V15, P30	43	322	327	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2002	5	8					790	795		10.1038/nn887	http://dx.doi.org/10.1038/nn887			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	577XT	12118256				2022-12-24	WOS:000177088900023
J	Hindges, R; McLaughlin, T; Genoud, N; Henkemeyer, M; O'Leary, DDM				Hindges, R; McLaughlin, T; Genoud, N; Henkemeyer, M; O'Leary, DDM			EphB forward signaling controls directional branch extension and arborization required for dorsal-ventral retinotopic mapping	NEURON			English	Article							RECEPTOR TYROSINE KINASES; RETINAL AXON GUIDANCE; VISUAL-SYSTEM; TRANSMEMBRANE LIGANDS; RETINOCOLLICULAR PROJECTION; RETINOTECTAL PROJECTION; ADHESIVE SPECIFICITY; SUPERIOR COLLICULUS; COMMISSURAL AXONS; TOPOGRAPHIC ORDER	We report that EphB receptors direct unique axonal behaviors required for mapping the dorsal-ventral (D-V) retinal axis along the lateral-medial (L-M) axis of the superior colliculus (SC). EphBs are expressed in a D-V gradient, ephrin-B1 in a L-M gradient in SC, and ephrin-B3 at its midline. EphBs and ephrin-Bs are expressed in countergradients in retina and SC. Developmental analyses reveal that retinal axons lack D-V ordering along the L-M axis, but directionally extend branches along it to establish ordered arbors. Directed branch extension is disrupted in EphB2; EphB3-deficient mice resulting in lateral ectopic arbors. Mice with kinase-inactive EphB2 have similar D-V mapping defects indicating that forward signaling dominates over reverse signaling. Our data suggest that branches of EphB expressing axons are attracted medially by ephrin-B1, and provide molecular mechanisms for D-V mapping in visual centers.	Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Kent Waldrep Fdn Ctr Basic Res Nerve Growth & Reg, Dallas, TX 75390 USA	Salk Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	O'Leary, DDM (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	doleary@salk.edu	Hindges, Robert/C-5344-2009	Hindges, Robert/0000-0003-0095-7913; Henkemeyer, Mark/0000-0002-7525-1061	NATIONAL EYE INSTITUTE [R01EY007025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066332] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY 07025] Funding Source: Medline; NIMH NIH HHS [R01 MH066332, R01 MH 66332] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Birgbauer E, 2000, DEVELOPMENT, V127, P1231; BONHOEFFER F, 1982, EMBO J, V1, P427, DOI 10.1002/j.1460-2075.1982.tb01186.x; BONHOEFFER F, 1985, NATURE, V315, P408, DOI 10.1038/315409a0; Braisted JE, 1997, DEV BIOL, V191, P14, DOI 10.1006/dbio.1997.8706; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Bruckner K, 1997, SCIENCE, V275, P1640, DOI 10.1126/science.275.5306.1640; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; Connor RJ, 1998, DEV BIOL, V193, P21, DOI 10.1006/dbio.1997.8786; Cowan CA, 2000, NEURON, V26, P417, DOI 10.1016/S0896-6273(00)81174-5; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Erkman L, 2000, NEURON, V28, P779, DOI 10.1016/S0896-6273(00)00153-7; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7; GIERER A, 1987, DEVELOPMENT, V101, P479; GOTTLIEB DI, 1976, P NATL ACAD SCI USA, V73, P410, DOI 10.1073/pnas.73.2.410; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Holash JA, 1995, DEV BIOL, V172, P683, DOI 10.1006/dbio.1995.8039; Holash JA, 1997, DEV BIOL, V182, P256, DOI 10.1006/dbio.1996.8496; Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0; Hollander E, 1997, CNS SPECTRUMS, V2, P16, DOI DOI 10.1017/S1092852900011068; HOMBERGER MR, 1999, NEURON, V22, P731; Huynh-Do U, 1999, EMBO J, V18, P2165, DOI 10.1093/emboj/18.8.2165; Koshiba-Takeuchi K, 2000, SCIENCE, V287, P134, DOI 10.1126/science.287.5450.134; Kullander K, 2001, GENE DEV, V15, P877, DOI 10.1101/gad.868901; Kullander K, 2001, NEURON, V29, P73, DOI 10.1016/S0896-6273(01)00181-7; MARCHASE RB, 1977, J CELL BIOL, V75, P237, DOI 10.1083/jcb.75.1.237; Marcus RC, 1996, DEV BIOL, V180, P786, DOI 10.1006/dbio.1996.0347; MARCUS RC, 1995, J NEUROSCI, V15, P6389; Monschau B, 1997, EMBO J, V16, P1258, DOI 10.1093/emboj/16.6.1258; Mui SH, 2002, DEVELOPMENT, V129, P797; Nakamoto M, 1996, CELL, V86, P755, DOI 10.1016/S0092-8674(00)80150-6; NAKAMURA H, 1989, J NEUROSCI, V9, P3776; O'Leary DDM, 1999, CELL, V96, P255, DOI 10.1016/S0092-8674(00)80565-6; OLEARY DDM, 1986, J NEUROSCI, V6, P3692; Orioli D, 1996, EMBO J, V15, P6035, DOI 10.1002/j.1460-2075.1996.tb00992.x; ROSKIES AL, 1994, SCIENCE, V265, P799, DOI 10.1126/science.8047886; Sakuta H, 2001, SCIENCE, V293, P111, DOI 10.1126/science.1058379; Schulte D, 1999, NEURON, V24, P541, DOI 10.1016/S0896-6273(00)81111-3; SIMON DK, 1992, DEV BRAIN RES, V69, P167, DOI 10.1016/0165-3806(92)90155-P; SIMON DK, 1992, J NEUROSCI, V12, P1212; SIMON DK, 1992, NEURON, V9, P977, DOI 10.1016/0896-6273(92)90249-D; Song HJ, 1999, CURR OPIN NEUROBIOL, V9, P355, DOI 10.1016/S0959-4388(99)80052-X; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; WALTER J, 1987, DEVELOPMENT, V101, P685; Wang HU, 1997, NEURON, V18, P383, DOI 10.1016/S0896-6273(00)81240-4; Yates PA, 2001, J NEUROSCI, V21, P8548, DOI 10.1523/JNEUROSCI.21-21-08548.2001; Yokoyama N, 2001, NEURON, V29, P85, DOI 10.1016/S0896-6273(01)00182-9	49	244	245	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 1	2002	35	3					475	487		10.1016/S0896-6273(02)00799-7	http://dx.doi.org/10.1016/S0896-6273(02)00799-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	582CB	12165470	Bronze			2022-12-24	WOS:000177331200009
J	Shen, Y; Hansel, C; Linden, DJ				Shen, Y; Hansel, C; Linden, DJ			Glutamate release during LTD at cerebellar climbing fiber-Purkinje cell synapses	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; PLASTICITY; EXPRESSION; KINETICS		Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Erasmus Univ, Dept Neurosci, NL-3000 DR Rotterdam, Netherlands	Johns Hopkins University; Erasmus University Rotterdam	Linden, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH051106, R37MH051106, R01MH051106] Funding Source: NIH RePORTER; NIMH NIH HHS [MH51106, MH01590] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bear MF, 2001, SYNAPSES, P455; Dittman JS, 1998, J NEUROSCI, V18, P6147; Hansel C, 2000, NEURON, V26, P473, DOI 10.1016/S0896-6273(00)81179-4; Hansel C, 2001, NAT NEUROSCI, V4, P467, DOI 10.1038/87419; Hashimoto K, 1998, J PHYSIOL-LONDON, V506, P391, DOI 10.1111/j.1469-7793.1998.391bw.x; Linden DJ, 2001, P NATL ACAD SCI USA, V98, P14066, DOI 10.1073/pnas.241384598; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; Malenka RC, 2001, SYNAPSES, P393; Matsuda S, 2000, EMBO J, V19, P2765, DOI 10.1093/emboj/19.12.2765; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; Strata P, 1998, TRENDS NEUROSCI, V21, P407, DOI 10.1016/S0166-2236(98)01305-8; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8	14	31	31	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2002	5	8					725	726		10.1038/nn895	http://dx.doi.org/10.1038/nn895			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	577XT	12134155				2022-12-24	WOS:000177088900012
J	Hinkle, DA; Connor, CE				Hinkle, DA; Connor, CE			Three-dimensional orientation tuning in macaque area V4	NATURE NEUROSCIENCE			English	Article							INFERIOR TEMPORAL CORTEX; 3-DIMENSIONAL SHAPES; BINOCULAR DISPARITY; OBJECT RECOGNITION; VISUAL PROPERTIES; SLANT PERCEPTION; NEURONS; MONKEY; SENSITIVITY; DEPTH	Tuning for the orientation of elongated, linear image elements (edges, bars, gratings), first discovered by Hubel and Wiesel, is considered a key feature of visual processing in the brain. It has been studied extensively in two dimensions (2D) using frontoparallel stimuli, but in real life most lines, edges and contours are slanted with respect to the viewer. Here we report that neurons in macaque area V4, an intermediate stage in the ventral (object-related) pathway of visual cortex, were tuned for 3D orientation-that is, for specific slants as well as for 2D orientation. The tuning for 3D orientation was consistent across depth position (binocular disparity) and position within the 2D classical receptive field. The existence of 3D orientation signals in the ventral pathway suggests that the brain may use such information to interpret 3D shape.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21218 USA; Johns Hopkins Univ, Zanvyl Krieger Mind Brain Inst, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University	Connor, CE (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 338 Krieger Hall,3400 N Charles St, Baltimore, MD 21218 USA.							Anzai A, 1999, J NEUROPHYSIOL, V82, P909, DOI 10.1152/jn.1999.82.2.909; BARLOW HB, 1967, J PHYSIOL-LONDON, V193, P327, DOI 10.1113/jphysiol.1967.sp008360; BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; BLAKEMORE C, 1972, J PHYSIOL-LONDON, V226, P725, DOI 10.1113/jphysiol.1972.sp010006; Bradley DC, 1998, NATURE, V392, P714, DOI 10.1038/33688; Bradley DC, 1998, J NEUROSCI, V18, P7552; Bridge H, 2001, J NEUROSCI, V21, P7293, DOI 10.1523/JNEUROSCI.21-18-07293.2001; CAGENELLO R, 1993, VISION RES, V33, P2189, DOI 10.1016/0042-6989(93)90099-I; DeAngelis GC, 1998, NATURE, V394, P677, DOI 10.1038/29299; DESIMONE R, 1987, J NEUROPHYSIOL, V57, P835, DOI 10.1152/jn.1987.57.3.835; DICKINSON SJ, 1992, CVGIP-IMAG UNDERSTAN, V55, P130, DOI 10.1016/1049-9660(92)90013-S; Dobbins AC, 1998, SCIENCE, V281, P552, DOI 10.1126/science.281.5376.552; Ernst MO, 2000, NAT NEUROSCI, V3, P69, DOI 10.1038/71140; GATTASS R, 1988, J NEUROSCI, V8, P1831; GILLAM B, 1992, PERCEPTION, V21, P427, DOI 10.1068/p210427; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; Hanazawa A, 2001, J NEUROSCI, V21, P4490, DOI 10.1523/JNEUROSCI.21-12-04490.2001; Hinkle DA, 2001, NEUROREPORT, V12, P365, DOI 10.1097/00001756-200102120-00036; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P229, DOI 10.1152/jn.1965.28.2.229; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; HUBEL DH, 1970, NATURE, V225, P41, DOI 10.1038/225041a0; Janssen P, 2000, NEURON, V27, P385, DOI 10.1016/S0896-6273(00)00045-3; Janssen P, 2000, SCIENCE, V288, P2054, DOI 10.1126/science.288.5473.2054; Janssen P, 2001, J NEUROSCI, V21, P9419, DOI 10.1523/JNEUROSCI.21-23-09419.2001; Janssen P, 1999, P NATL ACAD SCI USA, V96, P8217, DOI 10.1073/pnas.96.14.8217; MANLY BFJ, 1991, RANDOMIZATION MONTE, P114; MANTEL N, 1967, CANCER RES, V27, P209; MARDIA KV, 2000, DIRECTIONAL STAT, P248; MARR D, 1978, PROC R SOC SER B-BIO, V200, P269, DOI 10.1098/rspb.1978.0020; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1148, DOI 10.1152/jn.1983.49.5.1148; MITCHISON GJ, 1990, VISION RES, V30, P1781, DOI 10.1016/0042-6989(90)90159-I; NELSON JI, 1977, J NEUROPHYSIOL, V40, P260, DOI 10.1152/jn.1977.40.2.260; NINIO J, 1985, PERCEPTION, V14, P305, DOI 10.1068/p140305; Pasupathy A, 1999, J NEUROPHYSIOL, V82, P2490, DOI 10.1152/jn.1999.82.5.2490; Pasupathy A, 2001, J NEUROPHYSIOL, V86, P2505, DOI 10.1152/jn.2001.86.5.2505; POGGIO GF, 1977, J NEUROPHYSIOL, V40, P1392, DOI 10.1152/jn.1977.40.6.1392; POGGIO T, 1990, NATURE, V343, P263, DOI 10.1038/343263a0; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; ROY JP, 1992, J NEUROSCI, V12, P2478; Shikata E, 1996, NEUROREPORT, V7, P2389, DOI 10.1097/00001756-199610020-00022; Taira M, 2000, J NEUROPHYSIOL, V83, P3140, DOI 10.1152/jn.2000.83.5.3140; TARR MJ, 1989, COGNITIVE PSYCHOL, V21, P233, DOI 10.1016/0010-0285(89)90009-1; Uka T, 2000, J NEUROPHYSIOL, V84, P120, DOI 10.1152/jn.2000.84.1.120; Vetter T., 1995, CEREB CORTEX, V3, P261; VONDERHEYDT R, 1982, INVEST OPHTHALMOL  S, V22, P12; Watanabe M, 2002, J NEUROPHYSIOL, V87, P1960, DOI 10.1152/jn.00780.2000; WIENIAWANARKIEWICZ E, 1992, OPHTHAL PHYSL OPT, V12, P269, DOI 10.1111/j.1475-1313.1992.tb00304.x	49	97	100	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2002	5	7					665	670		10.1038/nn875	http://dx.doi.org/10.1038/nn875			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	566EP	12068303				2022-12-24	WOS:000176414300016
J	Ullman, S; Vidal-Naquet, M; Sali, E				Ullman, S; Vidal-Naquet, M; Sali, E			Visual features of intermediate complexity and their use in classification	NATURE NEUROSCIENCE			English	Article							OBJECT RECOGNITION; FACE RECOGNITION; NATURAL SCENES; CORTEX; SELECTIVITY; EIGENFACES; IMAGES; SHAPE	The human visual system analyzes shapes and objects in a series of stages in which stimulus features of increasing complexity are extracted and analyzed. The first stages use simple local features, and the image is subsequently represented in terms of larger and more complex features. These include features of intermediate complexity and partial object views. The nature and use of these higher-order representations remains an open question in the study of visual processing by the primate cortex. Here we show that intermediate complexity (IC) features are optimal for the basic visual task of classification. Moderately complex features are more informative for classification than very simple or very complex ones, and so they emerge naturally by the simple coding principle of information maximization with respect to a class of images. Our findings suggest a specific role for IC features in visual processing and a principle for their extraction.	Weizmann Inst Sci, Dept Appl Math & Comp Sci, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Ullman, S (corresponding author), Weizmann Inst Sci, Dept Appl Math & Comp Sci, POB 26, IL-76100 Rehovot, Israel.	shimon.ullman@weizmann.ac.il						ATICK JJ, 1992, NEURAL COMPUT, V4, P196, DOI 10.1162/neco.1992.4.2.196; Ballard DH, 1982, COMPUTER VISION; BARLOW H, 1989, COMP NEUR S, P54; Belhumeur PN, 1997, IEEE T PATTERN ANAL, V19, P711, DOI 10.1109/34.598228; Bell AJ, 1997, VISION RES, V37, P3327, DOI 10.1016/S0042-6989(97)00121-1; Bhat DN, 1998, IEEE T PATTERN ANAL, V20, P415, DOI 10.1109/34.677275; BRUNELLI R, 1993, IEEE T PATTERN ANAL, V15, P1042, DOI 10.1109/34.254061; DEVALOIS RL, 1982, VISION RES, V22, P545, DOI 10.1016/0042-6989(82)90113-4; FIELD DJ, 1994, NEURAL COMPUT, V6, P559, DOI 10.1162/neco.1994.6.4.559; Friedman N, 1997, MACH LEARN, V29, P131, DOI 10.1023/A:1007465528199; FUJITA I, 1992, NATURE, V360, P343, DOI 10.1038/360343a0; GALLANT JL, 1993, SCIENCE, V259, P100, DOI 10.1126/science.8418487; Grill-Spector K, 1998, HUM BRAIN MAPP, V6, P316, DOI 10.1002/(SICI)1097-0193(1998)6:4<316::AID-HBM9>3.0.CO;2-6; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; Mel BW, 1997, NEURAL COMPUT, V9, P777, DOI 10.1162/neco.1997.9.4.777; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; ROLLS ET, 1991, CURR OPIN NEUROBIOL, V1, P275; ROSCH E, 1976, COGNITIVE PSYCHOL, V8, P382, DOI 10.1016/0010-0285(76)90013-X; TANAKA K, 1993, SCIENCE, V262, P685, DOI 10.1126/science.8235589; TURK M, 1991, J COGNITIVE NEUROSCI, V3, P71, DOI 10.1162/jocn.1991.3.1.71; Ullman S, 1999, NEURAL NETWORKS, V12, P1021, DOI 10.1016/S0893-6080(99)00048-9; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Vogels R, 1999, NEUROREPORT, V10, P1811, DOI 10.1097/00001756-199906230-00002; Wiskott L, 1997, IEEE T PATTERN ANAL, V19, P775, DOI 10.1109/34.598235; Yang MH, 2002, IEEE T PATTERN ANAL, V24, P34, DOI 10.1109/34.982883	28	391	396	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2002	5	7					682	687		10.1038/nn870	http://dx.doi.org/10.1038/nn870			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	566EP	12055634				2022-12-24	WOS:000176414300019
J	Couve, A; Thomas, P; Calver, AR; Hirst, WD; Pangalos, MN; Walsh, FS; Smart, TG; Moss, SJ				Couve, A; Thomas, P; Calver, AR; Hirst, WD; Pangalos, MN; Walsh, FS; Smart, TG; Moss, SJ			Cyclic AMP-dependent protein kinase phosphorylation facilitates GABA(B) receptor-effector coupling	NATURE NEUROSCIENCE			English	Article							K+ CHANNELS; ACTIVATION; SUBUNITS; ASSOCIATION; DOMAINS; NEURONS; BINDING; SITES	GABA (gamma-aminobutyric acid)(B) receptors are heterodimeric G protein-coupled receptors that mediate slow synaptic inhibition in the central nervous system. Here we show that the functional coupling of GABA(B)R1/GABA(B)R2 receptors to inwardly rectifying K(+) channels rapidly desensitizes. This effect is alleviated after direct phosphorylation of a single serine residue (Ser892) in the cytoplasmic tail of GABA(B)R2 by cyclic AMP (cAMP)-dependent protein kinase (PKA). Basal phosphorylation of this residue is evident in rat brain membranes and in cultured neurons. Phosphorylation of Ser892 is modulated positively by pathways that elevate cAMP concentration, such as those involving forskolin and beta-adrenergic receptors. GABA(B) receptor agonists reduce receptor phosphorylation, which is consistent with PKA functioning in the control of GABA(B)-activated currents. Mechanistically, phosphorylation of Ser892 specifically enhances the membrane stability of GABA(B) receptors. We conclude that signaling pathways that activate PKA may have profound effects on GABA(B) receptor-mediated synaptic inhibition. These results also challenge the accepted view that phosphorylation is a universal negative modulator of G protein-coupled receptors.	UCL, MRC, Mol Cell Biol Lab, London WC1E 6BT, England; UCL, Dept Pharmacol, London WC1E 6BT, England; Univ London, Sch Pharm, Dept Pharmacol, London WC1N 1AX, England; GlaxoSmithKline Inc, Neurol Ctr Excellence Drug Discovery, Harlow CM19 5AW, Essex, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London School of Pharmacy; GlaxoSmithKline	Moss, SJ (corresponding author), UCL, MRC, Mol Cell Biol Lab, Gower St, London WC1E 6BT, England.	steve.moss@ucl.ac.uk	couve, andres/I-2249-2013	couve, andres/0000-0003-4216-8672; Hirst, Warren/0000-0003-0389-8891				Brandon NJ, 1999, J NEUROSCI, V19, P9228; Bunemann M, 1999, J PHYSIOL-LONDON, V517, P5, DOI 10.1111/j.1469-7793.1999.0005z.x; Cai ZH, 2001, J NEUROCHEM, V78, P756, DOI 10.1046/j.1471-4159.2001.00468.x; Calver AR, 2000, NEUROSCIENCE, V100, P155, DOI 10.1016/S0306-4522(00)00262-1; Calver AR, 2001, J NEUROSCI, V21, P1203; Cohen NA, 1996, NEURON, V17, P759, DOI 10.1016/S0896-6273(00)80207-X; Couve A, 2000, MOL CELL NEUROSCI, V16, P296, DOI 10.1006/mcne.2000.0908; Couve A, 1998, J BIOL CHEM, V273, P26361, DOI 10.1074/jbc.273.41.26361; Couve A, 2001, MOL CELL NEUROSCI, V17, P317, DOI 10.1006/mcne.2000.0938; HIRST WD, 2000, BRIT J PHARMACOL, V129, P80; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; KAMATCHI GL, 1990, MOL PHARMACOL, V38, P342; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kelly MJ, 1999, TRENDS ENDOCRIN MET, V10, P369, DOI 10.1016/S1043-2760(99)00190-3; KENELLY PJ, 1991, J BIOL CHEM, V76, P2626; Kuner R, 1999, SCIENCE, V283, P74, DOI 10.1126/science.283.5398.74; Leaney JL, 2000, J BIOL CHEM, V275, P921, DOI 10.1074/jbc.275.2.921; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Macek TA, 1998, J NEUROSCI, V18, P6138; MOSS SJ, 1992, J BIOL CHEM, V267, P14470; MOTT DD, 1994, INT REV NEUROBIOL, V36, P97, DOI 10.1016/S0074-7742(08)60304-9; Mullner C, 2000, J GEN PHYSIOL, V115, P547, DOI 10.1085/jgp.115.5.547; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Ruppert H, 1987, BAYERISCHES GEOLOGIS, V2, P1; Saitow F, 2000, J NEUROPHYSIOL, V84, P2016, DOI 10.1152/jn.2000.84.4.2016; Schaffhauser H, 2000, J NEUROSCI, V20, P5663, DOI 10.1523/JNEUROSCI.20-15-05663.2000; SESSLER FM, 1995, BRAIN RES, V675, P171, DOI 10.1016/0006-8993(95)00060-4; TANIYAMA K, 1992, J NEUROCHEM, V58, P1239, DOI 10.1111/j.1471-4159.1992.tb11334.x; Tsao P, 2000, CURR OPIN NEUROBIOL, V10, P365, DOI 10.1016/S0959-4388(00)00096-9; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Wooltorton JRA, 1997, EUR J NEUROSCI, V9, P2225, DOI 10.1111/j.1460-9568.1997.tb01641.x; YOSHIMURA M, 1995, LIFE SCI, V57, P2397, DOI 10.1016/0024-3205(95)02235-1; Zhang J, 1997, J GEN PHYSIOL, V110, P45, DOI 10.1085/jgp.110.1.45	33	100	105	2	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2002	5	5					415	424		10.1038/nn833	http://dx.doi.org/10.1038/nn833			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	546JY	11976702				2022-12-24	WOS:000175272000011
J	Song, HJ; Stevens, CF; Gage, FH				Song, HJ; Stevens, CF; Gage, FH			Neural stem cells from adult hippocampus develop essential properties of functional CNS neurons	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; PROGENITOR CELLS; IN-VITRO; RAT HIPPOCAMPUS; MESSENGER-RNAS; BONE-MARROW; GLIA; DIFFERENTIATION; NEUROGENESIS; EXPRESSION	Neural stem cells are present both in the developing nervous system and in the adult nervous system of all mammals, including humans. Little is known, however, about the extent to which stem cells in adults can give rise to new neurons. We used immunocytochemistry, electron microscopy, fluorescence microscopy (FM imaging) and electrophysiology to demonstrate that progeny of adult rat neural stem cells, when co-cultured with primary neurons and astrocytes from neonatal hippocampus, develop into electrically active neurons and integrate into neuronal networks with functional synaptic transmission. We also found that functional neurogenesis from adult stem cells is possible in co-culture with astrocytes from neonatal and adult hippocampus. These studies show that neural stem cells derived from adult tissues, like those derived from embryonic tissues, retain the potential to differentiate into functional neurons with essential properties of mature CNS neurons.	Salk Inst Biol Studies, Howard Hughes Med Inst, Mol Neurobiol Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Salk Institute; Salk Institute	Stevens, CF (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, Mol Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	cfs@salk.edu; gage@salk.edu						ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Auerbach JM, 2000, EUR J NEUROSCI, V12, P1696, DOI 10.1046/j.1460-9568.2000.00067.x; BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Blondel O, 2000, J NEUROSCI, V20, P8012; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Clarke D, 2001, CURR OPIN GENET DEV, V11, P575, DOI 10.1016/S0959-437X(00)00235-5; Finley MFA, 1996, J NEUROSCI, V16, P1056; Fitzsimonds RM, 1997, NATURE, V388, P439, DOI 10.1038/41267; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Goslin K., 1998, CULTURING NERVE CELL, P339; HALES TG, 1994, J NEUROSCI, V14, P5429; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Jessell TM, 2000, CURR OPIN NEUROBIOL, V10, P599, DOI 10.1016/S0959-4388(00)00136-7; Kandel E., 2000, PRINCIPLES NEURAL SC; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; MEHLER MF, 1993, NATURE, V362, P62, DOI 10.1038/362062a0; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; NICHOLLS JG, 1992, NEURON BRAIN, P149; NOBEL M, 1998, CULTURING NERVE CELL, P499; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Palmer TD, 1999, J NEUROSCI, V19, P8487; PALMER TD, 1989, BLOOD, V73, P438; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Roy NS, 2000, NAT MED, V6, P271; RYDER EF, 1990, J NEUROBIOL, V21, P356, DOI 10.1002/neu.480210209; Sah DWY, 1997, J NEUROBIOL, V32, P95, DOI 10.1002/(SICI)1097-4695(199701)32:1<95::AID-NEU9>3.0.CO;2-9; Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042; SCHUBERT D, 1974, NATURE, V249, P224, DOI 10.1038/249224a0; SCHWARTZ JP, 1992, GLIA, V5, P75, DOI 10.1002/glia.440050111; SONG HJ, IN PRESS NATURE; SUCHER NJ, 1993, J BIOL CHEM, V268, P22299; SUDHOF TC, 1989, SCIENCE, V245, P1474, DOI 10.1126/science.2506642; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; Takahashi J, 1999, J NEUROBIOL, V38, P65, DOI 10.1002/(SICI)1097-4695(199901)38:1<65::AID-NEU5>3.3.CO;2-H; Taupin P, 2000, NEURON, V28, P385, DOI 10.1016/S0896-6273(00)00119-7; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Toda H, 2000, EXP NEUROL, V165, P66, DOI 10.1006/exnr.2000.7473; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Vicario-Abejon C, 2000, EUR J NEUROSCI, V12, P677, DOI 10.1046/j.1460-9568.2000.00953.x; Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Ye GL, 2000, DEV BRAIN RES, V124, P33, DOI 10.1016/S0165-3806(00)00103-6; ZAHEER A, 1995, CELL MOL NEUROBIOL, V15, P221, DOI 10.1007/BF02073330	50	511	556	0	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2002	5	5					438	445		10.1038/nn844	http://dx.doi.org/10.1038/nn844			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	546JY	11953752				2022-12-24	WOS:000175272000014
J	Cloutier, JF; Giger, RJ; Koentges, G; Dulac, C; Kolodkin, AL; Ginty, DD				Cloutier, JF; Giger, RJ; Koentges, G; Dulac, C; Kolodkin, AL; Ginty, DD			Neuropilin-2 mediates axonal fasciculation, zonal segregation, but not axonal convergence, of primary accessory olfactory neurons	NEURON			English	Article							PUTATIVE PHEROMONE RECEPTORS; VOMERONASAL SYSTEM; SEMAPHORIN-III; SECRETED SEMAPHORINS; MULTIGENE FAMILY; EXPRESSION; GUIDANCE; BULB; ORGANIZATION; MAMMALS	The mechanisms that underlie axonal pathfinding of vomeronasal neurons from the vomeronasal organ (VNO) in the periphery to select glomeruli in the accessory olfactory bulb (AOB) are not well understood. Neuropilin-2, a receptor for secreted semaphorins, is expressed in V1R- and V3R-expressing, but not V2R-expressing, postnatal vomeronasal neurons. Analysis of the vomeronasal nerve in neuropilin-2 (npn-2) mutant mice reveals pathfinding defects at multiple choice points. Vomeronasal sensory axons are severely defasciculated and a subset innervates the main olfactory bulb (MOB). While most axons of V1R-expressing neurons reach the AOB and converge into distinct glomeruli in stereotypic locations, they are no longer restricted to their normal anterior AOB target zone. Thus, Npn-2 and candidate pheromone receptors play distinct and complementary roles in promoting the wiring and patterning of sensory neurons in the accessory olfactory system.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Harvard Univ, Howard Hughes Med Inst, Dept Cellular & Mol Biol, Cambridge, MA 02138 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Harvard University; Howard Hughes Medical Institute	Kolodkin, AL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.		Cloutier, Jean-François/K-2003-2012	Dulac, Catherine/0000-0001-5024-5418	NIMH NIH HHS [R01MH59199] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059199] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Belluscio L, 1999, CELL, V97, P209, DOI 10.1016/S0092-8674(00)80731-X; Berghard A, 1996, J NEUROSCI, V16, P909; Chen H, 1998, NEURON, V21, P1283, DOI 10.1016/S0896-6273(00)80648-0; Chen H, 1997, NEURON, V19, P547, DOI 10.1016/S0896-6273(00)80371-2; Chen H, 2000, NEURON, V25, P43, DOI 10.1016/S0896-6273(00)80870-3; de Castro F, 1999, J NEUROSCI, V19, P4428; Dulac C, 2000, CURR OPIN NEUROBIOL, V10, P511, DOI 10.1016/S0959-4388(00)00121-5; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Giger RJ, 1998, NEURON, V21, P1079, DOI 10.1016/S0896-6273(00)80625-X; Giger RJ, 2000, NEURON, V25, P29, DOI 10.1016/S0896-6273(00)80869-7; Giger RJ, 1996, J COMP NEUROL, V375, P378, DOI 10.1002/(SICI)1096-9861(19961118)375:3<378::AID-CNE3>3.0.CO;2-#; HALPERN M, 1995, BRAIN RES, V677, P157, DOI 10.1016/0006-8993(95)00159-N; HALPERN M, 1987, ANNU REV NEUROSCI, V10, P325, DOI 10.1146/annurev.ne.10.030187.001545; HE S, 1997, CELL, V90, P739; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; JONES DT, 1987, J BIOL CHEM, V262, P14241; Kawakami A, 1996, J NEUROBIOL, V29, P1, DOI 10.1002/(SICI)1097-4695(199601)29:1<1::AID-NEU1>3.0.CO;2-F; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; Knoll B, 2001, DEVELOPMENT, V128, P895; Kobayashi H, 1997, J NEUROSCI, V17, P8339; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Nagao H, 2000, NEUROREPORT, V11, P3023, DOI 10.1097/00001756-200009110-00039; Nakamura F, 2000, J NEUROBIOL, V44, P219, DOI 10.1002/1097-4695(200008)44:2<219::AID-NEU11>3.0.CO;2-W; Pantages E, 2000, NEURON, V28, P835, DOI 10.1016/S0896-6273(00)00157-4; Pasterkamp RJ, 1999, CELL MOL BIOL, V45, P763; Pasterkamp RJ, 1998, J NEUROSCI, V18, P9962; Raper JA, 2000, CURR OPIN NEUROBIOL, V10, P88, DOI 10.1016/S0959-4388(99)00057-4; Renzi MJ, 2000, NEURON, V28, P437, DOI 10.1016/S0896-6273(00)00123-9; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Rohm B, 2000, MECH DEVELOP, V93, P95, DOI 10.1016/S0925-4773(00)00269-0; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; Schwarting GA, 2000, J NEUROSCI, V20, P7691; STROTMANN J, 1994, CELL TISSUE RES, V278, P11, DOI 10.1007/s004410050189; STROTMANN J, 1992, NEUROREPORT, V3, P1053, DOI 10.1097/00001756-199212000-00005; Takahashi T, 2001, NEURON, V29, P429, DOI 10.1016/S0896-6273(01)00216-1; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Takahashi T, 1998, NAT NEUROSCI, V1, P487, DOI 10.1038/2203; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Tanaka M, 1999, P NATL ACAD SCI USA, V96, P14106, DOI 10.1073/pnas.96.24.14106; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; vonCampenhausen H, 1997, NEUROREPORT, V8, P2607, DOI 10.1097/00001756-199707280-00037; Williams-Hogarth LC, 2000, J COMP NEUROL, V423, P565, DOI 10.1002/1096-9861(20000807)423:4<565::AID-CNE3>3.0.CO;2-F; Yoshihara Y, 1997, J NEUROSCI, V17, P5830	48	110	110	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 14	2002	33	6					877	892		10.1016/S0896-6273(02)00635-9	http://dx.doi.org/10.1016/S0896-6273(02)00635-9			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	530ZK	11906695	Bronze			2022-12-24	WOS:000174389600006
J	d'Avella, A; Saltiel, P; Bizzi, E				d'Avella, A; Saltiel, P; Bizzi, E			Combinations of muscle synergies in the construction of a natural motor behavior	NATURE NEUROSCIENCE			English	Article							NONNEGATIVE MATRIX FACTORIZATION; SPINAL-CORD; ELECTROMYOGRAPHIC ACTIVITY; DIFFERENT DIRECTIONS; BLIND SEPARATION; MOVEMENTS; FROG; GENERATION; PATTERNS; ARM	A central issue in motor control is how the central nervous system generates the muscle activity patterns necessary to achieve a variety of behavioral goals. The many degrees of freedom of the musculoskeletal apparatus provide great flexibility but make the control problem extremely complex. Muscle synergies-coherent activations, in space or time, of a group of muscles-have been proposed as building blocks that could simplify the construction of motor behaviors. To evaluate this hypothesis, we developed a new method to extract invariant spatiotemporal components from the simultaneous recordings of the activity of many muscles. We used this technique to analyze the muscle patterns of intact and unrestrained frogs during kicking, a natural defensive behavior. Here we show that combinations of three time-varying muscle synergies underlie the variety of muscle patterns required to kick in different directions, that the recruitment of these synergies is related to movement kinematics, and that there are similarities among the synergies extracted from different behaviors.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; IRCCS, Fdn Santa Lucia, Human Physiol Sect, I-00179 Rome, Italy	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); IRCCS Santa Lucia	Bizzi, E (corresponding author), MIT, Dept Brain & Cognit Sci, 45 Carleton St, Cambridge, MA 02139 USA.	ebizzi@mit.edu	d'Avella, Andrea/K-6856-2018	d'Avella, Andrea/0000-0002-3393-4956; /0000-0002-7644-4498	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS009343] Funding Source: NIH RePORTER; NINDS NIH HHS [NS09343] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bernstein N.A., 1967, COORDINATION REGULAT; Bishop C. M., 1995, NEURAL NETWORKS PATT; BIZZI E, 1991, SCIENCE, V253, P287, DOI 10.1126/science.1857964; Brown TG, 1911, P R SOC LOND B-CONTA, V84, P308, DOI 10.1098/rspb.1911.0077; BUCHANAN TS, 1986, J NEUROPHYSIOL, V56, P1225, DOI 10.1152/jn.1986.56.5.1225; Cheng JG, 1998, J NEUROSCI, V18, P4295; d'Avella A, 2002, ADV NEUR IN, V14, P141; ECKER A, 1989, ANATOMY FROG; FLANDERS M, 1994, J NEUROPHYSIOL, V71, P811, DOI 10.1152/jn.1994.71.2.811; GISZTER SF, 1993, J NEUROSCI, V13, P467; GRILLNER S, 1979, EXP BRAIN RES, V34, P241; Grillner S., 1981, HDB PHYSL NERVOUS SY, P1179, DOI DOI 10.1002/CPHY.CP010226; Henry SM, 1998, J NEUROPHYSIOL, V80, P1939, DOI 10.1152/jn.1998.80.4.1939; Hoffman DS, 1999, J NEUROPHYSIOL, V81, P319, DOI 10.1152/jn.1999.81.1.319; HOGAN N, 1988, CAN J PHYSIOL PHARM, V66, P508, DOI 10.1139/y88-080; Kargo WJ, 2002, J EXP BIOL, V205, P1987; Kargo WJ, 2000, J NEUROSCI, V20, P409, DOI 10.1523/JNEUROSCI.20-01-00409.2000; KARST GM, 1991, J NEUROPHYSIOL, V66, P1594, DOI 10.1152/jn.1991.66.5.1594; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Lee DD, 2001, ADV NEUR IN, V13, P556; LEE WA, 1984, J MOTOR BEHAV, V16, P135; Lombard WP, 1907, AM J PHYSIOL, V20, P1, DOI 10.1152/ajplegacy.1907.20.1.1; MACPHERSON JM, 1991, LIFE SCI R, V50, P33; MACPHERSON JM, 1988, J NEUROPHYSIOL, V60, P218, DOI 10.1152/jn.1988.60.1.218; MAIER MA, 1995, EXP BRAIN RES, V103, P123, DOI 10.1007/BF00241970; Makeig S, 1997, P NATL ACAD SCI USA, V94, P10979, DOI 10.1073/pnas.94.20.10979; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; MUSSAIVALDI FA, 1994, P NATL ACAD SCI USA, V91, P7534, DOI 10.1073/pnas.91.16.7534; Rossignol Serge, 1994, Current Opinion in Neurobiology, V4, P894, DOI 10.1016/0959-4388(94)90139-2; Saltiel P, 2001, J NEUROPHYSIOL, V85, P605, DOI 10.1152/jn.2001.85.2.605; Saltiel P, 1998, J NEUROPHYSIOL, V80, P2323, DOI 10.1152/jn.1998.80.5.2323; Scott SH, 1997, J NEUROPHYSIOL, V77, P1016, DOI 10.1152/jn.1997.77.2.1016; Sherrington C, 1948, INTEGRATIVE ACTION N; Sherrington CS, 1910, J PHYSIOL-LONDON, V40, P28; SOECHTING JF, 1989, EXP BRAIN RES, V74, P535; Stein PSG, 1998, ANN NY ACAD SCI, V860, P142, DOI 10.1111/j.1749-6632.1998.tb09045.x; Tresch MC, 1999, NAT NEUROSCI, V2, P162, DOI 10.1038/5721; WADMAN W J, 1980, Journal of Human Movement Studies, V6, P19	39	812	817	5	114	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2003	6	3					300	308		10.1038/nn1010	http://dx.doi.org/10.1038/nn1010			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	648YB	12563264				2022-12-24	WOS:000181178300019
J	Wachtler, T; Sejnowski, TJ; Albright, TD				Wachtler, T; Sejnowski, TJ; Albright, TD			Representation of color stimuli in awake macaque primary visual cortex	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; FOVEAL STRIATE CORTEX; CEREBRAL-CORTEX; CHROMATIC MECHANISMS; NEURONAL RESPONSES; VISION MECHANISMS; RECEPTIVE-FIELDS; NATURAL SCENES; PURE COLOR; AREA V1	We investigated the responses of single neurons in primary visual cortex (area V1) of awake monkeys to chromatic stimuli. Chromatic tuning properties, determined for homogeneous color patches presented on a neutral gray background, varied strongly between cells. The continuum of preferred chromaticities and tuning widths indicated a distributed representation of color signals in V1. When stimuli were presented on colored backgrounds, chromatic tuning was different in most neurons, and the changes in tuning were consistent with some degree of sensitivity of the neurons to the chromatic contrast between stimulus and background. Quantitatively, the average response changes matched the magnitudes of color induction effects measured in human subjects under corresponding stimulus conditions.	Salk Inst Biol Studies, Sloan Ctr Theoret Neurobiol, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92037 USA	Salk Institute; Howard Hughes Medical Institute; Salk Institute; University of California System; University of California San Diego	Wachtler, T (corresponding author), Univ Freiburg, D-79104 Freiburg, Germany.		Wachtler, Thomas/K-3714-2014; Sejnowski, Terrence/AAV-5558-2021	Wachtler, Thomas/0000-0003-2015-6590; 	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Brown RO, 1997, CURR BIOL, V7, P844, DOI 10.1016/S0960-9822(06)00372-1; Chaudhuri A, 1997, VISUAL NEUROSCI, V14, P949, DOI 10.1017/S0952523800011664; Conway BR, 2001, J NEUROSCI, V21, P2768, DOI 10.1523/JNEUROSCI.21-08-02768.2001; Dacey DM, 2000, ANNU REV NEUROSCI, V23, P743, DOI 10.1146/annurev.neuro.23.1.743; De Valois RL, 2000, P NATL ACAD SCI USA, V97, P4997, DOI 10.1073/pnas.97.9.4997; DERRINGTON AM, 1984, J PHYSIOL-LONDON, V357, P241, DOI 10.1113/jphysiol.1984.sp015499; DEVALOIS RL, 1966, J OPT SOC AM, V56, P966, DOI 10.1364/JOSA.56.000966; DEVALOIS RL, 1974, VISION RES, V14, P53, DOI 10.1016/0042-6989(74)90116-3; DEVALOIS RL, 1993, VISION RES, V33, P1053, DOI 10.1016/0042-6989(93)90240-W; DOBKINS KR, 1994, J NEUROSCI, V14, P4854; DOW BM, 1987, J NEUROPHYSIOL, V57, P712, DOI 10.1152/jn.1987.57.3.712; GOURAS P, 1974, J PHYSIOL-LONDON, V238, P583, DOI 10.1113/jphysiol.1974.sp010545; GOURAS P, 1979, J NEUROPHYSIOL, V42, P850, DOI 10.1152/jn.1979.42.3.850; Hanazawa A, 2000, EUR J NEUROSCI, V12, P1753, DOI 10.1046/j.1460-9568.2000.00041.x; HURLBERT A, 1988, ADV NEURAL INF PROCE, V1, P297; Johnson EN, 2001, NAT NEUROSCI, V4, P409, DOI 10.1038/86061; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; KASTNER S, 1992, EUR J NEUROSCI, V4, P1079, DOI 10.1111/j.1460-9568.1992.tb00134.x; Kinoshita M, 2001, J NEUROPHYSIOL, V86, P2559, DOI 10.1152/jn.2001.86.5.2559; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961, DOI 10.1152/jn.1992.67.4.961; KOMATSU H, 1992, J NEUROSCI, V12, P408; Kraft JM, 1999, P NATL ACAD SCI USA, V96, P307, DOI 10.1073/pnas.96.1.307; LAND EH, 1959, P NATL ACAD SCI USA, V45, P115, DOI 10.1073/pnas.45.1.115; Lee TW, 2002, VISION RES, V42, P2095, DOI 10.1016/S0042-6989(02)00122-0; LENNIE P, 1990, J NEUROSCI, V10, P649; Li W, 2000, J NEUROPHYSIOL, V83, P941, DOI 10.1152/jn.2000.83.2.941; LIVINGSTONE MS, 1984, J NEUROSCI, V4, P309; Loop MS, 2000, VISUAL NEUROSCI, V17, P119, DOI 10.1017/S0952523800171123; LUTHER R, 1927, Z TECH PHYS, V8, P540; MACLEOD DIA, 1979, J OPT SOC AM, V69, P1183, DOI 10.1364/JOSA.69.001183; Martin PR, 1998, J PHYSIOL-LONDON, V513, P631, DOI 10.1111/j.1469-7793.1998.631ba.x; MAUNSELL JHR, 1987, ANNU REV NEUROSCI, V10, P363, DOI 10.1146/annurev.ne.10.030187.002051; MICHAEL CR, 1978, J NEUROPHYSIOL, V41, P572, DOI 10.1152/jn.1978.41.3.572; MICHAEL CR, 1978, J NEUROPHYSIOL, V41, P1233, DOI 10.1152/jn.1978.41.5.1233; MOTOKAWA K, 1962, TOHOKU J EXP MED, V78, P320, DOI 10.1620/tjem.78.320; Nathans J, 1999, NEURON, V24, P299, DOI 10.1016/S0896-6273(00)80845-4; Nothdurft HC, 1999, VISUAL NEUROSCI, V16, P15, DOI 10.1017/S0952523899156189; POGGIO GF, 1975, BRAIN RES, V100, P25, DOI 10.1016/0006-8993(75)90240-1; POPPEL E, 1986, NATURE, V320, P523, DOI 10.1038/320523a0; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; Rossi AF, 1999, J NEUROSCI, V19, P6145, DOI 10.1523/JNEUROSCI.19-14-06145.1999; SCHEIN SJ, 1990, J NEUROSCI, V10, P3369; Sillito AM, 1996, J PHYSIOL-PARIS, V90, P205, DOI 10.1016/S0928-4257(97)81424-6; STOCKMAN A, 1993, J OPT SOC AM A, V10, P2491, DOI 10.1364/JOSAA.10.002491; Tadmor Y, 2000, VISION RES, V40, P3145, DOI 10.1016/S0042-6989(00)00166-8; THORELL LG, 1984, VISION RES, V24, P751, DOI 10.1016/0042-6989(84)90216-5; TSO DY, 1988, J NEUROSCI, V8, P1712; Valberg A, 2001, VISION RES, V41, P1645, DOI 10.1016/S0042-6989(01)00041-4; VAUTIN RG, 1985, J NEUROPHYSIOL, V54, P273, DOI 10.1152/jn.1985.54.2.273; Wachtler T, 2001, VISION RES, V41, P1535, DOI 10.1016/S0042-6989(01)00017-7; Wachtler T, 2001, J OPT SOC AM A, V18, P65, DOI 10.1364/JOSAA.18.000065; WESNER MF, 1992, VISION RES, V32, P1623, DOI 10.1016/0042-6989(92)90155-C; WIESEL TN, 1966, J NEUROPHYSIOL, V29, P1115, DOI 10.1152/jn.1966.29.6.1115; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7; ZEKI S, 1983, NEUROSCIENCE, V9, P741, DOI 10.1016/0306-4522(83)90265-8; ZEKI S, 1983, NEUROSCIENCE, V9, P767, DOI 10.1016/0306-4522(83)90266-X; ZEKI S, 1980, NATURE, V284, P412, DOI 10.1038/284412a0; Zipser K, 1996, J NEUROSCI, V16, P7376	58	174	176	0	25	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 20	2003	37	4					681	691		10.1016/S0896-6273(03)00035-7	http://dx.doi.org/10.1016/S0896-6273(03)00035-7			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	648EH	12597864	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000181136500015
J	Li, Y; Gao, XB; Sakurai, T; van den Pol, AN				Li, Y; Gao, XB; Sakurai, T; van den Pol, AN			Hypocretin/orexin excites hypocretin neurons via a local glutamate neuron - A potential mechanism for orchestrating the hypothalamic arousal system	NEURON			English	Article							LOCUS-COERULEUS NEURONS; RECEPTOR MESSENGER-RNA; RAT-BRAIN; LATERAL HYPOTHALAMUS; HUMAN NARCOLEPSY; NEUROPEPTIDE-Y; PREPRO-OREXIN; SLEEP; EXPRESSION; AREA	Neurons that release hypocretin/orexin modulate sleep, arousal, and energy homeostasis; the absence of hypocretin results in narcolepsy. Here we present data on the physiological characteristics of these cells, identified with GFP in transgenic mouse brain slices. Hypocretin-1 and -2 depolarized hypocretin neurons by 15mV and evoked an increase in spike frequency (+366% from a 1-3 Hz baseline). The mechanism for this appears to be hypocretin-mediated excitation of local glutamatergic neurons that regulate hypocretin neuron activity, in part by presynaptic facilitation of glutamate release. This represents a possible mechanism for orchestrating the output of the diffuse hypothalamic arousal system. No direct effect of hypocretin on membrane properties of hypocretin cells was detected. Norepinephrine and serotonin, transmitters of other arousal systems, decreased spike frequency and evoked outward currents, whereas acetylcholine and histamine had little effect.	Yale Univ, Dept Neurosurg, New Haven, CT 06520 USA; Univ Tsukuba, Inst Basic Med Sci, Tsukuba, Ibaraki 305, Japan	Yale University; University of Tsukuba	van den Pol, AN (corresponding author), Yale Univ, Dept Neurosurg, New Haven, CT 06520 USA.		Gao, Xiao-Bing/C-3121-2011	Gao, Xiao-Bing/0000-0002-2035-4936; Li, Ying/0000-0001-9891-1408	NINDS NIH HHS [NS34887, NS41454, NS37788] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041454, R01NS037788, R01NS034887] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abrahamson EE, 2001, BRAIN RES, V889, P1, DOI 10.1016/S0006-8993(00)03015-8; ALAM MN, 2002, J PHYSL, V15, P619; ARMSTRONG WE, 1994, J PHYSIOL-LONDON, V475, P115, DOI 10.1113/jphysiol.1994.sp020053; BARKAI E, 1994, J NEUROPHYSIOL, V72, P644, DOI 10.1152/jn.1994.72.2.644; Bayer L, 2000, NEUROREPORT, V11, P531, DOI 10.1097/00001756-200002280-00021; BEKKERS JM, 1995, J NEUROPHYSIOL, V73, P1145, DOI 10.1152/jn.1995.73.3.1145; Bourgin P, 2000, J NEUROSCI, V20, P7760; Broberger C, 1998, J COMP NEUROL, V402, P460; Brown RE, 2001, NEUROPHARMACOLOGY, V40, P457, DOI 10.1016/S0028-3908(00)00178-7; Burlet S, 2002, J NEUROSCI, V22, P2862, DOI 10.1523/JNEUROSCI.22-07-02862.2002; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Chou TC, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-19-j0003.2001; Clark JD, 1985, AFR ARCHAEOL REV, V3, P3, DOI DOI 10.1007/BF01117453; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; DUFFY S, 1995, J NEUROSCI, V15, P5535; Elias CF, 1998, J COMP NEUROL, V402, P442, DOI 10.1002/(SICI)1096-9861(19981228)402:4<442::AID-CNE2>3.0.CO;2-R; Eriksson KS, 2001, J NEUROSCI, V21, P9273, DOI 10.1523/JNEUROSCI.21-23-09273.2001; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Fuhrmann G, 2002, J NEUROPHYSIOL, V88, P761, DOI 10.1152/jn.2002.88.2.761; Gao XB, 1999, J PHYSIOL-LONDON, V518, P81, DOI 10.1111/j.1469-7793.1999.0081r.x; Gerashchenko D, 2001, J NEUROSCI, V21, P7273, DOI 10.1523/JNEUROSCI.21-18-07273.2001; GRANIT R, 1963, J PHYSIOL-LONDON, V168, P911, DOI 10.1113/jphysiol.1963.sp007230; Griffond B, 1999, NEUROSCI LETT, V262, P77, DOI 10.1016/S0304-3940(98)00976-8; Grudt TJ, 2002, J PHYSIOL-LONDON, V538, P517, DOI 10.1113/jphysiol.2001.013120; Guzman-Marin R, 2000, BRAIN RES, V875, P23, DOI 10.1016/S0006-8993(00)02561-0; Hagan JJ, 1999, P NATL ACAD SCI USA, V96, P10911, DOI 10.1073/pnas.96.19.10911; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; Hokfelt T, 1987, Adv Exp Med Biol, V219, P21; Horvath TL, 1999, J NEUROSCI, V19, P1072; Horvath TL, 1999, J COMP NEUROL, V415, P145; Ivanov A, 2000, NEUROREPORT, V11, P1755, DOI 10.1097/00001756-200006050-00031; Kilduff TS, 2000, TRENDS NEUROSCI, V23, P359, DOI 10.1016/S0166-2236(00)01594-0; KIM YI, 1993, J PHYSIOL-LONDON, V464, P229, DOI 10.1113/jphysiol.1993.sp019632; Kirkwood A, 1999, J NEUROSCI, V19, P1599; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Liu RJ, 2002, J NEUROSCI, V22, P9453; Lopez M, 2000, BIOCHEM BIOPH RES CO, V269, P41, DOI 10.1006/bbrc.2000.2245; MADISON DV, 1988, J PHYSIOL-LONDON, V398, P123, DOI 10.1113/jphysiol.1988.sp017033; MADISON DV, 1987, J NEUROSCI, V7, P733; MADISON DV, 1984, J NEUROPHYSIOL, V67, P350; Marcus JN, 2001, J COMP NEUROL, V435, P6, DOI 10.1002/cne.1190; Moriguchi T, 1999, NEUROSCI LETT, V264, P101, DOI 10.1016/S0304-3940(99)00177-9; Nishino S, 2000, LANCET, V355, P39, DOI 10.1016/S0140-6736(99)05582-8; PALACIOS JM, 1981, NEUROSCIENCE, V6, P15, DOI 10.1016/0306-4522(81)90240-2; Peyron C, 1998, J NEUROSCI, V18, P9996; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; Sakurai T, 1999, J BIOL CHEM, V274, P17771, DOI 10.1074/jbc.274.25.17771; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Smith BN, 2002, NEUROSCIENCE, V115, P707, DOI 10.1016/S0306-4522(02)00488-8; Talley EM, 1997, J NEUROSCI, V17, P4473; TASKER JG, 1991, J PHYSIOL-LONDON, V434, P271, DOI 10.1113/jphysiol.1991.sp018469; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Trivedi P, 1998, FEBS LETT, V438, P71, DOI 10.1016/S0014-5793(98)01266-6; Usher M, 1999, SCIENCE, V283, P549, DOI 10.1126/science.283.5401.549; van den Pol AN, 2001, J COMP NEUROL, V433, P349, DOI 10.1002/cne.1144; van den Pol AN, 2002, J PHYSIOL-LONDON, V541, P169, DOI 10.1113/jphysiol.2002.017426; van den Pol AN, 1998, J NEUROSCI, V18, P7962; van den Pol AN, 2000, NEURON, V27, P415, DOI 10.1016/S0896-6273(00)00050-7; van den Pol AN, 1999, J NEUROSCI, V19, P3171; Wu M, 2002, J NEUROSCI, V22, P7754; Ziegler DR, 2002, J COMP NEUROL, V448, P217, DOI 10.1002/cne.10257	61	347	360	0	18	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 19	2002	36	6					1169	1181		10.1016/S0896-6273(02)01132-7	http://dx.doi.org/10.1016/S0896-6273(02)01132-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	628TA	12495630	Bronze			2022-12-24	WOS:000180011600018
J	Nishitani, N; Hari, R				Nishitani, N; Hari, R			Viewing lip forms: Cortical dynamics	NEURON			English	Article							PRIMARY MOTOR CORTEX; GRASP REPRESENTATIONS; MAGNETIC-FIELDS; MANUAL ACTIVITY; PERCEPTION; ACTIVATION; MOVEMENT; HUMANS; AREA; MECHANISMS	Viewing other persons' actions automatically activates brain areas belonging to the mirror-neuron system (MNS) assumed to link action execution and observation. We followed, by magnetoencephalographic cortical dynamics, subjects who observed still pictures of lip forms, on-line imitated them, or made similar forms in a self-paced manner. In all conditions and in both hemispheres, cortical activation progressed in 20-70 ms steps from the occipital cortex to the superior temporal region (where the strongest activation took place), the inferior parietal lobule, and the inferior frontal lobe (Broca's area), and finally, 513-140 ms later, to the primary motor cortex. The signals of Broca's area and motor cortex were significantly stronger during imitation than other conditions. These results demonstrate that still pictures, only implying motion, activate the human MNS in a well-defined temporal order.	Aalto Univ, Low Temp Lab, Brain Res Unit, FIN-02015 Espoo, Finland; Natl Rehabil Ctr Disabled, Res Inst, Cognit Sci Sect, Dept Sensory & Communicat Disorders, Tokorozawa, Saitama, Japan; Univ Helsinki, Cent Hosp, Div Clin Neurophysiol, FIN-00290 Helsinki, Finland	Aalto University; National Defense Medical College - Japan; University of Helsinki; Helsinki University Central Hospital	Nishitani, N (corresponding author), Aalto Univ, Low Temp Lab, Brain Res Unit, POB 2200, FIN-02015 Espoo, Finland.	nobu@rehab.go.jp	Hari, Riitta K/J-1880-2012	Hari, Riitta K/0000-0002-3142-2703				Allison T, 1999, CEREB CORTEX, V9, P415, DOI 10.1093/cercor/9.5.415; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Blakemore SJ, 2001, NAT REV NEUROSCI, V2, P561, DOI 10.1038/35086023; Bonda E, 1996, J NEUROSCI, V16, P3737; Calvert GA, 1997, SCIENCE, V276, P593, DOI 10.1126/science.276.5312.593; CAMPBELL R, 1980, Q J EXP PSYCHOL, V32, P85, DOI 10.1080/00335558008248235; Castelli F, 2000, NEUROIMAGE, V12, P314, DOI 10.1006/nimg.2000.0612; CORBETTA M, 1993, J NEUROSCI, V13, P1202; Decety J, 2002, NEUROIMAGE, V15, P265, DOI 10.1006/nimg.2001.0938; Decety J, 1997, BRAIN, V120, P1763, DOI 10.1093/brain/120.10.1763; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Frith U, 2001, NEURON, V32, P969, DOI 10.1016/S0896-6273(01)00552-9; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gerloff C, 1998, ELECTROMYOGR MOTOR C, V109, P444, DOI 10.1016/S0924-980X(98)00045-9; Grafton ST, 1996, EXP BRAIN RES, V112, P103; Grezes J, 1999, BRAIN, V122, P1875, DOI 10.1093/brain/122.10.1875; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Hari R, 1998, P NATL ACAD SCI USA, V95, P15061, DOI 10.1073/pnas.95.25.15061; Hari R, 2000, TRENDS COGN SCI, V4, P455, DOI 10.1016/S1364-6613(00)01549-7; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Iacoboni M, 2001, P NATL ACAD SCI USA, V98, P13995, DOI 10.1073/pnas.241474598; Jarvelainen J, 2001, NEUROREPORT, V12, P3493; Kanwisher N, 1997, J NEUROSCI, V17, P4302; KIMURA D, 1973, NEUROPSYCHOLOGIA, V11, P51, DOI 10.1016/0028-3932(73)90064-X; KIMURA D, 1973, NEUROPSYCHOLOGIA, V11, P45, DOI 10.1016/0028-3932(73)90063-8; Kourtzi Z, 2000, J COGNITIVE NEUROSCI, V12, P48, DOI 10.1162/08989290051137594; Krams M, 1998, EXP BRAIN RES, V120, P386, DOI 10.1007/s002210050412; KUHL PK, 1982, SCIENCE, V218, P1138, DOI 10.1126/science.7146899; Leiguarda RC, 2000, BRAIN, V123, P860, DOI 10.1093/brain/123.5.860; Levanen S, 2001, CEREB CORTEX, V11, P506, DOI 10.1093/cercor/11.6.506; Liberman AM, 2000, TRENDS COGN SCI, V4, P187, DOI 10.1016/S1364-6613(00)01471-6; LIBERMAN AM, 1985, COGNITION, V21, P1, DOI 10.1016/0010-0277(85)90021-6; Mataric MJ, 1998, COGNITIVE BRAIN RES, V7, P191, DOI 10.1016/S0926-6410(98)00025-1; MATELLI M, 1997, HANDB NEUR, V11, P9; Mayberry R I, 1998, New Dir Child Dev, P77; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; MELTZOFF AN, 1977, SCIENCE, V198, P75, DOI 10.1126/science.198.4312.75; Nagamine T, 1996, ELECTROEN CLIN NEURO, V99, P274, DOI 10.1016/0013-4694(96)95154-8; Nicoladis E, 1999, DEV PSYCHOL, V35, P514, DOI 10.1037/0012-1649.35.2.514; Nishitani N, 1999, J NEUROSCI, V19, P2647; Nishitani N, 2000, P NATL ACAD SCI USA, V97, P913, DOI 10.1073/pnas.97.2.913; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pedersen JR, 1998, NEUROIMAGE, V8, P214, DOI 10.1006/nimg.1998.0362; Peigneux P, 2000, NEUROIMAGE, V11, P644, DOI 10.1006/nimg.2000.0578; Pelissier P, 2000, Ann Chir Plast Esthet, V45, P41; POSNER MI, 1984, J NEUROSCI, V4, P1863; Preuss TM, 1996, J COMP NEUROL, V371, P649, DOI 10.1002/(SICI)1096-9861(19960805)371:4<649::AID-CNE12>3.0.CO;2-E; Puce A, 1998, J NEUROSCI, V18, P2188; Raij T, 2000, NEURON, V28, P617, DOI 10.1016/S0896-6273(00)00138-0; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; RIZZOLATTI G, 1988, EXP BRAIN RES, V71, P491, DOI 10.1007/BF00248742; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; Rizzolatti G, 1996, EXP BRAIN RES, V111, P246; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Strafella AP, 2000, NEUROREPORT, V11, P2289, DOI 10.1097/00001756-200007140-00044; Talairach J., 1988, COPLANAR STEREOTAXIC; Tootell RBH, 2000, NAT NEUROSCI, V3, P206, DOI 10.1038/72904; Uutela K, 1999, NEUROIMAGE, V10, P173, DOI 10.1006/nimg.1999.0454; Vanni S, 2001, P NATL ACAD SCI USA, V98, P2776, DOI 10.1073/pnas.041600898	62	276	281	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 19	2002	36	6					1211	1220		10.1016/S0896-6273(02)01089-9	http://dx.doi.org/10.1016/S0896-6273(02)01089-9			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	628TA	12495633	Bronze			2022-12-24	WOS:000180011600021
J	Felsen, G; Shen, YS; Yao, HS; Spor, G; Li, CY; Dan, Y				Felsen, G; Shen, YS; Yao, HS; Spor, G; Li, CY; Dan, Y			Dynamic modification of cortical orientation tuning mediated by recurrent connections	NEURON			English	Article							PRIMARY VISUAL-CORTEX; CLASSICAL RECEPTIVE-FIELD; CAT STRIATE CORTEX; UNDERLYING CONTRAST ADAPTATION; SPATIAL-FREQUENCY; SYNAPTIC DEPRESSION; RAPID ADAPTATION; SINGLE UNITS; GAIN-CONTROL; IN-VIVO	Receptive field properties of visual cortical neurons depend on the spatiotemporal context within which the stimuli are presented. We have examined the temporal context dependence of cortical orientation tuning using dynamic visual stimuli with rapidly changing orientations. We found that tuning to the orientation of the test stimulus depended on a briefly presented preceding stimulus, with the preferred orientation shifting away from the preceding orientation. Analyses of the spatial-phase dependence of the shift showed that the effect cannot be explained by purely feedforward mechanisms, but can be accounted for by activity-dependent changes in the recurrent interactions between different orientation columns. Thus, short-term plasticity of the intracortical circuit can mediate dynamic modification of orientation tuning, which may be important for efficient visual coding.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA; Chinese Acad Sci, Inst Neurosci, Shanghai 200031, Peoples R China	University of California System; University of California Berkeley; Chinese Academy of Sciences	Dan, Y (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA.	ydan@uclink4.berkeley.edu		Dan, Yang/0000-0002-3818-877X	NEI NIH HHS [R01 EY12561-01] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012561] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; ALLMAN J, 1985, ANNU REV NEUROSCI, V8, P407, DOI 10.1146/annurev.ne.08.030185.002203; BARLOW H, 1989, COMP NEUR S, P54; BAUMAN LA, 1991, VISION RES, V31, P933, DOI 10.1016/0042-6989(91)90201-F; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; BONDS AB, 1989, VISUAL NEUROSCI, V2, P41, DOI 10.1017/S0952523800004314; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; Carandini M, 1997, PHILOS T R SOC B, V352, P1149, DOI 10.1098/rstb.1997.0098; Chance FS, 1998, J NEUROSCI, V18, P4785; Chung S, 2002, NEURON, V34, P437, DOI 10.1016/S0896-6273(02)00659-1; Deneve S, 1999, NAT NEUROSCI, V2, P740, DOI 10.1038/11205; DEVALOIS KK, 1983, J PHYSIOL-LONDON, V336, P359, DOI 10.1113/jphysiol.1983.sp014586; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Dragoi V, 2000, NEURON, V28, P287, DOI 10.1016/S0896-6273(00)00103-3; Dragoi V, 2002, NAT NEUROSCI, V5, P883, DOI 10.1038/nn900; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; Fitzpatrick D, 2000, CURR OPIN NEUROBIOL, V10, P438, DOI 10.1016/S0959-4388(00)00113-6; Freeman TCB, 2002, NEURON, V35, P759, DOI 10.1016/S0896-6273(02)00819-X; Gibson JJ, 1937, PSYCHOL REV, V44, P222, DOI 10.1037/h0061358; Gilbert CD, 1996, CURR OPIN NEUROBIOL, V6, P269, DOI 10.1016/S0959-4388(96)80083-3; GILBERT CD, 1990, VISION RES, V30, P1689, DOI 10.1016/0042-6989(90)90153-C; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Levitt JB, 1997, NATURE, V387, P73, DOI 10.1038/387073a0; LI CY, 1994, VISION RES, V34, P2337, DOI 10.1016/0042-6989(94)90280-1; Mazer JA, 2002, P NATL ACAD SCI USA, V99, P1645, DOI 10.1073/pnas.022638499; MOVSHON JA, 1979, NATURE, V278, P850, DOI 10.1038/278850a0; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; OHZAWA I, 1985, J NEUROPHYSIOL, V54, P651, DOI 10.1152/jn.1985.54.3.651; Polat U, 1998, NATURE, V391, P580, DOI 10.1038/35372; REGAN D, 1985, J OPT SOC AM A, V2, P147, DOI 10.1364/JOSAA.2.000147; Ringach DL, 1997, NATURE, V387, P281, DOI 10.1038/387281a0; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; SAUL AB, 1989, VISUAL NEUROSCI, V2, P593, DOI 10.1017/S0952523800003527; SAUL AB, 1989, VISUAL NEUROSCI, V2, P609, DOI 10.1017/S0952523800003539; SCLAR G, 1982, EXP BRAIN RES, V46, P457; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P305, DOI 10.1113/jphysiol.1975.sp011056; SILLITO AM, 1995, NATURE, V378, P492, DOI 10.1038/378492a0; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Stratford KJ, 1996, NATURE, V382, P258, DOI 10.1038/382258a0; Swindale NV, 1998, BIOL CYBERN, V78, P45, DOI 10.1007/s004220050411; THOMSON AM, 1993, J NEUROPHYSIOL, V70, P2354, DOI 10.1152/jn.1993.70.6.2354; Troyer TW, 1998, J NEUROSCI, V18, P5908; Varela JA, 1997, J NEUROSCI, V17, P7926; Walker GA, 1999, J NEUROSCI, V19, P10536; Yao HS, 2001, NEURON, V32, P315, DOI 10.1016/S0896-6273(01)00460-3	45	98	99	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	DEC 5	2002	36	5					945	954		10.1016/S0896-6273(02)01011-5	http://dx.doi.org/10.1016/S0896-6273(02)01011-5			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	622VL	12467597	Bronze			2022-12-24	WOS:000179667800018
J	Patterson, RD; Uppenkamp, S; Johnsrude, IS; Griffiths, TD				Patterson, RD; Uppenkamp, S; Johnsrude, IS; Griffiths, TD			The processing of temporal pitch and melody information in auditory cortex	NEURON			English	Article							ITERATED RIPPLED NOISE; HUMAN BRAIN; VOLUME MEASUREMENT; HESCHLS GYRUS; LOWER LIMIT; SUBDIVISIONS; SOUND; DISCRIMINATION; MECHANISMS; STRENGTH	An fMRI experiment was performed to identify the main stages of melody processing in the auditory pathway. Spectrally matched sounds that produce no pitch, fixed pitch, or melody were all found to activate Heschl's gyrus (HG) and planum temporale (PT). Within this region, sounds with pitch produced more activation than those without pitch only in the lateral half of HG. When the pitch was varied to produce a melody, there was activation in regions beyond HG and PT, specifically in the superior temporal gyrus (STG) and planum polare (PP). The results support the view that there is hierarchy of pitch processing in which the center of activity moves anterolaterally away from primary auditory cortex as the processing of melodic sounds proceeds.	Univ Cambridge, Ctr Neural Basis Hearing, Dept Physiol, Cambridge CB2 3EG, England; MRC, Cognit & Brain Sci Unit, Cambridge CB2 2EF, England; Inst Neurol, Wellcome Dept Imaging Neurosci, London WC1N 3BG, England; Univ Newcastle, Sch Med, Auditory Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	University of Cambridge; University of London; University College London; Newcastle University - UK	Patterson, RD (corresponding author), Univ Cambridge, Ctr Neural Basis Hearing, Dept Physiol, Downing St, Cambridge CB2 3EG, England.	roy.patterson@mrc-cbu.cam.ac.uk	Johnsrude, Ingrid S/G-4694-2011	Johnsrude, Ingrid S/0000-0002-7810-1333				Brett M, 2002, NAT REV NEUROSCI, V3, P243, DOI 10.1038/nrn756; Edmister WB, 1999, HUM BRAIN MAPP, V7, P89, DOI 10.1002/(SICI)1097-0193(1999)7:2<89::AID-HBM2>3.3.CO;2-E; EHRET G, 1997, CENTRAL AUDITORY SYS; Griffiths TD, 1998, NAT NEUROSCI, V1, P422, DOI 10.1038/1637; Griffiths TD, 2001, NAT NEUROSCI, V4, P633, DOI 10.1038/88459; Guimaraes AR, 1998, HUM BRAIN MAPP, V6, P33, DOI 10.1002/(SICI)1097-0193(1998)6:1<33::AID-HBM3>3.0.CO;2-M; Hackett TA, 1998, J COMP NEUROL, V394, P475, DOI 10.1002/(SICI)1096-9861(19980518)394:4<475::AID-CNE6>3.0.CO;2-Z; Hackett TA, 2001, J COMP NEUROL, V441, P197, DOI 10.1002/cne.1407; Hall DA, 1999, HUM BRAIN MAPP, V7, P213, DOI 10.1002/(SICI)1097-0193(1999)7:3<213::AID-HBM5>3.0.CO;2-N; Hall DA, 2002, CEREB CORTEX, V12, P140, DOI 10.1093/cercor/12.2.140; Howard MA, 2000, J COMP NEUROL, V416, P79, DOI 10.1002/(SICI)1096-9861(20000103)416:1<79::AID-CNE6>3.0.CO;2-2; Johnsrude IS, 2000, BRAIN, V123, P155, DOI 10.1093/brain/123.1.155; Kaas JH, 2000, P NATL ACAD SCI USA, V97, P11793, DOI 10.1073/pnas.97.22.11793; Krumbholz K, 2000, J ACOUST SOC AM, V108, P1170, DOI 10.1121/1.1287843; Leonard CM, 1998, CEREB CORTEX, V8, P397, DOI 10.1093/cercor/8.5.397; Morosan P, 2001, NEUROIMAGE, V13, P684, DOI 10.1006/nimg.2000.0715; PALMER AR, 1992, ADV BIOSCI, V83, P231; Palmer AR, 1998, NEUROIMAGE, V7, pS359; PATTERSON RD, 1994, J ACOUST SOC AM, V96, P1419, DOI 10.1121/1.410286; Patterson RD, 1996, J ACOUST SOC AM, V100, P3286, DOI 10.1121/1.417212; PATTERSON RD, 1995, J ACOUST SOC AM, V98, P1890, DOI 10.1121/1.414456; Penhune VB, 1996, CEREB CORTEX, V6, P661, DOI 10.1093/cercor/6.5.661; Pressnitzer D, 2001, J ACOUST SOC AM, V109, P2074, DOI 10.1121/1.1359797; Rademacher J, 2001, NEUROIMAGE, V13, P669, DOI 10.1006/nimg.2000.0714; RADEMACHER J, 1993, CEREB CORTEX, V3, P313, DOI 10.1093/cercor/3.4.313; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Rivier F, 1997, NEUROIMAGE, V6, P288, DOI 10.1006/nimg.1997.0304; SAMSON S, 1988, BRAIN COGNITION, V7, P348, DOI 10.1016/0278-2626(88)90008-5; Schneider P, 2002, NAT NEUROSCI, V5, P688, DOI 10.1038/nn871; Talairach J., 1988, APPROACH CEREBRAL IM; Tardif E, 2001, EUR J NEUROSCI, V13, P1045, DOI 10.1046/j.0953-816x.2001.01456.x; Wessinger CM, 2001, J COGNITIVE NEUROSCI, V13, P1, DOI 10.1162/089892901564108; Yost WA, 1996, J ACOUST SOC AM, V100, P511, DOI 10.1121/1.415873; Yost WA, 1996, J ACOUST SOC AM, V99, P1066, DOI 10.1121/1.414593; YOST WA, 1998, PSYCHOPHYSICAL PHYSL, P546; ZATORRE RJ, 1994, J NEUROSCI, V14, P1908, DOI 10.1523/jneurosci.14-04-01908.1994; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7	37	524	535	2	56	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	NOV 14	2002	36	4					767	776		10.1016/S0896-6273(02)01060-7	http://dx.doi.org/10.1016/S0896-6273(02)01060-7			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	616PX	12441063	Bronze			2022-12-24	WOS:000179313100021
J	Delaney, AJ; Jahr, CE				Delaney, AJ; Jahr, CE			Kainate receptors differentially regulate release at two parallel fiber synapses	NEURON			English	Article							EXCITATORY SYNAPTIC TRANSMISSION; CEREBELLAR PURKINJE-CELLS; METABOTROPIC GLUTAMATE RECEPTORS; RAT HIPPOCAMPUS; NERVOUS-SYSTEM; GRANULE CELLS; ION CHANNELS; SUBUNIT; EXPRESSION; ACTIVATION	Presynaptic kainate receptors (KARs) facilitate or depress transmitter release at several synapses in the CNS. Here, we report that synaptically activated KARs presynaptically facilitate and depress transmission at parallel fiber synapses in the cerebellar cortex. Low-frequency stimulation of parallel fibers facilitates synapses onto both stellate cells and Purkinje cells, whereas high-frequency stimulation depresses stellate cell synapses but continues to facilitate Purkinje cell synapses. These effects are mimicked by exogenous KAR agonists and eliminated by blocking KARs. This differential frequency-dependent sensitivity of these two synapses regulates the balance of excitatory and inhibitory input to Purkinje cells and therefore their excitability.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA	Oregon Health & Science University	Jahr, CE (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, L474, Portland, OR 97201 USA.		Delaney, Andrew/H-4238-2018	Delaney, Andrew/0000-0001-8972-4870	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS040056, R01NS040056] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 40056] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; BAHN S, 1994, J NEUROSCI, V14, P5525; BATCHELOR AM, 1994, NEUROSCIENCE, V63, P911, DOI 10.1016/0306-4522(94)90558-4; BETTLER B, 1990, NEURON, V5, P583, DOI 10.1016/0896-6273(90)90213-Y; Chittajallu R, 1996, NATURE, V379, P78, DOI 10.1038/379078a0; Contractor A, 2000, J NEUROSCI, V20, P8269, DOI 10.1523/JNEUROSCI.20-22-08269.2000; Contractor A, 2001, NEURON, V29, P209, DOI 10.1016/S0896-6273(01)00191-X; Dehnes Y, 1998, J NEUROSCI, V18, P3606; EGEBJERG J, 1991, NATURE, V351, P745, DOI 10.1038/351745a0; Fogarty DJ, 2000, MOL BRAIN RES, V81, P164, DOI 10.1016/S0169-328X(00)00179-0; Frerking M, 2001, J NEUROSCI, V21, P2958, DOI 10.1523/JNEUROSCI.21-09-02958.2001; HERB A, 1992, NEURON, V8, P775, DOI 10.1016/0896-6273(92)90098-X; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Kamiya H, 1998, J PHYSIOL-LONDON, V509, P833, DOI 10.1111/j.1469-7793.1998.833bm.x; Kamiya H, 2000, J PHYSIOL-LONDON, V523, P653, DOI 10.1111/j.1469-7793.2000.t01-1-00653.x; Kerchner GA, 2001, J NEUROSCI, V21, P59, DOI 10.1523/JNEUROSCI.21-01-00059.2001; Kidd FL, 2002, NEURON, V34, P635, DOI 10.1016/S0896-6273(02)00699-2; Lauri SE, 2001, NEUROPHARMACOLOGY, V41, P907, DOI 10.1016/S0028-3908(01)00152-6; Lauri SE, 2001, NEURON, V32, P697, DOI 10.1016/S0896-6273(01)00511-6; Lee CS, 1999, ANN NY ACAD SCI, V868, P546, DOI 10.1111/j.1749-6632.1999.tb11325.x; Otis TS, 1997, SCIENCE, V277, P1515, DOI 10.1126/science.277.5331.1515; Palay S. L., 1974, CEREBELLAR CORTEX CY; Pemberton KE, 1998, J PHYSIOL-LONDON, V510, P401, DOI 10.1111/j.1469-7793.1998.401bk.x; PETRALIA RS, 1994, J COMP NEUROL, V349, P85, DOI 10.1002/cne.903490107; RENARD A, 1995, NEUROPHARMACOLOGY, V34, P335, DOI 10.1016/0028-3908(94)00165-O; Rodriguez-Moreno A, 1998, NEURON, V20, P1211, DOI 10.1016/S0896-6273(00)80501-2; Schmitz D, 2000, NEURON, V27, P327, DOI 10.1016/S0896-6273(00)00040-4; Schmitz D, 2001, SCIENCE, V291, P1972, DOI 10.1126/science.1057105; Smith TC, 1999, J PHYSIOL-LONDON, V517, P51, DOI 10.1111/j.1469-7793.1999.0051z.x; Swanson GT, 1996, J PHYSIOL-LONDON, V492, P129, DOI 10.1113/jphysiol.1996.sp021295; Tempia F, 1998, J NEUROPHYSIOL, V80, P520, DOI 10.1152/jn.1998.80.2.520; Vignes M, 1998, NEUROPHARMACOLOGY, V37, P1269, DOI 10.1016/S0028-3908(98)00148-8; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3	33	70	72	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 24	2002	36	3					475	482		10.1016/S0896-6273(02)01008-5	http://dx.doi.org/10.1016/S0896-6273(02)01008-5			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	608ZE	12408849	Bronze			2022-12-24	WOS:000178877700015
J	Schwaerzel, M; Heisenberg, M; Zars, T				Schwaerzel, M; Heisenberg, M; Zars, T			Extinction antagonizes olfactory memory at the subcellular level	NEURON			English	Article							DEPENDENT PROTEIN-KINASE; SHORT-TERM-MEMORY; MUSHROOM BODIES; ADENYLYL-CYCLASE; PREFERENTIAL EXPRESSION; DROSOPHILA-MELANOGASTER; SENSORY NEURONS; GENE; MUTANT; ACQUISITION	Memory loss occurs by diverse mechanisms, as different time constants of performance decrement and sensitivities to experimental manipulations suggest. While the phenomena of memory decay, interference, and extinction are well established behaviorally, little is known about them at the circuit or molecular level. In Drosophila, odorant memories lasting up to 3 hr can be localized to mushroom body Kenyon cells, a single neuronal level in the olfactory pathway. The plasticity underlying this memory trace can be induced without Kenyon cell synaptic output. Experimental extinction, i.e., presentation of the conditioned stimulus without the reinforcer, reduces memory performance and does so at the same circuit level as memory formation. Thus, unreinforced presentation of learned odorants antagonizes intracellularly the signaling cascade underlying memory formation.	Biozentrum, Lehrstuhl Genet & Neurobiol, Theodor Boveri Inst Biowissensch, D-97074 Wurzburg, Germany	University of Wurzburg	Zars, T (corresponding author), Univ Missouri, Div Biol, Columbia, MO 65211 USA.	zars@biozentrum.uni-wuerzburg.de		Zars, Troy/0000-0003-4114-9322				Antoni FA, 1998, J NEUROSCI, V18, P9650; BERGOLD PJ, 1992, NEURON, V8, P387, DOI 10.1016/0896-6273(92)90304-V; Berman DE, 2001, SCIENCE, V291, P2417, DOI 10.1126/science.1058165; BERNIER L, 1982, J NEUROSCI, V2, P1682; Bouton ME, 1999, PSYCHOL BULL, V125, P171, DOI 10.1037/0033-2909.125.2.171; BOUTON ME, 1993, PSYCHOL BULL, V114, P80, DOI 10.1037/0033-2909.114.1.80; Byrne JH, 1996, J NEUROSCI, V16, P425; Chain DG, 1999, NEURON, V22, P147, DOI 10.1016/S0896-6273(00)80686-8; Cheng YZ, 2001, CELL, V105, P757, DOI 10.1016/S0092-8674(01)00386-5; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; COWAN TM, 1986, J NEUROGENET, V3, P187, DOI 10.3109/01677068609106849; Crittenden JR, 1998, LEARN MEMORY, V5, P38; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Delgado R, 2000, NEURON, V28, P941, DOI 10.1016/S0896-6273(00)00165-3; DRAIN P, 1991, NEURON, V6, P71, DOI 10.1016/0896-6273(91)90123-H; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; FEANY MB, 1995, SCIENCE, V268, P869, DOI 10.1126/science.7754370; GREENBERG SM, 1987, NATURE, V329, P62, DOI 10.1038/329062a0; Grotewiel MS, 1998, NATURE, V391, P455, DOI 10.1038/35079; Guo A, 1996, LEARN MEMORY, V3, P49, DOI 10.1101/lm.3.1.49; HAN PL, 1992, NEURON, V9, P619, DOI 10.1016/0896-6273(92)90026-A; Heimbeck G, 2001, P NATL ACAD SCI USA, V98, P15336, DOI 10.1073/pnas.011314898; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; Heisenberg M, 1998, LEARN MEMORY, V5, P1; HEISENBERG M, 2002, NEUROFORUM, V8, P179; Iourgenko V, 1997, FEBS LETT, V413, P104, DOI 10.1016/S0014-5793(97)00891-0; Ito K, 1998, LEARN MEMORY, V5, P52; Kawasaki F, 2000, NAT NEUROSCI, V3, P859, DOI 10.1038/78753; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Koenig JH, 1999, J NEUROPHYSIOL, V81, P1495, DOI 10.1152/jn.1999.81.4.1495; Lattal KM, 2001, J NEUROSCI, V21, P5773, DOI 10.1523/JNEUROSCI.21-15-05773.2001; Lechner HA, 1998, NEURON, V20, P355, DOI 10.1016/S0896-6273(00)80977-0; Lee H, 1998, J NEUROSCI, V18, P8444; LEVIN LR, 1992, CELL, V68, P479, DOI 10.1016/0092-8674(92)90185-F; MADER M, 2001, THESIS J MAXIMILIANS; Malleret G, 2001, CELL, V104, P675, DOI 10.1016/S0092-8674(01)00264-1; MAUELSHAGEN J, 1993, J NEUROPHYSIOL, V69, P609, DOI 10.1152/jn.1993.69.2.609; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Medina JF, 2002, NATURE, V416, P330, DOI 10.1038/416330a; NIGHORN A, 1991, NEURON, V6, P455, DOI 10.1016/0896-6273(91)90253-V; Paterson JM, 2000, J NEUROCHEM, V75, P1358, DOI 10.1046/j.1471-4159.2000.0751358.x; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; QIU YH, 1991, J MOL BIOL, V222, P553, DOI 10.1016/0022-2836(91)90496-S; Rein K, 2002, CURR BIOL, V12, P227, DOI 10.1016/S0960-9822(02)00656-5; Repa JC, 2001, NAT NEUROSCI, V4, P724, DOI 10.1038/89512; SKOULAKIS EMC, 1993, NEURON, V11, P197, DOI 10.1016/0896-6273(93)90178-T; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; STRAUSFELD NJ, 1984, J INSECT PHYSIOL, V30, P73, DOI 10.1016/0022-1910(84)90109-4; Strausfeld NJ, 1998, LEARN MEMORY, V5, P11; Strausfeld NJ., 1976, ATLAS INSECT BRAIN, DOI 10.1007/978-3-642-66179-2; TECHNAU G, 1982, NATURE, V295, P405, DOI 10.1038/295405a0; Tettamanti M, 1997, DEV GENES EVOL, V207, P242, DOI 10.1007/s004270050112; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; Zars T, 2000, CURR OPIN NEUROBIOL, V10, P790, DOI 10.1016/S0959-4388(00)00147-1; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672; Zars T, 2000, LEARN MEMORY, V7, P18, DOI 10.1101/lm.7.1.18; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2; ZHONG Y, 1995, NATURE, V375, P588, DOI 10.1038/375588a0	60	139	139	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 29	2002	35	5					951	960		10.1016/S0896-6273(02)00832-2	http://dx.doi.org/10.1016/S0896-6273(02)00832-2			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	589UY	12372288	Bronze			2022-12-24	WOS:000177779800016
J	Neitz, J; Carroll, J; Yamauchi, Y; Neitz, M; Williams, DR				Neitz, J; Carroll, J; Yamauchi, Y; Neitz, M; Williams, DR			Color perception is mediated by a plastic neural mechanism that is adjustable in adults	NEURON			English	Article							CORTICAL MAPS; VISION; REORGANIZATION; RED; SENSITIVITY; EXPRESSION; OPPONENCY; PIGMENTS; ABSENCE; CORTEX	An intensely debated issue concerning visual-experience-dependent neural plasticity is whether experience is required only to maintain function or whether information from experience is used actively, relieving the necessity to hard-wire all connections and allowing adaptive adjustments. Here, an active role for experience is demonstrated in circuits for color vision. Chromatic experience was altered using colored filters. Over days there was a shift in color perception, as measured by the wavelength of unique yellow, which persisted 1-2 weeks after the filters were discontinued. Moreover, color-deficient adults were shown to have altered weightings of inputs to chromatic channels, demonstrating a large neural adjustment to their inherited photopigment defect. Thus, a neural normalization mechanism for color perception, determined by visual experience, operates to compensate for large genetic differences in retinal architecture and for changes in chromatic environment.	Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Dept Ophthalmol, Milwaukee, WI 53226 USA; Univ Rochester, Ctr Visual Sci, Rochester, NY 14627 USA	Medical College of Wisconsin; Medical College of Wisconsin; University of Rochester	Neitz, J (corresponding author), Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA.	jneitz@mcw.edu		Neitz, Jay/0000-0003-3877-6712; Neitz, Maureen/0000-0002-5404-3343	NEI NIH HHS [EY01931, EY09303, EY09620, EY04367, EY01319] Funding Source: Medline; NATIONAL EYE INSTITUTE [P30EY001319, R01EY009620, R01EY004367, P30EY001931, R01EY009303] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Albright TD, 2000, CELL, V100, pS1; ANDREWS DP, 1964, Q J EXP PSYCHOL, V16, P104, DOI 10.1080/17470216408416355; [Anonymous], 1991, COMPUTATIONAL MODELS, DOI [10.7551/mitpress/2002.003.0010, DOI 10.7551/MITPRESS/2002.003.0010]; [Anonymous], 1988, EYE BRAIN VISION; Balding SD, 1998, VISION RES, V38, P3359, DOI 10.1016/S0042-6989(97)00440-9; Baseler HA, 2002, NAT NEUROSCI, V5, P364, DOI 10.1038/nn817; Baseler HA, 1999, J NEUROSCI, V19, P2619; Brainard DH, 2000, J OPT SOC AM A, V17, P607, DOI 10.1364/JOSAA.17.000607; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Carroll J, 2001, COLOR RES APPL, V26, pS106, DOI 10.1002/1520-6378(2001)26:1+<::AID-COL24>3.0.CO;2-F; Carroll J, 2000, J OPT SOC AM A, V17, P499, DOI 10.1364/JOSAA.17.000499; CARROLL J, 2002, THESIS MED COLL WISC; CHINO YM, 1992, VISION RES, V32, P789, DOI 10.1016/0042-6989(92)90021-A; CICERONE CM, 1987, FARBE, V34, P59; Crowley JC, 2000, SCIENCE, V290, P1321, DOI 10.1126/science.290.5495.1321; Crowley JC, 1999, NAT NEUROSCI, V2, P1125, DOI 10.1038/16051; DEVALOIS RL, 1993, VISION RES, V33, P1053, DOI 10.1016/0042-6989(93)90240-W; EISNER A, 1982, PERCEPT PSYCHOPHYS, V31, P169, DOI 10.3758/BF03206217; GILBERT CD, 1992, NATURE, V356, P150, DOI 10.1038/356150a0; Hagstrom SA, 1998, NEUROREPORT, V9, P1963, DOI 10.1097/00001756-199806220-00009; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; HURVICH LM, 1964, PSYCHON SCI, V1, P11, DOI 10.3758/BF03342763; Jacobs GH, 1996, J OPT SOC AM A, V13, P641, DOI 10.1364/JOSAA.13.000641; JAMESON D, 1979, P NATL ACAD SCI USA, V76, P3034, DOI 10.1073/pnas.76.6.3034; Jordan G, 1997, DOC OPHTH P, V59, P67; KAAS JH, 1990, SCIENCE, V248, P229, DOI 10.1126/science.2326637; Kraft JM, 1999, P NATL ACAD SCI USA, V96, P307, DOI 10.1073/pnas.96.1.307; Kremers J, 2000, J OPT SOC AM A, V17, P517, DOI 10.1364/JOSAA.17.000517; Lennie P, 2000, CURR BIOL, V10, pR589, DOI 10.1016/S0960-9822(00)00632-1; Martin PR, 2001, NATURE, V410, P933, DOI 10.1038/35073587; Miyahara E, 1998, VISION RES, V38, P601, DOI 10.1016/S0042-6989(97)88334-4; Mollon JD, 1999, P NATL ACAD SCI USA, V96, P4743, DOI 10.1073/pnas.96.9.4743; MOLLON JD, 1982, ANNU REV PSYCHOL, V33, P41, DOI 10.1146/annurev.ps.33.020182.000353; Mollon JD, 2000, VANC ST COG, V9, P10; MOLLON JD, 1991, PIGMENTS PERCEPTION, P35; Neitz J, 1996, SCIENCE, V274, P801, DOI 10.1126/science.274.5288.801; NEITZ M, 1995, VISION RES, V35, P2395, DOI 10.1016/0042-6989(95)00008-9; Neitz M, 2001, COLOR RES APPL, V26, pS239, DOI 10.1002/1520-6378(2001)26:1+<::AID-COL51>3.0.CO;2-L; Nelson JH, 1938, P PHYS SOC, V50, P661, DOI 10.1088/0959-5309/50/5/305; Otake S, 2000, J OPT SOC AM A, V17, P615, DOI 10.1364/JOSAA.17.000615; PAULUS W, 1983, VISION RES, V23, P529, DOI 10.1016/0042-6989(83)90128-1; POKORNY J, 1991, NATO ADV SCI I A-LIF, V203, P23; POKORNY J, 1987, APPL OPTICS, V26, P1437, DOI 10.1364/AO.26.001437; POKORNY J, 1977, J OPT SOC AM, V67, P1196, DOI 10.1364/JOSA.67.001196; Polyak S., 1957, VERTEBRATE VISUAL SY; Regan BC, 2001, PHILOS T R SOC B, V356, P229, DOI 10.1098/rstb.2000.0773; Roorda A, 1999, NATURE, V397, P520, DOI 10.1038/17383; RUBIN ML, 1961, AM J OPHTHALMOL, V52, P166, DOI 10.1016/0002-9394(61)91112-6; SCHEFRIN BE, 1990, J OPT SOC AM A, V7, P305, DOI 10.1364/JOSAA.7.000305; SCHEFRIN BE, 1991, CLIN VISION SCI, V6, P219; Shevell SK, 1998, VISION RES, V38, P3371, DOI 10.1016/S0042-6989(97)00434-3; SNODDERLY DM, 1979, BEHAV SIGNIFICANCE C, P238; Stromeyer C. F., 1978, PERCEPTION, P97, DOI [10.1007/978-3-642-46354-9_4, DOI 10.1007/978-3-642-46354-9_4]; Sumner P, 2000, J EXP BIOL, V203, P1987; Wang Y, 1999, P NATL ACAD SCI USA, V96, P5251, DOI 10.1073/pnas.96.9.5251; WESNER MF, 1991, VISION RES, V31, P1021, DOI 10.1016/0042-6989(91)90207-L; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Wyszecki G., 2000, COLOR SCI CONCEPTS M, V2nd ed., P117; Yuste R, 1999, J NEUROBIOL, V41, P1, DOI 10.1002/(SICI)1097-4695(199910)41:1<1::AID-NEU1>3.0.CO;2-2	59	172	177	3	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 15	2002	35	4					783	792		10.1016/S0896-6273(02)00818-8	http://dx.doi.org/10.1016/S0896-6273(02)00818-8			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	585JE	12194876	Bronze			2022-12-24	WOS:000177521000017
J	Logothetis, NK; Merkle, H; Augath, M; Trinath, T; Ugurbil, K				Logothetis, NK; Merkle, H; Augath, M; Trinath, T; Ugurbil, K			Ultra high-resolution fMRI in monkeys with implanted RF coils	NEURON			English	Article							HIGH-SPATIAL-RESOLUTION; HUMAN BRAIN ACTIVATION; MULTIPLE VISUAL AREAS; HIGH MAGNETIC-FIELDS; FUNCTIONAL MRI; SURFACE COIL; SENSORY STIMULATION; TITANIUM IMPLANTS; NONHUMAN-PRIMATES; BLOOD OXYGENATION	Spatiotemporally resolved functional MRI (fMRI) in animals can reveal how wide-spread neural networks are organized and accompanying electrophysiological recordings can show how small neural assemblies contribute to this organization. Here we present a novel technique that yields high-resolution structural and functional images of the monkey brain with small, tissue-compatible, intraosteally implantable radiofrequency coils. Voxel sizes as small as 0.0113 mul with high signal-to-noise and contrast-to-noise ratios were obtained, revealing both structural and functional cortical architecture in great detail. Up to a certain point, contrast sensitivity increased with decreasing voxel size, probably because of the decreased partial volume effects. Spatial specificity was demonstrated by the lamina-specific activation in experiments comparing responses to moving and flickering stimuli. The implications of this technique for combined fMRI/electrophysiology experiments and its limitations in terms of spatial coverage are discussed.	Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany; Univ Minnesota, Dept Radiol, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA	Max Planck Society; University of Minnesota System; University of Minnesota Twin Cities	Logothetis, NK (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.	nikos.logothetis@tuebingen.mpg.de	Logothetis, Nikos/U-9282-2019; Ugurbil, Kamil/AAD-6058-2022		NCRR NIH HHS [RR08079] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; BANDETTINI PA, 1992, MAGNET RESON MED, V25, P390, DOI 10.1002/mrm.1910250220; BANDETTINI PA, 1993, MAGNET RESON MED, V30, P161, DOI 10.1002/mrm.1910300204; BROWNE M, 1994, BIOMATERIALS, V15, P894, DOI 10.1016/0142-9612(94)90113-9; BUTTS K, 1994, MAGNET RESON MED, V31, P67, DOI 10.1002/mrm.1910310111; Cheng K, 2001, NEURON, V32, P359, DOI 10.1016/S0896-6273(01)00477-9; CLARK VP, 1992, CEREB CORTEX, V2, P417, DOI 10.1093/cercor/2.5.417; Cochran DL, 1997, J PERIODONTOL, V68, P186, DOI 10.1902/jop.1997.68.2.186; Cochran DL, 1998, J BIOMED MATER RES, V40, P1, DOI 10.1002/(SICI)1097-4636(199804)40:1<1::AID-JBM1>3.0.CO;2-Q; COLBY CL, 1993, J NEUROPHYSIOL, V69, P902, DOI 10.1152/jn.1993.69.3.902; DANIEL PM, 1961, J PHYSIOL-LONDON, V159, P203, DOI 10.1113/jphysiol.1961.sp006803; DESIMONE R, 1986, J COMP NEUROL, V248, P164, DOI 10.1002/cne.902480203; DEVALOIS RL, 1982, VISION RES, V22, P531, DOI 10.1016/0042-6989(82)90112-2; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; DEYOE EA, 1994, J NEUROSCI METH, V54, P171, DOI 10.1016/0165-0270(94)90191-0; Disbrow E, 1999, BRAIN RES, V829, P167, DOI 10.1016/S0006-8993(99)01297-4; Disbrow EA, 2000, P NATL ACAD SCI USA, V97, P9718, DOI 10.1073/pnas.170205497; DOW BM, 1974, J NEUROPHYSIOL, V37, P927, DOI 10.1152/jn.1974.37.5.927; Dubowitz DJ, 2001, J NEUROSCI METH, V107, P71, DOI 10.1016/S0165-0270(01)00353-3; Duong TQ, 2000, MAGN RESON MED, V43, P383, DOI 10.1002/(SICI)1522-2594(200003)43:3<383::AID-MRM10>3.0.CO;2-Q; Duong TQ, 2001, P NATL ACAD SCI USA, V98, P10904, DOI 10.1073/pnas.191101098; DUVERNOY HM, 1981, BRAIN RES BULL, V7, P519, DOI 10.1016/0361-9230(81)90007-1; Eisenbarth E, 1996, BIOMATERIALS, V17, P1399, DOI 10.1016/0142-9612(96)87281-4; FARMER THR, 1990, INVEST RADIOL, V25, P552, DOI 10.1097/00004424-199005000-00013; FEINBERG DA, 1986, RADIOLOGY, V161, P527, DOI 10.1148/radiology.161.2.3763926; FRAHM J, 1993, MAGNET RESON MED, V29, P139, DOI 10.1002/mrm.1910290126; Fransson P, 1997, NMR BIOMED, V10, P204, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<204::AID-NBM452>3.0.CO;2-J; GARWOOD M, 1989, MAGNET RESON MED, V9, P25, DOI 10.1002/mrm.1910090105; GATTASS R, 1981, J COMP NEUROL, V201, P519, DOI 10.1002/cne.902010405; GOLDBERG ME, 1972, J NEUROPHYSIOL, V35, P542, DOI 10.1152/jn.1972.35.4.542; Gosain AK, 1999, J CRANIOFAC SURG, V10, P404, DOI 10.1097/00001665-199909000-00006; Grinvald A, 2000, NAT NEUROSCI, V3, P105, DOI 10.1038/72045; GRINVALD A, 1991, P NATL ACAD SCI USA, V88, P11559, DOI 10.1073/pnas.88.24.11559; Gross U M, 1988, Int J Oral Implantol, V5, P37; GRUETTER R, 1993, MAGNET RESON MED, V29, P804, DOI 10.1002/mrm.1910290613; Gruetter R, 1990, NMR BIOMED, V3, P265, DOI 10.1002/nbm.1940030605; HAACKE EM, 1994, NMR BIOMED, V7, P54, DOI 10.1002/nbm.1940070109; HAACKE EM, 1994, NMR BIOMED, V7, P374; HAREL N, 2002, P INT SCO MAG RES ME, V10, P9; HAWKEN MJ, 1988, J NEUROSCI, V8, P3541; HENDRICH K, 1994, MAGNET RESON MED, V31, P541, DOI 10.1002/mrm.1910310511; Hyde JS, 2001, MAGN RESON MED, V46, P114, DOI 10.1002/mrm.1166; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; LEE JH, 1995, MAGN RESON MED, V34, P308, DOI 10.1002/mrm.1910340305; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 1999, NAT NEUROSCI, V2, P555, DOI 10.1038/9210; LopezVillegas D, 1996, NMR BIOMED, V9, P297, DOI 10.1002/(SICI)1099-1492(199610)9:7<297::AID-NBM433>3.0.CO;2-4; MANSFIELD P, 1977, J PHYS C SOLID STATE, V10, pL55, DOI 10.1088/0022-3719/10/3/004; MCARDLE CB, 1986, AM J NEURORADIOL, V7, P885; MCKINNON GC, 1993, MAGNET RESON MED, V30, P609, DOI 10.1002/mrm.1910300512; MERBOLDT KD, 1995, MAGNET RESON MED, V34, P639, DOI 10.1002/mrm.1910340423; MERKLE H, 1999, P 16 ANN M EUR SOC M; MERKLE H, 2000, P 8 ANN SCI M INT SO; MERKLE H, 1999, P 7 M INT SOC NMR MI; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Rainer G, 2001, CURR BIOL, V11, P846, DOI 10.1016/S0960-9822(01)00242-1; RUDIN M, 1987, MAGNET RESON MED, V5, P443, DOI 10.1002/mrm.1910050505; SCHILLER PH, 1976, J NEUROPHYSIOL, V39, P1288, DOI 10.1152/jn.1976.39.6.1288; Sereno ME, 2002, NEURON, V33, P635, DOI 10.1016/S0896-6273(02)00598-6; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; SILVA AC, 2002, P ISMRM 10 M HON HAW, P11; Snowden RJ, 1994, VISUAL DETECTION MOT, P51; SUMMERS RM, 1995, MAGNET RESON MED, V33, P785, DOI 10.1002/mrm.1910330607; Tolias AS, 2001, J NEUROSCI, V21, P8594, DOI 10.1523/JNEUROSCI.21-21-08594.2001; TSO DY, 1990, SCIENCE, V249, P417, DOI 10.1126/science.2165630; UGURBIL K, 1993, MAGN RESON QUART, V9, P259; Ugurbil K, 1999, PHILOS T R SOC B, V354, P1195, DOI 10.1098/rstb.1999.0474; Vanduffel W, 2001, NEURON, V32, P565, DOI 10.1016/S0896-6273(01)00502-5; VON R, 1981, CRC CRIT R BIOMED EN, V5, P37; WALKER PM, 1991, MAGN RESON IMAGING, V9, P927, DOI 10.1016/0730-725X(91)90537-V; Weil A, 1928, ARCH NEURO PSYCHIATR, V20, P392, DOI 10.1001/archneurpsyc.1928.02210140160013; ZEKI SM, 1969, BRAIN RES, V14, P271, DOI 10.1016/0006-8993(69)90110-3; ZEKI SM, 1969, BRAIN RES, V13, P197, DOI 10.1016/0006-8993(69)90282-0; Zhang ZM, 2000, BRAIN RES, V852, P290, DOI 10.1016/S0006-8993(99)02243-X; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	80	122	125	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 18	2002	35	2					227	242		10.1016/S0896-6273(02)00775-4	http://dx.doi.org/10.1016/S0896-6273(02)00775-4			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	576YF	12160742	Bronze			2022-12-24	WOS:000177034200004
J	Lorenz, J; Cross, DJ; Minoshima, S; Morrow, TJ; Paulson, PE; Casey, KL				Lorenz, J; Cross, DJ; Minoshima, S; Morrow, TJ; Paulson, PE; Casey, KL			A unique representation of heat allodynia in the human brain	NEURON			English	Article							INDUCED SECONDARY HYPERALGESIA; LAMINA-I NEURONS; CAPSAICIN-RECEPTOR; DORSAL HORN; CEREBRAL ACTIVATION; PAIN; RESPONSES; MECHANISMS; STEM; NEUROSCIENCE	Skin inflammation causes innocuous heat to become painful. This condition, called heat allodynia, is a common feature of pathological pain states. Here, we show that heat allodynia is functionally and neuroanatomically distinct from normal heat pain. We subtracted positron emission tomography scans obtained during painful heating of normal skin from scans during equally intense but normally innocuous heating of capsaicin-treated skin. This comparison reveals the specific activation of a medial thalamic pathway to the frontal lobe during heat allodynia. The results suggest that different central pathways mediate the intensity and certain qualitative aspects of pain. In making this differentiation, the brain recognizes unique physiological features of different painful conditions, thus permitting adaptive responses to different pain states.	Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Physiol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; Vet Affairs Med Ctr, Neurol Res Labs, Ann Arbor, MI 48105 USA; Univ Hamburg, Inst Physiol, D-20246 Hamburg, Germany	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Hamburg	Casey, KL (corresponding author), Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA.	kencasey@umich.edu	Cross, Donna/GWZ-5049-2022; Lorenz, Juergen/H-1888-2018	Lorenz, Juergen/0000-0002-8561-6714; Cross, Donna/0000-0003-1918-2214; Minoshima, Satoshi/0000-0002-0043-3047	NICHD NIH HHS [P01HD33986, P01 HD033986-04] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD033986] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ADLER RJ, 1976, ANN PROBAB, V4, P1, DOI 10.1214/aop/1176996176; Andrew D, 2001, NAT NEUROSCI, V4, P72, DOI 10.1038/82924; [Anonymous], 1979, Pain, V6, P249; Baron R, 1999, NEUROLOGY, V53, P548, DOI 10.1212/WNL.53.3.548; BAUMANN TK, 1991, J NEUROPHYSIOL, V66, P212, DOI 10.1152/jn.1991.66.1.212; Beason-Held LL, 1999, J CEREBR BLOOD F MET, V19, P843, DOI 10.1097/00004647-199908000-00003; Becerra L, 2001, NEURON, V32, P927, DOI 10.1016/S0896-6273(01)00533-5; Bernard JF, 1996, PROG BRAIN RES, V107, P243; Bourgeais L, 2001, J NEUROSCI, V21, P2159, DOI 10.1523/JNEUROSCI.21-06-02159.2001; Casey KL, 2001, J NEUROPHYSIOL, V85, P951, DOI 10.1152/jn.2001.85.2.951; Casey KL, 1996, J NEUROPHYSIOL, V76, P571, DOI 10.1152/jn.1996.76.1.571; CASEY KL, 1994, J NEUROPHYSIOL, V71, P802, DOI 10.1152/jn.1994.71.2.802; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Coghill RC, 1999, J NEUROPHYSIOL, V82, P1934, DOI 10.1152/jn.1999.82.4.1934; CRAIG AD, 1995, J COMP NEUROL, V361, P225, DOI 10.1002/cne.903610204; Craig AD, 2000, NAT NEUROSCI, V3, P184, DOI 10.1038/72131; CRAIG AD, 1999, TXB PAIN, P183; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Denton D, 1999, P NATL ACAD SCI USA, V96, P5304, DOI 10.1073/pnas.96.9.5304; Derbyshire SWG, 1998, PAIN, V76, P127, DOI 10.1016/S0304-3959(98)00034-7; Dougherty PM, 1999, NEUROSCIENCE, V90, P1377, DOI 10.1016/S0306-4522(98)00551-X; FOX PT, 1984, J NEUROPHYSIOL, V51, P1109, DOI 10.1152/jn.1984.51.5.1109; Funahashi S, 2001, NEUROSCI RES, V39, P147, DOI 10.1016/S0168-0102(00)00224-8; Fuster J. M., 2015, PREFRONTAL CORTEX, V5th; GEORGE MS, 1995, AM J PSYCHIAT, V152, P341; HANDWERKER HO, 1994, PROG PAIN RES MANAG, V3, P195; Hsieh JC, 1996, PAIN, V64, P303, DOI 10.1016/0304-3959(95)00129-8; HSIEH JC, 1995, PAIN, V63, P225, DOI 10.1016/0304-3959(95)00048-W; Hunt SP, 2001, NAT REV NEUROSCI, V2, P83, DOI 10.1038/35053509; HYLDEN JLK, 1989, PAIN, V37, P229, DOI 10.1016/0304-3959(89)90135-8; Iadarola MJ, 1998, BRAIN, V121, P931, DOI 10.1093/brain/121.5.931; Lane RD, 1997, AM J PSYCHIAT, V154, P926; Liotti M, 2001, P NATL ACAD SCI USA, V98, P2035, DOI 10.1073/pnas.98.4.2035; MACLEAN PD, 1955, PSYCHOSOM MED, V17, P355, DOI 10.1097/00006842-195509000-00003; MACLEAN PD, 1957, ANNU REV PHYSIOL, V19, P397, DOI 10.1146/annurev.ph.19.030157.002145; MELZACK R, 1968, P423; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MINOSHIMA S, 1994, J NUCL MED, V35, P1528; Nakano Katsuma, 2000, Journal of Neurology, V247, DOI 10.1007/PL00007778; Paulson PE, 1998, PAIN, V76, P223, DOI 10.1016/S0304-3959(98)00048-7; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; PRICE DD, 1977, PAIN, V3, P307, DOI 10.1016/0304-3959(77)90063-X; PRICE DD, 1994, PAIN, V56, P217, DOI 10.1016/0304-3959(94)90097-3; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; RAJA SN, 1999, TXB PAIN, P00011; Reiman EM, 1997, AM J PSYCHIAT, V154, P918; Ringkamp M, 2001, J NEUROSCI, V21, P4460, DOI 10.1523/JNEUROSCI.21-12-04460.2001; Rosen SD, 1996, ANN INTERN MED, V124, P939, DOI 10.7326/0003-4819-124-11-199606010-00001; Schmelz M, 2000, BRAIN, V123, P560, DOI 10.1093/brain/123.3.560; Silverman DHS, 1997, GASTROENTEROLOGY, V112, P64, DOI 10.1016/S0016-5085(97)70220-8; Stucky CL, 2001, P NATL ACAD SCI USA, V98, P11845, DOI 10.1073/pnas.211373398; Tolle TR, 1999, ANN NEUROL, V45, P40, DOI 10.1002/1531-8249(199901)45:1<40::AID-ART8>3.0.CO;2-L; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; TOREBJORK HE, 1992, J PHYSIOL-LONDON, V448, P765, DOI 10.1113/jphysiol.1992.sp019069; Westlund KN, 1996, EXP BRAIN RES, V110, P151; WOOLF CJ, 1988, J PHYSIOL-PARIS, V83, P255; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; Yeomans DC, 1996, PAIN, V68, P141, DOI 10.1016/S0304-3959(96)03177-6	63	170	179	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 18	2002	35	2					383	393		10.1016/S0896-6273(02)00767-5	http://dx.doi.org/10.1016/S0896-6273(02)00767-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	576YF	12160755	Bronze			2022-12-24	WOS:000177034200017
J	Watase, K; Weeber, EJ; Xu, BS; Antalffy, B; Yuva-Paylor, L; Hashimoto, K; Kano, M; Atkinson, R; Sun, YL; Armstrong, DL; Sweatt, JD; Orr, HT; Paylor, R; Zoghbi, HY				Watase, K; Weeber, EJ; Xu, BS; Antalffy, B; Yuva-Paylor, L; Hashimoto, K; Kano, M; Atkinson, R; Sun, YL; Armstrong, DL; Sweatt, JD; Orr, HT; Paylor, R; Zoghbi, HY			A long CAG repeat in the mouse Sca1 locus replicates SCA1 features and reveals the impact of protein solubility on selective neurodegeneration	NEURON			English	Article							SPINOCEREBELLAR ATAXIA TYPE-1; TRANSGENIC MICE; EXPANDED POLYGLUTAMINE; HUNTINGTONS-DISEASE; TERM POTENTIATION; UBIQUITIN LIGASE; BINDING PROTEIN; PURKINJE-CELLS; EXPRESSION; DEFICITS	To faithfully recreate the features of the human neurodegenerative disease spinocerebellar ataxia type 1 (SCA1) in the mouse, we targeted 154 CAG repeats into the endogenous mouse locus. Sca1(154Q/2Q) mice developed a progressive neurological disorder that resembles human SCA1, featuring motor incoordination, cognitive deficits, wasting, and premature death, accompanied by Purkinje cell loss and age-related hippocampal synaptic dysfunction. Mutant ataxin-1 solubility varied with brain region, being most soluble in the neurons most vulnerable to degeneration. Solubility decreased overall as the mice aged; Purkinje cells, the most affected in SCA1, did not form aggregates of mutant protein until an advanced stage of disease. It appears that those neurons that cannot sequester the mutant protein efficiently and thereby curb its toxicity suffer the worst damage from polyglutamine-induced toxicity.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Kanazawa Univ, Grad Sch Med Sci, Dept Cellular Neurophysiol, Kanazawa, Ishikawa 9208640, Japan; Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Kanazawa University; University of Minnesota System; University of Minnesota Twin Cities	Zoghbi, HY (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	hzoghbi@bcm.tmc.edu	Weeber, Edwin J/A-5396-2012	Hashimoto, Kouichi/0000-0002-3884-8213; Orr, Harry/0000-0001-6118-741X; Kano, Masanobu/0000-0002-0725-3292; Sweatt, J. David/0000-0003-3567-485X; Zoghbi, Huda/0000-0002-0700-3349	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022920, R01NS027699, R37NS022920] Funding Source: NIH RePORTER; NINDS NIH HHS [NS27699, NS22920] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; Burk S, 2001, EUR NEUROL, V46, P43, DOI 10.1159/000050755; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; Clark HB, 1997, J NEUROSCI, V17, P7385; Cummings CJ, 1999, NEURON, V24, P879, DOI 10.1016/S0896-6273(00)81035-1; Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037/0735-7044.112.4.863; GENIS D, 1995, NEUROLOGY, V45, P24, DOI 10.1212/WNL.45.1.24; Gusella JF, 2000, NAT REV NEUROSCI, V1, P109, DOI 10.1038/35039051; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Kano M, 1997, NEURON, V18, P71, DOI 10.1016/S0896-6273(01)80047-7; KISH SJ, 1988, ANN NEUROL, V24, P200, DOI 10.1002/ana.410240205; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Kuemmerle S, 1999, ANN NEUROL, V46, P842; Lin CH, 2001, HUM MOL GENET, V10, P137, DOI 10.1093/hmg/10.2.137; Lin X, 2000, NAT NEUROSCI, V3, P157, DOI 10.1038/72101; Lin X, 1999, NEURON, V24, P499, DOI 10.1016/S0896-6273(00)81104-6; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; Logue SE, 1997, BEHAV NEUROSCI, V111, P104, DOI 10.1037/0735-7044.111.1.104; Lorenzetti D, 2000, HUM MOL GENET, V9, P779, DOI 10.1093/hmg/9.5.779; Matilla A, 1998, J NEUROSCI, V18, P5508, DOI 10.1523/JNEUROSCI.18-14-05508.1998; McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Muchowski PJ, 2002, P NATL ACAD SCI USA, V99, P727, DOI 10.1073/pnas.022628699; Nakamura K, 2001, HUM MOL GENET, V10, P1441, DOI 10.1093/hmg/10.14.1441; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; PAYLOR R, 1994, BEHAV NEUROSCI, V108, P810, DOI 10.1037/0735-7044.108.4.810; Roberson ED, 1996, J BIOL CHEM, V271, P30436, DOI 10.1074/jbc.271.48.30436; SERVADIO A, 1995, NAT GENET, V10, P94, DOI 10.1038/ng0595-94; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Skinner PJ, 1997, NATURE, V389, P971, DOI 10.1038/40153; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; TELENIUS H, 1993, HUM MOL GENET, V2, P1535, DOI 10.1093/hmg/2.10.1535; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217; ZOGHBI HY, 1995, SEMIN CELL BIOL, V6, P29, DOI 10.1016/1043-4682(95)90012-8	39	233	242	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 13	2002	34	6					905	919		10.1016/S0896-6273(02)00733-X	http://dx.doi.org/10.1016/S0896-6273(02)00733-X			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	563HF	12086639	Bronze			2022-12-24	WOS:000176249700009
J	Bahner, M; Frechter, S; Da Silva, N; Minke, B; Paulsen, R; Huber, A				Bahner, M; Frechter, S; Da Silva, N; Minke, B; Paulsen, R; Huber, A			Light-regulated subcellular translocation of Drosophila TRPL channels induces long-term adaptation and modifies the light-induced current	NEURON			English	Article							PDZ-DOMAIN PROTEIN; INAD SIGNALING COMPLEX; CA2+ CHANNEL; PHOTORECEPTOR MEMBRANE; LIMULUS PHOTORECEPTORS; FLY PHOTORECEPTORS; SENSITIVE CHANNELS; CATION CHANNEL; CALCIUM; MUTANT	Drosophila phototransduction results in the opening of two classes of cation channels, composed of the channel subunits transient receptor potential (TRP), TRP-like (TRPL), and TRPgamma. Here, we report that one of these subunits, TRPL, is translocated back and forth between the signaling membrane and an intracellular compartment by a light-regulated mechanism. A high level of rhabdomeral TRPL, characteristic of dark-raised flies, is functionally manifested in the properties of the light-induced current. These flies are more sensitive than flies with no or reduced TRPL level to dim background lights, and they respond to a wider range of light intensities, which fit them to function better in darkness or dim background illumination. Thus, TRPL translocation represents a novel mechanism to fine tune visual responses.	Univ Karlsruhe, Inst Zool, Dept Cell & Neurobiol, D-76128 Karlsruhe, Germany; Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Physiol, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Hadassah Med Sch, Kuhne Minerva Ctr Studies Visual Transduct, IL-91120 Jerusalem, Israel	Helmholtz Association; Karlsruhe Institute of Technology; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Huber, A (corresponding author), Univ Karlsruhe, Inst Zool, Dept Cell & Neurobiol, Kaiserstr 12, D-76128 Karlsruhe, Germany.	dc05@rz.uni-karlsruhe.de	Da Silva, Nicolas/T-3528-2019; Huber, Armin/GYU-6322-2022	Huber, Armin/0000-0003-3977-089X	NEI NIH HHS [EY 03529] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY003529] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bahner M, 2000, J BIOL CHEM, V275, P2901, DOI 10.1074/jbc.275.4.2901; BLEST AD, 1978, PROC R SOC SER B-BIO, V200, P463, DOI 10.1098/rspb.1978.0027; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; CHAMBERLAIN SC, 1979, SCIENCE, V206, P361, DOI 10.1126/science.482946; CHAMBERLAIN SC, 1984, J NEUROSCI, V4, P2792; COSENS DJ, 1969, NATURE, V224, P285, DOI 10.1038/224285a0; Hardie RC, 1996, J NEUROSCI, V16, P2924; HARDIE RC, 1991, P ROY SOC B-BIOL SCI, V245, P203, DOI 10.1098/rspb.1991.0110; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; HOCHSTRATE P, 1989, J COMP PHYSIOL A, V166, P179, DOI 10.1007/BF00193462; Huber A, 1998, FEBS LETT, V425, P317, DOI 10.1016/S0014-5793(98)00248-8; Huber A, 1996, J BIOL CHEM, V271, P11710, DOI 10.1074/jbc.271.20.11710; HUBER A, 1994, EUR J CELL BIOL, V63, P219; Huber A, 1996, EMBO J, V15, P7036, DOI 10.1002/j.1460-2075.1996.tb01095.x; Huber A, 2000, EUR J NEUROSCI, V12, P3909, DOI 10.1046/j.1460-9568.2000.00276.x; HUBER A, 2001, IN PRESS EUR J NEURO; Kanzaki M, 1999, NAT CELL BIOL, V1, P165, DOI 10.1038/11086; KLEINSCHMIDT J, 1975, J GEN PHYSIOL, V66, P617, DOI 10.1085/jgp.66.5.617; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANGER H, 1962, NATURE, V194, P111, DOI 10.1038/194111b0; Leung HT, 2000, J NEUROSCI, V20, P6797, DOI 10.1523/JNEUROSCI.20-18-06797.2000; MINKE B, 1975, NATURE, V258, P84, DOI 10.1038/258084a0; Minke B, 2000, HDB BIOL PHYSICS, V3; Montell C, 1999, ANNU REV CELL DEV BI, V15, P231, DOI 10.1146/annurev.cellbio.15.1.231; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; NAESSEL DR, 1979, J COMP PHYSL, V131, P205; Niemeyer BA, 1996, CELL, V85, P651, DOI 10.1016/S0092-8674(00)81232-5; Pak W.L., 1979, P67; PAULSEN R, 1984, J COMP PHYSIOL, V155, P47, DOI 10.1007/BF00610930; Paulsen R, 2000, PFLUG ARCH EUR J PHY, V439, pR181, DOI 10.1007/s004240000138; PERETZ A, 1994, J GEN PHYSIOL, V104, P1057, DOI 10.1085/jgp.104.6.1057; PERETZ A, 1994, NEURON, V12, P1257, DOI 10.1016/0896-6273(94)90442-1; PHILLIPS AM, 1992, NEURON, V8, P631, DOI 10.1016/0896-6273(92)90085-R; RANGANATHAN R, 1994, NEURON, V13, P837, DOI 10.1016/0896-6273(94)90250-X; RANGANATHAN R, 1991, NATURE, V354, P230, DOI 10.1038/354230a0; Reuss H, 1997, NEURON, V19, P1249, DOI 10.1016/S0896-6273(00)80416-X; SCOTT K, 1997, CELL, V91, P373; SUSSTOBY E, 1991, J GEN PHYSIOL, V98, P849, DOI 10.1085/jgp.98.4.849; Tsunoda S, 1999, CELL CALCIUM, V26, P165, DOI 10.1054/ceca.1999.0070; Tsunoda S, 2001, J NEUROSCI, V21, P150, DOI 10.1523/JNEUROSCI.21-01-00150.2001; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; Xu XZS, 1997, CELL, V89, P1155, DOI 10.1016/S0092-8674(00)80302-5; Xu XZS, 2000, NEURON, V26, P647, DOI 10.1016/S0896-6273(00)81201-5	45	112	118	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 28	2002	34	1					83	93		10.1016/S0896-6273(02)00630-X	http://dx.doi.org/10.1016/S0896-6273(02)00630-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536HR	11931743	Bronze			2022-12-24	WOS:000174695100011
J	Hallam, SJ; Goncharov, A; McEwen, J; Baran, R; Jin, YS				Hallam, SJ; Goncharov, A; McEwen, J; Baran, R; Jin, YS			SYD-1, a presynaptic protein with PDZ, C2 and rhoGAP-like domains, specifies axon identity in C-elegans	NATURE NEUROSCIENCE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; CULTURED HIPPOCAMPAL-NEURONS; GLUTAMIC-ACID DECARBOXYLASE; BINDING PROTEIN; NERVOUS-SYSTEM; CELL-LINEAGE; ACTIVE ZONE; MORPHOGENESIS; LOCALIZATION; POLARITY	Axons are defined by the presence of presynaptic specializations at specific locations. We show here that loss-of-function mutations in the C. elegans gene syd-1 cause presynaptic specializations to form in the dendritic processes of GABA-expressing motor neurons during initial differentiation. At a later developmental stage, however, syd-1 is not required for the polarity respecification of a subset of these neurons. The SYD-1 protein contains PDZ, C2 and rho-GTPase activating protein (GAP)-like domains, and is localized to presynaptic terminals in mature neurons. A truncated SYD-1 that lacks the rhoGAP domain interferes with neurite outgrowth and guidance. Our data indicate that syd-1 may be involved in specifying axon identity during initial polarity acquisition.	Univ Calif Santa Cruz, Sinsheimer Labs, Dept Mol Cellular & Dev Biol, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz	Jin, YS (corresponding author), Univ Calif Santa Cruz, Sinsheimer Labs, Dept Mol Cellular & Dev Biol, Santa Cruz, CA 95064 USA.			Jin, Yishi/0000-0002-9371-9860				Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Andersen SSL, 2000, BIOESSAYS, V22, P172, DOI 10.1002/(SICI)1521-1878(200002)22:2<172::AID-BIES8>3.0.CO;2-Q; Bamber BA, 1999, J NEUROSCI, V19, P5348; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Bradke F, 1997, NEURON, V19, P1175, DOI 10.1016/S0896-6273(00)80410-9; Bradke F, 2000, MICROSC RES TECHNIQ, V48, P3, DOI 10.1002/(SICI)1097-0029(20000101)48:1<3::AID-JEMT2>3.0.CO;2-O; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; BRENNER S, 1974, GENETICS, V77, P71; CLARK SG, 1994, GENETICS, V137, P987; Craven SE, 1998, CELL, V93, P495, DOI 10.1016/S0092-8674(00)81179-4; Crump JG, 2001, NEURON, V29, P115, DOI 10.1016/S0896-6273(01)00184-2; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Eastman C, 1999, J NEUROSCI, V19, P6225; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; Hallam SJ, 1998, NATURE, V395, P78, DOI 10.1038/25757; HORVITZ HR, 1980, GENETICS, V96, P435; Hung TJ, 1999, DEVELOPMENT, V126, P127; Jin YS, 1999, J NEUROSCI, V19, P539; Kaether C, 2000, MOL BIOL CELL, V11, P1213, DOI 10.1091/mbc.11.4.1213; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Koushika SP, 2001, NAT NEUROSCI, V4, P997, DOI 10.1038/nn732; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Mandai K, 1997, J CELL BIOL, V139, P517, DOI 10.1083/jcb.139.2.517; McCallum SJ, 1998, J BIOL CHEM, V273, P22537, DOI 10.1074/jbc.273.35.22537; McFarlane S, 2000, MOL NEUROBIOL, V22, P1, DOI 10.1385/MN:22:1-3:001; MCINTIRE SL, 1993, NATURE, V364, P337, DOI 10.1038/364337a0; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; Nonet ML, 1999, J NEUROSCI METH, V89, P33, DOI 10.1016/S0165-0270(99)00031-X; Rittinger K, 1998, NATURE, V392, P448, DOI 10.1038/33043; Rittinger K, 1997, NATURE, V388, P693, DOI 10.1038/41805; Rongo C, 1999, NATURE, V402, P195, DOI 10.1038/46065; Rongo C, 1998, CELL, V94, P751, DOI 10.1016/S0092-8674(00)81734-1; Seewald MJ, 2002, NATURE, V415, P662, DOI 10.1038/415662a; Simske JS, 1996, CELL, V85, P195, DOI 10.1016/S0092-8674(00)81096-X; SULSTON JE, 1976, PHILOS T ROY SOC B, V275, P287, DOI 10.1098/rstb.1976.0084; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Vaduva G, 1997, J CELL BIOL, V139, P1821, DOI 10.1083/jcb.139.7.1821; WHITE JG, 1978, NATURE, V271, P764, DOI 10.1038/271764a0; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wu WJ, 2000, NATURE, V405, P800, DOI 10.1038/35015585; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886; ZOLLER MJ, 1987, METHOD ENZYMOL, V154, P329	45	78	94	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1137	1146		10.1038/nn959	http://dx.doi.org/10.1038/nn959			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	609CG	12379863				2022-12-24	WOS:000178884600016
J	Schonherr, R; Mannuzzu, LM; Isacoff, EY; Heinemann, SH				Schonherr, R; Mannuzzu, LM; Isacoff, EY; Heinemann, SH			Conformational switch between slow and fast gating modes: Allosteric regulation of voltage sensor mobility in the EAG K+ channel	NEURON			English	Article							SHAKER POTASSIUM CHANNELS; BETA-GAMMA-SUBUNITS; GATED ION CHANNELS; S4 SEGMENT; TRANSMEMBRANE SEGMENTS; SODIUM-CHANNELS; ELECTROSTATIC INTERACTIONS; FUNCTIONAL EXPRESSION; MOLECULAR-BASIS; CA2+ CHANNELS	Voltage-gated EAG K+ channels switch between fast and slow gating modes in a Mg2+-dependent manner by an unknown mechanism. We analyzed molecular motions in and around the voltage-sensing S4 in bEAG1. Using accessibility and perturbation analyses, we found that activation increases both the charge occupancy and volume of S4 side chains in the gating canal. Fluorescence measurements suggest that mode switching is due to a motion of the S2/S3 side of the gating canal. We propose that when S4 is in the resting state and its thin end is in the gating canal, a conformational rearrangement of S2/S3 narrows the canal around S4, forming the Mg2+ binding site. Binding of Mg2+ is proposed to stabilize this conformation and to slow opening of the gate by impeding S4's voltage-sensing outward motion.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Jena, Fac Med, Res Unit Mol & Cellular Biophys, D-07747 Jena, Germany	University of California System; University of California Berkeley; Friedrich Schiller University of Jena	Isacoff, EY (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.		isacoff, ehud/AAP-1459-2020; Schönherr, Roland/K-8713-2013	Schönherr, Roland/0000-0003-0633-0775; Isacoff, Ehud Y./0000-0003-4775-9359; Heinemann, Stefan H./0000-0002-4144-0251	NINDS NIH HHS [R01NS35549, R01 NS035549-05] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035549] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Baker OS, 1998, NEURON, V20, P1283, DOI 10.1016/S0896-6273(00)80507-3; Baukrowitz T, 1996, SCIENCE, V271, P653, DOI 10.1126/science.271.5249.653; CATTERALL WA, 1986, TRENDS NEUROSCI, V9, P7, DOI 10.1016/0166-2236(86)90004-4; Cha A, 1999, NATURE, V402, P809, DOI 10.1038/45552; Davis MJ, 2001, AM J PHYSIOL-HEART C, V281, pH1835, DOI 10.1152/ajpheart.2001.281.5.H1835; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Elinder F, 2001, BIOPHYS J, V80, P1802, DOI 10.1016/S0006-3495(01)76150-4; Frings S, 1998, J GEN PHYSIOL, V111, P583, DOI 10.1085/jgp.111.4.583; Gandhi CS, 2000, NEURON, V27, P585, DOI 10.1016/S0896-6273(00)00068-4; Ganetzky B, 1983, J NEUROGENET, V1, P17, DOI 10.3109/01677068309107069; Glauner KS, 1999, NATURE, V402, P813, DOI 10.1038/45561; GUY HR, 1986, P NATL ACAD SCI USA, V83, P508, DOI 10.1073/pnas.83.2.508; Harris RE, 1998, BIOPHYS J, V74, P1808, DOI 10.1016/S0006-3495(98)77891-9; Herlitze S, 2001, P NATL ACAD SCI USA, V98, P4699, DOI 10.1073/pnas.051628998; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hong KH, 2000, J GEN PHYSIOL, V115, P51, DOI 10.1085/jgp.115.1.51; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Larsson HP, 2000, NEURON, V27, P573, DOI 10.1016/S0896-6273(00)00067-2; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Li-Smerin Y, 2001, J GEN PHYSIOL, V117, P205, DOI 10.1085/jgp.117.3.205; Li-Smerin YY, 2000, J GEN PHYSIOL, V115, P33, DOI 10.1085/jgp.115.1.33; Liu Y, 1996, NEURON, V16, P859, DOI 10.1016/S0896-6273(00)80106-3; Liu YS, 2001, NAT STRUCT BIOL, V8, P883, DOI 10.1038/nsb1001-883; Loots E, 2000, J GEN PHYSIOL, V116, P623, DOI 10.1085/jgp.116.5.623; LOPEZ GA, 1991, NEURON, V7, P327, DOI 10.1016/0896-6273(91)90271-Z; LUDWIG J, 1994, EMBO J, V13, P4451, DOI 10.1002/j.1460-2075.1994.tb06767.x; Ludwig J, 2000, MOL CELL NEUROSCI, V16, P59, DOI 10.1006/mcne.2000.0851; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; Occhiodoro T, 1998, FEBS LETT, V434, P177, DOI 10.1016/S0014-5793(98)00973-9; PAPAZIAN DM, 1995, NEURON, V14, P1293, DOI 10.1016/0896-6273(95)90276-7; Perozo E, 1999, SCIENCE, V285, P73, DOI 10.1126/science.285.5424.73; PLANELLSCASES R, 1995, P NATL ACAD SCI USA, V92, P9422, DOI 10.1073/pnas.92.20.9422; Saganich MJ, 1999, J NEUROSCI, V19, P10789, DOI 10.1523/JNEUROSCI.19-24-10789.1999; Schonherr R, 2000, EMBO J, V19, P3263, DOI 10.1093/emboj/19.13.3263; Schonherr R, 1999, J BIOL CHEM, V274, P5362, DOI 10.1074/jbc.274.9.5362; Schonherr R, 2002, FEBS LETT, V514, P204, DOI 10.1016/S0014-5793(02)02365-7; Schoppa NE, 1998, J GEN PHYSIOL, V111, P313, DOI 10.1085/jgp.111.2.313; Schoppa NE, 1998, J GEN PHYSIOL, V111, P271, DOI 10.1085/jgp.111.2.271; Schoppa NE, 1998, J GEN PHYSIOL, V111, P295, DOI 10.1085/jgp.111.2.295; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Silverman WR, 2000, J GEN PHYSIOL, V116, P663, DOI 10.1085/jgp.116.5.663; Smith PL, 2002, J GEN PHYSIOL, V119, P275, DOI 10.1085/jgp.119.3.275; Starace DM, 1997, NEURON, V19, P1319, DOI 10.1016/S0896-6273(00)80422-5; Starace DM, 2001, J GEN PHYSIOL, V117, P469, DOI 10.1085/jgp.117.5.469; Tang CY, 2000, J GEN PHYSIOL, V115, P319, DOI 10.1085/jgp.115.3.319; Terlau H, 1996, PFLUG ARCH EUR J PHY, V432, P301, DOI 10.1007/s004240050137; TiwariWoodruff SK, 1997, BIOPHYS J, V72, P1489, DOI 10.1016/S0006-3495(97)78797-6; Wang MH, 1999, J PHYSIOL-LONDON, V521, P315, DOI 10.1111/j.1469-7793.1999.00315.x; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448; Yusaf SP, 1996, PFLUG ARCH EUR J PHY, V433, P91, DOI 10.1007/s004240050253; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321	57	53	58	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 29	2002	35	5					935	949		10.1016/S0896-6273(02)00869-3	http://dx.doi.org/10.1016/S0896-6273(02)00869-3			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	589UY	12372287	Bronze			2022-12-24	WOS:000177779800015
J	Neumann, S; Bradke, F; Tessier-Lavigne, M; Basbaum, AI				Neumann, S; Bradke, F; Tessier-Lavigne, M; Basbaum, AI			Regeneration of sensory axons within the injured spinal cord induced by intraganglionic cAMP elevation	NEURON			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; CENTRAL-NERVOUS-SYSTEM; NEURITE GROWTH; CNS MYELIN; ADULT; RAT; NEURONS; LESION; SCAR; PROJECTIONS	The peripheral branch of primary sensory neurons regenerates after injury, but there is no regeneration when their central branch is severed by spinal cord injury. Here we show that microinjection of a membrane-permeable analog of cAMP in lumbar dorsal root ganglia markedly increases the regeneration of injured central sensory branches. The injured axons regrow into the spinal cord lesion, often traversing the injury site. This result mimics the effect of a conditioning peripheral nerve lesion. We also demonstrate that sensory neurons exposed to cAMP in vivo, when subsequently cultured in vitro, show enhanced growth of neurites and an ability to overcome inhibition by CNS myelin. Thus, stimulating cAMP signaling increases the intrinsic growth capacity of injured sensory axons. This approach may be useful in promoting regeneration after spinal cord injury.	Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, WM Keck Fdn, Ctr Integrat Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Tessier-Lavigne, M (corresponding author), Stanford Univ, Howard Hughes Med Inst, Dept Sci Biol, 371 Serra Mall, Stanford, CA 94305 USA.			Bradke, Frank/0000-0002-0345-3772				Andersen PL, 2000, EXP NEUROL, V166, P153, DOI 10.1006/exnr.2000.7485; Ba-Charvet KTN, 2001, J NEUROSCI, V21, P4281; BENFEY M, 1985, J NEUROCYTOL, V14, P279, DOI 10.1007/BF01258453; Blesch A, 1999, J NEUROSCI, V19, P3556; Bradbury EJ, 1999, EUR J NEUROSCI, V11, P3873, DOI 10.1046/j.1460-9568.1999.00809.x; BREGMAN BS, 1995, NATURE, V378, P498, DOI 10.1038/378498a0; Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001; Cai DM, 1999, NEURON, V22, P89, DOI 10.1016/S0896-6273(00)80681-9; COLMAN DR, 1982, J CELL BIOL, V95, P598, DOI 10.1083/jcb.95.2.598; DEHOOP MJ, 1997, CELL BIOL LAB HDB, P154; FAWCETT JW, 1992, TRENDS NEUROSCI, V15, P5, DOI 10.1016/0166-2236(92)90338-9; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Fitch MT, 1997, CELL TISSUE RES, V290, P379, DOI 10.1007/s004410050944; Jakeman LB, 1998, EXP NEUROL, V154, P170, DOI 10.1006/exnr.1998.6924; JAKEMAN LB, 1991, J COMP NEUROL, V307, P311, DOI 10.1002/cne.903070211; KALDERON N, 1990, P NATL ACAD SCI USA, V87, P10058, DOI 10.1073/pnas.87.24.10058; LAMOTTE CC, 1991, J COMP NEUROL, V311, P546, DOI 10.1002/cne.903110409; LAWSON SN, 1991, J PHYSIOL-LONDON, V435, P41, DOI 10.1113/jphysiol.1991.sp018497; LOGAN A, 1994, EUR J NEUROSCI, V6, P355, DOI 10.1111/j.1460-9568.1994.tb00278.x; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; OUDEGA M, 1994, EXP NEUROL, V129, P194, DOI 10.1006/exnr.1994.1161; Pasterkamp RJ, 1999, MOL CELL NEUROSCI, V13, P143, DOI 10.1006/mcne.1999.0738; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; Ramer MS, 2000, NATURE, V403, P312, DOI 10.1038/35002084; RAMONYCAJAL S, 1991, DEGENERATION REGENER; RICHARDSON PM, 1986, J NEUROCYTOL, V15, P585, DOI 10.1007/BF01611859; RICHARDSON PM, 1984, NATURE, V309, P791, DOI 10.1038/309791a0; ROBERTSON B, 1989, J NEUROCYTOL, V18, P77, DOI 10.1007/BF01188426; RYDEL RE, 1988, P NATL ACAD SCI USA, V85, P1257, DOI 10.1073/pnas.85.4.1257; SCHNELL L, 1994, NATURE, V367, P170, DOI 10.1038/367170a0; SCHWAB ME, 1988, J NEUROSCI, V8, P2381; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; SHAW G, 1986, EUR J CELL BIOL, V42, P1; Smith DS, 1997, J NEUROSCI, V17, P646; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515	37	436	481	0	17	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 13	2002	34	6					885	893		10.1016/S0896-6273(02)00702-X	http://dx.doi.org/10.1016/S0896-6273(02)00702-X			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	563HF	12086637	Bronze			2022-12-24	WOS:000176249700007
J	Huang, X; Cheng, HJ; Tessier-Lavigne, M; Jin, YS				Huang, X; Cheng, HJ; Tessier-Lavigne, M; Jin, YS			MAX-1, a novel PH/MyTH4/FERM domain cytoplasmic protein implicated in netrin-mediated axon repulsion	NEURON			English	Article							GROWTH CONE MIGRATIONS; C-ELEGANS; CAENORHABDITIS-ELEGANS; NERVOUS-SYSTEM; TRANSMEMBRANE PROTEIN; GUIDANCE RECEPTORS; LATERAL POSITION; ROBO RECEPTORS; GENE-TRANSFER; GUIDES CELL	The netrin UNC-6 repels motor axons by activating the UNC-5 receptor alone or in combination with the UNC-40/DCC receptor. In a genetic screen for C. elegans mutants exhibiting partial defects in motor axon projections, we isolated the max-1 gene (required for motor neuron axon guidance). max-1 loss-of-function mutations cause fully penetrant but variable axon guidance defects. Mutations in unc-5 and unc-6, but not in unc-40 dominantly enhance the mutant phenotypes of max-1, whereas overexpression of unc-5 or unc-6, but not of unc-40, bypasses the requirement for max-1. MAX-1 proteins contain PH, MyTH4, and FERM domains and appear to be localized to neuronal processes. Human MAX-1 and UNC5H2 colocalize in discrete subcellular regions of transfected cells. Our results suggest a possible role for MAX-1 in netrin-induced axon repulsion by modulating the UNC-5 receptor signaling pathway.	Univ Calif Santa Cruz, Sinsheimer Labs, Dept Mol Cellular & Dev Biol, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Sinsheimer Labs, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA; Stanford Univ, Howard Hughes Med Inst, Dept Biol Sci, Stanford, CA 94305 USA	University of California System; University of California Santa Cruz; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz; Howard Hughes Medical Institute; Stanford University	Jin, YS (corresponding author), Univ Calif Santa Cruz, Sinsheimer Labs, Dept Mol Cellular & Dev Biol, Santa Cruz, CA 95064 USA.	jin@biology.ucsc.edu	Cheng, Hwai-Jong/AAY-5067-2021	Cheng, Hwai-Jong/0000-0003-0647-0567; Jin, Yishi/0000-0002-9371-9860; Huang, Xun/0000-0002-2653-8293	NINDS NIH HHS [NS35546] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS035546, R01NS035546] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Bashaw GJ, 1999, CELL, V97, P917, DOI 10.1016/S0092-8674(00)80803-X; Berg JS, 2000, J CELL SCI, V113, P3439; Bloom L., 1993, THESIS MIT CAMBRIDGE; BRENNER S, 1974, GENETICS, V77, P71; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; CHALFIE M, 1985, J NEUROSCI, V5, P956; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; Chisholm A, 1999, CURR OPIN NEUROBIOL, V9, P603, DOI 10.1016/S0959-4388(99)00021-5; CHISHOLM AD, 1989, GENE DEV, V3, P1413, DOI 10.1101/gad.3.9.1413; Chishti AH, 1998, TRENDS BIOCHEM SCI, V23, P281, DOI 10.1016/S0968-0004(98)01237-7; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; Colavita A, 1998, SCIENCE, V281, P706, DOI 10.1126/science.281.5377.706; Colavita A, 1998, DEV BIOL, V194, P72, DOI 10.1006/dbio.1997.8790; Edwards AS, 2000, CURR OPIN CELL BIOL, V12, P217, DOI 10.1016/S0955-0674(99)00085-X; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; Forrester WC, 1997, DEVELOPMENT, V124, P1831; George SE, 1998, CELL, V92, P633, DOI 10.1016/S0092-8674(00)81131-9; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; HAMELIN M, 1992, EMBO J, V11, P2885, DOI 10.1002/j.1460-2075.1992.tb05357.x; HAMELIN M, 1993, NATURE, V364, P327, DOI 10.1038/364327a0; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; ISHII N, 1992, NEURON, V9, P873, DOI 10.1016/0896-6273(92)90240-E; Jin YS, 1999, J NEUROSCI, V19, P539; Keleman K, 2001, NEURON, V32, P605, DOI 10.1016/S0896-6273(01)00505-0; Kikuno R, 2000, NUCLEIC ACIDS RES, V28, P331, DOI 10.1093/nar/28.1.331; Kussel-Andermann P, 2000, EMBO J, V19, P6020, DOI 10.1093/emboj/19.22.6020; Kussel-Andermann P, 2000, J BIOL CHEM, V275, P29654, DOI 10.1074/jbc.M004393200; Lemmon MA, 1996, CELL, V85, P621, DOI 10.1016/S0092-8674(00)81022-3; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; MADURO M, 1995, GENETICS, V141, P977; MCINTIRE SL, 1992, NEURON, V8, P307, DOI 10.1016/0896-6273(92)90297-Q; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Merz DC, 2000, J NEUROBIOL, V44, P281, DOI 10.1002/1097-4695(200008)44:2&lt;281::AID-NEU16&gt;3.0.CO;2-4; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Muramatsu T, 1998, INT J MOL MED, V1, P55; Prasad BC, 1998, DEVELOPMENT, V125, P1561; Rajagopalan S, 2000, CELL, V103, P1033, DOI 10.1016/S0092-8674(00)00207-5; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Simpson JH, 2000, CELL, V103, P1019, DOI 10.1016/S0092-8674(00)00206-3; SONG H, 2001, NAT CELL BIOL, V3, pEB1; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Stein L, 2001, NUCLEIC ACIDS RES, V29, P82, DOI 10.1093/nar/29.1.82; Steven R, 1998, CELL, V92, P785, DOI 10.1016/S0092-8674(00)81406-3; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tuxworth RI, 2001, CURR BIOL, V11, P318, DOI 10.1016/S0960-9822(01)00097-5; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wills Z, 1999, NEURON, V22, P301, DOI 10.1016/S0896-6273(00)81091-0; Woollard A, 2000, GENE DEV, V14, P596; Zallen JA, 1999, DEVELOPMENT, V126, P3679; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2; [No title captured]	60	89	109	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 16	2002	34	4					563	576		10.1016/S0896-6273(02)00672-4	http://dx.doi.org/10.1016/S0896-6273(02)00672-4			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	553FT	12062040	Bronze			2022-12-24	WOS:000175665700010
J	Hardingham, GE; Fukunaga, Y; Bading, H				Hardingham, GE; Fukunaga, Y; Bading, H			Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways	NATURE NEUROSCIENCE			English	Article							FAMILY TRANSCRIPTION FACTOR; D-ASPARTATE RECEPTOR; GENE-EXPRESSION; MITOCHONDRIAL DEPOLARIZATION; DEPENDENT SURVIVAL; CALCIUM; GLUTAMATE; PHOSPHORYLATION; NUCLEAR; DEPHOSPHORYLATION	Here we report that synaptic and extrasynaptic NMDA (N-methyl-D-aspartate) receptors have opposite effects on CREB (cAMP response element binding protein) function, gene regulation and neuron survival. Calcium entry through synaptic NMDA receptors induced CREB activity and brain-derived neurotrophic factor (BDNF) gene expression as strongly as did stimulation of L-type calcium channels. In contrast, calcium entry through extrasynaptic NMDA receptors, triggered by bath glutamate exposure or hypoxic/ischemic conditions, activated a general and dominant CREB shut-off pathway that blocked induction of BDNF expression. Synaptic NMDA receptors have anti-apoptotic activity, whereas stimulation of extrasynaptic NMDA receptors caused loss of mitochondrial membrane potential (an early marker for glutamate-induced neuronal damage) and cell death. Specific blockade of extrasynaptic NMDA receptors may effectively prevent neuron loss following stroke and other neuropathological conditions associated with glutamate toxicity.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Bading, H (corresponding author), Heidelberg Univ, Interdisciplinary Ctr Neurosci, Dept Neurobiol, Neuenheimer Feld 364, D-69120 Heidelberg, Germany.	Hilmar.Bading@uni-hd.de		Hardingham, Giles/0000-0002-7629-5314				Bading H, 2000, EUR J BIOCHEM, V267, P5280, DOI 10.1046/j.1432-1327.2000.01565.x; BADING H, 1995, NEUROSCIENCE, V64, P653, DOI 10.1016/0306-4522(94)00462-E; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Bittigau P, 1997, J CHILD NEUROL, V12, P471, DOI 10.1177/088307389701200802; Bollen M, 2001, TRENDS BIOCHEM SCI, V26, P426, DOI 10.1016/S0968-0004(01)01836-9; Carafoli E, 2001, CRIT REV BIOCHEM MOL, V36, P107, DOI 10.1080/20014091074183; Chang KT, 2001, NEURON, V32, P855, DOI 10.1016/S0896-6273(01)00516-5; Chawla S, 2001, J NEUROCHEM, V79, P849, DOI 10.1046/j.1471-4159.2001.00645.x; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Fields RD, 1997, J NEUROSCI, V17, P7252; Fujikawa DG, 2000, NEUROSCIENCE, V98, P41, DOI 10.1016/S0306-4522(00)00085-3; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; HAGIWARA M, 1992, CELL, V70, P105, DOI 10.1016/0092-8674(92)90537-M; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; Hardingham GE, 2001, NAT NEUROSCI, V4, P565, DOI 10.1038/88380; HOSSMANN KA, 1994, ANN NEUROL, V36, P557, DOI 10.1002/ana.410360404; Hu SC, 1999, NEURON, V22, P799, DOI 10.1016/S0896-6273(00)80738-2; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Ikonomidou C, 2000, P NATL ACAD SCI USA, V97, P12885, DOI 10.1073/pnas.220412197; Keelan J, 1999, J PHYSIOL-LONDON, V520, P797, DOI 10.1111/j.1469-7793.1999.00797.x; KOKAIA Z, 1995, EXP NEUROL, V136, P73, DOI 10.1006/exnr.1995.1085; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Lipsky RH, 2001, J NEUROCHEM, V78, P254, DOI 10.1046/j.1471-4159.2001.00386.x; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; Olney J W, 1986, Adv Neurol, V44, P857; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Rossi DJ, 2000, NATURE, V403, P316, DOI 10.1038/35002090; Sala C, 2000, J NEUROSCI, V20, P3529, DOI 10.1523/JNEUROSCI.20-10-03529.2000; Sattler R, 1998, J NEUROCHEM, V71, P2349; Schinder AF, 1996, J NEUROSCI, V16, P6125; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; Stout AK, 1998, NAT NEUROSCI, V1, P366, DOI 10.1038/1577; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Tovar KR, 1999, J NEUROSCI, V19, P4180; TYMIANSKI M, 1993, J NEUROSCI, V13, P2085; Vergun O, 1999, J PHYSIOL-LONDON, V519, P451, DOI 10.1111/j.1469-7793.1999.0451m.x; Walton MR, 2000, TRENDS NEUROSCI, V23, P48, DOI 10.1016/S0166-2236(99)01500-3; WHITFIELD W, 1988, J ROYAL SOC HLTH, V1, P1; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; Young D, 1999, NAT MED, V5, P448, DOI 10.1038/7449	50	1254	1300	1	86	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2002	5	5					405	414		10.1038/nn835	http://dx.doi.org/10.1038/nn835			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	546JY	11953750				2022-12-24	WOS:000175272000010
J	Swadlow, HA; Gusev, AG				Swadlow, HA; Gusev, AG			Receptive-field construction in cortical inhibitory interneurons	NATURE NEUROSCIENCE			English	Article							AWAKE RABBIT; CORTEX; NEURONS		Univ Connecticut, Dept Psychol, Storrs, CT 06269 USA; Russian Acad Med Sci, Moscow Brain Res Inst, Moscow 103064, Russia	University of Connecticut; Russian Academy of Medical Sciences	Swadlow, HA (corresponding author), Univ Connecticut, Dept Psychol, 406 Babbidge Rd, Storrs, CT 06269 USA.	swadlow@psych.psy.uconn.edu			NIMH NIH HHS [MH64024] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064024] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Alonso JM, 2001, J NEUROSCI, V21, P4002, DOI 10.1523/JNEUROSCI.21-11-04002.2001; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; HARRIS RM, 1983, J COMP NEUROL, V220, P63, DOI 10.1002/cne.902200107; Krukowski AE, 2001, NAT NEUROSCI, V4, P424, DOI 10.1038/86084; Miller KD, 2001, CURR OPIN NEUROBIOL, V11, P488, DOI 10.1016/S0959-4388(00)00239-7; Miller LM, 2001, NEURON, V32, P151, DOI 10.1016/S0896-6273(01)00445-7; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; SIMONS DJ, 1989, J NEUROPHYSIOL, V61, P311, DOI 10.1152/jn.1989.61.2.311; SWADLOW HA, 1995, J NEUROPHYSIOL, V73, P1584, DOI 10.1152/jn.1995.73.4.1584; Swadlow HA, 1998, J NEUROPHYSIOL, V79, P567, DOI 10.1152/jn.1998.79.2.567; SWADLOW HA, 1989, J NEUROPHYSIOL, V62, P288, DOI 10.1152/jn.1989.62.1.288; Swadlow HA, 2000, J NEUROPHYSIOL, V83, P2802, DOI 10.1152/jn.2000.83.5.2802; Troyer TW, 1998, J NEUROSCI, V18, P5908; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X	15	119	122	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2002	5	5					403	404		10.1038/nn847	http://dx.doi.org/10.1038/nn847			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	546JY	11967546				2022-12-24	WOS:000175272000009
J	Hibino, H; Pironkova, R; Onwumere, O; Vologodskaia, M; Hudspeth, AJ; Lesage, F				Hibino, H; Pironkova, R; Onwumere, O; Vologodskaia, M; Hudspeth, AJ; Lesage, F			RIM binding proteins (RBPs) couple Rab3-interacting molecules (RIMs) to voltage-gated Ca2+ channels	NEURON			English	Article							COCHLEAR HAIR-CELLS; CALCIUM CHANNELS; NEUROTRANSMITTER RELEASE; SUBCELLULAR-LOCALIZATION; ALPHA(1D) SUBUNIT; SYNAPTIC VESICLES; CHICKENS COCHLEA; KINETIC-ANALYSIS; RAB3 EFFECTOR; ACTIVE ZONES	Ca2+ influx through voltage-gated channels initiates the exocytotic fusion of synaptic vesicles to the plasma membrane. Here we show that RIM binding proteins (RBPs), which associate with Ca2+ channels in hair cells, photoreceptors, and neurons, interact with a,p (L type) and alpha(1B) (N type) Ca2+ channel subunits. RBPs contain three Src homology 3 domains that bind to proline-rich motifs in a, subunits and Rab3-interacting molecules (RIMs). Overexpression in PC12 cells of fusion proteins that suppress the interactions of RBPs with RIMs and a, augments the exocytosis triggered by depolarization. RBPs may regulate the strength of synaptic transmission by creating a functional link between the synaptic-vesicle tethering apparatus, which includes RIMS and Rab3, and the fusion machinery, which includes Ca2+ channels and the SNARE complex.	Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Rockefeller Univ, Lab Sensory Neurosci, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University	Hudspeth, AJ (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10021 USA.		Lesage, Florian/D-5097-2011; Lesage, Florian/P-9780-2019	Lesage, Florian/0000-0002-4406-7106; Lesage, Florian/0000-0002-4406-7106	Howard Hughes Medical Institute Funding Source: Medline; NIDCD NIH HHS [R01 DC000241, F32 DC000317, R01 DC000241-26, DC 00317] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000241, F32DC000317] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Atlas D, 2001, J NEUROCHEM, V77, P972, DOI 10.1046/j.1471-4159.2001.00347.x; Betz A, 2001, NEURON, V30, P183, DOI 10.1016/S0896-6273(01)00272-0; BEZPROZVANNY I, 1995, NATURE, V378, P623, DOI 10.1038/378623a0; Boudin H, 2000, NEURON, V28, P485, DOI 10.1016/S0896-6273(00)00127-6; Catterall WA, 1999, ANN NY ACAD SCI, V868, P144, DOI 10.1111/j.1749-6632.1999.tb11284.x; Coppola T, 2001, J BIOL CHEM, V276, P32756, DOI 10.1074/jbc.M100929200; COREY DP, 1984, J PHYSIOL-LONDON, V354, P557, DOI 10.1113/jphysiol.1984.sp015393; Di Paolo G, 2002, NEURON, V33, P789, DOI 10.1016/S0896-6273(02)00601-3; Galiegue S, 1999, J BIOL CHEM, V274, P2938, DOI 10.1074/jbc.274.5.2938; GARCIA EP, 1995, J CELL BIOL, V129, P105, DOI 10.1083/jcb.129.1.105; Geppert M, 1998, ANNU REV NEUROSCI, V21, P75, DOI 10.1146/annurev.neuro.21.1.75; HAMA K, 1980, J NEUROCYTOL, V9, P845, DOI 10.1007/BF01205023; Haynes LP, 2001, J BIOL CHEM, V276, P9726, DOI 10.1074/jbc.M006959200; HELL JW, 1993, J CELL BIOL, V123, P949, DOI 10.1083/jcb.123.4.949; Heller S, 1998, P NATL ACAD SCI USA, V95, P11400, DOI 10.1073/pnas.95.19.11400; Hibino H, 1997, J NEUROSCI, V17, P4711; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HUDSPETH AJ, 1988, J PHYSIOL-LONDON, V400, P237, DOI 10.1113/jphysiol.1988.sp017119; JONES DH, 1974, BIOCHIM BIOPHYS ACTA, V356, P276, DOI 10.1016/0005-2736(74)90268-5; Kollmar R, 1997, P NATL ACAD SCI USA, V94, P14889, DOI 10.1073/pnas.94.26.14889; Kollmar R, 1997, P NATL ACAD SCI USA, V94, P14883, DOI 10.1073/pnas.94.26.14883; Koushika SP, 2001, NAT NEUROSCI, V4, P997, DOI 10.1038/nn732; Lin RC, 2000, ANNU REV CELL DEV BI, V16, P19, DOI 10.1146/annurev.cellbio.16.1.19; Liu HY, 1996, J NEUROSCI, V16, P7557; Lloyd TE, 2001, NAT NEUROSCI, V4, P965, DOI 10.1038/nn1001-965; Mayer BJ, 2001, J CELL SCI, V114, P1253; Mochida S, 2000, NEUROSCI RES, V36, P175, DOI 10.1016/S0168-0102(99)00128-5; Morgans CW, 1998, J NEUROSCI, V18, P2467; Morgans CW, 1999, EUR J NEUROSCI, V11, P2989, DOI 10.1046/j.1460-9568.1999.00719.x; Nishi R, 1996, METHOD CELL BIOL, V51, P249, DOI 10.1016/S0091-679X(08)60632-9; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; Phillips GR, 2001, NEURON, V32, P63, DOI 10.1016/S0896-6273(01)00450-0; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; Safieddine S, 1999, EUR J NEUROSCI, V11, P803, DOI 10.1046/j.1460-9568.1999.00487.x; SHIRATAKI H, 1993, MOL CELL BIOL, V13, P2061, DOI 10.1128/MCB.13.4.2061; Strom TM, 1998, NAT GENET, V19, P260, DOI 10.1038/940; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Wang Y, 2000, J BIOL CHEM, V275, P20033, DOI 10.1074/jbc.M909008199; WESTENBROEK RE, 1995, J NEUROSCI, V15, P6403; WESTENBROEK RE, 1992, NEURON, V9, P1099, DOI 10.1016/0896-6273(92)90069-P; Yang HD, 2002, J COMP NEUROL, V443, P275, DOI 10.1002/cne.10116; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500; ZIDANIC M, 1995, BIOPHYS J, V68, P1323, DOI 10.1016/S0006-3495(95)80305-X	44	191	199	0	19	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 25	2002	34	3					411	423		10.1016/S0896-6273(02)00667-0	http://dx.doi.org/10.1016/S0896-6273(02)00667-0			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	545JW	11988172	Green Accepted, Bronze			2022-12-24	WOS:000175214700012
J	Heins, N; Malatesta, P; Cecconi, F; Nakafuku, M; Tucker, KL; Hack, MA; Chapouton, P; Barde, YA; Gotz, M				Heins, N; Malatesta, P; Cecconi, F; Nakafuku, M; Tucker, KL; Hack, MA; Chapouton, P; Barde, YA; Gotz, M			Glial cells generate neurons: the role of the transcription factor Pax6	NATURE NEUROSCIENCE			English	Article							SUBVENTRICULAR ZONE; MOUSE; EXPRESSION; DIFFERENTIATION; ASTROCYTES; IDENTITY; GENES; IDENTIFICATION; RETROVIRUSES; NEUROGENIN2	Radial glial cells, ubiquitous throughout the developing CNS, guide radially migrating neurons and are the precursors of astrocytes. Recent evidence indicates that radial glial cells also generate neurons in the developing cerebral cortex. Here we investigated the role of the transcription factor Pax6 expressed in cortical radial glia. We showed that radial glial cells isolated from the cortex of Pax6 mutant mice have a reduced neurogenic potential, whereas the neurogenic potential of non-radial glial precursors is not affected. Consistent with defects in only one neurogenic lineage, the number of neurons in the Pax6 mutant cortex in vivo is reduced by half. Conversely, retrovirally mediated Pax6 expression instructs neurogenesis even in astrocytes from postnatal cortex in vitro. These results demonstrated an important role of Pax6 as intrinsic fate determinant of the neurogenic potential of glial cells.	Max Planck Inst Neurobiol, D-82152 Munich, Germany; Univ Roma Tor Vergata, Dipartimento Biol, I-00133 Rome, Italy; Univ Tokyo, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland	Max Planck Society; University of Rome Tor Vergata; University of Tokyo; Friedrich Miescher Institute for Biomedical Research	Gotz, M (corresponding author), Max Planck Inst Neurobiol, Klopferspitz 18A, D-82152 Munich, Germany.	mgoetz@neuro.mpg.de	Nakafuku, Masato/J-3068-2013; Barde, Yves/F-6019-2011; Cecconi, Francesco/K-3969-2016; Malatesta, Paolo/J-3570-2012	Cecconi, Francesco/0000-0002-5614-4359; Malatesta, Paolo/0000-0003-3045-3361; Nakafuku, Masato/0000-0001-7783-9005; Barde, Yves/0000-0002-7627-461X	Telethon [TCP99038] Funding Source: Medline	Telethon(Fondazione Telethon)		ANDERSON DJ, 1989, NEURON, V3, P1, DOI 10.1016/0896-6273(89)90110-4; Caric D, 1997, DEVELOPMENT, V124, P5087; Chapouton P, 1999, DEVELOPMENT, V126, P5569; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Estivill-Torrus G, 2002, DEVELOPMENT, V129, P455; Farah MH, 2000, DEVELOPMENT, V127, P693; Fode C, 2000, GENE DEV, V14, P67; GHATTAS IR, 1991, MOL CELL BIOL, V11, P5848, DOI 10.1128/MCB.11.12.5848; Goetz M, 1998, TRENDS NEUROSCI, V21, P135, DOI 10.1016/S0166-2236(98)01228-4; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Gowan K, 2001, NEURON, V31, P219, DOI 10.1016/S0896-6273(01)00367-1; GROVE EA, 1993, DEVELOPMENT, V117, P553; HAJIHOSSEINI M, 1993, EMBO J, V12, P4969, DOI 10.1002/j.1460-2075.1993.tb06190.x; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; Heins N, 2001, MOL CELL NEUROSCI, V18, P485, DOI 10.1006/mcne.2001.1046; Hildebrand B, 1997, NEUROSCIENCE, V78, P957, DOI 10.1016/S0306-4522(96)00676-8; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; Laywell ED, 2000, P NATL ACAD SCI USA, V97, P13883, DOI 10.1073/pnas.250471697; Lillien L, 1997, CURR BIOL, V7, pR168, DOI 10.1016/S0960-9822(97)70080-0; Lo LC, 1998, DEVELOPMENT, V125, P609; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Qian XM, 1998, DEVELOPMENT, V125, P3143; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; REID CB, 1995, NEURON, V15, P299, DOI 10.1016/0896-6273(95)90035-7; Scardigli R, 2001, NEURON, V31, P203, DOI 10.1016/S0896-6273(01)00358-0; SCHMAHL W, 1993, ACTA NEUROPATHOL, V86, P126, DOI 10.1007/BF00334879; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Skogh C, 2001, MOL CELL NEUROSCI, V17, P811, DOI 10.1006/mcne.2001.0973; Stoykova A, 2000, J NEUROSCI, V20, P8042; Stoykova A, 1997, DEVELOPMENT, V124, P3765; Stoykova A, 1996, DEVELOPMENT, V122, P3453; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Takebayashi H, 2000, MECH DEVELOP, V99, P143, DOI 10.1016/S0925-4773(00)00466-4; Tarabykin V, 2001, DEVELOPMENT, V128, P1983; Toresson H, 2000, DEVELOPMENT, V127, P4361; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; WALTHER C, 1991, DEVELOPMENT, V113, P1435; WILLIAMS BP, 1991, NEURON, V7, P685, DOI 10.1016/0896-6273(91)90381-9; WILLIAMS BP, 1995, NEURON, V14, P1181, DOI 10.1016/0896-6273(95)90265-1; Zhuo L, 1997, DEV BIOL, V187, P36, DOI 10.1006/dbio.1997.8601	48	580	602	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2002	5	4					308	315		10.1038/nn828	http://dx.doi.org/10.1038/nn828			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	534UQ	11896398				2022-12-24	WOS:000174606900010
J	Kida, S; Josselyn, SA; de Ortiz, SP; Kogan, JH; Chevere, I; Masushige, S; Silva, AJ				Kida, S; Josselyn, SA; de Ortiz, SP; Kogan, JH; Chevere, I; Masushige, S; Silva, AJ			CREB required for the stability of new and reactivated fear memories	NATURE NEUROSCIENCE			English	Article							LONG-TERM-MEMORY; ELEMENT-BINDING PROTEIN; SITE-SPECIFIC RECOMBINATION; CAMP-RESPONSIVE ELEMENT; CONTEXTUAL FEAR; MICE; HIPPOCAMPUS; RECONSOLIDATION; CONSOLIDATION; RETRIEVAL	The cAMP-responsive element binding protein (CREB) family of transcription factors is thought to be critical in memory formation. To define the role of CREB in distinct memory processes, we derived transgenic mice with an inducible and reversible CREB repressor by fusing CREBS133A to a tamoxifen (TAM)-dependent mutant of an estrogen receptor ligand-binding domain (LBD). We found that CREB is crucial for the consolidation of long-term conditioned fear memories, but not for encoding, storage or retrieval of these memories. Our studies also showed that CREB is required for the stability of reactivated or retrieved conditioned fear memories. Although the transcriptional processes necessary for the stability of initial and reactivated memories differ, CREB is required for both. The findings presented here delineate the memory processes that require CREB and demonstrate the power of LBD-inducible transgenic systems in the study of complex cognitive processes.	Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA; Tokyo Univ Agr, Fac Appl Biosci, Dept Biosci, SetagayaKu, Tokyo 1568502, Japan; Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; Univ Puerto Rico, Dept Biol, San Juan, PR 00931 USA	University of California System; University of California Los Angeles; Tokyo University of Agriculture; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Silva, AJ (corresponding author), Univ Calif Los Angeles, Dept Neurobiol, 695 Young Dr S,Gonda Bldg, Los Angeles, CA 90095 USA.	silvaa@mednet.ucla.edu	Silva, Alcino/ABD-7684-2021	Silva, Alcino/0000-0002-1587-4558; Silva, Alcino/0000-0001-5525-0494; Chevere Torres, Itzamarie/0000-0001-9001-8172				Anagnostaras SG, 2000, LEARN MEMORY, V7, P58, DOI 10.1101/lm.7.1.58; Berman DE, 2001, SCIENCE, V291, P2417, DOI 10.1126/science.1058165; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Brindle PK, 1992, CURR OPIN GENET DEV, V2, P199, DOI 10.1016/S0959-437X(05)80274-6; DANIELIAN PS, 1993, MOL ENDOCRINOL, V7, P232, DOI 10.1210/me.7.2.232; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; DAWSON RG, 1969, SCIENCE, V166, P525, DOI 10.1126/science.166.3904.525; de Ortiz SP, 2000, NEUROBIOL LEARN MEM, V74, P161, DOI 10.1006/nlme.1999.3952; Dudai Y, 1996, NEURON, V17, P367, DOI 10.1016/S0896-6273(00)80168-3; Fanselow MS, 2000, BEHAV BRAIN RES, V110, P73, DOI 10.1016/S0166-4328(99)00186-2; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Frankland PW, 2001, NATURE, V411, P309, DOI 10.1038/35077089; Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037/0735-7044.112.4.863; GERSON R, 1978, ANIM LEARN BEHAV, V6, P346, DOI 10.3758/BF03209625; GOLD PE, 1972, PHYSIOL BEHAV, V8, P797, DOI 10.1016/0031-9384(72)90286-7; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; GORDON WC, 1977, PHYSIOL BEHAV, V18, P95, DOI 10.1016/0031-9384(77)90099-3; GORDON WC, 1977, AM J PSYCHOL, V90, P231, DOI 10.2307/1422045; Guzowski JF, 1997, P NATL ACAD SCI USA, V94, P2693, DOI 10.1073/pnas.94.6.2693; Hall J, 2001, EUR J NEUROSCI, V13, P1453, DOI 10.1046/j.0953-816x.2001.01531.x; JAMIESON JL, 1970, PSYCHON SCI, V18, P14, DOI 10.3758/BF03332303; Josselyn SA, 2001, J NEUROSCI, V21, P2404, DOI 10.1523/JNEUROSCI.21-07-02404.2001; JUDGE ME, 1982, PHYSIOL BEHAV, V28, P585, DOI 10.1016/0031-9384(82)90034-8; Kogan JH, 2000, HIPPOCAMPUS, V10, P47, DOI 10.1002/(SICI)1098-1063(2000)10:1<47::AID-HIPO5>3.0.CO;2-6; Kogan JH, 1997, CURR BIOL, V7, P1, DOI 10.1016/S0960-9822(06)00022-4; Lamprecht R, 1997, J NEUROSCI, V17, P8443; Lattal KM, 2001, J NEUROSCI, V21, P5773, DOI 10.1523/JNEUROSCI.21-15-05773.2001; LOGIE C, 1995, P NATL ACAD SCI USA, V92, P5940, DOI 10.1073/pnas.92.13.5940; MACTUTUS CF, 1979, SCIENCE, V204, P1319, DOI 10.1126/science.572083; MACTUTUS CF, 1982, PHYSIOL BEHAV, V28, P939, DOI 10.1016/0031-9384(82)90218-9; MACTUTUS CF, 1980, BEHAV NEURAL BIOL, V30, P260, DOI 10.1016/S0163-1047(80)91150-4; MATTHIES H, 1989, PROG NEUROBIOL, V32, P277, DOI 10.1016/0301-0082(89)90024-5; Mayford M, 1996, P NATL ACAD SCI USA, V93, P13250, DOI 10.1073/pnas.93.23.13250; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; MISANIN JR, 1968, SCIENCE, V160, P554, DOI 10.1126/science.160.3827.554; Muratake T, 1996, GENOMICS, V36, P63, DOI 10.1006/geno.1996.0426; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Przybyslawski J, 1997, BEHAV BRAIN RES, V84, P241, DOI 10.1016/S0166-4328(96)00153-2; Przybyslawski J, 1999, J NEUROSCI, V19, P6623; Rodriguez WA, 1999, PROG NEURO-PSYCHOPH, V23, P1285, DOI 10.1016/S0278-5846(99)00063-9; Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73; SCHNEIDER AM, 1968, SCIENCE, V159, P219, DOI 10.1126/science.159.3811.219; Sengupta S, 2000, ONCOGENE, V19, P337, DOI 10.1038/sj.onc.1203256; Skoulakis EMC, 1996, NEURON, V17, P931, DOI 10.1016/S0896-6273(00)80224-X; SQUIRE LR, 1976, BEHAV BIOL, V18, P335, DOI 10.1016/S0091-6773(76)92295-1; Summers MJ, 1997, COGNITIVE BRAIN RES, V5, P311, DOI 10.1016/S0926-6410(97)00007-4; Taubenfeld SM, 2001, NAT NEUROSCI, V4, P813, DOI 10.1038/90520; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9	50	462	475	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2002	5	4					348	355		10.1038/nn819	http://dx.doi.org/10.1038/nn819			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	534UQ	11889468				2022-12-24	WOS:000174606900015
J	Ling, DSF; Benardo, LS; Serrano, PA; Blace, N; Kelly, MT; Crary, JF; Sacktor, TC				Ling, DSF; Benardo, LS; Serrano, PA; Blace, N; Kelly, MT; Crary, JF; Sacktor, TC			Protein kinase M zeta is necessary and sufficient for LTP maintenance	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; ACTIVATION; MECHANISMS; INDUCTION; CELLS		SUNY Downstate Med Ctr, Dept Physiol, Brooklyn, NY 11203 USA; SUNY Downstate Med Ctr, Dept Pharmacol, Brooklyn, NY 11203 USA; SUNY Downstate Med Ctr, Dept Neurol, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Sacktor, TC (corresponding author), SUNY Downstate Med Ctr, Dept Physiol, 450 Clarkson Ave, Brooklyn, NY 11203 USA.			Blace, Nancy/0000-0002-6174-6004				Bortolotto ZA, 2000, EUR J NEUROSCI, V12, P4055, DOI 10.1046/j.1460-9568.2000.00291.x; DENNY JB, 1990, BRAIN RES, V534, P201, DOI 10.1016/0006-8993(90)90130-4; Drier EA, 2002, NAT NEUROSCI, V5, P316, DOI 10.1038/nn820; Fukunaga K, 2000, J NEUROCHEM, V74, P807, DOI 10.1046/j.1471-4159.2000.740807.x; Lallena MJ, 1999, MOL CELL BIOL, V19, P2180; LLEDO PM, 1995, P NATL ACAD SCI USA, V92, P11175, DOI 10.1073/pnas.92.24.11175; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MALINOW R, 1988, NATURE, V335, P820, DOI 10.1038/335820a0; MCGLYNN E, 1992, J CELL BIOCHEM, V49, P239, DOI 10.1002/jcb.240490306; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Otmakhov N, 1997, J NEUROSCI, V17, P5357; SACKTOR TC, 1993, P NATL ACAD SCI USA, V90, P8342, DOI 10.1073/pnas.90.18.8342; SCHWARTZ JH, 1987, ANNU REV NEUROSCI, V10, P459; Shirke AM, 1997, J NEUROPHYSIOL, V78, P2682, DOI 10.1152/jn.1997.78.5.2682; Thompson LJ, 1996, J BIOL CHEM, V271, P15045, DOI 10.1074/jbc.271.25.15045	15	327	345	0	41	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2002	5	4					295	296		10.1038/nn829	http://dx.doi.org/10.1038/nn829			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	534UQ	11914719				2022-12-24	WOS:000174606900006
J	Shanley, LJ; Irving, AJ; Rae, MG; Ashford, MLJ; Harvey, J				Shanley, LJ; Irving, AJ; Rae, MG; Ashford, MLJ; Harvey, J			Leptin inhibits rat hippocampal neurons via activation of large conductance calcium-activated K+ channels	NATURE NEUROSCIENCE			English	Article							SENSITIVE POTASSIUM CHANNELS; CELL-LINE; CLONING; CRI-G1		Univ Dundee, Ninewells Hosp & Med Sch, Dept Pharmacol & Neurosci, Dundee DD1 9SY, Scotland	University of Dundee	Harvey, J (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Dept Pharmacol & Neurosci, Dundee DD1 9SY, Scotland.		rae, mark/M-1277-2019	Ashford, Michael/0000-0002-0861-7676; Harvey, Jenni/0000-0002-9858-001X; Rae, Mark/0000-0002-9836-2688				Behrens R, 2000, FEBS LETT, V474, P99, DOI 10.1016/S0014-5793(00)01584-2; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; FRANCIOLINI F, 1988, BIOCHIM BIOPHYS ACTA, V943, P419, DOI 10.1016/0005-2736(88)90373-2; Harvey J, 2000, J BIOL CHEM, V275, P4660, DOI 10.1074/jbc.275.7.4660; Harvey J, 1997, J PHYSIOL-LONDON, V504, P527, DOI 10.1111/j.1469-7793.1997.527bd.x; Latorre R, 1989, Acta Physiol Scand Suppl, V582, P13; Meera P, 2000, P NATL ACAD SCI USA, V97, P5562, DOI 10.1073/pnas.100118597; Powis JE, 1998, AM J PHYSIOL-REG I, V274, pR1468, DOI 10.1152/ajpregu.1998.274.5.R1468; Shanley LJ, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-24-j0001.2001; Spanswick D, 1997, NATURE, V390, P521, DOI 10.1038/37379; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Toro L, 1998, NEWS PHYSIOL SCI, V13, P112; WANN KT, 1994, EUR J NEUROSCI, V6, P607, DOI 10.1111/j.1460-9568.1994.tb00305.x	13	66	73	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2002	5	4					299	300		10.1038/nn824	http://dx.doi.org/10.1038/nn824			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	534UQ	11889470				2022-12-24	WOS:000174606900008
J	Furrer, MP; Kim, S; Wolf, B; Chiba, A				Furrer, MP; Kim, S; Wolf, B; Chiba, A			Robo and Frazzled/DCC mediate dendritic guidance at the CNS midline	NATURE NEUROSCIENCE			English	Article							GROWTH CONE GUIDANCE; NEURONS IN-VIVO; AXON GUIDANCE; DROSOPHILA CNS; RECEPTORS SPECIFY; COMMISSURAL AXONS; LATERAL POSITION; RHO-GTPASES; SLIT; GENES	Neuronal connectivity is established by the axo-dendritic polarity, correct guidance and targeting of neurons. Unlike for axons, the mechanisms responsible for directed outgrowth of dendrites are not well understood. Using single-cell labeling, we describe specific guidance defects in dendrites of identified neurons in frazzled, robo, netrin and commissureless mutant embryos of Drosophila melanogaster. We found that the cell-surface molecules Frazzled and Robo work as guidance molecules not only for axons but also for dendrites as they navigate within the CNS. Furthermore, we report that each neuron showed a cell-autonomous and independent use of guidance molecules.	Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Chiba, A (corresponding author), Univ Illinois, Dept Cell & Struct Biol, 601 S Goodwin Ave, Urbana, IL 61801 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040420] Funding Source: NIH RePORTER; NINDS NIH HHS [NS40420, NS350049] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bashaw GJ, 1999, CELL, V97, P917, DOI 10.1016/S0092-8674(00)80803-X; Battye R, 1999, DEVELOPMENT, V126, P2475; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Chiba A, 1999, INT REV NEUROBIOL, V43, P1, DOI 10.1016/S0074-7742(08)60538-3; Chisholm A, 1999, CURR OPIN NEUROBIOL, V9, P603, DOI 10.1016/S0959-4388(99)00021-5; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; Culotti JG, 1998, CURR OPIN CELL BIOL, V10, P609, DOI 10.1016/S0955-0674(98)80036-7; Gao FB, 1999, GENE DEV, V13, P2549, DOI 10.1101/gad.13.19.2549; Georgiou M, 2002, DEVELOPMENT, V129, P2947; Godenschwege TA, 2002, J NEUROSCI, V22, P3117, DOI 10.1523/JNEUROSCI.22-08-03117.2002; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; Hiramoto M, 2000, NATURE, V406, P886, DOI 10.1038/35022571; Keleman K, 2002, CELL, V110, P415, DOI 10.1016/S0092-8674(02)00901-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; Landgraf M, 1997, J NEUROSCI, V17, P9642; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Li Z, 2000, NAT NEUROSCI, V3, P217, DOI 10.1038/72920; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Merz DC, 2001, GENETICS, V158, P1071; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Rajagopalan S, 2000, CELL, V103, P1033, DOI 10.1016/S0092-8674(00)00207-5; ROTHBERG JM, 1990, GENE DEV, V4, P2169, DOI 10.1101/gad.4.12a.2169; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Simpson JH, 2000, CELL, V103, P1019, DOI 10.1016/S0092-8674(00)00206-3; Song HJ, 1999, CURR OPIN NEUROBIOL, V9, P355, DOI 10.1016/S0959-4388(99)80052-X; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Sweeney NT, 2002, DEV BIOL, V247, P76, DOI 10.1006/dbio.2002.0702; Tear G, 1996, NEURON, V16, P501, DOI 10.1016/S0896-6273(00)80070-7; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; WHARTON KA, 1993, MECH DEVELOP, V40, P141, DOI 10.1016/0925-4773(93)90072-6; Whitford KL, 2002, NEURON, V33, P47, DOI 10.1016/S0896-6273(01)00566-9; Wolf B, 1998, DEVELOPMENT, V125, P3853; Wolf BD, 2000, DEVELOPMENT, V127, P2001; Wu GY, 1999, J NEUROSCI, V19, P4472; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222	39	85	86	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2003	6	3					223	230		10.1038/nn1017	http://dx.doi.org/10.1038/nn1017			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	648YB	12592406				2022-12-24	WOS:000181178300010
J	Janssen, P; Vogels, R; Liu, Y; Orban, GA				Janssen, P; Vogels, R; Liu, Y; Orban, GA			At least at the level of inferior temporal cortex, the stereo correspondence problem is solved	NEURON			English	Article							VERGENCE EYE-MOVEMENTS; INFEROTEMPORAL CORTEX; MACAQUE MONKEY; DISPARITY SENSITIVITY; BINOCULAR DISPARITY; VISUAL AREA; NEURONS; SELECTIVITY; RESPONSES; DEPTH	Stereoscopic vision requires the correspondence problem to be solved, i.e., discarding "false" matches between images of the two eyes, while keeping correct ones. To advance our understanding of the underlying neuronal mechanisms, we compared single neuron responses to correlated and anticorrelated random dot stereograms (RDSs). Inferior temporal neurons, which respond selectively to disparity-defined three-dimensional shapes, showed robust selectivity for correlated RDSs portraying concave or convex surfaces, but unlike neurons in areas V1, MT/V5, and MST, were not selective for anticorrelated RDSs. These results show that the correspondence problem is solved at least in far extrastriate cortex, as it is in the monkey's perception.	KU Leuven Med Sch, Neuro & Psychofysiol Lab, B-3000 Louvain, Belgium; Univ Washington, Reg Primate Res Ctr, Seattle, WA 98195 USA; Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	KU Leuven; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Orban, GA (corresponding author), KU Leuven Med Sch, Neuro & Psychofysiol Lab, Herestr 49, B-3000 Louvain, Belgium.	guy.orban@med.kuleuven.ac.be		Orban, Guy/0000-0002-8179-9584				BURKHALTER A, 1986, J NEUROSCI, V6, P2327; CHELAZZI L, 1993, NATURE, V363, P345, DOI 10.1038/363345a0; Chelazzi L, 1998, J NEUROPHYSIOL, V80, P2918, DOI 10.1152/jn.1998.80.6.2918; CoboLewis AB, 1996, VISION RES, V36, P345, DOI 10.1016/0042-6989(95)00124-7; Cumming BG, 1997, NATURE, V389, P280, DOI 10.1038/38487; Cumming BG, 1999, J NEUROSCI, V19, P5602; Cumming BG, 2001, ANNU REV NEUROSCI, V24, P203, DOI 10.1146/annurev.neuro.24.1.203; Cumming BG, 1998, PERCEPTION, V27, P1367, DOI 10.1068/p271367; DeAngelis GC, 1998, NATURE, V394, P677, DOI 10.1038/29299; DESIMONE R, 1984, J NEUROSCI, V4, P2051; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; FELLEMAN DJ, 1987, J NEUROPHYSIOL, V57, P889, DOI 10.1152/jn.1987.57.4.889; Ferraina S, 2000, J NEUROPHYSIOL, V83, P625, DOI 10.1152/jn.2000.83.1.625; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; HARWERTH RS, 1979, VISION RES, V19, P985, DOI 10.1016/0042-6989(79)90223-2; Hinkle DA, 2001, NEUROREPORT, V12, P365, DOI 10.1097/00001756-200102120-00036; Howard IP, 1995, BINOCULAR VISION STE; HUBEL DH, 1970, NATURE, V225, P41, DOI 10.1038/225041a0; Janssen P, 2000, NEURON, V27, P385, DOI 10.1016/S0896-6273(00)00045-3; Janssen P, 2000, SCIENCE, V288, P2054, DOI 10.1126/science.288.5473.2054; Janssen P, 2001, J NEUROSCI, V21, P9419, DOI 10.1523/JNEUROSCI.21-23-09419.2001; Janssen P, 1999, P NATL ACAD SCI USA, V96, P8217, DOI 10.1073/pnas.96.14.8217; Janssen P, 1998, DOC OPHTHALMOL, V95, P247, DOI 10.1023/A:1001848105993; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Julesz B., 1971, FDN CYCLOPEAN PERCEP; KOMATSU H, 1992, J NEUROSCI, V12, P408; MARR D, 1979, PROC R SOC SER B-BIO, V204, P301, DOI 10.1098/rspb.1979.0029; Masson GS, 1997, NATURE, V389, P283, DOI 10.1038/38496; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1148, DOI 10.1152/jn.1983.49.5.1148; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Op De Beeck H, 2000, J COMP NEUROL, V426, P505, DOI 10.1002/1096-9861(20001030)426:4<505::AID-CNE1>3.0.CO;2-M; POGGIO GF, 1988, J NEUROSCI, V8, P4531; RICHMOND BJ, 1983, J NEUROPHYSIOL, V50, P1415, DOI 10.1152/jn.1983.50.6.1415; ROY JP, 1992, J NEUROSCI, V12, P2478; SALEEM KS, 1993, CEREB CORTEX, V3, P454, DOI 10.1093/cercor/3.5.454; Saleem KS, 2000, J NEUROSCI, V20, P5083; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Shikata E, 1996, NEUROREPORT, V7, P2389, DOI 10.1097/00001756-199610020-00022; Taira M, 2000, J NEUROPHYSIOL, V83, P3140, DOI 10.1152/jn.2000.83.5.3140; Takemura A, 2001, J NEUROPHYSIOL, V85, P2245, DOI 10.1152/jn.2001.85.5.2245; TANAKA K, 1991, J NEUROPHYSIOL, V66, P170, DOI 10.1152/jn.1991.66.1.170; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372; Tsutsui KI, 2002, SCIENCE, V298, P409, DOI 10.1126/science.1074128; Uka T, 2000, J NEUROPHYSIOL, V84, P120, DOI 10.1152/jn.2000.84.1.120; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; UNGERLEIDER LG, 1986, J COMP NEUROL, V248, P147, DOI 10.1002/cne.902480202; UNGERLEIDER LG, 1986, J COMP NEUROL, V248, P190, DOI 10.1002/cne.902480204; WESTHEIMER G, 1979, EXP BRAIN RES, V36, P585	48	95	98	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 20	2003	37	4					693	701		10.1016/S0896-6273(03)00023-0	http://dx.doi.org/10.1016/S0896-6273(03)00023-0			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	648EH	12597865	Bronze			2022-12-24	WOS:000181136500016
J	Bello, BC; Hirth, F; Gould, AP				Bello, BC; Hirth, F; Gould, AP			A pulse of the Drosophila Hox protein abdominal-A schedules the end of neural proliferation via neuroblast apoptosis	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; PROGRAMMED CELL-DEATH; BITHORAX COMPLEX; GENE-EXPRESSION; MOSAIC ANALYSIS; MELANOGASTER; SEGMENTATION; NEUROGENESIS; PATTERNS; MARKERS	Postembryonic neuroblasts are stem cell-like precursors that generate most neurons of the adult Drosophila central nervous system (CNS). Their capacity to divide is modulated along the anterior-posterior body axis, but the mechanism underlying this is unclear. We use clonal analysis of identified precursors in the abdomen to show that neuron production stops because the cell death program is activated in the neuroblast while it is still engaged in the cell cycle. A burst of expression of the Hox protein Abdominal-A (AbdA) specifies the time at which apoptosis occurs, thereby determining the final number of progeny that each neuroblast generates. These studies identify a mechanism linking the Hox axial patterning system to neural proliferation, and this involves temporal regulation of precursor cell death rather than the cell cycle.	Natl Inst Med Res, MRC, London NW7 1AA, England	MRC National Institute for Medical Research	Gould, AP (corresponding author), Natl Inst Med Res, MRC, Mill Hill, London NW7 1AA, England.	agould@nimr.mrc.ac.uk	Gould, Alex/M-5353-2019; Gould, Alex/A-7479-2010; Hirth, Frank/B-8384-2015	Gould, Alex/0000-0002-6875-6985; Gould, Alex/0000-0002-6875-6985; Hirth, Frank/0000-0001-8581-9450	Medical Research Council [MC_U117584237] Funding Source: researchfish; MRC [MC_U117584237] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ABRAMS JM, 1993, DEVELOPMENT, V117, P29; BENDER W, 1985, COLD SPRING HARB SYM, V50, P173, DOI 10.1101/SQB.1985.050.01.023; BRAND AH, 1993, DEVELOPMENT, V118, P401; BRAY SJ, 1989, GENE DEV, V3, P1130, DOI 10.1101/gad.3.8.1130; BROADUS J, 1995, MECH DEVELOP, V53, P393, DOI 10.1016/0925-4773(95)00454-8; Brodu V, 2002, DEVELOPMENT, V129, P2957; Campos-Ortega J, 1997, EMBRYONIC DEV DROSOP; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; DOE CQ, 1992, DEVELOPMENT, V116, P855; DUBOULE D, 1995, CURR OPIN GENET DEV, V5, P525, DOI 10.1016/0959-437X(95)90058-O; Durand B, 2000, BIOESSAYS, V22, P64; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; FLYBASE, 1999, NUCLEIC ACIDS RES, V27, P85; GARCIABELLIDO A, 1975, CIBA F SYMP, P161, DOI DOI 10.1002/9780470720110.CH8; Garrity PA, 1996, CELL, V85, P639, DOI 10.1016/S0092-8674(00)81231-3; GONZALEZREYES A, 1992, DEVELOPMENT, V116, P1059; Gould A, 1997, CURR OPIN GENET DEV, V7, P488, DOI 10.1016/S0959-437X(97)80075-5; Honarpour N, 2000, DEV BIOL, V218, P248, DOI 10.1006/dbio.1999.9585; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; KIMURA K, 1990, J NEUROSCI, V10, P403; Kuan CY, 2000, TRENDS NEUROSCI, V23, P291, DOI 10.1016/S0166-2236(00)01581-2; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Li L, 2000, GENE DEV, V14, P147; Liu TH, 2002, MECH DEVELOP, V112, P25, DOI 10.1016/S0925-4773(01)00626-8; Lohmann I, 2002, CELL, V110, P457, DOI 10.1016/S0092-8674(02)00871-1; Lohmann I, 2002, CURR BIOL, V12, pR514, DOI 10.1016/S0960-9822(02)01025-4; Mann RS, 2000, ANNU REV CELL DEV BI, V16, P243, DOI 10.1146/annurev.cellbio.16.1.243; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; MICHELSON AM, 1994, DEVELOPMENT, V120, P755; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Peterson C, 2002, DEVELOPMENT, V129, P1467; Pirrotta V, 1998, CELL, V93, P333, DOI 10.1016/S0092-8674(00)81162-9; Pompeiano M, 2000, J COMP NEUROL, V423, P1; PROKOP A, 1991, DEVELOPMENT, V111, P79; Prokop A, 1998, MECH DEVELOP, V74, P99, DOI 10.1016/S0925-4773(98)00068-9; RAFF MC, 1993, SCIENCE, V262, P695, DOI 10.1126/science.8235590; Ringrose L, 2001, BIOESSAYS, V23, P566, DOI 10.1002/bies.1082; SANCHEZHERRERO E, 1985, NATURE, V313, P108, DOI 10.1038/313108a0; SIMON J, 1995, CURR OPIN CELL BIOL, V7, P376, DOI 10.1016/0955-0674(95)80093-X; Sommer L, 2002, PROG NEUROBIOL, V66, P1, DOI 10.1016/S0301-0082(01)00022-3; Stadler HS, 2001, DEVELOPMENT, V128, P4177; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Truman James W., 1993, P1245; TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X; WAKIMOTO BT, 1981, DEV BIOL, V81, P51, DOI 10.1016/0012-1606(81)90347-X; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; WHITE K, 1978, DEV BIOL, V65, P296, DOI 10.1016/0012-1606(78)90029-5	50	151	154	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 23	2003	37	2					209	219		10.1016/S0896-6273(02)01181-9	http://dx.doi.org/10.1016/S0896-6273(02)01181-9			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	646UX	12546817	Bronze			2022-12-24	WOS:000181054900007
J	Crone, SA; Negro, A; Trumpp, A; Giovannini, M; Lee, KF				Crone, SA; Negro, A; Trumpp, A; Giovannini, M; Lee, KF			Colonic epithelial expression of ErbB2 is required for postnatal maintenance of the enteric nervous system	NEURON			English	Article							NEU DIFFERENTIATION FACTOR; ENDOTHELIN-B RECEPTOR; NORMAL HUMAN ADULT; MICE LACKING; TYROSINE KINASE; GERMLINE MUTATIONS; RET PROTOONCOGENE; GROWTH-FACTOR; HIRSCHSPRUNG; GENE	We utilized the Cre-LoxP system to establish erbB2 conditional mutant mice in order to investigate the role of erbB2 in postnatal development of the enteric nervous system. The erbB2/nestin-Cre conditional mutants exhibit retarded growth, distended colons, and premature death, resembling human Hirschsprung's disease. Enteric neurons and glia are present at birth in the colon of erbB2/nestin-Cre mutants; however, a marked loss of multiple classes of enteric neurons and glia occurs by 3 weeks of age. Furthermore, we demonstrate that the requirement for erbB2 in maintaining the enteric nervous system is not cell autonomous, but rather erbB2 signaling in the colonic epithelia is required for the postnatal survival of enteric neurons and glia.	Salk Inst Biol Studies, La Jolla, CA 92037 USA; Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; INSERM, U434, Inst Curie, F-75231 Paris 05, France	Salk Institute; University of California System; University of California San Diego; University of California System; University of California San Francisco; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Lee, KF (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	klee@salk.edu	Trumpp, Andreas/Z-2141-2019	Trumpp, Andreas/0000-0002-6212-3466; Crone, Steven/0000-0001-9644-2767				Akagi K, 1997, NUCLEIC ACIDS RES, V25, P1766, DOI 10.1093/nar/25.9.1766; Angrist M, 1996, NAT GENET, V14, P341, DOI 10.1038/ng1196-341; BADNER JA, 1990, AM J HUM GENET, V46, P568; Bates B, 1999, NAT NEUROSCI, V2, P115, DOI 10.1038/5669; BAYNASH AG, 1994, CELL, V79, P1277, DOI 10.1016/0092-8674(94)90018-3; Blaugrund E, 1996, DEVELOPMENT, V122, P309; Britsch S, 1998, GENE DEV, V12, P1825, DOI 10.1101/gad.12.12.1825; Burns AJ, 1998, DEVELOPMENT, V125, P4335; Bush TG, 1998, CELL, V93, P189, DOI 10.1016/S0092-8674(00)81571-8; Cacalano G, 1998, NEURON, V21, P53, DOI 10.1016/S0896-6273(00)80514-0; CARR A, 1994, REV MED VIROL, V4, P5, DOI 10.1002/rmv.1980040104; Chalazonitis AN, 2001, J NEUROSCI, V21, P5620, DOI 10.1523/JNEUROSCI.21-15-05620.2001; COSTA M, 1994, AM J GASTROENTEROL, V89, pS129; Crone SA, 2002, NAT MED, V8, P459, DOI 10.1038/nm0502-459; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; EDERY P, 1994, NATURE, V367, P378, DOI 10.1038/367378a0; Edery P, 1996, NAT GENET, V12, P442, DOI 10.1038/ng0496-442; Enomoto H, 1998, NEURON, V21, P317, DOI 10.1016/S0896-6273(00)80541-3; Erickson SL, 1997, DEVELOPMENT, V124, P4999; Gershon MD, 1997, CURR OPIN NEUROBIOL, V7, P101, DOI 10.1016/S0959-4388(97)80127-4; GONNELLA PA, 1987, J CLIN INVEST, V80, P22, DOI 10.1172/JCI113051; Goyal RK, 1996, NEW ENGL J MED, V334, P1106, DOI 10.1056/NEJM199604253341707; Hatano M, 1997, J CLIN INVEST, V100, P795, DOI 10.1172/JCI119593; Herbarth B, 1998, P NATL ACAD SCI USA, V95, P5161, DOI 10.1073/pnas.95.9.5161; Heuckeroth RO, 1999, NEURON, V22, P253, DOI 10.1016/S0896-6273(00)81087-9; Hofstra RMW, 1996, NAT GENET, V12, P445, DOI 10.1038/ng0496-445; HOLSCHNEIDER AM, 1982, HIRSCHSPRUNGS DIS, P293; HOSODA K, 1994, CELL, V79, P1267, DOI 10.1016/0092-8674(94)90017-5; Ivanchuk SM, 1996, HUM MOL GENET, V5, P2023, DOI 10.1093/hmg/5.12.2023; Kapitanovic S, 1997, GASTROENTEROLOGY, V112, P1103, DOI 10.1016/S0016-5085(97)70120-3; Keely SJ, 1999, J BIOL CHEM, V274, P33449, DOI 10.1074/jbc.274.47.33449; KIRSHNER J, 1988, DIS COLON RECTUM ANA; Koeppen HKW, 2001, HISTOPATHOLOGY, V38, P96, DOI 10.1046/j.1365-2559.2001.01084.x; Kuhlbrodt K, 1998, J BIOL CHEM, V273, P23033, DOI 10.1074/jbc.273.36.23033; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Morris JK, 1999, NEURON, V23, P273, DOI 10.1016/S0896-6273(00)80779-5; Newgreen D, 2002, PEDIATR DEVEL PATHOL, V5, P224, DOI 10.1007/s10024-001-0142-y; ORRURTREGER A, 1993, P NATL ACAD SCI USA, V90, P1867, DOI 10.1073/pnas.90.5.1867; Osako T, 1998, ONCOLOGY-BASEL, V55, P548, DOI 10.1159/000011911; PASINI B, 1995, NAT GENET, V10, P35, DOI 10.1038/ng0595-35; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; PRESS MF, 1990, ONCOGENE, V5, P953; PRIGENT SA, 1992, ONCOGENE, V7, P1273; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; Pusch CM, 2002, INT J MOL MED, V10, P367; Qiu Y, 1998, NATURE, V393, P83, DOI 10.1038/30012; Riethmacher D, 1997, NATURE, V389, P725, DOI 10.1038/39593; ROMEO G, 1994, NATURE, V367, P377, DOI 10.1038/367377a0; Rossi J, 1999, NEURON, V22, P243, DOI 10.1016/S0896-6273(00)81086-7; Salomon R, 1996, NAT GENET, V14, P345, DOI 10.1038/ng1196-345; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; SIMINOSKI K, 1986, J CELL BIOL, V103, P1979, DOI 10.1083/jcb.103.5.1979; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Southard-Smith EM, 1998, NAT GENET, V18, P60, DOI 10.1038/ng0198-60; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Taraviras S, 1999, DEVELOPMENT, V126, P2785; Verdi JM, 1996, NEURON, V16, P515, DOI 10.1016/S0896-6273(00)80071-9; Whoriskey JS, 1998, GROWTH FACTORS, V15, P307, DOI 10.3109/08977199809017485; Woldeyesus MT, 1999, GENE DEV, V13, P2538, DOI 10.1101/gad.13.19.2538; Wolpowitz D, 2000, NEURON, V25, P79, DOI 10.1016/S0896-6273(00)80873-9; Yamauchi Y, 1999, DEV BIOL, V212, P191, DOI 10.1006/dbio.1999.9323; Yanagisawa H, 1998, J CLIN INVEST, V102, P22, DOI 10.1172/JCI2698	65	54	55	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 9	2003	37	1					29	40		10.1016/S0896-6273(02)01128-5	http://dx.doi.org/10.1016/S0896-6273(02)01128-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	646UV	12526770	Bronze			2022-12-24	WOS:000181054700007
J	Ma, L; Harada, T; Harada, C; Romero, M; Hebert, JM; McConnell, SK; Parada, LF				Ma, L; Harada, T; Harada, C; Romero, M; Hebert, JM; McConnell, SK; Parada, LF			Neurotrophin-3 is required for appropriate establishment of thalamocortical connections	NEURON			English	Article							CORTICAL VISUAL IMPAIRMENT; OCULAR DOMINANCE COLUMNS; ANTERIOR THALAMIC NUCLEI; LONG-TERM POTENTIATION; CENTRAL-NERVOUS-SYSTEM; IN-VIVO; SYNAPTIC TRANSMISSION; DENDRITIC GROWTH; NEOCORTICAL SUBPLATE; RETROSPLENIAL CORTEX	In the vertebrate brain, the thalamus serves as a relay and integration station for diverse neuronal information en route from the periphery to the cortex. Formation of the thalamocortical tract occurs during pre- and postnatal development, with distinct thalamic nuclei projecting to specific cortical regions. The molecular forces that underlie the invasion by axons into specific cortical layers followed by activity-dependent maturation of synapses are poorly understood. We show that genetic ablation of neurotrophin-3 (NT-3) in the mouse neocortex results in reduction of a set of anatomically distinct axonal bundles projecting from thalamus through cortical white matter. These bundles include thalamocortical axons that normally establish connections with retrosplenial and visual cortex, sites of early postnatal NT-3 expression. These results implicate neurotrophins in the critical stage of precise thalamocortical connections.	Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Kent Waldrep Fdn Ctr Basic Res Nerve Growth & Reg, Dallas, TX 75390 USA; Stanford Univ, Dept Sci Biol, Stanford, CA 94305 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Stanford University	Parada, LF (corresponding author), Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75390 USA.		Parada, luis F/B-9400-2014; Romero-Ortega, Mario/K-6097-2019; Romero-Ortega, Mario I/T-2520-2018; Romero, Mario I/K-1250-2012	Romero-Ortega, Mario/0000-0003-2576-2629; Romero-Ortega, Mario I/0000-0003-2576-2629; 				ALDRICH MS, 1987, ANN NEUROL, V21, P149, DOI 10.1002/ana.410210207; ALLENDOERFER KL, 1994, ANNU REV NEUROSCI, V17, P185, DOI 10.1146/annurev.neuro.17.1.185; ALLENDOERFER KL, 1994, J NEUROSCI, V14, P1795; ANGEVINE JB, 1970, J COMP NEUROL, V139, P129, DOI 10.1002/cne.901390202; Antonini A, 1999, J NEUROSCI, V19, P4388; Auladell C, 2000, ANAT EMBRYOL, V201, P169, DOI 10.1007/PL00008238; Bagri A, 2002, NEURON, V33, P233, DOI 10.1016/S0896-6273(02)00561-5; BAKERNOBLES L, 1995, AM J OCCUP THER, V49, P899, DOI 10.5014/ajot.49.9.899; Bates B, 1999, NAT NEUROSCI, V2, P115, DOI 10.1038/5669; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; BICKNESE AR, 1994, J NEUROSCI, V14, P3500; BIRCH EE, 1991, DEV MED CHILD NEUROL, V33, P722; Braisted JE, 2000, J NEUROSCI, V20, P5792, DOI 10.1523/JNEUROSCI.20-15-05792.2000; Braisted JE, 1999, DEV BIOL, V208, P430, DOI 10.1006/dbio.1999.9216; CABELLI RJ, 1995, SCIENCE, V267, P1662, DOI 10.1126/science.7886458; Cabelli RJ, 1997, NEURON, V19, P63, DOI 10.1016/S0896-6273(00)80348-7; Carpenter M.B., 1985, CORE TEXT NEUROANATO, V3rd; CATALANO SM, 1991, P NATL ACAD SCI USA, V88, P2999, DOI 10.1073/pnas.88.8.2999; CHANG GQ, 1993, NEURON, V11, P595, DOI 10.1016/0896-6273(93)90072-Y; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; DeFreitas MF, 2001, J NEUROSCI, V21, P5121, DOI 10.1523/JNEUROSCI.21-14-05121.2001; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; GHOSH A, 1992, SCIENCE, V255, P1441, DOI 10.1126/science.1542795; Gordon JA, 1996, J NEUROSCI, V16, P3274; GRAFSTEIN B, 1971, SCIENCE, V172, P177, DOI 10.1126/science.172.3979.177; Hebert JM, 2000, DEV BIOL, V222, P296, DOI 10.1006/dbio.2000.9732; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Katz LC, 1999, CELL, V99, P673, DOI 10.1016/S0092-8674(00)81665-7; Kernie SG, 2000, EMBO J, V19, P1290, DOI 10.1093/emboj/19.6.1290; Kokaia M, 1998, J NEUROSCI, V18, P8730; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; KOSTOVIC I, 1990, J COMP NEUROL, V297, P441, DOI 10.1002/cne.902970309; Lein ES, 2000, J COMP NEUROL, V420, P1, DOI 10.1002/(SICI)1096-9861(20000424)420:1<1::AID-CNE1>3.0.CO;2-H; Liebl DJ, 1997, J NEUROSCI, V17, P9113; Lione LA, 1999, J NEUROSCI, V19, P10428; Lom B, 1999, J NEUROSCI, V19, P9928; LORE R, 1969, J COMP PHYSIOL PSYCH, V67, P177, DOI 10.1037/h0026797; Ma L, 2000, DEVELOPMENT, V127, P3777; Ma L, 1999, LEARN MEMORY, V6, P267; MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; MCCONNELL SK, 1995, NEURON, V15, P761, DOI 10.1016/0896-6273(95)90168-X; McQuillen PS, 2002, J NEUROSCI, V22, P3580; Metin C, 1996, J NEUROSCI, V16, P3219; Minichiello L, 1996, GENE DEV, V10, P2849, DOI 10.1101/gad.10.22.2849; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; REINIS S, 1984, BRAIN RES BULL, V12, P339, DOI 10.1016/0361-9230(84)90063-7; ROBERTSON RT, 1981, J COMP NEUROL, V195, P501, DOI 10.1002/cne.901950308; Shatz C J, 1992, Curr Opin Neurobiol, V2, P78, DOI 10.1016/0959-4388(92)90166-I; Shibata H, 1998, EUR J NEUROSCI, V10, P3210, DOI 10.1046/j.1460-9568.1998.00328.x; Shibata H, 2000, NEUROSCI RES, V38, P303, DOI 10.1016/S0168-0102(00)00174-7; SHIBATA H, 1993, J COMP NEUROL, V330, P533, DOI 10.1002/cne.903300409; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; SRIPANIDKULCHAI K, 1986, J COMP NEUROL, V254, P143, DOI 10.1002/cne.902540202; TESSAROLLO L, 1994, P NATL ACAD SCI USA, V91, P11844, DOI 10.1073/pnas.91.25.11844; TESSAROLLO L, 1993, DEVELOPMENT, V118, P463; VANGROEN T, 1995, J COMP NEUROL, V358, P584, DOI 10.1002/cne.903580411; Vigers AJ, 2000, J COMP NEUROL, V416, P398, DOI 10.1002/(SICI)1096-9861(20000117)416:3<398::AID-CNE10>3.0.CO;2-P; Wilkinson GA, 1996, J NEUROSCI, V16, P7661; WONG VCN, 1991, PEDIATR NEUROL, V7, P178, DOI 10.1016/0887-8994(91)90081-U; WONGRILEY MTT, 1989, TRENDS NEUROSCI, V12, P94, DOI 10.1016/0166-2236(89)90165-3; Xu BJ, 2000, NEURON, V26, P233, DOI 10.1016/S0896-6273(00)81153-8; Yokoyama N, 2001, NEURON, V29, P85, DOI 10.1016/S0896-6273(01)00182-9; ZHOU XF, 1994, BRAIN RES, V643, P162, DOI 10.1016/0006-8993(94)90022-1; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	72	60	61	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 14	2002	36	4					623	634		10.1016/S0896-6273(02)01021-8	http://dx.doi.org/10.1016/S0896-6273(02)01021-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	616PX	12441052	Bronze			2022-12-24	WOS:000179313100010
J	Elgersma, Y; Fedorov, NB; Ikonen, S; Choi, ES; Elgersma, M; Carvalho, OM; Giese, KP; Silva, AJ				Elgersma, Y; Fedorov, NB; Ikonen, S; Choi, ES; Elgersma, M; Carvalho, OM; Giese, KP; Silva, AJ			Inhibitory autophosphorylation of CaMKII controls PSD association, plasticity, and learning	NEURON			English	Article							PROTEIN-KINASE-II; LONG-TERM POTENTIATION; D-ASPARTATE RECEPTOR; MUTANT MICE; CALMODULIN; MEMORY; MECHANISM; TRANSLOCATION; LTP; PHOSPHORYLATION	To investigate the function of the a calcium-calmodulin-dependent kinase II (alphaCaMKII) inhibitory autophosphorylation at threonines 305 and/or 306, we generated knockin mice that express alphaCaMKII that cannot undergo inhibitory phosphorylation. In addition, we generated mice that express the inhibited form of alphaCaMKII, which resembles the persistently phosphorylated kinase at these sites. Our data demonstrate that blocking inhibitory phosphorylation increases CaMKII in the postsynaptic density (PSD), lowers the threshold for hippocampal long-term potentiation (LTP), and results in hippocampal-dependent learning that seems more rigid and less fine-tuned. Mimicking inhibitory phosphorylation dramatically decreased the association of CaMKII with the PSD and blocked both LTP and learning. These data demonstrate that inhibitory phosphorylation has a critical role in plasticity and learning.	Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; Erasmus MC, Dept Neurosci, NL-3000 DR Rotterdam, Netherlands	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Erasmus University Rotterdam; Erasmus MC	Silva, AJ (corresponding author), Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA.	silvaa@mednet.ucla.edu	Silva, Alcino/ABD-7684-2021; Giese, Karl P/A-3112-2011; Carvalho, Ofelia/L-2780-2014; Elgersma, Ype/F-5164-2013	Silva, Alcino/0000-0002-1587-4558; Giese, Karl P/0000-0003-4503-7344; Carvalho, Ofelia/0000-0002-7450-9980; Elgersma, Ype/0000-0002-3758-1297; Silva, Alcino/0000-0001-5525-0494	NIA NIH HHS [AG 13622] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG013622, U01AG013622, R37AG013622] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Anagnostaras SG, 2000, LEARN MEMORY, V7, P58, DOI 10.1101/lm.7.1.58; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Bayer KM, 2001, BIOCHEM BIOPH RES CO, V289, P917, DOI 10.1006/bbrc.2001.6063; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; BEACH ME, 1995, CELL, V81, P905, DOI 10.1016/0092-8674(95)90010-1; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Brocke L, 1999, J BIOL CHEM, V274, P22713, DOI 10.1074/jbc.274.32.22713; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Cho YH, 1998, SCIENCE, V279, P867, DOI 10.1126/science.279.5352.867; COLBRAN RJ, 1993, J BIOL CHEM, V268, P7163; COLBRAN RJ, 1990, J BIOL CHEM, V265, P11213; Coomber CJ, 1998, NEURAL COMPUT, V10, P1653, DOI 10.1162/089976698300017070; Dosemeci A, 1996, BIOPHYS J, V70, P2493, DOI 10.1016/S0006-3495(96)79821-1; Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037/0735-7044.112.4.863; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; HANSON PI, 1992, J BIOL CHEM, V267, P17216; HASHIMOTO Y, 1987, J BIOL CHEM, V262, P8051; Hinds HL, 1998, LEARN MEMORY, V5, P344; KANDEL ER, 1996, SCIENCE, V274, P1678; Kochan LD, 2000, NEUROSCIENCE, V95, P735; KURET J, 1985, J BIOL CHEM, V260, P6427; LICKTEIG R, 1988, J BIOL CHEM, V263, P19232; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; Lisman JE, 2001, NEURON, V31, P191, DOI 10.1016/S0896-6273(01)00364-6; LOU LL, 1989, J NEUROSCI, V9, P2020; Manabe T, 1998, NATURE, V394, P577, DOI 10.1038/29073; MAYFORD M, 1995, CELL, V81, P891, DOI 10.1016/0092-8674(95)90009-8; Meyer T, 2000, TRENDS CELL BIOL, V10, P238, DOI 10.1016/S0962-8924(00)01764-5; MUKHERJI S, 1994, J BIOL CHEM, V269, P13744; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; PATTON BL, 1990, J BIOL CHEM, V265, P11204; Rich RC, 1998, J BIOL CHEM, V273, P28424, DOI 10.1074/jbc.273.43.28424; Rotenberg A, 1996, CELL, V87, P1351, DOI 10.1016/S0092-8674(00)81829-2; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Shen K, 2000, NAT NEUROSCI, V3, P881, DOI 10.1038/78783; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Strack S, 1997, J BIOL CHEM, V272, P13467, DOI 10.1074/jbc.272.21.13467; Strack S, 1998, J BIOL CHEM, V273, P20689, DOI 10.1074/jbc.273.33.20689; Tan SE, 1996, BRAIN RES, V711, P234, DOI 10.1016/0006-8993(95)01411-X; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Yang EY, 1999, J BIOL CHEM, V274, P26199, DOI 10.1074/jbc.274.37.26199	43	215	226	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 24	2002	36	3					493	505		10.1016/S0896-6273(02)01007-3	http://dx.doi.org/10.1016/S0896-6273(02)01007-3			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	608ZE	12408851	Bronze			2022-12-24	WOS:000178877700017
J	Del Punta, K; Puche, A; Adams, NC; Rodriguez, I; Mombaerts, P				Del Punta, K; Puche, A; Adams, NC; Rodriguez, I; Mombaerts, P			A divergent pattern of sensory axonal projections is rendered convergent by second-order neurons in the accessory olfactory bulb	NEURON			English	Article							PUTATIVE PHEROMONE RECEPTORS; VOMERONASAL SYSTEM; MULTIGENE FAMILY; G-PROTEINS; MOUSE; ORGANIZATION; EXPRESSION; MAMMALS; GENES; MAP	The mammalian vomeronasal system is specialized in pheromone detection. The neural circuitry of the accessory olfactory bulb (AOB) provides an anatomical substrate for the coding of pheromone information. Here, we describe the axonal projection pattern of vomeronasal sensory neurons to the AOB and the dendritic connectivity pattern of second-order neurons. Genetically traced sensory neurons expressing a given gene of the V2R class of vomeronasal receptors project their axons to six to ten glomeruli distributed in globally conserved areas of the AOB, a theme similar to V1R-expressing neurons. Surprisingly, second-order neurons tend to project their dendrites to glomeruli innervated by axons of sensory neurons expressing the same V1R or the same V2R gene. Convergence of receptor type information in the olfactory bulb may represent a common design in olfactory systems.	Rockefeller Univ, New York, NY 10021 USA; Univ Maryland, Dept Anat & Neurobiol, Baltimore, MD 21201 USA	Rockefeller University; University System of Maryland; University of Maryland Baltimore	Mombaerts, P (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.			rodriguez, ivan/0000-0002-6468-0565	NIDCD NIH HHS [DC000347] Funding Source: Medline	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Belluscio L, 1999, CELL, V97, P209, DOI 10.1016/S0092-8674(00)80731-X; Berghard A, 1996, J NEUROSCI, V16, P909; Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; Brennan PA, 1999, NEUROSCIENCE, V90, P1463, DOI 10.1016/S0306-4522(98)00556-9; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Cajal S. R., 1911, HISTOLOGIE SYSTEME N; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Del Punta K, 2000, GENOME RES, V10, P1958, DOI 10.1101/gr.10.12.1958; Dudley CA, 1999, NEUROSCIENCE, V91, P1549, DOI 10.1016/S0306-4522(98)00711-8; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Halem HA, 2001, J NEUROSCI, V21, P2474, DOI 10.1523/JNEUROSCI.21-07-02474.2001; HALPERN M, 1995, BRAIN RES, V677, P157, DOI 10.1016/0006-8993(95)00159-N; HALPERN M, 1987, ANNU REV NEUROSCI, V10, P325, DOI 10.1146/annurev.ne.10.030187.001545; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; HILDEBRAND JG, 1995, P NATL ACAD SCI USA, V92, P67, DOI 10.1073/pnas.92.1.67; Holy TE, 2000, SCIENCE, V289, P1569, DOI 10.1126/science.289.5484.1569; Ishii T, 2001, GENES CELLS, V6, P71, DOI 10.1046/j.1365-2443.2001.00398.x; Jia CP, 1996, BRAIN RES, V719, P117, DOI 10.1016/0006-8993(96)00110-2; Jia CP, 1997, NEUROREPORT, V8, P1887, DOI 10.1097/00001756-199705260-00019; Keverne EB, 1999, SCIENCE, V286, P716, DOI 10.1126/science.286.5440.716; Kumar A, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-20-j0003.1999; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Martini S, 2001, J NEUROSCI, V21, P843, DOI 10.1523/JNEUROSCI.21-03-00843.2001; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mombaerts P, 2001, NAT NEUROSCI, V4, P1192, DOI 10.1038/nn751; Potter SM, 2001, J NEUROSCI, V21, P9713, DOI 10.1523/JNEUROSCI.21-24-09713.2001; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Rodriguez I, 2002, NAT NEUROSCI, V5, P134, DOI 10.1038/nn795; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; Sam M, 2001, NATURE, V412, P142, DOI 10.1038/35084137; Schaefer ML, 2001, J COMP NEUROL, V436, P351; Strotmann J, 2000, J NEUROSCI, V20, P6927, DOI 10.1523/JNEUROSCI.20-18-06927.2000; TAKAMI S, 1991, J COMP NEUROL, V311, P65, DOI 10.1002/cne.903110106; TAKAMI S, 1990, BRAIN RES, V510, P339, DOI 10.1016/0006-8993(90)91387-V; Treloar HB, 2002, J NEUROSCI, V22, P2469, DOI 10.1523/JNEUROSCI.22-07-02469.2002; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; vonCampenhausen H, 1997, NEUROREPORT, V8, P2607, DOI 10.1097/00001756-199707280-00037; Yoshihara Y, 1997, J NEUROSCI, V17, P5830; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X	44	116	117	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 12	2002	35	6					1057	1066		10.1016/S0896-6273(02)00904-2	http://dx.doi.org/10.1016/S0896-6273(02)00904-2			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	594GC	12354396	Bronze			2022-12-24	WOS:000178040000007
J	Li, B; Chen, NS; Luo, T; Otsu, Y; Murphy, TH; Raymond, LA				Li, B; Chen, NS; Luo, T; Otsu, Y; Murphy, TH; Raymond, LA			Differential regulation of synaptic and extrasynaptic NMDA receptors	NATURE NEUROSCIENCE			English	Article							CHANNEL ACTIVITY; INTERNALIZATION; PHOSPHATASE; NEURONS; SUBUNIT		Univ British Columbia, Dept Psychiat, Kinsmen Lab, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Raymond, LA (corresponding author), Univ British Columbia, Dept Psychiat, Kinsmen Lab, Vancouver, BC V6T 1Z3, Canada.		Raymond, Lynn A/A-6664-2010; Raymond, Lynn A./R-6707-2016; Chen, Nansheng/E-6450-2012; Murphy, Timothy/AAW-1975-2021; Murphy, Timothy H/I-4982-2014; Otsu, Yo/P-6353-2017	Raymond, Lynn A/0000-0002-8610-1042; Raymond, Lynn A./0000-0002-8610-1042; Murphy, Timothy/0000-0002-0093-4490; Murphy, Timothy H/0000-0002-0093-4490; Otsu, Yo/0000-0003-2828-5063; Li, Bo/0000-0002-0154-3088				Chen NS, 1999, J NEUROSCI, V19, P6844, DOI 10.1523/JNEUROSCI.19-16-06844.1999; Dingledine R, 1999, PHARMACOL REV, V51, P7; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Li JH, 1998, EUR J NEUROSCI, V10, P1704, DOI 10.1046/j.1460-9568.1998.00169.x; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; POSNER BI, 1994, J BIOL CHEM, V269, P4596; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; ROSENMUND C, 1993, NEURON, V10, P805, DOI 10.1016/0896-6273(93)90197-Y; Rumbaugh G, 1999, J NEUROSCI, V19, P10603, DOI 10.1523/JNEUROSCI.19-24-10603.1999; Stocca G, 1998, J PHYSIOL-LONDON, V507, P13, DOI 10.1111/j.1469-7793.1998.013bu.x; Tovar KR, 1999, J NEUROSCI, V19, P4180; Umemiya M, 2001, J NEUROSCI, V21, P1, DOI 10.1523/JNEUROSCI.21-01-00001.2001; Vissel B, 2001, NAT NEUROSCI, V4, P587, DOI 10.1038/88404; Wang YT, 1996, P NATL ACAD SCI USA, V93, P1721, DOI 10.1073/pnas.93.4.1721	14	125	132	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2002	5	9					833	834		10.1038/nn912	http://dx.doi.org/10.1038/nn912			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587RL	12195433				2022-12-24	WOS:000177656300008
J	Pennetta, G; Hiesinger, PR; Fabian-Fine, R; Meinertzhagen, IA; Bellen, HJ				Pennetta, G; Hiesinger, PR; Fabian-Fine, R; Meinertzhagen, IA; Bellen, HJ			Drosophila VAP-33A directs bouton formation at neuromuscular junctions in a dosage-dependent manner	NEURON			English	Article							SYNAPTIC PLASTICITY; FUNCTIONAL COMPONENTS; GENETIC DISSECTION; ENDOPLASMIC-RETICULUM; MICROTUBULE-BINDING; AXONAL-TRANSPORT; PROTEIN; EXPRESSION; HOMOLOG; DYNEIN	Aplysia VAP-33 (VAMP-associated protein) has been previously proposed to be involved in the control of neurotransmitter release. Here, we show that a Drosophila homolog of VAP-33, DVAP-33A, is localized to neuromuscular junctions. Loss of DVAP-33A causes a severe decrease in the number of boutons and a corresponding increase in bouton size. Conversely, presynaptic overexpression of DVAP-33A induces an increase in the number of boutons and a decrease in their size. Gain-of-function experiments show that the presynaptic dose of DVAP-33A tightly modulates the number of synaptic boutons. Our data also indicate that the presynaptic microtubule architecture is severely compromised in DVAP-33A mutants. We propose that a DVAP-33A-mediated interaction between microtubules and presynaptic membrane plays a pivotal role during bouton budding.	Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Baylor Coll Med, Dept Human & Mol Genet, Houston, TX 77030 USA; Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; Dalhousie Univ, Life Sci Ctr, Inst Neurosci, Halifax, NS B3H 4J1, Canada	Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Dalhousie University	Bellen, HJ (corresponding author), Baylor Coll Med, Howard Hughes Med Inst, 1 Baylor Plaza, Houston, TX 77030 USA.	hbellen@bcm.tmc.edu		Bellen, Hugo/0000-0001-5992-5989	NEI NIH HHS [EY-03592] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY003592] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; Ausubel FM, 1998, CURRENT PROTOCOLS MO; BELLEN HJ, 1989, GENE DEV, V3, P1288, DOI 10.1101/gad.3.9.1288; BELLEN HJ, 2000, DROSOPHILA LAB MANUA; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Bloom K, 2001, CURR BIOL, V11, pR326, DOI 10.1016/S0960-9822(01)00176-2; BRAND AH, 1993, DEVELOPMENT, V118, P401; BUDNIK V, 1990, J NEUROSCI, V10, P3754; Budnik V, 1999, NEUROMUSCULAR JUNCTI; Davis GW, 1998, NATURE, V392, P82, DOI 10.1038/32176; Davis GW, 1996, NEURON, V17, P669, DOI 10.1016/S0896-6273(00)80199-3; Dujardin DL, 2002, CURR OPIN CELL BIOL, V14, P44, DOI 10.1016/S0955-0674(01)00292-7; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Estes PS, 1996, J NEUROSCI, V16, P5443; Farkasovsky M, 2001, J CELL BIOL, V152, P251, DOI 10.1083/jcb.152.2.251; Galaud JP, 1997, BBA-PROTEIN STRUCT M, V1341, P79, DOI 10.1016/S0167-4838(97)00063-0; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gindhart JG, 1998, J CELL BIOL, V141, P443, DOI 10.1083/jcb.141.2.443; GOODE BL, 1994, J CELL BIOL, V124, P769, DOI 10.1083/jcb.124.5.769; GORCZYCA M, 1993, J NEUROSCI, V13, P3692; Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2; Hafen E., 1997, NATURE, V389, P559; Heil-Chapdelaine RA, 2000, J CELL BIOL, V151, P1337, DOI 10.1083/jcb.151.6.1337; Hiesinger PR, 2001, J COMP NEUROL, V429, P277, DOI 10.1002/1096-9861(20000108)429:2<277::AID-CNE8>3.0.CO;2-8; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Italiano JE, 1996, CELL, V84, P105, DOI 10.1016/S0092-8674(00)80997-6; JAN LY, 1982, P NATL ACAD SCI-BIOL, V79, P2700, DOI 10.1073/pnas.79.8.2700; JOHANSEN J, 1989, J NEUROSCI, V9, P710; Kagiwada S, 1998, J BACTERIOL, V180, P1700, DOI 10.1128/JB.180.7.1700-1708.1998; LAHEY T, 1994, NEURON, V13, P823, DOI 10.1016/0896-6273(94)90249-6; Lantz VA, 1998, J CELL BIOL, V140, P897, DOI 10.1083/jcb.140.4.897; Lapierre LA, 1999, J CELL SCI, V112, P3723; Laurent F, 2000, BIOCHEM BIOPH RES CO, V270, P286, DOI 10.1006/bbrc.2000.2387; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Lloyd TE, 2000, NEURON, V26, P45, DOI 10.1016/S0896-6273(00)81136-8; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Martin M, 1999, MOL BIOL CELL, V10, P3717, DOI 10.1091/mbc.10.11.3717; Miller A., 1950, BIOL DROSOPHILA, P420; Miller MA, 2001, SCIENCE, V291, P2144, DOI 10.1126/science.1057586; NIKAWA J, 1995, J BIOCHEM, V118, P39, DOI 10.1093/oxfordjournals.jbchem.a124889; Ohshiro T, 2000, NATURE, V408, P593, DOI 10.1038/35046087; Peng CY, 2000, NATURE, V408, P596, DOI 10.1038/35046094; Perez F, 1999, CELL, V96, P517, DOI 10.1016/S0092-8674(00)80656-X; Roberts TM, 2000, J CELL BIOL, V149, P7, DOI 10.1083/jcb.149.1.7; ROBERTSON HM, 1988, GENETICS, V118, P461; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; SKEHEL PA, 1995, SCIENCE, V269, P1580, DOI 10.1126/science.7667638; Skehel PA, 2000, P NATL ACAD SCI USA, V97, P1101, DOI 10.1073/pnas.97.3.1101; Sone M, 1997, SCIENCE, V275, P543, DOI 10.1126/science.275.5299.543; Sone M, 2000, DEVELOPMENT, V127, P4157; Soussan L, 1999, J CELL BIOL, V146, P301, DOI 10.1083/jcb.146.2.301; Stewart BA, 1996, J NEUROSCI, V16, P3877; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Torroja L, 1999, J NEUROSCI, V19, P7793; ZHONG Y, 1992, J NEUROSCI, V12, P644; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X	59	161	163	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 18	2002	35	2					291	306		10.1016/S0896-6273(02)00769-9	http://dx.doi.org/10.1016/S0896-6273(02)00769-9			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	576YF	12160747	Bronze			2022-12-24	WOS:000177034200009
J	Lopes, CMB; Zhang, HL; Rohacs, T; Jin, TH; Yang, J; Logothetis, DE				Lopes, CMB; Zhang, HL; Rohacs, T; Jin, TH; Yang, J; Logothetis, DE			Alterations in conserved Kir channel-PIP2 interactions underlie channelopathies	NEURON			English	Article							PROTEIN-KINASE-A; INOSITOL 1,4,5-TRISPHOSPHATE; PHOSPHOINOSITIDE BINDING; STRUCTURAL DETERMINANTS; POTASSIUM CHANNELS; ANCHORING PROTEIN; K+ CHANNELS; PIP2; ROMK; SPECIFICITY	Inwardly rectifying K+ (Kir) channels are important regulators of resting membrane potential and cell excitability. The activity of Kir channels is critically dependent on the integrity of channel interactions with phosphatidylinositol 4,5-bisphosphate (PlP(2)). Here we identify and characterize channel-PIP2 interactions that are conserved among Kir family members. We find basic residues that interact with PIP2, two of which have been associated with Andersen's and Bartter's syndromes. We show that several naturally occurring mutants decrease channel-PIP2 interactions, leading to disease.	NYU, Mt Sinai Sch Med, Dept Physiol & Biophys, New York, NY 10029 USA; Hebei Med Univ, Dept Pharmacol, Shijiazhuang, Peoples R China; Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Icahn School of Medicine at Mount Sinai; New York University; Hebei Medical University; Columbia University	Logothetis, DE (corresponding author), NYU, Mt Sinai Sch Med, Dept Physiol & Biophys, New York, NY 10029 USA.	diomedes@inka.mssm.edu			NHLBI NIH HHS [HL58552, HL59949] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059949, R01HL058552] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ali S, 1998, P NATL ACAD SCI USA, V95, P10274, DOI 10.1073/pnas.95.17.10274; Baukrowitz T, 1998, SCIENCE, V282, P1141, DOI 10.1126/science.282.5391.1141; Chanchevalap S, 2000, J BIOL CHEM, V275, P7811, DOI 10.1074/jbc.275.11.7811; Choe H, 1999, BIOPHYS J, V76, P1988, DOI 10.1016/S0006-3495(99)77357-1; Dart C, 2001, J BIOL CHEM, V276, P20499, DOI 10.1074/jbc.M101425200; Enkvetchakul D, 2000, BIOPHYS J, V78, P2334, DOI 10.1016/S0006-3495(00)76779-8; Fan Z, 1997, J BIOL CHEM, V272, P5388, DOI 10.1074/jbc.272.9.5388; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; Hilgemann DW, 1997, ANNU REV PHYSIOL, V59, P193, DOI 10.1146/annurev.physiol.59.1.193; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Hirose K, 1999, SCIENCE, V284, P1527, DOI 10.1126/science.284.5419.1527; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Itoh T, 2001, SCIENCE, V291, P1047, DOI 10.1126/science.291.5506.1047; Karolyi L, 1997, HUM MOL GENET, V6, P17; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; Kobrinsky E, 2000, NAT CELL BIOL, V2, P507, DOI 10.1038/35019544; Liou HH, 1999, P NATL ACAD SCI USA, V96, P5820, DOI 10.1073/pnas.96.10.5820; Lu T, 1999, P NATL ACAD SCI USA, V96, P9926, DOI 10.1073/pnas.96.17.9926; Lu T, 1999, NEURON, V22, P571, DOI 10.1016/S0896-6273(00)80711-4; Lupu VD, 1998, J BIOL CHEM, V273, P14067, DOI 10.1074/jbc.273.23.14067; Mao YX, 2001, CELL, V104, P433, DOI 10.1016/S0092-8674(01)00230-6; Perets T, 1996, FEBS LETT, V384, P189, DOI 10.1016/0014-5793(96)00303-1; Plaster NM, 2001, CELL, V105, P511, DOI 10.1016/S0092-8674(01)00342-7; Qu ZQ, 2000, J BIOL CHEM, V275, P31573, DOI 10.1074/jbc.M003473200; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Rohacs T, 2002, METHOD ENZYMOL, V345, P71; Rohacs T, 1999, J BIOL CHEM, V274, P36065, DOI 10.1074/jbc.274.51.36065; Schulte U, 1999, P NATL ACAD SCI USA, V96, P15298, DOI 10.1073/pnas.96.26.15298; Schwalbe RA, 1998, HUM MOL GENET, V7, P975, DOI 10.1093/hmg/7.6.975; Shyng SL, 2000, J GEN PHYSIOL, V116, P599, DOI 10.1085/jgp.116.5.599; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; Soom M, 2001, FEBS LETT, V490, P49, DOI 10.1016/S0014-5793(01)02136-6; Sui JL, 1998, P NATL ACAD SCI USA, V95, P1307, DOI 10.1073/pnas.95.3.1307; Xu ZC, 1996, J BIOL CHEM, V271, P9313, DOI 10.1074/jbc.271.16.9313; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhang Y, 1999, TUMOR TARGET, V4, P158	40	305	312	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 13	2002	34	6					933	944		10.1016/S0896-6273(02)00725-0	http://dx.doi.org/10.1016/S0896-6273(02)00725-0			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	563HF	12086641	Bronze			2022-12-24	WOS:000176249700011
J	Louissaint, A; Rao, S; Leventhal, C; Goldman, SA				Louissaint, A; Rao, S; Leventhal, C; Goldman, SA			Coordinated interaction of Neurogenesis and angiogenesis in the adult songbird brain	NEURON			English	Article							ENDOTHELIAL GROWTH-FACTOR; ESTROGEN-RECEPTOR-BETA; NEWLY GENERATED NEURONS; MESSENGER-RNA; FACTOR VEGF; CONTROL NUCLEUS; BLOOD-VESSELS; ANDROGEN RECEPTOR; N-CADHERIN; EXPRESSION	Neurogenesis proceeds throughout life in the higher vocal center (HVC) of the adult songbird neostriatum. Testosterone induces neuronal addition and endothelial division in HVC. We asked if testosterone-induced angiogenesis might contribute importantly to HVC neuronal recruitment. Testosterone upregulated both VEGF and its endothelial receptor, VEGF-R2/Quek1/ KDR, in HVC. This yielded a burst in local HVC angiogenesis. FACS-isolated HVC endothelial cells produced BDNF in a testosterone-dependent manner. In vivo, HVC BDNF rose by the third week after testosterone, lagging by over a week the rise in VEGF and VEGF-R2. In situ hybridization revealed that much of this induced BDNF mRNA was endothelial. In vivo, both angiogenesis and neuronal addition to HVC were substantially diminished by inhibition of VEGF-R2 tyrosine kinase. These findings suggest a causal interaction between testosterone-induced angiogenesis and neurogenesis in the adult forebrain.	Cornell Univ, Med Ctr, Dept Neurol & Neurosci, New York, NY 10021 USA	Cornell University	Goldman, SA (corresponding author), Cornell Univ, Med Ctr, Dept Neurol & Neurosci, 1300 York Ave, New York, NY 10021 USA.	sgoldm@mail.med.cornell.edu		Goldman, Steven/0000-0002-5498-4303	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS029813, R01NS033106] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM07739] Funding Source: Medline; NINDS NIH HHS [R01NS33106, R37/R01NS29813] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALITALO K, 1982, J CELL BIOCHEM, V18, P25, DOI 10.1002/jcb.1982.240180104; ALVAREZBUYLLA A, 1988, NATURE, V335, P353, DOI 10.1038/335353a0; Andersson C, 2001, J ENDOCRINOL, V169, P241, DOI 10.1677/joe.0.1690241; ARAUJO DM, 1993, BRAIN RES, V600, P49, DOI 10.1016/0006-8993(93)90400-H; Balthazart J, 1996, J NEUROBIOL, V31, P129, DOI 10.1002/(SICI)1097-4695(199610)31:2<129::AID-NEU1>3.3.CO;2-2; BARAMI K, 1994, NEURON, V13, P567, DOI 10.1016/0896-6273(94)90026-4; BARAMI K, 1995, J NEUROBIOL, V28, P82, DOI 10.1002/neu.480280108; Behar TN, 1997, EUR J NEUROSCI, V9, P2561, DOI 10.1111/j.1460-9568.1997.tb01685.x; Benraiss A, 2001, J NEUROSCI, V21, P6718, DOI 10.1523/JNEUROSCI.21-17-06718.2001; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Bernard DJ, 1999, ENDOCRINOLOGY, V140, P4633, DOI 10.1210/en.140.10.4633; BIEGEL D, 1995, BRAIN RES, V692, P183, DOI 10.1016/0006-8993(95)00511-N; BIRO S, 1994, CIRC RES, V74, P485, DOI 10.1161/01.RES.74.3.485; Bottjer SW, 1997, J NEUROBIOL, V33, P602, DOI 10.1002/(SICI)1097-4695(19971105)33:5<602::AID-NEU8>3.0.CO;2-8; BREIER G, 1992, DEVELOPMENT, V114, P521; CaulinGlaser T, 1996, J CLIN INVEST, V98, P36, DOI 10.1172/JCI118774; Dittrich F, 1999, P NATL ACAD SCI USA, V96, P8241, DOI 10.1073/pnas.96.14.8241; DRAGO J, 1991, P NATL ACAD SCI USA, V88, P2199, DOI 10.1073/pnas.88.6.2199; Fusani L, 2001, J NEUROBIOL, V49, P1, DOI 10.1002/neu.1061; GAHR M, 1990, J COMP NEUROL, V294, P30, DOI 10.1002/cne.902940104; GENSBURGER C, 1987, FEBS LETT, V217, P1, DOI 10.1016/0014-5793(87)81230-9; Goldman S A., 1995, NEUROSCIENTIST, V1, P338; GOLDMAN SA, 1992, J NEUROSCI, V12, P2532; GOLDMAN SA, 1983, P NATL ACAD SCI-BIOL, V80, P2390, DOI 10.1073/pnas.80.8.2390; Goldman SA, 1998, J NEUROBIOL, V36, P267, DOI 10.1002/(SICI)1097-4695(199808)36:2<267::AID-NEU12>3.3.CO;2-N; Goldman SA, 1998, TRENDS NEUROSCI, V21, P107, DOI 10.1016/S0166-2236(97)01191-0; GOLDMAN SA, 1990, J NEUROSCI, V10, P2931; Hanahan D, 1997, SCIENCE, V277, P48, DOI 10.1126/science.277.5322.48; Hennequin LF, 1999, J MED CHEM, V42, P5369, DOI 10.1021/jm990345w; HIDALGO A, 1995, J NEUROBIOL, V27, P470, DOI 10.1002/neu.480270404; Holzenberger M, 1997, J NEUROSCI, V17, P6974; Iafrati MD, 1997, NAT MED, V3, P545, DOI 10.1038/nm0597-545; Jain RK, 1998, P NATL ACAD SCI USA, V95, P10820, DOI 10.1073/pnas.95.18.10820; Jiang JW, 1998, J NEUROBIOL, V36, P1, DOI 10.1002/(SICI)1097-4695(199807)36:1<1::AID-NEU1>3.0.CO;2-6; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; JOHNSON F, 1995, J NEUROBIOL, V26, P87, DOI 10.1002/neu.480260108; KIRSCHENBAUM B, 1995, P NATL ACAD SCI USA, V92, P210, DOI 10.1073/pnas.92.1.210; LEGAN SJ, 1975, ENDOCRINOLOGY, V96, P50, DOI 10.1210/endo-96-1-50; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Leventhal C, 1999, MOL CELL NEUROSCI, V13, P450, DOI 10.1006/mcne.1999.0762; Levine AC, 1998, ENDOCRINOLOGY, V139, P4672, DOI 10.1210/en.139.11.4672; Li XC, 2000, P NATL ACAD SCI USA, V97, P8584, DOI 10.1073/pnas.140222497; Lindner V, 1998, CIRC RES, V83, P224, DOI 10.1161/01.RES.83.2.224; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; Mizisin AP, 1997, J NEUROPATH EXP NEUR, V56, P1290, DOI 10.1097/00005072-199712000-00004; Mosselman S, 1996, FEBS LETT, V392, P49, DOI 10.1016/0014-5793(96)00782-X; Mueller MD, 2000, P NATL ACAD SCI USA, V97, P10972, DOI 10.1073/pnas.200377097; Nag S, 1997, J NEUROPATH EXP NEUR, V56, P912, DOI 10.1097/00005072-199708000-00009; NASTIUK KL, 1995, J NEUROBIOL, V26, P213, DOI 10.1002/neu.480260206; NORDEEN EJ, 1989, DEV BRAIN RES, V49, P27, DOI 10.1016/0165-3806(89)90056-4; NOTTEBOHM F, 1985, ANN NY ACAD SCI, V457, P143, DOI 10.1111/j.1749-6632.1985.tb20803.x; NOTTEBOHM F, 1981, SCIENCE, V214, P1368, DOI 10.1126/science.7313697; Ogunshola OO, 2002, J BIOL CHEM, V277, P11410, DOI 10.1074/jbc.M111085200; Ogunshola OO, 2000, DEV BRAIN RES, V119, P139, DOI 10.1016/S0165-3806(99)00125-X; PALMER T, 2000, ADV DRUG DELIF REV, V15, P5; Proescholdt MA, 1999, J NEUROPATH EXP NEUR, V58, P613, DOI 10.1097/00005072-199906000-00006; Rasika S, 1999, NEURON, V22, P53, DOI 10.1016/S0896-6273(00)80678-9; ROBERTSON PL, 1985, DEV BRAIN RES, V23, P219, DOI 10.1016/0165-3806(85)90044-6; Rosenstein JM, 1998, P NATL ACAD SCI USA, V95, P7086, DOI 10.1073/pnas.95.12.7086; SHEN P, 1995, J COMP NEUROL, V360, P172, DOI 10.1002/cne.903600113; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; STOKES TM, 1974, J COMP NEUROL, V156, P337, DOI 10.1002/cne.901560305; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Suri C, 1998, SCIENCE, V282, P468, DOI 10.1126/science.282.5388.468; Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511; WALSH C, 1992, SCIENCE, V255, P434, DOI 10.1126/science.1734520; WALSH FS, 1992, COLD SPRING HARB SYM, V57, P431, DOI 10.1101/SQB.1992.057.01.048; Wedge SR, 2000, CANCER RES, V60, P970; Wilting J, 1997, CELL TISSUE RES, V288, P207, DOI 10.1007/s004410050807; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Yang XJ, 1996, J NEUROSCI, V16, P6089; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369; Zigova T, 1998, MOL CELL NEUROSCI, V11, P234, DOI 10.1006/mcne.1998.0684; [No title captured]	74	585	612	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 13	2002	34	6					945	960		10.1016/S0896-6273(02)00722-5	http://dx.doi.org/10.1016/S0896-6273(02)00722-5			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	563HF	12086642	Bronze			2022-12-24	WOS:000176249700012
J	Baseler, HA; Brewer, AA; Sharpe, LT; Morland, AB; Jagle, H; Wandell, BA				Baseler, HA; Brewer, AA; Sharpe, LT; Morland, AB; Jagle, H; Wandell, BA			Reorganization of human cortical maps caused by inherited photoreceptor abnormalities	NATURE NEUROSCIENCE			English	Article							HUMAN VISUAL-CORTEX; CLINICAL VISION CHARACTERISTICS; LATERAL GENICULATE-NUCLEUS; CONE PHOTORECEPTOR; CONGENITAL ACHROMATOPSIAS; FUNCTIONAL MRI; VISUALIZATION; TOPOGRAPHY; PLASTICITY; MUTATIONS	We describe a compelling demonstration of large-scale developmental reorganization in the human visual pathways. The developmental reorganization was observed in rod monochromats, a rare group of congenitally colorblind individuals who virtually lack cone photoreceptor function. Normal controls had a cortical region, spanning several square centimeters, that responded to signals initiated in the all-cone foveola but was inactive under rod viewing conditions; in rod monochromats this cortical region responded powerfully to rod-initiated signals. The measurements trace a causal pathway that begins with a genetic anomaly that directly influences sensory cells and ultimately results in a substantial central reorganization.	Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; Univ Tubingen, Tubingen, Germany	Stanford University; Stanford University; Eberhard Karls University of Tubingen	Wandell, BA (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.		Baseler, Heidi/AAI-7387-2020; Jägle, Herbert/GPP-2945-2022	Baseler, Heidi/0000-0003-0995-8453; Morland, Antony/0000-0002-6754-5545	NEI NIH HHS [EY30164] Funding Source: Medline; NIMH NIH HHS [T32 MH020016] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020016] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AHNELT PK, 1987, J COMP NEUROL, V255, P18, DOI 10.1002/cne.902550103; Andrews TJ, 1997, J NEUROSCI, V17, P2859; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; Das A, 1999, NATURE, V399, P655, DOI 10.1038/21371; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; GILBERT CD, 1992, NATURE, V356, P150, DOI 10.1038/356150a0; GLICKSTEIN M, 1975, VISION RES, V15, P633, DOI 10.1016/0042-6989(75)90276-X; Hadjikhani N, 2000, HUM BRAIN MAPP, V9, P55, DOI 10.1002/(SICI)1097-0193(2000)9:1<55::AID-HBM6>3.3.CO;2-L; HaegerstromPortnoy G, 1996, OPTOMETRY VISION SCI, V73, P446, DOI 10.1097/00006324-199607000-00001; HaegerstromPortnoy G, 1996, OPTOMETRY VISION SCI, V73, P457, DOI 10.1097/00006324-199607000-00002; HEINEN SJ, 1991, EXP BRAIN RES, V83, P670; HORTON JC, 1991, ARCH OPHTHALMOL-CHIC, V109, P816, DOI 10.1001/archopht.1991.01080060080030; KAAS JH, 1991, ANNU REV NEUROSCI, V14, P137, DOI 10.1146/annurev.neuro.14.1.137; Kapadia MK, 1999, P NATL ACAD SCI USA, V96, P12073, DOI 10.1073/pnas.96.21.12073; KAPADIA MK, 1994, J NEUROSCI, V14, P451; Kohl S, 1998, NAT GENET, V19, P257, DOI 10.1038/935; Kohl S, 2000, HUM MOL GENET, V9, P2107, DOI 10.1093/hmg/9.14.2107; MEYER CH, 1992, MAGNET RESON MED, V28, P202, DOI 10.1002/mrm.1910280204; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Osterberg G., 1935, ACTA OPHTHALMOL    S, V13, P1; PETTET MW, 1992, P NATL ACAD SCI USA, V89, P8366, DOI 10.1073/pnas.89.17.8366; Polyak S. L., 1941, RETINA-J RET VIT DIS; RODIECK RW, 1979, ANNU REV NEUROSCI, V2, P193, DOI 10.1146/annurev.ne.02.030179.001205; Sharpe L.T., 1999, COLOR VISION GENES P, P3; SHARPE LT, 1986, CLIN VISION SCI, V1, P39; Sharpe LT, 1990, NIGHT VISION BASIC C, P335; Sharpe LT, 1990, NIGHT VISION BASIC C, P253; Teo PC, 1997, IEEE T MED IMAGING, V16, P852, DOI 10.1109/42.650881; Wandell B.A., 1995, FDN VISION; Wandell BA, 1999, ANNU REV NEUROSCI, V22, P145, DOI 10.1146/annurev.neuro.22.1.145; Wandell BA, 2000, J COGNITIVE NEUROSCI, V12, P739, DOI 10.1162/089892900562561; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599; White LE, 2001, NATURE, V411, P1049, DOI 10.1038/35082568	35	114	115	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2002	5	4					364	370		10.1038/nn817	http://dx.doi.org/10.1038/nn817			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	534UQ	11914722				2022-12-24	WOS:000174606900017
J	Montgomery, JM; Madison, DV				Montgomery, JM; Madison, DV			State-dependent heterogeneity in synaptic depression between pyramidal cell pairs	NEURON			English	Article							LONG-TERM DEPRESSION; HIPPOCAMPAL SLICE CULTURES; NMDA-RECEPTOR; GLUTAMATE RECEPTORS; SILENT SYNAPSES; RAT HIPPOCAMPUS; CA1 REGION; AMPA RECEPTORS; AREA CA1; POTENTIATION	Paired recordings between CA3 pyramidal neurons were used to study the properties of synaptic plasticity in active and silent synapses. Synaptic depression is accompanied by decreases in both AMPAR and NMDAR function. The mechanisms of synaptic depression, and the potential to undergo activity-dependent plastic changes in efficacy, differ depending on whether a synapse is active, recently silent, or potentiated. These results suggest that silent and active synapses represent distinct synaptic "states," and that once unsilenced, synapses express plasticity in a graded manner. The state in which a synapse resides, and the states recently visited, determine its potential and mechanism for undergoing subsequent plastic changes.	Stanford Univ, Sch Med, Beckman Ctr, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA	Stanford University	Madison, DV (corresponding author), Stanford Univ, Sch Med, Beckman Ctr, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA.		Madison, Daniel/F-9341-2017	Madison, Daniel/0000-0002-0718-5373	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH048108, R01MH065541, R01MH056454] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH065541, MH48108, MH56454] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Atwood HL, 1999, LEARN MEMORY, V6, P542, DOI 10.1101/lm.6.6.542; BASHIR ZI, 1994, EXP BRAIN RES, V100, P437, DOI 10.1007/BF02738403; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Chung HJ, 2000, J NEUROSCI, V20, P7258; CLARK KA, 1995, J PHYSIOL-LONDON, V482, P39, DOI 10.1113/jphysiol.1995.sp020498; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; Debanne D, 1996, J PHYSIOL-LONDON, V491, P163, DOI 10.1113/jphysiol.1996.sp021204; Debanne D, 1999, J NEUROSCI, V19, P10664, DOI 10.1523/JNEUROSCI.19-24-10664.1999; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Fitzjohn SM, 1998, NEUROPHARMACOLOGY, V37, P1445, DOI 10.1016/S0028-3908(98)00145-2; FUJII S, 1991, BRAIN RES, V555, P112, DOI 10.1016/0006-8993(91)90867-U; Hansel C, 1996, J PHYSIOLOGY-PARIS, V90, P317, DOI 10.1016/S0928-4257(97)87906-5; Heynen AJ, 2000, NEURON, V28, P527, DOI 10.1016/S0896-6273(00)00130-6; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; KAUER JA, 1988, NEURON, V1, P911, DOI 10.1016/0896-6273(88)90148-1; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Kim CH, 2001, J NEUROSCI, V21, P4188, DOI 10.1523/JNEUROSCI.21-12-04188.2001; KULLMANN DM, 1994, NEURON, V12, P1111, DOI 10.1016/0896-6273(94)90318-2; Kullmann DM, 1996, NEURON, V17, P461, DOI 10.1016/S0896-6273(00)80178-6; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Liao DZ, 2001, J NEUROSCI, V21, P6008, DOI 10.1523/JNEUROSCI.21-16-06008.2001; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; Miles R, 1996, CURR OPIN NEUROBIOL, V6, P387, DOI 10.1016/S0959-4388(96)80124-3; Montgomery JM, 2001, NEURON, V29, P691, DOI 10.1016/S0896-6273(01)00244-6; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; Oliet SHR, 1996, SCIENCE, V271, P1294, DOI 10.1126/science.271.5253.1294; Pavlidis P, 1999, J NEUROPHYSIOL, V81, P2787, DOI 10.1152/jn.1999.81.6.2787; Pavlidis P, 2000, J NEUROSCI, V20, P4497, DOI 10.1523/JNEUROSCI.20-12-04497.2000; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; ROSENMUND C, 1995, J NEUROPHYSIOL, V73, P427, DOI 10.1152/jn.1995.73.1.427; Rumpel S, 1998, J NEUROSCI, V18, P8863; SELIG DK, 1995, J NEUROPHYSIOL, V74, P1075, DOI 10.1152/jn.1995.74.3.1075; SELIG DK, 1995, NEURON, V15, P417, DOI 10.1016/0896-6273(95)90045-4; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Shigemoto R, 1997, J NEUROSCI, V17, P7503, DOI 10.1523/jneurosci.17-19-07503.1997; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; TOVAR KR, 2002, IN PRESS NEURON; Vissel B, 2001, NAT NEUROSCI, V4, P587, DOI 10.1038/88404; WAGNER JJ, 1995, J NEUROSCI, V15, P1577; XIAO MY, 1994, EUR J NEUROSCI, V6, P1055, DOI 10.1111/j.1460-9568.1994.tb00600.x; XIAO MY, 1995, J NEUROSCI, V15, P4496; Zhuo M, 1999, P NATL ACAD SCI USA, V96, P4650, DOI 10.1073/pnas.96.8.4650	65	112	114	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 28	2002	33	5					765	777		10.1016/S0896-6273(02)00606-2	http://dx.doi.org/10.1016/S0896-6273(02)00606-2			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	529EC	11879653	Bronze			2022-12-24	WOS:000174286200012
J	Asamoah, OK; Wuskell, JP; Loew, LM; Bezanilla, F				Asamoah, OK; Wuskell, JP; Loew, LM; Bezanilla, F			A fluorometric approach to local electric field measurements in a voltage-gated ion channel	NEURON			English	Article							SHAKER K+ CHANNEL; XENOPUS-LAEVIS OOCYTES; POTASSIUM CHANNEL; SURFACE-CHARGE; SODIUM-CHANNELS; S4 SEGMENT; MEMBRANE; FLUORESCENCE; PROBES; MOVEMENT	Site-specific electrostatic measurements have been limited to soluble proteins purified for in vitro spectroscopic characterization or proteins of known structure; however, comparable measurements have not been made for functional membrane bound proteins. Here, using an electrochromic fluorophore, we describe a method to monitor localized electric field changes in a voltage-gated potassium channel. By coupling the novel probe Di-1-ANEPIA to cysteines in Shaker and tracking field-induced optical changes, in vivo electrostatic measurements were recorded with submillisecond resolution. This technique reports dynamic changes in the electric field during the gating process and elucidates the electric field profile within Shaker. The extension of this method to other membrane bound proteins, including transporters, will yield insight into the role of electrical forces on protein function.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol, Dept Physiol, Los Angeles, CA 90095 USA; Univ Connecticut, Ctr Hlth, Ctr Biomed Imaging Technol, Dept Physiol, Farmington, CT 06030 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Connecticut	Bezanilla, F (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol, Dept Physiol, Los Angeles, CA 90095 USA.			Loew, Leslie/0000-0002-1851-4646	NIGMS NIH HHS [GM35063, GM30376, 1 F31 GM20596-03] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM020596, R01GM030376, R37GM030376, R01GM035063] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Baker OS, 1998, NEURON, V20, P1283, DOI 10.1016/S0896-6273(00)80507-3; BEDLACK RS, 1994, NEURON, V13, P1187, DOI 10.1016/0896-6273(94)90056-6; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; BRINK F, 1954, PHARMACOL REV, V6, P243; Canepari M, 1996, EUR BIOPHYS J BIOPHY, V24, P359, DOI 10.1007/BF00576708; CARNEY LD, 1969, SCIENCE, V165, P608, DOI 10.1126/science.165.3893.608; Cha A, 1999, NATURE, V402, P809, DOI 10.1038/45552; Cha A, 1998, J GEN PHYSIOL, V112, P391, DOI 10.1085/jgp.112.4.391; Cha A, 1997, NEURON, V19, P1127, DOI 10.1016/S0896-6273(00)80403-1; COHEN LB, 1974, J MEMBRANE BIOL, V19, P1, DOI 10.1007/BF01869968; CUKIERMAN S, 1988, J GEN PHYSIOL, V92, P431, DOI 10.1085/jgp.92.4.431; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Elinder F, 1999, BIOPHYS J, V77, P1358, DOI 10.1016/S0006-3495(99)76984-5; Elinder F, 1998, J MEMBRANE BIOL, V165, P183, DOI 10.1007/s002329900432; FRANKENHAEUSER B, 1957, J PHYSIOL-LONDON, V137, P218, DOI 10.1113/jphysiol.1957.sp005808; GILBERT DL, 1969, BIOPHYS J, V9, P447, DOI 10.1016/S0006-3495(69)86396-4; Glauner KS, 1999, NATURE, V402, P813, DOI 10.1038/45561; GRAHAME DC, 1947, CHEM REV, V41, P441, DOI 10.1021/cr60130a002; GREEN WN, 1991, ANNU REV PHYSIOL, V53, P341, DOI 10.1146/annurev.ph.53.030191.002013; GROSS E, 1994, BIOPHYS J, V67, P208, DOI 10.1016/S0006-3495(94)80471-0; HASSNER A, 1984, J ORG CHEM, V49, P2546, DOI 10.1021/jo00188a006; HILLE B, 1975, PHILOS T R SOC B, V270, P301, DOI 10.1098/rstb.1975.0011; HILLE B, 1991, IONIC CHANNELS EXCIT, P445; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Islas LD, 2001, J GEN PHYSIOL, V117, P69, DOI 10.1085/jgp.117.1.69; JI S, 1993, J GEN PHYSIOL, V101, P355, DOI 10.1085/jgp.101.3.355; Lakowicz J. R., 1999, PRINCIPLES FLUORESCE, P1, DOI 10.1007/978-1-4757-3061-6_1; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; LOCKHART DJ, 1992, SCIENCE, V257, P947, DOI 10.1126/science.1502559; LOEW LM, 1992, J MEMBRANE BIOL, V130, P1, DOI 10.1007/bf00233734; LOEW LM, 1982, J BIOCHEM BIOPH METH, V6, P243, DOI 10.1016/0165-022X(82)90047-1; LOEW LM, 1978, BIOCHEMISTRY-US, V17, P4065, DOI 10.1021/bi00612a030; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; MEISTER A, 1995, BIOTHIOLS A, P3; OHMORI H, 1977, J PHYSIOL-LONDON, V267, P429, DOI 10.1113/jphysiol.1977.sp011821; Park ES, 1999, J PHYS CHEM B, V103, P9813, DOI 10.1021/jp992329g; PEITZSCH RM, 1995, BIOPHYS J, V68, P729, DOI 10.1016/S0006-3495(95)80253-5; PEROZO E, 1993, NEURON, V11, P353, DOI 10.1016/0896-6273(93)90190-3; Philippsen A, 2002, BIOPHYS J, V82, P1667, DOI 10.1016/S0006-3495(02)75517-3; RECTOR ES, 1978, J IMMUNOL METHODS, V24, P321, DOI 10.1016/0022-1759(78)90135-7; ROHR S, 1994, BIOPHYS J, V67, P1301, DOI 10.1016/S0006-3495(94)80602-2; Sadler SE, 2001, J CELL BIOCHEM, V83, P21, DOI 10.1002/jcb.1207; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Sorensen JB, 2000, J GEN PHYSIOL, V115, P209, DOI 10.1085/jgp.115.2.209; Starace DM, 1997, NEURON, V19, P1319, DOI 10.1016/S0896-6273(00)80422-5; Starace DM, 2001, J GEN PHYSIOL, V117, P469, DOI 10.1085/jgp.117.5.469; TASAKI I, 1968, P NATL ACAD SCI USA, V61, P883, DOI 10.1073/pnas.61.3.883; Waggoner A S, 1977, Ann N Y Acad Sci, V303, P217; Yuste R, 1997, CEREB CORTEX, V7, P546, DOI 10.1093/cercor/7.6.546; Zampighi GA, 1999, J GEN PHYSIOL, V113, P507, DOI 10.1085/jgp.113.4.507; Zhang J, 1996, BIOPHYS J, V71, P2501, DOI 10.1016/S0006-3495(96)79443-2; Zhang J, 1998, BIOPHYS J, V74, P48, DOI 10.1016/S0006-3495(98)77765-3	54	95	101	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 9	2003	37	1					85	97		10.1016/S0896-6273(02)01126-1	http://dx.doi.org/10.1016/S0896-6273(02)01126-1			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	646UV	12526775	Bronze			2022-12-24	WOS:000181054700012
J	Immke, DC; McCleskey, EW				Immke, DC; McCleskey, EW			Protons open acid-sensing ion channels by catalyzing relief of Ca2+ blockade	NEURON			English	Article							INDUCED SODIUM CURRENT; PLANAR LIPID BILAYERS; ROOT GANGLION NEURONS; GATED CATION CHANNEL; SENSORY NEURONS; NA+ CHANNEL; ISCHEMIA; CELLS; LOCALIZATION; SENSATION	Acid-sensing ion channels (ASICs) open when extracellular pH drops and they are enhanced by lactate, making them specialized for detecting lactic acidosis. Highly expressed on cardiac nociceptors and some other sensory neurons, ASICs may help trigger pain caused by tissue ischemia. We report that H+ opens ASIC3 by speeding release of Ca2+ from a high-affinity binding site (K-Ca = 150 nM) on the extracellular side of the pore. The bound Ca2+ blocks permeation and the channel conducts when multiple H+ ions relieve this block. Activation through Ca2+ explains sensitivity to lactate, which decreases extracellular [Ca2+], and it may prove relevant in CNS pathologies (stroke, seizure) that simultaneously drop pH and Ca2+.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA	Oregon Health & Science University	McCleskey, EW (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA.	mccleske@ohsu.edu						Adams CM, 1998, J BIOL CHEM, V273, P30204, DOI 10.1074/jbc.273.46.30204; AKAIKE N, 1994, PROG NEUROBIOL, V43, P73, DOI 10.1016/0301-0082(94)90016-7; AKAIKE N, 1990, J NEUROPHYSIOL, V63, P805, DOI 10.1152/jn.1990.63.4.805; Askwith CC, 2001, P NATL ACAD SCI USA, V98, P6459, DOI 10.1073/pnas.111155398; Babini E, 2002, J BIOL CHEM, V277, P41597, DOI 10.1074/jbc.M205877200; Benson CJ, 1999, CIRC RES, V84, P921; Berdiev BK, 2001, J BIOL CHEM, V276, P38755, DOI 10.1074/jbc.M107266200; COBBE SM, 1980, J MOL CELL CARDIOL, V12, P745, DOI 10.1016/0022-2828(80)90077-2; DAVIES NW, 1988, J PHYSIOL-LONDON, V400, P159, DOI 10.1113/jphysiol.1988.sp017116; de la Rosa DA, 2000, ANNU REV PHYSIOL, V62, P573, DOI 10.1146/annurev.physiol.62.1.573; de Weille JR, 1998, FEBS LETT, V433, P257, DOI 10.1016/S0014-5793(98)00916-8; Garcia-Anoveros J, 2001, J NEUROSCI, V21, P2678, DOI 10.1523/JNEUROSCI.21-08-02678.2001; Heinemann U, 1986, Adv Neurol, V44, P641; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Immke DC, 2001, NAT NEUROSCI, V4, P869, DOI 10.1038/nn0901-869; Ismailov II, 1997, BIOPHYS J, V72, P1182, DOI 10.1016/S0006-3495(97)78766-6; KONNERTH A, 1987, J PHYSIOL-LONDON, V386, P603, DOI 10.1113/jphysiol.1987.sp016553; KORKUSHKO AO, 1983, NEUROPHYSIOLOGY+, V15, P469; KOVALCHUK YN, 1990, NEUROSCI LETT, V115, P237, DOI 10.1016/0304-3940(90)90461-H; KRISHTAL OA, 1981, NEUROSCIENCE, V6, P2599, DOI 10.1016/0306-4522(81)90105-6; KRISHTAL OA, 1980, NEUROSCIENCE, V5, P2325, DOI 10.1016/0306-4522(80)90149-9; Lindemann B, 1996, PHYSIOL REV, V76, P719, DOI 10.1152/physrev.1996.76.3.719; Martell A.E., 1992, DETERMINATION USE ST; Martell A. E., 1974, CRITICAL STABILITY C; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; Sutherland SP, 2001, P NATL ACAD SCI USA, V98, P711, DOI 10.1073/pnas.011404498; TSIEN RW, 1987, ANNU REV BIOPHYS BIO, V16, P265; Waldmann R, 1997, J BIOL CHEM, V272, P20975, DOI 10.1074/jbc.272.34.20975; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Waldmann R, 1998, CURR OPIN NEUROBIOL, V8, P418, DOI 10.1016/S0959-4388(98)80070-6; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Zhang P, 2002, J GEN PHYSIOL, V120, P553, DOI 10.1085/jgp.20028574; Zhang P, 2001, J GEN PHYSIOL, V117, P563, DOI 10.1085/jgp.117.6.563	36	185	194	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 9	2003	37	1					75	84		10.1016/S0896-6273(02)01130-3	http://dx.doi.org/10.1016/S0896-6273(02)01130-3			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	646UV	12526774	Bronze			2022-12-24	WOS:000181054700011
J	Shin, OH; Rhee, JS; Tang, J; Sugita, S; Rosenmund, C; Sudhof, TC				Shin, OH; Rhee, JS; Tang, J; Sugita, S; Rosenmund, C; Sudhof, TC			Sr2+ binding to the Ca2+ binding site of the synaptotagmin 1 C2B domain triggers fast exocytosis without stimulating SNARE interactions	NEURON			English	Article							SYNAPTIC TRANSMISSION; TRANSMITTER RELEASE; ASYNCHRONOUS RELEASE; PROTEIN; SYNAPSES; RAT; LOCALIZATION; COMPONENTS; STRONTIUM; SYNTAXIN	Sr2+ triggers neurotransmitter release similar to Ca2+, but less efficiently. We now show that in synaptotagmin 1 knockout mice, the fast component of both Ca2+- and Sr2+-induced release is selectively impaired, suggesting that both cations partly act by binding to synaptotagmin 1. Both the C(2)A and the C2B domain of synaptotagmin 1 bind Ca2+ in phospholipid complexes, but only the C2B domain forms Sr2+/phospholipid complexes; therefore, Sr2+ binding to the C2B domain is sufficient to trigger fast release, although with decreased efficacy. Ca2+ induces binding of the synaptotagmin C, domains to SNARE proteins, whereas Sr2+ even at high concentrations does not. Thus, triggering of the fast component of release by Sr2+ as a Ca2+ agonist involves the formation of synaptotagmin/ phospholipid complexes, but does not require stimulated SNARE binding.	Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dept Mol Genet, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37077 Gottingen, Germany	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Max Planck Society	Sudhof, TC (corresponding author), Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dept Mol Genet, Dallas, TX 75390 USA.	thomas.sudhof@utsouthwestern.edu	Rosenmund, Christian/AAC-3596-2020	Rosenmund, Christian/0000-0002-3905-2444; Sugita, Shuzo/0000-0002-9182-873X				Adolfsen B, 2001, CELL MOL LIFE SCI, V58, P393, DOI 10.1007/PL00000865; ALTURI PP, 1998, J NEUROSCI, V18, P8214; BARRETT EF, 1972, J PHYSIOL-LONDON, V227, P691, DOI 10.1113/jphysiol.1972.sp010054; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; Capogna M, 1997, J NEUROSCI, V17, P7190; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; Chen XC, 2002, NEURON, V33, P397, DOI 10.1016/S0896-6273(02)00583-4; DODGE FA, 1969, J PHYSIOL-LONDON, V200, P267, DOI 10.1113/jphysiol.1969.sp008692; Earles CA, 2001, J CELL BIOL, V154, P1117, DOI 10.1083/jcb.200105020; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; Fernandez-Chacon R, 2002, J NEUROSCI, V22, P8438; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Fukuda M, 2002, J BIOL CHEM, V277, P4601, DOI 10.1074/jbc.C100588200; GEPPERT M, 1991, J BIOL CHEM, V266, P13548; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Geppert M, 1997, NATURE, V387, P810, DOI 10.1038/42954; Gerona RRL, 2000, J BIOL CHEM, V275, P6328, DOI 10.1074/jbc.275.9.6328; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Hagler DJ, 2001, J NEUROPHYSIOL, V85, P2324, DOI 10.1152/jn.2001.85.6.2324; JOHNSTON PA, 1989, J BIOL CHEM, V264, P1268; Katz B., 1969, RELEASE NEURAL TRANS; Kee Y, 1996, J NEUROSCI, V16, P1975; Kishimoto T, 2001, J PHYSIOL-LONDON, V533, P627, DOI 10.1111/j.1469-7793.2001.t01-1-00627.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; LI C, 1995, J BIOL CHEM, V270, P24898, DOI 10.1074/jbc.270.42.24898; Mackler JM, 2002, NATURE, V418, P340, DOI 10.1038/nature00846; MARQUEZE B, 1995, J NEUROSCI, V15, P4906; MATTHEW WD, 1981, J CELL BIOL, V91, P257, DOI 10.1083/jcb.91.1.257; MCMAHON HT, 1995, CELL, V83, P111, DOI 10.1016/0092-8674(95)90239-2; MILEDI R, 1966, NATURE, V212, P1233, DOI 10.1038/2121233a0; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; Pyott SJ, 2002, J PHYSIOL-LONDON, V539, P523, DOI 10.1113/jphysiol.2001.013277; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Robinson IM, 2002, NATURE, V418, P336, DOI 10.1038/nature00915; Rosenmund C, 2002, NEURON, V33, P411, DOI 10.1016/S0896-6273(02)00568-8; Rumpel E, 1999, J PHYSIOL-LONDON, V514, P447, DOI 10.1111/j.1469-7793.1999.447ae.x; Sabatini BL, 1999, ANNU REV PHYSIOL, V61, P521, DOI 10.1146/annurev.physiol.61.1.521; Sabatini BL, 1996, NATURE, V384, P170, DOI 10.1038/384170a0; Schiavo G, 1997, P NATL ACAD SCI USA, V94, P997, DOI 10.1073/pnas.94.3.997; Shin OH, 2002, NAT NEUROSCI, V5, P649, DOI 10.1038/nn869; SHOJIKASAI Y, 1992, SCIENCE, V256, P1820, DOI 10.1126/science.256.5065.1820; SILINSKY EM, 1978, J PHYSIOL-LONDON, V274, P157, DOI 10.1113/jphysiol.1978.sp012141; Sudhof TC, 2002, J BIOL CHEM, V277, P7629, DOI 10.1074/jbc.R100052200; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Sugita S, 2002, EMBO J, V21, P270, DOI 10.1093/emboj/21.3.270; Sugita S, 2001, NEURON, V30, P459, DOI 10.1016/S0896-6273(01)00290-2; Ubach J, 2001, BIOCHEMISTRY-US, V40, P5854, DOI 10.1021/bi010340c; ULLRICH B, 1994, NEURON, V13, P1281, DOI 10.1016/0896-6273(94)90415-4; Voets T, 2001, P NATL ACAD SCI USA, V98, P11680, DOI 10.1073/pnas.201398798; Xu-Friedman MA, 1999, BIOPHYS J, V76, P2029, DOI 10.1016/S0006-3495(99)77360-1; Xu-Friedman MA, 2000, J NEUROSCI, V20, P4414, DOI 10.1523/JNEUROSCI.20-12-04414.2000; Zhang XD, 2002, NEURON, V34, P599, DOI 10.1016/S0896-6273(02)00671-2	54	105	109	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 9	2003	37	1					99	108		10.1016/S0896-6273(02)01145-5	http://dx.doi.org/10.1016/S0896-6273(02)01145-5			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	646UV	12526776	Bronze, Green Published			2022-12-24	WOS:000181054700013
J	Barborica, A; Ferrera, VP				Barborica, A; Ferrera, VP			Estimating invisible target speed from neuronal activity in monkey frontal eye field	NATURE NEUROSCIENCE			English	Article							SUPERIOR COLLICULUS; PREFRONTAL CORTEX; MACAQUE; MOVEMENTS; SACCADES; SELECTIVITY; MODULATION; DECISION	Working memory involves transient storage of information and the ability to manipulate that information for short-range planning and prediction. The computational aspect of working memory can be probed using dynamic sensorimotor behavior requiring complex stimulus-response mappings. Such a transformation occurs when extrapolating the future location of a moving target that is rendered temporarily invisible. Estimating the trajectory of an invisible moving target requires encoding and storing several target features, including the direction and speed of motion. We trained monkeys to make saccades to the estimated position of invisible targets moving at various speeds. The activity of neurons in the frontal eye field (FEF) was consistently modulated according to the speed of target motion. A reconstruction algorithm showed that estimates of target speed based on FEF activity were similar to behavioral speed estimates. FEF may therefore be involved in updating an internal representation of target trajectory for predictive saccades.	Columbia Univ, Dept Psychiat, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, David Mahoney Ctr Mind & Brain, New York, NY 10032 USA	Columbia University; Columbia University	Ferrera, VP (corresponding author), Columbia Univ, Dept Psychiat, Ctr Neurobiol & Behav, 1051 Riverside Dr,Kolb Annex 504, New York, NY 10032 USA.		Barborica, Andrei/N-6204-2017	Barborica, Andrei/0000-0001-6783-3769; Ferrera, Vincent/0000-0002-6599-7740	NIMH NIH HHS [MH59244, R01 MH059244] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059244] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BARBAS H, 1981, J COMP NEUROL, V200, P407, DOI 10.1002/cne.902000309; Basso MA, 1997, NATURE, V389, P66, DOI 10.1038/37975; Basso MA, 1998, J NEUROSCI, V18, P7519; Bichot NP, 1996, NATURE, V381, P697, DOI 10.1038/381697a0; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; CARPENTER RHS, 1995, NATURE, V377, P59, DOI 10.1038/377059a0; Constantinidis C, 2001, NAT NEUROSCI, V4, P311, DOI 10.1038/85179; Everling S, 2000, J NEUROSCI, V20, P387, DOI 10.1523/JNEUROSCI.20-01-00387.2000; Ferraina S, 2000, J NEUROPHYSIOL, V83, P625, DOI 10.1152/jn.2000.83.1.625; Filion CM, 1996, J COMP PSYCHOL, V110, P386, DOI 10.1037/0735-7036.110.4.386; Fukushima K, 2002, EXP BRAIN RES, V145, P104, DOI 10.1007/s00221-002-1088-7; GOLDBERG ME, 1990, J NEUROPHYSIOL, V64, P489, DOI 10.1152/jn.1990.64.2.489; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Hooker C, 2000, SCHIZOPHR RES, V45, P83, DOI 10.1016/S0920-9964(99)00166-8; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; KEATING EG, 1991, EXP BRAIN RES, V86, P311; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; MOHLER CW, 1973, BRAIN RES, V61, P385, DOI 10.1016/0006-8993(73)90543-X; Opris I, 2001, EXP BRAIN RES, V138, P1, DOI 10.1007/s002210100686; Reddi BAJ, 2000, NAT NEUROSCI, V3, P827, DOI 10.1038/77739; ROBINSON DA, 1969, J NEUROPHYSIOL, V32, P637, DOI 10.1152/jn.1969.32.5.637; SCHALL JD, 1995, J NEUROSCI, V15, P6905; SCHALL JD, 1995, J NEUROSCI, V15, P4464; SEGRAVES MA, 1993, J NEUROPHYSIOL, V69, P1880, DOI 10.1152/jn.1993.69.6.1880; Tanaka M, 2002, J NEUROPHYSIOL, V87, P2684, DOI 10.1152/jn.2002.87.6.2684; Wurtz Robert H., 1994, Current Opinion in Neurobiology, V4, P857, DOI 10.1016/0959-4388(94)90134-1	28	82	82	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2003	6	1					66	74		10.1038/nn990	http://dx.doi.org/10.1038/nn990			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	630CE	12483216				2022-12-24	WOS:000180089300017
J	Sakai, K; Passingham, RE				Sakai, K; Passingham, RE			Prefrontal interactions reflect future task operations	NATURE NEUROSCIENCE			English	Article							FRONTAL-LOBE DAMAGE; WORKING-MEMORY; PREMOTOR CORTEX; EPISODIC MEMORY; LONDON TASK; ORGANIZATION; RETRIEVAL; DISSOCIATION; PERFORMANCE; NEURONS	When task instructions are given, the human brain establishes a task set before the task is actually performed. By introducing a delay between the instruction and the task, we have identified the neural correlates of task sets using functional magnetic resonance imaging (fMRI). Subjects were instructed to remember a sequence of positions or letters, either in the order presented or in the reverse order. Spatial or verbal processing areas were active during the delay, depending on whether positions or letters were to be remembered, whereas the anterior region of the prefrontal cortex (PFC) was active regardless of the domain of the items. Furthermore, the nature of the interaction between the anterior PFC and the domain-specific posterior prefrontal areas (superior frontal sulcus and left inferior frontal gyrus) depended on whether the items were to be remembered in the forward or backward order. Thus we have identified inter-regional interactions that reflect preparation for task performance.	Inst Neurol, Wellcome Dept Cognit Neurol, London WC1N 3BG, England; Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of London; University College London; University of Oxford	Sakai, K (corresponding author), Inst Neurol, Wellcome Dept Cognit Neurol, 12 Queen Sq, London WC1N 3BG, England.							Asaad WF, 2000, J NEUROPHYSIOL, V84, P451, DOI 10.1152/jn.2000.84.1.451; Baker SC, 1996, NEUROPSYCHOLOGIA, V34, P515, DOI 10.1016/0028-3932(95)00133-6; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Calton JL, 2002, NAT NEUROSCI, V5, P580, DOI 10.1038/nn862; Christoff K, 2000, PSYCHOBIOLOGY, V28, P168; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Crammond DJ, 2000, J NEUROPHYSIOL, V84, P986, DOI 10.1152/jn.2000.84.2.986; Dagher A, 1999, BRAIN, V122, P1973, DOI 10.1093/brain/122.10.1973; Duncan J, 1996, COGNITIVE PSYCHOL, V30, P257, DOI 10.1006/cogp.1996.0008; Duzel E, 1999, P NATL ACAD SCI USA, V96, P1794, DOI 10.1073/pnas.96.4.1794; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; Friston KJ, 1999, NEUROIMAGE, V10, P385, DOI 10.1006/nimg.1999.0484; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; KURATA K, 1988, EXP BRAIN RES, V69, P327; Lepage M, 2000, P NATL ACAD SCI USA, V97, P506, DOI 10.1073/pnas.97.1.506; Leung HC, 2002, J COGNITIVE NEUROSCI, V14, P659, DOI 10.1162/08989290260045882; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Meiran N, 2000, COGNITIVE PSYCHOL, V41, P211, DOI 10.1006/cogp.2000.0736; OScalaidhe SP, 1997, SCIENCE, V278, P1135, DOI 10.1126/science.278.5340.1135; Owen AM, 1999, EUR J NEUROSCI, V11, P567, DOI 10.1046/j.1460-9568.1999.00449.x; Pochon JB, 2001, CEREB CORTEX, V11, P260, DOI 10.1093/cercor/11.3.260; Postle BR, 1999, P NATL ACAD SCI USA, V96, P12959, DOI 10.1073/pnas.96.22.12959; ROGERS RD, 1995, J EXP PSYCHOL GEN, V124, P207, DOI 10.1037/0096-3445.124.2.207; Rogers RD, 1998, BRAIN, V121, P815, DOI 10.1093/brain/121.5.815; Rowe JB, 2000, SCIENCE, V288, P1656, DOI 10.1126/science.288.5471.1656; Rugg MD, 2000, TRENDS COGN SCI, V4, P108, DOI 10.1016/S1364-6613(00)01445-5; RUSHWORTH MFS, IN PRESS J COGN NEUR; Sakai K, 2002, NAT NEUROSCI, V5, P479, DOI 10.1038/nn846; SchlagRey M, 1997, NATURE, V390, P398, DOI 10.1038/37114; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Ungerleider LG, 1998, P NATL ACAD SCI USA, V95, P883, DOI 10.1073/pnas.95.3.883; Wallis JD, 2001, NATURE, V411, P953, DOI 10.1038/35082081; WILSON FAW, 1993, SCIENCE, V260, P1955, DOI 10.1126/science.8316836; Wylie G, 2000, PSYCHOL RES-PSYCH FO, V63, P212, DOI 10.1007/s004269900003	35	304	306	2	21	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2003	6	1					75	81		10.1038/nn987	http://dx.doi.org/10.1038/nn987			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	630CE	12469132				2022-12-24	WOS:000180089300018
J	Demarque, M; Represa, A; Becq, H; Khalilov, I; Ben-Ari, Y; Aniksztejn, L				Demarque, M; Represa, A; Becq, H; Khalilov, I; Ben-Ari, Y; Aniksztejn, L			Paracrine intercellular communication by a Ca-2+- and SNARE-independent release of GABA and glutamate prior to synapse formation	NEURON			English	Article							GAMMA-AMINOBUTYRIC-ACID; NEUROTRANSMITTER RELEASE; EXCITATORY ACTIONS; GROWTH CONES; RAT; TRANSPORTER; CA2+; ACTIVATION; EXPRESSION; RECEPTORS	GABA and glutamate receptors are expressed in immature "silent" CA1 pyramidal neurons prior to synapse formation, but their function is unknown. We now report the presence of tonic, spontaneous, and evoked currents in embryonic and neonatal CA1 neurons mediated primarily by the activation of GABA(A) receptors. These currents are mediated by a nonconventional release of transmitters, as they persist in the presence of calcium channel blockers or botulinium toxin and are observed in Munc18-1-deficient mice in which vesicular release is abolished. This paracrine communication is modulated by glutamate but not GABA transporters, which do not operate during this period of life. Thus, a Ca2+- and SNARE-independent release of transmitters underlies a paracrine mode of communication before synapse formation.	INSERM, INMED, U29, F-13273 Marseille 09, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Aniksztejn, L (corresponding author), INSERM, INMED, U29, Parc Sci Luminy,BP13, F-13273 Marseille 09, France.	anik@inmed.univ-mrs.fr	Aniksztejn, Laurent/E-2072-2017; Represa, Alfonso/M-7383-2016; Khalilov, Ilgam/B-5267-2015	Represa, Alfonso/0000-0002-5096-8939; Khalilov, Ilgam/0000-0002-9468-4778; Demarque, Michael/0000-0001-5073-1651; Ben-Ari, Yehezkel/0000-0001-6208-8480; Aniksztejn, laurent/0000-0001-9215-1698				BARBIN G, 1993, NEUROSCI LETT, V152, P150, DOI 10.1016/0304-3940(93)90505-F; Ben-Ari Y, 2001, TRENDS NEUROSCI, V24, P353, DOI 10.1016/S0166-2236(00)01813-0; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; BIMIR BV, 2000, J MEMBRANE BIOL, V174, P21; BORDEN LA, 1994, EUR J PHARM-MOLEC PH, V269, P219, DOI 10.1016/0922-4106(94)90089-2; Caillard O, 1998, J NEUROPHYSIOL, V79, P1341, DOI 10.1152/jn.1998.79.3.1341; Capogna M, 1997, J NEUROSCI, V17, P7190; Cotrina ML, 1998, P NATL ACAD SCI USA, V95, P15735, DOI 10.1073/pnas.95.26.15735; Diabira D, 1999, EUR J NEUROSCI, V11, P4015, DOI 10.1046/j.1460-9568.1999.00831.x; Dupuy ST, 1996, J NEUROSCI, V16, P6919; Flint AC, 1998, NEURON, V20, P43, DOI 10.1016/S0896-6273(00)80433-X; Furuta A, 1997, J NEUROSCI, V17, P8363; Gadea A, 2001, J NEUROSCI RES, V63, P461, DOI 10.1002/jnr.1040; GAHWILER B, 1999, P NATL ACAD SCI USA, V96, P8733; Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5; Gao XB, 2000, J PHYSIOL-LONDON, V523, P629, DOI 10.1111/j.1469-7793.2000.t01-1-00629.x; Gaspary HL, 1998, J NEUROPHYSIOL, V80, P270, DOI 10.1152/jn.1998.80.1.270; Haas K, 2001, NEURON, V29, P583, DOI 10.1016/S0896-6273(01)00235-5; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; Hennou S, 2002, EUR J NEUROSCI, V16, P197, DOI 10.1046/j.1460-9568.2002.02073.x; ISAACSON JS, 1993, NEURON, V10, P165, DOI 10.1016/0896-6273(93)90308-E; KATZ B, 1977, PROC R SOC SER B-BIO, V196, P59, DOI 10.1098/rspb.1977.0029; KOMURO H, 1993, SCIENCE, V260, P95, DOI 10.1126/science.8096653; LEINEKUGEL X, 1995, J PHYSIOL-LONDON, V487, P319, DOI 10.1113/jphysiol.1995.sp020882; Leinekugel X, 1997, NEURON, V18, P243, DOI 10.1016/S0896-6273(00)80265-2; Liu QY, 2000, J NEUROPHYSIOL, V84, P1392, DOI 10.1152/jn.2000.84.3.1392; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; LOTURCO JJ, 1991, J NEUROSCI, V11, P792; McLean HA, 1996, J PHYSIOL-LONDON, V496, P471, DOI 10.1113/jphysiol.1996.sp021699; Mochida S, 1998, P NATL ACAD SCI USA, V95, P14523, DOI 10.1073/pnas.95.24.14523; NEHER E, 1992, METHOD ENZYMOL, V207, P123; NELSON S, 1994, SCIENCE, V265, P774, DOI 10.1126/science.8047882; Nguyen L, 2001, CELL TISSUE RES, V305, P187, DOI 10.1007/s004410000343; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Parri HR, 2001, NAT NEUROSCI, V4, P803, DOI 10.1038/90507; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; ROZENBERG F, 1989, DEV BRAIN RES, V50, P177, DOI 10.1016/0165-3806(89)90193-4; Rusakov DA, 1998, J NEUROSCI, V18, P3158; Sato H, 2002, J NEUROSCI, V22, P8028; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; SCHWARTZ EA, 1987, SCIENCE, V238, P350, DOI 10.1126/science.2443977; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; Sjostrom PJ, 2002, CURR OPIN NEUROBIOL, V12, P305, DOI 10.1016/S0959-4388(02)00325-2; Soeda H, 1997, NEUROSCIENCE, V77, P1187, DOI 10.1016/S0306-4522(96)00465-4; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Sudhof TC, 2001, ANNU REV NEUROSCI, V24, P933, DOI 10.1146/annurev.neuro.24.1.933; SUPER H, 1994, J COMP NEUROL, V344, P101, DOI 10.1002/cne.903440108; TAYLOR J, 1991, J NEUROCHEM, V56, P273, DOI 10.1111/j.1471-4159.1991.tb02592.x; Tse FW, 2000, J PHYSIOL-LONDON, V526, P99, DOI 10.1111/j.1469-7793.2000.00099.x; Tyzio R, 1999, J NEUROSCI, V19, P10372; Ullensvang K, 1997, EUR J NEUROSCI, V9, P1646, DOI 10.1111/j.1460-9568.1997.tb01522.x; VALEYEV AY, 1993, NEUROSCI LETT, V155, P199, DOI 10.1016/0304-3940(93)90707-R; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Warr O, 1999, J PHYSIOL-LONDON, V514, P783, DOI 10.1111/j.1469-7793.1999.783ad.x; XIE ZP, 1986, P NATL ACAD SCI USA, V83, P7069, DOI 10.1073/pnas.83.18.7069; Yan XX, 1997, DEV BRAIN RES, V99, P1, DOI 10.1016/S0165-3806(96)00192-7; Zhang C, 2002, NAT NEUROSCI, V5, P425, DOI 10.1038/nn845	58	218	222	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 19	2002	36	6					1051	1061		10.1016/S0896-6273(02)01053-X	http://dx.doi.org/10.1016/S0896-6273(02)01053-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	628TA	12495621	Bronze			2022-12-24	WOS:000180011600009
J	Taschenberger, H; Leao, RM; Rowland, KC; Spirou, GA; von Gersdorff, H				Taschenberger, H; Leao, RM; Rowland, KC; Spirou, GA; von Gersdorff, H			Optimizing synaptic architecture and efficiency for high-frequency transmission	NEURON			English	Article							AUDITORY BRAIN-STEM; PRESYNAPTIC CALCIUM CURRENT; PURKINJE-CELL SYNAPSES; TRANSMITTER RELEASE; TRAPEZOID BODY; COCHLEAR NUCLEUS; MEDIAL NUCLEUS; NEUROTRANSMITTER RELEASE; DEVELOPMENTAL-CHANGES; POSTNATAL-DEVELOPMENT	Bursts of neuronal activity are transmitted more effectively as synapses mature. However, the mechanisms that control synaptic efficiency during development are poorly understood. Here, we study postnatal changes in synaptic ultrastructure and exocytosis in a calyx-type nerve terminal. Vesicle pool size, exocytotic efficiency (amount of exocytosis per Ca influx), Ca current facilitation, and the number of active zones (AZs) increased with age, whereas AZ area, number of docked vesicles per AZ, and release probability decreased with age. These changes led to AZs that are less prone to multivesicular release, resulting in reduced AMPA receptor saturation and desensitization. A greater multiplicity of small AZs with few docked vesicles, a larger pool of releasable vesicles, and a higher efficiency of release thus promote prolonged high-frequency firing in mature synapses.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; W Virginia Univ, Hlth Sci Ctr, Sch Med, Sensory Neurosci Res Ctr, Morgantown, WV 26506 USA; W Virginia Univ, Hlth Sci Ctr, Sch Med, Dept Otolaryngol, Morgantown, WV 26506 USA; W Virginia Univ, Hlth Sci Ctr, Sch Med, Dept Physiol, Morgantown, WV 26506 USA	Oregon Health & Science University; West Virginia University; West Virginia University; West Virginia University	von Gersdorff, H (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.		Leao, Ricardo/M-1933-2019; Leao, Ricardo M/C-4869-2012	Leao, Ricardo/0000-0002-3829-3342; Leao, Ricardo M/0000-0002-3829-3342; Taschenberger, Holger/0000-0003-3186-3231	NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015574] Funding Source: NIH RePORTER; NCRR NIH HHS [P20 RR15574] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Auger C, 1998, J NEUROSCI, V18, P4532; Bellingham MC, 1998, J PHYSIOL-LONDON, V511, P861, DOI 10.1111/j.1469-7793.1998.861bg.x; Beutner D, 2001, J NEUROSCI, V21, P4593, DOI 10.1523/JNEUROSCI.21-13-04593.2001; BLUE ME, 1983, J NEUROCYTOL, V12, P697, DOI 10.1007/BF01181531; Borst JGG, 1995, J PHYSIOL-LONDON, V489, P825, DOI 10.1113/jphysiol.1995.sp021095; Borst JGG, 1998, J PHYSIOL-LONDON, V513, P149, DOI 10.1111/j.1469-7793.1998.149by.x; Borst JGG, 1998, J PHYSIOL-LONDON, V506, P143, DOI 10.1111/j.1469-7793.1998.143bx.x; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; Borst JGG, 1999, PHILOS T R SOC B, V354, P347, DOI 10.1098/rstb.1999.0386; Brenowitz S, 2001, J NEUROSCI, V21, P9487, DOI 10.1523/JNEUROSCI.21-23-09487.2001; Caicedo A, 1999, EUR J NEUROSCI, V11, P51, DOI 10.1046/j.1460-9568.1999.00410.x; Carr CE, 2001, CURR OPIN NEUROBIOL, V11, P727, DOI 10.1016/S0959-4388(01)00276-8; Chavis P, 2001, NATURE, V411, P317, DOI 10.1038/35077101; Chen CF, 2002, NEURON, V33, P779, DOI 10.1016/S0896-6273(02)00611-6; Chuhma N, 2001, J PHYSIOL-LONDON, V530, P93, DOI 10.1111/j.1469-7793.2001.0093m.x; Chuhma N, 1998, J NEUROSCI, V18, P512; Clements JD, 1997, BIOPHYS J, V73, P220, DOI 10.1016/S0006-3495(97)78062-7; Clements JD, 1996, TRENDS NEUROSCI, V19, P163, DOI 10.1016/S0166-2236(96)10024-2; Craig AM, 2001, SYNAPSES, P571; Cuttle MF, 1998, J PHYSIOL-LONDON, V512, P723, DOI 10.1111/j.1469-7793.1998.723bd.x; Diamond JS, 1997, J NEUROSCI, V17, P4672; DiGregorio DA, 2002, NEURON, V35, P521, DOI 10.1016/S0896-6273(02)00787-0; Dobrunz LE, 2002, INT J DEV NEUROSCI, V20, P225, DOI 10.1016/S0736-5748(02)00015-1; Dosemeci A, 2001, P NATL ACAD SCI USA, V98, P10428, DOI 10.1073/pnas.181336998; ELMQVIST D, 1965, J PHYSIOL-LONDON, V178, P505, DOI 10.1113/jphysiol.1965.sp007639; Fiala JC, 2001, J MICROSC-OXFORD, V202, P468, DOI 10.1046/j.1365-2818.2001.00926.x; FORSYTHE ID, 1994, J PHYSIOL-LONDON, V479, P381, DOI 10.1113/jphysiol.1994.sp020303; Forsythe ID, 1998, NEURON, V20, P797, DOI 10.1016/S0896-6273(00)81017-X; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; Gillis Kevin D., 1995, P155; Hanse E, 2002, J NEUROSCI, V22, P4381, DOI 10.1523/JNEUROSCI.22-11-04381.2002; HARRIS KM, 1995, NEUROPHARMACOLOGY, V34, P1387, DOI 10.1016/0028-3908(95)00142-S; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Hsia AY, 1998, J NEUROPHYSIOL, V79, P2013, DOI 10.1152/jn.1998.79.4.2013; Hsu SF, 1996, J PHYSIOL-LONDON, V494, P539, DOI 10.1113/jphysiol.1996.sp021512; Ishikawa T, 2001, J PHYSIOL-LONDON, V533, P423, DOI 10.1111/j.1469-7793.2001.0423a.x; Iwasaki S, 1998, J PHYSIOL-LONDON, V509, P419, DOI 10.1111/j.1469-7793.1998.419bn.x; Iwasaki S, 2001, J PHYSIOL-LONDON, V534, P861, DOI 10.1111/j.1469-7793.2001.00861.x; JEANBAPTISTE M, 1975, J COMP NEUROL, V162, P111, DOI 10.1002/cne.901620107; Joshi I, 2002, J PHYSIOL-LONDON, V540, P861; KANDLER K, 1993, J COMP NEUROL, V328, P161, DOI 10.1002/cne.903280202; KUWABARA N, 1991, J COMP NEUROL, V314, P684, DOI 10.1002/cne.903140405; LENN NJ, 1966, AM J ANAT, V118, P375, DOI 10.1002/aja.1001180205; Lenzi D, 2002, NEURON, V36, P649, DOI 10.1016/S0896-6273(02)01025-5; Lin JW, 2002, TRENDS NEUROSCI, V25, P449, DOI 10.1016/S0166-2236(02)02212-9; Lohmann C, 1996, J COMP NEUROL, V367, P90, DOI 10.1002/(SICI)1096-9861(19960325)367:1<90::AID-CNE7>3.0.CO;2-E; Lu T, 2000, NEURON, V26, P683, DOI 10.1016/S0896-6273(00)81204-0; MARTIN AR, 1964, J PHYSIOL-LONDON, V175, P17, DOI 10.1113/jphysiol.1964.sp007500; Meinrenken CJ, 2002, J NEUROSCI, V22, P1648, DOI 10.1523/JNEUROSCI.22-05-01648.2002; Meyer AC, 2001, J NEUROSCI, V21, P7889, DOI 10.1523/JNEUROSCI.21-20-07889.2001; MINTZ IM, 1995, NEURON, V15, P675, DOI 10.1016/0896-6273(95)90155-8; MOREST D K, 1968, Zeitschrift fuer Anatomie und Entwicklungsgeschichte, V127, P201, DOI 10.1007/BF00526129; Mozhayeva MG, 2002, J NEUROSCI, V22, P654, DOI 10.1523/JNEUROSCI.22-03-00654.2002; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Nicol MJ, 2002, J PHYSIOL-LONDON, V539, P713, DOI 10.1113/jphysiol.2001.012972; Oertner TG, 2002, NAT NEUROSCI, V5, P657, DOI 10.1038/nn867; Oleskevich S, 2002, J PHYSIOL-LONDON, V540, P447, DOI 10.1113/jphysiol.2001.013821; Otis TS, 1996, J NEUROSCI, V16, P1634, DOI 10.1523/jneurosci.16-05-01634.1996; Parks TN, 2000, HEARING RES, V147, P77, DOI 10.1016/S0378-5955(00)00122-2; PARTIN KM, 1994, MOL PHARMACOL, V46, P129; Redd EE, 2000, HEARING RES, V147, P160, DOI 10.1016/S0378-5955(00)00129-5; Renger JJ, 2001, NEURON, V29, P469, DOI 10.1016/S0896-6273(01)00219-7; Roos J, 1999, CURR BIOL, V9, P1411, DOI 10.1016/S0960-9822(00)80087-1; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; ROSSI DJ, 1995, J NEUROPHYSIOL, V74, P24, DOI 10.1152/jn.1995.74.1.24; Rowland KC, 2000, J NEUROSCI, V20, P9135; Ryugo DK, 1996, J COMP NEUROL, V365, P141, DOI 10.1002/(SICI)1096-9861(19960129)365:1<141::AID-CNE11>3.0.CO;2-T; Sakaba T, 2001, J NEUROSCI, V21, P462, DOI 10.1523/JNEUROSCI.21-02-00462.2001; SATZLER K, 2002, IN PRESS J NEUROSCI; Scheuss V, 2002, J NEUROSCI, V22, P728, DOI 10.1523/JNEUROSCI.22-03-00728.2002; Schikorski T, 1997, J NEUROSCI, V17, P5858; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Sekiguchi M, 1997, J NEUROSCI, V17, P5760; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; Smith PH, 1998, J NEUROPHYSIOL, V79, P3127, DOI 10.1152/jn.1998.79.6.3127; SMITH PH, 1991, J COMP NEUROL, V304, P387, DOI 10.1002/cne.903040305; Sun JY, 2002, NATURE, V417, P555, DOI 10.1038/417555a; Sun JY, 2001, NEURON, V30, P171, DOI 10.1016/S0896-6273(01)00271-9; Taschenberger H, 2000, J NEUROSCI, V20, P9162; TATSUOKA H, 1989, J COMP NEUROL, V290, P343, DOI 10.1002/cne.902900304; Teng HB, 2000, J NEUROSCI, V20, P7986; TRUSSELL LO, 1993, NEURON, V10, P1185, DOI 10.1016/0896-6273(93)90066-Z; VAUGHN JE, 1989, SYNAPSE, V3, P255, DOI 10.1002/syn.890030312; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; Wu LG, 1999, J NEUROSCI, V19, P726; Wu LG, 1999, NEURON, V23, P821, DOI 10.1016/S0896-6273(01)80039-8; WU SH, 1987, HEARING RES, V30, P99, DOI 10.1016/0378-5955(87)90187-0; Xu-Friedman MA, 2001, J NEUROSCI, V21, P6666, DOI 10.1523/JNEUROSCI.21-17-06666.2001	91	299	300	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 19	2002	36	6					1127	1143		10.1016/S0896-6273(02)01137-6	http://dx.doi.org/10.1016/S0896-6273(02)01137-6			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	628TA	12495627	Bronze			2022-12-24	WOS:000180011600015
J	Mellem, JE; Brockie, PJ; Zheng, Y; Madsen, DM; Maricq, AV				Mellem, JE; Brockie, PJ; Zheng, Y; Madsen, DM; Maricq, AV			Decoding of polymodal sensory stimuli by postsynaptic glutamate receptors in C-elegans	NEURON			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; NERVOUS-SYSTEM; NEURONS; CHANNELS; PROTEIN; IDENTIFICATION; TRANSPORTER; LOCOMOTION; RESPONSES; CURRENTS	The C. elegans polymodal ASH sensory neurons detect mechanical, osmotic, and chemical stimuli and release glutamate to signal avoidance responses. To investigate the mechanisms of this polymodal signaling, we have characterized the role of postsynaptic glutamate receptors in mediating the response to these distinct stimuli. By studying the behavioral and electrophysiological properties of worms defective for non-NMDA (GLR-1 and GLR-2) and NMDA (NMR-1) receptor subunits, we show that while the osmotic avoidance response requires both NMDA and non-NMDA receptors, the response to mechanical stimuli only requires non-NMDA receptors. Furthermore, analysis of the EGL-3 proprotein convertase provides additional evidence that polymodal signaling in C. elegans occurs via the differential activation of postsynaptic glutamate receptor subtypes.	Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Maricq, AV (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	maricq@biology.utah.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035812] Funding Source: NIH RePORTER; NINDS NIH HHS [NS35812] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akopian A, 2000, J NEUROSCI, V20, P929, DOI 10.1523/JNEUROSCI.20-03-00929.2000; Barger AJ, 1998, J NEUROSCI, V18, P2871; Bargmann CI, 1998, ANNU REV NEUROSCI, V21, P279, DOI 10.1146/annurev.neuro.21.1.279; Bellocchio EE, 2000, SCIENCE, V289, P957, DOI 10.1126/science.289.5481.957; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; Brockie PJ, 2001, NEURON, V31, P617, DOI 10.1016/S0896-6273(01)00394-4; Brockie PJ, 2001, J NEUROSCI, V21, P1510, DOI 10.1523/JNEUROSCI.21-05-01510.2001; CHALFIE M, 1985, J NEUROSCI, V5, P956; Chen S, 2002, J NEUROSCI, V22, P2165, DOI 10.1523/JNEUROSCI.22-06-02165.2002; Colbert HA, 1997, J NEUROSCI, V17, P8259; CULOTTI JG, 1978, GENETICS, V90, P243; Dent JA, 2000, P NATL ACAD SCI USA, V97, P2674, DOI 10.1073/pnas.97.6.2674; Dingledine R, 1999, PHARMACOL REV, V51, P7; Gao XB, 2001, J PHYSIOL-LONDON, V533, P237, DOI 10.1111/j.1469-7793.2001.0237b.x; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; Hart AC, 1999, J NEUROSCI, V19, P1952; Hilliard MA, 2002, CURR BIOL, V12, P730, DOI 10.1016/S0960-9822(02)00813-8; HUME RI, 1991, SCIENCE, V253, P1028, DOI 10.1126/science.1653450; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; Kass J, 2001, J NEUROSCI, V21, P9265, DOI 10.1523/JNEUROSCI.21-23-09265.2001; Lee RYN, 1999, J NEUROSCI, V19, P159, DOI 10.1523/JNEUROSCI.19-01-00159.1999; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; Momiyama A, 2000, J PHYSIOL-LONDON, V523, P621, DOI 10.1111/j.1469-7793.2000.t01-1-00621.x; Rongo C, 1998, CELL, V94, P751, DOI 10.1016/S0092-8674(00)81734-1; Silva AP, 2001, J NEUROCHEM, V79, P286, DOI 10.1046/j.1471-4159.2001.00560.x; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Stern-Bach Y, 1998, NEURON, V21, P907, DOI 10.1016/S0896-6273(00)80605-4; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; WATANABE S, 1991, J BIOL CHEM, V266, P20803; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Zheng Y, 1999, NEURON, V24, P347, DOI 10.1016/S0896-6273(00)80849-1	33	125	135	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 5	2002	36	5					933	944		10.1016/S0896-6273(02)01088-7	http://dx.doi.org/10.1016/S0896-6273(02)01088-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	622VL	12467596	Bronze			2022-12-24	WOS:000179667800017
J	Yoshihara, M; Littleton, JT				Yoshihara, M; Littleton, JT			Synaptotagmin I functions as a calcium sensor to synchronize neurotransmitter release	NEURON			English	Article							PROTEIN-KINASE-C; SYNAPTIC-TRANSMISSION; TRANSMITTER RELEASE; SNARE COMPLEX; MEMBRANE-FUSION; CA2+ BINDING; NEUROMUSCULAR-JUNCTION; PHOSPHOLIPID-BINDING; C(2)A DOMAIN; DROSOPHILA	To characterize Ca2+-mediated synaptic vesicle fusion, we analyzed Drosophila synaptotagmin I mutants deficient in specific interactions mediated by its two Ca2+ binding C2 domains. In the absence of synaptotagmin 1, synchronous release is abolished and a kinetically distinct delayed asynchronous release pathway is uncovered. Synapses containing only the C2A domain of synaptotagmin partially recover synchronous fusion, but have an abolished Ca2+ cooperativity. Mutants that disrupt Ca2+ sensing by the C2B domain have synchronous release with normal Ca2+ cooperativity, but with reduced release probability. Our data suggest the Ca2+ cooperativity of neurotransmitter release is likely mediated through synaptotagmin-SNARE interactions, while phospholipid binding and oligomerization trigger rapid fusion with increased release probability. These results indicate that synaptotagmin is the major Ca2+ sensor for evoked release and functions to trigger synchronous fusion in response to Ca2+, while suppressing asynchronous release.	MIT, Dept Biol, Picower Ctr Learning & Memory, Cambridge, MA 02139 USA; MIT, Dept Biol, Picower Ctr Learning & Memory, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Yoshihara, M (corresponding author), MIT, Dept Biol, Picower Ctr Learning & Memory, Cambridge, MA 02139 USA.	motojiro@mit.edu			NINDS NIH HHS [R01 NS040296-02, R01 NS040296] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040296] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adolfsen B, 2001, CELL MOL LIFE SCI, V58, P393, DOI 10.1007/PL00000865; BROADIE K, 1994, P NATL ACAD SCI USA, V91, P10727, DOI 10.1073/pnas.91.22.10727; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; CHAPMAN ER, 1994, J BIOL CHEM, V269, P5735; Chapman ER, 1996, J BIOL CHEM, V271, P5844, DOI 10.1074/jbc.271.10.5844; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; Chen CF, 1999, J NEUROSCI, V19, P6257; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; Craxton M, 2001, GENOMICS, V77, P43, DOI 10.1006/geno.2001.6619; Davis AF, 1999, NEURON, V24, P363, DOI 10.1016/S0896-6273(00)80850-8; DIANTONIO A, 1994, NEURON, V12, P909, DOI 10.1016/0896-6273(94)90342-5; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; Earles CA, 2001, J CELL BIOL, V154, P1117, DOI 10.1083/jcb.200105020; Fergestad T, 2001, J NEUROSCI, V21, P9142, DOI 10.1523/JNEUROSCI.21-23-09142.2001; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; Fernandez-Chacon R, 2002, J NEUROSCI, V22, P8438; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Fukuda M, 2000, FEBS LETT, V482, P269, DOI 10.1016/S0014-5793(00)02064-0; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Gerona RRL, 2000, J BIOL CHEM, V275, P6328, DOI 10.1074/jbc.275.9.6328; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; HARRISON SD, 1994, NEURON, V13, P555, DOI 10.1016/0896-6273(94)90025-6; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; Hilgenberg LGW, 2002, MOL CELL NEUROSCI, V19, P97, DOI 10.1006/mcne.2001.1056; Hu K, 2002, NATURE, V415, P646, DOI 10.1038/415646a; JAN LY, 1976, J PHYSIOL-LONDON, V262, P189, DOI 10.1113/jphysiol.1976.sp011592; JORGENSEN EM, 1995, NATURE, V378, P196, DOI 10.1038/378196a0; KAMIYA H, 1994, NATURE, V371, P603, DOI 10.1038/371603a0; KATZ B, 1967, J PHYSIOL-LONDON, V189, P535, DOI 10.1113/jphysiol.1967.sp008183; Kee Y, 1996, J NEUROSCI, V16, P1975; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Littleton JT, 2001, J NEUROSCI, V21, P1421, DOI 10.1523/JNEUROSCI.21-05-01421.2001; LITTLETON JT, 1993, DEVELOPMENT, V118, P1077; LITTLETON JT, 1993, CELL, V74, P1125, DOI 10.1016/0092-8674(93)90733-7; LITTLETON JT, 1994, P NATL ACAD SCI USA, V91, P10888, DOI 10.1073/pnas.91.23.10888; Littleton JT, 1999, NATURE, V400, P757, DOI 10.1038/23462; Littleton JT, 1998, NEURON, V21, P401, DOI 10.1016/S0896-6273(00)80549-8; Mackler JM, 2002, NATURE, V418, P340, DOI 10.1038/nature00846; Marek KW, 2002, NEURON, V36, P805, DOI 10.1016/S0896-6273(02)01068-1; MORIMOTO T, 1995, NEURON, V15, P689, DOI 10.1016/0896-6273(95)90156-6; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; Osborne SL, 1999, J BIOL CHEM, V274, P59, DOI 10.1074/jbc.274.1.59; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; Reist NE, 1998, J NEUROSCI, V18, P7662; Robinson IM, 2002, NATURE, V418, P336, DOI 10.1038/nature00915; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Schiavo G, 1997, P NATL ACAD SCI USA, V94, P997, DOI 10.1073/pnas.94.3.997; SCHULZE KL, 1995, CELL, V80, P311, DOI 10.1016/0092-8674(95)90414-X; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Stewart BA, 2000, P NATL ACAD SCI USA, V97, P13955, DOI 10.1073/pnas.250491397; Sudhof TC, 1996, NEURON, V17, P379, DOI 10.1016/S0896-6273(00)80171-3; Sugita S, 1996, J BIOL CHEM, V271, P1262, DOI 10.1074/jbc.271.3.1262; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; VANDEGOOR J, 1995, P NATL ACAD SCI USA, V92, P5739, DOI 10.1073/pnas.92.12.5739; Wang CT, 2001, SCIENCE, V294, P1111, DOI 10.1126/science.1064002; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Yoshihara M, 1997, J NEUROSCI, V17, P8408; Yoshihara M, 2000, J NEUROSCI, V20, P8315, DOI 10.1523/JNEUROSCI.20-22-08315.2000; Yoshihara M, 1999, J NEUROSCI, V19, P2432; ZHANG JZ, 1994, CELL, V78, P751, DOI 10.1016/S0092-8674(94)90442-1; Zhang XD, 2002, NEURON, V34, P599, DOI 10.1016/S0896-6273(02)00671-2; ZHONG Y, 1991, SCIENCE, V251, P198, DOI 10.1126/science.1670967	62	210	217	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 5	2002	36	5					897	908		10.1016/S0896-6273(02)01065-6	http://dx.doi.org/10.1016/S0896-6273(02)01065-6			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	622VL	12467593	Bronze			2022-12-24	WOS:000179667800014
J	Carter, AG; Regehr, WG				Carter, AG; Regehr, WG			Quantal events shape cerebellar interneuron firing	NATURE NEUROSCIENCE			English	Article							NEOSTRIATAL CHOLINERGIC INTERNEURONS; SYNAPTIC CURRENTS; PYRAMIDAL CELLS; PURKINJE-CELLS; STELLATE CELLS; NEOCORTICAL NEURONS; MEMBRANE-PROPERTIES; CORTICAL-NEURONS; INHIBITORY CELLS; INVITRO	Many small synaptic inputs or one large input are needed to influence principal cell firing, whereas individual quanta exert little influence. However, the role of a quantum may be greater for small interneurons with high input resistances. Using dynamic clamp recordings, we found that individual quanta strongly influence rat cerebellar stellate cell firing. When the frequency of synaptic inputs was low, the timing of recent spikes regulated the influence of excitatory quanta. In contrast, when input frequency was high, spike timing was less important than interactions with other inputs. Inhibitory quanta rapidly terminated firing, whereas small numbers of coincident excitatory quanta reliably and rapidly triggered firing. Our results suggest that stellate cells achieve temporal precision through coincidence detection and disynaptic inhibition, despite their high resistances and long membrane time constants. Thus, we propose that small interneurons can process synaptic inputs in a fundamentally different way from principal cells.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02215 USA	Harvard University; Harvard Medical School	Regehr, WG (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02215 USA.		Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X	NINDS NIH HHS [N01-NS32405-01] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABELES M, 1982, ISRAEL J MED SCI, V18, P83; Abeles M, 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; [Anonymous], [No title captured]; ARMSTRONG DM, 1979, J PHYSIOL-LONDON, V289, P425, DOI 10.1113/jphysiol.1979.sp012745; Auger C, 1997, NEURON, V19, P139, DOI 10.1016/S0896-6273(00)80354-2; BARBOUR B, 1993, NEURON, V11, P759, DOI 10.1016/0896-6273(93)90085-6; Bennett BD, 1998, J NEUROSCI, V18, P8539; Bennett BD, 2000, J NEUROSCI, V20, P8493, DOI 10.1523/JNEUROSCI.20-22-08493.2000; BUZSAKI G, 1995, CURR OPIN NEUROBIOL, V5, P504, DOI 10.1016/0959-4388(95)80012-3; CALLAWAY JC, 1995, J NEUROSCI, V15, P2777; Carter AG, 2000, J NEUROSCI, V20, P4423, DOI 10.1523/JNEUROSCI.20-12-04423.2000; CLELAND BG, 1971, NATURE-NEW BIOL, V231, P191, DOI 10.1038/newbio231191a0; Eccles J. C, 1957, PHYSL NERVE CELLS; ECCLES JC, 1966, EXP BRAIN RES, V1, P1; ECCLES JC, 1966, J PHYSIOL-LONDON, V182, P268, DOI 10.1113/jphysiol.1966.sp007824; FETZ EE, 1983, J PHYSIOL-LONDON, V341, P387, DOI 10.1113/jphysiol.1983.sp014812; Fricker D, 2000, NEURON, V28, P559, DOI 10.1016/S0896-6273(00)00133-1; Galarreta M, 2001, SCIENCE, V292, P2295, DOI 10.1126/science.1061395; Geiger JRP, 1997, NEURON, V18, P1009, DOI 10.1016/S0896-6273(00)80339-6; GULYAS AI, 1993, EUR J NEUROSCI, V5, P1729, DOI 10.1111/j.1460-9568.1993.tb00240.x; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; Jaeger D, 1999, J NEUROSCI, V19, P6090, DOI 10.1523/JNEUROSCI.19-14-06090.1999; Kondo S, 1998, J PHYSIOL-LONDON, V509, P221, DOI 10.1111/j.1469-7793.1998.221bo.x; Kreitzer AC, 2002, NEURON, V34, P787, DOI 10.1016/S0896-6273(02)00695-5; LLANO I, 1993, J PHYSIOL-LONDON, V468, P177, DOI 10.1113/jphysiol.1993.sp019766; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Mann-Metzer P, 2002, J NEUROPHYSIOL, V87, P149, DOI 10.1152/jn.00310.2001; Mark MD, 2000, EUR J BIOCHEM, V267, P5830, DOI 10.1046/j.1432-1327.2000.01670.x; MASON A, 1991, J NEUROSCI, V11, P72; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; MIDTGAARD J, 1992, J PHYSIOL-LONDON, V457, P329, DOI 10.1113/jphysiol.1992.sp019381; MIDTGAARD J, 1992, J PHYSIOL-LONDON, V457, P355, DOI 10.1113/jphysiol.1992.sp019382; MILES R, 1990, J PHYSIOL-LONDON, V428, P61, DOI 10.1113/jphysiol.1990.sp018200; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; MILES R, 1986, J PHYSIOL-LONDON, V373, P397, DOI 10.1113/jphysiol.1986.sp016055; Nusser Z, 2001, BIOPHYS J, V80, P1251, DOI 10.1016/S0006-3495(01)76101-2; Oertel D, 1991, Curr Opin Neurobiol, V1, P221, DOI 10.1016/0959-4388(91)90082-I; OTMAKHOV N, 1993, NEURON, V10, P1101, DOI 10.1016/0896-6273(93)90058-Y; Palay SL, 1974, CEREBELLAR CORTEX CY, P348; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; REYES AD, 1993, J NEUROPHYSIOL, V69, P1661, DOI 10.1152/jn.1993.69.5.1661; ROBINSON HPC, 1993, J NEUROSCI METH, V49, P157, DOI 10.1016/0165-0270(93)90119-C; SAYER RJ, 1989, J NEUROSCI, V9, P840; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; SHARP AA, 1993, J NEUROPHYSIOL, V69, P992, DOI 10.1152/jn.1993.69.3.992; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Stevens CF, 1998, NAT NEUROSCI, V1, P210, DOI 10.1038/659; Sui JL, 1999, ADV SEC MESS PHOSPH, V33, P179; ZHANG S, 1994, J NEUROPHYSIOL, V72, P705, DOI 10.1152/jn.1994.72.2.705; [No title captured]	50	168	169	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2002	5	12					1309	1318		10.1038/nn970	http://dx.doi.org/10.1038/nn970			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	618ZE	12411959				2022-12-24	WOS:000179447500014
J	Lamprecht, R; Farb, CR; LeDoux, JE				Lamprecht, R; Farb, CR; LeDoux, JE			Fear memory formation involves p190 RhoGAP and ROCK proteins through a GRB2-mediated complex	NEURON			English	Article							LONG-TERM POTENTIATION; LATERAL AMYGDALA NEURONS; TYROSINE PHOSPHORYLATION; BASOLATERAL AMYGDALA; SIGNALING MOLECULES; ADAPTER PROTEINS; DENDRITIC SPINES; AXON OUTGROWTH; BEHAVING RAT; C-SRC	We used fear conditioning, which is known to alter synaptic efficacy in lateral amygdala (LA), to study molecular mechanisms underlying long-term memory. Following fear conditioning, the tyrosine phosphorylated protein p190 RhoGAP becomes associated with GRB2 in LA significantly more in conditioned than in control rats. RasGAP and Shc were also found to associate with GRB2 in LA significantly more in the conditioned animals. Inhibition of the p190 RhoGAP-downstream kinase ROCK in LA during fear conditioning impaired long- but not short-term memory. Thus, the p190 RhoGAP/ROCK pathway, which regulates the morphology of dendrites and axons during neural development, plays a central role, through a GRB2-mediated molecular complex, in fear memory formation in the lateral amygdala.	NYU, WM Keck Fdn Lab Neurobiol, Ctr Neural Sci, New York, NY 10003 USA	New York University	LeDoux, JE (corresponding author), NYU, WM Keck Fdn Lab Neurobiol, Ctr Neural Sci, New York, NY 10003 USA.				NIMH NIH HHS [MH58911, MH38774, MH00956, MH46516] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH038774, R01MH046516, K02MH000956, P50MH058911, R01MH038774] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Amano M, 2000, EXP CELL RES, V261, P44, DOI 10.1006/excr.2000.5046; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bauer EP, 2002, J NEUROSCI, V22, P5239, DOI 10.1523/JNEUROSCI.22-12-05239.2002; Berman DE, 1998, J NEUROSCI, V18, P10037; Billuart P, 2001, CELL, V107, P195, DOI 10.1016/S0092-8674(01)00522-0; Bito H, 2000, NEURON, V26, P431, DOI 10.1016/S0896-6273(00)81175-7; Blair HT, 2001, LEARN MEMORY, V8, P229, DOI 10.1101/lm.30901; Brouns MR, 2000, DEVELOPMENT, V127, P4891; Brouns MR, 2001, NAT CELL BIOL, V3, P361, DOI 10.1038/35070042; Buday L, 1999, BBA-REV BIOMEMBRANES, V1422, P187, DOI 10.1016/S0304-4157(99)00005-2; Cattaneo E, 1998, TRENDS NEUROSCI, V21, P476, DOI 10.1016/S0166-2236(98)01282-X; Chang HP, 2001, NEUROSCIENCE, V102, P289, DOI 10.1016/S0306-4522(00)00478-4; Collins DR, 2000, LEARN MEMORY, V7, P97, DOI 10.1101/lm.7.2.97; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Dudai Y., 1989, NEUROBIOLOGY MEMORY; Dupont H, 1999, EUR J BIOCHEM, V265, P530, DOI 10.1046/j.1432-1327.1999.00689.x; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Farb CR, 1997, SYNAPSE, V27, P106, DOI 10.1002/(SICI)1098-2396(199710)27:2<106::AID-SYN2>3.3.CO;2-F; Grant SGN, 2001, TRENDS BIOTECHNOL, V19, pS49, DOI 10.1016/S0167-7799(01)01799-1; Grant SGN, 2001, CURR OPIN NEUROBIOL, V11, P363, DOI 10.1016/S0959-4388(00)00220-8; Grotewiel MS, 1998, NATURE, V391, P455, DOI 10.1038/35079; Hatada Y, 2000, J NEUROSCI, V20, part. no.; HELMSTETTER FJ, 1994, BEHAV NEUROSCI, V108, P1005, DOI 10.1037/0735-7044.108.5.1005; Hirose M, 1998, J CELL BIOL, V141, P1625, DOI 10.1083/jcb.141.7.1625; Hu KQ, 1997, EMBO J, V16, P473, DOI 10.1093/emboj/16.3.473; Huang YQ, 2001, NEURON, V29, P485, DOI 10.1016/S0896-6273(01)00220-3; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LEDOUX JE, 1990, J NEUROSCI, V10, P1062; Li Z, 2002, NEURON, V33, P741, DOI 10.1016/S0896-6273(02)00621-9; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Muller J, 1997, BEHAV NEUROSCI, V111, P683, DOI 10.1037/0735-7044.111.4.683; Nader K, 2001, LEARN MEMORY, V8, P156, DOI 10.1101/lm.38101; Nakahara H, 1998, J BIOL CHEM, V273, P9, DOI 10.1074/jbc.273.1.9; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Narumiya S, 2000, METHOD ENZYMOL, V325, P273; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; Quirk GJ, 1997, NEURON, V19, P613, DOI 10.1016/S0896-6273(00)80375-X; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; Repa JC, 2001, NAT NEUROSCI, V4, P724, DOI 10.1038/89512; RIDLEY AJ, 1993, EMBO J, V12, P5151, DOI 10.1002/j.1460-2075.1993.tb06210.x; Rodrigues SM, 2002, J NEUROSCI, V22, P5219, DOI 10.1523/JNEUROSCI.22-12-05219.2002; Roof RW, 2000, FEBS LETT, V472, P117, DOI 10.1016/S0014-5793(00)01439-3; Roof RW, 1998, MOL CELL BIOL, V18, P7052, DOI 10.1128/MCB.18.12.7052; Schafe GE, 2001, TRENDS NEUROSCI, V24, P540, DOI 10.1016/S0166-2236(00)01969-X; SETTLEMAN J, 1992, NATURE, V359, P153, DOI 10.1038/359153a0; Sharma SV, 1998, ONCOGENE, V17, P271, DOI 10.1038/sj.onc.1201921; Snapper SB, 1999, ANNU REV IMMUNOL, V17, P905, DOI 10.1146/annurev.immunol.17.1.905; Tatsis N, 1998, J BIOL CHEM, V273, P34631, DOI 10.1074/jbc.273.51.34631; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Totsukawa G, 2000, J CELL BIOL, V150, P797, DOI 10.1083/jcb.150.4.797; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; WEILER IJ, 1995, BEHAV BRAIN RES, V66, P1, DOI 10.1016/0166-4328(94)00116-W; Weisskopf MG, 1999, J NEUROSCI, V19, P10512; Wilensky AE, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-24-j0006.1999; Zhao WQ, 1999, J BIOL CHEM, V274, P34893, DOI 10.1074/jbc.274.49.34893	62	86	88	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 14	2002	36	4					727	738		10.1016/S0896-6273(02)01047-4	http://dx.doi.org/10.1016/S0896-6273(02)01047-4			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	616PX	12441060	Bronze			2022-12-24	WOS:000179313100018
J	Wills, Z; Emerson, M; Rusch, J; Bikoff, J; Baum, B; Perrimon, N; Van Vactor, D				Wills, Z; Emerson, M; Rusch, J; Bikoff, J; Baum, B; Perrimon, N; Van Vactor, D			A Drosophila homolog of cyclase-associated proteins collaborates with the Abl tyrosine kinase to control midline axon pathfinding	NEURON			English	Article							LONG-RANGE GUIDANCE; ROBO RECEPTORS; GROWTH CONES; ACTIN; SLIT; OUTGROWTH; ROLES; MUTATIONS; PROFILIN; NEUROBIOLOGY	We demonstrate that Drosophila capulet (capt), a homolog of the adenylyl cyclase-associated protein that binds and regulates actin in yeast, associates with Abl in Drosophila cells, suggesting a functional relationship in vivo. We find a robust and specific genetic interaction between capt and Abl at the midline choice point where the growth cone repellent Slit functions to restrict axon crossing. Genetic interactions between capt and slit support a model where Capt and Abl collaborate as part of the repellent response. Further support for this model is provided by genetic interactions that both capt and Abl display with multiple members of the Roundabout receptor family. These studies identify Capulet as part of an emerging pathway linking guidance signals to regulation of cytoskeletal dynamics and suggest that the Abl pathway mediates signals downstream of multiple Roundabout receptors.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Program Neurosci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Van Vactor, D (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Cell Biol, Boston, MA 02115 USA.	davie@hms.harvard.edu	Bikoff, Jay/N-8107-2018	Van Vactor, Jr., David L./0000-0001-8156-9482; Perrimon, Norbert/0000-0001-7542-472X; Baum, Buzz/0000-0002-9201-6186; Wills, Zachary/0000-0001-9822-6742	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035909] Funding Source: NIH RePORTER; NINDS NIH HHS [NS35909] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ba-Charvet KTN, 1999, NEURON, V22, P463, DOI 10.1016/S0896-6273(00)80702-3; Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Bateman J, 2001, J CELL SCI, V114, P1973; Baum B, 2000, CURR BIOL, V10, P964, DOI 10.1016/S0960-9822(00)00640-0; BEGGS HE, 1994, J CELL BIOL, V127, P825, DOI 10.1083/jcb.127.3.825; Benlali A, 2000, CELL, V101, P271, DOI 10.1016/S0092-8674(00)80837-5; BENTLEY D, 1986, NATURE, V323, P712, DOI 10.1038/323712a0; COOLEY L, 1992, CELL, V69, P173, DOI 10.1016/0092-8674(92)90128-Y; FAN JH, 1993, J CELL BIOL, V121, P867, DOI 10.1083/jcb.121.4.867; FAN JH, 1995, NEURON, V14, P263, DOI 10.1016/0896-6273(95)90284-8; Flanagan JG, 1998, CELL, V92, P429, DOI 10.1016/S0092-8674(00)80935-6; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Forcet C, 2002, NATURE, V417, P443, DOI 10.1038/nature748; FREEMAN NL, 1995, J BIOL CHEM, V270, P5680, DOI 10.1074/jbc.270.10.5680; Freeman NL, 1996, MOL CELL BIOL, V16, P548; Gallo G, 1999, CURR BIOL, V9, pR490, DOI 10.1016/S0960-9822(99)80304-2; GERST JE, 1991, MOL CELL BIOL, V11, P1248, DOI 10.1128/MCB.11.3.1248; GERTLER FB, 1995, GENE DEV, V9, P521, DOI 10.1101/gad.9.5.521; GERTLER FB, 1993, GENE DEV, V7, P441, DOI 10.1101/gad.7.3.441; GIESELMANN R, 1992, FEBS LETT, V298, P149, DOI 10.1016/0014-5793(92)80043-G; Goldberg JL, 2000, NATURE, V403, P369, DOI 10.1038/35000309; Goodhill GJ, 1998, TRENDS NEUROSCI, V21, P226, DOI 10.1016/S0166-2236(97)01203-4; Goodman Corey S., 1993, P1131; Gottwald U, 1996, MOL BIOL CELL, V7, P261, DOI 10.1091/mbc.7.2.261; HAARER BK, 1993, MOL CELL BIOL, V13, P7864, DOI 10.1128/MCB.13.12.7864; Harris WA, 1999, NATURE, V398, P462, DOI 10.1038/18970; HENKEMEYER M, 1990, CELL, V63, P949, DOI 10.1016/0092-8674(90)90498-4; HENKEMEYER MJ, 1987, CELL, V51, P821, DOI 10.1016/0092-8674(87)90105-X; IGNELZI MA, 1994, NEURON, V12, P873, DOI 10.1016/0896-6273(94)90339-5; KAWAMUKAI M, 1992, MOL BIOL CELL, V3, P167, DOI 10.1091/mbc.3.2.167; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Koleske AJ, 1998, NEURON, V21, P1259, DOI 10.1016/S0896-6273(00)80646-7; Lanier LM, 2000, CURR OPIN NEUROBIOL, V10, P80, DOI 10.1016/S0959-4388(99)00058-6; Liebl EC, 2000, NEURON, V26, P107, DOI 10.1016/S0896-6273(00)81142-3; LIN CH, 1993, J CELL BIOL, V121, P1369, DOI 10.1083/jcb.121.6.1369; LIN DM, 1994, NEURON, V13, P1055, DOI 10.1016/0896-6273(94)90045-0; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Meima L, 1997, MOL CELL NEUROSCI, V9, P314, DOI 10.1006/mcne.1997.0621; Meima L, 1997, EUR J NEUROSCI, V9, P177, DOI 10.1111/j.1460-9568.1997.tb01365.x; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; Moriyama K, 2002, J CELL SCI, V115, P1591; Mueller BK, 1999, ANNU REV NEUROSCI, V22, P351, DOI 10.1146/annurev.neuro.22.1.351; Noordermeer JN, 1998, NEURON, V21, P991, DOI 10.1016/S0896-6273(00)80618-2; OCONNOR TP, 1993, J CELL BIOL, V123, P935, DOI 10.1083/jcb.123.4.935; Patel BN, 2002, CURR OPIN CELL BIOL, V14, P221, DOI 10.1016/S0955-0674(02)00308-3; Perrimon N, 1996, GENETICS, V144, P1681; Rajagopalan S, 2000, CELL, V103, P1033, DOI 10.1016/S0092-8674(00)00207-5; Rajagopalan S, 2000, NEURON, V28, P767, DOI 10.1016/S0896-6273(00)00152-5; ROTHBERG JM, 1990, GENE DEV, V4, P2169, DOI 10.1101/gad.4.12a.2169; Rusch J, 2000, NEURON, V28, P637, DOI 10.1016/S0896-6273(00)00143-4; Schwab ME, 2000, NATURE, V403, P257, DOI 10.1038/35002226; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Shima F, 2000, MOL CELL BIOL, V20, P26, DOI 10.1128/MCB.20.1.26-33.2000; Simpson JH, 2000, CELL, V103, P1019, DOI 10.1016/S0092-8674(00)00206-3; Simpson JH, 2000, NEURON, V28, P753, DOI 10.1016/S0896-6273(00)00151-3; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Stoker A, 1998, BIOESSAYS, V20, P463, DOI 10.1002/(SICI)1521-1878(199806)20:6<463::AID-BIES4>3.0.CO;2-N; Tessier-Lavigne M, 2000, SCIENCE, V287, P813, DOI 10.1126/science.287.5454.813; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Van Vactor D, 1999, NEURON, V22, P649, DOI 10.1016/S0896-6273(00)80723-0; Van Vactor D, 1999, ADV MOLEC BIOL, P490; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; VERHEYEN EM, 1994, DEVELOPMENT, V120, P717; VOJTEK A, 1991, CELL, V66, P497, DOI 10.1016/0092-8674(81)90013-1; Wills Z, 1999, NEURON, V22, P291, DOI 10.1016/S0896-6273(00)81090-9; Wills Z, 1999, NEURON, V22, P301, DOI 10.1016/S0896-6273(00)81091-0; YU G, 1994, J CELL SCI, V107, P1671; Yu J, 1999, J BIOL CHEM, V274, P19985, DOI 10.1074/jbc.274.28.19985; Zelicof A, 1996, J BIOL CHEM, V271, P18243, DOI 10.1074/jbc.271.30.18243	71	70	73	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 14	2002	36	4					611	622		10.1016/S0896-6273(02)01022-X	http://dx.doi.org/10.1016/S0896-6273(02)01022-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	616PX	12441051	Bronze			2022-12-24	WOS:000179313100009
J	Athos, J; Impey, S; Pineda, VV; Chen, X; Storm, DR				Athos, J; Impey, S; Pineda, VV; Chen, X; Storm, DR			Hippocampal CRE-mediated gene expression is required for contextual memory formation	NATURE NEUROSCIENCE			English	Article							ELEMENT-BINDING PROTEIN; LONG-TERM-MEMORY; CAMP-RESPONSIVE ELEMENT; CONSOLIDATION; TRANSCRIPTION; DROSOPHILA; INDUCTION; CASCADE; MICE; BETA		Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Storm, DR (corresponding author), Univ Washington, Dept Pharmacol, Box 357280,Hlth Sci Bldg, Seattle, WA 98195 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH064311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020498, F31NS042475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004158] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC 04158] Funding Source: Medline; NIGMS NIH HHS [T32 GM07270] Funding Source: Medline; NIMH NIH HHS [1F31MH064311-01] Funding Source: Medline; NINDS NIH HHS [NS 20498, 1F31NS042475-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Blum S, 1999, J NEUROSCI, V19, P3535; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Gass P, 1998, LEARN MEMORY, V5, P274; Graves L, 2002, HIPPOCAMPUS, V12, P18, DOI 10.1002/hipo.10003; Guzowski JF, 1997, P NATL ACAD SCI USA, V94, P2693, DOI 10.1073/pnas.94.6.2693; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Niehof M, 1997, MOL CELL BIOL, V17, P3600, DOI 10.1128/MCB.17.7.3600; Pittenger C, 2002, NEURON, V34, P447, DOI 10.1016/S0896-6273(02)00684-0; Taubenfeld SM, 2001, J NEUROSCI, V21, P84, DOI 10.1523/JNEUROSCI.21-01-00084.2001; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9	15	116	118	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1119	1120		10.1038/nn951	http://dx.doi.org/10.1038/nn951			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	609CG	12368807				2022-12-24	WOS:000178884600012
J	Werhahn, KJ; Mortensen, J; Van Boven, RW; Zeuner, KE; Cohen, LG				Werhahn, KJ; Mortensen, J; Van Boven, RW; Zeuner, KE; Cohen, LG			Enhanced tactile spatial acuity and cortical processing during acute hand deafferentation	NATURE NEUROSCIENCE			English	Article							RESOLUTION; ATTENTION; CORTEX; REPRESENTATION		NINDS, Human Cort Physiol Sect, NIH, Bethesda, MD 20892 USA; NIMH, Lab Brain & Cognit, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Cohen, LG (corresponding author), NINDS, Human Cort Physiol Sect, NIH, 10 Ctr Dr, Bethesda, MD 20892 USA.							Bodegard A, 2001, NEURON, V31, P317, DOI 10.1016/S0896-6273(01)00362-2; CALFORD MB, 1990, SCIENCE, V249, P805, DOI 10.1126/science.2389146; Crist RE, 2001, NAT NEUROSCI, V4, P519, DOI 10.1038/87470; Mesulam MM, 1999, PHILOS T R SOC B, V354, P1325, DOI 10.1098/rstb.1999.0482; NEVILLE HJ, 1987, BRAIN RES, V405, P268, DOI 10.1016/0006-8993(87)90296-4; PHILLIPS JR, 1981, J NEUROPHYSIOL, V46, P1192, DOI 10.1152/jn.1981.46.6.1192; Rioult-Pedotti MS, 1998, NAT NEUROSCI, V1, P230, DOI 10.1038/678; SADATO N, 1995, ANN NEUROL, V37, P74, DOI 10.1002/ana.410370114; Shuler MG, 2001, J NEUROSCI, V21, P5251, DOI 10.1523/JNEUROSCI.21-14-05251.2001; Van Boven RW, 2000, NEUROLOGY, V54, P2230; VANBOVEN RW, 1994, NEUROLOGY, V44, P2361, DOI 10.1212/WNL.44.12.2361; Werhahn KJ, 2002, BRAIN, V125, P1402, DOI 10.1093/brain/awf140	12	114	115	1	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2002	5	10					936	938		10.1038/nn917	http://dx.doi.org/10.1038/nn917			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	597VV	12219095				2022-12-24	WOS:000178242200011
J	Grossman, ED; Blake, R				Grossman, ED; Blake, R			Brain areas active during visual perception of biological motion	NEURON			English	Article							FUSIFORM FACE AREA; 3-DIMENSIONAL STRUCTURE; FUNCTIONAL MRI; OBJECT; CORTEX; ACTIVATION; ATTENTION; SYSTEMS; COLOR; SHAPE	Theories of vision posit that form and motion are represented by neural mechanisms segregated into functionally and anatomically distinct pathways. Using point-light animations of biological motion, we examine the extent to which form and motion pathways are mutually involved in perceiving figures depicted by the spatio-temporal integration of local motion components. Previous work discloses that viewing biological motion selectively activates a region on the posterior superior temporal sulcus (STSp). Here we report that the occipital and fusiform face areas (OFA and FFA) also contain neural signals capable of differentiating biological from nonbiological motion. EBA and LOC, although involved in perception of human form, do not contain neural signals selective for biological motion. Our results suggest that a network of distributed neural areas in the form and motion pathways underlie the perception of biological motion.	Vanderbilt Univ, Dept Psychol, Vanderbilt Vis Res Ctr, Nashville, TN 37203 USA	Vanderbilt University	Grossman, ED (corresponding author), Vanderbilt Univ, Dept Psychol, Vanderbilt Vis Res Ctr, Nashville, TN 37203 USA.	e.grossman@vanderbilt.edu						Ahlstrom V, 1997, PERCEPTION, V26, P1539, DOI 10.1068/p261539; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Bar M, 2001, NEURON, V29, P529, DOI 10.1016/S0896-6273(01)00224-0; Bonda E, 1996, J NEUROSCI, V16, P3737; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Bradley DC, 1998, NATURE, V392, P714, DOI 10.1038/33688; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BREITMEYER BG, 1976, PSYCHOL REV, V83, P1, DOI 10.1037/0033-295X.83.1.1; Chao LL, 1999, NEUROREPORT, V10, P2945, DOI 10.1097/00001756-199909290-00013; CORBETTA M, 1991, J NEUROSCI, V11, P2383; CUTTING JE, 1978, J EXP PSYCHOL HUMAN, V4, P357, DOI 10.1037/0096-1523.4.3.357; DONER J, 1984, J EXP PSYCHOL HUMAN, V10, P1; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Friston KJ, 1995, HUM BRAIN MAPP, V3, P302, DOI 10.1002/hbm.460030405; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; Goodale MA, 1998, COGNITION, V67, P181, DOI 10.1016/S0010-0277(98)00017-1; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Grossman E, 2000, J COGNITIVE NEUROSCI, V12, P711, DOI 10.1162/089892900562417; Grossman ED, 2001, VISION RES, V41, P1475, DOI 10.1016/S0042-6989(00)00317-5; HAXBY JV, 1991, P NATL ACAD SCI USA, V88, P1621, DOI 10.1073/pnas.88.5.1621; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; HOFFMAN E, 2000, NAT NEUROSCI, V2, P574; Howard RJ, 1996, CURR BIOL, V6, P1015, DOI 10.1016/S0960-9822(02)00646-2; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kourtzi Z, 2000, J NEUROSCI, V20, P3310, DOI 10.1523/JNEUROSCI.20-09-03310.2000; KULIKOWSKI JJ, 1973, J PHYSIOL-LONDON, V232, P149, DOI 10.1113/jphysiol.1973.sp010261; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; MATHER G, 1992, P ROY SOC B-BIOL SCI, V249, P149, DOI 10.1098/rspb.1992.0097; Neri P, 1998, NATURE, V395, P894, DOI 10.1038/27661; O'Toole AJ, 2002, TRENDS COGN SCI, V6, P261, DOI 10.1016/S1364-6613(02)01908-3; ORBAN GA, 1995, P NATL ACAD SCI USA, V92, P993, DOI 10.1073/pnas.92.4.993; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Puce A, 1998, J NEUROSCI, V18, P2188; SCHILLER PH, 1990, NATURE, V343, P68, DOI 10.1038/343068a0; Sereno ME, 2002, NEURON, V33, P635, DOI 10.1016/S0896-6273(02)00598-6; Skudlarski P, 1999, NEUROIMAGE, V9, P311, DOI 10.1006/nimg.1999.0402; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; Sunaert S, 1999, EXP BRAIN RES, V127, P355, DOI 10.1007/s002210050804; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Vaina LM, 2001, P NATL ACAD SCI USA, V98, P11656, DOI 10.1073/pnas.191374198; VanOostende S, 1997, CEREB CORTEX, V7, P690, DOI 10.1093/cercor/7.7.690; Watanabe T, 1998, P NATL ACAD SCI USA, V95, P11489, DOI 10.1073/pnas.95.19.11489; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; Wojciulik E, 1998, J NEUROPHYSIOL, V79, P1574, DOI 10.1152/jn.1998.79.3.1574; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P153, DOI 10.1097/00004728-199801000-00028	51	510	513	1	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 12	2002	35	6					1167	1175		10.1016/S0896-6273(02)00897-8	http://dx.doi.org/10.1016/S0896-6273(02)00897-8			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	594GC	12354405	Bronze			2022-12-24	WOS:000178040000016
J	Daw, MI; Bortolotto, ZA; Saulle, E; Zaman, S; Collingridge, GL; Isaac, JTR				Daw, MI; Bortolotto, ZA; Saulle, E; Zaman, S; Collingridge, GL; Isaac, JTR			Phosphatidylinositol 3 kinase regulates synapse specificity of hippocampal long-term depression	NATURE NEUROSCIENCE			English	Article							PHOSPHOINOSITIDE 3-KINASE; POTENTIATION; INHIBITOR; INDUCTION; MEMORY; RAT		Univ Bristol, Dept Anat, MRC, Ctr Synapt Plast, Bristol BS8 1TD, Avon, England	University of Bristol	Isaac, JTR (corresponding author), Univ Bristol, Dept Anat, MRC, Ctr Synapt Plast, Univ Walk, Bristol BS8 1TD, Avon, England.	j.t.r.isaac@bris.ac.uk	collingridge, graham/AAI-8362-2020; Collingridge, Graham L/C-4605-2015	Collingridge, Graham L/0000-0002-9572-5359; Daw, Michael/0000-0002-8374-5977; Zaman, Shahid/0000-0003-1639-6014				Bear MF, 1996, P NATL ACAD SCI USA, V93, P13453, DOI 10.1073/pnas.93.24.13453; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bortolotto ZA, 2000, EUR J NEUROSCI, V12, P4055, DOI 10.1046/j.1460-9568.2000.00291.x; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; Kelly A, 2000, NEUROPHARMACOLOGY, V39, P643, DOI 10.1016/S0028-3908(99)00169-0; Kemp N, 2001, PROG NEUROBIOL, V65, P339, DOI 10.1016/S0301-0082(01)00013-2; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; Osborne SL, 2001, NEURON, V32, P9, DOI 10.1016/S0896-6273(01)00455-X; Raymond CR, 2002, NEUROSCIENCE, V109, P531, DOI 10.1016/S0306-4522(01)00500-0; Sanes JR, 1999, NAT NEUROSCI, V2, P597, DOI 10.1038/10154; Sanna PP, 2002, J NEUROSCI, V22, P3359; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241	14	50	52	1	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2002	5	9					835	836		10.1038/nn903	http://dx.doi.org/10.1038/nn903			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587RL	12161757				2022-12-24	WOS:000177656300009
J	Gardner, JL; Lisberger, SG				Gardner, JL; Lisberger, SG			Serial linkage of target selection for orienting and tracking eye movements	NATURE NEUROSCIENCE			English	Article							MST NEURONAL-ACTIVITY; CORTICAL AREAS MT; SMOOTH-PURSUIT; SPATIAL ATTENTION; VISUAL-MOTION; NEURAL BASIS; FIELD; MICROSTIMULATION; MODULATION; INITIATION	Many natural actions require the coordination of two different kinds of movements. How are targets chosen under these circumstances: do central commands instruct different movement systems in parallel, or does the execution of one movement activate a serial chain that automatically chooses targets for the other movement? We examined a natural eye tracking action that consists of orienting saccades and tracking smooth pursuit eye movements, and found strong physiological evidence for a serial strategy. Monkeys chose freely between two identical spots that appeared at different sites in the visual field and moved in orthogonal directions. If a saccade was evoked to one of the moving targets by microstimulation in either the frontal eye field (FEF) or the superior colliculus (SC), then the same target was automatically chosen for pursuit. Our results imply that the neural signals responsible for saccade execution can also act as an internal command of target choice for other movement systems.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, WM Keck Fdn Ctr Integrat Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Bioengn Grad Grp, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Gardner, JL (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, WM Keck Fdn Ctr Integrat Neurosci, Box 0444, San Francisco, CA 94143 USA.			Gardner, Justin/0000-0003-2220-5050	Howard Hughes Medical Institute Funding Source: Medline; NEI NIH HHS [EY03878, R01 EY003878] Funding Source: Medline; NATIONAL EYE INSTITUTE [R37EY003878, R01EY003878] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BRITTEN KH, 1992, J NEUROSCI, V12, P4745; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; Chou IH, 2002, J NEUROSCI, V22, P4728, DOI 10.1523/JNEUROSCI.22-11-04728.2002; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Ferrera VP, 2000, J NEUROPHYSIOL, V84, P2725, DOI 10.1152/jn.2000.84.6.2725; FERRERA VP, 1995, J NEUROSCI, V15, P7472; Gardner JL, 2001, J NEUROSCI, V21, P2075, DOI 10.1523/JNEUROSCI.21-06-02075.2001; GLIMCHER PW, 1992, NATURE, V355, P542, DOI 10.1038/355542a0; Glimcher PW, 2001, TRENDS NEUROSCI, V24, P654, DOI 10.1016/S0166-2236(00)01932-9; GOTTLIEB JP, 1993, J NEUROPHYSIOL, V69, P786, DOI 10.1152/jn.1993.69.3.786; GREEN DM, 1966, SIGNAL DETECTION THE; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; Johansson RS, 2001, J NEUROSCI, V21, P6917, DOI 10.1523/JNEUROSCI.21-17-06917.2001; Kahlon M, 1999, J NEUROSCI, V19, P9039, DOI 10.1523/JNEUROSCI.19-20-09039.1999; KELLER EL, 1991, NEUROSCI RES, V11, P79, DOI 10.1016/0168-0102(91)90048-4; KOMATSU H, 1989, J NEUROPHYSIOL, V62, P31, DOI 10.1152/jn.1989.62.1.31; KOWLER E, 1984, VISION RES, V24, P1789, DOI 10.1016/0042-6989(84)90010-5; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; Krauzlis RJ, 1997, SCIENCE, V276, P1693, DOI 10.1126/science.276.5319.1693; Krauzlis RJ, 1999, J COGNITIVE NEUROSCI, V11, P641, DOI 10.1162/089892999563706; KRAUZLIS RJ, IN PRESS NEURON; Kustov AA, 1996, NATURE, V384, P74, DOI 10.1038/384074a0; LISBERGER SG, 1987, ANNU REV NEUROSCI, V10, P97, DOI 10.1146/annurev.ne.10.030187.000525; Lisberger SG, 1998, J NEUROPHYSIOL, V79, P1918, DOI 10.1152/jn.1998.79.4.1918; Lisberger SG, 1997, J NEUROSCI, V17, P7490; MILES FA, 1991, REPRESENTATIONS VISI, P185; Missal M, 2000, J NEUROPHYSIOL, V83, P2080, DOI 10.1152/jn.2000.83.4.2080; Moore T, 2001, P NATL ACAD SCI USA, V98, P1273, DOI 10.1073/pnas.021549498; MORRIS EJ, 1987, J NEUROPHYSIOL, V58, P1351, DOI 10.1152/jn.1987.58.6.1351; Recanzone GH, 1999, J NEUROPHYSIOL, V82, P1710, DOI 10.1152/jn.1999.82.4.1710; Recanzone GH, 2000, J NEUROPHYSIOL, V83, P777, DOI 10.1152/jn.2000.83.2.777; ROBINSON DA, 1972, VISION RES, V12, P1795, DOI 10.1016/0042-6989(72)90070-3; ROBINSON DA, 1969, J NEUROPHYSIOL, V32, P637, DOI 10.1152/jn.1969.32.5.637; Romo R, 1998, NATURE, V392, P387, DOI 10.1038/32891; Ross J, 2001, TRENDS NEUROSCI, V24, P113, DOI 10.1016/S0166-2236(00)01685-4; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; SCHALL JD, 1993, NATURE, V366, P467, DOI 10.1038/366467a0; SCHALL JD, 1995, J NEUROSCI, V15, P6905; Schall JD, 2001, NAT REV NEUROSCI, V2, P33, DOI 10.1038/35049054; Seidemann E, 1999, J NEUROPHYSIOL, V81, P1783, DOI 10.1152/jn.1999.81.4.1783; SHELIGA BM, 1994, EXP BRAIN RES, V98, P507; SHEPHERD M, 1986, Q J EXP PSYCHOL-A, V38, P475, DOI 10.1080/14640748608401609; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; Tanaka M, 2002, J NEUROPHYSIOL, V87, P2700, DOI 10.1152/jn.2002.87.6.2700; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Treue S, 1999, J NEUROSCI, V19, P7591, DOI 10.1523/JNEUROSCI.19-17-07591.1999; von Helmholtz H., 1867, HELMHOLTZS TREATISE; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503; Wurtz R. H, 1989, NEUROBIOLOGY SACCADI	50	40	40	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2002	5	9					892	899		10.1038/nn897	http://dx.doi.org/10.1038/nn897			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587RL	12145637	Green Accepted			2022-12-24	WOS:000177656300020
J	Zatorre, RJ; Bouffard, M; Ahad, P; Belin, P				Zatorre, RJ; Bouffard, M; Ahad, P; Belin, P			Where is 'where' in the human auditory cortex?	NATURE NEUROSCIENCE			English	Article							CORTICAL-NEURONS; SPATIAL LOCALIZATION; PARIETAL CORTEX; MACAQUE MONKEY; NEARBY SOURCES; HUMAN BRAIN; LOCATION; MOVEMENT; AREAS; ATTENTION	We examine the functional characteristics of auditory cortical areas that are sensitive to spatial cues in the human brain, and determine whether they can be dissociated from parietal lobe mechanisms. Three positron emission tomography (PET) experiments were conducted using a speaker array permitting quasi free-field sound presentation within the scanner. Posterior auditory cortex responded to sounds that varied in their spatial distribution, but only when multiple complex stimuli were presented simultaneously, implicating this cortical system in disambiguation of overlapping auditory sources. We also found that the right inferior parietal cortex is specifically recruited in localization tasks, and that its activity predicts behavioral performance, consistent with its involvement in sensorimotor integration and spatial transformation. These findings clarify the functional roles of posterior auditory and parietal cortices, and help to reconcile competing models of auditory cortical organization.	McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada	McGill University	Zatorre, RJ (corresponding author), McGill Univ, Montreal Neurol Inst, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.	robert.zatorre@mcgill.ca	Belin, Pascal/C-6247-2009	Belin, Pascal/0000-0002-7578-6365				Alain C, 2001, P NATL ACAD SCI USA, V98, P12301, DOI 10.1073/pnas.211209098; ANDERSEN RA, 1995, CEREB CORTEX, V5, P457, DOI 10.1093/cercor/5.5.457; Baumgart F, 1999, NATURE, V400, P724, DOI 10.1038/23390; Belin P, 2000, NAT NEUROSCI, V3, P965, DOI 10.1038/79890; Bregman A.S., 1990, AUDITORY SCENE ANAL; Brugge JF, 2001, AUDIOL NEURO-OTOL, V6, P173, DOI 10.1159/000046827; Brungart DS, 1999, J ACOUST SOC AM, V106, P1465, DOI 10.1121/1.427180; Brungart DS, 1999, J ACOUST SOC AM, V106, P1956, DOI 10.1121/1.427943; Bushara KO, 1999, NAT NEUROSCI, V2, P759, DOI 10.1038/11239; Clarke S, 2000, NEUROPSYCHOLOGIA, V38, P797, DOI 10.1016/S0028-3932(99)00141-4; Cohen YE, 1999, NEURON, V24, P769, DOI 10.1016/S0896-6273(00)81024-7; EFRON R, 1983, BRAIN LANG, V19, P254, DOI 10.1016/0093-934X(83)90069-X; Furukawa S, 2000, J NEUROSCI, V20, P1216, DOI 10.1523/JNEUROSCI.20-03-01216.2000; GALABURDA A, 1980, J COMP NEUROL, V190, P597, DOI 10.1002/cne.901900312; Griffiths TD, 1998, NAT NEUROSCI, V1, P74, DOI 10.1038/276; Griffiths TD, 2000, HUM BRAIN MAPP, V9, P72, DOI 10.1002/(SICI)1097-0193(200002)9:2<72::AID-HBM2>3.0.CO;2-9; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; Maeder PP, 2001, NEUROIMAGE, V14, P802, DOI 10.1006/nimg.2001.0888; Mesulam MM, 1999, PHILOS T R SOC B, V354, P1325, DOI 10.1098/rstb.1999.0482; Middlebrooks JC, 1999, J ACOUST SOC AM, V106, P1493, DOI 10.1121/1.427147; MIDDLEBROOKS JC, 1994, SCIENCE, V264, P842, DOI 10.1126/science.8171339; Mondor TA, 1998, J EXP PSYCHOL HUMAN, V24, P66, DOI 10.1037/0096-1523.24.1.66; Mrsic-Flogel TD, 2001, J NEUROPHYSIOL, V86, P1043, DOI 10.1152/jn.2001.86.2.1043; Paus T, 1996, EUR J NEUROSCI, V8, P2236, DOI 10.1111/j.1460-9568.1996.tb01187.x; Penhune VB, 1996, CEREB CORTEX, V6, P661, DOI 10.1093/cercor/6.5.661; Rauschecker JP, 1997, J COMP NEUROL, V382, P89; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; Recanzone GH, 2000, J NEUROPHYSIOL, V83, P2723, DOI 10.1152/jn.2000.83.5.2723; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Sereno AB, 1998, NATURE, V395, P500, DOI 10.1038/26752; Talairach J., 1988, COPLANAR STEREOTAXIC; Thivard L, 2000, NEUROREPORT, V11, P2969, DOI 10.1097/00001756-200009110-00028; Tian B, 2001, SCIENCE, V292, P290, DOI 10.1126/science.1058911; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; Warren JD, 2002, NEURON, V34, P139, DOI 10.1016/S0896-6273(02)00637-2; Weeks R, 2000, J NEUROSCI, V20, P2664; Westbury CF, 1999, CEREB CORTEX, V9, P392, DOI 10.1093/cercor/9.4.392; WHITFIELD IC, 1985, CEREB CORTEX, V4, P329; WIGHTMAN FL, 1989, J ACOUST SOC AM, V85, P868, DOI 10.1121/1.397558; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; Zatorre RJ, 2001, J NEUROSCI, V21, P6321, DOI 10.1523/JNEUROSCI.21-16-06321.2001; Zatorre RJ, 1999, NEUROIMAGE, V10, P544, DOI 10.1006/nimg.1999.0491	44	266	270	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2002	5	9					905	909		10.1038/nn904	http://dx.doi.org/10.1038/nn904			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587RL	12195426				2022-12-24	WOS:000177656300022
J	Fyhn, M; Molden, S; Hollup, S; Moser, MB; Moser, EI				Fyhn, M; Molden, S; Hollup, S; Moser, MB; Moser, EI			Hippocampal neurons responding to first-time dislocation of a target object	NEURON			English	Article							SINGLE UNIT-ACTIVITY; FREELY-MOVING RAT; PLACE CELLS; PYRAMIDAL CELLS; ENSEMBLE CODE; GOAL LOCATION; TASK; SPACE; MEMORY; BACKPROPAGATION	To examine how hippocampal neurons respond to a mismatch between retrieved and actual experience, we trained rats to find a hidden platform at a particular location in an annular watermaze and then moved the platform. Several cells that were silent at the new platform location before the move fired vigorously when the rat found the goal. The new activity was paralleled by reduced discharge in a subset of simultaneously recorded interneurons. The pattern of activity returned toward its original configuration as the rat learned the new location. The activation of specific hippocampal neurons following dislocation of a target object may be essential for synaptic plasticity and adaptive modification of the animal's representation of the environment.	Norwegian Univ Sci & Technol, Neurosci Unit, NO-7489 Trondheim, Norway; Norwegian Univ Sci & Technol, Dept Psychol, NO-7489 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Moser, EI (corresponding author), Norwegian Univ Sci & Technol, Neurosci Unit, NO-7489 Trondheim, Norway.	edvard.moser@svt.ntnu.no						BREESE CR, 1989, J NEUROSCI, V9, P1097; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; Czurko A, 1999, EUR J NEUROSCI, V11, P344, DOI 10.1046/j.1460-9568.1999.00446.x; Deadwyler SA, 1996, J NEUROSCI, V16, P354; EICHENBAUM H, 1987, J NEUROSCI, V7, P716; FRENCH AS, 1971, KYBERNETIK, V8, P165, DOI 10.1007/BF00291117; Gothard KM, 1996, J NEUROSCI, V16, P8027; Hollup SA, 2001, J NEUROSCI, V21, P4505, DOI 10.1523/JNEUROSCI.21-12-04505.2001; Hollup SA, 2001, J NEUROSCI, V21, P1635, DOI 10.1523/JNEUROSCI.21-05-01635.2001; Honey RC, 1998, J NEUROSCI, V18, P2226; Kay S. M., 1988, MODERN SPECTRAL ESTI; Knierim JJ, 2001, J NEUROPHYSIOL, V85, P105, DOI 10.1152/jn.2001.85.1.105; Kobayashi T, 1997, J NEUROPHYSIOL, V78, P597, DOI 10.1152/jn.1997.78.2.597; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Lever C, 2002, NATURE, V416, P90, DOI 10.1038/416090a; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MCNAUGHTON BL, 1983, J NEUROSCI METH, V8, P391, DOI 10.1016/0165-0270(83)90097-3; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; MOSER EI, 1994, LEARN MEMORY, V1, P55; Moser EI, 1996, J NEUROSCI, V16, P1247; MULLER RU, 1994, J NEUROSCI, V14, P7235; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1987, EXP BRAIN RES, V68, P1; OKEEFE J, 1976, EXP NEUROL, V51, P78, DOI 10.1016/0014-4886(76)90055-8; QUIRK GJ, 1990, J NEUROSCI, V10, P2008; Quirk MC, 2001, J NEUROSCI, V21, P240, DOI 10.1523/JNEUROSCI.21-01-00240.2001; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; Skaggs W., 1993, ADV NEURAL INFORM PR, V5, P1030; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Stern CE, 1996, P NATL ACAD SCI USA, V93, P8660, DOI 10.1073/pnas.93.16.8660; Thinus-Blanc C, 1991, Hippocampus, V1, P365, DOI 10.1002/hipo.450010404; Tsubokawa H, 1996, J NEUROPHYSIOL, V76, P2896, DOI 10.1152/jn.1996.76.5.2896; TULVING E, 1994, NEUROREPORT, V5, P2525, DOI 10.1097/00001756-199412000-00030; VINOGRADOVA OS, 1971, SHORT TERM CHANGES N, P95; WIGSTROM H, 1983, NATURE, V301, P603, DOI 10.1038/301603a0; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605; Zinyuk L, 2000, P NATL ACAD SCI USA, V97, P3771, DOI 10.1073/pnas.050576397	40	137	138	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 1	2002	35	3					555	566		10.1016/S0896-6273(02)00784-5	http://dx.doi.org/10.1016/S0896-6273(02)00784-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	582CB	12165476	Bronze			2022-12-24	WOS:000177331200015
J	Hashimoto, R; Sakai, KL				Hashimoto, R; Sakai, KL			Specialization in the left prefrontal cortex for sentence comprehension	NEURON			English	Article							SHORT-TERM-MEMORY; EVENT-RELATED FMRI; VERBAL WORKING-MEMORY; ANTERIOR CINGULATE; BRAIN ACTIVATION; NEURAL BASIS; LANGUAGE; DISSOCIATION; REGIONS; LOCALIZATION	Using functional magnetic resonance imaging (fMRI), we examined cortical activation under syntactic decision tasks and a short-term memory task for sentences, focusing on essential properties of syntactic processing. By comparing activation in these tasks with a short-term memory task for word lists, we found that two regions in the left prefrontal cortex showed selective activation for syntactic processing: the dorsal prefrontal cortex (DPFC) and the inferior frontal gyrus (IFG). Moreover, the left DPFC showed more prominent activation under the short-term memory task for sentences than that for word lists, which cannot be explained by general cognitive factors such as task difficulty and verbal short-term memory. These results support the proposal of specialized systems for sentence comprehension in the left prefrontal cortex.	Univ Tokyo, Grad Sch Arts & Sci, Dept Cognit & Behav Sci, Meguro Ku, Tokyo 1538902, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi 3320012, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Sakai, KL (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Cognit & Behav Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.	sakai@mind.c.u-tokyo.ac.jp		Hashimoto, Ryu-ichiro/0000-0002-9661-3412				Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Barch DM, 1997, NEUROPSYCHOLOGIA, V35, P1373, DOI 10.1016/S0028-3932(97)00072-9; Barch DM, 2000, J COGNITIVE NEUROSCI, V12, P298, DOI 10.1162/089892900562110; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Buckner RL, 1998, NEUROIMAGE, V7, P151, DOI 10.1006/nimg.1998.0327; Bunge SA, 2000, P NATL ACAD SCI USA, V97, P3573, DOI 10.1073/pnas.050583797; Cabeza R, 1997, NEURON, V19, P863, DOI 10.1016/S0896-6273(00)80967-8; Caplan D, 1999, BEHAV BRAIN SCI, V22, P77; Caplan D, 1999, NEUROIMAGE, V9, P343, DOI 10.1006/nimg.1998.0412; Chein JM, 2001, CEREB CORTEX, V11, P1003, DOI 10.1093/cercor/11.11.1003; Chomsky N., 1984, MODULAR APPROACHES S; Chomsky N, 1980, RULES REPRESENTATION; Clark CR, 2000, HUM BRAIN MAPP, V9, P42, DOI 10.1002/(SICI)1097-0193(2000)9:1<42::AID-HBM5>3.0.CO;2-6; Cohen J D, 1994, Hum Brain Mapp, V1, P293, DOI 10.1002/hbm.460010407; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Coltheart M, 1999, TRENDS COGN SCI, V3, P115, DOI 10.1016/S1364-6613(99)01289-9; Comrie B., 1989, LANGUAGE UNIVERSALS, V2nd; Cooke A, 2002, HUM BRAIN MAPP, V15, P80, DOI 10.1002/hbm.10006; Dapretto M, 1999, NEURON, V24, P427, DOI 10.1016/S0896-6273(00)80855-7; Dick F, 2001, PSYCHOL REV, V108, P759, DOI 10.1037//0033-295X.108.4.759; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Embick D, 2000, P NATL ACAD SCI USA, V97, P6150, DOI 10.1073/pnas.100098897; Fiebach CJ, 2001, J PSYCHOLINGUIST RES, V30, P321, DOI 10.1023/A:1010447102554; Fiez JA, 1996, J NEUROSCI, V16, P808; Fletcher PC, 1998, BRAIN, V121, P1239, DOI 10.1093/brain/121.7.1239; Fodor J. A, 1983, MODULARITY MIND; Friederici AD, 2000, BRAIN LANG, V74, P289, DOI 10.1006/brln.2000.2313; FRIEDERICI AD, 1993, COGNITIVE BRAIN RES, V1, P183, DOI 10.1016/0926-6410(93)90026-2; Gunter TC, 1999, PSYCHOPHYSIOLOGY, V36, P126, DOI 10.1017/S004857729997155X; Haegeman L., 1994, INTRO GOVT BINDING T, V2; Homae F, 2002, NEUROIMAGE, V16, P883, DOI 10.1006/nimg.2002.1138; Indefrey P, 2001, NEUROIMAGE, V14, P546, DOI 10.1006/nimg.2001.0867; JUST MA, 1992, PSYCHOL REV, V99, P122, DOI 10.1037/0033-295X.99.1.122; Just MA, 1996, SCIENCE, V274, P114, DOI 10.1126/science.274.5284.114; Kang AM, 1999, NEUROIMAGE, V10, P555, DOI 10.1006/nimg.1999.0493; KLUENDER R, 1993, J COGNITIVE NEUROSCI, V5, P196, DOI 10.1162/jocn.1993.5.2.196; MARTIN RC, 1993, MEM COGNITION, V21, P176, DOI 10.3758/BF03202730; MARTIN RC, 1987, BRAIN LANG, V32, P159, DOI 10.1016/0093-934X(87)90122-2; MASHUETZ C, 2000, J COGNITIVE NEUROSCI, V12, P130; MCCARTHY RA, 1987, BRAIN, V110, P1545, DOI 10.1093/brain/110.6.1545; MILNER B, 1991, NEUROPSYCHOLOGIA, V29, P601, DOI 10.1016/0028-3932(91)90013-X; Moro A, 2001, NEUROIMAGE, V13, P110, DOI 10.1006/nimg.2000.0668; MUNTE TF, 1993, J COGNITIVE NEUROSCI, V5, P335, DOI 10.1162/jocn.1993.5.3.335; NEVILLE H, 1991, J COGNITIVE NEUROSCI, V3, P151, DOI 10.1162/jocn.1991.3.2.151; Newman AJ, 2001, J PSYCHOLINGUIST RES, V30, P339, DOI 10.1023/A:1010499119393; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; PETRIDES M, 1995, P NATL ACAD SCI USA, V92, P5803, DOI 10.1073/pnas.92.13.5803; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; POTTER MC, 1993, MEM COGNITION, V21, P156, DOI 10.3758/BF03202727; Price CJ, 1997, J COGNITIVE NEUROSCI, V9, P727, DOI 10.1162/jocn.1997.9.6.727; Rosler F, 1998, J MEM LANG, V38, P150, DOI 10.1006/jmla.1997.2551; Rypma B, 1999, NEUROIMAGE, V9, P216, DOI 10.1006/nimg.1998.0404; Sakai KL, 2001, NEUROSCI RES, V39, P1, DOI 10.1016/S0168-0102(00)00205-4; Shallice T., 1988, NEUROPSYCHOLOGY MENT, DOI DOI 10.1017/IPM.2020.45; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Stromswold K, 1996, BRAIN LANG, V52, P452, DOI 10.1006/brln.1996.0024; TSIMPLI Ianthi-Maria, 1995, MIND SAVANT LANGUAGE; Tsujimura N., 1996, INTRO JAPANESE LINGU; Vos SH, 2001, PSYCHOPHYSIOLOGY, V38, P41, DOI 10.1111/1469-8986.3810041; WATERS G, 1991, COGNITIVE NEUROPSYCH, V8, P81, DOI 10.1080/02643299108253368; WATERS GS, 1995, COGN NEUROPSYCHOL, V12, P1, DOI 10.1080/02643299508251990	62	93	95	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 1	2002	35	3					589	597		10.1016/S0896-6273(02)00788-2	http://dx.doi.org/10.1016/S0896-6273(02)00788-2			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	582CB	12165479	Bronze			2022-12-24	WOS:000177331200018
J	Wang, Q; Bardgett, ME; Wong, M; Wozniak, DF; Lou, JY; McNeil, BD; Chen, C; Nardi, A; Reid, DC; Yamada, K; Ornitz, DM				Wang, Q; Bardgett, ME; Wong, M; Wozniak, DF; Lou, JY; McNeil, BD; Chen, C; Nardi, A; Reid, DC; Yamada, K; Ornitz, DM			Ataxia and paroxysmal dyskinesia in mice lacking axonally transported FGF14	NEURON			English	Article							FACTOR HOMOLOGOUS FACTORS; BEHAVIORAL-RESPONSES; DOPAMINE-RECEPTORS; GENE-EXPRESSION; ANIMAL-MODELS; SYNAPSIN I; COCAINE; STRIATUM; AMPHETAMINE; DYSTONIA	Fibroblast growth factor 14 (FGF14) belongs to a distinct subclass of FGFs that is expressed in the developing and adult CNS. We disrupted the Fgf14 gene and introduced an Fgf(14N-beta-Gal) allele that abolished Fgf14 expression and generated a fusion protein (FGF14N-beta-gal) containing the first exon of FGF14 and P-galactosidase. Fgf14-deficient mice were viable, fertile, and anatomically normal, but developed ataxia and a paroxysmal hyperkinetic movement disorder. Neuropharmacological studies showed that Fgf14-deficient mice have reduced responses to dopamine agonists. The paroxysmal hyperkinetic movement disorder phenocopies a form of dystonia, a disease often associated with dysfunction of the putamen. Strikingly, the FGF14N-beta-gal chimeric protein was efficiently transported into neuronal processes in the basal ganglia and cerebellum. Together, these studies identify a novel function for FGF14 in neuronal signaling and implicate FGF14 in axonal trafficking and synaptosomal function.	Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Ornitz, DM (corresponding author), Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA.	dornitz@pcg.wustl.edu	Nardi, Antonio E/A-7335-2014	Nardi, Antonio E/0000-0002-2152-4669; Chen, Chen/0000-0001-9159-4489; Ornitz, David/0000-0003-1592-7629; Bardgett, Mark/0000-0001-7028-2603; McNeil, Benjamin/0000-0001-7545-3598	NATIONAL CANCER INSTITUTE [R01CA060673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG011355] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AKIMOTO K, 1990, BRAIN RES, V507, P344, DOI 10.1016/0006-8993(90)90295-M; Alonso R, 1999, EUR J NEUROSCI, V11, P967, DOI 10.1046/j.1460-9568.1999.00506.x; Bahn S, 1997, P NATL ACAD SCI USA, V94, P9417, DOI 10.1073/pnas.94.17.9417; Bardgett ME, 1997, PSYCHOPHARMACOLOGY, V133, P142, DOI 10.1007/s002130050384; Bhatia KP, 1999, J NEUROL, V246, P149, DOI 10.1007/s004150050325; BrosnanWatters G, 1996, PHARMACOL BIOCHEM BE, V53, P701, DOI 10.1016/0091-3057(95)02073-X; BUTCHER SP, 1988, J NEUROCHEM, V50, P346, DOI 10.1111/j.1471-4159.1988.tb02919.x; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Chen JF, 2000, NEUROSCIENCE, V97, P195, DOI 10.1016/S0306-4522(99)00604-1; CLARK M, 1992, BRAIN RES, V582, P101, DOI 10.1016/0006-8993(92)90322-Z; Dawson TM, 2000, CELL, V101, P115, DOI 10.1016/S0092-8674(00)80629-7; Dickens M, 1997, SCIENCE, V277, P693, DOI 10.1126/science.277.5326.693; FERGUSON IA, 1991, J COMP NEUROL, V313, P693, DOI 10.1002/cne.903130412; FISHER RS, 1989, BRAIN RES REV, V14, P245, DOI 10.1016/0165-0173(89)90003-9; Frantz KJ, 1999, PHARMACOL BIOCHEM BE, V64, P821, DOI 10.1016/S0091-3057(99)00162-8; Gernert M, 2000, J NEUROSCI, V20, P7052, DOI 10.1523/JNEUROSCI.20-18-07052.2000; GERSHANIK O, 1983, NEUROLOGY, V33, P1489, DOI 10.1212/WNL.33.11.1489; GeterDouglass B, 1997, J PHARMACOL EXP THER, V283, P7; Goldfarb M., 2001, SCI STKE, V106, ppe37; GRAYBIEL AM, 1990, TRENDS NEUROSCI, V13, P244, DOI 10.1016/0166-2236(90)90104-I; GRAYBIEL AM, 1990, P NATL ACAD SCI USA, V87, P6912, DOI 10.1073/pnas.87.17.6912; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; JACKSON DM, 1994, PHARMACOL THERAPEUT, V64, P291, DOI 10.1016/0163-7258(94)90041-8; Jarman PR, 1998, J MED GENET, V35, P314, DOI 10.1136/jmg.35.4.314; Jones A, 1997, J NEUROSCI, V17, P1350; Jones SR, 1999, NAT NEUROSCI, V2, P649, DOI 10.1038/10204; Jovanovic JN, 2000, NAT NEUROSCI, V3, P323, DOI 10.1038/73888; Jovanovic JN, 1996, P NATL ACAD SCI USA, V93, P3679, DOI 10.1073/pnas.93.8.3679; KEEFE KA, 1995, NEUROSCIENCE, V66, P903, DOI 10.1016/0306-4522(95)00024-D; LeMoine C, 1997, J NEUROSCI, V17, P8038; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; LI L, 1995, P NATL ACAD SCI USA, V92, P9235, DOI 10.1073/pnas.92.20.9235; LOSCHER W, 1989, MOVEMENT DISORD, V4, P219, DOI 10.1002/mds.870040304; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Moratalla R, 1996, NEURON, V17, P147, DOI 10.1016/S0896-6273(00)80288-3; Moratalla R, 1996, P NATL ACAD SCI USA, V93, P14928, DOI 10.1073/pnas.93.25.14928; Munoz-Sanjuan I, 2000, J BIOL CHEM, V275, P2589, DOI 10.1074/jbc.275.4.2589; Naski MC, 1998, DEVELOPMENT, V125, P4977; Nobrega JN, 1996, NEUROSCIENCE, V71, P927, DOI 10.1016/0306-4522(95)00511-0; Nobrega JN, 1999, NEUROSCIENCE, V92, P211, DOI 10.1016/S0306-4522(98)00753-2; Obeso JA, 2000, ANN NEUROL, V47, pS22; Ornitz DM, 2001, GENOME BIOL, V2; Pellet JB, 2000, EUR J NEUROSCI, V12, P621, DOI 10.1046/j.1460-9568.2000.00945.x; Rehders JH, 2000, NEUROSCIENCE, V97, P267, DOI 10.1016/S0306-4522(00)00073-7; Richter A, 1998, PROG NEUROBIOL, V54, P633, DOI 10.1016/S0301-0082(97)00089-0; ROBERTSON GS, 1995, NEUROSCIENCE, V64, P1019, DOI 10.1016/0306-4522(94)00426-6; Schaefer ML, 2000, J NEUROSCI, V20, P4809; Schoorlemmer J, 2001, CURR BIOL, V11, P793, DOI 10.1016/S0960-9822(01)00232-9; Sheehan D.C., 1980, THEORY PRACTICE HIST; Smallwood PM, 1996, P NATL ACAD SCI USA, V93, P9850, DOI 10.1073/pnas.93.18.9850; Smith Y, 2000, TRENDS NEUROSCI, V23, pS28, DOI 10.1016/S1471-1931(00)00023-9; Surmeier D J, 1998, Adv Pharmacol, V42, P1020; Swanson CJ, 1997, PHARMACOL BIOCHEM BE, V58, P933, DOI 10.1016/S0091-3057(97)00043-9; Todd RD, 1998, MOL NEUROBIOL, V16, P135, DOI 10.1007/BF02740641; USHIJIMA I, 1995, PHARMACOL BIOCHEM BE, V52, P737, DOI 10.1016/0091-3057(95)00167-U; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Vidailhet Marie, 2000, Current Opinion in Neurology, V13, P457, DOI 10.1097/00019052-200008000-00015; Vitek JL, 2000, ANN NEUROL, V47, pS131; Waddington J.L., 1993, D1 D2 DOPAMINE RECEP; Wang Q, 2000, MECH DEVELOP, V90, P283, DOI 10.1016/S0925-4773(99)00241-5; Wang YY, 2000, J NEUROSCI, V20, P8305, DOI 10.1523/JNEUROSCI.20-22-08305.2000; Wichmann T, 1996, CURR OPIN NEUROBIOL, V6, P751, DOI 10.1016/S0959-4388(96)80024-9; Wozniak DF, 1996, BRAIN RES, V707, P165, DOI 10.1016/0006-8993(95)01230-3; XU M, 1994, CELL, V79, P945, DOI 10.1016/0092-8674(94)90026-4; Xu M, 2000, BRAIN RES, V852, P198, DOI 10.1016/S0006-8993(99)02258-1; Yamamoto S, 1998, BBA-GENE STRUCT EXPR, V1398, P38, DOI 10.1016/S0167-4781(98)00050-5; Yasuda J, 1999, MOL CELL BIOL, V19, P7245	67	133	137	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 3	2002	35	1					25	38		10.1016/S0896-6273(02)00744-4	http://dx.doi.org/10.1016/S0896-6273(02)00744-4			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	569KP	12123606	Bronze			2022-12-24	WOS:000176601800008
J	Calton, JL; Dickinson, AR; Snyder, LH				Calton, JL; Dickinson, AR; Snyder, LH			Non-spatial, motor-specific activation in posterior parietal cortex	NATURE NEUROSCIENCE			English	Article							LATERAL INTRAPARIETAL AREA; MACAQUE MONKEY; PREMOTOR CORTEX; PARIETOOCCIPITAL CORTEX; NEURONAL-ACTIVITY; REFERENCE FRAMES; CEREBRAL-CORTEX; VISUAL PATHWAYS; RESPONSES; REPRESENTATION	A localized cluster of neurons in macaque posterior parietal cortex, termed the parietal reach region (PRR), is activated when a reach is planned to a visible or remembered target. To explore the role of PRR in sensorimotor transformations, we tested whether cells would be activated when a reach is planned to an as-yet unspecified goal. Over one-third of PRR cells increased their firing after an instruction to prepare a reach, but not after an instruction to prepare a saccade, when the target of the movement remained unknown. A partially overlapping population (two-thirds of cells) was activated when the monkey was informed of the target location but not the type of movement to be made. Thus a subset of PRR neurons separately code spatial and effector-specific information, consistent with a role in specifying potential motor responses to particular targets.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Snyder, LH (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, Box 8108,660 S Euclid Ave, St Louis, MO 63110 USA.		Snyder, Lawrence H/A-4593-2017		NIMH NIH HHS [F32 MH012145, F32 MH012145-01] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH012145] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANDERSEN RA, 1985, SCIENCE, V230, P456, DOI 10.1126/science.4048942; ASSAD JA, 1995, NATURE, V373, P518, DOI 10.1038/373518a0; Basso MA, 1997, NATURE, V389, P66, DOI 10.1038/37975; Basso MA, 1998, J NEUROSCI, V18, P7519; Battaglia-Mayer A, 2000, J NEUROPHYSIOL, V83, P2374, DOI 10.1152/jn.2000.83.4.2374; Ben Hamed S, 2001, EXP BRAIN RES, V140, P127, DOI 10.1007/s002210100785; Bichot NP, 1996, NATURE, V381, P697, DOI 10.1038/381697a0; Boussaoud D, 1999, EXP BRAIN RES, V128, P170, DOI 10.1007/s002210050832; BUSHNELL MC, 1981, J NEUROPHYSIOL, V46, P755, DOI 10.1152/jn.1981.46.4.755; Cisek P, 2002, J NEUROPHYSIOL, V87, P1149, DOI 10.1152/jn.00443.2001; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; COLBY CL, 1991, NEUROPSYCHOLOGIA, V29, P517, DOI 10.1016/0028-3932(91)90008-V; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; Colby CL, 1998, NEURON, V20, P15, DOI 10.1016/S0896-6273(00)80429-8; COLBY CL, 1988, J COMP NEUROL, V269, P392, DOI 10.1002/cne.902690307; Dorris MC, 1998, J NEUROSCI, V18, P7015; Fattori P, 2001, EUR J NEUROSCI, V13, P2309, DOI 10.1046/j.0953-816x.2001.01618.x; Ferraina S, 1997, J NEUROPHYSIOL, V77, P1034, DOI 10.1152/jn.1997.77.2.1034; Ferraina S, 2001, J NEUROPHYSIOL, V85, P462, DOI 10.1152/jn.2001.85.1.462; Gold JI, 2000, NATURE, V404, P390, DOI 10.1038/35006062; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; Hoshi E, 2000, NATURE, V408, P466, DOI 10.1038/35044075; HYVARINEN J, 1974, BRAIN, V97, P673, DOI 10.1093/brain/97.1.673; Johnson PB, 1996, CEREB CORTEX, V6, P102, DOI 10.1093/cercor/6.2.102; KALASKA JF, 1995, CEREB CORTEX, V5, P410, DOI 10.1093/cercor/5.5.410; KURATA K, 1991, NEUROSCI RES, V12, P263, DOI 10.1016/0168-0102(91)90116-G; Kustov AA, 1996, NATURE, V384, P74, DOI 10.1038/384074a0; Kusunoki M, 2000, VISION RES, V40, P1459, DOI 10.1016/S0042-6989(99)00212-6; Lewis JW, 2000, J COMP NEUROL, V428, P79, DOI 10.1002/1096-9861(20001204)428:1<79::AID-CNE7>3.0.CO;2-Q; Linden JF, 1999, J NEUROPHYSIOL, V82, P343, DOI 10.1152/jn.1999.82.1.343; Mazzoni P, 1996, J NEUROPHYSIOL, V76, P1439, DOI 10.1152/jn.1996.76.3.1439; Mazzoni P, 1996, J NEUROPHYSIOL, V75, P1233, DOI 10.1152/jn.1996.75.3.1233; MOUNTCASTLE VB, 1975, J NEUROPHYSIOL, V38, P871, DOI 10.1152/jn.1975.38.4.871; Murata A, 1996, J NEUROPHYSIOL, V75, P2180, DOI 10.1152/jn.1996.75.5.2180; Obayashi S, 2001, NEUROIMAGE, V14, P853, DOI 10.1006/nimg.2001.0878; Paxinos G., 2000, RHESUS MONKEY BRAIN; Platt ML, 1997, J NEUROPHYSIOL, V78, P1574, DOI 10.1152/jn.1997.78.3.1574; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; ROBINSON DL, 1978, J NEUROPHYSIOL, V41, P910, DOI 10.1152/jn.1978.41.4.910; Sakata H, 1998, PHILOS T ROY SOC B, V353, P1363, DOI 10.1098/rstb.1998.0290; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Snyder LH, 2000, VISION RES, V40, P1433, DOI 10.1016/S0042-6989(00)00052-3; Tanne J, 1995, NEUROREPORT, V7, P267, DOI 10.1097/00001756-199512000-00064; Umeno MM, 2001, J NEUROPHYSIOL, V86, P2344, DOI 10.1152/jn.2001.86.5.2344; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; WISE SP, 1989, SOMATOSENS MOT RES, V6, P455, DOI 10.3109/08990228909144687	48	163	164	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2002	5	6					580	588		10.1038/nn862	http://dx.doi.org/10.1038/nn862			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	556XQ	12021766				2022-12-24	WOS:000175874600019
J	Colbert, CM; Pan, EH				Colbert, CM; Pan, EH			Ion channel properties underlying axonal action potential initiation in pyramidal neurons	NATURE NEUROSCIENCE			English	Article							SODIUM-CHANNELS; SPIKE-INITIATION; RAT HIPPOCAMPUS; CELL DENDRITES; GANGLION-CELLS; PROPAGATION; CA1; SEGMENT; SITE; BACKPROPAGATION	A high density of Na+ channels in the axon hillock, or initial segment, is believed to determine the threshold for action potential initiation in neurons. Here we report evidence for an alternative mechanism that lowers the threshold in the axon. We investigated properties and distributions of ion channels in outside-out patches from axons and somata of layer 5 pyramidal neurons in rat neocortical slices. Na+ channels in axonal patches (>30 mum from the soma) were activated by 7 mV less depolarization than were somatic Na+ channels. A-type K+ channels, which were prominent in somatic and dendritic patches, were rarely seen in axonal patches. We incorporated these findings into numerical simulations which indicate that biophysical properties of axonal channels, rather than a high density of channels in the initial segment, are most likely to determine the lowest threshold for action potential initiation.	Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA	University of Houston System; University of Houston	Colbert, CM (corresponding author), Univ Houston, Dept Biol & Biochem, 4800 Calhoun Rd, Houston, TX 77204 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS036982] Funding Source: NIH RePORTER; NINDS NIH HHS [NS36982] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams Paul R., 1992, Current Biology, V2, P625, DOI 10.1016/0960-9822(92)90093-P; Alessandri-Haber N, 1999, J PHYSIOL-LONDON, V518, P203, DOI 10.1111/j.1469-7793.1999.0203r.x; ANDREASEN M, 1995, J PHYSIOL-LONDON, V483, P421, DOI 10.1113/jphysiol.1995.sp020595; ANGELIDES KJ, 1988, J CELL BIOL, V106, P1911, DOI 10.1083/jcb.106.6.1911; [Anonymous], [No title captured]; Astman N, 1998, J NEUROPHYSIOL, V80, P1547, DOI 10.1152/jn.1998.80.3.1547; BUHL EH, 1994, J NEUROPHYSIOL, V71, P1289, DOI 10.1152/jn.1994.71.4.1289; CARRAS PL, 1992, J NEUROPHYSIOL, V67, P292, DOI 10.1152/jn.1992.67.2.292; CATTERALL WA, 1981, J NEUROSCI, V1, P777, DOI 10.1523/JNEUROSCI.01-07-00777.1981; CHAVEZNORIEGA LE, 1990, EXP BRAIN RES, V79, P633; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Colbert CM, 1996, J NEUROSCI, V16, P6676; DODGE FA, 1973, IBM J RES DEV, V17, P219, DOI 10.1147/rd.173.0219; EDWARDS C, 1958, J PHYSIOL-LONDON, V143, P138, DOI 10.1113/jphysiol.1958.sp006049; FARINAS I, 1991, J COMP NEUROL, V304, P70, DOI 10.1002/cne.903040106; GOGAN P, 1983, J PHYSIOL-LONDON, V335, P205, DOI 10.1113/jphysiol.1983.sp014529; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; Hines M, 1993, NEURAL SYSTEMS ANAL, P127; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; Kloosterman F, 2001, J NEUROPHYSIOL, V86, P2435, DOI 10.1152/jn.2001.86.5.2435; Luscher HR, 1998, J NEUROPHYSIOL, V80, P715, DOI 10.1152/jn.1998.80.2.715; Magee JC, 1998, J NEUROSCI, V18, P7613; Mainen ZF, 1995, NEURON, V15, P1427, DOI 10.1016/0896-6273(95)90020-9; MATSUMOTO E, 1985, J NEUROCYTOL, V14, P731, DOI 10.1007/BF01170825; MEL BW, 1994, NEURAL COMPUT, V6, P1031, DOI 10.1162/neco.1994.6.6.1031; MOORE JW, 1983, J PHYSIOL-LONDON, V336, P301, DOI 10.1113/jphysiol.1983.sp014582; MOORE JW, 1983, J PHYSIOL-LONDON, V336, P285, DOI 10.1113/jphysiol.1983.sp014581; PALAY SL, 1968, J CELL BIOL, V38, P193, DOI 10.1083/jcb.38.1.193; Rapp M, 1996, P NATL ACAD SCI USA, V93, P11985, DOI 10.1073/pnas.93.21.11985; Rasband MN, 1999, J NEUROCYTOL, V28, P319, DOI 10.1023/A:1007057512576; REGEHR WG, 1994, CURR BIOL, V4, P436, DOI 10.1016/S0960-9822(00)00096-8; Shadlen MN, 1998, J NEUROSCI, V18, P3870; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; TURNER RW, 1991, J NEUROSCI, V11, P2270; Zecevic D, 1996, NATURE, V381, P322, DOI 10.1038/381322a0	40	196	199	0	16	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2002	5	6					533	538		10.1038/nn857	http://dx.doi.org/10.1038/nn857			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	556XQ	11992119				2022-12-24	WOS:000175874600012
J	Hooper, SL; Buchman, E; Hobbs, KH				Hooper, SL; Buchman, E; Hobbs, KH			A computational role for slow conductances: single-neuron models that measure duration	NATURE NEUROSCIENCE			English	Article								Humans effortlessly interpret speech and music, whose patterns can contain sound durations up to thousands of milliseconds. How nervous systems measure such long durations is unclear. We show here that model neurons containing physiological slow conductances are 'naturally' sensitive to duration, replicate known duration-sensitive neurons and can be 'tuned' to respond to a wide range of specific durations. In addition, these models reproduce several other properties of duration-sensitive neurons not selected for in model construction. These data, and the widespread presence of slow conductances in nervous systems, suggest that slow conductances might play a major role in duration measurement.	Ohio Univ, Dept Biol Sci, Program Neurosci, Athens, OH 45701 USA	University System of Ohio; Ohio University	Hooper, SL (corresponding author), Ohio Univ, Dept Biol Sci, Program Neurosci, Athens, OH 45701 USA.							POTTER HD, 1965, J NEUROPHYSIOL, V28, P1155, DOI 10.1152/jn.1965.28.6.1155	1	37	36	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2002	5	6					552	556		10.1038/nn838	http://dx.doi.org/10.1038/nn838			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	556XQ	11992113				2022-12-24	WOS:000175874600015
J	Ishikawa, T; Sahara, Y; Takahashi, T				Ishikawa, T; Sahara, Y; Takahashi, T			A single packet of transmitter does not saturate postsynaptic glutamate receptors	NEURON			English	Article							CULTURED HIPPOCAMPAL-NEURONS; SYNAPTIC VESICLES; PYRAMIDAL CELLS; NMDA RECEPTORS; MULTIVESICULAR RELEASE; QUANTAL COMPONENTS; AUDITORY SYNAPSE; RAT HIPPOCAMPUS; MEDIAL NUCLEUS; TRAPEZOID BODY	Neurotransmitter is stored in synaptic vesicles and released by exocytosis into the synaptic cleft. One of the fundamental questions in central synaptic transmission is whether a quantal packet of transmitter saturates postsynaptic receptors. To address this question, we loaded the excitatory transmitter L-glutamate via whole-cell recording pipettes into the giant nerve terminal, the calyx of Held, in rat brainstem slices. This caused marked potentiations of both quantal and action potential-evoked EPSCs mediated by alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) or N-methyl-D-aspartate (NMDA) receptors. These results directly demonstrate that neither AMPA nor NMDA receptors are saturated by a single packet of transmitter, and indicate that vesicular transmitter content is an important determinant of synaptic efficacy.	Univ Tokyo, Grad Sch Med, Dept Neurobiol, Tokyo 1130033, Japan; Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Div Biochem & Cellular Biol, Tokyo, Japan	University of Tokyo; National Center for Neurology & Psychiatry - Japan	Takahashi, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Neurobiol, Tokyo 1130033, Japan.		Ishikawa, Taro/AAX-9928-2020; Takahashi, Tomoyuki/G-5951-2015	Ishikawa, Taro/0000-0003-2335-439X; Takahashi, Tomoyuki/0000-0002-8771-7666				Auger C, 1998, J NEUROSCI, V18, P4532; Auger C, 2000, J PHYSIOL-LONDON, V526, P3, DOI 10.1111/j.1469-7793.2000.t01-3-00003.x; BEKKERS JM, 1990, P NATL ACAD SCI USA, V87, P5359, DOI 10.1073/pnas.87.14.5359; Borst JGG, 1995, J PHYSIOL-LONDON, V489, P825, DOI 10.1113/jphysiol.1995.sp021095; BURGER PM, 1991, NEURON, V7, P287, DOI 10.1016/0896-6273(91)90267-4; BURGER PM, 1989, NEURON, V3, P715, DOI 10.1016/0896-6273(89)90240-7; CARPENTER RS, 1980, BIOCHEMISTRY-US, V19, P4373, DOI 10.1021/bi00559a034; Chuhma N, 1998, J NEUROSCI, V18, P512; Clements JD, 1998, J NEUROSCI, V18, P119; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; DAN Y, 1994, NEURON, V13, P909, DOI 10.1016/0896-6273(94)90256-9; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; Diamond JS, 1997, J NEUROSCI, V17, P4672; Frerking M, 1996, CURR OPIN NEUROBIOL, V6, P395, DOI 10.1016/S0959-4388(96)80125-5; Futai K, 2001, J NEUROSCI, V21, P3342, DOI 10.1523/JNEUROSCI.21-10-03342.2001; GULYAS AI, 1993, NATURE, V366, P683, DOI 10.1038/366683a0; HARRIS KM, 1989, J NEUROSCI, V9, P2982; HARTZELL HC, 1975, J PHYSIOL-LONDON, V251, P427, DOI 10.1113/jphysiol.1975.sp011102; Holmes WR, 1995, BIOPHYS J, V69, P1734, DOI 10.1016/S0006-3495(95)80043-3; Hori T, 1999, J NEUROSCI, V19, P7262, DOI 10.1523/JNEUROSCI.19-17-07262.1999; Ishikawa T, 2001, J PHYSIOL-LONDON, V533, P423, DOI 10.1111/j.1469-7793.2001.0423a.x; Iwasaki S, 2001, J PHYSIOL-LONDON, V534, P861, DOI 10.1111/j.1469-7793.2001.00861.x; Jabaudon D, 1999, P NATL ACAD SCI USA, V96, P8733, DOI 10.1073/pnas.96.15.8733; JACK JJB, 1981, J PHYSIOL-LONDON, V321, P65, DOI 10.1113/jphysiol.1981.sp013972; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; LAAKE JH, 1995, J NEUROCHEM, V65, P871; LARKMAN A, 1991, NATURE, V350, P344, DOI 10.1038/350344a0; LENN NJ, 1966, AM J ANAT, V118, P375, DOI 10.1002/aja.1001180205; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; MARC RE, 1990, J NEUROSCI, V10, P4006, DOI 10.1523/JNEUROSCI.10-12-04006.1990; McAllister AK, 2000, P NATL ACAD SCI USA, V97, P6173, DOI 10.1073/pnas.100126497; Meinrenken CJ, 2002, J NEUROSCI, V22, P1648, DOI 10.1523/JNEUROSCI.22-05-01648.2002; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; PATNEAU DK, 1993, J NEUROSCI, V13, P3496; PERKEL DJ, 1993, J PHYSIOL-LONDON, V471, P481, DOI 10.1113/jphysiol.1993.sp019911; Rusakov DA, 1998, NEUROPHARMACOLOGY, V37, P513, DOI 10.1016/S0028-3908(98)00023-9; Sahara Y, 2001, J PHYSIOL-LONDON, V536, P189, DOI 10.1111/j.1469-7793.2001.00189.x; Sakaba T, 2001, P NATL ACAD SCI USA, V98, P331, DOI 10.1073/pnas.021541098; SHUPLIAKOV O, 1995, J NEUROSCI, V15, P7168; Silver RA, 1996, J PHYSIOL-LONDON, V493, P167, DOI 10.1113/jphysiol.1996.sp021372; Silver RA, 1996, J PHYSIOL-LONDON, V494, P231, DOI 10.1113/jphysiol.1996.sp021487; Song HJ, 1997, NEURON, V18, P815, DOI 10.1016/S0896-6273(00)80320-7; Sun JY, 2001, NEURON, V30, P171, DOI 10.1016/S0896-6273(01)00271-9; TABB JS, 1991, J NEUROSCI, V11, P1822; Takahashi T, 2000, SCIENCE, V289, P460, DOI 10.1126/science.289.5478.460; TONG G, 1994, NEURON, V12, P51, DOI 10.1016/0896-6273(94)90151-1; Umemiya M, 1999, J PHYSIOL-LONDON, V521, P113, DOI 10.1111/j.1469-7793.1999.00113.x; Wu LG, 1999, NEURON, V23, P821, DOI 10.1016/S0896-6273(01)80039-8; Zhou Q, 2000, J PHYSIOL-LONDON, V525, P195, DOI 10.1111/j.1469-7793.2000.t01-1-00195.x	50	118	123	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 16	2002	34	4					613	621		10.1016/S0896-6273(02)00692-X	http://dx.doi.org/10.1016/S0896-6273(02)00692-X			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	553FT	12062044	Bronze			2022-12-24	WOS:000175665700014
J	Thomas, OM; Cumming, BG; Parker, AJ				Thomas, OM; Cumming, BG; Parker, AJ			A specialization for relative disparity in V2	NATURE NEUROSCIENCE			English	Article							RANDOM-DOT STEREOGRAMS; INFERIOR TEMPORAL CORTEX; VISUAL-CORTEX; DEPTH DISCRIMINATION; BINOCULAR DISPARITY; V1; RESPONSES; NEURONS; MOTION; REPRESENTATION	Stereoscopic depth perception relies on binocular disparities, or small geometric differences between the retinal images of each eye. The most reliable binocular depth judgments are those that are based on relative disparities between two simultaneously visible features in a scene. Many cortical areas contain neurons that are sensitive to disparity, but it is unclear whether any areas show a specific sensitivity to relative disparity. We recorded from neurons in the early cortical visual area V2 of the awake macaque during presentation of random-dot patterns. The depth of a central region ('center'), and that of an annular surrounding region ('surround'), were manipulated independently in these stimuli. Some cells were fully selective for the resulting relative disparities. Most showed partial selectivity, which nonetheless indicated a sensitivity for the depth relationship between center and surround. Both types of neural response could support psychophysical judgments of relative depth.	Univ Oxford, Physiol Lab, Oxford OX1 3PT, England; NEI, Sensorimotor Res Lab, NIH, Bethesda, MD 20892 USA	University of Oxford; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Thomas, OM (corresponding author), Univ Oxford, Physiol Lab, Parks Rd, Oxford OX1 3PT, England.		Parker, Andrew J/I-7867-2013	Parker, Andrew J/0000-0001-5800-0407; Thomas, Owen/0000-0003-2877-3075	NATIONAL EYE INSTITUTE [Z01EY000404, ZIAEY000404] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bakin JS, 2000, J NEUROSCI, V20, P8188; BARLOW HB, 1967, J PHYSIOL-LONDON, V193, P327, DOI 10.1113/jphysiol.1967.sp008360; Bradley DC, 1998, J NEUROSCI, V18, P7552; Cumming BG, 1999, J NEUROSCI, V19, P5602; Eifuku S, 1999, J NEUROPHYSIOL, V82, P2462, DOI 10.1152/jn.1999.82.5.2462; ERKELENS CJ, 1985, VISION RES, V25, P583, DOI 10.1016/0042-6989(85)90164-6; ERKELENS CJ, 1985, VISION RES, V25, P1689, DOI 10.1016/0042-6989(85)90141-5; Fleet DJ, 1996, VISION RES, V36, P1839, DOI 10.1016/0042-6989(95)00313-4; Janssen P, 2000, NEURON, V27, P385, DOI 10.1016/S0896-6273(00)00045-3; Janssen P, 2000, SCIENCE, V288, P2054, DOI 10.1126/science.288.5473.2054; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Julesz B., 1971, FDN CYCLOPEAN PERCEP; KUMAR T, 1992, VISION RES, V32, P1667, DOI 10.1016/0042-6989(92)90159-G; Ohzawa I, 1997, J NEUROPHYSIOL, V77, P2879, DOI 10.1152/jn.1997.77.6.2879; OHZAWA I, 1990, SCIENCE, V249, P1037, DOI 10.1126/science.2396096; POGGIO GF, 1985, VISION RES, V25, P397, DOI 10.1016/0042-6989(85)90065-3; Prince SJD, 2000, J NEUROSCI, V20, P3387, DOI 10.1523/JNEUROSCI.20-09-03387.2000; Prince SJD, 2002, J NEUROPHYSIOL, V87, P191, DOI 10.1152/jn.00465.2000; REGAN D, 1986, INVEST OPHTH VIS SCI, V27, P584; ROE AW, 1995, J NEUROSCI, V15, P3689; von der Heydt R, 2000, VISION RES, V40, P1955, DOI 10.1016/S0042-6989(00)00044-4; WESTHEIMER G, 1979, EXP BRAIN RES, V36, P585; [No title captured]	23	147	151	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2002	5	5					472	478		10.1038/nn837	http://dx.doi.org/10.1038/nn837			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	546JY	11967544				2022-12-24	WOS:000175272000019
J	Moore, KB; Schneider, ML; Vetter, ML				Moore, KB; Schneider, ML; Vetter, ML			Posttranslational mechanisms control the timing of bHLH function and regulate retinal cell fate	NEURON			English	Article							LOOP-HELIX GENES; XENOPUS-EMBRYOS; AMACRINE CELLS; ACHAETE-SCUTE; NEURONAL DIFFERENTIATION; VERTEBRATE RETINA; PRONEURAL GENES; NERVOUS-SYSTEM; EXPRESSION; LAEVIS	During central nervous system development, neurons are often born in a precise temporal sequence. Basic helix-loop-helix (bHLH) transcription factors are required for the development of specific subpopulations of neurons, but how they contribute to their ordered genesis is unclear. We show that the ability of bHLH factors to regulate the development of distinct neuronal subtypes in the Xenopus retina depends upon the timing of their function. In addition, we find that the timing of bHLH function can be regulated post-translationally, so that bHLH factors with overlapping expression can function independently. Specifically, XNeuroD function in the retina can be inhibited by glycogen synthase kinase 3beta (GSK3beta), while Xath5 function can be inhibited by Notch. Thus, the potential of bHLH factors to regulate the development of neuronal subtypes depends upon the context in which they function.	Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah	Vetter, ML (corresponding author), Univ Utah, Dept Neurobiol & Anat, 20 N 1900 E, Salt Lake City, UT 84132 USA.			Moore, Kathryn/0000-0002-6993-152X; Vetter, Monica/0000-0001-6262-8504	NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY010096, R01EY012274] Funding Source: NIH RePORTER; NCI NIH HHS [2P30CA42014] Funding Source: Medline; NEI NIH HHS [EY12274, EY10096] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALTSHULER DM, 1991, CELL LINEAGE CELL FA, P37; BeleckyAdams T, 1997, INVEST OPHTH VIS SCI, V38, P1293; Bray S, 2000, NEURON, V25, P1, DOI 10.1016/S0896-6273(00)80862-4; Brown NL, 1998, DEVELOPMENT, V125, P4821; Brown NL, 2001, DEVELOPMENT, V128, P2497; Cai L, 2000, DEVELOPMENT, V127, P3021; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Chien CT, 1996, P NATL ACAD SCI USA, V93, P13239, DOI 10.1073/pnas.93.23.13239; Chitnis A, 1996, DEVELOPMENT, V122, P2295; COFFMAN CR, 1993, CELL, V73, P659, DOI 10.1016/0092-8674(93)90247-N; DOMINGUEZ I, 1995, P NATL ACAD SCI USA, V92, P8498, DOI 10.1073/pnas.92.18.8498; Dorsky RI, 1997, NATURE, V385, P67, DOI 10.1038/385067a0; DORSKY RI, 1995, NEURON, V14, P487, DOI 10.1016/0896-6273(95)90305-4; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; Faber J., 1994, NORMAL TABLE XENOPUS, P2; FERREIRO B, 1993, MECH DEVELOP, V40, P25, DOI 10.1016/0925-4773(93)90085-C; Fode C, 2000, GENE DEV, V14, P67; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Harris WA, 1997, CURR OPIN GENET DEV, V7, P651, DOI 10.1016/S0959-437X(97)80013-5; Hatakeyama J, 2001, DEVELOPMENT, V128, P1313; HE X, 1995, NATURE, V374, P617, DOI 10.1038/374617a0; HISCOCK J, 1990, DEV BRAIN RES, V54, P105, DOI 10.1016/0165-3806(90)90070-F; HOLT CE, 1988, NEURON, V1, P15, DOI 10.1016/0896-6273(88)90205-X; HOLT CE, 1990, NEURON, V4, P203, DOI 10.1016/0896-6273(90)90095-W; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Hu M, 1999, DEV BIOL, V207, P309, DOI 10.1006/dbio.1998.9031; HUANG S, 1993, J NEUROSCI, V13, P3193; Huang S, 1997, J COMP NEUROL, V387, P42; Huang S, 1998, VISUAL NEUROSCI, V15, P969, DOI 10.1017/S0952523898155153; Hutcheson DA, 2001, DEV BIOL, V232, P327, DOI 10.1006/dbio.2001.0178; Jasoni CL, 1996, J COMP NEUROL, V369, P319; JOHNSON JE, 1990, NATURE, V346, P858, DOI 10.1038/346858a0; Kanekar S, 1997, NEURON, V19, P981, DOI 10.1016/S0896-6273(00)80391-8; Kay JN, 2001, NEURON, V30, P725, DOI 10.1016/S0896-6273(01)00312-9; Lee JE, 1997, CURR OPIN NEUROBIOL, V7, P13, DOI 10.1016/S0959-4388(97)80115-8; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Marcus EA, 1998, MOL CELL NEUROSCI, V12, P269, DOI 10.1006/mcne.1998.0713; Mastick GS, 1997, DEVELOPMENT, V124, P1985; Matter-Sadzinski L, 2001, DEVELOPMENT, V128, P217; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; MOODY SA, 1987, DEV BIOL, V119, P560, DOI 10.1016/0012-1606(87)90059-5; Morrow EM, 1999, DEVELOPMENT, V126, P23; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; OHNUMA S, 2002, IN PRESS DEVELOPMENT; Perron M, 1999, P NATL ACAD SCI USA, V96, P14996, DOI 10.1073/pnas.96.26.14996; Perron M, 1998, DEV BIOL, V199, P185, DOI 10.1006/dbio.1998.8939; PIERCE SB, 1995, DEVELOPMENT, V121, P755; RAYBORN ME, 1981, J COMP NEUROL, V195, P585, DOI 10.1002/cne.901950404; Schneider ML, 2001, MOL CELL NEUROSCI, V18, P458, DOI 10.1006/mcne.2001.1040; Sun Y, 2000, P NATL ACAD SCI USA, V97, P6815, DOI 10.1073/pnas.110154497; Tomita K, 1996, GENES CELLS, V1, P765, DOI 10.1111/j.1365-2443.1996.tb00016.x; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Yost C, 1998, CELL, V93, P1031, DOI 10.1016/S0092-8674(00)81208-8; ZHU BS, 1993, ANAT EMBRYOL, V187, P549, DOI 10.1007/BF00214433	59	90	95	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 11	2002	34	2					183	195		10.1016/S0896-6273(02)00666-9	http://dx.doi.org/10.1016/S0896-6273(02)00666-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	541GE	11970861	Bronze			2022-12-24	WOS:000174976200005
J	Logan, JM; Sanders, AL; Snyder, AZ; Morris, JC; Buckner, RL				Logan, JM; Sanders, AL; Snyder, AZ; Morris, JC; Buckner, RL			Under-recruitment and nonselective recruitment: Dissociable neural mechanisms associated with aging	NEURON			English	Article							POSITRON-EMISSION-TOMOGRAPHY; INFERIOR PREFRONTAL CORTEX; EPISODIC MEMORY; FRONTAL-CORTEX; RECOGNITION MEMORY; FUNCTIONAL MRI; BRAIN ACTIVITY; DIVIDED ATTENTION; AGE-DIFFERENCES; WORKING-MEMORY	Frontal contributions to cognitive decline in aging were explored using functional MRI. Frontal regions active in younger adults during self-initiated (intentional) memory encoding were under-recruited in older adults. Older adults showed less activity in anterior-ventral regions associated with controlled use of semantic information. Under-recruitment was reversed by requiring semantic elaboration suggesting it stemmed from difficulty in spontaneous recruitment of available frontal resources. In addition, older adults recruited multiple frontal regions in a nonselective manner for both verbal and nonverbal materials. Lack of selectivity was not reversed during semantically directed encoding even when under-recruitment was diminished. These findings suggest two separate forms of age-associated change in frontal cortex: under-recruitment and nonselective recruitment. The former is reversible and potentially amenable to cognitive training; the latter may reflect a less malleable change associated with cognitive decline in advanced aging.	Washington Univ, Dept Psychol, St Louis, MO 63130 USA; Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Howard Hughes Med Inst, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Howard Hughes Medical Institute	Buckner, RL (corresponding author), Washington Univ, Dept Psychol, St Louis, MO 63130 USA.		Kennedy, Kristen M/B-4699-2008; Morris, John C/A-1686-2012	Kennedy, Kristen M/0000-0001-5373-9026; 	NIA NIH HHS [AG05681, AG03991] Funding Source: Medline; NIMH NIH HHS [MH57506] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057506] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005681, P01AG003991] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Anderson ND, 2000, J COGNITIVE NEUROSCI, V12, P775, DOI 10.1162/089892900562598; Backman L, 1997, J COGNITIVE NEUROSCI, V9, P378, DOI 10.1162/jocn.1997.9.3.378; Baker JT, 2001, NEUROREPORT, V12, P1251, DOI 10.1097/00001756-200105080-00039; Balota D. A., 2000, OXFORD HDB MEMORY, P395, DOI DOI 10.1037/A0015086; Baltes PB, 1997, PSYCHOL AGING, V12, P12, DOI 10.1037/0882-7974.12.1.12; BANDETTINI PA, 1993, MAGNET RESON MED, V30, P161, DOI 10.1002/mrm.1910300204; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Buckner RL, 1996, P NATL ACAD SCI USA, V93, P1249, DOI 10.1073/pnas.93.3.1249; Buckner RL, 1999, NAT NEUROSCI, V2, P311, DOI 10.1038/7221; Buckner RL, 1996, PSYCHON B REV, V3, P149, DOI 10.3758/BF03212413; Buckner RL, 2001, J COGNITIVE NEUROSCI, V13, P406, DOI 10.1162/08989290151137430; BUCKNER RL, 2002, COGNITIVE NEUROSCIEN; Cabeza R, 1997, J NEUROSCI, V17, P391; CABEZA R, 2002, IN PRESS PSYCHOL AGI; Camp C., 2000, COGNITIVE REHABILITA, P224; Cao Y, 1999, STROKE, V30, P2331, DOI 10.1161/01.STR.30.11.2331; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; Craik F. I., 1982, AGING COGNITIVE PROC, P191, DOI DOI 10.1007/978-1-4684-4178-9_11; Craik F. I. M., 1977, HDB PSYCHOL AGING; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; Craik FIM, 1980, P GEORG TALL MEM C N; CRAIK FIM, 1975, J EXP PSYCHOL GEN, V104, P168; D'Esposito M, 1999, NEUROIMAGE, V10, P6, DOI 10.1006/nimg.1999.0444; DEMB JB, 1995, J NEUROSCI, V15, P5870; DEMPSTER FN, 1992, DEV REV, V12, P45, DOI 10.1016/0273-2297(92)90003-K; Dixit N.K., 2000, NEUROIMAGE, V11, pS94; Fletcher PC, 1998, BRAIN, V121, P1239, DOI 10.1093/brain/121.7.1239; GERSHBERG FB, 1995, NEUROPSYCHOLOGIA, V33, P1305, DOI 10.1016/0028-3932(95)00103-A; Gold BT, 2000, BRAIN LANG, V73, P456, DOI 10.1006/brln.2000.2317; GOODGLASS H, 1983, BOSTON NAMING TEST S; Grady CL, 1999, CEREB CORTEX, V9, P805, DOI 10.1093/cercor/9.8.805; GRADY CL, 1995, SCIENCE, V269, P218, DOI 10.1126/science.7618082; Grady CL, 2000, CURR OPIN NEUROBIOL, V10, P224, DOI 10.1016/S0959-4388(00)00073-8; Greenwood PM, 2000, J INT NEUROPSYCH SOC, V6, P705, DOI 10.1017/S1355617700666092; Hasher L, 1999, ATTENTION PERFORM, V17, P653; Hasher L., 1988, PSYCHOL LEARNING MOT, V22, P193, DOI [10.1016/S0079-7421(08)60041-9, DOI 10.1016/S0079-7421(08)60041-9]; Honda M, 1997, J NEUROL SCI, V146, P117, DOI 10.1016/S0022-510X(96)00291-2; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; HULICKA IM, 1966, J GENET PSYCHOL, V109, P135, DOI 10.1080/00221325.1966.10533690; Iidaka T, 2000, J COGNITIVE NEUROSCI, V12, P267, DOI 10.1162/089892900562093; Iidaka T, 2001, COGNITIVE BRAIN RES, V11, P1, DOI 10.1016/S0926-6410(00)00058-6; Kapur S, 1996, COGNITIVE BRAIN RES, V4, P243, DOI 10.1016/S0926-6410(96)00058-4; KAPUR S, 1994, P NATL ACAD SCI USA, V91, P2008, DOI 10.1073/pnas.91.6.2008; KAUSLER DH, 1988, AM J PSYCHOL, V101, P207, DOI 10.2307/1422835; Kelley WM, 1998, NEURON, V20, P927, DOI 10.1016/S0896-6273(00)80474-2; Kirchhoff BA, 2000, J NEUROSCI, V20, P6173, DOI 10.1523/JNEUROSCI.20-16-06173.2000; Knoke D, 1998, BRAIN COGNITION, V38, P261, DOI 10.1006/brcg.1998.1042; Konishi S, 2001, NEUROIMAGE, V13, P364, DOI 10.1006/nimg.2000.0691; Kucera H., 1967, COMPUTATIONAL ANAL P; Madden DJ, 1999, HUM BRAIN MAPP, V7, P115, DOI 10.1002/(SICI)1097-0193(1999)7:2<115::AID-HBM5>3.0.CO;2-N; Madden DJ, 1999, J COGNITIVE NEUROSCI, V11, P511, DOI 10.1162/089892999563571; McDermott KB, 1999, J COGNITIVE NEUROSCI, V11, P631, DOI 10.1162/089892999563698; McIntosh AR, 1999, CURR BIOL, V9, P1275, DOI 10.1016/S0960-9822(99)80512-0; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Moscovitch M, 1995, ANN NY ACAD SCI, V769, P119, DOI 10.1111/j.1749-6632.1995.tb38135.x; MYERSON J, 1990, PSYCHOL REV, V97, P475, DOI 10.1037/0033-295X.97.4.475; NIELSON KA, 2002, IN PRESS PSYCHOL AGI; Nyberg L., 1996, J GERONTOL B-PSYCHOL, V51, P234; O'Sullivan M, 2001, NEUROLOGY, V57, P632, DOI 10.1212/WNL.57.4.632; Ohyama M, 1996, STROKE, V27, P897, DOI 10.1161/01.STR.27.5.897; Otten LJ, 2001, BRAIN, V124, P399, DOI 10.1093/brain/124.2.399; Park D C, 2001, Dialogues Clin Neurosci, V3, P151; Park DC, 1996, PSYCHOL AGING, V11, P621, DOI 10.1037/0882-7974.11.4.621; PARK DC, 1990, J GERONTOL B-PSYCHOL, V45, P52; PETERSEN SE, 1988, NATURE, V331, P585, DOI 10.1038/331585a0; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Raz N, 1997, CEREB CORTEX, V7, P268, DOI 10.1093/cercor/7.3.268; Raz N., 2000, HDB AGING COGNITION, V2nd, P1; Reuter-Lorenz PA, 2001, EUR J COGN PSYCHOL, V13, P257, DOI 10.1080/09541440125972; Reuter-Lorenz PA, 2000, J COGNITIVE NEUROSCI, V12, P174, DOI 10.1162/089892900561814; Rosen HJ, 2000, NEUROLOGY, V55, P1883, DOI 10.1212/WNL.55.12.1883; Rypma B, 2000, NAT NEUROSCI, V3, P509, DOI 10.1038/74889; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Savage CR, 2001, BRAIN, V124, P219, DOI 10.1093/brain/124.1.219; Schacter DL, 1996, NEUROREPORT, V7, P1165, DOI 10.1097/00001756-199604260-00014; SHALLICE T, 1994, NATURE, V368, P633, DOI 10.1038/368633a0; Snyder AZ., 1996, QUANTIFICATION BRAIN, P131, DOI DOI 10.1016/B978-012389760-2/50028-1; Sohlberg M., 2001, COGNITIVE REHABILITA; Stuss DT, 1996, PSYCHOL AGING, V11, P387, DOI 10.1037/0882-7974.11.3.387; Sullivan EV, 2001, NEUROREPORT, V12, P99, DOI 10.1097/00001756-200101220-00027; Talairach J., 1988, COPLANAR STEREOTAXIC; Thulborn KR, 1999, STROKE, V30, P749, DOI 10.1161/01.STR.30.4.749; Thurstone L., 1949, EXAMINER MANUAL SRT; Wagner AD, 1998, NEUROREPORT, V9, P3711, DOI 10.1097/00001756-199811160-00026; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Wechsler D, 1973, MANUAL WECHSLER MEMO; Wechsler D, 1955, WAIS MANUAL; WEILLER C, 1995, ANN NEUROL, V37, P723, DOI 10.1002/ana.410370605; West RL, 1996, PSYCHOL BULL, V120, P272, DOI 10.1037/0033-2909.120.2.272; ZAGAR R, 1984, J CLIN PSYCHOL, V40, P1466, DOI 10.1002/1097-4679(198411)40:6<1466::AID-JCLP2270400635>3.0.CO;2-5	91	553	560	0	40	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 28	2002	33	5					827	840		10.1016/S0896-6273(02)00612-8	http://dx.doi.org/10.1016/S0896-6273(02)00612-8			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	529EC	11879658	Bronze			2022-12-24	WOS:000174286200017
J	Allen, CB; Celikel, T; Feldman, DE				Allen, CB; Celikel, T; Feldman, DE			Long-term depression induced by sensory deprivation during cortical map plasticity in vivo	NATURE NEUROSCIENCE			English	Article							EXPERIENCE-DEPENDENT PLASTICITY; RAT BARREL CORTEX; OCULAR DOMINANCE PLASTICITY; SYNAPTIC PLASTICITY; CRITICAL PERIOD; MONOCULAR DEPRIVATION; ALPHA-CAMKII; AREA CA1; POTENTIATION; LTP	Cortical map plasticity is thought to involve long-term depression (LTD) of cortical synapses, but direct evidence for LTD during plasticity or learning in vivo is lacking. One putative role for LTD is in the reduction of cortical responsiveness to behaviorally irrelevant or unused sensory stimuli, a common feature of map plasticity. Here we show that whisker deprivation, a manipulation that drives map plasticity in rat somatosensory cortex (S1), induces detectable LTD-like depression at intracortical excitatory synapses between cortical layer 4 (L4) and L2/3 pyramidal neurons. This synaptic depression occluded further LTD, enhanced LTP, was column specific, and was driven in part by competition between active and inactive whiskers. The synaptic locus of LTD and these properties suggest that LTD underlies the reduction of cortical responses to deprived whiskers, a major component of S1 map plasticity.	Univ Calif San Diego, Program Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Feldman, DE (corresponding author), Univ Calif San Diego, Program Neurosci, 9500 Gilman Dr, La Jolla, CA 92093 USA.	dfeldman@ucsd.edu	Celikel, Tansu/P-4235-2018		NCRR NIH HHS [P41-RR09754] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR009754] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; ARMSTRONGJAMES M, 1992, J NEUROPHYSIOL, V68, P1345, DOI 10.1152/jn.1992.68.4.1345; ARTOLA A, 1993, TRENDS NEUROSCI, V16, P480, DOI 10.1016/0166-2236(93)90081-V; BEAR MF, 1987, SCIENCE, V237, P42, DOI 10.1126/science.3037696; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; CASTROALAMANCOS MA, 1995, J NEUROSCI, V15, P5324; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; DAW NW, 1992, J NEUROPHYSIOL, V67, P197, DOI 10.1152/jn.1992.67.1.197; DIAMOND ME, 1994, SCIENCE, V265, P1885, DOI 10.1126/science.8091215; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; DUDEK SM, 1993, J NEUROSCI, V13, P2910; Fee MS, 1996, J NEUROSCI METH, V69, P175, DOI 10.1016/S0165-0270(96)00050-7; Feldman DE, 1999, J NEUROBIOL, V41, P92, DOI 10.1002/(SICI)1097-4695(199910)41:1<92::AID-NEU12>3.0.CO;2-U; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Feldmeyer D, 2002, J PHYSIOL-LONDON, V538, P803, DOI 10.1113/jphysiol.2001.012959; Finnerty GT, 2000, P NATL ACAD SCI USA, V97, P12864, DOI 10.1073/pnas.230175697; Finnerty GT, 1999, NATURE, V400, P367, DOI 10.1038/22553; FOX K, 1992, J NEUROSCI, V12, P1826; Froc DJ, 2000, J NEUROSCI, V20, P438, DOI 10.1523/JNEUROSCI.20-01-00438.2000; GERSTEIN GL, 1969, SCIENCE, V164, P828, DOI 10.1126/science.164.3881.828; Glazewski S, 1998, EUR J NEUROSCI, V10, P2107, DOI 10.1046/j.1460-9568.1998.00222.x; Glazewski S, 1996, SCIENCE, V272, P421, DOI 10.1126/science.272.5260.421; Glazewski S, 2000, NAT NEUROSCI, V3, P911, DOI 10.1038/78820; Glazewski S, 1996, J NEUROPHYSIOL, V75, P1714, DOI 10.1152/jn.1996.75.4.1714; Hensch TK, 1996, SCIENCE, V272, P554, DOI 10.1126/science.272.5261.554; Heynen AJ, 1996, NATURE, V381, P163, DOI 10.1038/381163a0; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KIRKWOOD A, 1994, J NEUROSCI, V14, P3404; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Lebel D, 2001, CEREB CORTEX, V11, P485, DOI 10.1093/cercor/11.6.485; LI XR, 1995, J COMP NEUROL, V357, P465, DOI 10.1002/cne.903570310; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; MIOCHE L, 1989, J NEUROPHYSIOL, V62, P185, DOI 10.1152/jn.1989.62.1.185; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; Panzeri S, 2001, NEURON, V29, P769, DOI 10.1016/S0896-6273(01)00251-3; Rema V, 1998, J NEUROSCI, V18, P10196; Renger JJ, 2002, P NATL ACAD SCI USA, V99, P1041, DOI 10.1073/pnas.022618799; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Rittenhouse CD, 1999, NATURE, V397, P347, DOI 10.1038/16922; Roberts EB, 1998, J NEUROPHYSIOL, V80, P1021, DOI 10.1152/jn.1998.80.3.1021; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; Trachtenberg JT, 2000, SCIENCE, V287, P2029, DOI 10.1126/science.287.5460.2029; Trachtenberg JT, 2001, J NEUROSCI, V21, P3476, DOI 10.1523/JNEUROSCI.21-10-03476.2001; Tsvetkov E, 2002, NEURON, V34, P289, DOI 10.1016/S0896-6273(02)00645-1; Walcott EC, 2002, NEUROSCIENCE, V112, P815, DOI 10.1016/S0306-4522(02)00131-8; Wallace H, 2001, J NEUROSCI, V21, P3881, DOI 10.1523/JNEUROSCI.21-11-03881.2001; Wallace H, 1999, SOMATOSENS MOT RES, V16, P122; WIESEL TN, 1965, J NEUROPHYSIOL, V28, P1029, DOI 10.1152/jn.1965.28.6.1029	50	187	191	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2003	6	3					291	299		10.1038/nn1012	http://dx.doi.org/10.1038/nn1012			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	648YB	12577061				2022-12-24	WOS:000181178300018
J	Sharon, R; Bar-Joseph, I; Frosch, MP; Walsh, DM; Hamilton, JA; Selkoe, DJ				Sharon, R; Bar-Joseph, I; Frosch, MP; Walsh, DM; Hamilton, JA; Selkoe, DJ			The formation of highly soluble oligomers of alpha-synuclein is regulated by fatty acids and enhanced in Parkinson's disease	NEURON			English	Article							RAT FRONTAL-CORTEX; LEWY BODIES; PROTEIN; BINDING; TRANSPORT; MEMBRANES; AGGREGATION; METABOLISM; DIFFUSION; DEMENTIA	Accumulation of misfolded proteins as insoluble aggregates occurs in several neurodegenerative diseases. In Parkinson's disease (PD) and dementia with Lewy bodies (DLB), alpha-synuclein (alphaS) accumulates in insoluble inclusions. To identify soluble alphaS oligomers that precede insoluble aggregates, we probed the cytosols of mesencephalic neuronal (MES) cells, normal and alphaS-transgenic mouse brains, and normal, PD, and DLB human brains. All contained highly soluble oligomers; of alphaS whose detection was enhanced by delipidation. Exposure of living MES neurons to polyunsaturated fatty acids (PUFAs) increased alphaS oligomer levels, whereas saturated FAs decreased them. PUFAs directly promoted oligomerization of recombinant alphaS. Transgenic mice accumulated soluble oligomers with age. PD and DLB brains had elevated amounts of the soluble, lipid-dependent oligomers. We conclude that alphaS interacts with PUFAs in vivo to promote the formation of highly soluble oligomers that precede the insoluble alphaS aggregates associated with neurodegeneration.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Selkoe, DJ (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02215 USA.		Frosch, Matthew P/ABD-7456-2021	Frosch, Matthew P/0000-0002-3940-9861; Hamilton, James/0000-0002-4747-7071	NINDS NIH HHS [NS 38375] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038375] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Baba M, 1998, AM J PATHOL, V152, P879; Bonen A, 1999, AM J PHYSIOL-ENDOC M, V276, pE642, DOI 10.1152/ajpendo.1999.276.4.E642; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cole NB, 2002, J BIOL CHEM, V277, P6344, DOI 10.1074/jbc.M108414200; CRAWFORD GDJ, 1992, J NEUROSCI, V12, P3382; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; EYLAR EH, 1969, ARCH BIOCHEM BIOPHYS, V132, P34, DOI 10.1016/0003-9861(69)90336-1; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Gai WP, 2000, EXP NEUROL, V166, P324, DOI 10.1006/exnr.2000.7527; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Hamilton JA, 1999, PROSTAG LEUKOTR ESS, V60, P291, DOI 10.1016/S0952-3278(99)80002-7; Hamilton JA, 1999, DIABETES, V48, P2255, DOI 10.2337/diabetes.48.12.2255; Hashimoto M, 2001, NEURON, V32, P213, DOI 10.1016/S0896-6273(01)00462-7; JAGER WAD, 1969, ARCH NEUROL-CHICAGO, V21, P615; Kahle PJ, 2001, AM J PATHOL, V159, P2215, DOI 10.1016/S0002-9440(10)63072-6; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; McLean PJ, 2000, J BIOL CHEM, V275, P8812, DOI 10.1074/jbc.275.12.8812; Nelson SO, 2000, IEEE INSTRU MEAS MAG, V3, P17, DOI 10.1109/5289.823818; OSHIRO Y, 1970, ARCH BIOCHEM BIOPHYS, V138, P392, DOI 10.1016/0003-9861(70)90361-9; Perrin RJ, 2000, J BIOL CHEM, V275, P34393, DOI 10.1074/jbc.M004851200; Perrin RJ, 2001, J BIOL CHEM, V276, P41958, DOI 10.1074/jbc.M105022200; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; RICHIERI GV, 1992, J BIOL CHEM, V267, P23495; SCHAFFER JE, 1994, CELL, V79, P427, DOI 10.1016/0092-8674(94)90252-6; Sharon R, 2001, P NATL ACAD SCI USA, V98, P9110, DOI 10.1073/pnas.171300598; Souza JM, 2000, FEBS LETT, V474, P116, DOI 10.1016/S0014-5793(00)01563-5; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; SPILLANTINI MG, 1997, NATURE, V388, P389; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600; Zimmer L, 2000, NEUROSCI LETT, V284, P25, DOI 10.1016/S0304-3940(00)00950-2; Zimmer L, 1998, NEUROSCI LETT, V240, P177, DOI 10.1016/S0304-3940(97)00938-5	37	438	451	0	37	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 20	2003	37	4					583	595		10.1016/S0896-6273(03)00024-2	http://dx.doi.org/10.1016/S0896-6273(03)00024-2			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	648EH	12597857	Bronze			2022-12-24	WOS:000181136500008
J	Lloyd, DM; Shore, DI; Spence, C; Calvert, GA				Lloyd, DM; Shore, DI; Spence, C; Calvert, GA			Multisensory representation of limb position in human premotor cortex	NATURE NEUROSCIENCE			English	Article							VIBROTACTILE REACTION-TIMES; HAND; TOUCH; ARM		McMaster Univ, Dept Psychol, Hamilton, ON L8S 4K1, Canada; John Radcliffe Hosp, FMRIB Ctr, Oxford OX3 9DU, England; Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; Univ Oxford, Physiol Lab, Oxford OX1 3PT, England	McMaster University; University of Oxford; University of Oxford; University of Oxford	Shore, DI (corresponding author), McMaster Univ, Dept Psychol, Hamilton, ON L8S 4K1, Canada.		Shore, David I/F-5109-2010	Lloyd, Donna/0000-0003-3589-7383; Calvert, Gemma/0000-0002-5487-8076				Beltramello A, 1998, ITAL J NEUROL SCI, V19, P277, DOI 10.1007/BF00713853; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; BRADSHAW JL, 1988, CAN J PSYCHOL, V42, P44, DOI 10.1037/h0084178; Graziano MSA, 1999, P NATL ACAD SCI USA, V96, P10418, DOI 10.1073/pnas.96.18.10418; Groh JM, 1996, J NEUROPHYSIOL, V75, P412, DOI 10.1152/jn.1996.75.1.412; Ladavas E, 2000, EXP BRAIN RES, V131, P458, DOI 10.1007/s002219900264; Obayashi S, 2000, NEUROREPORT, V11, P3499, DOI 10.1097/00001756-200011090-00020; Pavani F, 2000, PSYCHOL SCI, V11, P353, DOI 10.1111/1467-9280.00270; PIERSONSAVAGE JM, 1988, BRAIN, V111, P1531, DOI 10.1093/brain/111.6.1531; Rizzolatti G, 2002, CURR OPIN NEUROBIOL, V12, P149, DOI 10.1016/S0959-4388(02)00308-2; Shore DI, 2002, COGNITIVE BRAIN RES, V14, P153, DOI 10.1016/S0926-6410(02)00070-8; Spence C, 2001, PSYCHOL SCI, V12, P90, DOI 10.1111/1467-9280.00316; Wolpert DM, 1998, NAT NEUROSCI, V1, P529, DOI 10.1038/2245; Yamamoto S, 2001, NAT NEUROSCI, V4, P759, DOI 10.1038/89559	14	170	172	0	19	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2003	6	1					17	18		10.1038/nn991	http://dx.doi.org/10.1038/nn991			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	630CE	12483217				2022-12-24	WOS:000180089300009
J	Larocque, D; Pilotte, J; Chen, TP; Cloutier, F; Massie, B; Pedraza, L; Couture, R; Lasko, P; Almazan, G; Richard, S				Larocque, D; Pilotte, J; Chen, TP; Cloutier, F; Massie, B; Pedraza, L; Couture, R; Lasko, P; Almazan, G; Richard, S			Nuclear retention of MBP mRNAs in the Quaking viable mice	NEURON			English	Article							MYELIN BASIC-PROTEIN; RNA-BINDING PROTEIN; DYSMYELINATING MUTANT MICE; CENTRAL-NERVOUS-SYSTEM; EMBRYONIC LETHAL MUTATIONS; MESSENGER-RNA; SIGNAL-TRANSDUCTION; CAENORHABDITIS-ELEGANS; ABNORMAL EXPRESSION; PROTEOLIPID PROTEIN	Quaking viable (qk(v)) mice fail to properly compact myelin in their central nervous systems. Although the defect in the qkv mice involves a mutation affecting the expression of the alternatively spliced qk gene products, their roles in myelination are unknown. We show that the QKI RNA binding proteins regulate the nuclear export of MBP mRNAs. Disruption of the QKI nucleocytoplasmic equilibrium in oligodendrocytes results in nuclear and perikaryal retention of the MBP mRNAs and lack of export to cytoplasmic processes, as it occurs in qkv mice. MBP mRNA export defect leads to a reduction in the MBP levels and their improper cellular targeting to the periphery. Our findings suggest that OKI participates in myelination by regulating the mRNA export of key protein components.	McGill Univ, Terry Fox Mol Oncol Grp, Montreal, PQ H3T 1E2, Canada; McGill Univ, Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Bloomfield Ctr Res Aging, Montreal, PQ H3T 1E2, Canada; McGill Univ, Dept Oncol, Montreal, PQ H3T 1E2, Canada; McGill Univ, Dept Med, Montreal, PQ H3T 1E2, Canada; McGill Univ, Dept Microbiol, Montreal, PQ H3T 1E2, Canada; McGill Univ, Dept Immunol, Montreal, PQ H3T 1E2, Canada; Univ Montreal, Fac Med, Dept Physiol, Montreal, PQ H3C 3J7, Canada; Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada; Mt Sinai Sch Med, Dept Neurol, Corinne Goldsmith Dickinson Ctr Multiple Sclerosi, New York, NY 10029 USA; Mt Sinai Sch Med, Dept Biochem, New York, NY 10029 USA; Mt Sinai Sch Med, Dept Mol Biol, New York, NY 10029 USA; Mt Sinai Sch Med, Fishberg Ctr Neurobiol, New York, NY 10029 USA; McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 1B1, Canada; McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada	McGill University; Lady Davis Institute; McGill University; McGill University; McGill University; McGill University; McGill University; Universite de Montreal; National Research Council Canada; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; McGill University; McGill University; McGill University	Richard, S (corresponding author), McGill Univ, Terry Fox Mol Oncol Grp, Montreal, PQ H3T 1E2, Canada.		Lasko, Paul/C-6761-2014	Lasko, Paul/0000-0002-4037-3501				Ainger K, 1997, J CELL BIOL, V138, P1077, DOI 10.1083/jcb.138.5.1077; AINGER K, 1993, J CELL BIOL, V123, P431, DOI 10.1083/jcb.123.2.431; ALLINQUANT B, 1991, J CELL BIOL, V113, P393, DOI 10.1083/jcb.113.2.393; ALMAZAN G, 1993, J NEUROSCI RES, V36, P163, DOI 10.1002/jnr.490360206; [Anonymous], MYELIN; Baehrecke EH, 1997, DEVELOPMENT, V124, P1323; Barbarese E, 1999, J NEUROCYTOL, V28, P263, DOI 10.1023/A:1007097226688; BARBARESE E, 1991, J NEUROSCI RES, V29, P271, DOI 10.1002/jnr.490290302; BARTOSZEWICZ ZP, 1995, J NEUROSCI RES, V41, P27, DOI 10.1002/jnr.490410105; Bo L, 1995, J CELL BIOL, V131, P1811, DOI 10.1083/jcb.131.6.1811; BODE VC, 1984, GENETICS, V108, P457; BRAUN PE, 1990, DEV NEUROSCI-BASEL, V12, P286, DOI 10.1159/000111857; BROSTOFF SW, 1977, BRAIN RES, V120, P517, DOI 10.1016/0006-8993(77)90404-8; CAMPAGNONI AT, 1990, ANN NY ACAD SCI, V605, P270, DOI 10.1111/j.1749-6632.1990.tb42400.x; CARNOW TB, 1984, DEV BIOL, V106, P38, DOI 10.1016/0012-1606(84)90058-7; Carson JH, 2001, CURR OPIN NEUROBIOL, V11, P558, DOI 10.1016/S0959-4388(00)00249-X; Chen TP, 1998, MOL CELL BIOL, V18, P4863, DOI 10.1128/MCB.18.8.4863; COLMAN DR, 1982, J CELL BIOL, V95, P598, DOI 10.1083/jcb.95.2.598; Cox RD, 1999, GENOMICS, V57, P333, DOI 10.1006/geno.1999.5804; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; DEFERRA F, 1985, CELL, V43, P721, DOI 10.1016/0092-8674(85)90245-4; DELASSALLE A, 1981, J NEUROSCI RES, V6, P303, DOI 10.1002/jnr.490060305; Ebersole TA, 1996, NAT GENET, V12, P260, DOI 10.1038/ng0396-260; FRAIL DE, 1985, J NEUROCHEM, V45, P1071, DOI 10.1111/j.1471-4159.1985.tb05525.x; FUJITA N, 1990, J NEUROCHEM, V55, P1056, DOI 10.1111/j.1471-4159.1990.tb04596.x; HAN JR, 1995, P NATL ACAD SCI USA, V92, P9550, DOI 10.1073/pnas.92.21.9550; Hardy RJ, 1998, J NEUROSCI RES, V51, P417, DOI 10.1002/(SICI)1097-4547(19980215)51:4<417::AID-JNR1>3.0.CO;2-F; Hardy RJ, 1996, J NEUROSCI RES, V46, P246, DOI 10.1002/(SICI)1097-4547(19961015)46:2<246::AID-JNR13>3.0.CO;2-0; Hardy RJ, 1996, J NEUROSCI, V16, P7941; Hoek KS, 1998, BIOCHEMISTRY-US, V37, P7021, DOI 10.1021/bi9800247; Jan E, 1999, EMBO J, V18, P258, DOI 10.1093/emboj/18.1.258; JONES AR, 1995, GENE DEV, V9, P1491, DOI 10.1101/gad.9.12.1491; JUSTICE MJ, 1988, GENET RES, V51, P95, DOI 10.1017/S0016672300024101; Kiebler MA, 2000, NEURON, V25, P19, DOI 10.1016/S0896-6273(00)80868-5; Kuo H, 1995, BRAIN RES, V705, P31, DOI 10.1016/0006-8993(95)01065-3; LAWRENCE JB, 1986, CELL, V45, P407, DOI 10.1016/0092-8674(86)90326-0; Lee MH, 2001, GENE DEV, V15, P2408, DOI 10.1101/gad.915901; Li ZZ, 2000, J NEUROSCI, V20, P4944; LUBETZKI C, 1991, J NEUROCHEM, V56, P671, DOI 10.1111/j.1471-4159.1991.tb08202.x; Massie B, 1998, J VIROL, V72, P2289, DOI 10.1128/JVI.72.3.2289-2296.1998; Massie B, 1998, CYTOTECHNOLOGY, V28, P53, DOI 10.1023/A:1008013211222; Mezquita J, 1998, MOL REPROD DEV, V50, P70, DOI 10.1002/(SICI)1098-2795(199805)50:1&lt;70::AID-MRD9&gt;3.0.CO;2-U; Michael WM, 1997, EMBO J, V16, P3587, DOI 10.1093/emboj/16.12.3587; Nabel-Rosen H, 1999, MOL CELL, V4, P573, DOI 10.1016/S1097-2765(00)80208-7; Nabel-Rosen H, 2002, DEV CELL, V2, P183, DOI 10.1016/S1534-5807(01)00118-6; Pedraza L, 1997, NEURON, V18, P579, DOI 10.1016/S0896-6273(00)80299-8; Pilotte J, 2001, GENE DEV, V15, P845, DOI 10.1101/gad.860301; Saccomanno L, 1999, P NATL ACAD SCI USA, V96, P12605, DOI 10.1073/pnas.96.22.12605; SHEDLOVSKY A, 1988, P NATL ACAD SCI USA, V85, P180, DOI 10.1073/pnas.85.1.180; SIDMAN RL, 1964, SCIENCE, V144, P309, DOI 10.1126/science.144.3616.309; SORG BA, 1987, J NEUROCHEM, V49, P1146, DOI 10.1111/j.1471-4159.1987.tb10005.x; SORG BJA, 1986, J NEUROCHEM, V46, P379, DOI 10.1111/j.1471-4159.1986.tb12979.x; Tanaka H, 1997, MECH DEVELOP, V69, P209, DOI 10.1016/S0925-4773(97)00164-0; TRAPP BD, 1984, J CELL BIOL, V99, P594, DOI 10.1083/jcb.99.2.594; VERITY AN, 1988, J NEUROSCI RES, V21, P238, DOI 10.1002/jnr.490210216; Vernet C, 1997, TRENDS GENET, V13, P479, DOI 10.1016/S0168-9525(97)01269-9; Wu HY, 2001, MOL CELL NEUROSCI, V17, P292, DOI 10.1006/mcne.2000.0941; Wu J, 1999, J BIOL CHEM, V274, P29202, DOI 10.1074/jbc.274.41.29202; Wu JI, 2002, P NATL ACAD SCI USA, V99, P4233, DOI 10.1073/pnas.072090399; Wu XQ, 2000, BIOL REPROD, V62, P720, DOI 10.1095/biolreprod62.3.720; Zaffran S, 1997, DEVELOPMENT, V124, P2087; Zhang YY, 2001, J NEUROCHEM, V77, P165, DOI 10.1046/j.1471-4159.2001.00224.x; Zorn AM, 1997, GENE, V188, P199, DOI 10.1016/S0378-1119(96)00795-0	63	130	132	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 5	2002	36	5					815	829		10.1016/S0896-6273(02)01055-3	http://dx.doi.org/10.1016/S0896-6273(02)01055-3			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	622VL	12467586	Bronze			2022-12-24	WOS:000179667800007
J	Stettler, DD; Das, A; Bennett, J; Gilbert, CD				Stettler, DD; Das, A; Bennett, J; Gilbert, CD			Lateral connectivity and contextual interactions in macaque primary visual cortex	NEURON			English	Article							SQUIRREL-MONKEY SAIMIRI; CAT STRIATE CORTEX; CLASSICAL RECEPTIVE-FIELD; OCULAR DOMINANCE COLUMNS; INVIVO GENE-TRANSFER; HORIZONTAL CONNECTIONS; INTRINSIC CONNECTIONS; CORTICOCORTICAL CONNECTIONS; FUNCTIONAL ARCHITECTURE; ALERT MONKEYS	Two components of cortical circuits could mediate contour integration in primary visual cortex (V1): intrinsic horizontal connections and feedback from higher cortical areas. To distinguish between these, we combined functional mapping with a new technique for labeling axons, a recombinant adenovirus bearing the gene for green fluorescent protein (GFP), to determine the extent, density, and orientation specificity of V1 intrinsic connections and V2 to V1 feedback. Both connections cover portions of V1 representing regions of visual space up to eight times larger than receptive fields as classically defined, though the intrinsic connections are an order of magnitude denser than the feedback. Whereas the intrinsic connections link similarly oriented domains in V1, V2 to V1 feedback displays no such specificity. These findings suggest that V1 intrinsic horizontal connections provide a more likely substrate for contour integration.	Rockefeller Univ, New York, NY 10021 USA; Univ Penn, Kirby Ctr Mol Ophthalmol, Philadelphia, PA 19104 USA	Rockefeller University; University of Pennsylvania; Pennsylvania Medicine	Gilbert, CD (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.				NEI NIH HHS [EY07968] Funding Source: Medline; NIGMS NIH HHS [5T32 GM07524] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY007968] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007524] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKLI S, 1993, NAT GENET, V3, P224, DOI 10.1038/ng0393-224; ALLMAN J, 1985, ANNU REV NEUROSCI, V8, P407, DOI 10.1146/annurev.ne.08.030185.002203; ALLMAN J, 1985, PERCEPTION, V14, P105, DOI 10.1068/p140105; AMIR Y, 1993, J COMP NEUROL, V334, P19, DOI 10.1002/cne.903340103; BAJOCCHI G, 1993, NAT GENET, V3, P229, DOI 10.1038/ng0393-229; Blasdel G, 2001, J NEUROSCI, V21, P8286, DOI 10.1523/JNEUROSCI.21-20-08286.2001; Bosking WH, 1997, J NEUROSCI, V17, P2112; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; CHINO YM, 1992, VISION RES, V32, P789, DOI 10.1016/0042-6989(92)90021-A; Chklovskii DB, 2000, VISION RES, V40, P1765, DOI 10.1016/S0042-6989(00)00023-7; Crist RE, 2001, NAT NEUROSCI, V4, P519, DOI 10.1038/87470; DARIANSMITH C, 1995, J NEUROSCI, V15, P1631, DOI 10.1523/JNEUROSCI.15-03-01631.1995; DARIANSMITH C, 1994, NATURE, V368, P737, DOI 10.1038/368737a0; DAS A, 1995, J NEUROPHYSIOL, V74, P779, DOI 10.1152/jn.1995.74.2.779; DAS A, 1995, NATURE, V375, P780, DOI 10.1038/375780a0; DAS A, 1997, NATURE, V317, P58; DAVIDSON BL, 1993, NAT GENET, V3, P219, DOI 10.1038/ng0393-219; DRESP B, 1993, SPATIAL VISION, V7, P213, DOI 10.1163/156856893X00379; FIELD DJ, 1993, VISION RES, V33, P173, DOI 10.1016/0042-6989(93)90156-Q; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; Gattass R, 1997, CEREB CORTEX, V7, P110, DOI 10.1093/cercor/7.2.110; Geisler WS, 2001, VISION RES, V41, P711, DOI 10.1016/S0042-6989(00)00277-7; Gilbert C, 2000, VISION RES, V40, P1217, DOI 10.1016/S0042-6989(99)00234-5; GILBERT CD, 1989, J NEUROSCI, V9, P2432; GILBERT CD, 1990, COLD SPRING HARB SYM, V55, P663; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; GILBERT CD, 1990, VISION RES, V30, P1689, DOI 10.1016/0042-6989(90)90153-C; GILBERT CD, 1992, NATURE, V356, P150, DOI 10.1038/356150a0; GILBERT CD, 1983, J NEUROSCI, V3, P1116; GULYAS B, 1987, J NEUROPHYSIOL, V57, P1767, DOI 10.1152/jn.1987.57.6.1767; HEINEN SJ, 1991, EXP BRAIN RES, V83, P670; HENRY GH, 1991, EUR J NEUROSCI, V3, P186, DOI 10.1111/j.1460-9568.1991.tb00079.x; HIRSCH JA, 1991, J NEUROSCI, V11, P1800; HUBEL DH, 1977, BRAIN RES, V122, P336, DOI 10.1016/0006-8993(77)90299-2; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; Hupe JM, 2001, J NEUROPHYSIOL, V85, P134, DOI 10.1152/jn.2001.85.1.134; Ito M, 1999, NEURON, V22, P593, DOI 10.1016/S0896-6273(00)80713-8; KAAS JH, 1990, SCIENCE, V248, P229, DOI 10.1126/science.2326637; Kapadia MK, 2000, J NEUROPHYSIOL, V84, P2048, DOI 10.1152/jn.2000.84.4.2048; Kapadia MK, 1999, P NATL ACAD SCI USA, V96, P12073, DOI 10.1073/pnas.96.21.12073; KAPADIA MK, 1995, NEURON, V15, P843, DOI 10.1016/0896-6273(95)90175-2; Kinoshita M, 2001, J NEUROPHYSIOL, V86, P2559, DOI 10.1152/jn.2001.86.5.2559; Kisvarday ZF, 1997, CEREB CORTEX, V7, P605, DOI 10.1093/cercor/7.7.605; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; Lamme VAF, 1999, CEREB CORTEX, V9, P406, DOI 10.1093/cercor/9.4.406; LAMME VAF, 1995, J NEUROSCI, V15, P1605; Lamme VAF, 1998, P NATL ACAD SCI USA, V95, P3263, DOI 10.1073/pnas.95.6.3263; Lee TS, 1998, VISION RES, V38, P2429, DOI 10.1016/S0042-6989(97)00464-1; LEVAY S, 1975, J COMP NEUROL, V159, P559, DOI 10.1002/cne.901590408; Levitt JB, 1997, NATURE, V387, P73, DOI 10.1038/387073a0; LI W, 2002, IN PRESS J NEUROPHYS; MacEvoy SP, 1998, NAT NEUROSCI, V1, P616, DOI 10.1038/2849; MAFFEI L, 1976, VISION RES, V16, P1131, DOI 10.1016/0042-6989(76)90253-4; MALACH R, 1993, P NATL ACAD SCI USA, V90, P10469, DOI 10.1073/pnas.90.22.10469; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; NELSON JI, 1985, EXP BRAIN RES, V61, P54; PERKEL DJ, 1986, J COMP NEUROL, V253, P374, DOI 10.1002/cne.902530307; PETTET MW, 1992, P NATL ACAD SCI USA, V89, P8366, DOI 10.1073/pnas.89.17.8366; POLAT U, 1993, VISION RES, V33, P993, DOI 10.1016/0042-6989(93)90081-7; POLAT U, 1994, VISION RES, V34, P73, DOI 10.1016/0042-6989(94)90258-5; RAMACHANDRAN VS, 1991, NATURE, V350, P699, DOI 10.1038/350699a0; ROCKLAND KS, 1989, J COMP NEUROL, V285, P54, DOI 10.1002/cne.902850106; ROCKLAND KS, 1981, BRAIN RES, V212, P249, DOI 10.1016/0006-8993(81)90461-3; ROCKLAND KS, 1982, SCIENCE, V215, P1532, DOI 10.1126/science.7063863; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; ROSSI AF, 1996, SCIENCE, V273, P1391; SALIN PA, 1992, J COMP NEUROL, V320, P415, DOI 10.1002/cne.903200402; SALIN PA, 1989, J COMP NEUROL, V283, P486, DOI 10.1002/cne.902830405; Sceniak MP, 1999, NAT NEUROSCI, V2, P733, DOI 10.1038/11197; Schmidt KE, 1997, J NEUROSCI, V17, P5480; Sigman M, 2001, P NATL ACAD SCI USA, V98, P1935, DOI 10.1073/pnas.031571498; SILLITO AM, 1995, NATURE, V378, P492, DOI 10.1038/378492a0; Sincich LC, 2001, J NEUROSCI, V21, P4416, DOI 10.1523/JNEUROSCI.21-12-04416.2001; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; SOUSA APB, 1991, J COMP NEUROL, V308, P665, DOI 10.1002/cne.903080411; SYMONDS LL, 1984, J COMP NEUROL, V229, P1, DOI 10.1002/cne.902290103; TIGGES J, 1973, J COMP NEUROL, V148, P481, DOI 10.1002/cne.901480406; TIGGES J, 1974, J COMP NEUROL, V158, P219, DOI 10.1002/cne.901580208; TIGGES J, 1981, J COMP NEUROL, V202, P539, DOI 10.1002/cne.902020407; TOOTELL RBH, 1988, J NEUROSCI, V8, P1531; Toth LJ, 1996, P NATL ACAD SCI USA, V93, P9869, DOI 10.1073/pnas.93.18.9869; TSO DY, 1986, J NEUROSCI, V6, P1160; ULLMAN S, 1990, COLD SH Q B, V55, P889; WELIKY M, 1995, NEURON, V15, P541, DOI 10.1016/0896-6273(95)90143-4; WELLER RE, 1983, J COMP NEUROL, V220, P253, DOI 10.1002/cne.902200302; WERTHEIMER G, 1938, LAWS ORG PERCEPTUAL; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; WONGRILEY M, 1978, BRAIN RES, V147, P159, DOI 10.1016/0006-8993(78)90781-3; WONGRILEY M, 1979, BRAIN RES, V162, P201, DOI 10.1016/0006-8993(79)90284-1; Yoshioka T, 1996, CEREB CORTEX, V6, P297, DOI 10.1093/cercor/6.2.297; Zipser K, 1996, J NEUROSCI, V16, P7376	92	333	335	1	23	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 14	2002	36	4					739	750		10.1016/S0896-6273(02)01029-2	http://dx.doi.org/10.1016/S0896-6273(02)01029-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	616PX	12441061	Bronze			2022-12-24	WOS:000179313100019
J	Ledda, F; Paratcha, G; Ibanez, CF				Ledda, F; Paratcha, G; Ibanez, CF			Target-derived GFR alpha 1 as an attractive guidance signal for developing sensory and sympathetic axons via activation of Cdk5	NEURON			English	Article							MICE LACKING GDNF; RECEPTOR TYROSINE KINASE; ENTERIC NERVOUS-SYSTEM; C-RET PROTOONCOGENE; INDUCED CELL-DEATH; NEURONS IN-VIVO; NEUROTROPHIC FACTOR; SURVIVAL FACTOR; GROWTH-FACTOR; LIPID RAFTS	Immobilized and diffusible molecular cues regulate axon guidance during development. GFRalpha1, a GPI-anchored receptor for GDNF, is expressed as both membrane bound and secreted forms by accessory nerve cells and peripheral targets of developing sensory and sympathetic neurons during the period of target innervation. A relative deficit of GFRalpha1 in developing axons allows exogenous GFRalpha1 to capture GDNF and present it for recognition by axonal c-Ret receptors. Exogenous GFRalpha1 potentiates neurite outgrowth and acts as a long-range directional cue by creating positional information for c-Ret-expressing axons in the presence of a uniform concentration of GDNF. Soluble GFRalpha1 prolongs GDNF-mediated activation of cyclin-dependent kinase 5 (Cdk5), an event required for GFRalpha1-induced neurite outgrowth and axon guidance. Together with GDNF, target-derived GFRalpha1 can function in a non-cell-autonomous fashion as a chemoattractant cue with outgrowth promoting activity for peripheral neurons.	Karolinska Inst, Dept Neurosci, Div Mol Neurobiol, S-17177 Stockholm, Sweden	Karolinska Institutet	Ibanez, CF (corresponding author), Karolinska Inst, Dept Neurosci, Div Mol Neurobiol, S-17177 Stockholm, Sweden.							Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Alcantara S, 2000, DEVELOPMENT, V127, P1359; Arenas E, 1995, NEURON, V15, P1465, DOI 10.1016/0896-6273(95)90024-1; BUJBELLO A, 1995, NEURON, V15, P821, DOI 10.1016/0896-6273(95)90173-6; Cacalano G, 1998, NEURON, V21, P53, DOI 10.1016/S0896-6273(00)80514-0; CAMPENOT RB, 1992, CELL CELL INTERACTIO, P275; Connell-Crowley L, 2000, CURR BIOL, V10, P599, DOI 10.1016/S0960-9822(00)00487-5; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Durbec P, 1996, NATURE, V381, P789, DOI 10.1038/381789a0; EBENDAL T, 1989, NERVE GROWTH FACTORS, P81; Enomoto H, 2001, DEVELOPMENT, V128, P3963; Enomoto H, 1998, NEURON, V21, P317, DOI 10.1016/S0896-6273(00)80541-3; Erickson JT, 2001, J NEUROSCI, V21, P581, DOI 10.1523/JNEUROSCI.21-02-00581.2001; Fundin BT, 1999, DEVELOPMENT, V126, P2597; Ha DH, 1996, J COMP NEUROL, V373, P451; Harada T, 2001, NAT CELL BIOL, V3, P453, DOI 10.1038/35074516; Hashino E, 2001, DEVELOPMENT, V128, P3773; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; Klein RD, 1997, NATURE, V387, P717, DOI 10.1038/42722; LI LX, 1995, P NATL ACAD SCI USA, V92, P9771, DOI 10.1073/pnas.92.21.9771; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; MOUNT HTJ, 1995, P NATL ACAD SCI USA, V92, P9092, DOI 10.1073/pnas.92.20.9092; Naveilhan P, 1997, EUR J NEUROSCI, V9, P1450, DOI 10.1111/j.1460-9568.1997.tb01499.x; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; Nosrat CA, 1996, CELL TISSUE RES, V286, P191, DOI 10.1007/s004410050688; OPPENHEIM RW, 1995, NATURE, V373, P344, DOI 10.1038/373344a0; Paratcha G, 2001, NEURON, V29, P171, DOI 10.1016/S0896-6273(01)00188-X; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; Sanicola M, 1997, P NATL ACAD SCI USA, V94, P6238, DOI 10.1073/pnas.94.12.6238; Tansey MG, 2000, NEURON, V25, P611, DOI 10.1016/S0896-6273(00)81064-8; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; Trupp M, 1999, J BIOL CHEM, V274, P20885, DOI 10.1074/jbc.274.30.20885; TRUPP M, 1995, J CELL BIOL, V130, P137, DOI 10.1083/jcb.130.1.137; Trupp M, 1996, NATURE, V381, P785, DOI 10.1038/381785a0; Trupp M, 1998, MOL CELL NEUROSCI, V11, P47, DOI 10.1006/mcne.1998.0667; Trupp M, 1997, J NEUROSCI, V17, P3554; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Wang LC, 1996, NEURON, V17, P849, DOI 10.1016/S0896-6273(00)80217-2; WHITE LA, 1994, J NEUROSCI, V14, P6744; Worley DS, 2000, DEVELOPMENT, V127, P4383; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; Young HM, 2001, DEV BIOL, V229, P503, DOI 10.1006/dbio.2000.0100; Yu T, 1998, J NEUROSCI, V18, P4684	47	92	96	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 24	2002	36	3					387	401		10.1016/S0896-6273(02)01002-4	http://dx.doi.org/10.1016/S0896-6273(02)01002-4			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	608ZE	12408843	Bronze			2022-12-24	WOS:000178877700009
J	Sasaki, Y; Murakami, I; Cavanagh, P; Tootell, RHB				Sasaki, Y; Murakami, I; Cavanagh, P; Tootell, RHB			Human brain activity during illusory visual jitter as revealed by functional magnetic resonance imaging	NEURON			English	Article							RAT FOREPAW STIMULATION; SURFACE-BASED ANALYSIS; HUMAN CEREBRAL-CORTEX; AREA MT; EYE-MOVEMENTS; MACAQUE MONKEY; BLOOD-FLOW; MOTION; V1; ACTIVATION	One central problem in vision is how to compensate for retinal slip. A novel illusion (visual jitter) suggests the compensation mechanism is based solely on retinal motion. Adaptation to visual noise attenuates the motion signals used by the compensation stage, producing illusory jitter due to the undercompensation of retinal slip. Here, we investigated the neural substrate of retinal slip compensation during this illusion using high-field fMRI and retinotopic mapping in flattened cortical format. When jitter perception occurred, MR signal decreased in lower stages of the visual system but increased prominently in area MT+. In conclusion, visual areas as early as V1 are responsible for the adaptation stage, and MT+ is involved in the compensation stage. The present finding suggests the pathway from V1 to MT+ has an important role in stabilizing the visual world.	Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA; NTT Corp, NTT Commun Sci Labs, Human & Informat Sci Lab, Kanagawa 2430198, Japan; Harvard Univ, Dept Psychol, Vis Sci Lab, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Nippon Telegraph & Telephone Corporation; Harvard University	Sasaki, Y (corresponding author), Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, 149 13th St, Charlestown, MA 02129 USA.			Sasaki, Yuka/0000-0002-0061-0250	NEI NIH HHS [EY07980] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY007980] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALLMAN J, 1985, PERCEPTION, V14, P105, DOI 10.1068/p140105; Beauchamp MS, 1997, J NEUROPHYSIOL, V78, P516, DOI 10.1152/jn.1997.78.1.516; Born RT, 2000, NEURON, V26, P725, DOI 10.1016/S0896-6273(00)81208-8; BORN RT, 1992, NATURE, V357, P497, DOI 10.1038/357497a0; BOUSSAOUD D, 1991, J COMP NEUROL, V306, P554, DOI 10.1002/cne.903060403; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Culham JC, 1999, J NEUROPHYSIOL, V81, P388, DOI 10.1152/jn.1999.81.1.388; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DALE AM, 1997, HUM BRAIN MAPP, V5, P326; Demb JB, 1998, J NEUROSCI, V18, P6939; Demb JB, 1997, P NATL ACAD SCI USA, V94, P13363, DOI 10.1073/pnas.94.24.13363; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; DEYOE EA, 1994, J NEUROSCI METH, V54, P171, DOI 10.1016/0165-0270(94)90191-0; DUPONT P, 1994, J NEUROPHYSIOL, V72, P1420, DOI 10.1152/jn.1994.72.3.1420; Eden GF, 1996, NATURE, V382, P66, DOI 10.1038/382066a0; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; GALLETTI C, 1984, BRAIN RES, V301, P95, DOI 10.1016/0006-8993(84)90406-2; GATTASS R, 1988, J NEUROSCI, V8, P1831; Gur M, 1997, J NEUROSCI, V17, P2914; GUR M, 1987, VISION RES, V27, P2081, DOI 10.1016/0042-6989(87)90122-2; Gur M, 1997, VISION RES, V37, P257, DOI 10.1016/S0042-6989(96)00182-4; Hadjikhani N, 1998, NAT NEUROSCI, V1, P235, DOI 10.1038/681; He S, 1998, CURR BIOL, V8, P1215, DOI 10.1016/S0960-9822(07)00512-X; Hoge RD, 1999, NEUROIMAGE, V9, P573, DOI 10.1006/nimg.1999.0443; Huk AC, 2001, NEURON, V32, P161, DOI 10.1016/S0896-6273(01)00452-4; Hupe JM, 1998, NATURE, V394, P784, DOI 10.1038/29537; IBBOTSON MR, 1994, EXP BRAIN RES, V99, P148; Ilg UJ, 1996, EUR J NEUROSCI, V8, P1156; Kourtzi Z, 2000, J COGNITIVE NEUROSCI, V12, P48, DOI 10.1162/08989290051137594; Kruger G, 1999, NEUROREPORT, V10, P2939; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Leopold DA, 1998, EXP BRAIN RES, V123, P341, DOI 10.1007/s002210050577; Mandeville JB, 1999, J CEREBR BLOOD F MET, V19, P679, DOI 10.1097/00004647-199906000-00012; Mandeville JB, 1999, MAGN RESON MED, V42, P944, DOI 10.1002/(SICI)1522-2594(199911)42:5<944::AID-MRM15>3.0.CO;2-W; Mandeville JB, 1998, MAGNET RESON MED, V39, P615, DOI 10.1002/mrm.1910390415; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; McCarthy G., 1994, HUM BRAIN MAPP, V2, P234, DOI [10.1002/hbm.460020405, DOI 10.1002/HBM.460020405]; Mendola JD, 1999, J NEUROSCI, V19, P8560; Murakami I, 2001, VISION RES, V41, P173, DOI 10.1016/S0042-6989(00)00237-6; MURAKAMI I, 1995, VISION RES, V35, P1041, DOI 10.1016/0042-6989(94)00201-V; Murakami I, 1998, NATURE, V395, P798, DOI 10.1038/27435; SCHNEIDER W, 1993, NATURE, V365, P150, DOI 10.1038/365150a0; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; Stein J, 1997, TRENDS NEUROSCI, V20, P147, DOI 10.1016/S0166-2236(96)01005-3; TANAKA K, 1986, J NEUROSCI, V6, P134; TOOTELL RBH, 1995, NATURE, V375, P139, DOI 10.1038/375139a0; Tootell RBH, 1998, TRENDS COGN SCI, V2, P174, DOI 10.1016/S1364-6613(98)01171-1; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; Tootell RBH, 2001, CEREB CORTEX, V11, P298, DOI 10.1093/cercor/11.4.298; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P811, DOI 10.1073/pnas.95.3.811; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P818, DOI 10.1073/pnas.95.3.818; Tootell RBH, 1997, J NEUROSCI, V17, P7060; WADE NJ, 1993, PERCEPTION, V22, P1365, DOI 10.1068/p221365; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; Wohlgemuth A., 1911, AFTER EFFECT SEEN MO, V1; ZEKI S, 1991, J NEUROSCI, V11, P641; ZEKI S, 1993, P ROY SOC B-BIOL SCI, V252, P215, DOI 10.1098/rspb.1993.0068	62	25	25	3	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 12	2002	35	6					1147	1156		10.1016/S0896-6273(02)00899-1	http://dx.doi.org/10.1016/S0896-6273(02)00899-1			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	594GC	12354403	Bronze			2022-12-24	WOS:000178040000014
J	Webster, MA; Georgeson, MA; Webster, SM				Webster, MA; Georgeson, MA; Webster, SM			Neural adjustments to image blur	NATURE NEUROSCIENCE			English	Article							CONTRAST CONSTANCY; PERCEIVED CONTRAST; NATURAL SCENES; HUMAN-VISION; SENSITIVITY; STATISTICS; ADAPTATION; COLOR		Univ Nevada, Dept Psychol, Reno, NV 89557 USA; Aston Univ, Neurosci Res Inst, Birmingham B4 7ET, W Midlands, England	Nevada System of Higher Education (NSHE); University of Nevada Reno; Aston University	Webster, MA (corresponding author), Univ Nevada, Dept Psychol, Reno, NV 89557 USA.			Webster, Michael/0000-0001-8262-7525; Georgeson, Mark/0000-0002-8173-9522	NEI NIH HHS [R01 EY010834, EY10834] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010834, R29EY010834] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BRADY N, 1995, VISION RES, V35, P739, DOI 10.1016/0042-6989(94)00172-I; BURTON GJ, 1987, APPL OPTICS, V26, P157, DOI 10.1364/AO.26.000157; CHUBB C, 1989, P NATL ACAD SCI USA, V86, P9631, DOI 10.1073/pnas.86.23.9631; DeValois RL, 1988, SPATIAL VISION; Field DJ, 1997, VISION RES, V37, P3367, DOI 10.1016/S0042-6989(97)00181-8; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; GEORGESON MA, 1975, J PHYSIOL-LONDON, V252, P627, DOI 10.1113/jphysiol.1975.sp011162; Graham N.V.S, 1989, VISUAL PATTERN ANAL; Mon-Williams M, 1998, P ROY SOC B-BIOL SCI, V265, P71, DOI 10.1098/rspb.1998.0266; PESUDOVS K, 1993, OPTOMETRY VISION SCI, V70, P528, DOI 10.1097/00006324-199307000-00002; TADMOR Y, 1994, VISION RES, V34, P541, DOI 10.1016/0042-6989(94)90167-8; WATT RJ, 1987, PATTERN RECOGN LETT, V5, P139, DOI 10.1016/0167-8655(87)90035-3; Webster MA, 1996, NETWORK-COMP NEURAL, V7, P587, DOI 10.1088/0954-898X/7/4/002; Webster MA, 1999, P SOC PHOTO-OPT INS, V3644, P58, DOI 10.1117/12.348468	14	196	209	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2002	5	9					839	840		10.1038/nn906	http://dx.doi.org/10.1038/nn906			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587RL	12195427				2022-12-24	WOS:000177656300011
J	Kaminker, JS; Canon, J; Salecker, I; Banerjee, U				Kaminker, JS; Canon, J; Salecker, I; Banerjee, U			Control of photoreceptor axon target choice by transcriptional repression of Runt	NATURE NEUROSCIENCE			English	Article							RETINAL AXONS; EPH RECEPTORS; GLIAL-CELLS; DROSOPHILA; GROWTH; GENE; HEMATOPOIESIS; DOWNSTREAM; BRAKELESS; GUIDANCE	Drosophila photoreceptor neurons (R cells) project their axons to one of two layers in the optic lobe, the lamina or the medulla. The transcription factor Runt (Run) is normally expressed in the two inner R cells (R7 and R8) that project their axons to the medulla. Here we examine the relationship between Run and the ubiquitously expressed nuclear protein Brakeless (Bks), which has previously been shown to be important for axon termination in the lamina. We report that Bks represses Run in two of the outer R cells: R2 and R5. Expression of Run in R2 and R5 causes axonal mistargeting of all six outer R cells (R1-R6) to the inappropriate layer, without altering expression of cell-specific developmental markers.	Univ Calif Los Angeles, Inst Mol Biol, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Dept Human Genet, Los Angeles, CA 90095 USA; Natl Inst Med Res, Div Mol Neurobiol, London NW7 1AA, England	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; MRC National Institute for Medical Research	Banerjee, U (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	banerjee@mbi.ucla.edu	Salecker, Iris/V-1228-2018	Salecker, Iris/0000-0003-3775-7763				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; BRAND AH, 1993, DEVELOPMENT, V118, P401; Campos-Ortega J, 1997, EMBRYONIC DEV DROSOP; Canon J, 2000, SEMIN CELL DEV BIOL, V11, P327, DOI 10.1006/scdb.2000.0185; Chisholm A, 1999, CURR OPIN NEUROBIOL, V9, P603, DOI 10.1016/S0959-4388(99)00021-5; Clandinin TR, 2000, NEURON, V28, P427, DOI 10.1016/S0896-6273(00)00122-7; Dokucu ME, 1996, DEVELOPMENT, V122, P4139; Downing JR, 2001, LEUKEMIA, V15, P664, DOI 10.1038/sj.leu.2402035; Erkman L, 2000, NEURON, V28, P779, DOI 10.1016/S0896-6273(00)00153-7; Frankfort BJ, 2001, NEURON, V32, P403, DOI 10.1016/S0896-6273(01)00480-9; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Hing H, 1999, CELL, V97, P853, DOI 10.1016/S0092-8674(00)80798-9; Huang Z, 1996, CELL, V86, P411, DOI 10.1016/S0092-8674(00)80114-2; Huang Z, 1998, CELL, V95, P693, DOI 10.1016/S0092-8674(00)81639-6; Kaminker JS, 2001, DEVELOPMENT, V128, P2639; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; KANIA MA, 1990, GENE DEV, V4, P1701, DOI 10.1101/gad.4.10.1701; Klein R, 2001, CURR OPIN CELL BIOL, V13, P196, DOI 10.1016/S0955-0674(00)00197-6; LEVANON D, IN PRESS EMBO J; Meinertzhagen I.A., 1991, P341; Mollereau B, 2001, NATURE, V412, P911, DOI 10.1038/35091076; Newsome TP, 2000, CELL, V101, P283, DOI 10.1016/S0092-8674(00)80838-7; Perez SE, 1996, J NEUROBIOL, V30, P359, DOI 10.1002/(SICI)1097-4695(199607)30:3<359::AID-NEU5>3.0.CO;2-3; Poeck B, 2001, NEURON, V29, P99, DOI 10.1016/S0896-6273(01)00183-0; Rao Y, 2000, P NATL ACAD SCI USA, V97, P5966, DOI 10.1073/pnas.110135297; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; Schmucker D, 2001, CELL, V105, P701, DOI 10.1016/S0092-8674(01)00391-9; Senti KA, 2000, DEVELOPMENT, V127, P2291; Speck NA, 1999, CANCER RES, V59, p1789S; Stoker AW, 2001, CURR OPIN NEUROBIOL, V11, P95, DOI 10.1016/S0959-4388(00)00179-3; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Thor S, 1999, NATURE, V397, P76, DOI 10.1038/16275; Tissot M, 1997, J NEUROBIOL, V32, P281, DOI 10.1002/(SICI)1097-4695(199703)32:3<281::AID-NEU3>3.0.CO;2-3; White NM, 2000, DEVELOPMENT, V127, P1681; WIJMENGA C, 1995, GENOMICS, V26, P611, DOI 10.1016/0888-7543(95)80185-O	35	49	49	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2002	5	8					746	750		10.1038/nn889	http://dx.doi.org/10.1038/nn889			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	577XT	12118258				2022-12-24	WOS:000177088900017
J	Panov, AV; Gutekunst, CA; Leavitt, BR; Hayden, MR; Burke, JR; Strittmatter, WJ; Greenamyre, JT				Panov, AV; Gutekunst, CA; Leavitt, BR; Hayden, MR; Burke, JR; Strittmatter, WJ; Greenamyre, JT			Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines	NATURE NEUROSCIENCE			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; MUTANT HUNTINGTIN; WILD-TYPE; CELLULAR TOXICITY; MOUSE MODEL; IN-VIVO; BRAIN; PROTEIN; TRANSCRIPTION; NEURODEGENERATION	Huntington's disease (HD) is caused by an expansion of exonic CAG triplet repeats in the gene encoding huntingtin protein (Htt), but the mechanisms by which this mutant protein causes neurodegeneration remain unknown. Here we show that lymphoblast mitochondria from patients with HD have a lower membrane potential and depolarize at lower calcium loads than do mitochondria from controls. We found a similar defect in brain mitochondria from transgenic mice expressing full-length mutant huntingtin, and this defect preceded the onset of pathological or behavioral abnormalities by months. By electron microscopy, we identified N-terminal mutant huntingtin on neuronal mitochondrial membranes, and by incubating normal mitochondria with a fusion protein containing an abnormally long polyglutamine repeat, we reproduced the mitochondrial calcium defect seen in human patients and transgenic animals. Thus, mitochondrial calcium abnormalities occur early in HD pathogenesis and may be a direct effect of mutant huntingtin on the organelle.	Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC V5C 4H4, Canada; Duke Univ, Med Ctr, Div Neurol, Durham, NC 27616 USA	Emory University; University of British Columbia; Duke University	Greenamyre, JT (corresponding author), Emory Univ, Sch Med, Dept Neurol, Whitehead Biomed Res Bldg,615 Michael St, Atlanta, GA 30322 USA.		Leavitt, Blair R/G-1934-2012; Greenamyre, J. Timothy/B-4049-2011; Hayden, Michael R/D-8581-2011; Burke, James R/E-4245-2016	Hayden, Michael R/0000-0001-5159-1419; Burke, James R/0000-0002-3408-7787; Greenamyre, J. Timothy/0000-0003-3468-7878	NATIONAL INSTITUTE ON AGING [R01AG014648] Funding Source: NIH RePORTER; NIA NIH HHS [AG14648] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BEAL MF, 1995, ANN NEUROL, V38, P357, DOI 10.1002/ana.410380304; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Cattaneo E, 2001, TRENDS NEUROSCI, V24, P182, DOI 10.1016/S0166-2236(00)01721-5; Cha JHJ, 1998, P NATL ACAD SCI USA, V95, P6480, DOI 10.1073/pnas.95.11.6480; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Faber PW, 1998, HUM MOL GENET, V7, P1463, DOI 10.1093/hmg/7.9.1463; Greene JG, 1996, PROG NEUROBIOL, V48, P613, DOI 10.1016/0301-0082(96)00006-8; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; GUTEKUNST CA, 1995, P NATL ACAD SCI USA, V92, P8710, DOI 10.1073/pnas.92.19.8710; Gutekunst CA, 1998, J NEUROSCI, V18, P7674, DOI 10.1523/jneurosci.18-19-07674.1998; Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3; Kim YJ, 2001, P NATL ACAD SCI USA, V98, P12784, DOI 10.1073/pnas.221451398; Leavitt BR, 2001, AM J HUM GENET, V68, P313, DOI 10.1086/318207; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; Luthi-Carter R, 2000, HUM MOL GENET, V9, P1259, DOI 10.1093/hmg/9.9.1259; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Monoi H, 2000, BIOPHYS J, V78, P2892, DOI 10.1016/S0006-3495(00)76830-5; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Onodera O, 1997, BIOCHEM BIOPH RES CO, V238, P599, DOI 10.1006/bbrc.1997.7337; Ordway JM, 1997, CELL, V91, P753, DOI 10.1016/S0092-8674(00)80464-X; Orr HT, 2001, GENE DEV, V15, P925, DOI 10.1101/gad.888401; Rigamonti D, 2000, J NEUROSCI, V20, P3705, DOI 10.1523/JNEUROSCI.20-10-03705.2000; Sawa A, 1999, NAT MED, V5, P1194, DOI 10.1038/13518; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; SIMS NR, 1990, J NEUROCHEM, V55, P698, DOI 10.1111/j.1471-4159.1990.tb04189.x; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Tabrizi SJ, 1999, ANN NEUROL, V45, P25, DOI 10.1002/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Wanker EE, 1997, HUM MOL GENET, V6, P487, DOI 10.1093/hmg/6.3.487; Zeron MM, 2002, NEURON, V33, P849, DOI 10.1016/S0896-6273(02)00615-3; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581	34	780	805	2	50	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2002	5	8					731	736		10.1038/nn884	http://dx.doi.org/10.1038/nn884			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	577XT	12089530				2022-12-24	WOS:000177088900015
J	Domeniconi, M; Cao, ZU; Spencer, T; Sivasankaran, R; Wang, KC; Nikulina, E; Kimura, N; Cai, H; Deng, KW; Gao, Y; He, ZG; Filbin, MT				Domeniconi, M; Cao, ZU; Spencer, T; Sivasankaran, R; Wang, KC; Nikulina, E; Kimura, N; Cai, H; Deng, KW; Gao, Y; He, ZG; Filbin, MT			Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth	NEURON			English	Article							AXONAL REGENERATION; ADULT-RAT; GROWTH; MAG; IDENTIFICATION; PROTEIN; GANGLIOSIDES; ADHESION; ANTIBODY; LIGANDS	Myelin inhibitors of axonal regeneration, like Nogo and MAG, block regrowth after injury to the adult CNS. While a GPI-linked receptor for Nogo (NgR) has been identified, MAG's receptor is unknown. We show that MAG inhibits regeneration by interaction with NgR. Binding of and inhibition by MAG are lost if neuronal GPI-linked proteins are cleaved. Binding of MAG to NgR-expressing cells is GPI dependent and sialic acid independent. Conversely, NgR binds to MAG-expressing cells. MAG, but not a truncated MAG that binds neurons but does not inhibit regeneration, precipitates NgR from NgR-expressing cells, DRG, and cerebellar neurons, Importantly, NgR antibody, soluble NgR, or dominant-negative NgR each prevent inhibition of neurite outgrowth by MAG. Also, MAG and Nogo66 compete for binding to NgR. These results suggest redundancy in myelin inhibitors and indicate therapies for CNS injuries.	CUNY Hunter Coll, Dept Biol Sci, New York, NY 10021 USA; Harvard Univ, Sch Med, Childrens Hosp, Div Neurosci, Boston, MA 02115 USA	City University of New York (CUNY) System; Hunter College (CUNY); Harvard University; Boston Children's Hospital; Harvard Medical School	Filbin, MT (corresponding author), CUNY Hunter Coll, Dept Biol Sci, 695 Pk Ave, New York, NY 10021 USA.	filbin@genectr.hunter.cuny.edu	Spencer, Tim/AAK-2094-2020		NINDS NIH HHS [NS41073, NS 37060] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS041073, R01NS037060, R37NS037060] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001; Cai DM, 1999, NEURON, V22, P89, DOI 10.1016/S0896-6273(00)80681-9; CARONI P, 1988, NEURON, V1, P85, DOI 10.1016/0896-6273(88)90212-7; Cheng K, 2000, PSYCHOL SCI, V11, P403, DOI 10.1111/1467-9280.00278; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; Collins BE, 1997, J BIOL CHEM, V272, P1248, DOI 10.1074/jbc.272.2.1248; Crocker P R, 1998, Glycobiology, V8, pv; De Bellard M, 1999, J NEUROSCI RES, V56, P213, DOI 10.1002/(SICI)1097-4547(19990415)56:2<213::AID-JNR11>3.3.CO;2-L; DeBellard ME, 1996, MOL CELL NEUROSCI, V7, P89, DOI 10.1006/mcne.1996.0007; FAHRIG T, 1987, EMBO J, V6, P2875, DOI 10.1002/j.1460-2075.1987.tb02590.x; Filbin MT, 1996, MOL CELL NEUROSCI, V8, P84, DOI 10.1006/mcne.1996.0047; Fitch MT, 1999, CNS REGENERATION BAS, P55; Flanagan JG, 2000, METHOD ENZYMOL, V327, P198, DOI 10.1016/S0076-6879(00)27277-7; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Franzen R, 2001, J CELL BIOL, V155, P893, DOI 10.1083/jcb.200108137; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; Huang DW, 1999, NEURON, V24, P639, DOI 10.1016/S0896-6273(00)81118-6; Huber AB, 2002, J NEUROSCI, V22, P3553; JOHNSON PW, 1989, NEURON, V3, P377, DOI 10.1016/0896-6273(89)90262-6; KELM S, 1994, CURR BIOL, V4, P965, DOI 10.1016/S0960-9822(00)00220-7; Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999; Li M, 1996, J NEUROSCI RES, V46, P404, DOI 10.1002/(SICI)1097-4547(19961115)46:4<404::AID-JNR2>3.3.CO;2-W; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; MIKOL DD, 1990, J CELL BIOL, V110, P471, DOI 10.1083/jcb.110.2.471; MONTAG D, 1994, NEURON, V13, P229, DOI 10.1016/0896-6273(94)90472-3; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X; Prinjha R, 2000, NATURE, V403, P383, DOI 10.1038/35000287; Qiu J, 2000, GLIA, V29, P166, DOI 10.1002/(SICI)1098-1136(20000115)29:2<166::AID-GLIA10>3.0.CO;2-G; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; Quarles RH, 1997, J MOL NEUROSCI, V8, P1, DOI 10.1007/BF02736858; SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0; SCHNELL L, 1993, EUR J NEUROSCI, V5, P1156, DOI 10.1111/j.1460-9568.1993.tb00970.x; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Tang S, 1997, MOL CELL NEUROSCI, V9, P333, DOI 10.1006/mcne.1997.0633; Tang S, 1997, J CELL BIOL, V138, P1355, DOI 10.1083/jcb.138.6.1355; Tang S, 2001, MOL CELL NEUROSCI, V18, P259, DOI 10.1006/mcne.2001.1020; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; TRAPP BD, 1988, J CELL BIOL, V107, P675, DOI 10.1083/jcb.107.2.675; Vinson M, 2001, J BIOL CHEM, V276, P20280, DOI 10.1074/jbc.M100345200; Vyas AA, 2002, P NATL ACAD SCI USA, V99, P8412, DOI 10.1073/pnas.072211699; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Yamashita T, 2002, J CELL BIOL, V157, P565, DOI 10.1083/jcb.200202010; Yang LJS, 1996, P NATL ACAD SCI USA, V93, P814, DOI 10.1073/pnas.93.2.814	47	467	517	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 18	2002	35	2					283	290		10.1016/S0896-6273(02)00770-5	http://dx.doi.org/10.1016/S0896-6273(02)00770-5			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	576YF	12160746	Bronze			2022-12-24	WOS:000177034200008
J	Houart, C; Caneparo, L; Heisenberg, CP; Barth, KA; Take-Uchi, M; Wilson, SW				Houart, C; Caneparo, L; Heisenberg, CP; Barth, KA; Take-Uchi, M; Wilson, SW			Establishment of the telencephalon during gastrulation by local antagonism of Wnt signaling	NEURON			English	Article							MIDBRAIN-HINDBRAIN BOUNDARY; FOREBRAIN DEVELOPMENT; ZEBRAFISH GASTRULA; SPEMANN ORGANIZER; MOUSE FOREBRAIN; HEAD INDUCTION; NEURAL PLATE; BETA-CATENIN; XENOPUS; MESODERM	Cells at the anterior boundary of the neural plate (ANB) can induce telencephalic gene expression when transplanted to more posterior regions. Here, we identify a secreted Frizzled-related Wnt antagonist, Tic, that is expressed in ANB cells and can cell nonautonomously promote telencephalic gene expression in a concentration-dependent manner. Moreover, abrogation of Tlc function compromises telencephalic development. We also identify Wnt8b as a locally acting modulator of regional fate in the anterior neural plate and a likely target for antagonism by Tic. Finally, we show that tlc expression is regulated by signals that establish early antero-posterior and dorso-ventral ectodermal pattern. From these studies, we propose that local antagonism of Wnt activity within the anterior ectoderm is required to establish the telencephalon.	Kings Coll London, MRC, Ctr Dev Neurobiol, London SE1 9RT, England; UCL, Dept Anat & Dev Biol, London WC1E 6BT, England	University of London; King's College London; University of London; University College London	Houart, C (corresponding author), Kings Coll London, MRC, Ctr Dev Neurobiol, New Hunts House, London SE1 9RT, England.	corinne.houart@kcl.ac.uk; s.wilson@ucl.ac.uk	Caneparo, Luca/B-6620-2008; Houart, Corinne/B-5128-2009; Zebrafish, UCL/A-3125-2009; Wilson, Stephen W/B-9404-2008	Houart, Corinne/0000-0002-2062-3964; Wilson, Stephen W/0000-0002-8557-5940; Heisenberg, Carl-Philipp/0000-0002-0912-4566				Bachiller D, 2000, NATURE, V403, P658, DOI 10.1038/35001072; Barth KA, 1999, DEVELOPMENT, V126, P4977; Brand M, 1996, DEVELOPMENT, V123, P179; Brault V, 2001, DEVELOPMENT, V128, P1253; Deardorff MA, 2001, DEVELOPMENT, V128, P3655; Dorsky RI, 2002, DEV BIOL, V241, P229, DOI 10.1006/dbio.2001.0515; Erter CE, 2001, DEVELOPMENT, V128, P3571; Gamse D, 2000, BIOESSAYS, V22, P976; Glinka A, 1997, NATURE, V389, P517, DOI 10.1038/39092; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Heisenberg CP, 2001, GENE DEV, V15, P1427, DOI 10.1101/gad.194301; Heisenberg CP, 1996, DEVELOPMENT, V123, P191; Hoppler S, 1996, GENE DEV, V10, P2805, DOI 10.1101/gad.10.21.2805; Houart C, 1998, NATURE, V391, P788, DOI 10.1038/35853; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Joubin K, 2001, INT J DEV BIOL, V45, P165; Joyner AL, 2000, CURR OPIN CELL BIOL, V12, P736, DOI 10.1016/S0955-0674(00)00161-7; KELLY GM, 1995, DEVELOPMENT, V121, P1787; KELLY GM, 1995, DEV GENET, V17, P129, DOI 10.1002/dvg.1020170205; Kiecker C, 2001, DEVELOPMENT, V128, P4189; Kim CH, 2000, NATURE, V407, P913, DOI 10.1038/35038097; Lee SMK, 2000, DEVELOPMENT, V127, P457; Lekven AC, 2001, DEV CELL, V1, P103, DOI 10.1016/S1534-5807(01)00007-7; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Lumsden A, 1999, NAT CELL BIOL, V1, pE83, DOI 10.1038/12078; Marvin MJ, 2001, GENE DEV, V15, P316, DOI 10.1101/gad.855501; Masai I, 1997, NEURON, V18, P43, DOI 10.1016/S0896-6273(01)80045-3; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Monuki ES, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn752; Mukhopadhyay M, 2001, DEV CELL, V1, P423, DOI 10.1016/S1534-5807(01)00041-7; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nguyen VH, 1998, DEV BIOL, V199, P93, DOI 10.1006/dbio.1998.8927; Niehrs C, 1999, TRENDS GENET, V15, P314, DOI 10.1016/S0168-9525(99)01767-9; Rasmussen JT, 2001, P NATL ACAD SCI USA, V98, P3861, DOI 10.1073/pnas.071586298; Redies C, 2001, BIOESSAYS, V23, P1100, DOI 10.1002/bies.10014; Reifers F, 1998, DEVELOPMENT, V125, P2381; Schneider VA, 2001, GENE DEV, V15, P304, DOI 10.1101/gad.855601; Shanmugalingam S, 2000, DEVELOPMENT, V127, P2549; Shimamura K, 1997, DEVELOPMENT, V124, P2709; Shinya M, 2001, DEVELOPMENT, V128, P4153; Sirotkin HI, 2000, DEVELOPMENT, V127, P2583; Stern CD, 2001, NAT REV NEUROSCI, V2, P92, DOI 10.1038/35053563; Thisse B, 2000, NATURE, V403, P425, DOI 10.1038/35000200; van de Water S, 2001, DEVELOPMENT, V128, P3877; Varga ZM, 1999, DEVELOPMENT, V126, P5533; Wang SW, 1997, CELL, V88, P757, DOI 10.1016/S0092-8674(00)81922-4; Wilson SI, 2001, NAT NEUROSCI, V4, P1161, DOI 10.1038/nn747; Wilson SW, 2000, NEURON, V28, P641, DOI 10.1016/S0896-6273(00)00171-9; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Yamaguchi TP, 2001, CURR BIOL, V11, pR713, DOI 10.1016/S0960-9822(01)00417-1	50	241	246	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUL 18	2002	35	2					255	265		10.1016/S0896-6273(02)00751-1	http://dx.doi.org/10.1016/S0896-6273(02)00751-1			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	576YF	12160744	Bronze			2022-12-24	WOS:000177034200006
J	Togashi, H; Abe, K; Mizoguchi, A; Takaoka, K; Chisaka, O; Takeichi, M				Togashi, H; Abe, K; Mizoguchi, A; Takaoka, K; Chisaka, O; Takeichi, M			Cadherin regulates dendritic spine morphogenesis	NEURON			English	Article							LONG-TERM POTENTIATION; CELL-CELL ADHESION; ALPHA-CATENIN; N-CADHERIN; HIPPOCAMPAL-NEURONS; SYNAPTIC PLASTICITY; CYTOPLASMIC DOMAIN; JUNCTIONAL COMPLEX; BINDING-ACTIVITY; IN-VIVO	Synaptic remodeling has been postulated as a mechanism underlying synaptic plasticity, and cadherin adhesion molecules are thought to be a regulator of such a process. We examined the effects of cadherin blockage on synaptogenesis in cultured hippocampal neurons. This blockade resulted in alterations of dendritic spine morphology, such as filopodia-like elongation of the spine and bifurcation of its head structure, along with concomitant disruption of the distribution of postsynaptic proteins. The accumulation of synapsin at presynaptic sites and synaptic vesicle recycling were also perturbed, although these synaptic responses to the cadherin blockade became less evident upon the maturation of the synapses. These findings suggest that cadherin regulates dendritic spine morphogenesis and related synaptic functions, presumably cooperating with cadherin-independent adhesive mechanisms to maintain spine-axon contacts.	Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan; Kyoto Univ, Fac Med, Dept Anat & Neurobiol, Sakyo Ku, Kyoto 6068501, Japan; RIKEN, Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan	Kyoto University; Kyoto University; RIKEN	Takeichi, M (corresponding author), Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan.		Abe, Kentaro/A-6197-2008; Takeichi, Masatoshi/G-5903-2012; Abe, Kentaro/T-2247-2019	Takeichi, Masatoshi/0000-0002-9931-3378; Abe, Kentaro/0000-0002-3923-6323; Togashi, Hideru/0000-0002-3967-5940				Allison DW, 2000, J NEUROSCI, V20, P4545, DOI 10.1523/JNEUROSCI.20-12-04545.2000; Aono S, 1999, J CELL BIOL, V145, P551, DOI 10.1083/jcb.145.3.551; Benson DL, 1998, J NEUROSCI, V18, P6892; Bozdagi O, 2000, NEURON, V28, P245, DOI 10.1016/S0896-6273(00)00100-8; Brieher WM, 1996, J CELL BIOL, V135, P487, DOI 10.1083/jcb.135.2.487; Bruses JL, 2000, CURR OPIN CELL BIOL, V12, P593, DOI 10.1016/S0955-0674(00)00137-X; CALVERLEY RKS, 1990, BRAIN RES REV, V15, P215, DOI 10.1016/0165-0173(90)90002-6; Christie SB, 2002, J NEUROSCI, V22, P684, DOI 10.1523/JNEUROSCI.22-03-00684.2002; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; El-Hussein AE, 2000, SCIENCE, V290, P1364; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; FUJIMORI T, 1993, MOL BIOL CELL, V4, P37, DOI 10.1091/mbc.4.1.37; Goslin K., 1998, CULTURING NERVE CELL, P339; HIRANO S, 1992, CELL, V70, P293, DOI 10.1016/0092-8674(92)90103-J; Honjo Y, 2000, GENES CELLS, V5, P309, DOI 10.1046/j.1365-2443.2000.00327.x; Horikawa K, 1999, DEV BIOL, V215, P182, DOI 10.1006/dbio.1999.9463; HOSOKAWA T, 1995, J NEUROSCI, V15, P5560; Huntley GW, 1999, J COMP NEUROL, V407, P453; Inoue T, 1998, DEV DYNAM, V211, P338, DOI 10.1002/(SICI)1097-0177(199804)211:4<338::AID-AJA5>3.3.CO;2-R; Iwai Y, 2002, MOL CELL NEUROSCI, V19, P375, DOI 10.1006/mcne.2001.1081; Janssens B, 2001, J CELL SCI, V114, P3177; Jontes JD, 2000, NEURON, V27, P11, DOI 10.1016/S0896-6273(00)00003-9; Kavalali ET, 1999, P NATL ACAD SCI USA, V96, P12893, DOI 10.1073/pnas.96.22.12893; KINTNER C, 1992, CELL, V69, P225, DOI 10.1016/0092-8674(92)90404-Z; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; Kovacs EM, 2002, CURR BIOL, V12, P379, DOI 10.1016/S0960-9822(02)00661-9; Lee SH, 2000, CURR OPIN NEUROBIOL, V10, P125, DOI 10.1016/S0959-4388(99)00046-X; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Manabe T, 2000, MOL CELL NEUROSCI, V15, P534, DOI 10.1006/mcne.2000.0849; Muller D, 2000, HIPPOCAMPUS, V10, P596, DOI 10.1002/1098-1063(2000)10:5<596::AID-HIPO10>3.3.CO;2-P; Muller D, 1996, NEURON, V17, P413, DOI 10.1016/S0896-6273(00)80174-9; NAGAFUCHI A, 1988, EMBO J, V7, P3679, DOI 10.1002/j.1460-2075.1988.tb03249.x; Nakagawa M, 2001, J CELL SCI, V114, P1829; Nakagawa S, 1998, DEVELOPMENT, V125, P2963; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; Noren NK, 2001, J BIOL CHEM, V276, P33305, DOI 10.1074/jbc.C100306200; Ohkubo T, 1999, J BIOL CHEM, V274, P21409, DOI 10.1074/jbc.274.30.21409; OZAWA M, 1990, P NATL ACAD SCI USA, V87, P4246, DOI 10.1073/pnas.87.11.4246; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Pradhan D, 2001, J BIOL CHEM, V276, P4175, DOI 10.1074/jbc.M009259200; Rao A, 1998, J NEUROSCI, V18, P1217; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Roe S, 1998, CELL ADHES COMMUN, V5, P283, DOI 10.3109/15419069809040298; Rusakov DA, 1997, HIPPOCAMPUS, V7, P489, DOI 10.1002/(SICI)1098-1063(1997)7:5<489::AID-HIPO5>3.0.CO;2-C; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Scotti AL, 2001, P NATL ACAD SCI USA, V98, P3489, DOI 10.1073/pnas.061028798; SHIMOYAMA Y, 1992, CANCER RES, V52, P5770; Spacek J, 1998, J COMP NEUROL, V393, P58, DOI 10.1002/(SICI)1096-9861(19980330)393:1<58::AID-CNE6>3.0.CO;2-P; SPACEK J, 1985, ANAT EMBRYOL, V171, P235, DOI 10.1007/BF00341418; Suzuki SC, 1997, MOL CELL NEUROSCI, V9, P433, DOI 10.1006/mcne.1997.0626; SWIATEK PJ, 1993, GENE DEV, V7, P2071, DOI 10.1101/gad.7.11.2071; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Tanaka H, 2000, NEURON, V25, P93, DOI 10.1016/S0896-6273(00)80874-0; Tang LX, 1998, NEURON, V20, P1165, DOI 10.1016/S0896-6273(00)80497-3; Tepass U, 2000, NAT REV MOL CELL BIO, V1, P91, DOI 10.1038/35040042; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; UCHIDA N, 1994, DEV BIOL, V163, P75, DOI 10.1006/dbio.1994.1124; Watabe-Uchida M, 1998, J CELL BIOL, V142, P847, DOI 10.1083/jcb.142.3.847; Yamagata K, 1999, J BIOL CHEM, V274, P19473, DOI 10.1074/jbc.274.27.19473; YAMAGATA M, 1995, J NEUROSCI, V15, P4556; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4; Zhang WD, 2001, J NEUROSCI, V21, P5169, DOI 10.1523/JNEUROSCI.21-14-05169.2001; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	71	409	417	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 3	2002	35	1					77	89		10.1016/S0896-6273(02)00748-1	http://dx.doi.org/10.1016/S0896-6273(02)00748-1			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	569KP	12123610	Bronze			2022-12-24	WOS:000176601800012
J	Blazquez, PM; Fujii, N; Kojima, J; Graybiel, AM				Blazquez, PM; Fujii, N; Kojima, J; Graybiel, AM			A network representation of response probability in the striaturn	NEURON			English	Article							TONICALLY ACTIVE NEURONS; NEOSTRIATAL CHOLINERGIC INTERNEURONS; REFLEX BLINK HYPEREXCITABILITY; POSITRON-EMISSION TOMOGRAPHY; BASAL GANGLIA; MONKEY STRIATUM; DOPAMINE NEURONS; DISCHARGING NEURONS; PARKINSONS-DISEASE; PRIMATES STRIATUM	The striatum of the basal ganglia is considered a key structure in the learning circuitry of the brain. To analyze neural signals that underlie striatal plasticity, we recorded from an identifiable class of striatal interneurons as macaque monkeys underwent training in a range of conditioning and non-associative learning paradigms, and recorded eyeblink electromyographs as the measure of behavioral response. We found that the responses of these striatal interneurons were modifiable under all training conditions and that their population responses were tightly correlated with the probability that a given stimulus would evoke a behavioral response. Such a network signal, proportional to current response probability, could be crucial to the learning and decision functions of the basal ganglia.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; Washington Univ, Sch Med, St Louis, MO 63110 USA; Sayama Neurol Hosp, Sayama, Saitama 3501302, Japan	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Washington University (WUSTL)	Graybiel, AM (corresponding author), MIT, Dept Brain & Cognit Sci, 45 Carleton St,E25-618, Cambridge, MA 02139 USA.	graybiel@mit.edu		Graybiel, Ann/0000-0002-4326-7720; Sanchez Blazquez, Pilar/0000-0002-7211-4504	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025529] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS25529] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKINS PT, 1990, NATURE, V344, P240, DOI 10.1038/344240a0; Alcantara AA, 2001, J COMP NEUROL, V434, P445, DOI 10.1002/cne.1186; AOSAKI T, 1995, J NEUROPHYSIOL, V73, P1234, DOI 10.1152/jn.1995.73.3.1234; Aosaki T, 1996, J NEUROSCI, V16, P5141; AOSAKI T, 1994, J NEUROSCI, V14, P3969; AOSAKI T, 1994, SCIENCE, V265, P412, DOI 10.1126/science.8023166; Apicella P, 1996, NEUROSCI LETT, V203, P147, DOI 10.1016/0304-3940(96)12328-4; Apicella P, 1997, EXP BRAIN RES, V116, P456, DOI 10.1007/PL00005773; Basso MA, 1996, J NEUROSCI, V16, P7318; Basso MA, 1996, J NEUROSCI, V16, P7308, DOI 10.1523/jneurosci.16-22-07308.1996; BASSO MA, 1993, EXP BRAIN RES, V94, P88; Bennett BD, 1998, J NEUROSCI, V18, P8539; Bennett BD, 1999, J NEUROSCI, V19, P5586; Blaxton TA, 1996, J NEUROSCI, V16, P4032; BLUMENTHAL TD, 1991, PSYCHOPHYSIOLOGY, V28, P296, DOI 10.1111/j.1469-8986.1991.tb02198.x; BOLAM JP, 1986, BRAIN RES, V397, P279, DOI 10.1016/0006-8993(86)90629-3; Calabresi P, 2000, PROG NEUROBIOL, V61, P231, DOI 10.1016/S0301-0082(99)00030-1; Calabresi P, 2000, TRENDS NEUROSCI, V23, P120, DOI 10.1016/S0166-2236(99)01501-5; CHANG HT, 1992, BRAIN RES, V574, P307, DOI 10.1016/0006-8993(92)90830-3; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; CRIST CF, 1988, J NEUROSCI METH, V26, P117, DOI 10.1016/0165-0270(88)90160-4; CRUTCHER MD, 1984, EXP BRAIN RES, V53, P233, DOI 10.1007/BF00238153; Denny-Brown D, 1976, Res Publ Assoc Res Nerv Ment Dis, V55, P115; DICHIARA G, 1994, TRENDS NEUROSCI, V17, P228, DOI 10.1016/0166-2236(94)90005-1; Djurfeldt M, 1999, NEUROCOMPUTING, V26-7, P997, DOI 10.1016/S0925-2312(99)00096-X; EVINGER C, 1993, EXP BRAIN RES, V92, P507; FLAHERTY AW, 1994, J NEUROSCI, V14, P599; FUCHS AF, 1966, J APPL PHYSIOL, V21, P1068, DOI 10.1152/jappl.1966.21.3.1068; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Graybiel A. M., 1995, MODELS INFORMATION P, P103; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Graybiel AM, 1997, SCHIZOPHRENIA BULL, V23, P459, DOI 10.1093/schbul/23.3.459; Graybiel AM, 1998, NEUROBIOL LEARN MEM, V70, P119, DOI 10.1006/nlme.1998.3843; Grunewald A, 1999, J NEUROPHYSIOL, V82, P330, DOI 10.1152/jn.1999.82.1.330; Hikosaka O, 1998, NEUROBIOL LEARN MEM, V70, P137, DOI 10.1006/nlme.1998.3844; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P814, DOI 10.1152/jn.1989.61.4.814; Hollerman JR, 1998, J NEUROPHYSIOL, V80, P947, DOI 10.1152/jn.1998.80.2.947; HOWE AR, 1995, J NEUROSCI, V15, P458; Jog MS, 1999, SCIENCE, V286, P1745, DOI 10.1126/science.286.5445.1745; Kaneko S, 2000, SCIENCE, V289, P633, DOI 10.1126/science.289.5479.633; Kawagoe R, 1998, NAT NEUROSCI, V1, P411, DOI 10.1038/1625; KAWAGUCHI Y, 1995, TRENDS NEUROSCI, V18, P527, DOI 10.1016/0166-2236(95)98374-8; KERMADI I, 1995, J NEUROPHYSIOL, V74, P911, DOI 10.1152/jn.1995.74.3.911; Koos T, 1999, NAT NEUROSCI, V2, P467, DOI 10.1038/8138; Koos T, 2002, J NEUROSCI, V22, P529, DOI 10.1523/JNEUROSCI.22-02-00529.2002; LAPPER SR, 1992, NEUROSCIENCE, V51, P533, DOI 10.1016/0306-4522(92)90293-B; LOGAN CG, 1995, P NATL ACAD SCI USA, V92, P7500, DOI 10.1073/pnas.92.16.7500; Matsumoto N, 2001, J NEUROPHYSIOL, V85, P960, DOI 10.1152/jn.2001.85.2.960; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; Parthasarathy HB, 1997, J NEUROSCI, V17, P2477; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Ravel S, 1999, EXP BRAIN RES, V128, P531, DOI 10.1007/s002210050876; Raz A, 1996, J NEUROPHYSIOL, V76, P2083, DOI 10.1152/jn.1996.76.3.2083; RICHARDSON RT, 1985, BRAIN RES, V332, P219, DOI 10.1016/0006-8993(85)90591-8; ROBBINS TW, 1992, SEMIN NEUROSCI, V4, P119; ROLLS ET, 1983, BEHAV BRAIN RES, V7, P179, DOI 10.1016/0166-4328(83)90191-2; Sardo P, 2000, EUR J NEUROSCI, V12, P1801, DOI 10.1046/j.1460-9568.2000.00068.x; Schall JD, 1998, CURR OPIN NEUROBIOL, V8, P211, DOI 10.1016/S0959-4388(98)80142-6; Schall JD, 2001, NAT REV NEUROSCI, V2, P33, DOI 10.1038/35049054; Schneider J. S., 1987, BASAL GANGLIA BEHAVI, P103; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SCHULTZ W, 1987, J NEUROPHYSIOL, V57, P201, DOI 10.1152/jn.1987.57.1.201; Shidara M, 1998, J NEUROSCI, V18, P2613; Shimo Y, 2001, J NEUROSCI, V21, P7804, DOI 10.1523/JNEUROSCI.21-19-07804.2001; STEINMETZ JE, 1991, EMOTION AFFECTION, P97; Thomas TM, 2000, SYNAPSE, V37, P252, DOI 10.1002/1098-2396(20000915)37:4<252::AID-SYN2>3.0.CO;2-A; Thompson RF, 1996, P NATL ACAD SCI USA, V93, P13438, DOI 10.1073/pnas.93.24.13438; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; WHITE IM, 1994, EXP BRAIN RES, V99, P179; WILSON CJ, 1990, J NEUROSCI, V10, P508	71	93	94	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 14	2002	33	6					973	982		10.1016/S0896-6273(02)00627-X	http://dx.doi.org/10.1016/S0896-6273(02)00627-X			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	530ZK	11906702	Bronze			2022-12-24	WOS:000174389600013
J	Murphy, GJ; Isaacson, JS				Murphy, GJ; Isaacson, JS			Presynaptic cyclic nucleotide-gated ion channels modulate neurotransmission in the mammalian olfactory bulb	NEURON			English	Article							MOSSY FIBER SYNAPSES; TRANSMITTER RELEASE; RECEPTORS; NEURONS; INHIBITION; POTENTIATION; ENHANCEMENT; CONDUCTANCE; TERMINALS; MEDIATION	Cyclic nucleotide-gated channels (CNGCs) on the dendritic cilia of olfactory receptor neurons (ORNs) are critical for sensory transduction in the olfactory system. Do CNGCs also play a role in the axons and/or nerve terminals of ORNs? We find that the cyclic nucleotides cAMP and cGMP can both facilitate and depress synaptic transmission between olfactory nerve fibers and their targets in olfactory bulb glomeruli. Cyclic nucleotides increase intracellular Ca2+ in ORN terminals and enhance spontaneous transmitter release; at higher concentrations, cyclic nucleotides depress evoked transmission by altering olfactory nerve excitability. Cyclic nucleotides have no effect on transmission or nerve excitability, however, in mice lacking olfactory CNGCs. Taken together, our results identify a novel role for presynaptic CNGCs in modulating neurotransmission.	Univ Calif San Diego, Sch Med, Neurosci Grad Program, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Isaacson, JS (corresponding author), Univ Calif San Diego, Sch Med, Neurosci Grad Program, La Jolla, CA 92093 USA.			Murphy, Gabe/0000-0002-9321-8556	NIDCD NIH HHS [R01DC04682] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004682] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ARANCIO O, 1995, NATURE, V376, P74, DOI 10.1038/376074a0; Aroniadou-Anderjaska V, 2000, J NEUROPHYSIOL, V84, P1194, DOI 10.1152/jn.2000.84.3.1194; Baker H, 1999, J NEUROSCI, V19, P9313; Beaumont V, 2000, NAT NEUROSCI, V3, P133, DOI 10.1038/72072; BIELEFELDT K, 1993, J NEUROPHYSIOL, V70, P284, DOI 10.1152/jn.1993.70.1.284; Bradley J, 1997, J NEUROSCI, V17, P1993; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; Delaney AJ, 2002, NEURON, V36, P475, DOI 10.1016/S0896-6273(02)01008-5; ECCLES JC, 1962, J PHYSL, V160, P532; Ennis M, 2001, J NEUROPHYSIOL, V86, P2986, DOI 10.1152/jn.2001.86.6.2986; FRINGS S, 1995, NEURON, V15, P169, DOI 10.1016/0896-6273(95)90074-8; Katz B., 1969, RELEASE NEURAL TRANS; Kramer RH, 1996, J NEUROSCI, V16, P1285; Kuzmiski JB, 2001, J NEUROSCI, V21, P8707, DOI 10.1523/JNEUROSCI.21-22-08707.2001; Lin DM, 2000, NEURON, V26, P69, DOI 10.1016/S0896-6273(00)81139-3; MacDermott AB, 1999, ANNU REV NEUROSCI, V22, P443, DOI 10.1146/annurev.neuro.22.1.443; Matsuzaki O, 1999, NEUROSCIENCE, V94, P131, DOI 10.1016/S0306-4522(99)00228-6; Mellor J, 2002, SCIENCE, V295, P143, DOI 10.1126/science.1064285; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; Nicoll R A, 1979, Int Rev Neurobiol, V21, P217; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; RIEKE F, 1994, NEURON, V13, P863, DOI 10.1016/0896-6273(94)90252-6; Sakaba T, 2001, P NATL ACAD SCI USA, V98, P331, DOI 10.1073/pnas.021541098; Schmitz D, 2000, NEURON, V27, P327, DOI 10.1016/S0896-6273(00)00040-4; Schmitz D, 2001, SCIENCE, V291, P1972, DOI 10.1126/science.1057105; Shepherd G.M., 1998, SYNAPTIC ORG BRAIN, P159; Southan AP, 2000, J PHYSIOL-LONDON, V526, P91, DOI 10.1111/j.1469-7793.2000.t01-1-00091.x; Turecek R, 2001, NATURE, V411, P587, DOI 10.1038/35079084; Wachowiak M, 2001, NEURON, V32, P723, DOI 10.1016/S0896-6273(01)00506-2; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; YAU KW, 1989, ANNU REV NEUROSCI, V12, P289, DOI 10.1146/annurev.ne.12.030189.001445; Yoshida T, 2002, J NEUROSCI, V22, P4964, DOI 10.1523/JNEUROSCI.22-12-04964.2002; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315; Zhao HQ, 2001, CELL, V104, P651, DOI 10.1016/S0092-8674(02)01107-8; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	38	37	37	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 20	2003	37	4					639	647		10.1016/S0896-6273(03)00057-6	http://dx.doi.org/10.1016/S0896-6273(03)00057-6			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	648EH	12597861	Bronze			2022-12-24	WOS:000181136500012
J	Purcell, AL; Sharma, SK; Bagnall, MW; Sutton, MA; Carew, TJ				Purcell, AL; Sharma, SK; Bagnall, MW; Sutton, MA; Carew, TJ			Activation of a tyrosine kinase-MAPK cascade enhances the induction of long-term synaptic facilitation and long-term memory in Aplysia	NEURON			English	Article							LOCAL PROTEIN-SYNTHESIS; SENSORY NEURONS; NUCLEAR TRANSLOCATION; MOTOR SYNAPSES; POTENTIATION; RECEPTOR; SENSITIZATION; STIMULATION; PHOSPHORYLATION; HIPPOCAMPUS	Tyrosine kinases have been implicated in cellular processes thought to underlie learning and memory. Here we show that tyrosine kinases play a direct role in long-term synaptic facilitation (LTF) and long-term memory (LTM) for sensitization in Aplysia. Tyrosine kinase activity is required for serotonin-induced LTF of sensorimotor (SN-MN) synapses, and enhancement of endogenous tyrosine kinase activity facilitates the induction of LTF. These effects are mediated, at least in part, through mitogen-activated protein kinase (MAPK) activation and are blocked by transcriptional and translational inhibitors. Moreover, brain-derived neurotrophic factor (BDNF) also enhances the induction of LTF in a MAPK-dependent fashion. Finally, activation of endogenous tyrosine kinases enhances the induction of long-term memory for sensitization, and this enhancement also requires MAPK activation. Thus, tyrosine kinases, acting through MAPK, play a pivotal role in LTF and LTM formation.	Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; Univ Calif Irvine, Ctr Neurobiol Learning & Memory, Irvine, CA 92697 USA; Yale Univ, Interdepartmental Neurosci Program, New Haven, CT 06520 USA; Univ Calif Irvine, Ctr Neurobiol Learning & Memory, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; Yale University; University of California System; University of California Irvine	Carew, TJ (corresponding author), Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA.	tcarew@ucl.edu	Sharma, Shiv Kumar/AAC-9858-2021; Sutton, Michael/C-6264-2011	Sharma, Shiv/0000-0001-5249-4741; Bagnall, Martha/0000-0003-2102-6165; Sutton, Michael/0000-0002-0692-6459				AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; AKIYAMA T, 1991, METHOD ENZYMOL, V201, P362; BACSKAI BJ, 1993, SCIENCE, V260, P222, DOI 10.1126/science.7682336; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; Bartsch D, 1998, CELL, V95, P211, DOI 10.1016/S0092-8674(00)81752-3; Bevan AP, 1995, MOL CELL BIOCHEM, V153, P49, DOI 10.1007/BF01075918; Brown EJ, 1996, CELL, V86, P517, DOI 10.1016/S0092-8674(00)80125-7; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; CASTELLUCCI V, 1976, SCIENCE, V194, P1176, DOI 10.1126/science.11560; Chin J, 2002, J NEUROSCI, V22; Cleary LJ, 1998, J NEUROSCI, V18, P5988; CLEARY LJ, 1993, J NEUROPHYSIOL, V70, P1767, DOI 10.1152/jn.1993.70.5.1767; DURA JM, 1995, FEBS LETT, V370, P250, DOI 10.1016/0014-5793(95)00847-3; DURA JM, 1993, J NEUROGENET, V9, P1, DOI 10.3109/01677069309167272; EMPTAGE NJ, 1993, SCIENCE, V262, P253, DOI 10.1126/science.8211146; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; FROST WN, 1985, P NATL ACAD SCI USA, V82, P8266, DOI 10.1073/pnas.82.23.8266; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; Heuss C, 2000, TRENDS NEUROSCI, V23, P469, DOI 10.1016/S0166-2236(00)01643-X; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; KallooHosein HE, 1997, J BIOL CHEM, V272, P24325, DOI 10.1074/jbc.272.39.24325; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; Liu QR, 1997, J NEUROSCI, V17, P755; Lu YM, 1998, SCIENCE, V279, P1363, DOI 10.1126/science.279.5355.1363; Maguire C, 1999, HIPPOCAMPUS, V9, P519, DOI 10.1002/(SICI)1098-1063(1999)9:5<519::AID-HIPO5>3.0.CO;2-Y; Martin KC, 1997, NEURON, V18, P899, DOI 10.1016/S0896-6273(00)80330-X; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Mauelshagen J, 1996, J NEUROSCI, V16, P7099; Michael D, 1998, P NATL ACAD SCI USA, V95, P1864, DOI 10.1073/pnas.95.4.1864; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; Muller U, 1998, NEURON, V21, P1423, DOI 10.1016/S0896-6273(00)80660-1; ODELL TJ, 1991, NATURE, V353, P558, DOI 10.1038/353558a0; Patterson SL, 2001, NEURON, V32, P123, DOI 10.1016/S0896-6273(01)00443-3; Paul S, 2000, J NEUROSCI, V20, P5630, DOI 10.1523/JNEUROSCI.20-15-05630.2000; Pelkey KA, 2002, NEURON, V34, P127, DOI 10.1016/S0896-6273(02)00633-5; Purcell AL, 2001, J NEUROPHYSIOL, V85, P2398, DOI 10.1152/jn.2001.85.6.2398; Reuland DJ, 1998, HORM METAB RES, V30, P29, DOI 10.1055/s-2007-978826; ROSENBLUM K, 1995, P NATL ACAD SCI USA, V92, P1157, DOI 10.1073/pnas.92.4.1157; Schinder AF, 2000, TRENDS NEUROSCI, V23, P639, DOI 10.1016/S0166-2236(00)01672-6; Sherff CM, 1999, SCIENCE, V285, P1911, DOI 10.1126/science.285.5435.1911; SHERFF CM, 2002, IN PRESS INTEG COMP; Sutton MA, 2002, LEARN MEMORY, V9, P29, DOI 10.1101/lm.44802; Sutton MA, 2000, NEURON, V26, P219, DOI 10.1016/S0896-6273(00)81152-6; Sutton MA, 2001, NEURON, V31, P143, DOI 10.1016/S0896-6273(01)00342-7; SUTTON MA, 2002, IN PRESS INTEG COMP; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Takei N, 2001, J BIOL CHEM, V276, P42818, DOI 10.1074/jbc.M103237200; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; WALTERS ET, 1983, J NEUROPHYSIOL, V50, P1543, DOI 10.1152/jn.1983.50.6.1543; Whitechurch RA, 1997, COGNITIVE BRAIN RES, V6, P115, DOI 10.1016/S0926-6410(97)00022-0; Yanow SK, 1998, J NEUROCHEM, V70, P572; Yu XM, 1997, SCIENCE, V275, P674, DOI 10.1126/science.275.5300.674; Zhang F, 1997, SCIENCE, V275, P1318, DOI 10.1126/science.275.5304.1318	55	91	91	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 6	2003	37	3					473	484		10.1016/S0896-6273(03)00030-8	http://dx.doi.org/10.1016/S0896-6273(03)00030-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	647FF	12575954	Bronze			2022-12-24	WOS:000181081600012
J	Yoo, SY; Pennesi, ME; Weeber, EJ; Xu, BS; Atkinson, R; Chen, SM; Armstrong, DL; Wu, SM; Sweatt, JD; Zoghbi, HY				Yoo, SY; Pennesi, ME; Weeber, EJ; Xu, BS; Atkinson, R; Chen, SM; Armstrong, DL; Wu, SM; Sweatt, JD; Zoghbi, HY			SCA7 knockin mice model human SCA7 and reveal gradual accumulation of mutant ataxin-7 in neurons and abnormalities in short-term plasticity	NEURON			English	Article							MACHADO-JOSEPH DISEASE; DRIVEN RETINAL RESPONSES; RETINITIS-PIGMENTOSA; MOUSE MODEL; INFANTILE PHENOTYPE; HUNTINGTONS-DISEASE; CAG REPEATS; HUMAN BRAIN; PROTEIN; POLYGLUTAMINE	We targeted 266 CAG repeats (a number that causes infantile-onset disease) into the mouse Sca7 locus to generate an authentic model of spinocerebellar ataxia type 7 (SCA7). These mice reproduced features of infantile SCA7 (ataxia, visual impairments, and premature death) and showed impaired short-term synaptic potentiation; downregulation of photo receptor-specific genes, despite apparently normal CRX activity, led to shortening of photoreceptor outer segments. Wild-type ataxin-7 was barely detectable, as was mutant ataxin-7 in young animals; with increasing age, however, ataxin-7 staining became more pronounced. Neurons that appeared most vulnerable had relatively high levels of mutant ataxin-7; it is interesting, however, that marked dysfunction occurred in these neurons weeks prior to the appearance of nuclear inclusions. These data demonstrate that glutamine expansion stabilizes mutant ataxin-7, provide an explanation for selective neuronal vulnerability, and show that mutant ataxin-7 impairs posttetanic potentiation (PTP).	Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA	Baylor College of Medicine; Washington University (WUSTL); Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Zoghbi, HY (corresponding author), Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA.		Weeber, Edwin J/A-5396-2012	Zoghbi, Huda/0000-0002-0700-3349; Sweatt, J. David/0000-0003-3567-485X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY004446, R01EY012543, P30EY002520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS027699, R01NS027699] Funding Source: NIH RePORTER; NEI NIH HHS [EY02520, EY12543, EY04446, R01 EY012543] Funding Source: Medline; NICHD NIH HHS [HD24064] Funding Source: Medline; NINDS NIH HHS [NS27699] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Benton CS, 1998, NEUROLOGY, V51, P1081, DOI 10.1212/WNL.51.4.1081; Cancel G, 2000, BRAIN, V123, P2519, DOI 10.1093/brain/123.12.2519; CARPENTER S, 1966, ARCH NEUROL-CHICAGO, V14, P82; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Chen SM, 1996, J BIOL CHEM, V271, P28549, DOI 10.1074/jbc.271.45.28549; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; COLAN RV, 1981, ANN NEUROL, V10, P355, DOI 10.1002/ana.410100407; Cummings CJ, 1999, NEURON, V24, P879, DOI 10.1016/S0896-6273(00)81035-1; David G, 1997, NAT GENET, V17, P65, DOI 10.1038/ng0997-65; DEJONG PTVM, 1980, OPHTHALMOLOGY, V87, P793; deRaad S, 1996, OPHTHALMIC RES, V28, P99, DOI 10.1159/000267881; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591; Garden GA, 2002, J NEUROSCI, V22, P4897, DOI 10.1523/JNEUROSCI.22-12-04897.2002; Goldberg AFX, 1996, P NATL ACAD SCI USA, V93, P13726, DOI 10.1073/pnas.93.24.13726; Gusella JF, 2000, NAT REV NEUROSCI, V1, P109, DOI 10.1038/35039051; HAVENER WH, 1951, ARCH OPHTHALMOL-CHIC, V25, P40; Hong DH, 2000, P NATL ACAD SCI USA, V97, P3649, DOI 10.1073/pnas.060037497; HOOD DC, 1994, INVEST OPHTH VIS SCI, V35, P2948; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Johansson J, 1998, HUM MOL GENET, V7, P171, DOI 10.1093/hmg/7.2.171; Kato T, 2000, CLIN GENET, V58, P69, DOI 10.1034/j.1399-0004.2000.580112.x; KAWAKAMI H, 1995, NAT GENET, V9, P344, DOI 10.1038/ng0495-344; La Spada AR, 2001, NEURON, V31, P913, DOI 10.1016/S0896-6273(01)00422-6; LAMB TD, 1992, TRENDS NEUROSCI, V15, P291, DOI 10.1016/0166-2236(92)90079-N; LANG AE, 1994, ANN NEUROL, V36, P443, DOI 10.1002/ana.410360318; Lin CH, 2001, HUM MOL GENET, V10, P137, DOI 10.1093/hmg/10.2.137; Lin X, 2000, NAT NEUROSCI, V3, P157, DOI 10.1038/72101; Lindenberg KS, 2000, BRAIN PATHOL, V10, P385; Lyubarsky AL, 2000, J NEUROSCI, V20, P2209; Lyubarsky AL, 1999, J NEUROSCI, V19, P442, DOI 10.1523/JNEUROSCI.19-01-00442.1999; Mauger C, 1999, MOL BRAIN RES, V74, P35, DOI 10.1016/S0169-328X(99)00256-9; Morrow EM, 1998, TRENDS CELL BIOL, V8, P353, DOI 10.1016/S0962-8924(98)01341-5; Nakamura K, 2001, HUM MOL GENET, V10, P1441, DOI 10.1093/hmg/10.14.1441; NEETENS A, 1990, NEURO-OPHTHALMOLOGY, V10, P261, DOI 10.3109/01658109008997294; PENNESI ME, 2003, IN PRESS J NEUROSCI; Pierce EA, 2001, BIOESSAYS, V23, P605, DOI 10.1002/bies.1086; Pugh EN, 1998, PHOTOSTASIS AND RELATED PHENOMENA, P93, DOI 10.1007/978-1-4899-1549-8_7; Rattner A, 2001, NEURON, V32, P775, DOI 10.1016/S0896-6273(01)00531-1; Rich KA, 1997, J COMP NEUROL, V388, P47; Roberson ED, 1996, J BIOL CHEM, V271, P30436, DOI 10.1074/jbc.271.48.30436; RYAN SJ, 1975, ARCH OPHTHALMOL-CHIC, V93, P169, DOI 10.1001/archopht.1975.01010020177001; SATO K, 1995, NEUROLOGY, V45, P1934, DOI 10.1212/WNL.45.10.1934; SEMPLEROWLAND SL, 1991, ELECTROPHORESIS, V12, P307, DOI 10.1002/elps.1150120414; Skinner PJ, 1997, NATURE, V389, P971, DOI 10.1038/40153; Sobue G, 1996, J NEUROL NEUROSUR PS, V60, P354, DOI 10.1136/jnnp.60.3.354-a; Strom AL, 2002, GENE, V285, P91, DOI 10.1016/S0378-1119(02)00399-2; Sweatt JD, 1999, LEARN MEMORY, V6, P399, DOI 10.1101/lm.6.5.399; Takiyama Y, 1995, No To Shinkei, V47, P117; TO KW, 1993, OPHTHALMOLOGY, V100, P15; TRABOULSI EI, 1988, ARCH OPHTHALMOL-CHIC, V106, P801, DOI 10.1001/archopht.1988.01060130871043; Usdin MT, 1999, HUM MOL GENET, V8, P839, DOI 10.1093/hmg/8.5.839; van de Warrenburg BPC, 2001, J NEUROL, V248, P911, DOI 10.1007/s004150170082; Watase K, 2002, NEURON, V34, P905, DOI 10.1016/S0896-6273(02)00733-X; YOO SY, 2002, NEUROMUSCULAR DISORD, P1165; Yvert G, 2000, HUM MOL GENET, V9, P2491, DOI 10.1093/hmg/9.17.2491; Yvert G, 2001, HUM MOL GENET, V10, P1679, DOI 10.1093/hmg/10.16.1679; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217; Zoghbi HY, 2002, TRENDS GENET, V18, P463, DOI 10.1016/S0168-9525(02)02729-4; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	60	153	156	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 6	2003	37	3					383	401		10.1016/S0896-6273(02)01190-X	http://dx.doi.org/10.1016/S0896-6273(02)01190-X			19	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	647FF	12575948	Bronze			2022-12-24	WOS:000181081600006
J	Dzubay, JA; Otis, TS				Dzubay, JA; Otis, TS			Climbing fiber activation of metabotropic glutamate receptors on cerebellar Purkinje neurons	NEURON			English	Article							LONG-TERM DEPRESSION; IMPAIRED MOTOR COORDINATION; MICE LACKING MGLUR1; GAMMA MUTANT MICE; SYNAPSE ELIMINATION; PHOSPHOLIPASE C-BETA-4; DENDRITIC SPINES; INWARD CURRENT; CELLS; INNERVATION	In the cerebellum, metabotropic glutamate receptors (mGluRs) are required for distinct forms of synaptic plasticity expressed at parallel fiber (PF) and climbing fiber (CF) synapses. At PF synapses, mGluR activation generates a slow synaptic current and triggers intracellular calcium release; at CF synapses, mGluR activation has not been observed. This has led some investigators to propose that mGluR-dependent changes in CF synaptic strength are induced heterosynaptically. Here we describe an mGluR-mediated response to CF stimulation consisting of two parallel signaling pathways: one leading to a slow synaptic conductance and the other leading to internal calcium release. This additional target for glutamate broadens the signaling capabilities of CF synapses and raises the possibility that changes in CF strength are homosynaptically triggered.	Univ Calif Los Angeles, Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Brain Res Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Otis, TS (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA.				NINDS NIH HHS [NS07101, NS41651] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; Auger C, 2000, NEURON, V28, P547, DOI 10.1016/S0896-6273(00)00132-X; BATCHELOR AM, 1994, NEUROSCIENCE, V63, P911, DOI 10.1016/0306-4522(94)90558-4; Batchelor AM, 1997, NATURE, V385, P74, DOI 10.1038/385074a0; BAUDE A, 1993, NEURON, V11, P771, DOI 10.1016/0896-6273(93)90086-7; Brasnjo G, 2001, NEURON, V31, P607, DOI 10.1016/S0896-6273(01)00377-4; Canepari M, 2001, J PHYSIOL-LONDON, V533, P765, DOI 10.1111/j.1469-7793.2001.00765.x; Chen C, 1995, CELL, V83, P1233, DOI 10.1016/0092-8674(95)90148-5; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; CREPEL F, 1982, TRENDS NEUROSCI, V5, P266, DOI 10.1016/0166-2236(82)90168-0; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; Hansel C, 2000, NEURON, V26, P473, DOI 10.1016/S0896-6273(00)81179-4; Hansel C, 2001, NAT NEUROSCI, V4, P467, DOI 10.1038/87419; Hashimoto K, 2001, MOL NEUROBIOL, V23, P69; Hashimoto K, 2000, PROG BRAIN RES, V124, P31; Hirono M, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn764; Hirono M, 1998, BIOCHEM BIOPH RES CO, V251, P753, DOI 10.1006/bbrc.1998.9465; Ichise T, 2000, SCIENCE, V288, P1832, DOI 10.1126/science.288.5472.1832; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; Kakizawa S, 2000, J NEUROSCI, V20, P4954; Kano M, 1995, CELL, V83, P1223, DOI 10.1016/0092-8674(95)90147-7; Kano M, 1997, NEURON, V18, P71, DOI 10.1016/S0896-6273(01)80047-7; Kano M, 1998, P NATL ACAD SCI USA, V95, P15724, DOI 10.1073/pnas.95.26.15724; Levenes C, 1997, NEUROREPORT, V8, P571, DOI 10.1097/00001756-199701200-00038; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; Maejima T, 2001, NEURON, V31, P463, DOI 10.1016/S0896-6273(01)00375-0; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Netzeband JG, 1997, J NEUROPHYSIOL, V78, P63, DOI 10.1152/jn.1997.78.1.63; NUSSER Z, 1994, NEUROSCIENCE, V61, P421, DOI 10.1016/0306-4522(94)90421-9; Offermanns S, 1997, P NATL ACAD SCI USA, V94, P14089, DOI 10.1073/pnas.94.25.14089; Otis TS, 1997, SCIENCE, V277, P1515, DOI 10.1126/science.277.5331.1515; Palay S. L., 1974, CEREBELLAR CORTEX CY; PERKEL DJ, 1990, P ROY SOC B-BIOL SCI, V241, P116, DOI 10.1098/rspb.1990.0074; Petralia RS, 1997, J CHEM NEUROANAT, V13, P77, DOI 10.1016/S0891-0618(97)00023-9; Petralia RS, 1998, NEUROPHARMACOLOGY, V37, P1321, DOI 10.1016/S0028-3908(98)00118-X; RABACCHI S, 1992, SCIENCE, V256, P1823, DOI 10.1126/science.1352066; RABACCHI SA, 1992, J NEUROSCI, V12, P4712; Raymond JL, 1996, SCIENCE, V272, P1126, DOI 10.1126/science.272.5265.1126; Reichelt W, 2002, J NEUROPHYSIOL, V87, P1974, DOI 10.1152/jn.00704.2001; STAUB C, 1992, EUR J NEUROSCI, V4, P832, DOI 10.1111/j.1460-9568.1992.tb00193.x; Takechi H, 1998, NATURE, V396, P757, DOI 10.1038/25547; Tempia F, 2001, J NEUROPHYSIOL, V86, P1389, DOI 10.1152/jn.2001.86.3.1389; Tempia F, 1998, J NEUROPHYSIOL, V80, P520, DOI 10.1152/jn.1998.80.2.520	46	84	86	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 19	2002	36	6					1159	1167		10.1016/S0896-6273(02)01052-8	http://dx.doi.org/10.1016/S0896-6273(02)01052-8			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	628TA	12495629	Bronze			2022-12-24	WOS:000180011600017
J	Menard, C; Hein, P; Paquin, A; Savelson, A; Yang, XM; Lederfein, D; Barnabe-Heider, F; Mir, AA; Sterneck, E; Peterson, AC; Johnson, PF; Vinson, C; Miller, FD				Menard, C; Hein, P; Paquin, A; Savelson, A; Yang, XM; Lederfein, D; Barnabe-Heider, F; Mir, AA; Sterneck, E; Peterson, AC; Johnson, PF; Vinson, C; Miller, FD			An essential role for a MEK-C/EBP pathway during growth factor-regulated cortical neurogenesis	NEURON			English	Article							ALPHA-TUBULIN; TRANSCRIPTIONAL REGULATION; TUMOR-SUPPRESSOR; GENE-EXPRESSION; PROTEIN FAMILY; DIFFERENTIATION; BETA; PHOSPHORYLATION; PROLIFERATION; REGENERATION	Mammalian neurogenesis is determined by an interplay between intrinsic genetic mechanisms and extrinsic cues such as growth factors. Here, we have defined a signaling cascade, 6 MEK-C/EBP pathway, that is essential for cortical progenitor cells to become post-mitotic neurons. Inhibition of MEK or of the C/EBP family of transcription factors inhibits neurogenesis while expression of a C/EBPbeta mutant that is a phosphorylation-mimic at a MEK-Rsk site enhances neurogenesis. C/EBP mediates this positive effect by direct transcriptional I activation of neuron-specific genes such as Talpha1 alpha-tubulin. Conversely, inhibition of C/EBP-dependent transcription enhances CNTF-mediated generation of astrocytes from the same progenitor cells. Thus, activation of a MEK-C/EBP pathway enhances neurogenesis and inhibits gliogenesis, thereby providing a mechanism whereby growth factors can selectively bias progenitors to become neurons during development.	Univ Toronto, Inst Res, Hosp Sick Children, Toronto, ON M5G 1X8, Canada; McGill Univ, Ctr Neuronal Survival, Montreal Neurol Inst, Royal Victoria Hosp, Montreal, PQ, Canada; McGill Univ, Brain Tumor Res Ctr, Montreal Neurol Inst, Royal Victoria Hosp, Montreal, PQ, Canada; Natl Canc Inst, Frederick, MD 21702 USA; NCI, NIH, Bethesda, MD 20892 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McGill University; Royal Victoria Hospital; McGill University; Royal Victoria Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Miller, FD (corresponding author), Univ Toronto, Inst Res, Hosp Sick Children, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	fredam@sickkids.ca	; Johnson, Peter/A-1940-2012	Sterneck, Esta/0000-0001-7716-8766; Johnson, Peter/0000-0002-4145-4725				Baer M, 2000, J BIOL CHEM, V275, P26582, DOI 10.1074/jbc.M004268200; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Buck M, 1999, MOL CELL, V4, P1087, DOI 10.1016/S1097-2765(00)80237-3; Chen PL, 1996, GENE DEV, V10, P2794, DOI 10.1101/gad.10.21.2794; DAVIS RJ, 1995, MOL REPROD DEV, V42, P459, DOI 10.1002/mrd.1080420414; GHOSH A, 1995, NEURON, V15, P89, DOI 10.1016/0896-6273(95)90067-5; Gloster A, 1999, J COMP NEUROL, V405, P45, DOI 10.1002/(SICI)1096-9861(19990301)405:1<45::AID-CNE4>3.0.CO;2-M; GLOSTER A, 1994, J NEUROSCI, V14, P7319; Goodman RH, 2000, GENE DEV, V14, P1553; Greenwel P, 2000, MOL CELL BIOL, V20, P912, DOI 10.1128/MCB.20.3.912-918.2000; Hieber V, 1998, J NEUROBIOL, V37, P429, DOI 10.1002/(SICI)1097-4695(19981115)37:3<429::AID-NEU8>3.0.CO;2-N; Husain J, 1996, BIOCHEM J, V317, P523, DOI 10.1042/bj3170523; JOHNSON PF, 1994, LIVER GENE EXPRESSIO, P231; Krylov D, 1997, P NATL ACAD SCI USA, V94, P12274, DOI 10.1073/pnas.94.23.12274; Lasorella A, 2000, NATURE, V407, P592, DOI 10.1038/35036504; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; LICHTSTEINER S, 1987, CELL, V51, P963, DOI 10.1016/0092-8674(87)90583-6; Lillien L, 1998, CURR BIOL, V8, pR872, DOI 10.1016/S0960-9822(07)00548-9; MILLER FD, 1987, J CELL BIOL, V105, P3065, DOI 10.1083/jcb.105.6.3065; Mink S, 1997, MOL CELL BIOL, V17, P6609, DOI 10.1128/MCB.17.11.6609; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; NAKAJIMA T, 1993, P NATL ACAD SCI USA, V90, P2207, DOI 10.1073/pnas.90.6.2207; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Park JK, 1999, J NEUROSCI, V19, P10383; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Raballo R, 2000, J NEUROSCI, V20, P5012; Shen Q, 1998, J NEUROBIOL, V36, P162, DOI 10.1002/(SICI)1097-4695(199808)36:2<162::AID-NEU5>3.0.CO;2-#; Slack RS, 1998, J CELL BIOL, V140, P1497, DOI 10.1083/jcb.140.6.1497; Slack RS, 1996, J CELL BIOL, V135, P1085, DOI 10.1083/jcb.135.4.1085; Sterneck E, 1998, P NATL ACAD SCI USA, V95, P10908, DOI 10.1073/pnas.95.18.10908; Sterneck E, 1998, J NEUROCHEM, V70, P2424; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Toma JG, 2000, J NEUROSCI, V20, P7648; Tomita K, 2000, EMBO J, V19, P5460, DOI 10.1093/emboj/19.20.5460; Wadleigh DJ, 1999, BIOCHEM BIOPH RES CO, V264, P865, DOI 10.1006/bbrc.1999.1606; Wartiovaara K, 2002, J NEUROSCI, V22, P815, DOI 10.1523/JNEUROSCI.22-03-00815.2002; Williams BP, 1997, NEURON, V18, P553, DOI 10.1016/S0896-6273(00)80297-4; WILLIAMS SC, 1991, GENE DEV, V5, P1553, DOI 10.1101/gad.5.9.1553; WILLS G, 1995, LEARNING ORG, V2, P14	40	171	175	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 14	2002	36	4					597	610		10.1016/S0896-6273(02)01026-7	http://dx.doi.org/10.1016/S0896-6273(02)01026-7			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	616PX	12441050	Bronze			2022-12-24	WOS:000179313100008
J	Chang, YC; Weiss, DS				Chang, YC; Weiss, DS			Site-specific fluorescence reveals distinct structural changes with GABA receptor activation and antagonism	NATURE NEUROSCIENCE			English	Article							ACETYLCHOLINE BINDING-SITE; GLYCINE RECEPTOR; K+ CHANNEL; FUNCTIONAL EXPRESSION; MOLECULAR DISSECTION; SUBUNIT INTERFACES; AGONIST-BINDING; BETA-STRAND; IDENTIFICATION; RESIDUES	Neurotransmitter-operated ion channels, such as the GABA (gamma-aminobutyric acid) receptor, are important in fast synaptic transmission between neurons. Using site-specific fluorescent labeling and simultaneous electrophysiological analysis in Xenopus laevis oocytes expressing recombinant rho1 GABA receptors, we identified agonist-mediated molecular rearrangements at three positions within and near the agonist-binding pocket that were highly correlated with receptor activation. We also show that competitive antagonists induced distinct rearrangements on their own that stabilized the receptor in a closed state. Finally, the allosteric antagonist picrotoxin induced a global conformational change that was sensed in the subunit-subunit interface of the amino (N)-terminal domain, distant from its presumed site of action within the transmembrane domains. This first detection in real time of molecular rearrangements of a ligand-activated receptor provides insights into the structural correlates of activation, antagonism and allosteric modulation.	Univ Alabama Birmingham, Sch Med, Dept Neurobiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Weiss, DS (corresponding author), Univ Alabama Birmingham, Sch Med, Dept Neurobiol, 1719 6th Ave S CIRC410, Birmingham, AL 35294 USA.	dweiss@nrc.uab.edu			PHS HHS [07545, 35291] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Amin J, 1996, P ROY SOC B-BIOL SCI, V263, P273, DOI 10.1098/rspb.1996.0042; AMIN J, 1994, RECEPTOR CHANNEL, V2, P227; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Boileau AJ, 1999, J NEUROSCI, V19, P4847; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; CALVO DJ, 1995, NEUROREPORT, V6, P1118, DOI 10.1097/00001756-199505300-00011; Cha A, 1997, NEURON, V19, P1127, DOI 10.1016/S0896-6273(00)80403-1; Chang YC, 1996, J NEUROSCI, V16, P5415; Chang YC, 1998, MOL PHARMACOL, V53, P511, DOI 10.1124/mol.53.3.511; Changeux JP, 1998, NEURON, V21, P959, DOI 10.1016/S0896-6273(00)80616-9; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Cromer BA, 2002, TRENDS BIOCHEM SCI, V27, P280, DOI 10.1016/S0968-0004(02)02092-3; CZAJKOWSKI C, 1993, P NATL ACAD SCI USA, V90, P6285, DOI 10.1073/pnas.90.13.6285; DENNIS M, 1988, BIOCHEMISTRY-US, V27, P2346, DOI 10.1021/bi00407a016; FU DX, 1994, J BIOL CHEM, V269, P26152; GALZI JL, 1990, J BIOL CHEM, V265, P10430; Gandhi CS, 2000, NEURON, V27, P585, DOI 10.1016/S0896-6273(00)00068-4; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; KAO PN, 1984, J BIOL CHEM, V259, P1662; KAO PN, 1986, J BIOL CHEM, V261, P8085; Li M, 2000, J GEN PHYSIOL, V115, P491, DOI 10.1085/jgp.115.4.491; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; MARICQ AV, 1991, SCIENCE, V254, P432, DOI 10.1126/science.1718042; MIDDLETON RE, 1991, BIOCHEMISTRY-US, V30, P6987, DOI 10.1021/bi00242a026; NEWLAND CF, 1992, J PHYSIOL-LONDON, V447, P191, DOI 10.1113/jphysiol.1992.sp018998; NODA M, 1982, NATURE, V299, P793, DOI 10.1038/299793a0; OLSEN RW, 1982, ANNU REV PHARMACOL, V22, P245, DOI 10.1146/annurev.pa.22.040182.001333; PRIBILLA I, 1992, EMBO J, V11, P4305, DOI 10.1002/j.1460-2075.1992.tb05529.x; Prince RJ, 1996, J BIOL CHEM, V271, P25770, DOI 10.1074/jbc.271.42.25770; Ragozzino D, 1996, MOL PHARMACOL, V50, P1024; SCHOFIELD PR, 1987, NATURE, V328, P221, DOI 10.1038/328221a0; SIGEL E, 1992, EMBO J, V11, P2017, DOI 10.1002/j.1460-2075.1992.tb05258.x; SINE SM, 1995, NEURON, V15, P205, DOI 10.1016/0896-6273(95)90077-2; SMITH GB, 1995, TRENDS PHARMACOL SCI, V16, P162, DOI 10.1016/S0165-6147(00)89009-4; Sorensen JB, 2000, J GEN PHYSIOL, V115, P209, DOI 10.1085/jgp.115.2.209; Teissere JA, 2001, J NEUROSCI, V21, P4977, DOI 10.1523/JNEUROSCI.21-14-04977.2001; UNWIN N, 1995, NATURE, V373, P37, DOI 10.1038/373037a0; VANDENBERG RJ, 1992, NEURON, V9, P491, DOI 10.1016/0896-6273(92)90186-H; Xu M, 1995, BIOPHYS J, V69, P1858, DOI 10.1016/S0006-3495(95)80056-1; YOON KW, 1993, J PHYSIOL-LONDON, V464, P423, DOI 10.1113/jphysiol.1993.sp019643	42	81	83	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1163	1168		10.1038/nn926	http://dx.doi.org/10.1038/nn926			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	609CG	12368804				2022-12-24	WOS:000178884600019
J	Shewan, D; Dwivedy, A; Anderson, R; Holt, CE				Shewan, D; Dwivedy, A; Anderson, R; Holt, CE			Age-related changes underlie switch in netrin-1 responsiveness as growth cones advance along visual pathway	NATURE NEUROSCIENCE			English	Article							ADENOSINE A2B RECEPTOR; AXON GUIDANCE; INTERMEDIATE TARGET; PROTEIN-SYNTHESIS; CYCLIC-AMP; DCC; EXPRESSION; ATTRACTION; NEURONS; XENOPUS	Retinal axons are led out of the eye by netrin-1, an attractive guidance cue which is secreted at the optic nerve head. In the optic pathway, however, netrin-1 is expressed in areas that exclude retinal axon growth. This suggests that axons may change in their responsiveness to netrin-1 as they advance along the pathway. Indeed, in our 'whole-pathway' preparation in Xenopus, a gradual change from attraction to repulsion occurred as retinal axons emerged from progressively distal points along the pathway. We also found that axons that were aged in culture without pathway experience underwent a similar change, which correlated with a decline in cyclic AMP (cAMP) and netrin-1 receptor expression. Cyclic AMP elevators and adenosine A2b receptor agonists rejuvenated the behavior of old growth cones, causing them to regain attraction to netrin-1, whereas antagonists caused young growth cones to be repelled. These findings show that netrin-1 responsiveness is developmentally regulated and suggest that intrinsic changes that lower cAMP levels underlie this regulation.	Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England	University of Cambridge	Holt, CE (corresponding author), Univ Cambridge, Dept Anat, Downing St, Cambridge CB2 3DY, England.	ceh@mole.bio.cam.ac.uk		Holt, Christine Elizabeth/0000-0003-2829-121X				ANDERSON RB, IN PRESS MECH DEV; BASTIANI MJ, 1987, CELL, V48, P745, DOI 10.1016/0092-8674(87)90072-9; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Campbell DS, 2001, J NEUROSCI, V21, P8538, DOI 10.1523/JNEUROSCI.21-21-08538.2001; CORNEL E, 1992, NEURON, V9, P1001, DOI 10.1016/0896-6273(92)90061-H; Corset V, 2000, NATURE, V407, P747, DOI 10.1038/35037600; de la Torre JR, 1997, NEURON, V19, P1211, DOI 10.1016/S0896-6273(00)80413-4; Deiner MS, 1997, NEURON, V19, P575, DOI 10.1016/S0896-6273(00)80373-6; Diefenbach TJ, 2000, J NEUROSCI, V20, P1484; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; Erskine L, 2000, J NEUROSCI, V20, P4975; Feoktistov I, 1997, PHARMACOL REV, V49, P381; Gad JM, 2000, EXP EYE RES, V70, P711, DOI 10.1006/exer.2000.0823; Galko MJ, 2000, SCIENCE, V289, P1365, DOI 10.1126/science.289.5483.1365; GRANT P, 1986, DEV BIOL, V114, P475, DOI 10.1016/0012-1606(86)90212-5; HENDERSON LP, 1986, DEV BIOL, V113, P381, DOI 10.1016/0012-1606(86)90173-9; HOLT CE, 1989, J NEUROSCI, V9, P3123; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Hopker VH, 1999, NATURE, V401, P69, DOI 10.1038/43441; Johansson K, 2001, DEV BRAIN RES, V130, P133, DOI 10.1016/S0165-3806(01)00221-8; Kvanta A, 1997, EXP EYE RES, V65, P595, DOI 10.1006/exer.1996.0352; Lee SMK, 1997, DEVELOPMENT, V124, P959; LOHOF AM, 1992, J NEUROSCI, V12, P1253; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; O'Leary DDM, 1999, CURR OPIN NEUROBIOL, V9, P65, DOI 10.1016/S0959-4388(99)80008-7; Ringstedt T, 2000, J NEUROSCI, V20, P4983; SHEWAN D, 1995, J NEUROSCI, V15, P2057, DOI 10.1523/JNEUROSCI.15-03-02057.1995; Shirasaki R, 1998, SCIENCE, V279, P105, DOI 10.1126/science.279.5347.105; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Song HJ, 2001, NAT CELL BIOL, V3, pE81, DOI 10.1038/35060164; Stein E, 2001, SCIENCE, V291, P1976, DOI 10.1126/science.1059391; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Trousse F, 2001, DEVELOPMENT, V128, P3927; Wiemelt AP, 1997, J BIOL CHEM, V272, P31489, DOI 10.1074/jbc.272.50.31489; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	41	148	153	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2002	5	10					955	962		10.1038/nn919	http://dx.doi.org/10.1038/nn919			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	597VV	12352982				2022-12-24	WOS:000178242200014
J	Kikyo, H; Ohki, K; Miyashita, Y				Kikyo, H; Ohki, K; Miyashita, Y			Neural correlates for feeling-of-knowing: An fMRl parametric analysis	NEURON			English	Article							PREFRONTAL CORTEX; EPISODIC RETRIEVAL; CUE-FAMILIARITY; ANTERIOR CINGULATE; RECOGNITION MEMORY; ACCURACY; RECALL; INFORMATION; METAMEMORY; JUDGMENTS	The "feeling-of-knowing" (FOK) is a subjective sense of knowing a word before recalling it, and the FOK provides us clues to understanding the mechanisms of human metamemory systems. We investigated neural correlates for the FOK based on the recall-judgment-recognition paradigm. Event-related functional magnetic resonance imaging with a parametric analysis was used. We found activations in left dorsolateral, left anterior, bilateral inferior, and medial prefrontal cortices that significantly increased as the FOK became greater, and the activations remained significant even when the potentially confounding factor of the response latency was removed. Furthermore, we demonstrated that the FOK region in the right inferior frontal gyrus and a subset of the FOK region in the left inferior frontal gyrus are not recruited for successful recall processes, suggesting their particular role in metamemory processing.	Univ Tokyo, Sch Med, Dept Physiol, Bunkyo Ku, Tokyo 1130033, Japan; TOYOTA RIKEN, Nagakute, Aichi 4801192, Japan; Natl Inst Physiol Sci, Cognit Neurosci Lab, Aichi 4448585, Japan	University of Tokyo; RIKEN; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Miyashita, Y (corresponding author), Univ Tokyo, Sch Med, Dept Physiol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	yasushi_miyashita@m.u-tokyo.ac.jp	Miyashita, Yasushi/B-7171-2019	Miyashita, Yasushi/0000-0003-3496-8637				BLAKE M, 1973, J VERB LEARN VERB BE, V12, P311, DOI 10.1016/S0022-5371(73)80075-1; Buchel C, 1998, NEUROIMAGE, V8, P140, DOI 10.1006/nimg.1998.0351; Buckner RL, 1998, NEUROIMAGE, V7, P151, DOI 10.1006/nimg.1998.0327; COHEN G, 1995, MEMORY REAL WORLD, P179; Cohen JD, 2000, NAT NEUROSCI, V3, P421, DOI 10.1038/74783; COSTERMANS J, 1992, J EXP PSYCHOL LEARN, V18, P142, DOI 10.1037/0278-7393.18.1.142; Dobbins IG, 2002, NEURON, V35, P989, DOI 10.1016/S0896-6273(02)00858-9; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; Friston K J, 1994, Hum Brain Mapp, V1, P210, DOI 10.1002/hbm.460010306; FRISTON KJ, 1997, HUMAN BRAIN FUNCTION, P141; GRUNEBERG MM, 1974, ACTA PSYCHOL, V38, P257, DOI 10.1016/0001-6918(74)90010-9; HART JT, 1965, J EDUC PSYCHOL, V56, P208, DOI 10.1037/h0022263; HART JT, 1967, J VERB LEARN VERB BE, V6, P685, DOI 10.1016/S0022-5371(67)80072-0; Henson RNA, 1999, J NEUROSCI, V19, P3962; Kanwisher N, 2000, NAT REV NEUROSCI, V1, P91, DOI 10.1038/35039043; KAPUR S, 1995, NEUROREPORT, V6, P1880, DOI 10.1097/00001756-199510020-00014; Kikyo H, 2001, EUR J NEUROSCI, V14, P887, DOI 10.1046/j.0953-816x.2001.01711.x; Konishi S, 2000, NEUROIMAGE, V12, P276, DOI 10.1006/nimg.2000.0614; KORIAT A, 1993, PSYCHOL REV, V100, P609, DOI 10.1037/0033-295X.100.4.609; Koriat A, 2001, J EXP PSYCHOL LEARN, V27, P34, DOI 10.1037//0278-7393.27.1.34; LACHMAN JL, 1979, DEV PSYCHOL, V15, P543, DOI 10.1037/0012-1649.15.5.543; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Maril A, 2001, NEURON, V31, P653, DOI 10.1016/S0896-6273(01)00396-8; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; McDermott KB, 2000, J COGNITIVE NEUROSCI, V12, P965, DOI 10.1162/08989290051137503; METCALFE J, 1986, J EXP PSYCHOL LEARN, V12, P288, DOI 10.1037/0278-7393.12.2.288; METCALFE J, 1993, J EXP PSYCHOL LEARN, V19, P851, DOI 10.1037/0278-7393.19.4.851; METCALFE J, 1993, PSYCHOL REV, V100, P3, DOI 10.1037/0033-295X.100.1.3; METCALFE J, 2000, OXFORD HDB MEMORY; Miyashita Y, 2000, CURR OPIN NEUROBIOL, V10, P187, DOI 10.1016/S0959-4388(00)00071-4; MIYASHITA Y, 1999, NEW COGNITIVE NEUROS, P379; Nelson T. O., 1988, PRACTICAL ASPECTS ME, V1, P190; Nelson T.O., 1990, PSYCHOL LEARNING MOT, V26, P125, DOI [10.1016/S0079-7421(08)60053-5, DOI 10.1016/S0079-7421(08)60053-5, 10.1016/s0079-7421(08)60053-5]; NELSON TO, 1984, J EXP PSYCHOL GEN, V113, P282, DOI 10.1037/0096-3445.113.2.282; NELSON TO, 1980, J VERB LEARN VERB BE, V19, P338, DOI 10.1016/S0022-5371(80)90266-2; NELSON TO, 1984, PSYCHOL BULL, V95, P109, DOI 10.1037/0033-2909.95.1.109; Nyberg L, 1995, NEUROREPORT, V7, P249, DOI 10.1097/00001756-199512000-00060; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; REDER LM, 1987, COGNITIVE PSYCHOL, V19, P90, DOI 10.1016/0010-0285(87)90005-3; REDER LM, 1992, J EXP PSYCHOL LEARN, V18, P435, DOI 10.1037/0278-7393.18.3.435; Ricci PT, 1999, NEUROIMAGE, V9, P88, DOI 10.1006/nimg.1998.0386; SCHACTER DL, 1983, J EXP PSYCHOL LEARN, V9, P39, DOI 10.1037/0278-7393.9.1.39; SCHWARTZ BL, 1994, PSYCHON B REV, V1, P357, DOI 10.3758/BF03213977; SCHWARTZ BL, 1992, J EXP PSYCHOL LEARN, V18, P1074, DOI 10.1037/0278-7393.18.5.1074; SHIMAMURA AP, 1986, J EXP PSYCHOL LEARN, V12, P452, DOI 10.1037/0278-7393.12.3.452; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Talairach J., 1988, COPLANAR STEREOTAXIC; Vandenberghe R, 1996, NATURE, V383, P254, DOI 10.1038/383254a0; Wagner AD, 2001, NEURON, V31, P329, DOI 10.1016/S0896-6273(01)00359-2; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O	51	113	120	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 26	2002	36	1					177	186		10.1016/S0896-6273(02)00939-X	http://dx.doi.org/10.1016/S0896-6273(02)00939-X			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	598UP	12367516	Bronze			2022-12-24	WOS:000178295100017
J	Gold, BT; Buckner, RL				Gold, BT; Buckner, RL			Common prefrontal regions coactivate with dissociable posterior regions during controlled semantic and phonological tasks	NEURON			English	Article							POSITRON EMISSION TOMOGRAPHY; NONSPATIAL WORKING-MEMORY; INFERIOR FRONTAL-CORTEX; FUNCTIONAL MRI; HUMAN BRAIN; READING ALOUD; RETRIEVAL; WORD; ACTIVATION; PET	One of the most ubiquitous findings in functional neuroimaging research is activation of left inferior prefrontal cortex (LIPC) during tasks requiring controlled semantic retrieval. Here we show that LIPC participates in the controlled retrieval of nonsemantic representations as well as semantic representations. Results also demonstrate that LIPC coactivates with dissociable posterior regions depending on the information retrieved: activating with left temporal cortex during the controlled retrieval of semantics and with left posterior frontal and parietal cortex during the controlled retrieval of phonology. Correlation of performance to LIPC activation suggests a processing role associated with mapping relatively ambiguous stimulus-to-representation relationships during both semantic and phonological tasks. These findings suggest that LIPC participates in controlled processing across multiple information domains collaborating with dissociable posterior regions depending upon the kind of information retrieved.	Washington Univ, Dept Psychol, St Louis, MO 63130 USA; Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Howard Hughes Med Inst, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Howard Hughes Medical Institute	Gold, BT (corresponding author), Washington Univ, Dept Psychol, 1 Brookings Dr, St Louis, MO 63130 USA.	bgold@artsci.wustl.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057506] Funding Source: NIH RePORTER; NIMH NIH HHS [MH57506] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Asaad WF, 1998, NEURON, V21, P1399, DOI 10.1016/S0896-6273(00)80658-3; Awh E, 1996, PSYCHOL SCI, V7, P25, DOI 10.1111/j.1467-9280.1996.tb00662.x; BANDETTINI PA, 1993, MAGNET RESON MED, V30, P161, DOI 10.1002/mrm.1910300204; BARDE LHF, 2002, IN PRESS J COGN NEUR; Binder JR, 1997, J NEUROSCI, V17, P353, DOI 10.1523/JNEUROSCI.17-01-00353.1997; Bokde ALW, 2001, NEURON, V30, P609, DOI 10.1016/S0896-6273(01)00288-4; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Buckner RL, 2000, BRAIN, V123, P620, DOI 10.1093/brain/123.3.620; Buckner RL, 1996, PSYCHON B REV, V3, P149, DOI 10.3758/BF03212413; BUCKNER RL, 1995, J NEUROPHYSIOL, V74, P2163, DOI 10.1152/jn.1995.74.5.2163; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; COLTHEART M, 1993, PSYCHOL REV, V100, P589, DOI 10.1037/0033-295X.100.4.589; D'Esposito M, 1998, COGNITIVE BRAIN RES, V7, P1, DOI 10.1016/S0926-6410(98)00004-4; DEMB JB, 1995, J NEUROSCI, V15, P5870; DEMONET JF, 1992, BRAIN, V115, P1753, DOI 10.1093/brain/115.6.1753; Duncan J, 2001, NAT REV NEUROSCI, V2, P820, DOI 10.1038/35097575; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Fiez JA, 1996, J NEUROSCI, V16, P808; FIEZ JA, 1995, J COGNITIVE NEUROSCI, V7, P357, DOI 10.1162/jocn.1995.7.3.357; Fiez JA, 1997, HUM BRAIN MAPP, V5, P79, DOI 10.1002/(SICI)1097-0193(1997)5:2<79::AID-HBM1>3.3.CO;2-M; Fletcher PC, 2000, NEUROIMAGE, V12, P404, DOI 10.1006/nimg.2000.0633; FRIEDMAN RB, 1992, BRAIN LANG, V43, P400, DOI 10.1016/0093-934X(92)90109-R; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; FRITH CD, 1991, NEUROPSYCHOLOGIA, V29, P1137, DOI 10.1016/0028-3932(91)90029-8; Gabrieli JDE, 1998, P NATL ACAD SCI USA, V95, P906, DOI 10.1073/pnas.95.3.906; Gabrieli JDE, 1996, PSYCHOL SCI, V7, P278, DOI 10.1111/j.1467-9280.1996.tb00374.x; GLUSHKO RJ, 1979, J EXP PSYCHOL HUMAN, V5, P674, DOI 10.1037/0096-1523.5.4.674; Goldman-Rakic P. S., 2011, COMPR PHYSIOL, DOI [10.1002/CPHY.CP010509, DOI 10.1002/CPHY.CP010509]; Hagoort P, 1999, J COGNITIVE NEUROSCI, V11, P383, DOI 10.1162/089892999563490; Herbster AN, 1997, HUM BRAIN MAPP, V5, P84, DOI 10.1002/(SICI)1097-0193(1997)5:2<84::AID-HBM2>3.0.CO;2-I; HOWARD D, 1992, BRAIN, V115, P1769, DOI 10.1093/brain/115.6.1769; Jonides J, 1998, J NEUROSCI, V18, P5026; Kapur S, 1996, COGNITIVE BRAIN RES, V4, P243, DOI 10.1016/S0926-6410(96)00058-4; Kucera H., 1967, COMPUTATIONAL ANAL P; Logan JM, 2002, NEURON, V33, P827, DOI 10.1016/S0896-6273(02)00612-8; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; McDermott KB, 1999, J COGNITIVE NEUROSCI, V11, P631, DOI 10.1162/089892999563698; Milham MP, 2001, COGNITIVE BRAIN RES, V12, P467, DOI 10.1016/S0926-6410(01)00076-3; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; MILNER B, 1963, ARCH NEUROL-CHICAGO, V9, P90, DOI 10.1001/archneur.1963.00460070100010; Milner B., 1964, FRONTAL GRANULAR COR, P313; NEELY JH, 1977, J EXP PSYCHOL GEN, V106, P226, DOI 10.1037/0096-3445.106.3.226; Norman D. A., 1986, CONSCIOUSNESS SELF R, V4, P1; Owen AM, 1998, P NATL ACAD SCI USA, V95, P7721, DOI 10.1073/pnas.95.13.7721; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; Petersen S E, 1989, J Cogn Neurosci, V1, P153, DOI 10.1162/jocn.1989.1.2.153; PETRIDES M, 1982, NEUROPSYCHOLOGIA, V20, P249, DOI 10.1016/0028-3932(82)90100-2; Petrides M, 1994, HDB NEUROPSYCHOLOGY, V9, P59; Plaut DC, 1996, PSYCHOL REV, V103, P56, DOI 10.1037/0033-295X.103.1.56; Poldrack RA, 2001, J COGNITIVE NEUROSCI, V13, P687, DOI 10.1162/089892901750363235; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Price CJ, 1999, J COGNITIVE NEUROSCI, V11, P371, DOI 10.1162/089892999563481; Pugh KR, 1996, BRAIN, V119, P1221, DOI 10.1093/brain/119.4.1221; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; Roskies AL, 2001, J COGNITIVE NEUROSCI, V13, P829, DOI 10.1162/08989290152541485; Rumsey JM, 1997, BRAIN, V120, P739, DOI 10.1093/brain/120.5.739; Schmahmann J.D., 2000, MRI ATLAS HUMAN CERE; Shallice T., 1988, NEUROPSYCHOLOGY MENT, DOI DOI 10.1017/IPM.2020.45; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Snyder AZ., 1996, QUANTIFICATION BRAIN, P131, DOI DOI 10.1016/B978-012389760-2/50028-1; STUSS DT, 1984, PSYCHOL BULL, V95, P3, DOI 10.1037/0033-2909.95.1.3; Talairach J., 1988, COPLANAR STEREOTAXIC; Thompson-Schill SL, 1999, NEURON, V23, P513, DOI 10.1016/S0896-6273(00)80804-1; Thompson-Schill SL, 1998, P NATL ACAD SCI USA, V95, P15855, DOI 10.1073/pnas.95.26.15855; Thompson-Schill SL, 1997, P NATL ACAD SCI USA, V94, P14792, DOI 10.1073/pnas.94.26.14792; Vandenberghe R, 1996, NATURE, V383, P254, DOI 10.1038/383254a0; Wagner AD, 2001, NEURON, V31, P329, DOI 10.1016/S0896-6273(01)00359-2; Wagner AD, 2000, CEREB CORTEX, V10, P1176, DOI 10.1093/cercor/10.12.1176; ZATORRE RJ, 1992, SCIENCE, V256, P846, DOI 10.1126/science.1589767	69	308	312	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 15	2002	35	4					803	812		10.1016/S0896-6273(02)00800-0	http://dx.doi.org/10.1016/S0896-6273(02)00800-0			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	585JE	12194878	Bronze			2022-12-24	WOS:000177521000019
J	Smith, TC; Jahr, CE				Smith, TC; Jahr, CE			Self-inhibition of olfactory bulb neurons	NATURE NEUROSCIENCE			English	Article							DENDRODENDRITIC INHIBITION; PERIGLOMERULAR CELLS; NMDA RECEPTORS; GRANULE CELLS; RECIPROCAL SYNAPSES; GLOMERULAR LAYER; NERVE-TERMINALS; GABA RELEASE; MITRAL CELLS; RAT-BRAIN	The GABA (gamma-aminobutyric- acid)-containing periglomerular (PG) cells provide the first level of inhibition to mitral and tufted (M/T) cells, the output neurons of the olfactory bulb. We find that stimulation of PG cells of the rat olfactory bulb results in self-inhibition: release of GABA from an individual PG cell activates GABA(A) receptors on the same neuron. PG cells normally contain high concentrations of intracellular chloride and consequently are depolarized by GABA. Despite this, GABA inhibits PG cell firing by shunting excitatory signals. Finally, GABA released during self-inhibition may spill over to neighboring PG cells, resulting in a lateral spread of inhibition. Given the gatekeeping role of PG cells in the olfactory network, GABA-mediated self-inhibition will favor M/T cell excitation during intense sensory stimulation.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA	Oregon Health & Science University	Jahr, CE (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, L474,3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.				NINDS NIH HHS [F32 NS11093, NS21419] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021419, F32NS011093] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aroniadou-Anderjaska V, 2000, J NEUROPHYSIOL, V84, P1194, DOI 10.1152/jn.2000.84.3.1194; BURGER PM, 1991, NEURON, V7, P287, DOI 10.1016/0896-6273(91)90267-4; Chen WR, 2000, NEURON, V25, P625, DOI 10.1016/S0896-6273(00)81065-X; Christie JM, 2001, J NEUROPHYSIOL, V85, P169, DOI 10.1152/jn.2001.85.1.169; ECCLES JC, 1962, J PHYSL, V160, P532; Friedman D, 2000, J NEUROPHYSIOL, V84, P39, DOI 10.1152/jn.2000.84.1.39; FRITSCHY JM, 1995, J COMP NEUROL, V359, P154, DOI 10.1002/cne.903590111; Halabisky B, 2000, J NEUROSCI, V20, P5124; Isaacson JS, 1999, NEURON, V23, P377, DOI 10.1016/S0896-6273(00)80787-4; Isaacson JS, 1998, NEURON, V20, P749, DOI 10.1016/S0896-6273(00)81013-2; JAHR CE, 1982, NATURE, V297, P227, DOI 10.1038/297227a0; JAHR CE, 1982, J PHYSIOL-LONDON, V326, P213, DOI 10.1113/jphysiol.1982.sp014187; Kasowski HJ, 1999, J COMP NEUROL, V407, P261, DOI 10.1002/(SICI)1096-9861(19990503)407:2<261::AID-CNE7>3.0.CO;2-G; Kosaka K, 1998, NEUROSCI RES, V30, P101, DOI 10.1016/S0168-0102(98)00002-9; KYROZIS A, 1995, J NEUROSCI METH, V57, P27, DOI 10.1016/0165-0270(94)00116-X; LAURIE DJ, 1992, J NEUROSCI, V12, P1063; Lu T, 2001, J PHYSIOL-LONDON, V535, P125, DOI 10.1111/j.1469-7793.2001.t01-1-00125.x; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; McQuiston AR, 2001, J NEUROPHYSIOL, V86, P1899, DOI 10.1152/jn.2001.86.4.1899; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; NICOLL RA, 1969, BRAIN RES, V14, P157, DOI 10.1016/0006-8993(69)90037-7; NICOLL RA, 1979, J PHYSIOL-LONDON, V290, P113, DOI 10.1113/jphysiol.1979.sp012763; NICOLL RA, 1982, NATURE, V296, P441, DOI 10.1038/296441a0; PINCHING AJ, 1971, J CELL SCI, V9, P305; PINCHING AJ, 1971, J CELL SCI, V9, P379; PINCHING AJ, 1971, J CELL SCI, V9, P347; Pouzat C, 1999, J NEUROSCI, V19, P1675; PRICE JL, 1970, J CELL SCI, V7, P125; Puopolo M, 1998, EUR J NEUROSCI, V10, P1073, DOI 10.1046/j.1460-9568.1998.00115.x; RALL W, 1966, EXP NEUROL, V14, P44, DOI 10.1016/0014-4886(66)90023-9; RIBAK CE, 1977, BRAIN RES, V126, P1, DOI 10.1016/0006-8993(77)90211-6; Rozov A, 2001, J PHYSIOL-LONDON, V531, P807, DOI 10.1111/j.1469-7793.2001.0807h.x; Salin PA, 2001, J NEUROPHYSIOL, V85, P1275, DOI 10.1152/jn.2001.85.3.1275; SCHNEIDER SP, 1983, J NEUROPHYSIOL, V50, P358, DOI 10.1152/jn.1983.50.2.358; Schoppa NE, 1998, J NEUROSCI, V18, P6790; SEGAL MM, 1990, J NEUROPHYSIOL, V64, P1390, DOI 10.1152/jn.1990.64.5.1390; Shepherd G.M., 1998, SYNAPTIC ORG BRAIN, P159; SHEPHERD GM, 1963, J PHYSIOL-LONDON, V168, P101, DOI 10.1113/jphysiol.1963.sp007180; SIKLOS L, 1995, NEUROSCIENCE, V64, P165, DOI 10.1016/0306-4522(94)00382-F; STALEY KJ, 1992, J NEUROPHYSIOL, V68, P197, DOI 10.1152/jn.1992.68.1.197; TRAYNELIS SF, 1993, NEURON, V11, P279, DOI 10.1016/0896-6273(93)90184-S; WELLIS DP, 1990, J NEUROPHYSIOL, V64, P932, DOI 10.1152/jn.1990.64.3.932; WHITE EL, 1972, BRAIN RES, V37, P69, DOI 10.1016/0006-8993(72)90346-0; ZHANG SLJ, 1995, J PHYSIOL-LONDON, V483, P583, DOI 10.1113/jphysiol.1995.sp020608	44	63	63	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2002	5	8					760	766		10.1038/nn882	http://dx.doi.org/10.1038/nn882			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	577XT	12089528				2022-12-24	WOS:000177088900019
J	Barria, A; Malinow, R				Barria, A; Malinow, R			Subunit-specific NMDA receptor trafficking to synapses	NEURON			English	Article							D-ASPARTATE RECEPTOR; ER RETENTION SIGNAL; LONG-TERM DEPRESSION; NR1 SPLICE VARIANTS; AMPA RECEPTOR; VISUAL-CORTEX; THALAMOCORTICAL SYNAPSES; HIPPOCAMPAL-NEURONS; SYNAPTIC PLASTICITY; CRITICAL PERIOD	To elucidate mechanisms controlling the number and subunit composition of synaptic NMDA-Rs in hippocampal slice neurons, the NR1, NR2A, and NR2B subunits were optically and electrophysiologically tagged. The NR2 subunit directs delivery of receptors to synapses with different rules controlling NR2A and NR2B. Synaptic incorporation of NR2B-containing receptors is not limited by synaptic transmission nor enhanced by increased subunit expression. NR2A-containing receptors whose expression normally increases with age replace synaptic NR2B-containing receptors. Replacement is enhanced by increased NR2A expression and requires synaptic activity. Surprisingly, spontaneously released transmitter acting on synaptic NMDARs is sufficient for replacement and reduces NMDA-R responses. Thus, as with AMPA-Rs, synaptic trafficking of NMDA-Rs is tightly regulated and has subunit-specific rules with functionally important consequences.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Malinow, R (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.							Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Blahos J, 1996, J BIOL CHEM, V271, P15669, DOI 10.1074/jbc.271.26.15669; BURNASHEV N, 1992, SCIENCE, V257, P1415, DOI 10.1126/science.1382314; Calver AR, 2001, J NEUROSCI, V21, P1203; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Chavis P, 2001, NATURE, V411, P317, DOI 10.1038/35077101; CHOI DW, 1995, TRENDS NEUROSCI, V18, P58; Constantine-Paton M, 1998, CURR OPIN NEUROBIOL, V8, P139, DOI 10.1016/S0959-4388(98)80017-2; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Dingledine R, 1999, PHARMACOL REV, V51, P7; Feldman DE, 1998, NEURON, V21, P347, DOI 10.1016/S0896-6273(00)80544-9; Flint AC, 1997, J NEUROSCI, V17, P2469; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; Huh KH, 1999, J BIOL CHEM, V274, P151, DOI 10.1074/jbc.274.1.151; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; LAURIE DJ, 1994, J NEUROSCI, V14, P3180; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Lu HC, 2001, NEURON, V32, P619, DOI 10.1016/S0896-6273(01)00501-3; MACDONALD JF, 1991, J PHYSIOL-LONDON, V432, P483, DOI 10.1113/jphysiol.1991.sp018396; Mainen ZF, 1999, METHODS, V18, P231, DOI 10.1006/meth.1999.0776; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; MEGURO H, 1992, NATURE, V357, P70, DOI 10.1038/357070a0; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORI H, 1992, NATURE, V358, P673, DOI 10.1038/358673a0; Mori H, 1998, NEURON, V21, P571, DOI 10.1016/S0896-6273(00)80567-X; NAKANISHI N, 1992, P NATL ACAD SCI USA, V89, P8552, DOI 10.1073/pnas.89.18.8552; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Pagano A, 2001, J NEUROSCI, V21, P1189; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Philpot BD, 2001, NEUROPHARMACOLOGY, V41, P762, DOI 10.1016/S0028-3908(01)00136-8; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; PICCINI A, 2002, IN PRESS J NEUROSCI; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Scott DB, 2001, J NEUROSCI, V21, P3063, DOI 10.1523/JNEUROSCI.21-09-03063.2001; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Sheng M, 2000, ANNU REV PHYSIOL, V62, P755, DOI 10.1146/annurev.physiol.62.1.755; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Single FN, 2000, J NEUROSCI, V20, P2558; Sprengel R, 1998, CELL, V92, P279, DOI 10.1016/S0092-8674(00)80921-6; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; Steigerwald F, 2000, J NEUROSCI, V20, P4573, DOI 10.1523/JNEUROSCI.20-12-04573.2000; Stocca G, 1998, J PHYSIOL-LONDON, V507, P13, DOI 10.1111/j.1469-7793.1998.013bu.x; Tovar KR, 1999, J NEUROSCI, V19, P4180; Vissel B, 2001, NAT NEUROSCI, V4, P587, DOI 10.1038/88404; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; Xia H, 2001, NEUROPHARMACOLOGY, V41, P714, DOI 10.1016/S0028-3908(01)00103-4; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614; Zoghbi HY, 2000, CURR OPIN NEUROBIOL, V10, P655, DOI 10.1016/S0959-4388(00)00135-5; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	54	397	411	0	30	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 18	2002	35	2					345	353		10.1016/S0896-6273(02)00776-6	http://dx.doi.org/10.1016/S0896-6273(02)00776-6			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	576YF	12160751	Bronze			2022-12-24	WOS:000177034200013
J	Akaaboune, M; Grady, RM; Turney, S; Sanes, JR; Lichtman, JW				Akaaboune, M; Grady, RM; Turney, S; Sanes, JR; Lichtman, JW			Neurotransmitter receptor dynamics studied in vivo by reversible photo-unbinding of fluorescent ligands	NEURON			English	Article							EXTRAJUNCTIONAL ACETYLCHOLINE-RECEPTORS; DYSTROPHIN-GLYCOPROTEIN COMPLEX; DUCHENNE MUSCULAR-DYSTROPHY; UTROPHIN-DEFICIENT MICE; NEUROMUSCULAR-JUNCTIONS; SKELETAL-MUSCLE; INVIVO VISUALIZATION; CILIARY GANGLION; RAPSYN; SYNAPSE	We show that fluorescently tagged ligands with high affinity for their targets can be reversibly unbound by focused laser excitation. By sequential unbinding and relabeling with different colors of alpha-bungarotoxin, we selectively labeled adjacent pools of acetylcholine receptors [AChRs) at neuromuscular junctions of adult mice. Timelapse imaging in vivo revealed that synaptic AChRs completely intermingle over similar to4 days and many extrasynaptic AChRs are incorporated into the synapse each day. In mice that lacked alpha-dystrobrevin, a component of the dystrophin-glycoprotein complex, rates of AChR turnover, and intermingling were increased similar to4- to 5-fold. These results demonstrate remarkable molecular dynamism underlying macroscopic stability of the postsynaptic membrane, and establish alpha-dystrobrevin as a key control point for regulation of mobility and turnover.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Lichtman, JW (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, 660 S Euclid Ave, St Louis, MO 63110 USA.							Adams ME, 2000, J CELL BIOL, V150, P1385, DOI 10.1083/jcb.150.6.1385; Akaaboune M, 1999, SCIENCE, V286, P503, DOI 10.1126/science.286.5439.503; [Anonymous], 1991, MODERN MOL PHOTOCHEM; APEL ED, 1995, NEURON, V15, P115, DOI 10.1016/0896-6273(95)90069-1; Apel ED, 1997, NEURON, V18, P623, DOI 10.1016/S0896-6273(00)80303-7; AXELROD D, 1976, P NATL ACAD SCI USA, V73, P4594, DOI 10.1073/pnas.73.12.4594; AXELROD D, 1978, BIOCHIM BIOPHYS ACTA, V511, P23, DOI 10.1016/0005-2736(78)90062-7; Balasubramanian S, 1998, FEBS LETT, V432, P133, DOI 10.1016/S0014-5793(98)00804-7; BALICEGORDON RJ, 1990, J NEUROSCI, V10, P894; BALICEGORDON RJ, 1994, NATURE, V372, P519, DOI 10.1038/372519a0; BALICEGORDON RJ, 1993, NEURON, V11, P801, DOI 10.1016/0896-6273(93)90110-D; Bartoli M, 2001, J BIOL CHEM, V276, P24911, DOI 10.1074/jbc.M103258200; BETZ H, 1982, J BIOL CHEM, V257, P1390; BEWICK GS, 1994, P ROY SOC B-BIOL SCI, V258, P201, DOI 10.1098/rspb.1994.0163; BRENNER HR, 1976, J PHYSIOL-LONDON, V260, P159, DOI 10.1113/jphysiol.1976.sp011509; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Cartaud A, 1998, J BIOL CHEM, V273, P11321, DOI 10.1074/jbc.273.18.11321; Deconinck AE, 1997, CELL, V90, P717, DOI 10.1016/S0092-8674(00)80532-2; Deconinck AE, 1997, J CELL BIOL, V136, P883, DOI 10.1083/jcb.136.4.883; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; ENGEL AG, 1982, CIBA F SYMP, V90, P197; Enigk RE, 2001, FRONT BIOSCI, V6, pD53, DOI 10.2741/enigk; FAMBROUGH DM, 1979, PHYSIOL REV, V59, P165, DOI 10.1152/physrev.1979.59.1.165; GARDNER JM, 1979, CELL, V16, P661, DOI 10.1016/0092-8674(79)90039-4; GAUTAM M, 1995, NATURE, V377, P232, DOI 10.1038/377232a0; Grady RM, 1997, CELL, V90, P729, DOI 10.1016/S0092-8674(00)80533-4; Grady RM, 2000, NEURON, V25, P279, DOI 10.1016/S0896-6273(00)80894-6; Grady RM, 1999, NAT CELL BIOL, V1, P215, DOI 10.1038/12034; Grady RM, 1997, J CELL BIOL, V136, P871, DOI 10.1083/jcb.136.4.871; GREEN DPL, 1975, PHILOS T R SOC B, V270, P551, DOI 10.1098/rstb.1975.0031; JACOB MH, 1987, J CELL BIOL, V105, P1847, DOI 10.1083/jcb.105.4.1847; Jacobson C, 2001, J CELL BIOL, V152, P435, DOI 10.1083/jcb.152.3.435; KUROMI H, 1985, DEV BIOL, V109, P165, DOI 10.1016/0012-1606(85)90357-4; Liang F, 2001, J NEUROCHEM, V77, P1626, DOI 10.1046/j.1471-4159.2001.00377.x; LICHTMAN JW, 1987, J NEUROSCI, V7, P1215; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Missias AC, 1996, DEV BIOL, V179, P223, DOI 10.1006/dbio.1996.0253; Mohamed AS, 2001, J NEUROSCI, V21, P3806, DOI 10.1523/JNEUROSCI.21-11-03806.2001; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; RICH M, 1989, NEURON, V3, P677, DOI 10.1016/0896-6273(89)90236-5; RICH MM, 1989, J NEUROSCI, V9, P1781, DOI 10.1523/jneurosci.09-05-01781.1989; ROUSSELET A, 1982, EMBO J, V1, P439, DOI 10.1002/j.1460-2075.1982.tb01188.x; SALPETER MM, 1988, J CELL BIOL, V106, P2087, DOI 10.1083/jcb.106.6.2087; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; SOLER G, 1983, ARCH BIOCHEM BIOPHYS, V225, P872, DOI 10.1016/0003-9861(83)90100-5; STOUT AL, 1995, PHOTOCHEM PHOTOBIOL, V62, P239, DOI 10.1111/j.1751-1097.1995.tb05264.x; Straub V, 1997, CURR OPIN NEUROL, V10, P168, DOI 10.1097/00019052-199704000-00016; STYA M, 1984, J NEUROSCI, V4, P70; STYA M, 1983, J CELL BIOL, V97, P48, DOI 10.1083/jcb.97.1.48; Turney SG, 1996, J NEUROSCI METH, V64, P199, DOI 10.1016/0165-0270(95)00135-2; VANMIER P, 1994, J NEUROSCI, V14, P5672; WALD G, 1968, SCIENCE, V162, P230, DOI 10.1126/science.162.3850.230	53	85	87	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 13	2002	34	6					865	876		10.1016/S0896-6273(02)00739-0	http://dx.doi.org/10.1016/S0896-6273(02)00739-0			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	563HF	12086635	Bronze			2022-12-24	WOS:000176249700005
J	Gilmour, DT; Maischein, HM; Nusslein-Volhard, C				Gilmour, DT; Maischein, HM; Nusslein-Volhard, C			Migration and function of a glial subtype in the vertebrate peripheral nervous system	NEURON			English	Article							NEURAL CREST DEVELOPMENT; HIRSCHSPRUNG-DISEASE; TRACT FORMATION; AXON GUIDANCE; MOUSE MODEL; DANIO-RERIO; ZEBRAFISH; SOX10; MUTATIONS; DROSOPHILA	Glia-axon interactions are essential for the development and function of the nervous system. We combine in vivo imaging and genetics to address the mechanism by which the migration of these cells is coordinated during embryonic development. Using stable transgenic lines, we have followed the migration of one subset of glial cells and their target axons in living zebrafish embryos. These cells coalesce at an early stage and remain coupled throughout migration, with axons apparently pathfinding for glia. Mutant analysis demonstrates that axons provide instructive cues that are sufficient to control glial guidance. Furthermore, mutations in the transcription factor Sox10/cls uncouple the migration of axons and glia. Finally, genetic ablation of this glial subtype reveals an essential role in nerve fasciculation.	Max Planck Inst Entwicklungsbiol, Genet Abt, D-72076 Tubingen, Germany	Max Planck Society	Gilmour, DT (corresponding author), Max Planck Inst Entwicklungsbiol, Genet Abt, Spemannstr 35, D-72076 Tubingen, Germany.			Gilmour, Darren/0000-0001-7613-090X				Auld V, 1999, CELL MOL LIFE SCI, V55, P1377, DOI 10.1007/s000180050378; BHATTACHARYYA A, 1994, DEVELOPMENT, V120, P1411; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; BRONNERFRASER M, 1993, BIOESSAYS, V15, P221, DOI 10.1002/bies.950150402; CARPENTER EM, 1992, DEV BIOL, V150, P144, DOI 10.1016/0012-1606(92)90014-8; Dutton KA, 2001, DEVELOPMENT, V128, P4113; GIANGRANDE A, 1994, DEVELOPMENT, V120, P523; GILMOUR DT, 2002, IN PRESS ZEBRAFISH P; Gompel N, 2001, MECH DEVELOP, V105, P69, DOI 10.1016/S0925-4773(01)00382-3; Herbarth B, 1998, P NATL ACAD SCI USA, V95, P5161, DOI 10.1073/pnas.95.9.5161; HIDALGO A, 1995, DEVELOPMENT, V121, P3703; Hidalgo A, 2000, DEVELOPMENT, V127, P393; Karlstrom RO, 1999, GENE DEV, V13, P388, DOI 10.1101/gad.13.4.388; Kelsh RN, 1996, DEVELOPMENT, V123, P369; Kelsh RN, 2000, DEVELOPMENT, V127, P515; Kelsh RN, 2000, MECH DEVELOP, V93, P161, DOI 10.1016/S0925-4773(00)00250-1; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; LEDOURAIN N, 1999, NEURAL CREST; MARCUS RC, 1995, J COMP NEUROL, V359, P365, DOI 10.1002/cne.903590302; Morris JK, 1999, NEURON, V23, P273, DOI 10.1016/S0896-6273(00)80779-5; Noordermeer JN, 1998, NEURON, V21, P991, DOI 10.1016/S0896-6273(00)80618-2; Pingault V, 1998, NAT GENET, V18, P171, DOI 10.1038/ng0298-171; Schauerte HE, 1998, DEVELOPMENT, V125, P2983; Sepp KJ, 2001, DEV BIOL, V238, P47, DOI 10.1006/dbio.2001.0411; Shoji W, 1998, DEVELOPMENT, V125, P1275; Southard-Smith EM, 1998, NAT GENET, V18, P60, DOI 10.1038/ng0198-60; STREISINGER G, 1986, GENETICS, V112, P311; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; vanEeden FJM, 1996, DEVELOPMENT, V123, P153; Woldeyesus MT, 1999, GENE DEV, V13, P2538, DOI 10.1101/gad.13.19.2538; Wulf P, 1999, J NEUROSCI RES, V57, P467, DOI 10.1002/(SICI)1097-4547(19990815)57:4<467::AID-JNR6>3.3.CO;2-V	31	230	231	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 16	2002	34	4					577	588		10.1016/S0896-6273(02)00683-9	http://dx.doi.org/10.1016/S0896-6273(02)00683-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	553FT	12062041	Bronze			2022-12-24	WOS:000175665700011
J	Arnth-Jensen, N; Jabaudon, D; Scanziani, M				Arnth-Jensen, N; Jabaudon, D; Scanziani, M			Cooperation between independent hippocampal synapses is controlled by glutamate uptake	NATURE NEUROSCIENCE			English	Article							EXCITATORY SYNAPTIC CURRENTS; MULTIPLE RELEASE SITES; MOSSY FIBER SYNAPSES; PARALLEL FIBER; TRANSPORTERS; SPILLOVER; RECEPTORS; CELLS; TRANSMISSION; POTENTIATION	Localized action of released neurotransmitters is the basis for synaptic independence. In the hippocampal neuropil, where synapses are densely packed, it has been postulated that released glutamate, by diffusing out of the synaptic cleft, may also activate postsynaptic receptors at neighboring synapses. Here we show that neighboring excitatory synapses on hippocampal CA1 pyramidal cells can cooperate in the activation of postsynaptic receptors through the confluence of released glutamate, and that this cooperation is controlled by glutamate uptake. Furthermore, glutamate transporters control temporal interactions between transmitter transients originating from the same axon. Thus, cooperative interactions between excitatory synapses are modulated in space and time by glutamate uptake.	Univ Zurich, Brain Res Inst, CH-8057 Zurich, Switzerland; Univ Hosp Geneva, Dept Neurol, CH-1211 Geneva, Switzerland	University of Zurich; University of Geneva	Scanziani, M (corresponding author), Univ Zurich, Brain Res Inst, Winterthurerstr 190, CH-8057 Zurich, Switzerland.		Jabaudon, Denis/B-8802-2014	Jabaudon, Denis/0000-0003-2438-4769				Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; BARBOUR B, 1994, NEURON, V12, P1331, DOI 10.1016/0896-6273(94)90448-0; Barbour B, 1997, TRENDS NEUROSCI, V20, P377; Bergles DE, 1997, NEURON, V19, P1297, DOI 10.1016/S0896-6273(00)80420-1; Carter AG, 2000, J NEUROSCI, V20, P4423, DOI 10.1523/JNEUROSCI.20-12-04423.2000; Diamond JS, 2001, J NEUROSCI, V21, P8328, DOI 10.1523/JNEUROSCI.21-21-08328.2001; Engert F, 1997, NATURE, V388, P279, DOI 10.1038/40870; FOX SE, 1975, EXP NEUROL, V49, P299, DOI 10.1016/0014-4886(75)90213-7; GAHWILER BH, 1981, J NEUROSCI METH, V4, P329, DOI 10.1016/0165-0270(81)90003-0; Gegelashvili G, 1997, MOL PHARMACOL, V52, P6, DOI 10.1124/mol.52.1.6; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; HARTZELL HC, 1975, J PHYSIOL-LONDON, V251, P427, DOI 10.1113/jphysiol.1975.sp011102; HESTRIN S, 1990, NEURON, V5, P247, DOI 10.1016/0896-6273(90)90162-9; ISAACSON JS, 1993, J NEUROPHYSIOL, V70, P2187, DOI 10.1152/jn.1993.70.5.2187; Jabaudon D, 1999, P NATL ACAD SCI USA, V96, P8733, DOI 10.1073/pnas.96.15.8733; Lehre KP, 1998, J NEUROSCI, V18, P8751, DOI 10.1523/jneurosci.18-21-08751.1998; LI XM, 1994, POTENTIAL ANAL, V3, P339, DOI 10.1007/BF01049807; Lozovaya NA, 1999, NEUROSCIENCE, V91, P1321, DOI 10.1016/S0306-4522(98)00638-1; MALINOW R, 1994, P NATL ACAD SCI USA, V91, P8170, DOI 10.1073/pnas.91.17.8170; MENNERICK S, 1994, NATURE, V368, P59, DOI 10.1038/368059a0; Otis TS, 1996, J NEUROSCI, V16, P1634, DOI 10.1523/jneurosci.16-05-01634.1996; Rusakov DA, 1998, P NATL ACAD SCI USA, V95, P8975, DOI 10.1073/pnas.95.15.8975; SARANTIS M, 1993, NEURON, V11, P541, DOI 10.1016/0896-6273(93)90158-N; Scanziani M, 2000, NEURON, V25, P673, DOI 10.1016/S0896-6273(00)81069-7; Schmitz D, 2000, NEURON, V27, P327, DOI 10.1016/S0896-6273(00)00040-4; Semyanov A, 2000, NEURON, V25, P663, DOI 10.1016/S0896-6273(00)81068-5; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; Silver RA, 1996, J PHYSIOL-LONDON, V494, P231, DOI 10.1113/jphysiol.1996.sp021487; SPRUSTON N, 1995, J PHYSIOL-LONDON, V482, P325, DOI 10.1113/jphysiol.1995.sp020521; TAKAHASHI M, 1995, J NEUROSCI, V15, P5693; TONG G, 1994, NEURON, V13, P1195, DOI 10.1016/0896-6273(94)90057-4; TONG G, 1994, NEURON, V12, P51, DOI 10.1016/0896-6273(94)90151-1; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999; Vogt KE, 1999, P NATL ACAD SCI USA, V96, P1118, DOI 10.1073/pnas.96.3.1118	34	202	205	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2002	5	4					325	331		10.1038/nn825	http://dx.doi.org/10.1038/nn825			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	534UQ	11896395				2022-12-24	WOS:000174606900012
J	Subramaniam, JR; Lyons, WE; Liu, J; Bartnikas, TB; Rothstein, J; Price, DL; Cleveland, DW; Gitlin, JD; Wong, PC				Subramaniam, JR; Lyons, WE; Liu, J; Bartnikas, TB; Rothstein, J; Price, DL; Cleveland, DW; Gitlin, JD; Wong, PC			Mutant SOD1 causes motor neuron disease independent of copper chaperone-mediated copper loading	NATURE NEUROSCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CU,ZN SUPEROXIDE-DISMUTASE; CU,ZN-SUPEROXIDE DISMUTASE; HYDROGEN-PEROXIDE; MOUSE MODEL; CELL-DEATH; K-M; MICE; ALS; BINDING	Copper-mediated oxidative damage is proposed to play a critical role in the pathogenesis of Cu/Zn superoxide dismutase (SOD1)-linked familial amyotrophic lateral sclerosis (FALS). We tested this hypothesis by ablating the gene encoding the copper chaperone for SOD1 (CCS) in a series of FALS-linked SOD1 mutant mice. Metabolic Cu-64 labeling in SOD1-mutant mice lacking the CCS showed that the incorporation of copper into mutant SOD1 was significantly diminished in the absence of CCS. Motor neurons in CCS-/- mice showed increased rate of death after facial nerve axotomy, a response documented for SOD1(-/-) mice. Thus, CCS is necessary for the efficient incorporation of copper into SOD1 in motor neurons. Although the absence of CCS led to a significant reduction in the amount of copper-loaded mutant SOD1, however, it did not modify the onset and progression of motor neuron disease in SOD1-mutant mice. Hence, CCS-dependent copper loading of mutant SOD1 plays no role in the pathogenesis of motor neuron disease in these mouse models.	Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; Washington University (WUSTL); Johns Hopkins University; Johns Hopkins University	Wong, PC (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, 558 Ross Res Bldg,720 Rutland Ave, Baltimore, MD 21205 USA.	wong@jhmi.edu	Cleveland, Don/AAN-9783-2021; rothstein, jeffrey d/C-9470-2013	Subramaniam, Jamuna R/0000-0003-0343-2469; Cleveland, Don/0000-0002-1934-3682				Beaulieu JM, 2000, J NEUROSCI, V20, P5321, DOI 10.1523/JNEUROSCI.20-14-05321.2000; BECKMAN JS, 1993, NATURE, V364, P584, DOI 10.1038/364584a0; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Corson LB, 1998, P NATL ACAD SCI USA, V95, P6361, DOI 10.1073/pnas.95.11.6361; Crapo J D, 1978, Methods Enzymol, V53, P382; Crow JP, 1997, J NEUROCHEM, V69, P1945; Culotta VC, 1999, ADV EXP MED BIOL, V448, P247; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; Doroudchi MM, 2001, NEUROREPORT, V12, P1239, DOI 10.1097/00001756-200105080-00037; Estevez AG, 1999, SCIENCE, V286, P2498, DOI 10.1126/science.286.5449.2498; Facchinetti F, 1999, NEUROSCIENCE, V90, P1483, DOI 10.1016/S0306-4522(98)00492-8; Goto JJ, 2000, J BIOL CHEM, V275, P1007, DOI 10.1074/jbc.275.2.1007; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Julien JP, 2001, CELL, V104, P581, DOI 10.1016/S0092-8674(01)00244-6; Kuo YM, 2001, P NATL ACAD SCI USA, V98, P6836, DOI 10.1073/pnas.111057298; Lee LW, 2001, P NATL ACAD SCI USA, V98, P6842, DOI 10.1073/pnas.111058698; Li MW, 2000, SCIENCE, V288, P335, DOI 10.1126/science.288.5464.335; Liu HB, 2000, BIOCHEMISTRY-US, V39, P8125, DOI 10.1021/bi000846f; LYONS WE, 1995, J NEUROSCI, V15, P2985; Martin LJ, 1999, J NEUROPATH EXP NEUR, V58, P459, DOI 10.1097/00005072-199905000-00005; Mouton PR, 1998, NEUROBIOL AGING, V19, P371, DOI 10.1016/S0197-4580(98)00080-3; Pasinelli P, 2000, P NATL ACAD SCI USA, V97, P13901, DOI 10.1073/pnas.240305897; PROHASKA JR, 1993, J NUTR, V123, P1226, DOI 10.1093/jn/123.7.1226; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; RIPPS ME, 1995, P NATL ACAD SCI USA, V92, P689, DOI 10.1073/pnas.92.3.689; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sankarapandi S, 1999, J BIOL CHEM, V274, P34576, DOI 10.1074/jbc.274.49.34576; Singh RJ, 1998, P NATL ACAD SCI USA, V95, P6675, DOI 10.1073/pnas.95.12.6675; SUNDERMAN FW, 1970, CLIN CHEM, V16, P903; Torres AS, 2001, J BIOL CHEM, V276, P38410, DOI 10.1074/jbc.M104790200; WiedauPazos M, 1996, SCIENCE, V271, P515, DOI 10.1126/science.271.5248.515; Williamson T L, 2000, Science, V288, P399; Wong PC, 2000, P NATL ACAD SCI USA, V97, P2886, DOI 10.1073/pnas.040461197; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Yim HS, 1997, J BIOL CHEM, V272, P8861; Yim MB, 1996, P NATL ACAD SCI USA, V93, P5709, DOI 10.1073/pnas.93.12.5709	42	195	207	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2002	5	4					301	307		10.1038/nn823	http://dx.doi.org/10.1038/nn823			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	534UQ	11889469				2022-12-24	WOS:000174606900009
J	Pelkey, KA; Askalan, R; Paul, S; Kalia, LV; Nguyen, TH; Pitcher, GM; Salter, MW; Lombroso, PJ				Pelkey, KA; Askalan, R; Paul, S; Kalia, LV; Nguyen, TH; Pitcher, GM; Salter, MW; Lombroso, PJ			Tyrosine phosphatase STEP is a tonic brake on induction of long-term potentiation	NEURON			English	Article							D-ASPARTATE RECEPTOR; NMDA RECEPTOR; MOLECULAR CHARACTERIZATION; GLUTAMATE RECEPTORS; HIPPOCAMPAL-NEURONS; SPINAL-CORD; SRC FAMILY; 2B SUBUNIT; PHOSPHORYLATION; KINASE	The functional roles of protein tyrosine phosphatases (PTPs) in the developed CNS have been enigmatic. Here we show that striatal enriched tyrosine phosphatase (STEP) is a component of the N-methyl-D-aspartate receptor (NMDAR) complex. Functionally, exogenous STEP depressed NMDAR single-channel activity in excised membrane patches. STEP also depressed NMDAR-mediated synaptic currents whereas inhibiting endogenous STEP enhanced these currents. In hippocampal slices, administering STEP into CA1 neurons did not affect basal glutamatergic transmission evoked by Schaffer collateral stimulation but prevented tetanus-induced long-term potentiation (LTP). Conversely, inhibiting STEP in CA1 neurons enhanced transmission and occluded LTP induction through an NMDAR-, Src-, and Ca2+-dependent mechanism. Thus, STEP acts as a tonic brake on synaptic transmission by opposing Src-dependent upregulation of NMDARs.	Hosp Sick Children, Dept Physiol, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Programme Brain & Behav, Toronto, ON M5G 1X8, Canada; Univ Toronto, Inst Med Sci, Toronto, ON M5G 1X8, Canada; Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06520 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Yale University	Salter, MW (corresponding author), Hosp Sick Children, Dept Physiol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.			Kalia, Lorraine/0000-0002-9384-1305				Ali DW, 2001, CURR OPIN NEUROBIOL, V11, P336, DOI 10.1016/S0959-4388(00)00216-6; Arregui CO, 2000, NEUROCHEM RES, V25, P95, DOI 10.1023/A:1007595617447; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; BOULANGER LM, 1995, J NEUROSCI, V15, P1532; Boxall AR, 1996, NEURON, V16, P805, DOI 10.1016/S0896-6273(00)80100-2; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dunah AW, 2001, J NEUROSCI, V21, P5546, DOI 10.1523/JNEUROSCI.21-15-05546.2001; EDMONDS B, 1995, ANNU REV PHYSIOL, V57, P495; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; HERRON CE, 1986, NATURE, V322, P265, DOI 10.1038/322265a0; Hironaka K, 2000, J BIOL CHEM, V275, P16167, DOI 10.1074/jbc.M909302199; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Huang YQ, 2001, NEURON, V29, P485, DOI 10.1016/S0896-6273(01)00220-3; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Kohr G, 1996, J PHYSIOL-LONDON, V492, P445; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; Lin SY, 1999, MOL BRAIN RES, V70, P18, DOI 10.1016/S0169-328X(99)00122-9; LOMBROSO PJ, 1993, J NEUROSCI, V13, P3064; LOMBROSO PJ, 1991, P NATL ACAD SCI USA, V88, P7242, DOI 10.1073/pnas.88.16.7242; Lu WY, 1999, NAT NEUROSCI, V2, P331, DOI 10.1038/7243; Lu YM, 1998, SCIENCE, V279, P1363, DOI 10.1126/science.279.5355.1363; MACDONALD JF, 1982, BRAIN RES, V237, P248, DOI 10.1016/0006-8993(82)90575-3; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; Naegele Janice R., 1994, Critical Reviews in Neurobiology, V9, P105; ODELL TJ, 1991, NATURE, V353, P558, DOI 10.1038/353558a0; OYAMA T, 1995, NEUROSCIENCE, V69, P869, DOI 10.1016/0306-4522(95)00278-Q; Paul S, 2000, J NEUROSCI, V20, P5630, DOI 10.1523/JNEUROSCI.20-15-05630.2000; Rosenblum K, 1996, P NATL ACAD SCI USA, V93, P10457, DOI 10.1073/pnas.93.19.10457; Rosenblum K, 1997, J NEUROSCI, V17, P5129; Rostas JAP, 1996, P NATL ACAD SCI USA, V93, P10452, DOI 10.1073/pnas.93.19.10452; SALTER MW, 1994, J NEUROSCI, V14, P1563, DOI 10.1523/JNEUROSCI.14-03-01563.1994; SHENG M, 1992, NEURON, V9, P271, DOI 10.1016/0896-6273(92)90166-B; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; Stoker A, 1998, BIOESSAYS, V20, P463, DOI 10.1002/(SICI)1521-1878(199806)20:6<463::AID-BIES4>3.0.CO;2-N; Stoker AW, 2001, CURR OPIN NEUROBIOL, V11, P95, DOI 10.1016/S0959-4388(00)00179-3; Tonks NK, 2001, CURR OPIN CELL BIOL, V13, P182, DOI 10.1016/S0955-0674(00)00196-4; Vissel B, 2001, NAT NEUROSCI, V4, P587, DOI 10.1038/88404; WANG YT, 1994, NATURE, V369, P233, DOI 10.1038/369233a0; Wang YT, 1996, P NATL ACAD SCI USA, V93, P1721, DOI 10.1073/pnas.93.4.1721; Yu XM, 1997, SCIENCE, V275, P674, DOI 10.1126/science.275.5300.674	41	159	169	1	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 28	2002	34	1					127	138		10.1016/S0896-6273(02)00633-5	http://dx.doi.org/10.1016/S0896-6273(02)00633-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536HR	11931747	Bronze			2022-12-24	WOS:000174695100015
J	Akassoglou, K; Yu, WM; Akpinar, P; Strickland, S				Akassoglou, K; Yu, WM; Akpinar, P; Strickland, S			Fibrin inhibits peripheral nerve remyelination by regulating Schwann cell differentiation	NEURON			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; EXTRACELLULAR-MATRIX MOLECULES; DEFICIENT MICE; IN-VITRO; PLASMINOGEN-ACTIVATOR; MULTIPLE-SCLEROSIS; ENDOTHELIAL-CELLS; KINASE KINASE; BASAL LAMINA; LEWIS RATS	Remyelination is a critical step for functional nerve regeneration. Here we show that fibrin deposition in the peripheral nervous system after injury is a key regulator of remyelination. After sciatic nerve crush, fibrin is deposited and its clearance correlates with remyelination. Fibrin induces phosphorylation of ERK1/2 and production of p75 NGF low-affinity receptor in Schwann cells and maintains them in a nonmyelinating state, suppresses fibronectin production, and prevents synthesis of myelin proteins. In mice depleted of fibrin(ogen), remyelination of myelinated axons is accelerated due to the faster transition of the Schwann cells to a myelinating state. Regulation of fibrin clearance and/or deposition could be a key regulatory mechanism for Schwann differentiation after nerve damage.	Rockefeller Univ, Lab Neurobiol & Genet, New York, NY 10021 USA	Rockefeller University	Strickland, S (corresponding author), Rockefeller Univ, Lab Neurobiol & Genet, 1230 York Ave, New York, NY 10021 USA.		Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763; Strickland, Sidney/0000-0002-3072-9244; Akassoglou, Katerina/0000-0002-2632-1465	NINDS NIH HHS [R01 NS035704] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035704] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akassoglou K, 2000, J CELL BIOL, V149, P1157, DOI 10.1083/jcb.149.5.1157; Akassoglou K, 1998, AM J PATHOL, V153, P801, DOI 10.1016/S0002-9440(10)65622-2; ANTON ES, 1994, DEV BIOL, V164, P133, DOI 10.1006/dbio.1994.1186; Aplin AE, 2001, J CELL BIOL, V153, P273, DOI 10.1083/jcb.153.2.273; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; BELL WR, 1978, J LAB CLIN MED, V91, P592; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Bjartmar C, 2001, CURR OPIN NEUROL, V14, P271, DOI 10.1097/00019052-200106000-00003; Blakemore WF, 1999, J NEUROIMMUNOL, V98, P69, DOI 10.1016/S0165-5728(99)00083-1; BRADLEY W G, 1970, Experimental Neurology, V26, P275, DOI 10.1016/0014-4886(70)90125-1; Brenner KA, 2000, ONCOGENE, V19, P3156, DOI 10.1038/sj.onc.1203626; Bugge TH, 1996, CELL, V87, P709, DOI 10.1016/S0092-8674(00)81390-2; BUNGE RP, 1986, ANNU REV NEUROSCI, V9, P305; Busso N, 1998, J CLIN INVEST, V102, P41, DOI 10.1172/JCI2312; CHEN QM, 1994, J BIOL CHEM, V269, P26602; Chen R, 1971, Biochemistry, V10, P4487; Chernousov MA, 2000, HISTOL HISTOPATHOL, V15, P593, DOI 10.14670/HH-15.593; Cichowski K, 2001, CELL, V104, P593, DOI 10.1016/S0092-8674(01)00245-8; CLARK MB, 1991, GLIA, V4, P514, DOI 10.1002/glia.440040511; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; DONG Z, 1995, NEURON, V15, P585, DOI 10.1016/0896-6273(95)90147-7; Drew AF, 1998, BLOOD, V91, P1616, DOI 10.1182/blood.V91.5.1616.1616_1616_1624; ELDRIDGE CF, 1989, J NEUROSCI, V9, P625; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Feltri ML, 2002, J CELL BIOL, V156, P199, DOI 10.1083/jcb.200109021; FERNANDEZVALLE C, 1994, J NEUROBIOL, V25, P1207, DOI 10.1002/neu.480251004; Friedmann I, 1999, FASEB J, V13, P533, DOI 10.1096/fasebj.13.3.533; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; HO MK, 1982, J IMMUNOL, V128, P2281; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; HSIEH ST, 1994, J NEUROSCI, V14, P6392; Hughes PM, 1998, BRAIN, V121, P481, DOI 10.1093/brain/121.3.481; Inoue A, 1996, J NEUROIMMUNOL, V71, P131, DOI 10.1016/S0165-5728(96)00150-6; Jessen KR, 1999, ADV EXP MED BIOL, V468, P3; Jessen KR, 1999, TRENDS NEUROSCI, V22, P402, DOI 10.1016/S0166-2236(98)01391-5; Kieseier BC, 1999, NEUROLOGY, V53, P20, DOI 10.1212/WNL.53.1.20; Kioussi C, 1996, TRENDS GENET, V12, P84, DOI 10.1016/0168-9525(96)81411-9; Kitching AR, 1997, J EXP MED, V185, P963, DOI 10.1084/jem.185.5.963; KOH CS, 1993, J NEUROIMMUNOL, V47, P141, DOI 10.1016/0165-5728(93)90024-S; Kuhlmann T, 2001, J NEUROSCI, V21, P3401, DOI 10.1523/JNEUROSCI.21-10-03401.2001; Lansink M, 1998, BLOOD, V92, P927; LEFCORT F, 1992, DEVELOPMENT, V116, P767; LEMKE G, 1988, DEVELOPMENT, V102, P499; Levine JM, 2001, TRENDS NEUROSCI, V24, P39, DOI 10.1016/S0166-2236(00)01691-X; LISAK RP, 1994, J NEUROIMMUNOL, V55, P171, DOI 10.1016/0165-5728(94)90007-8; LORAND L, 1969, BIOCHEM BIOPH RES CO, V37, P219, DOI 10.1016/0006-291X(69)90722-0; Mathon NF, 2001, SCIENCE, V291, P872, DOI 10.1126/science.1056782; Milner R, 1997, DEV BIOL, V185, P215, DOI 10.1006/dbio.1997.8547; MORGAN L, 1991, J CELL BIOL, V112, P457, DOI 10.1083/jcb.112.3.457; Ng DCH, 2001, J BIOL CHEM, V276, P29490, DOI 10.1074/jbc.M100699200; PATERSON PY, 1976, FED PROC, V35, P2428; PEREZ RL, 1995, J IMMUNOL, V154, P1879; Perez RL, 1999, AM J RESP CELL MOL, V20, P1059, DOI 10.1165/ajrcmb.20.5.3281; PERRY VH, 1987, J EXP MED, V165, P1218, DOI 10.1084/jem.165.4.1218; PYTELA R, 1985, CELL, V40, P191, DOI 10.1016/0092-8674(85)90322-8; REICHARDT LF, 1991, ANNU REV NEUROSCI, V14, P531, DOI 10.1146/annurev.neuro.14.1.531; RICHARDSON PM, 1994, J NEUROL, V242, pS57, DOI 10.1007/BF00939244; Robertson AM, 1997, J ANAT, V190, P423, DOI 10.1046/j.1469-7580.1997.19030423.x; Rutkowski JL, 1999, J NEUROIMMUNOL, V101, P47, DOI 10.1016/S0165-5728(99)00132-0; SCHERER SS, 1994, J NEUROSCI RES, V38, P575, DOI 10.1002/jnr.490380510; SHAW G, 1985, EUR J CELL BIOL, V39, P205; Siebert H, 2000, J NEUROIMMUNOL, V110, P177, DOI 10.1016/S0165-5728(00)00343-X; Sobel RA, 1998, J NEUROPATH EXP NEUR, V57, P205, DOI 10.1097/00005072-199803000-00001; Soilu-Hanninen M, 1999, J NEUROSCI, V19, P4828; STOLL G, 1989, J NEUROCYTOL, V18, P671, DOI 10.1007/BF01187086; SUH TT, 1995, GENE DEV, V9, P2020, DOI 10.1101/gad.9.16.2020; Syroid DE, 2000, J NEUROSCI, V20, P5741, DOI 10.1523/JNEUROSCI.20-15-05741.2000; TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147; Thiagarajan P, 1996, BIOCHEMISTRY-US, V35, P4169, DOI 10.1021/bi952532b; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; Vogelezang MG, 1999, J NEUROSCI RES, V56, P323, DOI 10.1002/(SICI)1097-4547(19990515)56:4<323::AID-JNR1>3.0.CO;2-6; WOOLF CJ, 1990, NEUROSCIENCE, V34, P465, DOI 10.1016/0306-4522(90)90155-W; Zanazzi G, 2001, J CELL BIOL, V152, P1289, DOI 10.1083/jcb.152.6.1289; Zorick TS, 1996, CURR OPIN CELL BIOL, V8, P870, DOI 10.1016/S0955-0674(96)80090-1; Zorick TS, 1999, DEVELOPMENT, V126, P1397	76	144	158	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 14	2002	33	6					861	875		10.1016/S0896-6273(02)00617-7	http://dx.doi.org/10.1016/S0896-6273(02)00617-7			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	530ZK	11906694	Bronze			2022-12-24	WOS:000174389600005
J	Ma, D; Zerangue, N; Raab-Graham, K; Fried, SR; Jan, YN; Jan, LY				Ma, D; Zerangue, N; Raab-Graham, K; Fried, SR; Jan, YN; Jan, LY			Diverse trafficking patterns due to multiple traffic motifs in G protein-activated inwardly rectifying potassium channels from brain and heart	NEURON			English	Article							RECTIFIER K+ CHANNEL; ENDOPLASMIC-RETICULUM; SUBUNIT STOICHIOMETRY; MOLECULAR-CLONING; MESSENGER-RNAS; GIRK1; EXPRESSION; LOCALIZATION; SIGNALS; FAMILY	G protein-activated inwardly rectifying potassium channels (Kir3, GIRK) provide an important mechanism for neurotransmitter regulation of membrane excitability. GIRK channels are tetramers containing various combinations of Kir3 subunits (Kir3.1-Kir3.4). We find that different combinations of Kir3 subunits exhibit a surprisingly complex spectrum of trafficking phenotypes. Kir3.2 and Kir3.4, but not Kir3.1, contain ER export signals that are important for plasma membrane expression of Kir3.1/Kir3.2 and Kir3.1/Kir3.4 heterotetramers, the GIRK channels found in the brain and the heart, respectively. Additional motifs in Kir3.2 and Kir3.4 control the trafficking between endosome and plasma membrane. In contrast, the Kir3.3 subunit potently inhibits plasma membrane expression by diverting the heterotetrameric channels to lysosomes. Such rich trafficking behaviors provide a mechanism for dynamic regulation of GIRK channel density in the plasma membrane.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Jan, YN (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	gkw@itsa.ucsf.edu		/0000-0002-6129-2938; Jan, Yuh Nung/0000-0003-1367-6299; Jan, Lily/0000-0003-3938-8498; Raab-Graham, Kimberly/0000-0001-6502-057X				Andersson H, 1999, J BIOL CHEM, V274, P15080, DOI 10.1074/jbc.274.21.15080; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Chen SC, 1997, BRAIN RES, V778, P251, DOI 10.1016/S0006-8993(97)00896-2; Corey S, 1998, J BIOL CHEM, V273, P27499, DOI 10.1074/jbc.273.42.27499; Crump CM, 2001, EMBO J, V20, P2191, DOI 10.1093/emboj/20.9.2191; Dascal N, 1997, CELL SIGNAL, V9, P551, DOI 10.1016/S0898-6568(97)00095-8; Doring F, 1998, J NEUROSCI, V18, P8625; Grant B, 2001, NAT CELL BIOL, V3, P573, DOI 10.1038/35078549; Helenius A, 2001, PHILOS T ROY SOC B, V356, P147, DOI 10.1098/rstb.2000.0759; Hille B., 1992, IONIC CHANNELS EXCIT; Inanobe A, 1999, J PHYSIOL-LONDON, V521, P19, DOI 10.1111/j.1469-7793.1999.00019.x; Inanobe A, 1999, J NEUROSCI, V19, P1006; Isomoto S, 1997, JPN J PHYSIOL, V47, P11, DOI 10.2170/jjphysiol.47.11; Isomoto S, 1996, BIOCHEM BIOPH RES CO, V218, P286, DOI 10.1006/bbrc.1996.0050; Jelacic TM, 1999, J MEMBRANE BIOL, V169, P123, DOI 10.1007/s002329900524; Karschin C, 1996, J NEUROSCI, V16, P3559; Kennedy ME, 1996, NEUROPHARMACOLOGY, V35, P831, DOI 10.1016/0028-3908(96)00132-3; Kennedy ME, 1999, J BIOL CHEM, V274, P2571, DOI 10.1074/jbc.274.4.2571; Kirchhausen T, 1999, ANNU REV CELL DEV BI, V15, P705, DOI 10.1146/annurev.cellbio.15.1.705; KOBAYASHI T, 1995, BIOCHEM BIOPH RES CO, V208, P1166, DOI 10.1006/bbrc.1995.1456; KOFUJI P, 1995, P NATL ACAD SCI USA, V92, P6542, DOI 10.1073/pnas.92.14.6542; Krapivinsky G, 1998, NEURON, V20, P995, DOI 10.1016/S0896-6273(00)80480-8; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; LESAGE F, 1995, J BIOL CHEM, V270, P28660, DOI 10.1074/jbc.270.48.28660; LESAGE F, 1994, FEBS LETT, V353, P37, DOI 10.1016/0014-5793(94)01007-2; Liao YJ, 1996, J NEUROSCI, V16, P7137; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Lin SX, 2001, NAT CELL BIOL, V3, P567, DOI 10.1038/35078543; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Molloy SS, 1999, TRENDS CELL BIOL, V9, P28, DOI 10.1016/S0962-8924(98)01382-8; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Nelson CS, 1997, MOL BRAIN RES, V46, P185, DOI 10.1016/S0169-328X(96)00301-4; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; Partiseti M, 1998, FEBS LETT, V434, P171, DOI 10.1016/S0014-5793(98)00972-7; Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227; Sevier CS, 2000, MOL BIOL CELL, V11, P13, DOI 10.1091/mbc.11.1.13; Signorini S, 1997, P NATL ACAD SCI USA, V94, P923, DOI 10.1073/pnas.94.3.923; Waites CL, 2001, J CELL BIOL, V152, P1159, DOI 10.1083/jcb.152.6.1159; Wan L, 1998, CELL, V94, P205, DOI 10.1016/S0092-8674(00)81420-8; Wei JJ, 1998, GENOMICS, V51, P379, DOI 10.1006/geno.1998.5369; Wickman K, 1998, NEURON, V20, P103, DOI 10.1016/S0896-6273(00)80438-9; WICKMAN K, 1995, PHYSIOL REV, V75, P865, DOI 10.1152/physrev.1995.75.4.865; Wischmeyer E, 1997, MOL CELL NEUROSCI, V9, P194, DOI 10.1006/mcne.1997.0614; Yamada M, 1998, PHARMACOL REV, V50, P723; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zerangue N, 2001, P NATL ACAD SCI USA, V98, P2431, DOI 10.1073/pnas.051630198	49	173	174	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 28	2002	33	5					715	729		10.1016/S0896-6273(02)00614-1	http://dx.doi.org/10.1016/S0896-6273(02)00614-1			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	529EC	11879649	Bronze			2022-12-24	WOS:000174286200008
J	Liu, L; Yermolaieva, O; Johnson, WA; Abboud, FM; Welsh, MJ				Liu, L; Yermolaieva, O; Johnson, WA; Abboud, FM; Welsh, MJ			Identification and function of thermosensory neurons in Drosophila larvae	NATURE NEUROSCIENCE			English	Article							SENSORY NEURONS; EXPRESSION; MELANOGASTER; RECEPTOR; SPECIFICITY; INDICATORS; FIBERS; GENE; SKIN	Although the ability to sense temperature is critical for many organisms, the underlying mechanisms are poorly understood. Using the calcium reporter yellow cameleon 2.1 and electrophysiological recordings, we identified thermosensitive neurons and examined their physiologic response in Drosophila melanogaster larvae. In the head, terminal sensory organ neurons showed increased activity in response to cooling by less than or equal to1 degreesC, heating reduced their basal activity, and different units showed distinct response patterns. Neither cooling nor heating affected dorsal organ neurons. Body wall neurons showed a variety of distinct response patterns to both heating and cooling; the diverse thermal responses were strikingly similar to those described in mammals. These data establish a functional map of thermoresponsive neurons in Drosophila larvae and provide a foundation for understanding mechanisms of thermoreception in both insects and mammals.	Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; Univ Iowa, Dept Physiol & Biophys, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; Univ Iowa, Howard Hughes Med Inst, EMRB 500, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; Howard Hughes Medical Institute; University of Iowa	Welsh, MJ (corresponding author), Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.			Welsh, Michael/0000-0002-1646-6206; Johnson, Wayne/0000-0002-6961-5498; Abboud, Francois/0000-0002-7284-9148	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK025295] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL14388] Funding Source: Medline; NIDDK NIH HHS [DK25295] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BRAND AH, 1993, DEVELOPMENT, V118, P401; BREWSTER R, 1995, DEVELOPMENT, V121, P2923; BULLOCK TH, 1956, J PHYSIOL-LONDON, V134, P47, DOI 10.1113/jphysiol.1956.sp005624; Campbell AL, 2002, MICRON, V33, P211, DOI 10.1016/S0968-4328(01)00010-5; Campero M, 2001, J PHYSIOL-LONDON, V535, P855, DOI 10.1111/j.1469-7793.2001.t01-1-00855.x; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; DARIANSMITH I, 1973, J NEUROPHYSIOL, V36, P325, DOI 10.1152/jn.1973.36.2.325; DYKES RW, 1975, BRAIN RES, V98, P485, DOI 10.1016/0006-8993(75)90368-6; Grueber WB, 2002, DEVELOPMENT, V129, P2867; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hart S, 1998, BIOSCIENCE, V48, P3, DOI 10.2307/1313221; Heimbeck G, 1999, J NEUROSCI, V19, P6599; IGGO A, 1969, J PHYSIOL-LONDON, V200, P403, DOI 10.1113/jphysiol.1969.sp008701; KENSHALO DR, 1977, J NEUROPHYSIOL, V40, P319, DOI 10.1152/jn.1977.40.2.319; Kerr R, 2000, NEURON, V26, P583, DOI 10.1016/S0896-6273(00)81196-4; LONG RR, 1977, J NEUROPHYSIOL, V40, P489, DOI 10.1152/jn.1977.40.3.489; Martin J. H., 1991, PRINCIPLES NEURAL SC, V3, P341; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Oppliger FY, 2000, J INSECT PHYSIOL, V46, P135, DOI 10.1016/S0022-1910(99)00109-2; Python F, 2002, J COMP NEUROL, V445, P374, DOI 10.1002/cne.10188; RUBIN GM, 1985, COLD SPRING HARB SYM, V50, P329, DOI 10.1101/SQB.1985.050.01.042; Sayeed O, 1996, P NATL ACAD SCI USA, V93, P6079, DOI 10.1073/pnas.93.12.6079; Schmitz H, 1998, J COMP PHYSIOL A, V182, P647, DOI 10.1007/s003590050210; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Susser E, 1999, BRAIN, V122, P239, DOI 10.1093/brain/122.2.239; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Viana F, 2002, NAT NEUROSCI, V5, P254, DOI 10.1038/nn809; WU CF, 1983, J NEUROSCI, V3, P1888	29	135	137	2	18	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2003	6	3					267	273		10.1038/nn1009	http://dx.doi.org/10.1038/nn1009			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	648YB	12563263				2022-12-24	WOS:000181178300015
J	Sampo, B; Kaech, S; Kunz, S; Banker, G				Sampo, B; Kaech, S; Kunz, S; Banker, G			Two distinct mechanisms target membrane proteins to the axonal surface	NEURON			English	Article							CELL-ADHESION MOLECULES; CANINE KIDNEY-CELLS; HIPPOCAMPAL-NEURONS; PLASMA-MEMBRANE; C-TERMINUS; TRANSPORT; RECEPTOR; POLARITY; AXONIN-1; IDENTIFICATION	We have investigated the trafficking of two endogenous axonal membrane proteins, VAMP2 and NgCAM, in order to elucidate the cellular events that underlie their polarization. We found that VAMP2 is delivered to the surface of both axons and dendrites, but preferentially endocytosed from the dendritic membrane. A mutation in the cytoplasmic domain of VAMP2 that inhibits endocytosis abolished its axonal polarization. In contrast, the targeting of NgCAM depends on sequences in its ectodomain, which mediate its sorting into carriers that preferentially deliver their cargo proteins to the axonal membrane. These observations show that neurons use two distinct mechanisms to polarize proteins to the axonal domain: selective retention in the case of VAMP2, selective delivery in the case of NgCAM.	Oregon Hlth & Sci Univ, Ctr Res Occupat & Environm Toxicol, Portland, OR 97239 USA; Scripps Res Inst, Div Virol, Dept Neuropharmacol, La Jolla, CA 92037 USA	Oregon Health & Science University; Scripps Research Institute	Banker, G (corresponding author), Oregon Hlth & Sci Univ, Ctr Res Occupat & Environm Toxicol, Portland, OR 97239 USA.	bankerg@ohsu.edu	; Kunz, Stefan/K-5840-2017	Kaech Petrie, Stefanie/0000-0002-6246-6434; Kunz, Stefan/0000-0001-6030-9550	NIMH NIH HHS [MH66179] Funding Source: Medline; NINDS NIH HHS [NS17112] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017112] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Arnold DB, 1999, NEURON, V23, P149, DOI 10.1016/S0896-6273(00)80761-8; Benting JH, 1999, J CELL BIOL, V146, P313, DOI 10.1083/jcb.146.2.313; Buchstaller A, 1996, J CELL BIOL, V135, P1593, DOI 10.1083/jcb.135.6.1593; Burack MA, 2000, NEURON, V26, P465, DOI 10.1016/S0896-6273(00)81178-2; Cheng CL, 2002, J NEUROSCI, V22, P10643; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; DEHOOP M, 1995, J CELL BIOL, V130, P1447, DOI 10.1083/jcb.130.6.1447; Demyanenko GP, 1999, J NEUROSCI, V19, P4907; DOTTI CG, 1988, J NEUROSCI, V8, P1454; DOTTI CG, 1991, NATURE, V349, P158, DOI 10.1038/349158a0; Eiraku M, 2002, J BIOL CHEM, V277, P25400, DOI 10.1074/jbc.M110793200; El-Husseini AE, 2001, J BIOL CHEM, V276, P44984, DOI 10.1074/jbc.M103049200; FAIVRESARRAILH C, 1993, MOL NEUROBIOL, V7, P49, DOI 10.1007/BF02780608; Ferreira A, 2002, CELL MOL LIFE SCI, V59, P589, DOI 10.1007/s00018-002-8451-5; Fitzli D, 2000, J CELL BIOL, V149, P951, DOI 10.1083/jcb.149.4.951; Foletti DL, 1999, NEURON, V23, P641, DOI 10.1016/S0896-6273(01)80022-2; Garrido JJ, 2001, EMBO J, V20, P5950, DOI 10.1093/emboj/20.21.5950; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; Goslin K., 1998, CULTURING NERVE CELL, P339; Grote E, 1996, J CELL BIOL, V132, P537, DOI 10.1083/jcb.132.4.537; GRUMET M, 1991, J CELL BIOL, V113, P1399, DOI 10.1083/jcb.113.6.1399; Gut A, 1998, J BIOL CHEM, V273, P29381, DOI 10.1074/jbc.273.45.29381; HALFTER W, 1994, DEV BRAIN RES, V78, P87, DOI 10.1016/0165-3806(94)90013-2; HAMMERTON RW, 1991, SCIENCE, V254, P847, DOI 10.1126/science.1658934; Hannah MJ, 1998, METHODS, V16, P170, DOI 10.1006/meth.1998.0664; Hollenbeck PJ, 1999, NATURE, V397, P653, DOI 10.1038/17693; Hortsch M, 1996, NEURON, V17, P587, DOI 10.1016/S0896-6273(00)80192-0; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Jareb M, 1998, NEURON, V20, P855, DOI 10.1016/S0896-6273(00)80468-7; Jenkins SM, 2001, J CELL BIOL, V155, P739, DOI 10.1083/jcb.200109026; Kamiguchi H, 1998, J NEUROSCI, V18, P5311, DOI 10.1523/JNEUROSCI.18-14-05311.1998; Kollins KM, 1999, J NEUROBIOL, V39, P119, DOI 10.1002/(SICI)1097-4695(199904)39:1<119::AID-NEU10>3.0.CO;2-M; Kunimoto M, 1995, J CELL BIOL, V131, P1821, DOI 10.1083/jcb.131.6.1821; Kunz S, 1998, J CELL BIOL, V143, P1673, DOI 10.1083/jcb.143.6.1673; Ledesma MD, 1999, EMBO J, V18, P1761, DOI 10.1093/emboj/18.7.1761; Li ZY, 2001, NEURON, V31, P593, DOI 10.1016/S0896-6273(01)00398-1; Lim ST, 2000, NEURON, V25, P385, DOI 10.1016/S0896-6273(00)80902-2; Lowenstein P. R., 1994, Gene Therapy, V1, pS32; MATTER K, 1994, CURR OPIN CELL BIOL, V6, P545, DOI 10.1016/0955-0674(94)90075-2; Matter K, 2000, CURR BIOL, V10, pR39, DOI 10.1016/S0960-9822(99)00256-0; Maximov A, 2002, J NEUROSCI, V22, P6939; McMahon HT, 1999, CURR BIOL, V9, pR332, DOI 10.1016/S0960-9822(99)80206-1; Missler M, 1998, J NEUROCHEM, V71, P1339; Nelson WJ, 2001, TRENDS CELL BIOL, V11, P483, DOI 10.1016/S0962-8924(01)02145-6; Nonet ML, 1999, MOL BIOL CELL, V10, P2343, DOI 10.1091/mbc.10.7.2343; Prekeris R, 1999, J NEUROSCI, V19, P10324; Rodriguez-Boulan E, 1999, TRENDS CELL BIOL, V9, P291, DOI 10.1016/S0962-8924(99)01595-0; Roos J, 2000, NAT NEUROSCI, V3, P415, DOI 10.1038/74773; Ruberti F, 2000, J NEUROSCI, V20, part. no.; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Sheehan D, 1996, NEUROREPORT, V7, P1297, DOI 10.1097/00001756-199605170-00016; Silverman MA, 2001, P NATL ACAD SCI USA, V98, P7051, DOI 10.1073/pnas.111146198; SONDEREGGER P, 1998, IG SUPERFAMILY MOL N; Steiner P, 2002, J CELL BIOL, V157, P1197, DOI 10.1083/jcb.200202022; Stowell JN, 1999, NEURON, V22, P525, DOI 10.1016/S0896-6273(00)80707-2; Taubenblatt P, 1999, J CELL SCI, V112, P3559; Tienari PJ, 1996, EMBO J, V15, P5218, DOI 10.1002/j.1460-2075.1996.tb00907.x; Vogt L, 1996, CURR BIOL, V6, P1153, DOI 10.1016/S0960-9822(02)70682-9; West AE, 1997, J CELL BIOL, V139, P917, DOI 10.1083/jcb.139.4.917; West AE, 1997, J NEUROSCI, V17, P6038; Wilson JM, 2000, MOL BIOL CELL, V11, P2657, DOI 10.1091/mbc.11.8.2657; Winckler B, 1999, NATURE, V397, P698, DOI 10.1038/17789	65	202	208	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 20	2003	37	4					611	624		10.1016/S0896-6273(03)00058-8	http://dx.doi.org/10.1016/S0896-6273(03)00058-8			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	648EH	12597859	Bronze			2022-12-24	WOS:000181136500010
J	Moores, E; Laiti, L; Chelazzi, L				Moores, E; Laiti, L; Chelazzi, L			Associative knowledge controls deployment of visual selective attention	NATURE NEUROSCIENCE			English	Article							FIGURE GROUND ORGANIZATION; INFERIOR TEMPORAL CORTEX; OBJECT IDENTIFICATION; NEURAL MECHANISMS; SCENE PERCEPTION; WORKING-MEMORY; SEARCH; RECOGNITION; V4; NEURONS	According to some models of visual selective attention, objects in a scene activate corresponding neural representations, which compete for perceptual awareness and motor behavior. During a visual search for a target object, top-down control exerted by working memory representations of the target's defining properties resolves competition in favor of the target. These models, however, ignore the existence of associative links among object representations. Here we show that such associations can strongly influence deployment of attention in humans. In the context of visual search, objects associated with the target were both recalled more often and recognized more accurately than unrelated distractors. Notably, both target and associated objects competitively weakened recognition of unrelated distractors and slowed responses to a luminance probe. Moreover, in a speeded search protocol, associated objects rendered search both slower and less accurate. Finally, the first saccades after onset of the stimulus array were more often directed toward associated than control items.	Univ Verona, Dept Neurol & Vis Sci, Physiol Sect, I-37134 Verona, Italy; Aston Univ, Neurosci Res Inst, Birmingham B4 7ET, W Midlands, England	University of Verona; Aston University	Chelazzi, L (corresponding author), Univ Verona, Dept Neurol & Vis Sci, Physiol Sect, Strada Le Grazie 8, I-37134 Verona, Italy.	leonardo.chelazzi@univr.it	Chelazzi, Leonardo/B-6084-2011	Chelazzi, Leonardo/0000-0001-8566-0611; moores, elisabeth/0000-0003-3997-0832				Anderson J.R., 1973, HUMAN ASS MEMORY; Awh E, 1998, J EXP PSYCHOL HUMAN, V24, P780, DOI 10.1037/0096-1523.24.3.780; BIEDERMAN I, 1982, COGNITIVE PSYCHOL, V14, P143, DOI 10.1016/0010-0285(82)90007-X; BIEDERMAN I, 1973, J EXP PSYCHOL, V97, P22, DOI 10.1037/h0033776; BOYCE SJ, 1989, J EXP PSYCHOL HUMAN, V15, P556, DOI 10.1037/0096-1523.15.3.556; BUNDESEN C, 1990, PSYCHOL REV, V97, P523, DOI 10.1037/0033-295X.97.4.523; Butter CM, 2000, VIS COGN, V7, P769, DOI 10.1080/13506280050144425; CHELAZZI L, 1993, NATURE, V363, P345, DOI 10.1038/363345a0; Chelazzi L, 1998, J NEUROPHYSIOL, V80, P2918, DOI 10.1152/jn.1998.80.6.2918; Chun MM, 2000, TRENDS COGN SCI, V4, P170, DOI 10.1016/S1364-6613(00)01476-5; Chun MM, 1999, PSYCHOL SCI, V10, P360, DOI 10.1111/1467-9280.00168; COLLINS AM, 1975, PSYCHOL REV, V82, P407, DOI 10.1037/0033-295X.82.6.407; Deese James, 1965, STRUCTURE ASS LANGUA; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Downing PE, 2000, PSYCHOL SCI, V11, P467, DOI 10.1111/1467-9280.00290; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; Estes W.K., 1994, CLASSIFICATION COGNI; Findlay JM, 1997, VISION RES, V37, P617, DOI 10.1016/S0042-6989(96)00218-0; Fodor J. A, 1983, MODULARITY MIND; FRIEDMAN A, 1979, J EXP PSYCHOL GEN, V108, P316, DOI 10.1037/0096-3445.108.3.316; GLASER WR, 1992, COGNITION, V42, P61, DOI 10.1016/0010-0277(92)90040-O; Hebb Donald O., 1949, ORG BEHAV; Henderson JM, 1999, ANNU REV PSYCHOL, V50, P243, DOI 10.1146/annurev.psych.50.1.243; Hollingworth A, 1998, J EXP PSYCHOL GEN, V127, P398, DOI 10.1037/0096-3445.127.4.398; Humphreys GW, 1997, PHILOS T R SOC B, V352, P1275, DOI 10.1098/rstb.1997.0110; ISHAI A, 1995, SCIENCE, V268, P1712; LaBerge D., 1995, ATTENTIONAL PROCESSI; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; McClelland James L, 2000, OXFORD HDB MEMORY, P583; OCHSNER KN, 1994, CURR OPIN NEUROBIOL, V4, P189, DOI 10.1016/0959-4388(94)90071-X; PALMER SE, 1975, MEM COGNITION, V3, P519, DOI 10.3758/BF03197524; Parasuraman R, 2001, VIS COGN, V8, P103, DOI 10.1080/13506280042000045; PETERSON MA, 1994, PERCEPT PSYCHOPHYS, V56, P551, DOI 10.3758/BF03206951; PETERSON MA, 1993, COGNITIVE PSYCHOL, V25, P383, DOI 10.1006/cogp.1993.1010; Peterson MA, 2001, VIS COGN, V8, P329, DOI 10.1080/13506280143000034; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; POSNER MI, 1994, TRENDS NEUROSCI, V17, P75, DOI 10.1016/0166-2236(94)90078-7; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; Roediger H. L., 1993, HANDB NEUR, P63; ROEDIGER HL, 1995, J EXP PSYCHOL LEARN, V21, P803, DOI 10.1037/0278-7393.21.4.803; SPERLING G, 1960, PSYCHOL MONOGR, V74, P1, DOI 10.1037/h0093759; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; VANDERHEIDEN AHC, 1992, SELECTIVE ATTENTION; WOLFE JM, 1999, FLEETING MEMORIES; Yantis S., 1998, ATTENTION, V1, P223, DOI DOI 10.1037/0096-1523.16.4.812	48	214	229	4	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2003	6	2					182	189		10.1038/nn996	http://dx.doi.org/10.1038/nn996			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	640CL	12514738				2022-12-24	WOS:000180669100019
J	Gitai, Z; Yu, TW; Lundquist, EA; Tessier-Lavigne, M; Bargmann, CI				Gitai, Z; Yu, TW; Lundquist, EA; Tessier-Lavigne, M; Bargmann, CI			The netrin receptor UNC-40/DCC stimulates axon attraction and outgrowth through enabled and, in parallel, Rac and UNC-115/AbLIM	NEURON			English	Article							GROWTH CONE GUIDANCE; C-ELEGANS; CAENORHABDITIS-ELEGANS; ACTIN-BINDING; CELL-MIGRATION; COLORECTAL-CANCER; TYROSINE KINASE; LISTERIA-MONOCYTOGENES; SIGNAL-TRANSDUCTION; ENA/VASP FAMILY	Netrins promote axon outgrowth and turning through DCC/UNC-40 receptors. To characterize Netrin signaling, we generated a gain-of-function UNC-40 molecule, MYR::UNC-40. MYR::UNC-40 causes axon guidance defects, excess axon branching, and excessive axon and cell body outgrowth. These defects are suppressed by loss-of-function mutations in ced-10 (a Rac GTPase), unc-34 (an Enabled homolog), and unc-115 (a putative actin binding protein). ced-10, unc-34, and unc-115 also function in endogenous unc-40 signaling. Our results indicate that Enabled functions in axonal attraction as well as axon repulsion. UNC-40 has two conserved cytoplasmic motifs that mediate distinct downstream pathways: CED-10, UNC-115, and the UNC-40 P2 motif act in one pathway, and UNC-34 and the UNC-40 P1 motif act in the other. Thus, UNC-40 might act as a scaffold to deliver several independent signals to the actin cytoskeleton.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA; Howard Hughes Med Inst, Dept Biol Sci, Stanford, CA 94305 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of Kansas; Howard Hughes Medical Institute	Tessier-Lavigne, M (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA.		Gitai, Zemer/AAI-6989-2021; Yu, Timothy W./AAF-5738-2019	Yu, Timothy W./0000-0003-2988-7701; Bargmann, Cornelia/0000-0002-8484-0618				ALETTA JM, 1988, J NEUROSCI, V8, P1425; Awasaki T, 2000, NEURON, V26, P119, DOI 10.1016/S0896-6273(00)81143-5; Bachmann C, 1999, J BIOL CHEM, V274, P23549, DOI 10.1074/jbc.274.33.23549; Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Bashaw GJ, 1999, CELL, V97, P917, DOI 10.1016/S0092-8674(00)80803-X; Baumeister R, 1996, GENE DEV, V10, P1395, DOI 10.1101/gad.10.11.1395; Bear JE, 2000, CELL, V101, P717, DOI 10.1016/S0092-8674(00)80884-3; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Bloom L, 1997, P NATL ACAD SCI USA, V94, P3414, DOI 10.1073/pnas.94.7.3414; Branda CS, 1999, CURR OPIN GENET DEV, V9, P479, DOI 10.1016/S0959-437X(99)80073-2; BRAY D, 1988, ANNU REV CELL BIOL, V4, P43, DOI 10.1146/annurev.cb.04.110188.000355; BRENNER S, 1974, GENETICS, V77, P71; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; Colavita A, 1998, DEV BIOL, V194, P72, DOI 10.1006/dbio.1997.8790; de la Torre JR, 1997, NEURON, V19, P1211, DOI 10.1016/S0896-6273(00)80413-4; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Erkman L, 2000, NEURON, V28, P779, DOI 10.1016/S0896-6273(00)00153-7; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; George SE, 1998, CELL, V92, P633, DOI 10.1016/S0092-8674(00)81131-9; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; GERTLER FB, 1995, GENE DEV, V9, P521, DOI 10.1101/gad.9.5.521; GORDONWEEKS PR, 1987, NEUROSCIENCE, V21, P977, DOI 10.1016/0306-4522(87)90052-2; Hakeda-Suzuki S, 2002, NATURE, V416, P438, DOI 10.1038/416438a; HAMELIN M, 1992, EMBO J, V11, P2885, DOI 10.1002/j.1460-2075.1992.tb05357.x; HAMELIN M, 1993, NATURE, V364, P327, DOI 10.1038/364327a0; Hao JC, 2001, NEURON, V32, P25, DOI 10.1016/S0896-6273(01)00448-2; HEDGECOCK EM, 1985, DEV BIOL, V111, P158, DOI 10.1016/0012-1606(85)90443-9; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Hu HL, 2001, NEURON, V32, P39, DOI 10.1016/S0896-6273(01)00453-6; Huttelmaier S, 1999, FEBS LETT, V451, P68, DOI 10.1016/S0014-5793(99)00546-3; ISHII N, 1992, NEURON, V9, P873, DOI 10.1016/0896-6273(92)90240-E; Jin YS, 1999, J NEUROSCI, V19, P539; Jin Z, 1997, J NEUROSCI, V17, P6256; KAMPS MP, 1985, P NATL ACAD SCI USA, V82, P4625, DOI 10.1073/pnas.82.14.4625; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kishore RS, 2002, DEV BIOL, V241, P339, DOI 10.1006/dbio.2001.0513; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; Korey CA, 2000, J NEUROBIOL, V44, P184, DOI 10.1002/1097-4695(200008)44:2<184::AID-NEU8>3.0.CO;2-N; Lambrechts A, 2000, J BIOL CHEM, V275, P36143, DOI 10.1074/jbc.M006274200; Laurent V, 1999, J CELL BIOL, V144, P1245, DOI 10.1083/jcb.144.6.1245; Leonardo ED, 1997, NATURE, V386, P833, DOI 10.1038/386833a0; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; Lundquist EA, 1998, NEURON, V21, P385, DOI 10.1016/S0896-6273(00)80547-4; Lundquist EA, 2001, DEVELOPMENT, V128, P4475; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; MCINTIRE SL, 1992, NEURON, V8, P307, DOI 10.1016/0896-6273(92)90297-Q; MCKIM KS, 1994, MOL GEN GENET, V242, P346, DOI 10.1007/BF00280425; Mello C, 1995, METHOD CELL BIOL, V48, P451; Merz DC, 2001, GENETICS, V158, P1071; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Ng J, 2002, NATURE, V416, P442, DOI 10.1038/416442a; Niebuhr K, 1997, EMBO J, V16, P5433, DOI 10.1093/emboj/16.17.5433; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; OGURA K, 1994, GENE DEV, V8, P2389, DOI 10.1101/gad.8.20.2389; OTSUKA AJ, 1995, J CELL BIOL, V129, P1081, DOI 10.1083/jcb.129.4.1081; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Roof DJ, 1997, J CELL BIOL, V138, P575, DOI 10.1083/jcb.138.3.575; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Shekarabi M, 2002, MOL CELL NEUROSCI, V19, P1, DOI 10.1006/mcne.2001.1075; Stein E, 2001, SCIENCE, V291, P1976, DOI 10.1126/science.1059391; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Steven R, 1998, CELL, V92, P785, DOI 10.1016/S0092-8674(00)81406-3; Su MW, 2000, DEVELOPMENT, V127, P585; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Vikis HG, 2000, P NATL ACAD SCI USA, V97, P12457, DOI 10.1073/pnas.220421797; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; Wightman B, 1997, DEVELOPMENT, V124, P2571; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Yu TW, 2002, NAT NEUROSCI, V5, P1147, DOI 10.1038/nn956; Zallen JA, 1999, DEVELOPMENT, V126, P3679; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2; Zipkin ID, 1997, CELL, V90, P883, DOI 10.1016/S0092-8674(00)80353-0	79	185	207	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 9	2003	37	1					53	65		10.1016/S0896-6273(02)01149-2	http://dx.doi.org/10.1016/S0896-6273(02)01149-2			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	646UV	12526772	Bronze			2022-12-24	WOS:000181054700009
J	Schummers, J; Marino, J; Sur, M				Schummers, J; Marino, J; Sur, M			Synaptic integration by V1 neurons depends on location within the orientation map	NEURON			English	Article							PRIMARY VISUAL-CORTEX; CAT STRIATE CORTEX; CORTICAL SIMPLE CELLS; RECEPTIVE-FIELDS; COMPLEX CELLS; IN-VIVO; FUNCTIONAL ARCHITECTURE; POSTSYNAPTIC POTENTIALS; NETWORK MODEL; SELECTIVITY	Neurons in the primary visual cortex (V1) are organized into an orientation map consisting of orientation domains arranged radially around "pinwheel centers" at which the representations of all orientations converge. We have combined optical imaging of intrinsic signals with intracellular recordings to estimate the subthreshold inputs and spike outputs of neurons located near pinwheel centers or in orientation domains. We find that neurons near pinwheel centers have subthreshold responses to all stimulus orientations but spike responses to only a narrow range of orientations. Across the map, the selectivity of inputs covaries with the selectivity of orientations in the local cortical network, while the selectivity of spike outputs does not. Thus, the input-output transformation performed by V1 neurons is powerfully influenced by the local structure of the orientation map.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Univ A Coruna, Neurosci & Motor Control Grp Neurocom, La Coruna 15006, Spain	Massachusetts Institute of Technology (MIT); Universidade da Coruna	Sur, M (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.	msur@ai.mit.edu		Schummers, James/0000-0002-1030-824X				Alonso JM, 1998, NAT NEUROSCI, V1, P395, DOI 10.1038/1609; Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; Azouz R, 2000, P NATL ACAD SCI USA, V97, P8110, DOI 10.1073/pnas.130200797; BLASDEL GG, 1992, J NEUROSCI, V12, P3139, DOI 10.1523/JNEUROSCI.12-08-03139.1992; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Bosking WH, 1997, J NEUROSCI, V17, P2112; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Chance FS, 1999, NAT NEUROSCI, V2, P277, DOI 10.1038/6381; CHAPMAN B, 1991, J NEUROSCI, V11, P1347; CROOK JM, 1991, NEUROSCIENCE, V40, P1, DOI 10.1016/0306-4522(91)90169-O; Crook JM, 1997, VISUAL NEUROSCI, V14, P141, DOI 10.1017/S095252380000883X; Das A, 1999, NATURE, V399, P655, DOI 10.1038/21371; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Dragoi V, 2000, NEURON, V28, P287, DOI 10.1016/S0896-6273(00)00103-3; Dragoi V, 2001, NATURE, V411, P80, DOI 10.1038/35075070; FERSTER D, 1986, J NEUROSCI, V6, P1284; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; GILBERT CD, 1990, VISION RES, V30, P1689, DOI 10.1016/0042-6989(90)90153-C; Gillespie DC, 2001, NAT NEUROSCI, V4, P1014, DOI 10.1038/nn731; Hirsch JA, 1998, J NEUROSCI, V18, P9517; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Kisvarday ZF, 1997, CEREB CORTEX, V7, P605, DOI 10.1093/cercor/7.7.605; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961, DOI 10.1152/jn.1992.67.4.961; Lampl I, 2001, NEURON, V30, P263, DOI 10.1016/S0896-6273(01)00278-1; Levitt JB, 1997, NATURE, V387, P73, DOI 10.1038/387073a0; MALACH R, 1993, P NATL ACAD SCI USA, V90, P10469, DOI 10.1073/pnas.90.22.10469; Maldonado PE, 1997, SCIENCE, V276, P1551, DOI 10.1126/science.276.5318.1551; Martinez LM, 2002, J PHYSIOL-LONDON, V540, P321, DOI 10.1113/jphysiol.2001.012776; Martinez LM, 2001, NEURON, V32, P515, DOI 10.1016/S0896-6273(01)00489-5; McLaughlin D, 2000, P NATL ACAD SCI USA, V97, P8087, DOI 10.1073/pnas.110135097; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; Rao SC, 1997, J COMP NEUROL, V387, P358; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Ringach DL, 1997, NATURE, V387, P281, DOI 10.1038/387281a0; Ringach DL, 2002, J NEUROPHYSIOL, V87, P1018, DOI 10.1152/jn.00614.2001; Schuett S, 2001, NEURON, V32, P325, DOI 10.1016/S0896-6273(01)00472-X; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; SOMERS D, 2001, CAT PRIMARY VISUAL C, P471; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Swindale NV, 1998, BIOL CYBERN, V78, P45, DOI 10.1007/s004220050411; Toth LJ, 1997, CEREB CORTEX, V7, P703, DOI 10.1093/cercor/7.8.703; VOLGUSHEV M, 1993, VISUAL NEUROSCI, V10, P1151, DOI 10.1017/S0952523800010257; Volgushev M, 2000, EUR J NEUROSCI, V12, P257, DOI 10.1046/j.1460-9568.2000.00909.x; Volgushev M, 2002, J PHYSIOL-LONDON, V540, P307, DOI 10.1113/jphysiol.2001.012974; VOLGUSHEV M, 1995, VISUAL NEUROSCI, V12, P621, DOI 10.1017/S0952523800008919; Wielaard DJ, 2001, J NEUROSCI, V21, P5203, DOI 10.1523/JNEUROSCI.21-14-05203.2001; Yao HS, 2001, NEURON, V32, P315, DOI 10.1016/S0896-6273(01)00460-3; Yousef T, 2001, NEUROREPORT, V12, P1693, DOI 10.1097/00001756-200106130-00035	50	109	111	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	DEC 5	2002	36	5					969	978		10.1016/S0896-6273(02)01012-7	http://dx.doi.org/10.1016/S0896-6273(02)01012-7			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	622VL	12467599	Green Submitted, Bronze			2022-12-24	WOS:000179667800020
J	Weitz, D; Ficek, N; Kremmer, E; Bauer, PJ; Kaupp, UB				Weitz, D; Ficek, N; Kremmer, E; Bauer, PJ; Kaupp, UB			Subunit stoichiometry of the CNG channel of rod photoreceptors	NEURON			English	Article							NUCLEOTIDE-GATED CHANNELS; ACID-RICH PROTEINS; ION CHANNELS; BETA-SUBUNIT; CATION CHANNEL; INTERSUBUNIT INTERACTION; FUNCTIONAL EXPRESSION; CALCIUM-CALMODULIN; POTASSIUM CHANNEL; OLFACTORY NEURONS	Cyclic nucleotide-gated (CNG) channels play a central role in the conversion of sensory stimuli into electrical signals. CNG channels form heterooligomeric complexes built of A and B subunits. Here, we study the subunit stoichiometry of the native rod CNG channel by chemical crosslinking. The apparent molecular weight (M-w) of each crosslink product was determined by SDS-PAGE, and its composition was analyzed by Western blotting using antibodies specific for the A1 or B1 subunit. The number of crosslink products and their M-w as well as the immunological identification of A1 and B1 subunits in the crosslink products led us to conclude that the native rod CNG channel is a tetramer composed of three A1 and one B1 subunit. This is an example of violation of symmetry in tetrameric channels.	Forschungszentrum Julich, Inst Biol Informat Verarbeitung, D-52425 Julich, Germany; GSF, Inst Mol Immunol, D-81377 Munich, Germany	Helmholtz Association; Research Center Julich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Kaupp, UB (corresponding author), Forschungszentrum Julich, Inst Biol Informat Verarbeitung, D-52425 Julich, Germany.	a.eckert@fz-juelich.de						Bonigk W, 1999, J NEUROSCI, V19, P5332; BONIGK W, 1993, NEURON, V10, P865, DOI 10.1016/0896-6273(93)90202-3; BRADLEY J, 1994, P NATL ACAD SCI USA, V91, P8890, DOI 10.1073/pnas.91.19.8890; Bradley J, 2001, SCIENCE, V294, P2176, DOI 10.1126/science.1063415; Brown RL, 1998, BIOPHYS J, V75, P825, DOI 10.1016/S0006-3495(98)77571-X; Burns ME, 2001, ANNU REV NEUROSCI, V24, P779, DOI 10.1146/annurev.neuro.24.1.779; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; CHEN TY, 1993, NATURE, V362, P764, DOI 10.1038/362764a0; Colville CA, 1996, J BIOL CHEM, V271, P32968, DOI 10.1074/jbc.271.51.32968; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; Flynn GE, 2001, NEURON, V30, P689, DOI 10.1016/S0896-6273(01)00324-5; Gerstner A, 2000, J NEUROSCI, V20, P1324; GORDON SE, 1995, P NATL ACAD SCI USA, V92, P10222, DOI 10.1073/pnas.92.22.10222; Gordon SE, 1997, NEURON, V19, P431, DOI 10.1016/S0896-6273(00)80951-4; GOULDING EH, 1993, NATURE, V364, P61, DOI 10.1038/364061a0; Grunwald ME, 1998, J BIOL CHEM, V273, P9148, DOI 10.1074/jbc.273.15.9148; He YJ, 2000, P NATL ACAD SCI USA, V97, P895, DOI 10.1073/pnas.97.2.895; HENN DK, 1995, P NATL ACAD SCI USA, V92, P7425, DOI 10.1073/pnas.92.16.7425; Higgins MK, 2002, EMBO J, V21, P2087, DOI 10.1093/emboj/21.9.2087; HSU YT, 1994, J BIOL CHEM, V269, P29765; HSU YT, 1993, NATURE, V361, P76, DOI 10.1038/361076a0; HU DH, 1989, BIOMED RES-TOKYO, V10, P165, DOI 10.2220/biomedres.10.165; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; Korschen HG, 1999, NATURE, V400, P761, DOI 10.1038/23468; KORSCHEN HG, 1995, NEURON, V15, P627, DOI 10.1016/0896-6273(95)90151-5; LIMAN ER, 1994, NEURON, V13, P611, DOI 10.1016/0896-6273(94)90029-9; Liu DT, 1998, NEURON, V21, P235, DOI 10.1016/S0896-6273(00)80530-9; Liu DT, 1996, NEURON, V16, P983, DOI 10.1016/S0896-6273(00)80121-X; LIU MY, 1994, SCIENCE, V266, P1348, DOI 10.1126/science.266.5189.1348; LUDWIG J, 1990, FEBS LETT, V270, P24, DOI 10.1016/0014-5793(90)81226-E; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; Mallouk N, 2002, J MEMBRANE BIOL, V185, P129, DOI 10.1007/s00232-001-0119-9; MCCORMACK K, 1992, BIOPHYS J, V63, P1406, DOI 10.1016/S0006-3495(92)81703-4; Molday RS, 1998, VISION RES, V38, P1315, DOI 10.1016/S0042-6989(97)00409-4; Molokanova E, 1997, J NEUROSCI, V17, P9068; Munger SD, 2001, SCIENCE, V294, P2172, DOI 10.1126/science.1063224; Poetsch A, 2001, J BIOL CHEM, V276, P48009, DOI 10.1074/jbc.M108941200; Raab-Graham KF, 1998, J BIOL CHEM, V273, P19699, DOI 10.1074/jbc.273.31.19699; Richards MJ, 2000, BIOCHEMISTRY-US, V39, P14003, DOI 10.1021/bi001639i; Rosenbaum T, 2002, NEURON, V33, P703, DOI 10.1016/S0896-6273(02)00599-8; Sautter A, 1998, P NATL ACAD SCI USA, V95, P4696, DOI 10.1073/pnas.95.8.4696; SCHNETKAMP PPM, 1982, METHOD ENZYMOL, V81, P110; Schulteis CT, 1996, BIOCHEMISTRY-US, V35, P12133, DOI 10.1021/bi961083s; Schwarzer A, 2000, J BIOL CHEM, V275, P13448, DOI 10.1074/jbc.275.18.13448; Seifert R, 1999, EMBO J, V18, P119, DOI 10.1093/emboj/18.1.119; SERRE V, 1995, J MEMBRANE BIOL, V146, P145; Shammat IM, 1999, NEURON, V23, P809, DOI 10.1016/S0896-6273(01)80038-6; Sukharev SI, 1999, J MEMBRANE BIOL, V171, P183, DOI 10.1007/s002329900570; Trudeau MC, 2002, P NATL ACAD SCI USA, V99, P8424, DOI 10.1073/pnas.122015999; Trudeau MC, 2002, NEURON, V34, P197, DOI 10.1016/S0896-6273(02)00647-5; Varnum MD, 1996, BIOPHYS J, V70, P2667, DOI 10.1016/S0006-3495(96)79836-3; Weitz D, 1998, EMBO J, V17, P2273, DOI 10.1093/emboj/17.8.2273; WOHLFART P, 1992, J BIOL CHEM, V267, P644; Zheng J, 2000, NEURON, V28, P369, DOI 10.1016/S0896-6273(00)00117-3	55	131	135	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 5	2002	36	5					881	889		10.1016/S0896-6273(02)01098-X	http://dx.doi.org/10.1016/S0896-6273(02)01098-X			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	622VL	12467591	Bronze			2022-12-24	WOS:000179667800012
J	Chiu, CY; Weliky, M				Chiu, CY; Weliky, M			Relationship of correlated spontaneous activity to functional ocular dominance columns in the developing visual cortex	NEURON			English	Article							HORIZONTAL CONNECTIONS; IN-VIVO; FERRET; ORGANIZATION; PLASTICITY; NEURONS; MAPS	Utilizing a multielectrode array to record spontaneous and visually evoked activity of cortical neurons in area 17, we investigate the relationship between long-range correlated spontaneous activity and functional ocular dominance columns during early ferret postnatal development (P24-P29). In regions of visual cortex containing alternating ocular dominance patches, periodic fluctuations in correlated activity are observed in which spontaneous activity is most highly correlated between cortical patches exhibiting the same eye preference. However, these fluctuations are present even within large contralateral eye-dominated bands which lack any periodic alternations in ocular dominance. Thus, the organization of ocular dominance columns cannot fully account for the patterns of correlated activity we observe. Our results suggest that patterns of long-range correlated activity reflect an intrinsic periodicity of cortical connectivity that is constrained by segregated eye-specific LGN afferents.	Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA; Univ Rochester, Interdepartmental Program Neurosci, Rochester, NY 14627 USA	University of Rochester; University of Rochester	Weliky, M (corresponding author), Univ Rochester, Dept Brain & Cognit Sci, 601 Elmwood Ave, Rochester, NY 14627 USA.	weliky@cvs.rochester.edu		Chiu, Chiayu/0000-0001-5809-6306				[Anonymous], [No title captured]; Chiu CY, 2001, J NEUROSCI, V21, P8906, DOI 10.1523/JNEUROSCI.21-22-08906.2001; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; Crair MC, 2001, J COMP NEUROL, V430, P235, DOI 10.1002/1096-9861(20010205)430:2<235::AID-CNE1028>3.0.CO;2-P; Crowley JC, 2000, SCIENCE, V290, P1321, DOI 10.1126/science.290.5495.1321; Crowley JC, 1999, NAT NEUROSCI, V2, P1125, DOI 10.1038/16051; Durack JC, 1996, CEREB CORTEX, V6, P178, DOI 10.1093/cercor/6.2.178; GILBERT CD, 1989, J NEUROSCI, V9, P2432; Godecke I, 1997, EUR J NEUROSCI, V9, P1754; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; HERRMANN K, 1994, EUR J NEUROSCI, V6, P1729, DOI 10.1111/j.1460-9568.1994.tb00565.x; Issa NP, 1999, J NEUROSCI, V19, P6965, DOI 10.1523/JNEUROSCI.19-16-06965.1999; LAW MI, 1988, J COMP NEUROL, V278, P157, DOI 10.1002/cne.902780202; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; MILLER KD, 1989, SCIENCE, V245, P605, DOI 10.1126/science.2762813; Mooney R, 1996, NEURON, V17, P863, DOI 10.1016/S0896-6273(00)80218-4; Ruthazer ES, 1999, J COMP NEUROL, V407, P151; Ruthazer ES, 1996, J NEUROSCI, V16, P7253; Schwartz TH, 1998, NEURON, V20, P541, DOI 10.1016/S0896-6273(00)80993-9; Snedecor GW., 1989, STAT METHODS, P177; Trachtenberg JT, 2001, J NEUROSCI, V21, P3476, DOI 10.1523/JNEUROSCI.21-10-03476.2001; von der Malsburg C., 1976, EXP BRAIN RES, V(Suppl 1), P463; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599; White LE, 1999, J NEUROSCI, V19, P7089, DOI 10.1523/JNEUROSCI.19-16-07089.1999; YUSTE R, 1992, SCIENCE, V257, P666, DOI 10.1126/science.1496379	25	43	43	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 12	2002	35	6					1123	1134		10.1016/S0896-6273(02)00867-X	http://dx.doi.org/10.1016/S0896-6273(02)00867-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	594GC	12354401	Bronze			2022-12-24	WOS:000178040000012
J	Spiridon, M; Kanwisher, N				Spiridon, M; Kanwisher, N			How distributed is visual category information in human occipito-temporal cortex? An fMRI study	NEURON			English	Article							HUMAN EXTRASTRIATE CORTEX; AREA; FACES; REPRESENTATION; RECOGNITION; FUSIFORM; OBJECTS	We used fMRI to study the distribution of object category information in the ventral visual pathway. Extending the findings of Haxby et al. (2001), we find that categories of stimuli can be distinguished by the pattern of activation they elicit across this entire pathway, even when the stimuli within a category differ in viewpoint, exemplar, or image format. However, regions within the ventral visual pathway are neither interchangeable nor equipotential. Although the FFA and PPA permit excellent discrimination between preferred versus nonpreferred stimuli (e.g., faces-bottles and houses-bottles, respectively), we find that neither region alone permits accurate discrimination between pairs of nonpreferred stimuli (e.g., bottles-shoes). These findings indicate that the ventral visual pathway is not homogeneous, but contains some regions (including FFA and PPA) that are primarily involved in the analysis of a single class of stimulus.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Spiridon, M (corresponding author), MIT, Dept Brain & Cognit Sci, NE20-464, Cambridge, MA 02139 USA.				NEI NIH HHS [EY13455] Funding Source: Medline; NIMH NIH HHS [MH59150] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY013455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059150] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aguirre GK, 1998, NEURON, V21, P373, DOI 10.1016/S0896-6273(00)80546-2; Burock MA, 2000, HUM BRAIN MAPP, V11, P249, DOI 10.1002/1097-0193(200012)11:4<249::AID-HBM20>3.3.CO;2-X; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Epstein R, 1999, NEURON, V23, P115, DOI 10.1016/S0896-6273(00)80758-8; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Grill-Spector K, 1998, NEURON, V21, P191, DOI 10.1016/S0896-6273(00)80526-7; Halgren E, 1999, HUM BRAIN MAPP, V7, P29; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; HAXBY JV, 1994, J NEUROSCI, V14, P6336; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; Kanwisher N, 1997, J NEUROSCI, V17, P4302; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P604; Puce A, 1996, J NEUROSCI, V16, P5205; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; TOVEE MJ, 1993, J NEUROPHYSIOL, V70, P640, DOI 10.1152/jn.1993.70.2.640; Wada Y, 2001, J NEUROL NEUROSUR PS, V71, P254, DOI 10.1136/jnnp.71.2.254	17	220	226	0	16	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 12	2002	35	6					1157	1165		10.1016/S0896-6273(02)00877-2	http://dx.doi.org/10.1016/S0896-6273(02)00877-2			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	594GC	12354404	Bronze			2022-12-24	WOS:000178040000015
J	Wilson, CA; Doms, RW; Zheng, H; Lee, VMY				Wilson, CA; Doms, RW; Zheng, H; Lee, VMY			Presenilins are not required for A beta 42 production in the early secretory pathway	NATURE NEUROSCIENCE			English	Article							AMYLOID PRECURSOR PROTEIN; TRANS-GOLGI NETWORK; BETA-PROTEIN; ALZHEIMERS-DISEASE; SENILE PLAQUES; ENDOPLASMIC-RETICULUM; CELL-SURFACE; ACCUMULATION; CLEAVAGE; MICE	Presenilins 1 and 2 (PS1/PS2) have been suggested to be gamma-secretases responsible for the proteolytic cleavage of amyloid precursor protein (APP) to form amyloid-beta (Abeta), a protein implicated in the development of Alzheimer's disease. Here we examined whether these presenilins are required for the generation of multiple Abeta species by analyzing the production of several forms of secreted and intracellular Abeta in mouse cells lacking PS1, PS2 or both proteins. Although most Abeta species were abolished in PS1/PS2(-/-) cells, the production of intracellular Abeta42 generated in the endoplasmic reticulum/intermediate compartment was unaffected by the absence of these proteins, either singly or in combination. These results indicate that production of this pool of Abeta occurs independently of PS1/PS2, and therefore, another gamma-secretase activity must be responsible for cleavage of APP within the early secretory compartments.	Univ Penn, Sch Med, Dept Pathol & Lab Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; Merck Res Labs, Rahway, NJ 07065 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Merck & Company	Lee, VMY (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA.							Armogida M, 2001, NAT CELL BIOL, V3, P1030, DOI 10.1038/ncb1101-1030; Bahr BA, 1998, J COMP NEUROL, V397, P139; Citron M, 1996, P NATL ACAD SCI USA, V93, P13170, DOI 10.1073/pnas.93.23.13170; CITRON M, 1995, NEURON, V14, P661, DOI 10.1016/0896-6273(95)90323-2; Cook DG, 1997, NAT MED, V3, P1021, DOI 10.1038/nm0997-1021; D'Andrea MR, 2001, HISTOPATHOLOGY, V38, P120, DOI 10.1046/j.1365-2559.2001.01082.x; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; DOMS RW, 1989, J CELL BIOL, V109, P61, DOI 10.1083/jcb.109.1.61; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; FUJIWARA T, 1988, J BIOL CHEM, V263, P18545; Ginsberg SD, 1999, ANN NEUROL, V45, P174, DOI 10.1002/1531-8249(199902)45:2<174::AID-ANA7>3.0.CO;2-E; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Greenfield JP, 1999, P NATL ACAD SCI USA, V96, P742, DOI 10.1073/pnas.96.2.742; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Kienlen-Campard P, 2002, J BIOL CHEM, V277, P15666, DOI 10.1074/jbc.M200887200; Klafki HW, 1996, J BIOL CHEM, V271, P28655, DOI 10.1074/jbc.271.45.28655; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; MARTIN LJ, 1994, AM J PATHOL, V145, P1358; Masliah E, 1996, J NEUROSCI, V16, P5795; Murphy MP, 2000, J BIOL CHEM, V275, P26277, DOI 10.1074/jbc.M002812200; Ponting CP, 2002, HUM MOL GENET, V11, P1037, DOI 10.1093/hmg/11.9.1037; Qian S, 1998, NEURON, V20, P611, DOI 10.1016/S0896-6273(00)80999-X; SARASTE J, 1984, CELL, V38, P535, DOI 10.1016/0092-8674(84)90508-7; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; SELKOE DJ, 1997, MOL GENETIC BASIS NE, P601; SEUBERT P, 1993, NATURE, V361, P260, DOI 10.1038/361260a0; Sinha S, 1999, P NATL ACAD SCI USA, V96, P11049, DOI 10.1073/pnas.96.20.11049; Sisodia SS, 2002, SCIENCE, V295, P805, DOI 10.1126/science.1069661; Skovronsky DM, 2000, BIOCHEMISTRY-US, V39, P810, DOI 10.1021/bi991728z; Skovronsky DM, 1998, J CELL BIOL, V141, P1031, DOI 10.1083/jcb.141.4.1031; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Wang R, 1996, J BIOL CHEM, V271, P31894, DOI 10.1074/jbc.271.50.31894; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; WildBode C, 1997, J BIOL CHEM, V272, P16085, DOI 10.1074/jbc.272.26.16085; Wilson CA, 1999, J NEUROPATH EXP NEUR, V58, P787, DOI 10.1097/00005072-199908000-00001; Wirths O, 2001, NEUROSCI LETT, V306, P116, DOI 10.1016/S0304-3940(01)01876-6; Wolfe MS, 1998, J MED CHEM, V41, P6, DOI 10.1021/jm970621b; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wong PC, 1997, NATURE, V387, P288, DOI 10.1038/387288a0; Xu HX, 1997, P NATL ACAD SCI USA, V94, P3748, DOI 10.1073/pnas.94.8.3748; Yang AJ, 1999, J BIOL CHEM, V274, P20650, DOI 10.1074/jbc.274.29.20650; Zhang Y, 2002, J CELL BIOL, V156, P519, DOI 10.1083/jcb.200110119; Zhang ZH, 2000, NAT CELL BIOL, V2, P463, DOI 10.1038/35017108	50	87	90	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2002	5	9					849	855		10.1038/nn898	http://dx.doi.org/10.1038/nn898			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587RL	12145638				2022-12-24	WOS:000177656300014
J	Mann, F; Ray, S; Harris, WA; Holt, CE				Mann, F; Ray, S; Harris, WA; Holt, CE			Topographic mapping in dorsoventral axis of the xenopus retinotectal system depends on signaling through ephrin-13 ligands	NEURON			English	Article							RECEPTOR TYROSINE KINASES; EPH RECEPTORS; CELL-ADHESION; GROWTH CONES; TRANSMEMBRANE LIGANDS; CYTOPLASMIC DOMAIN; COMMISSURAL AXONS; INTEGRIN FUNCTION; RETINAL AXONS; EXPRESSION	Ephrin-B and EphB are distributed in matching dorsoventral gradients in the embryonic Xenopus visual system with retinal axons bearing high levels of ligand (dorsal) projecting to tectal regions with high receptor expression (ventral). In vitro stripe assays show that dorsal retinal axons prefer to grow on EphB receptor stripes supporting an attractive guidance mechanism. In vivo disruption of EphB/ephrin-B function by application of exogenous EphB or expression of dominant-negative ephrin-B ligand in dorsal retinal axons causes these axons to shift dorsally in the tectum, while misexpression of wild-type ephrin-B in ventral axons causes them to shift ventrally. These dorsoventral targeting errors are consistent with the hypothesis that an attractive mechanism that requires ephrin-B cytoplasmic domain is critical for retinotectal mapping in this axis.	Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England	University of Cambridge	Mann, F (corresponding author), Univ Cambridge, Dept Anat, Downing St, Cambridge CB2 3DY, England.	fm222@cam.ac.uk	Mann, Fanny/G-2786-2016; Ray, Samiran/AAZ-4916-2020	Mann, Fanny/0000-0003-4839-4347; Ray, Samiran/0000-0002-3738-4672; Holt, Christine Elizabeth/0000-0003-2829-121X				Adams RH, 2001, CELL, V104, P57, DOI 10.1016/S0092-8674(01)00191-X; Baier H, 1996, DEVELOPMENT, V123, P415; Barbieri AM, 1999, P NATL ACAD SCI USA, V96, P10729, DOI 10.1073/pnas.96.19.10729; Becker E, 2000, MOL CELL BIOL, V20, P1537, DOI 10.1128/MCB.20.5.1537-1545.2000; Birgbauer E, 2000, DEVELOPMENT, V127, P1231; Birgbauer E, 2001, DEVELOPMENT, V128, P3041; Bohme B, 1996, J BIOL CHEM, V271, P24747, DOI 10.1074/jbc.271.40.24747; Braisted JE, 1997, DEV BIOL, V191, P14, DOI 10.1006/dbio.1997.8706; BRANDLI AW, 1995, DEV DYNAM, V203, P119; Bruckner K, 1997, SCIENCE, V275, P1640, DOI 10.1126/science.275.5306.1640; CHIEN CB, 1993, NEURON, V11, P237, DOI 10.1016/0896-6273(93)90181-P; CHIEN CB, 1995, DEVELOPMENT, V121, P2621; Connor RJ, 1998, DEV BIOL, V193, P21, DOI 10.1006/dbio.1997.8786; CORNEL E, 1992, NEURON, V9, P1001, DOI 10.1016/0896-6273(92)90061-H; Davy A, 2000, EMBO J, V19, P5396, DOI 10.1093/emboj/19.20.5396; Davy A, 1999, GENE DEV, V13, P3125, DOI 10.1101/gad.13.23.3125; Drescher U, 1997, CURR OPIN NEUROBIOL, V7, P75, DOI 10.1016/S0959-4388(97)80123-7; Durbin L, 1998, GENE DEV, V12, P3096, DOI 10.1101/gad.12.19.3096; EAGLESON G, 1995, J NEUROBIOL, V28, P146, DOI 10.1002/neu.480280203; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Helbling PM, 1999, DEV DYNAM, V216, P361, DOI 10.1002/(SICI)1097-0177(199912)216:4/5<361::AID-DVDY5>3.0.CO;2-W; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Holash JA, 1995, DEV BIOL, V172, P683, DOI 10.1006/dbio.1995.8039; Holash JA, 1997, DEV BIOL, V182, P256, DOI 10.1006/dbio.1996.8496; Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0; HOLT CE, 1983, NATURE, V301, P150, DOI 10.1038/301150a0; HOLT CE, 1990, NEURON, V4, P203, DOI 10.1016/0896-6273(90)90095-W; Hornberger MR, 1999, NEURON, V22, P731, DOI 10.1016/S0896-6273(00)80732-1; Huai JS, 2001, J BIOL CHEM, V276, P6689, DOI 10.1074/jbc.M008127200; Huynh-Do U, 1999, EMBO J, V18, P2165, DOI 10.1093/emboj/18.8.2165; Irie A, 2002, DEVELOPMENT, V129, P61; Jones TL, 1997, ONCOGENE, V14, P2159, DOI 10.1038/sj.onc.1201082; JONES TL, 1995, ONCOGENE, V10, P1111; Jones TL, 1998, P NATL ACAD SCI USA, V95, P576, DOI 10.1073/pnas.95.2.576; Klein R, 1999, CURR BIOL, V9, pR691, DOI 10.1016/S0960-9822(99)80441-2; Knoll B, 2001, DEVELOPMENT, V128, P895; Koshiba-Takeuchi K, 2000, SCIENCE, V287, P134, DOI 10.1126/science.287.5450.134; Kullander K, 2001, GENE DEV, V15, P877, DOI 10.1101/gad.868901; Kullander K, 2001, NEURON, V29, P73, DOI 10.1016/S0896-6273(01)00181-7; Li HS, 1997, DEVELOPMENT, V124, P603; Liu Y, 2001, MECH DEVELOP, V100, P115, DOI 10.1016/S0925-4773(00)00505-0; Lu Q, 2001, CELL, V105, P69, DOI 10.1016/S0092-8674(01)00297-5; Mann F, 1998, J NEUROSCI, V18, P9409; Marcus RC, 1996, DEV BIOL, V180, P786, DOI 10.1006/dbio.1996.0347; Meima L, 1997, MOL CELL NEUROSCI, V9, P314, DOI 10.1006/mcne.1997.0621; Mellitzer G, 1999, NATURE, V400, P77, DOI 10.1038/21907; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; Nakagawa S, 2000, NEURON, V25, P599, DOI 10.1016/S0896-6273(00)81063-6; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; O'Leary DDM, 1999, CURR OPIN NEUROBIOL, V9, P65, DOI 10.1016/S0959-4388(99)80008-7; Orioli D, 1996, EMBO J, V15, P6035, DOI 10.1002/j.1460-2075.1996.tb00992.x; Riehl R, 1996, NEURON, V17, P837, DOI 10.1016/S0896-6273(00)80216-0; SCALES JB, 1995, ONCOGENE, V11, P1745; Schulte D, 1999, NEURON, V24, P541, DOI 10.1016/S0896-6273(00)81111-3; SHIMAMURA K, 1994, DEVELOPMENT, V120, P2225; Smith A, 1997, CURR BIOL, V7, P561, DOI 10.1016/S0960-9822(06)00255-7; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Stein E, 1998, GENE DEV, V12, P667, DOI 10.1101/gad.12.5.667; Tanaka M, 1998, ONCOGENE, V17, P1509, DOI 10.1038/sj.onc.1202068; Trowe T, 1996, DEVELOPMENT, V123, P439; VIELMETTER J, 1990, EXP BRAIN RES, V81, P283; Wang HU, 1997, NEURON, V18, P383, DOI 10.1016/S0896-6273(00)81240-4; Wilkinson DG, 2000, INT REV CYTOL, V196, P177; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Xu QL, 1999, NATURE, V399, P267, DOI 10.1038/20452; Yokoyama N, 2001, NEURON, V29, P85, DOI 10.1016/S0896-6273(01)00182-9; Zou JX, 1999, P NATL ACAD SCI USA, V96, P13813, DOI 10.1073/pnas.96.24.13813	68	162	163	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 1	2002	35	3					461	473		10.1016/S0896-6273(02)00786-9	http://dx.doi.org/10.1016/S0896-6273(02)00786-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	582CB	12165469	Bronze			2022-12-24	WOS:000177331200008
J	Everling, S; Tinsley, CJ; Gaffan, D; Duncan, J				Everling, S; Tinsley, CJ; Gaffan, D; Duncan, J			Filtering of neural signals by focused attention in the monkey prefrontal cortex	NATURE NEUROSCIENCE			English	Article							SELECTIVE VISUAL-ATTENTION; GO/NO-GO DISCRIMINATION; FRONTAL EYE FIELD; TARGET SELECTION; PARIETAL CORTEX; UNIT-ACTIVITY; HUMAN BRAIN; NEURONS; MACAQUE; MECHANISMS	Prefrontal cortex is thought to be important in attention and awareness. Here we recorded the activity of prefrontal neurons in monkeys carrying out a focused attention task. Having directed attention to one location, monkeys monitored a stream of visual objects, awaiting a predefined target. Although neurons rarely discriminated between one non-target and another, they commonly discriminated between targets and non-targets. From the onset of the visual response, this target/non-target discrimination was effectively eliminated when the same objects appeared at an unattended location in the opposite visual hemifield. The results show that, in prefrontal cortex, filtering of ignored locations is strong, early and spatially global. Such filtering may be important in blindness to unattended signals-a conspicuous aspect of human selective attention.	MRC, Cognit & Brain Sci Unit, Cambridge CB2 2EF, England; Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of Oxford	Duncan, J (corresponding author), MRC, Cognit & Brain Sci Unit, 15 Chaucer Rd, Cambridge CB2 2EF, England.		Everling, Stefan/K-5208-2013; Everling, Stefan/AAR-8687-2020	Everling, Stefan/0000-0001-9714-9757; Tinsley, Chris/0000-0002-9369-443X; Duncan, John/0000-0002-9695-2764				BAYNES K, 1986, BRAIN, V109, P99, DOI 10.1093/brain/109.1.99; Beck DM, 2001, NAT NEUROSCI, V4, P645, DOI 10.1038/88477; Bichot NP, 1996, NATURE, V381, P697, DOI 10.1038/381697a0; Broadbent D.E., 1958, PERCEPTION COMMUNICA; BUSHNELL MC, 1981, J NEUROPHYSIOL, V46, P755, DOI 10.1152/jn.1981.46.4.755; Chelazzi L, 1998, J NEUROPHYSIOL, V80, P2918, DOI 10.1152/jn.1998.80.6.2918; CORBETTA M, 1993, J NEUROSCI, V13, P1202; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Dell'Acqua R, 2001, PERCEPT PSYCHOPHYS, V63, P777, DOI 10.3758/BF03194437; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Duncan J, 2001, NAT REV NEUROSCI, V2, P820, DOI 10.1038/35097575; Duncan J, 1999, J EXP PSYCHOL GEN, V128, P450, DOI 10.1037/0096-3445.128.4.450; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; Hasegawa RP, 2000, J NEUROPHYSIOL, V84, P1692, DOI 10.1152/jn.2000.84.3.1692; Jiang Y, 2000, SCIENCE, V287, P643, DOI 10.1126/science.287.5453.643; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; Rainer G, 1998, P NATL ACAD SCI USA, V95, P15008, DOI 10.1073/pnas.95.25.15008; Reynolds JH, 1999, J NEUROSCI, V19, P1736; ROCK I, 1992, COGNITIVE PSYCHOL, V24, P502, DOI 10.1016/0010-0285(92)90017-V; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; SAKAGAMI M, 1994, EXP BRAIN RES, V97, P423; SATO T, 1988, J NEUROPHYSIOL, V60, P344, DOI 10.1152/jn.1988.60.1.344; SCHALL JD, 1995, J NEUROSCI, V15, P6905; Seidemann E, 1999, J NEUROPHYSIOL, V81, P1783, DOI 10.1152/jn.1999.81.4.1783; Shulman GL, 2001, P NATL ACAD SCI USA, V98, P313, DOI 10.1073/pnas.021381198; Thompson KG, 1996, J NEUROPHYSIOL, V76, P4040, DOI 10.1152/jn.1996.76.6.4040; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; VANVOORHIS S, 1977, PERCEPT PSYCHOPHYS, V22, P54, DOI 10.3758/BF03206080; WATANABE M, 1986, BRAIN RES, V382, P1, DOI 10.1016/0006-8993(86)90104-6; WATANABE M, 1986, BRAIN RES, V382, P15, DOI 10.1016/0006-8993(86)90105-8	37	163	166	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2002	5	7					671	676		10.1038/nn874	http://dx.doi.org/10.1038/nn874			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	566EP	12068302				2022-12-24	WOS:000176414300017
J	Pun, S; Sigrist, M; Santos, AF; Ruegg, MA; Sanes, JR; Jessell, TM; Arber, S; Caroni, P				Pun, S; Sigrist, M; Santos, AF; Ruegg, MA; Sanes, JR; Jessell, TM; Arber, S; Caroni, P			An intrinsic distinction in neuromuscular junction assembly and maintenance in different skeletal muscles	NEURON			English	Article							ACETYLCHOLINE-RECEPTORS; SYNAPTIC EFFICACY; TRANSGENIC MICE; IN-VIVO; AGRIN; MUSK; RAPSYN; CELLS; OVEREXPRESSION; EXPRESSION	We analyzed the formation of neuromuscular junctions (NMJs) in individual muscles of the mouse embryo. Skeletal muscles can be assigned to one of two distinct classes of muscles, termed "Fast Synapsing" (FaSyn) and "Delayed Synapsing" (DeSyn) muscles, which differ significantly with respect to the initial focal clustering of postsynaptic AChRs, the timing of presynaptic maturation, and the maintenance of NMJs in young adult mice. Differences between classes were intrinsic to the muscles and manifested in the absence of innervation or agrin. Paralysis or denervation of young adult muscles resulted in disassembly of AChR clusters on DeSyn muscles, whereas those on FaSyn muscles were preserved. Our results show that postsynaptic differentiation processes intrinsic to FaSyn and DeSyn muscles influence the formation of NMJs during development and their maintenance in the adult.	Friedrich Miescher Inst, CH-4058 Basel, Switzerland; Biozentrum, Dept Cell Biol, CN-4056 Basel, Switzerland; Biozentrum, Dept Pharmacol, CN-4056 Basel, Switzerland; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Columbia Univ HHSC, Dept Biochem & Mol Biophys, HHMI, New York, NY 10032 USA	Friedrich Miescher Institute for Biomedical Research; Washington University (WUSTL); Columbia University; Howard Hughes Medical Institute	Caroni, P (corresponding author), Friedrich Miescher Inst, Maulbeerstr 66, CH-4058 Basel, Switzerland.		Ruegg, Markus/X-7256-2019	Ruegg, Markus/0000-0002-4974-9384; Arber, Silvia/0000-0002-6261-250X				AIGNER L, 1995, CELL, V83, P269, DOI 10.1016/0092-8674(95)90168-X; Akaaboune M, 1999, SCIENCE, V286, P503, DOI 10.1126/science.286.5439.503; ANDERSON MJ, 1977, J PHYSIOL-LONDON, V268, P757, DOI 10.1113/jphysiol.1977.sp011880; Apel ED, 1997, NEURON, V18, P623, DOI 10.1016/S0896-6273(00)80303-7; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Burgess RW, 1999, NEURON, V23, P33, DOI 10.1016/S0896-6273(00)80751-5; Burke RE, 1994, MYOLOGY, P464; Caroni P, 1997, J NEUROSCI METH, V71, P3, DOI 10.1016/S0165-0270(96)00121-5; Davis GW, 1998, NATURE, V392, P82, DOI 10.1038/32176; Davis GW, 2000, NEURON, V26, P551, DOI 10.1016/S0896-6273(00)81190-3; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; DENZER AJ, 1995, J CELL BIOL, V131, P1547, DOI 10.1083/jcb.131.6.1547; Fitzsimonds RM, 1998, PHYSIOL REV, V78, P143, DOI 10.1152/physrev.1998.78.1.143; Frank E, 1977, Soc Gen Physiol Ser, V32, P285; Frey D, 2000, J NEUROSCI, V20, P2534; Fuhrer C, 1999, J NEUROSCI, V19, P6405; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; GAUTAM M, 1995, NATURE, V377, P232, DOI 10.1038/377232a0; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; Gonzalez M, 1999, NEURON, V24, P567, DOI 10.1016/S0896-6273(00)81113-7; HARRIS A J, 1981, Philosophical Transactions of the Royal Society of London B Biological Sciences, V293, P287, DOI 10.1098/rstb.1981.0078; JONES CL, 1979, J MORPHOL, V162, P275, DOI 10.1002/jmor.1051620207; Jones G, 1997, P NATL ACAD SCI USA, V94, P2654, DOI 10.1073/pnas.94.6.2654; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; OROURKE NA, 1994, NEURON, V12, P921, DOI 10.1016/0896-6273(94)90343-3; REYNOLDS ML, 1992, J NEUROCYTOL, V21, P50, DOI 10.1007/BF01206897; Robitaille R, 1998, NEURON, V21, P847, DOI 10.1016/S0896-6273(00)80600-5; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Skorpen J, 1999, MOL CELL NEUROSCI, V13, P192, DOI 10.1006/mcne.1999.0743; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; Yang X, 2000, SCIENCE, V287, P131, DOI 10.1126/science.287.5450.131; Zhou H, 1999, J CELL BIOL, V146, P1133, DOI 10.1083/jcb.146.5.1133	36	95	96	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 25	2002	34	3					357	370		10.1016/S0896-6273(02)00670-0	http://dx.doi.org/10.1016/S0896-6273(02)00670-0			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	545JW	11988168	Bronze			2022-12-24	WOS:000175214700008
J	Lu, XF; Matsuzawa, M; Hikosaka, O				Lu, XF; Matsuzawa, M; Hikosaka, O			A neural correlate of oculomotor sequences in supplementary eye field	NEURON			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; PRESUPPLEMENTARY MOTOR AREAS; MEMORY-GUIDED SACCADES; NEURONAL-ACTIVITY; TEMPORAL ORGANIZATION; MOVEMENTS; HAND; COORDINATION; ACTIVATION; CORTEX	Complex learned motor sequences can be composed of a combination of a small number of elementary actions. To investigate how the brain represents such sequences, we devised an oculomotor sequence task in which the monkey had to choose the target solely by the sequential context, not by the current stimulus combination. We found that many neurons in the supplementary eye field (SEF) became active with a specific target direction (D neuron) or a specific target/distractor combination (C neuron). Furthermore, such activity was often selective for one among several sequences that included the combination (S neuron). These results suggest that the SEF contributes to the generation of saccades in many learned sequences.	Juntendo Univ, Sch Med, Dept Physiol, Tokyo 1138421, Japan	Juntendo University	Hikosaka, O (corresponding author), NEI, Sensorimotor Res Lab, NIH, Bldg 49,Room 2A50, Bethesda, MD 20892 USA.				NATIONAL EYE INSTITUTE [ZIAEY000415, Z01EY000415] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Amador N, 2000, J NEUROPHYSIOL, V84, P2166, DOI 10.1152/jn.2000.84.4.2166; BALLARD DH, 1992, PHILOS T R SOC B, V337, P331, DOI 10.1098/rstb.1992.0111; BASHINSKI HS, 1980, PERCEPT PSYCHOPHYS, V28, P241, DOI 10.3758/BF03204380; CARNAHAN H, 1991, J MOTOR BEHAV, V23, P109, DOI 10.1080/00222895.1991.9942028; CHEN LL, 1995, J NEUROPHYSIOL, V73, P1101, DOI 10.1152/jn.1995.73.3.1101; Clower WT, 1998, J NEUROPHYSIOL, V80, P1562, DOI 10.1152/jn.1998.80.3.1562; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; EPELBOIM J, 1995, VISION RES, V35, P3401, DOI 10.1016/0042-6989(95)00080-X; GAYMARD B, 1990, ANN NEUROL, V28, P622, DOI 10.1002/ana.410280504; HIKOSAKA O, 1995, J NEUROPHYSIOL, V74, P1652, DOI 10.1152/jn.1995.74.4.1652; HIKOSAKA O, 1999, NEW COGNITIVE NEUROS, P553; Johansson RS, 2001, J NEUROSCI, V21, P6917, DOI 10.1523/JNEUROSCI.21-17-06917.2001; Kawashima R, 1998, EXP BRAIN RES, V122, P1, DOI 10.1007/s002210050485; Lu XF, 1998, J NEUROPHYSIOL, V79, P2245, DOI 10.1152/jn.1998.79.5.2245; Miyashita K, 1996, J NEUROPHYSIOL, V76, P1361, DOI 10.1152/jn.1996.76.2.1361; MURI RM, 1994, EXP BRAIN RES, V101, P521; MURI RM, 1995, EXP BRAIN RES, V104, P163; Nakamura K, 1998, J NEUROPHYSIOL, V80, P2671, DOI 10.1152/jn.1998.80.5.2671; OLSON CR, 1995, SCIENCE, V269, P985, DOI 10.1126/science.7638625; Petit L, 1996, J NEUROSCI, V16, P3714; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; PRABLANC C, 1986, EXP BRAIN RES, V62, P293; Sakai K, 1998, J NEUROSCI, V18, P1827; SCHLAG J, 1987, J NEUROPHYSIOL, V57, P179, DOI 10.1152/jn.1987.57.1.179; SchlagRey M, 1997, NATURE, V390, P398, DOI 10.1038/37114; Shima K, 2000, J NEUROPHYSIOL, V84, P2148, DOI 10.1152/jn.2000.84.4.2148; Stuphorn V, 2000, NATURE, V408, P857, DOI 10.1038/35048576; TANJI J, 1994, NATURE, V371, P413, DOI 10.1038/371413a0; van Donkelaar P, 2000, EXP BRAIN RES, V133, P414, DOI 10.1007/s002210000422; WURTZ RH, 1980, PROGR PSYCHOBIOLOGY, V9, P43	30	74	74	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 11	2002	34	2					317	325		10.1016/S0896-6273(02)00657-8	http://dx.doi.org/10.1016/S0896-6273(02)00657-8			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	541GE	11970872	Bronze			2022-12-24	WOS:000174976200016
J	Tsvetkov, E; Carlezon, WA; Benes, FM; Kandel, ER; Bolshakov, VY				Tsvetkov, E; Carlezon, WA; Benes, FM; Kandel, ER; Bolshakov, VY			Fear conditioning occludes LTP-induced presynaptic enhancement of synaptic transmission in the cortical pathway to the lateral amygdala	NEURON			English	Article							LONG-TERM POTENTIATION; AMPA RECEPTORS; FREQUENCY STIMULATION; NMDA RECEPTORS; LATE-PHASE; MEMORY; EXPRESSION; PLASTICITY; INDUCTION; NUCLEUS	Auditory information critical for fear conditioning, a model of emotional learning, is conveyed to the lateral nucleus of the amygdala via two routes: directly from the medial geniculate nucleus and indirectly from the auditory cortex. Here we show in the cortico-amygdala pathway that learned fear occludes electrically induced long-term potentiation (LTP). Quantal analysis of the expression of LTP in this pathway reveals a significant presynaptic component reflected in an increase in probability of transmitter release. Conditioned fear also is accompanied by the enhancement in transmitter release at this cortico-amygdala synapse. These results indicate that the synaptic projections from the auditory cortex to the lateral amygdala are modified during the acquisition and expression of fear to auditory stimulation, thus further strengthening the proposed link between LTP in the auditory pathways to the amygdala and learned fear.	Harvard Univ, McLean Hosp, Sch Med, Dept Psychiat, Belmont, MA 02478 USA; Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, Ctr Neurobiol & Behav, Dept Physiol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Biophys, New York, NY 10032 USA	Harvard University; McLean Hospital; Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute	Bolshakov, VY (corresponding author), Harvard Univ, McLean Hosp, Sch Med, Dept Psychiat, 115 Mill St, Belmont, MA 02478 USA.	vadimb@mclean.harvard.edu	anand, amit/A-7222-2009; Tsvetkov, Evgeny A/B-6573-2016; Tsvetkov, Evgeny/C-1085-2016	Tsvetkov, Evgeny A/0000-0002-6784-0907; Tsvetkov, Evgeny/0000-0001-9339-1677; /0000-0002-4162-3947	NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012736] Funding Source: NIH RePORTER; NIDA NIH HHS [DA12736] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; Bauer EP, 2001, NAT NEUROSCI, V4, P687, DOI 10.1038/89465; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bolshakov VY, 1997, NEURON, V19, P635, DOI 10.1016/S0896-6273(00)80377-3; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; BORDI F, 1992, J NEUROSCI, V12, P2493; Bozdagi O, 2000, NEURON, V28, P245, DOI 10.1016/S0896-6273(00)00100-8; Campeau S, 1997, NEUROSCIENCE, V78, P1087, DOI 10.1016/S0306-4522(96)00632-X; CAMPEAU S, 1995, J NEUROSCI, V15, P2312, DOI 10.1523/JNEUROSCI.15-03-02312.1995; EICHENBAUM H, 1995, NATURE, V378, P131, DOI 10.1038/378131a0; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Gasparini S, 2000, P NATL ACAD SCI USA, V97, P9741, DOI 10.1073/pnas.170032297; Gewirtz JC, 1997, NATURE, V388, P471, DOI 10.1038/41325; GROVER LM, 1990, NATURE, V347, P477, DOI 10.1038/347477a0; Huang YY, 1998, NEURON, V21, P169, DOI 10.1016/S0896-6273(00)80524-3; Isaac JTR, 1996, P NATL ACAD SCI USA, V93, P8710, DOI 10.1073/pnas.93.16.8710; KAPP B S, 1992, P229; Kapp BS, 1984, NEUROPSYCHOLOGY MEMO, P473; Laezza F, 1999, SCIENCE, V285, P1411, DOI 10.1126/science.285.5432.1411; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Ma L, 1999, NAT NEUROSCI, V2, P24, DOI 10.1038/4525; Mahanty NK, 1998, NATURE, V394, P683, DOI 10.1038/29312; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; Malleret G, 2001, CELL, V104, P675, DOI 10.1016/S0092-8674(01)00264-1; Maren S, 1999, TRENDS NEUROSCI, V22, P561, DOI 10.1016/S0166-2236(99)01465-4; Maren S, 1996, BEHAV NEUROSCI, V110, P1365, DOI 10.1037/0735-7044.110.6.1365; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; MISERENDINO MJD, 1990, NATURE, V345, P716, DOI 10.1038/345716a0; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; O'Dell T J, 1994, Learn Mem, V1, P129; Phelps EA, 2001, NAT NEUROSCI, V4, P437, DOI 10.1038/86110; Pitkanen A, 1997, TRENDS NEUROSCI, V20, P517, DOI 10.1016/S0166-2236(97)01125-9; Regehr WG, 2001, SYNAPSES, P135; Repa JC, 2001, NAT NEUROSCI, V4, P724, DOI 10.1038/89512; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; ROMANSKI LM, 1992, J NEUROSCI, V12, P4501; ROMANSKI LM, 1993, BEHAV NEUROSCI, V107, P444, DOI 10.1037/0735-7044.107.3.444; Scott SK, 1997, NATURE, V385, P254, DOI 10.1038/385254a0; Stevens CF, 1998, NEURON, V20, P1, DOI 10.1016/S0896-6273(00)80426-2; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Weisskopf MG, 1999, J NEUROPHYSIOL, V81, P930, DOI 10.1152/jn.1999.81.2.930; Winder DG, 1999, NEURON, V24, P715, DOI 10.1016/S0896-6273(00)81124-1; Zakharenko SS, 2001, NAT NEUROSCI, V4, P711, DOI 10.1038/89498; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	50	251	258	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 11	2002	34	2					289	300		10.1016/S0896-6273(02)00645-1	http://dx.doi.org/10.1016/S0896-6273(02)00645-1			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	541GE	11970870	Bronze			2022-12-24	WOS:000174976200014
J	Drier, EA; Tello, MK; Cowan, M; Wu, P; Blace, N; Sacktor, TC; Yin, JCP				Drier, EA; Tello, MK; Cowan, M; Wu, P; Blace, N; Sacktor, TC; Yin, JCP			Memory enhancement and formation by atypical PKM activity in Drosophila melanogaster	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE-C; LONG-TERM POTENTIATION; CAENORHABDITIS-ELEGANS; PERSISTENT ACTIVATION; CONSOLIDATED MEMORY; CELL-POLARITY; M-ZETA; MAINTENANCE; BAZOOKA; FACILITATION	Synaptic stimulation activates signal transduction pathways, producing persistently active protein kinases. PKMzeta is a truncated, persistently active isoform of atypical protein kinase C-zeta (aPKCzeta), which lacks the N-terminal pseudosubstrate regulatory domain. Using a Pavlovian olfactory learning task in Drosophila, we found that induction of the mouse aPKMzeta (MaPKMzeta) transgene enhanced memory. The enhancement required persistent kinase activity and was temporally specific, with optimal induction at 30 minutes after training. Induction also enhanced memory after massed training and corrected the memory defect of radish mutants, but did not improve memory produced by spaced training. The 'M' isoform of the Drosophila homolog of MaPKCzeta (DaPKM) was present and active in fly heads. Chelerythrine, an inhibitor of PKMzeta, and the induction of a dominant-negative MaPKMzeta transgene inhibited memory without affecting learning. Finally, induction of DaPKM after training also enhanced memory. These results show that atypical PKM is sufficient to enhance memory in Drosophila and suggest that it is necessary for normal memory maintenance.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Grad Program Genet, Stony Brook, NY 11794 USA; SUNY Downstate Med Ctr, Dept Physiol, Lab Mol Neurosci, Brooklyn, NY 11203 USA; SUNY Downstate Med Ctr, Dept Pharmacol, Lab Mol Neurosci, Brooklyn, NY 11203 USA; SUNY Downstate Med Ctr, Dept Neurol, Lab Mol Neurosci, Brooklyn, NY 11203 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Yin, JCP (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.			Blace, Nancy/0000-0002-6174-6004	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035575] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA015753] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Angenstein F, 1997, PROG NEURO-PSYCHOPH, V21, P427, DOI 10.1016/S0278-5846(97)00012-2; Bandyopadhyay G, 1999, BIOCHEM J, V337, P461, DOI 10.1042/0264-6021:3370461; Bortolotto ZA, 2000, EUR J NEUROSCI, V12, P4055, DOI 10.1046/j.1460-9568.2000.00291.x; BOYNTON S, 1992, GENETICS, V131, P655; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; CONNOLLY JB, 1998, DROSOPHILA PRACTICAL, P265; Dubnau J, 1998, ANNU REV NEUROSCI, V21, P407, DOI 10.1146/annurev.neuro.21.1.407; FOLKERS E, 1993, P NATL ACAD SCI USA, V90, P8123, DOI 10.1073/pnas.90.17.8123; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Frey U, 1998, TRENDS NEUROSCI, V21, P181, DOI 10.1016/S0166-2236(97)01189-2; Grunbaum L, 1998, J NEUROSCI, V18, P4384; HERBERT JM, 1990, BIOCHEM BIOPH RES CO, V172, P993, DOI 10.1016/0006-291X(90)91544-3; Hrabetova S, 1996, J NEUROSCI, V16, P5324; INOUE M, 1977, J BIOL CHEM, V252, P7610; Izumi Y, 1998, J CELL BIOL, V143, P95, DOI 10.1083/jcb.143.1.95; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Kane NS, 1997, NEURON, V18, P307, DOI 10.1016/S0896-6273(00)80270-6; Knoblich JA, 2001, NAT REV MOL CELL BIO, V2, P11, DOI 10.1038/35048085; Lallena MJ, 1999, MOL CELL BIOL, V19, P2180; Laudanna C, 1998, J BIOL CHEM, V273, P30306, DOI 10.1074/jbc.273.46.30306; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Ling DSF, 2002, NAT NEUROSCI, V5, P295, DOI 10.1038/nn829; LISMAN JE, 1985, P NATL ACAD SCI USA, V82, P3055, DOI 10.1073/pnas.82.9.3055; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Mehta D, 2001, J BIOL CHEM, V276, P22614, DOI 10.1074/jbc.M101927200; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Muller HAJ, 1996, J CELL BIOL, V134, P149, DOI 10.1083/jcb.134.1.149; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Osten P, 1996, J NEUROSCI, V16, P2444; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; Qiu RG, 2000, CURR BIOL, V10, P697, DOI 10.1016/S0960-9822(00)00535-2; Romanelli A, 1999, MOL CELL BIOL, V19, P2921; SACKTOR TC, 1993, P NATL ACAD SCI USA, V90, P8342, DOI 10.1073/pnas.90.18.8342; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; SCHWARTZ JH, 1993, P NATL ACAD SCI USA, V90, P8310, DOI 10.1073/pnas.90.18.8310; Sossin W S, 1994, Learn Mem, V1, P189; Suzuki A, 2001, J CELL BIOL, V152, P1183, DOI 10.1083/jcb.152.6.1183; Tabuse Y, 1998, DEVELOPMENT, V125, P3607; TAKAI Y, 1977, BIOCHEM BIOPH RES CO, V77, P542, DOI 10.1016/S0006-291X(77)80013-2; Thompson LJ, 1996, J BIOL CHEM, V271, P15045, DOI 10.1074/jbc.271.25.15045; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; VanderZee EA, 1997, PROG NEURO-PSYCHOPH, V21, P379, DOI 10.1016/S0278-5846(97)00010-9; Waddell S, 2001, ANNU REV NEUROSCI, V24, P1283, DOI 10.1146/annurev.neuro.24.1.1283; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9	49	133	139	0	22	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2002	5	4					316	324		10.1038/nn820	http://dx.doi.org/10.1038/nn820			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	534UQ	11914720				2022-12-24	WOS:000174606900011
J	Kaufmann, N; DeProto, J; Ranjan, R; Wan, H; Van Vactor, D				Kaufmann, N; DeProto, J; Ranjan, R; Wan, H; Van Vactor, D			Drosophila liprin-alpha and the receptor phosphatase Dlar control synapse morphogenesis	NEURON			English	Article							ABL TYROSINE KINASE; EXCHANGE FACTOR; NEUROMUSCULAR-JUNCTION; AXON GUIDANCE; PTP-DELTA; GROWTH; LAR; BRAIN; PHOSPHORYLATION; ULTRASTRUCTURE	Here, we examine the synaptic function of the receptor protein tyrosine phosphatase (RPTP), Dlar, and an associated intracellular protein, Dliprin-alpha, at the Drosophila larval neuromuscular junction. We show that Dliprin-alpha and Dlar are required for normal synaptic morphology. We also find that synapse complexity is proportional to the amount of Dlar gene product, suggesting that Dlar activity determines synapse size. Ultrastructural analysis reveals that Dliprin-alpha and Dlar are required to define the size and shape of the presynaptic active zone. Accordingly, there is a concomitant decrease in synaptic transmission in both mutants. Finally, epistasis analysis indicates that Dliprin-alpha is required for Dlar's action at the synapse. These data suggest a model where Dliprin-alpha and Dlar cooperate to regulate the formation and/or maintenance of a network of presynaptic proteins.	Harvard Univ, Sch Med, Dept Cell Biol, Program Neurosci, Boston, MA 02115 USA; Harvard Univ, Sch Med, DFCI Harvard Canc Ctr, Boston, MA 02115 USA; Childrens Hosp, Div Neurol, Boston, MA 02115 USA; Renovis Inc, San Francisco, CA 94080 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Van Vactor, D (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Program Neurosci, Boston, MA 02115 USA.	davie@hms.harvard.edu		Van Vactor, Jr., David L./0000-0001-8156-9482	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035909, P01NS040043] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 40043, NS 35909] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; BATE M, 1995, NEURON, V15, P513, DOI 10.1016/0896-6273(95)90141-8; Bateman J, 2000, NEURON, V26, P93, DOI 10.1016/S0896-6273(00)81141-1; Beumer KJ, 1999, DEVELOPMENT, V126, P5833; CHANG HG, 1994, J PHYSIOL-LONDON, V476, P1; Coussens CM, 2000, NEUROPHARMACOLOGY, V39, P2267, DOI 10.1016/S0028-3908(00)00087-3; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; Dresbach T, 2001, CELL MOL LIFE SCI, V58, P94, DOI 10.1007/PL00000781; Gallo G, 1999, CURR BIOL, V9, pR490, DOI 10.1016/S0960-9822(99)80304-2; Gramates LS, 1999, INT REV NEUROBIOL, V43, P93, DOI 10.1016/S0074-7742(08)60542-5; JAN LY, 1976, J PHYSIOL-LONDON, V262, P189, DOI 10.1113/jphysiol.1976.sp011592; JOHANSEN J, 1989, J NEUROSCI, V9, P710; Kaufmann N, 1998, DEVELOPMENT, V125, P453; Krueger NX, 1996, CELL, V84, P611, DOI 10.1016/S0092-8674(00)81036-3; LAHEY T, 1994, NEURON, V13, P823, DOI 10.1016/0896-6273(94)90249-6; Lanier LM, 2000, CURR OPIN NEUROBIOL, V10, P80, DOI 10.1016/S0959-4388(99)00058-6; LEBEUX YJ, 1975, CELL TISSUE RES, V160, P37; Liebl EC, 2000, NEURON, V26, P107, DOI 10.1016/S0896-6273(00)81142-3; Lnenicka GA, 2000, J NEUROBIOL, V43, P186, DOI 10.1002/(SICI)1097-4695(200005)43:2<186::AID-NEU8>3.3.CO;2-E; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; MARTIN AR, 1955, J PHYSIOL-LONDON, V130, P114, DOI 10.1113/jphysiol.1955.sp005397; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Penzes P, 2000, J BIOL CHEM, V275, P6395, DOI 10.1074/jbc.275.9.6395; Phillips GR, 2001, NEURON, V32, P63, DOI 10.1016/S0896-6273(01)00450-0; PULIDO R, 1995, P NATL ACAD SCI USA, V92, P11686, DOI 10.1073/pnas.92.25.11686; Rodesch CK, 2000, NEUROREPORT, V11, pR45, DOI 10.1097/00001756-200012180-00002; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; Serra-Pages C, 1998, J BIOL CHEM, V273, P15611, DOI 10.1074/jbc.273.25.15611; SERRAPAGES C, 1995, EMBO J, V14, P2827, DOI 10.1002/j.1460-2075.1995.tb07282.x; Sheng MHT, 2001, SYNAPSES, P315; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; Stoker AW, 2001, CURR OPIN NEUROBIOL, V11, P95, DOI 10.1016/S0959-4388(00)00179-3; Uetani N, 2000, EMBO J, V19, P2775, DOI 10.1093/emboj/19.12.2775; Van Vactor D, 1999, ADV MOLEC BIOL, P490; Wills Z, 1999, NEURON, V22, P291, DOI 10.1016/S0896-6273(00)81090-9; Wills Z, 1999, NEURON, V22, P301, DOI 10.1016/S0896-6273(00)81091-0; Wyszynski M, 2002, NEURON, V34, P39, DOI 10.1016/S0896-6273(02)00640-2; Zampighi GA, 1997, J STRUCT BIOL, V119, P347, DOI 10.1006/jsbi.1997.3882; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X	45	225	230	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 28	2002	34	1					27	38		10.1016/S0896-6273(02)00643-8	http://dx.doi.org/10.1016/S0896-6273(02)00643-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536HR	11931739	Bronze			2022-12-24	WOS:000174695100007
J	Ibanez-Tallon, I; Miwa, JM; Wang, HL; Adams, NC; Crabtree, GW; Sine, SM; Heintz, N				Ibanez-Tallon, I; Miwa, JM; Wang, HL; Adams, NC; Crabtree, GW; Sine, SM; Heintz, N			Novel modulation of neuronal nicotinic acetylcholine receptors by association with the endogenous prototoxin lynx1	NEURON			English	Article							FRONTAL-LOBE EPILEPSY; ALPHA-BUNGAROTOXIN BINDING; IMMUNOCYTOCHEMICAL LOCALIZATION; PATCH-CLAMP; SUBUNIT; MUTATION; BRAIN; GENE; BETA-2-SUBUNIT; NEUROTOXINS	We previously identified lynx1 as a neuronal membrane molecule related to snake alpha-neurotoxins able to modulate nAChRs. Here, we show that lynx1 colocalizes with nAChRs on CNS neurons and physically associates with nAChRs. Single-channel recordings show that lynx1 promotes the largest of three current amplitudes elicited by ACh through alpha(4)beta(2) nAChRs and that lynx1 enhances desensitization. Macroscopic recordings quantify the enhancement of desensitization onset by lynx1 and further show that it slows recovery from desensitization and increases the EC50. These experiments establish that direct interaction of lynx1 with nAChRs can result in a novel type of functional modulation and suggest that prototoxins may play important roles in vivo by modulating functional properties of their cognate CNS receptors.	Rockefeller Univ, Mol Biol Lab, Howard Hughes Med Inst, New York, NY 10021 USA; Rockefeller Univ, Dev Neurobiol Lab, New York, NY 10021 USA; Mayo Clin & Mayo Fdn, Receptor Biol Lab, Dept Physiol & Biophys, Rochester, MN 55905 USA; Columbia Univ, Dept Cell Biol & Anat, Ctr Neurobiol & Behav, New York, NY 10032 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University; Mayo Clinic; Columbia University	Heintz, N (corresponding author), Rockefeller Univ, Mol Biol Lab, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10021 USA.	heintz@rockefeller.edu		Miwa, Julie/0000-0002-4418-3756	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS031744, R01NS031744, P01NS030532, R01NS022061] Funding Source: NIH RePORTER; NCI NIH HHS [CA 09673] Funding Source: Medline; NINDS NIH HHS [P01 NS30532, NS-22061, NS-31744] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Buisson B, 2000, NEUROPHARMACOLOGY, V39, P2561, DOI 10.1016/S0028-3908(00)00158-1; Buisson B, 1996, J NEUROSCI, V16, P7880; Buisson B, 2001, J NEUROSCI, V21, P1819, DOI 10.1523/JNEUROSCI.21-06-01819.2001; Changeux JP, 1998, BRAIN RES REV, V26, P198, DOI 10.1016/S0165-0173(97)00040-4; Chou JH, 2001, GENETICS, V157, P211; DELTORO ED, 1994, J COMP NEUROL, V349, P325, DOI 10.1002/cne.903490302; Elgoyhen AB, 2001, P NATL ACAD SCI USA, V98, P3501, DOI 10.1073/pnas.051622798; Everitt BJ, 1997, ANNU REV PSYCHOL, V48, P649, DOI 10.1146/annurev.psych.48.1.649; Figl A, 1998, J PHYSIOL-LONDON, V513, P655, DOI 10.1111/j.1469-7793.1998.655ba.x; FLORES CM, 1992, MOL PHARMACOL, V41, P31; GERZANICH V, 1996, J PHARMACOL EXP THER, V286, P311; Grant GA, 1998, BIOCHEMISTRY-US, V37, P12166, DOI 10.1021/bi981227y; Hall ZW, 1999, NEURON, V23, P4, DOI 10.1016/S0896-6273(00)80745-X; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HILL JA, 1993, J NEUROSCI, V13, P1551; Horie M, 1998, GENOMICS, V53, P365, DOI 10.1006/geno.1998.5462; ISOM LL, 1995, CELL, V83, P433, DOI 10.1016/0092-8674(95)90121-3; Kuryatov A, 1997, J NEUROSCI, V17, P9035; Lindstrom J, 1997, MOL NEUROBIOL, V15, P193, DOI 10.1007/BF02740634; Lukas RJ, 1999, PHARMACOL REV, V51, P397; MARKS MJ, 1992, J NEUROSCI, V12, P2765; Miwa JM, 1999, NEURON, V23, P105, DOI 10.1016/S0896-6273(00)80757-6; NAKAYAMA H, 1995, MOL BRAIN RES, V32, P321, DOI 10.1016/0169-328X(95)00092-7; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Phillips HA, 2001, AM J HUM GENET, V68, P225, DOI 10.1086/316946; RamirezLatorre J, 1996, NATURE, V380, P347, DOI 10.1038/380347a0; Rogers SW, 1998, J NEUROSCI, V18, P4825; Role LW, 1996, NEURON, V16, P1077, DOI 10.1016/S0896-6273(00)80134-8; SCHOEPFER R, 1990, NEURON, V5, P35, DOI 10.1016/0896-6273(90)90031-A; Sine SM, 1997, J BIOL CHEM, V272, P23521, DOI 10.1074/jbc.272.38.23521; Smit AB, 2001, NATURE, V411, P261, DOI 10.1038/35077000; STEINLEIN OK, 1995, NAT GENET, V11, P201, DOI 10.1038/ng1095-201; Tsetlin V, 1999, EUR J BIOCHEM, V264, P281, DOI 10.1046/j.1432-1327.1999.00623.x; Wang HL, 2000, J GEN PHYSIOL, V116, P449, DOI 10.1085/jgp.116.3.449; Weiland S, 1996, FEBS LETT, V398, P91, DOI 10.1016/S0014-5793(96)01215-X; White JD, 1998, ORG SYN TH, V4, P53; Zuo J, 1997, NATURE, V388, P769, DOI 10.1038/42009; Zwart R, 1998, MOL PHARMACOL, V54, P1124, DOI 10.1124/mol.54.6.1124	38	162	174	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 14	2002	33	6					893	903		10.1016/S0896-6273(02)00632-3	http://dx.doi.org/10.1016/S0896-6273(02)00632-3			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	530ZK	11906696	Bronze			2022-12-24	WOS:000174389600007
J	Rivera, JF; Ahmad, S; Quick, MW; Liman, ER; Arnold, DB				Rivera, JF; Ahmad, S; Quick, MW; Liman, ER; Arnold, DB			An evolutionarily conserved dileucine motif in Shal K+ channels mediates dendritic targeting	NATURE NEUROSCIENCE			English	Article							HUMAN TRANSFERRIN RECEPTOR; KINESIN SUPERFAMILY MOTOR; A-TYPE; HIPPOCAMPAL-NEURONS; CYTOPLASMIC DOMAIN; POTASSIUM CHANNEL; MDCK CELLS; STRUCTURAL REQUIREMENTS; PYRAMIDAL NEURONS; SORTING SIGNALS	The molecular mechanisms underlying polarized sorting of proteins in neurons are poorly understood. Here we report the identification of a 16 amino-acid, dileucine-containing motif that mediates dendritic targeting in a variety of neuronal cell types in slices of rat brain. This motif is present in the carboxy (C) termini of Shal-family K+ channels and is highly conserved from C. elegans to humans. It is necessary for dendritic targeting of potassium channel Kv4.2 and is sufficient to target the axonally localized channels Kv1.3 and Kv1.4 to the dendrites. It can also mediate dendritic targeting of a non-channel protein, CD8.	Univ So Calif, Program Mol Biol, Los Angeles, CA 90089 USA; Univ So Calif, Program Neurosci, Los Angeles, CA 90089 USA; Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California; University of Southern California	Arnold, DB (corresponding author), Univ So Calif, Program Mol Biol, 835 W 37th St, Los Angeles, CA 90089 USA.		Liman, Emily/AAC-7383-2021	liman, emily/0000-0003-4765-5496	NIDCD NIH HHS [DC04213] Funding Source: Medline; NINDS NIH HHS [NS41963] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041963] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARNOLD D, 1994, P NATL ACAD SCI USA, V91, P9970, DOI 10.1073/pnas.91.21.9970; Arnold DB, 1999, NEURON, V23, P149, DOI 10.1016/S0896-6273(00)80761-8; Baro DJ, 2000, J NEUROSCI, V20, P6619, DOI 10.1523/JNEUROSCI.20-17-06619.2000; Burack MA, 2000, NEURON, V26, P465, DOI 10.1016/S0896-6273(00)81178-2; CASANOVA JE, 1991, CELL, V66, P65, DOI 10.1016/0092-8674(91)90139-P; Cooper EC, 1998, J NEUROSCI, V18, P965; CRAIG AM, 1995, NATURE, V375, P592, DOI 10.1038/375592a0; DOTTI CG, 1990, CELL, V62, P63, DOI 10.1016/0092-8674(90)90240-F; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dwyer ND, 2001, NEURON, V31, P277, DOI 10.1016/S0896-6273(01)00361-0; Francesconi A, 2002, J NEUROSCI, V22, P2196, DOI 10.1523/JNEUROSCI.22-06-02196.2002; Garrido JJ, 2001, EMBO J, V20, P5950, DOI 10.1093/emboj/20.21.5950; Hanlon DW, 1997, NEURON, V18, P439, DOI 10.1016/S0896-6273(00)81244-1; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Hoffman DA, 1998, J NEUROSCI, V18, P3521; HUNZIKER W, 1991, CELL, V66, P907, DOI 10.1016/0092-8674(91)90437-4; Jareb M, 1998, NEURON, V20, P855, DOI 10.1016/S0896-6273(00)80468-7; KOREN G, 1990, NEURON, V4, P39, DOI 10.1016/0896-6273(90)90442-I; KUNDU A, 1994, J VIROL, V68, P1812, DOI 10.1128/JVI.68.3.1812-1818.1994; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; Lim ST, 2000, NEURON, V25, P385, DOI 10.1016/S0896-6273(00)80902-2; Marszalek JR, 1999, J CELL BIOL, V145, P469, DOI 10.1083/jcb.145.3.469; MATTER K, 1994, CURR OPIN CELL BIOL, V6, P545, DOI 10.1016/0955-0674(94)90075-2; MATTER K, 1994, J CELL BIOL, V126, P991, DOI 10.1083/jcb.126.4.991; MATTER K, 1992, CELL, V71, P741, DOI 10.1016/0092-8674(92)90551-M; Moriyoshi K, 1996, NEURON, V16, P255, DOI 10.1016/S0896-6273(00)80044-6; Nakagawa T, 2000, CELL, V103, P569, DOI 10.1016/S0092-8674(00)00161-6; Odorizzi G, 1997, J CELL BIOL, V137, P1255, DOI 10.1083/jcb.137.6.1255; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Rapoport I, 1998, EMBO J, V17, P2148, DOI 10.1093/emboj/17.8.2148; Ruberti F, 2000, J NEUROSCI, V20, part. no.; Saito N, 1997, NEURON, V18, P425, DOI 10.1016/S0896-6273(00)81243-X; Serodio P, 1998, J NEUROPHYSIOL, V79, P1081, DOI 10.1152/jn.1998.79.2.1081; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; SHENG M, 1992, NEURON, V9, P271, DOI 10.1016/0896-6273(92)90166-B; Smart SL, 1998, NEURON, V20, P809, DOI 10.1016/S0896-6273(00)81018-1; Song WJ, 1998, J NEUROSCI, V18, P3124; Stowell JN, 1999, NEURON, V22, P525, DOI 10.1016/S0896-6273(00)80707-2; Tsunoda S, 2001, J NEUROSCI, V21, P150, DOI 10.1523/JNEUROSCI.21-01-00150.2001; VEH RW, 1995, EUR J NEUROSCI, V7, P2189, DOI 10.1111/j.1460-9568.1995.tb00641.x; Whitworth TL, 2001, J BIOL CHEM, V276, P42932, DOI 10.1074/jbc.M107638200; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978	43	100	103	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2003	6	3					243	250		10.1038/nn1020	http://dx.doi.org/10.1038/nn1020			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	648YB	12592409				2022-12-24	WOS:000181178300012
J	Miyashiro, KY; Beckel-Mitchener, A; Purk, TP; Becker, KG; Barret, T; Liu, L; Carbonetto, S; Weiler, IJ; Greenough, WT; Eberwine, J				Miyashiro, KY; Beckel-Mitchener, A; Purk, TP; Becker, KG; Barret, T; Liu, L; Carbonetto, S; Weiler, IJ; Greenough, WT; Eberwine, J			RNA cargoes associating with in cellular functioning in Fmrl Fmr1 reveal deficits null mice	NEURON			English	Article							X MENTAL-RETARDATION; FRAGILE-X; MESSENGER-RNA; PROTEIN FMRP; KNOCKOUT MICE; BINDING; IDENTIFICATION; LOCALIZATION; TRANSLATION; EXPRESSION	The Fragile X mental retardation-1 (Fmr1) gene encodes a multifunctional protein, FMRP, with intrinsic RNA binding activity. We have developed an approach, antibody-positioned RNA amplification (APRA), to identify the RNA cargoes associated with the in vivo configured FMRP messenger ribonucleoprotein (mRNP) complex. Using APRA as a primary screen, putative FMRP RNA cargoes were assayed for their ability to bind directly to FMRP using traditional methods of assessing RNA-protein interactions, including UV-crosslinking and filter binding assays. Approximately 60% of the APRA-defined mRNAs directly associate with FMRP. By examining a subset of these mRNAs and their encoded proteins in brain tissue from Fmr1 knockout mice, we have observed that some of these cargoes as well as the proteins they encode show discrete changes in abundance and/or differential subcellular distribution. These data are consistent with spatially selective regulation of multiple biological pathways by FMRP.	Univ Penn, Sch Med, Dept Pharmacol, Dept Psychiat, Philadelphia, PA 19104 USA; McGill Univ, Dept Neurol & Neurosurg, Neurosci Res Ctr, Montreal, PQ H3A 2B4, Canada; Univ Illinois, WM Keck Ctr Comparat & Funct Genomics, Urbana, IL 61801 USA; NIA, DNA Array Unit, Gerontol Res Ctr, NIH, Baltimore, MD 21224 USA; Univ Illinois, Beckman Inst, Dept Psychol, Dept Psychiat,Neurosci Program, Urbana, IL 61801 USA	University of Pennsylvania; McGill University; University of Illinois System; University of Illinois Urbana-Champaign; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Illinois System; University of Illinois Urbana-Champaign	Eberwine, J (corresponding author), Univ Penn, Sch Med, Dept Pharmacol, Dept Psychiat, Philadelphia, PA 19104 USA.	eberwine@pharm.med.upenn.edu	Eberwine, James/B-2247-2010	Becker, Kevin/0000-0002-6794-6656	NIA NIH HHS [AG9900] Funding Source: Medline; NICHD NIH HHS [HD37175] Funding Source: Medline; NIMH NIH HHS [MH64272, MH58561] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037175] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH064272] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG009900, R37AG009900] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; AUTH D, 1992, P NATL ACAD SCI USA, V89, P4368, DOI 10.1073/pnas.89.10.4368; BAKKER CE, 1994, CELL, V78, P23; Bardoni B, 1999, HUM MOL GENET, V8, P2557, DOI 10.1093/hmg/8.13.2557; Bardoni B, 1997, NEUROBIOL DIS, V4, P329, DOI 10.1006/nbdi.1997.0142; Brown V, 1998, J BIOL CHEM, V273, P15521, DOI 10.1074/jbc.273.25.15521; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; BUCHHALTER JR, 1990, DEV BRAIN RES, V56, P211, DOI 10.1016/0165-3806(90)90084-C; Ceman S, 1999, MOL CELL BIOL, V19, P7925; Ceman S, 2000, BIOCHEM BIOPH RES CO, V279, P904, DOI 10.1006/bbrc.2000.4035; Collaborative Linkage Study of Autism, 2001, Am J Med Genet, V105, P609; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; Corbin F, 1997, HUM MOL GENET, V6, P1465, DOI 10.1093/hmg/6.9.1465; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Dawson S, 2002, J BIOL CHEM, V277, P10893, DOI 10.1074/jbc.M107313200; DEBOULLE K, 1993, NAT GENET, V3, P31, DOI 10.1038/ng0193-31; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; DYKENS EM, 1997, HDB AUTISM PERVASIVE, P388; Eberwine J, 2001, J NEUROSCI, V21, P8310, DOI 10.1523/JNEUROSCI.21-21-08310.2001; Feinstein C, 1998, J AUTISM DEV DISORD, V28, P393, DOI 10.1023/A:1026000404855; HAGERMAN RJ, 1989, AM J ORTHOPSYCHIAT, V59, P142, DOI 10.1111/j.1939-0025.1989.tb01641.x; Hessl D, 2002, PSYCHONEUROENDOCRINO, V27, P855, DOI 10.1016/S0306-4530(01)00087-7; *INT MOL GEN STUD, 2001, AM J HUM GENET, V69, P5700; Irwin SA, 2000, NEUROBIOL LEARN MEM, V73, P87, DOI 10.1006/nlme.1999.3914; Joels M, 2001, J NEUROENDOCRINOL, V13, P657, DOI 10.1046/j.1365-2826.2001.00688.x; Keene JD, 2001, P NATL ACAD SCI USA, V98, P7018, DOI 10.1073/pnas.111145598; Laggerbauer B, 2001, HUM MOL GENET, V10, P329, DOI 10.1093/hmg/10.4.329; Li ZZ, 2001, NUCLEIC ACIDS RES, V29, P2276, DOI 10.1093/nar/29.11.2276; Morales J, 2002, NEURON, V34, P961, DOI 10.1016/S0896-6273(02)00731-6; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; Philippe A, 1999, HUM MOL GENET, V8, P805, DOI 10.1093/hmg/8.5.805; REISS AL, 1990, J AM ACAD CHILD PSY, V29, P885, DOI 10.1097/00004583-199011000-00007; Rogers SJ, 2001, J DEV BEHAV PEDIATR, V22, P409, DOI 10.1097/00004703-200112000-00008; Roozendaal B, 2000, PSYCHONEUROENDOCRINO, V25, P213, DOI 10.1016/S0306-4530(99)00058-X; RUDELLI RD, 1985, ACTA NEUROPATHOL, V67, P289, DOI 10.1007/BF00687814; Schaeffer C, 2001, EMBO J, V20, P4803, DOI 10.1093/emboj/20.17.4803; Schenck A, 2001, P NATL ACAD SCI USA, V98, P8844, DOI 10.1073/pnas.151231598; Shao YJ, 2002, AM J MED GENET, V114, P99, DOI 10.1002/ajmg.10153; Siomi MC, 1996, MOL CELL BIOL, V16, P3825; Sittler A, 1996, HUM MOL GENET, V5, P95, DOI 10.1093/hmg/5.1.95; SPERBER BR, 1995, NEUROSCI LETT, V197, P149, DOI 10.1016/0304-3940(95)11902-9; Steward O, 1998, NEUROREPORT, V9, P477, DOI 10.1097/00001756-199802160-00022; Sun HT, 2001, AM J MED GENET, V103, P81, DOI 10.1002/1096-8628(20010915)103:1<81::AID-AJMG1505>3.0.CO;2-T; Sung YJ, 2000, BIOCHEM BIOPH RES CO, V275, P973, DOI 10.1006/bbrc.2000.3405; Tamanini F, 1999, BIOCHEM J, V343, P517, DOI 10.1042/0264-6021:3430517; Tamanini F, 1997, HUM MOL GENET, V6, P1315, DOI 10.1093/hmg/6.8.1315; TECOTT LH, 1988, SCIENCE, V240, P1661, DOI 10.1126/science.2454508; Tenenbaum SA, 2000, P NATL ACAD SCI USA, V97, P14085, DOI 10.1073/pnas.97.26.14085; Trifillis P, 1999, RNA, V5, P1071, DOI 10.1017/S1355838299981803; Turner G, 1996, AM J MED GENET, V64, P196, DOI 10.1002/(SICI)1096-8628(19960712)64:1<196::AID-AJMG35>3.0.CO;2-G; WARREN ST, 1994, JAMA-J AM MED ASSOC, V271, P536, DOI 10.1001/jama.271.7.536; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; Wisbeck JM, 2000, J DEV BEHAV PEDIATR, V21, P278, DOI 10.1097/00004703-200008000-00004; Zhang HT, 2001, P NATL ACAD SCI USA, V98, P5497, DOI 10.1073/pnas.101124598; ZHANG Y, 1995, EMBO J, V14, P5358, DOI 10.1002/j.1460-2075.1995.tb00220.x; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X	56	394	406	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 6	2003	37	3					417	431		10.1016/S0896-6273(03)00034-5	http://dx.doi.org/10.1016/S0896-6273(03)00034-5			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	647FF	12575950	Bronze			2022-12-24	WOS:000181081600008
J	Doetsch, F; Petreanu, L; Caille, I; Garcia-Verdugo, JM; Alvarez-Buylla, A				Doetsch, F; Petreanu, L; Caille, I; Garcia-Verdugo, JM; Alvarez-Buylla, A			EGF converts transit-amplifying neurogenic precursors in the adult brain into multipotent stem cells	NEURON			English	Article							EPIDERMAL GROWTH-FACTOR; CENTRAL-NERVOUS-SYSTEM; RADIAL GLIAL-CELLS; MAMMALIAN BRAIN; MOUSE-BRAIN; SUBVENTRICULAR ZONE; NEURONAL MIGRATION; CELLULAR COMPOSITION; SUBEPENDYMAL CELLS; VENTRICULAR ZONE	Neural stem cells in the subventricular zone (SVZ) continue to generate new neurons in the adult brain. SVZ cells exposed to EGF in culture grow to form neurospheres that are multipotent and self-renewing. We show here that the majority of these EGF-responsive cells are not derived from relatively quiescent stem cells in vivo, but from the highly mitotic, Dlx2(+), transit-amplifying C cells. When exposed to EGF, C cells downregulate Dlx2, arrest neuronal production, and become highly proliferative and invasive. Killing Dlx2(+) cells dramatically reduces the in vivo response to EGF and neurosphere formation in vitro. Furthermore, purified C cells are 53-fold enriched for neurosphere generation. We conclude that transit-amplifying cells retain stem cell competence under the influence of growth factors.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Rockefeller Univ, New York, NY 10021 USA; Univ Valencia, E-46100 Burjassot, Spain; Univ Calif San Francisco, Brain Tumor Res Ctr, San Francisco, CA 94143 USA	Harvard University; Rockefeller University; University of Valencia; University of California System; University of California San Francisco	Doetsch, F (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 16 Divin Ave, Cambridge, MA 02138 USA.	doetsch@fas.harvard.edu; abuylla@itsa.ucsf.edu	García-Verdugo, José Manuel/L-8421-2017; Caillé, Isabelle/AAC-9575-2021	García-Verdugo, José Manuel/0000-0001-9872-6499; Caille, Isabelle/0000-0002-9054-2641; Petreanu, Leopoldo/0000-0003-1434-4691; Alvarez-Buylla, Arturo/0000-0003-4426-8925	NICHD NIH HHS [HD32116] Funding Source: Medline; NINDS NIH HHS [NS28478] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD032116] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028478, R29NS028478, R37NS028478] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alvarez-Buylla A, 1998, J NEUROSCI, V18, P1020; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; ALVAREZBUYLLA A, 1990, NEURON, V5, P101, DOI 10.1016/0896-6273(90)90038-H; Bachoo RM, 2002, CANCER CELL, V1, P269, DOI 10.1016/S1535-6108(02)00046-6; Burrows RC, 1997, NEURON, V19, P251, DOI 10.1016/S0896-6273(00)80937-X; Calaora V, 1996, NEUROSCIENCE, V73, P581, DOI 10.1016/0306-4522(96)00042-5; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Caric D, 2001, DEVELOPMENT, V128, P4203; Chen CMA, 1999, DEV BIOL, V214, P370, DOI 10.1006/dbio.1999.9432; Chiasson BJ, 1999, J NEUROSCI, V19, P4462; Corbin JG, 2000, DEVELOPMENT, V127, P5007; Craig CG, 1996, J NEUROSCI, V16, P2649; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Doetsch F, 2002, J NEUROSCI, V22, P2255, DOI 10.1523/JNEUROSCI.22-06-02255.2002; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 1997, J NEUROSCI, V17, P5046; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; Eisenstat DD, 1999, J COMP NEUROL, V414, P217, DOI 10.1002/(SICI)1096-9861(19991115)414:2<217::AID-CNE6>3.0.CO;2-I; Fallon J, 2000, P NATL ACAD SCI USA, V97, P14686, DOI 10.1073/pnas.97.26.14686; Fisher GH, 1999, ONCOGENE, V18, P5253, DOI 10.1038/sj.onc.1203087; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Geschwind DH, 2001, NEURON, V29, P325, DOI 10.1016/S0896-6273(01)00209-4; Globus J.H., 1944, J NEUROPATH EXP NEUR, V3, P1; Gritti A, 1999, J NEUROSCI, V19, P3287; He WL, 2001, J NEUROSCI, V21, P8854, DOI 10.1523/JNEUROSCI.21-22-08854.2001; Hitoshi S, 2002, DEVELOPMENT, V129, P233; Holland EC, 1998, P NATL ACAD SCI USA, V95, P1218, DOI 10.1073/pnas.95.3.1218; Holland EC, 2001, NAT REV GENET, V2, P120, DOI 10.1038/35052535; Holland EC, 1998, GENE DEV, V12, P3675, DOI 10.1101/gad.12.23.3675; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jankovski A, 1996, J COMP NEUROL, V371, P376; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Laywell ED, 2000, P NATL ACAD SCI USA, V97, P13883, DOI 10.1073/pnas.250471697; LILLIEN L, 1995, NATURE, V377, P158, DOI 10.1038/377158a0; Lim DA, 1999, P NATL ACAD SCI USA, V96, P7526, DOI 10.1073/pnas.96.13.7526; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Malatesta P, 2000, DEVELOPMENT, V127, P5253; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; MORSHEAD CM, 1992, J NEUROSCI, V12, P249; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Ostenfeld T, 2002, DEV BRAIN RES, V134, P43, DOI 10.1016/S0165-3806(01)00291-7; Palmer TD, 2001, NATURE, V411, P42, DOI 10.1038/35075141; Palmer TD, 1999, J NEUROSCI, V19, P8487; PALMER TD, 1995, MOL CELL NEUROSCI, V6, P474, DOI 10.1006/mcne.1995.1035; Panganiban G, 2002, DEVELOPMENT, V129, P4371; Peretto P, 1997, BRAIN RES BULL, V42, P9, DOI 10.1016/S0361-9230(96)00116-5; Petreanu L, 2002, J NEUROSCI, V22, P6106; PORTEUS MH, 1994, J NEUROSCI, V14, P6370; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rietze RL, 2001, NATURE, V412, P736, DOI 10.1038/35089085; Roy NS, 1999, J NEUROSCI, V19, P9986, DOI 10.1523/jneurosci.19-22-09986.1999; Santa-Olalla J, 1999, J NEUROBIOL, V40, P14, DOI 10.1002/(SICI)1097-4695(199907)40:1<14::AID-NEU2>3.0.CO;2-U; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; SEROOGY KB, 1993, J NEUROCHEM, V60, P1777, DOI 10.1111/j.1471-4159.1993.tb13403.x; SEROOGY KB, 1995, BRAIN RES, V670, P157, DOI 10.1016/0006-8993(94)01300-7; SOTELO JR, 1958, Z ZELLFORSCH MIK ANA, V49, P1, DOI 10.1007/BF00335059; Suslov ON, 2002, P NATL ACAD SCI USA, V99, P14506, DOI 10.1073/pnas.212525299; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Terskikh AV, 2001, P NATL ACAD SCI USA, V98, P7934, DOI 10.1073/pnas.131200898; Thomas LB, 1996, GLIA, V17, P1; Tropepe V, 1997, J NEUROSCI, V17, P7850; Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192; Weickert CS, 2000, J COMP NEUROL, V423, P359, DOI 10.1002/1096-9861(20000731)423:3<359::AID-CNE1>3.0.CO;2-0; Weiss S, 1996, J NEUROSCI, V16, P7599; Weiss S, 1996, TRENDS NEUROSCI, V19, P387, DOI 10.1016/S0166-2236(96)10035-7; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7	77	800	834	2	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 19	2002	36	6					1021	1034		10.1016/S0896-6273(02)01133-9	http://dx.doi.org/10.1016/S0896-6273(02)01133-9			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	628TA	12495619	Bronze			2022-12-24	WOS:000180011600007
J	Zhang, XH; Poo, MM				Zhang, XH; Poo, MM			Localized synaptic Potentiation by BDNF requires local protein synthesis in the developing axon	NEURON			English	Article							LONG-TERM POTENTIATION; HIGH-FREQUENCY STIMULATION; NEUROTROPHIC FACTOR; MESSENGER-RNA; SUBCELLULAR-LOCALIZATION; NEUROTRANSMITTER RELEASE; RETROGRADE TRANSPORT; SYMPATHETIC NEURONS; TRANSMITTER RELEASE; INTRACELLULAR CA2+	Brain-derived neurotrophic factor (BDNF) is known to promote neuronal survival, guide axonal pathfinding, and participate in activity-dependent synaptic plasticity. In Xenopus nerve-muscle cultures, localized contact of a single BDNF-coated bead with the presynaptic axon resulted in potentiation of transmitter secretion at the developing synapses, but only when the bead was placed within 60 mum from the synapse. The localized potentiation induced by BDNF is accompanied by a persistent local elevation of [Ca2+](i) in the axon and requires constitutive presynaptic protein translation, even for axons severed from the cell body. Thus, presynaptic local TrkB signaling and protein synthesis allow a localized source of BDNF to potentiate transmitter secretion from nearby synapses, a property suited for spatially restricted synaptic modification by neurotrophins.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Poo, MM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA.	mpoo@uclink.berkeley.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037831] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 37831] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Aoki C, 2000, J NEUROSCI RES, V59, P454, DOI 10.1002/(SICI)1097-4547(20000201)59:3<454::AID-JNR21>3.0.CO;2-H; Bassell GJ, 1998, J NEUROSCI, V18, P251; Beaumont V, 2001, NEURON, V32, P489, DOI 10.1016/S0896-6273(01)00483-4; BERNINGER B, 1993, NEUROREPORT, V4, P1303, DOI 10.1097/00001756-199309150-00004; Bhattacharyya A, 1997, J NEUROSCI, V17, P7007; BLOCHL A, 1995, EUR J NEUROSCI, V7, P1220, DOI 10.1111/j.1460-9568.1995.tb01112.x; Boulanger L, 1999, SCIENCE, V284, P1982, DOI 10.1126/science.284.5422.1982; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Cabelli RJ, 1996, J NEUROSCI, V16, P7965; CABELLI RJ, 1995, SCIENCE, V267, P1662, DOI 10.1126/science.7886458; Cabelli RJ, 1997, NEURON, V19, P63, DOI 10.1016/S0896-6273(00)80348-7; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Chang SH, 1999, P NATL ACAD SCI USA, V96, P4095, DOI 10.1073/pnas.96.7.4095; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; DAVIS L, 1992, J NEUROSCI, V12, P4867; DIAMOND J, 1992, J NEUROSCI, V12, P1454; Drake CT, 1999, J NEUROSCI, V19, P8009; Eng H, 1999, J NEUROSCI, V19, P1; Engert F, 1997, NATURE, V388, P279, DOI 10.1038/40870; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; EVERS J, 1989, J NEUROSCI, V9, P1523; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; FUNAKOSHI H, 1995, SCIENCE, V268, P1495, DOI 10.1126/science.7770776; Gallo G, 1997, J NEUROSCI, V17, P5445; Goodman LJ, 1996, MOL CELL NEUROSCI, V7, P222, DOI 10.1006/mcne.1996.0017; Gottschalk WA, 1999, LEARN MEMORY, V6, P243; Grimes ML, 1997, P NATL ACAD SCI USA, V94, P9909, DOI 10.1073/pnas.94.18.9909; Hartmann M, 2001, EMBO J, V20, P5887, DOI 10.1093/emboj/20.21.5887; He XP, 2000, J CELL BIOL, V149, P783, DOI 10.1083/jcb.149.4.783; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Jovanovic JN, 2000, NAT NEUROSCI, V3, P323, DOI 10.1038/73888; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kleiman RJ, 2000, J NEUROPHYSIOL, V84, P472, DOI 10.1152/jn.2000.84.1.472; Koenig E, 2000, J NEUROSCI, V20, P8390, DOI 10.1523/JNEUROSCI.20-22-08390.2000; Koenig E, 1999, NEUROSCIENCE, V89, P5, DOI 10.1016/S0306-4522(98)00282-6; Kojima M, 2001, J NEUROSCI RES, V64, P1, DOI 10.1002/jnr.1080; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Kryl D, 1999, J NEUROSCI, V19, P5823, DOI 10.1523/JNEUROSCI.19-14-05823.1999; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; Li YX, 1998, J NEUROSCI, V18, P10231; LOHOF AM, 1992, J NEUROSCI, V12, P1253; LOHOF AM, 1993, NATURE, V363, P350, DOI 10.1038/363350a0; MacInnis BL, 2002, SCIENCE, V295, P1536, DOI 10.1126/science.1064913; MAFFEI L, 1992, J NEUROSCI, V12, P4651; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Martin KC, 2000, CURR OPIN NEUROBIOL, V10, P587, DOI 10.1016/S0959-4388(00)00128-8; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; MILEDI R, 1973, PROC R SOC SER B-BIO, V183, P421, DOI 10.1098/rspb.1973.0026; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; OlinkCoux M, 1996, J NEUROSCI, V16, P1346; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; PATTERSON SL, 1992, NEURON, V9, P1081, DOI 10.1016/0896-6273(92)90067-N; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Pozzo-Miller LD, 1999, J NEUROSCI, V19, P4972; Purves, 1985, PRINCIPLES NEURAL DE; Schacher S, 2002, J NEUROSCI, V22, P1831, DOI 10.1523/JNEUROSCI.22-05-01831.2002; Schuman EM, 1997, NEURON, V18, P339, DOI 10.1016/S0896-6273(00)81234-9; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Song HJ, 1999, CURR OPIN NEUROBIOL, V9, P355, DOI 10.1016/S0959-4388(99)80052-X; STEWARD O, 1988, J NEUROSCI, V8, P176; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; STEWARD O, 1982, J NEUROSCI, V2, P284; Steward O, 1997, NEURON, V18, P9, DOI 10.1016/S0896-6273(01)80041-6; STIRPE F, 1980, J BIOL CHEM, V255, P6947; Stoop R, 1996, J NEUROSCI, V16, P3256; STOOP R, 1995, SCIENCE, V267, P695, DOI 10.1126/science.7839148; Tabti N, 1998, CULTURING NERVE CELL, P237; Tongiorgi E, 1997, J NEUROSCI, V17, P9492; von Bartheld CS, 2001, MOL NEUROBIOL, V24, P1, DOI 10.1385/MN:24:1-3:001; vonBartheld CS, 1996, J NEUROSCI, V16, P2995; vonBartheld CS, 1996, NATURE, V379, P830, DOI 10.1038/379830a0; Wang X, 1998, WORLD J GASTROENTERO, V4, P18, DOI 10.3748/wjg.v4.i1.18; Wang XH, 1997, NEURON, V19, P825, DOI 10.1016/S0896-6273(00)80964-2; Yang F, 2001, NAT NEUROSCI, V4, P19, DOI 10.1038/82858; Ying SW, 2002, J NEUROSCI, V22, P1532, DOI 10.1523/JNEUROSCI.22-05-01532.2002; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x; Zheng JQ, 2001, J NEUROSCI, V21, P9291, DOI 10.1523/JNEUROSCI.21-23-09291.2001	86	162	168	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 14	2002	36	4					675	688		10.1016/S0896-6273(02)01023-1	http://dx.doi.org/10.1016/S0896-6273(02)01023-1			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	616PX	12441056	Bronze			2022-12-24	WOS:000179313100014
J	Lawrence, NS; Ross, TJ; Stein, EA				Lawrence, NS; Ross, TJ; Stein, EA			Cognitive mechanisms of nicotine on visual attention	NEURON			English	Article							SHORT-TERM-MEMORY; SUSTAINED ATTENTION; SUBCUTANEOUS NICOTINE; TRANSDERMAL NICOTINE; BASAL FOREBRAIN; PERFORMANCE; ACTIVATION; VIGILANCE; SMOKING; SYSTEM	Understanding nicotine's neurobiological and cognitive mechanisms may help explain both its addictive properties and potential therapeutic applications. As such, functional MRI was used to determine the neural substrates of nicotine's effects on a sustained attention (rapid visual information-processing) task. Performance was associated with activation in a fronto-parietal-thalamic network in both smokers and nonsmokers. Along with subtle behavioral deficits, mildly abstinent smokers showed less task-induced brain activation in the parietal cortex and caudate than did nonsmokers. Transdermal nicotine replacement improved task performance in smokers and increased task-induced brain activation in the parietal cortex, thalamus, and caudate, while nicotine induced a generalized increase in occipital cortex activity. These data suggest that nicotine improves attention in smokers by enhancing activation in areas traditionally associated with visual attention, arousal, and motor activation.	Med Coll Wisconsin, Dept Psychiat, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Dept Pharmacol, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Dept Cellular Biol, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Biophys Res Inst, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Stein, EA (corresponding author), NIDA, Neuroimaging Res Branch, Intramural Res Program, 5500 Nathan Shock Dr, Baltimore, MD 21224 USA.	estein@intra.nida.nih.gov	Lawrence, Natalia/A-1588-2010; Stein, Elliot/C-7349-2008; Ross, Thomas/B-7469-2008	Ross, Thomas/0000-0002-7745-3572; Lawrence, Natalia/0000-0003-1969-6637	NIDA NIH HHS [DA09465] Funding Source: Medline; PHS HHS [M01 00058] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA009465] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Arndt S, 1996, J CEREBR BLOOD F MET, V16, P1271, DOI 10.1097/00004647-199611000-00023; ASTONJONES G, 1994, J NEUROSCI, V14, P4467; Bushnell Philip J., 2000, Neurotoxicology and Teratology, V22, P487, DOI 10.1016/S0892-0362(00)00077-5; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; CORBETTA M, 1991, J NEUROSCI, V11, P2383; Coull JT, 1998, NEUROPSYCHOLOGIA, V36, P1325, DOI 10.1016/S0028-3932(98)00035-9; COULL JT, 1995, PSYCHOPHARMACOLOGY, V121, P222, DOI 10.1007/BF02245633; Coull JT, 1996, NEUROPSYCHOLOGIA, V34, P1085, DOI 10.1016/0028-3932(96)00029-2; Coull JT, 1998, PROG NEUROBIOL, V55, P343, DOI 10.1016/S0301-0082(98)00011-2; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; EDWARDS JA, 1985, ADDICT BEHAV, V10, P113, DOI 10.1016/0306-4603(85)90017-6; Ernst M, 2001, P NATL ACAD SCI USA, V98, P4728, DOI 10.1073/pnas.061369098; Everitt BJ, 1997, ANNU REV PSYCHOL, V48, P649, DOI 10.1146/annurev.psych.48.1.649; Foulds J, 1996, PSYCHOPHARMACOLOGY, V127, P31, DOI 10.1007/BF02805972; Furey ML, 2000, SCIENCE, V290, P2315, DOI 10.1126/science.290.5500.2315; Ghatan PH, 1998, PSYCHOPHARMACOLOGY, V136, P179, DOI 10.1007/s002130050554; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; JONES GMM, 1992, PSYCHOPHARMACOLOGY, V108, P485, DOI 10.1007/BF02247426; KIEVIT J, 1975, SCIENCE, V187, P660, DOI 10.1126/science.1114317; Kinomura S, 1996, SCIENCE, V271, P512, DOI 10.1126/science.271.5248.512; Knott V, 1999, PHARMACOL BIOCHEM BE, V63, P253, DOI 10.1016/S0091-3057(99)00006-4; LABERGE D, 1990, J NEUROSCI, V10, P613; Mancuso G, 1999, PSYCHOPHARMACOLOGY, V142, P18, DOI 10.1007/s002130050857; Marrocco RT, 1998, ATTENTIVE BRAIN, P35; MESULAM MM, 1983, NEUROSCIENCE, V10, P1185, DOI 10.1016/0306-4522(83)90108-2; MUIR JL, 1995, PSYCHOPHARMACOLOGY, V118, P82; Murphy FC, 1998, NEUROPSYCHOLOGIA, V36, P1103, DOI 10.1016/S0028-3932(98)00012-8; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Parasuraman R, 1998, ATTENTIVE BRAIN, P221; PARDO JV, 1991, NATURE, V349, P61, DOI 10.1038/349061a0; Parrott AC, 1996, HUM PSYCHOPHARM CLIN, V11, P391; Paterson D, 2000, PROG NEUROBIOL, V61, P75, DOI 10.1016/S0301-0082(99)00045-3; Paus T, 1997, J COGNITIVE NEUROSCI, V9, P392, DOI 10.1162/jocn.1997.9.3.392; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Rezvani AH, 2001, BIOL PSYCHIAT, V49, P258, DOI 10.1016/S0006-3223(00)01094-5; Rueckert L, 1996, NEUROPSYCHOLOGIA, V34, P953, DOI 10.1016/0028-3932(96)00016-4; Rueckert L, 1998, NEUROPSYCHOLOGIA, V36, P653, DOI 10.1016/S0028-3932(97)00150-4; RUSSELL MAH, 1974, J ROY STAT SOC A STA, V137, P313, DOI 10.2307/2344953; SAHAKIAN B, 1989, BRIT J PSYCHIAT, V154, P797, DOI 10.1192/bjp.154.6.797; Sarter M, 2001, BRAIN RES REV, V35, P146, DOI 10.1016/S0165-0173(01)00044-3; SHERWOOD N, 1993, HUM PSYCHOPHARM CLIN, V8, P155, DOI 10.1002/hup.470080303; Stein EA, 1998, AM J PSYCHIAT, V155, P1009, DOI 10.1176/ajp.155.8.1009; STOLERMAN IP, 1995, MED RES REV, V15, P47, DOI 10.1002/med.2610150105; Talairach J., 1988, COPLANAR STEREOTAXIC; Warburton DM, 1998, PSYCHOPHARMACOLOGY, V135, P305, DOI 10.1007/s002130050514; WARBURTON DM, 1994, PSYCHOPHARMACOLOGY, V115, P539, DOI 10.1007/BF02245578; WESNES K, 1984, PSYCHOPHARMACOLOGY, V82, P338, DOI 10.1007/BF00427682; WESNES K, 1983, NEUROPSYCHOBIOLOGY, V9, P223, DOI 10.1159/000117969; WESNES K, 1984, PSYCHOPHARMACOLOGY, V84, P5, DOI 10.1007/BF00432014; WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341	51	248	259	2	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 24	2002	36	3					539	548		10.1016/S0896-6273(02)01004-8	http://dx.doi.org/10.1016/S0896-6273(02)01004-8			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	608ZE	12408855	Bronze			2022-12-24	WOS:000178877700021
J	Blasi, V; Young, AC; Tansy, AP; Petersen, SE; Snyder, AZ; Corbetta, M				Blasi, V; Young, AC; Tansy, AP; Petersen, SE; Snyder, AZ; Corbetta, M			Word retrieval learning modulates right frontal cortex in patients with left frontal damage	NEURON			English	Article							LEFT PREFRONTAL CORTEX; VISUAL WORKING-MEMORY; RIGHT-HEMISPHERE; FUNCTIONAL MRI; POSTSTROKE APHASIA; BRAIN PLASTICITY; RECOVERY; ANATOMY; LANGUAGE; SPEECH	Previous studies have suggested that recovery or compensation of language function after a lesion in the left hemisphere may depend on mechanisms in the right hemisphere. However, a direct relationship between performance and right hemisphere activity has not been established. Here, we show that patients with left frontal lesions and partially recovered aphasia learn, at a normal rate, a novel word retrieval task that requires the damaged cortex. Verbal learning is accompanied by specific response decrements in right frontal and right occipital cortex, strongly supporting the compensatory role of the right hemisphere. Furthermore, responses in left occipital cortex are abnormal and not modulated by practice. These findings indicate that frontal cortex is a source of top-down signals during learning.	Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Corbetta, M (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	mau@npg.wustl.edu	blasi, valeria/AAA-6407-2019; Corbetta, Maurizio/AAZ-5219-2020; Petersen, Steve/ABF-1368-2020	blasi, valeria/0000-0002-8395-0452; CORBETTA, MAURIZIO/0000-0001-8295-3304	NINDS NIH HHS [NS06833] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS006833, P50NS006833] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALEXANDER MP, 1989, ARCH NEUROL-CHICAGO, V46, P885, DOI 10.1001/archneur.1989.00520440075023; ALEXANDER MP, 1997, BEHAV NEUROLOGY NEUR, P133; BALOTA DA, 1994, HDB PSYCHOLINGUISTIC, P303; BASSO A, 1989, CORTEX, V25, P555, DOI 10.1016/S0010-9452(89)80017-6; Belin P, 1996, NEUROLOGY, V47, P1504, DOI 10.1212/WNL.47.6.1504; BLUMSTEIN SE, 1995, SPEECH LANGUAGE COMM, P339; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; BUCKNER RL, 1995, J NEUROSCI, V15, P12; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; Buckner RL, 2000, BRAIN, V123, P620, DOI 10.1093/brain/123.3.620; Buckner RL, 1996, P NATL ACAD SCI USA, V93, P1249, DOI 10.1073/pnas.93.3.1249; BUCKNER RL, 1995, J NEUROPHYSIOL, V74, P2163, DOI 10.1152/jn.1995.74.5.2163; CAPPA SF, 1992, APHASIOLOGY, V6, P359, DOI 10.1080/02687039208248607; Courtney SM, 1996, CEREB CORTEX, V6, P39, DOI 10.1093/cercor/6.1.39; DERENZI E, 1987, CORTEX, V23, P575, DOI 10.1016/S0010-9452(87)80050-3; Desmond JE, 1998, NEUROIMAGE, V7, P368, DOI 10.1006/nimg.1998.0340; DRINKERS NF, 2000, NEW COGNITIVE NEUROS, P949; Gabrieli JDE, 1998, P NATL ACAD SCI USA, V95, P906, DOI 10.1073/pnas.95.3.906; Gabrieli JDE, 1996, PSYCHOL SCI, V7, P278, DOI 10.1111/j.1467-9280.1996.tb00374.x; GAZZANIGA MS, 1983, AM PSYCHOL, V38, P525, DOI 10.1037/0003-066X.38.5.525; Goodglass H., 1964, CORTEX, V1, P133, DOI [10.1016/S0010-9452(64)80018-6, DOI 10.1016/S0010-9452(64)80018-6]; Gowers WR, 1887, LECT DIAGNOSIS DIS B; Heiss WD, 1999, ANN NEUROL, V45, P430, DOI 10.1002/1531-8249(199904)45:4<430::AID-ANA3>3.0.CO;2-P; Hodges JR, 2001, PHILOS T R SOC B, V356, P1423, DOI 10.1098/rstb.2001.0943; Karbe H, 1998, BRAIN LANG, V64, P215, DOI 10.1006/brln.1998.1961; Kelley WM, 1998, NEURON, V20, P927, DOI 10.1016/S0896-6273(00)80474-2; KERTESZ A, 1977, BRAIN, V100, P1, DOI 10.1093/brain/100.1.1; KINSBOURNE M, 1971, ARCH NEUROL-CHICAGO, V25, P302, DOI 10.1001/archneur.1971.00490040028003; Kinsbourne M, 1977, Adv Neurol, V18, P41; KNIGHT RT, 1989, BRAIN RES, V504, P338, DOI 10.1016/0006-8993(89)91381-4; Leff A, 2002, ANN NEUROL, V51, P553, DOI 10.1002/ana.10181; MILLER EK, 1994, SCIENCE, V263, P520, DOI 10.1126/science.8290960; Miller EK, 1996, J NEUROSCI, V16, P5154; MOHR JP, 1978, NEUROLOGY, V28, P311, DOI 10.1212/WNL.28.4.311; Musso M, 1999, BRAIN, V122, P1781, DOI 10.1093/brain/122.9.1781; Ojemann JG, 1998, HUM BRAIN MAPP, V6, P203, DOI 10.1002/(SICI)1097-0193(1998)6:4<203::AID-HBM2>3.0.CO;2-7; Ollinger JM, 2001, NEUROIMAGE, V13, P210, DOI 10.1006/nimg.2000.0710; PETERSEN SE, 1988, NATURE, V331, P585, DOI 10.1038/331585a0; PETERSEN SE, 1993, ANNU REV NEUROSCI, V16, P509, DOI 10.1146/annurev.ne.16.030193.002453; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; Rainer G, 2000, NEURON, V27, P179, DOI 10.1016/S0896-6273(00)00019-2; Rijntjes M, 2002, PROG NEUROBIOL, V66, P109, DOI 10.1016/S0301-0082(01)00027-2; Rosen HJ, 2000, NEUROLOGY, V55, P1883, DOI 10.1212/WNL.55.12.1883; Swick D, 1998, ATTENTIVE BRAIN, P143; Thompson-Schill SL, 1999, NEURON, V23, P513, DOI 10.1016/S0896-6273(00)80804-1; Thompson-Schill SL, 1998, P NATL ACAD SCI USA, V95, P15855, DOI 10.1073/pnas.95.26.15855; Thulborn KR, 1999, STROKE, V30, P749, DOI 10.1161/01.STR.30.4.749; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; Vandenberghe R, 1996, NATURE, V383, P254, DOI 10.1038/383254a0; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Wernicke K., 1908, MODERN CLIN MED DIS; WISE R, 1991, BRAIN, V114, P1803, DOI 10.1093/brain/114.4.1803; YAMAGUCHI S, 1990, BRAIN RES, V521, P281, DOI 10.1016/0006-8993(90)91553-S; ZAIDEL E, 1981, BRAIN LANG, V14, P205, DOI 10.1016/0093-934X(81)90077-8	57	130	131	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 26	2002	36	1					159	170		10.1016/S0896-6273(02)00936-4	http://dx.doi.org/10.1016/S0896-6273(02)00936-4			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	598UP	12367514	Bronze			2022-12-24	WOS:000178295100015
J	Burns, ME; Mendez, A; Chen, J; Baylor, DA				Burns, ME; Mendez, A; Chen, J; Baylor, DA			Dynamics of cyclic GMP synthesis in retinal rods	NEURON			English	Article							CYTOPLASMIC CALCIUM-CONCENTRATION; PHOTORECEPTOR LIGHT ADAPTATION; GUANYLATE-CYCLASE; OUTER SEGMENTS; SALAMANDER RODS; PHOTOTRANSDUCTION CASCADE; SENSITIVE CONDUCTANCE; PLASMA-MEMBRANE; GATED CHANNELS; DARK NOISE	In retinal rods, Ca2+ exerts negative feedback control on cGMP synthesis by guanylate cyclase (GC). This feedback loop was disrupted in mouse rods lacking guanylate cyclase activating proteins GCAP1 and GCAP2 (GCAPs(-/-)). Comparison of the behavior of wild-type and GCAPs(-/-) rods allowed us to investigate the role of the feedback loop in normal rod function. We have found that regulation of GC is apparently the only Ca2+ feedback loop operating during the single photon response. Analysis of the rods' light responses and cellular dark noise suggests that GC normally responds to light-driven changes in [Ca2+] rapidly and highly cooperatively. Rapid feedback to GC speeds the rod's temporal responsiveness and improves its signal-to-noise ratio by minimizing fluctuations in cGMP.	Stanford Univ, Med Ctr, Dept Neurobiol, Stanford, CA 94305 USA; Univ So Calif, Keck Sch Med, Doheny Eye Inst, Mary D Allen Lab Vis Res, Los Angeles, CA 90033 USA; Univ So Calif, Keck Sch Med, Dept Ophthalmol, Los Angeles, CA 90033 USA; Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA; Univ Calif Davis, Dept Psychiat, Davis, CA 95616 USA; Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA	Stanford University; Doheny Eye Institute; University of Southern California; University of Southern California; University of Southern California; University of California System; University of California Davis; University of California System; University of California Davis	Burns, ME (corresponding author), Stanford Univ, Med Ctr, Dept Neurobiol, Stanford, CA 94305 USA.		Méndez, Ana/F-9729-2016	Méndez, Ana/0000-0001-6393-1644	NATIONAL EYE INSTITUTE [R01EY012703, R01EY014047, R01EY005750] Funding Source: NIH RePORTER; NEI NIH HHS [EY05750, EY12703, R01 EY014047-02, R01 EY012703, R01 EY014047] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; BAYLOR DA, 1973, J PHYSIOL-LONDON, V234, P163, DOI 10.1113/jphysiol.1973.sp010340; BAYLOR DA, 1980, J PHYSIOL-LONDON, V309, P591, DOI 10.1113/jphysiol.1980.sp013529; Calvert PD, 1998, J GEN PHYSIOL, V111, P39, DOI 10.1085/jgp.111.1.39; Calvert PD, 2002, J GEN PHYSIOL, V119, P129, DOI 10.1085/jgp.119.2.129; CERVETTO L, 1989, NATURE, V337, P740, DOI 10.1038/337740a0; Chen CK, 2000, NATURE, V403, P557, DOI 10.1038/35000601; CORNWALL MC, 1994, J PHYSIOL-LONDON, V480, P261, DOI 10.1113/jphysiol.1994.sp020358; Detwiler PB, 2000, METHOD ENZYMOL, V316, P133; Dizhoor AM, 1998, J BIOL CHEM, V273, P17311, DOI 10.1074/jbc.273.28.17311; DIZHOOR AM, 1994, NEURON, V12, P1345, DOI 10.1016/0896-6273(94)90449-9; DODD RL, 1998, THESIS STANFORD U ST; FAIN GL, 1989, J PHYSIOL-LONDON, V416, P215, DOI 10.1113/jphysiol.1989.sp017757; FESENKO EE, 1985, NATURE, V313, P310, DOI 10.1038/313310a0; GORCZYCA WA, 1995, J BIOL CHEM, V270, P22029, DOI 10.1074/jbc.270.37.22029; GRAYKELLER MP, 1994, NEURON, V13, P849, DOI 10.1016/0896-6273(94)90251-8; HAYNES LW, 1986, NATURE, V321, P66, DOI 10.1038/321066a0; HODGKIN AL, 1988, J PHYSIOL-LONDON, V403, P439, DOI 10.1113/jphysiol.1988.sp017258; HSU YT, 1993, NATURE, V361, P76, DOI 10.1038/361076a0; Karpen JW, 1996, J GEN PHYSIOL, V107, P169, DOI 10.1085/jgp.107.2.169; KAWAMURA S, 1991, NATURE, V349, P420, DOI 10.1038/349420a0; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; KOUTALOS Y, 1995, J GEN PHYSIOL, V106, P863, DOI 10.1085/jgp.106.5.863; KOUTALOS Y, 1995, J GEN PHYSIOL, V106, P891, DOI 10.1085/jgp.106.5.891; LAMB TD, 1981, J PHYSIOL-LONDON, V319, P463, DOI 10.1113/jphysiol.1981.sp013921; Laura RP, 1998, BIOCHEMISTRY-US, V37, P11264, DOI 10.1021/bi9809674; LOLLEY RN, 1982, VISION RES, V22, P1481, DOI 10.1016/0042-6989(82)90213-9; Lyubarsky A, 1996, J GEN PHYSIOL, V107, P19, DOI 10.1085/jgp.107.1.19; Lyubarsky AL, 1996, J NEUROSCI, V16, P563, DOI 10.1523/jneurosci.16-02-00563.1996; MATTHEWS HR, 1995, J PHYSIOL-LONDON, V484, P267, DOI 10.1113/jphysiol.1995.sp020664; Matthews HR, 2000, METHOD ENZYMOL, V316, P146; MCCARTHY ST, 1994, BIOPHYS J, V67, P2076, DOI 10.1016/S0006-3495(94)80691-5; Mendez A, 2000, NEURON, V28, P153, DOI 10.1016/S0896-6273(00)00093-3; Mendez A, 2001, P NATL ACAD SCI USA, V98, P9948, DOI 10.1073/pnas.171308998; NAKATANI K, 1988, J PHYSIOL-LONDON, V395, P731, DOI 10.1113/jphysiol.1988.sp016943; Nikonov S, 2000, J GEN PHYSIOL, V116, P795, DOI 10.1085/jgp.116.6.795; Nikonov S, 1998, J GEN PHYSIOL, V111, P7, DOI 10.1085/jgp.111.1.7; Olshevskaya EV, 1999, J BIOL CHEM, V274, P10823, DOI 10.1074/jbc.274.16.10823; PEPPERBERG DR, 1992, VISUAL NEUROSCI, V8, P9, DOI 10.1017/S0952523800006441; Pugh EN, 1999, CURR OPIN NEUROBIOL, V9, P410, DOI 10.1016/S0959-4388(99)80062-2; Pugh EN, 1997, BIOSCIENCE REP, V17, P429; PUGH EN, 1993, BIOCHIM BIOPHYS ACTA, V1141, P111, DOI 10.1016/0005-2728(93)90038-H; Rieke F, 1996, BIOPHYS J, V71, P2553, DOI 10.1016/S0006-3495(96)79448-1; Rudnicka-Nawrot M, 1998, BIOCHEMISTRY-US, V37, P248, DOI 10.1021/bi972306x; Ruiz M, 1999, BIOCHEMISTRY-US, V38, P10642, DOI 10.1021/bi990532w; Sampath AP, 1998, J GEN PHYSIOL, V111, P53, DOI 10.1085/jgp.111.1.53; TORRE V, 1986, P NATL ACAD SCI USA, V83, P7109, DOI 10.1073/pnas.83.18.7109; Tsang SH, 1998, SCIENCE, V282, P117, DOI 10.1126/science.282.5386.117; Tucker CL, 1999, P NATL ACAD SCI USA, V96, P9039, DOI 10.1073/pnas.96.16.9039; Whitlock GG, 1999, NEURON, V23, P337, DOI 10.1016/S0896-6273(00)80784-9; Woodruff ML, 2002, J PHYSIOL-LONDON, V542, P843, DOI 10.1113/jphysiol.2001.013987; Yang RB, 1997, J BIOL CHEM, V272, P13738, DOI 10.1074/jbc.272.21.13738; YAU KW, 1984, NATURE, V311, P661, DOI 10.1038/311661a0; YAU KW, 1985, NATURE, V317, P252, DOI 10.1038/317252a0; Yu H, 1999, J BIOL CHEM, V274, P15547, DOI 10.1074/jbc.274.22.15547; ZIMMERMAN AL, 1986, NATURE, V321, P70, DOI 10.1038/321070a0	56	179	180	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 26	2002	36	1					81	91		10.1016/S0896-6273(02)00911-X	http://dx.doi.org/10.1016/S0896-6273(02)00911-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	598UP	12367508	Bronze			2022-12-24	WOS:000178295100009
J	Mata, NL; Radu, RA; Clemmons, RS; Travis, GH				Mata, NL; Radu, RA; Clemmons, RS; Travis, GH			Isomerization and oxidation of vitamin a in cone-dominant retinas: A novel pathway for visual-pigment regeneration in daylight	NEURON			English	Article							RETINALDEHYDE-BINDING PROTEIN; MONKEY MACACA-FASCICULARIS; ROD OUTER SEGMENTS; IMMUNOCYTOCHEMICAL LOCALIZATION; ACYLTRANSFERASE ACTIVITY; VERTEBRATE RETINA; SMALL-INTESTINE; CHICKEN RETINA; ACYL-COENZYME; EPITHELIUM	The first step toward light perception is 11-cis to all-trans photoisomerization of the retinaldehyde chromophore in a rod or cone opsin-pigment molecule. Light sensitivity of the opsin pigment is restored through a multistep pathway called the visual cycle, which effects all-trans to 11-cis re-isomerization of the retinoid chromophore. The maximum throughput of the known visual cycle, however, is too slow to explain sustained photosensitivity in bright light. Here, we demonstrate three novel enzymatic activities in cone-dominant ground-squirrel and chicken retinas: an all-trans-retinol isomerase, an 11-cis-retinyl-ester synthase, and an 11-cis-retinol dehydrogenase. Together these activities comprise a novel pathway that regenerates opsin photopigments at a rate 20-fold faster than the known visual cycle. We suggest that this pathway is responsible for sustained daylight vision in vertebrates.	Univ Calif Los Angeles, Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75235 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Travis, GH (corresponding author), Univ Calif Los Angeles, Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA.		Radu, Roxana A./K-8924-2019; Travis, Gabriel Harvey/AIF-1062-2022	Travis, Gabriel Harvey/0000-0003-4020-9493; Radu, Roxana/0000-0002-5064-6403	NEI NIH HHS [R01 EY011713-13, R01 EY011713] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011713] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADLER AJ, 1991, EXP EYE RES, V53, P337, DOI 10.1016/0014-4835(91)90239-B; BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P589; BOK D, 1984, INVEST OPHTH VIS SCI, V25, P877; BUNTMILAM AH, 1983, J CELL BIOL, V97, P703, DOI 10.1083/jcb.97.3.703; BURKHARDT DA, 1994, J NEUROSCI, V14, P1091, DOI 10.1523/JNEUROSCI.14-03-01091.1994; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Chen P, 2001, NAT GENET, V28, P256, DOI 10.1038/90089; CHEN Y, 1994, BIOCHEMISTRY-US, V33, P10658, DOI 10.1021/bi00201a013; Cideciyan AV, 2000, VISUAL NEUROSCI, V17, P667, DOI 10.1017/S0952523800175029; Cornwall MC, 2000, INVEST OPHTH VIS SCI, V41, pS598; Crabb JW, 1998, PROTEIN SCI, V7, P746, DOI 10.1002/pro.5560070324; DAS SR, 1992, BIOCHEM J, V285, P907, DOI 10.1042/bj2850907; DEFOE DM, 1983, INVEST OPHTH VIS SCI, V24, P1211; DEIGNER PS, 1989, SCIENCE, V244, P968, DOI 10.1126/science.2727688; DEUTSCH J, 1994, ANAL BIOCHEM, V220, P321, DOI 10.1006/abio.1994.1344; FUKADA Y, 1990, BIOCHEMISTRY-US, V29, P3133, DOI 10.1021/bi00464a033; FULTON BS, 1987, BIOCHEMISTRY-US, V26, P7938, DOI 10.1021/bi00398a059; GOLDSTEIN EB, 1973, VISION RES, V13, P527, DOI 10.1016/0042-6989(73)90022-9; GULCAN HG, 1993, INVEST OPHTH VIS SCI, V34, P3187; GUPTA BD, 1990, J PHYSIOL-LONDON, V430, P483, DOI 10.1113/jphysiol.1990.sp018303; Hao WS, 1999, J BIOL CHEM, V274, P6085, DOI 10.1074/jbc.274.10.6085; HELGERUD P, 1983, J CLIN INVEST, V71, P747, DOI 10.1172/JCI110822; HOOD DC, 1973, VISION RES, V13, P1943, DOI 10.1016/0042-6989(73)90065-5; Jang GF, 2001, J BIOL CHEM, V276, P32456, DOI 10.1074/jbc.M104949200; Jang GF, 2000, J BIOL CHEM, V275, P28128; JONES GJ, 1989, P NATL ACAD SCI USA, V86, P9606, DOI 10.1073/pnas.86.23.9606; Kefalov VJ, 2001, INVEST OPHTH VIS SCI, V42, pS119; Krebs WK I.P., 1982, STRUCTURE EYE, P175; LAI YL, 1982, NATURE, V298, P848, DOI 10.1038/298848a0; Limb GA, 2002, INVEST OPHTH VIS SCI, V43, P864; LIN ZS, 1989, VISION RES, V29, P1699, DOI 10.1016/0042-6989(89)90152-1; MACDONALD PN, 1988, J BIOL CHEM, V263, P12478; MAKINO CL, 1991, J PHYSIOL-LONDON, V442, P761, DOI 10.1113/jphysiol.1991.sp018818; MATA NL, 1992, J BIOL CHEM, V267, P9794; MEYER DB, 1973, EXP EYE RES, V17, P347, DOI 10.1016/0014-4835(73)90244-3; Mondal MS, 2000, BIOCHEMISTRY-US, V39, P5215, DOI 10.1021/bi9929554; NICOTRA CMA, 1994, MOL CELL BIOCHEM, V132, P45, DOI 10.1007/BF00925674; PALCZEWSKI K, 1994, BIOCHEMISTRY-US, V33, P13741, DOI 10.1021/bi00250a027; Palczewski K, 1999, BIOCHEMISTRY-US, V38, P12012, DOI 10.1021/bi990504d; PERRY RJ, 1991, J PHYSIOL-LONDON, V433, P561, DOI 10.1113/jphysiol.1991.sp018444; PUGH EN, 2000, HDB BIOL PHYSICS, P184; RANDO RR, 1983, J AM CHEM SOC, V105, P2879, DOI 10.1021/ja00347a058; RASMUSSEN KE, 1975, EXP EYE RES, V20, P151, DOI 10.1016/0014-4835(75)90153-0; Rattner A, 2000, J BIOL CHEM, V275, P11034, DOI 10.1074/jbc.275.15.11034; Rodieck R.W., 1998, 1 STEPS SEEING; RODRIGUEZ KA, 1989, AM J PHYSIOL, V256, pR255, DOI 10.1152/ajpregu.1989.256.1.R255; Ruiz A, 1999, J BIOL CHEM, V274, P3834, DOI 10.1074/jbc.274.6.3834; Saari J. C., 1994, Retinoids: from basic science to clinical applications., P43; SAARI JC, 1989, J BIOL CHEM, V264, P8636; SAARI JC, 1988, J BIOL CHEM, V263, P8084; SAARI JC, 1987, J BIOL CHEM, V262, P7618; Saari JC, 1998, VISION RES, V38, P1325, DOI 10.1016/S0042-6989(97)00198-3; SAARI JC, 1993, BIOCHEM J, V291, P697, DOI 10.1042/bj2910697; SCHNAPF JL, 1990, J PHYSIOL-LONDON, V427, P681, DOI 10.1113/jphysiol.1990.sp018193; SHI YQ, 1993, BIOCHEMISTRY-US, V32, P1257, DOI 10.1021/bi00056a009; SIMON A, 1995, J BIOL CHEM, V270, P1107, DOI 10.1074/jbc.270.34.19979; Stecher H, 1999, J BIOL CHEM, V274, P8577, DOI 10.1074/jbc.274.13.8577; TARDI PG, 1992, LIPIDS, V27, P65, DOI 10.1007/BF02537062; TREHAN A, 1990, BIOCHEMISTRY-US, V29, P309, DOI 10.1021/bi00454a001; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; WEST RW, 1975, J COMP NEUROL, V159, P439, DOI 10.1002/cne.901590402; Winston A, 1998, BIOCHEMISTRY-US, V37, P2044, DOI 10.1021/bi971908d; YOUNG RW, 1971, J ULTRA MOL STRUCT R, V34, P190, DOI 10.1016/S0022-5320(71)90014-1	65	286	296	1	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 26	2002	36	1					69	80		10.1016/S0896-6273(02)00912-1	http://dx.doi.org/10.1016/S0896-6273(02)00912-1			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	598UP	12367507	Bronze, Green Accepted			2022-12-24	WOS:000178295100008
J	Chatterjee, S; Callaway, EM				Chatterjee, S; Callaway, EM			S cone contributions to the magnocellular visual pathway in macaque monkey	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; RETINAL GANGLION-CELLS; BLUE-SENSITIVE CONES; PRIMATE RETINA; STRIATE CORTEX; CHROMATIC MECHANISMS; PHYSIOLOGICAL-BASIS; RECEPTIVE-FIELDS; HORIZONTAL CELLS; SINGLE NEURONS	The magnocellular visual pathway is believed to receive input from long (L) and middle (M), but not short (S), wavelength-sensitive cones. Recording from neurons in magnocellular layers of lateral geniculate nucleus (LGN) in macaque monkeys, we found that magnocellular neurons were unequivocally responsive to S cone-isolating stimuli. A quantitative analysis suggests that S cones provided about 10% of the input to these cells, on average, while L:M ratios were far more variable. S cone signals influenced responses with the same sign as L and M cone inputs (i.e., no color opponency). Magnocellular afferent recordings following inactivation of primary visual cortex demonstrated that S cone signals were feedforward in nature and did not arise from cortical feedback to LGN.	Salk Inst Biol Studies, Syst Neurobiol Labs, La Jolla, CA 92037 USA; Univ Calif San Diego, Neurosci Program, La Jolla, CA 92093 USA	Salk Institute; University of California System; University of California San Diego	Chatterjee, S (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Labs, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Callaway, Edward/D-4336-2011	Callaway, Edward/0000-0002-6366-5267	NATIONAL EYE INSTITUTE [R01EY010742] Funding Source: NIH RePORTER; NEI NIH HHS [EY10742] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aguilar M., 1954, OPT ACTA, V1, DOI [10.1080/713818657, DOI 10.1080/713818657]; BLASDEL GG, 1983, J NEUROSCI, V3, P1389; Brainard DH, 2000, J OPT SOC AM A, V17, P607, DOI 10.1364/JOSAA.17.000607; Bumsted K, 1999, J COMP NEUROL, V403, P502; Calkins DJ, 2001, PROG RETIN EYE RES, V20, P255, DOI 10.1016/S1350-9462(00)00026-4; Calkins DJ, 2000, J OPT SOC AM A, V17, P597, DOI 10.1364/JOSAA.17.000597; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; CAVANAGH P, 1991, VISION RES, V31, P2109, DOI 10.1016/0042-6989(91)90169-6; Chander D, 2001, J NEUROSCI, V21, P9904, DOI 10.1523/JNEUROSCI.21-24-09904.2001; CHAPMAN B, 1991, J NEUROSCI, V11, P1347; Chichilnisky EJ, 1999, NAT NEUROSCI, V2, P889, DOI 10.1038/13189; CHICHILNISKY EJ, 1993, VISION RES, V33, P2113, DOI 10.1016/0042-6989(93)90010-T; Conway BR, 2001, J NEUROSCI, V21, P2768, DOI 10.1523/JNEUROSCI.21-08-02768.2001; Cottaris NP, 1998, NATURE, V395, P896, DOI 10.1038/27666; CREUTZFELDT OD, 1979, EXP BRAIN RES, V35, P527; DACEY DM, 1994, NATURE, V367, P731, DOI 10.1038/367731a0; Dacey DM, 2000, J OPT SOC AM A, V17, P589, DOI 10.1364/JOSAA.17.000589; Dacey DM, 1996, SCIENCE, V271, P656, DOI 10.1126/science.271.5249.656; DEMONASTERIO FM, 1981, SCIENCE, V213, P1278, DOI 10.1126/science.7268439; DERRINGTON AM, 1984, J PHYSIOL-LONDON, V357, P241, DOI 10.1113/jphysiol.1984.sp015499; Dobkins KR, 2000, J OPT SOC AM A, V17, P545, DOI 10.1364/JOSAA.17.000545; Dobkins KR, 2000, NEURON, V25, P15, DOI 10.1016/S0896-6273(00)80867-3; Dougherty RF, 1999, NEURON, V24, P893, DOI 10.1016/S0896-6273(00)81036-3; DRUM B, 1983, VISION RES, V23, P1433, DOI 10.1016/0042-6989(83)90155-4; EISNER A, 1980, J OPT SOC AM, V70, P121, DOI 10.1364/JOSA.70.000121; FITZPATRICK D, 1994, VISUAL NEUROSCI, V11, P307, DOI 10.1017/S0952523800001656; GEGENFURTNER KR, 1994, VISUAL NEUROSCI, V11, P455, DOI 10.1017/S095252380000239X; Goodchild AK, 1996, J COMP NEUROL, V366, P55, DOI 10.1002/(SICI)1096-9861(19960226)366:1<55::AID-CNE5>3.0.CO;2-J; Hendry SHC, 2000, ANNU REV NEUROSCI, V23, P127, DOI 10.1146/annurev.neuro.23.1.127; HOOD DC, 1986, HDB PERCEPTION HUMAN; Johnson EN, 2001, NAT NEUROSCI, V4, P409, DOI 10.1038/86061; KAISER PK, 1990, J PHYSIOL-LONDON, V422, P153, DOI 10.1113/jphysiol.1990.sp017978; KLUG KY, 1993, INVEST OPHTH VIS SCI, V34, pA1398; LEE BB, 1989, J PHYSIOL-LONDON, V414, P223, DOI 10.1113/jphysiol.1989.sp017685; LEE BB, 1988, J PHYSIOL-LONDON, V404, P323, DOI 10.1113/jphysiol.1988.sp017292; Lee BB, 1997, VISION RES, V37, P2813, DOI 10.1016/S0042-6989(97)00108-9; LEE J, 1989, J PHYSIOL-LONDON, V413, P563, DOI 10.1113/jphysiol.1989.sp017669; LENNIE P, 1993, J OPT SOC AM A, V10, P1283, DOI 10.1364/JOSAA.10.001283; LENNIE P, 1990, J NEUROSCI, V10, P649; LEVITT JB, 1994, J COMP NEUROL, V342, P551, DOI 10.1002/cne.903420405; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; LIVINGSTONE MS, 1987, J NEUROSCI, V7, P3416; MARIMONT DH, 1994, J OPT SOC AM A, V11, P3113, DOI 10.1364/JOSAA.11.003113; Martin PR, 1998, J PHYSIOL-LONDON, V513, P631, DOI 10.1111/j.1469-7793.1998.631ba.x; Martin PR, 1999, J COMP NEUROL, V406, P1, DOI 10.1002/(SICI)1096-9861(19990329)406:1<1::AID-CNE1>3.0.CO;2-1; MAUNSELL JHR, 1990, J NEUROSCI, V10, P3323; MERIGAN WH, 1993, ANNU REV NEUROSCI, V16, P369, DOI 10.1146/annurev.ne.16.030193.002101; Mullen KT, 1996, VISION RES, V36, P1995, DOI 10.1016/0042-6989(95)00261-8; NOTHDURFT HC, 1982, EXP BRAIN RES, V48, P43; Packer OS, 1996, J NEUROSCI, V16, P2251; PADMOS P, 1975, VISION RES, V15, P617, DOI 10.1016/0042-6989(75)90311-9; Ringach DL, 1997, VISION RES, V37, P2455, DOI 10.1016/S0042-6989(96)00247-7; Rodieck R.W., 1998, 1 STEPS SEEING; Roorda A, 2001, VISION RES, V41, P1291, DOI 10.1016/S0042-6989(01)00043-8; Roorda A, 1999, NATURE, V397, P520, DOI 10.1038/17383; Sawatari A, 2000, NEURON, V25, P459, DOI 10.1016/S0896-6273(00)80908-3; SCHILLER PH, 1978, J NEUROPHYSIOL, V41, P788, DOI 10.1152/jn.1978.41.3.788; SCHNEEWEISS A, 1988, GERIATR CARDIOVASC, V1, P255; Seidemann E, 1999, NEURON, V24, P911, DOI 10.1016/S0896-6273(00)81038-7; SHAPIRO MB, 1985, J AM STAT ASSOC, V80, P803, DOI 10.2307/2288535; SHAPLEY R, 1986, TRENDS NEUROSCI, V9, P229, DOI 10.1016/0166-2236(86)90064-0; SHERMAN SM, 1986, EXP BRAIN RES, V63, P1; SNODDERLY DM, 1984, INVEST OPHTH VIS SCI, V25, P674; STOCKMAN A, 1993, J OPT SOC AM A, V10, P2491, DOI 10.1364/JOSAA.10.002491; STOCKMAN A, 1993, J OPT SOC AM A, V10, P1396, DOI 10.1364/JOSAA.10.001396; Teufel HJ, 2000, J OPT SOC AM A, V17, P994, DOI 10.1364/JOSAA.17.000994; VERDON W, 1987, J OPT SOC AM A, V4, P91, DOI 10.1364/JOSAA.4.000091; VOS JJ, 1990, VISION RES, V30, P937, DOI 10.1016/0042-6989(90)90059-T; Wandell B.A., 1995, FDN VISION; Wandell BA, 1999, NEURON, V24, P901, DOI 10.1016/S0896-6273(00)81037-5; WIESEL TN, 1966, J NEUROPHYSIOL, V29, P1115, DOI 10.1152/jn.1966.29.6.1115; WIKLER KC, 1990, J NEUROSCI, V10, P3390; Yabuta NH, 2001, SCIENCE, V292, P297, DOI 10.1126/science.1057916	73	88	89	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 12	2002	35	6					1135	1146		10.1016/S0896-6273(02)00874-7	http://dx.doi.org/10.1016/S0896-6273(02)00874-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	594GC	12354402	Bronze			2022-12-24	WOS:000178040000013
J	Kuromi, H; Kidokoro, Y				Kuromi, H; Kidokoro, Y			Selective replenishment of two vesicle pools depends on the source of Ca2+ at the Drosophila synapse	NEURON			English	Article							DISTINCT POOLS; CALCIUM; ENDOCYTOSIS; INHIBITION; TRANSMITTER; METABOLISM; MEMBRANE; MUTANT; FIBER	After synaptic vesicles (SVs) undergo exocytosis, SV pools are replenished by recycling SVs at nerve terminals. At Drosophila neuromuscular synapses, there are two distinct SV pools (i.e., the exo/endo cycling pool (ECP), which primarily maintains synaptic transmission, and the reserve pool (RP), which participates in synaptic transmission only during tetanic stimulation). Labeling endocytosed vesicular structures with a fluorescent styryl dye, FM1-43, and measuring intracellular Call concentrations with a Ca2+ indicator, rhod-2, we show here that the ECP is replenished by SVs endocytosed during stimulation, and this process depends on external Ca2+. In contrast, the RP is refilled after cessation of tetanus by a process mediated by Ca2+ released from internal stores.	Gunma Univ, Sch Med, Inst Behav Sci, Maebashi, Gumma 3718511, Japan	Gunma University	Kuromi, H (corresponding author), Gunma Univ, Sch Med, Inst Behav Sci, 3-39-22 Showa Machi, Maebashi, Gumma 3718511, Japan.	kuromi@med.gunma-u.ac.jp						AIUCHI T, 1985, BIOCHIM BIOPHYS ACTA, V843, P20, DOI 10.1016/0304-4165(85)90044-3; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BIRKS R, 1961, CAN J BIOCHEM PHYS, V39, P787, DOI 10.1139/o61-081; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Delgado R, 2000, NEURON, V28, P941, DOI 10.1016/S0896-6273(00)00165-3; Dittman JS, 1998, J NEUROSCI, V18, P6147; ELLISDAVIES GCR, 1994, P NATL ACAD SCI USA, V91, P187, DOI 10.1073/pnas.91.1.187; Gad H, 1998, NEURON, V21, P607, DOI 10.1016/S0896-6273(00)80570-X; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; HARTWIG JH, 1992, NATURE, V356, P618, DOI 10.1038/356618a0; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; JAN LY, 1976, J PHYSIOL-LONDON, V262, P189, DOI 10.1113/jphysiol.1976.sp011592; JOHNSON LV, 1980, P NATL ACAD SCI-BIOL, V77, P990, DOI 10.1073/pnas.77.2.990; Kamiya H, 2000, J PHYSIOL-LONDON, V523, P653, DOI 10.1111/j.1469-7793.2000.t01-1-00653.x; KOENIG JH, 1993, J NEUROSCI, V13, P2313, DOI 10.1523/JNEUROSCI.13-06-02313.1993; KOENIG JH, 1983, J CELL BIOL, V96, P1517, DOI 10.1083/jcb.96.6.1517; Koenig JH, 1996, J CELL BIOL, V135, P797, DOI 10.1083/jcb.135.3.797; Kuromi H, 1998, NEURON, V20, P917, DOI 10.1016/S0896-6273(00)80473-0; Kuromi H, 2000, NEURON, V27, P133, DOI 10.1016/S0896-6273(00)00015-5; MELAMED N, 1993, J NEUROSCI, V13, P632; NARAHASHI T, 1974, PHYSIOL REV, V54, P813, DOI 10.1152/physrev.1974.54.4.813; PIERIBONE VA, 1995, NATURE, V375, P493, DOI 10.1038/375493a0; POODRY CA, 1979, J CELL BIOL, V81, P520, DOI 10.1083/jcb.81.3.520; Prekeris R, 1997, J CELL BIOL, V137, P1589, DOI 10.1083/jcb.137.7.1589; RAMASWAMI M, 1994, NEURON, V13, P363, DOI 10.1016/0896-6273(94)90353-0; Richards DA, 2000, NEURON, V27, P551, DOI 10.1016/S0896-6273(00)00065-9; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; Sankaranarayanan S, 2001, NAT NEUROSCI, V4, P129, DOI 10.1038/83949; Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Tabb JS, 1998, J CELL SCI, V111, P3221; Tang YG, 1997, NEURON, V18, P483, DOI 10.1016/S0896-6273(00)81248-9; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; VONGERSDORFF H, 1994, NATURE, V370, P652, DOI 10.1038/370652a0; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; Wu LG, 1996, NEURON, V17, P769, DOI 10.1016/S0896-6273(00)80208-1	36	73	76	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 18	2002	35	2					333	343		10.1016/S0896-6273(02)00777-8	http://dx.doi.org/10.1016/S0896-6273(02)00777-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	576YF	12160750	Bronze			2022-12-24	WOS:000177034200012
J	Kleinfeld, D; Sachdev, RNS; Merchant, LM; Jarvis, MR; Ebner, FF				Kleinfeld, D; Sachdev, RNS; Merchant, LM; Jarvis, MR; Ebner, FF			Adaptive filtering of vibrissa input in motor cortex of rat	NEURON			English	Article							BARREL FIELD CORTEX; CORTICOTHALAMIC PROJECTIONS; SOMATOSENSORY CORTEX; WHISKER STIMULATION; RESPONSE PROPERTIES; RECEPTIVE-FIELDS; CEREBRAL-CORTEX; SENSORY INPUT; AWAKE RATS; ADULT-RATS	We studied the transformation of sensory input as it progresses from vibrissa primary sensor (S1) to motor (M1) cortex. Single-unit activity was obtained from alert adult rats that did not to whisk upon application of punctate, rhythmic stimulation of individual vibrissae. The spike response of units in S1 cortex largely reproduced the shape of the stimulus. In contrast, the spiking output of units in M1 cortex were modulated solely as a sinusoid at the repetition rate of the stimulus for frequencies between 5 and 15 Hz; this range corresponds to that of natural whisking. Thus, the S1 to M1 transformation extracts the fundamental frequency from a spectrally rich stimulus. We discuss our results in terms of a band-pass filter with a center frequency that adapts to the change in stimulation rate.	Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; Univ Calif San Diego, Grad Program Neurosci, La Jolla, CA 92093 USA; Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Vanderbilt University; California Institute of Technology	Kleinfeld, D (corresponding author), Univ Calif San Diego, Dept Phys, 9500 Gilman Drive 0319, La Jolla, CA 92093 USA.			Sachdev, Robert/0000-0002-6627-0199	NIMH NIH HHS [MH59867] Funding Source: Medline; NINDS NIH HHS [NS13031] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS013031] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahissar E, 2000, NATURE, V406, P302, DOI 10.1038/35018568; Ahissar E, 1997, P NATL ACAD SCI USA, V94, P11633, DOI 10.1073/pnas.94.21.11633; ANDERSSON G, 1995, ACTA PHYSIOL SCAND, V153, P381, DOI 10.1111/j.1748-1716.1995.tb09876.x; ARMSTRONGJAMES M, 1992, J NEUROPHYSIOL, V68, P1345, DOI 10.1152/jn.1992.68.4.1345; ARMSTRONGJAMES M, 1988, EXP BRAIN RES, V70, P155; ARMSTRONGJAMES M, 1987, J COMP NEUROL, V263, P265, DOI 10.1002/cne.902630209; ASANUMA H, 1980, EXP BRAIN RES, V38, P349; Bermejo R, 1996, SOMATOSENS MOT RES, V13, P225, DOI 10.3109/08990229609052578; Best RE., 1984, PHASE LOCKED LOOPS T; Bruehl C, 1998, EPILEPSY RES, V32, P379, DOI 10.1016/S0920-1211(98)00066-7; CARVELL GE, 1991, SOMATOSENS MOT RES, V8, P159, DOI 10.3109/08990229109144740; CARVELL GE, 1990, J NEUROSCI, V10, P2638; Carvell GE, 1996, SOMATOSENS MOT RES, V13, P115, DOI 10.3109/08990229609051399; CASSELLA JV, 1987, J NEUROSCI METH, V19, P105, DOI 10.1016/0165-0270(87)90025-2; CHAPIN JK, 1981, BRAIN RES BULL, V6, P63, DOI 10.1016/S0361-9230(81)80069-X; CHAPIN JK, 1984, J COMP NEUROL, V229, P199, DOI 10.1002/cne.902290206; CHIAIA NL, 1991, J COMP NEUROL, V314, P217, DOI 10.1002/cne.903140203; Dayan P., 2002, THEORETICAL NEUROSCI; Deschenes M, 1998, BRAIN RES REV, V28, P286, DOI 10.1016/S0165-0173(98)00017-4; DIAMOND ME, 1992, J COMP NEUROL, V319, P66, DOI 10.1002/cne.903190108; DONOGHUE JP, 1988, J NEUROSCI, V8, P3221; DONOGHUE JP, 1982, J COMP NEUROL, V212, P76, DOI 10.1002/cne.902120106; DONOGHUE JP, 1990, EXP BRAIN RES, V79, P492; Ermentrout GB, 2001, NEURON, V29, P33, DOI 10.1016/S0896-6273(01)00178-7; Farkas T, 1999, NEUROSCIENCE, V90, P353, DOI 10.1016/S0306-4522(98)00451-5; Fee MS, 1997, J NEUROPHYSIOL, V78, P1144, DOI 10.1152/jn.1997.78.2.1144; GIOANNI Y, 1985, BRAIN RES, V344, P49, DOI 10.1016/0006-8993(85)91188-6; HERMAN D, 1985, EXP BRAIN RES, V57, P598; HESS WJ, 1982, PHONETICA, V39, P219, DOI 10.1159/000261664; IZRAELI R, 1995, EXP BRAIN RES, V104, P41; JACOBS KM, 1991, SCIENCE, V251, P944, DOI 10.1126/science.2000496; Jarvis MR, 2001, NEURAL COMPUT, V13, P717, DOI 10.1162/089976601300014312; Keller A, 1996, NEUROREPORT, V7, P2373, DOI 10.1097/00001756-199610020-00019; Kim U, 1999, J COMP NEUROL, V408, P489; Kleinfeld D, 1999, SOMATOSENS MOT RES, V16, P69, DOI 10.1080/08990229970528; Kleinfeld D, 1996, J COMP NEUROL, V375, P89, DOI 10.1002/(SICI)1096-9861(19961104)375:1<89::AID-CNE6>3.0.CO;2-K; KLEINFELD D, 1997, J COMP NEUROL, V378; Kuramoto Y., 1984, CHEM OSCILLATIONS WA; MAYS LE, 1980, SCIENCE, V208, P1163, DOI 10.1126/science.6769161; MCCALL RB, 1979, BRAIN RES, V169, P11, DOI 10.1016/0006-8993(79)90370-6; MIYASHITA E, 1994, EXP BRAIN RES, V99, P223; NEAFSEY EJ, 1986, BRAIN RES REV, V11, P77, DOI 10.1016/0165-0173(86)90011-1; NICOLELIS MAL, 1995, SCIENCE, V268, P1353, DOI 10.1126/science.7761855; O'Connor SM, 2002, J NEUROPHYSIOL, V87, P2137, DOI 10.1152/jn.00229.2001; PARRY TJ, 1993, PHYSIOL BEHAV, V53, P1011, DOI 10.1016/0031-9384(93)90283-L; PERCIVAL DB, 1993, SPECTRAL ANAL PHYSIC; PIERCE JR, 1991, J ACOUST SOC AM, V90, P1889, DOI 10.1121/1.401667; Sachdev RNS, 2000, J NEUROPHYSIOL, V84, P1497, DOI 10.1152/jn.2000.84.3.1497; SANDERSON KJ, 1984, BRAIN RES, V292, P251, DOI 10.1016/0006-8993(84)90761-3; SHARP FR, 1982, J COMP NEUROL, V208, P255, DOI 10.1002/cne.902080305; SIMONS DJ, 1983, BRAIN RES, V276, P178, DOI 10.1016/0006-8993(83)90561-9; SIMONS DJ, 1978, J NEUROPHYSIOL, V41, P798, DOI 10.1152/jn.1978.41.3.798; SIMONS DJ, 1985, J NEUROPHYSIOL, V54, P615, DOI 10.1152/jn.1985.54.3.615; SOMPOLINSKY H, 1990, P NATL ACAD SCI USA, V87, P7200, DOI 10.1073/pnas.87.18.7200; Sosnik R, 2001, J NEUROPHYSIOL, V86, P339, DOI 10.1152/jn.2001.86.1.339; SWADLOW HA, 1994, J NEUROPHYSIOL, V71, P437, DOI 10.1152/jn.1994.71.2.437; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; Veinante P, 2000, J COMP NEUROL, V424, P197, DOI 10.1002/1096-9861(20000821)424:2<197::AID-CNE1>3.0.CO;2-6; WEISS DS, 1994, CEREB CORTEX, V4, P205, DOI 10.1093/cercor/4.2.205; WELKER C, 1971, BRAIN RES, V26, P259, DOI 10.1016/S0006-8993(71)80004-5; WONGRILEY MTT, 1976, BRAIN RES, V108, P257, DOI 10.1016/0006-8993(76)90185-2; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X	62	84	84	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 13	2002	34	6					1021	1034		10.1016/S0896-6273(02)00732-8	http://dx.doi.org/10.1016/S0896-6273(02)00732-8			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	563HF	12086648	Bronze			2022-12-24	WOS:000176249700018
J	Peretz, D; Williamson, RA; Legname, G; Matsunaga, Y; Vergara, J; Burton, DR; DeArmond, SJ; Prusiner, SB; Scott, MR				Peretz, D; Williamson, RA; Legname, G; Matsunaga, Y; Vergara, J; Burton, DR; DeArmond, SJ; Prusiner, SB; Scott, MR			A change in the conformation of prions accompanies the emergence of a new prion strain	NEURON			English	Article							CREUTZFELDT-JAKOB-DISEASE; BOVINE SPONGIFORM ENCEPHALOPATHY; SECONDARY STRUCTURE; MOLECULAR-BASIS; SCRAPIE AGENT; PRP ISOFORMS; CELLULAR PRP; PROTEIN; MICE; TRANSMISSION	To investigate the role of the pathogenic prion protein (PrPSc) in controlling susceptibility to foreign prions, two Syrian hamster (SHa) prion strains, Sc237 and DY, were transmitted to transgenic mice expressing chimeric SHa/mouse PrP genes, Tg(MH2M), First passage of SHa(Sc237) prions exhibited prolonged incubation times, diagnostic of a species barrier. PrPSc of the new MH2M(Sc237) strain possessed different structural properties from those of SHa(Sc237), as demonstrated by relative conformational stability measurements. This change was accompanied by a disease phenotype different from the SHa(Sc237) strain. Conversely, transmission of SHa(DY) prions to Tg(MH2M) mice showed no species barrier, and the MH2M(DY) strain retained the conformational and disease-specific properties of SHa(DY). These results suggest a causal relationship between species barriers, changes in PrPSc conformation, and the emergence of new prion strains.	Scripps Res Inst, Res Inst, Dept Immunol & Mol Biol, La Jolla, CA 92037 USA; Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	Scripps Research Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Prusiner, SB (corresponding author), Scripps Res Inst, Res Inst, Dept Immunol & Mol Biol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ind@itsa.ucsf.edu	Legname, Giuseppe/C-1723-2012	Legname, Giuseppe/0000-0003-0716-4393				Anderson RM, 1996, NATURE, V382, P779, DOI 10.1038/382779a0; Bartz JC, 2000, J VIROL, V74, P5542, DOI 10.1128/JVI.74.12.5542-5547.2000; BASLER K, 1986, CELL, V46, P417, DOI 10.1016/0092-8674(86)90662-8; BASTIDAS RB, 1997, J MOL BIOL, V273, P614; BENDHEIM PE, 1984, NATURE, V310, P418, DOI 10.1038/310418a0; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; BESSEN RA, 1992, J VIROL, V66, P2096, DOI 10.1128/JVI.66.4.2096-2101.1992; BRUCE M, 1994, PHILOS T R SOC B, V343, P405, DOI 10.1098/rstb.1994.0036; Bruce M E, 1991, Curr Top Microbiol Immunol, V172, P125; BRUCE ME, 1987, J GEN VIROL, V68, P79, DOI 10.1099/0022-1317-68-1-79; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; BURTON DR, 1991, P NATL ACAD SCI USA, V88, P10134, DOI 10.1073/pnas.88.22.10134; CARLSON GA, 1986, CELL, V46, P503, DOI 10.1016/0092-8674(86)90875-5; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; CARTER P, 1992, BIO-TECHNOL, V10, P163, DOI 10.1038/nbt0292-163; Caughey B, 1998, J BIOL CHEM, V273, P32230, DOI 10.1074/jbc.273.48.32230; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; COUSENS SN, 1990, J NEUROL NEUROSUR PS, V53, P459, DOI 10.1136/jnnp.53.6.459; DeArmond SJ, 1999, COLD SPRING HARBOR M, V38, P585; Dickinson A. G., 1976, Slow virus diseases of animals and man,, P209; GASSET M, 1993, P NATL ACAD SCI USA, V90, P1, DOI 10.1073/pnas.90.1.1; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Horiuchi M, 2000, P NATL ACAD SCI USA, V97, P5836, DOI 10.1073/pnas.110523897; Horiuchi M, 1999, EMBO J, V18, P3193, DOI 10.1093/emboj/18.12.3193; Ironside JW, 1997, AMYLOID, V4, P66, DOI 10.3109/13506129708995272; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; KIMBERLIN RH, 1977, J GEN VIROL, V34, P295, DOI 10.1099/0022-1317-34-2-295; KIMBERLIN RH, 1989, J GEN VIROL, V70, P2017, DOI 10.1099/0022-1317-70-8-2017; KIMBERLIN RH, 1979, SLOW TRANSMISSIBLE D, V2, P33; KITAMOTO T, 1987, LAB INVEST, V57, P230; Kuwajima Kunihiro, 1995, V40, P115; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lasmezas CI, 1996, NATURE, V381, P743, DOI 10.1038/381743a0; MALMGREN R, 1979, SLOW TRANSMISSIBLE D, V1, P93; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; MURAMOTO T, 1992, AM J PATHOL, V140, P1411; OESCH B, 1994, BIOCHEMISTRY-US, V33, P5926, DOI 10.1021/bi00185a033; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Pan T, 2001, J BIOL CHEM, V276, P37284, DOI 10.1074/jbc.M107358200; Parchi P, 2000, P NATL ACAD SCI USA, V97, P10168, DOI 10.1073/pnas.97.18.10168; Parchi P, 1996, ANN NEUROL, V39, P767, DOI 10.1002/ana.410390613; Pattison I. H., 1965, NINDB MONOGRAPH, V2, P249; PATTISON IH, 1966, RES VET SCI, V7, P207; Peretz D, 2001, PROTEIN SCI, V10, P854, DOI 10.1110/ps.39201; Pergami P, 1996, ANAL BIOCHEM, V236, P63, DOI 10.1006/abio.1996.0132; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1982, ANN NEUROL, V11, P353, DOI 10.1002/ana.410110406; PRUSINER SB, 1984, CELL, V38, P127, DOI 10.1016/0092-8674(84)90533-6; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; Prusiner SB, 1999, COLD SPRING HARBOR M, V38, P67; PRUSINER SB, 1993, P NATL ACAD SCI USA, V90, P2793, DOI 10.1073/pnas.90.7.2793; PRUSINER SB, 1987, PRION NOVEL INFECT P; Ridley RM, 1996, NEURODEGENERATION, V5, P219, DOI 10.1006/neur.1996.0030; SAFAR J, 1993, PROTEIN SCI, V2, P2206, DOI 10.1002/pro.5560021220; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; SCOTT M, 1993, CELL, V73, P979, DOI 10.1016/0092-8674(93)90275-U; SCOTT M, 1989, CELL, V59, P847, DOI 10.1016/0092-8674(89)90608-9; SCOTT MR, 1992, PROTEIN SCI, V1, P986, DOI 10.1002/pro.5560010804; Scott MR, 1999, P NATL ACAD SCI USA, V96, P15137, DOI 10.1073/pnas.96.26.15137; Scott MR, 1997, J VIROL, V71, P9032, DOI 10.1128/JVI.71.12.9032-9044.1997; SERBAN D, 1990, NEUROLOGY, V40, P110, DOI 10.1212/WNL.40.1.110; Somerville RA, 1997, NATURE, V386, P564, DOI 10.1038/386564a0; TARABOULOS A, 1992, P NATL ACAD SCI USA, V89, P7620, DOI 10.1073/pnas.89.16.7620; TELLING GC, 1995, CELL, V83, P79, DOI 10.1016/0092-8674(95)90236-8; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Wadsworth JDF, 1999, NAT CELL BIOL, V1, P55, DOI 10.1038/9030; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9	69	175	181	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 13	2002	34	6					921	932		10.1016/S0896-6273(02)00726-2	http://dx.doi.org/10.1016/S0896-6273(02)00726-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	563HF	12086640	Bronze			2022-12-24	WOS:000176249700010
J	Zhang, C; Zhou, Z				Zhang, C; Zhou, Z			Ca2+-independent but voltage-dependent secretion in mammalian dorsal root ganglion neurons	NATURE NEUROSCIENCE			English	Article							ADRENAL CHROMAFFIN CELLS; TRANSMITTER RELEASE; AMPEROMETRIC DETECTION; QUANTAL SECRETION; EXOCYTOSIS; CATECHOLAMINES; COMPETENT; KINETICS; PATHWAYS; CALCIUM	We have investigated the Ca2+ dependence of vesicular secretion from the soma of dorsal root ganglion (DRG) neurons, which secrete neuropeptides by exocytosis of dense-core vesicles. In patch-clamped somata of rat DRG neurons, we found a depolarization-induced membrane capacitance increase (DeltaC(m)) in the absence of extracellular Ca2+ and in the presence of a Ca2+ chelator (BAPTA) in the intracellular solution. Depletion of internal Ca2+ stores by thapsigargin in the Ca2+-free bath also did not block the DeltaC(m), indicating that Ca2+ release from internal Ca2+ stores may not have been involved. Furthermore, the Ca2+-independent DeltaC(m) was blocked by whole-cell dialysis with tetanus toxin and was accompanied by pulsatile secretion of false transmitters, as detected by amperometric measurements. These results indicate the existence of Ca2+-independent but voltage-dependent vesicular secretion (CIVDS) in a mammalian sensory neuron.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Zhou, Z (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	zzhou@ion.ac.cn	zhou, zhuan/A-8285-2011					BERS DM, 1991, EXCITATION CONTRACTI; Chow RH, 1996, NEURON, V16, P369, DOI 10.1016/S0896-6273(00)80054-9; Ding JP, 1998, BIOPHYS J, V74, P268, DOI 10.1016/S0006-3495(98)77785-9; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; Gillis Kevin D., 1995, P155; HORRIGAN FT, 1994, NEURON, V13, P1119, DOI 10.1016/0896-6273(94)90050-7; Hu ZH, 1997, J PHYSIOL-LONDON, V501, P67, DOI 10.1111/j.1469-7793.1997.067bo.x; Huang LYM, 1996, NEURON, V17, P135, DOI 10.1016/S0896-6273(00)80287-1; Jaffe EH, 1998, J NEUROSCI, V18, P3548; Katz B., 1969, RELEASE NEURAL TRANS; Kim KY, 2000, PROTEIN EXPRES PURIF, V20, P1, DOI 10.1006/prep.2000.1300; Matthews G, 1996, ANNU REV NEUROSCI, V19, P219; Moser T, 2000, P NATL ACAD SCI USA, V97, P883, DOI 10.1073/pnas.97.2.883; MULKEY RM, 1991, NATURE, V350, P153, DOI 10.1038/350153a0; Neher E., 1986, EXPT BRAIN RES SERIE, P80; Parnas H, 2000, TRENDS NEUROSCI, V23, P60, DOI 10.1016/S0166-2236(99)01498-8; Puopolo M, 2001, NEURON, V30, P211, DOI 10.1016/S0896-6273(01)00274-4; Smith C, 1998, NEURON, V20, P1243, DOI 10.1016/S0896-6273(00)80504-8; Sun JY, 2001, NEURON, V30, P171, DOI 10.1016/S0896-6273(01)00271-9; WIGHTMAN RM, 1991, P NATL ACAD SCI USA, V88, P10754, DOI 10.1073/pnas.88.23.10754; Xu GY, 2000, J PHYSIOL-LONDON, V528, P339, DOI 10.1111/j.1469-7793.2000.00339.x; Xu T, 1998, NAT NEUROSCI, V1, P192, DOI 10.1038/642; You ZD, 2000, NEUROREPORT, V11, P3113, DOI 10.1097/00001756-200009280-00015; ZHANG X, 1995, J COMP NEUROL, V352, P481, DOI 10.1002/cne.903520402; ZHOU Z, 1995, J BIOL CHEM, V270, P3498, DOI 10.1074/jbc.270.8.3498; ZHOU Z, 1995, P NATL ACAD SCI USA, V92, P6938, DOI 10.1073/pnas.92.15.6938; Zhou Z, 1996, J BIOL CHEM, V271, P270, DOI 10.1074/jbc.271.1.270; ZHOU ZA, 1993, J PHYSIOL-LONDON, V469, P245, DOI 10.1113/jphysiol.1993.sp019813	28	104	108	2	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2002	5	5					425	430		10.1038/nn845	http://dx.doi.org/10.1038/nn845			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	546JY	11953753				2022-12-24	WOS:000175272000012
J	Zeron, MM; Hansson, O; Chen, NS; Wellington, CL; Leavitt, BR; Brundin, P; Hayden, MR; Raymond, LA				Zeron, MM; Hansson, O; Chen, NS; Wellington, CL; Leavitt, BR; Brundin, P; Hayden, MR; Raymond, LA			Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease	NEURON			English	Article							RAT STRIATAL NEURONS; MUTANT HUNTINGTIN; CELL-DEATH; PROJECTION NEURONS; TERMINAL FRAGMENTS; QUINOLINIC ACID; TRANSGENIC MICE; NERVOUS-SYSTEM; PROTEIN-KINASE; LOCALIZATION	Previous work suggests N-methyl-D-aspartate receptor (NMDAR) activation may be involved in degeneration of medium-sized spiny striatal neurons in Huntington's disease (HD). Here we show that these neurons are more vulnerable to NMDAR-mediated death in a YAC transgenic FVB/N mouse model of HD expressing full-length mutant huntingtin, compared with wild-type FVB/N mice. Excitotoxic death of these neurons was increased after intrastriatal injection of quinolinate in vivo, and after NMDA but not AMPA exposure in culture. NMDA-induced cell death was abolished by an NR2B subtype-specific antagonist. In contrast, NMDAR-mediated death of cerebellar granule neurons was not enhanced, consistent with cell-type and NMDAR subtype specificity. Moreover, increased NMDA-evoked current amplitude and caspase-3 activity were observed in transgenic striatal neurons. Our data support a role for NR2B-subtype NMDAR activation as a trigger for selective neuronal degeneration in HD.	Lund Univ, Kinsmen Lab Neurol Res, Dept Psychiat, Biomed Ctr A10, S-22184 Lund, Sweden; Lund Univ, Sect Neuronal Survival, Wallenberg Neurosci Ctr, Biomed Ctr A10, S-22184 Lund, Sweden; Univ British Columbia, Ctr Mol Med & Therapeut, Dept Med Genet, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Physiol, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Div Neurol, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Med, Vancouver, BC V6T 1Z3, Canada	Lund University; Lund University; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Raymond, LA (corresponding author), Lund Univ, Kinsmen Lab Neurol Res, Dept Psychiat, Biomed Ctr A10, S-22184 Lund, Sweden.		Leavitt, Blair R/G-1934-2012; Raymond, Lynn A./R-6707-2016; Raymond, Lynn A/A-6664-2010; Hayden, Michael R/D-8581-2011; Chen, Nansheng/E-6450-2012; Hansson, Oskar/A-7134-2013	Raymond, Lynn A./0000-0002-8610-1042; Raymond, Lynn A/0000-0002-8610-1042; Hayden, Michael R/0000-0001-5159-1419; Hansson, Oskar/0000-0001-8467-7286				ALBIN RL, 1990, NEW ENGL J MED, V322, P1293, DOI 10.1056/NEJM199005033221807; BEAL MF, 1992, FASEB J, V6, P3338, DOI 10.1096/fasebj.6.15.1464368; BEAL MF, 1986, NATURE, V321, P168, DOI 10.1038/321168a0; BRORSON JR, 1995, J NEUROSCI, V15, P4515; Budd SL, 2000, P NATL ACAD SCI USA, V97, P6161, DOI 10.1073/pnas.100121097; Calabresi P, 2000, PROG NEUROBIOL, V61, P231, DOI 10.1016/S0301-0082(99)00030-1; CALABRESI P, 1987, NEUROSCIENCE, V20, P293, DOI 10.1016/0306-4522(87)90021-2; Cepeda C, 2001, J NEUROSCI RES, V66, P525, DOI 10.1002/jnr.1244; Cepeda C, 2001, EUR J NEUROSCI, V14, P1577, DOI 10.1046/j.0953-816x.2001.01783.x; Cepeda C, 1998, DEV NEUROSCI-BASEL, V20, P1, DOI 10.1159/000017294; Chen M, 2000, NAT MED, V6, P797, DOI 10.1038/77528; Chen NS, 1997, MOL PHARMACOL, V51, P1015, DOI 10.1124/mol.51.6.1015; Chen NS, 1999, J NEUROCHEM, V72, P1890, DOI 10.1046/j.1471-4159.1999.0721890.x; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Clarke G, 2000, NATURE, V406, P195, DOI 10.1038/35018098; Cooper JK, 1998, HUM MOL GENET, V7, P783, DOI 10.1093/hmg/7.5.783; COYLE JT, 1976, NATURE, V263, P244, DOI 10.1038/263244a0; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DIFIGLIA M, 1990, TRENDS NEUROSCI, V13, P286, DOI 10.1016/0166-2236(90)90111-M; FERRANTE RJ, 1985, SCIENCE, V230, P561, DOI 10.1126/science.2931802; GREENE JG, 1993, J NEUROCHEM, V61, P1151, DOI 10.1111/j.1471-4159.1993.tb03634.x; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Hackam AS, 1998, J CELL BIOL, V141, P1097, DOI 10.1083/jcb.141.5.1097; Hansson O, 1999, P NATL ACAD SCI USA, V96, P8727, DOI 10.1073/pnas.96.15.8727; Hansson O, 2001, EUR J NEUROSCI, V14, P1492, DOI 10.1046/j.0953-816x.2001.01767.x; HANTRAYE P, 1990, EXP NEUROL, V108, P91, DOI 10.1016/0014-4886(90)90014-J; Harper PS, 1991, HUNTINGTONS DIS; Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HOWE AR, 1995, J NEUROSCI, V15, P458; Kim YJ, 2001, P NATL ACAD SCI USA, V98, P12784, DOI 10.1073/pnas.221451398; Kovacs AD, 2001, EXP NEUROL, V168, P47, DOI 10.1006/exnr.2000.7576; Kuppenbender KD, 1999, J COMP NEUROL, V415, P204; Laforet GA, 2001, J NEUROSCI, V21, P9112, DOI 10.1523/JNEUROSCI.21-23-09112.2001; LANDWEHRMEYER GB, 1995, J NEUROSCI, V15, P5297; Levine MS, 1999, J NEUROSCI RES, V58, P515, DOI 10.1002/(SICI)1097-4547(19991115)58:4<515::AID-JNR5>3.0.CO;2-F; Li H, 2000, NAT GENET, V25, P385, DOI 10.1038/78054; Li SH, 1999, J NEUROSCI, V19, P5159; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Martindale D, 1998, NAT GENET, V18, P150, DOI 10.1038/ng0298-150; MCGEER EG, 1976, NATURE, V263, P517, DOI 10.1038/263517a0; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Ona VO, 1999, NATURE, V399, P263, DOI 10.1038/20446; PorteraCailliau C, 1996, J NEUROCHEM, V66, P692, DOI 10.1046/j.1471-4159.1996.66020692.x; Sanchez I, 1999, NEURON, V22, P623, DOI 10.1016/S0896-6273(00)80716-3; Sapp E, 1999, J NEUROPATH EXP NEUR, V58, P165, DOI 10.1097/00005072-199902000-00006; SATHER W, 1992, J PHYSIOL-LONDON, V450, P643, DOI 10.1113/jphysiol.1992.sp019148; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Sun Y, 2001, J BIOL CHEM, V276, P24713, DOI 10.1074/jbc.M103501200; Thompson CL, 2000, NEUROSCI LETT, V283, P85, DOI 10.1016/S0304-3940(00)00930-7; Tobin AJ, 2000, TRENDS CELL BIOL, V10, P531, DOI 10.1016/S0962-8924(00)01853-5; Trump BF, 1997, TOXICOL PATHOL, V25, P82, DOI 10.1177/019262339702500116; Vallano ML, 1996, J NEUROSCI, V16, P631; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; WANG LY, 1993, SCIENCE, V259, P1173, DOI 10.1126/science.8382377; WANG LY, 1994, J PHYSIOL-LONDON, V475, P431, DOI 10.1113/jphysiol.1994.sp020083; Wellington CL, 2000, J BIOL CHEM, V275, P19831, DOI 10.1074/jbc.M001475200; Wellington CL, 2000, CLIN GENET, V57, P1, DOI 10.1034/j.1399-0004.2000.570101.x; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; YOUNG AB, 1988, SCIENCE, V241, P981, DOI 10.1126/science.2841762; Zeron MM, 2001, MOL CELL NEUROSCI, V17, P41, DOI 10.1006/mcne.2000.0909	64	481	501	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 14	2002	33	6					849	860		10.1016/S0896-6273(02)00615-3	http://dx.doi.org/10.1016/S0896-6273(02)00615-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	530ZK	11906693	Bronze			2022-12-24	WOS:000174389600004
J	Kuhara, A; Inada, H; Katsura, I; Mori, I				Kuhara, A; Inada, H; Katsura, I; Mori, I			Negative regulation and gain control of sensory neurons by the C-elegans calcineurin TAX-6	NEURON			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; NUCLEOTIDE-GATED CHANNEL; GLR-1 GLUTAMATE-RECEPTOR; S-MODULIN; RHODOPSIN PHOSPHORYLATION; CAPSAICIN-RECEPTOR; DEFECTIVE-MUTANTS; ION-CHANNEL; RAT-BRAIN; IN-VIVO	Animals sense and adapt to variable environments by regulating appropriate sensory signal transduction pathways. Here, we show that calcineurin plays a key role in regulating the gain of sensory neuron responsiveness across multiple modalities. C. elegans animals bearing a loss-of-function mutation in TAX-6, a calcineurin A subunit, exhibit pleiotropic abnormalities, including many aberrant sensory behaviors. The tax-6 mutant defect in thermosensation is consistent with hyperactivation of the AFD thermosensory neurons. Conversely, constitutive activation of TAX-6 causes a behavioral phenotype consistent with inactivation of AFD neurons. In olfactory neurons, the impaired olfactory response of tax-6 mutants to an AWC-sensed odorant is caused by hyperadaptation, which is suppressible by a mutation causing defective olfactory adaptation. Taken together, our results suggest that stimulus-evoked calcium entry activates calcineurin, which in turn negatively regulates multiple aspects of sensory signaling.	Nagoya Univ, Japan Sci & Technol Corp, PRESTO, Nagoya, Aichi 4648602, Japan; Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi 4648602, Japan; Natl Inst Genet, Struct Biol Ctr, Mishima, Shizuoka 4118540, Japan	Japan Science & Technology Agency (JST); Nagoya University; Nagoya University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Mori, I (corresponding author), Nagoya Univ, Japan Sci & Technol Corp, PRESTO, Nagoya, Aichi 4648602, Japan.	m46920a@nucc.cc.nagoya-u.ac.jp	Inada, Hitoshi/T-2773-2019; Kuhara, Atsushi/S-5855-2018; Inada, Hitoshi/GQH-1084-2022	Inada, Hitoshi/0000-0002-6121-3830; Kuhara, Atsushi/0000-0003-2994-8658; Inada, Hitoshi/0000-0002-6121-3830				AITKEN A, 1984, EUR J BIOCHEM, V139, P663, DOI 10.1111/j.1432-1033.1984.tb08055.x; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; BLUMENTHAL T, 1995, TRENDS GENET, V11, P132, DOI 10.1016/S0168-9525(00)89026-5; BRENNER S, 1974, GENETICS, V77, P71; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; CHEN J, 1995, SCIENCE, V267, P374, DOI 10.1126/science.7824934; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; COLBERT HA, 1995, NEURON, V14, P803, DOI 10.1016/0896-6273(95)90224-4; Colbert HA, 1997, J NEUROSCI, V17, P8259; Crabtree GR, 1999, CELL, V96, P611, DOI 10.1016/S0092-8674(00)80571-1; CULOTTI JG, 1978, GENETICS, V90, P243; CYERT MS, 1991, P NATL ACAD SCI USA, V88, P7376, DOI 10.1073/pnas.88.16.7376; DUSENBERY DB, 1975, GENETICS, V80, P297; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; GOTO S, 1986, BRAIN RES, V397, P161, DOI 10.1016/0006-8993(86)91381-8; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; HASHIMOTO Y, 1990, J BIOL CHEM, V265, P1924; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; Hobert O, 1997, NEURON, V19, P345, DOI 10.1016/S0896-6273(00)80944-7; Hong CS, 1996, GENETICS, V142, P879; Huang T, 2001, MOL CELL BIOL, V21, P1111, DOI 10.1128/MCB.21.4.1111-1120.2001; ITO A, 1989, BIOCHEM BIOPH RES CO, V163, P1492, DOI 10.1016/0006-291X(89)91148-0; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; KAWAMURA S, 1993, NATURE, V362, P855, DOI 10.1038/362855a0; KAWAMURA S, 1993, J BIOL CHEM, V268, P14579; KINCAID RL, 1990, J BIOL CHEM, V265, P11312; KISSINGER CR, 1995, NATURE, V378, P641, DOI 10.1038/378641a0; KLENCHIN VA, 1995, J BIOL CHEM, V270, P16147, DOI 10.1074/jbc.270.27.16147; Komatsu H, 1999, BRAIN RES, V821, P160, DOI 10.1016/S0006-8993(99)01111-7; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; KUNO T, 1992, J NEUROCHEM, V58, P1643, DOI 10.1111/j.1471-4159.1992.tb10036.x; Lautermilch NJ, 2000, J NEUROSCI, V20, P315, DOI 10.1523/JNEUROSCI.20-01-00315.2000; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; MALENKA RC, 1994, CELL, V78, P535, DOI 10.1016/0092-8674(94)90517-7; Malleret G, 2001, CELL, V104, P675, DOI 10.1016/S0092-8674(01)00264-1; Mansuy IM, 1998, CELL, V92, P39, DOI 10.1016/S0092-8674(00)80897-1; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Mori I, 1999, ANNU REV GENET, V33, P399, DOI 10.1146/annurev.genet.33.1.399; Ogura K, 1997, GENE DEV, V11, P1801, DOI 10.1101/gad.11.14.1801; OHGURO H, 1995, J BIOL CHEM, V270, P14259, DOI 10.1074/jbc.270.24.14259; OKEEFE SJ, 1992, NATURE, V357, P692, DOI 10.1038/357692a0; OKKEMA PG, 1993, GENETICS, V135, P385; Prasad BC, 1998, DEVELOPMENT, V125, P1561; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; Shibasaki F, 1996, NATURE, V382, P370, DOI 10.1038/382370a0; Tachibanaki S, 2000, J BIOL CHEM, V275, P3313, DOI 10.1074/jbc.275.5.3313; Take-uchi M, 1998, P NATL ACAD SCI USA, V95, P11775, DOI 10.1073/pnas.95.20.11775; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; Winder DG, 1998, CELL, V92, P25, DOI 10.1016/S0092-8674(00)80896-X; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384	56	107	118	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 28	2002	33	5					751	763		10.1016/S0896-6273(02)00607-4	http://dx.doi.org/10.1016/S0896-6273(02)00607-4			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	529EC	11879652	Bronze			2022-12-24	WOS:000174286200011
J	Hirbec, H; Francis, JC; Lauri, SE; Braithwaite, SP; Coussen, F; Mulle, C; Dev, KK; Couthino, V; Meyer, G; Isaac, JTR; Collingridge, GL; Henley, JM				Hirbec, H; Francis, JC; Lauri, SE; Braithwaite, SP; Coussen, F; Mulle, C; Dev, KK; Couthino, V; Meyer, G; Isaac, JTR; Collingridge, GL; Henley, JM			Rapid and differential regulation of AMPA and kainate receptors at hippocampal mossy fibre Synapses by PICK1 and GRIP	NEURON			English	Article							LONG-TERM POTENTIATION; KINASE-C-ALPHA; SYNAPTIC ACTIVATION; PDZ DOMAINS; DEPENDENT REGULATION; BINDING-PROTEIN; PHOSPHORYLATION; PSD-95; MODULATION; INTERACTS	We identified four PDZ domain-containing proteins, syntenin, PICK1, GRIP, and PSD95, as interactors with the kainate receptor (KAR) subunits GluR5(2b), GluR5(2c), and GluR6. Of these, we show that both GRIP and PICK1 interactions are required to maintain KAR-mediated synaptic function at mossy fiber-CA3 synapses. In addition, PKCalpha can phosphorylate ct-GluR5(2b) at residues S880 and S886, and PKC activity is required to maintain KAR-mediated synaptic responses. We propose that PICK1 targets PKCalpha to phosphorylate KARs, causing their stabilization at the synapse by an interaction with GRIP. Importantly, this mechanism is not involved in the constitutive recycling of AMPA receptors since blockade of PDZ interactions can simultaneously increase AMPAR- and decrease KAR-mediated synaptic transmission at the same population of synapses.	Univ Bristol, Sch Med Sci, Dept Anat, MRC Ctr Synapt Plast, Bristol BS8 1TD, Avon, England	University of Bristol	Henley, JM (corresponding author), Inst Biol, INSERM, U583, 4 Blvd Henri IV, F-34060 Montpellier, France.	j.m.henley@bris.ac.uk	Hirbec, Helene/ABE-4188-2021; collingridge, graham/AAI-8362-2020; Collingridge, Graham L/C-4605-2015; Lauri, Sari/AAD-6417-2021; Henley, Jeremy M/A-2776-2009	Hirbec, Helene/0000-0002-5593-5255; Collingridge, Graham L/0000-0002-9572-5359; Lauri, Sari/0000-0002-5895-1357; Henley, Jeremy/0000-0003-3589-8335; Dev, Kumlesh/0000-0003-4274-9119; Mulle, Christophe/0000-0003-2709-6615	MRC [G9629038] Funding Source: UKRI; Medical Research Council [G9629038] Funding Source: Medline; Wellcome Trust [059917] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Anderson WW, 2001, J NEUROSCI METH, V108, P71, DOI 10.1016/S0165-0270(01)00374-0; BAHN S, 1994, J NEUROSCI, V14, P5525; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bortolotto ZA, 1999, NATURE, V402, P297, DOI 10.1038/46290; Braithwaite SP, 2000, NEUROPHARMACOLOGY, V39, P919, DOI 10.1016/S0028-3908(99)00171-9; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chetkovich DM, 2002, J NEUROSCI, V22, P5791; Chittajallu R, 1999, TRENDS PHARMACOL SCI, V20, P26, DOI 10.1016/S0165-6147(98)01286-3; Chittajallu R, 1996, NATURE, V379, P78, DOI 10.1038/379078a0; Chung HJ, 2000, J NEUROSCI, V20, P7258; Clarke VRJ, 1997, NATURE, V389, P599, DOI 10.1038/39315; Contractor A, 2000, J NEUROSCI, V20, P8269, DOI 10.1523/JNEUROSCI.20-22-08269.2000; Contractor A, 2001, NEURON, V29, P209, DOI 10.1016/S0896-6273(01)00191-X; Coussen F, 2002, J NEUROSCI, V22, P6426, DOI 10.1523/jneurosci.22-15-06426.2002; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; Dev KK, 1999, NEUROPHARMACOLOGY, V38, P635, DOI 10.1016/S0028-3908(98)00230-5; Dev KK, 2000, J NEUROSCI, V20, P7252; El-Hussein AE, 2000, SCIENCE, V290, P1364; Garcia EP, 1998, NEURON, V21, P727, DOI 10.1016/S0896-6273(00)80590-5; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; GRAY EG, 1962, J ANAT, V96, P79; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; Hanley JG, 2002, NEURON, V34, P53, DOI 10.1016/S0896-6273(02)00638-4; Hirbec H, 2002, J BIOL CHEM, V277, P15221, DOI 10.1074/jbc.C200112200; Kidd FL, 1999, NATURE, V400, P569, DOI 10.1038/23040; Kidd FL, 2002, NEURON, V34, P635, DOI 10.1016/S0896-6273(02)00699-2; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Kim E, 1996, NEUROPHARMACOLOGY, V35, P993, DOI 10.1016/0028-3908(96)00093-7; Koroll M, 2001, J BIOL CHEM, V276, P10646, DOI 10.1074/jbc.M010647200; Lauri SE, 2001, NEURON, V32, P697, DOI 10.1016/S0896-6273(01)00511-6; Lerma J, 2001, PHYSIOL REV, V81, P971, DOI 10.1152/physrev.2001.81.3.971; Li P, 1999, NAT NEUROSCI, V2, P972, DOI 10.1038/14771; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mulle C, 1998, NATURE, V392, P601, DOI 10.1038/33408; Nakajima Y, 1999, J BIOL CHEM, V274, P27573, DOI 10.1074/jbc.274.39.27573; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Perez JL, 2001, J NEUROSCI, V21, P5417, DOI 10.1523/JNEUROSCI.21-15-05417.2001; Ponting CP, 1997, BIOESSAYS, V19, P469, DOI 10.1002/bies.950190606; RAYMOND LA, 1993, NATURE, V361, P637, DOI 10.1038/361637a0; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; Schmitz D, 2000, NEURON, V27, P327, DOI 10.1016/S0896-6273(00)00040-4; Schmitz D, 2001, SCIENCE, V291, P1972, DOI 10.1126/science.1057105; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; Sheng M, 2001, P NATL ACAD SCI USA, V98, P7058, DOI 10.1073/pnas.111146298; STAUDINGER J, 1995, J CELL BIOL, V128, P263, DOI 10.1083/jcb.128.3.263; Staudinger J, 1997, J BIOL CHEM, V272, P32019, DOI 10.1074/jbc.272.51.32019; Tezuka T, 1999, P NATL ACAD SCI USA, V96, P435, DOI 10.1073/pnas.96.2.435; Vignes M, 1997, NEUROPHARMACOLOGY, V36, P1477, DOI 10.1016/S0028-3908(97)00158-5; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; WANG LY, 1993, SCIENCE, V259, P1173, DOI 10.1126/science.8382377; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Zimmermann P, 2001, MOL BIOL CELL, V12, P339, DOI 10.1091/mbc.12.2.339	55	167	175	3	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 20	2003	37	4					625	638		10.1016/S0896-6273(02)01191-1	http://dx.doi.org/10.1016/S0896-6273(02)01191-1			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	648EH	12597860	Green Accepted, Bronze			2022-12-24	WOS:000181136500011
J	Voutsinos-Porche, B; Bonvento, G; Tanaka, K; Steiner, P; Welker, E; Chatton, JY; Magistretti, PJ; Pellerin, L				Voutsinos-Porche, B; Bonvento, G; Tanaka, K; Steiner, P; Welker, E; Chatton, JY; Magistretti, PJ; Pellerin, L			Glial glutamate transporters mediate a functional metabolic crosstalk between neurons and astrocytes in the mouse developing cortex	NEURON			English	Article							ENERGY-METABOLISM; HIPPOCAMPAL ASTROCYTES; GLUCOSE-TRANSPORTER; AEROBIC GLYCOLYSIS; SYNAPTIC EFFICACY; SPINAL-CORD; IN-VITRO; CELLS; BRAIN; MODULATION	Neuron-glia interactions are essential for synaptic function, and glial glutamate (re)uptake plays a key role at glutamatergic synapses. In knockout mice, for either glial glutamate transporters, GLAST or GLT-1 a classical metabolic response to synaptic activation (i.e., enhancement of glucose utilization) is decreased at an early functional stage in the somatosensory barrel cortex following activation of whiskers. Investigation in vitro demonstrates that glial glutamate transport represents a critical step for triggering enhanced glucose utilization, but also lactate release from astrocytes through a mechanism involving changes in intracellular Na+ concentration. These data suggest that a metabolic crosstalk takes place between neurons and astrocytes in the developing cortex, which would be regulated by synaptic activity and mediated by glial glutamate transporters.	Univ Lausanne, Inst Physiol, Lausanne, Switzerland; CNRS, FRE 2363, Paris, France; CEA, Serv Hosp Frederic Joliot, CNRS URA2210, F-91406 Orsay, France; Tokyo Med & Dent Univ, Med Res Inst, Tokyo, Japan; Univ Lausanne, Ecole Polytech Fed Lausanne, Fac Sci Vie, Lausanne, Switzerland; Univ Lausanne, Inst Biol Cellulaire & Morphol, Lausanne, Switzerland	University of Lausanne; Centre National de la Recherche Scientifique (CNRS); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Tokyo Medical & Dental University (TMDU); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; University of Lausanne	Pellerin, L (corresponding author), Univ Lausanne, Inst Physiol, Lausanne, Switzerland.		Pellerin, Luc/A-8912-2017; Bonvento, Gilles/F-6023-2013	Pellerin, Luc/0000-0002-1016-1970; Bonvento, Gilles/0000-0002-2886-4228; Magistretti, Pierre Julius/0000-0002-6678-320X; Chatton, Jean-Yves/0000-0002-8911-0315				Ames A, 2000, BRAIN RES REV, V34, P42, DOI 10.1016/S0165-0173(00)00038-2; [Anonymous], 1893, INT MONATSSCHR ANAT; Araque A, 1998, EUR J NEUROSCI, V10, P2129, DOI 10.1046/j.1460-9568.1998.00221.x; Bergles DE, 1997, NEURON, V19, P1297, DOI 10.1016/S0896-6273(00)80420-1; Bonvento G, 2002, TRENDS NEUROSCI, V25, P359, DOI 10.1016/S0166-2236(02)02168-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chatton JY, 2000, EUR J NEUROSCI, V12, P3843, DOI 10.1046/j.1460-9568.2000.00269.x; Cholet N, 2001, J CEREBR BLOOD F MET, V21, P404, DOI 10.1097/00004647-200104000-00009; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Debernardi R, 1999, BRAIN RES, V850, P39, DOI 10.1016/S0006-8993(99)02022-3; Erzurumlu RS, 2001, TRENDS NEUROSCI, V24, P589, DOI 10.1016/S0166-2236(00)01958-5; Furuta A, 1997, J NEUROSCI, V17, P8363; Gallo V, 2000, TRENDS PHARMACOL SCI, V21, P252, DOI 10.1016/S0165-6147(00)01494-2; Grosche J, 1999, NAT NEUROSCI, V2, P139, DOI 10.1038/5692; Haugeto O, 1996, J BIOL CHEM, V271, P27715, DOI 10.1074/jbc.271.44.27715; Kacem K, 1998, GLIA, V23, P1; KEYNES RD, 1959, J PHYSIOL-LONDON, V147, P626, DOI 10.1113/jphysiol.1959.sp006265; KIM WT, 1994, GLIA, V11, P173, DOI 10.1002/glia.440110211; KIMELBERG HK, 1989, J NEUROSCI, V9, P1141; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu HC, 2001, NEURON, V32, P619, DOI 10.1016/S0896-6273(01)00501-3; Magistretti PJ, 1999, PHILOS T R SOC B, V354, P1155, DOI 10.1098/rstb.1999.0471; Magistretti PJ, 1999, SCIENCE, V283, P496, DOI 10.1126/science.283.5401.496; MELZER P, 1985, BRAIN RES, V348, P229, DOI 10.1016/0006-8993(85)90441-X; MELZER P, 1994, DEV BRAIN RES, V77, P227, DOI 10.1016/0165-3806(94)90199-6; MENDOZA SA, 1980, J CELL PHYSIOL, V105, P153, DOI 10.1002/jcp.1041050117; MORGELLO S, 1995, GLIA, V14, P43, DOI 10.1002/glia.440140107; Newman EA, 1998, J NEUROSCI, V18, P4022; PARKER JC, 1967, J GEN PHYSIOL, V50, P893, DOI 10.1085/jgp.50.4.893; PAUL RJ, 1979, SCIENCE, V206, P1414, DOI 10.1126/science.505014; Pellerin L, 1997, J NEUROCHEM, V69, P2132; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Pfrieger FW, 1997, SCIENCE, V277, P1684, DOI 10.1126/science.277.5332.1684; POITRYYAMATE CL, 1995, J NEUROSCI, V15, P5179; Robitaille R, 1998, NEURON, V21, P847, DOI 10.1016/S0896-6273(00)80600-5; Rose CR, 1996, J NEUROSCI, V16, P5393; Shibata T, 1997, J NEUROSCI, V17, P9212; Sibson NR, 1998, P NATL ACAD SCI USA, V95, P316, DOI 10.1073/pnas.95.1.316; Sibson NR, 2001, J NEUROCHEM, V76, P975, DOI 10.1046/j.1471-4159.2001.00074.x; Stanimirovic DB, 1999, INT J DEV NEUROSCI, V17, P173, DOI 10.1016/S0736-5748(99)00028-3; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; TONG G, 1994, NEURON, V13, P1195, DOI 10.1016/0896-6273(94)90057-4; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Watase K, 1998, EUR J NEUROSCI, V10, P976, DOI 10.1046/j.1460-9568.1998.00108.x; Yamada K, 1998, J NEUROSCI, V18, P5706; YAMADA KA, 1993, J NEUROSCI, V13, P3904; YAROWSKY P, 1986, J NEUROSCI, V6, P859	47	216	227	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 23	2003	37	2					275	286		10.1016/S0896-6273(02)01170-4	http://dx.doi.org/10.1016/S0896-6273(02)01170-4			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	646UX	12546822	Bronze			2022-12-24	WOS:000181054900012
J	Menz, MD; Freeman, RD				Menz, MD; Freeman, RD			Stereoscopic depth processing in the visual cortex: a coarse-to-fine mechanism	NATURE NEUROSCIENCE			English	Article							BINOCULAR DISPARITY; STRIATE CORTEX; COMPLEX CELLS; NEURAL REPRESENTATION; SPATIAL SCALES; CONNECTIVITY; SENSITIVITY; COMPUTATION; DYNAMICS; NEURONS	For binocular animals viewing a three-dimensional scene, the left and right eyes receive slightly different information, and the brain uses this 'binocular disparity' to interpret stereoscopic depth. An important theoretical conjecture in this mechanism is that coarse processing precedes and constrains finely detailed processing. We present three types of neurophysiological data from the cat's visual cortex that are consistent with a temporal coarse-to-fine tuning of disparity information. First, the disparity tuning of cortical cells generally sharpened during the time course of response. Second, cells responsive to large and small spatial scale had relatively shorter and longer temporal latencies, respectively. Third, cross-correlation analysis between simultaneously recorded pairs of cortical cells showed that connections between disparity-tuned neurons were generally stronger for coarse-to-fine processing than for fine-to-coarse processing. These results are consistent with theoretical and behavioral studies and suggest that rapid, coarse percepts are refined over time in stereoscopic depth perception.	Univ Calif Berkeley, Sch Optometry, Grp Vis Sci, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Menz, MD (corresponding author), Smith Kettlewell Eye Res Inst, 2318 Fillmore St, San Francisco, CA 94115 USA.				NATIONAL EYE INSTITUTE [R01EY003716, R01EY001175] Funding Source: NIH RePORTER; NEI NIH HHS [EY01175, EY03716] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AERTSEN AMHJ, 1985, BRAIN RES, V340, P341, DOI 10.1016/0006-8993(85)90931-X; Alonso JM, 1998, NAT NEUROSCI, V1, P395, DOI 10.1038/1609; ANDERSON CH, 1987, P NATL ACAD SCI USA, V84, P6297, DOI 10.1073/pnas.84.17.6297; Anzai A, 1999, J NEUROPHYSIOL, V82, P891, DOI 10.1152/jn.1999.82.2.891; Anzai A, 1999, J NEUROPHYSIOL, V82, P909, DOI 10.1152/jn.1999.82.2.909; Bredfeldt CE, 2002, J NEUROSCI, V22, P1976, DOI 10.1523/JNEUROSCI.22-05-01976.2002; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1091, DOI 10.1152/jn.1993.69.4.1091; Fleet DJ, 1996, VISION RES, V36, P1839, DOI 10.1016/0042-6989(95)00313-4; Li G., 1985, EXPLORING DATA TABLE, P281; MARR D, 1979, PROC R SOC SER B-BIO, V204, P301, DOI 10.1098/rspb.1979.0029; Mazer JA, 2002, P NATL ACAD SCI USA, V99, P1645, DOI 10.1073/pnas.022638499; MOORE GP, 1970, BIOPHYS J, V10, P876, DOI 10.1016/S0006-3495(70)86341-X; NISHIHARA HK, 1984, OPT ENG, V23, P536, DOI 10.1117/12.7973334; NOMURA M, 1993, BIOL CYBERN, V69, P165, DOI 10.1007/BF00226200; Ohzawa I, 1997, J NEUROPHYSIOL, V77, P2879, DOI 10.1152/jn.1997.77.6.2879; OHZAWA I, 1990, SCIENCE, V249, P1037, DOI 10.1126/science.2396096; Pack CC, 2001, NATURE, V409, P1040, DOI 10.1038/35059085; Parker DM, 1997, PERCEPTION, V26, P1169, DOI 10.1068/p261169; PERKEL DH, 1967, BIOPHYS J, V7, P419, DOI 10.1016/S0006-3495(67)86597-4; Press W. H., 1992, ART SCI COMPUTING; Qian N, 1997, VISION RES, V37, P1811, DOI 10.1016/S0042-6989(96)00331-8; Quam L. H., 1987, READINGS COMPUT VIS, P80; Ringach DL, 1997, NATURE, V387, P281, DOI 10.1038/387281a0; ROHALY AM, 1994, VISION RES, V34, P1315, DOI 10.1016/0042-6989(94)90205-4; ROHALY AM, 1993, J OPT SOC AM A, V10, P2433, DOI 10.1364/JOSAA.10.002433; SANGER TD, 1988, BIOL CYBERN, V59, P405, DOI 10.1007/BF00336114; SMALLMAN HS, 1995, VISION RES, V35, P1047, DOI 10.1016/0042-6989(94)00197-T; Smallman HS, 1997, PERCEPTION, V26, P977, DOI 10.1068/p260977; Wheatstone C., 1838, PHILOS T ROY SOC LON, P371, DOI DOI 10.1098/RSTL.1838.0019; WILSON HR, 1991, J OPT SOC AM A, V8, P229, DOI 10.1364/JOSAA.8.000229	30	85	85	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2003	6	1					59	65		10.1038/nn986	http://dx.doi.org/10.1038/nn986			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	630CE	12469131				2022-12-24	WOS:000180089300016
J	Eto, M; Bock, R; Brautigan, DL; Linden, DJ				Eto, M; Bock, R; Brautigan, DL; Linden, DJ			Cerebellar long-term synaptic depression requires PKC-mediated activation of CPI-17, a myosin/moesin phosphatase inhibitor	NEURON			English	Article							PROTEIN-KINASE-C; MYOSIN-BINDING SUBUNIT; RHO-ASSOCIATED KINASE; PURKINJE-CELLS; GLUTAMATE SENSITIVITY; MESSENGER-RNA; SMOOTH-MUSCLE; LATE-PHASE; RAT-BRAIN; PHOSPHORYLATION	Cerebellar LTD requires brief activation of PKC and is expressed as a functional downregulation of AMPA receptors. Modulation of vascular smooth-muscle contraction by G protein-coupled receptors (called Ca2+ sensitization) also involves PKC phosphorylation and activation of a specific inhibitor of myosin/moesin phosphatase (MMP). This inhibitor, called CPI-17, is also expressed in brain. Here, we tested the hypothesis that LTD, like Ca2+ sensitization, employs a PKC/CPI-17 cascade. Introduction of activated recombinant CPI-17 into cells produced a use-dependent attenuation of glutamate-evoked responses and occluded subsequent LTD. Moreover, the requirement for endogenous CPI-17 in LTD was demonstrated with neutralizing antibodies plus gene silencing by siRNA. These interventions had no effect on basal synaptic strength but blocked LTD induction. Thus, a biochemical circuit that involves PKC-mediated activation of CPI-17 modulates the distinct physiological processes of vascular contractility and cerebellar LTD.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Univ Virginia, Sch Med, Ctr Cell Signaling, Charlottesville, VA 22908 USA	Johns Hopkins University; University of Virginia	Linden, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	dlinden@jhmi.edu	Bock, Roland/G-2982-2016; Eto, Masumi/ABE-4700-2020	Bock, Roland/0000-0002-8654-1080; Eto, Masumi/0000-0002-0651-5836	NCI NIH HHS [CA40024] Funding Source: Medline; NIGMS NIH HHS [GM56362] Funding Source: Medline; NIMH NIH HHS [MH01590, MH51106] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056362] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH051106, R01MH051106, R29MH051106] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ABE H, 1992, MOL BRAIN RES, V13, P283, DOI 10.1016/0169-328X(92)90211-S; Ahn S, 1999, NEURON, V23, P559, DOI 10.1016/S0896-6273(00)80808-9; AJIMA A, 1995, NEUROREPORT, V6, P297, DOI 10.1097/00001756-199501000-00018; Bahl R, 2001, MOL BRAIN RES, V90, P101, DOI 10.1016/S0169-328X(01)00089-4; Bear MF, 2001, SYNAPSES, P455; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; Blitzer RD, 1995, NEURON, V15, P1403, DOI 10.1016/0896-6273(95)90018-7; Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; CHEN MX, 1994, EMBO J, V13, P4278, DOI 10.1002/j.1460-2075.1994.tb06748.x; Chung HJ, 2000, J NEUROSCI, V20, P7258; CREPEL F, 1988, BRAIN RES, V458, P397, DOI 10.1016/0006-8993(88)90486-6; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Eto M, 1999, BIOCHEMISTRY-US, V38, P16952, DOI 10.1021/bi992030o; Eto M, 1997, FEBS LETT, V410, P356, DOI 10.1016/S0014-5793(97)00657-1; ETO M, 1995, J BIOCHEM, V118, P1104, DOI 10.1093/oxfordjournals.jbchem.a124993; Eto M, 2001, J BIOL CHEM, V276, P29072, DOI 10.1074/jbc.M103206200; Eto M, 2000, CELL MOTIL CYTOSKEL, V46, P222, DOI 10.1002/1097-0169(200007)46:3<222::AID-CM6>3.3.CO;2-2; Freeman JH, 1998, NEUROREPORT, V9, P2237, DOI 10.1097/00001756-199807130-00016; Fukata Y, 1998, J CELL BIOL, V141, P409, DOI 10.1083/jcb.141.2.409; Hammond SM, 2001, NAT REV GENET, V2, P110, DOI 10.1038/35052556; Hansel C, 2001, NAT NEUROSCI, V4, P467, DOI 10.1038/87419; HARTELL NA, 1994, NEUROREPORT, V5, P833, DOI 10.1097/00001756-199403000-00024; HASHIKAWA T, 1995, NEUROSCI RES, V22, P133, DOI 10.1016/0168-0102(95)00886-X; Hayashi Y, 2001, J BIOL CHEM, V276, P39858, DOI 10.1074/jbc.M107302200; HEMART N, 1995, EUR J NEUROSCI, V7, P45, DOI 10.1111/j.1460-9568.1995.tb01019.x; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; KANO M, 1987, NATURE, V325, P276, DOI 10.1038/325276a0; Kasahara J, 1998, NEUROSCI LETT, V247, P139, DOI 10.1016/S0304-3940(98)00299-7; Kimura K, 1998, J BIOL CHEM, V273, P5542, DOI 10.1074/jbc.273.10.5542; KINCAID RL, 1987, P NATL ACAD SCI USA, V84, P1118, DOI 10.1073/pnas.84.4.1118; Kitazawa T, 1999, J PHYSIOL-LONDON, V520, P139, DOI 10.1111/j.1469-7793.1999.00139.x; Kitazawa T, 2000, J BIOL CHEM, V275, P9897, DOI 10.1074/jbc.275.14.9897; KONNERTH A, 1992, P NATL ACAD SCI USA, V89, P7051, DOI 10.1073/pnas.89.15.7051; LI YM, 1993, BIOCHEM PHARMACOL, V46, P1435, DOI 10.1016/0006-2952(93)90109-A; Linden D J, 1994, Learn Mem, V1, P121; LINDEN DJ, 1993, NEURON, V11, P1093, DOI 10.1016/0896-6273(93)90222-D; LINDEN DJ, 1991, SCIENCE, V254, P1656, DOI 10.1126/science.1721243; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; Linden DJ, 2001, P NATL ACAD SCI USA, V98, P14066, DOI 10.1073/pnas.241384598; Linden DJ, 1996, NEURON, V17, P483, DOI 10.1016/S0896-6273(00)80180-4; Linden DJ, 1997, NEURON, V18, P983, DOI 10.1016/S0896-6273(00)80337-2; Linden DJ, 1999, J NEUROSCI, V19, P10221; Liu QR, 2002, J BIOL CHEM, V277, P13312, DOI 10.1074/jbc.M107558200; Matsuda S, 1999, J NEUROCHEM, V73, P1765, DOI 10.1046/j.1471-4159.1999.731765.x; Matsumoto M, 2000, INORG REACT MECH, V2, P19; Morishita W, 2001, NEURON, V32, P1133, DOI 10.1016/S0896-6273(01)00554-2; Narasimhan K, 1996, NEURON, V17, P333, DOI 10.1016/S0896-6273(00)80164-6; Ohki SY, 2001, J MOL BIOL, V314, P839, DOI 10.1006/jmbi.2001.5200; SAKAGAMI H, 1994, MOL BRAIN RES, V25, P7, DOI 10.1016/0169-328X(94)90273-9; Sansom SC, 1997, J BIOL CHEM, V272, P9902; Senba S, 1999, J BIOCHEM-TOKYO, V125, P354, DOI 10.1093/oxfordjournals.jbchem.a022294; SHIGEMOTO R, 1994, NEURON, V12, P1245, DOI 10.1016/0896-6273(94)90441-3; Skinner JA, 2001, BIOCHEM J, V356, P257, DOI 10.1042/0264-6021:3560257; Strasser G, 1998, PHYSICA E, V2, P515, DOI 10.1016/S1386-9477(98)00106-4; Tan I, 2001, J BIOL CHEM, V276, P21209, DOI 10.1074/jbc.M102615200; Usuda N, 1996, J HISTOCHEM CYTOCHEM, V44, P13, DOI 10.1177/44.1.8543776; Walsh AH, 1997, FEBS LETT, V416, P230, DOI 10.1016/S0014-5793(97)01210-6; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Woodsome TP, 2001, J PHYSIOL-LONDON, V535, P553, DOI 10.1111/j.1469-7793.2001.t01-1-00553.x; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8	62	74	75	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 19	2002	36	6					1145	1158		10.1016/S0896-6273(02)01107-8	http://dx.doi.org/10.1016/S0896-6273(02)01107-8			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	628TA	12495628	Bronze			2022-12-24	WOS:000180011600016
J	Baccus, SA; Meister, M				Baccus, SA; Meister, M			Fast and slow contrast adaptation in retinal circuitry	NEURON			English	Article							WHITE-NOISE ANALYSIS; TEMPORAL CONTRAST; GAIN-CONTROL; AMACRINE CELLS; BIPOLAR CELLS; SIGNALS; SENSITIVITY; MECHANISMS; DISCHARGE; SYNAPSES	The visual system adapts to the magnitude of intensity fluctuations, and this process begins in the retina. Following the switch from a low-contrast environment to one of high contrast, ganglion cell sensitivity declines in two distinct phases: a fast change occurs in <0.1 s, and a slow decrease over similar to 10 s. To examine where these modulations arise, we recorded intracellularly from every major cell type in the salamander retina. Certain bipolar and amacrine cells, and all ganglion cells, adapted to contrast. Generally, these neurons showed both fast and slow adaptation. Fast effects of a contrast increase included accelerated kinetics, decreased sensitivity, and a depolarization of the baseline membrane potential. Slow adaptation did not affect kinetics, but produced a gradual hyperpolarization. This hyperpolarization can account for slow adaptation in the spiking output of ganglion cells.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Baccus, SA (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 16 Divin Ave, Cambridge, MA 02138 USA.	baccus@fas.harvard.edu		Meister, Markus/0000-0003-2136-6506				BARLOW HB, 1969, J PHYSIOL-LONDON, V202, P699, DOI 10.1113/jphysiol.1969.sp008836; BAYLOR DA, 1971, J PHYSIOL-LONDON, V214, P265, DOI 10.1113/jphysiol.1971.sp009432; Berry MJ, 1997, P NATL ACAD SCI USA, V94, P5411, DOI 10.1073/pnas.94.10.5411; Berry MJ, 1998, J NEUROSCI, V18, P2200; Berry MJ, 1999, NATURE, V398, P334, DOI 10.1038/18678; BLAKEMORE C, 1969, J PHYSIOL-LONDON, V203, P237, DOI 10.1113/jphysiol.1969.sp008862; Brown SP, 2001, NAT NEUROSCI, V4, P44, DOI 10.1038/82888; Burrone J, 1997, J PHYSIOL-LONDON, V505, P571, DOI 10.1111/j.1469-7793.1997.571ba.x; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; Chander D, 2001, J NEUROSCI, V21, P9904, DOI 10.1523/JNEUROSCI.21-24-09904.2001; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; DeWeese M, 1998, NEURAL COMPUT, V10, P1179, DOI 10.1162/089976698300017403; ENROTHCUGELL C, 1975, J PHYSIOL-LONDON, V247, P551, DOI 10.1113/jphysiol.1975.sp010947; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; GREENLEE MW, 1991, VISION RES, V31, P223, DOI 10.1016/0042-6989(91)90113-J; Harris RA, 2000, NEURON, V28, P595, DOI 10.1016/S0896-6273(00)00136-7; HUNTER IW, 1986, BIOL CYBERN, V55, P135; KANEKO A, 1985, J PHYSIOL-LONDON, V358, P131, DOI 10.1113/jphysiol.1985.sp015544; Keat J, 2001, NEURON, V30, P803, DOI 10.1016/S0896-6273(01)00322-1; Kim KJ, 2001, J NEUROSCI, V21, P287, DOI 10.1523/JNEUROSCI.21-01-00287.2001; Macneil MA, 1999, J COMP NEUROL, V413, P305; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; OHZAWA I, 1985, J NEUROPHYSIOL, V54, P651, DOI 10.1152/jn.1985.54.3.651; Pugh EN, 1999, CURR OPIN NEUROBIOL, V9, P410, DOI 10.1016/S0959-4388(99)80062-2; Rieke F, 2001, J NEUROSCI, V21, P9445, DOI 10.1523/JNEUROSCI.21-23-09445.2001; SAKAI HM, 1987, J NEUROPHYSIOL, V58, P1329, DOI 10.1152/jn.1987.58.6.1329; SAKAI HM, 1988, VISUAL NEUROSCI, V1, P287, DOI 10.1017/S0952523800001942; SAKAI HM, 1995, J GEN PHYSIOL, V105, P815, DOI 10.1085/jgp.105.6.815; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4286; SHAPLEY RM, 1978, J PHYSIOL-LONDON, V285, P275, DOI 10.1113/jphysiol.1978.sp012571; SMIMAKIS SM, 1997, NATURE, V386, P69; Truchard AM, 2000, J NEUROSCI, V20, P3017; VICTOR JD, 1987, J PHYSIOL-LONDON, V386, P219, DOI 10.1113/jphysiol.1987.sp016531; Warland DK, 1997, J NEUROPHYSIOL, V78, P2336, DOI 10.1152/jn.1997.78.5.2336; Wu SM, 2000, J NEUROSCI, V20, P4462, DOI 10.1523/JNEUROSCI.20-12-04462.2000; YANG CY, 1991, J COMP NEUROL, V312, P19, DOI 10.1002/cne.903120103; Yang J, 1999, VISION RES, V39, P4045, DOI 10.1016/S0042-6989(99)00116-9; Yang XL, 1996, J NEUROPHYSIOL, V76, P3863, DOI 10.1152/jn.1996.76.6.3863	38	358	365	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 5	2002	36	5					909	919		10.1016/S0896-6273(02)01050-4	http://dx.doi.org/10.1016/S0896-6273(02)01050-4			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	622VL	12467594	Bronze			2022-12-24	WOS:000179667800015
J	Godenschwege, TA; Hu, HL; Shan-Crofts, X; Goodman, CS; Murphey, RK				Godenschwege, TA; Hu, HL; Shan-Crofts, X; Goodman, CS; Murphey, RK			Bi-directional signaling by Semaphorin 1a during central synapse formation in Drosophila	NATURE NEUROSCIENCE			English	Article							GIANT-FIBER SYSTEM; OUTGROWTH-RELATED PROTEIN; ABL TYROSINE KINASE; TRANSMEMBRANE SEMAPHORIN; NEURITE-OUTGROWTH; HUMAN CD100; SYNAPTOGENESIS; EXPRESSION; MUTATIONS; INTERACTS	Semaphorins have been intensively studied for their role in dendritic and axonal pathfinding, but less is known about their potential role in synapse formation. In the adult giant fiber (GF) system of fruit flies (Drosophila melanogaster), we show that transmembrane Semaphorin 1a (Sema-1a) is involved in synapse formation in addition to its role in guidance during pathfinding. Cell-autonomous rescue experiments showed that Sema-1a is involved in assembly of a central synapse and that it is required both pre- and postsynaptically. We also found that pre- but not postsynaptic gain-of-function Sema-la was able to disrupt the GF-motor neuron synapse and that the phenotype depended on a proline-rich intracellular domain that contains a putative Enabled binding site. We suggest that transmembrane Sema-1a is part of a bi-directional signaling system that leads to the formation of the GF synapse and possibly acts as both a ligand and a receptor.	Univ Massachusetts, Dept Biol, Morrill Sci Ctr, Amherst, MA 01003 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of Massachusetts System; University of Massachusetts Amherst; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Murphey, RK (corresponding author), Univ Massachusetts, Dept Biol, Morrill Sci Ctr, Amherst, MA 01003 USA.	rmurphey@bio.umass.edu	Godenschwege, Tanja A/A-2830-2010	Godenschwege, Tanja A/0000-0003-3322-4134; Hu, Hailan/0000-0002-0425-5057	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044609] Funding Source: NIH RePORTER; NINDS NIH HHS [NS44609] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allen MJ, 1999, J NEUROSCI, V19, P9374; Allen MJ, 2000, MOL CELL NEUROSCI, V16, P754, DOI 10.1006/mcne.2000.0903; Allen MJ, 1998, J COMP NEUROL, V397, P519, DOI 10.1002/(SICI)1096-9861(19980810)397:4<519::AID-CNE5>3.0.CO;2-4; BAINBRIDGE SP, 1981, J EMBRYOL EXP MORPH, V66, P57; Billard C, 2000, BLOOD, V95, P965, DOI 10.1182/blood.V95.3.965.003k39_965_972; Blagburn JM, 1999, J COMP NEUROL, V404, P449; Eckhardt F, 1997, MOL CELL NEUROSCI, V9, P409, DOI 10.1006/mcne.1997.0644; GERTLER FB, 1995, GENE DEV, V9, P521, DOI 10.1101/gad.9.5.521; Godenschwege TA, 2002, J NEUROSCI, V22, P3117, DOI 10.1523/JNEUROSCI.22-08-03117.2002; Hall KT, 1996, P NATL ACAD SCI USA, V93, P11780, DOI 10.1073/pnas.93.21.11780; Harris BZ, 2001, J CELL SCI, V114, P3219; HARRIS WA, 1987, DEVELOPMENT, V101, P123; He Zhigang, 2002, Sci STKE, V2002, pre1, DOI 10.1126/stke.2002.119.re1; Herold C, 1996, J IMMUNOL, V157, P5262; Inagaki S, 2001, J BIOL CHEM, V276, P9174, DOI 10.1074/jbc.M009051200; Jacobs K, 2000, DEVELOPMENT, V127, P5203; KING DG, 1980, J NEUROCYTOL, V9, P753, DOI 10.1007/BF01205017; Klostermann A, 2000, J BIOL CHEM, V275, P39647, DOI 10.1074/jbc.M006316200; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Lanier LM, 2000, CURR OPIN NEUROBIOL, V10, P80, DOI 10.1016/S0959-4388(99)00058-6; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Ohoka Y, 2001, BIOCHEM BIOPH RES CO, V280, P237, DOI 10.1006/bbrc.2000.4080; Phelan P, 1996, J NEUROSCI, V16, P1101; Prehoda KE, 1999, CELL, V97, P471, DOI 10.1016/S0092-8674(00)80757-6; Raper JA, 2000, CURR OPIN NEUROBIOL, V10, P88, DOI 10.1016/S0959-4388(99)00057-4; Schultze W, 2001, J NEUROCHEM, V78, P482, DOI 10.1046/j.1471-4159.2001.00447.x; Shinozaki K, 1999, MOL BRAIN RES, V71, P364, DOI 10.1016/S0169-328X(99)00181-3; TANOUYE MA, 1980, J NEUROPHYSIOL, V44, P405, DOI 10.1152/jn.1980.44.2.405; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tomita S, 2001, J CELL BIOL, V153, pF19, DOI 10.1083/jcb.153.5.F19; Yu HH, 1999, NEURON, V22, P11, DOI 10.1016/S0896-6273(00)80672-8; Yu HH, 1998, NEURON, V20, P207, DOI 10.1016/S0896-6273(00)80450-X; Yu HH, 2000, GENETICS, V156, P723	33	100	100	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2002	5	12					1294	1301		10.1038/nn976	http://dx.doi.org/10.1038/nn976			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	618ZE	12436113				2022-12-24	WOS:000179447500012
J	Suzuki, R; Morcuende, S; Webber, M; Hunt, SP; Dickenson, AH				Suzuki, R; Morcuende, S; Webber, M; Hunt, SP; Dickenson, AH			Superficial NK1-expressing neurons control spinal excitability through activation of descending pathways	NATURE NEUROSCIENCE			English	Article							SUBSTANCE-P RECEPTOR; NOXIOUS INHIBITORY CONTROLS; CENTRAL-NERVOUS-SYSTEM; LAMINA I NEURONS; PAIN-CONTROL; DORSAL-HORN; 5-HT3 RECEPTORS; NEUROKININ-1 RECEPTOR; PROJECTION NEURONS; RAT	The increase in pain sensitivity that follows injury is regulated by superficially located projection neurons in the dorsal horn of the spinal cord that express the neurokinin-1 (NK1) receptor. After selective ablation of these neurons in rats, we identified changes in receptive field size, mechanical and thermal coding and central sensitization of deeper dorsal horn neurons that are important for both pain sensations and reflexes. We were able to reproduce these changes by pharmacological block of descending serotonergic facilitatory pathways. Using Fos histochemistry, we found changes in the activation of serotonergic neurons in the brainstem as well as evidence for a loss of descending control of spinal excitability. We conclude that NK1-positive spinal projection neurons, activated by primary afferent input, project to higher brain areas that control spinal excitability- and therefore pain sensitivity-primarily through descending pathways from the brainstem.	UCL, Dept Pharmacol, London WC1E 6BT, England; UCL, Dept Anat & Dev Biol, London WC1E 6BT, England	University of London; University College London; University of London; University College London	Suzuki, R (corresponding author), UCL, Dept Pharmacol, Gower St, London WC1E 6BT, England.	ucklrsu@ucl.ac.uk	Morcuende, Sara/G-8672-2015; HUNT, STEPHEN P/C-1646-2008	Morcuende, Sara/0000-0003-1471-7005; Hunt, Stephen/0000-0001-9453-5505				Ali Z, 1996, NEUROSCI LETT, V208, P203, DOI 10.1016/0304-3940(95)12600-7; BASBAUM AI, 1978, ANN NEUROL, V4, P451, DOI 10.1002/ana.410040511; Bernard JF, 1998, J COMP NEUROL, V401, P429; Bernard JF, 1996, PROG BRAIN RES, V107, P243; Bester H, 2001, J NEUROSCI, V21, P1039, DOI 10.1523/JNEUROSCI.21-03-01039.2001; BOUHASSIRA D, 1992, BRAIN RES, V595, P353, DOI 10.1016/0006-8993(92)91071-L; BOWKER RM, 1983, BRAIN RES, V288, P33, DOI 10.1016/0006-8993(83)90079-3; Cheunsuang O, 2000, NEUROSCIENCE, V97, P335, DOI 10.1016/S0306-4522(00)00035-X; Chung F, 1999, EUR J ANAESTH, V16, P669, DOI 10.1046/j.1365-2346.1999.00547.x; Cui M, 1999, J PHARMACOL EXP THER, V289, P868; DEEGAN R, 1992, AM J MED SCI, V304, P373, DOI 10.1097/00000441-199212000-00009; DICKENSON AH, 1995, BRIT J ANAESTH, V75, P193, DOI 10.1093/bja/75.2.193; DING YQ, 1995, BRAIN RES, V674, P336, DOI 10.1016/0006-8993(95)00022-I; DUBNER R, 1999, PAIN S, V6, pS27; Gauriau C, 2002, EXP PHYSIOL, V87, P251, DOI 10.1113/eph8702357; Green GM, 2000, PAIN, V89, P81, DOI 10.1016/S0304-3959(00)00346-8; Herrero JF, 2000, PROG NEUROBIOL, V61, P169, DOI 10.1016/S0301-0082(99)00051-9; Hunt SP, 2001, NAT REV NEUROSCI, V2, P83, DOI 10.1038/35053509; Hunt SP, 2000, TRENDS PHARMACOL SCI, V21, P284, DOI 10.1016/S0165-6147(00)01496-6; Janusonis S, 2001, J COMP NEUROL, V440, P31, DOI 10.1002/cne.1368; KIA HK, 1995, NEUROREPORT, V6, P257, DOI 10.1097/00001756-199501000-00008; KIDD EJ, 1993, BRAIN RES, V612, P289, DOI 10.1016/0006-8993(93)91674-H; Laporte AM, 1996, J CHEM NEUROANAT, V11, P67, DOI 10.1016/0891-0618(96)00130-5; LIGHT AR, 1993, SOMATOSENS MOT RES, V10, P309, DOI 10.3109/08990229309028840; Lima D, 2002, PROG NEUROBIOL, V66, P81, DOI 10.1016/S0301-0082(01)00025-9; Mantyh PW, 1997, SCIENCE, V278, P275, DOI 10.1126/science.278.5336.275; Marshall GE, 1996, NEUROSCIENCE, V72, P255, DOI 10.1016/0306-4522(95)00558-7; Mason P, 1997, J NEUROPHYSIOL, V77, P1087, DOI 10.1152/jn.1997.77.3.1087; McLeod AL, 1998, P NATL ACAD SCI USA, V95, P15775, DOI 10.1073/pnas.95.26.15775; Miquel MC, 2002, EUR J NEUROSCI, V15, P449, DOI 10.1046/j.0953-816x.2001.01872.x; Nichols ML, 1999, SCIENCE, V286, P1558, DOI 10.1126/science.286.5444.1558; Oyama T, 1996, NEUROSCI RES, V25, P129; Polgar E, 2002, NEUROSCIENCE, V109, P799, DOI 10.1016/S0306-4522(01)00304-9; Roila F, 1997, EUR J CANCER, V33, P1364, DOI 10.1016/S0959-8049(97)00003-8; Satoh O, 1996, BRAIN RES, V728, P27, DOI 10.1016/0006-8993(96)00371-x; SCHOUENBORG J, 1985, BRAIN RES, V328, P23, DOI 10.1016/0006-8993(85)91318-6; Suzuki R, 2000, EXP NEUROL, V163, P408, DOI 10.1006/exnr.2000.7371; TECOTT LH, 1993, P NATL ACAD SCI USA, V90, P1430, DOI 10.1073/pnas.90.4.1430; THOMPSON SWN, 1990, EUR J NEUROSCI, V2, P638, DOI 10.1111/j.1460-9568.1990.tb00453.x; Todd AJ, 2000, EUR J NEUROSCI, V12, P689, DOI 10.1046/j.1460-9568.2000.00950.x; Todd AJ, 2002, J NEUROSCI, V22, P4103, DOI 10.1523/JNEUROSCI.22-10-04103.2002; URBAN M, 1999, P NATL ACAD SCI USA, V95, P2630; Villanueva Luis, 1995, Biological Research, V28, P113; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Yu XH, 1999, J NEUROSCI, V19, P3545; Zeitz KP, 2002, J NEUROSCI, V22, P1010, DOI 10.1523/JNEUROSCI.22-03-01010.2002; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	47	319	333	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2002	5	12					1319	1326		10.1038/nn966	http://dx.doi.org/10.1038/nn966			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	618ZE	12402039				2022-12-24	WOS:000179447500015
J	Milekic, MH; Alberini, CM				Milekic, MH; Alberini, CM			Temporally graded requirement for protein synthesis following memory reactivation	NEURON			English	Article							AVOIDANCE-RESPONSE; RETROGRADE-AMNESIA; CONSOLIDATION; HIPPOCAMPAL; RETRIEVAL; FEAR; RECONSOLIDATION; EXTINCTION; STORAGE	Learning of new information is transformed into long-lasting memory through a process known as consolidation, which requires protein synthesis. Classical theory held that once consolidated, memory was insensitive to disruption. However, old memories that are insensitive to protein synthesis inhibitors can become vulnerable if they are recalled (reactivated). These findings led to a new hypothesis that when an old memory is reactivated, it again becomes labile and, similar to a newly formed memory, requires a process of reconsolidation in order to be maintained. Here, we show that the requirement for protein synthesis of a reactivated memory is evident only when the memory is recent. In fact, memory vulnerability decreases as the time between the original training and the recall increases.	Mt Sinai Sch Med, Dept Physiol & Biophys, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Alberini, CM (corresponding author), Mt Sinai Sch Med, Dept Physiol & Biophys, New York, NY 10029 USA.	cristina.alberini@mssm.edu			NIMH NIH HHS [MH 65635] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065635] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Andersen P, 1998, BRAIN RES REV, V26, P353, DOI 10.1016/S0165-0173(97)00042-8; Anokhin KV, 2002, EUR J NEUROSCI, V15, P1759, DOI 10.1046/j.1460-9568.2002.02023.x; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Berman DE, 2001, SCIENCE, V291, P2417, DOI 10.1126/science.1058165; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; DAVIS HP, 1980, BEHAV NEURAL BIOL, V28, P99, DOI 10.1016/S0163-1047(80)93202-1; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fendt M, 1999, NEUROSCI BIOBEHAV R, V23, P743, DOI 10.1016/S0149-7634(99)00016-0; Freeman JH, 1999, NEUROBIOL LEARN MEM, V72, P259, DOI 10.1006/nlme.1998.3896; Geinisman Y, 2001, J NEUROSCI, V21, P5568, DOI 10.1523/JNEUROSCI.21-15-05568.2001; Gold P.E, 1975, SHORT TERM MEMORY, P335; JUDGE ME, 1982, PHYSIOL BEHAV, V28, P585, DOI 10.1016/0031-9384(82)90034-8; Kida S, 2002, NAT NEUROSCI, V5, P348, DOI 10.1038/nn819; LEWIS DJ, 1979, PSYCHOL BULL, V86, P1054, DOI 10.1037/0033-2909.86.5.1054; LIANG KC, 1982, BEHAV BRAIN RES, V4, P237, DOI 10.1016/0166-4328(82)90002-X; Lorenzini CGA, 1999, NEUROBIOL LEARN MEM, V71, P1; MACTUTUS CF, 1979, SCIENCE, V204, P1319, DOI 10.1126/science.572083; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; MISANIN JR, 1968, SCIENCE, V160, P554, DOI 10.1126/science.160.3827.554; MUNOZ C, 1981, BRAIN RES BULL, V6, P399, DOI 10.1016/S0361-9230(81)80010-X; Nadel L, 2000, NAT REV NEUROSCI, V1, P209, DOI 10.1038/35044572; Nader K, 2000, NAT REV NEUROSCI, V1, P216, DOI 10.1038/35044580; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; O'Malley A, 2000, NEUROSCIENCE, V99, P229, DOI 10.1016/S0306-4522(00)00182-2; RICHARDSON R, 1982, PHYSIOL PSYCHOL, V10, P384; Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; Sutherland GR, 2000, CURR OPIN NEUROBIOL, V10, P180, DOI 10.1016/S0959-4388(00)00079-9; Taubenfeld SM, 2001, NAT NEUROSCI, V4, P813, DOI 10.1038/90520; Vianna MRM, 2001, P NATL ACAD SCI USA, V98, P12251, DOI 10.1073/pnas.211433298	31	348	355	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 24	2002	36	3					521	525		10.1016/S0896-6273(02)00976-5	http://dx.doi.org/10.1016/S0896-6273(02)00976-5			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	608ZE	12408853	Bronze			2022-12-24	WOS:000178877700019
J	Suzuki, S; Grabowecky, M				Suzuki, S; Grabowecky, M			Evidence for perceptual "trapping" and adaptation in multistable binocular rivalry	NEURON			English	Article							MONKEY INFEROTEMPORAL CORTEX; MOTION PERCEPTION; VISUAL-CORTEX; REAL IMAGES; OBJECT; RESPONSES; NEURONS; VISION; SHAPE; ORIENTATION	When a different pattern is presented to each eye, the perceived image spontaneously alternates between the two patterns (binocular rivalry); the dynamics of these bistable alternations are known to be stochastic. Examining multistable binocular rivalry (involving four dominant percepts), we demonstrated path dependence and on-line adaptation, which were equivalent whether perceived patterns were formed by single-eye dominance or by mixed-eye dominance. The spontaneous perceptual transitions tended to get trapped within a pair of related global patterns (e.g., opponent shapes and symmetric patterns), and during such trapping, the probability of returning to the repeatedly experienced patterns gradually decreased (postselection pattern adaptation). These results suggest that the structure of global shape coding and its adaptation play a critical role in directing spontaneous alternations of visual awareness in perceptual multistability.	Northwestern Univ, Dept Psychol, Evanston, IL 60208 USA	Northwestern University	Suzuki, S (corresponding author), Northwestern Univ, Dept Psychol, 2029 Sheridan Rd, Evanston, IL 60208 USA.	satoru@northwestern.edu						ATTNEAVE F, 1971, SCI AM, V225, P62, DOI 10.1038/scientificamerican1271-62; BLAKE R, 1980, PERCEPTION, V9, P223, DOI 10.1068/p090223; BLAKE R, 1989, PSYCHOL REV, V96, P145, DOI 10.1037/0033-295X.96.1.145; BLAKE R, 1992, VISUAL NEUROSCI, V8, P469, DOI 10.1017/S0952523800004971; BLAKE R, 1990, PERCEPT PSYCHOPHYS, V48, P593, DOI 10.3758/BF03211605; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; Blake R, 1998, J COGNITIVE NEUROSCI, V10, P46, DOI 10.1162/089892998563770; BLAKE R, 1974, VISION RES, V14, P687, DOI 10.1016/0042-6989(74)90065-0; BLAKE RR, 1971, J EXP PSYCHOL, V88, P327, DOI 10.1037/h0030877; Bonneh Y, 2001, VISION RES, V41, P981, DOI 10.1016/S0042-6989(01)00013-X; Bonneh Y, 1999, VISION RES, V39, P271, DOI 10.1016/S0042-6989(98)00112-6; BORSELLINO A, 1972, KYBERNETIK, V10, P139, DOI 10.1007/BF00290512; CAVANAGH P, 1992, SCIENCE, V257, P1563, DOI 10.1126/science.1523411; COGAN R, 1973, J GEN PSYCHOL, V89, P297, DOI 10.1080/00221309.1973.9710832; COGAN R, 1972, PERCEPT MOTOR SKILL, V35, P569, DOI 10.2466/pms.1972.35.2.569; DIAZCANEJA E, 1928, PHILOS T R SOC LON B, V353, P1801; FOX R, 1967, PERCEPT PSYCHOPHYS, V2, P432, DOI 10.3758/BF03208783; FUJITA I, 1992, NATURE, V360, P343, DOI 10.1038/360343a0; HASSELMO ME, 1989, BEHAV BRAIN RES, V32, P203, DOI 10.1016/S0166-4328(89)80054-3; Hikosaka K, 1999, BEHAV BRAIN RES, V100, P67, DOI 10.1016/S0166-4328(98)00114-4; ITO M, 1995, J NEUROPHYSIOL, V73, P218, DOI 10.1152/jn.1995.73.1.218; Kovacs I, 1996, P NATL ACAD SCI USA, V93, P15508, DOI 10.1073/pnas.93.26.15508; Lack L.C., 1978, SELECTIVE ATTENTION; LACK LC, 1974, PERCEPT PSYCHOPHYS, V15, P193, DOI 10.3758/BF03205846; LATHROP RG, 1966, J EXP PSYCHOL, V72, P120, DOI 10.1037/h0023314; Lee SH, 1999, VISION RES, V39, P1447, DOI 10.1016/S0042-6989(98)00269-7; LEHKY SR, 1988, PERCEPTION, V17, P215, DOI 10.1068/p170215; LEHKY SR, 1995, P ROY SOC B-BIOL SCI, V259, P71, DOI 10.1098/rspb.1995.0011; Levelt W., 1965, BINOCULAR RIVALRY; Logothetis NK, 1998, PHILOS T R SOC B, V353, P1801, DOI 10.1098/rstb.1998.0333; Logothetis NK, 1996, NATURE, V380, P621, DOI 10.1038/380621a0; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; LUESCHOW A, 1994, CEREB CORTEX, V4, P523, DOI 10.1093/cercor/4.5.523; MILLER EK, 1993, J NEUROSCI, V13, P1460; Morita M, 2002, COGNITIVE BRAIN RES, V13, P169, DOI 10.1016/S0926-6410(01)00109-4; PETERSON MA, 1991, J EXP PSYCHOL HUMAN, V17, P1075, DOI 10.1037/0096-1523.17.4.1075; PETERSON MA, 1991, J EXP PSYCHOL HUMAN, V17, P170, DOI 10.1037/0096-1523.17.1.170; Polonsky A, 2000, NAT NEUROSCI, V3, P1153, DOI 10.1038/80676; RAMACHANDRAN VS, 1983, NATURE, V304, P529, DOI 10.1038/304529a0; REGAN D, 1992, VISION RES, V32, P1845, DOI 10.1016/0042-6989(92)90046-L; Renart A, 2001, NEUROCOMPUTING, V38, P1525, DOI 10.1016/S0925-2312(01)00548-3; RICHARDS W, 1994, BIOL CYBERN, V70, P345, DOI 10.1007/BF00200331; Shenberg DL, 1997, P NATL ACAD SCI USA, V94, P3408, DOI 10.1073/pnas.94.7.3408; SUGIE N, 1982, BIOL CYBERN, V43, P13, DOI 10.1007/BF00337283; Suzuki S, 2001, VISION RES, V41, P3883, DOI 10.1016/S0042-6989(01)00249-8; Suzuki S, 1998, J EXP PSYCHOL HUMAN, V24, P1315, DOI 10.1037/0096-1523.24.5.1315; Suzuki S, 2000, PSYCHOL SCI, V11, P202, DOI 10.1111/1467-9280.00242; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; TAYLOR MM, 1974, PERCEPT PSYCHOPHYS, V16, P9, DOI 10.3758/BF03203243; Tong F, 2001, NATURE, V411, P195, DOI 10.1038/35075583; Tsunoda K, 2001, NAT NEUROSCI, V4, P832, DOI 10.1038/90547; Verstraten FAJ, 2000, VISION RES, V40, P3651, DOI 10.1016/S0042-6989(00)00213-3; VOGELS R, 1995, VISUAL NEUROSCI, V12, P207, DOI 10.1017/S0952523800007884; WADE NJ, 1974, PERCEPT PSYCHOPHYS, V15, P227, DOI 10.3758/BF03213937; WADE NJ, 1975, PERCEPT PSYCHOPHYS, V17, P571, DOI 10.3758/BF03203971; Wang G, 1996, SCIENCE, V272, P1665, DOI 10.1126/science.272.5268.1665; Wang Y, 2000, NAT NEUROSCI, V3, P807, DOI 10.1038/77712; Wilson HR, 2001, NATURE, V412, P907, DOI 10.1038/35091066; YU K, 1992, J EXP PSYCHOL HUMAN, V18, P1158, DOI 10.1037/0096-1523.18.4.1158	59	65	65	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 26	2002	36	1					143	157		10.1016/S0896-6273(02)00934-0	http://dx.doi.org/10.1016/S0896-6273(02)00934-0			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	598UP	12367513	Bronze			2022-12-24	WOS:000178295100014
J	Olausson, H; Lamarre, Y; Backlund, H; Morin, C; Wallin, BG; Starck, G; Ekholm, S; Strigo, I; Worsley, K; Vallbo, AB; Bushnell, MC				Olausson, H; Lamarre, Y; Backlund, H; Morin, C; Wallin, BG; Starck, G; Ekholm, S; Strigo, I; Worsley, K; Vallbo, AB; Bushnell, MC			Unmyelinated tactile afferents signal touch and project to insular cortex	NATURE NEUROSCIENCE			English	Article							HAIRY SKIN; PAIN MECHANISMS; UNITS; FIBERS; MECHANORECEPTORS; NEURONS; SENSIBILITY; ACTIVATION; STIMULI; FIELDS	There is dual tactile innervation of the human hairy skin: in addition to fast-conducting myelinated afferent fibers, there is a system of slow-conducting unmyelinated (C) afferents that respond to light touch. In a unique patient lacking large myelinated afferents, we found that activation of C tactile (CT) afferents produced a faint sensation of pleasant touch. Functional magnetic resonance imaging (fMRI) analysis during CT stimulation showed activation of the insular region, but not of somatosensory areas S1 and S2. These findings identify CT as a system for limbic touch that may underlie emotional, hormonal and affiliative responses to caress-like, skin-to-skin contact between individuals.	Sahlgrens Univ Hosp, Dept Clin Neurophysiol, S-41345 Gothenburg, Sweden; Univ Montreal, Dept Physiol, Montreal, PQ H3C 3J7, Canada; Gothenburg Univ, Dept Physiol, S-41345 Gothenburg, Sweden; McGill Univ, Dept Anesthesia, Montreal, PQ H3G 1Y6, Canada; Sahlgrens Univ Hosp, Dept Radiat Phys, S-41345 Gothenburg, Sweden; Sahlgrens Univ Hosp, Dept Radiol, S-41345 Gothenburg, Sweden; McGill Univ, Dept Math & Stat, Montreal, PQ H3G 1Y6, Canada	Sahlgrenska University Hospital; Universite de Montreal; University of Gothenburg; McGill University; Sahlgrenska University Hospital; Sahlgrenska University Hospital; McGill University	Olausson, H (corresponding author), Sahlgrens Univ Hosp, Dept Clin Neurophysiol, S-41345 Gothenburg, Sweden.	olausson@physiol.gu.se	strigo, irina A/L-9882-2016	strigo, irina A/0000-0002-8799-716X; Starck, Goran/0000-0002-7917-012X				Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Bartels A, 2000, NEUROREPORT, V11, P3829, DOI 10.1097/00001756-200011270-00046; BESSOU P, 1971, J NEUROPHYSIOL, V34, P116, DOI 10.1152/jn.1971.34.1.116; Brooks JCW, 2002, NEUROIMAGE, V15, P293, DOI 10.1006/nimg.2001.0974; BURGESS PR, 1968, J NEUROPHYSIOL, V31, P833, DOI 10.1152/jn.1968.31.6.833; COGHILL RC, 1994, J NEUROSCI, V14, P4095; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Craig AD, 1996, PROG BRAIN RES, V107, P225; Craig AD, 2002, J NEUROPHYSIOL, V87, P1902, DOI 10.1152/jn.00578.2001; Craig AD, 2000, J PAIN, V1, P33, DOI 10.1016/S1526-5900(00)90086-5; Craig AD, 2000, NAT NEUROSCI, V3, P184, DOI 10.1038/72131; Damasio A. R., 1999, FEELING WHAT HAPPENS; Disbrow E, 1998, HUM BRAIN MAPP, V6, P150, DOI 10.1002/(SICI)1097-0193(1998)6:3<150::AID-HBM4>3.3.CO;2-V; DOUGLAS WW, 1957, J PHYSIOL-LONDON, V139, P385, DOI 10.1113/jphysiol.1957.sp005899; Drzezga A, 2001, PAIN, V92, P295, DOI 10.1016/S0304-3959(01)00271-8; Edin BB, 2001, J PHYSIOL-LONDON, V531, P289, DOI 10.1111/j.1469-7793.2001.0289j.x; Essick GK, 1999, NEUROREPORT, V10, P2083, DOI 10.1097/00001756-199907130-00017; FORGET R, 1995, CAN J PHYSIOL PHARM, V73, P285, DOI 10.1139/y95-039; FRIEDMAN DP, 1986, J COMP NEUROL, V252, P323, DOI 10.1002/cne.902520304; GEORGOPOULOS AP, 1976, J NEUROPHYSIOL, V39, P71, DOI 10.1152/jn.1976.39.1.71; HARLOW HF, 1958, AM PSYCHOL, V13, P673, DOI 10.1037/h0047884; IGGO A, 1960, J PHYSIOL-LONDON, V152, P337, DOI 10.1113/jphysiol.1960.sp006491; JARVILEHTO T, 1976, EXP BRAIN RES, V25, P45; JOHANSSON RS, 1979, J PHYSIOL-LONDON, V286, P283, DOI 10.1113/jphysiol.1979.sp012619; KAKUDA N, 1992, NEUROSCI RES, V15, P179, DOI 10.1016/0168-0102(92)90003-U; Kandel E., 2000, PRINCIPLES NEURAL SC; KONIETZNY F, 1977, PFLUG ARCH EUR J PHY, V368, P39, DOI 10.1007/BF01063452; KUMAZAWA T, 1977, J NEUROPHYSIOL, V40, P1325, DOI 10.1152/jn.1977.40.6.1325; KUMAZAWA T, 1977, J PHYSIOLOGY PARIS, V73, P287; Light AR, 1999, J NEUROPHYSIOL, V82, P3316, DOI 10.1152/jn.1999.82.6.3316; LIGHT AR, 1979, J COMP NEUROL, V186, P151, DOI 10.1002/cne.901860204; MACKENZIE RA, 1975, J NEUROL NEUROSUR PS, V38, P865, DOI 10.1136/jnnp.38.9.865; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; NORDIN M, 1990, J PHYSIOL-LONDON, V426, P229, DOI 10.1113/jphysiol.1990.sp018135; Olausson H, 2001, BRAIN, V124, P916, DOI 10.1093/brain/124.5.916; Olausson H, 1997, MUSCLE NERVE, V20, P1414, DOI 10.1002/(SICI)1097-4598(199711)20:11<1414::AID-MUS9>3.0.CO;2-D; PERL ER, 1968, J PHYSIOL-LONDON, V197, P593, DOI 10.1113/jphysiol.1968.sp008576; ROBINSON CJ, 1980, J COMP NEUROL, V192, P69, DOI 10.1002/cne.901920105; Stoleru S, 1999, ARCH SEX BEHAV, V28, P1, DOI 10.1023/A:1018733420467; SUGIURA Y, 1986, SCIENCE, V234, P358, DOI 10.1126/science.3764416; TALAIRACH Y, 1988, COPLANAR STEREOTAXIC; Uvnas-Moberg K, 1998, PSYCHONEUROENDOCRINO, V23, P819, DOI 10.1016/S0306-4530(98)00056-0; VALLBO A, 1993, BRAIN RES, V628, P301, DOI 10.1016/0006-8993(93)90968-S; Vallbo AB, 1999, J NEUROPHYSIOL, V81, P2753, DOI 10.1152/jn.1999.81.6.2753; VALLBO AB, 1995, J PHYSIOL-LONDON, V483, P783, DOI 10.1113/jphysiol.1995.sp020622; White J., 1969, PAIN NEUROSURGEON 40; Worsley KJ, 2002, NEUROIMAGE, V15, P1, DOI 10.1006/nimg.2001.0933; YARNITSKY D, 1995, PAIN, V60, P329, DOI 10.1016/0304-3959(94)00132-X; Zotterman Y, 1939, J PHYSIOL-LONDON, V95, P1	49	609	625	0	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2002	5	9					900	904		10.1038/nn896	http://dx.doi.org/10.1038/nn896			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587RL	12145636				2022-12-24	WOS:000177656300021
J	Koechlin, E; Danek, A; Brunod, Y; Grafman, J				Koechlin, E; Danek, A; Brunod, Y; Grafman, J			Medial prefrontal and subcortical mechanisms underlying the acquisition of motor and cognitive action sequences in humans	NEURON			English	Article							POSITRON-EMISSION-TOMOGRAPHY; ANTERIOR CINGULATE CORTEX; VENTRAL STRIATUM; BASAL GANGLIA; PARKINSONS-DISEASE; NEURONAL-ACTIVITY; WORKING-MEMORY; REWARD; MONKEY; ORGANIZATION	The anterior media[ prefrontal cortex (AMPC) in humans is involved in affect and in regulating goal-directed behaviors. The precise function of the AMPC, however, is poorly understood. Using magnetic resonance imaging, we found that bilateral regions in the AMPC were selectively recruited to compute the reliability of subjects' expectations that developed when subjects were learning sequences of cognitive tasks. In contrast, regions similarly recruited in learning sequences of motor acts were found in the ventral striatum. Our results show that beyond the execution of motor acts, the AMPC is selectively engaged in computing the relevance of cognitive goals that subjects intend to achieve. This indicates that the fronto-striatal circuit, including the ventral striatum and AMPC, subserves hierarchically distinct evaluative processes mediating the human ability to build behavioral plans, ranging from motor to cognitive action plans.	Univ Paris 06, INSERM, U483, F-75005 Paris, France; NINDS, Cognit Neurosci Sect, Bethesda, MD 20892 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Koechlin, E (corresponding author), Univ Paris 06, INSERM, U483, 9 Quai St Bernard, F-75005 Paris, France.	koechlin@ccr.jussieu.fr	Koechlin, Etienne/AAF-5717-2021; Koechlin, Etienne/E-5061-2016; Danek, Adrian/G-7339-2011	Koechlin, Etienne/0000-0002-6514-9311; Koechlin, Etienne/0000-0002-6514-9311; Danek, Adrian/0000-0001-8857-5383; Grafman, Jordan H./0000-0001-8645-4457				ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; APICELLA P, 1991, EXP BRAIN RES, V85, P491; BARBAS H, 1989, J COMP NEUROL, V286, P353, DOI 10.1002/cne.902860306; Bechara A, 1998, J NEUROSCI, V18, P428; Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; BENES FM, 1993, SCHIZOPHRENIA BULL, V19, P537, DOI 10.1093/schbul/19.3.537; BROWN RG, 1988, BRAIN, V111, P323, DOI 10.1093/brain/111.2.323; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; Dehaene S, 1997, P NATL ACAD SCI USA, V94, P13293, DOI 10.1073/pnas.94.24.13293; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; DICKINSON A, 1980, CON ANIMAL LEARNING; Doyon J, 1996, EUR J NEUROSCI, V8, P637, DOI 10.1111/j.1460-9568.1996.tb01249.x; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; FRISTON KJ, 1991, J CEREBR BLOOD F MET, V11, P690, DOI 10.1038/jcbfm.1991.122; Furey ML, 1997, P NATL ACAD SCI USA, V94, P6512, DOI 10.1073/pnas.94.12.6512; Fuster J.M., 1989, PREFRONTAL CORTEX; Gordon AM, 1998, EXP BRAIN RES, V121, P153, DOI 10.1007/s002210050447; GRAF P, 1985, J EXP PSYCHOL LEARN, V11, P501, DOI 10.1037/0278-7393.11.3.501; Grafman J, 1995, ANN NY ACAD SCI, V769, P337, DOI 10.1111/j.1749-6632.1995.tb38149.x; GRAFTON ST, 1995, J COGNITIVE NEUROSCI, V7, P497, DOI 10.1162/jocn.1995.7.4.497; Graybiel A. M., 1995, MODELS INFORMATION P, P103; Graybiel AM, 1997, SCHIZOPHRENIA BULL, V23, P459, DOI 10.1093/schbul/23.3.459; HABER SN, 1995, J NEUROSCI, V15, P4851; Hertz JA, 2018, INTRO THEORY NEURAL; JENKINS IH, 1994, J NEUROSCI, V14, P3775; Jueptner M, 1997, J NEUROPHYSIOL, V77, P1325, DOI 10.1152/jn.1997.77.3.1325; Just MA, 1996, SCIENCE, V274, P114, DOI 10.1126/science.274.5284.114; Koechlin E, 2000, P NATL ACAD SCI USA, V97, P7651, DOI 10.1073/pnas.130177397; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; LEWIS DA, 1988, BRAIN RES, V449, P225, DOI 10.1016/0006-8993(88)91040-2; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Pallier C, 1997, BEHAV RES METH INS C, V29, P322, DOI 10.3758/BF03200583; Robbins TW, 1996, CURR OPIN NEUROBIOL, V6, P228, DOI 10.1016/S0959-4388(96)80077-8; Rogers RD, 1998, BRAIN, V121, P815, DOI 10.1093/brain/121.5.815; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1997, CURR OPIN NEUROBIOL, V7, P191, DOI 10.1016/S0959-4388(97)80007-4; SCHULTZ W, 1992, J NEUROSCI, V12, P4595, DOI 10.1523/jneurosci.12-12-04595.1992; SCHULTZ W, 1995, MODELS INFORMATION P, P11; Shidara M, 1998, J NEUROSCI, V18, P2613; SHIDARA M, 2002, IN PRESS SCIENCE; Shima K, 2000, J NEUROPHYSIOL, V84, P2148, DOI 10.1152/jn.2000.84.4.2148; Simpson JR, 2001, P NATL ACAD SCI USA, V98, P683, DOI 10.1073/pnas.98.2.683; Strange BA, 2001, CEREB CORTEX, V11, P1040, DOI 10.1093/cercor/11.11.1040; TALAIRACH J, 1988, COPLANAR STEREOAXIC; TANJI J, 1994, NATURE, V371, P413, DOI 10.1038/371413a0; WILLINGHAM DB, 1989, J EXP PSYCHOL LEARN, V15, P1047, DOI 10.1037/0278-7393.15.6.1047; Worsley KJ, 2000, STAT PROBABIL LETT, V47, P135, DOI 10.1016/S0167-7152(99)00149-2	50	68	68	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUL 18	2002	35	2					371	381		10.1016/S0896-6273(02)00742-0	http://dx.doi.org/10.1016/S0896-6273(02)00742-0			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	576YF	12160754	Bronze			2022-12-24	WOS:000177034200016
J	Rilling, JK; Gutman, DA; Zeh, TR; Pagnoni, G; Berns, GS; Kilts, CD				Rilling, JK; Gutman, DA; Zeh, TR; Pagnoni, G; Berns, GS; Kilts, CD			A neural basis for social cooperation	NEURON			English	Article							REPEATED PRISONERS-DILEMMA; ORBITOFRONTAL CORTEX; ANTERIOR CINGULATE; RECIPROCAL ALTRUISM; PREFRONTAL CORTEX; REWARD; BRAIN; EVOLUTION; RESPONSES; EMOTION	Cooperation based on reciprocal altruism has evolved in only a small number of species, yet it constitutes the core behavioral principle of human social life. The iterated Prisoner's Dilemma Game has been used to model this form of cooperation. We used fMRI to scan 36 women as they played an iterated Prisoner's Dilemma Game with another woman to investigate the neurobiological basis of cooperative social behavior. Mutual cooperation was associated with consistent activation in brain areas that have been linked with reward processing: nucleus accumbens, the caudate nucleus, ventromedial frontal/orbitofrontal cortex, and rostral anterior cingulate cortex. We propose that activation of this neural network positively reinforces reciprocal altruism, thereby motivating subjects to resist the temptation to selfishly accept but not reciprocate favors.	Emory Univ, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA	Emory University	Rilling, JK (corresponding author), Princeton Univ, Green Hall, Princeton, NJ 08544 USA.		Tudusciuc, Oana/C-1339-2011; Gutman, David/U-2713-2018; Pagnoni, Giuseppe/F-3398-2015	Gutman, David/0000-0002-1386-8701; Pagnoni, Giuseppe/0000-0002-8272-8091	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061010] Funding Source: NIH RePORTER; NIDA NIH HHS [DA00367] Funding Source: Medline; NIGMS NIH HHS [T32 GM008169] Funding Source: Medline; NIMH NIH HHS [MH61010] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANDREONI J, 1993, ECON J, V103, P570, DOI 10.2307/2234532; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Aziz Q, 2000, J NEUROSCI, V20, P2657; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; BOYD R, 1988, ETHOL SOCIOBIOL, V9, P211, DOI 10.1016/0162-3095(88)90022-2; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Cohen JD, 2000, NAT NEUROSCI, V3, P421, DOI 10.1038/74783; Davidson RJ, 2000, AM PSYCHOL, V55, P1196, DOI 10.1037/0003-066X.55.11.1196; Drevets WC, 1998, COGNITION EMOTION, V12, P353, DOI 10.1080/026999398379646; Francis S, 1999, NEUROREPORT, V10, P453, DOI 10.1097/00001756-199902250-00003; Frank R. H., 1988, PASSIONS REASON STRA; Friston K, 1995, HUM BRAIN MAPP, V2, P1; FRISTON KJ, 1995, NEUROIMAGE, V2, P166, DOI 10.1006/nimg.1995.1019; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; HOTTES JH, 1974, J PERS, V42, P260, DOI 10.1111/j.1467-6494.1974.tb00673.x; Koepp MJ, 1998, NATURE, V393, P266, DOI 10.1038/30498; Lee Richard, 1968, MAN HUNTER; Nesse R M, 1990, Hum Nat, V1, P261, DOI 10.1007/BF02733986; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Pagnoni G, 2002, NAT NEUROSCI, V5, P97, DOI 10.1038/nn802; Rapoport A., 1965, PRISONERS DILEMMA ST; Ridley Matt, 1996, ORIGINS VIRTUE; Rogers RD, 1999, J NEUROSCI, V19, P9029, DOI 10.1523/JNEUROSCI.19-20-09029.1999; ROLLS ET, 1999, BRAIN EMOTION; Sahlins M., 1972, STONE AGE EC; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; SKOTKO V, 1974, J CONFLICT RESOLUT, V18, P707, DOI 10.1177/002200277401800411; Thut G, 1997, NEUROREPORT, V8, P1225, DOI 10.1097/00001756-199703240-00033; Trivers R. L., 1985, SOCIAL EVOLUTION; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Whalen PJ, 1998, BIOL PSYCHIAT, V44, P1219, DOI 10.1016/S0006-3223(98)00251-0	38	860	878	9	207	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 18	2002	35	2					395	405		10.1016/S0896-6273(02)00755-9	http://dx.doi.org/10.1016/S0896-6273(02)00755-9			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	576YF	12160756	Bronze			2022-12-24	WOS:000177034200018
J	Oertner, TG; Sabatini, BL; Nimchinsky, EA; Svoboda, K				Oertner, TG; Sabatini, BL; Nimchinsky, EA; Svoboda, K			Facilitation at single synapses probed with optical quantal analysis	NATURE NEUROSCIENCE			English	Article							METHYL-D-ASPARTATE; CULTURED HIPPOCAMPAL-NEURONS; DENDRITIC SPINES; MULTIVESICULAR RELEASE; SILENT SYNAPSES; NMDA RECEPTORS; SYNAPTIC TRANSMISSION; EXCITATORY SYNAPSES; PYRAMIDAL NEURONS; CA1 SYNAPSES	Many synapses can change their strength rapidly in a use-dependent manner, but the mechanisms of such short-term plasticity remain unknown. To understand these mechanisms, measurements of neurotransmitter release at single synapses are required. We probed transmitter release by imaging transient increases in [Ca2+] mediated by synaptic N-methyl-D-aspartate receptors (NMDARs) in individual dendritic spines of CA1 pyramidal neurons in rat brain slices, enabling quantal analysis at single synapses. We found that changes in release probability, produced by paired-pulse facilitation (PPF) or by manipulation of presynaptic adenosine receptors, were associated with changes in glutamate concentration in the synaptic cleft, indicating that single synapses can release a variable amount of glutamate per action potential. The relationship between release probability and response size is consistent with a binomial model of vesicle release with several (> 5) independent release sites per active zone, suggesting that multivesicular release contributes to facilitation at these synapses.	Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Svoboda, K (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.		Nimchinsky, Esther/GXF-5277-2022; Oertner, Thomas/F-2214-2010	Oertner, Thomas/0000-0002-2312-7528				Arnth-Jensen N, 2002, NAT NEUROSCI, V5, P325, DOI 10.1038/nn825; Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; Auger C, 1998, J NEUROSCI, V18, P4532; Auger C, 2000, J PHYSIOL-LONDON, V526, P3, DOI 10.1111/j.1469-7793.2000.t01-3-00003.x; Barbour B, 2001, J NEUROSCI, V21, P7969, DOI 10.1523/JNEUROSCI.21-20-07969.2001; BEKKERS JM, 1990, P NATL ACAD SCI USA, V87, P5359, DOI 10.1073/pnas.87.14.5359; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Choi S, 2000, NAT NEUROSCI, V3, P330, DOI 10.1038/73895; CLEMENTS JD, 1991, NEURON, V7, P605, DOI 10.1016/0896-6273(91)90373-8; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; Diamond JS, 2001, J NEUROSCI, V21, P8328, DOI 10.1523/JNEUROSCI.21-21-08328.2001; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Emptage N, 1999, NEURON, V22, P115, DOI 10.1016/S0896-6273(00)80683-2; FABER DS, 1992, SCIENCE, V258, P1494, DOI 10.1126/science.1279813; Hanse E, 2001, J PHYSIOL-LONDON, V531, P467, DOI 10.1111/j.1469-7793.2001.0467i.x; HARRIS KM, 1989, J NEUROSCI, V9, P2982; HARRIS KM, 1995, NEUROPHARMACOLOGY, V34, P1387, DOI 10.1016/0028-3908(95)00142-S; Isaac JTR, 1998, NEUROPHARMACOLOGY, V37, P1399, DOI 10.1016/S0028-3908(98)00140-3; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Katz B., 1969, RELEASE NEURAL TRANS; KORN H, 1981, SCIENCE, V213, P898, DOI 10.1126/science.6266015; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Mainen ZF, 1999, METHODS, V18, P231, DOI 10.1006/meth.1999.0776; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; McAllister AK, 2000, P NATL ACAD SCI USA, V97, P6173, DOI 10.1073/pnas.100126497; NEHER E, 1995, NEUROPHARMACOLOGY, V34, P1423, DOI 10.1016/0028-3908(95)00144-U; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; REDMAN S, 1990, PHYSIOL REV, V70, P165, DOI 10.1152/physrev.1990.70.1.165; Regehr WG, 2001, SYNAPSES, P135; Renger JJ, 2001, NEURON, V29, P469, DOI 10.1016/S0896-6273(01)00219-7; Rusakov DA, 1998, J NEUROSCI, V18, P3158; Sabatini BL, 2000, NATURE, V408, P589, DOI 10.1038/35046076; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Sabatini BL, 2001, CURR OPIN NEUROBIOL, V11, P349, DOI 10.1016/S0959-4388(00)00218-X; SATHER W, 1992, J PHYSIOL-LONDON, V450, P643, DOI 10.1113/jphysiol.1992.sp019148; Schikorski T, 1997, J NEUROSCI, V17, P5858; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; SPRUSTON N, 1995, J PHYSIOL-LONDON, V482, P325, DOI 10.1113/jphysiol.1995.sp020521; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; Stuart G, 1998, J NEUROSCI, V18, P3501; TONG G, 1994, NEURON, V12, P51, DOI 10.1016/0896-6273(94)90151-1; Umemiya M, 1999, J PHYSIOL-LONDON, V521, P113, DOI 10.1111/j.1469-7793.1999.00113.x; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Williams SR, 2002, SCIENCE, V295, P1907, DOI 10.1126/science.1067903; WU LG, 1994, NEURON, V12, P1139, DOI 10.1016/0896-6273(94)90321-2; Wu LG, 1997, TRENDS NEUROSCI, V20, P204, DOI 10.1016/S0166-2236(96)01015-6; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	50	237	242	0	16	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2002	5	7					657	664		10.1038/nn867	http://dx.doi.org/10.1038/nn867			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	566EP	12055631				2022-12-24	WOS:000176414300015
J	Lei, H; Christensen, TA; Hildebrand, JG				Lei, H; Christensen, TA; Hildebrand, JG			Local inhibition modulates odor-evoked synchronization of glomerulus-specific output neurons	NATURE NEUROSCIENCE			English	Article							CONTEXT-DEPENDENT MODULATION; SPHINX MOTH; ANTENNAL LOBES; OLFACTORY-BULB; PROJECTION NEURONS; MITRAL CELLS; INFORMATION; OSCILLATIONS; PHEROMONE; RESPONSES	At the first stage of olfactory processing in the brain, synchronous firing across glomeruli may help to temporally bind multiple and spatially distributed input streams activated by a given odor. This hypothesis, however, has never been tested in an organism in which the odor-tuning properties of several spatially identifiable glomeruli are known. Using the sphinx moth, an insect that meets these specific criteria, we recorded odor-evoked responses simultaneously from pairs of projection neurons (PNs) innervating the same or different glomeruli in the macroglomerular complex (MGC), which is involved in processing pheromonal information. PNs that branched in the same glomerulus and were activated by the same pheromone component also showed the strongest coincident responses to each odor pulse. Glomerulus-specific PN pairs were also inhibited by the pheromone component that selectively activated PNs in the neighboring glomerulus, and about 70% of all intraglomerular pairs showed increased synchronization when stimulated with a mixture of the two odorants. Thus, when two adjacent glomeruli receive their inputs simultaneously, the temporal tuning of output from each glomerulus is enhanced by reciprocal and inhibitory interglomerular interactions.	Univ Arizona, Div Neurobiol, Arizona Res Labs, Tucson, AZ 85721 USA	University of Arizona	Christensen, TA (corresponding author), Univ Arizona, Div Neurobiol, Arizona Res Labs, POB 210077, Tucson, AZ 85721 USA.	tc@neurobio.arizona.edu	Lei, Hong/ABH-1356-2020					Adrian ED, 1942, J PHYSIOL-LONDON, V100, P459, DOI 10.1113/jphysiol.1942.sp003955; AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; BARLOW HB, 1964, J PHYSIOL-LONDON, V173, P377, DOI 10.1113/jphysiol.1964.sp007463; Belluscio L, 2001, J NEUROSCI, V21, P2113, DOI 10.1523/JNEUROSCI.21-06-02113.2001; BUONVISO N, 1990, J NEUROPHYSIOL, V63, P447, DOI 10.1152/jn.1990.63.3.447; Carlson GC, 2000, J NEUROSCI, V20, P2011; Christensen TA, 1998, J NEUROSCI, V18, P5999; Christensen TA, 1997, J NEUROPHYSIOL, V77, P775, DOI 10.1152/jn.1997.77.2.775; Christensen TA, 1997, INSECT PHEROMONE RESEARCH, P184; Christensen TA, 2000, NAT NEUROSCI, V3, P927, DOI 10.1038/78840; CHRISTENSEN TA, 1993, J COMP PHYSIOL A, V173, P385, DOI 10.1007/BF00193512; CHRISTENSEN TA, 2000, NEUROBIOLOGY TASTE S, P201; Deadwyler SA, 1996, J NEUROSCI, V16, P354; Desmaisons D, 1999, J NEUROSCI, V19, P10727, DOI 10.1523/JNEUROSCI.19-24-10727.1999; Fuss SH, 2001, J NEUROSCI, V21, P8396, DOI 10.1523/JNEUROSCI.21-21-08396.2001; Galizia CG, 2001, J INSECT PHYSIOL, V47, P115, DOI 10.1016/S0022-1910(00)00106-2; Gelperin A, 1999, J EXP BIOL, V202, P1855; HANSSON BS, 1991, J COMP NEUROL, V312, P264, DOI 10.1002/cne.903120209; Heinbockel T, 1999, J COMP NEUROL, V409, P1; Johnson BA, 1998, J COMP NEUROL, V393, P457, DOI 10.1002/(SICI)1096-9861(19980420)393:4<457::AID-CNE5>3.0.CO;2-#; Kashiwadani H, 1999, J NEUROPHYSIOL, V82, P1786, DOI 10.1152/jn.1999.82.4.1786; Kay LM, 1999, NAT NEUROSCI, V2, P1003, DOI 10.1038/14801; King JR, 2000, J NEUROSCI, V20, P2391; LANCET D, 1986, ANNU REV NEUROSCI, V9, P329, DOI 10.1146/annurev.ne.09.030186.001553; Laurent G, 1999, SCIENCE, V286, P723, DOI 10.1126/science.286.5440.723; Laurent G, 1996, J NEUROSCI, V16, P3837; Lei H, 2001, J COMP NEUROL, V432, P356, DOI 10.1002/cne.1108; Maynard EM, 1999, J NEUROSCI, V19, P8083; Mellon D, 1999, J NEUROPHYSIOL, V81, P1231, DOI 10.1152/jn.1999.81.3.1231; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; MURLIS J, 1992, ANNU REV ENTOMOL, V37, P505, DOI 10.1146/annurev.en.37.010192.002445; Murthy VN, 1996, J NEUROPHYSIOL, V76, P3968, DOI 10.1152/jn.1996.76.6.3968; Nicolelis MAL, 1998, NAT NEUROSCI, V1, P621, DOI 10.1038/2855; Nowak LG, 1999, J NEUROPHYSIOL, V81, P1057, DOI 10.1152/jn.1999.81.3.1057; RALL W, 1966, EXP NEUROL, V14, P44, DOI 10.1016/0014-4886(66)90023-9; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Rieke F., 1997, SPIKES EXPLORING NEU; ROSPARS JP, 1992, CELL TISSUE RES, V270, P205, DOI 10.1007/BF00328007; Rospars JP, 2000, CHEM SENSES, V25, P119, DOI 10.1093/chemse/25.2.119; Schoppa NE, 2001, NEURON, V31, P639, DOI 10.1016/S0896-6273(01)00389-0; SHEPHERD GM, 1990, SYNAPTIC ORG BRAIN, P139; Shields VDC, 2001, J COMP PHYSIOL A, V186, P1135, DOI 10.1007/s003590000165; Shipley MT, 1996, J NEUROBIOL, V30, P123; SINGER MS, 1994, NEUROREPORT, V5, P1297, DOI 10.1097/00001756-199406020-00036; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; VAADIA E, 1991, NEURONAL COOPERATIVI, P205; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Vickers NJ, 2001, NATURE, V410, P466, DOI 10.1038/35068559; WALDROP B, 1987, J COMP PHYSIOL A, V161, P23, DOI 10.1007/BF00609452	50	104	106	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2002	5	6					557	565		10.1038/nn859	http://dx.doi.org/10.1038/nn859			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	556XQ	12006983				2022-12-24	WOS:000175874600016
J	Trevisani, M; Smart, D; Gunthorpe, MJ; Tognetto, M; Barbieri, M; Campi, B; Amadesi, S; Gray, J; Jerman, JC; Brough, SJ; Owen, D; Smith, GD; Randall, AD; Harrison, S; Bianchi, A; Davis, JB; Geppetti, P				Trevisani, M; Smart, D; Gunthorpe, MJ; Tognetto, M; Barbieri, M; Campi, B; Amadesi, S; Gray, J; Jerman, JC; Brough, SJ; Owen, D; Smith, GD; Randall, AD; Harrison, S; Bianchi, A; Davis, JB; Geppetti, P			Ethanol elicits and potentiates nociceptor responses via the vanilloid receptor-1	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE-C; CAPSAICIN RECEPTOR; SENSORY NEURONS; PAIN; BRADYKININ; CHANNEL; HEAT; SENSITIZATION; CAPSAZEPINE; ANANDAMIDE	The vanilloid receptor-1 (VR1) is a heat-gated ion channel that is responsible for the burning sensation elicited by capsaicin. A similar sensation is reported by patients with esophagitis when they consume alcoholic beverages or are administered alcohol by injection as a medical treatment. We report here that ethanol activates primary sensory neurons, resulting in neuropeptide release or plasma extravasation in the esophagus, spinal cord or skin. Sensory neurons from trigeminal or dorsal root ganglia as well as VR1-expressing HEK293 cells responded to ethanol in a concentration-dependent and capsazepine-sensitive fashion. Ethanol potentiated the response of VR1 to capsaicin, protons and heat and lowered the threshold for heat activation of VR1 from similar to42degreesC to similar to34degreesC. This provides a likely mechanistic explanation for the ethanol-induced sensory responses that occur at body temperature and for the sensitivity of inflamed tissues to ethanol, such as might be found in esophagitis, neuralgia or wounds.	GlaxoSmithKline, Neurol CEDD, Harlow CM19 5AW, Essex, England; Univ Ferrara, Headache Ctr, Dept Expt & Clin Med, I-44100 Ferrara, Italy; Univ Catania, Dept Pharmacol, I-95123 Catania, Italy; GlaxoSmithKline, Discovery Res, Harlow CM19 5AW, Essex, England	GlaxoSmithKline; University of Ferrara; University of Catania; GlaxoSmithKline	Davis, JB (corresponding author), GlaxoSmithKline, Neurol CEDD, 3rd Ave, Harlow CM19 5AW, Essex, England.		barbieri, mario/AAJ-1477-2021; Geppetti, Pierangelo/AHA-7897-2022	barbieri, mario/0000-0001-9074-764X; Randall, Andrew/0000-0001-8852-3671				BEVAN S, 1992, BRIT J PHARMACOL, V107, P544, DOI 10.1111/j.1476-5381.1992.tb12781.x; BOLANOWSKI SJ, 1995, J PERIODONTAL RES, V30, P192, DOI 10.1111/j.1600-0765.1995.tb01273.x; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cesare P, 1996, P NATL ACAD SCI USA, V93, P15435, DOI 10.1073/pnas.93.26.15435; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Docherty RJ, 1997, BRIT J PHARMACOL, V121, P1461, DOI 10.1038/sj.bjp.0701272; FARDY MJ, 1994, BRIT J ORAL MAX SURG, V32, P387, DOI 10.1016/0266-4356(94)90031-0; Forman SA, 1999, MOL PHARMACOL, V55, P102, DOI 10.1124/mol.55.1.102; Hayes P, 2000, PAIN, V88, P205, DOI 10.1016/S0304-3959(00)00353-5; HOLZER P, 1991, PHARMACOL REV, V43, P143; Hwang SW, 2000, P NATL ACAD SCI USA, V97, P6155, DOI 10.1073/pnas.97.11.6155; Liang YF, 2001, J PHYSIOL-LONDON, V532, P229, DOI 10.1111/j.1469-7793.2001.0229g.x; Nagy I, 1999, J NEUROSCI, V19, P10647, DOI 10.1523/JNEUROSCI.19-24-10647.1999; Premkumar LS, 2000, NATURE, V408, P985, DOI 10.1038/35050121; SARIA A, 1983, N-S ARCH PHARMACOL, V324, P212, DOI 10.1007/BF00503897; Smart D, 2000, BRIT J PHARMACOL, V129, P227, DOI 10.1038/sj.bjp.0703050; Smid SD, 1998, NEUROGASTROENT MOTIL, V10, P403; Stubbs CD, 1999, ALCOHOL CLIN EXP RES, V23, P1552; Tognetto M, 2001, J NEUROSCI, V21, P1104; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Wick MJ, 1998, P NATL ACAD SCI USA, V95, P6504, DOI 10.1073/pnas.95.11.6504; Yiangou Y, 2001, LANCET, V357, P1338, DOI 10.1016/S0140-6736(00)04503-7; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	24	333	353	1	31	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2002	5	6					546	551		10.1038/nn852	http://dx.doi.org/10.1038/nn852			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	556XQ	11992116				2022-12-24	WOS:000175874600014
J	Wei, F; Qiu, CS; Liauw, J; Robinson, DA; Ho, N; Chatila, T; Zhuo, M				Wei, F; Qiu, CS; Liauw, J; Robinson, DA; Ho, N; Chatila, T; Zhuo, M			Calcium-calmodulin-dependent protein kinase IV is required for fear memory	NATURE NEUROSCIENCE			English	Article							LONG-TERM-MEMORY; CAMP-RESPONSIVE ELEMENT; CREB PHOSPHORYLATION; GENETIC ENHANCEMENT; LATE-PHASE; POTENTIATION; AMYGDALA; NUCLEUS; CONSOLIDATION; TRANSCRIPTION	The ability to remember potential dangers in an environment is necessary to the survival of animals and humans. The cyclic AMP-responsive element binding protein (CREB) is a key transcription factor in synaptic plasticity and memory consolidation. We have found that in CaMKIV-/- mice-which are deficient in a component of the calcium-calmodulin-dependent protein kinase (CaMK) pathway, a major pathway of CREB activation-fear memory, but not persistent pain, was significantly reduced. CREB activation by fear conditioning and synaptic potentiation in the amygdala and cortical areas was reduced or blocked. We propose that cognitive memory related to a noxious shock can be disassociated from behavioral responses to tissue injury and inflammation.	Washington Univ, Pain Ctr, Dept Anesthesiol, St Louis, MO 63110 USA; Washington Univ, Pain Ctr, Dept Anat, St Louis, MO 63110 USA; Washington Univ, Pain Ctr, Dept Neurobiol, St Louis, MO 63110 USA; Washington Univ, Pain Ctr, Dept Psychiat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Immunol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Ctr Immunol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Zhuo, M (corresponding author), Washington Univ, Pain Ctr, Dept Anesthesiol, St Louis, MO 63110 USA.	zhuom@morpheus.wustl.edu	Zhuo, Min/A-2072-2008	Zhuo, Min/0000-0001-9062-3241; Chatila, Talal/0000-0001-7439-2762; Robinson, Daphne/0000-0002-8817-6937	PHS HHS [10833, 38680] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; BARTON O, 1979, COMPREHENSIVE ORGANI, V2, P83; BEACH ME, 1995, CELL, V81, P905, DOI 10.1016/0092-8674(95)90010-1; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; Davis M, 1997, PHILOS T ROY SOC B, V352, P1675, DOI 10.1098/rstb.1997.0149; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; Falls WA, 2000, BEHAV NEUROSCI, V114, P998, DOI 10.1037//0735-7044.114.5.998; FOSTER JL, 1984, J BIOL CHEM, V259, P3049; Frankland PW, 2001, NATURE, V411, P309, DOI 10.1038/35077089; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Guzowski JF, 1997, P NATL ACAD SCI USA, V94, P2693, DOI 10.1073/pnas.94.6.2693; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; Ho N, 2000, J NEUROSCI, V20, P6459, DOI 10.1523/JNEUROSCI.20-17-06459.2000; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Josselyn SA, 2001, J NEUROSCI, V21, P2404, DOI 10.1523/JNEUROSCI.21-07-02404.2001; Kang HJ, 2001, CELL, V106, P771, DOI 10.1016/S0092-8674(01)00497-4; Kerchner GA, 2001, NAT NEUROSCI, V4, P453, DOI 10.1038/87396; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Liao BR, 1999, P NATL ACAD SCI USA, V96, P6217, DOI 10.1073/pnas.96.11.6217; Lisman J, 1997, SCIENCE, V276, P2001, DOI 10.1126/science.276.5321.2001; LIVINGSTONE MS, 1984, CELL, V37, P205, DOI 10.1016/0092-8674(84)90316-7; Maren S, 1999, TRENDS NEUROSCI, V22, P561, DOI 10.1016/S0166-2236(99)01465-4; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; NAKAMURA Y, 1995, NEUROSCIENCE, V68, P181, DOI 10.1016/0306-4522(95)00092-W; Repa JC, 2001, NAT NEUROSCI, V4, P724, DOI 10.1038/89512; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; SAH P, 1991, J PHYSIOL-LONDON, V433, P615, DOI 10.1113/jphysiol.1991.sp018446; Schafe GE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-18-j0003.2000; Schafe GE, 2000, J NEUROSCI, V20, P8177; Schafe GE, 2001, TRENDS NEUROSCI, V24, P540, DOI 10.1016/S0166-2236(00)01969-X; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Soderling TR, 2000, CURR OPIN NEUROBIOL, V10, P375, DOI 10.1016/S0959-4388(00)00090-8; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Teruel MN, 2000, CURR BIOL, V10, P86, DOI 10.1016/S0960-9822(00)00295-5; Wei F, 2001, NAT NEUROSCI, V4, P164, DOI 10.1038/83993; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9	50	186	201	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2002	5	6					573	579		10.1038/nn0602-855	http://dx.doi.org/10.1038/nn0602-855			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	556XQ	12006982				2022-12-24	WOS:000175874600018
J	Graziano, MSA; Taylor, CSR; Moore, T				Graziano, MSA; Taylor, CSR; Moore, T			Complex movements evoked by microstimulation of precentral cortex	NEURON			English	Article							DORSOMEDIAL FRONTAL-CORTEX; MONKEY MOTOR CORTEX; ELECTRICAL-STIMULATION; PREMOTOR CORTEX; EYE-MOVEMENTS; SUPERIOR COLLICULUS; MACAQUE MONKEYS; RHESUS-MONKEYS; ARM MOVEMENTS; SPINAL-CORD	Electrical microstimulation was used to study primary motor and premotor cortex in monkeys. Each stimulation train was 500 ms in duration, approximating the time scale of normal reaching and grasping movements and the time scale of the neuronal activity that normally accompanies movement. This stimulation on a behaviorally relevant time scale evoked coordinated, complex postures that involved many joints. For example, stimulation of one site caused the mouth to open and also caused the hand to shape into a grip posture and move to the mouth. Stimulation of this site always drove the joints toward this final posture, regardless of the direction of movement required to reach the posture. Stimulation of other cortical sites evoked different postures. Postures that involved the arm were arranged across cortex to form a map of hand positions around the body. This stimulation-evoked map encompassed both primary motor and the adjacent premotor cortex. We suggest that these regions fit together into a single map of the workspace around the body.	Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA	Princeton University	Graziano, MSA (corresponding author), Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA.	graziano@princeton.edu			NATIONAL EYE INSTITUTE [R01EY011347] Funding Source: NIH RePORTER; NEI NIH HHS [EY-11347] Funding Source: Medline; NIMH NIH HHS [MH-12336] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ASANUMA H, 1976, EXP BRAIN RES, V26, P443; BIZZI E, 1989, HDB NEUROPSYCHOLOGY, V2, P229; Britten KH, 1998, NAT NEUROSCI, V1, P59, DOI 10.1038/259; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; CAGGIULA AR, 1966, SCIENCE, V153, P1284, DOI 10.1126/science.153.3741.1284; COLBY CL, 1988, J COMP NEUROL, V269, P392, DOI 10.1002/cne.902690307; DeAngelis GC, 1998, NATURE, V394, P677, DOI 10.1038/29299; DONOGHUE JP, 1992, EXP BRAIN RES, V89, P1; DUM RP, 1991, J NEUROSCI, V11, P667; Dum RP, 1996, J NEUROSCI, V16, P6513; Evarts EV, 1981, HDB PHYSL NERVOUS SY, VII, P1083; Ferrier D, 1873, Br Med J, V1, P457; FETZ EE, 1980, J NEUROPHYSIOL, V43, P1070, DOI 10.1152/jn.1980.43.4.1070; Fogassi L, 1996, J NEUROPHYSIOL, V76, P141, DOI 10.1152/jn.1996.76.1.141; Freedman EG, 1996, J NEUROPHYSIOL, V76, P927, DOI 10.1152/jn.1996.76.2.927; FRITSCH G, 1870, CEREB CORTEX, P73; Fulton JF, 1935, BRAIN, V58, P311, DOI 10.1093/brain/58.2.311; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; GISZTER SF, 1993, J NEUROSCI, V13, P467; GOTTLIEB JP, 1993, J NEUROPHYSIOL, V69, P786, DOI 10.1152/jn.1993.69.3.786; Graziano MSA, 1999, NATURE, V397, P428, DOI 10.1038/17115; Graziano MSA, 1997, J NEUROPHYSIOL, V77, P2268, DOI 10.1152/jn.1997.77.5.2268; Graziano MSA, 2000, EXP BRAIN RES, V135, P259, DOI 10.1007/s002210000518; HOEBEL BG, 1969, ANN NY ACAD SCI, V157, P758, DOI 10.1111/j.1749-6632.1969.tb12919.x; HUNTLEY GW, 1991, J NEUROPHYSIOL, V66, P390, DOI 10.1152/jn.1991.66.2.390; Kakei S, 1999, SCIENCE, V285, P2136, DOI 10.1126/science.285.5436.2136; KENNEDY H, 1986, J COMP NEUROL, V247, P398, DOI 10.1002/cne.902470309; KURATA K, 1989, EXP BRAIN RES, V77, P245, DOI 10.1007/BF00274982; LEMON RN, 1976, PROC R SOC SER B-BIO, V194, P313, DOI 10.1098/rspb.1976.0082; Maier MA, 2002, CEREB CORTEX, V12, P281, DOI 10.1093/cercor/12.3.281; Moran DW, 2000, NAT NEUROSCI, V3, P963, DOI 10.1038/79880; MORASSO P, 1981, EXP BRAIN RES, V42, P223; OKADA E, 1991, PHYSIOL BEHAV, V50, P229, DOI 10.1016/0031-9384(91)90525-S; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; Preuss TM, 1996, J COMP NEUROL, V371, P649, DOI 10.1002/(SICI)1096-9861(19960805)371:4<649::AID-CNE12>3.0.CO;2-E; QUAADE F, 1974, ACTA NEUROCHIR, V30, P111, DOI 10.1007/BF01405759; Reina GA, 2001, J NEUROPHYSIOL, V85, P2576, DOI 10.1152/jn.2001.85.6.2576; RIZZOLATTI G, 1988, EXP BRAIN RES, V71, P491, DOI 10.1007/BF00248742; RIZZOLATTI G, 1981, BEHAV BRAIN RES, V2, P147, DOI 10.1016/0166-4328(81)90053-X; ROBINSON DA, 1972, VISION RES, V12, P1795, DOI 10.1016/0042-6989(72)90070-3; ROBINSON DA, 1969, J NEUROPHYSIOL, V32, P637, DOI 10.1152/jn.1969.32.5.637; Russo GS, 2000, J NEUROPHYSIOL, V84, P2605, DOI 10.1152/jn.2000.84.5.2605; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; SANES JN, 1995, SCIENCE, V268, P1775, DOI 10.1126/science.7792606; SATO KC, 1989, J NEUROPHYSIOL, V62, P959, DOI 10.1152/jn.1989.62.4.959; SCHIEBER MH, 1993, SCIENCE, V261, P489, DOI 10.1126/science.8332915; SCHILLER PH, 1972, J NEUROPHYSIOL, V35, P915, DOI 10.1152/jn.1972.35.6.915; Scott SH, 2000, NAT NEUROSCI, V3, P964, DOI 10.1038/79888; SESSLE BJ, 1982, J PHYSIOL-LONDON, V323, P245, DOI 10.1113/jphysiol.1982.sp014071; Stanford TR, 1996, J NEUROPHYSIOL, V76, P3360, DOI 10.1152/jn.1996.76.5.3360; STRICK PL, 1978, BRAIN RES, V154, P366, DOI 10.1016/0006-8993(78)90707-2; TEHOVNIK EJ, 1993, EXP BRAIN RES, V96, P430; Tehovnik EJ, 1996, J NEUROSCI METH, V65, P1, DOI 10.1016/0165-0270(95)00131-X; TEHOVNIK EJ, 1995, BEHAV BRAIN RES, V67, P147, DOI 10.1016/0166-4328(94)00151-5; Thier P, 1998, J NEUROPHYSIOL, V80, P1713, DOI 10.1152/jn.1998.80.4.1713; Todorov E, 2000, NAT NEUROSCI, V3, P391, DOI 10.1038/73964; WEINRICH M, 1982, J NEUROSCI, V2, P1329; WOOLSEY CN, 1950, RES PUBL ASSOC RES N, V30, P238; Wu CWH, 2000, J COMP NEUROL, V423, P140, DOI 10.1002/1096-9861(20000717)423:1<140::AID-CNE12>3.0.CO;2-3	59	607	628	0	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 30	2002	34	5					841	851		10.1016/S0896-6273(02)00698-0	http://dx.doi.org/10.1016/S0896-6273(02)00698-0			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	558DV	12062029	Bronze			2022-12-24	WOS:000175951800017
J	Kao, HT; Song, HJ; Porton, B; Ming, GL; Hoh, J; Abraham, M; Czernik, AJ; Pieribone, VA; Poo, MM; Greengard, P				Kao, HT; Song, HJ; Porton, B; Ming, GL; Hoh, J; Abraham, M; Czernik, AJ; Pieribone, VA; Poo, MM; Greengard, P			A protein kinase A-dependent molecular switch in synapsins regulates neurite outgrowth	NATURE NEUROSCIENCE			English	Article							SYNAPTIC VESICLE PHOSPHOPROTEINS; GROWTH CONE GUIDANCE; NEUROTRANSMITTER RELEASE; NEURONAL DIFFERENTIATION; NEUROMUSCULAR SYNAPSES; ACTIN POLYMERIZATION; AXONAL GROWTH; PHOSPHORYLATION; CELLS; RAT	Cyclic AMP (cAMP) promotes neurite outgrowth in a variety of neuronal cell lines through the activation of protein kinase A (PKA). We show here, using both Xenopus laevis embryonic neuronal culture and intact X. laevis embryos, that the nerve growth-promoting action of cAMP/PKA is mediated in part by the phosphorylation of synapsins at a single amino acid residue. Expression of a mutated form of synapsin that prevents phosphorylation at this site, or introduction of phospho-specific antibodies directed against this site, decreased basal and dibutyryl cAMP-stimulated neurite outgrowth. Expression of a mutation mimicking constitutive phosphorylation at this site increased neurite outgrowth, both under basal conditions and in the presence of a PKA inhibitor. These results provide a potential molecular approach for stimulating neuron regeneration, after injury and in neuro-degenerative diseases.	Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA; Rockefeller Univ, Lab Stat Genet, New York, NY 10021 USA; NYU, Med Ctr, Dept Psychiat, New York, NY 10016 USA; Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Yale Univ, Sch Med, John B Pierce Lab, New Haven, CT 06510 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Rockefeller University; Rockefeller University; New York University; Salk Institute; University of California System; University of California San Diego; Yale University; The John B Pierce Laboratory, Inc; University of California System; University of California Berkeley	Kao, HT (corresponding author), Rockefeller Univ, Mol & Cellular Neurosci Lab, 1230 York Ave, New York, NY 10021 USA.	kaoh@rockvax.rockefeller.edu	Ming, Guo-li/J-7880-2013	Pieribone, Vincent/0000-0002-5836-5454; Ming, Guo-li/0000-0002-2517-6075	NIA NIH HHS [AG15072] Funding Source: Medline; NIMH NIH HHS [MH39327] Funding Source: Medline; NINDS NIH HHS [R29 NS35941, NS37831] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH039327, R01MH039327] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037831, R29NS035941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG015072] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		CACERES A, 1991, J NEUROSCI, V11, P1515; Cai DM, 1999, NEURON, V22, P89, DOI 10.1016/S0896-6273(00)80681-9; CHIN LS, 1995, P NATL ACAD SCI USA, V92, P9230, DOI 10.1073/pnas.92.20.9230; CZERNIK AJ, 1987, P NATL ACAD SCI USA, V84, P7518, DOI 10.1073/pnas.84.21.7518; CZERNIK AJ, 1991, METHOD ENZYMOL, P264; Doherty P, 2000, MOL CELL NEUROSCI, V16, P283, DOI 10.1006/mcne.2000.0907; Esser L, 1998, EMBO J, V17, P977, DOI 10.1093/emboj/17.4.977; FEANY MB, 1992, CELL, V70, P861, DOI 10.1016/0092-8674(92)90319-8; Ferreira A, 2000, J NEUROSCI, V20, P3736, DOI 10.1523/JNEUROSCI.20-10-03736.2000; FERREIRA A, 1995, P NATL ACAD SCI USA, V92, P9225, DOI 10.1073/pnas.92.20.9225; FESCE R, 1992, J BIOL CHEM, V267, P11289; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; GRANT P, 1986, DEV BIOL, V114, P475, DOI 10.1016/0012-1606(86)90212-5; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; HAN HQ, 1991, NATURE, V349, P697, DOI 10.1038/349697a0; Hilfiker S, 1999, PHILOS T ROY SOC B, V354, P269, DOI 10.1098/rstb.1999.0378; Hosaka M, 1998, J BIOL CHEM, V273, P13371, DOI 10.1074/jbc.273.22.13371; Hosaka M, 1998, J BIOL CHEM, V273, P1425, DOI 10.1074/jbc.273.3.1425; JOHNSON EM, 1972, J BIOL CHEM, V247, P5650; Jovanovic JN, 2000, NAT NEUROSCI, V3, P323, DOI 10.1038/73888; Jovanovic JN, 1996, P NATL ACAD SCI USA, V93, P3679, DOI 10.1073/pnas.93.8.3679; Kao HT, 1999, J EXP ZOOL, V285, P360, DOI 10.1002/(SICI)1097-010X(19991215)285:4<360::AID-JEZ4>3.3.CO;2-V; KASE H, 1987, BIOCHEM BIOPH RES CO, V142, P436, DOI 10.1016/0006-291X(87)90293-2; LEVITAN IB, 1997, NEURON; LIESI P, 1983, NATURE, V306, P265, DOI 10.1038/306265a0; Lin WC, 1995, J NEUROSCI, V15, P8331; LU B, 1992, NEURON, V8, P521, DOI 10.1016/0896-6273(92)90280-Q; Lu B, 1996, NEUROSCIENCE, V74, P1087, DOI 10.1016/0306-4522(96)00187-X; Matsubara M, 1996, J BIOL CHEM, V271, P21108, DOI 10.1074/jbc.271.35.21108; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Nielander HB, 1997, EUR J NEUROSCI, V9, P2712, DOI 10.1111/j.1460-9568.1997.tb01700.x; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; PICCIOTTO MR, 1993, J BIOL CHEM, V268, P26512; Porton B, 1999, J NEUROCHEM, V73, P2266, DOI 10.1046/j.1471-4159.1999.0732266.x; RYDEL RE, 1988, P NATL ACAD SCI USA, V85, P1257, DOI 10.1073/pnas.85.4.1257; SCHAEFFER E, 1994, P NATL ACAD SCI USA, V91, P3882, DOI 10.1073/pnas.91.9.3882; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; SKENE JHP, 1989, ANNU REV NEUROSCI, V12, P127, DOI 10.1146/annurev.ne.12.030189.001015; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Song HJ, 1999, CURR OPIN NEUROBIOL, V9, P355, DOI 10.1016/S0959-4388(99)80052-X; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; SUDHOF TC, 1989, SCIENCE, V245, P1474, DOI 10.1126/science.2506642; Tabti N, 1998, CULTURING NERVE CELL, P237; Zhong ZG, 1999, NEUROSCI LETT, V260, P93, DOI 10.1016/S0304-3940(98)00969-0	45	119	124	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2002	5	5					431	437		10.1038/nn840	http://dx.doi.org/10.1038/nn840			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	546JY	11976703				2022-12-24	WOS:000175272000013
J	Kahn, I; Yeshurun, Y; Rotshtein, P; Fried, I; Ben-Bashat, D; Hendler, T				Kahn, I; Yeshurun, Y; Rotshtein, P; Fried, I; Ben-Bashat, D; Hendler, T			The role of the amygdala in signaling prospective outcome of choice	NEURON			English	Article							ORBITAL PREFRONTAL CORTEX; ORBITOFRONTAL CORTEX; BASOLATERAL AMYGDALA; EMOTIONAL RESPONSES; NEUROTOXIC LESIONS; FACIAL EXPRESSIONS; LATERAL AMYGDALA; FUNCTIONAL MRI; FEAR; ACTIVATION	Can brain activity reveal a covert choice? Making a choice often evokes distinct emotions that accompany decision processes. Amygdala has been implicated in choice behavior that is guided by a prospective negative outcome. However, its specific involvement in emotional versus cognitive processing of choice behavior has been a subject of controversy. In this study, the human amygdala was monitored by functional magnetic resonance imaging (fMRI) while subjects were playing in a naturalistic choice paradigm against the experimenter. In order to win, players had to occasionally choose to bluff their opponent, risk "getting caught," and suffer a loss. A critical period, when choice has been made but outcome was still unknown, activated the amygdala preferentially following the choice that entailed risk of loss. Thus, the response of the amygdala differentiated between subject's covert choice of either playing fair or foul. These results support a role of the amygdala in choice behavior, both in the appraisal of inherent value of choice and the signaling of prospective negative outcomes.	Tel Aviv Sourasky Med Ctr, Wohl Inst Adv Imaging, IL-64239 Tel Aviv, Israel; Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, Sch Comp Sci, Sackler Fac Exact Sci, IL-69978 Tel Aviv, Israel; Univ Calif Los Angeles, Div Neurosurg, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Hendler, T (corresponding author), Tel Aviv Sourasky Med Ctr, Wohl Inst Adv Imaging, 6 Weizmann St, IL-64239 Tel Aviv, Israel.		hendler, talma/C-7677-2012	Ben Bashat, Dafna/0000-0001-8396-1031; Kahn, Itamar/0000-0002-1895-8677; Rotshtein, Pia/0000-0002-0301-9511				Adolphs R, 1998, NATURE, V393, P470, DOI 10.1038/30982; ADOLPHS R, 1995, J NEUROSCI, V15, P5879; Baxter MG, 2000, J NEUROSCI, V20, P4311; Bechara A, 1999, J NEUROSCI, V19, P5473; BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6; Critchley HD, 2001, NEURON, V29, P537, DOI 10.1016/S0896-6273(01)00225-2; DAMASIO AR, 1994, SCI AM, V271, P144, DOI 10.1038/scientificamerican1094-144; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; Dierks T, 1999, NEURON, V22, P615, DOI 10.1016/S0896-6273(00)80715-1; Elliott R, 2000, CEREB CORTEX, V10, P308, DOI 10.1093/cercor/10.3.308; Elliott R, 1997, NEUROPSYCHOLOGIA, V35, P1395, DOI 10.1016/S0028-3932(97)00055-9; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Goebel R, 1998, EUR J NEUROSCI, V10, P1563, DOI 10.1046/j.1460-9568.1998.00181.x; Hatfield T, 1996, J NEUROSCI, V16, P5256; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Killcross S, 1997, NATURE, V388, P377, DOI 10.1038/41097; Kluver H, 1997, J NEUROPSYCH CLIN N, V9, P606; Knight DC, 1999, NEUROREPORT, V10, P3665, DOI 10.1097/00001756-199911260-00037; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; LABAR KS, 1995, J NEUROSCI, V15, P6846; LaBar KS, 1998, NEURON, V20, P937, DOI 10.1016/S0896-6273(00)80475-4; LeDoux J, 1998, BIOL PSYCHIAT, V44, P1229, DOI 10.1016/S0006-3223(98)00282-0; LeDoux J. E., 1996, EMOTIONAL BRAIN MYST; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; LOOMES G, 1986, REV ECON STUD, V53, P271, DOI 10.2307/2297651; LOOMES G, 1989, ECON J, V99, P140, DOI 10.2307/2234076; Malkova L, 1997, J NEUROSCI, V17, P6011; Mellers B, 1999, J EXP PSYCHOL GEN, V128, P332, DOI 10.1037/0096-3445.128.3.332; Mellers BA, 1997, PSYCHOL SCI, V8, P423, DOI 10.1111/j.1467-9280.1997.tb00455.x; Meunier M, 1999, EUR J NEUROSCI, V11, P4403, DOI 10.1046/j.1460-9568.1999.00854.x; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; Pare D, 2000, J NEUROSCI, V20, P2701; Phelps EA, 2001, NAT NEUROSCI, V4, P437, DOI 10.1038/86110; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Quirk GJ, 1997, NEURON, V19, P613, DOI 10.1016/S0896-6273(00)80375-X; Rogers RD, 1999, J NEUROSCI, V19, P9029, DOI 10.1523/JNEUROSCI.19-20-09029.1999; ROLLS ET, 1999, BRAIN EMOTION; Rotshtein P, 2001, NEURON, V32, P747, DOI 10.1016/S0896-6273(01)00513-X; Schneider F, 1997, PSYCHIAT RES-NEUROIM, V76, P75, DOI 10.1016/S0925-4927(97)00063-2; Schneider F, 2000, NEUROPSYCHOBIOLOGY, V42, P192, DOI 10.1159/000026693; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; Talairach J, 1988, CO PLANAR STEREOTAXI; TRANEL D, 1990, ARCH NEUROL-CHICAGO, V47, P349, DOI 10.1001/archneur.1990.00530030131029; Whalen PJ, 1998, J NEUROSCI, V18, P411; Zalla T, 2000, EUR J NEUROSCI, V12, P1764, DOI 10.1046/j.1460-9568.2000.00064.x; Zola-Morgan S, 1991, Hippocampus, V1, P207, DOI 10.1002/hipo.450010208	52	75	75	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 14	2002	33	6					983	994		10.1016/S0896-6273(02)00626-8	http://dx.doi.org/10.1016/S0896-6273(02)00626-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	530ZK	11906703	Bronze			2022-12-24	WOS:000174389600014
J	Di Paolo, G; Sankaranarayanan, S; Wenk, MR; Daniell, L; Perucco, E; Caldarone, BJ; Flavell, R; Picciotto, MR; Ryan, TA; Cremona, O; De Camilli, P				Di Paolo, G; Sankaranarayanan, S; Wenk, MR; Daniell, L; Perucco, E; Caldarone, BJ; Flavell, R; Picciotto, MR; Ryan, TA; Cremona, O; De Camilli, P			Decreased synaptic vesicle recycling efficiency and cognitive deficits in amphiphysin 1 knockout mice	NEURON			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; SH3 DOMAIN; DROSOPHILA AMPHIPHYSIN; ACTIN CYTOSKELETON; POOL MOBILIZATION; BINDING-PROTEIN; DYNAMIN; INTERACTS; MEMBRANE; BRAIN	The function of the clathrin coat in synaptic vesicle endocytosis is assisted by a variety of accessory factors, among which amphiphysin (amphiphysin 1 and 2) is one of the best characterized. A putative endocytic function of amphiphysin was supported by dominant-negative interference studies. We have now generated amphiphysin 1 knockout mice and found that lack of amphiphysin 1 causes a parallel dramatic reduction of amphiphysin 2 selectively in brain. Cell-free assembly of endocytic protein scaffolds is defective in mutant brain extracts. Knockout mice exhibit defects in synaptic vesicle recycling that are unmasked by stimulation and suggest impairments at multiple stages of the cycle. These defects correlate with increased mortality due to rare irreversible seizures and with major learning deficits, suggesting a critical role of amphiphysin for higher brain functions.	Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; Yale Univ, Sch Med, Immunol Sect, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06510 USA; Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA; Univ Piemonte Orientale, Dipartimento Sci Med, I-28100 Novara, Italy; Univ Vita Salute San Raffaele Milano, San Raffaele Sci Inst, I-20132 Milan, Italy	Howard Hughes Medical Institute; Yale University; Yale University; Yale University; Yale University; Cornell University; University of Eastern Piedmont Amedeo Avogadro; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	De Camilli, P (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA.	pietro.decamilli@yale.edu	Cremona, Ottavio/AAB-8793-2019; Ryan, Timothy/AAO-8286-2020; Picciotto, Marina R./F-8747-2012; Wenk, Markus Rene/D-1441-2014	Cremona, Ottavio/0000-0001-9462-1040; Picciotto, Marina R./0000-0002-4404-1280; Ryan, Timothy/0000-0003-2533-9548	NATIONAL CANCER INSTITUTE [P01CA046128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM061925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH025642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS036251, R01NS036251] Funding Source: NIH RePORTER; NCI NIH HHS [CA46128] Funding Source: Medline; NIDA NIH HHS [DA00436] Funding Source: Medline; NIGMS NIH HHS [GM61925] Funding Source: Medline; NIMH NIH HHS [MH25642] Funding Source: Medline; NINDS NIH HHS [NS24692, NS36251] Funding Source: Medline; Telethon [D.111] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Telethon(Fondazione Telethon)		Banker G., 1991, CULTURING NERVE CELL; Bauerfeind R, 1997, J BIOL CHEM, V272, P30984, DOI 10.1074/jbc.272.49.30984; Brodin L, 2000, CURR OPIN NEUROBIOL, V10, P312, DOI 10.1016/S0959-4388(00)00097-0; Burger KNJ, 2000, BIOCHEMISTRY-US, V39, P12485, DOI 10.1021/bi000971r; Butler MH, 1997, J CELL BIOL, V137, P1355, DOI 10.1083/jcb.137.6.1355; Caldarone BJ, 2000, NEUROPHARMACOLOGY, V39, P2779, DOI 10.1016/S0028-3908(00)00137-4; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Cousin MA, 2000, J NEUROCHEM, V75, P1645, DOI 10.1046/j.1471-4159.2000.0751645.x; Cousin MA, 1998, NEUROSCI LETT, V253, P1, DOI 10.1016/S0304-3940(98)00610-7; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Cremona O, 1997, CURR OPIN NEUROBIOL, V7, P323, DOI 10.1016/S0959-4388(97)80059-1; CROUZET M, 1991, YEAST, V7, P727, DOI 10.1002/yea.320070708; D'Adamo P, 1998, NAT GENET, V19, P134, DOI 10.1038/487; David C, 1996, P NATL ACAD SCI USA, V93, P331, DOI 10.1073/pnas.93.1.331; DECAMILLI P, 1993, J EXP MED, V178, P2219, DOI 10.1084/jem.178.6.2219; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; Dunaevsky A, 2000, J NEUROSCI, V20, P6007, DOI 10.1523/JNEUROSCI.20-16-06007.2000; Elliott K, 1999, ONCOGENE, V18, P3564, DOI 10.1038/sj.onc.1202670; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Gad H, 2000, NEURON, V27, P301, DOI 10.1016/S0896-6273(00)00038-6; Gad H, 1998, NEURON, V21, P607, DOI 10.1016/S0896-6273(00)80570-X; Galarreta M, 1998, NAT NEUROSCI, V1, P587, DOI 10.1038/2822; Ge K, 2000, GENOMICS, V67, P210, DOI 10.1006/geno.2000.6216; Geli MI, 1998, J CELL SCI, V111, P1031; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Hussain NK, 2001, NAT CELL BIOL, V3, P927, DOI 10.1038/ncb1001-927; Kadlec L, 1997, P NATL ACAD SCI USA, V94, P12390, DOI 10.1073/pnas.94.23.12390; Kittler JT, 2000, J NEUROSCI, V20, P7972; Kraushaar U, 2000, J NEUROSCI, V20, P5594, DOI 10.1523/JNEUROSCI.20-15-05594.2000; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Leprince C, 1997, J BIOL CHEM, V272, P15101, DOI 10.1074/jbc.272.24.15101; Leventis PA, 2001, TRAFFIC, V2, P839; Lombardi R, 2001, J BIOL CHEM, V276, P6016, DOI 10.1074/jbc.M008735200; Luthi A, 2001, J NEUROSCI, V21, P9101, DOI 10.1523/JNEUROSCI.21-23-09101.2001; Marks B, 1998, CURR BIOL, V8, P740, DOI 10.1016/S0960-9822(98)70297-0; Marsh M, 1999, SCIENCE, V285, P215, DOI 10.1126/science.285.5425.215; Mayford M, 1999, TRENDS GENET, V15, P463, DOI 10.1016/S0168-9525(99)01846-6; McMahon HT, 1997, FEBS LETT, V413, P319, DOI 10.1016/S0014-5793(97)00928-9; McNiven MA, 2000, J CELL BIOL, V151, P187, DOI 10.1083/jcb.151.1.187; McPherson PS, 2001, TRAFFIC, V2, P375, DOI 10.1034/j.1600-0854.2001.002006375.x; McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0; Modregger J, 2000, J CELL SCI, V113, P4511; MORRIS RGM, 1989, J NEUROSCI, V9, P3040; Mundigl O, 1998, J NEUROSCI, V18, P93; Navarro P, 1997, BBA-PROTEIN STRUCT M, V1343, P187, DOI 10.1016/S0167-4838(97)00108-8; NICHOLLS DG, 1986, NATURE, V321, P772, DOI 10.1038/321772a0; Ochoa GC, 2000, J CELL BIOL, V150, P377, DOI 10.1083/jcb.150.2.377; Owen DJ, 1998, EMBO J, V17, P5273, DOI 10.1093/emboj/17.18.5273; Owen DJ, 2000, CURR OPIN CELL BIOL, V12, P467, DOI 10.1016/S0955-0674(00)00118-6; PAYLOR R, 1994, BEHAV NEUROSCI, V108, P810, DOI 10.1037/0735-7044.108.4.810; Qualmann B, 1999, MOL BIOL CELL, V10, P501, DOI 10.1091/mbc.10.2.501; Qualmann B, 2000, J CELL BIOL, V150, pF111, DOI 10.1083/jcb.150.5.F111; Ramjaun AR, 1999, J BIOL CHEM, V274, P19785, DOI 10.1074/jbc.274.28.19785; Ramjaun AR, 1997, J BIOL CHEM, V272, P16700, DOI 10.1074/jbc.272.26.16700; Ramjaun AR, 1998, J NEUROCHEM, V70, P2369; Razzaq A, 2000, GENE, V241, P167, DOI 10.1016/S0378-1119(99)00451-5; Razzaq A, 2001, GENE DEV, V15, P2967, DOI 10.1101/gad.207801; Roos J, 1998, J BIOL CHEM, V273, P19108, DOI 10.1074/jbc.273.30.19108; Roos J, 1999, CURR BIOL, V9, P1411, DOI 10.1016/S0960-9822(00)80087-1; Routhier EL, 2001, J BIOL CHEM, V276, P21670, DOI 10.1074/jbc.M101096200; Ryan TA, 1999, J NEUROSCI, V19, P1317; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; Sakisaka T, 1997, MOL CELL BIOL, V17, P3841, DOI 10.1128/MCB.17.7.3841; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; Silva AJ, 1996, CURR BIOL, V6, P1509, DOI 10.1016/S0960-9822(96)00756-7; SIVADON P, 1995, MOL GEN GENET, V246, P485, DOI 10.1007/BF00290452; Slepnev VI, 2000, J BIOL CHEM, V275, P17583, DOI 10.1074/jbc.M910430199; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Slepnev VI, 1998, SCIENCE, V281, P821, DOI 10.1126/science.281.5378.821; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; Teng HB, 2000, J NEUROSCI, V20, P7986; Turrigiano GG, 2000, NEURON, V26, P5, DOI 10.1016/S0896-6273(00)81131-9; Varela JA, 1999, J NEUROSCI, V19, P4293; Wasiak S, 2001, J BIOL CHEM, V276, P26622, DOI 10.1074/jbc.M100591200; WechslerReya R, 1997, J BIOL CHEM, V272, P31453, DOI 10.1074/jbc.272.50.31453; Wickman K, 2000, J NEUROSCI, V20, P5608, DOI 10.1523/JNEUROSCI.20-15-05608.2000; Wigge P, 1997, MOL BIOL CELL, V8, P2003, DOI 10.1091/mbc.8.10.2003; Wigge P, 1998, TRENDS NEUROSCI, V21, P339, DOI 10.1016/S0166-2236(98)01264-8; Wigge P, 1997, CURR BIOL, V7, P554, DOI 10.1016/S0960-9822(06)00254-5; Witke W, 1998, EMBO J, V17, P967, DOI 10.1093/emboj/17.4.967; Yang D, 1997, P NATL ACAD SCI USA, V94, P3004, DOI 10.1073/pnas.94.7.3004; Zelhof AC, 2001, DEVELOPMENT, V128, P5005	83	170	172	2	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 28	2002	33	5					789	804		10.1016/S0896-6273(02)00601-3	http://dx.doi.org/10.1016/S0896-6273(02)00601-3			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	529EC	11879655	Bronze			2022-12-24	WOS:000174286200014
J	Pack, CC; Born, RT; Livingstone, MS				Pack, CC; Born, RT; Livingstone, MS			Two-dimensional substructure of stereo and motion interactions in macaque visual cortex	NEURON			English	Article							DISPARITY-SELECTIVE NEURONS; CAT STRIATE CORTEX; PRIMATE AREA MT; RECEPTIVE-FIELDS; COMPLEX CELLS; CORTICAL AREA; APERTURE PROBLEM; MONKEY; DIRECTION; DEPTH	The analysis of object motion and stereoscopic depth are important tasks that are begun at early stages of the primate visual system. Using sparse white noise, we mapped the receptive field substructure of motion and disparity interactions in neurons in V1 and MT of alert monkeys. Interactions in both regions revealed subunits similar in structure to V1 simple cells. For both motion and stereo, the scale and shape of the receptive field substructure could be predicted from conventional tuning for bars or dot-field stimuli, indicating that the small-scale interactions were repeated across the receptive fields. We also found neurons in V1 and in MT that were tuned to combinations of spatial and temporal binocular disparities, suggesting a possible neural substrate for the perceptual Pulfrich phenomenon. Our observations constrain computational and developmental models of motion-stereo integration.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Pack, CC (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.		Born, Richard/M-6454-2019	Born, Richard/0000-0003-4360-427X; Livingstone, Margaret/0000-0002-1950-0123	NEI NIH HHS [R01 EY013135-01, R01 EY013135-02, EY12196, R01 EY013135-03, EY11379, EY13135] Funding Source: Medline; NINDS NIH HHS [NS07484] Funding Source: Medline; NATIONAL EYE INSTITUTE [P30EY012196, R01EY013135, R01EY011379] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; Anzai A, 2001, NAT NEUROSCI, V4, P513, DOI 10.1038/87462; Anzai A, 1999, J NEUROPHYSIOL, V82, P909, DOI 10.1152/jn.1999.82.2.909; BAKER CL, 1986, J NEUROPHYSIOL, V55, P1136, DOI 10.1152/jn.1986.55.6.1136; Born RT, 2000, NEURON, V26, P725, DOI 10.1016/S0896-6273(00)81208-8; BRADLEY DC, 1995, NATURE, V373, P609, DOI 10.1038/373609a0; Bradley DC, 1998, NATURE, V392, P714, DOI 10.1038/33688; Bradley DC, 1998, J NEUROSCI, V18, P7552; Britten KH, 1999, J NEUROSCI, V19, P5074; BURR DC, 1979, VISION RES, V19, P523, DOI 10.1016/0042-6989(79)90137-8; Cumming BG, 2001, ANNU REV NEUROSCI, V24, P203, DOI 10.1146/annurev.neuro.24.1.203; DeAngelis GC, 1999, J NEUROSCI, V19, P1398; Dodd JV, 2001, J NEUROSCI, V21, P4809, DOI 10.1523/JNEUROSCI.21-13-04809.2001; Duncan RO, 2000, J NEUROSCI, V20, P5885, DOI 10.1523/JNEUROSCI.20-15-05885.2000; EMERSON RC, 1987, J NEUROPHYSIOL, V58, P33, DOI 10.1152/jn.1987.58.1.33; Fernandez JM, 2002, VISION RES, V42, P883, DOI 10.1016/S0042-6989(02)00023-8; GASKA JP, 1994, VISUAL NEUROSCI, V11, P805, DOI 10.1017/S0952523800003102; HOWARD IP, 1989, EXP BRAIN RES, V78, P309; Lappe M, 1996, NEURAL COMPUT, V8, P1449, DOI 10.1162/neco.1996.8.7.1449; Livingstone MS, 2001, NEURON, V30, P781, DOI 10.1016/S0896-6273(01)00313-0; Livingstone MS, 1998, NEURON, V20, P509, DOI 10.1016/S0896-6273(00)80991-5; Livingstone MS, 1999, NAT NEUROSCI, V2, P825, DOI 10.1038/12199; LIVINGSTONE MS, 2003, IN PRESS J NEUROPHYS; MARDIA KV, 1975, J ROY STAT SOC B, V34, P102; Marr D., 1982, VISION; Martinez LM, 2001, NEURON, V32, P515, DOI 10.1016/S0896-6273(01)00489-5; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1148, DOI 10.1152/jn.1983.49.5.1148; MIKAMI A, 1986, J NEUROPHYSIOL, V55, P1328, DOI 10.1152/jn.1986.55.6.1328; Morgan MJ, 1997, VISION RES, V37, P2737, DOI 10.1016/S0042-6989(97)00074-6; MORGAN MJ, 1995, NATURE, V378, P380, DOI 10.1038/378380a0; Movshon J.A., 1985, PATTERN RECOGN, P117; Movshon JA, 1996, J NEUROSCI, V16, P7733; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P79, DOI 10.1113/jphysiol.1978.sp012489; O'Keefe LP, 1998, VISUAL NEUROSCI, V15, P305, DOI 10.1017/S0952523898152094; Pack CC, 2001, NATURE, V409, P1040, DOI 10.1038/35059085; Pack CC, 2001, NATURE, V414, P905, DOI 10.1038/414905a; Perez R, 1999, EUR J NEUROSCI, V11, P2593, DOI 10.1046/j.1460-9568.1999.00700.x; Prince SJD, 2002, J NEUROPHYSIOL, V87, P191, DOI 10.1152/jn.00465.2000; Pulfrich C, 1922, NATURWISSENSCHAFTEN, V10, P553, DOI 10.1007/BF01571319; Qian N, 1997, VISION RES, V37, P1683, DOI 10.1016/S0042-6989(96)00164-2; ROY JP, 1992, J NEUROSCI, V12, P2478; Smith EL, 1997, J NEUROPHYSIOL, V78, P351, DOI 10.1152/jn.1997.78.1.351; Stoner GR, 1998, VISION RES, V38, P387, DOI 10.1016/S0042-6989(97)00132-6; SZULBORSKI RG, 1990, VISION RES, V30, P249, DOI 10.1016/0042-6989(90)90040-R; van Ee R, 2001, NATURE, V410, P690, DOI 10.1038/35070569; Von Gruenau Michael, 1993, Spatial Vision, V7, P227, DOI 10.1163/156856893X00388	46	53	53	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 6	2003	37	3					525	535		10.1016/S0896-6273(02)01187-X	http://dx.doi.org/10.1016/S0896-6273(02)01187-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	647FF	12575958	Bronze			2022-12-24	WOS:000181081600016
J	Tan, J; Town, T; Crawford, F; Mori, T; DelleDonne, A; Crescentini, R; Obregon, D; Flavell, RA; Mullan, MJ				Tan, J; Town, T; Crawford, F; Mori, T; DelleDonne, A; Crescentini, R; Obregon, D; Flavell, RA; Mullan, MJ			Role of CD40 ligand in amyloidosis in transgenic Alzheimer's mice	NATURE NEUROSCIENCE			English	Article							PRECURSOR PROTEIN; MICROGLIAL ACTIVATION; ENDOTHELIAL-CELLS; BETA-SECRETASE; SMOOTH-MUSCLE; MOUSE MODEL; DISEASE; PATHOLOGY; ATHEROSCLEROSIS; INFLAMMATION	We have shown that interaction of CD40 with CD40L enables microglial activation in response to amyloid-beta peptide (Abeta), which is associated with Alzheimer's disease (AD)-like neuronal tau hyperphosphorylation in vivo. Here we report that transgenic mice overproducing Abeta, but deficient in CD40L, showed decreased astrocytosis and microgliosis associated with diminished Abeta levels and beta-amyloid plaque load. Furthermore, in the PSAPP transgenic mouse model of AD, a depleting antibody against CD40L caused marked attenuation of Abeta/beta-amyloid pathology, which was associated with decreased amyloidogenic processing of amyloid precursor protein (APP) and increased circulating levels of Abeta. Conversely, in neuroblastoma cells overexpressing wild-type human APP, the CD40-CD40L interaction resulted in amyloidogenic APP processing. These findings suggest several possible mechanisms underlying mitigation of AD pathology in response to CD40L depletion, and validate the CD40-CD40L interaction as a target for therapeutic intervention in AD.	Univ S Florida, Roskamp Inst, Dept Psychiat, Tampa, FL 33613 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA	State University System of Florida; University of South Florida; Howard Hughes Medical Institute; Yale University	Mullan, MJ (corresponding author), Univ S Florida, Roskamp Inst, Dept Psychiat, 3515 E Fletcher Ave, Tampa, FL 33613 USA.		Tan, Jun/I-5339-2012	Mullan, Michael/0000-0002-1473-7527				BALL MJ, 1985, LANCET, V1, P14; Barger SW, 1997, NATURE, V388, P878, DOI 10.1038/42257; Calingasan NY, 2002, NEUROBIOL AGING, V23, P31, DOI 10.1016/S0197-4580(01)00246-9; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; DeMattos RB, 2002, SCIENCE, V295, P2264, DOI 10.1126/science.1067568; DiCarlo G, 2001, NEUROBIOL AGING, V22, P1007, DOI 10.1016/S0197-4580(01)00292-5; Giulian D, 1999, AM J HUM GENET, V65, P13, DOI 10.1086/302477; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Irizarry MC, 1997, J NEUROPATH EXP NEUR, V56, P965, DOI 10.1097/00005072-199709000-00002; ITAGAKI S, 1989, J NEUROIMMUNOL, V24, P173, DOI 10.1016/0165-5728(89)90115-X; Jantzen PT, 2002, J NEUROSCI, V22, P2246, DOI 10.1523/JNEUROSCI.22-06-02246.2002; Johnson D, 1997, EDN, V42, P94; Lim GP, 2000, J NEUROSCI, V20, P5709, DOI 10.1523/JNEUROSCI.20-15-05709.2000; Lim GP, 2001, J NEUROSCI, V21, P8370, DOI 10.1523/JNEUROSCI.21-21-08370.2001; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Mach F, 1997, P NATL ACAD SCI USA, V94, P1931, DOI 10.1073/pnas.94.5.1931; McGeer EG, 1998, EXP GERONTOL, V33, P371, DOI 10.1016/S0531-5565(98)00013-8; MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0; Nguyen VT, 1998, EUR J IMMUNOL, V28, P2537, DOI 10.1002/(SICI)1521-4141(199808)28:08<2537::AID-IMMU2537>3.0.CO;2-1; Piguet PF, 2001, AM J PATHOL, V159, P733, DOI 10.1016/S0002-9440(10)61744-0; Qiao XX, 2001, EUR J NEUROSCI, V14, P474, DOI 10.1046/j.0953-816x.2001.01666.x; Rogers J, 1996, NEUROBIOL AGING, V17, P681, DOI 10.1016/0197-4580(96)00115-7; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; SCHMIDT ML, 1990, AM J PATHOL, V136, P1069; Schonbeck U, 2000, P NATL ACAD SCI USA, V97, P7458, DOI 10.1073/pnas.97.13.7458; Schonbeck U, 1997, J BIOL CHEM, V272, P19569, DOI 10.1074/jbc.272.31.19569; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Tan J, 1999, SCIENCE, V286, P2352, DOI 10.1126/science.286.5448.2352; Tan J, 2002, EMBO J, V21, P643, DOI 10.1093/emboj/21.4.643; Thinakaran G, 1996, J BIOL CHEM, V271, P9390, DOI 10.1074/jbc.271.16.9390; Togo T, 2000, BRAIN RES, V885, P117, DOI 10.1016/S0006-8993(00)02984-X; Wilcock DM, 2001, DNA CELL BIOL, V20, P731, DOI 10.1089/10445490152717596; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6	35	175	182	0	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2002	5	12					1288	1293		10.1038/nn968	http://dx.doi.org/10.1038/nn968			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	618ZE	12402041				2022-12-24	WOS:000179447500011
J	Baker, CI; Behrmann, M; Olson, CR				Baker, CI; Behrmann, M; Olson, CR			Impact of learning on representation of parts and wholes in monkey inferotemporal cortex	NATURE NEUROSCIENCE			English	Article							INFERIOR TEMPORAL CORTEX; SHAPE REPRESENTATION; RECOGNITION MEMORY; PERIRHINAL NEURONS; ADULT MONKEYS; VISUAL IMAGES; MACAQUE; OBJECTS; FAMILIARITY; RESPONSES	Here we investigated the impact of visual discrimination training on neuronal responses to parts of images and to whole images in inferotemporal (IT) cortex. Monkeys were trained to discriminate among 'baton' stimuli consisting of discrete top and bottom parts joined by a vertical stem. With separate features at each end, we were able to manipulate the two parts of each baton independently. After training the monkeys, we used single-cell recording to compare neuronal responses to learned and unlearned batons. Responses to learned batons, though not enhanced in strength, were enhanced in selectivity for both individual parts and for whole batons. Whole-baton selectivity arose from a form of conjunctive encoding whereby two parts together exerted a greater influence on neuronal activity than predicted by the additive influence of each part considered individually. These results indicate a possible neural mechanism for holistic or configural effects in expert versus novice observers.	Ctr Neural Basis Cognit, Mellon Inst 115, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA; Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University	Baker, CI (corresponding author), Ctr Neural Basis Cognit, Mellon Inst 115, 4400 5th Ave, Pittsburgh, PA 15213 USA.		Baker, Chris/P-8442-2019	Baker, Chris/0000-0001-6861-8964; Behrmann, Marlene/0000-0002-3814-1015	NATIONAL EYE INSTITUTE [R01EY011831] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY11831] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BAYLIS GC, 1987, EXP BRAIN RES, V65, P614; Bussey TJ, 2002, EUR J NEUROSCI, V15, P355, DOI 10.1046/j.0953-816x.2001.01850.x; Bussey TJ, 2002, EUR J NEUROSCI, V15, P365, DOI 10.1046/j.0953-816x.2001.01851.x; Desimone R, 1998, PHILOS T R SOC B, V353, P1245, DOI 10.1098/rstb.1998.0280; Desimone R, 1996, P NATL ACAD SCI USA, V93, P13494, DOI 10.1073/pnas.93.24.13494; DESIMONE R, 1984, J NEUROSCI, V4, P2051; Erickson CA, 1999, J NEUROSCI, V19, P10404; Erickson CA, 2000, NAT NEUROSCI, V3, P1143, DOI 10.1038/80664; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Freedman DJ, 2002, J NEUROPHYSIOL, V88, P929, DOI 10.1152/jn.2002.88.2.929; Gauthier I, 2002, J EXP PSYCHOL HUMAN, V28, P431, DOI 10.1037//0096-1523.28.2.431; Goldstone RL, 2000, J EXP PSYCHOL HUMAN, V26, P86, DOI 10.1037/0096-1523.26.1.86; Goldstone RL, 1998, ANNU REV PSYCHOL, V49, P585, DOI 10.1146/annurev.psych.49.1.585; Hasegawa I, 2002, NAT NEUROSCI, V5, P90, DOI 10.1038/nn0202-90; Kobatake E, 1998, J NEUROPHYSIOL, V80, P324, DOI 10.1152/jn.1998.80.1.324; LI L, 1993, J NEUROPHYSIOL, V69, P1918, DOI 10.1152/jn.1993.69.6.1918; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; LOGOTHETIS NK, 1995, CEREB CORTEX, V3, P270; Messinger A, 2001, P NATL ACAD SCI USA, V98, P12239, DOI 10.1073/pnas.211431098; MILLER EK, 1991, SCIENCE, V254, P1377, DOI 10.1126/science.1962197; MIYASHITA Y, 1993, NEUROPSYCHOLOGIA, V31, P1119, DOI 10.1016/0028-3932(93)90036-Y; Murray EA, 1999, TRENDS COGN SCI, V3, P142, DOI 10.1016/S1364-6613(99)01303-0; Op de Beeck H, 2001, NAT NEUROSCI, V4, P1244, DOI 10.1038/nn767; Op De Beeck H, 2000, J COMP NEUROL, V426, P505, DOI 10.1002/1096-9861(20001030)426:4<505::AID-CNE1>3.0.CO;2-M; Pasupathy A, 2001, J NEUROPHYSIOL, V86, P2505, DOI 10.1152/jn.2001.86.5.2505; PERRETT DI, 1982, EXP BRAIN RES, V47, P329; SAKAI K, 1994, NEUROREPORT, V5, P829, DOI 10.1097/00001756-199403000-00023; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; Sheinberg DL, 2002, PERCEPTUAL LEARNING, P95; Sigala N, 2002, NATURE, V415, P318, DOI 10.1038/415318a; Tanaka J. W., 1997, PSYCHOL LEARN MOTIV, V36, P83, DOI DOI 10.1016/S0079-7421(08)60282-0; TANAKA JW, IN PRESS ANAL HOLIST; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; TANAKA K, 1991, J NEUROPHYSIOL, V66, P170, DOI 10.1152/jn.1991.66.1.170; Tsunoda K, 2001, NAT NEUROSCI, V4, P832, DOI 10.1038/90547; Vogels R, 1999, EUR J NEUROSCI, V11, P1239, DOI 10.1046/j.1460-9568.1999.00531.x; VOGELS R, 1994, EUR J NEUROSCI, V6, P1680, DOI 10.1111/j.1460-9568.1994.tb00560.x; Wallis G, 1999, TRENDS COGN SCI, V3, P22, DOI 10.1016/S1364-6613(98)01261-3; Xiang JZ, 1999, EUR J NEUROSCI, V11, P3715, DOI 10.1046/j.1460-9568.1999.00790.x; Xiang JZ, 1998, NEUROPHARMACOLOGY, V37, P657, DOI 10.1016/S0028-3908(98)00030-6; YAMANE S, 1988, EXP BRAIN RES, V73, P209, DOI 10.1007/BF00279674; Zar JH, 1999, BIOSTATISTICAL ANAL	43	225	227	0	17	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1210	1216		10.1038/nn960	http://dx.doi.org/10.1038/nn960			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	609CG	12379864	Green Published			2022-12-24	WOS:000178884600025
J	Irie, F; Yamaguchi, Y				Irie, F; Yamaguchi, Y			EphB receptors regulate dendritic spine development via intersectin, Cdc42 and N-WASP	NATURE NEUROSCIENCE			English	Article							ARP2/3 COMPLEX; ACTIN; MORPHOGENESIS; PROTEINS; NEURONS; GTPASES; RAC; RHO		Burnham Inst, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Yamaguchi, Y (corresponding author), Burnham Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD025938] Funding Source: NIH RePORTER; NICHD NIH HHS [HD25938] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Ethell IM, 2001, NEURON, V31, P1001, DOI 10.1016/S0896-6273(01)00440-8; Halpain S, 2000, TRENDS NEUROSCI, V23, P141, DOI 10.1016/S0166-2236(00)01576-9; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Hussain NK, 1999, J BIOL CHEM, V274, P15671, DOI 10.1074/jbc.274.22.15671; Hussain NK, 2001, NAT CELL BIOL, V3, P927, DOI 10.1038/ncb1001-927; LANDIS DMD, 1983, J CELL BIOL, V97, P1169, DOI 10.1083/jcb.97.4.1169; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Takenawa T, 2001, J CELL SCI, V114, P1801	14	220	224	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1117	1118		10.1038/nn964	http://dx.doi.org/10.1038/nn964			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	609CG	12389031				2022-12-24	WOS:000178884600011
J	Ng, M; Roorda, RD; Lima, SQ; Zemelman, BV; Morcillo, P; Miesenbock, G				Ng, M; Roorda, RD; Lima, SQ; Zemelman, BV; Morcillo, P; Miesenbock, G			Transmission of olfactory information between three populations of neurons in the antennal lobe of the fly	NEURON			English	Article							UNIGLOMERULAR PROJECTION NEURONS; GREEN FLUORESCENT PROTEIN; DROSOPHILA-MELANOGASTER; SYNAPTIC TRANSMISSION; ODOR REPRESENTATION; NEURAL ASSEMBLIES; OUTPUT NEURONS; BULB; BRAIN; MAP	Three classes of neurons form synapses in the antennal lobe of Drosophila, the insect counterpart of the vertebrate olfactory bulb: olfactory receptor neurons, projection neurons, and inhibitory local interneurons., We have targeted a genetically encoded optical reporter of synaptic transmission to each of these classes of neurons and visualized population responses to natural odors. The activation of an odor-specific ensemble of olfactory receptor neurons leads, to the activation of a symmetric ensemble of projection neurons across the glomerular synaptic relay. Virtually all excited glomeruli receive inhibitory input from local interneurons. The extent, odor specificity, and partly interglomerular origin of this input suggest that inhibitory circuits assemble combinatorially during odor presentations. These circuits may serve as dynamic templates that extract higher order features from afferent activity patterns.	Mem Sloan Kettering Canc Ctr, Lab Neural Syst, Cellular Biochem & Biophys Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Miesenbock, G (corresponding author), Mem Sloan Kettering Canc Ctr, Lab Neural Syst, Cellular Biochem & Biophys Program, 1275 York Ave, New York, NY 10021 USA.			Lima, Susana/0000-0003-2446-9869; Morcillo, Patrick/0000-0001-9543-2487; Zemelman, Boris/0000-0003-2463-4887; Miesenboeck, Gero/0000-0003-2940-3228				BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROADIE KS, 2000, DROSOPHILA PROTOCOLS, P273; BUCHNER E, 1991, J NEUROGENET, V7, P153, DOI 10.3109/01677069109167432; CINELLI AR, 1995, J NEUROPHYSIOL, V73, P2053, DOI 10.1152/jn.1995.73.5.2053; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Conway JH, 1999, SPHERE PACKINGS LATT; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; DIANTONIO A, 1993, J NEUROSCI, V13, P4924; Faber T, 1999, NAT NEUROSCI, V2, P74, DOI 10.1038/4576; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Galizia CG, 1999, NAT NEUROSCI, V2, P473, DOI 10.1038/8144; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; GRIGLIATTI TA, 1973, MOL GEN GENET, V120, P107, DOI 10.1007/BF00267238; GRINVALD A, 1985, ANNU REV NEUROSCI, V8, P263; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; HAMMING RW, 1980, CODING INFORMATION T; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Isaacson JS, 1998, NEURON, V20, P749, DOI 10.1016/S0896-6273(00)81013-2; JACKSON FR, 1990, J NEUROCHEM, V54, P1068, DOI 10.1111/j.1471-4159.1990.tb02359.x; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Joerges J, 1997, NATURE, V387, P285, DOI 10.1038/387285a0; Kauer JS, 2001, ANNU REV NEUROSCI, V24, P963, DOI 10.1146/annurev.neuro.24.1.963; Klagges BRE, 1996, J NEUROSCI, V16, P3154; KOENIG JH, 1983, J CELL BIOL, V96, P1517, DOI 10.1083/jcb.96.6.1517; KOSAKA T, 1983, J CELL BIOL, V97, P499, DOI 10.1083/jcb.97.2.499; Laissue PP, 1999, J COMP NEUROL, V405, P543; Laurent G, 1999, SCIENCE, V286, P723, DOI 10.1126/science.286.5440.723; Laurent G, 2001, ANNU REV NEUROSCI, V24, P263, DOI 10.1146/annurev.neuro.24.1.263; LAURENT G, 1994, SCIENCE, V265, P1872, DOI 10.1126/science.265.5180.1872; Laurent G, 1996, NEURON, V16, P473, DOI 10.1016/S0896-6273(00)80066-5; Lei H, 2002, NAT NEUROSCI, V5, P557, DOI 10.1038/nn859; LI Z, 1989, BIOL CYBERN, V61, P379, DOI 10.1007/BF00200803; MacLeod K, 1996, SCIENCE, V274, P976, DOI 10.1126/science.274.5289.976; MALUN D, 1991, J COMP NEUROL, V305, P348, DOI 10.1002/cne.903050215; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Meister M, 2001, J NEUROSCI, V21, P1351; Miesenbock G, 1997, P NATL ACAD SCI USA, V94, P3402, DOI 10.1073/pnas.94.7.3402; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; NICOLL RA, 1982, NATURE, V296, P441, DOI 10.1038/296441a0; Pikovsky A., 2001, SYNCHRONIZATION UNIV; RALL W, 1968, J NEUROPHYSIOL, V31, P884, DOI 10.1152/jn.1968.31.6.884; RODRIGUES V, 1984, BRAIN RES, V324, P374, DOI 10.1016/0006-8993(84)90053-2; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Sachse S, 2002, J NEUROPHYSIOL, V87, P1106, DOI 10.1152/jn.00325.2001; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Schmid SL, 1998, CURR OPIN CELL BIOL, V10, P504, DOI 10.1016/S0955-0674(98)80066-5; Schoppa NE, 2001, NEURON, V31, P639, DOI 10.1016/S0896-6273(01)00389-0; Shepherd G.M., 1998, SYNAPTIC ORG BRAIN, P159; Spors H, 2002, NEURON, V34, P301, DOI 10.1016/S0896-6273(02)00644-X; STEWART WB, 1979, J COMP NEUROL, V185, P715, DOI 10.1002/cne.901850407; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Stopfer M, 1999, NATURE, V402, P664, DOI 10.1038/45244; Sun XJ, 1997, J COMP NEUROL, V379, P2, DOI 10.1002/(SICI)1096-9861(19970303)379:1<2::AID-CNE2>3.0.CO;2-8; TSIEN RY, 1989, ANNU REV NEUROSCI, V12, P227, DOI 10.1146/annurev.neuro.12.1.227; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wachowiak M, 2001, NEURON, V32, P723, DOI 10.1016/S0896-6273(01)00506-2; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Yuste R, 2000, METHOD ENZYMOL, V327, P522, DOI 10.1016/S0076-6879(00)27300-X; Zemelman BV, 2001, CURR OPIN NEUROBIOL, V11, P409, DOI 10.1016/S0959-4388(00)00227-0	69	352	357	1	27	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 24	2002	36	3					463	474		10.1016/S0896-6273(02)00975-3	http://dx.doi.org/10.1016/S0896-6273(02)00975-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	608ZE	12408848	Bronze			2022-12-24	WOS:000178877700014
J	Ji, RR; Samad, TA; Jin, SX; Schmoll, R; Woolf, CJ				Ji, RR; Samad, TA; Jin, SX; Schmoll, R; Woolf, CJ			p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia	NEURON			English	Article							NERVE GROWTH-FACTOR; ROOT GANGLION NEURONS; SIGNAL-REGULATED KINASE; PROTEIN-KINASE; CAPSAICIN RECEPTOR; PAIN HYPERSENSITIVITY; VANILLOID RECEPTOR-1; MESSENGER-RNA; IMMUNOCYTOCHEMICAL LOCALIZATION; PERIPHERAL INFLAMMATION	Peripheral inflammation induces p38 MAPK activation in the soma of C fiber nociceptors in the dorsal root ganglion [DRG) after 24 hr. Inflammation also increases protein, but not mRNA levels, of the heat-gated ion channel TRPV1 (VR1) in these cells, which is then transported to peripheral but not central C fiber terminals. Inhibiting p38 activation in the DRG reduces the increase in TRPV1 in the DRG and inflamed skin and diminishes inflammation-induced heat hypersensitivity without affecting inflammatory swelling or basal pain sensitivity. p38 activation in the DRG is secondary to peripheral production of NGF during inflammation and is required for NGF-induced increases in TRPV1. The activation of p38 in the DRG following retrograde NGF transport, by increasing TRPV1 levels in nociceptor peripheral terminals in a transcription-independent fashion, contributes to the maintenance of inflammatory heat hypersensitivity.	Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Neural Plast Res Grp, Boston, MA 02129 USA; Harvard Univ, Sch Med, Boston, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Ji, RR (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Neural Plast Res Grp, Boston, MA 02129 USA.	ji@helix.mgh.harvard.edu	Ji, Ru-Rong/L-7070-2017; Woolf, Clifford/A-9784-2010	Ji, Ru-Rong/0000-0002-9355-3688; 	NINDS NIH HHS [R01 NS40698, R 01 NS39518, R01 NS040698] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039518, R01NS040698] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aley KO, 2001, J NEUROSCI, V21, P6933, DOI 10.1523/JNEUROSCI.21-17-06933.2001; Amaya F, 2000, MOL CELL NEUROSCI, V15, P331, DOI 10.1006/mcne.1999.0828; AVERILL S, 1995, EUR J NEUROSCI, V7, P1484, DOI 10.1111/j.1460-9568.1995.tb01143.x; Badger AM, 1996, J PHARMACOL EXP THER, V279, P1453; Bolshakov VY, 2000, NAT NEUROSCI, V3, P1107, DOI 10.1038/80624; Carlton SM, 2001, NEUROSCI LETT, V310, P53, DOI 10.1016/S0304-3940(01)02093-6; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Faour WH, 2001, J BIOL CHEM, V276, P31720, DOI 10.1074/jbc.M104036200; Garcia-Anoveros J, 2001, J NEUROSCI, V21, P2678, DOI 10.1523/JNEUROSCI.21-08-02678.2001; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Guo A, 1999, EUR J NEUROSCI, V11, P946, DOI 10.1046/j.1460-9568.1999.00503.x; HOKFELT T, 1994, TRENDS NEUROSCI, V17, P22, DOI 10.1016/0166-2236(94)90031-0; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; Ji RR, 1999, NAT NEUROSCI, V2, P1114, DOI 10.1038/16040; Ji RR, 2002, J NEUROSCI, V22, P478, DOI 10.1523/JNEUROSCI.22-02-00478.2002; Ji RR, 1996, REGUL PEPTIDES, V66, P179, DOI 10.1016/S0167-0115(96)00101-2; Ji RR, 1995, J NEUROSCI, V15, P8156; Ji RR, 2001, NEUROBIOL DIS, V8, P1, DOI 10.1006/nbdi.2000.0360; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Karim F, 2001, J NEUROSCI, V21, P3771, DOI 10.1523/JNEUROSCI.21-11-03771.2001; Kedei N, 2001, J BIOL CHEM, V276, P28613, DOI 10.1074/jbc.M103272200; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; LESLIE TA, 1995, NEUROSCIENCE, V67, P753, DOI 10.1016/0306-4522(95)00101-N; LINDSAY RM, 1989, NATURE, V337, P362, DOI 10.1038/337362a0; Mannion RJ, 1999, P NATL ACAD SCI USA, V96, P9385, DOI 10.1073/pnas.96.16.9385; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; Michael GJ, 1997, J NEUROSCI, V17, P8476; Miller FD, 2001, NEURON, V32, P767, DOI 10.1016/S0896-6273(01)00529-3; Morooka T, 1998, J BIOL CHEM, V273, P24285, DOI 10.1074/jbc.273.38.24285; Nicholas RS, 1999, NEUROSCIENCE, V91, P1425, DOI 10.1016/S0306-4522(98)00706-4; NOGUCHI K, 1988, MOL BRAIN RES, V4, P31, DOI 10.1016/0169-328X(88)90015-0; Novakovic SD, 1998, J NEUROSCI, V18, P2174; Paul A, 1999, CELL SIGNAL, V11, P491, DOI 10.1016/S0898-6568(99)00018-2; Porreca F, 1999, P NATL ACAD SCI USA, V96, P7640, DOI 10.1073/pnas.96.14.7640; Premkumar LS, 2000, NATURE, V408, P985, DOI 10.1038/35050121; Raught B, 1999, INT J BIOCHEM CELL B, V31, P43, DOI 10.1016/S1357-2725(98)00131-9; Samad TA, 2001, NATURE, V410, P471, DOI 10.1038/35068566; Sammons MJ, 2000, BRAIN RES, V876, P48, DOI 10.1016/S0006-8993(00)02596-8; Sanchez JF, 2001, NEUROSCIENCE, V107, P373, DOI 10.1016/S0306-4522(01)00373-6; Smith GD, 2002, NATURE, V418, P186, DOI 10.1038/nature00894; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; Stanisz AM, 2000, ANN NY ACAD SCI, V917, P268; STEIN C, 1988, PHARMACOL BIOCHEM BE, V31, P445, DOI 10.1016/0091-3057(88)90372-3; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Tanaka M, 1998, NEUROREPORT, V9, P967, DOI 10.1097/00001756-199804200-00003; Tohda C, 2001, J NEUROCHEM, V76, P1628, DOI 10.1046/j.1471-4159.2001.00193.x; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Voilley N, 2001, J NEUROSCI, V21, P8026, DOI 10.1523/JNEUROSCI.21-20-08026.2001; Wang XM, 1998, J BIOL CHEM, V273, P9373, DOI 10.1074/jbc.273.16.9373; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Winston J, 2001, PAIN, V89, P181, DOI 10.1016/S0304-3959(00)00370-5; WINTER J, 1988, NEURON, V1, P973, DOI 10.1016/0896-6273(88)90154-7; WOOLF CJ, 1983, NATURE, V306, P686, DOI 10.1038/306686a0; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; WOOLF CJ, 1994, NEUROSCIENCE, V62, P327, DOI 10.1016/0306-4522(94)90366-2; Xing J, 1998, MOL CELL BIOL, V18, P1946, DOI 10.1128/MCB.18.4.1946; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Yiangou Y, 2001, LANCET, V357, P1338, DOI 10.1016/S0140-6736(00)04503-7; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	64	949	997	5	62	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 26	2002	36	1					57	68		10.1016/S0896-6273(02)00908-X	http://dx.doi.org/10.1016/S0896-6273(02)00908-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	598UP	12367506	Bronze			2022-12-24	WOS:000178295100007
J	Vassalli, A; Rothman, A; Feinstein, P; Zapotocky, M; Mombaerts, P				Vassalli, A; Rothman, A; Feinstein, P; Zapotocky, M; Mombaerts, P			Minigenes impart odorant receptor-specific axon guidance in the olfactory bulb	NEURON			English	Article							GENE-EXPRESSION; GENOMIC STRUCTURE; SENSORY NEURONS; MOUSE; PROJECTIONS; CLUSTER; FAMILY; MAP; TRANSCRIPTION; ORGANIZATION	An olfactory sensory neuron (OSN) expresses selectively one member from a repertoire of similar to1000 odorant receptor (OR) genes and projects its axon to a specific glomerulus in the olfactory bulb. Both processes are here recapitulated by MOR23 and M71 OR minigenes, introduced into mice. Minigenes of 9 kb and as short as 2.2 kb are selectively expressed by neurons that do not coexpress the endogenous gene but coproject their axons to the same glomeruli. Deletion of a 395 bp upstream region in the MOR23 minigene abolishes expression. In this region we recognize sequence motifs conserved in many OR genes. Transgenic lines expressing the OR in ectopic epithelial zones form ectopic glomeruli, which also receive input from OSNs expressing the cognate endogenous receptor. This suggests a recruitment through homotypic interactions between OSNs expressing the same OR.	Rockefeller Univ, New York, NY 10021 USA	Rockefeller University	Vassalli, A (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.		Zapotocky, Martin/B-8225-2008; Vassalli, Anne/M-7866-2016	Zapotocky, Martin/0000-0002-0437-2528; Vassalli, Anne/0000-0002-5314-5620				Asai H, 1996, BIOCHEM BIOPH RES CO, V221, P240, DOI 10.1006/bbrc.1996.0580; Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buck LB, 2000, CELL, V100, P611, DOI 10.1016/S0092-8674(00)80698-4; Bulger M, 2000, P NATL ACAD SCI USA, V97, P14560, DOI 10.1073/pnas.97.26.14560; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Dugas JC, 2001, GENOMICS, V71, P53, DOI 10.1006/geno.2000.6415; Ebrahimi FAW, 2000, CURR BIOL, V10, P219, DOI 10.1016/S0960-9822(00)00342-0; Hoppe R, 2000, GENOMICS, V66, P284, DOI 10.1006/geno.2000.6205; Ishii T, 2001, GENES CELLS, V6, P71, DOI 10.1046/j.1365-2443.2001.00398.x; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lane RP, 2001, P NATL ACAD SCI USA, V98, P7390, DOI 10.1073/pnas.131215398; LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; MANN RS, 1995, BIOESSAYS, V17, P855, DOI 10.1002/bies.950171007; Mohler WA, 1996, P NATL ACAD SCI USA, V93, P12423, DOI 10.1073/pnas.93.22.12423; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mombaerts P, 2001, NAT NEUROSCI, V4, P1192, DOI 10.1038/nn751; Mombaerts P, 2001, ANNU REV GENOM HUM G, V2, P493, DOI 10.1146/annurev.genom.2.1.493; Mori T, 2000, BIOL PHARM BULL, V23, P165; Nagao H, 2000, NEUROREPORT, V11, P3023, DOI 10.1097/00001756-200009110-00039; Pyrski M, 2001, J NEUROSCI, V21, P4637, DOI 10.1523/JNEUROSCI.21-13-04637.2001; Qasba P, 1998, J NEUROSCI, V18, P227; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Serizawa S, 2000, NAT NEUROSCI, V3, P687, DOI 10.1038/76641; Sosinsky A, 2000, GENOMICS, V70, P49, DOI 10.1006/geno.2000.6363; STORMO GD, 1989, P NATL ACAD SCI USA, V86, P1183, DOI 10.1073/pnas.86.4.1183; Strotmann J, 2000, J NEUROSCI, V20, P6927, DOI 10.1523/JNEUROSCI.20-18-06927.2000; Sullivan SL, 1996, P NATL ACAD SCI USA, V93, P884, DOI 10.1073/pnas.93.2.884; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Touhara K, 1999, P NATL ACAD SCI USA, V96, P4040, DOI 10.1073/pnas.96.7.4040; Tsuboi A, 1999, J NEUROSCI, V19, P8409; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wang SS, 1997, J NEUROSCI, V17, P4149; Xie SY, 2000, MAMM GENOME, V11, P1070, DOI 10.1007/s003350010217; Yoshihara Y, 1997, J NEUROSCI, V17, P5830; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800	40	196	199	1	18	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 15	2002	35	4					681	696		10.1016/S0896-6273(02)00793-6	http://dx.doi.org/10.1016/S0896-6273(02)00793-6			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	585JE	12194868	Bronze			2022-12-24	WOS:000177521000009
J	Honma, Y; Araki, T; Gianino, S; Bruce, A; Heuckeroth, RO; Johnson, EM; Milbrandt, J				Honma, Y; Araki, T; Gianino, S; Bruce, A; Heuckeroth, RO; Johnson, EM; Milbrandt, J			Artemin is a vascular-derived neurotropic factor for developing sympathetic neurons	NEURON			English	Article							MICE LACKING GDNF; SUPERIOR CERVICAL-GANGLION; PERIPHERAL NERVOUS-SYSTEM; NEURAL CREST; IN-VIVO; AUTONOMIC GANGLIA; ENTERIC NEURONS; RENAL AGENESIS; SURVIVAL; MIGRATION	Artemin (ARTN) is a member of the GDNF family of ligands and signals through the Ret/GFRalpha3 receptor complex. Characterization of ARTN- and GFRalpha3-deficient mice revealed similar abnormalities in the migration and axonal projection pattern of the entire sympathetic nervous system. This resulted in abnormal innervation of target tissues and consequent cell death due to deficiencies of target-derived neurotrophic support. ARTN is expressed along blood vessels and in cells nearby to sympathetic axonal projections. In the developing vasculature, ARTN is expressed in smooth muscle cells of the vessels, and it acts as a guidance factor that encourages sympathetic fibers to follow blood vessels as they project toward their final target tissues. The chemoattractive properties of ARTN were confirmed by the demonstration that sympathetic neuroblasts migrate and project axons toward ARTN-soaked beads implanted into mouse embryos.	Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Milbrandt, J (corresponding author), Washington Univ, Sch Med, Dept Pathol, 660 S Euclid Ave,POB 8118, St Louis, MO 63110 USA.		Araki, Toshiyuki/H-4289-2019	Araki, Toshiyuki/0000-0003-3625-2042; Milbrandt, Jeffrey/0000-0002-5477-7689; Heuckeroth, Robert/0000-0002-3282-1765	NIA NIH HHS [AG13730, AG 13729] Funding Source: Medline; NICHD NIH HHS [HD01487] Funding Source: Medline; NINDS NIH HHS [NS39358] Funding Source: Medline; PHS HHS [K57038-01] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K12HD001487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039358] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013730, R01AG013729] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Albers KM, 1996, J CELL BIOL, V134, P487, DOI 10.1083/jcb.134.2.487; Anderson DJ, 1997, COLD SPRING HARB SYM, V62, P493; Andres R, 2001, DEVELOPMENT, V128, P3685; Baloh RH, 2000, CURR OPIN NEUROBIOL, V10, P103, DOI 10.1016/S0959-4388(99)00048-3; Baloh RH, 1998, P NATL ACAD SCI USA, V95, P5801, DOI 10.1073/pnas.95.10.5801; Baloh RH, 1998, NEURON, V21, P1291, DOI 10.1016/S0896-6273(00)80649-2; BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; Baudet C, 2000, DEVELOPMENT, V127, P4335; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Britsch S, 1998, GENE DEV, V12, P1825, DOI 10.1101/gad.12.12.1825; CALLAHAN CA, 1994, P NATL ACAD SCI USA, V91, P5972, DOI 10.1073/pnas.91.13.5972; Chalazonitis A, 1998, DEV BIOL, V204, P385, DOI 10.1006/dbio.1998.9090; Christiansen JH, 2000, CURR OPIN CELL BIOL, V12, P719, DOI 10.1016/S0955-0674(00)00158-7; COSTA M, 1984, NEUROSCIENCE, V13, P911, DOI 10.1016/0306-4522(84)90105-2; Damon DH, 2001, AM J PHYSIOL-HEART C, V280, pH1722, DOI 10.1152/ajpheart.2001.280.4.H1722; Durbec PL, 1996, DEVELOPMENT, V122, P349; Elshamy WM, 1996, DEVELOPMENT, V122, P491; Enomoto H, 2000, DEVELOPMENT, V127, P4877; Enomoto H, 2001, DEVELOPMENT, V128, P3963; Enomoto H, 1998, NEURON, V21, P317, DOI 10.1016/S0896-6273(00)80541-3; Fagan AM, 1996, J NEUROSCI, V16, P6208; FERNHOLM M, 1971, Z ANAT ENTWICKLUNGS, V133, P305, DOI 10.1007/BF00519305; Francis N, 1999, DEV BIOL, V210, P411, DOI 10.1006/dbio.1999.9269; Garcia-Castro M, 1999, CURR OPIN CELL BIOL, V11, P695, DOI 10.1016/S0955-0674(99)00038-1; GOLDSTEIN RS, 1991, DEVELOPMENT, V112, P327; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; Hearn CJ, 1998, DEV BIOL, V197, P93, DOI 10.1006/dbio.1998.8876; Heuckeroth RO, 1998, DEV BIOL, V200, P116, DOI 10.1006/dbio.1998.8955; Heuckeroth RO, 1999, NEURON, V22, P253, DOI 10.1016/S0896-6273(00)81087-9; Hirsch MR, 1998, DEVELOPMENT, V125, P599; HOYLE GW, 1993, NEURON, V10, P1019, DOI 10.1016/0896-6273(93)90051-R; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Kandel E., 2000, PRINCIPLES NEURAL SC; KISHIMOTO S, 1982, J INVEST DERMATOL, V79, P141, DOI 10.1111/1523-1747.ep12500043; Kotzbauer PT, 1996, NATURE, V384, P467, DOI 10.1038/384467a0; Krull CE, 2001, MECH DEVELOP, V105, P37, DOI 10.1016/S0925-4773(01)00395-1; LEDOUARIN NM, 1986, SCIENCE, V231, P1515, DOI 10.1126/science.3952494; Lewandoski M, 1997, CURR BIOL, V7, P148, DOI 10.1016/S0960-9822(06)00059-5; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Martin P, 1999, METH MOL B, V97, P7, DOI 10.1385/1-59259-270-8:7; Milbrandt J, 1998, NEURON, V20, P245, DOI 10.1016/S0896-6273(00)80453-5; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Morin X, 1997, NEURON, V18, P411, DOI 10.1016/S0896-6273(00)81242-8; Naveilhan P, 1998, P NATL ACAD SCI USA, V95, P1295, DOI 10.1073/pnas.95.3.1295; Nishino J, 1999, NEURON, V23, P725, DOI 10.1016/S0896-6273(01)80031-3; Patel TD, 2000, NEURON, V25, P345, DOI 10.1016/S0896-6273(00)80899-5; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; RUBIN E, 1985, J NEUROSCI, V5, P673; Saarma M, 1999, MICROSC RES TECHNIQ, V45, P292, DOI 10.1002/(SICI)1097-0029(19990515/01)45:4/5<292::AID-JEMT13>3.0.CO;2-8; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; Schmidt RE, 1998, J NEUROPATH EXP NEUR, V57, P158, DOI 10.1097/00005072-199802000-00007; Schneider C, 1999, NEURON, V24, P861, DOI 10.1016/S0896-6273(00)81033-8; Schuchardt A, 1996, DEVELOPMENT, V122, P1919; Smith PG, 1998, J COMP NEUROL, V400, P529, DOI 10.1002/(SICI)1096-9861(19981102)400:4<529::AID-CNE7>3.0.CO;2-C; Snider WD, 1996, NEURON, V16, P229, DOI 10.1016/S0896-6273(00)80039-2; Song HJ, 1999, CURR OPIN NEUROBIOL, V9, P355, DOI 10.1016/S0959-4388(99)80052-X; Tang MJ, 1998, J CELL BIOL, V142, P1337, DOI 10.1083/jcb.142.5.1337; Taraviras S, 1999, DEVELOPMENT, V126, P2785; Tessarollo L, 1997, P NATL ACAD SCI USA, V94, P14776, DOI 10.1073/pnas.94.26.14776; Widenfalk J, 1998, EUR J NEUROSCI, V10, P1508, DOI 10.1046/j.1460-9568.1998.00192.x; Young HM, 2001, ANAT REC, V262, P1; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417	64	244	260	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 18	2002	35	2					267	282		10.1016/S0896-6273(02)00774-2	http://dx.doi.org/10.1016/S0896-6273(02)00774-2			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	576YF	12160745	Bronze			2022-12-24	WOS:000177034200007
J	Cossart, R; Epsztein, J; Tyzio, R; Becq, H; Hirsch, J; Ben-Ari, Y; Crepel, V				Cossart, R; Epsztein, J; Tyzio, R; Becq, H; Hirsch, J; Ben-Ari, Y; Crepel, V			Quantal release of glutamate generates pure kainate and mixed AMPA/kainate EPSCs in hippocampal neurons	NEURON			English	Article							EXCITATORY POSTSYNAPTIC CURRENTS; RECEPTOR-MEDIATED RESPONSES; SYNAPTIC TRANSMISSION; GLUR6-DEFICIENT MICE; PYRAMIDAL NEURONS; AMPA RECEPTORS; MOSSY FIBERS; IN-VITRO; INTERNEURONS; ACTIVATION	The relative contribution of kainate receptors to ongoing glutamatergic activity is at present unknown. We report the presence of spontaneous, miniature, and minimal stimulation-evoked excitatory postsynaptic currents (EPSCs) that are mediated solely by kainate receptors (EPSCkainate) or by both AMPA and kainate receptors (EPSCAMPA/kanate). EPSCkainate and EPSCAMPA/kainate are selectively enriched in CA1 interneurons and mossy fibers synapses of CA3 pyramidal neurons, respectively. In CA1 interneurons, the decay time constant of EPSCkainate (circa 10 ms) is comparable to values obtained in heterologous expression systems. In both hippocampal neurons, the quantal release of glutamate generates kainate receptor-mediated EPSCs that provide as much as half of the total glutamatergic current. Kainate receptors are, therefore, key players of the ongoing glutamatergic transmission in the hippocampus.	INMED INSERM U29, F-13273 Marseille 9, France; Univ Mediterranee, F-13273 Marseille 9, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Ben-Ari, Y (corresponding author), INMED INSERM U29, Parc Sci Luminy,BP 13, F-13273 Marseille 9, France.	ben-ari@inmed.univ-mrs.fr	Cossart, Rosa/E-7674-2014; Epsztein, Jerome/O-7922-2016; Crépel, Valérie/E-1870-2016; Cossart, Rosa/AAT-7934-2020	Cossart, Rosa/0000-0003-2111-6638; Epsztein, Jerome/0000-0002-5344-3986; Crépel, Valérie/0000-0003-0408-3766; Cossart, Rosa/0000-0003-2111-6638; Ben-Ari, Yehezkel/0000-0001-6208-8480				ASCHER P, 1988, J PHYSIOL-LONDON, V399, P247; Bekkers JM, 1996, J NEUROPHYSIOL, V75, P1250, DOI 10.1152/jn.1996.75.3.1250; Ben-Ari Y, 2000, TRENDS NEUROSCI, V23, P580, DOI 10.1016/S0166-2236(00)01659-3; BENARI Y, 1985, NEUROSCIENCE, V14, P375, DOI 10.1016/0306-4522(85)90299-4; Bureau I, 2000, P NATL ACAD SCI USA, V97, P6838, DOI 10.1073/pnas.97.12.6838; Bureau I, 1999, J NEUROSCI, V19, P653; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Cossart R, 1998, NAT NEUROSCI, V1, P470, DOI 10.1038/2185; Cui CH, 1999, J NEUROSCI, V19, P8281; DeVries SH, 2000, NEURON, V28, P847, DOI 10.1016/S0896-6273(00)00158-6; Frerking M, 1998, NAT NEUROSCI, V1, P479, DOI 10.1038/2194; Frerking M, 2000, CURR OPIN NEUROBIOL, V10, P342, DOI 10.1016/S0959-4388(00)00094-5; Garcia EP, 1998, NEURON, V21, P727, DOI 10.1016/S0896-6273(00)80590-5; Henze DA, 1997, J NEUROPHYSIOL, V77, P1075, DOI 10.1152/jn.1997.77.3.1075; Katona I, 1999, NEUROSCIENCE, V88, P37, DOI 10.1016/S0306-4522(98)00302-9; Kidd FL, 1999, NATURE, V400, P569, DOI 10.1038/23040; Lerma J, 2001, PHYSIOL REV, V81, P971, DOI 10.1152/physrev.2001.81.3.971; Li H, 1998, NEUROPHARMACOLOGY, V37, P1279, DOI 10.1016/S0028-3908(98)00109-9; Li P, 1999, NATURE, V397, P161, DOI 10.1038/16469; LIVSEY CT, 1992, NEURON, V8, P745, DOI 10.1016/0896-6273(92)90095-U; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; McAllister AK, 2000, P NATL ACAD SCI USA, V97, P6173, DOI 10.1073/pnas.100126497; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; MILES R, 1983, NATURE, V306, P371, DOI 10.1038/306371a0; Mulle C, 2000, NEURON, V28, P475, DOI 10.1016/S0896-6273(00)00126-4; Mulle C, 1998, NATURE, V392, P601, DOI 10.1038/33408; PATERNAIN AV, 1995, NEURON, V14, P185, DOI 10.1016/0896-6273(95)90253-8; PETRALIA RS, 1994, J COMP NEUROL, V349, P85, DOI 10.1002/cne.903490107; Qin LX, 2001, J COMP NEUROL, V440, P284, DOI 10.1002/cne.1386; REPRESA A, 1987, NEUROSCIENCE, V20, P739, DOI 10.1016/0306-4522(87)90237-5; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Swanson GT, 1996, J PHYSIOL-LONDON, V492, P129, DOI 10.1113/jphysiol.1996.sp021295; Swanson GT, 1998, J PHYSIOL-LONDON, V513, P639, DOI 10.1111/j.1469-7793.1998.639ba.x; Traub RD, 2000, EUR J NEUROSCI, V12, P4093, DOI 10.1046/j.1460-9568.2000.00300.x; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; Watt AJ, 2000, NEURON, V26, P659, DOI 10.1016/S0896-6273(00)81202-7; WILDING TJ, 1995, MOL PHARMACOL, V47, P582	37	115	118	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 3	2002	35	1					147	159		10.1016/S0896-6273(02)00753-5	http://dx.doi.org/10.1016/S0896-6273(02)00753-5			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	569KP	12123615	Bronze			2022-12-24	WOS:000176601800017
J	Sack, AT; Sperling, JM; Prvulovic, D; Formisano, E; Goebel, R; Di Salle, F; Dierks, T; Linden, DEJ				Sack, AT; Sperling, JM; Prvulovic, D; Formisano, E; Goebel, R; Di Salle, F; Dierks, T; Linden, DEJ			Tracking the mind's image in the brain II: Transcranial magnetic stimulation reveals parietal asymmetry in visuospatial imagery	NEURON			English	Article							MENTAL-IMAGERY; FUNCTIONAL-ANATOMY; VISUAL-IMAGERY; ATTENTION; CORTEX; ACTIVATION; SYSTEM; SAFETY; SPACE; TASK	The functional relevance of brain activity during visuospatial tasks was investigated by combining functional magnetic resonance imaging with unilateral repetitive transcranial magnetic stimulation (rTMS). The cognitive tasks involved visuospatial operations on visually presented and mentally imagined material ("mental clock task"). While visuospatial operations were associated with activation of the intraparietal sulcus region bilaterally, only the group which received rTMS to the right parietal lobe showed an impairment of performance during and immediately after rTMS. This functional parietal asymmetry might indicate a capacity of the right parietal lobe to compensate for a temporary suppression of the left. This is compatible with current theories of spatial hemineglect and constitutes a constraint for models of distributed information processing in the parietal lobes.	Goethe Univ Frankfurt, Dept Psychiat, Lab Neurophysiol & Neuroimaging, DE-60590 Frankfurt, Germany; Univ Maastricht, Fac Psychol, Dept Cognit Neurosci, NL-6200 MD Maastricht, Netherlands; Univ Naples Federico II, Dept Neuroradiol, I-80131 Naples, Italy; Univ Hosp Clin Psychiat, Dept Psychiat Neurophysiol, CH-3000 Bern 60, Switzerland; Max Planck Inst Hirnforsch, DE-60528 Frankfurt, Germany	Goethe University Frankfurt; Maastricht University; University of Naples Federico II; University of Bern; University Hospital of Bern; Max Planck Society	Linden, DEJ (corresponding author), Goethe Univ Frankfurt, Dept Psychiat, Lab Neurophysiol & Neuroimaging, Theodor Stern Kai 7, DE-60590 Frankfurt, Germany.	linden@mpih-frankfurt.mpg.de	Dierks, Thomas/B-7092-2012; Linden, David E J/C-7355-2013; Linden, David/S-9948-2019	Dierks, Thomas/0000-0002-4173-5308; Linden, David E J/0000-0002-5638-9292; Linden, David/0000-0002-5638-9292; Di Salle, Francesco/0000-0002-0226-8460; Formisano, Elia/0000-0001-5008-2460; Sack, Alexander/0000-0002-1471-0885; Goebel, Rainer/0000-0003-1780-2467				Bohning DE, 1999, BIOL PSYCHIAT, V45, P385, DOI 10.1016/S0006-3223(98)00368-0; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Carpenter PA, 1999, J COGNITIVE NEUROSCI, V11, P9, DOI 10.1162/089892999563210; Chen R, 1997, ELECTROMYOGR MOTOR C, V105, P415, DOI 10.1016/S0924-980X(97)00036-2; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Culham JC, 2001, CURR OPIN NEUROBIOL, V11, P157, DOI 10.1016/S0959-4388(00)00191-4; DEsposito M, 1997, NEUROPSYCHOLOGIA, V35, P725, DOI 10.1016/S0028-3932(96)00121-2; Diwadkar VA, 2000, NEUROIMAGE, V12, P85, DOI 10.1006/nimg.2000.0586; Draper N.R., 1998, WILEY SERIES PROBABI, V326; Driver J, 2001, COGNITION, V79, P39, DOI 10.1016/S0010-0277(00)00124-4; FARAH MJ, 1989, TRENDS NEUROSCI, V12, P395, DOI 10.1016/0166-2236(89)90079-9; FARAH MJ, 1985, NEUROPSYCHOLOGIA, V23, P115, DOI 10.1016/0028-3932(85)90049-1; Formisano E, 2002, NEURON, V35, P185, DOI 10.1016/S0896-6273(02)00747-X; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Goebel R, 1998, NEUROREPORT, V9, P713, DOI 10.1097/00001756-199803090-00028; Hallett M, 2000, NATURE, V406, P147, DOI 10.1038/35018000; Hilgetag CC, 2001, NAT NEUROSCI, V4, P953, DOI 10.1038/nn0901-953; HOMAN RW, 1987, ELECTROEN CLIN NEURO, V66, P376, DOI 10.1016/0013-4694(87)90206-9; JENKINS WM, 1990, NEUROPSYCHOLOGIA, V28, P573, DOI 10.1016/0028-3932(90)90035-M; Karnath HO, 2001, NATURE, V411, P950, DOI 10.1038/35082075; Klein I, 2000, J COGNITIVE NEUROSCI, V12, P15, DOI 10.1162/089892900564037; Kosslyn SM, 1999, SCIENCE, V284, P167, DOI 10.1126/science.284.5411.167; KOSSLYN SM, 1994, TRENDS NEUROSCI, V17, P290, DOI 10.1016/0166-2236(94)90059-0; Lamm C, 2001, NEUROIMAGE, V14, P268, DOI 10.1006/nimg.2001.0850; Landis T, 2000, SPATIAL VISION, V13, P179, DOI 10.1163/156856800741199; Leonards U, 2000, J COGNITIVE NEUROSCI, V12, P61, DOI 10.1162/089892900564073; Linden DEJ, 1999, CEREB CORTEX, V9, P815, DOI 10.1093/cercor/9.8.815; MARSHALL JC, 2001, NEUROIMAGE, V14, P2; Mellet E, 1996, J NEUROSCI, V16, P6504; Mellet E, 1998, NEUROIMAGE, V8, P129, DOI 10.1006/nimg.1998.0355; Mellet E, 2000, J COGNITIVE NEUROSCI, V12, P98, DOI 10.1162/08989290051137620; Mesulam MM, 1999, PHILOS T R SOC B, V354, P1325, DOI 10.1098/rstb.1999.0482; PASCUALLEONE A, 1994, NEUROREPORT, V5, P2517, DOI 10.1097/00001756-199412000-00028; ROLAND PE, 1994, TRENDS NEUROSCI, V17, P281, DOI 10.1016/0166-2236(94)90057-4; Sack AT, 2002, COGNITIVE BRAIN RES, V13, P85, DOI 10.1016/S0926-6410(01)00087-8; Seitz RJ, 1999, STROKE, V30, P1844, DOI 10.1161/01.STR.30.9.1844; TROJANO L, 1994, BRAIN COGNITION, V24, P213, DOI 10.1006/brcg.1994.1012; Trojano L, 2000, CEREB CORTEX, V10, P473, DOI 10.1093/cercor/10.5.473; TROJANO L, 2002, IN PRESS NEUROPSYCHO; Vallar G, 1996, J Int Neuropsychol Soc, V2, P452; Walsh V, 1999, NEUROPSYCHOLOGIA, V37, P125; Wang H, 1996, NEUROREPORT, V7, P521, DOI 10.1097/00001756-199601310-00035; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; Wojciulik E, 1999, NEURON, V23, P747, DOI 10.1016/S0896-6273(01)80033-7; Ziemann U, 1996, J PHYSIOL-LONDON, V496, P873, DOI 10.1113/jphysiol.1996.sp021734	46	115	117	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 3	2002	35	1					195	204		10.1016/S0896-6273(02)00745-6	http://dx.doi.org/10.1016/S0896-6273(02)00745-6			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	569KP	12123619	Bronze, Green Published			2022-12-24	WOS:000176601800021
J	Jorntell, H; Ekerot, CF				Jorntell, H; Ekerot, CF			Reciprocal bidirectional plasticity of parallel fiber receptive fields in cerebellar Purkinje cells and their afferent interneurons	NEURON			English	Article							LONG-TERM DEPRESSION; NUCLEUS INTERPOSITUS ANTERIOR; CLIMBING FIBERS; TOPOGRAPHICAL ORGANIZATION; COMPLEX SPIKES; CAT CEREBELLUM; GLUTAMATE; RAT; CORTEX; POTENTIATION	The highly specific relationships between parallel fiber (PF) and climbing fiber (CF) receptive fields in Purkinje cells and interneurons suggest that normal PF receptive fields are established by CF-specific plasticity. To test this idea, we used PF stimulation that was either paired or unpaired with CF activity. Conspicuously, unpaired PF stimulation that induced long-lasting, very large increases in the receptive field sizes of Purkinje cells induced long-lasting decreases in receptive field sizes of their afferent interneurons. In contrast, PF stimulation paired with CIF activity that induced long-lasting decreases in the receptive fields of Purkinje cells induced long-lasting, large increases in the receptive fields of interneurons. These properties, and the fact the mossy fiber receptive fields were unchanged, suggest that the receptive field changes were due to bidirectional PF synaptic plasticity in Purkinje cells and interneurons.	Lund Univ, Biomed Ctr F10, Dept Physiol Sci, Sect Neurophysiol, SE-22184 Lund, Sweden	Lund University	Jorntell, H (corresponding author), Lund Univ, Biomed Ctr F10, Dept Physiol Sci, Sect Neurophysiol, Tornavagen 10, SE-22184 Lund, Sweden.							ANDERSSON G, 1987, J PHYSIOL-LONDON, V385, P107, DOI 10.1113/jphysiol.1987.sp016487; Batchelor AM, 1997, NATURE, V385, P74, DOI 10.1038/385074a0; BISHOP GA, 1982, J COMP NEUROL, V210, P1, DOI 10.1002/cne.902100102; DECAMILLI P, 1984, NEUROSCIENCE, V11, P761, DOI 10.1016/0306-4522(84)90193-3; ECCLES JC, 1966, EXP BRAIN RES, V1, P1; Eccles JC, 1967, CEREBELLUM NEURONAL; EKEROT CF, 1985, BRAIN RES, V342, P357, DOI 10.1016/0006-8993(85)91136-9; EKEROT CF, 1991, J PHYSIOL-LONDON, V441, P257, DOI 10.1113/jphysiol.1991.sp018750; EKEROT CF, 1995, EXP BRAIN RES, V106, P365; Ekerot CF, 2001, EUR J NEUROSCI, V13, P1303, DOI 10.1046/j.0953-816x.2001.01499.x; Garwicz M, 1998, J PHYSIOL-LONDON, V512, P277, DOI 10.1111/j.1469-7793.1998.277bf.x; GARWICZ M, 1994, J PHYSIOL-LONDON, V474, P245, DOI 10.1113/jphysiol.1994.sp020017; GELLMAN R, 1985, J NEUROPHYSIOL, V54, P40, DOI 10.1152/jn.1985.54.1.40; GILBERT PFC, 1977, BRAIN RES, V128, P309, DOI 10.1016/0006-8993(77)90997-0; Hansel C, 2001, NAT NEUROSCI, V4, P467, DOI 10.1038/87419; HARVEY RJ, 1991, PROG NEUROBIOL, V36, P437, DOI 10.1016/0301-0082(91)90012-P; HAWKES R, 1989, BRAIN RES, V476, P279, DOI 10.1016/0006-8993(89)91248-1; HIRANO T, 1991, SYNAPSE, V7, P321, DOI 10.1002/syn.890070408; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; Ito M, 1984, CEREBELLUM NEURAL CO; Jorntell H, 1999, J PHYSIOL-LONDON, V514, P551, DOI 10.1111/j.1469-7793.1999.551ae.x; Kitazawa S, 1998, NATURE, V392, P494, DOI 10.1038/33141; Linden DJ, 1999, J NEUROSCI, V19, P10221; Palay S.L., 1974, CEREBELLAR CORTEX; PITCHITPORNCHAI C, 1994, J COMP NEUROL, V342, P206; SAKURAI M, 1987, J PHYSIOL-LONDON, V394, P463, DOI 10.1113/jphysiol.1987.sp016881; Salin PA, 1996, NEURON, V16, P797, DOI 10.1016/S0896-6273(00)80099-9; Sugihara I, 1999, J COMP NEUROL, V414, P131; Sultan F, 2001, EUR J NEUROSCI, V13, P2123, DOI 10.1046/j.0953-816x.2001.01593.x; Tempia F, 1998, J NEUROPHYSIOL, V80, P520, DOI 10.1152/jn.1998.80.2.520; THACH WT, 1968, J NEUROPHYSIOL, V31, P785, DOI 10.1152/jn.1968.31.5.785; Wang SSH, 2000, P NATL ACAD SCI USA, V97, P8635, DOI 10.1073/pnas.130414597; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1	34	215	215	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 30	2002	34	5					797	806		10.1016/S0896-6273(02)00713-4	http://dx.doi.org/10.1016/S0896-6273(02)00713-4			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	558DV	12062025	Bronze			2022-12-24	WOS:000175951800013
J	Kreitzer, AC; Carter, AG; Regehr, WG				Kreitzer, AC; Carter, AG; Regehr, WG			Inhibition of interneuron firing extends the spread of endocannabinoid signaling in the cerebellum	NEURON			English	Article							RECTIFYING POTASSIUM CHANNELS; ACID AMIDE HYDROLASE; CB1 RECEPTOR; CANNABINOID CB1; PURKINJE-CELLS; ENDOGENOUS CANNABINOIDS; RETROGRADE INHIBITION; LOCALIZATION; CURRENTS; NEURONS	Endocannabinoids serve as retrograde messengers in many brain regions. These diffusible lipophilic molecules are released by postsynaptic cells and regulate presynaptic neurotransmitter release. Here we describe an additional mechanism that mediates the spread of endocannabinoid signaling to distant inhibitory synapses. Depolarization of cerebellar Purkinje cells reduced the firing rate of nearby interneurons, and this reduction in firing was blocked by the cannabinoid receptor antagonist AM251. The cannabinoid receptor agonist WIN55,212-2 also reduced firing rates in interneurons, and this inhibition arose from the activation of a small potassium conductance. Thus, endocannabinoids released from the dendrites of depolarized neurons can lead to inhibition of firing in nearby cells. Because interneurons can project over several hundred micrometers, this inhibition of firing allows cells to regulate synaptic inputs at distances well beyond the limits of endocannabinoid diffusion.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Regehr, WG (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	wade_regehr@hms.harvard.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032405] Funding Source: NIH RePORTER; NINDS NIH HHS [R01-NS32405-01] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Cajal S. R., 1911, HISTOLOGIE SYSTEME N, V2; COMPTON DR, 1992, J PHARMACOL EXP THER, V263, P1118; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; DAMBRA TE, 1992, J MED CHEM, V35, P124, DOI 10.1021/jm00079a016; DEADWYLER SA, 1995, J PHARMACOL EXP THER, V273, P734; DEADWYLER SA, 1993, RECEPTOR CHANNEL, V1, P121; DeSanty KP, 2001, PHARMACOL BIOCHEM BE, V69, P251, DOI 10.1016/S0091-3057(01)00539-1; Di Marzo V, 1998, TRENDS NEUROSCI, V21, P521, DOI 10.1016/S0166-2236(98)01283-1; Diana MA, 2002, J NEUROSCI, V22, P200, DOI 10.1523/JNEUROSCI.22-01-00200.2002; Egertova M, 1998, P ROY SOC B-BIOL SCI, V265, P2081, DOI 10.1098/rspb.1998.0543; HENRY DJ, 1995, NEUROSCI LETT, V186, P91, DOI 10.1016/0304-3940(95)11289-9; HERRINGTON J, 1995, PULSE CONTROL V4 5 I; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Karschin C, 1996, J NEUROSCI, V16, P3559; Kreitzer AC, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-20-j0005.2001; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Ledent C, 1999, SCIENCE, V283, P401, DOI 10.1126/science.283.5400.401; Lee MY, 2000, BRAIN RES, V864, P52, DOI 10.1016/S0006-8993(00)02134-X; Liao YJ, 1996, J NEUROSCI, V16, P7137; LLANO I, 1991, NEURON, V6, P565, DOI 10.1016/0896-6273(91)90059-9; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; MACKIE K, 1995, J NEUROSCI, V15, P6552; Maejima T, 2001, NEURON, V31, P463, DOI 10.1016/S0896-6273(01)00375-0; MATSUDA LA, 1993, J COMP NEUROL, V327, P535, DOI 10.1002/cne.903270406; McAllister SD, 1999, J PHARMACOL EXP THER, V291, P618; MIDTGAARD J, 1992, J PHYSIOL-LONDON, V457, P329, DOI 10.1113/jphysiol.1992.sp019381; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Palay S.L., 1974, CEREBELLAR CORTEX; Patel S, 2001, J PHARMACOL EXP THER, V297, P629; Pertwee RG, 1997, PHARMACOL THERAPEUT, V74, P129, DOI 10.1016/S0163-7258(97)82001-3; Sanudo-Pena MC, 1999, LIFE SCI, V65, P703, DOI 10.1016/S0024-3205(99)00293-3; SHARP AA, 1993, J NEUROPHYSIOL, V69, P992, DOI 10.1152/jn.1993.69.3.992; Sodickson DL, 1996, J NEUROSCI, V16, P6374; STANDEN NB, 1978, J PHYSIOL-LONDON, V280, P169, DOI 10.1113/jphysiol.1978.sp012379; Sullivan JM, 2000, LEARN MEMORY, V7, P132, DOI 10.1101/lm.7.3.132; Sultan F, 1998, J COMP NEUROL, V393, P353; Tsou K, 1998, NEUROSCIENCE, V83, P393, DOI 10.1016/S0306-4522(97)00436-3; Tsou K, 1998, NEUROSCI LETT, V254, P137, DOI 10.1016/S0304-3940(98)00700-9; VINCENT P, 1993, NEURON, V11, P885, DOI 10.1016/0896-6273(93)90118-B; Wilson RI, 2001, NEURON, V31, P453, DOI 10.1016/S0896-6273(01)00372-5; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	42	117	121	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 30	2002	34	5					787	796		10.1016/S0896-6273(02)00695-5	http://dx.doi.org/10.1016/S0896-6273(02)00695-5			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	558DV	12062024	Bronze			2022-12-24	WOS:000175951800012
J	Swanson, GT; Green, T; Sakai, R; Contractor, A; Che, W; Kamiya, H; Heinemann, SF				Swanson, GT; Green, T; Sakai, R; Contractor, A; Che, W; Kamiya, H; Heinemann, SF			Differential activation of individual subunits in heteromeric kainate receptors	NEURON			English	Article							LIGAND-BINDING CORE; GLUTAMATE-RECEPTOR; HIGH-AFFINITY; ION CHANNELS; AMPA; AGONIST; GLUR5; BEHAVIOR; CLONING	Neuronal kainate receptors are assembled from subunits with dissimilar specificities for agonists and antagonists. The composite biophysical behavior of heteromeric kainate receptors is determined by intersubunit interactions whose nature is unclear. Here we use dysiherbaine, a selective kainate receptor agonist, to show that GluR5 subunits assembled in heteromeric GluR5/KA-2 kainate receptor complexes can gate current without concomitant activation of their partner KA-2 subunits. A long-lasting interaction between dysiherbaine and GluR5 subunits elicits a tonic current from GluR5/KA-2 receptors; subsequent cooperative gating of KA-2 subunits can be elicited by both agonists, such as glutamate, and some classically defined antagonists, such as CNQX. This study demonstrates that each type of subunit within a heteromeric kainate receptor contributes a distinct conductance upon activation by agonist binding, and therefore provides insight into the biophysical function of ionotropic glutamate receptors.	Univ Texas, Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA; Univ Liverpool, Dept Pharmacol & Therapeut, Liverpool L69 3GE, Merseyside, England; Kitasato Univ, Sch Fisheries Sci, Sanriku, Iwate 0220101, Japan; Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Liverpool; Kitasato University; Salk Institute	Swanson, GT (corresponding author), Univ Texas, Med Branch, Dept Pharmacol & Toxicol, 301 Univ Blvd, Galveston, TX 77555 USA.			Contractor, Anis/0000-0002-5131-2536				Abele R, 1999, BIOCHEMISTRY-US, V38, P10949, DOI 10.1021/bi982928y; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Cui CH, 1999, J NEUROSCI, V19, P8281; Dingledine R, 1999, PHARMACOL REV, V51, P7; EGEBJERG J, 1991, NATURE, V351, P745, DOI 10.1038/351745a0; HERB A, 1992, NEURON, V8, P775, DOI 10.1016/0896-6273(92)90098-X; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; PARTIN KM, 1993, NEURON, V11, P1069, DOI 10.1016/0896-6273(93)90220-L; Paternain AV, 2000, J NEUROSCI, V20, P196, DOI 10.1523/JNEUROSCI.20-01-00196.2000; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Sakai R, 2001, J PHARMACOL EXP THER, V296, P650; Schiffer HH, 1997, NEURON, V19, P1141, DOI 10.1016/S0896-6273(00)80404-3; Smith TC, 2000, NAT NEUROSCI, V3, P992, DOI 10.1038/79931; SOMMER B, 1992, EMBO J, V11, P1651, DOI 10.1002/j.1460-2075.1992.tb05211.x; STEMBACH Y, 1994, NEURON, V13, P1345; Swanson GT, 1998, MOL PHARMACOL, V53, P942; Swanson GT, 1997, NEURON, V19, P913, DOI 10.1016/S0896-6273(00)80972-1; Taverna F, 2000, J BIOL CHEM, V275, P8475, DOI 10.1074/jbc.275.12.8475; WERNER P, 1991, NATURE, V351, P742, DOI 10.1038/351742a0	20	80	82	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 16	2002	34	4					589	598		10.1016/S0896-6273(02)00676-1	http://dx.doi.org/10.1016/S0896-6273(02)00676-1			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	553FT	12062042	Bronze			2022-12-24	WOS:000175665700012
J	Hasson, U; Levy, I; Behrmann, M; Hendler, T; Malach, R				Hasson, U; Levy, I; Behrmann, M; Hendler, T; Malach, R			Eccentricity bias as an organizing principle for human high-order object areas	NEURON			English	Article							HUMAN VISUAL-CORTEX; FUSIFORM FACE AREA; PROCESSING STAGES; WORD RECOGNITION; REPRESENTATION; PERCEPTION; ACTIVATION; FMRI; IDENTIFICATION; PASS	We have recently proposed a center-periphery organization based on resolution needs, in which objects engaging in recognition processes requiring central-vision (e.g., face-related) are associated with center-biased representations, while objects requiring large-scale feature integration (e.g., buildings) are associated with periphery-biased representations. Here we tested this hypothesis by comparing the center-periphery organization with activations to five object categories: faces, buildings, tools, letter strings, and words. We found that faces, letter strings, and words were mapped preferentially within the center-biased representation. Faces showed a hemispheric lateralization opposite to that of letter strings and words. In contrast, buildings were mapped mainly to the periphery-biased representation, while tools activated both central and peripheral representations. The results are compatible with the notion that center-periphery organization allows the optimal allocation of cortical magnification to the specific requirements of various recognition processes.	Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, IL-91904 Jerusalem, Israel; Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA; Tel Aviv Sourasky Med Ctr, Wohl Inst Adv Imaging, Dept Imaging, IL-64239 Tel Aviv, Israel; Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	Weizmann Institute of Science; Hebrew University of Jerusalem; Carnegie Mellon University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Malach, R (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	rafi.malach@weizmann.ac.il	hendler, talma/C-7677-2012	Levy, Ifat/0000-0001-7851-9070; Hasson, Uri/0000-0002-3599-7168; Behrmann, Marlene/0000-0002-3814-1015				Aguirre GK, 1998, NEURON, V21, P373, DOI 10.1016/S0896-6273(00)80546-2; Beauregard M, 1997, J COGNITIVE NEUROSCI, V9, P441, DOI 10.1162/jocn.1997.9.4.441; Behrmann M, 1998, NEUROPSYCHOLOGIA, V36, P1115, DOI 10.1016/S0028-3932(98)00005-0; Bookheimer SY, 1995, HUM BRAIN MAPP, V3, P93, DOI 10.1002/hbm.460030206; COSTEN NP, 1994, PERCEPTION, V23, P129, DOI 10.1068/p230129; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Edelman S, 1998, BEHAV BRAIN SCI, V21, P449, DOI 10.1017/S0140525X98001253; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Fiez JA, 1998, P NATL ACAD SCI USA, V95, P914, DOI 10.1073/pnas.95.3.914; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gauthier I, 2000, J COGNITIVE NEUROSCI, V12, P495, DOI 10.1162/089892900562165; Gold J, 1999, VISION RES, V39, P3537, DOI 10.1016/S0042-6989(99)00080-2; Grill-Spector K, 1998, NEURON, V21, P191, DOI 10.1016/S0896-6273(00)80526-7; Grill-Spector K, 1998, HUM BRAIN MAPP, V6, P316, DOI 10.1002/(SICI)1097-0193(1998)6:4<316::AID-HBM9>3.0.CO;2-6; Grill-Spector K, 2000, NAT NEUROSCI, V3, P837, DOI 10.1038/77754; Halgren E, 1999, HUM BRAIN MAPP, V7, P29; HASSON U, 2001, J COGNITIVE NEUROSCI, V13, P1; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; HAYES T, 1986, PERCEPTION, V15, P595, DOI 10.1068/p150595; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; Ivry R.B., 1998, 2 SIDES PERCEPTION; Jacobs RA, 1999, TRENDS COGN SCI, V3, P31, DOI 10.1016/S1364-6613(98)01260-1; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Karnath HO, 2001, NATURE, V411, P950, DOI 10.1038/35082075; Kobatake E, 1998, J NEUROPHYSIOL, V80, P324, DOI 10.1152/jn.1998.80.1.324; Leff AP, 2001, BRAIN, V124, P510, DOI 10.1093/brain/124.3.510; Lerner Y, 2001, CEREB CORTEX, V11, P287, DOI 10.1093/cercor/11.4.287; Levy I, 2001, NAT NEUROSCI, V4, P533, DOI 10.1038/87490; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; Makela P, 2001, VISION RES, V41, P599, DOI 10.1016/S0042-6989(00)00259-5; Malach R, 2002, TRENDS COGN SCI, V6, P176, DOI 10.1016/S1364-6613(02)01870-3; Mechelli A, 2000, J COGNITIVE NEUROSCI, V12, P145, DOI 10.1162/089892900564000; Melmoth DR, 2000, INVEST OPHTH VIS SCI, V41, P2811; Moore CJ, 1999, NEUROIMAGE, V10, P181, DOI 10.1006/nimg.1999.0450; NAZIR TA, 1992, PERCEPT PSYCHOPHYS, V52, P315, DOI 10.3758/BF03209148; O'Craven KM, 1999, NATURE, V401, P584, DOI 10.1038/44134; Oliva A, 1997, COGNITIVE PSYCHOL, V34, P72, DOI 10.1006/cogp.1997.0667; Price CJ, 1996, CEREB CORTEX, V6, P62, DOI 10.1093/cercor/6.1.62; Puce A, 1996, J NEUROSCI, V16, P5205; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; ROLLS ET, 1989, EXP BRAIN RES, V76, P153; Rumsey JM, 1997, BRAIN, V120, P739, DOI 10.1093/brain/120.5.739; Schyns PG, 1999, COGNITION, V69, P243, DOI 10.1016/S0010-0277(98)00069-9; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Springer SP, 1997, LEFT BRAIN RIGHT BRA; Tagamets MA, 2000, J COGNITIVE NEUROSCI, V12, P281, DOI 10.1162/089892900562101; Talairach J., 1988, COPLANAR STEREOTAXIC; Tarr MJ, 2000, NAT NEUROSCI, V3, P764, DOI 10.1038/77666; Tong F, 2000, COGNITIVE NEUROPSYCH, V17, P257, DOI 10.1080/026432900380607; Tootell RBH, 2001, CEREB CORTEX, V11, P298, DOI 10.1093/cercor/11.4.298; Tootell RBH, 1997, J NEUROSCI, V17, P7060; Uchida I, 1999, NEUROIMAGE, V9, P208, DOI 10.1006/nimg.1999.0400	56	363	364	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 25	2002	34	3					479	490		10.1016/S0896-6273(02)00662-1	http://dx.doi.org/10.1016/S0896-6273(02)00662-1			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	545JW	11988177	Bronze			2022-12-24	WOS:000175214700017
J	Lewicki, MS				Lewicki, MS			Efficient coding of natural sounds	NATURE NEUROSCIENCE			English	Article							INDEPENDENT COMPONENT ANALYSIS; AUDITORY-NERVE FIBERS; INFORMATION-TRANSMISSION; REPRESENTATIONS; SEPARATION; FRAMEWORK; FILTERS; SPARSE	The auditory system encodes sound by decomposing the amplitude signal arriving at the ear into multiple frequency bands whose center frequencies and bandwidths are approximately exponential functions of the distance from the stapes. This organization is thought to result from the adaptation of cochlear mechanisms to the animal's auditory environment. Here we report that several basic auditory nerve fiber tuning properties can be accounted for by adapting a population of filter shapes to encode natural sounds efficiently. The form of the code depends on sound class, resembling a Fourier transformation when optimized for animal vocalizations and a wavelet transformation when optimized for non-biological environmental sounds. Only for the combined set does the optimal code follow scaling characteristics of physiological data. These results suggest that auditory nerve fibers encode a broad set of natural sounds in a manner consistent with information theoretic principles.	Carnegie Mellon Univ, Dept Comp Sci, Pittsburgh, PA 15213 USA; Carnegie Mellon Univ, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA	Carnegie Mellon University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lewicki, MS (corresponding author), Carnegie Mellon Univ, Dept Comp Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA.							Amari S, 1996, ADV NEUR IN, V8, P757; Aticky JJ, 2011, NETWORK-COMP NEURAL, V22, P4, DOI [10.1088/0954-898X/3/2/009, 10.3109/0954898X.2011.638888]; ATTIAS H, 1997, ADV NEURAL INFORMATI, V9; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bell AJ, 1996, NETWORK-COMP NEURAL, V7, P261, DOI 10.1088/0954-898X/7/2/005; Bell AJ, 1997, VISION RES, V37, P3327, DOI 10.1016/S0042-6989(97)00121-1; Box GE, 1992, BAYESIAN INFERENCE S; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; CARDOSO JF, 1997, IEEE SIGNAL PROCESS, V4, P109; CARNEY LH, 1988, J NEUROPHYSIOL, V60, P1653, DOI 10.1152/jn.1988.60.5.1653; COMON P, 1994, SIGNAL PROCESS, V36, P287, DOI 10.1016/0165-1684(94)90029-9; DEBOER E, 1978, J ACOUST SOC AM, V63, P115, DOI 10.1121/1.381704; Emmons LH, 1997, SOUNDS NEOTROPICAL R; EVANS EF, 1977, PSYCHOPHYSICS PHYSL, P185; EVANS EF, 1975, HDB SENSORY PHYSIOLO, V5, P1; FIELD DJ, 1994, NEURAL COMPUT, V6, P559, DOI 10.1162/neco.1994.6.4.559; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; FURTH PM, 1995, IEEE T CIRCUITS-I, V42, P966, DOI 10.1109/81.477209; Irino T, 1997, J ACOUST SOC AM, V101, P412, DOI 10.1121/1.417975; Kiang NYS, 1965, DISCHARGE PATTERNS S; Laughlin S.B., 1983, PHYS BIOLOGICAL PROC, P42; Lewicki MS, 1999, ADV NEUR IN, V11, P730; Lewicki MS, 1999, J OPT SOC AM A, V16, P1587, DOI 10.1364/JOSAA.16.001587; Lewicki MS, 2000, NEURAL COMPUT, V12, P337, DOI 10.1162/089976600300015826; LINSKER R, 1990, ANNU REV NEUROSCI, V13, P257, DOI 10.1146/annurev.neuro.13.1.257; Mallat S., 1999, WAVELET TOUR SIGNAL, DOI 10.1016/B978-012466606-1/50008-8; MALLAT SG, 1989, IEEE T PATTERN ANAL, V11, P674, DOI 10.1109/34.192463; Moore B, 1986, FREQUENCY SELECTIVIT; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Pearlmutter B. A., 1996, Progress in Neural Information Processing. Proceedings of the International Conference on Neural Information Processing, P151; RHODE WS, 1985, HEARING RES, V18, P159, DOI 10.1016/0378-5955(85)90008-5; Rieke F, 1995, P ROY SOC B-BIOL SCI, V262, P259, DOI 10.1098/rspb.1995.0204; Schwartz O, 2001, NAT NEUROSCI, V4, P819, DOI 10.1038/90526; SIMONS J, 1979, THEOR CHEM ADV PERSP, V3, P1; van Hateren JH, 1998, P ROY SOC B-BIOL SCI, V265, P2315, DOI 10.1098/rspb.1998.0577; VOSS RF, 1975, NATURE, V258, P317, DOI 10.1038/258317a0; ZOHARIAN AS, 1981, J ACOUST SOC AM, V69, P832	38	417	423	3	37	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2002	5	4					356	363		10.1038/nn831	http://dx.doi.org/10.1038/nn831			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	534UQ	11896400	Green Submitted			2022-12-24	WOS:000174606900016
J	Petrucelli, L; O'Farrell, C; Lockhart, PJ; Baptista, M; Kehoe, K; Vink, L; Choi, P; Wolozin, B; Farrer, M; Hardy, J; Cookson, MR				Petrucelli, L; O'Farrell, C; Lockhart, PJ; Baptista, M; Kehoe, K; Vink, L; Choi, P; Wolozin, B; Farrer, M; Hardy, J; Cookson, MR			Parkin protects against the toxicity associated with mutant alpha-synuclein: Proteasome dysfunction selectively affects catecholaminergic neurons	NEURON			English	Article							INDUCED CELL-DEATH; SUBSTANTIA-NIGRA; WILD-TYPE; BODY FORMATION; DEGRADATION; DISEASE; GENE; AGGREGATION; EXPRESSION; MUTATION	One hypothesis for the etiology of Parkinson's disease (PD) is that subsets of neurons are vulnerable to a failure in proteasome-mediated protein turnover. Here we show that overexpression of mutant alpha-synuclein increases sensitivity to proteasome inhibitors by decreasing proteasome function. Overexpression of parkin decreases sensitivity to proteasome inhibitors in a manner dependent on parkin's ubiquitin-protein E3 ligase activity, and antisense knockdown of parkin increases sensitivity to proteasome inhibitors. Mutant alpha-synuclein also causes selective toxicity to catecholaminergic neurons in primary midbrain cultures, an effect that can be mimicked by the application of proteasome inhibitors. Parkin is capable of rescuing the toxic effects of mutant alpha-synuclein or proteasome inhibition in these cells. Therefore, parkin and alpha-synuclein are linked by common effects on a pathway associated with selective cell death in catecholaminergic neurons.	NIA, Neurogenet Lab, Bethesda, MD 20892 USA; Mayo Clin Jacksonville, Neurogenet Lab, Jacksonville, FL 32224 USA; Loyola Univ, Med Ctr, Dept Pharmacol, Maywood, IL 60153 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Mayo Clinic; Loyola University Chicago	Cookson, MR (corresponding author), NIA, Neurogenet Lab, Bethesda, MD 20892 USA.	cookson@mail.nih.gov	Lockhart, Paul J/E-7753-2011; Hardy, John/C-2451-2009; Cookson, Mark/AAW-2516-2021	Lockhart, Paul J/0000-0003-2531-8413; Hardy, John/0000-0002-3122-0423; Cookson, Mark/0000-0002-1058-3831; Farrer, Matthew/0000-0003-1159-5321	NINDS NIH HHS [R01-NS41816-01, P01-NS40256] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS040256, R01NS041816] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000953] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ancolio K, 2000, NEUROSCI LETT, V285, P79, DOI 10.1016/S0304-3940(00)01049-1; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bennett MC, 1999, J BIOL CHEM, V274, P33855, DOI 10.1074/jbc.274.48.33855; Braak H, 2000, J NEUROL, V247, P3; Burke RE, 1998, J NEUROCHEM, V71, P517; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Cookson MR, 1998, J NEUROCHEM, V70, P501; Coopersmith R, 1999, BIOTECHNIQUES, V27, P1156, DOI 10.2144/99276st01; Ellis RJ, 2001, CURR OPIN STRUC BIOL, V11, P114, DOI 10.1016/S0959-440X(00)00172-X; Farrer M, 2000, MOVEMENT DISORD, V15, P1075, DOI 10.1002/1531-8257(200011)15:6<1075::AID-MDS1004>3.0.CO;2-2; Farrer M, 2001, ANN NEUROL, V50, P293, DOI 10.1002/ana.1132; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Ghee M, 2000, J NEUROCHEM, V75, P2221, DOI 10.1046/j.1471-4159.2000.0752221.x; Gilon T, 1998, EMBO J, V17, P2759, DOI 10.1093/emboj/17.10.2759; Hashimoto M, 2001, NEURON, V32, P213, DOI 10.1016/S0896-6273(01)00462-7; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; IVERSKY VN, 2002, FEBS LETT, V515, P99; Junn E, 2002, NEUROSCI LETT, V320, P146, DOI 10.1016/S0304-3940(02)00016-2; Kirik D, 2002, J NEUROSCI, V22, P2780, DOI 10.1523/JNEUROSCI.22-07-02780.2002; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Ko LW, 2000, J NEUROCHEM, V75, P2546, DOI 10.1046/j.1471-4159.2000.0752546.x; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lee HJ, 2002, J BIOL CHEM, V277, P5411, DOI 10.1074/jbc.M105326200; Lee M, 2001, J NEUROCHEM, V76, P998, DOI 10.1046/j.1471-4159.2001.00149.x; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Maraganore DM, 1999, NEUROLOGY, V53, P1858, DOI 10.1212/WNL.53.8.1858; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Matsuoka Y, 2001, NEUROBIOL DIS, V8, P535, DOI 10.1006/nbdi.2001.0392; McNaught KS, 2002, NEUROREPORT, V13, P1437, DOI 10.1097/00001756-200208070-00018; McNaught KSP, 2001, NEUROSCI LETT, V297, P191, DOI 10.1016/S0304-3940(00)01701-8; Mena MA, 1997, J NEUROCHEM, V69, P21; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Neve RL, 1997, NEUROSCIENCE, V79, P435, DOI 10.1016/S0306-4522(96)00645-8; Ostrerova-Golts N, 2000, J NEUROSCI, V20, P6048, DOI 10.1523/JNEUROSCI.20-16-06048.2000; PAKKENBERG B, 1991, J NEUROL NEUROSUR PS, V54, P30, DOI 10.1136/jnnp.54.1.30; Paxinou E, 2001, J NEUROSCI, V21, P8053, DOI 10.1523/JNEUROSCI.21-20-08053.2001; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rathke-Hartlieb S, 2001, J NEUROCHEM, V77, P1181, DOI 10.1046/j.1471-4159.2001.00366.x; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Shtilerman MD, 2002, BIOCHEMISTRY-US, V41, P3855, DOI 10.1021/bi0120906; Stefanis L, 2001, J NEUROSCI, V21, P9549, DOI 10.1523/JNEUROSCI.21-24-09549.2001; Tanaka Y, 2001, HUM MOL GENET, V10, P919, DOI 10.1093/hmg/10.9.919; Tofaris GK, 2001, FEBS LETT, V509, P22, DOI 10.1016/S0014-5793(01)03115-5; van der Putten H, 2000, J NEUROSCI, V20, P6021, DOI 10.1523/JNEUROSCI.20-16-06021.2000; Wintermeyer P, 2000, NEUROREPORT, V11, P2079, DOI 10.1097/00001756-200007140-00004; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797; Zhou WB, 2000, BRAIN RES, V866, P33, DOI 10.1016/S0006-8993(00)02215-0	53	460	470	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 19	2002	36	6					1007	1019		10.1016/S0896-6273(02)01125-X	http://dx.doi.org/10.1016/S0896-6273(02)01125-X			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	628TA	12495618	Bronze			2022-12-24	WOS:000180011600006
J	Wang, XZ; Weiner, JA; Levi, S; Craig, AM; Bradley, A; Sanes, JR				Wang, XZ; Weiner, JA; Levi, S; Craig, AM; Bradley, A; Sanes, JR			Gamma protocadherins are required for survival of spinal interneurons	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; N-CADHERIN; GENOMIC ORGANIZATION; HIPPOCAMPAL-NEURONS; ADHESION MOLECULES; LARGE FAMILY; DIVERSITY; RECEPTOR; BRAIN; SUPERFAMILY	The murine genome contains similar to70 protocadherin (Pcdh) genes. Many are expressed in the nervous system, suggesting that Pcdhs may specify neuronal connectivity. Here, we analyze the 22 contiguous genes of the Pcdh-gamma cluster. Individual neurons express subsets of Pcdh-gamma genes. Pcdh-gamma proteins are present in most neurons and associated with, but not confined to, synapses. Early steps in neuronal migration, axon outgrowth, and synapse formation proceed in mutant mice lacking all 22 Pcdh-gamma genes. At late embryonic stages, however, dramatic neurodegeneration leads to neonatal death. In mutant spinal cord, many interneurons are lost, but sensory and motor neurons are relatively spared. In cultures from mutant spinal cord, neurons differentiate and form synapses but then die. Thus, Pcdh-gamma genes are dispensable for at least some aspects of connectivity but required for survival of specific neuronal types.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	Washington University (WUSTL); Baylor College of Medicine; Wellcome Trust Sanger Institute	Sanes, JR (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.		Craig, Ann Marie/M-2054-2014; Weiner, Joshua/AAA-6532-2021; LEVI, SABINE/AAX-5607-2020	Weiner, Joshua/0000-0002-3352-2847; Bradley, Allan/0000-0002-2349-8839				Alagramam KN, 2001, HUM MOL GENET, V10, P1709, DOI 10.1093/hmg/10.16.1709; Angst BD, 2001, J CELL SCI, V114, P629; Bechade C, 1996, EUR J NEUROSCI, V8, P429, DOI 10.1111/j.1460-9568.1996.tb01226.x; Benson DL, 2001, NAT REV NEUROSCI, V2, P899, DOI 10.1038/35104078; Bozdagi O, 2000, NEURON, V28, P245, DOI 10.1016/S0896-6273(00)00100-8; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; DEOLMOS JS, 1971, BRAIN RES, V33, P523, DOI 10.1016/0006-8993(71)90130-2; Dreyer WJ, 1999, GENETICA, V107, P249, DOI 10.1023/A:1003909311678; Frank M, 2002, CURR OPIN CELL BIOL, V14, P557, DOI 10.1016/S0955-0674(02)00365-4; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; Hamada S, 2001, NEUROSCI RES, V41, P207, DOI 10.1016/S0168-0102(01)00281-4; Inoue A, 1997, SCIENCE, V276, P1428, DOI 10.1126/science.276.5317.1428; Iwai Y, 1997, NEURON, V19, P77, DOI 10.1016/S0896-6273(00)80349-9; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Levi S, 2002, J NEUROSCI, V22, P4274, DOI 10.1523/JNEUROSCI.22-11-04274.2002; Lowrie MB, 2000, PROG NEUROBIOL, V61, P543, DOI 10.1016/S0301-0082(99)00065-9; Manabe T, 2000, MOL CELL NEUROSCI, V15, P534, DOI 10.1006/mcne.2000.0849; Nijhawan D, 2000, ANNU REV NEUROSCI, V23, P73, DOI 10.1146/annurev.neuro.23.1.73; Nollet F, 2000, J MOL BIOL, V299, P551, DOI 10.1006/jmbi.2000.3777; NORNES HO, 1978, BRAIN RES, V159, P1, DOI 10.1016/0006-8993(78)90105-1; Obata S, 1998, CELL ADHES COMMUN, V6, P323, DOI 10.3109/15419069809010791; Oliveira ALR, 2002, J COMP NEUROL, V447, P381, DOI 10.1002/cne.10248; PFENNINGER KH, 1971, J ULTRA MOL STRUCT R, V34, P103, DOI 10.1016/S0022-5320(71)90007-4; Price SR, 2002, CELL, V109, P205, DOI 10.1016/S0092-8674(02)00695-5; Rao A, 2000, J NEUROSCI, V20, P8344, DOI 10.1523/JNEUROSCI.20-22-08344.2000; Redies C, 2000, PROG NEUROBIOL, V61, P611, DOI 10.1016/S0301-0082(99)00070-2; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Riehl R, 1996, NEURON, V17, P837, DOI 10.1016/S0896-6273(00)80216-0; SANO K, 1993, EMBO J, V12, P2249, DOI 10.1002/j.1460-2075.1993.tb05878.x; Senzaki K, 1999, CELL, V99, P635, DOI 10.1016/S0092-8674(00)81552-4; Serafini T, 1999, CELL, V98, P133, DOI 10.1016/S0092-8674(00)81008-9; Serpinskaya AS, 1999, DEV BIOL, V205, P65, DOI 10.1006/dbio.1998.9112; Shapiro L, 1999, NEURON, V23, P427, DOI 10.1016/S0896-6273(00)80796-5; Sugino H, 2000, GENOMICS, V63, P75, DOI 10.1006/geno.1999.6066; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Tang LX, 1998, NEURON, V20, P1165, DOI 10.1016/S0896-6273(00)80497-3; Tasic B, 2002, MOL CELL, V10, P21, DOI 10.1016/S1097-2765(02)00578-6; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; TOMASELLI KJ, 1988, NEURON, V1, P33, DOI 10.1016/0896-6273(88)90207-3; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Wang XZ, 2002, GENE DEV, V16, P1890, DOI 10.1101/gad.1004802; Wolverton T, 2001, GENOMICS, V76, P66, DOI 10.1006/geno.2001.6592; Wu Q, 2001, GENOME RES, V11, P389, DOI 10.1101/gr.167301; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Yagi T, 2000, GENE DEV, V14, P1169; YAMAGATA M, 1995, J NEUROSCI, V15, P4556; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119	48	195	200	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 5	2002	36	5					843	854		10.1016/S0896-6273(02)01090-5	http://dx.doi.org/10.1016/S0896-6273(02)01090-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	622VL	12467588	Bronze			2022-12-24	WOS:000179667800009
J	Wu, P; Tarasenko, YI; Gu, YP; Huang, LYM; Coggeshall, RE; Yu, YJ				Wu, P; Tarasenko, YI; Gu, YP; Huang, LYM; Coggeshall, RE; Yu, YJ			Region-specific generation of cholinergic neurons from fetal human neural stem cells grafted in adult rat	NATURE NEUROSCIENCE			English	Article							PROGENITOR CELLS; IN-VITRO; NERVOUS-SYSTEM; SPINAL-CORD; HUMAN BRAIN; HUMAN CNS; TRANSPLANTATION; GROWTH; DIFFERENTIATION; ESTABLISHMENT	Pluripotent or multipotent stem cells isolated from human embryos or adult central nervous system (CNS) may provide new neurons to ameliorate neural disorders. A major obstacle, however, is that the majority of such cells do not differentiate into neurons when grafted into non-neurogenic areas of the adult CNS. Here we report a new in vitro priming procedure that generates a nearly pure population of neurons from fetal human neural stem cells (hNSCs) transplanted into adult rat CNS. Furthermore, the grafted cells differentiated by acquiring a cholinergic phenotype in a region-specific manner. This technology may advance stem cell-based therapy to replace lost neurons in neural injury or neurodegenerative disorders.	Univ Texas, Med Branch, Dept Anat & Neurosci, Galveston, TX 77555 USA; Univ Texas, Med Branch, Dept Physiol & Biophys, Galveston, TX 77555 USA; Univ Texas, Med Branch, Dept Radiat Oncol, Galveston, TX 77555 USA; Univ Texas, Med Branch, Inst Marine Biomed, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Wu, P (corresponding author), Univ Texas, Med Branch, Dept Anat & Neurosci, Galveston, TX 77555 USA.	piwu@utmb.edu	wu, Ping/G-8958-2011					Anderson DJ, 2001, NEURON, V30, P19, DOI 10.1016/S0896-6273(01)00260-4; Bonfanti L, 2001, CONT NEUROS, P49; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; Brustle O, 1998, NAT BIOTECHNOL, V16, P1040, DOI 10.1038/3481; Caldwell MA, 2001, NAT BIOTECHNOL, V19, P475, DOI 10.1038/88158; Cao QL, 2001, EXP NEUROL, V167, P48, DOI 10.1006/exnr.2000.7536; Carpenter MK, 1999, EXP NEUROL, V158, P265, DOI 10.1006/exnr.1999.7098; COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A; Fannon M, 2000, BIOCHEMISTRY-US, V39, P1434, DOI 10.1021/bi991895z; Flax JD, 1998, NAT BIOTECHNOL, V16, P1033, DOI 10.1038/3473; Fricker RA, 1999, J NEUROSCI, V19, P5990, DOI 10.1523/JNEUROSCI.19-14-05990.1999; Isacson O, 1997, TRENDS NEUROSCI, V20, P477, DOI 10.1016/S0166-2236(97)01081-3; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Johansson CB, 1999, EXP CELL RES, V253, P733, DOI 10.1006/excr.1999.4678; KAN MK, 1993, SCIENCE, V259, P1918, DOI 10.1126/science.8456318; Messam CA, 2000, EXP NEUROL, V161, P585, DOI 10.1006/exnr.1999.7319; Ostenfeld T, 2000, EXP NEUROL, V164, P215, DOI 10.1006/exnr.2000.7427; Palmer TD, 2001, NATURE, V411, P42, DOI 10.1038/35075141; Reubinoff BE, 2001, NAT BIOTECHNOL, V19, P1134, DOI 10.1038/nbt1201-1134; Roy NS, 2000, NAT MED, V6, P271; Schmitz HD, 2001, HISTOCHEM CELL BIOL, V116, P89; Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726; Sheen VL, 1999, EXP NEUROL, V158, P47, DOI 10.1006/exnr.1999.7104; Shihabuddin LS, 1999, ARCH NEUROL-CHICAGO, V56, P29, DOI 10.1001/archneur.56.1.29; Shihabuddin LS, 2000, J NEUROSCI, V20, P8727; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; Svendsen CN, 1998, J NEUROSCI METH, V85, P141, DOI 10.1016/S0165-0270(98)00126-5; Svendsen CN, 1997, EXP NEUROL, V148, P135, DOI 10.1006/exnr.1997.6634; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Vescovi AL, 1999, EXP NEUROL, V156, P71, DOI 10.1006/exnr.1998.6998; Villa A, 2000, EXP NEUROL, V161, P67, DOI 10.1006/exnr.1999.7237; Whittemore SR, 1999, EXP CELL RES, V252, P75, DOI 10.1006/excr.1999.4621; Wu P, 2002, GENE THER, V9, P245, DOI 10.1038/sj.gt.3301646; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	38	178	207	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2002	5	12					1271	1278		10.1038/nn974	http://dx.doi.org/10.1038/nn974			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	618ZE	12426573				2022-12-24	WOS:000179447500009
J	Hack, I; Bancila, M; Loulier, K; Carroll, P; Cremer, H				Hack, I; Bancila, M; Loulier, K; Carroll, P; Cremer, H			Reelin is a detachment signal in tangential chain-migration during postnatal neurogenesis	NATURE NEUROSCIENCE			English	Article							MESSENGER-RNA EXPRESSION; CAJAL-RETZIUS CELLS; RADIAL GLIAL-CELLS; NEURONAL MIGRATION; OLFACTORY-BULB; SUBVENTRICULAR ZONE; NERVOUS-SYSTEM; VLDL RECEPTOR; ADULT-MOUSE; FOREBRAIN	During development, Reelin acts on migrating neuronal precursors and controls correct cell positioning in the cortex and other brain structures by a hitherto unidentified mechanism. Here we show that in the postnatal mouse brain, Reelin acts as a detachment signal for chain-migrating interneuron precursors in the olfactory bulb. Neuronal precursors cultured in Matrigel detached from chains and migrated individually in the presence of exogenously added Reelin protein or Reelin-expressing brain tissues. Furthermore, we found that in reeler mutant mice, neuronal precursors accumulated in the olfactory bulb and remained in clusters, indicating that they did not change from tangential chain-migration to radial individual migration. Our data provide direct evidence that Reelin acts as a detachment signal, but not a stop or guidance cue. We propose that Reelin may have comparable functions during development.	Univ Mediterranee, INSERM, CNRS, NMDA,IBDM, F-13288 Marseille 9, France; CNRS, UPR 9040, F-91198 Gif Sur Yvette, France; Univ Montpellier 2, INSERM, U432, F-34095 Montpellier 05, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Cremer, H (corresponding author), Univ Mediterranee, INSERM, CNRS, NMDA,IBDM, Campus Luminy, F-13288 Marseille 9, France.		Carroll, Patrick/AAL-7773-2021; Loulier, Karine/E-5529-2017	Loulier, Karine/0000-0001-6216-2708; Cremer, Harold/0000-0002-8673-5176				Alcantara S, 1998, J NEUROSCI, V18, P7779; Alvarez-Buylla A, 1998, J NEUROBIOL, V36, P105, DOI 10.1002/(SICI)1097-4695(199808)36:2<105::AID-NEU1>3.0.CO;2-5; Braids OC, 2001, ENVIRON FORENSICS, V2, P189, DOI 10.1006/enfo.2000.0040; Carroll P, 2001, MOL CELL NEUROSCI, V17, P611, DOI 10.1006/mcne.2001.0966; Chazal G, 2000, J NEUROSCI, V20, P1446; Conover JC, 2000, NAT NEUROSCI, V3, P1091, DOI 10.1038/80606; COROTTO FS, 1994, NEUROSCIENCE, V61, P739, DOI 10.1016/0306-4522(94)90397-2; Cremer H, 1998, P NATL ACAD SCI USA, V95, P13242, DOI 10.1073/pnas.95.22.13242; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; DArcangelo G, 1997, J NEUROSCI, V17, P23, DOI 10.1523/JNEUROSCI.17-01-00023.1997; deBergeyck V, 1997, MOL BRAIN RES, V50, P85, DOI 10.1016/S0169-328X(97)00166-6; Derer P, 2001, J COMP NEUROL, V440, P136, DOI 10.1002/cne.1375; Dulabon L, 2000, NEURON, V27, P33, DOI 10.1016/S0896-6273(00)00007-6; Frotscher M, 1998, CURR OPIN NEUROBIOL, V8, P570, DOI 10.1016/S0959-4388(98)80082-2; GALILEO DS, 1992, NEURON, V9, P1117, DOI 10.1016/0896-6273(92)90070-T; Gilmore EC, 2000, CURR BIOL, V10, pR162, DOI 10.1016/S0960-9822(00)00332-8; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Hong SE, 2000, NAT GENET, V26, P93, DOI 10.1038/79246; Hu HY, 2000, J NEUROSCI RES, V61, P480, DOI 10.1002/1097-4547(20000901)61:5<480::AID-JNR2>3.0.CO;2-M; Hu HY, 1999, NEURON, V23, P703, DOI 10.1016/S0896-6273(01)80029-5; JACOBOWITZ DM, 1991, J COMP NEUROL, V304, P198, DOI 10.1002/cne.903040205; Jacques TS, 1998, DEVELOPMENT, V125, P3167; Kim HM, 2002, P NATL ACAD SCI USA, V99, P4020, DOI 10.1073/pnas.062698299; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Magdaleno S, 2002, NEURON, V33, P573, DOI 10.1016/S0896-6273(02)00582-2; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Miyata T, 1997, J NEUROSCI, V17, P3599; Murase S, 2002, J NEUROSCI, V22, P3568; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; ORourke NA, 1996, NEURON, V16, P1061, DOI 10.1016/S0896-6273(00)80130-0; Quattrocchi CC, 2002, J BIOL CHEM, V277, P303, DOI 10.1074/jbc.M106996200; Rice DS, 2001, ANNU REV NEUROSCI, V24, P1005, DOI 10.1146/annurev.neuro.24.1.1005; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; Schiffmann SN, 1997, EUR J NEUROSCI, V9, P1055, DOI 10.1111/j.1460-9568.1997.tb01456.x; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; WYSS JM, 1980, BRAIN RES, V188, P566, DOI 10.1016/0006-8993(80)90056-6	42	242	260	1	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2002	5	10					939	945		10.1038/nn923	http://dx.doi.org/10.1038/nn923			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	597VV	12244323				2022-12-24	WOS:000178242200012
J	Frey, S; Petrides, M				Frey, S; Petrides, M			Orbitofrontal cortex and memory formation	NEURON			English	Article							PREFRONTAL CORTEX; RHESUS-MONKEY; VISUAL RECOGNITION; CORTICAL AFFERENTS; FRONTAL-CORTEX; HUMAN BRAIN; LESIONS; REGISTRATION; LOCALIZATION; CONNECTIONS	Which one of the many regions of the anatomically heterogeneous prefrontal cortex is part of the critical core of the neural circuit for encoding? This positron emission tomography (PET) experiment measured changes in cerebral blood flow (CBF) in normal human participants during the presentation of abstract visual information in four conditions that varied in their encoding demands. As encoding increased across the different conditions, there was an increase in activity in the right orbitofrontal cortex and the right parahippocampal region. No significant activation peaks were present in any other region of the frontal or temporal lobe. These findings indicate that the orbitofrontal cortex, which is massively connected to the medial temporal cortex, is a critical frontal region for memory formation.	McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada	McGill University	Frey, S (corresponding author), McGill Univ, Montreal Neurol Inst, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.							BACHEVALIER J, 1986, BEHAV BRAIN RES, V20, P249, DOI 10.1016/0166-4328(86)90225-1; BARBAS H, 1989, J COMP NEUROL, V286, P353, DOI 10.1002/cne.902860306; Barbas H, 1995, HIPPOCAMPUS, V5, P511, DOI 10.1002/hipo.450050604; Brodmann K, 1909, VERGLEICHENDE LOCALI; Buckner RL, 1999, NAT NEUROSCI, V2, P311, DOI 10.1038/7221; Carmichael ST, 1995, J COMP NEUROL, V363, P615, DOI 10.1002/cne.903630408; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Courtney SM, 1996, CEREB CORTEX, V6, P39, DOI 10.1093/cercor/6.1.39; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; Fletcher PC, 1998, BRAIN, V121, P1239, DOI 10.1093/brain/121.7.1239; Frey S, 2000, P NATL ACAD SCI USA, V97, P8723, DOI 10.1073/pnas.140543497; GAZZANIG.MS, 1965, BRAIN, V88, P221, DOI 10.1093/brain/88.2.221; Haxby JV, 1996, P NATL ACAD SCI USA, V93, P922, DOI 10.1073/pnas.93.2.922; INSAUSTI R, 1987, J COMP NEUROL, V264, P356, DOI 10.1002/cne.902640306; Lavenex P, 2002, J COMP NEUROL, V447, P394, DOI 10.1002/cne.10243; Meunier M, 1997, NEUROPSYCHOLOGIA, V35, P999, DOI 10.1016/S0028-3932(97)00027-4; MEUNIER M, 1993, J NEUROSCI, V13, P5418, DOI 10.1523/JNEUROSCI.13-12-05418.1993; Milner B, 1972, Clin Neurosurg, V19, P421; MILNER B, 1971, BRIT MED BULL, V27, P272, DOI 10.1093/oxfordjournals.bmb.a070866; MISHKIN M, 1982, PHILOS T R SOC B, V298, P85, DOI 10.1098/rstb.1982.0074; Ojemann JG, 1997, NEUROIMAGE, V6, P156, DOI 10.1006/nimg.1997.0289; Petrides M, 1996, PHILOS T ROY SOC B, V351, P1455, DOI 10.1098/rstb.1996.0130; Petrides M, 2002, P NATL ACAD SCI USA, V99, P5649, DOI 10.1073/pnas.072092299; Petrides M., 2000, HDB NEUROPSYCHOLOGY; PETRIDES M, 1994, HDB NEUROPSYCHOLOGY; RAICHLE ME, 1983, J NUCL MED, V24, P790; Savage CR, 2001, BRAIN, V124, P219, DOI 10.1093/brain/124.1.219; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; SUZUKI WA, 1993, J NEUROSCI, V13, P2430, DOI 10.1523/JNEUROSCI.13-06-02430.1993; Talairach J., 1988, COPLANAR STEREOTAXIC; TULVING E, 1994, NEUROREPORT, V5, P2525, DOI 10.1097/00001756-199412000-00030; VOGT BA, 1987, J COMP NEUROL, V262, P271, DOI 10.1002/cne.902620208; Wagner AD, 1998, NEUROREPORT, V9, P3711, DOI 10.1097/00001756-199811160-00026; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; WOODS RP, 1993, J COMPUT ASSIST TOMO, V17, P536, DOI 10.1097/00004728-199307000-00004; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Zola SM, 2000, J NEUROSCI, V20, P451, DOI 10.1523/JNEUROSCI.20-01-00451.2000	37	85	85	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 26	2002	36	1					171	176		10.1016/S0896-6273(02)00901-7	http://dx.doi.org/10.1016/S0896-6273(02)00901-7			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	598UP	12367515	Bronze			2022-12-24	WOS:000178295100016
J	Turk, DJ; Heatherton, TF; Kelley, WM; Funnell, MG; Gazzaniga, MS; Macrae, CN				Turk, DJ; Heatherton, TF; Kelley, WM; Funnell, MG; Gazzaniga, MS; Macrae, CN			Mike or me? Self-recognition in a split-brain patient	NATURE NEUROSCIENCE			English	Article									Dartmouth Coll, Ctr Cognit Neurosci, Dept Psychol & Brain Sci, Hanover, NH 03755 USA	Dartmouth College	Turk, DJ (corresponding author), Dartmouth Coll, Ctr Cognit Neurosci, Dept Psychol & Brain Sci, Moore Hall, Hanover, NH 03755 USA.	david.j.turk@dartmouth.edu	Turk, David/C-5201-2008; Turk, David J/G-8878-2013; Heatherton, Todd F/H-5478-2011; Macrae, Neil/C-4761-2008		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031443] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS031443, R01 NS31443] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Conway MA, 2000, PSYCHOL REV, V107, P261, DOI 10.1037//0033-295X.107.2.261; Conway MA, 1999, MEMORY, V7, P679, DOI 10.1080/096582199387805; DERENZI E, 1986, NEUROPSYCHOLOGIA, V24, P385; GAZZANIGA MS, 1983, ANN NEUROL, V13, P536, DOI 10.1002/ana.410130511; Gazzaniga MS, 1998, SCI AM, V279, P50, DOI 10.1038/scientificamerican0798-50; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Keenan JP, 1999, NEUROPSYCHOLOGIA, V37, P1421, DOI 10.1016/S0028-3932(99)00025-1; Keenan JP, 2000, TRENDS COGN SCI, V4, P338, DOI 10.1016/S1364-6613(00)01521-7; Keenan JP, 2000, NEUROPSYCHOLOGIA, V38, P1047, DOI 10.1016/S0028-3932(99)00145-1; Keenan JP, 2001, NATURE, V409, P305, DOI 10.1038/35053167; Kircher TTJ, 2000, COGNITIVE BRAIN RES, V10, P133, DOI 10.1016/S0926-6410(00)00036-7; Kircher TTJ, 2002, NEUROPSYCHOLOGIA, V40, P683, DOI 10.1016/S0028-3932(01)00138-5; Kircher TTJ, 2001, COGNITION, V78, pB1, DOI 10.1016/S0010-0277(00)00104-9; Maguire EA, 1999, HIPPOCAMPUS, V9, P54, DOI 10.1002/(SICI)1098-1063(1999)9:1<54::AID-HIPO6>3.0.CO;2-O	14	134	143	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2002	5	9					841	842		10.1038/nn907	http://dx.doi.org/10.1038/nn907			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587RL	12195428				2022-12-24	WOS:000177656300012
J	Xiang, Y; Li, Y; Zhang, Z; Cui, K; Wang, S; Yuan, XB; Wu, CP; Poo, MM; Duan, SM				Xiang, Y; Li, Y; Zhang, Z; Cui, K; Wang, S; Yuan, XB; Wu, CP; Poo, MM; Duan, SM			Nerve growth cone guidance mediated by G protein-coupled receptors	NATURE NEUROSCIENCE			English	Article							LYMPHOCYTE CHEMOATTRACTANT; PHOSPHOINOSITIDE 3-KINASE; NEURONAL MIGRATION; MOLECULAR-BIOLOGY; CHEMOKINE; CHEMOTAXIS; SYSTEM; CELLS; PROLIFERATION; ATTRACTION	Growing axons navigate by responding to chemical guidance cues. Here we report that growth cones of rat cerebellar axons in culture turned away from a gradient of SDF-1, a chemokine that attracts migrating leukocytes and cerebellar granule cells via a G protein-coupled receptor (GPCR). Similarly, Xenopus spinal growth cones turned away from a gradient of baclofen, an agonist of the GABA(B) receptor. This response was mediated by G(i) and subsequent activation of phospholipase C (PLC), which triggered two pathways: protein kinase C (PKC) led to repulsion, and inositol 1,4,5-triphosphate (IP3) receptor activation led to attractive turning. Under normal culture conditions, PKC-dependent repulsion dominated, but the repulsion could be converted to attraction by inhibiting PKC or by elevating cytosolic cGMP. Thus, GPCRs can mediate both repulsive and attractive axon guidance in vitro, and chemokines may serve as guidance cues for axon pathfinding.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China; Univ Calif Berkeley, Dept Cell & Mol Biol, Div Neurobiol, Berkeley, CA 94720 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of California System; University of California Berkeley	Duan, SM (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	shumin@ion.ac.cn	Zhang, Zhe/C-2685-2011; wang, sheng/B-1969-2010	Yuan, Xiaobing/0000-0002-1632-8460				BERRIDGE MJ, 1989, CELL, V59, P411, DOI 10.1016/0092-8674(89)90026-3; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Borghesani PR, 2002, DEVELOPMENT, V129, P1435; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; DEVREOTES PN, 1988, ANNU REV CELL BIOL, V4, P649, DOI 10.1146/annurev.cb.04.110188.003245; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; Hesselgesser J, 1999, J NEUROVIROL, V5, P13, DOI 10.3109/13550289909029741; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Hopker VH, 1999, NATURE, V401, P69, DOI 10.1038/43441; IGARASHI M, 1993, SCIENCE, V259, P77, DOI 10.1126/science.8418498; Klein RS, 2001, DEVELOPMENT, V128, P1971; Lu Q, 2001, CELL, V105, P69, DOI 10.1016/S0092-8674(01)00297-5; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; McGrath KE, 1999, DEV BIOL, V213, P442, DOI 10.1006/dbio.1999.9405; Mennicken F, 1999, TRENDS PHARMACOL SCI, V20, P73, DOI 10.1016/S0165-6147(99)01308-5; Meucci O, 1998, P NATL ACAD SCI USA, V95, P14500, DOI 10.1073/pnas.95.24.14500; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Mueller BK, 1999, ANNU REV NEUROSCI, V22, P351, DOI 10.1146/annurev.neuro.22.1.351; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; Nakamura F, 2000, J NEUROBIOL, V44, P219, DOI 10.1002/1097-4695(200008)44:2<219::AID-NEU11>3.0.CO;2-W; OBERLEY LW, 1982, SUPEROXIDE DISMUTASE, V1, P1; Poznansky MC, 2000, NAT MED, V6, P543, DOI 10.1038/75022; Raper JA, 2000, CURR OPIN NEUROBIOL, V10, P88, DOI 10.1016/S0959-4388(99)00057-4; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Song HJ, 1999, CURR OPIN NEUROBIOL, V9, P355, DOI 10.1016/S0959-4388(99)80052-X; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Song HJ, 2001, NAT CELL BIOL, V3, pE81, DOI 10.1038/35060164; Sotsios Y, 1999, J IMMUNOL, V163, P5954; Takei K, 1998, SCIENCE, V282, P1705, DOI 10.1126/science.282.5394.1705; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wang JF, 2000, BLOOD, V95, P2505, DOI 10.1182/blood.V95.8.2505.008k24_2505_2513; Wu JY, 2001, NATURE, V410, P948, DOI 10.1038/35073616; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Xia MQ, 1999, J NEUROVIROL, V5, P32, DOI 10.3109/13550289909029743; Yee KT, 1999, NEURON, V24, P607, DOI 10.1016/S0896-6273(00)81116-2; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748; Zheng JQ, 2000, NATURE, V403, P89, DOI 10.1038/47501; Zhou FQ, 2001, J CELL BIOL, V153, P1071, DOI 10.1083/jcb.153.5.1071; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	43	184	192	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2002	5	9					843	848		10.1038/nn899	http://dx.doi.org/10.1038/nn899			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587RL	12161754				2022-12-24	WOS:000177656300013
J	Reppas, JB; Usrey, WM; Reid, RC				Reppas, JB; Usrey, WM; Reid, RC			Saccadic eye movements modulate visual responses in the lateral geniculate nucleus	NEURON			English	Article							RETINAL GANGLION-CELLS; UNDERLYING CONTRAST ADAPTATION; RECEPTIVE-FIELD PROPERTIES; TEMPORAL IMPULSE-RESPONSE; NONLAGGED CELLS; RHESUS-MONKEY; AREA MT; CAT; NEURONS; SUPPRESSION	We studied the effects of saccadic eye movements on visual signaling in the primate lateral geniculate nucleus (LGN), the earliest stage of central visual processing. Visual responses were probed with spatially uniform flickering stimuli, so that retinal processing was uninfluenced by eye movements. Nonetheless, saccades had diverse effects, altering not only response strength but also the temporal and chromatic properties of the receptive field. Of these changes, the most prominent was a biphasic modulation of response strength, weak suppression followed by strong enhancement. Saccadic modulation was widespread, and affected both of the major processing streams in the LGN. Our results demonstrate that during natural viewing, thalamic response properties can vary dramatically, even over the course of a single fixation.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Reid, RC (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.				NEI NIH HHS [EY12196, EY12185, EY06604] Funding Source: Medline; NATIONAL EYE INSTITUTE [P30EY012196] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bair W, 1998, VISUAL NEUROSCI, V15, P779, DOI 10.1017/S0952523898154160; BARLOW HB, 1957, J PHYSIOL-LONDON, V136, P469, DOI 10.1113/jphysiol.1957.sp005774; BEELER GW, 1967, VISION RES, V7, P769, DOI 10.1016/0042-6989(67)90039-9; Benardete EA, 1999, VISUAL NEUROSCI, V16, P355, DOI 10.1017/S0952523899162151; Brown SP, 2001, NAT NEUROSCI, V4, P44, DOI 10.1038/82888; BURR DC, 1994, NATURE, V371, P511, DOI 10.1038/371511a0; Burr DC, 1996, VISION RES, V36, P2069, DOI 10.1016/0042-6989(95)00282-0; Busettini C, 1996, J NEUROPHYSIOL, V75, P1392, DOI 10.1152/jn.1996.75.4.1392; BUTTNER U, 1973, J NEUROPHYSIOL, V36, P127, DOI 10.1152/jn.1973.36.1.127; Cai RH, 1997, NATURE, V386, P601, DOI 10.1038/386601a0; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; Carpenter RHS, 1988, MOVEMENTS EYES; Chander D, 2001, J NEUROSCI, V21, P9904, DOI 10.1523/JNEUROSCI.21-24-09904.2001; Chichilnisky EJ, 1996, VISUAL NEUROSCI, V13, P591, DOI 10.1017/S0952523800008270; COHEN B, 1968, J NEUROPHYSIOL, V31, P806, DOI 10.1152/jn.1968.31.6.806; Dan Y, 1996, J NEUROSCI, V16, P3351; Derrington AM, 1998, VISUAL NEUROSCI, V15, P875, DOI 10.1017/S0952523898155128; Diamond MR, 2000, J NEUROSCI, V20, P3449, DOI 10.1523/JNEUROSCI.20-09-03449.2000; DiCarlo JJ, 2000, NAT NEUROSCI, V3, P814, DOI 10.1038/77722; DOTY RW, 1973, EXP BRAIN RES, V18, P189; ESTEVEZ O, 1982, VISION RES, V22, P681, DOI 10.1016/0042-6989(82)90104-3; EYSEL UT, 1986, J PHYSIOL-LONDON, V370, P233, DOI 10.1113/jphysiol.1986.sp015932; Fischer WH, 1996, EXP BRAIN RES, V110, P435; FRANCESCONI W, 1988, J NEUROPHYSIOL, V59, P1690, DOI 10.1152/jn.1988.59.6.1690; Gallant JL, 1998, NEUROREPORT, V9, P2153, DOI 10.1097/00001756-199806220-00045; Gur M, 1997, VISION RES, V37, P257, DOI 10.1016/S0042-6989(96)00182-4; HARTVEIT E, 1993, VISUAL NEUROSCI, V10, P325, DOI 10.1017/S0952523800003722; Hendry SHC, 2000, ANNU REV NEUROSCI, V23, P127, DOI 10.1146/annurev.neuro.23.1.127; HUMPHREY AL, 1992, J NEUROPHYSIOL, V68, P673, DOI 10.1152/jn.1992.68.3.673; IKEDA M, 1986, VISION RES, V26, P1431, DOI 10.1016/0042-6989(86)90166-5; KAPLAN E, 1986, P NATL ACAD SCI USA, V83, P2755, DOI 10.1073/pnas.83.8.2755; KAPOULA Z, 1986, VISION RES, V26, P735, DOI 10.1016/0042-6989(86)90087-8; KAPOULA ZA, 1986, EXP BRAIN RES, V61, P386; Keat J, 2001, NEURON, V30, P803, DOI 10.1016/S0896-6273(01)00322-1; LAL R, 1989, SCIENCE, V243, P93, DOI 10.1126/science.2911723; Lankheet MJM, 1998, VISUAL NEUROSCI, V15, P37, DOI 10.1017/S0952523898151027; Lappe M, 2000, NATURE, V403, P892, DOI 10.1038/35002588; Lee D, 1998, J NEUROPHYSIOL, V79, P922, DOI 10.1152/jn.1998.79.2.922; Leopold DA, 1998, EXP BRAIN RES, V123, P341, DOI 10.1007/s002210050577; Lisberger SG, 1998, J NEUROPHYSIOL, V79, P1918, DOI 10.1152/jn.1998.79.4.1918; LO FS, 1988, EXP BRAIN RES, V71, P618, DOI 10.1007/BF00248755; LU SM, 1993, VISUAL NEUROSCI, V10, P631, DOI 10.1017/S0952523800005332; MASTRONARDE DN, 1987, J NEUROPHYSIOL, V57, P381, DOI 10.1152/jn.1987.57.2.381; MAUNSELL JHR, 1990, J NEUROSCI, V10, P3323; MCCORMICK DA, 1988, NATURE, V334, P246, DOI 10.1038/334246a0; MERIGAN WH, 1993, ANNU REV NEUROSCI, V16, P369, DOI 10.1146/annurev.ne.16.030193.002101; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; Ramcharan EJ, 2001, VISUAL NEUROSCI, V18, P253, DOI 10.1017/S0952523801182106; REID RC, 1992, NATURE, V356, P716, DOI 10.1038/356716a0; Reid RC, 1997, VISUAL NEUROSCI, V14, P1015, DOI 10.1017/S0952523800011743; RICHARDS W, 1969, J OPT SOC AM, V59, P617, DOI 10.1364/JOSA.59.000617; Rieke F, 2001, J NEUROSCI, V21, P9445, DOI 10.1523/JNEUROSCI.21-23-09445.2001; RIGGS LA, 1987, INVEST OPHTH VIS SCI, V28, P334; ROBINSON DL, 1986, EXP BRAIN RES, V62, P625; Ross J, 2001, TRENDS NEUROSCI, V24, P113, DOI 10.1016/S0166-2236(00)01685-4; Ross J, 1997, NATURE, V386, P598, DOI 10.1038/386598a0; Rottach KG, 1998, J NEUROPHYSIOL, V79, P2895, DOI 10.1152/jn.1998.79.6.2895; Rowe MH, 2001, VISUAL NEUROSCI, V18, P219, DOI 10.1017/S0952523801182076; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; SCHILLER PH, 1990, TRENDS NEUROSCI, V13, P392, DOI 10.1016/0166-2236(90)90117-S; SHAPLEY RM, 1981, J PHYSIOL-LONDON, V318, P161; SHIOIRI S, 1989, VISION RES, V29, P915, DOI 10.1016/0042-6989(89)90106-5; SINGER W, 1974, BRAIN RES, V72, P185, DOI 10.1016/0006-8993(74)90858-0; SKAVENSKI AA, 1975, VISION RES, V15, P1269, DOI 10.1016/0042-6989(75)90173-X; SMIMAKIS SM, 1997, NATURE, V386, P69; STEVENSON SB, 1986, VISION RES, V26, P1815, DOI 10.1016/0042-6989(86)90133-1; Thiele A, 2002, SCIENCE, V295, P2460, DOI 10.1126/science.1068788; Tolias AS, 2001, NEURON, V29, P757, DOI 10.1016/S0896-6273(01)00250-1; UCHIKAWA K, 1995, J OPT SOC AM A, V12, P661, DOI 10.1364/JOSAA.12.000661; Usrey WM, 1999, J NEUROPHYSIOL, V82, P3527, DOI 10.1152/jn.1999.82.6.3527; Usrey WM, 1998, NATURE, V395, P384, DOI 10.1038/26487; Vassilev A, 2000, VISION RES, V40, P989, DOI 10.1016/S0042-6989(99)00220-5; VOLKMANN FC, 1986, VISION RES, V26, P1401, DOI 10.1016/0042-6989(86)90164-1; WIESEL TN, 1966, J NEUROPHYSIOL, V29, P1096; Wolfe J, 1998, VISUAL NEUROSCI, V15, P653, DOI 10.1017/S0952523898154068; WURTZ RH, 1969, J NEUROPHYSIOL, V32, P987, DOI 10.1152/jn.1969.32.6.987	77	155	157	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 29	2002	35	5					961	974		10.1016/S0896-6273(02)00823-1	http://dx.doi.org/10.1016/S0896-6273(02)00823-1			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	589UY	12372289	Bronze			2022-12-24	WOS:000177779800017
J	Bhave, G; Zhu, WG; Wang, HB; Brasier, DJ; Oxford, GS; Gereau, RW				Bhave, G; Zhu, WG; Wang, HB; Brasier, DJ; Oxford, GS; Gereau, RW			cAMP-dependent protein kinase regulates desensitization of the capsaicin receptor (VR1) by direct phosphorylation	NEURON			English	Article							ROOT GANGLION NEURONS; RAT SENSORY NEURONS; VANILLOID RECEPTOR-1; TRANSDUCTION CASCADE; PAIN; HYPERALGESIA; ANANDAMIDE; ACTIVATION; CURRENTS; MUTATION	The capsaicin receptor, VR1 (also known as TRPV1), is a ligand-gated ion channel expressed on nociceptive sensory neurons that responds to noxious thermal and chemical stimuli. Capsaicin responses in sensory neurons exhibit robust potentiation by cAMP-dependent protein kinase (PKA). In this study, we demonstrate that PKA reduces VR1 desensitization and directly phosphorylates VR1. In vitro phosphorylation, phosphopeptide mapping, and protein sequencing of VR1 cytoplasmic domains delineate several candidate PKA phosphorylation sites. Electrophysiological analysis of phosphorylation site mutants clearly pinpoints Ser116 as the residue responsible for PKA-dependent modulation of VR1. Given the significant roles of VR1 and PKA in inflammatory pain hypersensitivity, VR1 phosphorylation at Ser116 by PKA may represent an important molecular mechanism involved in the regulation of VR1 function after tissue injury.	Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA	Baylor College of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Gereau, RW (corresponding author), Baylor Coll Med, Div Neurosci, 1 Baylor Plaza, Houston, TX 77030 USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042595, R01NS018788, P01NS039420] Funding Source: NIH RePORTER; NIMH NIH HHS [R01MH60230] Funding Source: Medline; NINDS NIH HHS [P01NS39420, R01NS42595, R01NS18788] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson AE, 2000, J BIOL CHEM, V275, P5337, DOI 10.1074/jbc.275.8.5337; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; CHOLEWINSKI A, 1993, NEUROSCIENCE, V55, P1015, DOI 10.1016/0306-4522(93)90315-7; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; De Petrocellis L, 2001, J NEUROCHEM, V77, P1660, DOI 10.1046/j.1471-4159.2001.00406.x; Docherty RJ, 1996, PFLUG ARCH EUR J PHY, V431, P828, DOI 10.1007/BF02332166; Gereau RW, 1998, NEURON, V20, P143, DOI 10.1016/S0896-6273(00)80442-0; HINGTGEN CM, 1995, J NEUROSCI, V15, P5411; HU HJ, 2002, IN PRESS J NEUROSCI; Hwang SW, 2000, P NATL ACAD SCI USA, V97, P6155, DOI 10.1073/pnas.97.11.6155; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Koplas PA, 1997, J NEUROSCI, V17, P3525; Kuzhikandathil EV, 2001, J NEUROSCI, V21, P8697, DOI 10.1523/JNEUROSCI.21-22-08697.2001; Lee YS, 2000, NEUROSCI LETT, V288, P57, DOI 10.1016/S0304-3940(00)01208-8; LEVINE JD, 1989, NEUROSCIENCE, V32, P571, DOI 10.1016/0306-4522(89)90279-0; Levine JD, 1999, TXB PAIN, P59; Liu SW, 1996, GEOL J U, p[2, 75 ]; Lopshire JC, 1998, J NEUROSCI, V18, P6081; Malmberg AB, 1997, J NEUROSCI, V17, P7462; Mammen A L, 1999, Methods Enzymol, V294, P353; Piper AS, 1999, J PHYSIOL-LONDON, V518, P721, DOI 10.1111/j.1469-7793.1999.0721p.x; Szallasi A, 1999, PHARMACOL REV, V51, P159; TAIWO YO, 1991, NEUROSCIENCE, V44, P131, DOI 10.1016/0306-4522(91)90255-M; TAIWO YO, 1989, NEUROSCIENCE, V32, P577, DOI 10.1016/0306-4522(89)90280-7; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Welch JM, 2000, P NATL ACAD SCI USA, V97, P13889, DOI 10.1073/pnas.230146497; WITHOLT B, 1976, ANAL BIOCHEM, V74, P160, DOI 10.1016/0003-2697(76)90320-1; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	29	448	476	0	24	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 15	2002	35	4					721	731		10.1016/S0896-6273(02)00802-4	http://dx.doi.org/10.1016/S0896-6273(02)00802-4			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	585JE	12194871	Green Published, Bronze			2022-12-24	WOS:000177521000012
J	Myat, A; Henry, P; McCabe, V; Flintoft, L; Rotin, D; Tear, G				Myat, A; Henry, P; McCabe, V; Flintoft, L; Rotin, D; Tear, G			Drosophila Nedd4, a ubiquitin ligase, is recruited by commissureless to control cell surface levels of the roundabout receptor	NEURON			English	Article							GROWTH CONE GUIDANCE; CENTRAL-NERVOUS-SYSTEM; AXON GUIDANCE; CNS MIDLINE; PROTEASOME PATHWAY; GENETIC-ANALYSIS; SYNAPTIC GROWTH; PROTEIN LIGASES; FLOOR PLATE; WW DOMAIN	Crossing the midline produces changes in axons such that they are no longer attracted to the midline. In Drosophila, Roundabout reaches high levels on axons once they have crossed the midline, and this prohibits recrossing. Roundabout protein levels are regulated by Commissureless. We show that Commissureless binds to and is regulated by the ubiquitin ligase DNedd4. We further show that the ability of Commissureless to regulate Roundabout protein levels requires an intact DNedd4 binding site and ubiquitin acceptor sites within the Commissureless protein. The ability of Commissureless to regulate Robo in the embryo also requires a Commissureless/DNedd4 interaction. Our results show that changes in axonal sensitivity to external cues during pathfinding across the midline makes use of ubiquitin-dependent mechanisms to regulate transmembrane protein levels.	Kings Coll London, MRC, Ctr Dev Neurobiol, Mol Neurobiol Grp, London SE1 1UL, England; Kings Coll London, MRC, Ctr Dev Neurobiol, Dept Dev Neurobiol, London SE1 1UL, England; Univ Toronto, Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada	University of London; King's College London; University of London; King's College London; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Tear, G (corresponding author), Kings Coll London, MRC, Ctr Dev Neurobiol, Mol Neurobiol Grp, New Hunts House,Guys Campus, London SE1 1UL, England.	guy.tear@kcl.ac.uk	Tear, Guy/C-5444-2009	Tear, Guy/0000-0002-3114-7537				Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Bonifacino JS, 1998, ANNU REV CELL DEV BI, V14, P19, DOI 10.1146/annurev.cellbio.14.1.19; Bonkowsky JL, 1999, NATURE, V402, P540, DOI 10.1038/990122; BOVOLENTA P, 1990, DEVELOPMENT, V109, P435; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Castellan NJ, 1988, NONPARAMETRIC STAT B; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; COLAMARINO SA, 1995, ANNU REV NEUROSCI, V18, P497, DOI 10.1146/annurev.ne.18.030195.002433; Cornell M, 1999, GENETICS, V152, P567; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; DINOCERA PP, 1983, P NATL ACAD SCI-BIOL, V80, P7095; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; Dunn R, 2001, J BIOL CHEM, V276, P25974, DOI 10.1074/jbc.M104113200; Fang P, 1999, HUM MOL GENET, V8, P129, DOI 10.1093/hmg/8.1.129; Georgiou M, 2002, DEVELOPMENT, V129, P2947; Govers R, 1999, EMBO J, V18, P28, DOI 10.1093/emboj/18.1.28; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; Harvey KF, 1999, TRENDS CELL BIOL, V9, P166, DOI 10.1016/S0962-8924(99)01541-X; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 1999, TRENDS CELL BIOL, V9, P107, DOI 10.1016/S0962-8924(98)01491-3; Hu G, 1997, GENE DEV, V11, P2701, DOI 10.1101/gad.11.20.2701; Hummel T, 1999, DEV BIOL, V209, P381, DOI 10.1006/dbio.1999.9235; Kanelis V, 2001, NAT STRUCT BIOL, V8, P407, DOI 10.1038/87562; Kasanov J, 2001, CHEM BIOL, V8, P231, DOI 10.1016/S1074-5521(01)00005-9; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; KLAMBT C, 1991, CELL, V64, P801, DOI 10.1016/0092-8674(91)90509-W; KUMAR S, 1992, BIOCHEM BIOPH RES CO, V185, P1155, DOI 10.1016/0006-291X(92)91747-E; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; O'Connor TP, 1999, CELL MOL LIFE SCI, V55, P1358, DOI 10.1007/s000180050376; OH CE, 1994, J NEUROSCI, V14, P3166; Rotin D, 2000, J MEMBRANE BIOL, V176, P1; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Shen CP, 1997, CELL, V90, P449, DOI 10.1016/S0092-8674(00)80505-X; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shirasaki R, 1998, SCIENCE, V279, P105, DOI 10.1126/science.279.5347.105; Stein E, 2001, SCIENCE, V291, P1976, DOI 10.1126/science.1059391; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Stoeckli ET, 1998, CURR OPIN NEUROBIOL, V8, P73, DOI 10.1016/S0959-4388(98)80010-X; Sudol M, 1996, PROG BIOPHYS MOL BIO, V65, P113, DOI 10.1016/S0079-6107(96)00008-9; Tear G, 1999, CELL MOL LIFE SCI, V55, P1365, DOI 10.1007/s000180050377; Tear G, 1996, NEURON, V16, P501, DOI 10.1016/S0896-6273(00)80070-7; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Wolf B, 1998, DEVELOPMENT, V125, P3853; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	51	134	138	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 1	2002	35	3					447	459		10.1016/S0896-6273(02)00795-X	http://dx.doi.org/10.1016/S0896-6273(02)00795-X			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	582CB	12165468	Bronze			2022-12-24	WOS:000177331200007
J	Hernandez-Deviez, DJ; Casanova, JE; Wilson, JM				Hernandez-Deviez, DJ; Casanova, JE; Wilson, JM			Regulation of dendritic development by the ARF exchange factor ARNO	NATURE NEUROSCIENCE			English	Article							RHO-GTPASES; NEURONS; GROWTH; RAC		Univ Arizona, Coll Med, Dept Cell Biol & Anat, Tucson, AZ 85718 USA; Univ Virginia, Dept Cell Biol, Charlottesville, VA 22908 USA	University of Arizona; University of Virginia	Wilson, JM (corresponding author), Univ Arizona, Coll Med, Dept Cell Biol & Anat, Box 245044, Tucson, AZ 85718 USA.	jeanw@email.arizona.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032991, R29AI032991] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA043329] Funding Source: NIH RePORTER; NIAID NIH HHS [AI32991] Funding Source: Medline; NIDA NIH HHS [DA43329] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		ALTMAN J, 1990, J COMP NEUROL, V301, P325, DOI 10.1002/cne.903010302; Chardin P, 1996, NATURE, V384, P481, DOI 10.1038/384481a0; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; Frank S, 1998, J BIOL CHEM, V273, P23, DOI 10.1074/jbc.273.1.23; Frank SR, 1998, MOL BIOL CELL, V9, P3133, DOI 10.1091/mbc.9.11.3133; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Li Z, 2000, NAT NEUROSCI, V3, P217, DOI 10.1038/72920; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Scott EK, 2001, NAT NEUROSCI, V4, P359, DOI 10.1038/86006; Suzuki I, 2002, MOL BRAIN RES, V98, P41, DOI 10.1016/S0169-328X(01)00312-6; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1	13	94	95	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2002	5	7					623	624		10.1038/nn865	http://dx.doi.org/10.1038/nn865			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	566EP	12032543				2022-12-24	WOS:000176414300006
J	Maldve, RE; Zhang, TA; Ferrani-Kile, K; Schreiber, SS; Lippmann, MJ; Snyder, GL; Fienberg, AA; Leslie, SW; Gonzales, RA; Morrisett, RA				Maldve, RE; Zhang, TA; Ferrani-Kile, K; Schreiber, SS; Lippmann, MJ; Snyder, GL; Fienberg, AA; Leslie, SW; Gonzales, RA; Morrisett, RA			DARPP-32 and regulation of the ethanol sensitivity of NMDA receptors in the nucleus accumbens	NATURE NEUROSCIENCE			English	Article							D-ASPARTATE RECEPTORS; GENE-EXPRESSION; DOPAMINE; PHOSPHORYLATION; PHOSPHOPROTEIN; DEPHOSPHORYLATION; ATTENUATION; INHIBITION; ACTIVATION; PATHWAY	The medium spiny neurons of the nucleus accumbens receive both an excitatory glutamatergic input from forebrain and a dopaminergic input from the ventral tegmental area. This integration point may constitute a locus whereby the N-methyl-D-aspartate (NMDA)-subtype of glutamate receptors promotes drug reinforcement. Here we investigate how dopaminergic inputs alter the ethanol sensitivity of NMDA receptors in rats and mice and report that previous dopamine receptor-1 (D1) activation, culminating in dopamine and cAMP-regulated phosphoprotein-32 kD (DARPP-32) and NMDA receptor subunit-1 (NR1)-NMDA receptor phosphorylation, strongly decreases ethanol inhibition of NMDA responses. The regulation of ethanol sensitivity of NMDA receptors by D1 receptors was absent in DARPP-32 knockout mice. We propose that DARPP-32 mediated blunting of the response to ethanol subsequent to activation of ventral tegmental area dopaminergic neurons initiates molecular alterations that influence synaptic plasticity in this circuit, thereby promoting the development of ethanol reinforcement.	Univ Texas, Waggoner Ctr Alcohol & Addict Res, Austin, TX 78712 USA; Univ Texas, Coll Pharm, Austin, TX 78712 USA; Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Rockefeller University	Morrisett, RA (corresponding author), Univ Texas, Waggoner Ctr Alcohol & Addict Res, 2500 Speedway, Austin, TX 78712 USA.	ramorris@mail.utexas.edu			NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011836, T32AA007471, R01AA011852, R01AA011845] Funding Source: NIH RePORTER; NIAAA NIH HHS [R01AA11845, U01AA13CR, R01AA11836, R01AA11852, T32AA07471] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Anders DL, 2000, J BIOL CHEM, V275, P15019, DOI 10.1074/jbc.275.20.15019; Biala G, 1999, ALCOHOL ALCOHOLISM, V34, P175, DOI 10.1093/alcalc/34.2.175; Brodie MS, 1999, ALCOHOL CLIN EXP RES, V23, P1848, DOI 10.1111/j.1530-0277.1999.tb04082.x; El-Ghundi M, 1998, EUR J PHARMACOL, V353, P149, DOI 10.1016/S0014-2999(98)00414-2; FEDOROV NB, 1993, J NEUROSCI METH, V50, P83, DOI 10.1016/0165-0270(93)90058-Y; Fienberg AA, 1998, SCIENCE, V281, P838, DOI 10.1126/science.281.5378.838; Givens B, 2000, HIPPOCAMPUS, V10, P111, DOI 10.1002/(SICI)1098-1063(2000)10:1<111::AID-HIPO12>3.0.CO;2-1; Gonzales RA, 1998, J NEUROSCI, V18, P10663; GRANT KA, 1991, BEHAV PHARMACOL, V2, P87; HALPAIN S, 1990, NATURE, V343, P369, DOI 10.1038/343369a0; HEMMINGS HC, 1984, NATURE, V310, P503, DOI 10.1038/310503a0; HEMMINGS HC, 1986, J NEUROSCI, V6, P1469; HOFFMAN PL, 1989, J NEUROCHEM, V52, P1937, DOI 10.1111/j.1471-4159.1989.tb07280.x; Kalluri HSG, 1999, MOL BRAIN RES, V68, P159, DOI 10.1016/S0169-328X(99)00057-1; KOMBIAN SB, 1994, NATURE, V368, P242, DOI 10.1038/368242a0; LOVINGER DM, 1989, SCIENCE, V243, P1721, DOI 10.1126/science.2467382; MORRISETT RA, 1993, J NEUROSCI, V13, P2264; Nestler EJ, 2001, SCIENCE, V292, P2266, DOI 10.1126/science.1063024; PENNARTZ CMA, 1993, EUR J NEUROSCI, V5, P107, DOI 10.1111/j.1460-9568.1993.tb00475.x; Rajadhyaksha A, 1999, J NEUROSCI, V19, P6348; Risinger FO, 2001, J NEUROSCI, V21, P340, DOI 10.1523/JNEUROSCI.21-01-00340.2001; SNYDER GL, 1992, J NEUROSCI, V12, P3071, DOI 10.1523/JNEUROSCI.12-08-03071.1992; Snyder GL, 1998, J NEUROSCI, V18, P10297; Thomas MJ, 2000, J NEUROSCI, V20, P5581, DOI 10.1523/JNEUROSCI.20-15-05581.2000; Thomas MP, 2000, NEUROPHARMACOLOGY, V39, P218, DOI 10.1016/S0028-3908(99)00107-0; Thomas MP, 1998, J PHARMACOL EXP THER, V287, P87; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Vorel SR, 2001, SCIENCE, V292, P1175, DOI 10.1126/science.1058043; Wise RA, 1998, DRUG ALCOHOL DEPEN, V51, P13, DOI 10.1016/S0376-8716(98)00063-5; Woodward JJ, 2000, CRIT REV NEUROBIOL, V14, P69	30	116	121	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2002	5	7					641	648		10.1038/nn877	http://dx.doi.org/10.1038/nn877			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	566EP	12068305				2022-12-24	WOS:000176414300013
J	Mazurek, ME; Shadlen, MN				Mazurek, ME; Shadlen, MN			Limits to the temporal fidelity of cortical spike rate signals	NATURE NEUROSCIENCE			English	Article							ORNSTEIN-UHLENBECK PROCESS; VISUAL AREA MT; FIRING RATE; SENSORY DISCRIMINATION; INPUT SYNCHRONY; NEURAL CODES; NEURONS; CORTEX; VARIABILITY; DISCHARGE	The cerebral cortex processes information primarily through changes in the spike rates of neurons within local ensembles. To evaluate how reliably the average spike rate of a group of cortical neurons can represent a time-varying signal, we simulated an ensemble with realistic spike discharge behavior. We found that weak interneuronal correlation, or synchrony, allows the variability in spike rates of individual neurons to compromise the ensemble representation of time-varying signals. Brief cycles of sinusoidal modulation at frequencies above 115 Hz could not be represented by an ensemble of hundreds of neurons whose interneuronal correlation mimics that of the visual cortex. The spike variability and correlation assumed in our simulations are likely to apply to many areas of cortex and therefore may constrain the fidelity of neural computations underlying higher brain function.	Univ Washington, Howard Hughes Med Inst, Dept Physiol & Biophys, Reg Primate Res Ctr, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Shadlen, MN (corresponding author), Univ Washington, Howard Hughes Med Inst, Dept Physiol & Biophys, Reg Primate Res Ctr, Box 357290, Seattle, WA 98195 USA.	shadlen@u.washington.edu	Shadlen, Michael Neil/AAL-1870-2020	Shadlen, Michael/0000-0002-2002-2210	NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000166] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011378] Funding Source: NIH RePORTER	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; Albright TD, 2000, NEURON, V25, pS1, DOI 10.1016/S0896-6273(00)80912-5; Bair W, 1996, NEURAL COMPUT, V8, P1185, DOI 10.1162/neco.1996.8.6.1185; Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; Braitenberg V, 1991, ANATOMY CORTEX STAT; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Brody CD, 1999, NEURAL COMPUT, V11, P1527, DOI 10.1162/089976699300016124; Brody CD, 1999, NEURAL COMPUT, V11, P1537, DOI 10.1162/089976699300016133; DAS A, 1995, J NEUROPHYSIOL, V74, P779, DOI 10.1152/jn.1995.74.2.779; Destexhe A, 1999, J NEUROPHYSIOL, V81, P1531, DOI 10.1152/jn.1999.81.4.1531; Di Lorenzo PM, 2000, BRAIN RES, V852, P383, DOI 10.1016/S0006-8993(99)02187-3; Engel AK, 1997, CEREB CORTEX, V7, P571, DOI 10.1093/cercor/7.6.571; FETZ E, 1991, CEREB CORTEX, P1; Gawne TJ, 1996, CEREB CORTEX, V6, P482, DOI 10.1093/cercor/6.3.482; GAWNE TJ, 1993, J NEUROSCI, V13, P2758; GERSTEIN GL, 1964, BIOPHYS J, V4, P41, DOI 10.1016/S0006-3495(64)86768-0; Green DM, 1966, SIGNAL DETECTION THE; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Hernandez A, 2000, P NATL ACAD SCI USA, V97, P6191, DOI 10.1073/pnas.120018597; JOHNSON KO, 1980, J NEUROPHYSIOL, V43, P1793, DOI 10.1152/jn.1980.43.6.1793; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; Lee D, 1998, J NEUROSCI, V18, P1161; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; MOUNTCASTLE VB, 1969, J NEUROPHYSIOL, V32, P452, DOI 10.1152/jn.1969.32.3.452; MURTHY VN, 1994, NEURAL COMPUT, V6, P1111, DOI 10.1162/neco.1994.6.6.1111; Oertel D, 1999, ANNU REV PHYSIOL, V61, P497, DOI 10.1146/annurev.physiol.61.1.497; Oram MW, 1999, J NEUROPHYSIOL, V81, P3021, DOI 10.1152/jn.1999.81.6.3021; Press W. H., 1992, ART SCI COMPUTING; RICCIARDI LM, 1979, BIOL CYBERN, V35, P1, DOI 10.1007/BF01845839; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; Romo R, 2000, NEURON, V26, P273, DOI 10.1016/S0896-6273(00)81156-3; Salinas E, 2000, J NEUROSCI, V20, P6193, DOI 10.1523/JNEUROSCI.20-16-06193.2000; Salinas E, 2000, J NEUROSCI, V20, P5503, DOI 10.1523/JNEUROSCI.20-14-05503.2000; SALZMAN CD, 1992, J NEUROSCI, V12, P2331; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; Shadlen MN, 1999, NEURON, V24, P67, DOI 10.1016/S0896-6273(00)80822-3; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Shinomoto S, 1999, NEURAL COMPUT, V11, P935, DOI 10.1162/089976699300016511; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Stevens CF, 1998, NAT NEUROSCI, V1, P210, DOI 10.1038/659; Teich MC, 1997, J OPT SOC AM A, V14, P529, DOI 10.1364/JOSAA.14.000529; TSO DY, 1986, J NEUROSCI, V6, P1160; Usrey WM, 2000, J NEUROSCI, V20, P5461, DOI 10.1523/JNEUROSCI.20-14-05461.2000; VAADIA E, 1995, NATURE, V373, P515, DOI 10.1038/373515a0; VANKAN PLE, 1985, EXP BRAIN RES, V60, P559, DOI 10.1007/BF00236942; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; WERNER G, 1963, J NEUROPHYSIOL, V26, P958, DOI 10.1152/jn.1963.26.6.958; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0; ZOHARY E, 1994, NATURE, V371, P358, DOI 10.1038/371358c0	50	106	106	0	3	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2002	5	5					463	471		10.1038/nn836	http://dx.doi.org/10.1038/nn836			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	546JY	11976706				2022-12-24	WOS:000175272000018
J	Chen, CF; Blitz, DM; Regehr, WG				Chen, CF; Blitz, DM; Regehr, WG			Contributions of receptor desensitization and saturation to plasticity at the retinogeniculate synapse	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; PAIRED-PULSE DEPRESSION; PURKINJE-CELL SYNAPSES; MULTIPLE RELEASE SITES; NON-NMDA RECEPTORS; CLIMBING FIBER; RETINAL INPUTS; SIGNAL TRANSMISSION; COCHLEAR NUCLEUS; VISUAL RESPONSES	The retinogeniculate synapse conveys visual information from the retina to thalamic relay neurons. Here, we examine the mechanisms of short-term plasticity that can influence transmission at this connection in mouse brain slices. Our studies show that synaptic strength is modified by physiological activity patterns due to marked depression at high frequencies. Postsynaptic mechanisms of plasticity make prominent contributions to this synaptic depression. During trains of retinal input stimulation, receptor desensitization attenuates the AMPA EPSC while the NMDA EPSC saturates. This differential plasticity may help explain the distinct roles of these receptors in shaping the relay neuron response to visual stimulation with the AMPA component being important for transient responses, while sustained high frequency responses rely more on the NMDA component.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Harvard Univ, Childrens Hosp, Sch Med, Div Neurosci, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Chen, CF (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.				NINDS NIH HHS [KO8-NS02056, 5 T32 NS07484, P01-NS38312, R01-NS32405] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS038312, R01NS032405, K08NS002056, T32NS007484] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Barbour B, 1997, TRENDS NEUROSCI, V20, P377; Bellingham MC, 1999, NEURON, V23, P159, DOI 10.1016/S0896-6273(00)80762-X; Brenowitz S, 2001, J NEUROSCI, V21, P1857, DOI 10.1523/JNEUROSCI.21-06-01857.2001; CANT NB, 1979, NEUROSCIENCE, V4, P1925, DOI 10.1016/0306-4522(79)90066-6; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; Chen CY, 1999, AM J PHYSIOL-HEART C, V277, pH1350, DOI 10.1152/ajpheart.1999.277.4.H1350; CLELAND BG, 1985, J PHYSIOL-LONDON, V369, P249, DOI 10.1113/jphysiol.1985.sp015899; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; DANGELO E, 1995, J PHYSIOL-LONDON, V484, P397, DOI 10.1113/jphysiol.1995.sp020673; DIAMOND JS, 1995, NEURON, V15, P1097, DOI 10.1016/0896-6273(95)90098-5; Dittman JS, 1998, J NEUROSCI, V18, P6147; Dittman JS, 2000, J NEUROSCI, V20, P1374; Dzubay JA, 1999, J NEUROSCI, V19, P5265; FAMIGLIETTI EV, 1972, J COMP NEUROL, V144, P285, DOI 10.1002/cne.901440304; Guido W, 1995, Int J Neurosci, V80, P41, DOI 10.3109/00207459508986093; HAMOS JE, 1987, J COMP NEUROL, V259, P165, DOI 10.1002/cne.902590202; HAMOS JE, 1985, NATURE, V317, P618, DOI 10.1038/317618a0; Hashimoto K, 1998, J PHYSIOL-LONDON, V506, P391, DOI 10.1111/j.1469-7793.1998.391bw.x; HEGGELUND P, 1990, J NEUROPHYSIOL, V63, P1347, DOI 10.1152/jn.1990.63.6.1347; HESTRIN S, 1992, NEURON, V9, P991, DOI 10.1016/0896-6273(92)90250-H; Hjelmstad GO, 1999, J NEUROPHYSIOL, V81, P3096, DOI 10.1152/jn.1999.81.6.3096; Kinney GA, 1997, J NEUROPHYSIOL, V78, P1320, DOI 10.1152/jn.1997.78.3.1320; KWON YH, 1991, J NEUROPHYSIOL, V66, P414, DOI 10.1152/jn.1991.66.2.414; LENN NJ, 1966, AM J ANAT, V118, P375, DOI 10.1002/aja.1001180205; MAGLEBY KL, 1987, SYNAPTIC FUNCTION, P21; MASTRONARDE DN, 1987, J NEUROPHYSIOL, V57, P381, DOI 10.1152/jn.1987.57.2.381; MASTRONARDE DN, 1992, VISUAL NEUROSCI, V8, P407, DOI 10.1017/S0952523800004934; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; McCormick David A., 1994, Current Opinion in Neurobiology, V4, P550, DOI 10.1016/0959-4388(94)90056-6; Oleskevich S, 2000, J PHYSIOL-LONDON, V524, P513, DOI 10.1111/j.1469-7793.2000.00513.x; OLVERMAN HJ, 1988, NEUROSCIENCE, V26, P1, DOI 10.1016/0306-4522(88)90123-6; Otis T, 1996, J NEUROSCI, V16, P7496; Otis TS, 1997, SCIENCE, V277, P1515, DOI 10.1126/science.277.5331.1515; Otis TS, 1996, J NEUROSCI, V16, P1634, DOI 10.1523/jneurosci.16-05-01634.1996; PARKS TN, 1981, J COMP NEUROL, V203, P425, DOI 10.1002/cne.902030307; Peters A., 1991, FINE STRUCTURE NERVO; RAMAN IM, 1994, J NEUROSCI, V14, P4998; RAMOA AS, 1994, J NEUROSCI, V14, P2098; Rowe MH, 2001, VISUAL NEUROSCI, V18, P219, DOI 10.1017/S0952523801182076; SHARP AA, 1993, J NEUROPHYSIOL, V69, P992, DOI 10.1152/jn.1993.69.3.992; Sherman SM, 1996, J NEUROPHYSIOL, V76, P1367, DOI 10.1152/jn.1996.76.3.1367; SILLITO AM, 1990, J NEUROPHYSIOL, V63, P347, DOI 10.1152/jn.1990.63.2.347; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; Silver RA, 1996, J PHYSIOL-LONDON, V494, P231, DOI 10.1113/jphysiol.1996.sp021487; Steriade M., 1997, THALAMUS; Trussell LO, 1997, CURR OPIN NEUROBIOL, V7, P487, DOI 10.1016/S0959-4388(97)80027-X; Trussell LO, 1999, ANNU REV PHYSIOL, V61, P477, DOI 10.1146/annurev.physiol.61.1.477; TRUSSELL LO, 1993, NEURON, V10, P1185, DOI 10.1016/0896-6273(93)90066-Z; TURNER JP, 1994, J PHYSIOL-LONDON, V480, P281, DOI 10.1113/jphysiol.1994.sp020359; Turner JP, 1998, J PHYSIOL-LONDON, V510, P829, DOI 10.1111/j.1469-7793.1998.829bj.x; Urwyler S, 1996, NEUROPHARMACOLOGY, V35, P643, DOI 10.1016/S0028-3908(96)00049-4; Usrey WM, 1998, NATURE, V395, P384, DOI 10.1038/26487; Usrey WM, 1999, ANNU REV PHYSIOL, V61, P435, DOI 10.1146/annurev.physiol.61.1.435; Vissel B, 2001, NAT NEUROSCI, V4, P587, DOI 10.1038/88404; Walmsley B, 1998, TRENDS NEUROSCI, V21, P81, DOI 10.1016/S0166-2236(97)01170-3; Wang XK, 2000, J CEREBR BLOOD F MET, V20, P15, DOI 10.1097/00004647-200001000-00004; WILSON JR, 1984, PROC R SOC SER B-BIO, V221, P411, DOI 10.1098/rspb.1984.0042; Xu-Friedman MA, 2001, J NEUROSCI, V21, P6666, DOI 10.1523/JNEUROSCI.21-17-06666.2001; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	61	120	121	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 28	2002	33	5					779	788		10.1016/S0896-6273(02)00611-6	http://dx.doi.org/10.1016/S0896-6273(02)00611-6			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	529EC	11879654	Bronze			2022-12-24	WOS:000174286200013
J	O'Doherty, JP; Deichmann, R; Critchley, HD; Dolan, RJ				O'Doherty, JP; Deichmann, R; Critchley, HD; Dolan, RJ			Neural responses during anticipation of a primary taste reward	NEURON			English	Article							BRAIN-STIMULATION REWARD; ORBITOFRONTAL CORTEX; DOPAMINE NEURONS; BASOLATERAL AMYGDALA; INCENTIVE SALIENCE; PREFRONTAL CORTEX; MACAQUE MONKEY; FMRI; ACTIVATION; AMPHETAMINE	The aim of this study was to determine the brain regions involved in anticipation of a primary taste reward and to compare these regions to those responding to the receipt of a taste reward. Using fMRI, we scanned human subjects who were presented with visual cues that signaled subsequent reinforcement with a pleasant sweet taste (1 M glucose), a moderately unpleasant salt taste (0.2 M saline), or a neutral taste. Expectation of a pleasant taste produced activation in dopaminergic midbrain, posterior dorsal amygdala, striatum, and orbitofrontal cortex (OFC). Apart from OFC, these regions were not activated by reward receipt. The findings indicate that when rewards are predictable, brain regions recruited during expectation are, in part, dissociable from areas responding to reward receipt.	Inst Neurol, WEllcome Dept Imaging Neurosci, London WC1 3BG, England; Royal Free Hosp, Sch Med, London NW3 2PF, England	University of London; University College London; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	O'Doherty, JP (corresponding author), Inst Neurol, WEllcome Dept Imaging Neurosci, 12 Queen Sq, London WC1 3BG, England.		O'Doherty, John P/F-1204-2013; critchley, hugo d/G-9267-2011	critchley, hugo d/0000-0002-2445-9284; Dolan, Ray/0000-0001-9356-761X				ADOLPHS R, 1995, J NEUROSCI, V15, P5879; Baxter MG, 2000, J NEUROSCI, V20, P4311; BAYLIS LL, 1991, EXP BRAIN RES, V86, P617; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Berridge KC, 1996, NEUROSCI BIOBEHAV R, V20, P1, DOI 10.1016/0149-7634(95)00033-B; BERRIDGE KC, 1989, BEHAV NEUROSCI, V103, P36, DOI 10.1037/0735-7044.103.1.36; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Breiter HC, 1997, NEURON, V19, P591, DOI 10.1016/S0896-6273(00)80374-8; Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6; Constable RT, 1999, MAGNET RESON MED, V42, P110, DOI 10.1002/(SICI)1522-2594(199907)42:1<110::AID-MRM15>3.0.CO;2-3; Critchley HD, 2001, NEURON, V29, P537, DOI 10.1016/S0896-6273(01)00225-2; Critchley HD, 1996, J NEUROPHYSIOL, V75, P1673, DOI 10.1152/jn.1996.75.4.1673; Deichmann R, 2000, NEUROIMAGE, V12, P112, DOI 10.1006/nimg.2000.0601; Deichmann R, 2002, NEUROIMAGE, V15, P120, DOI 10.1006/nimg.2001.0985; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Duvernoy HM, 1995, HUMAN BRAIN STEM CER; DUVEROY HM, 1999, HUMAN BRAIN; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; Everitt BJ, 1999, ANN NY ACAD SCI, V877, P412, DOI 10.1111/j.1749-6632.1999.tb09280.x; FRAHM J, 1988, MAGNET RESON MED, V6, P474, DOI 10.1002/mrm.1910060412; Francis S, 1999, NEUROREPORT, V10, P453, DOI 10.1097/00001756-199902250-00003; Friston K.J., 1994, HUMAN BRAIN MAPPING, V1, P210; Friston KJ, 1999, NEUROIMAGE, V10, P385, DOI 10.1006/nimg.1999.0484; FRISTON KJ, 1995, HUMAN BRAIN MAPPING, V2, P165; GALLISTEL CR, 1984, PHARMACOL BIOCHEM BE, V20, P73, DOI 10.1016/0091-3057(84)90104-7; Glover GH, 1999, MAGNET RESON MED, V42, P290, DOI 10.1002/(SICI)1522-2594(199908)42:2<290::AID-MRM11>3.0.CO;2-N; Hikosaka K, 2000, CEREB CORTEX, V10, P263, DOI 10.1093/cercor/10.3.263; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; Koepp MJ, 1998, NATURE, V393, P266, DOI 10.1038/30498; LaBar KS, 1998, NEURON, V20, P937, DOI 10.1016/S0896-6273(00)80475-4; LEDOUX JE, 1995, ANNU REV PSYCHOL, V46, P209, DOI 10.1146/annurev.ps.46.020195.001233; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Malkova L, 1997, J NEUROSCI, V17, P6011; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; MIRENOWICZ J, 1994, J NEUROPHYSIOL, V72, P1024, DOI 10.1152/jn.1994.72.2.1024; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Doherty J, 2001, J NEUROPHYSIOL, V85, P1315, DOI 10.1152/jn.2001.85.3.1315; O'Doherty J, 2000, NEUROREPORT, V11, P893, DOI 10.1097/00001756-200003200-00046; OADES RD, 1987, BRAIN RES REV, V12, P117, DOI 10.1016/0165-0173(87)90011-7; Ojemann JG, 1997, NEUROIMAGE, V6, P156, DOI 10.1006/nimg.1997.0289; OLDS ME, 1963, J COMP NEUROL, V120, P259, DOI 10.1002/cne.901200206; ONO T, 2000, NEW COGNITIVE NEUROS; ORDIDGE RJ, 1994, MAGNET RESON MED, V32, P335, DOI 10.1002/mrm.1910320309; Parkinson JA, 2000, EUR J NEUROSCI, V12, P405, DOI 10.1046/j.1460-9568.2000.00960.x; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; POSSE S, 1992, MAGNET RESON MED, V25, P12, DOI 10.1002/mrm.1910250103; Ramnani N, 2000, J NEUROPHYSIOL, V84, P3026, DOI 10.1152/jn.2000.84.6.3026; Rescorla R., 1972, CLASSICAL CONDITION, DOI DOI 10.1101/GR.110528.110; Rolls ET, 1997, CRIT REV NEUROBIOL, V11, P263, DOI 10.1615/CritRevNeurobiol.v11.i4.20; ROLLS ET, 1989, EUR J NEUROSCI, V1, P53, DOI 10.1111/j.1460-9568.1989.tb00774.x; SANGHERA MK, 1979, EXP NEUROL, V63, P610, DOI 10.1016/0014-4886(79)90175-4; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; SCOTT TR, 1993, J NEUROPHYSIOL, V69, P1810, DOI 10.1152/jn.1993.69.6.1810; Sell LA, 1999, EUR J NEUROSCI, V11, P1042, DOI 10.1046/j.1460-9568.1999.00522.x; Small DM, 1999, NEUROREPORT, V10, P7, DOI 10.1097/00001756-199901180-00002; Small DM, 1997, NEUROREPORT, V8, P3913, DOI 10.1097/00001756-199712220-00014; Spanagel R, 1999, TRENDS NEUROSCI, V22, P521, DOI 10.1016/S0166-2236(99)01447-2; SUTTON RS, 1981, PSYCHOL REV, V88, P135, DOI 10.1037/0033-295X.88.2.135; THORPE SJ, 1983, EXP BRAIN RES, V49, P93; Thut G, 1997, NEUROREPORT, V8, P1225, DOI 10.1097/00001756-199703240-00033; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Wilkinson LS, 1998, EUR J NEUROSCI, V10, P1019, DOI 10.1046/j.1460-9568.1998.00119.x; Wise RA, 1996, ANNU REV NEUROSCI, V19, P319, DOI 10.1146/annurev.ne.19.030196.001535; WISE RA, 1985, BEHAV BRAIN SCI, V8, P178, DOI 10.1017/S0140525X00020306; WISE RA, 1993, BEHAV BRAIN RES, V55, P195, DOI 10.1016/0166-4328(93)90115-7; Wyvell CL, 2000, J NEUROSCI, V20, P8122; Zald DH, 1997, P NATL ACAD SCI USA, V94, P4119, DOI 10.1073/pnas.94.8.4119; Zald DH, 1998, BRAIN, V121, P1143, DOI 10.1093/brain/121.6.1143	73	794	802	4	56	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 28	2002	33	5					815	826		10.1016/S0896-6273(02)00603-7	http://dx.doi.org/10.1016/S0896-6273(02)00603-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	529EC	11879657	Bronze, Green Published			2022-12-24	WOS:000174286200016
J	Gleason, MR; Higashijima, S; Dallman, J; Liu, K; Mandel, G; Fetcho, JR				Gleason, MR; Higashijima, S; Dallman, J; Liu, K; Mandel, G; Fetcho, JR			Translocation of CaM kinase II to synaptic sites in vivo	NATURE NEUROSCIENCE			English	Article							TRANSGENIC ZEBRAFISH; LARVAL ZEBRAFISH; XENOPUS-LAEVIS; NEURONS; INTERNEURONS; EMBRYOS		SUNY Stony Brook, Howard Hughes Med Inst, Stony Brook, NY 11794 USA; SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA	Howard Hughes Medical Institute; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Mandel, G (corresponding author), SUNY Stony Brook, Howard Hughes Med Inst, Stony Brook, NY 11794 USA.		Dallman, Julia/I-1414-2019; Dallman, Julia/AGG-3507-2022	Dallman, Julia/0000-0002-5839-807X; Higashijima, Shin-ichi/0000-0001-6350-4992	NINDS NIH HHS [NS26539, R01 NS026539, R01 NS026539-25] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026539, R29NS026539, R37NS026539] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BERNHARDT RR, 1990, J COMP NEUROL, V302, P603, DOI 10.1002/cne.903020315; CLARKE JDW, 1984, J PHYSIOL-LONDON, V348, P511, DOI 10.1113/jphysiol.1984.sp015122; Dosemeci A, 2000, J NEUROSCI, V20, P3076, DOI 10.1523/JNEUROSCI.20-09-03076.2000; Elgersma Y, 2002, NEURON, V36, P493, DOI 10.1016/S0896-6273(02)01007-3; Hale ME, 2001, J COMP NEUROL, V437, P1, DOI 10.1002/cne.1266; Higashijima S, 1997, DEV BIOL, V192, P289, DOI 10.1006/dbio.1997.8779; Park HC, 2000, DEV BIOL, V227, P279, DOI 10.1006/dbio.2000.9898; ROBERTS A, 1990, EUR J NEUROSCI, V2, P1051, DOI 10.1111/j.1460-9568.1990.tb00017.x; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Shen K, 2000, NAT NEUROSCI, V3, P881, DOI 10.1038/78783; SILLAR KT, 1988, NATURE, V331, P262, DOI 10.1038/331262a0; Strack S, 1997, J BIOL CHEM, V272, P13467, DOI 10.1074/jbc.272.21.13467	12	64	67	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2003	6	3					217	218		10.1038/nn1011	http://dx.doi.org/10.1038/nn1011			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	648YB	12563265				2022-12-24	WOS:000181178300007
J	Adams, DL; Horton, JC				Adams, DL; Horton, JC			Capricious expression of cortical columns in the primate brain	NATURE NEUROSCIENCE			English	Article							OCULAR DOMINANCE COLUMNS; LATERAL GENICULATE-NUCLEUS; SQUIRREL-MONKEY; VISUAL-CORTEX; STRIATE CORTEX; OLD-WORLD; ENUCLEATION; AFFERENTS; MACAQUE		Univ Calif San Francisco, Beckman Vis Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Adams, DL (corresponding author), Univ Calif San Francisco, Beckman Vis Ctr, 10 Kirkham St, San Francisco, CA 94143 USA.	dadams@itsa.ucsf.edu	Adams, Daniel L/A-5229-2009	Adams, Daniel L/0000-0003-0376-4949; Horton, Jonathan/0000-0002-3952-435X				Adams DL, 2002, SCIENCE, V298, P572, DOI 10.1126/science.1074887; HENDRICKSON AE, 1978, J COMP NEUROL, V182, P123, DOI 10.1002/cne.901820108; HENDRICKSON AE, 1985, BRAIN RES, V333, P340, DOI 10.1016/0006-8993(85)91589-6; Horton JC, 1996, J NEUROSCI, V16, P5510; Horton JC, 1998, J NEUROSCI, V18, P5433, DOI 10.1523/JNEUROSCI.18-14-05433.1998; Horton JC, 1996, J NEUROSCI, V16, P7228; Hubel D H, 1976, Cold Spring Harb Symp Quant Biol, V40, P581; HUBEL DH, 1969, NATURE, V221, P747, DOI 10.1038/221747a0; Kaschube M, 2002, J NEUROSCI, V22, P7206; Livingstone MS, 1996, J NEUROSCI, V16, P2086; LIVINGSTONE MS, 1995, VISION RES, V35, P345, DOI 10.1016/0042-6989(94)00133-7; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; PURVES D, 1992, TRENDS NEUROSCI, V15, P362, DOI 10.1016/0166-2236(92)90180-G; SHATZ CJ, 1977, BRAIN RES, V131, P103, DOI 10.1016/0006-8993(77)90031-2; TIGGES J, 1977, J COMP NEUROL, V176, P87, DOI 10.1002/cne.901760106	15	76	76	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2003	6	2					113	114		10.1038/nn1004	http://dx.doi.org/10.1038/nn1004			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	640CL	12536211				2022-12-24	WOS:000180669100008
J	Dacey, DM; Peterson, BB; Robinson, FR; Gamlin, PD				Dacey, DM; Peterson, BB; Robinson, FR; Gamlin, PD			Fireworks in the primate retina: In vitro photodynamics reveals diverse LGN-projecting ganglion cell types	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; PRIMARY VISUAL-CORTEX; MAMMALIAN RETINA; NERVOUS-SYSTEM; MONKEY; DYE; MORPHOLOGY; PATHWAY; SPECIFICITY; THERAPY	Diverse cell types and parallel pathways are characteristic of the vertebrate nervous system, yet it remains a challenge to define the basic components of most neural structures. We describe a process termed retrograde photodynamics that allowed us to rapidly make the link between morphology, physiology, and connectivity for ganglion cells in the macaque retina that project to the lateral geniculate nucleus (LGN). Rhodamine dextran injected into the LGN was transported retrogradely and sequestered within the cytoplasm of ganglion cell bodies. Exposure of the retina to light in vitro liberated the tracer and allowed it to diffuse throughout the dendrites, revealing the cell's complete morphology. Eight previously unknown LGN-projecting cell types were identified. Cells could also be targeted in vitro for intracellular recording and physiological analysis. The photodynamic process was also observed in pyramidal cells in a rat neocortical slice.	Univ Alabama, Dept Physiol Opt, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Dacey, DM (corresponding author), Univ Washington, Dept Biol Struct, Seattle, WA 98175 USA.		Gamlin, Paul/W-2169-2019	Gamlin, Paul/0000-0002-2966-4762; Robinson, Farrel/0000-0002-3903-8327; Dacey, Dennis/0000-0001-8476-5585	NCRR NIH HHS [RR00166] Funding Source: Medline; NEI NIH HHS [EY10578, EY09625, EY06678, EY09380, P30EY01730] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000166] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY006678, P30EY001730, R01EY010578, R01EY009625, R01EY009380] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Ackroyd R, 2001, PHOTOCHEM PHOTOBIOL, V74, P656, DOI 10.1562/0031-8655(2001)074<0656:THOPAP>2.0.CO;2; Born RT, 2001, CURR BIOL, V11, pR566, DOI 10.1016/S0960-9822(01)00345-1; Briggs F, 2001, J NEUROSCI, V21, P3600, DOI 10.1523/JNEUROSCI.21-10-03600.2001; Chattipakorn SC, 2002, J NEUROPHYSIOL, V87, P1515, DOI 10.1152/jn.00365.2001; Dacey D, 2000, VISION RES, V40, P1801, DOI 10.1016/S0042-6989(00)00039-0; Dacey DM, 2000, ANNU REV NEUROSCI, V23, P743, DOI 10.1146/annurev.neuro.23.1.743; DACEY DM, 1994, NATURE, V367, P731, DOI 10.1038/367731a0; DACEY DM, 1992, P NATL ACAD SCI USA, V89, P9666, DOI 10.1073/pnas.89.20.9666; Dacey DM, 1996, SCIENCE, V271, P656, DOI 10.1126/science.271.5249.656; DACEY DM, 2002, IN PRESS IOVS, V43; DEMONASTERIO FM, 1975, J PHYSIOL-LONDON, V251, P167, DOI 10.1113/jphysiol.1975.sp011086; DIWU ZJ, 1994, PHARMACOL THERAPEUT, V63, P1, DOI 10.1016/0163-7258(94)90054-X; Dougherty TJ, 1998, JNCI-J NATL CANCER I, V90, P889, DOI 10.1093/jnci/90.12.889; ENROTHCUGELL C, 1983, J PHYSIOL-LONDON, V341, P279, DOI 10.1113/jphysiol.1983.sp014806; Gamlin PDR, 2001, INVEST OPHTH VIS SCI, V42, pS676; GANDIN E, 1983, PHOTOCHEM PHOTOBIOL, V37, P271, DOI 10.1111/j.1751-1097.1983.tb04472.x; He SG, 1998, VISUAL NEUROSCI, V15, P369, DOI 10.1017/S095252389815215X; Kaplan E., 1990, Progress in Retinal Research, V9, P273, DOI 10.1016/0278-4327(90)90009-7; Lee B. B., 1999, COLOR VISION GENES P, P203; LEE BB, 1994, VISION RES, V34, P3081, DOI 10.1016/0042-6989(94)90074-4; LEE BB, 1990, J OPT SOC AM A, V7, P2223, DOI 10.1364/JOSAA.7.002223; LEE BB, 1988, J PHYSIOL-LONDON, V404, P323, DOI 10.1113/jphysiol.1988.sp017292; MacNeil MA, 1998, NEURON, V20, P971, DOI 10.1016/S0896-6273(00)80478-X; Martin PR, 1997, EUR J NEUROSCI, V9, P1536, DOI 10.1111/j.1460-9568.1997.tb01509.x; Masland RH, 2000, ANNU REV NEUROSCI, V23, P249, DOI 10.1146/annurev.neuro.23.1.249; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; Masland RH, 2001, CURR OPIN NEUROBIOL, V11, P431, DOI 10.1016/S0959-4388(00)00230-0; MILLER JP, 1979, SCIENCE, V206, P702, DOI 10.1126/science.386514; NIRENBERG S, 1993, J NEUROSCI, V13, P3238, DOI 10.1523/jneurosci.13-08-03238.1993; Nirenberg S, 1997, NEURON, V18, P637, DOI 10.1016/S0896-6273(00)80304-9; Packer O, 2001, VISION RES, V41, P427, DOI 10.1016/S0042-6989(00)00271-6; PERRY VH, 1984, NEUROSCIENCE, V12, P1101, DOI 10.1016/0306-4522(84)90006-X; PICAUD S, 1993, J NEUROSCI RES, V35, P629, DOI 10.1002/jnr.490350606; PICAUD S, 1990, J NEUROSCI METH, V33, P101, DOI 10.1016/0165-0270(90)90014-7; PU M, 1994, J NEUROSCI, V14, P4338; Reiner A, 2000, J NEUROSCI METH, V103, P23, DOI 10.1016/S0165-0270(00)00293-4; Rodieck R.W., 1998, 1 STEPS SEEING; RODIECK RW, 1993, J COMP NEUROL, V338, P289, DOI 10.1002/cne.903380211; SANDELL JH, 1988, J HISTOCHEM CYTOCHEM, V36, P555, DOI 10.1177/36.5.3356898; Sawatari A, 2000, NEURON, V25, P459, DOI 10.1016/S0896-6273(00)80908-3; SPIKES JD, 1991, PHOTOCHEM PHOTOBIOL, V54, P1079, DOI 10.1111/j.1751-1097.1991.tb02132.x; STERLING P, 1998, SYNAPTIC ORG BRAIN, P205; Vaney D.I., 1990, PROGR RETINAL RES, V9, P49, DOI [10.1016/0278-4327(90)90004-2, DOI 10.1016/0278-4327(90)90004-2]; Vercelli A, 2000, BRAIN RES BULL, V51, P11, DOI 10.1016/S0361-9230(99)00229-4; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; WATANABE M, 1989, J COMP NEUROL, V289, P434, DOI 10.1002/cne.902890308; WAYNE CE, 2001, PHOTOCHEMISTRY; WEINSTEIN JN, 1977, SCIENCE, V195, P489, DOI 10.1126/science.835007; White AJR, 1998, J NEUROPHYSIOL, V80, P2063, DOI 10.1152/jn.1998.80.4.2063; YANG G, 1994, J NEUROSCI, V14, P5267	50	233	241	1	20	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 9	2003	37	1					15	27		10.1016/S0896-6273(02)01143-1	http://dx.doi.org/10.1016/S0896-6273(02)01143-1			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	646UV	12526769	Bronze			2022-12-24	WOS:000181054700006
J	Zonta, M; Angulo, MC; Gobbo, S; Rosengarten, B; Hossmann, KA; Pozzan, T; Carmignoto, G				Zonta, M; Angulo, MC; Gobbo, S; Rosengarten, B; Hossmann, KA; Pozzan, T; Carmignoto, G			Neuron-to-astrocyte signaling is central to the dynamic control of brain microcirculation	NATURE NEUROSCIENCE			English	Article							CEREBRAL-BLOOD-FLOW; NITRIC-OXIDE; SOMATOSENSORY STIMULATION; INTRACELLULAR CALCIUM; FUNCTIONAL HYPEREMIA; NMDA RECEPTORS; GLUTAMATE; MICROVESSELS; RAT; ACTIVATION	The cellular mechanisms underlying functional hyperemia-the coupling of neuronal activation to cerebral blood vessel responses-are not yet known. Here we show in rat cortical slices that the dilation of arterioles triggered by neuronal activity is dependent on glutamate-mediated [Ca2+](i) oscillations in astrocytes. Inhibition of these Ca2+ responses resulted in the impairment of activity-dependent vasodilation, whereas selective activation-by patch pipette-of single astrocytes that were in contact with arterioles triggered vessel relaxation. We also found that a cyclooxygenase product is centrally involved in this astrocyte-mediated control of arterioles. In vivo blockade of glutamate-mediated [Ca2+](i) elevations in astrocytes reduced the blood flow increase in the somatosensory cortex during contralateral forepaw stimulation. Taken together, our findings show that neuron-to-astrocyte signaling is a key mechanism in functional hyperemia.	Univ Padua, CNR, Ist Neurosci, I-35121 Padua, Italy; Univ Padua, Dipartimento Sci Biomed Sperimentali, I-35121 Padua, Italy; Ciudad Univ, Ed manuel Ancizar, Ctr Int Fis, Bogota, Colombia; Max Planck Inst Neurol Res, Dept Expt Neurol, D-50931 Cologne, Germany	Consiglio Nazionale delle Ricerche (CNR); University of Padua; University of Padua; Universidad Nacional de Colombia; Max Planck Society	Carmignoto, G (corresponding author), Univ Padua, CNR, Ist Neurosci, Viale G Colombo 3, I-35121 Padua, Italy.	gcarmi@bio.unipd.it	Angulo, Maria Cecilia/B-8236-2014; Zonta, Micaela/AAX-3505-2020; Carmignoto, Giorgio/A-8375-2018	Angulo, Maria Cecilia/0000-0002-0758-0496; Zonta, Micaela/0000-0002-9982-6405; Carmignoto, Giorgio/0000-0003-3063-6774	Telethon [1095] Funding Source: Medline	Telethon(Fondazione Telethon)		Alkayed NJ, 1997, STROKE, V28, P1066, DOI 10.1161/01.STR.28.5.1066; Araque A, 1998, J NEUROSCI, V18, P6822; Bakalova R, 2002, EXP BIOL MED, V227, P465, DOI 10.1177/153537020222700710; Bezzi P, 1998, NATURE, V391, P281, DOI 10.1038/34651; Brinker G, 1999, MAGNET RESON MED, V41, P469, DOI 10.1002/(SICI)1522-2594(199903)41:3<469::AID-MRM7>3.0.CO;2-9; Carmignoto G, 2000, PROG NEUROBIOL, V62, P561, DOI 10.1016/S0301-0082(00)00029-0; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; de la Torre JC, 2002, STROKE, V33, P1152, DOI 10.1161/01.STR.0000014421.15948.67; Fagni L, 2000, TRENDS NEUROSCI, V23, P80, DOI 10.1016/S0166-2236(99)01492-7; Faraci FM, 1998, PHYSIOL REV, V78, P53, DOI 10.1152/physrev.1998.78.1.53; Farber NE, 1997, ANESTHESIOLOGY, V87, P1191, DOI 10.1097/00000542-199711000-00024; FERGUS A, 1995, BRAIN RES, V694, P78, DOI 10.1016/0006-8993(95)00768-L; Fergus A, 1997, BRAIN RES, V754, P35, DOI 10.1016/S0006-8993(97)00040-1; FOX PT, 1988, SCIENCE, V241, P462, DOI 10.1126/science.3260686; GARTHWAITE J, 1988, NATURE, V336, P385, DOI 10.1038/336385a0; Gartner R, 2001, BIOFACTORS, V14, P199; Gasparini F, 1999, NEUROPHARMACOLOGY, V38, P1493, DOI 10.1016/S0028-3908(99)00082-9; GOLANOV EV, 1994, J CEREBR BLOOD F MET, V14, P492, DOI 10.1038/jcbfm.1994.61; Golgi C, 1885, RIV SPER FREMIAT MED, V11, P72; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; IADECOLA C, 1993, AM J PHYSIOL, V264, pR738, DOI 10.1152/ajpregu.1993.264.4.R738; IADECOLA C, 1993, TRENDS NEUROSCI, V16, P206, DOI 10.1016/0166-2236(93)90156-G; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Krimer LS, 1998, NAT NEUROSCI, V1, P286, DOI 10.1038/1099; Lindauer U, 1999, AM J PHYSIOL-HEART C, V277, pH799, DOI 10.1152/ajpheart.1999.277.2.H799; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Monn JA, 1999, J MED CHEM, V42, P1027, DOI 10.1021/jm980616n; Niwa K, 2000, J NEUROSCI, V20, P763, DOI 10.1523/JNEUROSCI.20-02-00763.2000; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Parri HR, 2001, NAT NEUROSCI, V4, P803, DOI 10.1038/90507; Paspalas CD, 1998, BRAIN RES BULL, V45, P247, DOI 10.1016/S0361-9230(97)00327-4; Pasti L, 1997, J NEUROSCI, V17, P7817; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; PETERS A, 1991, FINE STRUCTURE NERVO, P276; Porter JT, 1996, J NEUROSCI, V16, P5073; Raichle ME, 2001, NATURE, V412, P128, DOI 10.1038/35084300; REINHARD JF, 1979, SCIENCE, V206, P85, DOI 10.1126/science.482930; Robitaille R, 1998, NEURON, V21, P847, DOI 10.1016/S0896-6273(00)80600-5; Roy C S, 1890, J Physiol, V11, P85; SAGHER O, 1993, J CEREBR BLOOD F MET, V13, P676, DOI 10.1038/jcbfm.1993.86; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Schmitz B, 1997, J CEREBR BLOOD F MET, V17, P1202, DOI 10.1097/00004647-199711000-00009; Skeberdis VA, 2001, NEUROPHARMACOLOGY, V40, P856, DOI 10.1016/S0028-3908(01)00005-3; VAUCHER E, 1995, J NEUROSCI, V15, P7427; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999; White RP, 1998, STROKE, V29, P467, DOI 10.1161/01.STR.29.2.467; Yang G, 1999, AM J PHYSIOL-REG I, V277, pR1760, DOI 10.1152/ajpregu.1999.277.6.R1760; Yang G, 2000, J NEUROSCI, V20, P6968, DOI 10.1523/JNEUROSCI.20-18-06968.2000	48	1083	1113	3	80	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2003	6	1					43	50		10.1038/nn980	http://dx.doi.org/10.1038/nn980			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	630CE	12469126				2022-12-24	WOS:000180089300014
J	Shmuel, A; Yacoub, E; Pfeuffer, J; Van de Moortele, PF; Adriany, G; Hu, XP; Ugurbil, K				Shmuel, A; Yacoub, E; Pfeuffer, J; Van de Moortele, PF; Adriany, G; Hu, XP; Ugurbil, K			Sustained negative BOLD, blood flow and oxygen consumption response and its coupling to the positive response in the human brain	NEURON			English	Article							MAGNETIC-RESONANCE; FUNCTIONAL MRI; OXIDATIVE-METABOLISM; SENSORY STIMULATION; CEREBRAL-CORTEX; VISUAL-CORTEX; FMRI SIGNAL; ACTIVATION; TIME; INHIBITION	Most fMRI studies are based on the detection of a positive BOLD response (PBR). Here, we demonstrate and characterize a robust sustained negative BOLD response (NBR) in the human occipital cortex, triggered by stimulating part of the visual field. The NBR was spatially adjacent to but segregated from the PBR. It depended on the stimulus and thus on the pattern of neuronal activity. The time courses of the NBR and PBR were similar, and their amplitudes covaried both with increasing stimulus duration and increasing stimulus contrast. The NBR was associated with reductions in blood flow and with decreases in oxygen consumption. Our findings support the contribution to the NBR of (1) a significant component of reduction in neuronal activity and (2) possibly a component of hemodynamic changes independent of the local changes in neuronal activity.	Univ Minnesota, Sch Med, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Shmuel, A (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.		Van de Moortele, Pierre-François/H-5087-2011; Adriany, Gregor/AAK-1323-2020; Adriany, Gregor/R-6656-2016; Shmuel, Amir/G-8690-2013; Yacoub, Essa/AAS-7757-2021; Ugurbil, Kamil/AAD-6058-2022	Van de Moortele, Pierre-François/0000-0002-6941-5947; Pfeuffer, Josef/0000-0001-9887-0458; Hu, Xiaoping/0000-0001-7014-5983; Adriany, Gregor/0000-0002-6428-9005	NCRR NIH HHS [RR08079, S10 RR13957] Funding Source: Medline; NIBIB NIH HHS [EB000331] Funding Source: Medline; NIMH NIH HHS [MH55346] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR013957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH055346] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Allison JD, 2000, NEUROLOGY, V54, P135, DOI 10.1212/WNL.54.1.135; Angelucci A, 2002, J NEUROSCI, V22, P8633; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; BANDETTINI PA, 1992, MAGNET RESON MED, V25, P390, DOI 10.1002/mrm.1910250220; BANDETTINI PA, 1993, MAGNET RESON MED, V30, P161, DOI 10.1002/mrm.1910300204; Baron JC, 2001, CEREBROVASC DIS, V11, P2, DOI 10.1159/000049119; BLAKEMORE C, 1972, EXP BRAIN RES, V15, P439; BORN RT, 1991, P NATL ACAD SCI USA, V88, P7071, DOI 10.1073/pnas.88.16.7071; BOXERMAN JL, 1995, MAGNET RESON MED, V34, P4, DOI 10.1002/mrm.1910340103; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Davis TL, 1998, P NATL ACAD SCI USA, V95, P1834, DOI 10.1073/pnas.95.4.1834; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; FOX PT, 1986, P NATL ACAD SCI USA, V83, P1140, DOI 10.1073/pnas.83.4.1140; FROSTIG RD, 1990, P NATL ACAD SCI USA, V87, P6082, DOI 10.1073/pnas.87.16.6082; Goutte C, 2001, HUM BRAIN MAPP, V13, P165, DOI 10.1002/hbm.1031; GRUBB RL, 1974, STROKE, V5, P630, DOI 10.1161/01.STR.5.5.630; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Harel N, 2002, J CEREBR BLOOD F MET, V22, P908, DOI 10.1097/00004647-200208000-00002; Hoge RD, 1999, MAGNET RESON MED, V42, P849, DOI 10.1002/(SICI)1522-2594(199911)42:5<849::AID-MRM4>3.0.CO;2-Z; Hu XP, 1997, MAGNET RESON MED, V37, P877, DOI 10.1002/mrm.1910370612; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; KIM SG, 1995, MAGNET RESON MED, V34, P293, DOI 10.1002/mrm.1910340303; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Lee SP, 2001, MAGNET RESON MED, V45, P791, DOI 10.1002/mrm.1107; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 2002, PHILOS T R SOC B, V357, P1003, DOI 10.1098/rstb.2002.1114; Mandeville JB, 1998, MAGNET RESON MED, V39, P615, DOI 10.1002/mrm.1910390415; Martin E, 2000, HUM BRAIN MAPP, V10, P132, DOI 10.1002/1097-0193(200007)10:3<132::AID-HBM40>3.0.CO;2-2; Ngan SC, 2002, ARTIF INTELL MED, V25, P19, DOI 10.1016/S0933-3657(02)00006-4; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; OGAWA S, 1993, MAGNET RESON MED, V29, P205, DOI 10.1002/mrm.1910290208; Ogawa S, 2000, P NATL ACAD SCI USA, V97, P11026, DOI 10.1073/pnas.97.20.11026; OGAWA S, 1993, BIOPHYS J, V64, P800; Pfeuffer J, 2002, MAGNET RESON MED, V47, P903, DOI 10.1002/mrm.10154; Pfeuffer J, 2002, MAGN RESON MED, V47, P344, DOI 10.1002/mrm.10065; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Saad ZS, 2001, HUM BRAIN MAPP, V13, P74, DOI 10.1002/hbm.1026; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Sherman SM, 1996, VISUAL NEUROSCI, V13, P205, DOI 10.1017/S0952523800007446; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Smith AT, 2000, NEUROREPORT, V11, P271, DOI 10.1097/00001756-200002070-00010; SOKOLOFF L, 1977, J NEUROCHEM, V29, P13, DOI 10.1111/j.1471-4159.1977.tb03919.x; Strupp JP, 1996, NEUROIMAGE, V3, pS607; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P818, DOI 10.1073/pnas.95.3.818; Ugurbil K, 2000, ANNU REV BIOMED ENG, V2, P633, DOI 10.1146/annurev.bioeng.2.1.633; Victor JD, 2000, CEREB CORTEX, V10, P2, DOI 10.1093/cercor/10.1.2; Yacoub E, 2001, MAGN RESON MED, V45, P588, DOI 10.1002/mrm.1080	50	458	464	3	39	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 19	2002	36	6					1195	1210		10.1016/S0896-6273(02)01061-9	http://dx.doi.org/10.1016/S0896-6273(02)01061-9			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	628TA	12495632	Bronze			2022-12-24	WOS:000180011600020
J	Gutlerner, JL; Penick, EC; Snyder, EM; Kauer, JA				Gutlerner, JL; Penick, EC; Snyder, EM; Kauer, JA			Novel protein kinase A-dependent long-term depression of excitatory synapses	NEURON			English	Article							VENTRAL TEGMENTAL AREA; BEHAVIORAL SENSITIZATION; AMPA RECEPTORS; INCENTIVE-SENSITIZATION; SYNAPTIC-TRANSMISSION; PHOSPHORYLATION SITES; GLUTAMATE RECEPTORS; DOPAMINE NEURONS; CA1 REGION; POTENTIATION	Dopamine neurons of the ventral tegmental area (VTA) are critically involved in processing novel and rewarding information, and mediate the addictive properties of many drugs of abuse. Excitatory synapses on these neurons, like those in other brain regions, exhibit long-term depression (LTD). Amphetamine or dopamine block LTD at VTA synapses, indicating that both pathological and local physiological stimuli regulate LTD. Here we show that in common with other forms of LTD, VTA LTD results from a selective decrease in AMPA receptor function accompanied by a decrease in cell surface AMPA receptors. However, unlike the case for any previously described form of LTD, activation of cyclic AMP-dependent protein kinase (PKA) is necessary and sufficient to trigger LTD at synapses on VTA dopamine neurons.	Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Brown University; Brown University	Kauer, JA (corresponding author), Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA.	julie_kauer@brown.edu		Kauer, Julie/0000-0002-3362-1642; Gutlerner, Johanna/0000-0002-6817-6147	NIDA NIH HHS [DA 06048] Funding Source: Medline; PHS HHS [11289] Funding Source: Medline	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Bonci A, 1999, J NEUROSCI, V19, P3723; BRANDON EP, 1995, P NATL ACAD SCI USA, V92, P8851, DOI 10.1073/pnas.92.19.8851; Carlezon WA, 1997, SCIENCE, V277, P812, DOI 10.1126/science.277.5327.812; Chung HJ, 2000, J NEUROSCI, V20, P7258; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GRACE AA, 1989, J NEUROSCI, V9, P3463; Hanoune J, 2001, ANNU REV PHARMACOL, V41, P145, DOI 10.1146/annurev.pharmtox.41.1.145; Huang LQ, 1999, NEUROSCI LETT, V274, P71, DOI 10.1016/S0304-3940(99)00561-3; Huang Y Y, 1994, Learn Mem, V1, P74; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; JOHNSON SW, 1992, J PHYSIOL-LONDON, V450, P455, DOI 10.1113/jphysiol.1992.sp019136; Jones S, 2000, J NEUROSCI, V20, P5575, DOI 10.1523/JNEUROSCI.20-15-05575.2000; Jones S, 1999, J NEUROSCI, V19, P9780; KALIVAS PW, 1993, J PHARMACOL EXP THER, V267, P486; Kameyama K, 1998, NEURON, V21, P1163, DOI 10.1016/S0896-6273(00)80633-9; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; KELLER BU, 1992, EMBO J, V11, P891, DOI 10.1002/j.1460-2075.1992.tb05127.x; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; LINDEN DJ, 1991, SCIENCE, V254, P1656, DOI 10.1126/science.1721243; LINDEN DJ, 1995, ANNU REV NEUROSCI, V18, P319, DOI 10.1146/annurev.ne.18.030195.001535; LISMAN J, 1994, TRENDS NEUROSCI, V17, P406, DOI 10.1016/0166-2236(94)90014-0; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451, DOI 10.1152/jn.1993.70.4.1451; Mansvelder HD, 2000, NEURON, V27, P349, DOI 10.1016/S0896-6273(00)00042-8; Matsuda S, 2000, EMBO J, V19, P2765, DOI 10.1093/emboj/19.12.2765; McMahon LL, 1997, NEURON, V18, P295, DOI 10.1016/S0896-6273(00)80269-X; MONS N, 1993, SYNAPSE, V14, P51, DOI 10.1002/syn.890140108; Morishita W, 2001, NEURON, V32, P1133, DOI 10.1016/S0896-6273(01)00554-2; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Nayak A, 1998, NATURE, V394, P680, DOI 10.1038/29305; O'Donnell P, 1999, PSYCHOBIOLOGY, V27, P187; Otmakhova NA, 2000, J NEUROSCI, V20, P4446, DOI 10.1523/JNEUROSCI.20-12-04446.2000; Overton PG, 1999, NEUROREPORT, V10, P221, DOI 10.1097/00001756-199902050-00004; PENNARTZ CMA, 1994, PROG NEUROBIOL, V42, P719, DOI 10.1016/0301-0082(94)90025-6; Pierce RC, 1996, J PHARMACOL EXP THER, V278, P384; Robinson TE, 2001, ADDICTION, V96, P103, DOI 10.1046/j.1360-0443.2001.9611038.x; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Schultz W, 1997, CURR OPIN NEUROBIOL, V7, P191, DOI 10.1016/S0959-4388(97)80007-4; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Tavalin SJ, 2002, J NEUROSCI, V22, P3044, DOI 10.1523/JNEUROSCI.22-08-03044.2002; Tecott LH, 1998, P NATL ACAD SCI USA, V95, P15026, DOI 10.1073/pnas.95.25.15026; Thomas MJ, 2000, J NEUROSCI, V20, P5581, DOI 10.1523/JNEUROSCI.20-15-05581.2000; Tolliver BK, 1999, J PHARMACOL EXP THER, V289, P38; Tolliver BK, 1996, J PHARMACOL EXP THER, V278, P411; TONG ZY, 1995, BRAIN RES, V674, P63, DOI 10.1016/0006-8993(94)01439-O; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Vezina P, 1996, J NEUROSCI, V16, P2411; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; White FJ, 1996, ANNU REV NEUROSCI, V19, P405, DOI 10.1146/annurev.ne.19.030196.002201; WHITE FJ, 1995, J PHARMACOL EXP THER, V273, P445; Winder DG, 1998, CELL, V92, P25, DOI 10.1016/S0092-8674(00)80896-X; WISE RA, 1987, PSYCHOL REV, V94, P469, DOI 10.1037/0033-295X.94.4.469; Wolf ME, 1998, PROG NEUROBIOL, V54, P679, DOI 10.1016/S0301-0082(97)00090-7; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; Yu T, 2001, P NATL ACAD SCI USA, V98, P5264, DOI 10.1073/pnas.091093998	63	52	53	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 5	2002	36	5					921	931		10.1016/S0896-6273(02)01051-6	http://dx.doi.org/10.1016/S0896-6273(02)01051-6			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	622VL	12467595	Bronze			2022-12-24	WOS:000179667800016
J	Horch, HW; Katz, LC				Horch, HW; Katz, LC			BDNF release from single cells elicits local dendritic growth in nearby neurons	NATURE NEUROSCIENCE			English	Article							RETROGRADE AXONAL-TRANSPORT; NEUROTROPHIC FACTOR; HIPPOCAMPAL-NEURONS; TRKB RECEPTORS; FULL-LENGTH; VISUAL-CORTEX; POSTSYNAPTIC NEURONS; TRUNCATED RECEPTORS; SYMPATHETIC NEURONS; STRIATE CORTEX	In cultured neurons, the exogenous application of neurotrophins (in homogenous concentrations) alters many features of axonal and dendritic arbors. In vivo, however, release of endogenous neurotrophins from neuronal processes creates spatially heterogeneous neurotrophin distributions. To probe the consequences of such endogenous neurotrophin distribution, we produced 'donor neurons' in ferret cortex brain slices that co-expressed brain-derived neurotrophic factor (BDNF) and red fluorescent protein (RFP). Using two-photon microscopy, we analyzed their effects on 'recipient neurons' that expressed green fluorescent protein (GFP) alone. BDNF released from dendrites and cell bodies acted directly on nearby recipient neurons to increase dendritic branching in a distance-dependent manner. Three-dimensional analysis of donor and recipient dendrites indicated that the BDNF source had to be within 4.5 mum to induce dendritic growth in the recipient neuron. Thus, BDNF released from an individual cell alters the structure of nearby dendrites on an exquisitely local scale.	Duke Univ, Med Ctr, Dept Neurobiol, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute	Horch, HW (corresponding author), Bowdoin Coll, Dept Biol, 6500 Coll Stn, Brunswick, ME 04011 USA.	hhorch@bowdoin.edu			NEI NIH HHS [EY-11553] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011553] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALLENDOERFER KL, 1994, J NEUROSCI, V14, P1795; Aoki C, 2000, J NEUROSCI RES, V59, P454, DOI 10.1002/(SICI)1097-4547(20000201)59:3<454::AID-JNR21>3.0.CO;2-H; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; BARTLETT WP, 1984, J NEUROSCI, V4, P1944; BIFFO S, 1995, DEVELOPMENT, V121, P2461; CAMPENOT RB, 1982, DEV BIOL, V93, P1, DOI 10.1016/0012-1606(82)90232-9; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; DALVA MB, 1994, SCIENCE, V265, P255, DOI 10.1126/science.7912852; DISTEFANO PS, 1992, NEURON, V8, P983, DOI 10.1016/0896-6273(92)90213-W; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Fryer RH, 1996, J COMP NEUROL, V374, P21, DOI 10.1002/(SICI)1096-9861(19961007)374:1<21::AID-CNE2>3.0.CO;2-P; Gallo G, 2000, J NEUROBIOL, V44, P159, DOI 10.1002/1097-4695(200008)44:2<159::AID-NEU6>3.0.CO;2-H; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; Goodman LJ, 1996, MOL CELL NEUROSCI, V7, P222, DOI 10.1006/mcne.1996.0017; Haapasalo A, 1999, ONCOGENE, V18, P1285, DOI 10.1038/sj.onc.1202401; HENDRY IA, 1974, BRAIN RES, V68, P103, DOI 10.1016/0006-8993(74)90536-8; Horch HW, 1999, NEURON, V23, P353; Jarvis CR, 1997, J NEUROPHYSIOL, V78, P2363, DOI 10.1152/jn.1997.78.5.2363; Kafitz KW, 1999, NATURE, V401, P918, DOI 10.1038/44847; KATZ LC, 1988, J NEUROSCI, V8, P3160; KATZ LC, 1987, J NEUROSCI, V7, P1223; KATZ LC, 1991, EUR J NEUROSCI, V3, P1, DOI 10.1111/j.1460-9568.1991.tb00805.x; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; Kohara K, 2001, SCIENCE, V291, P2419, DOI 10.1126/science.1057415; Korte M, 1996, P NATL ACAD SCI USA, V93, P12547, DOI 10.1073/pnas.93.22.12547; KOSSEL A, 1995, J NEUROSCI, V15, P3913; Kossel AH, 1997, J NEUROSCI, V17, P9634; Kryl D, 1999, J NEUROSCI, V19, P5823, DOI 10.1523/JNEUROSCI.19-14-05823.1999; Kuruvilla R, 2000, NEURON, V27, P499, DOI 10.1016/S0896-6273(00)00061-1; Lom B, 1999, J NEUROSCI, V19, P9928; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; Mowla SJ, 1999, J NEUROSCI, V19, P2069; Murphy DD, 1998, P NATL ACAD SCI USA, V95, P11412, DOI 10.1073/pnas.95.19.11412; Nedivi E, 1998, SCIENCE, V281, P1863, DOI 10.1126/science.281.5384.1863; Ozdinler PH, 2001, J COMP NEUROL, V438, P377; PEICHL L, 1979, J PHYSIOL-LONDON, V291, P117, DOI 10.1113/jphysiol.1979.sp012803; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2; Shepherd G. M., 1998, SYNAPTIC ORG BRAIN; Shimada A, 1998, J NEUROSCI, V18, P8559; Tongiorgi E, 1997, J NEUROSCI, V17, P9492; Whitford KL, 2002, NEURON, V33, P47, DOI 10.1016/S0896-6273(01)00566-9; Yacoubian TA, 2000, NAT NEUROSCI, V3, P342, DOI 10.1038/73911; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x; Zervas M, 1999, J COMP NEUROL, V413, P429, DOI 10.1002/(SICI)1096-9861(19991025)413:3<429::AID-CNE6>3.0.CO;2-7	50	301	307	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1177	1184		10.1038/nn927	http://dx.doi.org/10.1038/nn927			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	609CG	12368805				2022-12-24	WOS:000178884600021
J	Beattie, MS; Harrington, AW; Lee, R; Kim, JY; Boyce, SL; Longo, FM; Bresnahan, JC; Hempstead, BL; Yoon, SO				Beattie, MS; Harrington, AW; Lee, R; Kim, JY; Boyce, SL; Longo, FM; Bresnahan, JC; Hempstead, BL; Yoon, SO			ProNGF induces p75-mediated death of oligodendrocytes following spinal cord injury	NEURON			English	Article							NERVE GROWTH-FACTOR; P75 NEUROTROPHIN RECEPTOR; TUMOR-NECROSIS-FACTOR; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CELL-DEATH; FACTOR-I; HIPPOCAMPAL-NEURONS; PROGENITOR CELLS; GENE-EXPRESSION; MESSENGER-RNA	The neurotrophin receptor p75 is induced by various injuries to the nervous system, but its role after injury has remained unclear. Here, we report that p75 is required for the death of oligodendrocytes following spinal cord injury, and its action is mediated mainly by proNGF. Oligodendrocytes undergoing apoptosis expressed p75, and the absence of p75 resulted in a decrease in the number of apoptotic oligodendrocytes and increased survival of oligodendrocytes. ProNGF is likely responsible for activating p75 in vivo, since the proNGF from the injured spinal cord induced apoptosis among p75(+/+), but not among p75(-/-), oligodendrocytes in culture, and its action was blocked by proNGF-specific antibody. Together, these data suggest that the role of proNGF is to eliminate damaged cells by activating the apoptotic machinery of p75 after injury.	Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA; Ohio State Univ, Biochem Program, Columbus, OH 43210 USA; Ohio State Univ, Mol Cellular & Dev Biol Program, Columbus, OH 43210 USA; Ohio State Univ, Med Ctr, Neurobiotechnol Ctr, Columbus, OH 43210 USA; Cornell Univ, Weill Med Coll, Dept Med, New York, NY 10021 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Vet Affairs Med Ctr, Dept Neurol, San Francisco, CA 94143 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Cornell University; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Yoon, SO (corresponding author), Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA.		Yoon, Sung Ok/C-5992-2012; Beattie, Michael S/A-8953-2009		NIA NIH HHS [R01 AG009873, R01 AG09873] Funding Source: Medline; NINDS NIH HHS [NS 39492, R01 NS039472-01A1, R01 NS039472, R01 NS30687, R01 NS038079, R01 NS030687, NS 38079] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030687, R01NS038079, R01NS039492, R01NS039472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG009873] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Beattie MS, 2000, J NEUROTRAUM, V17, P915, DOI 10.1089/neu.2000.17.915; BENGZON J, 1992, BRAIN RES, V587, P338, DOI 10.1016/0006-8993(92)91016-8; Bentley CA, 2000, J NEUROSCI, V20, P7706; Bhat RV, 1996, GLIA, V17, P169; BLIGHT AR, 1993, ADV NEUROL, V59, P91; Brandoli C, 2001, MOL BRAIN RES, V87, P61, DOI 10.1016/S0169-328X(00)00284-9; Calza L, 1997, P NATL ACAD SCI USA, V94, P3368, DOI 10.1073/pnas.94.7.3368; Casha S, 2001, NEUROSCIENCE, V103, P203, DOI 10.1016/S0306-4522(00)00538-8; Chang A, 2000, J NEUROSCI, V20, P6404, DOI 10.1523/JNEUROSCI.20-17-06404.2000; Chao MV, 2002, NEURON, V33, P9, DOI 10.1016/S0896-6273(01)00573-6; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; de Castro R, 2000, NEUROREPORT, V11, P3551, DOI 10.1097/00001756-200011090-00029; DONOVAN MJ, 1995, AM J PATHOL, V147, P309; Dowling P, 1999, NEUROLOGY, V53, P1676, DOI 10.1212/WNL.53.8.1676; ERNFORS P, 1989, NEURON, V2, P1605, DOI 10.1016/0896-6273(89)90049-4; Fahnestock M, 2001, MOL CELL NEUROSCI, V18, P210, DOI 10.1006/mcne.2001.1016; Farhadi HF, 2000, J NEUROSCI, V20, P4059; Frade JM, 1998, NEURON, V20, P35, DOI 10.1016/S0896-6273(00)80432-8; Fuss B, 2000, DEV BIOL, V218, P259, DOI 10.1006/dbio.1999.9574; Giehl KM, 2001, J NEUROSCI, V21, P3492, DOI 10.1523/JNEUROSCI.21-10-03492.2001; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; Hammarberg H, 1998, J COMP NEUROL, V400, P57; Harrington AW, 2002, J NEUROSCI, V22, P156, DOI 10.1523/JNEUROSCI.22-01-00156.2002; Hermann GE, 2001, NEUROBIOL DIS, V8, P590, DOI 10.1006/nbdi.2001.0414; HEUMANN R, 1987, J CELL BIOL, V104, P1623, DOI 10.1083/jcb.104.6.1623; Hisahara S, 1997, J NEUROCHEM, V69, P10; HUBER LJ, 1995, DEV BIOL, V167, P227, DOI 10.1006/dbio.1995.1019; Kim GM, 2001, J NEUROSCI, V21, P6617, DOI 10.1523/JNEUROSCI.21-17-06617.2001; KOLIATSOS VE, 1991, BRAIN RES, V549, P297, DOI 10.1016/0006-8993(91)90471-7; Krenz NR, 2000, J NEUROCHEM, V74, P730, DOI 10.1046/j.1471-4159.2000.740730.x; Ladiwala U, 1998, J NEUROSCI, V18, P1297; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Li GL, 1996, J NEUROPATH EXP NEUR, V55, P280, DOI 10.1097/00005072-199603000-00003; Liu XZ, 1997, J NEUROSCI, V17, P5395; LOUIS JC, 1993, SCIENCE, V259, P689, DOI 10.1126/science.8430320; LUBETZKI C, 1991, J NEUROCHEM, V56, P671, DOI 10.1111/j.1471-4159.1991.tb08202.x; McDonald JW, 1998, NAT MED, V4, P291, DOI 10.1038/nm0398-291; Mowla SJ, 1999, J NEUROSCI, V19, P2069; MUFSON EJ, 1992, P NATL ACAD SCI USA, V89, P569, DOI 10.1073/pnas.89.2.569; Nataf S, 1998, J NEUROSCI RES, V52, P83; Oh JD, 2000, BRAIN RES, V853, P174, DOI 10.1016/S0006-8993(99)02054-5; Park JA, 2000, J NEUROSCI, V20, P9096; Pulford BE, 1999, EXP NEUROL, V159, P114, DOI 10.1006/exnr.1999.7143; Reinshagen M, 2000, J NEUROCHEM, V74, P2127, DOI 10.1046/j.1471-4159.2000.0742127.x; REYNOLDS ME, 1991, BRAIN RES, V559, P149, DOI 10.1016/0006-8993(91)90298-A; RICHARDSON PM, 1984, J NEUROSCI, V4, P1683; Rosen CJ, 1999, J CLIN DENSITOM, V2, P3, DOI 10.1385/JCD:2:1:3; Roux PP, 1999, J NEUROSCI, V19, P6887, DOI 10.1523/JNEUROSCI.19-16-06887.1999; Schnell L, 1999, J NEUROPATH EXP NEUR, V58, P245, DOI 10.1097/00005072-199903000-00004; Sharma HS, 1997, ACT NEUR S, V70, P130; Shuman SL, 1997, J NEUROSCI RES, V50, P798, DOI 10.1002/(SICI)1097-4547(19971201)50:5<798::AID-JNR16>3.0.CO;2-Y; Springer JE, 1999, NAT MED, V5, P943, DOI 10.1038/11387; Syroid DE, 2000, J NEUROSCI, V20, P5741, DOI 10.1523/JNEUROSCI.20-15-05741.2000; TANIUCHI M, 1988, J NEUROSCI, V8, P664; Warden P, 2001, EXP NEUROL, V168, P213, DOI 10.1006/exnr.2000.7622; Widenfalk J, 2001, J NEUROSCI, V21, P3457, DOI 10.1523/JNEUROSCI.21-10-03457.2001; YAO DL, 1995, J NEUROSCI RES, V40, P647, DOI 10.1002/jnr.490400510; YAO DL, 1995, P NATL ACAD SCI USA, V92, P6190, DOI 10.1073/pnas.92.13.6190; Yoon SO, 1998, J NEUROSCI, V18, P3273	61	348	389	1	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 24	2002	36	3					375	386		10.1016/S0896-6273(02)01005-X	http://dx.doi.org/10.1016/S0896-6273(02)01005-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	608ZE	12408842	Green Accepted, Bronze			2022-12-24	WOS:000178877700008
J	Nelson, LE; Guo, TZ; Lu, J; Saper, CB; Franks, NP; Maze, M				Nelson, LE; Guo, TZ; Lu, J; Saper, CB; Franks, NP; Maze, M			The sedative component of anesthesia is mediated by GABA(A) receptors in an endogenous sleep pathway	NATURE NEUROSCIENCE			English	Article							FOS-LIKE IMMUNOREACTIVITY; C-FOS; TUBEROMAMMILLARY NUCLEUS; NITROUS-OXIDE; RAT-BRAIN; NEURONS; PROPOFOL; ACTIVATION; HYPOTHALAMUS; WAKEFULNESS	We investigated the role of regionally discrete GABA (gamma-aminobutyric acid) receptors in the sedative response to pharmacological agents that act on GABA(A) receptors (muscimol, propofol and pentobarbital; 'GABAergic agents') and to ketamine, a general anesthetic that does not affect GABA(A) receptors. Behavioral studies in rats showed that the sedative response to centrally administered GABAergic agents was attenuated by the GABA(A) receptor antagonist gabazine (systemically administered). The sedative response to ketamine, by contrast, was unaffected by gabazine. Using c-Fos as a marker of neuronal activation, we identified a possible role for the tuberomammillary nucleus (TMN): when gabazine was microinjected directly into the TMN, it attenuated the sedative response to GABAergic agents. Furthermore, the GABA(A) receptor agonist muscimol produced a dose-dependent sedation when it was administered into the TMN. We conclude that the TMN is a discrete neural locus that has a key role in the sedative response to GABAergic anesthetics.	Chelsea & Westminster Hosp, Imperial Coll Sch Med, Dept Anaesthet & Intens Care, London SW10 9NH, England; Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, Blackett Lab, Biophys Sect, London SW7 2BW, England; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA	Imperial College London; Imperial College London; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Franks, NP (corresponding author), Chelsea & Westminster Hosp, Imperial Coll Sch Med, Dept Anaesthet & Intens Care, London SW10 9NH, England.	n.franks@ic.ac.uk	Saper, Clifford/L-3815-2019	Franks, Nicholas/0000-0003-4874-4212	NHLBI NIH HHS [HL60292] Funding Source: Medline; NIA NIH HHS [AG09975] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL060292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG009975] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ADODRA S, 1995, BRIT J PHARMACOL, V115, P953, DOI 10.1111/j.1476-5381.1995.tb15903.x; AIRAKSINEN MS, 1992, J COMP NEUROL, V323, P103, DOI 10.1002/cne.903230109; AKAIKE N, 1990, AM J PHYSIOL, V258, pC452, DOI 10.1152/ajpcell.1990.258.3.C452; ALKIRE MT, 1995, ANESTHESIOLOGY, V82, P393, DOI 10.1097/00000542-199502000-00010; ANIS NA, 1983, BRIT J PHARMACOL, V79, P565, DOI 10.1111/j.1476-5381.1983.tb11031.x; BARKER JL, 1973, SCIENCE, V182, P720, DOI 10.1126/science.182.4113.720; Belelli D, 1999, TRENDS PHARMACOL SCI, V20, P496, DOI 10.1016/S0165-6147(99)01405-4; CHENG SC, 1985, ANESTHESIOLOGY, V63, P147, DOI 10.1097/00000542-198508000-00005; Chou TC, 2002, J NEUROSCI, V22, P977, DOI 10.1523/JNEUROSCI.22-03-00977.2002; CIRELLI C, 1993, ARCH ITAL BIOL, V131, P327; Cirelli C, 2000, SLEEP, V23, P453; COLLINGRIDGE GL, 1984, J PHYSIOL-LONDON, V356, P551, DOI 10.1113/jphysiol.1984.sp015482; CORREASALES C, 1992, ANESTHESIOLOGY, V76, P948, DOI 10.1097/00000542-199206000-00013; Depczynski B, 1998, ANN NY ACAD SCI, V863, P120, DOI 10.1111/j.1749-6632.1998.tb10689.x; Devor M, 2001, PAIN, V94, P101, DOI 10.1016/S0304-3959(01)00345-1; Elmquist JK, 1996, J COMP NEUROL, V371, P85, DOI 10.1002/(SICI)1096-9861(19960715)371:1<85::AID-CNE5>3.0.CO;2-H; ERICSON H, 1991, J COMP NEUROL, V305, P462, DOI 10.1002/cne.903050309; Fiset P, 1999, J NEUROSCI, V19, P5506; FRANKS NP, 1994, NATURE, V367, P607, DOI 10.1038/367607a0; Franks NP, 1998, NATURE, V396, P324, DOI 10.1038/24525; GAGE PW, 1985, BRIT J PHARMACOL, V85, P229, DOI 10.1111/j.1476-5381.1985.tb08851.x; Gallopin T, 2000, NATURE, V404, P992, DOI 10.1038/35010109; HALES TG, 1991, BRIT J PHARMACOL, V104, P619, DOI 10.1111/j.1476-5381.1991.tb12479.x; HARA M, 1993, ANESTHESIOLOGY, V79, P781, DOI 10.1097/00000542-199310000-00021; HOFFMAN GE, 1993, FRONT NEUROENDOCRIN, V14, P173, DOI 10.1006/frne.1993.1006; Jevtovic-Todorovic V, 1998, NAT MED, V4, P460, DOI 10.1038/nm0498-460; Krasowski MD, 1999, CELL MOL LIFE SCI, V55, P1278, DOI 10.1007/s000180050371; Lam DW, 1998, BRAIN RES, V784, P179, DOI 10.1016/S0006-8993(97)01334-6; Lin JS, 1996, J NEUROSCI, V16, P1523; LIN JS, 1988, NEUROPHARMACOLOGY, V27, P111, DOI 10.1016/0028-3908(88)90159-1; LIN LH, 1993, J NEUROCHEM, V60, P1548, DOI 10.1111/j.1471-4159.1993.tb03320.x; MONTI JM, 1993, LIFE SCI, V53, P1331, DOI 10.1016/0024-3205(93)90592-Q; Nitz D, 1996, AM J PHYSIOL-REG I, V271, pR1707, DOI 10.1152/ajpregu.1996.271.6.R1707; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pompeiano M, 1995, NEUROPHYSIOL CLIN, V25, P329, DOI 10.1016/0987-7053(96)84906-9; SAPER CB, 1985, J COMP NEUROL, V237, P21, DOI 10.1002/cne.902370103; Sawamura S, 2000, J NEUROSCI, V20, P9242; Sherin JE, 1998, J NEUROSCI, V18, P4705; Sherin JE, 1996, SCIENCE, V271, P216, DOI 10.1126/science.271.5246.216; Steininger TL, 1999, BRAIN RES, V840, P138, DOI 10.1016/S0006-8993(99)01648-0; Steininger TL, 2001, J COMP NEUROL, V429, P638; Stell BM, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-10-j0003.2002; TANELIAN DL, 1993, ANESTHESIOLOGY, V78, P757, DOI 10.1097/00000542-199304000-00020; VILLAR MJ, 1990, NEUROSCIENCE, V36, P181, DOI 10.1016/0306-4522(90)90361-7; WAUD DR, 1972, J PHARMACOL EXP THER, V183, P577	45	422	436	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2002	5	10					979	984		10.1038/nn913	http://dx.doi.org/10.1038/nn913			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	597VV	12195434				2022-12-24	WOS:000178242200017
J	Tadin, D; Lappin, JS; Blake, R; Grossman, ED				Tadin, D; Lappin, JS; Blake, R; Grossman, ED			What constitutes an efficient reference frame for vision?	NATURE NEUROSCIENCE			English	Article							BIOLOGICAL MOTION PERCEPTION; EYE-MOVEMENTS; VISUAL-MOTION; IMAGE SEGMENTATION; SPACE; CORTEX; MODEL; COHERENCE; RESPONSES; CONTRAST	Vision requires a reference frame. To what extent does this reference frame depend on the structure of the visual input, rather than just on retinal landmarks? This question is particularly relevant to the perception of dynamic scenes, when keeping track of external motion relative to the retina is difficult. We tested human subjects' ability to discriminate the motion and temporal coherence of changing elements that were embedded in global patterns and whose perceptual organization was manipulated in a way that caused only minor changes to the retinal image. Coherence discriminations were always better when local elements were perceived to be organized as a global moving form than when they were perceived to be unorganized, individually moving entities. Our results indicate that perceived form influences the neural representation of its component features, and from this, we propose a new method for studying perceptual organization.	Vanderbilt Univ, Vanderbilt Vis Res Ctr, Nashville, TN 37203 USA	Vanderbilt University	Tadin, D (corresponding author), Vanderbilt Univ, Vanderbilt Vis Res Ctr, 301 Wilson Hall,111 21st Ave S, Nashville, TN 37203 USA.			Tadin, Duje/0000-0003-1571-5589	NEI NIH HHS [T32-EY07135, EY07760, P30-EY08126, P30 EY008126, R01 EY007760, T32 EY007135] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY007760, T32EY007135, P30EY008126] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Battaglia-Mayer A, 2000, J NEUROPHYSIOL, V83, P2374, DOI 10.1152/jn.2000.83.4.2374; Blake R, 1997, P NATL ACAD SCI USA, V94, P7115, DOI 10.1073/pnas.94.13.7115; Boussaoud D, 1999, EXP BRAIN RES, V128, P170, DOI 10.1007/s002210050832; Bradley DC, 1996, SCIENCE, V273, P1544, DOI 10.1126/science.273.5281.1544; Brainard D. H., 1997, SPATIAL VISION, V10, P443, DOI DOI 10.1163/156856897X00357; Buneo CA, 2002, NATURE, V416, P632, DOI 10.1038/416632a; Cavanagh P, 2001, COGNITION, V80, P47, DOI 10.1016/S0010-0277(00)00153-0; CRAIK FIM, 1975, J EXP PSYCHOL GEN, V104, P268, DOI 10.1037/0096-3445.104.3.268; Croner LJ, 1997, VISION RES, V37, P1415, DOI 10.1016/S0042-6989(96)00299-4; Croner LJ, 1999, J NEUROSCI, V19, P3935; Crowell JA, 1998, NAT NEUROSCI, V1, P732, DOI 10.1038/3732; DAY RH, 1971, NATURE, V230, P55, DOI 10.1038/230055a0; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; FOX R, 1982, SCIENCE, V218, P486, DOI 10.1126/science.7123249; Gibson JJ, 1950, PERCEPTION VISUAL WO; Haarmeier T, 1997, NATURE, V389, P849, DOI 10.1038/39872; Haarmeier T, 2001, NEURON, V32, P527, DOI 10.1016/S0896-6273(01)00486-X; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; JOHANSSON G, 1994, PERCEIVING EVENTS AND OBJECTS, P29; Lappin JS, 2000, PSYCHOL REV, V107, P6, DOI 10.1037/0033-295X.107.1.6; Lappin JS, 2001, VISION RES, V41, P1631, DOI 10.1016/S0042-6989(01)00035-9; Lee SH, 1999, SCIENCE, V284, P1165, DOI 10.1126/science.284.5417.1165; LEGGE GE, 1981, VISION RES, V21, P205, DOI 10.1016/0042-6989(81)90114-0; Lorenceau J, 2001, NAT NEUROSCI, V4, P745, DOI 10.1038/89543; LORENCEAU J, 1992, VISION RES, V32, P263, DOI 10.1016/0042-6989(92)90137-8; MARR D, 1981, P R SOC LOND B, V211, P150; MORGAN MJ, 1982, Q J EXP PSYCHOL-A, V34, P211, DOI 10.1080/14640748208400837; MURAKAMI I, 1995, VISION RES, V35, P1835, DOI 10.1016/0042-6989(94)00269-R; NAKAYAMA K, 1978, VISION RES, V18, P1663, DOI 10.1016/0042-6989(78)90258-4; NAWROT M, 1990, VISION RES, V30, P1439, DOI 10.1016/0042-6989(90)90025-G; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Pavlova M, 2000, PERCEPT PSYCHOPHYS, V62, P889, DOI 10.3758/BF03212075; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; QUICK RF, 1974, KYBERNETIK, V16, P65, DOI 10.1007/BF00271628; Regan David, 2000, HUMAN PERCEPTION OBJ; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Snyder LH, 2000, CURR OPIN NEUROBIOL, V10, P747, DOI 10.1016/S0959-4388(00)00152-5; SOECHTING JF, 1992, ANNU REV NEUROSCI, V15, P167, DOI 10.1146/annurev.ne.15.030192.001123; Turano KA, 1999, VISION RES, V39, P1177, DOI 10.1016/S0042-6989(98)00174-6; Vaina LM, 2001, P NATL ACAD SCI USA, V98, P11656, DOI 10.1073/pnas.191374198; Verghese P, 1996, NATURE, V381, P161, DOI 10.1038/381161a0; Wade NJ, 1996, PERCEPTION, V25, P187, DOI 10.1068/p250187; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1314, DOI 10.3758/BF03194545; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544	44	49	49	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2002	5	10					1010	1015		10.1038/nn914	http://dx.doi.org/10.1038/nn914			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	597VV	12219092	Green Accepted			2022-12-24	WOS:000178242200021
J	Kotecha, SA; Oak, JN; Jackson, MF; Perez, Y; Orser, BA; Van Tol, HHM; MacDonald, JF				Kotecha, SA; Oak, JN; Jackson, MF; Perez, Y; Orser, BA; Van Tol, HHM; MacDonald, JF			A D2 class dopamine receptor transactivates a receptor tyrosine kinase to inhibit NMDA receptor transmission	NEURON			English	Article							LONG-TERM POTENTIATION; GROWTH-FACTOR RECEPTOR; PROTEIN-COUPLED RECEPTORS; CALCIUM-DEPENDENT INACTIVATION; SIGNAL-REGULATED KINASE; SYNAPTIC-TRANSMISSION; PREFRONTAL CORTEX; HIPPOCAMPAL-FORMATION; EGF RECEPTOR; RAT	Receptor tyrosine kinases (RTKs) are membrane spanning proteins with intrinsic kinase activity. Although these receptors are known to be involved in proliferation and differentiation of cells, their roles in regulating central synaptic transmission are largely unknown. In CA1 pyramidal neurons, activation of D2 class dopamine receptors depressed excitatory transmission mediated by the NMDA subtype of glutamate receptor. This depression resulted from the quinpirole-induced release of intracellular Ca2+ and enhanced Ca2+-dependent inactivation of NMDA receptors. The dopamine receptor-mediated depression was dependent on the "transactivation" of PDGFRbeta. Therefore, RTK transactivation provides a novel mechanism of communication between dopaminergic and glutamatergic systems and might help to explain how,reciprocal changes in these systems could be linked to the deficits in cognition, memory, and attention observed in schizophrenia and attention deficit hyperactivity disorder.	Univ Toronto, Fac Med, Dept Physiol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Fac Med, Dept Pharmacol, Toronto, ON, Canada; Univ Toronto, Fac Med, Dept Psychiat, Toronto, ON M5S 1A1, Canada; Univ Toronto, Fac Med, Dept Anesthesiol, Toronto, ON, Canada; Univ Toronto, Fac Med, Inst Med Sci, Toronto, ON, Canada; Univ Toronto, Fac Med, Ctr Addict & Mental Hlth, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada	MacDonald, JF (corresponding author), Univ Toronto, Fac Med, Dept Physiol, Toronto, ON M5S 1A8, Canada.	j.macdonald@utoronto.ca	Jackson, Mike/H-5573-2012	Jackson, Mike/0000-0002-4730-201X	NHLBI NIH HHS [T32 HL007572] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABE K, 1992, BRAIN RES, V587, P102, DOI 10.1016/0006-8993(92)91433-F; AMSTEN AF, 2000, NEUROPSYCHOPHARMACOL, V23, P405; Barkley RA, 1998, SCI AM, V279, P66, DOI 10.1038/scientificamerican0998-66; Blank T, 1997, P NATL ACAD SCI USA, V94, P14859, DOI 10.1073/pnas.94.26.14859; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Calabresi P, 1997, J NEUROSCI, V17, P4536; Castro NG, 1999, BRIT J PHARMACOL, V126, P1847, DOI 10.1038/sj.bjp.0702479; CLAESSONWELSH L, 1994, J BIOL CHEM, V269, P32023; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; Defagot MC, 2000, J NEUROSCI RES, V59, P202, DOI 10.1002/(SICI)1097-4547(20000115)59:2<202::AID-JNR6>3.3.CO;2-X; Della Rocca GJ, 1999, J BIOL CHEM, V274, P13978, DOI 10.1074/jbc.274.20.13978; DESCARRIES L, 1987, NEUROSCIENCE, V21, P807, DOI 10.1016/0306-4522(87)90038-8; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; GASBARRI A, 1994, BRAIN RES, V668, P71, DOI 10.1016/0006-8993(94)90512-6; Gurden H, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0003.2000; Gutkind JS, 1998, J BIOL CHEM, V273, P1839, DOI 10.1074/jbc.273.4.1839; Hall RA, 1999, J CELL BIOL, V145, P927, DOI 10.1083/jcb.145.5.927; HARVEY J, 1993, NEUROSCI LETT, V162, P165, DOI 10.1016/0304-3940(93)90586-A; Heldin CH, 1998, BIOCHIM BIOPHYS ACTA, V1378, P79; Hernandez-Lopez S, 2000, J NEUROSCI, V20, P8987; Herrlich A, 1998, P NATL ACAD SCI USA, V95, P8985, DOI 10.1073/pnas.95.15.8985; Hsu KS, 1996, J NEUROPHYSIOL, V76, P1887, DOI 10.1152/jn.1996.76.3.1887; Huang YQ, 2001, NEURON, V29, P485, DOI 10.1016/S0896-6273(01)00220-3; HUANG YY, 1995, P NATL ACAD SCI USA, V92, P2446, DOI 10.1073/pnas.92.7.2446; INGLESE J, 1994, P NATL ACAD SCI USA, V91, P3637, DOI 10.1073/pnas.91.9.3637; Jentsch JD, 1999, NEUROPSYCHOPHARMACOL, V20, P201, DOI 10.1016/S0893-133X(98)00060-8; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Kotecha SA, 1997, J COMP NEUROL, V386, P277; Krupp JJ, 1999, J NEUROSCI, V19, P1165; LAWTHO D, 1994, NEUROSCI RES, V21, P151, DOI 10.1016/0168-0102(94)90157-0; Lei SB, 1999, J BIOL CHEM, V274, P30617, DOI 10.1074/jbc.274.43.30617; Lewis DA, 2000, NEURON, V28, P325, DOI 10.1016/S0896-6273(00)00111-2; Lu WY, 2000, J NEUROSCI, V20, P4452, DOI 10.1523/JNEUROSCI.20-12-04452.2000; Lu WY, 1999, NAT NEUROSCI, V2, P331, DOI 10.1038/7243; Lu WY, 1998, J PHYSIOL-LONDON, V512, P29, DOI 10.1111/j.1469-7793.1998.029bf.x; Luttrell LM, 1999, CURR OPIN CELL BIOL, V11, P177, DOI 10.1016/S0955-0674(99)80023-4; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Man HY, 2000, CELL MOL LIFE SCI, V57, P1526, DOI 10.1007/PL00000637; MCBAIN CJ, 1994, PHYSIOL REV, V74, P723, DOI 10.1152/physrev.1994.74.3.723; MEADORWOODRUFF JH, 1994, NEUROPSYCHOPHARMACOL, V10, P239, DOI 10.1038/npp.1994.27; Mohn AR, 1999, CELL, V98, P427, DOI 10.1016/S0092-8674(00)81972-8; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; Oak JN, 2001, MOL PHARMACOL, V60, P92, DOI 10.1124/mol.60.1.92; Oak JN, 2000, EUR J PHARMACOL, V405, P303, DOI 10.1016/S0014-2999(00)00562-8; Otani S, 1998, NEUROSCIENCE, V85, P669, DOI 10.1016/S0306-4522(97)00677-5; Otmakhova NA, 1999, J NEUROSCI, V19, P1437; Peavy RD, 2001, J NEUROSCI, V21, P9619, DOI 10.1523/JNEUROSCI.21-24-09619.2001; Pierce KL, 2000, P NATL ACAD SCI USA, V97, P1489, DOI 10.1073/pnas.97.4.1489; POPOV N, 1988, J HIRNFORSCH, V29, P473; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; ROSENMUND C, 1993, NEURON, V10, P805, DOI 10.1016/0896-6273(93)90197-Y; Sawutz DG, 1996, BIOCHEM PHARMACOL, V51, P1631, DOI 10.1016/0006-2952(96)00112-8; Seamans JK, 2001, P NATL ACAD SCI USA, V98, P301, DOI 10.1073/pnas.011518798; SEEMAN P, 1994, TRENDS PHARMACOL SCI, V15, P264, DOI 10.1016/0165-6147(94)90323-9; Snyder GL, 1998, J NEUROSCI, V18, P10297; Swanson J, 1998, CURR OPIN NEUROBIOL, V8, P263, DOI 10.1016/S0959-4388(98)80150-5; Todd RD, 2001, TRENDS PHARMACOL SCI, V22, P55, DOI 10.1016/S0165-6147(00)01612-6; Uchida S, 2000, NEUROPHARMACOLOGY, V39, P191, DOI 10.1016/S0028-3908(99)00111-2; Umemiya M, 1997, J NEUROPHYSIOL, V78, P1248, DOI 10.1152/jn.1997.78.3.1248; Valenzuela CF, 1997, BRAIN RES REV, V24, P77; Valenzuela CF, 1996, J BIOL CHEM, V271, P16151, DOI 10.1074/jbc.271.27.16151; WANG LY, 1995, J PHYSIOL-LONDON, V486, P83, DOI 10.1113/jphysiol.1995.sp020792; Weickert TW, 2000, ARCH GEN PSYCHIAT, V57, P907, DOI 10.1001/archpsyc.57.9.907; Weinberger DR, 1999, BIOL PSYCHIAT, V45, P395, DOI 10.1016/S0006-3223(98)00331-X; Zhang S, 1998, NEURON, V21, P443, DOI 10.1016/S0896-6273(00)80553-X; Zheng P, 1999, NEUROSCIENCE, V91, P527, DOI 10.1016/S0306-4522(98)00604-6	67	178	184	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 12	2002	35	6					1111	1122		10.1016/S0896-6273(02)00859-0	http://dx.doi.org/10.1016/S0896-6273(02)00859-0			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	594GC	12354400	Bronze			2022-12-24	WOS:000178040000011
J	Kim, AH; Yano, H; Cho, H; Meyer, D; Monks, B; Margolis, B; Birnbaum, MJ; Chao, MV				Kim, AH; Yano, H; Cho, H; Meyer, D; Monks, B; Margolis, B; Birnbaum, MJ; Chao, MV			Akt1 regulates a JNK scaffold during excitotoxic apoptosis	NEURON			English	Article							ACTIVATED PROTEIN-KINASE; N-TERMINAL KINASE; PROMOTES CELL-SURVIVAL; SIGNAL-TRANSDUCTION; FUNCTIONAL DOMAINS; GLUTAMATE; GROWTH; DEATH; PHOSPHORYLATION; TRANSCRIPTION	Cell survival is determined by a balance among signaling cascades, including those that recruit the Akt and JNK pathways. Here we describe a novel interaction between Akt1 and JNK interacting protein 1 (JIP1), a JNK pathway scaffold. Direct association between Akt1 and JIP1 was observed in primary neurons. Neuronal exposure to an excitotoxic stimulus decreased the Akt1 -JIP1 interaction and concomitantly increased association between JIP1 and JNK. Akt1 interaction with JIP1 inhibited JIP1-mediated potentiation of JNK activity by decreasing JIP1 binding to specific JNK pathway kinases. Consistent with this view, neurons from Akt1-deficient mice exhibited higher susceptibility to kainate than wild-type littermates. Overexpression of Akt1 mutants that bind JIP1 reduced excitotoxic apoptosis. These results suggest that Akt1 binding to JIP1 acts as a regulatory gate preventing JNK activation, which is released under conditions of excitotoxic injury.	NYU, Sch Med, Mol Neurobiol Program, Skirball Inst Biomol Med, New York, NY 10016 USA; Univ Michigan, Howard Hughes Med Inst, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Penn, Sch Med, Howard Hughes Med Inst, Dept Internal Med, Philadelphia, PA 19104 USA	New York University; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Pennsylvania	Chao, MV (corresponding author), NYU, Sch Med, Mol Neurobiol Program, Skirball Inst Biomol Med, New York, NY 10016 USA.	chao@saturn.med.nyu.edu	Kim, Albert H./HGF-0057-2022	Chao, Moses/0000-0002-6969-3744; Birnbaum, Morris/0000-0001-9972-8680	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD023315] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA056490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021072] Funding Source: NIH RePORTER; NCI NIH HHS [CA56490] Funding Source: Medline; NICHD NIH HHS [HD23315] Funding Source: Medline; NINDS NIH HHS [NS21072] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahmed NN, 1997, P NATL ACAD SCI USA, V94, P3627, DOI 10.1073/pnas.94.8.3627; Behrens A, 1999, NAT GENET, V21, P326, DOI 10.1038/6854; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Bock BC, 2000, J BIOL CHEM, V275, P14231, DOI 10.1074/jbc.275.19.14231; Bonny C, 1998, J BIOL CHEM, V273, P1843, DOI 10.1074/jbc.273.4.1843; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Cerezo A, 1998, MOL BIOL CELL, V9, P3107, DOI 10.1091/mbc.9.11.3107; Cheng JK, 2000, MOL CELL BIOL, V20, P2334, DOI 10.1128/MCB.20.7.2334-2342.2000; CHENG JQ, 1992, P NATL ACAD SCI USA, V89, P9267, DOI 10.1073/pnas.89.19.9267; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; DATTA K, 1995, MOL CELL BIOL, V15, P2304; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; DeCoster MA, 1998, J NEUROSCI RES, V53, P297, DOI 10.1002/(SICI)1097-4547(19980801)53:3<297::AID-JNR3>3.0.CO;2-5; DEL PL, 1997, SCIENCE, V278, P687; Dickens M, 1997, SCIENCE, V277, P693, DOI 10.1126/science.277.5326.693; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Eilers A, 2001, J NEUROCHEM, V76, P1439, DOI 10.1046/j.1471-4159.2001.00150.x; Elion EA, 2000, CURR OPIN MICROBIOL, V3, P573, DOI 10.1016/S1369-5274(00)00143-0; FERKANY JW, 1984, NATURE, V308, P561, DOI 10.1038/308561a0; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Harding TC, 2001, J BIOL CHEM, V276, P4531, DOI 10.1074/jbc.C000815200; Hetman M, 2000, J NEUROSCI, V20, P2567; Holland PM, 1997, J BIOL CHEM, V272, P24994, DOI 10.1074/jbc.272.40.24994; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Ito M, 1999, MOL CELL BIOL, V19, P7539; Kelkar N, 2000, MOL CELL BIOL, V20, P1030, DOI 10.1128/MCB.20.3.1030-1043.2000; Kerchner GA, 1999, HANDB EXP PHARM, V141, P443; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Kim AH, 2000, BRAIN RES, V886, P99, DOI 10.1016/S0006-8993(00)02944-9; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; KOH JY, 1990, J NEUROSCI, V10, P693; Lawlor MA, 2001, J CELL SCI, V114, P2903; Meyer D, 1999, J BIOL CHEM, V274, P35113, DOI 10.1074/jbc.274.49.35113; NAKANISHI S, 1994, ANNU REV BIOPH BIOM, V23, P319, DOI 10.1146/annurev.bb.23.060194.001535; Negri S, 2000, GENOMICS, V64, P324, DOI 10.1006/geno.2000.6129; Nihalani D, 2000, J BIOL CHEM, V275, P7273, DOI 10.1074/jbc.275.10.7273; Okubo Y, 1998, J BIOL CHEM, V273, P25961, DOI 10.1074/jbc.273.40.25961; Park HS, 2002, J BIOL CHEM, V277, P2573, DOI 10.1074/jbc.M110299200; Pellet JB, 2000, EUR J NEUROSCI, V12, P621, DOI 10.1046/j.1460-9568.2000.00945.x; POLLARD H, 1994, NEUROREPORT, V5, P1053, DOI 10.1097/00001756-199405000-00009; Rameau GA, 2000, NEUROPHARMACOLOGY, V39, P2255, DOI 10.1016/S0028-3908(00)00066-6; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Sarmiere PD, 2001, MOL CELL NEUROSCI, V18, P320, DOI 10.1006/mcne.2001.1021; Savinainen A, 2001, J BIOL CHEM, V276, P11382, DOI 10.1074/jbc.M100190200; SCHREIBER SS, 1993, J MOL NEUROSCI, V4, P149, DOI 10.1007/BF02782498; Schwarzschild MA, 1997, J NEUROSCI, V17, P3455; Tibbles LA, 1996, EMBO J, V15, P7026, DOI 10.1002/j.1460-2075.1996.tb01094.x; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Whitmarsh AJ, 1998, SCIENCE, V281, P1671, DOI 10.1126/science.281.5383.1671; Whitmarsh AJ, 2001, GENE DEV, V15, P2421, DOI 10.1101/gad.922801; Xia Y, 1998, GENE DEV, V12, P3369, DOI 10.1101/gad.12.21.3369; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147; Yasuda J, 1999, MOL CELL BIOL, V19, P7245	61	175	180	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 15	2002	35	4					697	709		10.1016/S0896-6273(02)00821-8	http://dx.doi.org/10.1016/S0896-6273(02)00821-8			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	585JE	12194869	Bronze			2022-12-24	WOS:000177521000010
J	DiGregorio, DA; Nusser, Z; Silver, RA				DiGregorio, DA; Nusser, Z; Silver, RA			Spillover of glutamate onto synaptic AMPA receptors enhances fast transmission at a cerebellar synapse	NEURON			English	Article							BETA-HYDROXYASPARTATE DERIVATIVES; PURKINJE-CELL SYNAPSES; MULTIPLE RELEASE SITES; TIME-COURSE; GRANULE CELLS; NMDA RECEPTORS; CLIMBING FIBER; PARALLEL FIBER; RAT; CURRENTS	Diffusion of glutamate from the synaptic cleft can activate high-affinity receptors, but is not thought to contribute to fast AMPA receptor-mediated transmission. Here, we show that single AMPA receptor EPSCs at the cerebellar mossy fiber-granule cell connection are mediated by both direct release of glutamate and rapid diffusion of glutamate from neighboring synapses. Immunogold localization revealed that AMPA receptors are located exclusively in postsynaptic densities, indicating that spillover of glutamate occurs between synaptic contacts. Spillover currents contributed half the synaptic charge and exhibited little trial-to-trial variability. We propose that spillover of glutamate improves transmission efficacy by both increasing the amplitude and duration of the EPSP and reducing fluctuations arising from the probabilistic nature of transmitter release.	UCL, Dept Physiol, London WC1E 6BT, England; Hungarian Acad Sci, Inst Expt Med, Lab Cellular Neurophysiol, H-1083 Budapest, Hungary	University of London; University College London; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine	Silver, RA (corresponding author), UCL, Dept Physiol, Gower St, London WC1E 6BT, England.	a.silver@ucl.ac.uk	Nusser, Zoltan/K-8587-2014	Silver, Robin/0000-0002-5480-6638; Nusser, Zoltan/0000-0001-7004-4111				Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; BARBOUR B, 1994, NEURON, V12, P1331, DOI 10.1016/0896-6273(94)90448-0; Barbour B, 1997, TRENDS NEUROSCI, V20, P377; Brickley SG, 2001, NATURE, V409, P88, DOI 10.1038/35051086; Bureau I, 2000, P NATL ACAD SCI USA, V97, P6838, DOI 10.1073/pnas.97.12.6838; Carter AG, 2000, J NEUROSCI, V20, P4423, DOI 10.1523/JNEUROSCI.20-12-04423.2000; Chen S, 2002, J NEUROSCI, V22, P2165, DOI 10.1523/JNEUROSCI.22-06-02165.2002; Choi S, 2000, NAT NEUROSCI, V3, P330, DOI 10.1038/73895; Clements JD, 1996, TRENDS NEUROSCI, V19, P163, DOI 10.1016/S0166-2236(96)10024-2; DANGELO E, 1995, J PHYSIOL-LONDON, V484, P397, DOI 10.1113/jphysiol.1995.sp020673; Diamond JS, 1997, J NEUROSCI, V17, P4672; Eccles J.C., 1967, CEREBELLUM COMPUTATI; FABER DS, 1988, P NATL ACAD SCI USA, V85, P8708, DOI 10.1073/pnas.85.22.8708; Fricker D, 2000, NEURON, V28, P559, DOI 10.1016/S0896-6273(00)00133-1; Galarreta M, 2001, SCIENCE, V292, P2295, DOI 10.1126/science.1061395; Geiger JRP, 1997, NEURON, V18, P1009, DOI 10.1016/S0896-6273(00)80339-6; HAMORI J, 1983, J COMP NEUROL, V220, P365, DOI 10.1002/cne.902200402; Harsch A, 2000, J NEUROSCI, V20, P6181, DOI 10.1523/JNEUROSCI.20-16-06181.2000; HARTZELL HC, 1975, J PHYSIOL-LONDON, V251, P427, DOI 10.1113/jphysiol.1975.sp011102; Hausser M, 1997, J NEUROSCI, V17, P7606; HESTRIN S, 1992, NEURON, V9, P991, DOI 10.1016/0896-6273(92)90250-H; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Isaacson JS, 1999, NEURON, V23, P377, DOI 10.1016/S0896-6273(00)80787-4; JAKAB RL, 1988, ANAT EMBRYOL, V179, P81, DOI 10.1007/BF00305102; Li P, 1999, NATURE, V397, P161, DOI 10.1038/16469; Maex R, 1998, J NEUROPHYSIOL, V80, P2521, DOI 10.1152/jn.1998.80.5.2521; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Matsubara A, 1996, J NEUROSCI, V16, P4457; MENNERICK S, 1995, J NEUROSCI, V15, P3178; Mitchell SJ, 2000, NATURE, V404, P498, DOI 10.1038/35006649; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; NUSSER Z, 1995, EUR J NEUROSCI, V7, P630, DOI 10.1111/j.1460-9568.1995.tb00667.x; Otis TS, 1996, J NEUROSCI, V16, P1634, DOI 10.1523/jneurosci.16-05-01634.1996; Overstreet LS, 1999, J NEUROSCI, V19, P9663; Palay SL, 1974, CEREBELLAR CORTEX CO; Renger JJ, 2001, NEURON, V29, P469, DOI 10.1016/S0896-6273(01)00219-7; Rossi DJ, 1998, NEURON, V20, P783, DOI 10.1016/S0896-6273(00)81016-8; Roth A, 2001, J PHYSIOL-LONDON, V535, P445, DOI 10.1111/j.1469-7793.2001.00445.x; Rusakov DA, 2001, BIOPHYS J, V81, P1947, DOI 10.1016/S0006-3495(01)75846-8; SARANTIS M, 1993, NEURON, V11, P541, DOI 10.1016/0896-6273(93)90158-N; Scanziani M, 1997, NATURE, V385, P630, DOI 10.1038/385630a0; SHEPPARD GM, 1998, SYNAPTIC ORG BRAIN; Shigeri Y, 2001, J NEUROCHEM, V79, P297, DOI 10.1046/j.1471-4159.2001.00588.x; Shimamoto K, 2000, BIOORG MED CHEM LETT, V10, P2407, DOI 10.1016/S0960-894X(00)00487-X; Silver RA, 1996, J PHYSIOL-LONDON, V493, P167, DOI 10.1113/jphysiol.1996.sp021372; SILVER RA, 1992, NATURE, V355, P163, DOI 10.1038/355163a0; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; Silver RA, 1996, J PHYSIOL-LONDON, V494, P231, DOI 10.1113/jphysiol.1996.sp021487; Smith TC, 1999, J PHYSIOL-LONDON, V517, P51, DOI 10.1111/j.1469-7793.1999.0051z.x; TAKAHASHI M, 1995, J NEUROSCI, V15, P5693; TRUSSELL LO, 1993, NEURON, V10, P1185, DOI 10.1016/0896-6273(93)90066-Z; TYRRELL T, 1992, PHILOS T ROY SOC B, V336, P239, DOI 10.1098/rstb.1992.0059; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Wahl LM, 1996, J NEUROPHYSIOL, V75, P597, DOI 10.1152/jn.1996.75.2.597; Walmsley B, 1998, TRENDS NEUROSCI, V21, P81, DOI 10.1016/S0166-2236(97)01170-3; WILDING TJ, 1995, MOL PHARMACOL, V47, P582	56	177	178	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	AUG 1	2002	35	3					521	533		10.1016/S0896-6273(02)00787-0	http://dx.doi.org/10.1016/S0896-6273(02)00787-0			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	582CB	12165473	Bronze			2022-12-24	WOS:000177331200012
J	Muzio, L; DiBenedetto, B; Stoykova, A; Boncinelli, E; Gruss, P; Mallamaci, A				Muzio, L; DiBenedetto, B; Stoykova, A; Boncinelli, E; Gruss, P; Mallamaci, A			Conversion of cerebral cortex into basal ganglia in Emx2(-/-) Pax6(Sey/Sey) double-mutant mice	NATURE NEUROSCIENCE			English	Article							DORSAL TELENCEPHALON; TRANSCRIPTION FACTOR; AREA IDENTITY; GENE; MOUSE; NEURONS; EMX2; EXPRESSION; PAX6; HOMEODOMAIN	The molecular mechanisms that activate morphogenesis of cerebral cortex are currently the subject of intensive experimental analysis. Transcription factor genes of the homeobox, basic helix-loop-helix (bHLH) and zinc-finger families have recently been shown to have essential roles in this process. However, the actual selector genes activating corticogenesis have not yet been identified. Here we show that high-level expression of at least one functional allele of either of the homeobox genes Emx2 or Pax6 in the dorsal telencephalon is necessary and sufficient to stably activate morphogenesis of cerebral cortex and to repress that of adjacent structures, such as striatum.	Ist Sci H San Raffaele, Dept Biol & Technol Res DIBIT, I-20132 Milan, Italy; Max Planck Inst Biophys Chem, D-37018 Gottingen, Germany; Scuola Int Super Studi Avanzati, I-34014 Trieste, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Max Planck Society; International School for Advanced Studies (SISSA)	Mallamaci, A (corresponding author), Ist Sci H San Raffaele, Dept Biol & Technol Res DIBIT, Via Olgettina 58, I-20132 Milan, Italy.	mallamaci.antonio@hsr.it	Di Benedetto, Barbara/B-7190-2016; Muzio, Luca/AAB-2308-2022; Mallamaci, Antonello/A-2975-2015; Di Benedetto, Barbara/E-2315-2013	Di Benedetto, Barbara/0000-0001-6537-9072; Muzio, Luca/0000-0002-1068-865X; Mallamaci, Antonello/0000-0002-3621-1307; 				Ajiro K, 1996, J BIOL CHEM, V271, P13197, DOI 10.1074/jbc.271.22.13197; Bishop KM, 2000, SCIENCE, V288, P344, DOI 10.1126/science.288.5464.344; Briata P, 1996, MECH DEVELOP, V57, P169, DOI 10.1016/0925-4773(96)00544-8; Bulchand S, 2001, MECH DEVELOP, V100, P165, DOI 10.1016/S0925-4773(00)00515-3; Bulfone A, 1999, MECH DEVELOP, V84, P133, DOI 10.1016/S0925-4773(99)00053-2; Caric D, 1997, DEVELOPMENT, V124, P5087; Chapouton P, 1999, DEVELOPMENT, V126, P5569; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Corbin JG, 2000, DEVELOPMENT, V127, P5007; Dou CL, 1999, CEREB CORTEX, V9, P543, DOI 10.1093/cercor/9.6.543; ERICSON J, 1995, CELL, V81, P747, DOI 10.1016/0092-8674(95)90536-7; Fode C, 2000, GENE DEV, V14, P67; FRANTZ GD, 1994, J NEUROSCI, V14, P5725; Furuta Y, 1997, DEVELOPMENT, V124, P2203; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Grove EA, 1998, DEVELOPMENT, V125, P2315; HALL PA, 1990, CELL TISSUE KINET, V23, P505, DOI 10.1111/j.1365-2184.1990.tb01343.x; Hallonet M, 1998, DEVELOPMENT, V125, P2599; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; Inoue T, 2001, DEVELOPMENT, V128, P561; Kohtz JD, 1998, DEVELOPMENT, V125, P5079; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Lee SMK, 2000, DEVELOPMENT, V127, P457; Mallamaci A, 1998, MECH DEVELOP, V77, P165, DOI 10.1016/S0925-4773(98)00141-5; Mallamaci A, 1996, MECH DEVELOP, V58, P165, DOI 10.1016/S0925-4773(96)00571-0; Mallamaci A, 2000, NAT NEUROSCI, V3, P679, DOI 10.1038/76630; Mallamaci A, 2000, J NEUROSCI, V20, P1109, DOI 10.1523/JNEUROSCI.20-03-01109.2000; Marin O, 2000, J NEUROSCI, V20, P6063; Marin O, 2001, SCIENCE, V293, P872, DOI 10.1126/science.1061891; Monuki ES, 2001, NEURON, V32, P591, DOI 10.1016/S0896-6273(01)00504-9; Muzio L, 2002, CEREB CORTEX, V12, P129, DOI 10.1093/cercor/12.2.129; Pellegrini M, 1996, DEVELOPMENT, V122, P3893; Shimamura K, 1997, DEVELOPMENT, V124, P2709; SIMEONE A, 1993, EMBO J, V12, P2735, DOI 10.1002/j.1460-2075.1993.tb05935.x; Stoykova A, 2000, J NEUROSCI, V20, P8042; Stoykova A, 1997, DEVELOPMENT, V124, P3765; Sussel L, 1999, DEVELOPMENT, V126, P3359; Takahashi T, 1996, J NEUROSCI, V16, P5762; Tarabykin V, 2001, DEVELOPMENT, V128, P1983; Theil T, 1999, DEVELOPMENT, V126, P3561; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tole S, 2000, J NEUROSCI, V20, P2618; Tole S, 2000, DEV BIOL, V217, P254, DOI 10.1006/dbio.1999.9509; Toresson H, 2000, DEVELOPMENT, V127, P4361; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Warren N, 1999, CEREB CORTEX, V9, P627, DOI 10.1093/cercor/9.6.627; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Wichterle H, 1999, NAT NEUROSCI, V2, P461, DOI 10.1038/8131; Yoshida M, 1997, DEVELOPMENT, V124, P101; Yun K, 2001, DEVELOPMENT, V128, P193	50	129	130	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2002	5	8					737	745		10.1038/nn892	http://dx.doi.org/10.1038/nn892			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	577XT	12118260	Green Published			2022-12-24	WOS:000177088900016
J	Meng, YH; Zhang, Y; Tregoubov, V; Janus, C; Cruz, L; Jackson, M; Lu, WY; MacDonald, JF; Wang, JY; Falls, DL; Jial, ZP				Meng, YH; Zhang, Y; Tregoubov, V; Janus, C; Cruz, L; Jackson, M; Lu, WY; MacDonald, JF; Wang, JY; Falls, DL; Jial, ZP			Abnormal spine morphology and enhanced LTP in LIMK-1 knockout mice	NEURON			English	Article							LONG-TERM POTENTIATION; PROTEIN-KINASE; SYNAPTIC-TRANSMISSION; COFILIN PHOSPHORYLATION; ZINC-FINGER; ACTIN CYTOSKELETON; DENDRITIC SPINES; CELL MOTILITY; ALPHA-ACTININ; PLASTICITY	In vitro studies indicate a role for the LIM kinase family in the regulation of cofilin phosphorylation and actin dynamics. In addition, abnormal expression of LIMK-1 is associated with Williams syndrome, a mental disorder with profound deficits in visuospatial cognition. However, the in vivo function of this family of kinases remains elusive. Using LIMK-1 knockout mice, we demonstrate a significant role for LIMK-1 in vivo in regulating cofilin and the actin cytoskeleton. Furthermore, we show that the knockout mice exhibited significant abnormalities in spine morphology and in synaptic function, including enhanced hippocampal long-term potentiation. The knockout mice also showed altered fear responses and spatial learning. These results indicate that LIMK-1 plays a critical role in dendritic spine morphogenesis and brain function.	Hosp Sick Children, Program Brain & Behav, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; Ctr Res Neurodegenerat Dis, Toronto, ON M5S 3H2, Canada; Emory Univ, Dept Biol, Atlanta, GA 30322 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Emory University	Jial, ZP (corresponding author), Hosp Sick Children, Program Brain & Behav, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	jia@sickkids.ca	Jia, zhengping/AAZ-4190-2021; Jackson, Mike/H-5573-2012; Lu, Wei-Yang/K-4404-2013	Jackson, Mike/0000-0002-4730-201X; 				Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; BAMBURG JR, 1987, J CELL BIOL, V105, P2817, DOI 10.1083/jcb.105.6.2817; Bellugi U, 1999, TRENDS NEUROSCI, V22, P197, DOI 10.1016/S0166-2236(99)01397-1; BERNARD O, 1994, CELL GROWTH DIFFER, V5, P1159; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Carlier MF, 1999, J BIOL CHEM, V274, P33827, DOI 10.1074/jbc.274.48.33827; Cole JC, 2000, J PHYSIOL-LONDON, V525, P579, DOI 10.1111/j.1469-7793.2000.t01-2-00579.x; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Ehlers MD, 2002, TRENDS NEUROSCI, V25, P64, DOI 10.1016/S0166-2236(02)02061-1; FINCH DM, 1990, BRAIN RES, V518, P269, DOI 10.1016/0006-8993(90)90979-L; Frangiskakis JM, 1996, CELL, V86, P59, DOI 10.1016/S0092-8674(00)80077-X; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; JANUS C, 1995, BEHAV PROCESS, V34, P129, DOI 10.1016/0376-6357(94)00060-T; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; Kim CH, 1999, J NEUROSCI, V19, P4314; Kirov SA, 1999, J NEUROSCI, V19, P2876; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; Krupp JJ, 1999, J NEUROSCI, V19, P1165; Kuroda S, 1996, J BIOL CHEM, V271, P31029, DOI 10.1074/jbc.271.49.31029; Kuromi H, 1998, NEURON, V20, P917, DOI 10.1016/S0896-6273(00)80473-0; LANDIS DMD, 1988, NEURON, V1, P201, DOI 10.1016/0896-6273(88)90140-7; Lian JP, 2000, J BIOL CHEM, V275, P2869, DOI 10.1074/jbc.275.4.2869; Lu YM, 1997, J NEUROSCI, V17, P5196; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MALENKA RC, 1986, NATURE, V321, P175, DOI 10.1038/321175a0; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Meberg PJ, 1998, CELL MOTIL CYTOSKEL, V39, P172, DOI 10.1002/(SICI)1097-0169(1998)39:2<172::AID-CM8>3.0.CO;2-8; Minamide LS, 2000, NAT CELL BIOL, V2, P628, DOI 10.1038/35023579; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; MIZUNO K, 1994, ONCOGENE, V9, P1605; Morales M, 2000, NEURON, V27, P539, DOI 10.1016/S0896-6273(00)00064-7; Mori T, 1997, MOL BRAIN RES, V45, P247, DOI 10.1016/S0169-328X(96)00257-4; MORRIS R, 1996, HIPPOCAMPUS FUNCTION, P55; Nakayama AY, 2000, HIPPOCAMPUS, V10, P582, DOI 10.1002/1098-1063(2000)10:5<582::AID-HIPO8>3.0.CO;2-K; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; PARFITT KD, 1993, J PHYSIOL-LONDON, V471, P245, DOI 10.1113/jphysiol.1993.sp019900; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; PROSCHEL C, 1995, ONCOGENE, V11, P1271; Rao A, 2000, HIPPOCAMPUS, V10, P527, DOI 10.1002/1098-1063(2000)10:5<527::AID-HIPO3>3.0.CO;2-B; ROSENMUND C, 1993, NEURON, V10, P805, DOI 10.1016/0896-6273(93)90197-Y; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Smart FM, 2000, HIPPOCAMPUS, V10, P542, DOI 10.1002/1098-1063(2000)10:5<542::AID-HIPO4>3.3.CO;2-Z; Smolich B, 1997, J BIOCHEM-TOKYO, V121, P382; Sorra KE, 2000, HIPPOCAMPUS, V10, P501, DOI 10.1002/1098-1063(2000)10:5<501::AID-HIPO1>3.0.CO;2-T; Sumi T, 2001, J BIOL CHEM, V276, P670, DOI 10.1074/jbc.M007074200; Sumida J, 1998, VICTORIAN STUD, V42, P147, DOI 10.2979/VIC.1998.42.1.147; Toshima J, 2001, MOL BIOL CELL, V12, P1131, DOI 10.1091/mbc.12.4.1131; Wang JY, 1998, J BIOL CHEM, V273, P20525, DOI 10.1074/jbc.273.32.20525; Wang JY, 2000, J COMP NEUROL, V416, P319, DOI 10.1002/(SICI)1096-9861(20000117)416:3<319::AID-CNE4>3.0.CO;2-Q; Wyszynski M, 1997, NATURE, V385, P439, DOI 10.1038/385439a0; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Yuste R, 2000, NAT NEUROSCI, V3, P653, DOI 10.1038/76609; Zhou Q, 2001, P NATL ACAD SCI USA, V98, P1261, DOI 10.1073/pnas.031573798	60	509	527	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 3	2002	35	1					121	133		10.1016/S0896-6273(02)00758-4	http://dx.doi.org/10.1016/S0896-6273(02)00758-4			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	569KP	12123613	Bronze			2022-12-24	WOS:000176601800015
J	Wemmie, JA; Chen, JG; Askwith, CC; Hruska-Hageman, AM; Price, MP; Nolan, BC; Yoder, PG; Lamani, E; Hoshi, T; Freeman, JH; Welsh, MJ				Wemmie, JA; Chen, JG; Askwith, CC; Hruska-Hageman, AM; Price, MP; Nolan, BC; Yoder, PG; Lamani, E; Hoshi, T; Freeman, JH; Welsh, MJ			The acid-activated ion channel ASIC contributes to synaptic plasticity, learning, and memory	NEURON			English	Article							MAMMALIAN DEGENERIN MDEG; LONG-TERM POTENTIATION; GATED NA+ CHANNEL; NEUROPEPTIDE-FF; PURKINJE-CELLS; CEREBELLAR LTD; NMDA; RECEPTOR; PH; BRAIN	Many central neurons possess large acid-activated currents, yet their molecular identity is unknown. We found that eliminating the acid sensing ion channel (ASIC) abolished H+-gated currents in hippocampal neurons. Neuronal H+-gated currents and transient acidification are proposed to play a role in synaptic transmission. Investigating this possibility, we found ASIC in hippocampus, in synaptosomes, and in dendrites localized at synapses. Moreover, loss of ASIC impaired hippocampal long-term potentiation. ASIC null mice had reduced excitatory postsynaptic potentials and NMDA receptor activation during high-frequency stimulation. Consistent with these findings, null mice displayed defective spatial learning and eye-blink conditioning. These results identify ASIC as a key component of acid-activated currents and implicate these currents in processes underlying synaptic plasticity, learning, and memory.	Univ Iowa, Dept Physiol & Biophys, Iowa City, IA 52242 USA; Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA; Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA; Univ Iowa, Howard Hughes Med Inst, Iowa City, IA 52242 USA; Dept Vet Affairs Med Ctr, Iowa City, IA 52242 USA; Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Pharmacol, Wuhan 430074, Peoples R China; Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; Howard Hughes Medical Institute; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; Huazhong University of Science & Technology; University of Pennsylvania	Welsh, MJ (corresponding author), Univ Iowa, Dept Physiol & Biophys, Iowa City, IA 52242 USA.	mjwelsh@blue.weeg.uiowa.edu	Telch, Michael J/E-7027-2010	Welsh, Michael/0000-0002-1646-6206; Wemmie, John/0000-0001-7531-9065	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK025295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038890] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 14338, HL 64645] Funding Source: Medline; NIDDK NIH HHS [DK 25295] Funding Source: Medline; NIGMS NIH HHS [GM 57654] Funding Source: Medline; NINDS NIH HHS [NS 38890] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABELIOVICH A, 1993, CELL, V75, P1263, DOI 10.1016/0092-8674(93)90614-V; Askwith CC, 2000, NEURON, V26, P133, DOI 10.1016/S0896-6273(00)81144-7; Baron A, 2001, J BIOL CHEM, V276, P35361, DOI 10.1074/jbc.M105208200; Bassilana F, 1997, J BIOL CHEM, V272, P28819, DOI 10.1074/jbc.272.46.28819; BENARI Y, 1992, TRENDS NEUROSCI, V15, P333, DOI 10.1016/0166-2236(92)90049-E; Benson CJ, 2002, P NATL ACAD SCI USA, V99, P2338, DOI 10.1073/pnas.032678399; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Chen CC, 1998, P NATL ACAD SCI USA, V95, P10240, DOI 10.1073/pnas.95.17.10240; Chen L, 1996, J NEUROSCI, V16, P2829; CHESLER M, 1992, TRENDS NEUROSCI, V15, P396, DOI 10.1016/0166-2236(92)90191-A; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; CHOI DW, 1987, J NEUROSCI, V7, P369; COTTRELL GA, 1992, EXP PHYSIOL, V77, P881, DOI 10.1113/expphysiol.1992.sp003655; Craven SE, 1999, NEURON, V22, P497, DOI 10.1016/S0896-6273(00)80705-9; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; DeVries SH, 2001, NEURON, V32, P1107, DOI 10.1016/S0896-6273(01)00535-9; During MJ, 2000, SCIENCE, V287, P1453, DOI 10.1126/science.287.5457.1453; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; Freeman JH, 2000, J NEUROSCI, V20, P813, DOI 10.1523/JNEUROSCI.20-02-00813.2000; GarciaAnoveros J, 1997, P NATL ACAD SCI USA, V94, P1459, DOI 10.1073/pnas.94.4.1459; GOTTFRIED JA, 1994, J PHYSIOL-LONDON, V478, P373, DOI 10.1113/jphysiol.1994.sp020258; GRUOL DL, 1980, BRAIN RES, V183, P247, DOI 10.1016/0006-8993(80)90138-9; Hruska-Hageman AM, 2002, BIOCHEM J, V361, P443, DOI 10.1042/0264-6021:3610443; HUANG YY, 1987, NEUROSCIENCE, V22, P9, DOI 10.1016/0306-4522(87)90193-X; KAVALIERS M, 1993, NEUROSCI LETT, V157, P75, DOI 10.1016/0304-3940(93)90646-3; Kleschevnikov AM, 2001, HIPPOCAMPUS, V11, P168, DOI 10.1002/hipo.1034; KRISHTAL OA, 1981, NEUROSCI LETT, V24, P243, DOI 10.1016/0304-3940(81)90164-6; KRISHTAL OA, 1987, BRAIN RES, V436, P352, DOI 10.1016/0006-8993(87)91678-7; LINDEN DJ, 1994, NEURON, V12, P457, DOI 10.1016/0896-6273(94)90205-4; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; LINGUEGLIA E, 1995, NATURE, V378, P730, DOI 10.1038/378730a0; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; MALENKA RC, 1991, NEURON, V6, P53, DOI 10.1016/0896-6273(91)90121-F; MALENKA RC, 1986, NATURE, V321, P175, DOI 10.1038/321175a0; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Mauk MD, 1998, NEURON, V20, P359, DOI 10.1016/S0896-6273(00)80978-2; MENNERICK S, 1995, J NEUROPHYSIOL, V73, P320, DOI 10.1152/jn.1995.73.1.320; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Mohn AR, 1999, CELL, V98, P427, DOI 10.1016/S0092-8674(00)81972-8; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; MULLER WE, 1994, LIFE SCI, V55, P2147, DOI 10.1016/0024-3205(94)00395-5; OBRENOVITCH TP, 1988, J CEREBR BLOOD F MET, V8, P866, DOI 10.1038/jcbfm.1988.144; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Price MP, 1996, J BIOL CHEM, V271, P7879, DOI 10.1074/jbc.271.14.7879; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; Saybasili H, 1998, BRAIN RES, V786, P128, DOI 10.1016/S0006-8993(97)01461-3; Schehr RS, 1996, NAT BIOTECHNOL, V14, P1549, DOI 10.1038/nbt1196-1549; SCHULZ PE, 1994, J NEUROSCI, V14, P5325; Shibuki K, 1996, NEURON, V16, P587, DOI 10.1016/S0896-6273(00)80078-1; SLOMIANKA L, 1992, NEUROSCIENCE, V48, P325, DOI 10.1016/0306-4522(92)90494-M; Stowell JN, 1999, NEURON, V22, P525, DOI 10.1016/S0896-6273(00)80707-2; TANG CM, 1990, P NATL ACAD SCI USA, V87, P6445, DOI 10.1073/pnas.87.16.6445; Thompson RF, 1996, P NATL ACAD SCI USA, V93, P13438, DOI 10.1073/pnas.93.24.13438; Traynelis SF, 2001, NEURON, V32, P960, DOI 10.1016/S0896-6273(01)00549-9; TRAYNELIS SF, 1990, NATURE, V345, P347, DOI 10.1038/345347a0; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Varming T, 1999, NEUROPHARMACOLOGY, V38, P1875, DOI 10.1016/S0028-3908(99)00079-9; VYKLICKY L, 1990, J PHYSIOL-LONDON, V430, P497, DOI 10.1113/jphysiol.1990.sp018304; Waldmann R, 1997, J BIOL CHEM, V272, P20975, DOI 10.1074/jbc.272.34.20975; Waldmann R, 1996, J BIOL CHEM, V271, P10433, DOI 10.1074/jbc.271.18.10433; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Waldmann R, 1998, CURR OPIN NEUROBIOL, V8, P418, DOI 10.1016/S0959-4388(98)80070-6; WESTBROOK GL, 1987, NATURE, V328, P640, DOI 10.1038/328640a0; Yu XM, 1998, NATURE, V396, P469, DOI 10.1038/24877	65	522	551	1	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 25	2002	34	3					463	477		10.1016/S0896-6273(02)00661-X	http://dx.doi.org/10.1016/S0896-6273(02)00661-X			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	545JW	11988176	Bronze			2022-12-24	WOS:000175214700016
J	Saal, D; Dong, Y; Bonci, A; Malenka, RC				Saal, D; Dong, Y; Bonci, A; Malenka, RC			Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons	NEURON			English	Article							VENTRAL TEGMENTAL AREA; LONG-TERM POTENTIATION; GLUCOCORTICOID RECEPTORS; ADDICTION; PLASTICITY; COCAINE; GLUTAMATE; NEUROBIOLOGY; HIPPOCAMPUS; MECHANISMS	Drug seeking and drug self-administration in both animals and humans can be triggered by drugs of abuse themselves or by stressful events. Here, we demonstrate that in vivo administration of drugs of abuse with different molecular mechanisms of action as well as acute stress both increase strength at excitatory synapses on midbrain dopamine neurons. Psychoactive drugs with minimal abuse potential do not cause this change. The synaptic effects of stress, but not of cocaine, are blocked by the glucocorticoid receptor antagonist RU486. These results suggest that plasticity at excitatory synapses on dopamine neurons may be a key neural adaptation contributing to addiction and its interactions with stress and thus may be an attractive therapeutic target for reducing the risk of addiction.	Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Palo Alto, CA 94304 USA; Univ Calif San Francisco, Dept Neurol, Ernest Gallo Clin & Res Ctr, San Francisco, CA 94110 USA; Univ Calif San Francisco, Wheeler Ctr Neurobiol Addict, San Francisco, CA 94110 USA	Stanford University; University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco	Malenka, RC (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Palo Alto, CA 94304 USA.		Dong, Yan/A-4154-2016	Dong, Yan/0000-0003-0016-9028				Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Cadepond F, 1997, ANNU REV MED, V48, P129; Cameron DL, 1997, NEUROSCIENCE, V77, P155, DOI 10.1016/S0306-4522(96)00444-7; Carlezon WA, 2002, TRENDS NEUROSCI, V25, P610, DOI 10.1016/S0166-2236(02)02289-0; Carlezon WA, 1997, SCIENCE, V277, P812, DOI 10.1126/science.277.5327.812; Douma BRK, 1998, PSYCHONEUROENDOCRINO, V23, P33, DOI 10.1016/S0306-4530(97)00091-7; Everitt BJ, 2002, J NEUROSCI, V22, P3312; Fitzgerald LW, 1996, J NEUROSCI, V16, P274; Georges F, 2002, J NEUROSCI, V22, P5173, DOI 10.1523/JNEUROSCI.22-12-05173.2002; HEIKINHEIMO O, 1993, ANN MED, V25, P71, DOI 10.3109/07853899309147861; Horger BA, 1996, CRIT REV NEUROBIOL, V10, P395; Huber JD, 2001, PHARMACOL BIOCHEM BE, V69, P451, DOI 10.1016/S0091-3057(01)00521-4; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; Kelley AE, 2002, J NEUROSCI, V22, P3306; Kim JJ, 1996, P NATL ACAD SCI USA, V93, P4750, DOI 10.1073/pnas.93.10.4750; Koob GF, 1996, MOL PSYCHIATR, V1, P186; Koob GF, 1998, NEURON, V21, P467, DOI 10.1016/S0896-6273(00)80557-7; Kullmann DM, 2000, PROG BRAIN RES, V125, P339; Lu WX, 2002, NEUROPSYCHOPHARMACOL, V26, P1, DOI 10.1016/S0893-133X(01)00272-X; Marinelli M, 1998, P NATL ACAD SCI USA, V95, P7742, DOI 10.1073/pnas.95.13.7742; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Nestler E.J., 2015, MOL NEUROPHARMACOLOG; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Neuhoff H, 2002, J NEUROSCI, V22, P1290, DOI 10.1523/JNEUROSCI.22-04-01290.2002; OBrien CP, 1997, SCIENCE, V278, P66, DOI 10.1126/science.278.5335.66; Piazza PV, 1998, TRENDS PHARMACOL SCI, V19, P67, DOI 10.1016/S0165-6147(97)01115-2; PIERETTI S, 1991, GEN PHARMACOL, V22, P929, DOI 10.1016/0306-3623(91)90232-U; Robinson TE, 2000, ADDICTION, V95, pS91; Shaham Y, 2000, BRAIN RES REV, V33, P13, DOI 10.1016/S0165-0173(00)00024-2; SHORS TJ, 1989, SCIENCE, V244, P224, DOI 10.1126/science.2704997; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; Wise RA, 1996, CURR OPIN NEUROBIOL, V6, P243, DOI 10.1016/S0959-4388(96)80079-1; Xu L, 1997, NATURE, V387, P497, DOI 10.1038/387497a0; Xu L, 1998, P NATL ACAD SCI USA, V95, P3204, DOI 10.1073/pnas.95.6.3204; Zhang XF, 1997, J PHARMACOL EXP THER, V281, P699	36	817	837	2	89	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 20	2003	37	4					577	582		10.1016/S0896-6273(03)00021-7	http://dx.doi.org/10.1016/S0896-6273(03)00021-7			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	648EH	12597856	Bronze			2022-12-24	WOS:000181136500007
J	Nickols, JC; Valentine, W; Kanwal, S; Carter, BD				Nickols, JC; Valentine, W; Kanwal, S; Carter, BD			Activation of the transcription factor NF-kappa B in Schwann cells is required for peripheral myelin formation	NATURE NEUROSCIENCE			English	Article							GENE-EXPRESSION; NERVOUS-SYSTEM; KROX-20; DIFFERENTIATION; INHIBITION; MEDIATORS; APOPTOSIS; SURVIVAL; GROWTH; OCT-6	Peripheral myelin formation is initiated by axonal cues that trigger a differentiation program in associated Schwann cells. Here, we define one essential differentiation signal: activation of the transcription factor NF-kappaB. In rat sciatic nerves, NF-kappaB was highly upregulated in pre-myelinating Schwann cells, and then its expression progressively declined until it was nearly absent in adults. Similarly, in co-cultures of Schwann cells and sensory neurons, NF-kappaB activation paralleled myelination, and blocking its activity or using cells from mice lacking the NF-kappaB subunit p65 markedly attenuated myelination. Inhibiting NF-kappaB also prevented activation of Oct-6, a transcription factor induced by axonal contact and required for proper myelin formation. These results show that the activation of NF-kappaB is an essential signal for the progression of axon-associated Schwann cells into a myelinating phenotype.	Vanderbilt Univ, Sch Med, Nashville, TN 37232 USA; Vanderbilt Univ, Ctr Mol Neurosci, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Pathol, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Carter, BD (corresponding author), Vanderbilt Univ, Sch Med, 221 Kirkland Hall, Nashville, TN 37232 USA.	bruce.carter@vanderbilt.edu			NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES006387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038220] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES06387] Funding Source: Medline; NIMH NIH HHS [MH19732] Funding Source: Medline; NINDS NIH HHS [NS38220] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arroyo EJ, 1998, J NEUROSCI, V18, P7891; Bermingham JR, 1996, GENE DEV, V10, P1751, DOI 10.1101/gad.10.14.1751; Betz UAK, 1998, J EXP MED, V188, P1955, DOI 10.1084/jem.188.10.1955; Blanchard AD, 1996, J NEUROSCI RES, V46, P630, DOI 10.1002/(SICI)1097-4547(19961201)46:5<630::AID-JNR11>3.0.CO;2-0; Bushdid PB, 1998, NATURE, V392, P615, DOI 10.1038/33435; Carter BD, 1996, SCIENCE, V272, P542, DOI 10.1126/science.272.5261.542; Chan JR, 2001, P NATL ACAD SCI USA, V98, P14661, DOI 10.1073/pnas.251543398; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; Coetzee T, 1996, CELL, V86, P209, DOI 10.1016/S0092-8674(00)80093-8; EINHEBER S, 1993, J CELL BIOL, V123, P1223, DOI 10.1083/jcb.123.5.1223; Feltri ML, 2002, J CELL BIOL, V156, P199, DOI 10.1083/jcb.200109021; Forghani R, 1999, J NEUROSCI METH, V89, P129, DOI 10.1016/S0165-0270(99)00043-6; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Haggiag S, 2001, J NEUROSCI RES, V64, P564, DOI 10.1002/jnr.1108; Huang CJ, 2002, INT J DEV NEUROSCI, V20, P289, DOI 10.1016/S0736-5748(02)00022-9; Jaegle M, 1996, SCIENCE, V273, P507, DOI 10.1126/science.273.5274.507; KUNSCH C, 1992, MOL CELL BIOL, V12, P4412, DOI 10.1128/MCB.12.10.4412; Lee HH, 1999, P NATL ACAD SCI USA, V96, P9136, DOI 10.1073/pnas.96.16.9136; LIN YZ, 1995, J BIOL CHEM, V270, P14255, DOI 10.1074/jbc.270.24.14255; Mattson MP, 2000, J NEUROCHEM, V74, P443, DOI 10.1046/j.1471-4159.2000.740443.x; MONUKI ES, 1989, NEURON, V3, P783, DOI 10.1016/0896-6273(89)90247-X; Nagarajan R, 2001, NEURON, V30, P355, DOI 10.1016/S0896-6273(01)00282-3; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Scherer SS, 1997, CURR OPIN NEUROL, V10, P386, DOI 10.1097/00019052-199710000-00006; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Xu JH, 1998, J CELL BIOL, V140, P709, DOI 10.1083/jcb.140.3.709; Zorick TS, 1999, DEVELOPMENT, V126, P1397	28	147	150	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2003	6	2					161	167		10.1038/nn995	http://dx.doi.org/10.1038/nn995			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	640CL	12514737				2022-12-24	WOS:000180669100016
J	Anagnostaras, SG; Murphy, GG; Hamilton, SE; Mitchell, SL; Rahnama, NP; Nathanson, NM; Silva, AJ				Anagnostaras, SG; Murphy, GG; Hamilton, SE; Mitchell, SL; Rahnama, NP; Nathanson, NM; Silva, AJ			Selective cognitive dysfunction in acetylcholine M-1 muscarinic receptor mutant mice	NATURE NEUROSCIENCE			English	Article							LONG-TERM-MEMORY; CONTEXTUAL FEAR; CHOLINERGIC MODULATION; RETROGRADE-AMNESIA; DORSAL HIPPOCAMPUS; RATS; SCOPOLAMINE; LESIONS; ACQUISITION; BRAIN	Blockade of cholinergic neurotransmission by muscarinic receptor antagonists produces profound deficits in attention and memory. However, the antagonists used in previous studies bind to more than one of the five muscarinic receptor subtypes. Here we examined memory in mice with a null mutation of the gene coding the M, receptor, the most densely distributed muscarinic receptor in the hippocampus and forebrain. In contrast with previous studies using nonselective pharmacological antagonists, the M-1 receptor deletion produced a selective phenotype that included both enhancements and deficits in memory. Long-term potentiation (LTP) in response to theta burst stimulation in the hippocampus was also reduced in mutant mice. M-1 null mutant mice showed normal or enhanced memory for tasks that involved matching-to-sample problems, but they were severely impaired in nonmatching-to-sample working memory as well as consolidation. Our results suggest that the M-1 receptor is specifically involved in memory processes for which the cortex and hippocampus interact.	Univ Calif Los Angeles, Inst Brain Res, Dept Neurobiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Brain Res, Dept Psychol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Brain Res, Dept Psychiat, Los Angeles, CA 90095 USA; Emory Univ, Dept Psychol, Atlanta, GA 30322 USA; Ctr Behav Neurosci, Atlanta, GA 30322 USA; Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Emory University; University of Washington; University of Washington Seattle	Silva, AJ (corresponding author), Univ Calif Los Angeles, Inst Brain Res, Dept Neurobiol, 2554 Gonda Ctr,Box 951761, Los Angeles, CA 90095 USA.		Silva, Alcino/ABD-7684-2021	Silva, Alcino/0000-0002-1587-4558; Silva, Alcino/0000-0001-5525-0494; Nathanson, Neil/0000-0002-9216-121X; Anagnostaras, Stephan/0000-0002-6906-1181	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS010932, R01NS026920] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG005858, R01AG017499] Funding Source: NIH RePORTER; NIA NIH HHS [F32 AG5858, R01 AG17499] Funding Source: Medline; NINDS NIH HHS [R01 NS26920, F32 NS10932] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alreja M, 2000, J NEUROSCI, V20, P8103; Anagnostaras SG, 1999, NEUROPSYCHOPHARMACOL, V21, P731, DOI 10.1016/S0893-133X(99)00083-4; Anagnostaras SG, 2001, HIPPOCAMPUS, V11, P8; Anagnostaras SG, 1999, J NEUROSCI, V19, P1106; Anagnostaras SG, 2000, LEARN MEMORY, V7, P58, DOI 10.1101/lm.7.1.58; Bontempi B, 1999, NATURE, V400, P671, DOI 10.1038/23270; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Bussiere T, 2002, NEUROSCIENCE, V112, P75, DOI 10.1016/S0306-4522(02)00056-8; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Cain DP, 1998, NEUROSCI BIOBEHAV R, V22, P181, DOI 10.1016/S0149-7634(97)00005-5; Caulfield MP, 1998, PHARMACOL REV, V50, P279; D'Esposito M, 1999, NEUROPSYCHOLOGIA, V37, P1303, DOI 10.1016/S0028-3932(99)00021-4; Dias R, 2000, EUR J NEUROSCI, V12, P4457, DOI 10.1046/j.0953-816X.2000.01323.x; EICHENBAUM H, 1994, BEHAV BRAIN SCI, V17, P449, DOI 10.1017/S0140525X00035391; Fornari RV, 2000, LEARN MEMORY, V7, P287, DOI 10.1101/lm.34900; Frankland PW, 2001, NATURE, V411, P309, DOI 10.1038/35077089; Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037/0735-7044.112.4.863; Fransen E, 2002, J NEUROSCI, V22, P1081, DOI 10.1523/JNEUROSCI.22-03-01081.2002; Gale GD, 2001, HIPPOCAMPUS, V11, P371, DOI 10.1002/hipo.1051.abs; Gerber DJ, 2001, P NATL ACAD SCI USA, V98, P15312, DOI 10.1073/pnas.261583798; HAGEN JJ, 1986, BEHAV NEUROSCI, V100, P483; Hamilton SE, 2001, LIFE SCI, V68, P2489, DOI 10.1016/S0024-3205(01)01043-8; Hamilton SE, 2001, J BIOL CHEM, V276, P15850, DOI 10.1074/jbc.M011563200; Hamilton SE, 1997, P NATL ACAD SCI USA, V94, P13311, DOI 10.1073/pnas.94.24.13311; Hasselmo ME, 1999, TRENDS COGN SCI, V3, P351, DOI 10.1016/S1364-6613(99)01365-0; HUERTA PT, 1995, NEURON, V15, P1053, DOI 10.1016/0896-6273(95)90094-2; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kogan JH, 2000, HIPPOCAMPUS, V10, P47, DOI 10.1002/(SICI)1098-1063(2000)10:1<47::AID-HIPO5>3.0.CO;2-6; Konorski J., 1967, INTEGRATIVE ACTIVITY; LEVEY AI, 1991, J NEUROSCI, V11, P3218; LEVEY AI, 1995, J NEUROSCI, V15, P4077; LEVY A, 1983, BEHAV NEURAL BIOL, V39, P229, DOI 10.1016/S0163-1047(83)90893-2; Maren S, 1997, BEHAV BRAIN RES, V88, P261, DOI 10.1016/S0166-4328(97)00088-0; Maren S, 1998, TRENDS COGN SCI, V2, P39, DOI 10.1016/S1364-6613(98)01123-1; Marino MJ, 1998, P NATL ACAD SCI USA, V95, P11465, DOI 10.1073/pnas.95.19.11465; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Miyakawa T, 2001, J NEUROSCI, V21, P5239, DOI 10.1523/JNEUROSCI.21-14-05239.2001; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; OLTON DS, 1979, BEHAV BRAIN SCI, V2, P313, DOI 10.1017/S0140525X00062713; OLTON DS, 1972, PHYSIOL BEHAV, V9, P353, DOI 10.1016/0031-9384(72)90158-8; PHILLIPS RG, 1994, LEARN MEMORY, V1, P34; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Rudy JW, 1996, NEUROBIOL LEARN MEM, V65, P73, DOI 10.1006/nlme.1996.0008; Shiozaki K, 2001, J NEUROL SCI, V193, P23, DOI 10.1016/S0022-510X(01)00638-4; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Wallenstein GV, 2001, NEUROBIOL LEARN MEM, V75, P245, DOI 10.1006/nlme.2001.4005; Wallis RM, 1999, LIFE SCI, V64, P395, DOI 10.1016/S0024-3205(98)00585-2; WEI J, 1994, J NEUROCHEM, V63, P815; WINSLOW JT, 1995, PSYCHOPHARMACOLOGY, V121, P164, DOI 10.1007/BF02245626	50	405	415	0	24	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2003	6	1					51	58		10.1038/nn992	http://dx.doi.org/10.1038/nn992			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	630CE	12483218				2022-12-24	WOS:000180089300015
J	Perez, CA; Huang, LQ; Rong, MQ; Kozak, JA; Preuss, AK; Zhang, HL; Max, M; Margolskee, RF				Perez, CA; Huang, LQ; Rong, MQ; Kozak, JA; Preuss, AK; Zhang, HL; Max, M; Margolskee, RF			A transient receptor potential channel expressed in taste receptor cells	NATURE NEUROSCIENCE			English	Article							CAPACITATIVE CA2+ ENTRY; TRP GENE FAMILY; SWEET TASTE; ACTIVATED CHANNEL; PLASMA-MEMBRANE; XENOPUS OOCYTES; TRANSDUCTION; BITTER; GUSTDUCIN; MOUSE	We used differential screening of cDNAs from individual taste receptor cells to identify candidate taste transduction elements in mice. Among the differentially expressed clones, one encoded Trpm5, a member of the mammalian family of transient receptor potential (TRP) channels. We found Trpm5 to be expressed in a restricted manner, with particularly high levels in taste tissue. In taste cells, Trpm5 was coexpressed with taste-signaling molecules such as alpha-gustducin, Ggamma(13), phospholipase C-beta(2) (PLC-beta(2)) and inositol 1,4,5-trisphosphate receptor type III (IP(3)R3). Our heterologous expression studies of Trpm5 indicate that it functions as a cationic channel that is gated when internal calcium stores are depleted. Trpm5 may be responsible for capacitative calcium entry in taste receptor cells that respond to bitter and/or sweet compounds.	NYU, Mt Sinai Sch Med, Howard Hughes Med Inst, New York, NY 10029 USA; NYU, Mt Sinai Sch Med, Dept Physiol & Biophys, New York, NY 10029 USA; Cellular Genom Inc, Branford, CT 06405 USA; Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; Hebei Med Univ, Dept Pharmacol, Shijiazhuang 050017, Hebei Province, Peoples R China	Howard Hughes Medical Institute; Icahn School of Medicine at Mount Sinai; New York University; Icahn School of Medicine at Mount Sinai; New York University; University of California System; University of California Irvine; Hebei Medical University	Margolskee, RF (corresponding author), NYU, Mt Sinai Sch Med, Howard Hughes Med Inst, Box 1677,1425 Madison Ave, New York, NY 10029 USA.	margolskee@msvax.mssm.edu	Perez, Cristian A./A-2341-2008	Margolskee, Robert/0000-0002-9572-2887; Huang, Liquan/0000-0003-3400-0685	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003155, R01DC003055] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC03155, DC03055, DC00310] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Asano-Miyoshi M, 2001, CHEM SENSES, V26, P259, DOI 10.1093/chemse/26.3.259; Bachmanov AA, 2001, CHEM SENSES, V26, P925, DOI 10.1093/chemse/26.7.925; Bernhardt SJ, 1996, J PHYSIOL-LONDON, V490, P325, DOI 10.1113/jphysiol.1996.sp021147; Birnbaumer L, 2000, RECENT PROG HORM RES, V55, P127; Bobanovic LK, 1999, BIOCHEM J, V340, P593, DOI 10.1042/0264-6021:3400593; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Chan KW, 1996, J GEN PHYSIOL, V107, P381, DOI 10.1085/jgp.107.3.381; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chaudhari N, 2000, NAT NEUROSCI, V3, P113, DOI 10.1038/72053; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Clapp TR, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-6; Enklaar T, 2000, GENOMICS, V67, P179, DOI 10.1006/geno.2000.6234; Gilbertson TA, 2000, CURR OPIN NEUROBIOL, V10, P519, DOI 10.1016/S0959-4388(00)00118-5; Gillo B, 1996, P NATL ACAD SCI USA, V93, P14146, DOI 10.1073/pnas.93.24.14146; Halaszovich CR, 2000, J BIOL CHEM, V275, P37423, DOI 10.1074/jbc.M007010200; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Huang LQ, 1999, NAT NEUROSCI, V2, P1055, DOI 10.1038/15981; Kitagawa M, 2001, BIOCHEM BIOPH RES CO, V283, P236, DOI 10.1006/bbrc.2001.4760; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Liman ER, 1999, P NATL ACAD SCI USA, V96, P5791, DOI 10.1073/pnas.96.10.5791; Lindemann B, 2001, NATURE, V413, P219, DOI 10.1038/35093032; Lomax RB, 1998, CELL CALCIUM, V23, P229, DOI 10.1016/S0143-4160(98)90121-X; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Max M, 2001, NAT GENET, V28, P58, DOI 10.1038/88270; MCLAUGHLIN SK, 1992, NATURE, V357, P563, DOI 10.1038/357563a0; Ming D, 1998, P NATL ACAD SCI USA, V95, P8933, DOI 10.1073/pnas.95.15.8933; Misaka T, 1997, J BIOL CHEM, V272, P22623, DOI 10.1074/jbc.272.36.22623; Montell C, 2002, MOL CELL, V9, P229, DOI 10.1016/S1097-2765(02)00448-3; Montmayeur JP, 2001, NAT NEUROSCI, V4, P492, DOI 10.1038/87440; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Ogura T, 2002, J NEUROPHYSIOL, V87, P2643, DOI 10.1152/jn.2002.87.6.2643; Ogura T, 2002, J NEUROPHYSIOL, V87, P3152, DOI 10.1152/jn.2002.87.6.3152; Ogura T, 1997, J NEUROSCI, V17, P3580; Paulsen M, 2000, HUM MOL GENET, V9, P1829, DOI 10.1093/hmg/9.12.1829; Prawitt D, 2000, HUM MOL GENET, V9, P203, DOI 10.1093/hmg/9.2.203; Putney JW, 1999, BIOESSAYS, V21, P38; RANDRIAMAMPITA C, 1993, NATURE, V364, P809, DOI 10.1038/364809a0; Rossler P, 2000, CHEM SENSES, V25, P413, DOI 10.1093/chemse/25.4.413; Rossler P, 1998, EUR J CELL BIOL, V77, P253; Sainz E, 2001, J NEUROCHEM, V77, P896, DOI 10.1046/j.1471-4159.2001.00292.x; Stortkuhl KF, 1999, J NEUROSCI, V19, P4839; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0; Wong GT, 1999, J NEUROSCI, V19, P5802, DOI 10.1523/JNEUROSCI.19-14-05802.1999; Yan WT, 2001, AM J PHYSIOL-CELL PH, V280, pC742, DOI 10.1152/ajpcell.2001.280.4.C742; Yatsuki H, 2000, DNA RES, V7, P195, DOI 10.1093/dnares/7.3.195	50	428	454	1	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1169	1176		10.1038/nn952	http://dx.doi.org/10.1038/nn952			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	609CG	12368808				2022-12-24	WOS:000178884600020
J	Song, W; Ranjan, R; Dawson-Scully, K; Bronk, P; Marin, L; Seroude, L; Lin, YJ; Nie, ZP; Atwood, HL; Benzer, S; Zinsmaier, KE				Song, W; Ranjan, R; Dawson-Scully, K; Bronk, P; Marin, L; Seroude, L; Lin, YJ; Nie, ZP; Atwood, HL; Benzer, S; Zinsmaier, KE			Presynaptic regulation of neurotransmission in Drosophila by the G protein-coupled receptor Methuselah	NEURON			English	Article							CYSTEINE-STRING PROTEIN; TRANSMITTER RELEASE; KINASE-C; CALCIUM SENSITIVITY; SYNAPTIC VESICLES; ALPHA-LATROTOXIN; LIFE-SPAN; EXOCYTOSIS; INHIBITION; MEMBRANE	Regulation of synaptic strength is essential for neuronal information processing, but the molecular mechanisms that control changes in neuroexocytosis are only partially known. Here we show that the putative G protein-coupled receptor Methuselah (Mth) is required in the presynaptic motor neuron to acutely upregulate neurotransmitter exocytosis at larval Drosophila NMJs. Mutations in the mth gene reduce evoked neurotransmitter release by similar to50%, and decrease synaptic area and the density of docked and clustered vesicles. Prebut not postsynaptic expression of normal Mth restored normal release in mth mutants. Conditional expression of Mth restored normal release and normal vesicle docking and clustering but not the reduced size of synaptic sites, suggesting that Mth acutely adjusts vesicle trafficking to synaptic sites.	Univ Arizona, Arizona Res Labs, Div Neurobiol, Tucson, AZ 85721 USA; Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada	University of Arizona; University of Pennsylvania; California Institute of Technology; University of Toronto	Zinsmaier, KE (corresponding author), Univ Arizona, Arizona Res Labs, Div Neurobiol, Tucson, AZ 85721 USA.	kez@neurobio.arizona.edu	Dawson-Scully, Ken/B-6438-2008; Gimenez, Luis E Diaz/D-9291-2011	Seroude, Laurent/0000-0002-4785-3890; Song, Wei/0000-0001-6531-8317	NEI NIH HHS [EY09278] Funding Source: Medline; NIA NIH HHS [AG16630] Funding Source: Medline; NINDS NIH HHS [R01NS38274] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY009278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016630] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ailion M, 1999, P NATL ACAD SCI USA, V96, P7394, DOI 10.1073/pnas.96.13.7394; Atwood H. L., 1997, Invertebrate Neuroscience, V3, P81, DOI 10.1007/BF02480362; ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; Atwood HL, 1999, LEARN MEMORY, V6, P542, DOI 10.1101/lm.6.6.542; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Bahner M, 2000, J BIOL CHEM, V275, P2901, DOI 10.1074/jbc.275.4.2901; Bear MF, 1996, P NATL ACAD SCI USA, V93, P13453, DOI 10.1073/pnas.93.24.13453; Bittner MA, 1998, J NEUROSCI, V18, P2914; Blackmer T, 2001, SCIENCE, V292, P293, DOI 10.1126/science.1058803; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROADIE KS, 1993, J NEUROSCI, V13, P167; Brody T, 2000, J CELL BIOL, V150, pF83, DOI 10.1083/jcb.150.2.F83; Bronk P, 2001, NEURON, V30, P475, DOI 10.1016/S0896-6273(01)00292-6; CHANG HG, 1994, J PHYSIOL-LONDON, V476, P1; Davis GW, 1998, NATURE, V392, P82, DOI 10.1038/32176; Davletov BA, 1998, EMBO J, V17, P3909, DOI 10.1093/emboj/17.14.3909; Dawson-Scully K, 2000, J NEUROSCI, V20, P6039, DOI 10.1523/JNEUROSCI.20-16-06039.2000; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; Delgado R, 2000, NEURON, V28, P941, DOI 10.1016/S0896-6273(00)00165-3; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; DOE CQ, 1988, NATURE, V333, P376, DOI 10.1038/333376a0; Fergestad T, 1999, J NEUROSCI, V19, P5847, DOI 10.1523/JNEUROSCI.19-14-05847.1999; FINKELSTEIN A, 1976, SCIENCE, V193, P1009, DOI 10.1126/science.948756; Gems D, 2000, GENETICS, V154, P1597; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; Gu GG, 1997, J NEUROBIOL, V33, P265, DOI 10.1002/(SICI)1097-4695(199709)33:3<265::AID-NEU5>3.0.CO;2-#; Gudermann T, 1996, ANNU REV PHARMACOL, V36, P429; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; HANNUN YA, 1989, CLIN CHIM ACTA, V185, P333, DOI 10.1016/0009-8981(89)90224-6; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Isaacson JS, 1997, NEURON, V18, P143, DOI 10.1016/S0896-6273(01)80053-2; JAN LY, 1976, J PHYSIOL-LONDON, V262, P189, DOI 10.1113/jphysiol.1976.sp011592; Ji TH, 1998, J BIOL CHEM, V273, P17299, DOI 10.1074/jbc.273.28.17299; JIA XX, 1993, J NEUROBIOL, V24, P1025, DOI 10.1002/neu.480240804; JOHANSEN J, 1989, J NEUROSCI, V9, P710; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KOENIG JH, 1993, J NEUROSCI, V13, P2313, DOI 10.1523/JNEUROSCI.13-06-02313.1993; KOENIG JH, 1989, J NEUROSCI, V9, P1937; KOENIG JH, 1989, J NEUROSCI, V9, P3844; Koenig JH, 1998, P NATL ACAD SCI USA, V95, P12677, DOI 10.1073/pnas.95.21.12677; KURDYAK P, 1994, J COMP NEUROL, V350, P463, DOI 10.1002/cne.903500310; Lin YJ, 1998, SCIENCE, V282, P943, DOI 10.1126/science.282.5390.943; LITTLETON JT, 1994, GENETICS, V138, P111; Marder E, 1996, P NATL ACAD SCI USA, V93, P13481, DOI 10.1073/pnas.93.24.13481; MARTIN AR, 1955, J PHYSIOL-LONDON, V130, P114, DOI 10.1113/jphysiol.1955.sp005397; MILLER CA, 1983, P NATL ACAD SCI-BIOL, V80, P7641, DOI 10.1073/pnas.80.24.7641; Miller RJ, 1998, ANNU REV PHARMACOL, V38, P201, DOI 10.1146/annurev.pharmtox.38.1.201; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.48.28495; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; Ranjan R, 1998, J NEUROSCI, V18, P956; Renger JJ, 2000, J NEUROSCI, V20, P3980; Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Stevens CF, 1998, NEURON, V21, P885, DOI 10.1016/S0896-6273(00)80603-0; Stewart BA, 1996, J NEUROSCI, V16, P3877; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Stimson DT, 2001, J NEUROSCI, V21, P3034, DOI 10.1523/JNEUROSCI.21-09-03034.2001; Takahashi T, 2000, SCIENCE, V289, P460, DOI 10.1126/science.289.5478.460; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; VERHAGE M, 1991, NEURON, V6, P517, DOI 10.1016/0896-6273(91)90054-4; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; Wong K, 1999, J NEUROPHYSIOL, V82, P1497, DOI 10.1152/jn.1999.82.3.1497; Wu LG, 1997, TRENDS NEUROSCI, V20, P204, DOI 10.1016/S0166-2236(96)01015-6; Yuan LL, 1999, SCIENCE, V283, P1343, DOI 10.1126/science.283.5406.1343; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9; ZINSMAIER KE, 1990, J NEUROGENET, V7, P15, DOI 10.3109/01677069009084150; ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2	70	52	57	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 26	2002	36	1					105	119		10.1016/S0896-6273(02)00932-7	http://dx.doi.org/10.1016/S0896-6273(02)00932-7			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	598UP	12367510	Green Published, Bronze			2022-12-24	WOS:000178295100011
J	Zenisek, D; Steyer, JA; Feldman, ME; Almers, W				Zenisek, D; Steyer, JA; Feldman, ME; Almers, W			A membrane marker leaves synaptic vesicles in milliseconds after exocytosis in retinal bipolar cells	NEURON			English	Article							NEUROTRANSMITTER RELEASE; CAPACITANCE MEASUREMENTS; TRANSMITTER RELEASE; FAST ENDOCYTOSIS; FUSION PORE; KINETICS; RIBBON; KISS; FLUORESCENCE; TRANSPORT	Perhaps synaptic vesicles can recycle so rapidly because they avoid complete exocytosis, and release transmitter through a fusion pore that opens transiently. This view emerges from imaging whole terminals where the fluorescent lipid FM1-43 seems unable to leave vesicles during transmitter release. Here we imaged single, FM1-43-stained synaptic vesicles by evanescent field fluorescence microscopy, and tracked the escape of dye from single vesicles by watching the increase in fluorescence after exocytosis. Dye left rapidly and completely during most or all exocytic events. We conclude that vesicles at this terminal allow lipid exchange soon after exocytosis, and lose their dye even if they connected with the plasma membrane only briefly. At the level of single vesicles, therefore, observations with FM1-43 provide no evidence that exocytosis of synaptic vesicles is incomplete.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; Univ Calif Berkeley, Dept Biol, Berkeley, CA 94720 USA; Cornell Univ, Dept Biomed Sci, Ithaca, NY 14853 USA; Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	Oregon Health & Science University; University of California System; University of California Berkeley; Cornell University; Yale University	Almers, W (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA.	almersw@ohsu.edu	Zenisek, David/C-6555-2011; 李, 应辉/A-7739-2011		NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060600] Funding Source: NIH RePORTER; NIMH NIH HHS [MH60600] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Albillos A, 1997, NATURE, V389, P509, DOI 10.1038/39081; Ales E, 1999, NAT CELL BIOL, V1, P40, DOI 10.1038/9012; Axelrod D, 2001, J BIOMED OPT, V6, P6, DOI 10.1117/1.1335689; Betz WJ, 1996, CURR OPIN NEUROBIOL, V6, P365, DOI 10.1016/S0959-4388(96)80121-8; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BLOOM JA, 1983, BIOPHYS J, V42, P295, DOI 10.1016/S0006-3495(83)84397-5; BRUNS D, 1995, NATURE, V377, P62, DOI 10.1038/377062a0; Chernomordik LV, 1998, J CELL BIOL, V140, P1369, DOI 10.1083/jcb.140.6.1369; Crank J., 1970, MATH DIFFUSION; FERNANDEZ JM, 1984, NATURE, V312, P453, DOI 10.1038/312453a0; Fesce Riccardo, 1994, Trends in Cell Biology, V4, P1, DOI 10.1016/0962-8924(94)90025-6; GINGELL D, 1979, BIOPHYS J, V26, P507, DOI 10.1016/S0006-3495(79)85268-6; Gomis A, 1999, J NEUROSCI, V19, P6309; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HEIDELBERGER R, 1992, J PHYSL, V207, P623; HELLEN EH, 1988, SPECTROSCOPIC MEMBRA, P47; Henkel AW, 1996, CURR OPIN NEUROBIOL, V6, P350, DOI 10.1016/S0959-4388(96)80119-X; Henkel AW, 1995, J NEUROSCI, V15, P8246; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; JACOBSON K, 1981, BIOCHEMISTRY-US, V20, P5268, DOI 10.1021/bi00521a027; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Kavalali ET, 1999, PHILOS T ROY SOC B, V354, P337, DOI 10.1098/rstb.1999.0385; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Klyachko VA, 2002, NATURE, V418, P89, DOI 10.1038/nature00852; MELDOLESI J, 1981, PHILOS T ROY SOC B, V296, P55, DOI 10.1098/rstb.1981.0171; Mennerick S, 1997, J NEUROPHYSIOL, V78, P51, DOI 10.1152/jn.1997.78.1.51; Mennerick S, 1996, NEURON, V17, P1241, DOI 10.1016/S0896-6273(00)80254-8; MONCK JR, 1990, P NATL ACAD SCI USA, V87, P7804, DOI 10.1073/pnas.87.20.7804; Neves G, 1999, J PHYSIOL-LONDON, V515, P181, DOI 10.1111/j.1469-7793.1999.181ad.x; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Pyle JL, 2000, NEURON, V28, P221, DOI 10.1016/S0896-6273(00)00098-2; Richards DA, 2000, NEURON, V27, P551, DOI 10.1016/S0896-6273(00)00065-9; Rouze NC, 1998, J NEUROSCI, V18, P8614; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; Ryan TA, 2001, CURR OPIN NEUROBIOL, V11, P544, DOI 10.1016/S0959-4388(00)00247-6; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042; Schmoranzer J, 2000, J CELL BIOL, V149, P23, DOI 10.1083/jcb.149.1.23; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Smith CB, 1996, NATURE, V380, P531, DOI 10.1038/380531a0; SPRUCE AE, 1990, NEURON, V4, P643, DOI 10.1016/0896-6273(90)90192-I; Stevens CF, 2000, P NATL ACAD SCI USA, V97, P12828, DOI 10.1073/pnas.230438697; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; Steyer JA, 1997, NATURE, V388, P474, DOI 10.1038/41329; Steyer JA, 2001, NAT REV MOL CELL BIO, V2, P268, DOI 10.1038/35067069; Sund SE, 1999, BIOPHYS J, V77, P2266, DOI 10.1016/S0006-3495(99)77066-9; THOMAS P, 1994, J CELL BIOL, V124, P667, DOI 10.1083/jcb.124.5.667; TORRITARELLI F, 1985, J CELL BIOL, V101, P1386, DOI 10.1083/jcb.101.4.1386; TSE FW, 1993, J CELL BIOL, V121, P543, DOI 10.1083/jcb.121.3.543; Tsuboi T, 2000, CURR BIOL, V10, P1307, DOI 10.1016/S0960-9822(00)00756-9; VALTORTA F, 1990, NEUROSCIENCE, V35, P477, DOI 10.1016/0306-4522(90)90323-V; Valtorta F, 2001, TRENDS CELL BIOL, V11, P324, DOI 10.1016/S0962-8924(01)02058-X; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; von Gersdorff H, 1998, NEURON, V21, P1177, DOI 10.1016/S0896-6273(00)80634-0; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; vonGersdorff H, 1997, J NEUROSCI, V17, P1919; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500	59	148	151	2	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 12	2002	35	6					1085	1097		10.1016/S0896-6273(02)00896-6	http://dx.doi.org/10.1016/S0896-6273(02)00896-6			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	594GC	12354398	Bronze			2022-12-24	WOS:000178040000009
J	Reisel, D; Bannerman, DM; Schmitt, WB; Deacon, RMJ; Flint, J; Borchardt, T; Seeburg, PH; Rawlins, JNP				Reisel, D; Bannerman, DM; Schmitt, WB; Deacon, RMJ; Flint, J; Borchardt, T; Seeburg, PH; Rawlins, JNP			Spatial memory dissociations in mice lacking GluR1	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; HIPPOCAMPUS; IMPAIRMENT; ANTAGONIST; LESIONS; COMPONENTS; BLOCKADE; RATS; AP5	Gene-targeted mice lacking the AMPA receptor subunit GluR1 (GluR-A) have deficits in hippocampal CA3-CA1 long-term potentiation. We now report that they showed normal spatial reference learning and memory, both on the hidden platform watermaze task and on an appetitively motivated Y-maze task. In contrast, they showed a specific spatial working memory impairment during tests of non-matching to place on both the Y-maze and an elevated T-maze. In addition, successful watermaze and Y-maze reference memory performance depended on hippocampal function in both wild-type and mutant mice; bilateral hippocampal lesions profoundly impaired performance on both tasks, to a similar extent in both groups. These results suggest that different forms of hippocampus-dependent spatial memory involve different aspects of neural processing within the hippocampus.	Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Max Planck Inst Med Res, Dept Mol Neurobiol, D-69120 Heidelberg, Germany	University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Max Planck Society	Bannerman, DM (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.		Borchardt, Thilo/E-7844-2011	Borchardt, Thilo/0000-0002-2960-0267; Bannerman, David/0000-0002-3024-7595; Reisel, Dan/0000-0001-9018-4621; Flint, Jonathan/0000-0002-9427-4429				BANNERMAN DM, 1995, NATURE, V378, P182, DOI 10.1038/378182a0; Bannerman DM, 1999, BEHAV NEUROSCI, V113, P1170, DOI 10.1037/0735-7044.113.6.1170; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Chen C, 1997, ANNU REV NEUROSCI, V20, P157, DOI 10.1146/annurev.neuro.20.1.157; Deacon RMJ, 2002, BEHAV BRAIN RES, V133, P57, DOI 10.1016/S0166-4328(01)00451-X; Hoffman DA, 2002, P NATL ACAD SCI USA, V99, P7740, DOI 10.1073/pnas.092157999; Logue SE, 1997, BEHAV NEUROSCI, V111, P104, DOI 10.1037/0735-7044.111.1.104; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1990, EUR J NEUROSCI, V2, P1016, DOI 10.1111/j.1460-9568.1990.tb00014.x; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OLTON DS, 1979, BEHAV BRAIN SCI, V2, P313, DOI 10.1017/S0140525X00062713; Paulsen O, 2000, CURR OPIN NEUROBIOL, V10, P172, DOI 10.1016/S0959-4388(00)00076-3; Pike FG, 1999, J PHYSIOL-LONDON, V518, P571, DOI 10.1111/j.1469-7793.1999.0571p.x; RAWLINS JNP, 1982, BEHAV BRAIN RES, V5, P331, DOI 10.1016/0166-4328(82)90039-0; SAUCIER D, 1995, NATURE, V378, P186, DOI 10.1038/378186a0; Steele RJ, 1999, HIPPOCAMPUS, V9, P118, DOI 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; TONKISS J, 1991, EXP BRAIN RES, V85, P349; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805	26	265	276	0	20	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2002	5	9					868	873		10.1038/nn910	http://dx.doi.org/10.1038/nn910			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587RL	12195431				2022-12-24	WOS:000177656300017
J	Dockendorff, TC; Su, HS; McBride, SMJ; Yang, ZH; Choi, CH; Siwicki, KK; Sehgal, A; Jongens, TA				Dockendorff, TC; Su, HS; McBride, SMJ; Yang, ZH; Choi, CH; Siwicki, KK; Sehgal, A; Jongens, TA			Drosophila lacking dfmr1 activity show defects in circadian output and fail to maintain courtship interest	NEURON			English	Article							LONG-TERM-MEMORY; MENTAL-RETARDATION PROTEIN; FRAGILE-X-SYNDROME; BEHAVIORAL RHYTHMS; LOCOMOTOR-ACTIVITY; MUSHROOM BODIES; NERVOUS-SYSTEM; RNA-BINDING; KINASE-A; GENE	Fragile X mental retardation is a prominent genetic disorder caused by the lack of the FMR1 gene product, a known RNA binding protein. Specific physiologic pathways regulated by FMR1 function have yet to be identified. Adult dfmr1 (also called dfxr) mutant flies display arrhythmic circadian activity and have erratic patterns of locomotor activity, whereas overexpression of dFMR1 leads to a lengthened period. dfmr1 mutant males also display reduced courtship activity which appears to result from their inability to maintain courtship interest. Molecular analysis fails to reveal any defects in the expression of clock components; however, the CREB output is affected. Morphological analysis of neurons required for normal circadian behavior reveals subtle abnormalities, suggesting that defects in axonal pathfinding or synapse formation may cause the observed behavioral defects.	Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Swarthmore Coll, Dept Biol, Swarthmore, PA 19081 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Howard Hughes Medical Institute; University of Pennsylvania; Swarthmore College	Jongens, TA (corresponding author), Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA.	jongens@mail.med.upenn.edu						ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; Backes M, 2000, AM J MED GENET, V95, P150; Bakker CE, 2000, EXP CELL RES, V258, P162, DOI 10.1006/excr.2000.4932; BAKKER CE, 1994, CELL, V78, P23; BALLINGER DG, 1988, P NATL ACAD SCI USA, V85, P3960, DOI 10.1073/pnas.85.11.3960; Belvin MP, 1999, NEURON, V22, P777, DOI 10.1016/S0896-6273(00)80736-9; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; de Vries BBA, 1998, J MED GENET, V35, P579, DOI 10.1136/jmg.35.7.579; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Faulkner DL, 1998, DEV GENET, V23, P264, DOI 10.1002/(SICI)1520-6408(1998)23:4<264::AID-DVG2>3.0.CO;2-6; Feng Y, 1997, J NEUROSCI, V17, P1539; FERVEUR JF, 1995, SCIENCE, V267, P902, DOI 10.1126/science.7846534; Gould EL, 2000, AM J MED GENET, V95, P307; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; Guo HF, 2000, NATURE, V403, P895, DOI 10.1038/35002593; HAGERMAN RJ, 1996, FRAGILE X SYNDROME D, P3; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Helfrich-Forster C, 2000, J NEUROSCI, V20, P3339, DOI 10.1523/JNEUROSCI.20-09-03339.2000; Helfrich-Forster C, 1998, J COMP PHYSIOL A, V182, P435, DOI 10.1007/s003590050192; HELFRICHFORSTER C, 1995, P NATL ACAD SCI USA, V92, P612, DOI 10.1073/pnas.92.2.612; HELFRICHFORSTER C, 1993, J COMP NEUROL, V337, P177, DOI 10.1002/cne.903370202; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Jefferis GSXE, 2002, CURR OPIN NEUROBIOL, V12, P80, DOI 10.1016/S0959-4388(02)00293-3; Jin P, 2000, HUM MOL GENET, V9, P901, DOI 10.1093/hmg/9.6.901; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Majercak J, 1997, MOL CELL BIOL, V17, P5915, DOI 10.1128/MCB.17.10.5915; Martin JR, 1999, J COMP PHYSIOL A, V185, P277, DOI 10.1007/s003590050387; Martin JR, 1998, LEARN MEMORY, V5, P179; McBride SMJ, 1999, NEURON, V24, P967, DOI 10.1016/S0896-6273(00)81043-0; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Orgad S, 2000, GENETICS, V155, P1267; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; REISCHMANN T, 1995, S AFR J GEOL, V1, P1; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Rorth P, 1998, DEVELOPMENT, V125, P1049; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; SEHGAL A, 1994, SCIENCE, V263, P1603, DOI 10.1126/science.8128246; Shimizu K, 1999, FEBS LETT, V458, P363, DOI 10.1016/S0014-5793(99)01190-4; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; SIOMI H, 1994, CELL, V77, P33, DOI 10.1016/0092-8674(94)90232-1; SIOMI MC, 1995, EMBO J, V14, P2401, DOI 10.1002/j.1460-2075.1995.tb07237.x; Siomi MC, 1996, MOL CELL BIOL, V16, P3825; SKOULAKIS EMC, 1993, NEURON, V11, P197, DOI 10.1016/0896-6273(93)90178-T; Wan LL, 2000, MOL CELL BIOL, V20, P8536, DOI 10.1128/MCB.20.22.8536-8547.2000; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; Williams JA, 2001, SCIENCE, V293, P2251, DOI 10.1126/science.1063097; Williams JA, 2001, ANNU REV PHYSIOL, V63, P729, DOI 10.1146/annurev.physiol.63.1.729; Yang ZH, 2001, NEURON, V29, P453, DOI 10.1016/S0896-6273(01)00218-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; ZHANG Y, 1995, EMBO J, V14, P5358, DOI 10.1002/j.1460-2075.1995.tb00220.x; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X	56	228	235	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 13	2002	34	6					973	984		10.1016/S0896-6273(02)00724-9	http://dx.doi.org/10.1016/S0896-6273(02)00724-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	563HF	12086644	Bronze			2022-12-24	WOS:000176249700014
J	Zhu, JJ; Malinow, R				Zhu, JJ; Malinow, R			Acute versus chronic NMDA receptor blockade and synaptic AMPA receptor delivery	NATURE NEUROSCIENCE			English	Article							SILENT SYNAPSES; POTENTIATION; MATURATION; ACTIVATION; NUMBER		Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Univ Virginia, Sch Med, Dept Pharmacol, Charlottesville, VA 22908 USA	Cold Spring Harbor Laboratory; University of Virginia	Malinow, R (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	malinow@cshl.org						Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Gomperts SN, 2000, J NEUROSCI, V20, P2229; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hsia AY, 1998, J NEUROPHYSIOL, V79, P2013, DOI 10.1152/jn.1998.79.4.2013; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; Liao DZ, 2001, J NEUROSCI, V21, P6008, DOI 10.1523/JNEUROSCI.21-16-06008.2001; Luthi A, 2001, NAT NEUROSCI, V4, P1102, DOI 10.1038/nn744; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614	15	50	52	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2002	5	6					513	514		10.1038/nn0602-850	http://dx.doi.org/10.1038/nn0602-850			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	556XQ	11967548				2022-12-24	WOS:000175874600008
J	Del Negro, CA; Morgado-Valle, C; Feldman, JL				Del Negro, CA; Morgado-Valle, C; Feldman, JL			Respiratory rhythm: An emergent network property?	NEURON			English	Article							PRE-BOTZINGER COMPLEX; NEUROPROTECTIVE AGENT RILUZOLE; STEM IN-VITRO; PATCH-CLAMP RECORDINGS; CHICK SENSORY NEURONS; PREBOTZINGER COMPLEX; PACEMAKER NEURONS; NEONATAL-RAT; NEWBORN RATS; SYNAPTIC TRANSMISSION	We tested the hypothesis that pacemaker neurons generate breathing rhythm in mammals. We monitored respiratory-related motor nerve rhythm in neonatal rodent slice preparations. Blockade of the persistent sodium current (I(NaP)), which was postulated to underlie voltage-dependent bursting in respiratory pacemaker neurons, with riluzole (less than or equal to200 muM) did not alter the frequency of respiratory-related motor output. Yet, in every pacemaker neuron recorded (50/50), bursting was abolished at much lower concentrations of riluzole (less than or equal to520 muM). Thus, eliminating the pacemaker population (our statistics confirm that this population is reduced at least 94%, p < 0.05) does not affect respiratory rhythm. These results suggest that voltage-dependent bursting in pacemaker neurons is not essential for respiratory rhythmogenesis, which may instead be an emergent network property.	Univ Calif Los Angeles, Dept Neurobiol, Syst Neurobiol Lab, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Del Negro, CA (corresponding author), Univ Calif Los Angeles, Dept Neurobiol, Syst Neurobiol Lab, Box 95-1763, Los Angeles, CA 90095 USA.	delnegro@ucla.edu	Del Negro, Christopher A./AAB-4565-2020; Del Negro, Ciro/K-3451-2013; feldman, jack/AAO-7505-2021; Morgado-Valle, Consuelo/G-6109-2019	Del Negro, Christopher A./0000-0002-7848-8224; feldman, jack/0000-0003-3692-9412; Morgado-Valle, Consuelo/0000-0003-0158-7096	NHLBI NIH HHS [HL-40959, R01 HL040959] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL040959] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baker RE, 1995, INT J DEV NEUROSCI, V13, P799, DOI 10.1016/0736-5748(95)00081-X; Ballanyi K, 1999, PROG NEUROBIOL, V59, P583, DOI 10.1016/S0301-0082(99)00009-X; Brockhaus J, 1998, EUR J NEUROSCI, V10, P3823, DOI 10.1046/j.1460-9568.1998.00396.x; Butera RJ, 1999, J NEUROPHYSIOL, V82, P398, DOI 10.1152/jn.1999.82.1.398; Butera RJ, 1999, J NEUROPHYSIOL, V82, P382, DOI 10.1152/jn.1999.82.1.382; CHERAMY A, 1992, NEUROSCI LETT, V147, P209, DOI 10.1016/0304-3940(92)90597-Z; DEBONO MW, 1993, EUR J PHARMACOL, V235, P283, DOI 10.1016/0014-2999(93)90147-A; Del Negro CA, 2001, J NEUROPHYSIOL, V86, P59, DOI 10.1152/jn.2001.86.1.59; Duprat F, 2000, MOL PHARMACOL, V57, P906; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; FELDMAN JL, 1989, ANN NY ACAD SCI, V563, P114, DOI 10.1111/j.1749-6632.1989.tb42194.x; FOX AP, 1987, J PHYSIOL-LONDON, V394, P149, DOI 10.1113/jphysiol.1987.sp016864; FOX AP, 1987, J PHYSIOL-LONDON, V394, P173, DOI 10.1113/jphysiol.1987.sp016865; FUNK GD, 1993, J NEUROPHYSIOL, V70, P1497, DOI 10.1152/jn.1993.70.4.1497; Ge Q, 1998, J PHYSIOL-LONDON, V509, P255, DOI 10.1111/j.1469-7793.1998.255bo.x; Gray PA, 2001, NAT NEUROSCI, V4, P927, DOI 10.1038/nn0901-927; Gray PA, 1999, SCIENCE, V286, P1566, DOI 10.1126/science.286.5444.1566; Huang CS, 1997, J PHARMACOL EXP THER, V282, P1280; Inoue S., 1997, VIDEO MICROSCOPY FUN; Jehle T, 2000, BRIT J PHARMACOL, V130, P1227, DOI 10.1038/sj.bjp.0703424; JOHNSON SM, 1994, J NEUROPHYSIOL, V72, P2598, DOI 10.1152/jn.1994.72.6.2598; Koshiya N, 1999, NATURE, V400, P360, DOI 10.1038/22540; Manly BFJ., 2017, RANDOMIZATION MONTE, DOI 10.1201/9781315273075; MARTIN D, 1993, EUR J PHARMACOL, V250, P473, DOI 10.1016/0014-2999(93)90037-I; MIZOULE J, 1985, NEUROPHARMACOLOGY, V24, P767, DOI 10.1016/0028-3908(85)90011-5; ONIMARU H, 1990, PFLUG ARCH EUR J PHY, V417, P425, DOI 10.1007/BF00370663; Onimaru H, 1997, JPN J PHYSIOL, V47, P385, DOI 10.2170/jjphysiol.47.385; ONIMARU H, 1989, EXP BRAIN RES, V76, P530, DOI 10.1007/BF00248909; Rekling JC, 1998, ANNU REV PHYSIOL, V60, P385, DOI 10.1146/annurev.physiol.60.1.385; Rekling JC, 1997, J NEUROPHYSIOL, V78, P2483, DOI 10.1152/jn.1997.78.5.2483; Rekling JC, 1996, J NEUROPHYSIOL, V75, P795, DOI 10.1152/jn.1996.75.2.795; Rekling JC, 1997, J NEUROPHYSIOL, V78, P3508, DOI 10.1152/jn.1997.78.6.3508; Rekling JC, 2000, J NEUROSCI, V20, part. no.; Richter DW, 2001, TRENDS NEUROSCI, V24, P464, DOI 10.1016/S0166-2236(00)01867-1; Ritter B, 2000, EUR J NEUROSCI, V12, P2975, DOI 10.1046/j.1460-9568.2000.00152.x; Rybak IA, 2001, ADV EXP MED BIOL, V499, P159; Shao XM, 1997, J NEUROPHYSIOL, V77, P1853, DOI 10.1152/jn.1997.77.4.1853; Siniscalchi A, 1997, BRIT J PHARMACOL, V120, P225, DOI 10.1038/sj.bjp.0700905; Smith JC, 2000, RESP PHYSIOL, V122, P131, DOI 10.1016/S0034-5687(00)00155-9; SMITH JC, 1992, NEUROSCI LETT, V134, P153, DOI 10.1016/0304-3940(92)90504-Z; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; SMITH JC, 1997, NEURONS NETWORKS MOT, P97; Song JH, 1997, J PHARMACOL EXP THER, V282, P707; Stefani A, 1997, EXP NEUROL, V147, P115, DOI 10.1006/exnr.1997.6554; Thoby-Brisson M, 2001, J NEUROPHYSIOL, V86, P104, DOI 10.1152/jn.2001.86.1.104; Umemiya M, 1995, BRIT J PHARMACOL, V116, P3227, DOI 10.1111/j.1476-5381.1995.tb15128.x; Urbani A, 2000, EUR J NEUROSCI, V12, P3567, DOI 10.1046/j.1460-9568.2000.00242.x; Wang H, 2001, J COMP NEUROL, V434, P128, DOI 10.1002/cne.1169; Xu L, 2001, J PHARMACOL EXP THER, V299, P227	49	187	187	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 30	2002	34	5					821	830		10.1016/S0896-6273(02)00712-2	http://dx.doi.org/10.1016/S0896-6273(02)00712-2			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	558DV	12062027	Bronze			2022-12-24	WOS:000175951800015
J	Bradley, SR; Pieribone, VA; Wang, WG; Severson, CA; Jacobs, RA; Richerson, GB				Bradley, SR; Pieribone, VA; Wang, WG; Severson, CA; Jacobs, RA; Richerson, GB			Chemosensitive serotonergic neurons are closely associated with large medullary arteries	NATURE NEUROSCIENCE			English	Article							INFANT-DEATH-SYNDROME; RAPHE NEURONS; IMMUNOREACTIVITY; NUCLEI; SYSTEM; CATS; RAT		Yale Univ, Dept Neurol, New Haven, CT 06510 USA; Yale Univ, Dept Cell & Mol Physiol, New Haven, CT 06510 USA; J Pierce Lab, New Haven, CT 06510 USA; Salk Inst Biol Studies, La Jolla, CA 92037 USA; Vet Affairs Med Ctr, West Haven, CT 06516 USA	Yale University; Yale University; Yale University; The John B Pierce Laboratory, Inc; Salk Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Richerson, GB (corresponding author), Yale Univ, Dept Neurol, 333 Cedar St, New Haven, CT 06510 USA.			Richerson, George/0000-0001-5696-1554; Pieribone, Vincent/0000-0002-5836-5454	NHLBI NIH HHS [HL-52539] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bernard DG, 1996, J APPL PHYSIOL, V80, P108, DOI 10.1152/jappl.1996.80.1.108; FELTEN DL, 1979, AM J ANAT, V155, P467, DOI 10.1002/aja.1001550405; JACOBS BL, 1992, PHYSIOL REV, V72, P165, DOI 10.1152/physrev.1992.72.1.165; Kinney HC, 2001, J NEUROPATH EXP NEUR, V60, P228, DOI 10.1093/jnen/60.3.228; LALLEY PM, 1986, J PHYSIOL-LONDON, V380, P373, DOI 10.1113/jphysiol.1986.sp016291; LARNICOL N, 1994, J PHYSIOLOGY-PARIS, V88, P81, DOI 10.1016/0928-4257(94)90094-9; MITCHELL RA, 1963, J APPL PHYSIOL, V18, P523, DOI 10.1152/jappl.1963.18.3.523; Panigrahy A, 2000, J NEUROPATH EXP NEUR, V59, P377, DOI 10.1093/jnen/59.5.377; Richerson GB, 2001, RESP PHYSIOL, V129, P175, DOI 10.1016/S0034-5687(01)00289-4; SCHEIBEL ME, 1975, EXP NEUROL, V47, P316, DOI 10.1016/0014-4886(75)90260-5; SCHLAEFKE ME, 1970, RESP PHYSIOL, V10, P198, DOI 10.1016/0034-5687(70)90083-6; STEINBUSCH HWM, 1981, NEUROSCIENCE, V6, P557, DOI 10.1016/0306-4522(81)90146-9; VEASEY SC, 1995, J NEUROSCI, V15, P5346; Wang WG, 1998, J PHYSIOL-LONDON, V511, P433, DOI 10.1111/j.1469-7793.1998.433bh.x; Wang WG, 2001, J NEUROPHYSIOL, V85, P2224, DOI 10.1152/jn.2001.85.5.2224	15	123	125	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2002	5	5					401	402		10.1038/nn848	http://dx.doi.org/10.1038/nn848			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	546JY	11967547				2022-12-24	WOS:000175272000008
J	Gerdeman, GL; Ronesi, J; Lovinger, DM				Gerdeman, GL; Ronesi, J; Lovinger, DM			Postsynaptic endocannabinoid release is critical to long-term depression in the striatum	NATURE NEUROSCIENCE			English	Article							CB1 CANNABINOID RECEPTOR; EXCITATORY SYNAPTIC TRANSMISSION; ACID AMIDE HYDROLASE; ENDOGENOUS CANNABINOIDS; KNOCKOUT MICE; DORSAL STRIATUM; PURKINJE-CELLS; BASAL GANGLIA; RAT; NEURONS	The striatum functions critically in movement control and habit formation. The development and function of cortical input to the striatum are thought to be regulated by activity-dependent plasticity of corticostriatal glutamatergic synapses. Here we show that the induction of a form of striatal synaptic plasticity, long-term depression (LTD), is dependent on activation of the CB1 cannabinoid receptor. LTD was facilitated by blocking cellular endocannabinoid uptake, and postsynaptic loading of anandamide (AEA) produced presynaptic depression. The endocannabinoid necessary for striatal LTD is thus likely to be released postsynaptically as a retrograde messenger. These findings demonstrate a new role for endocannabinoids in the induction of long-term synaptic plasticity in a circuit necessary for habit formation and motor control.	Vanderbilt Univ, Dept Physiol & Mol Biophys, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; Vanderbilt Univ, Ctr Mol Neurosci, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Lovinger, DM (corresponding author), NIAAA, Lab Integrat Neurosci, 158H Pk 5 Bldg, Rockville, MD 20852 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA005923] Funding Source: NIH RePORTER; NIDA NIH HHS [DA05923] Funding Source: Medline; NINDS NIH HHS [NS30470] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Auclair N, 2000, J NEUROPHYSIOL, V83, P3287, DOI 10.1152/jn.2000.83.6.3287; Beltramo M, 1997, SCIENCE, V277, P1094, DOI 10.1126/science.277.5329.1094; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Cadas H, 1996, J NEUROSCI, V16, P3934; CALABRESI P, 1992, J NEUROSCI, V12, P4224; Calabresi P, 1999, J NEUROSCI, V19, P2489; Calabresi P, 1997, J NEUROSCI, V17, P4536; Calabresi P, 1996, TRENDS NEUROSCI, V19, P19, DOI 10.1016/0166-2236(96)81862-5; Choi S, 1997, P NATL ACAD SCI USA, V94, P2665, DOI 10.1073/pnas.94.6.2665; Choi SK, 1997, J NEUROSCI, V17, P8613; Day TA, 2001, MOL PHARMACOL, V59, P1369, DOI 10.1124/mol.59.6.1369; Deutsch DG, 2001, J BIOL CHEM, V276, P6967, DOI 10.1074/jbc.M003161200; DEVANE WA, 1988, MOL PHARMACOL, V34, P605; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 1998, TRENDS NEUROSCI, V21, P521, DOI 10.1016/S0166-2236(98)01283-1; DIMARZO V, 1994, NATURE, V372, P686, DOI 10.1038/372686a0; Gerdeman G, 2001, J NEUROPHYSIOL, V85, P468, DOI 10.1152/jn.2001.85.1.468; Giuffrida A, 1999, NAT NEUROSCI, V2, P358, DOI 10.1038/7268; GOUGH AL, 1978, NEUROPHARMACOLOGY, V17, P137, DOI 10.1016/0028-3908(78)90126-0; Graybiel AM, 2000, NEURON, V28, P343, DOI 10.1016/S0896-6273(00)00113-6; Gubellini P, 2001, NEUROPHARMACOLOGY, V40, P839, DOI 10.1016/S0028-3908(01)00021-1; HERKENHAM M, 1991, BRAIN RES, V547, P267, DOI 10.1016/0006-8993(91)90970-7; Hillard CJ, 2000, CHEM PHYS LIPIDS, V108, P123, DOI 10.1016/S0009-3084(00)00191-2; Huang CC, 2001, J PHYSIOL-LONDON, V532, P731, DOI 10.1111/j.1469-7793.2001.0731e.x; Jog MS, 1999, SCIENCE, V286, P1745, DOI 10.1126/science.286.5445.1745; Knowlton BJ, 1996, SCIENCE, V273, P1399, DOI 10.1126/science.273.5280.1399; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Leckman JF, 2000, NEURON, V28, P349, DOI 10.1016/S0896-6273(00)00114-8; Ledent C, 1999, SCIENCE, V283, P401, DOI 10.1126/science.283.5400.401; Levenes C, 1998, J PHYSIOL-LONDON, V510, P867, DOI 10.1111/j.1469-7793.1998.867bj.x; LOVINGER DM, 1993, J NEUROPHYSIOL, V70, P1937, DOI 10.1152/jn.1993.70.5.1937; Maccarrone M, 2000, J BIOL CHEM, V275, P13484, DOI 10.1074/jbc.275.18.13484; Maejima T, 2001, NEURON, V31, P463, DOI 10.1016/S0896-6273(01)00375-0; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Partridge JG, 2000, J NEUROPHYSIOL, V84, P1422, DOI 10.1152/jn.2000.84.3.1422; Rodriguez JJ, 2001, J NEUROSCI, V21, P823, DOI 10.1523/JNEUROSCI.21-03-00823.2001; Steiner H, 1999, P NATL ACAD SCI USA, V96, P5786, DOI 10.1073/pnas.96.10.5786; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Sung KW, 2001, J NEUROPHYSIOL, V86, P2405, DOI 10.1152/jn.2001.86.5.2405; Tang KC, 2001, P NATL ACAD SCI USA, V98, P1255, DOI 10.1073/pnas.031374698; Varma N, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-24-j0003.2001; WALSH JP, 1993, BRAIN RES, V608, P123, DOI 10.1016/0006-8993(93)90782-I; Wilson CJ, 1996, J NEUROSCI, V16, P2397; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	48	542	557	0	18	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2002	5	5					446	451		10.1038/nn832	http://dx.doi.org/10.1038/nn832			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	546JY	11976704				2022-12-24	WOS:000175272000015
J	Gau, D; Lemberger, T; von Gall, C; Kretz, O; Minh, NL; Gass, P; Schmid, W; Schibler, U; Korf, HW; Schutz, G				Gau, D; Lemberger, T; von Gall, C; Kretz, O; Minh, NL; Gass, P; Schmid, W; Schibler, U; Korf, HW; Schutz, G			Phosphorylation of CREB Ser142 regulates light-induced phase shifts of the circadian clock	NEURON			English	Article								Biological rhythms are driven in mammals by a central circadian clock located in the suprachiasmatic nucleus (SCN). Light-induced phase shifting of this clock is correlated with phosphorylation of CREB at Ser133 in the SCN. Here, we characterize phosphorylation of CREB at Ser142 and describe its contribution to the entrainment of the clock. In the SCN, light and glutamate strongly induce CREB Ser142 phosphorylation. To determine the physiological relevance of phosphorylation at Ser142, we generated a mouse mutant, CREBS142A, lacking this phosphorylation site. Light-induced phase shifts of locomotion and expression of c-Fos and mPer1 in the SCN are significantly attenuated in CREBS142A mutants. Our findings provide genetic evidence that CREB Ser142 phosphorylation is involved in the entrainment of the mammalian clock and reveal a novel phosphorylation-dependent regulation of CREB activity.	German Canc Res Ctr, Div Mol Biol Cell 1, D-69120 Heidelberg, Germany; Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland; Zent Inst Seel Gesundheit, D-68159 Mannheim, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); University of Geneva; Central Institute of Mental Health	Schutz, G (corresponding author), German Canc Res Ctr, Div Mol Biol Cell 1, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.		Lemberger, Thomas/A-7301-2008; Von+Gall, Charlotte/AAJ-2160-2021; Korf, Horst/ACX-9860-2022	Lemberger, Thomas/0000-0002-2499-4025; Von+Gall, Charlotte/0000-0002-5088-3118; Korf, Horst/0000-0002-5051-0303; Kretz, Oliver/0000-0003-1152-5956					0	203	208	1	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 11	2002	34	2					245	252		10.1016/S0896-6273(02)00656-6	http://dx.doi.org/10.1016/S0896-6273(02)00656-6			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	541GE	11970866	Bronze			2022-12-24	WOS:000174976200010
J	Haggard, P; Clark, S; Kalogeras, J				Haggard, P; Clark, S; Kalogeras, J			Voluntary action and conscious awareness	NATURE NEUROSCIENCE			English	Article							INTENTION	Humans have the conscious experience of 'free will': we feel we can generate our actions, and thus affect our environment. Here we used the perceived time of intentional actions and of their sensory consequences as a means to study consciousness of action. These perceived times were attracted together in conscious awareness, so that subjects perceived voluntary movements as occurring later and their sensory consequences as occurring earlier than they actually did. Comparable involuntary movements caused by magnetic brain stimulation reversed this attraction effect. We conclude that the CNS applies a specific neural mechanism to produce intentional binding of actions and their effects in conscious awareness.	UCL, Inst Cognit Neurosci, London WC1N 3AR, England	University of London; University College London	Haggard, P (corresponding author), UCL, Inst Cognit Neurosci, 17 Queen Sq, London WC1N 3AR, England.	p.haggard@ucl.ac.uk	Haggard, Patrick/A-5081-2010	Haggard, Patrick/0000-0001-7798-793X				Blakemore SJ, 2000, NEUROREPORT, V11, pR11, DOI 10.1097/00001756-200008030-00002; Blakemore SJ, 1999, J COGNITIVE NEUROSCI, V11, P551, DOI 10.1162/089892999563607; BREITMEYER BG, 1985, BEHAV BRAIN SCI, V8, P539, DOI 10.1017/S0140525X00044915; Daprati E, 1997, COGNITION, V65, P71, DOI 10.1016/S0010-0277(97)00039-5; Elsner B, 2001, J EXP PSYCHOL HUMAN, V27, P229, DOI 10.1037/0096-1523.27.1.229; Fink GR, 1999, BRAIN, V122, P497, DOI 10.1093/brain/122.3.497; FRITH C. D., 1992, COGNITIVE NEUROPSYCH; Haggard P, 1999, EXP BRAIN RES, V126, P128, DOI 10.1007/s002210050722; Haggard P, 1999, EXP BRAIN RES, V127, P102, DOI 10.1007/s002210050778; Hommel B, 1996, PSYCHOL RES-PSYCH FO, V59, P176, DOI 10.1007/BF00425832; LIBET B, 1983, BRAIN, V106, P623, DOI 10.1093/brain/106.3.623; Reason J., 1991, HUMAN ERROR, DOI 10.1017/cbo9781139062367; Shore DI, 2001, PSYCHOL SCI, V12, P205, DOI 10.1111/1467-9280.00337; Sternberg S., 1973, ATTENTION PERFORM, VIV, P629; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497	15	888	897	8	162	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2002	5	4					382	385		10.1038/nn827	http://dx.doi.org/10.1038/nn827			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	534UQ	11896397				2022-12-24	WOS:000174606900020
J	Hanley, JG; Khatri, L; Hanson, PI; Ziff, EB				Hanley, JG; Khatri, L; Hanson, PI; Ziff, EB			NSF ATPase and alpha-/beta-SNAPs disassemble the AMPA receptor-PICK1 complex	NEURON			English	Article							SENSITIVE FUSION PROTEIN; DOMAIN-CONTAINING PROTEIN; PDZ DOMAIN; SYNAPTIC TRANSMISSION; MEMBRANE-FUSION; CRYSTAL-STRUCTURE; C-TERMINUS; IN-VITRO; GLUR2; BINDING	AMPA receptor (AMPAR) trafficking is crucial for synaptic plasticity that may be important for learning and memory. NSF and PICK1 bind the AMPAR GluR2 subunit and are involved in trafficking of AMPARs. Here, we show that GluR2, PICK1, NSF, and alpha-/beta-SNAPs form a complex in the presence of ATPgammaS. Similar to SNARE complex disassembly, NSF ATPase activity disrupts PICK1-GluR2 interactions in this complex. alpha-and beta-SNAP have differential effects on this reaction. SNAP overexpression in hippocampal neurons leads to corresponding changes in AMPAR trafficking by acting on GluR2-PICK1 complexes. This demonstrates that the previously reported synaptic stabilization of AMPARs by NSF involves disruption of GluR2-PICK1 interactions. Furthermore, we are reporting a non-SNARE substrate for NSF disassembly activity.	NYU, Sch Med, Dept Biochem, Howard Hughes Med Inst, New York, NY 10016 USA; Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Howard Hughes Medical Institute; New York University; Washington University (WUSTL)	Ziff, EB (corresponding author), NYU, Sch Med, Dept Biochem, Howard Hughes Med Inst, New York, NY 10016 USA.		Hanson, Phyllis/E-9420-2012	Ziff, Edward/0000-0001-7389-8649; Hanley, Jonathan/0000-0003-1704-4707	NATIONAL INSTITUTE ON AGING [R01AG013620, R37AG013620] Funding Source: NIH RePORTER; NIA NIH HHS [AG 13620] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Barnard RJO, 1997, J CELL BIOL, V139, P875, DOI 10.1083/jcb.139.4.875; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Braithwaite SP, 2000, NEUROPHARMACOLOGY, V39, P919, DOI 10.1016/S0028-3908(99)00171-9; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Chung HJ, 2000, J NEUROSCI, V20, P7258; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Fleming KG, 1998, J BIOL CHEM, V273, P15675, DOI 10.1074/jbc.273.25.15675; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; HANSON PI, 1995, J BIOL CHEM, V270, P16955, DOI 10.1074/jbc.270.28.16955; HAYASHI T, 1995, EMBO J, V14, P2317, DOI 10.1002/j.1460-2075.1995.tb07226.x; Iwakura Y, 2001, J BIOL CHEM, V276, P40025, DOI 10.1074/jbc.M103125200; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Lin RC, 2000, ANNU REV CELL DEV BI, V16, P19, DOI 10.1146/annurev.cellbio.16.1.19; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; Man HY, 2000, CELL MOL LIFE SCI, V57, P1526, DOI 10.1007/PL00000637; Matsuda S, 1999, J NEUROCHEM, V73, P1765, DOI 10.1046/j.1471-4159.1999.731765.x; Matsuda S, 2000, EMBO J, V19, P2765, DOI 10.1093/emboj/19.12.2765; May AP, 1999, NAT CELL BIOL, V1, P175, DOI 10.1038/11097; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Perez JL, 2001, J NEUROSCI, V21, P5417, DOI 10.1523/JNEUROSCI.21-15-05417.2001; Rice LM, 1999, MOL CELL, V4, P85, DOI 10.1016/S1097-2765(00)80190-2; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; SCHIAVO G, 1995, NATURE, V378, P733, DOI 10.1038/378733a0; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; SIEGEL SJ, 1994, P NATL ACAD SCI USA, V91, P564, DOI 10.1073/pnas.91.2.564; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; Sudlow AW, 1996, FEBS LETT, V393, P185, DOI 10.1016/0014-5793(96)00880-0; Takeya R, 2000, BIOCHEM BIOPH RES CO, V267, P149, DOI 10.1006/bbrc.1999.1932; Tarricone C, 2001, NATURE, V411, P215, DOI 10.1038/35075620; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; WHITEHEART SW, 1993, NATURE, V362, P353, DOI 10.1038/362353a0; WILSON DW, 1992, J CELL BIOL, V117, P531, DOI 10.1083/jcb.117.3.531; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3	46	150	163	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 28	2002	34	1					53	67		10.1016/S0896-6273(02)00638-4	http://dx.doi.org/10.1016/S0896-6273(02)00638-4			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536HR	11931741	Bronze			2022-12-24	WOS:000174695100009
J	Mansvelder, HD; Keath, JR; McGehee, DS				Mansvelder, HD; Keath, JR; McGehee, DS			Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas	NEURON			English	Article							VENTRAL TEGMENTAL AREA; INDUCED DOPAMINE RELEASE; RAT HIPPOCAMPAL INTERNEURONS; FREELY MOVING RATS; ACETYLCHOLINE-RECEPTORS; NUCLEUS-ACCUMBENS; SUBSTANTIA-NIGRA; GABAERGIC NEURONS; CA1 INTERNEURONS; GABA RELEASE	A single nicotine exposure increases dopamine levels in the mesolimbic reward system for hours, but nicotine concentrations experienced by smokers desensitize nAChRs on dopamine neurons in seconds to minutes. Here, we show that persistent modulation of both GABAergic and glutamatergic synaptic transmission by nicotine can contribute to the sustained increase in dopamine neuron excitability. Nicotine enhances GABAergic transmission transiently, which is followed by a persistent depression of these inhibitory inputs due to nAChR desensitization. Simultaneously, nicotine enhances glutamatergic transmission through nAChRs that desensitize less than those on GABA neurons. The net effect is a shift toward excitation of the dopamine reward system. These results suggest that spatial and temporal differences in nicotinic receptor activity on both excitatory and inhibitory neurons in reward areas coordinate to reinforce nicotine self-administration.	Univ Chicago, Dept Anesthesia & Crit Care, Chicago, IL 60637 USA; Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	McGehee, DS (corresponding author), Univ Chicago, Dept Anesthesia & Crit Care, 5841 S Maryland Ave,MC 4028, Chicago, IL 60637 USA.		Mansvelder, Huibert/N-6138-2018	Mansvelder, Huibert/0000-0003-1365-5340	NIDA NIH HHS [DA07255] Funding Source: Medline; NINDS NIH HHS [NS35090] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007255] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Alkondon M, 2000, NEUROPHARMACOLOGY, V39, P2726, DOI 10.1016/S0028-3908(00)00156-8; Alkondon M, 2000, J NEUROSCI, V20, P66, DOI 10.1523/JNEUROSCI.20-01-00066.2000; Alkondon M, 1999, J NEUROSCI, V19, P2693; Alkondon M, 1997, J PHARMACOL EXP THER, V283, P1396; ALKONDON M, 1992, MOL PHARMACOL, V41, P802; ALKONDON M, 1993, J PHARMACOL EXP THER, V265, P1455; Blaha CD, 1996, J NEUROSCI, V16, P714; Bonci A, 1999, J NEUROSCI, V19, P3723; Camara AL, 1997, NEUROTOXICOLOGY, V18, P589; Cameron AC., 2013, REGRESSION ANAL COUN, V2nd ed, DOI 10.1017/CBO9781139013567; Charpantier E, 1998, NEUROREPORT, V9, P3097, DOI 10.1097/00001756-199809140-00033; CORRIGALL WA, 1994, BRAIN RES, V653, P278, DOI 10.1016/0006-8993(94)90401-4; Corringer PJ, 1998, J NEUROSCI, V18, P648; Court JA, 1998, NEUROSCIENCE, V87, P63, DOI 10.1016/S0306-4522(98)00088-8; Dani JA, 2000, EUR J PHARMACOL, V393, P31, DOI 10.1016/S0014-2999(00)00003-0; David V, 1997, PSYCHOPHARMACOLOGY, V130, P85, DOI 10.1007/s002130050214; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; DiFranza JR, 2000, TOB CONTROL, V9, P313, DOI 10.1136/tc.9.3.313; FELDBERG W, 1945, PHYSIOL REV, V25, P596, DOI 10.1152/physrev.1945.25.4.596; Fenster CP, 1997, J NEUROSCI, V17, P5747; Fiorillo CD, 2000, J NEUROSCI, V20, P7855; Fisher JL, 1998, J PHYSIOLOGY-PARIS, V92, P209, DOI 10.1016/S0928-4257(98)80012-0; Frazier CJ, 1998, J NEUROSCI, V18, P8228; Frazier CJ, 1998, J NEUROSCI, V18, P1187; Garzon M, 1999, J COMP NEUROL, V410, P197, DOI 10.1002/(SICI)1096-9861(19990726)410:2<197::AID-CNE3>3.0.CO;2-D; Gray R, 1996, NATURE, V383, P713, DOI 10.1038/383713a0; Grottick AJ, 2000, J PHARMACOL EXP THER, V294, P1112; Hamid S, 1997, NEUROSCI RES, V29, P81, DOI 10.1016/S0168-0102(97)00074-6; Hefft S, 1999, J PHYSIOL-LONDON, V515, P769, DOI 10.1111/j.1469-7793.1999.769ab.x; HENNINGFIELD JE, 1993, DRUG ALCOHOL DEPEN, V33, P23, DOI 10.1016/0376-8716(93)90030-T; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; Ikemoto S, 1997, BEHAV NEUROSCI, V111, P369, DOI 10.1037/0735-7044.111.2.369; Ikemoto S, 1997, J NEUROCHEM, V69, P137, DOI 10.1046/j.1471-4159.1997.69010137.x; IMPERATO A, 1986, EUR J PHARMACOL, V132, P337, DOI 10.1016/0014-2999(86)90629-1; Ji D, 2001, NEURON, V31, P131, DOI 10.1016/S0896-6273(01)00332-4; Ji DY, 2000, J NEUROPHYSIOL, V83, P2682, DOI 10.1152/jn.2000.83.5.2682; JOHNSON SW, 1992, J PHYSIOL-LONDON, V450, P455, DOI 10.1113/jphysiol.1992.sp019136; Jones S, 1999, TRENDS NEUROSCI, V22, P555, DOI 10.1016/S0166-2236(99)01471-X; Jones S, 1997, J PHYSIOL-LONDON, V504, P603, DOI 10.1111/j.1469-7793.1997.603bd.x; KALIVAS PW, 1993, NEUROSCIENCE, V57, P1047, DOI 10.1016/0306-4522(93)90048-K; Klink R, 2001, J NEUROSCI, V21, P1452, DOI 10.1523/JNEUROSCI.21-05-01452.2001; KOOB GF, 1992, TRENDS PHARMACOL SCI, V13, P177, DOI 10.1016/0165-6147(92)90060-J; Lena C, 1997, J NEUROSCI, V17, P576; LENA C, 1993, J NEUROSCI, V13, P2680, DOI 10.1523/JNEUROSCI.13-06-02680.1993; Lu Y, 1999, J PHARMACOL EXP THER, V291, P1127; LUETJE CW, 1990, FASEB J, V4, P2753, DOI 10.1096/fasebj.4.10.2197155; Mansvelder HD, 2000, NEURON, V27, P349, DOI 10.1016/S0896-6273(00)00042-8; MCGEHEE DS, 1995, SCIENCE, V269, P1692, DOI 10.1126/science.7569895; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; McQuiston AR, 1999, J NEUROSCI, V19, P2887; MERCURI NB, 1995, EUR J NEUROSCI, V7, P462, DOI 10.1111/j.1460-9568.1995.tb00342.x; NISELL M, 1994, SYNAPSE, V16, P36, DOI 10.1002/syn.890160105; OAKMAN SA, 1995, J NEUROSCI, V15, P5859; Peto R, 1999, NAT MED, V5, P15, DOI 10.1038/4691; PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D; Picciotto MR, 1998, NATURE, V391, P173, DOI 10.1038/34413; Pidoplichko VI, 1997, NATURE, V390, P401, DOI 10.1038/37120; Radcliffe KA, 1999, ANN NY ACAD SCI, V868, P591, DOI 10.1111/j.1749-6632.1999.tb11332.x; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; Schilstrom B, 1998, NEUROSCIENCE, V85, P1005, DOI 10.1016/S0306-4522(98)00114-6; Schilstrom B, 1998, NEUROSCIENCE, V82, P781; SEGUELA P, 1993, J NEUROSCI, V13, P596; Steffensen SC, 1998, J NEUROSCI, V18, P8003; Vanderschuren LJMJ, 1999, J NEUROSCI, V19, P9579, DOI 10.1523/jneurosci.19-21-09579.1999; WALAAS I, 1980, NEUROSCIENCE, V5, P63, DOI 10.1016/0306-4522(80)90071-8; Westerink BHC, 1996, J NEUROSCI, V16, P2605; World Health Organisation, 1999, COMB TOB EP; Yin RY, 2000, BRAIN RES BULL, V51, P507, DOI 10.1016/S0361-9230(00)00237-9	68	536	552	1	21	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 14	2002	33	6					905	919		10.1016/S0896-6273(02)00625-6	http://dx.doi.org/10.1016/S0896-6273(02)00625-6			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	530ZK	11906697	Bronze			2022-12-24	WOS:000174389600008
J	Moita, MAP; Rosis, S; Zhou, Y; LeDoux, JE; Blair, HT				Moita, MAP; Rosis, S; Zhou, Y; LeDoux, JE; Blair, HT			Hippocampal place cells acquire location-specific responses to the conditioned stimulus during auditory fear conditioning	NEURON			English	Article							LATERAL AMYGDALA NEURONS; LONG-TERM POTENTIATION; COMPLEX-SPIKE CELLS; CONTEXTUAL FEAR; RECOGNITION MEMORY; UNIT-ACTIVITY; RETROGRADE-AMNESIA; THETA-CELLS; RAT; BEHAVIOR	We recorded neurons from the hippocampus of freely behaving rats during an auditory fear conditioning task. Rats received either paired or unpaired presentations of an auditory conditioned stimulus (CS) and an electric shock unconditioned stimulus (US). Hippocampal neurons (place and theta cells) acquired responses to the auditory CS in the paired but not in the unpaired group. After CS-US pairing, rhythmic firing of theta cells became synchronized to the onset of the CS. Conditioned responses of place cells were gated by their location-specific firing, so that after CS-US pairing, place cells responded to the CS only when the rat was within the cell's place field. These findings may help to elucidate how the hippocampus contributes to context-specific memory formation during associative learning.	Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; NYU, Ctr Neural Sci, New York, NY 10003 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	University of California System; University of California Los Angeles; New York University; Cold Spring Harbor Laboratory	Blair, HT (corresponding author), Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA.	blair@psych.ucla.edu		Blair, Hugh/0000-0001-8256-5109; Moita, Marta/0000-0002-5144-6905	NIMH NIH HHS [MH46516, MH00956, MH12341, MH38774] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH038774, R37MH038774, R01MH046516, K02MH000956] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ABELES M, 1982, J NEUROSCI METH, V5, P317, DOI 10.1016/0165-0270(82)90002-4; Anagnostaras SG, 2001, HIPPOCAMPUS, V11, P8; Anagnostaras SG, 1999, J NEUROSCI, V19, P1106; BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; BERGER TW, 1976, SCIENCE, V192, P483, DOI 10.1126/science.1257783; BERGER TW, 1980, BRAIN RES, V193, P229, DOI 10.1016/0006-8993(80)90960-9; BERGER TW, 1983, J NEUROPHYSIOL, V50, P1197, DOI 10.1152/jn.1983.50.5.1197; BEST MR, 1976, EXP NEUROL, V51, P564, DOI 10.1016/0014-4886(76)90180-1; Blair HT, 2001, LEARN MEMORY, V8, P229, DOI 10.1101/lm.30901; BOLLES RC, 1980, BEHAV BRAIN SCI, V3, P291, DOI 10.1017/S0140525X0000491X; BOUTON ME, 1980, ANIM LEARN BEHAV, V8, P429, DOI 10.3758/BF03199629; Buchel C, 1999, J NEUROSCI, V19, P10869; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; BUZSAKI G, 1979, ELECTROEN CLIN NEURO, V47, P64, DOI 10.1016/0013-4694(79)90033-6; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Collins DR, 2000, LEARN MEMORY, V7, P97, DOI 10.1101/lm.7.2.97; Corcoran KA, 2001, J NEUROSCI, V21, P1720, DOI 10.1523/JNEUROSCI.21-05-01720.2001; Desmedt A, 1998, J NEUROSCI, V18, P480; EICHENBAUM H, 1989, J NEUROSCI, V9, P2764; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; FANSELOW MS, 1980, PAVLOVIAN J BIOL SCI, V15, P177; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; FOX SE, 1981, EXP BRAIN RES, V41, P399; Freeman JH, 1997, EXP BRAIN RES, V115, P445, DOI 10.1007/PL00005714; Hampson RE, 1999, NATURE, V402, P610, DOI 10.1038/45154; Holland PC, 1999, CURR OPIN NEUROBIOL, V9, P195, DOI 10.1016/S0959-4388(99)80027-0; Kim JJ, 1997, TRENDS NEUROSCI, V20, P177, DOI 10.1016/S0166-2236(96)10081-3; KIM JJ, 1995, BEHAV NEUROSCI, V109, P195, DOI 10.1037/0735-7044.109.2.195; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; LaBar KS, 1998, NEURON, V20, P937, DOI 10.1016/S0896-6273(00)80475-4; LAROCHE S, 1987, BEHAV NEURAL BIOL, V47, P356, DOI 10.1016/S0163-1047(87)90474-2; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LEUNG LS, 1980, BRAIN RES, V198, P119; LEVY WB, 1979, BRAIN RES, V175, P233, DOI 10.1016/0006-8993(79)91003-5; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; McEchron MD, 1997, J NEUROPHYSIOL, V78, P1030, DOI 10.1152/jn.1997.78.2.1030; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; MCNAUGHTON N, 1986, EXP BRAIN RES, V62, P250; Medina JF, 2002, NAT REV NEUROSCI, V3, P122, DOI 10.1038/nrn728; MULLER RU, 1987, J NEUROSCI, V7, P1935; Munera A, 2001, J NEUROPHYSIOL, V86, P2571, DOI 10.1152/jn.2001.86.5.2571; NADEL L, 2002, NEURAL BASIS NAVIGAT, P235, DOI DOI 10.1007/978-1-4615-0887-8_13; O'Keefe J, 1999, HIPPOCAMPUS, V9, P352, DOI 10.1002/(SICI)1098-1063(1999)9:4<352::AID-HIPO3>3.0.CO;2-1; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OLDS J, 1972, J NEUROPHYSIOL, V35, P202, DOI 10.1152/jn.1972.35.2.202; OTTO T, 1992, HIPPOCAMPUS, V2, P323, DOI 10.1002/hipo.450020310; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Pine DS, 2001, BIOL PSYCHIAT, V50, P225, DOI 10.1016/S0006-3223(01)01159-3; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; Redish AD, 2001, BEHAV BRAIN RES, V127, P81, DOI 10.1016/S0166-4328(01)00356-4; Repa JC, 2001, NAT NEUROSCI, V4, P724, DOI 10.1038/89512; RICHENBAUM H, 2000, CURR BIOL, V10, pR785; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; SAINSBURY RS, 1984, PHYSIOL BEHAV, V33, P621, DOI 10.1016/0031-9384(84)90381-0; SAINSBURY RS, 1987, PHYSIOL BEHAV, V39, P513, DOI 10.1016/0031-9384(87)90382-9; SAKURAI Y, 1994, J NEUROSCI, V14, P2606; Skaggs W., 1993, ADV NEURAL INFORM PR, V5, P1030; SMITH OA, 1980, FED PROC, V39, P2487; Squire LR, 1996, P NATL ACAD SCI USA, V93, P13515, DOI 10.1073/pnas.93.24.13515; STOLAR N, 1989, BEHAV NEUROSCI, V103, P919, DOI 10.1037/0735-7044.103.5.919; Tulving E, 1998, HIPPOCAMPUS, V8, P198, DOI 10.1002/(SICI)1098-1063(1998)8:3<198::AID-HIPO2>3.3.CO;2-J; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Wiebe SP, 1999, J NEUROSCI, V19, P10562; Wiebe SP, 2001, J NEUROSCI, V21, P3955, DOI 10.1523/JNEUROSCI.21-11-03955.2001; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605	66	187	189	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 6	2003	37	3					485	497		10.1016/S0896-6273(03)00033-3	http://dx.doi.org/10.1016/S0896-6273(03)00033-3			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	647FF	12575955	Bronze			2022-12-24	WOS:000181081600013
J	Maguire, EA; Valentine, ER; Wilding, JM; Kapur, N				Maguire, EA; Valentine, ER; Wilding, JM; Kapur, N			Routes to remembering: the brains behind superior memory	NATURE NEUROSCIENCE			English	Article							HUMAN NAVIGATION; MORPHOMETRY; HANDEDNESS; MNEMONICS; ASYMMETRY; IMAGERY	Why do some people have superior memory capabilities? We addressed this age-old question by examining individuals renowned for outstanding memory feats in forums such as the World Memory Championships. Using neuropsychological measures, as well as structural and functional brain imaging, we found that superior memory was not driven by exceptional intellectual ability or structural brain differences. Rather, we found that superior memorizers; used a spatial learning strategy, engaging brain regions such as the hippocampus that are critical for memory and for spatial memory in particular. These results illustrate how functional neuroimaging might prove valuable in delineating the neural substrates of mnemonic techniques, which could broaden the scope for memory improvement in the general population and the memory-impaired.	UCL, Neurol Inst, Wellcome Dept Imaging Neurosci, London WC1N 3BG, England; Univ London, Royal Holloway & Bedford New Coll, Dept Psychol, Egham TW20 0EX, Surrey, England; Southampton Gen Hosp, Wessex Neurol Ctr, Dept Clin Neuropsychol, Southampton SO16 6YD, Hants, England; Univ Southampton, Dept Psychol, Southampton SO16 6YD, Hants, England	University of London; University College London; University of London; Royal Holloway University London; University of Southampton; University of Southampton	Maguire, EA (corresponding author), UCL, Neurol Inst, Wellcome Dept Imaging Neurosci, 12 Queen Sq, London WC1N 3BG, England.	e.maguire@fil.ion.ucl.ac.uk	Valentine, Elizabeth/AAY-1032-2021		Wellcome Trust [071173] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Amidzic O, 2001, NATURE, V412, P603, DOI 10.1038/35088119; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; BELLEZZA FS, 1981, REV EDUC RES, V51, P247, DOI 10.2307/1170198; BENDER BG, 1978, J EDUC PSYCHOL, V70, P583, DOI 10.1037/0022-0663.70.4.583; BENNETTLEVY J, 1980, CORTEX, V16, P543, DOI 10.1016/S0010-9452(80)80002-5; Bentley W. A., 1962, SNOW CRYSTALS; BOWER GH, 1970, AM SCI, V58, P496; BROWN E, 1975, J HIST BEHAV SCI, V11, P342, DOI 10.1002/1520-6696(197510)11:4<342::AID-JHBS2300110404>3.0.CO;2-D; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Butcher J, 2000, LANCET, V356, P836; Chase W.G., 1982, PSYCHOL LEARN MOTIV, V16, P1, DOI [10.1016/S0079-7421(08)60546-0, DOI 10.1016/S0079-7421(08)60546-0]; COUGHLAN AK, 1985, ADULT MEMORY INFORMA; Deichmann R, 2000, NEUROIMAGE, V12, P112, DOI 10.1006/nimg.2000.0601; Dolan RJ, 1997, NATURE, V388, P582, DOI 10.1038/41561; Gadian DG, 2000, BRAIN, V123, P499, DOI 10.1093/brain/123.3.499; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Good CD, 2001, NEUROIMAGE, V14, P685, DOI 10.1006/nimg.2001.0857; Luria A.R., 1975, MIND MNEMONIST; Maguire EA, 2001, BRAIN, V124, P1156, DOI 10.1093/brain/124.6.1156; Maguire EA, 1998, SCIENCE, V280, P921, DOI 10.1126/science.280.5365.921; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Maguire EA, 2001, SCAND J PSYCHOL, V42, P225, DOI 10.1111/1467-9450.00233; MCMILLAN TM, 1984, CORTEX, V20, P333, DOI 10.1016/S0010-9452(84)80002-7; NEISSER U, 1982, MEMORY OBSERVED REME, P377; Nelson H., 1991, NATL ADULT READING T; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Osterrieth PA, 1944, ARCH PSYCHOLOGIE, V30, P205; Pesenti M, 2001, NAT NEUROSCI, V4, P103, DOI 10.1038/82831; *PSYCH CORP, 1986, WECHSL AD INT SCAL R; Psychological Corporation, 1999, WECHSL ABBR SCAL INT; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; RICHARDSON JTE, 1995, NEUROPSYCHOLOGIA, V33, P1345, DOI 10.1016/0028-3932(95)00068-E; ROEDIGER HL, 1980, J EXP PSYCHOL-HUM L, V6, P558, DOI 10.1037/0278-7393.6.5.558; SCHLAUG G, 1995, SCIENCE, V267, P699, DOI 10.1126/science.7839149; Tomaiuolo F, 1999, EUR J NEUROSCI, V11, P3033, DOI 10.1046/j.1460-9568.1999.00718.x; Toni I, 1999, EXP BRAIN RES, V127, P19, DOI 10.1007/s002210050770; Verhaeghen P, 1996, PSYCHOL AGING, V11, P164, DOI 10.1037/0882-7974.11.1.164; Wilding J. M., 1997, SUPERIOR MEMORY; Wilson B. A., 2002, NEUROPSYCHOLOGY MEMO, P263; Yates Frances, 1992, ART MEMORY	41	190	194	0	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2003	6	1					90	95		10.1038/nn988	http://dx.doi.org/10.1038/nn988			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	630CE	12483214				2022-12-24	WOS:000180089300020
J	Marek, KW; Davis, GW				Marek, KW; Davis, GW			Transgenically encoded protein photoinactivation (FIAsH-FALI): Acute inactivation of synaptotagmin I	NEURON			English	Article							GROWTH CONE MOTILITY; SYNAPTIC TRANSMISSION; NEUROTRANSMITTER RELEASE; NEURITE OUTGROWTH; C2B DOMAIN; DROSOPHILA; MUTANTS; VESICLES; SECRETION; MOLECULES	We demonstrate a noninvasive technique for protein photoinactivation using a transgenically encoded tag. A tetracysteine motif that binds the membrane-permeable fluorescein derivative 4',5'-bis(1,3,2-dithioarsoIan-2-yl)fluorescein (FlAsH) was engineered into synaptotagmin I (Syt 14C). Neuronally expressed Syt 14C rescues the syt I null mutation, can be visualized after FlAsH labeling, and is normally distributed at the Drosophila neuromuscular synapse. Illumination of FlAsH bound Syt 14C at 488 nm decreases evoked release in seconds demonstrating efficient fluorophore-assisted light inactivation (FlAsH-FALl) of Syt I. The inactivation of Syt I is proportional to the duration of illumination and follows first-order kinetics. In addition, Syt I FlAsH-FALl is specific and does not impair Syt I-independent vesicle fusion. We demonstrate that Syt I is required for a post-docking step during vesicle fusion but does not function to stabilize the docked vesicle state.	Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Davis, GW (corresponding author), Univ Calif San Francisco, Dept Biochem, 513 Parnassus Ave, San Francisco, CA 94143 USA.				PHS HHS [44908-32374] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Adams SR, 2002, J AM CHEM SOC, V124, P6063, DOI 10.1021/ja017687n; Adolfsen B, 2001, CELL MOL LIFE SCI, V58, P393, DOI 10.1007/PL00000865; Aravamudan B, 1999, NAT NEUROSCI, V2, P965, DOI 10.1038/14764; Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; Beck S, 2002, PROTEOMICS, V2, P247, DOI 10.1002/1615-9861(200203)2:3<247::AID-PROT247>3.0.CO;2-K; BROADIE K, 1994, P NATL ACAD SCI USA, V91, P10727, DOI 10.1073/pnas.91.22.10727; BROADIE K, 1995, NEURON, V15, P663, DOI 10.1016/0896-6273(95)90154-X; Buchstaller A, 2000, MICROSC RES TECHNIQ, V48, P97, DOI 10.1002/(SICI)1097-0029(20000115)48:2<97::AID-JEMT5>3.0.CO;2-G; Castelo L, 1999, MOL BIOL CELL, V10, P1511, DOI 10.1091/mbc.10.5.1511; DIANTONIO A, 1993, CELL, V73, P1281, DOI 10.1016/0092-8674(93)90356-U; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; JORGENSEN EM, 1995, NATURE, V378, P196, DOI 10.1038/378196a0; Littleton JT, 2001, J NEUROSCI, V21, P1421, DOI 10.1523/JNEUROSCI.21-05-01421.2001; LITTLETON JT, 1993, CELL, V74, P1125, DOI 10.1016/0092-8674(93)90733-7; LITTLETON JT, 1994, P NATL ACAD SCI USA, V91, P10888, DOI 10.1073/pnas.91.23.10888; Liu CWA, 1999, CELL MOTIL CYTOSKEL, V43, P232, DOI 10.1002/(SICI)1097-0169(1999)43:3<232::AID-CM6>3.0.CO;2-7; Madhani HD, 1998, TRENDS GENET, V14, P151, DOI 10.1016/S0168-9525(98)01425-5; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; Paradis S, 2001, NEURON, V30, P737, DOI 10.1016/S0896-6273(01)00326-9; Plump AS, 2002, NEURON, V33, P219, DOI 10.1016/S0896-6273(01)00586-4; Rajfur Z, 2002, NAT CELL BIOL, V4, P286, DOI 10.1038/ncb772; Reist NE, 1998, J NEUROSCI, V18, P7662; Robinson IM, 2002, NATURE, V418, P336, DOI 10.1038/nature00915; SCHULZE KL, 1995, CELL, V80, P311, DOI 10.1016/0092-8674(95)90414-X; Sheng ZH, 1997, P NATL ACAD SCI USA, V94, P5405, DOI 10.1073/pnas.94.10.5405; Stewart BA, 2000, P NATL ACAD SCI USA, V97, P13955, DOI 10.1073/pnas.250491397; Surrey T, 1998, P NATL ACAD SCI USA, V95, P4293, DOI 10.1073/pnas.95.8.4293; Takei K, 1999, J NEUROSCI, V19, P9469; Wang FS, 1996, SCIENCE, V273, P660, DOI 10.1126/science.273.5275.660; White B, 2001, CURR BIOL, V11, pR1041, DOI 10.1016/S0960-9822(01)00621-2	35	148	153	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 5	2002	36	5					805	813		10.1016/S0896-6273(02)01068-1	http://dx.doi.org/10.1016/S0896-6273(02)01068-1			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	622VL	12467585	Bronze			2022-12-24	WOS:000179667800006
J	Zheng, J; Trudeau, MC; Zagotta, WN				Zheng, J; Trudeau, MC; Zagotta, WN			Rod cyclic nucleotide-gated channels have a stoichiometry of three CNGA1 subunits and one CNG131 subunit	NEURON			English	Article							PHOTORECEPTOR CELLS; FUNCTIONAL EXPRESSION; ODOR ADAPTATION; CATION CHANNEL; RETINAL RODS; BETA-SUBUNIT; CALMODULIN; MODULATION; PROTEIN; CAMP	Phototransduction relies on the precise balance of speed and sensitivity to achieve optimal performance. The cyclic nucleotide-gated (CNG) ion channels, with their Ca2+ permeability, high sensitivity to changes in cytosolic cGMP, rapid gating kinetics, and Ca2+-calmodulin modulation, are beautifully optimized for their role in light detection. Many of these specializations come about from the heteromeric composition of the native channel, comprised of CNGA1 and CNGB1 subunits. However, the stoichiometry and arrangement of these subunits is unknown. Here we have used an approach based on fluorescence resonance energy transfer (FRET) to determine the composition of the intact functional channel in the surface membrane. We find, surprisingly, that the channel contains three CNGA1 subunits and only one CNGB1 subunit. These results have implications for CNG channel function in particular and assembly of membrane proteins in general.	Univ Washington, Sch Med, Dept Physiol & Biophys, Howard Hughes Med Inst, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Zagotta, WN (corresponding author), Univ Washington, Sch Med, Dept Physiol & Biophys, Howard Hughes Med Inst, Box 357290, Seattle, WA 98195 USA.	zagotta@u.washington.edu			NEI NIH HHS [EY10329, R01 EY010329, R01 EY010329-09] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010329] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bauer PJ, 1996, J PHYSIOL-LONDON, V494, P675, DOI 10.1113/jphysiol.1996.sp021523; Bonigk W, 1999, J NEUROSCI, V19, P5332; Bradley J, 1997, J NEUROSCI, V17, P1993; BRADLEY J, 1994, P NATL ACAD SCI USA, V91, P8890, DOI 10.1073/pnas.91.19.8890; Bradley J, 2001, SCIENCE, V294, P2176, DOI 10.1126/science.1063415; CHEN TY, 1994, P NATL ACAD SCI USA, V91, P11757, DOI 10.1073/pnas.91.24.11757; CHEN TY, 1993, NATURE, V362, P764, DOI 10.1038/362764a0; CLEGG RM, 1992, METHOD ENZYMOL, V211, P353; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; GORDON SE, 1995, J PHYSIOL-LONDON, V486, P533, DOI 10.1113/jphysiol.1995.sp020832; He YJ, 2000, P NATL ACAD SCI USA, V97, P895, DOI 10.1073/pnas.97.2.895; Hein R, 1996, CURR BIOL, V6, P178, DOI 10.1016/S0960-9822(02)00450-5; HSU YT, 1994, J BIOL CHEM, V269, P29765; HSU YT, 1993, NATURE, V361, P76, DOI 10.1038/361076a0; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; KORSCHEN HG, 1995, NEURON, V15, P627, DOI 10.1016/0896-6273(95)90151-5; LIMAN ER, 1994, NEURON, V13, P611, DOI 10.1016/0896-6273(94)90029-9; Liu DT, 1998, NEURON, V21, P235, DOI 10.1016/S0896-6273(00)80530-9; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Munger SD, 2001, SCIENCE, V294, P2172, DOI 10.1126/science.1063224; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Picco C, 1996, J GEN PHYSIOL, V108, P265, DOI 10.1085/jgp.108.4.265; Rebrik TI, 1998, J GEN PHYSIOL, V112, P537, DOI 10.1085/jgp.112.5.537; Sautter A, 1998, P NATL ACAD SCI USA, V95, P4696, DOI 10.1073/pnas.95.8.4696; SELVIN PR, 1995, METHOD ENZYMOL, V246, P300; Shammat IM, 1999, NEURON, V23, P809, DOI 10.1016/S0896-6273(01)80038-6; TANAKA JC, 1989, BIOCHEMISTRY-US, V28, P2776, DOI 10.1021/bi00433a006; Trudeau MC, 2002, P NATL ACAD SCI USA, V99, P8424, DOI 10.1073/pnas.122015999; Trudeau MC, 2002, NEURON, V34, P197, DOI 10.1016/S0896-6273(02)00647-5; YAU KW, 1989, ANNU REV NEUROSCI, V12, P289, DOI 10.1146/annurev.ne.12.030189.001445; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315	31	191	198	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 5	2002	36	5					891	896		10.1016/S0896-6273(02)01099-1	http://dx.doi.org/10.1016/S0896-6273(02)01099-1			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	622VL	12467592	Bronze			2022-12-24	WOS:000179667800013
J	Finkelstein, R; Miller, T; Baughman, R				Finkelstein, R; Miller, T; Baughman, R			The challenge of translational research - a perspective from the NINDS	NATURE NEUROSCIENCE			English	Article									NINDS, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Finkelstein, R (corresponding author), NINDS, NIH, 6001 Execut Blvd, Bethesda, MD 20892 USA.		Baughman, Robert/O-9078-2014	Baughman, Robert/0000-0002-8557-9458					0	10	10	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5			S			1029	1030		10.1038/nn933	http://dx.doi.org/10.1038/nn933			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	611WT	12403978				2022-12-24	WOS:000179041300006
J	Turnley, AM; Faux, CH; Rietze, RL; Coonan, JR; Bartlett, PF				Turnley, AM; Faux, CH; Rietze, RL; Coonan, JR; Bartlett, PF			Suppressor of cytokine signaling 2 regulates neuronal differentiation by inhibiting growth hormone signaling	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELL; VENTRICULAR ZONE; SOCS PROTEINS; MOUSE-BRAIN; RECEPTOR; GENES; PRECURSORS; MECHANISMS; PROLIFERATION	The intracellular mechanisms that determine the response of neural progenitor cells to growth factors and regulate their differentiation into either neurons or astrocytes remain unclear. We found that expression of SOCS2, an intracellular regulator of cytokine signaling, was restricted to mouse progenitor cells and neurons in response to leukemia inhibitory factor (LIF)-like cytokines. Progenitors lacking SOCS2 produced fewer neurons and more astrocytes in vitro, and Socs2(-/-) mice had fewer neurons and neurogenin-1 (Ngn1)-expressing cells in the developing cortex, whereas overexpression of SOCS2 increased neuronal differentiation. We also report that growth hormone inhibited Ngn1 expression and neuronal production, and this action was blocked by SOCS2 overexpression. These findings indicate that SOCS2 promotes neuronal differentiation by blocking growth hormone-mediated downregulation of Ngn1.	Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; Univ Queensland, Inst Brain Res, Brisbane, Qld 4072, Australia; Univ Melbourne, Ctr Neurosci, Parkville, Vic 3010, Australia	Walter & Eliza Hall Institute; University of Queensland; University of Melbourne	Bartlett, PF (corresponding author), Walter & Eliza Hall Inst Med Res, PO Royal Melbourne Hosp, Melbourne, Vic 3050, Australia.	bartlett@wehi.edu.au	Bartlett, Perry/F-3813-2012; Turnley, Ann/A-8125-2010	Turnley, Ann/0000-0002-8442-127X				Bartlett PF, 1998, IMMUNOL CELL BIOL, V76, P414, DOI 10.1046/j.1440-1711.1998.00762.x; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Cai L, 2000, DEVELOPMENT, V127, P3021; DELFS J, 1980, NATURE, V283, P676, DOI 10.1038/283676a0; EDENS A, 1994, ENDOCRINOLOGY, V135, P2802, DOI 10.1210/en.135.6.2802; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Faux CH, 2001, J NEUROSCI, V21, P5587, DOI 10.1523/JNEUROSCI.21-15-05587.2001; Fode C, 2000, GENE DEV, V14, P67; Greenhalgh CJ, 2002, MOL ENDOCRINOL, V16, P1394, DOI 10.1210/me.16.6.1394; Hansen JA, 1999, MOL ENDOCRINOL, V13, P1832, DOI 10.1210/me.13.11.1832; Hilton DJ, 1998, P NATL ACAD SCI USA, V95, P114, DOI 10.1073/pnas.95.1.114; HOJVAT S, 1982, BRAIN RES, V239, P543, DOI 10.1016/0006-8993(82)90529-7; HOJVAT S, 1982, DEV BRAIN RES, V4, P427, DOI 10.1016/0165-3806(82)90186-9; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Koblar SA, 1998, P NATL ACAD SCI USA, V95, P3178, DOI 10.1073/pnas.95.6.3178; Krebs DL, 2001, STEM CELLS, V19, P378, DOI 10.1634/stemcells.19-5-378; KRULICH L, 1968, ENDOCRINOLOGY, V83, P783, DOI 10.1210/endo-83-4-783; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Li WW, 1998, J NEUROSCI, V18, P8853; LOBIE PE, 1993, DEV BRAIN RES, V74, P225, DOI 10.1016/0165-3806(93)90008-X; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Metcalf D, 2000, NATURE, V405, P1069, DOI 10.1038/35016611; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; MURPHY M, 1990, J NEUROSCI RES, V25, P463, DOI 10.1002/jnr.490250404; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Nakashima K, 2001, P NATL ACAD SCI USA, V98, P5868, DOI 10.1073/pnas.101109698; Nicholson SE, 1999, EMBO J, V18, P375, DOI 10.1093/emboj/18.2.375; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Polizzotto MN, 2000, J COMP NEUROL, V423, P348; Rajan P, 1998, J NEUROSCI, V18, P3620; Ram PA, 1999, J BIOL CHEM, V274, P35553, DOI 10.1074/jbc.274.50.35553; Ram PK, 2000, J BIOL CHEM, V275, P39487, DOI 10.1074/jbc.M004755200; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Richards LJ, 1996, EUR J NEUROSCI, V8, P291, DOI 10.1111/j.1460-9568.1996.tb01213.x; Rietze RL, 2001, NATURE, V412, P736, DOI 10.1038/35089085; Solecki DJ, 2001, NEURON, V31, P557, DOI 10.1016/S0896-6273(01)00395-6; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Thomas HE, 1997, J NEUROIMMUNOL, V78, P132, DOI 10.1016/S0165-5728(97)00091-X; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Williams BP, 1997, NEURON, V18, P553, DOI 10.1016/S0896-6273(00)80297-4	41	133	138	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1155	1162		10.1038/nn954	http://dx.doi.org/10.1038/nn954			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	609CG	12368809				2022-12-24	WOS:000178884600018
J	Livet, J; Sigrist, M; Stroebel, S; De Paola, V; Price, SR; Henderson, CE; Jessell, TM; Arber, S				Livet, J; Sigrist, M; Stroebel, S; De Paola, V; Price, SR; Henderson, CE; Jessell, TM; Arber, S			ETS gene Pea3 controls the central position and terminal arborization of specific motor neuron pools	NEURON			English	Article							LIM HOMEOBOX GENES; CHICK HIND LIMB; SPINAL-CORD; TRANSGENIC MICE; AXON GUIDANCE; HOMEODOMAIN PROTEIN; PATHWAY SELECTION; MUSCLE; MOTONEURONS; IDENTITY	The projection of developing axons to their targets is a crucial step in the assembly of neuronal circuits. In the spinal cord, the differentiation of specific motor neuron pools is associated with the expression of ETS class transcription factors, notably PEA3 and ER81. Their initial expression coincides with the arrival of motor axons in the vicinity of muscle targets and depends on limb-derived signals. We show that in Pea3 mutant mice, the axons of specific motor neuron pools fail to branch normally within their target muscles, and the cell bodies of these motor neurons are mispositioned within the spinal cord. Thus, the induction of an intrinsic program of ETS gene expression by peripheral signals is required to coordinate the central position and terminal arborization of specific sets of spinal motor neurons.	Univ Basel, Bioctr, Dept Cell Biol, CH-4056 Basel, Switzerland; Friedrich Miescher Inst, CH-4058 Basel, Switzerland; Univ Mediterranee, Dev Biol Inst Marseille, CNRS, INSERM,U382, F-13288 Marseille, France; Columbia Univ, Ctr Neurobiol & Behav, Dept Biochem & Mol Biophys, Howard Hughes Med Inst, New York, NY 10032 USA	University of Basel; Friedrich Miescher Institute for Biomedical Research; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Columbia University; Howard Hughes Medical Institute	Arber, S (corresponding author), Univ Basel, Bioctr, Dept Cell Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.		livet, jean/C-2766-2012; de paola, vincenzo/B-4900-2016	livet, jean/0000-0003-3079-4908; de paola, vincenzo/0000-0001-9987-8291; Arber, Silvia/0000-0002-6261-250X; Price, Stephen/0000-0001-7804-9849; Henderson, Christopher/0000-0002-9936-3279				AIGNER L, 1995, CELL, V83, P269, DOI 10.1016/0092-8674(95)90168-X; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; BAULAC M, 1981, ACTA ANAT, V109, P209; BOVOLENTA P, 1990, DEVELOPMENT, V109, P435; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Brose K, 2000, CURR OPIN NEUROBIOL, V10, P95, DOI 10.1016/S0959-4388(99)00066-5; Caroni P, 1997, J NEUROSCI METH, V71, P3, DOI 10.1016/S0165-0270(96)00121-5; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Garces A, 2000, J NEUROSCI, V20, P4992; Glover JC, 2000, PHYSIOL REV, V80, P615, DOI 10.1152/physrev.2000.80.2.615; Greene E. C., 1935, T AM PHILOS SOC, V27; Haase G, 2002, NEURON, V35, P893, DOI 10.1016/S0896-6273(02)00864-4; HAASE P, 1985, NEUROSCI LETT, V60, P313, DOI 10.1016/0304-3940(85)90596-8; HARLAN DM, 1991, J BIOL CHEM, V266, P14399; Hollyday M., 1980, Current Topics in Developmental Biology, V15, P181; Jacob J, 2001, BIOESSAYS, V23, P582, DOI 10.1002/bies.1084; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; Kunes S, 2000, CURR OPIN NEUROBIOL, V10, P58, DOI 10.1016/S0959-4388(99)00051-3; Laing MA, 2000, MOL CELL BIOL, V20, P9337, DOI 10.1128/MCB.20.24.9337-9345.2000; LANCEJONES C, 1981, PROC R SOC SER B-BIO, V214, P19, DOI 10.1098/rspb.1981.0080; LANCEJONES C, 1979, J MORPHOL, V162, P275; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P371, DOI 10.1113/jphysiol.1978.sp012545; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P391, DOI 10.1113/jphysiol.1978.sp012546; Landmesser LT, 2001, INT J DEV NEUROSCI, V19, P175, DOI 10.1016/S0736-5748(00)00090-3; LEWIS J, 1981, J EMBRYOL EXP MORPH, V64, P211; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; McCrea DA, 2001, J PHYSIOL-LONDON, V533, P41, DOI 10.1111/j.1469-7793.2001.0041b.x; MCHANWELL S, 1981, PHILOS T ROY SOC B, V293, P477, DOI 10.1098/rstb.1981.0082; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; Milner LD, 1999, J NEUROSCI, V19, P3007; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; PHELAN KA, 1990, J NEUROSCI, V10, P2699; Price SR, 2002, CELL, V109, P205, DOI 10.1016/S0092-8674(02)00695-5; REICHARDT LF, 1989, DEV NEUROSCI-BASEL, V11, P332, DOI 10.1159/000111910; ROMANES G. J., 1964, PROGR BRAIN RES, V11, P93; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Senti KA, 2000, DEVELOPMENT, V127, P2291; Sharma K, 2000, NATURE, V406, P515, DOI 10.1038/35020078; Sharma K, 2001, CURR OPIN CELL BIOL, V13, P204, DOI 10.1016/S0955-0674(00)00198-8; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Vallstedt A, 2001, NEURON, V31, P743, DOI 10.1016/S0896-6273(01)00412-3; VarelaEchavarria A, 1997, NEURON, V18, P193, DOI 10.1016/S0896-6273(00)80261-5; Yamamoto Y, 1999, DEV BIOL, V214, P60, DOI 10.1006/dbio.1999.9413; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748; ZENKER W, 1990, ANAT EMBRYOL, V182, P273	51	186	187	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 29	2002	35	5					877	892		10.1016/S0896-6273(02)00863-2	http://dx.doi.org/10.1016/S0896-6273(02)00863-2			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	589UY	12372283	Bronze			2022-12-24	WOS:000177779800011
J	Hagell, P; Piccini, P; Bjorklund, A; Brundin, P; Rehncrona, S; Widner, H; Crabb, L; Pavese, N; Oertel, WH; Quinn, N; Brooks, DJ; Lindvall, O				Hagell, P; Piccini, P; Bjorklund, A; Brundin, P; Rehncrona, S; Widner, H; Crabb, L; Pavese, N; Oertel, WH; Quinn, N; Brooks, DJ; Lindvall, O			Dyskinesias following neural transplantation in Parkinson's disease	NATURE NEUROSCIENCE			English	Article							DOPAMINE NEURONS		Wallenberg Neurosci Ctr, Sect Restorat Neurol, SE-22184 Lund, Sweden; Wallenberg Neurosci Ctr, Div Neurobiol, SE-22184 Lund, Sweden; Wallenberg Neurosci Ctr, Sect Neuronal Survival, SE-22184 Lund, Sweden; Univ Hosp, Dept Clin Neurosci, Div Neurol, SE-22185 Lund, Sweden; Univ Hosp, Dept Clin Neurosci, Div Neurosurg, SE-22185 Lund, Sweden; Hammersmith Hosp, Imperial Coll, Fac Med, MRC,Clin Sci Ctr, London W12 0NN, England; Hammersmith Hosp, Imperial Coll, Fac Med, Div Neurosci, London W12 0NN, England; Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England; Sobell Dept Motor Neurosci & Movement Disorders, London WC1N 3BG, England; Univ Marburg, Dept Neurol, DE-35033 Marburg, Germany	Lund University; Skane University Hospital; Lund University; Skane University Hospital; Imperial College London; Imperial College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; Philipps University Marburg	Lindvall, O (corresponding author), Wallenberg Neurosci Ctr, Sect Restorat Neurol, SE-22184 Lund, Sweden.	olle.lindvall@neurol.lu.se	Hagell, Peter/G-9559-2014; Hagell, Peter/F-5915-2010; Björklund, Anders/ABA-1326-2020	Hagell, Peter/0000-0003-2174-372X; Hagell, Peter/0000-0003-2174-372X; Pavese, Nicola/0000-0002-6801-6194; Brooks, David/0000-0003-2602-2518; Piccini, Paola/0000-0003-4162-6141; Bjorklund, Anders/0000-0002-5676-6203	MRC [MC_U120036861] Funding Source: UKRI; Medical Research Council [MC_U120036861] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		BOYCE S, 1990, CLIN NEUROPHARMACOL, V13, P448, DOI 10.1097/00002826-199010000-00006; Cubo E, 2001, ARCH NEUROL-CHICAGO, V58, P1379, DOI 10.1001/archneur.58.9.1379; Fahn S.E., 1987, RECENT DEV PARKINSON, V153, P293; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Hagell P, 1999, MOVEMENT DISORD, V14, P448, DOI 10.1002/1531-8257(199905)14:3<448::AID-MDS1010>3.0.CO;2-0; Hauser RA, 1999, ARCH NEUROL-CHICAGO, V56, P179, DOI 10.1001/archneur.56.2.179; LANGSTON JW, 1992, MOVEMENT DISORD, V7, P2, DOI 10.1002/mds.870070103; Lee CS, 2000, BRAIN, V123, P1365, DOI 10.1093/brain/123.7.1365; LINDVALL O, 1989, ARCH NEUROL-CHICAGO, V46, P615, DOI 10.1001/archneur.1989.00520420033021; Lindvall O, 2000, Prog Brain Res, V127, P299; LUQUIN MR, 1992, MOVEMENT DISORD, V7, P117, DOI 10.1002/mds.870070204; Nutt JG, 2000, ANN NEUROL, V47, pS160; WIDNER H, 1992, NEW ENGL J MED, V327, P1556, DOI 10.1056/NEJM199211263272203	13	324	341	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2002	5	7					627	628		10.1038/nn863	http://dx.doi.org/10.1038/nn863			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	566EP	12042822	Green Published			2022-12-24	WOS:000176414300009
J	Macaluso, E; Frith, CD; Driver, J				Macaluso, E; Frith, CD; Driver, J			Crossmodal spatial influences of touch on extrastriate visual areas take current gaze direction into account	NEURON			English	Article							POSITRON-EMISSION-TOMOGRAPHY; POSTERIOR PARIETAL CORTEX; MODAL LINKS; MINDS EYE; ATTENTION; VISION; NEURONS; SPACE; MOVEMENTS; BRAIN	Recent results indicate that crossmodal interactions can affect activity in cortical regions traditionally regarded as "unimodal." Previously we found that combining touch on one hand with visual stimulation in the anatomically corresponding hemifield could boost responses in contralateral visual cortex. Here we manipulated which visual hemifield corresponded to the location of the stimulated hand, by changing gaze direction such that right-hand touch could now arise in either the left or right visual field. Crossmodal effects on visual cortex switched from one hemisphere to the other, depending on gaze direction, regardless of whether the hand was seen. This indicates that crossmodal influences of touch upon visual cortex depend on spatial alignment for the multimodal stimuli, with gaze posture taken into account.	UCL, Inst Cognit Neurosci, London, England; Inst Neurol, Wellcome Dept Cognit Neurol, London WC1N 3BG, England	University of London; University College London; University of London; University College London	Macaluso, E (corresponding author), UCL, Inst Cognit Neurosci, London, England.	e.macaluso@fil.ion.ucl.ac.uk	Frith, Chris D/A-2171-2009; Driver, Jon/A-4779-2010; Macaluso, Emiliano/H-3139-2017; Macaluso, Emiliano/AAE-9185-2019	Frith, Chris D/0000-0002-8665-0690; Macaluso, Emiliano/0000-0002-1919-5288; Macaluso, Emiliano/0000-0002-1919-5288				Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; Bertelson P, 2000, PERCEPT PSYCHOPHYS, V62, P321, DOI 10.3758/BF03205552; Bremmer F, 2001, NEUROIMAGE, V14, pS46, DOI 10.1006/nimg.2001.0817; Bremmer F, 2001, NEURON, V29, P287, DOI 10.1016/S0896-6273(01)00198-2; BRUCE C, 1981, J NEUROPHYSIOL, V46, P369, DOI 10.1152/jn.1981.46.2.369; BURTON H, 1993, SOMATOSENS MOT RES, V10, P297, DOI 10.3109/08990229309028839; Calvert GA, 2000, CURR BIOL, V10, P649, DOI 10.1016/S0960-9822(00)00513-3; Calvert GA, 1999, NEUROREPORT, V10, P2619, DOI 10.1097/00001756-199908200-00033; COGHILL RC, 1994, J NEUROSCI, V14, P4095; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; DeSouza JFX, 2000, J NEUROSCI, V20, P5835, DOI 10.1523/JNEUROSCI.20-15-05835.2000; Downar J, 2000, NAT NEUROSCI, V3, P277, DOI 10.1038/72991; Driver J, 1998, CURR OPIN NEUROBIOL, V8, P245, DOI 10.1016/S0959-4388(98)80147-5; Driver J, 1998, TRENDS COGN SCI, V2, P254, DOI 10.1016/S1364-6613(98)01188-7; Duhamel JR, 1998, J NEUROPHYSIOL, V79, P126, DOI 10.1152/jn.1998.79.1.126; Eimer M, 2000, PSYCHOPHYSIOLOGY, V37, P697, DOI 10.1111/1469-8986.3750697; Francis ST, 2000, NEUROIMAGE, V11, P188, DOI 10.1006/nimg.2000.0541; GALLETTI C, 1989, J NEUROSCI, V9, P1112; Graziano Michael S. A., 1995, P1021; Graziano MSA, 1999, P NATL ACAD SCI USA, V96, P10418, DOI 10.1073/pnas.96.18.10418; Henson R.N.A., 1999, NEUROIMAGE, V9, P125, DOI DOI 10.1016/J.NEUROIMAGE.2011.06.078; KAWASHIMA R, 1995, P NATL ACAD SCI USA, V92, P5969, DOI 10.1073/pnas.92.13.5969; Kennett S, 2001, J COGNITIVE NEUROSCI, V13, P462, DOI 10.1162/08989290152001899; Kinsbourne M, 1970, Trans Am Neurol Assoc, V95, P143; LEINONEN L, 1980, EXP BRAIN RES, V39, P203; Macaluso E, 2000, SCIENCE, V289, P1206, DOI 10.1126/science.289.5482.1206; Macaluso E, 2001, SCIENCE, V292; Macaluso E, 2001, NEUROPSYCHOLOGIA, V39, P1304, DOI 10.1016/S0028-3932(01)00119-1; Macaluso E, 2000, J NEUROPHYSIOL, V83, P3062, DOI 10.1152/jn.2000.83.5.3062; Massaro DW, 1999, TRENDS COGN SCI, V3, P310, DOI 10.1016/S1364-6613(99)01360-1; McDonald JJ, 2000, NATURE, V407, P906, DOI 10.1038/35038085; McDonald JJ, 2001, SCIENCE, V292; Meredith MA, 1996, J NEUROPHYSIOL, V75, P1843, DOI 10.1152/jn.1996.75.5.1843; Rosenbluth D, 2002, NEURON, V33, P143, DOI 10.1016/S0896-6273(01)00559-1; Sathian K, 1997, NEUROREPORT, V8, P3877, DOI 10.1097/00001756-199712220-00008; Shams L, 2000, NATURE, V408, P788, DOI 10.1038/35048669; Snyder LH, 2000, CURR OPIN NEUROBIOL, V10, P747, DOI 10.1016/S0959-4388(00)00152-5; Spence C, 1998, PERCEPT PSYCHOPHYS, V60, P544, DOI 10.3758/BF03206045; Spence C, 2000, J EXP PSYCHOL HUMAN, V26, P1298, DOI 10.1037//0096-1523.26.4.1298; Stein BE., 1993, MERGING SENSES; Stricanne B, 1996, J NEUROPHYSIOL, V76, P2071, DOI 10.1152/jn.1996.76.3.2071; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O	43	73	75	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 16	2002	34	4					647	658		10.1016/S0896-6273(02)00678-5	http://dx.doi.org/10.1016/S0896-6273(02)00678-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	553FT	12062047	Bronze			2022-12-24	WOS:000175665700017
J	Aydar, E; Palmer, CP; Klyachko, VA; Jackson, MB				Aydar, E; Palmer, CP; Klyachko, VA; Jackson, MB			The sigma receptor as a ligand-regulated auxiliary potassium channel subunit	NEURON			English	Article							PITUITARY MELANOTROPE CELLS; GATED K+ CHANNELS; BETA-SUBUNIT; FUNCTIONAL EXPRESSION; MOLECULAR-CLONING; NERVE-TERMINALS; MODULATION; COEXPRESSION; SENSITIVITY; HALOPERIDOL	The sigma receptor is a novel protein that mediates the modulation of ion channels by psychotropic drugs through a unique transduction mechanism depending neither on G proteins nor protein phosphorylation. The present study investigated sigma receptor signal transduction by reconstituting responses in Xenopus oocytes. Sigma receptors modulated voltage-gated K+ channels (Kv1.4 or Kv1.5) in different ways in the presence and absence of ligands. Association between Kv1.4 channels and sigma receptors was demonstrated by coimmunoprecipitation. These results indicate a novel mechanism of signal transduction dependent on protein-protein interactions. Domain accessibility experiments suggested a structure for the sigma receptor with two cytoplasmic termini and two membrane-spanning segments. The ligand-independent effects on channels suggest that sigma receptors serve as auxiliary subunits to voltage-gated K+ channels with distinct functional interactions, depending on the presence or absence of ligand.	Univ Wisconsin, Sch Med, Dept Physiol, Madison, WI 53706 USA; Univ Wisconsin, Bock Labs, Dept Mol Biol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Jackson, MB (corresponding author), Univ Wisconsin, Sch Med, Dept Physiol, 1300 Univ Ave, Madison, WI 53706 USA.		Klyachko, Vitaly/E-9431-2012		NINDS NIH HHS [NS 30016] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030016, R37NS030016] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADELMAN JP, 1995, CURR OPIN NEUROBIOL, V5, P286, DOI 10.1016/0959-4388(95)80040-9; BIELEFELDT K, 1992, J PHYSIOL-LONDON, V458, P41, DOI 10.1113/jphysiol.1992.sp019405; Connor JX, 1998, J BIOL CHEM, V273, P28906, DOI 10.1074/jbc.273.44.28906; De Costa B.R., 1994, SIGMA RECEPTORS, P45; Dworetzky SI, 1996, J NEUROSCI, V16, P4543; Hanner M, 1996, P NATL ACAD SCI USA, V93, P8072, DOI 10.1073/pnas.93.15.8072; Hayashi T, 2001, P NATL ACAD SCI USA, V98, P491, DOI 10.1073/pnas.021413698; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; Ishiguro H, 1998, NEUROSCI LETT, V257, P45, DOI 10.1016/S0304-3940(98)00797-6; Jonas EA, 1996, CURR OPIN NEUROBIOL, V6, P318, DOI 10.1016/S0959-4388(96)80114-0; KAHOUN JR, 1992, P NATL ACAD SCI USA, V89, P1393, DOI 10.1073/pnas.89.4.1393; Kekuda R, 1996, BIOCHEM BIOPH RES CO, V229, P553, DOI 10.1006/bbrc.1996.1842; KNAUS HG, 1994, J BIOL CHEM, V269, P23336; Leff P, 1997, TRENDS PHARMACOL SCI, V18, P355, DOI 10.1016/S0165-6147(97)90664-7; Liu F, 2000, NATURE, V403, P274, DOI 10.1038/35002014; Lupardus PJ, 2000, J PHYSIOL-LONDON, V526, P527, DOI 10.1111/j.1469-7793.2000.00527.x; MARTIN WR, 1976, J PHARMACOL EXP THER, V197, P517; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Morin-Surun MP, 1999, P NATL ACAD SCI USA, V96, P8196, DOI 10.1073/pnas.96.14.8196; MORIO Y, 1994, BRAIN RES, V637, P190, DOI 10.1016/0006-8993(94)91232-7; PAJOR AM, 1992, AM J PHYSIOL, V263, pR489, DOI 10.1152/ajpregu.1992.263.3.R489; Perez-Garcia MT, 1999, J GEN PHYSIOL, V113, P897, DOI 10.1085/jgp.113.6.897; Pongs O, 1999, ANN NY ACAD SCI, V868, P344, DOI 10.1111/j.1749-6632.1999.tb11296.x; PRAGNELL M, 1990, NEURON, V4, P807, DOI 10.1016/0896-6273(90)90207-V; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; Seth P, 1997, BIOCHEM BIOPH RES CO, V241, P535, DOI 10.1006/bbrc.1997.7840; SHENG M, 1993, NATURE, V365, P72, DOI 10.1038/365072a0; Shi G, 1999, J MEMBRANE BIOL, V168, P265, DOI 10.1007/s002329900515; Soriani O, 1998, J PHARMACOL EXP THER, V286, P163; Soriani O, 1999, J PHARMACOL EXP THER, V289, P321; SPENGLER D, 1993, NATURE, V365, P170, DOI 10.1038/365170a0; SU TP, 1993, CRIT REV NEUROBIOL, V7, P187; Suessbrich H, 1997, BRIT J PHARMACOL, V120, P968, DOI 10.1038/sj.bjp.0700989; TSENGCRANK JCL, 1990, FEBS LETT, V268, P63, DOI 10.1016/0014-5793(90)80973-M; WALKER JM, 1993, ASPECTS SYNAPTIC TRA, P91; WICKMAN K, 1995, PHYSIOL REV, V75, P865, DOI 10.1152/physrev.1995.75.4.865; Wilke RA, 1999, J BIOL CHEM, V274, P18387, DOI 10.1074/jbc.274.26.18387; Wilke RA, 1999, J PHYSIOL-LONDON, V517, P391, DOI 10.1111/j.1469-7793.1999.00391.x; Yamamoto H, 1999, FEBS LETT, V445, P19, DOI 10.1016/S0014-5793(99)00084-8; ZUKIN SR, 1979, P NATL ACAD SCI USA, V76, P5372, DOI 10.1073/pnas.76.10.5372; [No title captured]	42	323	337	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 25	2002	34	3					399	410		10.1016/S0896-6273(02)00677-3	http://dx.doi.org/10.1016/S0896-6273(02)00677-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	545JW	11988171	Bronze			2022-12-24	WOS:000175214700011
J	Chung, S; Li, XR; Nelson, SB				Chung, S; Li, XR; Nelson, SB			Short-term depression at thalamocortical synapses contributes to rapid adaptation of cortical sensory responses in vivo	NEURON			English	Article							CAT VISUAL-CORTEX; UNDERLYING CONTRAST ADAPTATION; MEDIAL NUCLEUS VPM; RAT BARREL CORTEX; SOMATOSENSORY CORTEX; SYNAPTIC DEPRESSION; PYRAMIDAL NEURONS; SIMPLE CELLS; ORIENTATION SELECTIVITY; TEMPORAL INTERACTIONS	In vivo whole-cell recordings revealed that during repeated stimulation, synaptic responses to deflection of facial whiskers rapidly adapt. Extracellular recordings in the somatosensory thalamus revealed that part of the adaptation occurs subcortically, but because cortical adaptation is stronger and recovers more slowly, cortical mechanisms must also contribute. Trains of sensory stimuli that produce profound sensory adaptation did not alter intrinsic membrane properties, including resting membrane potential, input resistance, and current-evoked firing. Synaptic input evoked via intracortical stimulation was also unchanged; however, synaptic input from the somatosensory thalamus was depressed by sensory stimulation, and this depression recovered with a time course matching that of the recovery of sensory responsiveness. These data strongly suggest that synaptic depression of thalamic input to the cortex contributes to the dynamic regulation of neuronal sensitivity during rapid changes in sensory input.	Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Nelson, SB (corresponding author), Brandeis Univ, Dept Biol, Mailstop 008,415 South St, Waltham, MA 02454 USA.	nelson@brandeis.edu		Nelson, Sacha/0000-0002-0108-8599	NEI NIH HHS [EY 11116] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011116] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Adorjan P, 1999, REV NEUROSCIENCE, V10, P181; Ahissar E, 2000, NATURE, V406, P302, DOI 10.1038/35018568; Ahissar E, 2001, J NEUROPHYSIOL, V86, P354, DOI 10.1152/jn.2001.86.1.354; Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Angulo MC, 1999, J NEUROSCI, V19, P1566; ARMSTRONGJAMES M, 1993, J NEUROSCI, V13, P2149; ARMSTRONGJAMES M, 1991, J COMP NEUROL, V303, P211, DOI 10.1002/cne.903030204; BARLOW H, 1989, COMP NEUR S, P54; BLAKEMORE C, 1969, J PHYSIOL-LONDON, V203, P237, DOI 10.1113/jphysiol.1969.sp008862; BONDS AB, 1991, VISUAL NEUROSCI, V6, P239, DOI 10.1017/S0952523800006258; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Brumberg JC, 1999, J NEUROPHYSIOL, V82, P1808, DOI 10.1152/jn.1999.82.4.1808; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; CastroAlamancos MA, 1997, REV NEUROSCIENCE, V8, P95; CastroAlamancos MA, 1996, J NEUROSCI, V16, P2767; CastroAlamancos MA, 1996, SCIENCE, V272, P274, DOI 10.1126/science.272.5259.274; Chance FS, 1998, J NEUROSCI, V18, P4785; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; Chung S, 1998, NEURON, V20, P1177, DOI 10.1016/S0896-6273(00)80498-5; CONNORS BW, 1982, J PHARMACOL EXP THER, V220, P476; DEALY RS, 1974, J PHYSIOL-LONDON, V241, P261, DOI 10.1113/jphysiol.1974.sp010652; DEBRUYN EJ, 1986, BRAIN RES, V383, P339, DOI 10.1016/0006-8993(86)90036-3; DIAMOND ME, 1992, J COMP NEUROL, V318, P462, DOI 10.1002/cne.903180410; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Fanselow EE, 1999, J NEUROSCI, V19, P7603, DOI 10.1523/JNEUROSCI.19-17-07603.1999; FERSTER D, 1985, J PHYSIOL-LONDON, V367, P233, DOI 10.1113/jphysiol.1985.sp015822; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; FERSTER D, 1992, J NEUROSCI, V12, P1262; FINLAYSON PG, 1995, EXP BRAIN RES, V106, P145; Friedberg MH, 1999, J NEUROPHYSIOL, V81, P2243, DOI 10.1152/jn.1999.81.5.2243; Galarreta M, 1998, NAT NEUROSCI, V1, P587, DOI 10.1038/2822; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Gil Z, 1997, NEURON, V19, P679, DOI 10.1016/S0896-6273(00)80380-3; Gil Z, 1999, NEURON, V23, P385, DOI 10.1016/S0896-6273(00)80788-6; GREENLEE MW, 1991, VISION RES, V31, P223, DOI 10.1016/0042-6989(91)90113-J; Hartings JA, 1998, J NEUROPHYSIOL, V80, P1016, DOI 10.1152/jn.1998.80.2.1016; HELLWEG FC, 1977, J NEUROPHYSIOL, V40, P463, DOI 10.1152/jn.1977.40.3.463; Hirsch JA, 1998, J NEUROSCI, V18, P9517; HUMPHREY GK, 1995, CURR BIOL, V5, P545, DOI 10.1016/S0960-9822(95)00107-2; MADDESS T, 1988, BIOL CYBERN, V59, P229, DOI 10.1007/BF00332911; MCCORMICK DA, 1990, NEUROSCIENCE, V39, P103, DOI 10.1016/0306-4522(90)90225-S; Moore CI, 1999, TRENDS NEUROSCI, V22, P513, DOI 10.1016/S0166-2236(99)01452-6; Moore CI, 1998, J NEUROPHYSIOL, V80, P2882, DOI 10.1152/jn.1998.80.6.2882; MORIN D, 1981, BRAIN RES, V205, P49, DOI 10.1016/0006-8993(81)90719-8; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; NATHAN T, 1990, NEUROSCI LETT, V110, P309, DOI 10.1016/0304-3940(90)90865-7; NELSON S, 1994, SCIENCE, V265, P774, DOI 10.1126/science.8047882; NELSON SB, 1991, J NEUROSCI, V11, P344; NELSON SB, 1991, J NEUROSCI, V11, P369; OHZAWA I, 1982, NATURE, V298, P266, DOI 10.1038/298266a0; Reyes A, 1999, J NEUROSCI, V19, P3827; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4286; Sheth BR, 1998, J NEUROPHYSIOL, V79, P464, DOI 10.1152/jn.1998.79.1.464; SHIPLEY MT, 1974, J NEUROPHYSIOL, V37, P73, DOI 10.1152/jn.1974.37.1.73; SHU ZJ, 1993, NATURE, V364, P721, DOI 10.1038/364721a0; SIMONS DJ, 1983, BRAIN RES, V276, P178, DOI 10.1016/0006-8993(83)90561-9; SIMONS DJ, 1989, J NEUROPHYSIOL, V61, P311, DOI 10.1152/jn.1989.61.2.311; Sosnik R, 2001, J NEUROPHYSIOL, V86, P339, DOI 10.1152/jn.2001.86.1.339; STALEY KJ, 1992, J NEUROPHYSIOL, V68, P197, DOI 10.1152/jn.1992.68.1.197; Stratford KJ, 1996, NATURE, V382, P258, DOI 10.1038/382258a0; Swadlow HA, 2001, NAT NEUROSCI, V4, P402, DOI 10.1038/86054; THOMSON AM, 1993, J NEUROPHYSIOL, V70, P2354, DOI 10.1152/jn.1993.70.6.2354; Todorov EV, 1997, COMPUTATIONAL NEUROSCIENCE: TRENDS IN RESEARCH, 1997, P525; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Varela JA, 1997, J NEUROSCI, V17, P7926; WAITE PME, 1973, J PHYSIOL-LONDON, V228, P541, DOI 10.1113/jphysiol.1973.sp010099; WELKER E, 1993, EUR J NEUROSCI, V5, P691, DOI 10.1111/j.1460-9568.1993.tb00534.x; Wilson DA, 1998, J NEUROPHYSIOL, V80, P998, DOI 10.1152/jn.1998.80.2.998; Zhu JJ, 1999, J NEUROPHYSIOL, V81, P1171, DOI 10.1152/jn.1999.81.3.1171	71	377	391	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	APR 25	2002	34	3					437	446		10.1016/S0896-6273(02)00659-1	http://dx.doi.org/10.1016/S0896-6273(02)00659-1			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	545JW	11988174	Bronze			2022-12-24	WOS:000175214700014
J	Cowley, MA; Smith, RG; Diano, S; Tschop, M; Pronchuk, N; Grove, KL; Strasburger, CJ; Bidlingmaier, M; Esterman, M; Heiman, ML; Garcia-Segura, LM; Nillni, EA; Mendez, P; Low, MJ; Sotonyi, P; Friedman, JM; Liu, HY; Pinto, S; Colmers, WF; Cone, RD; Horvath, TL				Cowley, MA; Smith, RG; Diano, S; Tschop, M; Pronchuk, N; Grove, KL; Strasburger, CJ; Bidlingmaier, M; Esterman, M; Heiman, ML; Garcia-Segura, LM; Nillni, EA; Mendez, P; Low, MJ; Sotonyi, P; Friedman, JM; Liu, HY; Pinto, S; Colmers, WF; Cone, RD; Horvath, TL			The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis	NEURON			English	Article							GROWTH-HORMONE SECRETAGOGUE; INNERVATE NEUROENDOCRINE CELLS; Y-CONTAINING NEURONS; ARCUATE NUCLEUS; NEUROPEPTIDE-Y; GH SECRETAGOGUE; ACYLATED PEPTIDE; MESSENGER-RNA; PARAVENTRICULAR NUCLEUS; FOOD-INTAKE	The gastrointestinal peptide hormone ghrelin stimulates appetite in rodents and humans via hypothalamic actions. We discovered expression of ghrelin in a previously uncharacterized group of neurons adjacent to the third ventricle between the dorsal, ventral, paraventricular, and arcuate hypothalamic nuclei. These neurons send efferents onto key hypothalamic circuits, including those producing neuropeptide Y (NPY), Agouti-related protein (AGRP), proopiomelanocortin (POMC) products, and corticotropin-releasing hormone (CRH). Within the hypothalamus, ghrelin bound mostly on presynaptic terminals of NPY neurons. Using electrophysiological recordings, we found that ghrelin stimulated the activity of arcuate NPY neurons and mimicked the effect of NPY in the paraventricular nucleus of the hypothalamus (PVH). We propose that at these sites, release of ghrelin may stimulate the release of orexigenic peptides and neurotransmitters, thus representing a novel regulatory circuit controlling energy homeostasis.	Yale Med Sch, Dept Obstet & Gynecol, New Haven, CT 06520 USA; Yale Med Sch, Dept Neurobiol, New Haven, CT 06520 USA; Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Div Neurosci, Beaverton, OR 97006 USA; Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; German Inst Human Nutr, D-14558 Bergholz Rehbrucke, Germany; Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA; Univ Alberta, Dept Pharmacol, Edmonton, AB T6G 2H7, Canada; Innenstadt Univ Hosp, Neuroendocrine Labs, D-80336 Munich, Germany; CSIC, Inst Cajal, E-28002 Madrid, Spain; Rhode Isl Hosp, Brown Med Sch, Dept Med, Div Endocrinol, Providence, RI 02903 USA; Szent Istvan Univ, Fac Vet Med, Dept Anat & Histol, H-1078 Budapest, Hungary; Rockefeller Univ, Dept Mol Genet, New York, NY 10021 USA	Yale University; Yale University; Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center; Baylor College of Medicine; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Eli Lilly; University of Alberta; University of Munich; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Hungarian University of Agriculture & Life Sciences; Rockefeller University	Horvath, TL (corresponding author), Yale Med Sch, Dept Obstet & Gynecol, New Haven, CT 06520 USA.	tamas.horvath@yale.edu	Tschoep, Matthias H/I-5443-2014; Garcia-Segura, Luis M/U-3711-2017; Colmers, William/C-3106-2013; Mendez, Pablo/J-7552-2017; Cowley, Michael A/B-9428-2008	Garcia-Segura, Luis M/0000-0002-2450-2916; Colmers, William/0000-0001-7902-3560; Mendez, Pablo/0000-0001-9862-6818; Cowley, Michael A/0000-0001-7811-134X; Tschoep, Matthias/0000-0002-4744-371X; Bidlingmaier, Martin/0000-0002-4681-6668; Low, Malcolm/0000-0002-9900-3708	NCRR NIH HHS [RR-14451] Funding Source: Medline; NIA NIH HHS [AG-018895] Funding Source: Medline; NIDDK NIH HHS [DK-62202, DK-61619, DK-60711, DK-51730] Funding Source: Medline; NIMH NIH HHS [MH-59847] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR014451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060711, R01DK051730, R56DK062202, R01DK062202, R01DK061619] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018895] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ahima RS, 2000, FRONT NEUROENDOCRIN, V21, P263, DOI 10.1006/frne.2000.0197; Arvat E, 2000, J ENDOCRINOL INVEST, V23, P493, DOI 10.1007/BF03343763; Arvat E, 2001, J CLIN ENDOCR METAB, V86, P1169, DOI 10.1210/jc.86.3.1169; Banks WA, 2002, J PHARMACOL EXP THER, V302, P822, DOI 10.1124/jpet.102.034827; Batterham RL, 2002, NATURE, V418, P650, DOI 10.1038/nature00887; Bednarek MA, 2000, J MED CHEM, V43, P4370, DOI 10.1021/jm0001727; BROWNSTEIN M, 1975, ENDOCRINOLOGY, V96, P1456, DOI 10.1210/endo-96-6-1456; CHRONWALL BM, 1985, NEUROSCIENCE, V15, P1159, DOI 10.1016/0306-4522(85)90260-X; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Cowley MA, 1999, NEURON, V24, P155, DOI 10.1016/S0896-6273(00)80829-6; Cummings DE, 2001, DIABETES, V50, P1714, DOI 10.2337/diabetes.50.8.1714; Date Y, 2002, GASTROENTEROLOGY, V123, P1120, DOI 10.1053/gast.2002.35954; Date Y, 2000, ENDOCRINOLOGY, V141, P4255, DOI 10.1210/en.141.11.4255; de la Cour CD, 2001, REGUL PEPTIDES, V99, P141, DOI 10.1016/S0167-0115(01)00243-9; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; DeFalco J, 2001, SCIENCE, V291, P2608, DOI 10.1126/science.1056602; Dickson SL, 1997, ENDOCRINOLOGY, V138, P771, DOI 10.1210/en.138.2.771; Fong TM, 1997, BIOCHEM BIOPH RES CO, V237, P629, DOI 10.1006/bbrc.1997.7200; Fuxe K, 1997, NEUROSCI LETT, V225, P49, DOI 10.1016/S0304-3940(97)00184-5; Gualillo O, 2001, ENDOCRINOLOGY, V142, P788, DOI 10.1210/en.142.2.788; Guan XM, 1997, MOL BRAIN RES, V48, P23, DOI 10.1016/S0169-328X(97)00071-5; Hahn TM, 1998, NAT NEUROSCI, V1, P271, DOI 10.1038/1082; Haskell-Luevano C, 1999, ENDOCRINOLOGY, V140, P1408, DOI 10.1210/en.140.3.1408; Hattori N, 2001, J CLIN ENDOCR METAB, V86, P4284, DOI 10.1210/jc.86.9.4284; Heisler LK, 2002, SCIENCE, V297, P609, DOI 10.1126/science.1072327; Hewson AK, 2000, J NEUROENDOCRINOL, V12, P1047, DOI 10.1046/j.1365-2826.2000.00584.x; Horvath TL, 1997, BRAIN RES, V756, P283, DOI 10.1016/S0006-8993(97)00184-4; Horvath TL, 1997, ENDOCRINOLOGY, V138, P1312, DOI 10.1210/en.138.3.1312; Horvath TL, 1998, J NEUROSCI, V18, P1546; Horvath TL, 2001, ENDOCRINOLOGY, V142, P4163, DOI 10.1210/en.142.10.4163; Kalra SP, 1999, ENDOCR REV, V20, P68, DOI 10.1210/er.20.1.68; Kamegai J, 2000, ENDOCRINOLOGY, V141, P4797, DOI 10.1210/en.141.12.4797; Kamegai J, 2001, DIABETES, V50, P2438, DOI 10.2337/diabetes.50.11.2438; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Korbonits M, 2001, J CLIN ENDOCR METAB, V86, P881, DOI 10.1210/jc.86.2.881; Lu S, 2002, NEUROSCI LETT, V321, P157, DOI 10.1016/S0304-3940(01)02544-7; Mori K, 2000, FEBS LETT, V486, P213, DOI 10.1016/S0014-5793(00)02308-5; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Oliver C, 1977, Front Horm Res, V4, P162; Powis JE, 1998, AM J PHYSIOL-REG I, V274, pR1468, DOI 10.1152/ajpregu.1998.274.5.R1468; Pronchuk N, 2002, ENDOCRINOLOGY, V143, P535, DOI 10.1210/en.143.2.535; Sakata I, 2002, PEPTIDES, V23, P531, DOI 10.1016/S0196-9781(01)00633-7; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Shintani M, 2001, DIABETES, V50, P227, DOI 10.2337/diabetes.50.2.227; Smith RG, 1997, ENDOCR REV, V18, P621, DOI 10.1210/er.18.5.621; Spanswick D, 1997, NATURE, V390, P521, DOI 10.1038/37379; Tanaka M, 2001, BBA-GENE STRUCT EXPR, V1522, P62, DOI 10.1016/S0167-4781(01)00304-9; Toran-Allerand CD, 2002, J NEUROSCI, V22, P8391; Toshinai K, 2001, BIOCHEM BIOPH RES CO, V281, P1220, DOI 10.1006/bbrc.2001.4518; Tschop M, 2001, DIABETES, V50, P707, DOI 10.2337/diabetes.50.4.707; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Tschop M, 2002, ENDOCRINOLOGY, V143, P558, DOI 10.1210/en.143.2.558; Tschop M, 2001, J ENDOCRINOL INVEST, V24, pRC19, DOI 10.1007/BF03351037; Tung YCL, 2001, J NEUROENDOCRINOL, V13, P209, DOI 10.1046/j.1365-2826.2001.00615.x; Volante M, 2002, J CLIN ENDOCR METAB, V87, P1300, DOI 10.1210/jc.87.3.1300; Wang LX, 2002, NEUROSCI LETT, V325, P47; WATTS AG, 1987, J COMP NEUROL, V258, P204, DOI 10.1002/cne.902580204; Willesen MG, 1999, NEUROENDOCRINOLOGY, V70, P306, DOI 10.1159/000054491; Wren AM, 2000, ENDOCRINOLOGY, V141, P4325, DOI 10.1210/en.141.11.4325; Wren AM, 2001, J CLIN ENDOCR METAB, V86, P5992, DOI 10.1210/jc.86.12.5992; Wren AM, 2001, DIABETES, V50, P2540, DOI 10.2337/diabetes.50.11.2540; ZAMIR N, 1986, BRAIN RES, V373, P240, DOI 10.1016/0006-8993(86)90337-9	62	1232	1285	4	97	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 20	2003	37	4					649	661		10.1016/S0896-6273(03)00063-1	http://dx.doi.org/10.1016/S0896-6273(03)00063-1			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	648EH	12597862	Bronze			2022-12-24	WOS:000181136500013
J	Boschat, C; Pelofi, C; Randin, O; Roppolo, D; Luscher, C; Broillet, MC; Rodriguez, I				Boschat, C; Pelofi, C; Randin, O; Roppolo, D; Luscher, C; Broillet, MC; Rodriguez, I			Pheromone detection mediated by a V1r vomeronasal receptor	NATURE NEUROSCIENCE			English	Article							MULTIGENE FAMILY; MAMMALS; NEURONS; SYSTEM; MOUSE		Univ Geneva, Dep Zool & Anim Biol, CH-1211 Geneva, Switzerland; Univ Lausanne, Inst Pharmacol & Toxicol, CH-1005 Lausanne, Switzerland; Univ Geneva, Dept Physiol & Neurol, CH-1211 Geneva, Switzerland	University of Geneva; University of Lausanne; University of Geneva	Rodriguez, I (corresponding author), Univ Geneva, Dep Zool & Anim Biol, CH-1211 Geneva, Switzerland.		Lüscher, Christian/A-2496-2011	Lüscher, Christian/0000-0001-7917-4596; Broillet, Marie-Christine/0000-0002-0487-6638; rodriguez, ivan/0000-0002-6468-0565				Belluscio L, 1999, CELL, V97, P209, DOI 10.1016/S0092-8674(00)80731-X; Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; Del Punta K, 2002, NATURE, V419, P70, DOI 10.1038/nature00955; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; HALPERN M, 1987, ANNU REV NEUROSCI, V10, P325, DOI 10.1146/annurev.ne.10.030187.001545; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; JEMIOLO B, 1989, PHYSIOL BEHAV, V46, P293, DOI 10.1016/0031-9384(89)90270-9; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; Rodriguez I, 2000, NAT GENET, V26, P18, DOI 10.1038/79124; Rodriguez I, 2002, NAT NEUROSCI, V5, P134, DOI 10.1038/nn795; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; Sam M, 2001, NATURE, V412, P142, DOI 10.1038/35084137	14	177	182	0	23	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2002	5	12					1261	1262		10.1038/nn978	http://dx.doi.org/10.1038/nn978			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	618ZE	12436115				2022-12-24	WOS:000179447500006
J	Pasupathy, A; Connor, CE				Pasupathy, A; Connor, CE			Population coding of shape in area V4	NATURE NEUROSCIENCE			English	Article							INFERIOR TEMPORAL NEURONS; INFEROTEMPORAL CORTEX; 3-DIMENSIONAL SHAPES; OBJECT RECOGNITION; VISUAL-CORTEX; MACAQUE; REPRESENTATION; FEATURES; SELECTIVITY; MONKEY	Shape is represented in the visual system by patterns of activity across populations of neurons. We studied the population code for shape in area V4 of macaque monkeys, which is part of the ventral (object-related) pathway in primate visual cortex. We have previously found that many macaque V4 neurons are tuned for the curvature and object-centered position of boundary fragments (such as 'concavity on the right'). Here we tested the hypothesis that populations of such cells represent complete shapes as aggregates of boundary fragments. To estimate the population representation of a given shape, we scaled each cell's tuning peak by its response to that shape, summed across cells and smoothed. The resulting population response surface contained 3-8 peaks that represented major boundary features and could be used to reconstruct (approximately) the original shape. This exemplifies how a multi-peaked neural population response can represent a complex stimulus in terms of its constituent elements.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21218 USA; MIT, Ctr Learning & Memory, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Johns Hopkins Univ, Zanvyl Krieger Mind Brain Inst, Baltimore, MD 21218 USA	Johns Hopkins University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Johns Hopkins University	Connor, CE (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21218 USA.							Baker CI, 2002, NAT NEUROSCI, V5, P1210, DOI 10.1038/nn960; Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371; Bartels RH, 1987, INTRO SPLINES USE CO; BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; Deneve S, 1999, NAT NEUROSCI, V2, P740, DOI 10.1038/11205; DESIMONE R, 1984, J NEUROSCI, V4, P2051; DESIMONE R, 1987, J NEUROPHYSIOL, V57, P835, DOI 10.1152/jn.1987.57.3.835; DICKINSON SJ, 1992, CVGIP-IMAG UNDERSTAN, V55, P130, DOI 10.1016/1049-9660(92)90013-S; Edelman S, 2000, SPATIAL VISION, V13, P255, DOI 10.1163/156856800741072; Edelman S., 1999, REPRESENTATION RECOG; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; FUJITA I, 1992, NATURE, V360, P343, DOI 10.1038/360343a0; GALLANT JL, 1993, SCIENCE, V259, P100, DOI 10.1126/science.8418487; GATTASS R, 1988, J NEUROSCI, V8, P1831; GOCHIN PM, 1994, J NEUROPHYSIOL, V71, P2325, DOI 10.1152/jn.1994.71.6.2325; Hanazawa A, 2001, J NEUROSCI, V21, P4490, DOI 10.1523/JNEUROSCI.21-12-04490.2001; HOFFMAN DD, 1984, COGNITION, V18, P65, DOI 10.1016/0010-0277(84)90022-2; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; Janssen P, 1999, P NATL ACAD SCI USA, V96, P8217, DOI 10.1073/pnas.96.14.8217; Kobatake E, 1998, J NEUROPHYSIOL, V80, P324, DOI 10.1152/jn.1998.80.1.324; KOBATAKE E, 1994, J NEUROPHYSIOL, V71, P856, DOI 10.1152/jn.1994.71.3.856; Lewis JE, 1998, NATURE, V391, P76, DOI 10.1038/34172; MARDIA KV, 1976, BIOMETRIKA, V63, P403, DOI 10.2307/2335637; MARR D, 1978, PROC R SOC SER B-BIO, V200, P269, DOI 10.1098/rspb.1978.0020; MILNER PM, 1974, PSYCHOL REV, V81, P521, DOI 10.1037/h0037149; MOUNTCASTLE VB, 1995, CEREB CORTEX, V5, P377, DOI 10.1093/cercor/5.5.377; Olson CR, 1996, CURR OPIN NEUROBIOL, V6, P165, DOI 10.1016/S0959-4388(96)80069-9; Op de Beeck H, 2001, NAT NEUROSCI, V4, P1244, DOI 10.1038/nn767; Pasupathy A, 1999, J NEUROPHYSIOL, V82, P2490, DOI 10.1152/jn.1999.82.5.2490; Pasupathy A, 2001, J NEUROPHYSIOL, V86, P2505, DOI 10.1152/jn.2001.86.5.2505; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; Rolls ET, 1997, EXP BRAIN RES, V114, P149, DOI 10.1007/PL00005615; Salinas E, 1994, J Comput Neurosci, V1, P89, DOI 10.1007/BF00962720; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; Sigala N, 2002, NATURE, V415, P318, DOI 10.1038/415318a; SUTHERLAND NS, 1968, PROC R SOC SER B-BIO, V171, P297, DOI 10.1098/rspb.1968.0072; TANAKA K, 1991, J NEUROPHYSIOL, V66, P170, DOI 10.1152/jn.1991.66.1.170; Treue S, 2000, NAT NEUROSCI, V3, P270, DOI 10.1038/72985; Tsunoda K, 2001, NAT NEUROSCI, V4, P832, DOI 10.1038/90547; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Wang Y, 2000, NAT NEUROSCI, V3, P807, DOI 10.1038/77712; YOUNG MP, 1992, SCIENCE, V256, P1327, DOI 10.1126/science.1598577; ZEKI SM, 1973, BRAIN RES, V53, P422, DOI 10.1016/0006-8993(73)90227-8; Zemel RS, 1998, NEURAL COMPUT, V10, P403, DOI 10.1162/089976698300017818; Zhang KC, 1998, J NEUROPHYSIOL, V79, P1017, DOI 10.1152/jn.1998.79.2.1017; [No title captured]; [No title captured]	49	362	366	0	31	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2002	5	12					1332	1338		10.1038/nn972	http://dx.doi.org/10.1038/nn972			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	618ZE	12426571				2022-12-24	WOS:000179447500017
J	O'Connor, DH; Fukui, MM; Pinsk, MA; Kastner, S				O'Connor, DH; Fukui, MM; Pinsk, MA; Kastner, S			Attention modulates responses in the human lateral geniculate nucleus	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; INTERMODAL SELECTIVE ATTENTION; EXTRASTRIATE CORTEX; DIRECTED ATTENTION; NEURAL MECHANISMS; SPATIAL ATTENTION; FUNCTIONAL MRI; CORTICAL AREAS; HUMAN BRAIN; ACTIVATION	Attentional mechanisms are important for selecting relevant information and filtering out irrelevant information from cluttered visual scenes. Selective attention has previously been shown to affect neural activity in both extrastriate and striate visual cortex. Here, evidence from functional brain imaging shows that attentional response modulation is not confined to cortical processing, but can occur as early as the thalamic level. We found that attention modulated neural activity in the human lateral geniculate nucleus (LGN) in several ways: it enhanced neural responses to attended stimuli, attenuated responses to ignored stimuli and increased baseline activity in the absence of visual stimulation. The LGN, traditionally viewed as the gateway to visual cortex, may also serve as a 'gatekeeper' in controlling attentional response gain.	Princeton Univ, Dept Psychol, Ctr Study Brain Mind & Behav, Princeton, NJ 08544 USA	Princeton University	Kastner, S (corresponding author), Princeton Univ, Dept Psychol, Ctr Study Brain Mind & Behav, Green Hall, Princeton, NJ 08544 USA.			Kastner, Sabine/0000-0002-9742-965X				Bender DB, 2001, J NEUROPHYSIOL, V85, P219, DOI 10.1152/jn.2001.85.1.219; Chen W, 1998, MAGN RESON MED, V39, P89, DOI 10.1002/mrm.1910390115; Chen W, 1999, P NATL ACAD SCI USA, V96, P2430, DOI 10.1073/pnas.96.5.2430; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; CORBETTA M, 1990, SCIENCE, V248, P1556, DOI 10.1126/science.2360050; CRICK F, 1984, P NATL ACAD SCI-BIOL, V81, P4586, DOI 10.1073/pnas.81.14.4586; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; Guillery RW, 1998, TRENDS NEUROSCI, V21, P28, DOI 10.1016/S0166-2236(97)01157-0; Guillery RW, 2002, NEURON, V33, P163, DOI 10.1016/S0896-6273(01)00582-7; Hadjikhani N, 1998, NAT NEUROSCI, V1, P235, DOI 10.1038/681; Ito M, 1999, NEURON, V22, P593, DOI 10.1016/S0896-6273(00)80713-8; Jones EG, 1985, THALAMUS; Kanwisher N, 2000, NAT REV NEUROSCI, V1, P91, DOI 10.1038/35039043; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; Kastner S, 2001, J NEUROPHYSIOL, V86, P1398, DOI 10.1152/jn.2001.86.3.1398; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; KOCH C, 1985, HUM NEUROBIOL, V4, P219; LAVIE N, 1994, PERCEPT PSYCHOPHYS, V56, P183, DOI 10.3758/BF03213897; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; MAUNSELL JHR, 1995, SCIENCE, V270, P764, DOI 10.1126/science.270.5237.764; Mehta AD, 2000, CEREB CORTEX, V10, P359, DOI 10.1093/cercor/10.4.359; Mehta SD, 2000, CEREB CORTEX, V10, P343, DOI 10.1093/cercor/10.4.343; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; Posner MI, 1999, P NATL ACAD SCI USA, V96, P2585, DOI 10.1073/pnas.96.6.2585; Rees G, 1997, SCIENCE, V278, P1616, DOI 10.1126/science.278.5343.1616; Reppas JB, 2002, NEURON, V35, P961, DOI 10.1016/S0896-6273(02)00823-1; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Sherman S.M., 2001, EXPLORING THALAMUS, V1st Edn; Sherman SM, 2001, TRENDS NEUROSCI, V24, P122, DOI 10.1016/S0166-2236(00)01714-8; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; Talairach I., 1988, COPLANAR STEREOTACTI; Vanduffel W, 2000, CEREB CORTEX, V10, P109, DOI 10.1093/cercor/10.2.109; Watanabe T, 1998, P NATL ACAD SCI USA, V95, P11489, DOI 10.1073/pnas.95.19.11489; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; WOODS RP, 1993, J COMPUT ASSIST TOMO, V17, P536, DOI 10.1097/00004728-199307000-00004	42	452	460	7	40	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1203	1209		10.1038/nn957	http://dx.doi.org/10.1038/nn957			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	609CG	12379861				2022-12-24	WOS:000178884600024
J	Blanpied, TA; Scott, DB; Ehlers, MD				Blanpied, TA; Scott, DB; Ehlers, MD			Dynamics and regulation of clathrin coats at specialized endocytic zones of dendrites and spines	NEURON			English	Article							SYNAPTIC VESICLE ENDOCYTOSIS; LONG-TERM DEPRESSION; AMPA RECEPTOR ENDOCYTOSIS; MEDIATED ENDOCYTOSIS; GLUTAMATE RECEPTORS; HIPPOCAMPAL-NEURONS; INTERNALIZATION; PLASTICITY; PROTEINS; BINDING	Endocytosis is a fundamental mechanism by which neurons control intercellular signaling, nutrient uptake, and synaptic transmission. This process is carried out by the assembly of clathrin coats and the budding of clathrin-coated vesicles from the neuronal plasma membrane. Here, we demonstrate that in young neurons, clathrin assembly and disassembly occur rapidly, locally, and repeatedly at "hot spots" throughout dendrites and at the tips of dendritic filopodia. In contrast, clathrin coats in mature dendrites reside in stable, long-lasting zones at sites of endocytosis, where clathrin undergoes continuous exchange with local cytosolic pools. In dendritic spines, endocytic zones lie lateral to the postsynaptic density (PSD) where they develop and persist independent of synaptic activity, akin to the PSD itself. These results reveal the presence of a novel specialization dedicated to endocytosis near the postsynaptic membrane.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pharmacol, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Ehlers, MD (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.			Blanpied, Thomas/0000-0003-4957-557X	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F31AA013220] Funding Source: NIH RePORTER; NIAAA NIH HHS [F31 AA13220] Funding Source: Medline; NIMH NIH HHS [MH 64748] Funding Source: Medline; NINDS NIH HHS [NS 39402] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Augustine GJ, 1999, J PHYSIOL-LONDON, V520, P33, DOI 10.1111/j.1469-7793.1999.00033.x; Beattie EC, 2000, J NEUROSCI, V20, P7325; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Benmerah A, 1999, J CELL SCI, V112, P1303; Borgdorff AJ, 2002, NATURE, V417, P649, DOI 10.1038/nature00780; Brodin L, 2000, CURR OPIN NEUROBIOL, V10, P312, DOI 10.1016/S0959-4388(00)00097-0; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Claing A, 2002, PROG NEUROBIOL, V66, P61, DOI 10.1016/S0301-0082(01)00023-5; Cooney JR, 2002, J NEUROSCI, V22, P2215, DOI 10.1523/JNEUROSCI.22-06-02215.2002; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Engqvist-Goldstein AEY, 2001, J CELL BIOL, V154, P1209, DOI 10.1083/jcb.200106089; Fiala JC, 1998, J NEUROSCI, V18, P8900; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Gad H, 1998, NEURON, V21, P607, DOI 10.1016/S0896-6273(00)80570-X; Gaidarov I, 1999, NAT CELL BIOL, V1, P1, DOI 10.1038/8971; Hasbani MJ, 2001, J NEUROSCI, V21, P2393, DOI 10.1523/JNEUROSCI.21-07-02393.2001; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Itoh T, 2001, SCIENCE, V291, P1047, DOI 10.1126/science.291.5506.1047; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Kittler JT, 2000, J NEUROSCI, V20, P7972; LARKIN JM, 1986, J CELL BIOL, V103, P2619, DOI 10.1083/jcb.103.6.2619; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Merrifield CJ, 1999, NAT CELL BIOL, V1, P72, DOI 10.1038/9048; MILLER TM, 1984, J CELL BIOL, V98, P685, DOI 10.1083/jcb.98.2.685; Morgan JR, 2001, NEURON, V32, P289, DOI 10.1016/S0896-6273(01)00467-6; Morgan JR, 2000, J NEUROSCI, V20, P8667; Moss SJ, 2001, NAT REV NEUROSCI, V2, P240, DOI 10.1038/35067500; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Okamoto PM, 2001, J BIOL CHEM, V276, P48458, DOI 10.1074/jbc.M104927200; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Qualmann B, 2000, J CELL BIOL, V150, pF111, DOI 10.1083/jcb.150.5.F111; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; Santini F, 2002, J CELL BIOL, V156, P665, DOI 10.1083/jcb.200110132; Scott DB, 2001, J NEUROSCI, V21, P3063, DOI 10.1523/JNEUROSCI.21-09-03063.2001; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Sorra KE, 2000, HIPPOCAMPUS, V10, P501, DOI 10.1002/1098-1063(2000)10:5<501::AID-HIPO1>3.0.CO;2-T; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; Sun JY, 2002, NATURE, V417, P555, DOI 10.1038/417555a; Teng HB, 1999, J NEUROSCI, V19, P4855; Toni N, 2001, J NEUROSCI, V21, P6245, DOI 10.1523/JNEUROSCI.21-16-06245.2001; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Wenk MR, 2001, NEURON, V32, P79, DOI 10.1016/S0896-6273(01)00456-1; Wu XF, 2001, J CELL BIOL, V155, P291, DOI 10.1083/jcb.200104085; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; Zhou Q, 2001, P NATL ACAD SCI USA, V98, P1261, DOI 10.1073/pnas.031573798	54	264	275	1	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 24	2002	36	3					435	449		10.1016/S0896-6273(02)00979-0	http://dx.doi.org/10.1016/S0896-6273(02)00979-0			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	608ZE	12408846	Bronze			2022-12-24	WOS:000178877700012
J	Taha, S; Hanover, JL; Silva, AJ; Stryker, MP				Taha, S; Hanover, JL; Silva, AJ; Stryker, MP			Autophosphorylation of alpha CaMKII is required for ocular dominance plasticity	NEURON			English	Article							DEPENDENT PROTEIN-KINASE; PRIMARY VISUAL-CORTEX; LONG-TERM POTENTIATION; MONOCULAR DEPRIVATION; CRITICAL-PERIOD; STRIATE CORTEX; EXPERIENCE; EXPRESSION; INHIBITION; BRAIN	Experience is a powerful sculptor of developing neural connections. In the primary visual cortex (V1), cortical connections are particularly susceptible to the effects of sensory manipulation during a postnatal critical period. At the molecular level, this activity-dependent plasticity requires the transformation of synaptic depolarization into changes in synaptic weight. The molecule a calcium-calmodulin kinase type II (alphaCaMKII) is known to play a central role in this transformation. Importantly, alphaCaMKII function is modulated by autophosphorylation, which promotes Ca2+-independent kinase activity. Here we show that mice possessing a mutant form of alphaCaMKII that is unable to autophosphorylate show impairments in ocular dominance plasticity. These results confirm the importance of alphaCaMKII in visual cortical plasticity and suggest that synaptic changes induced by monocular deprivation are stored specifically in glutamatergic synapses made onto excitatory neurons.	Univ Calif San Francisco, WM Ctr Integrat Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Stryker, MP (corresponding author), Univ Calif San Francisco, WM Ctr Integrat Neurosci, San Francisco, CA 94143 USA.		Silva, Alcino/ABD-7684-2021	Silva, Alcino/0000-0002-1587-4558; Stryker, Michael/0000-0003-1546-5831; Silva, Alcino/0000-0001-5525-0494	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS016033, P50NS016033] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 16033, P01 NS016033-210017, P01 NS016033] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; BURGIN KE, 1990, J NEUROSCI, V10, P1788; DASH PK, 1991, P NATL ACAD SCI USA, V88, P5061, DOI 10.1073/pnas.88.11.5061; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Feng TP, 1995, PROG BRAIN RES, V105, P55; FONG YL, 1989, J BIOL CHEM, V264, P16759; FREEMAN RD, 1982, J NEUROPHYSIOL, V47, P139, DOI 10.1152/jn.1982.47.2.139; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Glazewski S, 2000, NAT NEUROSCI, V3, P911, DOI 10.1038/78820; Gordon JA, 1996, NEURON, V17, P491, DOI 10.1016/S0896-6273(00)80181-6; Gordon JA, 1996, J NEUROSCI, V16, P3274; Hanover JL, 1999, J NEUROSCI, V19, part. no.; HANSON PI, 1989, NEURON, V3, P59, DOI 10.1016/0896-6273(89)90115-3; HENDRY SHC, 1986, P NATL ACAD SCI USA, V83, P1536, DOI 10.1073/pnas.83.5.1536; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; KELLY PT, 1987, J NEUROCHEM, V49, P1927, DOI 10.1111/j.1471-4159.1987.tb02456.x; KENNEDY MB, 1983, P NATL ACAD SCI-BIOL, V80, P7357, DOI 10.1073/pnas.80.23.7357; KRATZ KE, 1976, J NEUROPHYSIOL, V39, P501, DOI 10.1152/jn.1976.39.3.501; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; LISMAN J, 1994, TRENDS NEUROSCI, V17, P406, DOI 10.1016/0166-2236(94)90014-0; Liu XB, 1996, P NATL ACAD SCI USA, V93, P7332, DOI 10.1073/pnas.93.14.7332; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; Mower AF, 2002, J NEUROSCI, V22, P2237, DOI 10.1523/JNEUROSCI.22-06-02237.2002; MOWER GD, 1989, DEV BRAIN RES, V45, P211, DOI 10.1016/0165-3806(89)90040-0; PETTIT DL, 1994, SCIENCE, V266, P1881, DOI 10.1126/science.7997883; Pham TA, 1999, NEURON, V22, P63, DOI 10.1016/S0896-6273(00)80679-0; Roberts EB, 1998, J NEUROPHYSIOL, V80, P1021, DOI 10.1152/jn.1998.80.3.1021; SILLITO AM, 1981, NATURE, V291, P318, DOI 10.1038/291318a0; Soderling TR, 2000, CURR OPIN NEUROBIOL, V10, P375, DOI 10.1016/S0959-4388(00)00090-8; Taha S, 2002, NEURON, V34, P425, DOI 10.1016/S0896-6273(02)00673-6; Tighilet B, 1998, J NEUROSCI, V18, P2129; WAXHAM MN, 1990, P NATL ACAD SCI USA, V87, P1273, DOI 10.1073/pnas.87.4.1273; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3; Zou DJ, 1999, J NEUROSCI, V19, P8909, DOI 10.1523/JNEUROSCI.19-20-08909.1999	38	90	92	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 24	2002	36	3					483	491		10.1016/S0896-6273(02)00966-2	http://dx.doi.org/10.1016/S0896-6273(02)00966-2			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	608ZE	12408850	Bronze			2022-12-24	WOS:000178877700016
J	Xiong, ZQ; McNamara, JO				Xiong, ZQ; McNamara, JO			Fleeting activation of ionotropic glutamate receptors sensitizes cortical neurons to complement attack	NEURON			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; EXCITOTOXIC CELL-DEATH; ALZHEIMERS-DISEASE; NERVOUS-SYSTEM; NEUROTOXICITY; IMMUNOREACTIVITY; LOCALIZATION; INHIBITION; ANTIBODIES; SUPEROXIDE	Insidious attack of cortical neurons by complement has been implicated in Alzheimer's and other neurodegenerative diseases. Excitotoxicity, triggered by excessive activation of glutamate receptors, has been implicated in neuronal death following diverse insults, including ischemia and seizures. Clinical studies suggested that a minimal excitotoxic insult might sensitize neurons to complement attack. We found that fleeting activation of ionotropic glutamate receptors sensitizes neurons but not astrocytes to complement attack. The complement molecule effecting cytotoxicity was the membrane attack complex. The site within the complement cascade at which sensitization was effected was the membrane attack pathway. Sensitization mediated by glutamate receptor activation required Ca-o(2+) and generation of reactive oxygen species. These in vitro findings predict that a fleeting excitotoxic insult could act synergistically with complement to destroy cortical neurons and accelerate neurological deterioration.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med Neurol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pharmacol & Mol Canc Biol, Durham, NC 27710 USA; Durham Vet Affairs Med Ctr, Durham, NC 27710 USA	Duke University; Duke University; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center	Xiong, ZQ (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.				NINDS NIH HHS [NS 036808] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036808] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Asghar SS, 2000, FRONT BIOSCI-LANDMRK, V5, pE63, DOI 10.2741/asghar; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Ciani E, 1996, BRAIN RES, V728, P1; COMPSTON DAS, 1989, NEUROPATH APPL NEURO, V15, P307, DOI 10.1111/j.1365-2990.1989.tb01231.x; Davoust N, 1999, J IMMUNOL, V163, P6551; Doble A, 1999, PHARMACOL THERAPEUT, V81, P163, DOI 10.1016/S0163-7258(98)00042-4; DUGAN LL, 1995, J NEUROSCI, V15, P6377; Gasque P, 2000, IMMUNOPHARMACOLOGY, V49, P171, DOI 10.1016/S0162-3109(00)80302-1; He XP, 1998, NEURON, V20, P153, DOI 10.1016/S0896-6273(00)80443-2; Huang J, 1999, SCIENCE, V285, P595, DOI 10.1126/science.285.5427.595; ITAGAKI S, 1994, BRAIN RES, V645, P78, DOI 10.1016/0006-8993(94)91640-3; JIANG HX, 1994, J IMMUNOL, V152, P5050; Kokmen E, 1996, NEUROLOGY, V46, P154, DOI 10.1212/WNL.46.1.154; LAFONCAZAL M, 1993, NATURE, V364, P535, DOI 10.1038/364535a0; Li QY, 2001, J NEUROCHEM, V78, P746, DOI 10.1046/j.1471-4159.2001.00457.x; Liszewski MK, 1996, ADV IMMUNOL, V61, P201; MATIS LA, 1995, NAT MED, V1, P839, DOI 10.1038/nm0895-839; MAYER MM, 1972, P NATL ACAD SCI USA, V69, P2954, DOI 10.1073/pnas.69.10.2954; MCGEER PL, 1989, NEUROSCI LETT, V107, P341, DOI 10.1016/0304-3940(89)90843-4; Morgan BP, 1999, CRIT REV IMMUNOL, V19, P173; MORGAN BP, 1995, CRIT REV CL LAB SCI, V32, P265, DOI 10.3109/10408369509084686; MORGAN BP, 1994, EUR J CLIN INVEST, V24, P219, DOI 10.1111/j.1365-2362.1994.tb01078.x; Oguni H, 1991, CHRONIC ENCEPHALITIS, P7; Patel M, 1996, NEURON, V16, P345, DOI 10.1016/S0896-6273(00)80052-5; PIDDLESDEN SJ, 1994, J IMMUNOL, V152, P5477; SCOLDING NJ, 1989, NATURE, V339, P620, DOI 10.1038/339620a0; SHIN ML, 1998, HUMAN COMPLEMENT SYS, P499; Singhrao SK, 1999, EXP NEUROL, V159, P362, DOI 10.1006/exnr.1999.7170; Vergun O, 2001, J PHYSIOL-LONDON, V531, P147, DOI 10.1111/j.1469-7793.2001.0147j.x; VOLICER L, 1995, DEMENTIA, V6, P258, DOI 10.1159/000106956; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Webster S, 1997, NEUROBIOL AGING, V18, P415, DOI 10.1016/S0197-4580(97)00042-0; Whitney KD, 1999, NEUROLOGY, V53, P699, DOI 10.1212/WNL.53.4.699; Whitney KD, 2000, J NEUROSCI, V20, P7307	34	24	30	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 24	2002	36	3					363	374		10.1016/S0896-6273(02)00977-7	http://dx.doi.org/10.1016/S0896-6273(02)00977-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	608ZE	12408841	Bronze			2022-12-24	WOS:000178877700007
J	Dragoi, V; Sharma, J; Miller, EK; Sur, M				Dragoi, V; Sharma, J; Miller, EK; Sur, M			Dynamics of neuronal sensitivity in visual cortex and local feature discrimination	NATURE NEUROSCIENCE			English	Article							ORIENTATION SELECTIVITY; SYNAPTIC DEPRESSION; RECEPTIVE-FIELDS; NATURAL SCENES; ADAPTATION; STATISTICS; V1; CONTRAST; INHIBITION; PLASTICITY	A striking aspect of natural scenes is that image features such as line orientation are strongly correlated at neighboring spatial locations but not at distant locations. Thus, during the viewing of a scene, eye movements are often accompanied by a change in the orientation structure of the image. How does this behavior influence the discrimination of local features and their encoding by visual cortical neurons? Here we examined the perceived changes in orientation induced by brief exposure to oriented image patterns in monkeys and humans, and then used reverse correlation to investigate dynamic changes in neuronal sensitivity in the primary visual cortex (V1) of behaving monkeys. Whereas brief adaptation to an oriented grating impaired identification of nearby orientations by broadening orientation selectivity and changing the preferred orientation of individual V1 neurons, it actually enhanced the identification of orthogonal orientations by sharpening neuronal selectivity. Hence, successive exposure to image patches of dissimilar spatial structure enhances both the ability to discriminate local features and the encoding of these features by V1 neurons.	MIT, Dept Brain & Cognit Sci, Picower Ctr Learning & Memory, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Dragoi, V (corresponding author), MIT, Dept Brain & Cognit Sci, Picower Ctr Learning & Memory, 45 Carleton St, Cambridge, MA 02139 USA.	vdragoi@ai.mit.edu	Miller, Earl K./AAE-8187-2019	Miller, Earl K./0000-0002-0582-6958				Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Andrews TJ, 1999, VISION RES, V39, P2947, DOI 10.1016/S0042-6989(99)00019-X; ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; BLAKEMORE C, 1969, J PHYSIOL-LONDON, V200, pP11; Blakemore C., 2010, VISION CODING EFFICI, P363, DOI 10.1017/cbo9780511626197.034; Carandini M, 1998, NEUROPHARMACOLOGY, V37, P501, DOI 10.1016/S0028-3908(98)00069-0; CHANDRAN PKG, 1985, ADV CAPD, V1, P18; CHAPMAN B, 1991, J NEUROSCI, V11, P1347; Clifford CWG, 2001, VISION RES, V41, P151, DOI 10.1016/S0042-6989(00)00248-0; Coppola DM, 1998, P NATL ACAD SCI USA, V95, P4002, DOI 10.1073/pnas.95.7.4002; DEBOER E, 1968, IEEE T BIO-MED ENG, VBM15, P169, DOI 10.1109/TBME.1968.4502561; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Dragoi V, 2000, J NEUROPHYSIOL, V83, P1019, DOI 10.1152/jn.2000.83.2.1019; Dragoi V, 2000, NEURON, V28, P287, DOI 10.1016/S0896-6273(00)00103-3; Dragoi V, 2001, NEURON, V32, P1181, DOI 10.1016/S0896-6273(01)00540-2; Dragoi V, 2001, NATURE, V411, P80, DOI 10.1038/35075070; FERSTER D, 1986, J NEUROSCI, V6, P1284; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Galarreta M, 1998, NAT NEUROSCI, V1, P587, DOI 10.1038/2822; Gallant JL, 1998, NEUROREPORT, V9, P2153, DOI 10.1097/00001756-199806220-00045; Geisler WS, 2001, VISION RES, V41, P711, DOI 10.1016/S0042-6989(00)00277-7; Green DM, 1966, SIGNAL DETECTION THE; Mazer JA, 2002, P NATL ACAD SCI USA, V99, P1645, DOI 10.1073/pnas.022638499; McLaughlin D, 2000, P NATL ACAD SCI USA, V97, P8087, DOI 10.1073/pnas.110135097; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; NELSON SB, 1991, J NEUROSCI, V11, P344; Rainer G, 1999, J NEUROSCI, V19, P5493; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Reinagel P, 1999, NETWORK-COMP NEURAL, V10, P341, DOI 10.1088/0954-898X/10/4/304; Ringach DL, 1997, NATURE, V387, P281, DOI 10.1038/387281a0; Rossi AF, 1996, SCIENCE, V273, P1104, DOI 10.1126/science.273.5278.1104; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; Sceniak MP, 1999, NAT NEUROSCI, V2, P733, DOI 10.1038/11197; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Sigman M, 2001, P NATL ACAD SCI USA, V98, P1935, DOI 10.1073/pnas.031571498; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; SIMONCELLI EP, 1999, ADV NEURAL INFORMATI, V11; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Super H, 2001, SCIENCE, V293, P120, DOI 10.1126/science.1060496; Theunissen FE, 2001, NETWORK-COMP NEURAL, V12, P289, DOI 10.1088/0954-898X/12/3/304; TOLHURST DJ, 1992, OPHTHAL PHYSL OPT, V12, P229, DOI 10.1111/j.1475-1313.1992.tb00296.x; Troyer TW, 1998, J NEUROSCI, V18, P5908; van Hateren JH, 1998, P ROY SOC B-BIOL SCI, V265, P2315, DOI 10.1098/rspb.1998.0577; Varela JA, 1999, J NEUROSCI, V19, P4293; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; WORGOTTER F, 1991, EXP BRAIN RES, V83, P665; Yarbus A.L., 1967, EYE MOVEMENT VISION	47	156	159	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2002	5	9					883	891		10.1038/nn900	http://dx.doi.org/10.1038/nn900			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587RL	12161755				2022-12-24	WOS:000177656300019
J	Takeyama, K; Ito, S; Yamamoto, A; Tanimoto, H; Furutani, T; Kanuka, H; Miura, M; Tabata, T; Kato, S				Takeyama, K; Ito, S; Yamamoto, A; Tanimoto, H; Furutani, T; Kanuka, H; Miura, M; Tabata, T; Kato, S			Androgen-dependent neurodegeneration by polyglutamine-expanded human androgen receptor in Drosophila	NEURON			English	Article							NUCLEAR RECEPTOR; BINDING DOMAIN; INTRANUCLEAR INCLUSIONS; AGGREGATE FORMATION; ESTROGEN-RECEPTOR; CELL-DEATH; PROTEIN; COACTIVATOR; ACTIVATION; GENE	Spinal and bulbar muscular atrophy (SBMA) is an X-linked, adult-onset, neurodegenerative disorder affecting only males and is caused by expanded polyglutamine (polyQ) stretches in the N-terminal A/B domain of human androgen receptor (hAR). Although no overt phenotype was detected in adult fly eye photoreceptor neurons expressing mutant hAR (polyQ 52), ingestion of androgen or its known antagonists caused marked neurodegeneration with nuclear localization and structural alteration of the hAR mutant. Ligand-independent toxicity was detected with a truncated polyQ-expanded A/B domain alone, which was attenuated with cytosolic trapping by coexpression of the unliganded hAR E/F ligand binding domain. Thus, our findings suggest that the full binding of androgen to the polyQ-expanded hAR mutants leads to structural alteration with nuclear translocation that eventually results in the onset of SBMA in male patients.	Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; Yamanouchi Pharmaceut Co Ltd, Inst Drug Discovery Res, Tsukuba, Ibaraki 3058585, Japan; RIKEN, Brain Sci Inst, Lab Cell Recovery Mech, Wako, Saitama 3510198, Japan; Japan Sci & Technol, CREST, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; Astellas Pharmaceuticals; RIKEN; Japan Science & Technology Agency (JST)	Kato, S (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.		Tanimoto, Hiromu/J-6810-2016					Akimaru H, 1997, NATURE, V386, P735, DOI 10.1038/386735a0; Bai JW, 2000, CELL, V103, P1047, DOI 10.1016/S0092-8674(00)00208-7; Becker M, 2000, J CELL BIOL, V149, P255, DOI 10.1083/jcb.149.2.255; Bender M, 1997, CELL, V91, P777, DOI 10.1016/S0092-8674(00)80466-3; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROWN TR, 1988, P NATL ACAD SCI USA, V85, P8151, DOI 10.1073/pnas.85.21.8151; Choong CS, 1998, J MOL ENDOCRINOL, V21, P235, DOI 10.1677/jme.0.0210235; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Freedman LP, 1999, CELL, V97, P5, DOI 10.1016/S0092-8674(00)80708-4; Glass CK, 2000, GENE DEV, V14, P121; He B, 1999, J BIOL CHEM, V274, P37219, DOI 10.1074/jbc.274.52.37219; Ikonen T, 1997, J BIOL CHEM, V272, P29821, DOI 10.1074/jbc.272.47.29821; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; Kanuka H, 1999, MOL CELL, V4, P757, DOI 10.1016/S1097-2765(00)80386-X; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Kazemi-Esfarjani P, 2000, SCIENCE, V287, P1837, DOI 10.1126/science.287.5459.1837; KENNEDY WR, 1968, NEUROLOGY, V18, P671, DOI 10.1212/WNL.18.7.671; Kim TW, 1998, NEURON, V21, P657, DOI 10.1016/S0896-6273(00)80581-4; Kitagawa H, 2002, MOL CELL BIOL, V22, P3698, DOI 10.1128/MCB.22.11.3698-3706.2002; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; LA SA, 1991, NATURE, V352, P77; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Merry DE, 1998, HUM MOL GENET, V7, P693, DOI 10.1093/hmg/7.4.693; Merry DE, 1998, GENETIC INSTABILITIES AND HEREDITARY NEUROLOGICAL DISEASES, P101; MOSES K, 1991, GENE DEV, V5, P583, DOI 10.1101/gad.5.4.583; PINSKY L, 1992, CLIN INVEST MED, V15, P456; Poujol N, 2000, J BIOL CHEM, V275, P24022, DOI 10.1074/jbc.M001999200; Ross CA, 1997, NEURON, V19, P1147, DOI 10.1016/S0896-6273(00)80405-5; Ruijter E, 1999, ENDOCR REV, V20, P22, DOI 10.1210/er.20.1.22; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Simeoni S, 2000, HUM MOL GENET, V9, P133, DOI 10.1093/hmg/9.1.133; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Stenoien DL, 1999, HUM MOL GENET, V8, P731, DOI 10.1093/hmg/8.5.731; Takeyama K, 1997, SCIENCE, V277, P1827, DOI 10.1126/science.277.5333.1827; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; Tomura A, 2001, J BIOL CHEM, V276, P28395, DOI 10.1074/jbc.M101755200; Toyoshima F, 1998, EMBO J, V17, P2728, DOI 10.1093/emboj/17.10.2728; Tsuneizumi K, 1997, NATURE, V389, P627, DOI 10.1038/39362; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; Watanabe M, 2001, EMBO J, V20, P1341, DOI 10.1093/emboj/20.6.1341; White KP, 1997, SCIENCE, V276, P114, DOI 10.1126/science.276.5309.114; Yamamoto A, 2000, J CELL BIOL, V150, P873, DOI 10.1083/jcb.150.4.873; Yanagisawa J, 2002, MOL CELL, V9, P553, DOI 10.1016/S1097-2765(02)00478-1; YONG EL, 1994, LANCET, V344, P826, DOI 10.1016/S0140-6736(94)92385-X; ZHOU ZX, 1994, J BIOL CHEM, V269, P13115	49	230	236	1	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 29	2002	35	5					855	864		10.1016/S0896-6273(02)00875-9	http://dx.doi.org/10.1016/S0896-6273(02)00875-9			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	589UY	12372281	Bronze			2022-12-24	WOS:000177779800009
J	Luo, ZG; Wang, Q; Zhou, JZ; Wang, JB; Luo, ZJ; Liu, MY; He, X; Wynshaw-Boris, A; Xiong, WC; Lu, B; Mei, L				Luo, ZG; Wang, Q; Zhou, JZ; Wang, JB; Luo, ZJ; Liu, MY; He, X; Wynshaw-Boris, A; Xiong, WC; Lu, B; Mei, L			Regulation of AChR clustering by dishevelled interacting with MuSK and PAK1	NEURON			English	Article							RECEPTOR TYROSINE KINASE; ACETYLCHOLINE-RECEPTOR; POSTSYNAPTIC DIFFERENTIATION; NEUROMUSCULAR-JUNCTION; SIGNALING PATHWAY; GENE-EXPRESSION; CELL POLARITY; CRD DOMAIN; AGRIN; PROTEIN	An important aspect of synapse development is the clustering of neurotransmitter receptors in the postsynaptic membrane. Although MuSK is required for acetylcholine receptor (AChR) clustering at the neuromuscular junction (NMJ), the underlying molecular mechanisms remain unclear. We report here that in muscle cells, MuSK interacts with Dishevelled (Dvl), a signaling molecule important for planar cell polarity. Disruption of the MuSK-Dvl interaction inhibits Agrin- and neuron-induced AChR clustering. Expression of dominant-negative Dvl1 in postsynaptic muscle cells reduces the amplitude of spontaneous synaptic currents at the NMJ. Moreover, Dvl1 interacts with downstream kinase PAK1. Agrin activates PAK, and this activation requires Dvl. Inhibition of PAK1 activity attenuates AChR clustering. These results demonstrate important roles of DO and PAK in Agrin/MuSK-induced AChR clustering and reveal a novel function of Dvl in synapse development.	Univ Alabama Birmingham, Civitan Int Res Ctr, Dept Neurobiol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Civitan Int Res Ctr, Dept Pathol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Civitan Int Res Ctr, Dept Phys Med & Rehabil, Birmingham, AL 35294 USA; Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China; NICHD, Unit Synapse Dev & Plast, Dev Neurobiol Lab, NIH, Bethesda, MD 20892 USA; Univ Calif San Diego, Sch Med, Dept Pediat & Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Ctr Canc, La Jolla, CA 92093 USA; Boston Univ, Sch Med, Evans Dept Med, Endocrinol Sect,Diabet & Metab Res Unit, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; Texas A&M Univ Syst, Hlth Sci Ctr, Dept Med Biochem & Genet, Inst Biosci & Technol, Houston, TX 77030 USA; Harvard Univ, Sch Med, Childrens Hosp, Div Neurosci, Boston, MA 02115 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of California System; University of California San Diego; University of California System; University of California San Diego; Boston University; Boston University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Harvard University; Boston Children's Hospital; Harvard Medical School	Mei, L (corresponding author), Univ Alabama Birmingham, Civitan Int Res Ctr, Dept Neurobiol, 1530 3rd Ave S, Birmingham, AL 35294 USA.	lmei@nrc.uab.edu	Mei, Lin/G-8755-2012; Lu, Bai/A-4018-2012; Luo, Zhen-Ge/GNM-7635-2022; Luo, Zhijun/AAE-9302-2019	Luo, Zhijun/0000-0001-8105-5289; Lu, Bai/0000-0001-5418-9759; Luo, Zhen-Ge/0000-0001-5037-0542; Liu, Mingyao/0000-0001-7339-5048	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000714] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Borges LS, 2001, J CELL BIOL, V153, P1, DOI 10.1083/jcb.153.1.1; Borges LS, 2002, J NEUROBIOL, V50, P69, DOI 10.1002/neu.10020; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Burden SJ, 1998, GENE DEV, V12, P133, DOI 10.1101/gad.12.2.133; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; CAMPANELLI JT, 1991, CELL, V67, P909, DOI 10.1016/0092-8674(91)90364-5; Colledge M, 1998, P NATL ACAD SCI USA, V95, P3341, DOI 10.1073/pnas.95.7.3341; Colman H, 1997, SCIENCE, V275, P356, DOI 10.1126/science.275.5298.356; Dai ZS, 2000, J CELL BIOL, V150, P1321, DOI 10.1083/jcb.150.6.1321; Dale TC, 1998, BIOCHEM J, V329, P209; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; FALLON JR, 1994, TRENDS NEUROSCI, V17, P469, DOI 10.1016/0166-2236(94)90135-X; Ferns M, 1996, J CELL BIOL, V132, P937, DOI 10.1083/jcb.132.5.937; Ferns M, 2001, NEURON, V30, P311, DOI 10.1016/S0896-6273(01)00311-7; Fuhrer C, 1996, J BIOL CHEM, V271, P32474, DOI 10.1074/jbc.271.50.32474; Fukumoto S, 2001, J BIOL CHEM, V276, P17479, DOI 10.1074/jbc.C000880200; GANJU P, 1995, ONCOGENE, V11, P281; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; GAUTAM M, 1995, NATURE, V377, P232, DOI 10.1038/377232a0; Gillespie SKH, 1996, NEURON, V16, P953, DOI 10.1016/S0896-6273(00)80118-X; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; Glass DJ, 1997, P NATL ACAD SCI USA, V94, P8848, DOI 10.1073/pnas.94.16.8848; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Herbst R, 2000, EMBO J, V19, P67, DOI 10.1038/sj.emboj.7592228b; HOCH W, 1994, J CELL BIOL, V126, P1, DOI 10.1083/jcb.126.1.1; Huang YZ, 2000, NEURON, V26, P443, DOI 10.1016/S0896-6273(00)81176-9; Huang YZ, 2001, J BIOL CHEM, V276, P19318, DOI 10.1074/jbc.M100494200; JENNINGS CGB, 1993, P NATL ACAD SCI USA, V90, P2895, DOI 10.1073/pnas.90.7.2895; Kim HW, 2001, MOL CELL, V7, P1095, DOI 10.1016/S1097-2765(01)00248-9; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Klingensmith J, 1996, MECH DEVELOP, V58, P15, DOI 10.1016/S0925-4773(96)00549-7; KLINGENSMITH J, 1994, GENE DEV, V8, P118, DOI 10.1101/gad.8.1.118; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Li L, 1999, J BIOL CHEM, V274, P129, DOI 10.1074/jbc.274.1.129; Lijam N, 1997, CELL, V90, P895, DOI 10.1016/S0092-8674(00)80354-2; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; LU B, 1992, NEURON, V8, P521, DOI 10.1016/0896-6273(92)90280-Q; Lumeng C, 1999, NAT NEUROSCI, V2, P611, DOI 10.1038/10165; Malbon CC, 2001, BIOCHEM BIOPH RES CO, V287, P589, DOI 10.1006/bbrc.2001.5630; Masiakowski P, 1998, CURR BIOL, V8, pR407, DOI 10.1016/S0960-9822(98)70263-5; McMahan Uel J., 1992, Current Opinion in Cell Biology, V4, P869, DOI 10.1016/0955-0674(92)90113-Q; Megeath LJ, 1998, J NEUROSCI, V18, P672; Mohamed AS, 2001, J NEUROSCI, V21, P3806, DOI 10.1523/JNEUROSCI.21-11-03806.2001; Nguyen QT, 2000, J NEUROSCI, V20, P6077, DOI 10.1523/JNEUROSCI.20-16-06077.2000; NOORDERMEER J, 1994, NATURE, V367, P80, DOI 10.1038/367080a0; PERRIMON N, 1987, DEV BIOL, V119, P587, DOI 10.1016/0012-1606(87)90061-3; Pizzuti A, 1996, HUM MOL GENET, V5, P953, DOI 10.1093/hmg/5.7.953; QU Z, 1994, J NEUROSCI, V14, P6834; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Sells MA, 2000, J CELL BIOL, V151, P1449, DOI 10.1083/jcb.151.7.1449; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Si JT, 1996, J BIOL CHEM, V271, P19752, DOI 10.1074/jbc.271.33.19752; Si JT, 1999, J NEUROSCI, V19, P8498; Smith CL, 2001, J NEUROSCI, V21, P3151, DOI 10.1523/JNEUROSCI.21-09-03151.2001; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; Sun TQ, 2001, NAT CELL BIOL, V3, P628, DOI 10.1038/35083016; SUSSMAN DJ, 1994, DEV BIOL, V166, P73, DOI 10.1006/dbio.1994.1297; Tanowitz M, 1996, BRAIN RES, V712, P299, DOI 10.1016/0006-8993(95)01475-6; THEISEN H, 1994, DEVELOPMENT, V120, P347; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; Tsang M, 1996, DEV DYNAM, V207, P253, DOI 10.1002/(SICI)1097-0177(199611)207:3<253::AID-AJA2>3.0.CO;2-G; TSIM KWK, 1992, NEURON, V8, P677, DOI 10.1016/0896-6273(92)90089-V; VALENZUELA DM, 1995, NEURON, V15, P573, DOI 10.1016/0896-6273(95)90146-9; WALLACE BG, 1991, NEURON, V6, P869, DOI 10.1016/0896-6273(91)90227-Q; WALLACE BG, 1989, J NEUROSCI, V9, P1294; WALLACE BG, 1988, J CELL BIOL, V107, P267, DOI 10.1083/jcb.107.1.267; Wang CY, 2001, NEURON, V32, P99, DOI 10.1016/S0896-6273(01)00434-2; Weston C, 2000, J CELL BIOL, V150, P205, DOI 10.1083/jcb.150.1.205; Won S, 1999, J NEUROCHEM, V73, P2358, DOI 10.1046/j.1471-4159.1999.0732358.x; Wybenga-Groot LE, 2001, CELL, V106, P745, DOI 10.1016/S0092-8674(01)00496-2; Xia CZ, 2001, P NATL ACAD SCI USA, V98, P6174, DOI 10.1073/pnas.101137298; Xu YK, 1998, CURR BIOL, V8, pR405, DOI 10.1016/S0960-9822(98)70262-3; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; Yang X, 2000, SCIENCE, V287, P131, DOI 10.1126/science.287.5450.131; Zhou H, 1999, J CELL BIOL, V146, P1133, DOI 10.1083/jcb.146.5.1133	83	196	205	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 1	2002	35	3					489	505		10.1016/S0896-6273(02)00783-3	http://dx.doi.org/10.1016/S0896-6273(02)00783-3			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	582CB	12165471	Bronze			2022-12-24	WOS:000177331200010
J	Smolders, I; Bortolotto, ZA; Clarke, VRJ; Warre, R; Khan, GM; O'Neill, MJ; Ornstein, PL; Bleakman, D; Ogden, A; Weiss, B; Stables, JP; Ho, KH; Ebinger, G; Collingridge, GL; Lodge, D; Michotte, Y				Smolders, I; Bortolotto, ZA; Clarke, VRJ; Warre, R; Khan, GM; O'Neill, MJ; Ornstein, PL; Bleakman, D; Ogden, A; Weiss, B; Stables, JP; Ho, KH; Ebinger, G; Collingridge, GL; Lodge, D; Michotte, Y			Antagonists of GLU(K5)-containing kainate receptors prevent pilocarpine-induced limbic seizures	NATURE NEUROSCIENCE			English	Article							MOSSY FIBER SYNAPSES; SYNAPTIC TRANSMISSION; HIPPOCAMPAL-NEURONS; RAT HIPPOCAMPUS; KAINIC ACID; EPILEPTIFORM ACTIVITY; ANTIEPILEPTIC DRUGS; CEREBRAL-ISCHEMIA; PYRAMIDAL CELLS; GLUR5 SUBTYPE	Developments in the molecular biology and pharmacology of GLU(K5), a subtype of the kainate class of ionotropic glutamate receptors, have enabled insights into the roles of this subunit in synaptic transmission and plasticity. However, little is known about the possible functions of GLU(K5)-containing kainate receptors in pathological conditions. We report here that, in hippocampal slices, selective antagonists of GLU(K5)-containing kainate receptors prevented development of epileptiform activity-evoked by the muscarinic agonist, pilocarpine-and inhibited the activity when it was preestablished. In conscious rats, these GLU(K5) antagonists prevented and interrupted limbic seizures induced by intra-hippocampal pilocarpine perfusion, and attenuated accompanying rises in extracellular L-glutamate and GABA. This anticonvulsant activity occurred without overt side effects. GLU(K5) antagonism also prevented epileptiform activity induced by electrical stimulation, both in vitro and in vivo. Therefore, we propose that subtype-selective GLU(K5) kainate receptor antagonists offer a potential new therapy for epilepsy.	Free Univ Brussels, Inst Pharmaceut, Dept Pharmaceut Chem & Drug Anal, B-1090 Brussels, Belgium; Univ Bristol, Sch Med, Dept Anat, MRC Ctr Synapt Plast, Bristol BS8 1TD, Avon, England; Eli Lilly & Co, Lilly Res Ctr, Windlesham GU20 6PH, Surrey, England; Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA; NINDS, Epilepsy Branch, NIH, Bethesda, MD 20892 USA; Allelix Pharmaceut, Mississauga, ON L4V 1V7, Canada; Univ Hosp AZ VUB, Dept Neurol, B-1090 Brussels, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel; University of Bristol; Eli Lilly; Eli Lilly; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Vrije Universiteit Brussel	Lodge, D (corresponding author), Free Univ Brussels, Inst Pharmaceut, Dept Pharmaceut Chem & Drug Anal, Laarbeeklaan 103, B-1090 Brussels, Belgium.		Smolders, Ilse J/J-9399-2013; Collingridge, Graham L/C-4605-2015; Ornstein, Paul/E-4212-2016; Michotte, Yvette/G-9818-2013; collingridge, graham/AAI-8362-2020	Smolders, Ilse J/0000-0003-2140-0751; Collingridge, Graham L/0000-0002-9572-5359; Ornstein, Paul/0000-0002-4335-1877; Clarke, Vernon/0000-0002-6154-6555				ASHWOOD TJ, 1986, EXP BRAIN RES, V62, P189; BENARI Y, 1980, BRAIN RES, V191, P79, DOI 10.1016/0006-8993(80)90316-9; BETTLER B, 1995, NEUROPHARMACOLOGY, V34, P123, DOI 10.1016/0028-3908(94)00141-E; Bleakman D, 1998, NEUROPHARMACOLOGY, V37, P1187, DOI 10.1016/S0028-3908(98)00139-7; Bleakman D, 1996, MOL PHARMACOL, V49, P581; Bortolotto ZA, 1999, NATURE, V402, P297, DOI 10.1038/46290; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Chittajallu R, 1999, TRENDS PHARMACOL SCI, V20, P26, DOI 10.1016/S0165-6147(98)01286-3; Chittajallu R, 1996, NATURE, V379, P78, DOI 10.1038/379078a0; Clarke VRJ, 1997, NATURE, V389, P599, DOI 10.1038/39315; Contractor A, 2001, NEURON, V29, P209, DOI 10.1016/S0896-6273(01)00191-X; Cossart R, 1998, NAT NEUROSCI, V1, P470, DOI 10.1038/2185; Curry WJ, 1998, AM FAM PHYSICIAN, V57, P513; De Sarro G, 1999, PHARMACOL BIOCHEM BE, V63, P621, DOI 10.1016/S0091-3057(99)00027-1; Frerking M, 1998, NAT NEUROSCI, V1, P479, DOI 10.1038/2194; Frerking M, 1999, P NATL ACAD SCI USA, V96, P12917, DOI 10.1073/pnas.96.22.12917; Huettner JE, 2001, TRENDS NEUROSCI, V24, P365, DOI 10.1016/S0166-2236(00)01830-0; KEHL SJ, 1984, NEUROSCIENCE, V11, P111, DOI 10.1016/0306-4522(84)90217-3; KRNJEVIC K, 1991, GABA MECH EPILEPSY, P47; Lauri SE, 2001, NEUROPHARMACOLOGY, V41, P907, DOI 10.1016/S0028-3908(01)00152-6; Lauri SE, 2001, NEURON, V32, P697, DOI 10.1016/S0896-6273(01)00511-6; Li H, 1998, NEUROPHARMACOLOGY, V37, P1279, DOI 10.1016/S0028-3908(98)00109-9; Li H, 2001, NAT NEUROSCI, V4, P612, DOI 10.1038/88432; LODGE D, 2000, IUPHAR COMPENDIUM RE, P189; Matagne A, 1998, EPILEPSY RES, V31, P59, DOI 10.1016/S0920-1211(98)00016-3; MATTSON RH, 1995, EPILEPSIA S2, V36, P13; Min MY, 1999, P NATL ACAD SCI USA, V96, P9932, DOI 10.1073/pnas.96.17.9932; Mulle C, 1998, NATURE, V392, P601, DOI 10.1038/33408; NADLER JV, 1978, NATURE, V271, P676, DOI 10.1038/271676a0; O'Neill MJ, 1998, NEUROPHARMACOLOGY, V37, P1211, DOI 10.1016/S0028-3908(98)00134-8; O'Neill MJ, 2000, NEUROPHARMACOLOGY, V39, P1575, DOI 10.1016/S0028-3908(99)00250-6; PATERNAIN AV, 1995, NEURON, V14, P185, DOI 10.1016/0896-6273(95)90253-8; Paternain AV, 2000, J NEUROSCI, V20, P196, DOI 10.1523/JNEUROSCI.20-01-00196.2000; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; Rodriguez-Moreno A, 2000, P NATL ACAD SCI USA, V97, P1293, DOI 10.1073/pnas.97.3.1293; RodriguezMoreno A, 1997, NEURON, V19, P893, DOI 10.1016/S0896-6273(00)80970-8; Rogawski MA, 2001, NEUROPHARMACOLOGY, V40, P28, DOI 10.1016/S0028-3908(00)00112-X; RogviHansen BA, 1995, PHARMACOL THERAPEUT, V68, P425, DOI 10.1016/0163-7258(95)02014-4; Rutecki PA, 1998, J NEUROPHYSIOL, V79, P3019, DOI 10.1152/jn.1998.79.6.3019; Sander T, 1997, AM J MED GENET, V74, P416; Schmitz D, 2001, SCIENCE, V291, P1972, DOI 10.1126/science.1057105; Smolders I, 1997, BRIT J PHARMACOL, V121, P1171, DOI 10.1038/sj.bjp.0701231; SMOLDERS I, 1995, J NEUROSCI METH, V57, P47, DOI 10.1016/0165-0270(94)00124-Y; STASHEFF SF, 1985, BRAIN RES, V344, P296, DOI 10.1016/0006-8993(85)90807-8; TURSKI L, 1989, SYNAPSE, V3, P154, DOI 10.1002/syn.890030207; Vignes M, 1997, NEUROPHARMACOLOGY, V36, P1477, DOI 10.1016/S0028-3908(97)00158-5; Vignes M, 1998, NEUROPHARMACOLOGY, V37, P1269, DOI 10.1016/S0028-3908(98)00148-8; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; Wilding TJ, 2001, J PHYSIOL-LONDON, V532, P411, DOI 10.1111/j.1469-7793.2001.0411f.x; WILDING TJ, 1995, MOL PHARMACOL, V47, P582	50	121	126	0	17	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2002	5	8					796	804		10.1038/nn880	http://dx.doi.org/10.1038/nn880			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	577XT	12080343				2022-12-24	WOS:000177088900024
J	Grefkes, C; Weiss, PH; Zilles, K; Fink, GR				Grefkes, C; Weiss, PH; Zilles, K; Fink, GR			Crossmodal processing of object features in human anterior intraparietal cortex: an fMRI study implies equivalencies between humans and monkeys	NEURON			English	Article							PARIETAL CORTEX; POSTERIOR PARIETAL; NEURAL MECHANISMS; SPATIAL ATTENTION; MENTAL ROTATION; VISUAL GUIDANCE; INFERIOR AREA-6; MACAQUE MONKEY; TACTILE SHAPE; HAND ACTION	The organization of macaque posterior parietal cortex (PPC) reflects its functional specialization in integrating polymodal sensory information for object recognition and manipulation. Neuropsychological and recent human imaging studies imply equivalencies between human and macaque PPC, and in particular, the cortex buried in the intraparietal sulcus (IPS). Using functional MRI, we tested the hypothesis that an area in human anterior intraparietal cortex is activated when healthy subjects perform a crossmodal visuo-tactile delayed matching-to-sample task with objects. Tactile or visual object presentation (encoding and recognition) both significantly activated anterior intraparietal cortex. As hypothesized, neural activity in this area was further enhanced when subjects transferred object information between modalities (crossmodal matching). Based on both the observed functional properties and the anatomical location, we suggest that this area in anterior IPS is the human equivalent of macaque area AIP.	Forschungszentrum Julich, Inst Med, D-52425 Julich, Germany; Univ Dusseldorf, C&O Vogt Brain Res Inst, D-40001 Dusseldorf, Germany; Rhein Westfal TH Aachen Klinikum, Dept Neurol, D-52074 Aachen, Germany	Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf; RWTH Aachen University; RWTH Aachen University Hospital	Fink, GR (corresponding author), Forschungszentrum Julich, Inst Med, Postfach 1913, D-52425 Julich, Germany.	g.fink@fz-juelich.de	Zilles, Karl/Y-3784-2019; Grefkes, Christian/H-3972-2013; Weiss, Peter H./H-8983-2013; Fink, Gereon R./E-1616-2012; Zilles, Karl/J-9704-2013; Fink, Gereon R./AFW-9377-2022	Zilles, Karl/0000-0002-4705-4175; Grefkes, Christian/0000-0002-1656-720X; Weiss, Peter H./0000-0002-5230-9080; Fink, Gereon R./0000-0002-8230-1856; Zilles, Karl/0000-0001-9296-9959; Fink, Gereon R./0000-0002-8230-1856				Andersen RA, 1997, PHILOS T ROY SOC B, V352, P1421, DOI 10.1098/rstb.1997.0128; Banati RB, 2000, NEUROPSYCHOLOGIA, V38, P115, DOI 10.1016/S0028-3932(99)00074-3; Binkofski F, 1998, NEUROLOGY, V50, P1253, DOI 10.1212/WNL.50.5.1253; Binkofski F, 1999, EUR J NEUROSCI, V11, P3276, DOI 10.1046/j.1460-9568.1999.00753.x; Bodegard A, 2001, NEURON, V31, P317, DOI 10.1016/S0896-6273(01)00362-2; Bremmer F, 2001, NEUROIMAGE, V14, pS46, DOI 10.1006/nimg.2001.0817; Bremmer F, 2001, NEURON, V29, P287, DOI 10.1016/S0896-6273(01)00198-2; Bremmer F, 1997, PARIETAL LOBE CONTRI, P619; Brodmann, 1909, VERGLEICHENDE LOKALI; Butters N, 1970, Cortex, V6, P174; BUTTERS N, 1968, CORTEX, P328; Caselli R. J., 1997, BEHAV NEUROLOGY NEUR, P277; CASELLI RJ, 1993, NEUROLOGY, V43, P762, DOI 10.1212/WNL.43.4.762; CASELLI RJ, 1991, MAYO CLIN PROC, V66, P129, DOI 10.1016/S0025-6196(12)60484-4; Cohen MS, 1996, BRAIN, V119, P89, DOI 10.1093/brain/119.1.89; Colby CL, 1996, COGNITIVE BRAIN RES, V5, P105, DOI 10.1016/S0926-6410(96)00046-8; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; CORBETTA M, 1995, SCIENCE, V270, P802, DOI 10.1126/science.270.5237.802; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; CORBETTA M, 1993, J NEUROSCI, V13, P1202; Culham JC, 2001, CURR OPIN NEUROBIOL, V11, P157, DOI 10.1016/S0959-4388(00)00191-4; DiGirolamo GJ, 2001, NEUROREPORT, V12, P2065, DOI 10.1097/00001756-200107030-00054; Driver J, 1998, NAT NEUROSCI, V1, P17, DOI 10.1038/217; Duhamel JR, 1998, J NEUROPHYSIOL, V79, P126, DOI 10.1152/jn.1998.79.1.126; Fink GR, 2000, NEUROLOGY, V54, P1324, DOI 10.1212/WNL.54.6.1324; Fink GR, 1996, NATURE, V382, P626, DOI 10.1038/382626a0; Fink GR, 1997, BRAIN, V120, P1779, DOI 10.1093/brain/120.10.1779; FRISTON KJ, 1995, NEUROIMAGE, V2, P157, DOI 10.1006/nimg.1995.1018; Friston KJ, 1999, NEUROIMAGE, V10, P385, DOI 10.1006/nimg.1999.0484; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Friston KJ, 1999, NEUROIMAGE, V10, P1, DOI 10.1006/nimg.1999.0439; GALLESE V, 1994, NEUROREPORT, V5, P1525, DOI 10.1097/00001756-199407000-00029; Grafton ST, 1996, EXP BRAIN RES, V112, P103; Grefkes C, 2001, NEUROIMAGE, V14, P617, DOI 10.1006/nimg.2001.0858; Gurd JM, 2002, BRAIN, V125, P1024, DOI 10.1093/brain/awf093; Hadjikhani N, 1998, J NEUROSCI, V18, P1072; HYVARINEN J, 1981, BRAIN RES, V206, P287, DOI 10.1016/0006-8993(81)90533-3; Jancke L, 2001, CEREB CORTEX, V11, P114, DOI 10.1093/cercor/11.2.114; JEANNEROD M, 1995, TRENDS NEUROSCI, V18, P314, DOI 10.1016/0166-2236(95)93921-J; Jordan K, 2001, NEUROIMAGE, V13, P143, DOI 10.1006/nimg.2000.0677; Lepage M, 2001, NEUROIMAGE, V14, P572, DOI 10.1006/nimg.2001.0866; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; Lewis JW, 2000, J COMP NEUROL, V428, P79, DOI 10.1002/1096-9861(20001204)428:1<79::AID-CNE7>3.0.CO;2-Q; Luppino G, 1999, EXP BRAIN RES, V128, P181, DOI 10.1007/s002210050833; Macaluso E, 2002, CEREB CORTEX, V12, P357, DOI 10.1093/cercor/12.4.357; Macaluso E, 2001, NEUROPSYCHOLOGIA, V39, P1304, DOI 10.1016/S0028-3932(01)00119-1; MATELLI M, 1986, J COMP NEUROL, V251, P281, DOI 10.1002/cne.902510302; MCNALLY C, 1982, CORTEX, V18, P91, DOI 10.1016/S0010-9452(82)80021-X; Murata A, 1996, J NEUROPHYSIOL, V75, P2180, DOI 10.1152/jn.1996.75.5.2180; Murata A, 2000, J NEUROPHYSIOL, V83, P2580, DOI 10.1152/jn.2000.83.5.2580; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ono M, 1990, ATLAS CEREBRAL SULCI; Paus T, 1996, NEUROPSYCHOLOGIA, V34, P475, DOI 10.1016/0028-3932(95)00134-4; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Price CJ, 1997, NEUROIMAGE, V5, P261, DOI 10.1006/nimg.1997.0269; REED CL, 1994, NEUROPSYCHOLOGIA, V32, P527, DOI 10.1016/0028-3932(94)90142-2; RIZZOLATTI G, 1988, EXP BRAIN RES, V71, P491, DOI 10.1007/BF00248742; Roland PE, 1996, CURR OPIN NEUROBIOL, V6, P773, DOI 10.1016/S0959-4388(96)80027-4; Rushworth MFS, 2001, J NEUROSCI, V21, P5262, DOI 10.1523/JNEUROSCI.21-14-05262.2001; Rushworth MFS, 2001, J COGNITIVE NEUROSCI, V13, P698, DOI 10.1162/089892901750363244; Sakata H, 1998, PHILOS T ROY SOC B, V353, P1363, DOI 10.1098/rstb.1998.0290; Sakata H, 1997, TRENDS NEUROSCI, V20, P350, DOI 10.1016/S0166-2236(97)01067-9; SAKATA H, 1995, CEREB CORTEX, V5, P429, DOI 10.1093/cercor/5.5.429; Sakata H, 1999, EXP BRAIN RES, V128, P160, DOI 10.1007/s002210050831; Sakata Hideo, 1994, Current Opinion in Neurobiology, V4, P847, DOI 10.1016/0959-4388(94)90133-3; Shikata E, 2001, J NEUROPHYSIOL, V85, P1309, DOI 10.1152/jn.2001.85.3.1309; Simon O, 2002, NEURON, V33, P475, DOI 10.1016/S0896-6273(02)00575-5; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; TAIRA M, 1990, EXP BRAIN RES, V83, P29; Talairach J., 1988, COPLANAR STEREOTAXIC; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Valenza N, 2001, BRAIN, V124, P2287, DOI 10.1093/brain/124.11.2287; Vandenberghe R, 2001, NEUROIMAGE, V14, P661, DOI 10.1006/nimg.2001.0860; VONECONOMO K, 1925, CYTOARCHITEKTONIK; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Zilles K, 2001, NEUROIMAGE, V14, pS8, DOI 10.1006/nimg.2001.0823	76	238	240	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 3	2002	35	1					173	184		10.1016/S0896-6273(02)00741-9	http://dx.doi.org/10.1016/S0896-6273(02)00741-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	569KP	12123617	Bronze			2022-12-24	WOS:000176601800019
J	Walker, MP; Brakefield, T; Morgan, A; Hobson, JA; Stickgold, R				Walker, MP; Brakefield, T; Morgan, A; Hobson, JA; Stickgold, R			Practice with sleep makes perfect: Sleep-dependent motor skill learning	NEURON			English	Article							PRIMARY SOMATOSENSORY CORTEX; OWL MONKEYS; DISCRIMINATION; MEMORY; ACQUISITION; REORGANIZATION; REPRESENTATION; IMPROVEMENT; PLASTICITY	Improvement in motor skill performance is known to continue for at least 24 hr following training, yet the relative contributions of time spent awake and asleep are unknown. Here we provide evidence that a night of sleep results in a 20% increase in motor speed without loss of accuracy, while an equivalent period of time during wake provides no significant benefit. Furthermore, a significant correlation exists between the improved performance overnight and the amount of stage 2 NREM sleep, particularly late in the night. This finding of sleep-dependent motor skill improvement may have important implications for the efficient learning of all skilled actions in humans.	Harvard Univ, Sch Med, Dept Psychiat, Neurophysiol Lab, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Walker, MP (corresponding author), Harvard Univ, Sch Med, Dept Psychiat, Neurophysiol Lab, 74 Fenwood Rd, Boston, MA 02115 USA.	mwalker@hms.harvard.edu			NIDA NIH HHS [DA11744-01A1] Funding Source: Medline; NIMH NIH HHS [MH-48832] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011744] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; De Gennaro L, 2000, J SLEEP RES, V9, P155, DOI 10.1046/j.1365-2869.2000.00193.x; FOGEL S, 2001, ACTAS FISIOLOGIA URU; Gais S, 2000, NAT NEUROSCI, V3, P1335, DOI 10.1038/81881; Hallett M, 2001, BRAIN RES REV, V36, P169, DOI 10.1016/S0165-0173(01)00092-3; HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x; JENKINS WM, 1990, J NEUROPHYSIOL, V63, P82, DOI 10.1152/jn.1990.63.1.82; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Karni A, 1996, COGNITIVE BRAIN RES, V5, P39, DOI 10.1016/S0926-6410(96)00039-0; Liu J, 1997, RES Q EXERCISE SPORT, V68, P145, DOI 10.1080/02701367.1997.10607990; Maquet P, 2001, SCIENCE, V294, P1048, DOI 10.1126/science.1062856; Miller RGJ, 1991, SIMULTANEOUS STAT IN; Peigneux P, 2001, NEUROREPORT, V12, pA111, DOI 10.1097/00001756-200112210-00001; RECANZONE GH, 1992, CEREB CORTEX, V2, P181, DOI 10.1093/cercor/2.3.181; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1031, DOI 10.1152/jn.1992.67.5.1031; Rechtschaffen A., 1968, MANUAL STANDARDIZED; SALZARULO P, 1995, BEHAV BRAIN RES, V69, P23, DOI 10.1016/0166-4328(95)00022-L; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Sejnowski TJ, 2000, BRAIN RES, V886, P208, DOI 10.1016/S0006-8993(00)03007-9; Shadmehr R, 1997, J NEUROSCI, V17, P409, DOI 10.1523/JNEUROSCI.17-01-00409.1997; SMITH C, 1994, J SLEEP RES, V3, P206, DOI 10.1111/j.1365-2869.1994.tb00133.x; SMITH C, 1982, PHYSIOL BEHAV, V29, P469, DOI 10.1016/0031-9384(82)90268-2; Stickgold R, 2000, NAT NEUROSCI, V3, P1237, DOI 10.1038/81756; Stickgold R, 2000, J COGNITIVE NEUROSCI, V12, P246, DOI 10.1162/089892900562075; Stickgold R, 2001, SCIENCE, V294, P1052, DOI 10.1126/science.1063530; TWEED S, 1999, SLEEP S1, V22; WILLIAMS RL, 1978, SLEEP DISORDERS DIAG	30	835	851	4	147	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 3	2002	35	1					205	211		10.1016/S0896-6273(02)00746-8	http://dx.doi.org/10.1016/S0896-6273(02)00746-8			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	569KP	12123620	Bronze			2022-12-24	WOS:000176601800022
J	Yang, B; Slonimsky, JD; Birren, SJ				Yang, B; Slonimsky, JD; Birren, SJ			A rapid switch in sympathetic neurotransmitter release properties mediated by the p75 receptor	NATURE NEUROSCIENCE			English	Article							NERVE GROWTH-FACTOR; CILIARY NEUROTROPHIC FACTOR; AFFINITY NGF RECEPTOR; SIGNAL-TRANSDUCTION; CHOLINERGIC DIFFERENTIATION; SYNAPTIC TRANSMISSION; NEURONAL APOPTOSIS; CARDIAC MYOCYTES; DOPAMINE NEURONS; CELL-SURVIVAL	Cardiac function is modulated by norepinephrine release from innervating sympathetic neurons. These neurons also form excitatory connections onto cardiac myocytes in culture. Here we report that brain-derived neurotrophic factor (BDNF) altered the neurotransmitter release properties of these sympathetic neuron-myocyte connections in rodent cell culture, leading to a rapid shift from excitatory to inhibitory cholinergic transmission in response to neuronal stimulation. Fifteen minutes of BDNF perfusion was sufficient to cause this shift to inhibitory transmission, indicating that BDNF promotes preferential release of acetylcholine in response to neuronal stimulation. We found that p75(-/-) neurons did not release acetylcholine in response to BDNF and that neurons overexpressing p75 showed increased cholinergic transmission, indicating that the actions of BDNF are mediated through the p75 neurotrophin receptor. Our findings indicate that p75 is involved in modulating the release of distinct neurotransmitter pools, resulting in a functional switch between excitatory and inhibitory neurotransmission in individual neurons.	Brandeis Univ, Dept Biol, Volen Ctr Complex Syst, Waltham, MA 02454 USA	Brandeis University	Birren, SJ (corresponding author), Brandeis Univ, Dept Biol, Volen Ctr Complex Syst, 415 South St,M-S 008, Waltham, MA 02454 USA.	birren@brandeis.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040168] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS40168] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Atwal JK, 2000, NEURON, V27, P265, DOI 10.1016/S0896-6273(00)00035-0; Bamji SX, 1998, J CELL BIOL, V140, P911, DOI 10.1083/jcb.140.4.911; Blochl A, 1996, J BIOL CHEM, V271, P21100; Brodski C, 2000, P NATL ACAD SCI USA, V97, P9683, DOI 10.1073/pnas.160080697; CasacciaBonnefil P, 1996, NATURE, V383, P716, DOI 10.1038/383716a0; CHUN LLY, 1977, J CELL BIOL, V75, P712, DOI 10.1083/jcb.75.3.712; Collin C, 2001, EUR J NEUROSCI, V13, P1273, DOI 10.1046/j.0953-816x.2001.01500.x; CONFORTI L, 1991, J DEV PHYSIOL, V15, P237; DePotter WP, 1997, NEUROCHEM RES, V22, P911, DOI 10.1023/A:1022458322406; DOBROWSKY RT, 1994, SCIENCE, V265, P1596, DOI 10.1126/science.8079174; Esposito D, 2001, J BIOL CHEM, V276, P32687, DOI 10.1074/jbc.M011674200; Fagan AM, 1996, J NEUROSCI, V16, P6208; FURSHPAN EJ, 1976, P NATL ACAD SCI USA, V73, P4225, DOI 10.1073/pnas.73.11.4225; FURSHPAN EJ, 1986, J NEUROSCI, V6, P1061; Gonzalez-Hernandez T, 2001, EUR J NEUROSCI, V13, P57, DOI 10.1046/j.1460-9568.2001.01371.x; Gottschalk W, 1998, J NEUROSCI, V18, P6830; HANTZOPOULOS PA, 1994, NEURON, V13, P187, DOI 10.1016/0896-6273(94)90469-3; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Jiang H, 1999, J BIOL CHEM, V274, P26209, DOI 10.1074/jbc.274.37.26209; JOHNSON MI, 1985, J CELL BIOL, V101, P217, DOI 10.1083/jcb.101.1.217; Jonas P, 1998, SCIENCE, V281, P419, DOI 10.1126/science.281.5375.419; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; KORSCHING S, 1983, P NATL ACAD SCI-BIOL, V80, P3513, DOI 10.1073/pnas.80.11.3513; LANDIS SC, 1983, DEV BIOL, V98, P349, DOI 10.1016/0012-1606(83)90365-2; LANDIS SC, 1976, P NATL ACAD SCI USA, V73, P4220, DOI 10.1073/pnas.73.11.4220; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Lockhart ST, 1997, J NEUROSCI, V17, P9573; Lockhart ST, 2000, J NEUROBIOL, V42, P460, DOI 10.1002/(SICI)1097-4695(200003)42:4<460::AID-NEU7>3.3.CO;2-R; LOHOF AM, 1993, NATURE, V363, P350, DOI 10.1038/363350a0; MacPhee I, 1999, J NEUROCHEM, V72, P1423, DOI 10.1046/j.1471-4159.1999.721423.x; Majdan M, 1997, J NEUROSCI, V17, P6988; MARTIN DP, 1990, J NEUROSCI, V10, P184; Martinez A, 1998, J NEUROSCI, V18, P7336; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Numakawa T, 1999, BRAIN RES, V842, P431, DOI 10.1016/S0006-8993(99)01867-3; POTTER DD, 1986, J NEUROSCI, V6, P1080; SAADAT S, 1989, J CELL BIOL, V108, P1807, DOI 10.1083/jcb.108.5.1807; Sloviter RS, 1996, J COMP NEUROL, V373, P593; Stoop R, 1996, J NEUROSCI, V16, P3256; Sudhof TC, 2001, ANNU REV NEUROSCI, V24, P933, DOI 10.1146/annurev.neuro.24.1.933; Sulzer D, 1998, J NEUROSCI, V18, P4588, DOI 10.1523/jneurosci.18-12-04588.1998; Sulzer D, 2000, AMINO ACIDS, V19, P45, DOI 10.1007/s007260070032; Takei N, 1997, J NEUROCHEM, V68, P370; Tyler WJ, 2001, J NEUROSCI, V21, P4249, DOI 10.1523/JNEUROSCI.21-12-04249.2001; VERDI JM, 1994, NEURON, V12, P733, DOI 10.1016/0896-6273(94)90327-1; Walker MC, 2001, NEURON, V29, P703, DOI 10.1016/S0896-6273(01)00245-8; Weihe E, 1996, P NATL ACAD SCI USA, V93, P3547, DOI 10.1073/pnas.93.8.3547; YAN H, 1991, J BIOL CHEM, V266, P12099; Yoon SO, 1998, J NEUROSCI, V18, P3273	50	94	98	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2002	5	6					539	545		10.1038/nn853	http://dx.doi.org/10.1038/nn853			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	556XQ	11992117				2022-12-24	WOS:000175874600013
J	Eaton, BA; Fetter, RD; Davis, GW				Eaton, BA; Fetter, RD; Davis, GW			Dynactin is necessary for synapse stabilization	NEURON			English	Article							TUMOR-SUPPRESSOR GENE; DYNEIN HEAVY-CHAIN; CYTOPLASMIC DYNEIN; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL COMPONENTS; AXONAL-TRANSPORT; STRUCTURAL PLASTICITY; ACTIN CYTOSKELETON; MITOTIC SPINDLE; CELL CORTEX	We present evidence that synapse retraction occurs during normal synaptic growth at the Drosophila neuromuscular junction (NMJ). An RNAi-based screen to identify the molecular mechanisms that regulate synapse retraction identified Arp-1/centractin, a subunit of the dynactin complex. Arp-1 dsRNA enhances synapse retraction, and this effect is phenocopied by a mutation in P150/Glued, also a dynactin component. The Glued protein is enriched within the presynaptic nerve terminal, and presynaptic expression of a dominant-negative Glued transgene enhances retraction. Retraction is associated with a local disruption of the synaptic microtubule cytoskeleton. Electrophysiological, ultrastructural, and immunohistochemical data support a model in which presynaptic retraction precedes disassembly of the postsynaptic apparatus. Our data suggests that dynactin functions locally within the presynaptic arbor to promote synapse stability.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Davis, GW (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, 513 Parnassus Ave, San Francisco, CA 94143 USA.	gdavis@biochem.ucsf.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS042533] Funding Source: NIH RePORTER; NINDS NIH HHS [F32 NS42533] Funding Source: Medline; PHS HHS [44908-32374] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Adames NR, 2000, J CELL BIOL, V149, P863, DOI 10.1083/jcb.149.4.863; Ahmad FJ, 1998, J CELL BIOL, V140, P391, DOI 10.1083/jcb.140.2.391; Allen MJ, 1999, J NEUROSCI, V19, P9374; Amberg DC, 1997, MOL BIOL CELL, V8, P729, DOI 10.1091/mbc.8.4.729; Berrueta L, 1999, CURR BIOL, V9, P425, DOI 10.1016/S0960-9822(99)80190-0; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Carminati JL, 1997, J CELL BIOL, V138, P629, DOI 10.1083/jcb.138.3.629; CLARK SW, 1994, J CELL BIOL, V127, P129, DOI 10.1083/jcb.127.1.129; Cohen-Cory S, 1999, J NEUROSCI, V19, P9996; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; Colman H, 1997, SCIENCE, V275, P356, DOI 10.1126/science.275.5298.356; Davis GW, 1996, NEURON, V17, P669, DOI 10.1016/S0896-6273(00)80199-3; DESAI CJ, 1994, J NEUROSCI, V14, P7272; Dillman JF, 1996, P NATL ACAD SCI USA, V93, P141, DOI 10.1073/pnas.93.1.141; Dujardin DL, 2002, CURR OPIN CELL BIOL, V14, P44, DOI 10.1016/S0955-0674(01)00292-7; ENGELFRIET J, 1997, HDB GRAPH GRAMMARS C, V1, P1, DOI [10.1142/9789812384720_0001, DOI 10.1142/9789812384720_0001, DOI 10.1142/9789812384720_]; Evangelista M, 1997, SCIENCE, V276, P118, DOI 10.1126/science.276.5309.118; Featherstone DE, 2002, NAT NEUROSCI, V5, P141, DOI 10.1038/nn789; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Garces JA, 1999, CURR BIOL, V9, P1497, DOI 10.1016/S0960-9822(00)80122-0; Guan B, 1996, CURR BIOL, V6, P695, DOI 10.1016/S0960-9822(09)00451-5; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Han GS, 2001, CURR BIOL, V11, P719, DOI 10.1016/S0960-9822(01)00200-7; Holleran EA, 2001, J BIOL CHEM, V276, P36598, DOI 10.1074/jbc.M104838200; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Karki S, 1999, CURR OPIN CELL BIOL, V11, P45, DOI 10.1016/S0955-0674(99)80006-4; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KURDYAK P, 1994, J COMP NEUROL, V350, P463, DOI 10.1002/cne.903500310; LAHEY T, 1994, NEURON, V13, P823, DOI 10.1016/0896-6273(94)90249-6; LETINSKY MS, 1976, J NEUROCYTOL, V5, P691, DOI 10.1007/BF01181582; Li SH, 1998, J NEUROSCI, V18, P1261, DOI 10.1523/jneurosci.18-04-01261.1998; Ligon LA, 2001, NAT CELL BIOL, V3, P913, DOI 10.1038/ncb1001-913; Liu Z, 2000, NAT CELL BIOL, V2, P776, DOI 10.1038/35041011; Lnenicka GA, 2000, J NEUROBIOL, V43, P186, DOI 10.1002/(SICI)1097-4695(200005)43:2<186::AID-NEU8>3.3.CO;2-E; Madden K, 1998, ANNU REV MICROBIOL, V52, P687, DOI 10.1146/annurev.micro.52.1.687; Martin M, 1999, MOL BIOL CELL, V10, P3717, DOI 10.1091/mbc.10.11.3717; Matus A, 2000, HIPPOCAMPUS, V10, P555, DOI 10.1002/1098-1063(2000)10:5<555::AID-HIPO5>3.0.CO;2-Z; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; MCGRAIL M, 1995, J CELL BIOL, V131, P411, DOI 10.1083/jcb.131.2.411; MEYEROWITZ EM, 1978, DEV BIOL, V62, P112, DOI 10.1016/0012-1606(78)90096-9; Morales M, 2000, NEURON, V27, P539, DOI 10.1016/S0896-6273(00)00064-7; Morrison EE, 2002, MOL BRAIN RES, V98, P145, DOI 10.1016/S0169-328X(01)00290-X; Murphey RK, 1999, DEV BIOL, V209, P86, DOI 10.1006/dbio.1999.9217; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Paradis S, 2001, NEURON, V30, P737, DOI 10.1016/S0896-6273(01)00326-9; Phillis R, 1996, DEVELOPMENT, V122, P2955; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; Reddy S, 1997, J NEUROBIOL, V33, P711, DOI 10.1002/(SICI)1097-4695(19971120)33:6<711::AID-NEU1>3.0.CO;2-C; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Saitoe M, 2001, SCIENCE, V293, P514, DOI 10.1126/science.1061270; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Sato T, 1968, J Electron Microsc (Tokyo), V17, P158; Schafer DA, 1999, ANNU REV CELL DEV BI, V15, P341, DOI 10.1146/annurev.cellbio.15.1.341; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; Schuyler SC, 2001, J CELL SCI, V114, P247; Schuyler SC, 2001, CELL, V105, P421, DOI 10.1016/S0092-8674(01)00364-6; Sharp PA, 2001, GENE DEV, V15, P485, DOI 10.1101/gad.880001; SWAROOP A, 1985, P NATL ACAD SCI USA, V82, P1751, DOI 10.1073/pnas.82.6.1751; Tanaka H, 2000, NEURON, V25, P93, DOI 10.1016/S0896-6273(00)80874-0; Thomas U, 2000, CURR BIOL, V10, P1108, DOI 10.1016/S0960-9822(00)00696-5; Vallee RB, 2000, BBA-MOL CELL RES, V1496, P89, DOI 10.1016/S0167-4889(00)00011-2; Valtz N, 1996, J CELL BIOL, V135, P725, DOI 10.1083/jcb.135.3.725; WatermanStorer CM, 1996, J BIOL CHEM, V271, P1153, DOI 10.1074/jbc.271.2.1153; WERNIG A, 1980, J NEUROCYTOL, V9, P277, DOI 10.1007/BF01181538; White BH, 2001, NEURON, V31, P699, DOI 10.1016/S0896-6273(01)00415-9; Zahner JE, 1996, MOL CELL BIOL, V16, P1857; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X	72	196	201	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 30	2002	34	5					729	741		10.1016/S0896-6273(02)00721-3	http://dx.doi.org/10.1016/S0896-6273(02)00721-3			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	558DV	12062020	Bronze			2022-12-24	WOS:000175951800008
J	Kidd, FL; Coumis, U; Collingridge, GL; Crabtree, JW; Isaac, JTR				Kidd, FL; Coumis, U; Collingridge, GL; Crabtree, JW; Isaac, JTR			A presynaptic kainate receptor is involved in regulating the dynamic properties of thalamocortical synapses during development	NEURON			English	Article							MOSSY FIBER SYNAPSES; EXCITATORY SYNAPTIC TRANSMISSION; LONG-TERM POTENTIATION; RAT HIPPOCAMPUS; NEOCORTICAL SYNAPSES; CRITICAL PERIOD; RELEASE; CORTEX; CA1; INTERNEURONS	Previous studies have shown that pharmacological activation of presynaptic kainate receptors at glutamatergic synapses facilitates or depresses transmission in a dose-dependent manner. However, the only synaptically activated kainate autoreceptor described to date is facilitatory. Here, we describe a kainate autoreceptor that depresses synaptic transmission. This autoreceptor is present at developing thalamocortical synapses in the barrel cortex, specifically regulates transmission at frequencies corresponding to those observed in vivo during whisker activation, and is developmentally down regulated during the first postnatal week. This receptor may, therefore, limit the transfer of high-frequency activity to the developing cortex, the loss of which mechanism may be important for the maturation of sensory processing.	Univ Bristol, Dept Anat, MRC, Ctr Synapt Plast, Bristol BS8 1TD, Avon, England	University of Bristol	Isaac, JTR (corresponding author), Univ Bristol, Dept Anat, MRC, Ctr Synapt Plast, Bristol BS8 1TD, Avon, England.		collingridge, graham/AAI-8362-2020; Collingridge, Graham L/C-4605-2015	Collingridge, Graham L/0000-0002-9572-5359				Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; Anderson WW, 2001, J NEUROSCI METH, V108, P71, DOI 10.1016/S0165-0270(01)00374-0; ARMSTRONGJAMES M, 1975, J PHYSIOL-LONDON, V246, P501, DOI 10.1113/jphysiol.1975.sp010902; BAHN S, 1994, J NEUROSCI, V14, P5525; Bleisch TJ, 1997, BIOORG MED CHEM LETT, V7, P1161, DOI 10.1016/S0960-894X(97)00185-6; Bortolotto ZA, 1999, NATURE, V402, P297, DOI 10.1038/46290; CastroAlamancos MA, 1997, PROG NEUROBIOL, V51, P581, DOI 10.1016/S0301-0082(97)00002-6; Chittajallu R, 1996, NATURE, V379, P78, DOI 10.1038/379078a0; Clarke VRJ, 1997, NATURE, V389, P599, DOI 10.1038/39315; Contractor A, 2000, J NEUROSCI, V20, P8269, DOI 10.1523/JNEUROSCI.20-22-08269.2000; Contractor A, 2001, NEURON, V29, P209, DOI 10.1016/S0896-6273(01)00191-X; Cossart R, 2001, NEURON, V29, P497, DOI 10.1016/S0896-6273(01)00221-5; Cossart R, 1998, NAT NEUROSCI, V1, P470, DOI 10.1038/2185; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; Crick F, 1998, NATURE, V391, P245, DOI 10.1038/34584; DAVIES CH, 1993, NEUROPHARMACOLOGY, V32, P1071, DOI 10.1016/0028-3908(93)90073-C; Feldman DE, 1998, NEURON, V21, P347, DOI 10.1016/S0896-6273(00)80544-9; Finnerty GT, 2000, P NATL ACAD SCI USA, V97, P12864, DOI 10.1073/pnas.230175697; Finnerty GT, 1999, NATURE, V400, P367, DOI 10.1038/22553; FOX K, 1995, NEURON, V15, P485, DOI 10.1016/0896-6273(95)90136-1; Frerking M, 2001, J NEUROSCI, V21, P2958, DOI 10.1523/JNEUROSCI.21-09-02958.2001; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; Gil Z, 1997, NEURON, V19, P679, DOI 10.1016/S0896-6273(00)80380-3; Gil Z, 1999, NEURON, V23, P385, DOI 10.1016/S0896-6273(00)80788-6; ISAACSON JS, 1993, NEURON, V10, P165, DOI 10.1016/0896-6273(93)90308-E; Kamiya H, 1998, J PHYSIOL-LONDON, V509, P833, DOI 10.1111/j.1469-7793.1998.833bm.x; Kamiya H, 2000, J PHYSIOL-LONDON, V523, P653, DOI 10.1111/j.1469-7793.2000.t01-1-00653.x; Kerchner GA, 2001, NEURON, V32, P477, DOI 10.1016/S0896-6273(01)00479-2; Kidd FL, 1999, NATURE, V400, P569, DOI 10.1038/23040; Kidd FL, 2001, J NEUROPHYSIOL, V86, P1139, DOI 10.1152/jn.2001.86.3.1139; Kullmann DM, 2001, NEURON, V32, P561, DOI 10.1016/S0896-6273(01)00507-4; Lauri SE, 2001, NEUROPHARMACOLOGY, V41, P907, DOI 10.1016/S0028-3908(01)00152-6; Lauri SE, 2001, NEURON, V32, P697, DOI 10.1016/S0896-6273(01)00511-6; Lebrand C, 1996, NEURON, V17, P823, DOI 10.1016/S0896-6273(00)80215-9; Lerma J, 2001, PHYSIOL REV, V81, P971, DOI 10.1152/physrev.2001.81.3.971; Markram H, 1998, NEUROPHARMACOLOGY, V37, P489, DOI 10.1016/S0028-3908(98)00049-5; NICOLELIS MAL, 1994, J NEUROSCI, V14, P3511; Scanziani M, 1997, NATURE, V385, P630, DOI 10.1038/385630a0; Schmitz D, 2000, NEURON, V27, P327, DOI 10.1016/S0896-6273(00)00040-4; Schmitz D, 2001, P NATL ACAD SCI USA, V98, P11003, DOI 10.1073/pnas.191351498; Schmitz D, 2001, SCIENCE, V291, P1972, DOI 10.1126/science.1057105; Semyanov A, 2001, NAT NEUROSCI, V4, P718, DOI 10.1038/89506; Sherman SM, 1998, P NATL ACAD SCI USA, V95, P7121, DOI 10.1073/pnas.95.12.7121; Stratford KJ, 1996, NATURE, V382, P258, DOI 10.1038/382258a0; Thomas NK, 1998, NEUROPHARMACOLOGY, V37, P1223, DOI 10.1016/S0028-3908(98)00124-5; THOMSON AM, 1994, TRENDS NEUROSCI, V17, P119, DOI 10.1016/0166-2236(94)90121-X; VANDERKLOOT W, 1994, PHYSIOL REV, V74, P899, DOI 10.1152/physrev.1994.74.4.899; Vignes M, 1998, NEUROPHARMACOLOGY, V37, P1269, DOI 10.1016/S0028-3908(98)00148-8	49	63	66	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 16	2002	34	4					635	646		10.1016/S0896-6273(02)00699-2	http://dx.doi.org/10.1016/S0896-6273(02)00699-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	553FT	12062046	Bronze			2022-12-24	WOS:000175665700016
J	Greschner, M; Bongard, M; Rujan, P; Ammermuller, J				Greschner, M; Bongard, M; Rujan, P; Ammermuller, J			Retinal ganglion cell synchronization by fixational eye movements improves feature estimation	NATURE NEUROSCIENCE			English	Article							VISUAL-CORTEX; TURTLE; CLASSIFICATION; POPULATION; RESPONSES; NEURONS; MACAQUE; NETWORK; MONKEYS; STRIATE	Image movements relative to the retina are essential for the visual perception of stationary objects during fixation. Here we have measured fixational eye and head movements of the turtle, and determined their effects on the activity of retinal ganglion cells by simulating the movements on the isolated retina. We show that ganglion cells respond mainly to components of periodic eye movement that have amplitudes of roughly the diameter of a photoreceptor. Drift or small head movements have little effect. Driven cells that are located along contrast borders are synchronized, which reliably signals a preceding movement. In an artificial neural network, the estimation of spatial frequencies for various square wave gratings improves when timelocked to this synchronization. This could potentially improve stimulus feature estimation by the brain.	Univ Oldenburg, Dept Biol, Neurobiol Grp, D-26111 Oldenburg, Germany; Univ Oldenburg, Dept Phys, Complex Syst Grp, D-26111 Oldenburg, Germany	Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg	Ammermuller, J (corresponding author), Univ Oldenburg, Dept Biol, Neurobiol Grp, D-26111 Oldenburg, Germany.							Bair W, 1998, VISUAL NEUROSCI, V15, P779, DOI 10.1017/S0952523898154160; BARLOW HB, 1952, J PHYSIOL-LONDON, V116, P290, DOI 10.1113/jphysiol.1952.sp004706; Berry MJ, 1997, P NATL ACAD SCI USA, V94, P5411, DOI 10.1073/pnas.94.10.5411; BOWLING DB, 1980, J PHYSIOL-LONDON, V299, P173, DOI 10.1113/jphysiol.1980.sp013118; Brivanlou IH, 1998, NEURON, V20, P527, DOI 10.1016/S0896-6273(00)80992-7; COAKLEY D, 1983, MINUTE EYE MOVEMENT; EIZENMAN M, 1985, VISION RES, V25, P1635, DOI 10.1016/0042-6989(85)90134-8; ENROTHCU.C, 1973, J PHYSIOL-LONDON, V233, P271, DOI 10.1113/jphysiol.1973.sp010308; FAHLE M, 1991, VISION RES, V31, P209, DOI 10.1016/0042-6989(91)90112-I; Fernandez E, 2000, BRAIN RES, V887, P222, DOI 10.1016/S0006-8993(00)03072-9; Ferrandez JM, 1999, LECT NOTES COMPUT SC, V1607, P289; GRANDA AM, 1989, J NEUROPHYSIOL, V62, P723, DOI 10.1152/jn.1989.62.3.723; Gur M, 1997, J NEUROSCI, V17, P2914; Hartline HK, 1938, AM J PHYSIOL, V121, P400, DOI 10.1152/ajplegacy.1938.121.2.400; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; JONES KE, 1992, ANN BIOMED ENG, V20, P423, DOI 10.1007/BF02368134; Keat J, 2001, NEURON, V30, P803, DOI 10.1016/S0896-6273(01)00322-1; KOLB H, 1987, VISION RES, V27, P1445, DOI 10.1016/0042-6989(87)90154-4; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; Leopold DA, 1998, EXP BRAIN RES, V123, P341, DOI 10.1007/s002210050577; Meister M, 1999, NEURON, V22, P435, DOI 10.1016/S0896-6273(00)80700-X; Normann RA, 2001, VISION RES, V41, P1261, DOI 10.1016/S0042-6989(00)00273-X; NOTHMORE DPM, 1991, VISUAL NEUROSCI, V7, P627; RIGGS LA, 1952, J OPT SOC AM, V42, P872; ROSENBERG AF, 1991, J NEUROPHYSIOL, V65, P1022, DOI 10.1152/jn.1991.65.5.1022; RUJAN P, 1993, J PHYS I, V3, P277, DOI 10.1051/jp1:1993129; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; SHAPLEY R, 1986, SCIENCE, V231, P999, DOI 10.1126/science.3945816; Shoham S, 1997, LECT NOTES COMPUT SC, V1240, P44, DOI 10.1007/BFb0032462; Snodderly DM, 2001, VISUAL NEUROSCI, V18, P259, DOI 10.1017/S0952523801182118; Stanley GB, 1999, J NEUROSCI, V19, P8036, DOI 10.1523/jneurosci.19-18-08036.1999; Steinman R M, 1990, Rev Oculomot Res, V4, P115; Warland DK, 1997, J NEUROPHYSIOL, V78, P2336, DOI 10.1152/jn.1997.78.5.2336	35	93	96	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2002	5	4					341	347		10.1038/nn821	http://dx.doi.org/10.1038/nn821			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	534UQ	11914721				2022-12-24	WOS:000174606900014
J	Nunn, JA; Gregory, LJ; Brammer, M; Williams, SCR; Parslow, DM; Morgan, MJ; Morris, RG; Bullmore, ET; Baron-Cohen, S; Gray, JA				Nunn, JA; Gregory, LJ; Brammer, M; Williams, SCR; Parslow, DM; Morgan, MJ; Morris, RG; Bullmore, ET; Baron-Cohen, S; Gray, JA			Functional magnetic resonance imaging of synesthesia: activation of V4/V8 by spoken words	NATURE NEUROSCIENCE			English	Article							GENERIC BRAIN ACTIVATION; VERBAL MEMORY; VISUAL-MOTION; COLOR-CENTER; SYNAESTHESIA; CORTEX; FMRI; INFORMATION; PERCEPTION; ANATOMY	In 'colored-hearing' synesthesia, individuals report color experiences when they hear spoken words. If the synesthetic color experience resembles that of normal color perception, one would predict activation of parts of the visual system specialized for such perception, namely the human 'color center', referred to as either V4 or V8. Using functional magnetic resonance imaging (fMRI), we here locate the region activated by speech in synesthetes to area V4/V8 in the left hemisphere, and demonstrate overlap with V4/V8 activation in normal controls in response to color. No activity was detected in areas V1 or V2, suggesting that activity in primary visual cortex is not necessary for such experience. Control subjects showed no activity in V4/V8 when imagining colors in response to spoken words, despite over-training on word-color associations similar to those spontaneously reported by synesthetes.	Univ London Goldsmiths Coll, Dept Psychol, London SE14 6NW, England; Inst Psychiat, Brain Image Anal Unit, London SE5 8AF, England; Inst Psychiat, Dept Psychol, London SE5 8AF, England; City Univ London, Appl Vis Res Ctr, London EC1V 0HB, England; Univ Cambridge, Addenbrookes Hosp, Dept Psychiat, Cambridge CB2 2QQ, England; Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England; Univ Manchester, Manchester M13 9PL, Lancs, England	University of London; Goldsmiths University London; University of London; King's College London; University of London; King's College London; City University London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of Manchester	Nunn, JA (corresponding author), Univ London Goldsmiths Coll, Dept Psychol, London SE14 6NW, England.		Bullmore, Ed/C-1706-2012; Brammer, Michael J/B-7128-2012; Williams, Steve C/D-6979-2011	Bullmore, Ed/0000-0002-8955-8283; Brammer, Michael J/0000-0001-9800-2052; Williams, Steve C/0000-0003-4299-1941; opoku, anita/0000-0001-7243-8157	Medical Research Council [G0600977] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ANDREASEN NC, 1995, AM J PSYCHIAT, V152, P1576; Bailey M. E. S., 1997, SYNAESTHESIA CLASSIC, P182; BARBUR JL, 1993, BRAIN, V116, P1293, DOI 10.1093/brain/116.6.1293; Barnes J, 1999, NEUROREPORT, V10, P195, DOI 10.1097/00001756-199901180-00037; BARONCOHEN S, 1987, PERCEPTION, V16, P761, DOI 10.1068/p160761; BARONCOHEN S, 1993, PERCEPTION, V22, P419, DOI 10.1068/p220419; BaronCohen S, 1996, PERCEPTION, V25, P1073, DOI 10.1068/p251073; Bartels A, 2000, EUR J NEUROSCI, V12, P172, DOI 10.1046/j.1460-9568.2000.00905.x; Brammer MJ, 1997, MAGN RESON IMAGING, V15, P763, DOI 10.1016/S0730-725X(97)00135-5; Bullmore ET, 1999, HUM BRAIN MAPP, V7, P38, DOI 10.1002/(SICI)1097-0193(1999)7:1<38::AID-HBM4>3.3.CO;2-H; Bullmore ET, 2001, HUM BRAIN MAPP, V12, P61, DOI 10.1002/1097-0193(200102)12:2<61::AID-HBM1004>3.0.CO;2-W; CRICK F, 1995, NATURE, V375, P121, DOI 10.1038/375121a0; Cytowic Richard, 1997, SYNAESTHESIA CLASSIC, P17; DEHAY C, 1984, EXP BRAIN RES, V57, P208; Ffytche DH, 1998, NAT NEUROSCI, V1, P738, DOI 10.1038/3738; FLETCHER PC, 1995, BRAIN, V118, P401, DOI 10.1093/brain/118.2.401; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; GRASBY PM, 1993, BRAIN, V116, P1, DOI 10.1093/brain/116.1.1; Gray J. A., 1997, SYNAESTHESIA CLASSIC, P173; GRAY JA, 1999, NEURONAL BASES PSYCH, V8, P450; Grossenbacher P. G., 1997, SYNAESTHESIA CLASSIC, P148; Grossenbacher PG, 2001, TRENDS COGN SCI, V5, P36, DOI 10.1016/S1364-6613(00)01571-0; Hadjikhani N, 1998, NAT NEUROSCI, V1, P235, DOI 10.1038/681; Hadjikhani N, 1998, J NEUROSCI, V18, P1072; Howard RJ, 1998, NEUROREPORT, V9, P1019, DOI 10.1097/00001756-199804200-00012; JOHANSSON S, 1982, FREQUENCY ANAL ENGLI; Kiehl KA, 1999, HUM BRAIN MAPP, V7, P225, DOI 10.1002/(SICI)1097-0193(1999)7:4<225::AID-HBM1>3.0.CO;2-P; Maddock RJ, 1997, PSYCHIAT RES-NEUROIM, V75, P1, DOI 10.1016/S0925-4927(97)00018-8; Milner A. D., 1995, VISUAL BRAIN ACTION; Nelson H., 1991, NATL ADULT READING T; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; PAULESU E, 1995, BRAIN, V118, P661, DOI 10.1093/brain/118.3.661; Ramachandran VS, 2001, P ROY SOC B-BIOL SCI, V268, P979, DOI 10.1098/rspb.2000.1576; Talairach I., 1988, COPLANAR STEREOTACTI; Tong F, 2001, NATURE, V411, P195, DOI 10.1038/35075583; TOOTELL RBH, 1995, NATURE, V375, P139, DOI 10.1038/375139a0; Zeki S, 1998, BRAIN, V121, P1669, DOI 10.1093/brain/121.9.1669; ZEKI S, 1991, J NEUROSCI, V11, P641; ZEKI S, 1993, P ROY SOC B-BIOL SCI, V252, P215, DOI 10.1098/rspb.1993.0068; [No title captured]	41	257	260	0	131	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2002	5	4					371	375		10.1038/nn818	http://dx.doi.org/10.1038/nn818			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	534UQ	11914723				2022-12-24	WOS:000174606900018
J	Ehlers, MD				Ehlers, MD			Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system	NATURE NEUROSCIENCE			English	Article							LONG-TERM FACILITATION; NMDA RECEPTORS; GLUTAMATE RECEPTORS; PROTEIN-SYNTHESIS; AMPA RECEPTORS; DENSITY; SYNAPSES; CREB; MODULATION; ACTIVATION	Experience-dependent remodeling of the postsynaptic density (PSD) is critical for synapse formation and plasticity in the mammalian brain. Here, in cultured rat hippocampal neurons, I found long-lasting, global changes in the molecular composition of the PSD dictated by synaptic activity. These changes were bidirectional, reversible, modular, and involved multiple classes of PSD proteins. Moreover, activity-dependent remodeling was accompanied by altered protein turnover, occurred with corresponding increases or decreases in ubiquitin conjugation of synaptic proteins and required proteasome-mediated degradation. These modifications, in turn, reciprocally altered synaptic signaling to the downstream effectors CREB (cyclic AMP response element binding protein) and ERK-MAPK (extracellular signal regulated kinase-MAP kinase). These results indicate that activity regulates postsynaptic composition and signaling through the ubiquitin-proteasome system, providing a mechanistic link between synaptic activity, protein turnover and the functional reorganization of synapses.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University	Ehlers, MD (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Box 3209, Durham, NC 27710 USA.	ehlers@neuro.duke.edu			NIMH NIH HHS [MH64748] Funding Source: Medline; NINDS NIH HHS [NS39402] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039402] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams JP, 2002, ANNU REV PHARMACOL, V42, P135, DOI 10.1146/annurev.pharmtox.42.082701.145401; Akaaboune M, 1999, SCIENCE, V286, P503, DOI 10.1126/science.286.5439.503; Boeckers TM, 2002, J NEUROCHEM, V81, P903, DOI 10.1046/j.1471-4159.2002.00931.x; Burbea M, 2002, NEURON, V35, P107, DOI 10.1016/S0896-6273(02)00749-3; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Chain DG, 1999, NEURON, V22, P147, DOI 10.1016/S0896-6273(00)80686-8; CHAPMAN AP, 1994, NEUROSCI LETT, V168, P238, DOI 10.1016/0304-3940(94)90459-6; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Fong DK, 2002, J NEUROSCI, V22, P2153, DOI 10.1523/JNEUROSCI.22-06-02153.2002; GEINISMAN Y, 1991, BRAIN RES, V566, P77, DOI 10.1016/0006-8993(91)91683-R; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2001, NAT NEUROSCI, V4, P565, DOI 10.1038/88380; Hegde AN, 1997, CELL, V89, P115, DOI 10.1016/S0092-8674(00)80188-9; Hegde AN, 2002, NAT REV NEUROSCI, V3, P854, DOI 10.1038/nrn961; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mammen AL, 1997, J NEUROSCI, V17, P7351; Marrs GS, 2001, NAT NEUROSCI, V4, P1006, DOI 10.1038/nn717; Meyer T, 2000, TRENDS CELL BIOL, V10, P238, DOI 10.1016/S0962-8924(00)01764-5; Michel JJC, 2002, ANNU REV PHARMACOL, V42, P235, DOI 10.1146/annurev.pharmtox.42.083101.135801; Minichiello L, 2002, NEURON, V36, P121, DOI 10.1016/S0896-6273(02)00942-X; Murphey RK, 2002, NEURON, V36, P5, DOI 10.1016/S0896-6273(02)00943-1; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Okabe S, 1999, NAT NEUROSCI, V2, P804, DOI 10.1038/12175; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Sala C, 2000, J NEUROSCI, V20, P3529, DOI 10.1523/JNEUROSCI.20-10-03529.2000; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Thiagarajan TC, 2002, NEURON, V36, P1103, DOI 10.1016/S0896-6273(02)01049-8; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Tovar KR, 2002, NEURON, V34, P253; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Watt AJ, 2000, NEURON, V26, P659, DOI 10.1016/S0896-6273(00)81202-7; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; WILSON SM, 2002, NAT GENET, V7, P7; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071	50	777	802	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2003	6	3					231	242		10.1038/nn1013	http://dx.doi.org/10.1038/nn1013			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	648YB	12577062				2022-12-24	WOS:000181178300011
J	Kim, G; Kandler, K				Kim, G; Kandler, K			Elimination and strengthening of glycinergic/GABAergic connections during tonotopic map formation	NATURE NEUROSCIENCE			English	Article							SUPERIOR OLIVARY NUCLEUS; CENTRAL AUDITORY-SYSTEM; VISUAL-CORTEX; DEVELOPMENTAL-CHANGES; DEPENDENT REFINEMENT; SYNAPSE ELIMINATION; DOMINANCE COLUMNS; SPINAL NEURONS; PLASTICITY; GLYCINE	Synapse elimination and strengthening are central mechanisms for the developmental organization of excitatory neuronal networks. Little is known, however, about whether these processes are also involved in establishing precise inhibitory circuits. We examined the development of functional connectivity before hearing onset in rats in the tonotopically organized, glycinergic pathway from the medial nucleus of the trapezoid body (MNTB) to the lateral superior olive (LSO), which is part of the mammalian sound localization system. We found that LSO neurons became functionally disconnected from similar to75% of their initial inputs, resulting in a two-fold sharpening of functional topography. This was accompanied by a 12-fold increase in the synaptic conductance generated by maintained individual inputs. Functional elimination of MNTB-LSO synapses was restricted to the period when these glycinergic/GABAergic synapses are excitatory. These results provide new insights into the mechanisms by which precisely organized inhibitory circuits are established during development.	Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kandler, K (corresponding author), Univ Pittsburgh, Sch Med, Dept Neurobiol, 3500 Terrace St, Pittsburgh, PA 15261 USA.	kkarl@pitt.edu		Kandler, Karl/0000-0002-6053-6400; Kim, Gunsoo/0000-0001-9318-8329	NIDCD NIH HHS [DC04199, R01 DC004199] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004199] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Aizenman CD, 1998, NEURON, V21, P827, DOI 10.1016/S0896-6273(00)80598-X; ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; Ben-Ari Y, 2001, TRENDS NEUROSCI, V24, P353, DOI 10.1016/S0166-2236(00)01813-0; BLATCHLEY BJ, 1987, DEV BRAIN RES, V32, P75, DOI 10.1016/0165-3806(87)90140-4; BORMANN J, 1987, J PHYSIOL-LONDON, V385, P243, DOI 10.1113/jphysiol.1987.sp016493; BOUDREAU JC, 1968, J NEUROPHYSIOL, V31, P442, DOI 10.1152/jn.1968.31.3.442; CALLAWAY EM, 1993, P NATL ACAD SCI USA, V90, P7661, DOI 10.1073/pnas.90.16.7661; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; Colman H, 1997, SCIENCE, V275, P356, DOI 10.1126/science.275.5298.356; Davis GW, 1998, NATURE, V392, P82, DOI 10.1038/32176; Ehrlich I, 1999, J PHYSIOL-LONDON, V520, P121, DOI 10.1111/j.1469-7793.1999.00121.x; FRIAUF E, 1992, EUR J NEUROSCI, V4, P798, DOI 10.1111/j.1460-9568.1992.tb00190.x; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; GRANTYN R, 1995, PERSPECT DEV NEUROBI, V2, P387; Gubellini P, 2001, EUR J NEUROSCI, V14, P1937, DOI 10.1046/j.0953-816x.2001.01823.x; HELFERT RH, 1986, J COMP NEUROL, V244, P533, DOI 10.1002/cne.902440409; HENDRY SHC, 1986, NATURE, V320, P750, DOI 10.1038/320750a0; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; IRVINE DRF, 1992, SPRINGER HDB AUDITOR, V2, P153; JACKSON H, 1982, J NEUROSCI, V2, P1736; Jonas P, 1998, SCIENCE, V281, P419, DOI 10.1126/science.281.5375.419; KANDLER K, 1995, EUR J NEUROSCI, V7, P1773, DOI 10.1111/j.1460-9568.1995.tb00697.x; KANDLER K, 1995, J NEUROSCI, V15, P6890; KANDLER K, 1998, IMAGING NEURONS, P271; Kapfer C, 2002, NAT NEUROSCI, V5, P247, DOI 10.1038/nn810; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Kirsch J, 1998, NATURE, V392, P717, DOI 10.1038/33694; Knudsen EI, 2002, NATURE, V417, P322, DOI 10.1038/417322a; Kotak VC, 1998, J NEUROSCI, V18, P4646; Kotak VC, 1996, J NEUROSCI, V16, P1836; Kotak VC, 2000, J NEUROSCI, V20, P5820, DOI 10.1523/JNEUROSCI.20-15-05820.2000; Kullmann PHM, 2002, EUR J NEUROSCI, V15, P1093, DOI 10.1046/j.1460-9568.2002.01946.x; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; Lohmann C, 1998, J NEUROBIOL, V34, P97, DOI 10.1002/(SICI)1097-4695(19980205)34:2<97::AID-NEU1>3.0.CO;2-6; Purves, 1985, PRINCIPLES NEURAL DE; Rico B, 2002, NAT NEUROSCI, V5, P225, DOI 10.1038/nn808; Rietzel HJ, 1998, J COMP NEUROL, V390, P20; Rozas C, 2001, J NEUROSCI, V21, P6791, DOI 10.1523/JNEUROSCI.21-17-06791.2001; SANES DH, 1993, EUR J NEUROSCI, V5, P570, DOI 10.1111/j.1460-9568.1993.tb00522.x; SANES DH, 1991, J NEUROBIOL, V22, P837, DOI 10.1002/neu.480220805; SANES DH, 1993, J NEUROSCI, V13, P2627, DOI 10.1523/JNEUROSCI.13-06-02627.1993; Sanes DH, 2000, HEARING RES, V147, P46, DOI 10.1016/S0378-5955(00)00119-2; Stellwagen D, 2002, NEURON, V33, P357, DOI 10.1016/S0896-6273(02)00577-9; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; TAKAHASHI T, 1992, NEURON, V9, P1155, DOI 10.1016/0896-6273(92)90073-M; von Gersdorff H, 2002, NAT REV NEUROSCI, V3, P53, DOI 10.1038/nrn705	50	172	179	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2003	6	3					282	290		10.1038/nn1015	http://dx.doi.org/10.1038/nn1015			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	648YB	12577063				2022-12-24	WOS:000181178300017
J	Monier, C; Chavane, F; Baudot, P; Graham, LJ; Fregnac, Y				Monier, C; Chavane, F; Baudot, P; Graham, LJ; Fregnac, Y			Orientation and direction selectivity of synaptic inputs in visual cortical neurons: A diversity of combinations produces spike tuning	NEURON			English	Article							CAT STRIATE CORTEX; FUNCTIONALLY CHARACTERIZED SITES; SIMPLE CELLS; MOVING STIMULI; AREA 17; INTRACORTICAL INHIBITION; INTRACELLULAR ANALYSIS; SHUNTING INHIBITION; RECEPTIVE-FIELDS; IN-VIVO	This intracellular study investigates synaptic mechanisms of orientation and direction selectivity in cat area 17. Visually evoked inhibition was analyzed in 88 cells by detecting spike suppression, hyperpolarization, and reduction of trial-to-trial variability of membrane potential. In 25 of these cells, inhibition visibility was enhanced by depolarization and spike inactivation and by direct measurement of synaptic conductances. We conclude that excitatory and inhibitory inputs share the tuning preference of spiking output in 60% of cases, whereas inhibition is tuned to a different orientation in 40% of cases. For this latter type of cells, conductance measurements showed that excitation shared either the preference of the spiking output or that of the inhibition. This diversity of input combinations may reflect inhomogeneities in functional intracortical connectivity regulated by correlation-based activity-dependent processes.	CNRS, UPR 2191, Unite Neurosci Integrat & Computat, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Graham, LJ (corresponding author), Univ Paris 05, UFR Biomed, CNRS, UMR 8119, 45 Rue St Peres, F-75270 Paris 06, France.		Chavane, Frederic/ABB-1487-2021	Chavane, Frederic/0000-0001-7916-2640				Adorjan P, 1999, VISUAL NEUROSCI, V16, P303, DOI 10.1017/S0952523899162114; AHMED B, 1994, J COMP NEUROL, V341, P39, DOI 10.1002/cne.903410105; Anderson J, 2000, NAT NEUROSCI, V3, P617, DOI 10.1038/75797; Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; BENEVENTO LA, 1972, NATURE-NEW BIOL, V238, P124, DOI 10.1038/newbio238124a0; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; BERMAN NJ, 1991, J PHYSIOL-LONDON, V440, P697, DOI 10.1113/jphysiol.1991.sp018731; BISHOP PO, 1973, J PHYSIOL-LONDON, V231, P31, DOI 10.1113/jphysiol.1973.sp010218; BONHOEFFER T, 1995, EUR J NEUROSCI, V7, P1973, DOI 10.1111/j.1460-9568.1995.tb00720.x; Borg-Graham LJ, 2001, NAT NEUROSCI, V4, P176, DOI 10.1038/84007; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; BorgGraham L, 1996, J PHYSIOLOGY-PARIS, V90, P185, DOI 10.1016/S0928-4257(97)81421-0; Bringuier V, 1999, SCIENCE, V283, P695, DOI 10.1126/science.283.5402.695; Bringuier V, 1997, J PHYSIOL-LONDON, V500, P751, DOI 10.1113/jphysiol.1997.sp022056; BUSH PC, 1994, J NEUROPHYSIOL, V71, P2183, DOI 10.1152/jn.1994.71.6.2183; Buzas P, 2001, J COMP NEUROL, V437, P259, DOI 10.1002/cne.1282; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; CREUTZFELDT OD, 1974, EXP BRAIN RES, V21, P251; Crook JM, 1997, VISUAL NEUROSCI, V14, P141, DOI 10.1017/S095252380000883X; Crook JM, 1998, EUR J NEUROSCI, V10, P2056, DOI 10.1046/j.1460-9568.1998.00218.x; Das A, 1999, NATURE, V399, P655, DOI 10.1038/21371; DEAN AF, 1981, EXP BRAIN RES, V44, P437; DEANGELIS GC, 1992, J NEUROPHYSIOL, V68, P144, DOI 10.1152/jn.1992.68.1.144; DOUGLAS R, 1999, CEREBRAL CORTEX MODE, P251; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P659, DOI 10.1113/jphysiol.1991.sp018730; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; DOUGLAS RJ, 1988, NATURE, V332, P642, DOI 10.1038/332642a0; Dragoi V, 2001, NATURE, V411, P80, DOI 10.1038/35075070; EYSEL UT, 1994, NEUROREPORT, V5, P2033, DOI 10.1097/00001756-199410270-00011; EYSEL UT, 1990, EXP BRAIN RES, V80, P626; FERSTER D, 1987, TRENDS NEUROSCI, V10, P487, DOI 10.1016/0166-2236(87)90126-3; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; FERSTER D, 1986, J NEUROSCI, V6, P1284; FERSTER D, 1992, J NEUROSCI, V12, P1262; Fregnac Y, 2002, HDB BRAIN THEORY NEU, P512; HEGGELUND P, 1978, EXP BRAIN RES, V32, P197; Hirsch JA, 1998, J NEUROSCI, V18, P9517; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; INNOCENTI GM, 1974, BRAIN RES, V80, P122, DOI 10.1016/0006-8993(74)90728-8; KISVARDAY ZF, 1994, EUR J NEUROSCI, V6, P1619, DOI 10.1111/j.1460-9568.1994.tb00553.x; Kisvarday ZF, 2001, CEREB CORTEX, V11, P636, DOI 10.1093/cercor/11.7.636; Maldonado PE, 1997, SCIENCE, V276, P1551, DOI 10.1126/science.276.5318.1551; Martinez LM, 2002, J PHYSIOL-LONDON, V540, P321, DOI 10.1113/jphysiol.2001.012776; McLaughlin D, 2000, P NATL ACAD SCI USA, V97, P8087, DOI 10.1073/pnas.110135097; Mechler F, 1998, J NEUROSCI, V18, P6583; NELSON S, 1994, SCIENCE, V265, P774, DOI 10.1126/science.8047882; Pare D, 1998, J NEUROPHYSIOL, V79, P1450, DOI 10.1152/jn.1998.79.3.1450; Ringach DL, 2002, J NEUROPHYSIOL, V87, P1018, DOI 10.1152/jn.00614.2001; Roerig B, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-24-j0002.1999; RUFF PI, 1987, BIOL CYBERN, V57, P147, DOI 10.1007/BF00364147; Sabatini SP, 1999, BIOL CYBERN, V80, P171, DOI 10.1007/s004220050515; SATO H, 1991, BRAIN RES, V544, P156, DOI 10.1016/0006-8993(91)90899-7; Schuett S, 2001, NEURON, V32, P325, DOI 10.1016/S0896-6273(01)00472-X; Schummers J, 2002, NEURON, V36, P969, DOI 10.1016/S0896-6273(02)01012-7; SCLAR G, 1982, EXP BRAIN RES, V46, P457; Shmuel A, 1996, J NEUROSCI, V16, P6945; SILLITO AM, 1979, J PHYSIOL-LONDON, V289, P33, DOI 10.1113/jphysiol.1979.sp012723; SILLITO AM, 1995, NATURE, V378, P492, DOI 10.1038/378492a0; SILLITO AM, 1980, BRAIN RES, V194, P517, DOI 10.1016/0006-8993(80)91234-2; SOMERS DC, 1995, J NEUROSCI, V15, P5448; THOMPSON KG, 1994, VISUAL NEUROSCI, V11, P939, DOI 10.1017/S0952523800003898; Troyer TW, 1998, J NEUROSCI, V18, P5908; VOLGUSHEV M, 1993, VISUAL NEUROSCI, V10, P1151, DOI 10.1017/S0952523800010257; Volgushev M, 2000, EUR J NEUROSCI, V12, P257, DOI 10.1046/j.1460-9568.2000.00909.x; WORGOTTER F, 1991, J NEUROSCI, V11, P1959; WORGOTTER F, 1987, BIOL CYBERN, V57, P349, DOI 10.1007/BF00354980; Yousef T, 1999, EUR J NEUROSCI, V11, P4291, DOI 10.1046/j.1460-9568.1999.00863.x; Zar JH, 1974, BIOSTATISTICAL ANAL	69	287	292	0	20	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 20	2003	37	4					663	680		10.1016/S0896-6273(03)00064-3	http://dx.doi.org/10.1016/S0896-6273(03)00064-3			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	648EH	12597863	Bronze			2022-12-24	WOS:000181136500014
J	Bushara, KO; Hanakawa, T; Immisch, I; Toma, K; Kansaku, K; Hallett, M				Bushara, KO; Hanakawa, T; Immisch, I; Toma, K; Kansaku, K; Hallett, M			Neural correlates of cross-modal binding	NATURE NEUROSCIENCE			English	Article							HUMAN BRAIN; ATTENTION; CORTEX	Little is known about how the brain binds together signals from multiple sensory modalities to produce unified percepts of objects and events in the external world. Using event-related functional magnetic resonance imaging (fMRI) in humans, we measured transient brain responses to auditory/visual binding, as evidenced by a sound-induced change in visual motion perception. Identical auditory and visual stimuli were presented in all trials, but in some trials they were perceived to be bound together and in others they were perceived as unbound unimodal events. Cross-modal binding was associated with higher activity in multimodal areas, but lower activity in predominantly unimodal areas. This activation pattern suggests that a reciprocal and 'competitive' interaction between multimodal and unimodal areas underlies the perceptual interpretation of simultaneous signals from multiple sensory modalities.	Minneapolis Vet Affairs Med Ctr, Serv Neurol, Minneapolis, MN 55417 USA; NINDS, Human Motor Control Sect, NIH, Bethesda, MD 20892 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Bushara, KO (corresponding author), Minneapolis Vet Affairs Med Ctr, Serv Neurol, Room 4B135,1 Vet Dr, Minneapolis, MN 55417 USA.	busha001@umn.edu	Hanakawa, Takashi/A-6536-2011		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002669, ZIANS002669] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALHO K, 1994, PSYCHOPHYSIOLOGY, V31, P469, DOI 10.1111/j.1469-8986.1994.tb01050.x; Bushara KO, 2001, J NEUROSCI, V21, P300, DOI 10.1523/JNEUROSCI.21-01-00300.2001; Calvert GA, 2001, NEUROIMAGE, V14, P427, DOI 10.1006/nimg.2001.0812; Driver J, 1996, NATURE, V381, P66, DOI 10.1038/381066a0; FLETCHER PC, 1995, NEUROIMAGE, V2, P195, DOI 10.1006/nimg.1995.1025; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Fuster JM, 2000, NATURE, V405, P347, DOI 10.1038/35012613; Josephs O, 1999, PHILOS T R SOC B, V354, P1215, DOI 10.1098/rstb.1999.0475; Macaluso E, 2000, SCIENCE, V289, P1206, DOI 10.1126/science.289.5482.1206; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; MORRELL LK, 1968, J EXP PSYCHOL, V77, P14, DOI 10.1037/h0021289; Sekuler R, 1997, NATURE, V385, P308, DOI 10.1038/385308a0; Spence C, 2001, PERCEPT PSYCHOPHYS, V63, P330, DOI 10.3758/BF03194473; Stein BE, 1998, EXP BRAIN RES, V123, P124, DOI 10.1007/s002210050553; VANGELDEREN P, 1995, P NATL ACAD SCI USA, V92, P6906, DOI 10.1073/pnas.92.15.6906; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79	16	171	173	2	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2003	6	2					190	195		10.1038/nn993	http://dx.doi.org/10.1038/nn993			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	640CL	12496761				2022-12-24	WOS:000180669100020
J	Yasuda, H; Barth, AL; Stellwagen, D; Malenka, RC				Yasuda, H; Barth, AL; Stellwagen, D; Malenka, RC			A developmental switch in the signaling cascades for LTP induction	NATURE NEUROSCIENCE			English	Article							CALMODULIN-KINASE-II; ADENYLATE-CYCLASE; AREA CA1; BRAIN; ACTIVATION		Stanford Univ, Sch Med, Nancy Pritzker Lab, Dept Psychiat & Behav Sci, Stanford, CA 94304 USA	Stanford University	Malenka, RC (corresponding author), Stanford Univ, Sch Med, Nancy Pritzker Lab, Dept Psychiat & Behav Sci, Stanford, CA 94304 USA.			Yasuda, Hiroki/0000-0001-5911-609X				Adams JP, 2002, ANNU REV PHARMACOL, V42, P135, DOI 10.1146/annurev.pharmtox.42.082701.145401; Blitzer RD, 1995, NEURON, V15, P1403, DOI 10.1016/0896-6273(95)90018-7; Chang BH, 1998, P NATL ACAD SCI USA, V95, P10890, DOI 10.1073/pnas.95.18.10890; CHAVEZNORIEGA LE, 1994, J NEUROSCI, V14, P310; CHETKOVICH DM, 1993, J NEUROCHEM, V61, P1933, DOI 10.1111/j.1471-4159.1993.tb09836.x; Constantine-Paton M, 1998, CURR OPIN NEUROBIOL, V8, P139, DOI 10.1016/S0959-4388(98)80017-2; Fiala JC, 1998, J NEUROSCI, V18, P8900; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KELLY PT, 1985, DEV BRAIN RES, V18, P211, DOI 10.1016/0165-3806(85)90265-2; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; ROSENBERG GB, 1987, METHOD ENZYMOL, V139, P776; Tao HZW, 2001, NEURON, V31, P569, DOI 10.1016/S0896-6273(01)00393-2	15	235	249	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2003	6	1					15	16		10.1038/nn985	http://dx.doi.org/10.1038/nn985			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	630CE	12469130				2022-12-24	WOS:000180089300008
J	Connolly, JD; Goodale, MA; Menon, RS; Munoz, DP				Connolly, JD; Goodale, MA; Menon, RS; Munoz, DP			Human fMRI evidence for the neural correlates of preparatory set	NATURE NEUROSCIENCE			English	Article							FRONTAL EYE-FIELD; POSITRON EMISSION TOMOGRAPHY; MOVEMENT-RELATED ACTIVITY; LATERAL INTRAPARIETAL AREA; SUPPLEMENTARY MOTOR AREA; EVENT-RELATED FMRI; ANTI-SACCADE TASK; PREMOTOR CORTEX; NEURONAL-ACTIVITY; SUPERIOR COLLICULUS	We used functional magnetic resonance imaging (fMRI) to study readiness and intention signals in frontal and parietal areas that have been implicated in planning saccadic eye movements-the frontal eye fields (FEF) and intraparietal sulcus (IPS). To track fMRI signal changes correlated with readiness to act, we used an event-related design with variable gap periods between disappearance of the fixation point and appearance of the target. To track changes associated with intention, subjects were instructed before the gap period to make either a pro-saccade (look at target) or an anti-saccade (look away from target). FEF activation increased during the gap period and was higher for anti- than for pro-saccade trials. No signal increases were observed during the gap period in the IPS. Our findings suggest that within the frontoparietal networks that control saccade generation, the human FEF, but not the IPS, is critically involved in preparatory set, coding both the readiness and intention to perform a particular movement.	Univ Western Ontario, Dept Psychol, CIHR Grp Act & Percept, London, ON N6C 5C2, Canada; John P Robarts Res Inst, London, ON N6A 5K8, Canada; Queens Univ, Dept Physiol, Ctr Neurosci Studies, Kingston, ON K7L 3N6, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Queens University - Canada	Goodale, MA (corresponding author), Univ Western Ontario, Dept Psychol, CIHR Grp Act & Percept, London, ON N6C 5C2, Canada.		Menon, Ravi S/K-5500-2013; Menon, Ravi/ABA-8654-2020; Goodale, Melvyn A/M-5907-2013	Menon, Ravi S/0000-0002-7916-0263; Menon, Ravi/0000-0002-7916-0263; Goodale, Melvyn A/0000-0001-6748-0561				Ben Hamed S, 2002, EXP BRAIN RES, V142, P512, DOI 10.1007/s00221-001-0954-z; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; Connolly JD, 2000, J NEUROPHYSIOL, V84, P1645, DOI 10.1152/jn.2000.84.3.1645; DIAS EC, 1994, J NEUROPHYSIOL, V72, P2532, DOI 10.1152/jn.1994.72.5.2532; Doricchi F, 1997, EXP BRAIN RES, V116, P50, DOI 10.1007/PL00005744; DORRIS MC, 1995, J NEUROPHYSIOL, V73, P2558, DOI 10.1152/jn.1995.73.6.2558; Dorris MC, 1997, J NEUROSCI, V17, P8566; EVARTS EV, 1984, NEUROPHYSIOLOGICAL A; Everling S, 1998, NEUROPSYCHOLOGIA, V36, P885, DOI 10.1016/S0028-3932(98)00020-7; Everling S, 2000, J NEUROSCI, V20, P387, DOI 10.1523/JNEUROSCI.20-01-00387.2000; Everling S, 1999, J NEUROSCI, V19, P2740; Everling S, 1998, J NEUROPHYSIOL, V80, P1584, DOI 10.1152/jn.1998.80.3.1584; FISCHER B, 1993, BEHAV BRAIN SCI, V16, P553, DOI 10.1017/S0140525X00031575; FISCHER B, 1992, EXP BRAIN RES, V89, P415; FUNAHASHI S, 1993, NATURE, V365, P753, DOI 10.1038/365753a0; Gaymard B, 1998, EXP BRAIN RES, V123, P159, DOI 10.1007/s002210050557; Gaymard B, 1999, EXP BRAIN RES, V129, P288, DOI 10.1007/s002210050899; Gottlieb J, 1999, NAT NEUROSCI, V2, P906, DOI 10.1038/13209; GUITTON D, 1985, EXP BRAIN RES, V58, P455; HALLETT PE, 1978, VISION RES, V18, P1279, DOI 10.1016/0042-6989(78)90218-3; Hebb D. O., 1972, TXB PHYSL, P77; Kollias SS, 2000, NEURORADIOLOGY, V42, P591, DOI 10.1007/s002340000355; Kurata K, 2000, J NEUROPHYSIOL, V84, P1667, DOI 10.1152/jn.2000.84.3.1667; KURATA K, 1993, J NEUROPHYSIOL, V69, P187, DOI 10.1152/jn.1993.69.1.187; KURATA K, 1994, J NEUROPHYSIOL, V71, P1151, DOI 10.1152/jn.1994.71.3.1151; Lee KM, 1999, NEUROIMAGE, V9, P117, DOI 10.1006/nimg.1998.0393; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Luna B, 2001, NEUROIMAGE, V13, P786, DOI 10.1006/nimg.2000.0743; Munoz DP, 2000, CAN J PHYSIOL PHARM, V78, P934, DOI 10.1139/cjpp-78-11-934; Munoz DP, 1998, EXP BRAIN RES, V121, P391, DOI 10.1007/s002210050473; ODRISCOLL GA, 1995, P NATL ACAD SCI USA, V92, P925, DOI 10.1073/pnas.92.3.925; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Passingham RE., 1993, FRONTAL LOBES VOLUNT; Paus T, 1996, NEUROPSYCHOLOGIA, V34, P475, DOI 10.1016/0028-3932(95)00134-4; Pierrot-Deseilligny C., 1991, BRAIN, V114, P1472, DOI 10.1093/brain/114.3.1473; Pollmann S, 2000, HUM BRAIN MAPP, V9, P26, DOI 10.1002/(SICI)1097-0193(2000)9:1<26::AID-HBM3>3.3.CO;2-U; RIVAUD S, 1994, EXP BRAIN RES, V102, P110; SASLOW MG, 1967, J OPT SOC AM, V57, P1024, DOI 10.1364/JOSA.57.001024; Schall JD, 2001, NAT REV NEUROSCI, V2, P33, DOI 10.1038/35049054; SCHALL JD, 1995, J NEUROSCI, V15, P4464; SchlagRey M, 1997, NATURE, V390, P398, DOI 10.1038/37114; Schluter ND, 1999, NEUROPSYCHOLOGIA, V37, P233; Sereno MI, 2001, SCIENCE, V294, P1350, DOI 10.1126/science.1063695; Snyder LH, 2000, VISION RES, V40, P1433, DOI 10.1016/S0042-6989(00)00052-3; STANTON GB, 1995, J COMP NEUROL, V353, P291, DOI 10.1002/cne.903530210; Sweeney JA, 1996, J NEUROPHYSIOL, V75, P454, DOI 10.1152/jn.1996.75.1.454; Toni I, 1999, CEREB CORTEX, V9, P35, DOI 10.1093/cercor/9.1.35; Umeno MM, 2001, J NEUROPHYSIOL, V86, P2344, DOI 10.1152/jn.2001.86.5.2344; WISE SP, 1989, SOMATOSENS MOT RES, V6, P455, DOI 10.3109/08990228909144687	50	260	263	0	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2002	5	12					1345	1352		10.1038/nn969	http://dx.doi.org/10.1038/nn969			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	618ZE	12411958				2022-12-24	WOS:000179447500019
J	Romo, R; Hernandez, A; Zainos, A; Lemus, L; Brody, CD				Romo, R; Hernandez, A; Zainos, A; Lemus, L; Brody, CD			Neuronal correlates of decision-making in secondary somatosensory cortex	NATURE NEUROSCIENCE			English	Article							POSTERIOR PARIETAL CORTEX; PREFRONTAL CORTEX; PSYCHOPHYSICAL MEASUREMENTS; SENSORY DISCRIMINATION; VISUAL RESPONSES; MONKEY PRIMARY; CONNECTIONS; AREAS; PREMOTOR; CHOICE	The ability to discriminate between two sequential stimuli requires evaluation of current sensory information in reference to stored information. Where and how does this evaluation occur? We trained monkeys to compare two mechanical vibrations applied sequentially to the fingertips and to report which of the two had the higher frequency. We recorded single neurons in secondary somatosensory cortex (S2) while the monkeys performed the task. During the first stimulus period, the firing rate of S2 neurons encoded the stimulus frequency. During the second stimulus period, however, some S2 neurons did not merely encode the stimulus frequency. The responses of these neurons were a function of both the remembered (first) and current (second) stimulus. Moreover, a few hundred milliseconds after the presentation of the second stimulus, these responses were correlated with the monkey's decision. This suggests that some S2 neurons may combine past and present sensory information for decision-making.	Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Universidad Nacional Autonoma de Mexico; Cold Spring Harbor Laboratory	Romo, R (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Apartado Postal 70-253, Mexico City 04510, DF, Mexico.	rromo@ifisiol.unam.mx	Lemus, Luis/E-6760-2019	Lemus, Luis/0000-0002-6608-3684; romo, ranulfo/0000-0003-3529-3635; zainos, antonio/0000-0001-6137-1794				Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Burton H., 1996, PAIN AND TOUCH, P105; Carmichael ST, 1995, J COMP NEUROL, V363, P642, DOI 10.1002/cne.903630409; CAVADA C, 1989, J COMP NEUROL, V287, P393, DOI 10.1002/cne.902870402; CHAPMAN CE, 1988, EXP BRAIN RES, V72, P316; CHAPMAN CE, 1994, CAN J PHYSIOL PHARM, V72, P558, DOI 10.1139/y94-080; Dodd JV, 2001, J NEUROSCI, V21, P4809, DOI 10.1523/JNEUROSCI.21-13-04809.2001; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; GODSCHALK M, 1984, EXP BRAIN RES, V56, P410; Hernandez A, 1997, J NEUROSCI, V17, P6391; Hernandez A, 2000, P NATL ACAD SCI USA, V97, P6191, DOI 10.1073/pnas.120018597; Hernandez A, 2002, NEURON, V33, P959, DOI 10.1016/S0896-6273(02)00613-X; Horwitz GD, 2001, J NEUROPHYSIOL, V86, P2527, DOI 10.1152/jn.2001.86.5.2527; HSIAO SS, 1993, J NEUROPHYSIOL, V70, P444, DOI 10.1152/jn.1993.70.1.444; Jiang W, 1997, J NEUROPHYSIOL, V77, P1656, DOI 10.1152/jn.1997.77.3.1656; JOHNSON KO, 1980, J NEUROPHYSIOL, V43, P1793, DOI 10.1152/jn.1980.43.6.1793; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; LEICHNETZ GR, 1986, J COMP NEUROL, V254, P460, DOI 10.1002/cne.902540403; LUPPINO G, 1993, J COMP NEUROL, V338, P114, DOI 10.1002/cne.903380109; MILLER EK, 1993, J NEUROSCI, V13, P1460; MISHKIN M, 1979, NEUROPSYCHOLOGIA, V17, P139, DOI 10.1016/0028-3932(79)90005-8; MOUNTCASTLE VB, 1990, J NEUROSCI, V10, P3032; MURRAY EA, 1984, BEHAV BRAIN RES, V11, P67, DOI 10.1016/0166-4328(84)90009-3; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; PREUSS TM, 1989, J COMP NEUROL, V282, P293, DOI 10.1002/cne.902820210; Pruett JR, 2001, J NEUROPHYSIOL, V86, P2069, DOI 10.1152/jn.2001.86.4.2069; Ro JY, 2000, EXP BRAIN RES, V135, P1, DOI 10.1007/s002210000496; Romo R, 1998, NATURE, V392, P387, DOI 10.1038/32891; Romo R, 2000, NEURON, V26, P273, DOI 10.1016/S0896-6273(00)81156-3; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; Salinas E, 2000, J NEUROSCI, V20, P5503, DOI 10.1523/JNEUROSCI.20-14-05503.2000; Schall JD, 2001, NAT REV NEUROSCI, V2, P33, DOI 10.1038/35049054; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; SINCLAIR RJ, 1993, J NEUROPHYSIOL, V70, P331, DOI 10.1152/jn.1993.70.1.331; TOKUNO H, 1993, J COMP NEUROL, V333, P199, DOI 10.1002/cne.903330206; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372; [No title captured]	37	258	263	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1217	1225		10.1038/nn950	http://dx.doi.org/10.1038/nn950			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	609CG	12368806				2022-12-24	WOS:000178884600026
J	Wang, JM; Zhang, LL; Yao, Y; Viroonchatapan, N; Rothe, E; Wang, ZZ				Wang, JM; Zhang, LL; Yao, Y; Viroonchatapan, N; Rothe, E; Wang, ZZ			A transmembrane motif governs the surface trafficking of nicotinic acetylcholine receptors	NATURE NEUROSCIENCE			English	Article							TRANSFECTED COS CELLS; ENDOPLASMIC-RETICULUM; ALPHA-SUBUNIT; MONOCLONAL-ANTIBODY; GLYCINE RECEPTOR; BINDING-SITE; DETERMINANTS; RETENTION; DOMAINS; COMPLEX	Surface expression of the nicotinic acetylcholine receptor (AChR) requires the assembly of multiple subunits in the endoplasmic reticulum (ER). Little is known, however, about the mechanism by which assembled receptor pentamers are transported to the cell membrane while unassembled subunits are retained in the ER. Here we report that a motif conserved in the transmembrane domain of AChR subunits is critically involved in this process. In COS cells, mutation within this signal allowed surface expression of unassembled subunits. Conversely, insertion of the sequence to unrelated proteins that are normally transported to the surface resulted in ER retention. The signal is buried in AChR pentamers, but is exposed on unassembled subunits in the ER, where it promotes protein degradation. We therefore conclude that this signal ensures surface trafficking of only functional AChRs.	Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wang, ZZ (corresponding author), Univ Pittsburgh, Sch Med, Dept Neurobiol, 3500 Terrace St, Pittsburgh, PA 15261 USA.	zzwang+@pitt.edu			NINDS NIH HHS [R01-NS38301] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038301] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barnes EM, 2000, LIFE SCI, V66, P1063, DOI 10.1016/S0024-3205(99)00469-5; BLACK R, 1987, J CELL BIOL, V105, P1329, DOI 10.1083/jcb.105.3.1329; BLOUNT P, 1990, J CELL BIOL, V111, P2613, DOI 10.1083/jcb.111.6.2613; BLOUNT P, 1990, J CELL BIOL, V111, P2601, DOI 10.1083/jcb.111.6.2601; BLOUNT P, 1988, J BIOL CHEM, V263, P1072; BLOUNT P, 1991, J CELL BIOL, V113, P1125, DOI 10.1083/jcb.113.5.1125; BONIFACINO J S, 1991, Current Opinion in Cell Biology, V3, P592, DOI 10.1016/0955-0674(91)90028-W; BONIFACINO JS, 1990, SCIENCE, V247, P79, DOI 10.1126/science.2294595; CHANDLER LP, 1985, J BIOL CHEM, V260, P3360; Dineley KT, 2000, J BIOL CHEM, V275, P13974, DOI 10.1074/jbc.275.18.13974; Fewell SW, 2001, ANNU REV GENET, V35, P149, DOI 10.1146/annurev.genet.35.102401.090313; FORSAYETH JR, 1992, J CELL BIOL, V117, P841, DOI 10.1083/jcb.117.4.841; FROEHNER SC, 1983, J BIOL CHEM, V258, P7112; GELMAN MS, 1995, J BIOL CHEM, V270, P15085, DOI 10.1074/jbc.270.25.15085; GREEN WN, 1993, CELL, V74, P57, DOI 10.1016/0092-8674(93)90294-Z; Griffon N, 1999, EMBO J, V18, P4711, DOI 10.1093/emboj/18.17.4711; GU Y, 1991, J CELL BIOL, V114, P799, DOI 10.1083/jcb.114.4.799; GU Y, 1990, NEURON, V5, P147, DOI 10.1016/0896-6273(90)90305-Y; GULLICK WJ, 1983, BIOCHEMISTRY-US, V22, P3312, DOI 10.1021/bi00283a003; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Keller SH, 2001, J BIOL CHEM, V276, P18384, DOI 10.1074/jbc.M100691200; KREIENKAMP HJ, 1995, NEURON, V14, P635, DOI 10.1016/0896-6273(95)90320-8; KUHSE J, 1995, CURR OPIN NEUROBIOL, V5, P318, DOI 10.1016/0959-4388(95)80044-1; KUROSAKI T, 1987, FEBS LETT, V214, P253, DOI 10.1016/0014-5793(87)80065-0; Lindstrom J, 1996, Ion Channels, V4, P377; MALEK TR, 1983, P NATL ACAD SCI-BIOL, V80, P5694, DOI 10.1073/pnas.80.18.5694; MERLIE JP, 1983, CELL, V34, P747, DOI 10.1016/0092-8674(83)90531-7; MURAKAMI K, 1994, J BIOCHEM, V116, P164, DOI 10.1093/oxfordjournals.jbchem.a124489; Nicke A, 1999, J RECEPT SIGNAL TR R, V19, P493, DOI 10.3109/10799899909036667; NILSSON T, 1994, CURR OPIN CELL BIOL, V6, P517, DOI 10.1016/0955-0674(94)90070-1; RATNAM M, 1986, BIOCHEMISTRY-US, V25, P2621, DOI 10.1021/bi00357a051; SAEDI MS, 1991, J CELL BIOL, V112, P1007, DOI 10.1083/jcb.112.5.1007; SINE SM, 1991, J BIOL CHEM, V266, P13679; SMITH MM, 1987, J BIOL CHEM, V262, P4367; VERRALL S, 1992, CELL, V68, P23, DOI 10.1016/0092-8674(92)90203-O; Wang ZZ, 1996, J BIOL CHEM, V271, P27575, DOI 10.1074/jbc.271.44.27575; Wang ZZ, 1996, J CELL BIOL, V135, P809, DOI 10.1083/jcb.135.3.809; Yang M, 1997, J BIOL CHEM, V272, P1970, DOI 10.1074/jbc.272.3.1970; YONG G, 1989, J CELL BIOL, V109, P729, DOI 10.1083/jcb.109.2.729	39	83	83	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2002	5	10					963	970		10.1038/nn918	http://dx.doi.org/10.1038/nn918			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	597VV	12219096				2022-12-24	WOS:000178242200015
J	Liu, J; Harris, A; Kanwisher, N				Liu, J; Harris, A; Kanwisher, N			Stages of processing in face perception: an MEG study	NATURE NEUROSCIENCE			English	Article							OCCIPITOTEMPORAL CORTEX; VISUAL-CORTEX; TIME-COURSE; RESPONSES; HUMANS; RECOGNITION; CATEGORIES; EXPERTISE; STIMULI; OBJECTS	Here we used magnetoencephalography (MEG) to investigate stages of processing in face perception in humans. We found a face-selective MEG response occurring only 100 ms after stimulus onset (the 'M100'), 70 ms earlier than previously reported. Further, the amplitude of this M100 response was correlated with successful categorization of stimuli as faces, but not with successful recognition of individual faces, whereas the previously-described face-selective 'M170' response was correlated with both processes. These data suggest that face processing proceeds through two stages: an initial stage of face categorization, and a later stage at which the identity of the individual face is extracted.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; MGH MIT HMS Athinoula A Martinos Ctr Biomed Imagi, Charlestown, MA 02129 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Liu, J (corresponding author), MIT, Dept Brain & Cognit Sci, NE20-443, Cambridge, MA 02139 USA.		Liu, Jia/C-5630-2011	Liu, Jia/0000-0003-0383-0934; Harris, Alison/0000-0002-0559-2821	NATIONAL EYE INSTITUTE [R01EY013455] Funding Source: NIH RePORTER; NEI NIH HHS [EY13455] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Allison T, 1999, CEREB CORTEX, V9, P415, DOI 10.1093/cercor/9.5.415; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; BENTIN S, IN PRESS ENCY COGNIT; Braeutigam S, 2001, NEUROREPORT, V12, P1531, DOI 10.1097/00001756-200105250-00046; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Eimer M, 2000, NEUROREPORT, V11, P2319, DOI 10.1097/00001756-200007140-00050; Farah M.J., 1995, VISUAL COGNITION INV, P101; George N, 1997, NEUROREPORT, V8, P1417, DOI 10.1097/00001756-199704140-00019; Gomez Gonzalez Carlos M., 1994, Brain Topography, V7, P41; GRILLSPECTOR K, 2001, J VISION, V1, pA474; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Jeffreys DA, 1996, VIS COGN, V3, P1, DOI 10.1080/713756729; JOLICOEUR P, 1984, COGNITIVE PSYCHOL, V16, P243, DOI 10.1016/0010-0285(84)90009-4; Kawasaki H, 2001, NAT NEUROSCI, V4, P15, DOI 10.1038/82850; Keysers C, 2001, J COGNITIVE NEUROSCI, V13, P90, DOI 10.1162/089892901564199; KOVACS G, 1995, P NATL ACAD SCI USA, V92, P5587, DOI 10.1073/pnas.92.12.5587; Liu J, 2000, NEUROREPORT, V11, P337, DOI 10.1097/00001756-200002070-00023; Mouchetant-Rostaing Y, 2000, EUR J NEUROSCI, V12, P303, DOI 10.1046/j.1460-9568.2000.00888.x; ORAM MW, 1992, J NEUROPHYSIOL, V68, P70, DOI 10.1152/jn.1992.68.1.70; Rainer G, 2001, CURR BIOL, V11, P846, DOI 10.1016/S0960-9822(01)00242-1; ROLLS ET, 1984, HUM NEUROBIOL, V3, P209; ROSCH E, 1976, COGNITIVE PSYCHOL, V8, P382, DOI 10.1016/0010-0285(76)90013-X; SADR J, IN PRESS COGNIT SCI; SADR J, 2001, 20016 MIT ART INT LA; Sams M, 1997, NEUROSCIENCE, V77, P49, DOI 10.1016/S0306-4522(96)00419-8; Schendan HE, 1998, PSYCHOPHYSIOLOGY, V35, P240, DOI 10.1017/S004857729897010X; Seeck M, 1997, NEUROREPORT, V8, P2749, DOI 10.1097/00001756-199708180-00021; Streit M, 2000, NEUROSCI LETT, V278, P13, DOI 10.1016/S0304-3940(99)00884-8; Sugase Y, 1999, NATURE, V400, P869, DOI 10.1038/23703; TANAKA JW, 1991, COGNITIVE PSYCHOL, V23, P457, DOI 10.1016/0010-0285(91)90016-H; Tanaka JW, 2001, J EXP PSYCHOL GEN, V130, P534, DOI 10.1037/0096-3445.130.3.534; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; THORPE SJ, 1989, CONNECTIONISM IN PERSPECTIVE, P63; Thorpe SJ, 2001, SCIENCE, V291, P260, DOI 10.1126/science.1058249; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P818, DOI 10.1073/pnas.95.3.818; VanRullen R, 2001, J COGNITIVE NEUROSCI, V13, P454, DOI 10.1162/08989290152001880; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828	37	493	499	2	46	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2002	5	9					910	916		10.1038/nn909	http://dx.doi.org/10.1038/nn909			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587RL	12195430				2022-12-24	WOS:000177656300023
J	Cai, DM; Deng, KW; Mellado, W; Lee, J; Ratan, RR; Filbin, MT				Cai, DM; Deng, KW; Mellado, W; Lee, J; Ratan, RR; Filbin, MT			Arginase I and Polyamines act downstream from cyclic AMP in overcoming inhibition of axonal growth MAG and myelin in vitro	NEURON			English	Article							RAT HIPPOCAMPAL-NEURONS; D-ASPARTATE RECEPTORS; NITRIC-OXIDE; ORNITHINE DECARBOXYLASE; NEURITE GROWTH; SCIATIC-NERVE; NR2 SUBUNITS; SPINAL-CORD; L-ARGININE; REGENERATION	Elevation of cAMP can overcome myelin inhibitors to encourage regeneration of the CNS. We show that a consequence of elevated cAMP is the synthesis of polyamines, resulting from an up-regulation of Arginase I, a key enzyme in their synthesis. Inhibiting polyamine synthesis blocks the cAMP effect on regeneration. Either over-expression of Arginase I or exogenous polyamines can overcome inhibition by MAG and by myelin in general. While MAG/myelin support the growth of young DRG neurons, they become inhibitory as DRGs mature. Endogenous Arginase I levels are high in young DRGs but drop spontaneously at an age that coincides with the switch from promotion to inhibition by MAG/myelin. Over-expressing Arginase I in maturing DRGs blocks that switch. Arginase I and polyamines are more specific targets than cAMP for intervention to encourage regeneration after CNS injury.	CUNY Hunter Coll, Dept Biol, New York, NY 10024 USA; Harvard Univ, Sch Med, Neurosci Program, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA	City University of New York (CUNY) System; Hunter College (CUNY); Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Filbin, MT (corresponding author), CUNY Hunter Coll, Dept Biol, 695 Pk Ave, New York, NY 10024 USA.	filbin@genectr.hunter.cuny.edu		Cai, Dongming/0000-0002-0601-6826	NINDS NIH HHS [NS41073, NS 37060, NS40591] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS041073, R01NS040591, R37NS037060, R01NS037060] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Abe K, 1997, BRAIN RES, V766, P281, DOI 10.1016/S0006-8993(97)00750-6; Banan A, 1998, AM J PHYSIOL-GASTR L, V274, pG879, DOI 10.1152/ajpgi.1998.274.5.G879; BATES CA, 1993, EXP NEUROL, V123, P106, DOI 10.1006/exnr.1993.1144; BOUCHER JL, 1994, BIOCHEM BIOPH RES CO, V203, P1614, DOI 10.1006/bbrc.1994.2371; Bregman B S, 1983, Brain Res, V285, P137; Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001; Cai DM, 1999, NEURON, V22, P89, DOI 10.1016/S0896-6273(00)80681-9; CARBONETTO S, 1987, J NEUROSCI, V7, P610; CARONI P, 1988, J CELL BIOL, V106, P1281, DOI 10.1083/jcb.106.4.1281; Chao J, 1997, MOL PHARMACOL, V51, P861, DOI 10.1124/mol.51.5.861; Cheng K, 2000, PSYCHOL SCI, V11, P403, DOI 10.1111/1467-9280.00278; CHU PJ, 1995, BRAIN RES, V673, P233, DOI 10.1016/0006-8993(94)01419-I; Cohen S.S., 1998, GUIDE POLYAMINES, V1st ed.; De Bellard M, 1999, J NEUROSCI RES, V56, P213, DOI 10.1002/(SICI)1097-4547(19990415)56:2<213::AID-JNR11>3.3.CO;2-L; DeBellard ME, 1996, MOL CELL NEUROSCI, V7, P89, DOI 10.1006/mcne.1996.0007; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; DORNAY M, 1986, EXP NEUROL, V92, P665, DOI 10.1016/0014-4886(86)90307-9; Esch F, 1998, J NEUROSCI, V18, P4083; GILAD GM, 1988, DEV BRAIN RES, V38, P175, DOI 10.1016/0165-3806(88)90042-9; Gilad VH, 1996, BRAIN RES, V724, P141, DOI 10.1016/0006-8993(96)00287-9; Gnegy ME, 2000, CRIT REV NEUROBIOL, V14, P91; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Hanson MG, 1998, J NEUROSCI, V18, P7361; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Huang DW, 1999, NEURON, V24, P639, DOI 10.1016/S0896-6273(00)81118-6; INGOGLIA NA, 1982, J NEUROSCI, V2, P1412; KAMINSKA B, 1992, FEBS LETT, V304, P198, DOI 10.1016/0014-5793(92)80618-Q; Kashiwagi K, 1997, MOL PHARMACOL, V52, P701, DOI 10.1124/mol.52.4.701; KAUPPILA T, 1992, BRAIN RES, V575, P299, DOI 10.1016/0006-8993(92)90093-O; Kepka-Lenhart D, 2000, AM J PHYSIOL-REG I, V279, pR2237; LI H, 2001, AM J PHYSIOL-REG I, V353, pR245; LINDQUIST TD, 1985, J NEUROCHEM, V44, P1913, DOI 10.1111/j.1471-4159.1985.tb07187.x; LIU BP, 2002, IN PRESS SCIENCE; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; Meyer-Franke A, 1998, NEURON, V21, P681, DOI 10.1016/S0896-6273(00)80586-3; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Morris SM, 1998, AM J PHYSIOL-ENDOC M, V275, pE740, DOI 10.1152/ajpendo.1998.275.5.E740; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; NAKAMURA H, 1990, BRAIN RES, V530, P108, DOI 10.1016/0006-8993(90)90664-W; NEBES VL, 1988, MOL ENDOCRINOL, V2, P444, DOI 10.1210/mend-2-5-444; Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X; NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x; Prinjha R, 2000, NATURE, V403, P383, DOI 10.1038/35000287; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Shen YJ, 1998, MOL CELL NEUROSCI, V12, P79, DOI 10.1006/mcne.1998.0700; SLOTKIN TA, 1986, BRAIN RES BULL, V17, P307, DOI 10.1016/0361-9230(86)90236-4; SLOTKIN TA, 1982, J PHARMACOL EXP THER, V222, P741; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Williams K, 1997, BIOCHEM J, V325, P289, DOI 10.1042/bj3250289; WILLIAMS K, 1994, MOL PHARMACOL, V45, P803; Wolff J, 1998, BIOCHEMISTRY-US, V37, P10722, DOI 10.1021/bi980400n	55	252	260	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 15	2002	35	4					711	719		10.1016/S0896-6273(02)00826-7	http://dx.doi.org/10.1016/S0896-6273(02)00826-7			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	585JE	12194870	Bronze			2022-12-24	WOS:000177521000011
J	Poolos, NP; Migliore, M; Johnston, D				Poolos, NP; Migliore, M; Johnston, D			Pharmacological upregulation of h-channels reduces the excitability of pyramidal neuron dendrites	NATURE NEUROSCIENCE			English	Article							RAT HIPPOCAMPAL-NEURONS; ACTION-POTENTIALS; NA+ CHANNELS; LAMOTRIGINE INHIBITION; PACEMAKER; BACKPROPAGATION; ENHANCEMENT; ATTENUATION; MODULATION; CURRENTS	The dendrites of pyramidal neurons have markedly different electrical properties from those of the soma, owing to the non-uniform distribution of voltage-gated ion channels in dendrites. It is thus possible that drugs acting on ion channels might preferentially alter dendritic, but not somatic, excitability. Using dendritic and somatic whole-cell and cell-attached recordings in rat hippocampal slices, we found that the anticonvulsant lamotrigine selectively reduced action potential firing from dendritic depolarization, while minimally affecting firing at the soma. This regional and input-specific effect resulted from an increase in the hyperpolarization-activated cation current (I-h), a voltage-gated current present predominantly in dendrites. These results demonstrate that neuronal excitability can be altered by drugs acting selectively on dendrites, and suggest an important role for 1 h in controlling dendritic excitability and epileptogenesis.	Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; Yale Univ, Sch Med, Neurobiol Sect, New Haven, CT 06520 USA; CNR, Inst Adv Diagnost Methodol, I-90146 Palermo, Italy	Baylor College of Medicine; Baylor College of Medicine; Yale University; Consiglio Nazionale delle Ricerche (CNR)	Johnston, D (corresponding author), Baylor Coll Med, Div Neurosci, 1 Baylor Plaza, Houston, TX 77030 USA.	dan@ltp.neusc.bcm.tmc.edu	Migliore, Michele/D-7448-2011	Migliore, Michele/0000-0002-7584-6292				[Anonymous], 1999, DENDRITES; Beaumont V, 2000, NAT NEUROSCI, V3, P133, DOI 10.1038/72072; Calabrese JR, 1999, EUR NEUROPSYCHOPHARM, V9, pS107, DOI 10.1016/S0924-977X(99)00022-X; Chen C, 2001, J GEN PHYSIOL, V117, P491, DOI 10.1085/jgp.117.5.491; Chen K, 2001, NAT MED, V7, P331, DOI 10.1038/85480; Colbert CM, 1997, J NEUROSCI, V17, P6512; Coulter DA, 1997, J CHILD NEUROL, V12, pS2, DOI 10.1177/0883073897012001031; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; Harris NC, 1995, J NEUROPHYSIOL, V74, P2366, DOI 10.1152/jn.1995.74.6.2366; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Johnston D, 2000, J PHYSIOL-LONDON, V525, P75, DOI 10.1111/j.1469-7793.2000.00075.x; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; Kuo CC, 1997, BRIT J PHARMACOL, V121, P1231, DOI 10.1038/sj.bjp.0701221; Lupica CR, 2001, J NEUROPHYSIOL, V86, P261, DOI 10.1152/jn.2001.86.1.261; Magee J, 1998, ANNU REV PHYSIOL, V60, P327, DOI 10.1146/annurev.physiol.60.1.327; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Magee JC, 1998, J NEUROSCI, V18, P7613; MESSENHEIMER J, 1996, TREATMENT EPILEPSY P, P899; Migliore M, 1999, J COMPUT NEUROSCI, V7, P5, DOI 10.1023/A:1008906225285; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; Poolos NP, 1999, J NEUROSCI, V19, P5205; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Shorvon SD, 2000, HDB EPILEPSY TREATME; Stefani A, 1996, EUR J PHARMACOL, V307, P113, DOI 10.1016/0014-2999(96)00265-8; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Stuart G, 1998, J NEUROSCI, V18, P3501; Wang SJ, 2001, NEUROREPORT, V12, P2255, DOI 10.1097/00001756-200107200-00042; WHITE HS, 1997, EPILEPSIES, V2, P1; XIE XM, 1995, PFLUG ARCH EUR J PHY, V430, P437, DOI 10.1007/BF00373920	30	314	328	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2002	5	8					767	774		10.1038/nn891	http://dx.doi.org/10.1038/nn891			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	577XT	12118259				2022-12-24	WOS:000177088900020
J	Zhao, AZ; Huan, JN; Gupta, S; Pal, R; Sahu, A				Zhao, AZ; Huan, JN; Gupta, S; Pal, R; Sahu, A			A phosphatidylinositol 3kinase-phosphodiesterase 3B-cyclic AMP pathway in hypothalamic action of leptin on feeding	NATURE NEUROSCIENCE			English	Article							CONCENTRATING HORMONE MCH; NEUROPEPTIDE-Y NPY; GALANIN GAL; FOOD-INTAKE; PHOSPHODIESTERASE; RAT		Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Sahu, A (corresponding author), Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, 3550 Terrace St, Pittsburgh, PA 15261 USA.				NIDDK NIH HHS [DK 52844] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052844] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahima RS, 2000, FRONT NEUROENDOCRIN, V21, P263, DOI 10.1006/frne.2000.0197; Ahmad M, 2000, CELL SIGNAL, V12, P541, DOI 10.1016/S0898-6568(00)00093-0; AKABAYASHI A, 1994, BRAIN RES, V660, P323, DOI 10.1016/0006-8993(94)91306-4; BEAVO JA, 1990, TRENDS PHARMACOL SCI, V11, P150, DOI 10.1016/0165-6147(90)90066-H; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gillard ER, 1998, J NEUROSCI, V18, P2646; RAHN T, 1994, FEBS LETT, V350, P314, DOI 10.1016/0014-5793(94)00797-7; Sahu A, 1998, ENDOCRINOLOGY, V139, P4739, DOI 10.1210/en.139.11.4739; SAHU A, 1993, TRENDS ENDOCRIN MET, V4, P217, DOI 10.1016/1043-2760(93)90125-X; Sahu A, 1998, ENDOCRINOLOGY, V139, P795, DOI 10.1210/en.139.2.795; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Sheriff S, 1997, MOL PHARMACOL, V51, P597, DOI 10.1124/mol.51.4.597; SHITNIZUALBERGI.M, 2001, J NEUROSCI, V21, P1238; Zhao AZ, 2000, J BIOL CHEM, V275, P11348, DOI 10.1074/jbc.275.15.11348	14	182	193	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2002	5	8					727	728		10.1038/nn885	http://dx.doi.org/10.1038/nn885			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	577XT	12101402				2022-12-24	WOS:000177088900013
J	Lossin, C; Wang, DW; Rhodes, TH; Vanoye, CG; George, AL				Lossin, C; Wang, DW; Rhodes, TH; Vanoye, CG; George, AL			Molecular basis of an inherited epilepsy	NEURON			English	Article							FEBRILE SEIZURES PLUS; NEURONAL SODIUM-CHANNEL; GENERALIZED EPILEPSY; MUTATIONS; GENE; INACTIVATION; CURRENTS; SCN1A; GAMMA-2-SUBUNIT; MICROCULTURES	Epilepsy is a common neurological condition that reflects neuronal hyperxcitability arising from largely unknown cellular and molecular mechanisms. In generalized epilepsy with febrile seizures plus, an autosomal dominant epilepsy syndrome, mutations in three genes coding for voltage-gated sodium channel a or beta1 subunits (SCN1A, SCN2A, SCN1B) and one GABA receptor subunit gene (GABRG2) have been identified. Here, we characterize the functional effects of three mutations in the human neuronal sodium channel a subunit SCN1A by heterologous expression with its known accessory subunits, beta1 and beta2, in cultured mammalian cells. SCN1A mutations alter channel inactivation, resulting in persistent inward sodium current. This gain-of-function abnormality will likely enhance excitability of neuronal membranes by causing prolonged membrane depolarization, a plausible underlying biophysical mechanism responsible for this inherited human epilepsy.	Vanderbilt Univ, Div Med Genet, Nashville, TN 37232 USA; Vanderbilt Univ, Ctr Mol Neurosci, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Med, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	George, AL (corresponding author), Vanderbilt Univ, Div Med Genet, 221 Kirkland Hall, Nashville, TN 37232 USA.			Lossin, Christoph/0000-0001-8101-2924	NINDS NIH HHS [NS3287] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abou-Khalil B, 2001, NEUROLOGY, V57, P2265, DOI 10.1212/WNL.57.12.2265; Alekov AK, 2001, EUR J NEUROSCI, V13, P2171, DOI 10.1046/j.0953-816x.2001.01590.x; Alekov AK, 2000, J PHYSIOL-LONDON, V529, P533, DOI 10.1111/j.1469-7793.2000.00533.x; AYALA GF, 1970, J NEUROPHYSIOL, V33, P73, DOI 10.1152/jn.1970.33.1.73; Baulac S, 2001, NAT GENET, V28, P46, DOI 10.1038/88254; BENNETT PB, 1995, NATURE, V376, P683, DOI 10.1038/376683a0; Berkovic SF, 2001, CHANNELOPATHIES OF THE NERVOUS SYSTEM, P239; Browne TR, 2001, NEW ENGL J MED, V344, P1145, DOI 10.1056/NEJM200104123441507; CANNON SC, 1993, BIOPHYS J, V65, P270, DOI 10.1016/S0006-3495(93)81045-2; Cannon SC, 2000, KIDNEY INT, V57, P772, DOI 10.1046/j.1523-1755.2000.00914.x; Catterall W A, 1999, Adv Neurol, V79, P441; CATTERALL WA, 1992, PHYSIOL REV, V72, pS15, DOI 10.1152/physrev.1992.72.suppl_4.S15; Claes L, 2001, AM J HUM GENET, V68, P1327, DOI 10.1086/320609; Dudek FE, 1998, CELL BIOL INT, V22, P793, DOI 10.1006/cbir.1999.0397; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Escayg A, 2001, AM J HUM GENET, V68, P866, DOI 10.1086/319524; Goldin AL, 2000, NEURON, V28, P365, DOI 10.1016/S0896-6273(00)00116-1; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; JEFFERYS JGR, 1995, PHYSIOL REV, V75, P689, DOI 10.1152/physrev.1995.75.4.689; KRAFTE DS, 1990, J GEN PHYSIOL, V96, P689, DOI 10.1085/jgp.96.4.689; MATSUMOTO H, 1964, EXP NEUROL, V9, P305, DOI 10.1016/0014-4886(64)90026-3; McCormick DA, 2001, ANNU REV PHYSIOL, V63, P815, DOI 10.1146/annurev.physiol.63.1.815; Meisler MH, 2001, ANNU REV GENET, V35, P567, DOI 10.1146/annurev.genet.35.102401.091142; MOORMAN JR, 1990, NEURON, V4, P243, DOI 10.1016/0896-6273(90)90099-2; Reckziegel G, 1998, J PHYSIOL-LONDON, V509, P139, DOI 10.1111/j.1469-7793.1998.139bo.x; SAH DWY, 1995, J NEUROPHYSIOL, V74, P1889, DOI 10.1152/jn.1995.74.5.1889; Scheffer IE, 1997, BRAIN, V120, P479, DOI 10.1093/brain/120.3.479; Segal MM, 2002, NOVART FDN SYMP, V241, P173; SEGAL MM, 1994, J NEUROPHYSIOL, V72, P1874, DOI 10.1152/jn.1994.72.4.1874; SEGAL MM, 1991, J NEUROPHYSIOL, V65, P761, DOI 10.1152/jn.1991.65.4.761; SHIN C, 1994, ANNU REV MED, V45, P379; Singh R, 1999, ANN NEUROL, V45, P75, DOI 10.1002/1531-8249(199901)45:1<75::AID-ART13>3.0.CO;2-W; Spampanato J, 2001, J NEUROSCI, V21, P7481, DOI 10.1523/JNEUROSCI.21-19-07481.2001; Sugawara T, 2001, NEUROLOGY, V57, P703, DOI 10.1212/WNL.57.4.703; Sugawara T, 2001, P NATL ACAD SCI USA, V98, P6384, DOI 10.1073/pnas.111065098; Wallace RH, 2001, AM J HUM GENET, V68, P859, DOI 10.1086/319516; Wallace RH, 2001, NAT GENET, V28, P49, DOI 10.1038/ng0501-49; Wallace RH, 1998, NAT GENET, V19, P366, DOI 10.1038/1252; ZHOU JY, 1991, NEURON, V7, P775, DOI 10.1016/0896-6273(91)90280-D	39	266	297	0	38	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 13	2002	34	6					877	884		10.1016/S0896-6273(02)00714-6	http://dx.doi.org/10.1016/S0896-6273(02)00714-6			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	563HF	12086636	Bronze			2022-12-24	WOS:000176249700006
J	Redmond, L; Kashani, AH; Ghosh, A				Redmond, L; Kashani, AH; Ghosh, A			Calcium regulation of dendritic growth via CaM kinase IV and CREB-mediated transcription	NEURON			English	Article							BINDING PROTEIN; VISUAL-CORTEX; NEURONS; PHOSPHORYLATION; ACTIVATION; NUCLEUS; CELLS; GENE; CBP; MATURATION	We report that CaM kinase IV and CREB play a critical role in mediating calcium-induced dendritic growth in cortical neurons. Calcium-dependent dendritic growth is suppressed by CaM kinase inhibitors, a constitutively active form of CaM kinase IV induces dendritic growth in the absence of extracellular stimulation, and a kinase-dead form of CaM kinase IV suppresses dendritic growth induced by calcium influx. CaM kinase IV activates the transcription factor CREB, and expression of a dominant negative form of CREB blocks calcium- and CaM kinase IV-induced dendritic growth. In cortical slice cultures, dendritic growth is attenuated by inhibitors of voltage-sensitive calcium channels and by dominant negative CREB. These experiments indicate that calcium-induced dendritic growth is regulated by activation of a transcriptional program that involves CaM kinase IV and CREB-mediated signaling to the nucleus.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University	Ghosh, A (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolf St, Baltimore, MD 21205 USA.	aghosh@jhmi.edu			NIMH NIH HHS [MH60598] Funding Source: Medline; NINDS NIH HHS [NS39993] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039993] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BENES FM, 1977, BRAIN RES, V122, P1, DOI 10.1016/0006-8993(77)90658-8; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Chawla S, 2001, J NEUROCHEM, V79, P849, DOI 10.1046/j.1471-4159.2001.00645.x; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; COLEMAN PD, 1968, J ANAT, V102, P363; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; DEITCH JS, 1984, J COMP NEUROL, V229, P66, DOI 10.1002/cne.902290106; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; GREENOUGH WT, 1973, EXP NEUROL, V40, P491, DOI 10.1016/0014-4886(73)90090-3; Hardingham GE, 2001, NAT NEUROSCI, V4, P565, DOI 10.1038/88380; Ho N, 1996, J EXP MED, V184, P101, DOI 10.1084/jem.184.1.101; HOLLOWAY RALPH L., 1966, BRAIN RES, V2, P393, DOI 10.1016/0006-8993(66)90009-6; Horch HW, 1999, NEURON, V23, P353; Hu SC, 1999, NEURON, V22, P799, DOI 10.1016/S0896-6273(00)80738-2; Impey S, 2002, NEURON, V34, P235, DOI 10.1016/S0896-6273(02)00654-2; JURASKA JM, 1982, J COMP NEUROL, V212, P208, DOI 10.1002/cne.902120210; KALB RG, 1994, DEVELOPMENT, V120, P3063; Kornhauser JM, 2002, NEURON, V34, P221, DOI 10.1016/S0896-6273(02)00655-4; LOHMANN C, 2002, IN PRESS NATURE; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Mao BQ, 2001, NEURON, V32, P883, DOI 10.1016/S0896-6273(01)00518-9; Mason CA, 1997, PERSPECT DEV NEUROBI, V5, P69; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; MILLER M, 1981, J COMP NEUROL, V203, P555, DOI 10.1002/cne.902030402; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; PURVES D, 1981, J NEUROSCI, V1, P441; Rajan I, 1998, J NEUROSCI, V18, P7836; RAKIC P, 1973, J COMP NEUROL, V152, P133, DOI 10.1002/cne.901520203; Redmond L, 2000, NAT NEUROSCI, V3, P30, DOI 10.1038/71104; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; SOTELO C, 1975, BRAIN RES, V94, P19, DOI 10.1016/0006-8993(75)90874-4; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; Sun PQ, 1996, J BIOL CHEM, V271, P3066, DOI 10.1074/jbc.271.6.3066; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; VOLKMAR FR, 1972, SCIENCE, V176, P1445, DOI 10.1126/science.176.4042.1445; WALTON KM, 1992, MOL ENDOCRINOL, V6, P647, DOI 10.1210/me.6.4.647; Whitford KL, 2002, NEURON, V33, P47, DOI 10.1016/S0896-6273(01)00566-9; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P978, DOI 10.1152/jn.1963.26.6.978; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Wu GY, 1999, J NEUROSCI, V19, P4472; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976	51	359	373	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 13	2002	34	6					999	1010		10.1016/S0896-6273(02)00737-7	http://dx.doi.org/10.1016/S0896-6273(02)00737-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	563HF	12086646	Bronze			2022-12-24	WOS:000176249700016
J	Fortin, NJ; Agster, KL; Eichenbaum, HB				Fortin, NJ; Agster, KL; Eichenbaum, HB			Critical role of the hippocampus in memory for sequences of events	NATURE NEUROSCIENCE			English	Article							RECOGNITION MEMORY; OBJECT-RECOGNITION; EPISODIC MEMORY; MONKEYS; DAMAGE; RATS; IMPAIRMENT; ASSOCIATOR; ABLATION; LOCATION	Recent models of hippocampal function emphasize the potential role of this brain structure in encoding and retrieving sequences of events that compose episodic memories. Here we show that hippocampal lesions produce a severe and selective impairment in the capacity of rats to remember the sequential ordering of a series of odors, despite an intact capacity to recognize odors that recently occurred. These findings support the hypothesis that hippocampal networks mediate associations between sequential events that constitute elements of an episodic memory.	Boston Univ, Dept Psychol, Lab Cognit Neurobiol, Boston, MA 02215 USA	Boston University	Eichenbaum, HB (corresponding author), Boston Univ, Dept Psychol, Lab Cognit Neurobiol, 64 Cummington St, Boston, MA 02215 USA.	hbe@bu.edu		Fortin, Norbert/0000-0002-6793-6984	NIA NIH HHS [P01 AG009973-070005, P01 AG009973, AG09973] Funding Source: Medline; NIMH NIH HHS [R01 MH052090, R01 MH052090-05, MH52090] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG009973] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Bunsey M, 1996, NATURE, V379, P255, DOI 10.1038/379255a0; CHIBA AA, 1994, BEHAV NEURAL BIOL, V61, P123, DOI 10.1016/S0163-1047(05)80065-2; Clayton NS, 1998, NATURE, V395, P272, DOI 10.1038/26216; Dudchenko PA, 2000, J NEUROSCI, V20, P2964; Dusek JA, 1997, P NATL ACAD SCI USA, V94, P7109, DOI 10.1073/pnas.94.13.7109; EICHENBAUM H, 1994, BEHAV BRAIN SCI, V17, P449, DOI 10.1017/S0140525X00035391; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; GAFFAN D, 1994, EXP BRAIN RES, V99, P411; GAFFAN D, 1994, J COGNITIVE NEUROSCI, V6, P305, DOI 10.1162/jocn.1994.6.4.305; JARRARD LE, 1986, HIPPOCAMPUS, V4, P93; KESNER RP, 1982, SCIENCE, V218, P173, DOI 10.1126/science.7123228; Kesner RP, 1990, NEUROBIOLOGY COMP CO, P179; Levy WB, 1996, HIPPOCAMPUS, V6, P579, DOI 10.1002/(SICI)1098-1063(1996)6:6<579::AID-HIPO3>3.0.CO;2-C; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; Mishkin M, 1997, PHILOS T R SOC B, V352, P1461, DOI 10.1098/rstb.1997.0132; MISHKIN M, 1978, NATURE, V273, P297, DOI 10.1038/273297a0; Mumby DG, 2001, BEHAV BRAIN RES, V127, P159, DOI 10.1016/S0166-4328(01)00367-9; Murray EA, 1999, TRENDS COGN SCI, V3, P142, DOI 10.1016/S1364-6613(99)01303-0; Murray EA, 1996, SEMIN NEUROSCI, V8, P13, DOI 10.1006/smns.1996.0003; Murray EA, 1998, J NEUROSCI, V18, P6568; RAWLINS JNP, 1985, BEHAV BRAIN SCI, V8, P479, DOI 10.1017/S0140525X00001291; Shapiro Matthew L., 1994, P87; Sohal VS, 1998, NEURAL COMPUT, V10, P869, DOI 10.1162/089976698300017539; Swanson L. W., 1992, BRAIN MAPS STRUCTURE; TREVES A, 1994, HIPPOCAMPUS, V4, P374, DOI 10.1002/hipo.450040319; Tulving E, 1998, HIPPOCAMPUS, V8, P198, DOI 10.1002/(SICI)1098-1063(1998)8:3<198::AID-HIPO2>3.3.CO;2-J; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Wallenstein GV, 1998, TRENDS NEUROSCI, V21, P317, DOI 10.1016/S0166-2236(97)01220-4; Zola SM, 2000, J NEUROSCI, V20, P451, DOI 10.1523/JNEUROSCI.20-01-00451.2000; ZOLAMORGAN S, 1994, HIPPOCAMPUS, V4, P483, DOI 10.1002/hipo.450040410	32	596	604	0	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2002	5	5					458	462		10.1038/nn834	http://dx.doi.org/10.1038/nn834			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	546JY	11976705	Green Accepted			2022-12-24	WOS:000175272000017
J	Impey, S; Fong, AL; Wang, YH; Cardinaux, JR; Fass, DM; Obrietan, K; Wayman, GA; Storm, DR; Soderling, TR; Goodman, RH				Impey, S; Fong, AL; Wang, YH; Cardinaux, JR; Fass, DM; Obrietan, K; Wayman, GA; Storm, DR; Soderling, TR; Goodman, RH			Phosphorylation of CBP mediates transcriptional activation by neural activity and CaM kinase IV	NEURON			English	Article							LONG-TERM-MEMORY; RUBINSTEIN-TAYBI SYNDROME; ELEMENT-BINDING PROTEIN; GENE-EXPRESSION; CREB PHOSPHORYLATION; DEPENDENT TRANSCRIPTION; SYNAPTIC PLASTICITY; COACTIVATOR CBP; NUCLEAR; CALCIUM	Activity-regulated transcription has been implicated in adaptive plasticity in the CNS. In many instances, this plasticity depends upon the transcription factor CREB. Precisely how neuronal activity regulates CREB remains unclear. To address this issue, we examined the phosphorylation state of components of the CREB transcriptional pathway. We show that NMDA activates transcription of CREB-responsive genes in hippocampal neurons, with ERK responsible for persistent CREB phosphorylation and CaM kinase IV (CaMKIV) responsible for phosphorylating the CREB coactivator, CBP. Ser301 of CBP was identified as a major target of CaMKIV phosphorylation in vitro and in vivo. CaM kinase inhibitors attenuated phosphorylation at Ser301 and blocked CBP-dependent transcription. Additionally, mutation of Ser301 impaired NMDA- and CaMKIV-stimulated transcription. These findings demonstrate that activity-induced CaMKIV signaling contributes to CREB/CBP-dependent transcription by phosphorylating CBP at Ser301.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA; Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA	Oregon Health & Science University; University System of Ohio; Ohio State University; University of Washington; University of Washington Seattle	Impey, S (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd,L474, Portland, OR 97201 USA.	impeys@ohsu.edu	Cardinaux, Jean-René/G-5391-2012	Cardinaux, Jean-René/0000-0001-6423-0014				Ahn S, 1999, NEURON, V23, P559, DOI 10.1016/S0896-6273(00)80808-9; Ahn S, 2000, ANNU REV PHYSIOL, V62, P803, DOI 10.1146/annurev.physiol.62.1.803; Ait-Si-Ali S, 1999, BIOCHEM BIOPH RES CO, V262, P157, DOI 10.1006/bbrc.1999.1132; Ait-Si-Ali S, 1998, NATURE, V396, P184, DOI 10.1038/24190; BANNISTER AJ, 1995, EMBO J, V14, P4758, DOI 10.1002/j.1460-2075.1995.tb00157.x; Bartsch D, 1998, CELL, V95, P211, DOI 10.1016/S0092-8674(00)81752-3; Belvin MP, 1999, NEURON, V22, P777, DOI 10.1016/S0896-6273(00)80736-9; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Brivanlou AH, 2002, SCIENCE, V295, P813, DOI 10.1126/science.1066355; Cardinaux JR, 2000, MOL CELL BIOL, V20, P1546, DOI 10.1128/MCB.20.5.1546-1552.2000; Carlezon WA, 1997, SCIENCE, V277, P812, DOI 10.1126/science.277.5327.812; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; Cruzalegui FH, 1999, EMBO J, V18, P1335, DOI 10.1093/emboj/18.5.1335; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; Dudai Y, 1997, NEURON, V18, P179, DOI 10.1016/S0896-6273(00)80257-3; ENSLEN H, 1995, BIOCHEM BIOPH RES CO, V207, P1038, DOI 10.1006/bbrc.1995.1289; Fields RD, 1997, J NEUROSCI, V17, P7252; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; Ho N, 2000, J NEUROSCI, V20, P6459, DOI 10.1523/JNEUROSCI.20-17-06459.2000; Hu SC, 1999, NEURON, V22, P799, DOI 10.1016/S0896-6273(00)80738-2; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Janknecht R, 1996, BIOCHEM BIOPH RES CO, V228, P831, DOI 10.1006/bbrc.1996.1740; JENSEN KF, 1991, P NATL ACAD SCI USA, V88, P2850, DOI 10.1073/pnas.88.7.2850; Kandel ER, 1999, PHILOS T R SOC B, V354, P2027, DOI 10.1098/rstb.1999.0542; Kane CD, 2000, EMBO J, V19, P691, DOI 10.1093/emboj/19.4.691; Kasahara J, 2000, J NEUROSCI RES, V59, P594, DOI 10.1002/(SICI)1097-4547(20000301)59:5<594::AID-JNR2>3.3.CO;2-H; Kasahara J, 2001, J BIOL CHEM, V276, P24044, DOI 10.1074/jbc.M100247200; Kawasaki H, 1998, NATURE, V393, P284, DOI 10.1038/30538; Kung AL, 2000, GENE DEV, V14, P272; Liu FC, 1996, NEURON, V17, P1133, DOI 10.1016/S0896-6273(00)80245-7; Liu YZ, 1998, J BIOL CHEM, V273, P32400, DOI 10.1074/jbc.273.49.32400; LUNDBLAD JR, 1995, NATURE, V374, P85, DOI 10.1038/374085a0; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; Obrietan K, 1999, J BIOL CHEM, V274, P17748, DOI 10.1074/jbc.274.25.17748; Parker D, 1998, MOL CELL, V2, P353, DOI 10.1016/S1097-2765(00)80279-8; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; Pham TA, 1999, NEURON, V22, P63, DOI 10.1016/S0896-6273(00)80679-0; SEGER R, 1994, J BIOL CHEM, V269, P25699; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Soutoglou E, 2000, J BIOL CHEM, V275, P12515, DOI 10.1074/jbc.275.17.12515; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; Suzuki T, 1999, BRAIN RES, V840, P36, DOI 10.1016/S0006-8993(99)01762-X; Swope DL, 1996, J BIOL CHEM, V271, P28138, DOI 10.1074/jbc.271.45.28138; Tanaka Y, 1997, P NATL ACAD SCI USA, V94, P10215, DOI 10.1073/pnas.94.19.10215; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; WALTON KM, 1992, MOL ENDOCRINOL, V6, P647, DOI 10.1210/me.6.4.647; Walton MR, 2000, TRENDS NEUROSCI, V23, P48, DOI 10.1016/S0166-2236(99)01500-3; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Xu L, 1998, NATURE, V395, P301, DOI 10.1038/26270; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; Yuan ZM, 1999, ONCOGENE, V18, P5714, DOI 10.1038/sj.onc.1202930; Zanger K, 2001, MOL CELL, V7, P551, DOI 10.1016/S1097-2765(01)00202-7	64	280	285	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 11	2002	34	2					235	244		10.1016/S0896-6273(02)00654-2	http://dx.doi.org/10.1016/S0896-6273(02)00654-2			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	541GE	11970865	Bronze			2022-12-24	WOS:000174976200009
J	Trudeau, MC; Zagotta, WN				Trudeau, MC; Zagotta, WN			An intersubunit interaction regulates trafficking of rod cyclic nucleotide-gated channels and is disrupted in an inherited form of blindness	NEURON			English	Article							SUBUNIT STOICHIOMETRY; RETINITIS-PIGMENTOSA; PLASMA-MEMBRANE; CATION CHANNEL; ION CHANNELS; PROTEIN; PHOTORECEPTOR; CONDUCTANCE; ARRANGEMENT; RESOLUTION	A mutation in a cyclic nucleotide-gated channel (CNGA1) is associated with retinitis pigmentosa (RP), a common, inherited eye disease. Expression of mutant (CNGA1-RP) homomeric channels in Xenopus oocytes revealed no measurable differences compared to wild-type CNGA1 homomers. As native retinal rod CNG channels comprise CNGA1 and CNGB1 subunits, we coexpressed CNGA1-RP and CNGB1. Surprisingly, this subunit combination did not produce detectable channels at the membrane surface. We show that the mechanism underlying this defect involves an inter-subunit interaction between CNGA1 and CNGB1 that was not formed between CNGA1-RP and CNGB1 sub-units. In the absence of this interaction, a short N-terminal region in CNGB1 prevented membrane expression. Thus, disruption of a regulatory interaction by mutation in CNGA1 exposed a region of CNGB1 that disrupted surface expression of heteromeric CNGA1-RP/CNGB1 channels, accounting for this instance of RP.	Univ Washington, Howard Hughes Med Inst, Dept Physiol & Biophys, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Zagotta, WN (corresponding author), Univ Washington, Howard Hughes Med Inst, Dept Physiol & Biophys, Seattle, WA 98195 USA.				NATIONAL EYE INSTITUTE [T32EY007031, R01EY010329] Funding Source: NIH RePORTER; NEI NIH HHS [T32 EY07031, R01 EY010329-09, R01 EY010329] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bareil C, 2001, HUM GENET, V108, P328, DOI 10.1007/s004390100496; CHEN TY, 1994, P NATL ACAD SCI USA, V91, P11757, DOI 10.1073/pnas.91.24.11757; CHEN TY, 1993, NATURE, V362, P764, DOI 10.1038/362764a0; DRYJA TP, 1995, P NATL ACAD SCI USA, V92, P10177, DOI 10.1073/pnas.92.22.10177; FESENKO EE, 1985, NATURE, V313, P310, DOI 10.1038/313310a0; Gordon SE, 1997, NEURON, V19, P431, DOI 10.1016/S0896-6273(00)80951-4; GORDON SE, 1995, NEURON, V14, P177; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; He YJ, 2000, P NATL ACAD SCI USA, V97, P895, DOI 10.1073/pnas.97.2.895; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; KORSCHEN HG, 1995, NEURON, V15, P627, DOI 10.1016/0896-6273(95)90151-5; Kurahashi T, 1997, NATURE, V385, P725, DOI 10.1038/385725a0; Liu DT, 1996, NEURON, V16, P983, DOI 10.1016/S0896-6273(00)80121-X; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Matulef K, 1999, NEURON, V24, P443, DOI 10.1016/S0896-6273(00)80857-0; Misaka T, 1997, J BIOL CHEM, V272, P22623, DOI 10.1074/jbc.272.36.22623; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; Phelan JK, 2000, MOL VIS, V6, P116; Rho SH, 2000, FEBS LETT, V478, P246, DOI 10.1016/S0014-5793(00)01863-9; Richards MJ, 2000, BIOCHEMISTRY-US, V39, P14003, DOI 10.1021/bi001639i; Savchenko A, 1997, NATURE, V390, P694, DOI 10.1038/37803; Shammat IM, 1999, NEURON, V23, P809, DOI 10.1016/S0896-6273(01)80038-6; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; Varnum MD, 1996, BIOPHYS J, V70, P2667, DOI 10.1016/S0006-3495(96)79836-3; Varnum MD, 1997, SCIENCE, V278, P110, DOI 10.1126/science.278.5335.110; WEBER IT, 1987, J MOL BIOL, V198, P311, DOI 10.1016/0022-2836(87)90315-9; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	28	53	57	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 11	2002	34	2					197	207		10.1016/S0896-6273(02)00647-5	http://dx.doi.org/10.1016/S0896-6273(02)00647-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	541GE	11970862	Bronze			2022-12-24	WOS:000174976200006
J	Meyer-Luehmann, M; Stalder, M; Herzig, MC; Kaeser, SA; Kohler, E; Pfeifer, M; Boncristiano, S; Mathews, PM; Mercken, M; Abramowski, D; Staufenbiel, M; Jucker, M				Meyer-Luehmann, M; Stalder, M; Herzig, MC; Kaeser, SA; Kohler, E; Pfeifer, M; Boncristiano, S; Mathews, PM; Mercken, M; Abramowski, D; Staufenbiel, M; Jucker, M			Extracellular amyloid formation and associated pathology in neural grafts	NATURE NEUROSCIENCE			English	Article							PROTEIN-TRANSGENIC MICE; DISEASE-LIKE PATHOLOGY; HOST PRION PROTEIN; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; A-BETA; PLAQUE-FORMATION; MOUSE MODEL; CEREBRAL-CORTEX; HUMAN BRAIN	Amyloid precursor protein (APP) processing and the generation of beta-amyloid peptide (Abeta) are important in the pathogenesis of Alzheimer's disease. Although this has been studied extensively at the molecular and cellular levels, much less is known about the mechanisms of amyloid accumulation in vivo. We transplanted transgenic APP23 and wild-type B6 embryonic neural cells into the neocortex and hippocampus of both B6 and APP23 mice. APP23 grafts into wild-type hosts did not develop amyloid deposits up to 20 months after grafting. In contrast, both transgenic and wild-type grafts into young transgenic hosts developed amyloid plaques as early as 3 months after grafting. Although largely diffuse in nature, some of the amyloid deposits in wild-type grafts were congophilic and were surrounded by neuritic changes and gliosis, similar to the amyloid-associated pathology previously described in APP23 mice. Our results indicate that diffusion of soluble Abeta in the extracellular space is involved in the spread of Abeta pathology, and that extracellular amyloid formation can lead to neurodegeneration.	Univ Basel, Inst Pathol, Dept Neuropathol, CH-4003 Basel, Switzerland; NYU, Sch Med, Nathan Kline Inst Psychiat Res, Orangeburg, NY 10962 USA; Johnson & Johnson Pharmaceut Res & Dev, B-2340 Beerse, Belgium; Novartis Pharma AG, Nervous Syst Res, CH-4002 Basel, Switzerland	University of Basel; Nathan Kline Institute for Psychiatric Research; New York University; Johnson & Johnson; Janssen Pharmaceuticals; Novartis	Jucker, M (corresponding author), Univ Basel, Inst Pathol, Dept Neuropathol, Schonbeinstr 40, CH-4003 Basel, Switzerland.		Herzig, Martin/R-4601-2016	Herzig, Martin/0000-0002-0500-353X; Mathews, Paul/0000-0003-1742-7687; Meyer-Luehmann, Melanie/0000-0003-3661-2220				Bayer TA, 2001, BRAIN PATHOL, V11, P1; Bayer TA, 1996, ACTA NEUROPATHOL, V92, P130, DOI 10.1007/s004010050500; Bi X, 2002, NEUROSCIENCE, V112, P827, DOI 10.1016/S0306-4522(02)00132-X; Boncristiano S, 2002, J NEUROSCI, V22, P3234, DOI 10.1523/JNEUROSCI.22-08-03234.2002; Bondolfi L, 2002, J NEUROSCI, V22, P515, DOI 10.1523/JNEUROSCI.22-02-00515.2002; Brandner S, 1996, P NATL ACAD SCI USA, V93, P13148, DOI 10.1073/pnas.93.23.13148; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; Calhoun ME, 1999, P NATL ACAD SCI USA, V96, P14088, DOI 10.1073/pnas.96.24.14088; Calhoun ME, 1998, NATURE, V395, P755, DOI 10.1038/27351; CLINTON RJ, 1988, J COMP NEUROL, V277, P557, DOI 10.1002/cne.902770409; D'Andrea MR, 2001, HISTOPATHOLOGY, V38, P120, DOI 10.1046/j.1365-2559.2001.01082.x; DeMattos RB, 2002, SCIENCE, V295, P2264, DOI 10.1126/science.1067568; Frautschy SA, 1998, AM J PATHOL, V152, P307; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; Gates MA, 1996, NEUROSCIENCE, V74, P579, DOI 10.1016/0306-4522(96)00146-7; Geula C, 1998, NAT MED, V4, P827, DOI 10.1038/nm0798-827; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; HOLTZMAN DM, 1992, P NATL ACAD SCI USA, V89, P1383, DOI 10.1073/pnas.89.4.1383; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Kane MD, 2000, J NEUROSCI, V20, P3606, DOI 10.1523/JNEUROSCI.20-10-03606.2000; Lazarov O, 2002, J NEUROSCI, V22, P9785; MANTIONE JR, 1995, BRAIN RES, V671, P333, DOI 10.1016/0006-8993(94)01400-C; MARTIN LJ, 1994, AM J PATHOL, V145, P1358; Mathews PM, 2002, J BIOL CHEM, V277, P36415, DOI 10.1074/jbc.M205208200; Nagele RG, 2002, NEUROSCIENCE, V110, P199, DOI 10.1016/S0306-4522(01)00460-2; Ohsawa K, 2000, J CELL SCI, V113, P3073; PALKOVITS M, 1983, METHOD ENZYMOL, V103, P368; Pfeifer M, 2002, SCIENCE, V298, P1379, DOI 10.1126/science.1078259; Phinney AL, 1999, J NEUROSCI, V19, P8552; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; RICHARDS SJ, 1991, EMBO J, V10, P297, DOI 10.1002/j.1460-2075.1991.tb07950.x; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; SNOW AD, 1994, NEURON, V12, P219, DOI 10.1016/0896-6273(94)90165-1; Stalder M, 1999, AM J PATHOL, V154, P1673, DOI 10.1016/S0002-9440(10)65423-5; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Sykova E, 1999, NEUROSCIENCE, V91, P783, DOI 10.1016/S0306-4522(98)00603-4; Urbanc B, 2002, P NATL ACAD SCI USA, V99, P13990, DOI 10.1073/pnas.222433299; Walsh DM, 2000, BIOCHEMISTRY-US, V39, P10831, DOI 10.1021/bi001048s; Weller RO, 1998, J NEUROPATH EXP NEUR, V57, P885, DOI 10.1097/00005072-199810000-00001; WildBode C, 1997, J BIOL CHEM, V272, P16085, DOI 10.1074/jbc.272.26.16085; Wiltfang J, 1997, ELECTROPHORESIS, V18, P527, DOI 10.1002/elps.1150180332; Wirths O, 2001, NEUROSCI LETT, V306, P116, DOI 10.1016/S0304-3940(01)01876-6; Wirths O, 2002, BRAIN PATHOL, V12, P275, DOI 10.1111/j.1750-3639.2002.tb00442.x; Wong TP, 1999, J NEUROSCI, V19, P2706	50	109	110	0	10	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2003	6	4					370	377		10.1038/nn1022	http://dx.doi.org/10.1038/nn1022			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	660KV	12598899				2022-12-24	WOS:000181833100014
J	Schnitzer, MJ; Meister, M				Schnitzer, MJ; Meister, M			Multineuronal firing patterns in the signal from eye to brain	NEURON			English	Article							RETINAL GANGLION-CELLS; LATERAL GENICULATE-NUCLEUS; CAT VISUAL-CORTEX; INFORMATION; DISCHARGE; NEURONS; IDENTIFICATION; ADAPTATION; RESPONSES; GOLDFISH	Population codes in the brain have generally been characterized by recording responses from one neuron at a time. This approach will miss codes that rely on concerted patterns of action potentials from many cells. Here we analyze visual signaling in populations of ganglion cells recorded from the isolated salamander retina. These neurons tend to fire synchronously far more frequently than expected by chance. We present an efficient algorithm to identify what groups of cells cooperate in this way. Such groups can include up to seven or more neurons and may account for more than 50% of all the spikes recorded from the retina. These firing patterns represent specific messages about the visual stimulus that differ significantly from what one would derive by single-cell analysis.	Lucent Technol, Bell Labs, Biol Computat & Theoret Phys Res Dept, Murray Hill, NJ 07974 USA; Harvard Univ, Mol & Cellular Biol Dept, Cambridge, MA 02138 USA	Alcatel-Lucent; Lucent Technologies; AT&T; Harvard University	Meister, M (corresponding author), Lucent Technol, Bell Labs, Biol Computat & Theoret Phys Res Dept, Murray Hill, NJ 07974 USA.			Meister, Markus/0000-0003-2136-6506	NEI NIH HHS [EY10020] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010020] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ABELES M, 1988, J NEUROPHYSIOL, V60, P909, DOI 10.1152/jn.1988.60.3.909; Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; ARNETT D, 1981, J PHYSIOL-LONDON, V317, P29, DOI 10.1113/jphysiol.1981.sp013812; ARNETT DW, 1978, EXP BRAIN RES, V32, P49; Balasubramanian V, 2001, NEURAL COMPUT, V13, P799, DOI 10.1162/089976601300014358; Brivanlou IH, 1998, NEURON, V20, P527, DOI 10.1016/S0896-6273(00)80992-7; BUZSAKI G, 1989, J NEUROSCI METH, V28, P209, DOI 10.1016/0165-0270(89)90038-1; Chapin JK, 1999, J NEUROSCI METH, V94, P121, DOI 10.1016/S0165-0270(99)00130-2; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; CLELAND BG, 1971, J PHYSIOL-LONDON, V217, P473, DOI 10.1113/jphysiol.1971.sp009581; CLELAND BG, 1976, J PHYSIOL-LONDON, V255, P299, DOI 10.1113/jphysiol.1976.sp011281; Dan Y, 1998, NAT NEUROSCI, V1, P501, DOI 10.1038/2217; DellaSantina CC, 1997, J NEUROSCI METH, V72, P71, DOI 10.1016/S0165-0270(96)00159-8; DeVries SH, 1999, J NEUROPHYSIOL, V81, P908, DOI 10.1152/jn.1999.81.2.908; FROSTIG RD, 1990, BIOL CYBERN, V62, P487, DOI 10.1007/BF00205110; GERSTEIN GL, 1978, BRAIN RES, V140, P43, DOI 10.1016/0006-8993(78)90237-8; GERSTEIN GL, 1985, J NEUROPHYSIOL, V54, P1513, DOI 10.1152/jn.1985.54.6.1513; GHOSE GM, 1994, J NEUROPHYSIOL, V71, P330, DOI 10.1152/jn.1994.71.1.330; HUNTER IW, 1986, BIOL CYBERN, V55, P135; JOHNSEN JA, 1983, J PHYSIOL-LONDON, V345, P439, DOI 10.1113/jphysiol.1983.sp014987; Kim KJ, 2001, J NEUROSCI, V21, P287, DOI 10.1523/JNEUROSCI.21-01-00287.2001; KOVACS GTA, 1994, IEEE T BIO-MED ENG, V41, P567, DOI 10.1109/10.293244; Laughlin SB, 2001, CURR OPIN NEUROBIOL, V11, P475, DOI 10.1016/S0959-4388(00)00237-3; MASTRONARDE DN, 1983, J NEUROPHYSIOL, V49, P303, DOI 10.1152/jn.1983.49.2.303; MASTRONARDE DN, 1989, TRENDS NEUROSCI, V12, P75, DOI 10.1016/0166-2236(89)90140-9; Meister M, 1999, NEURON, V22, P435, DOI 10.1016/S0896-6273(00)80700-X; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; MEISTER M, 1995, SCIENCE, V270, P1207, DOI 10.1126/science.270.5239.1207; Meister M, 1996, P NATL ACAD SCI USA, V93, P609, DOI 10.1073/pnas.93.2.609; Nordhausen CT, 1996, BRAIN RES, V726, P129; Oram MW, 1999, J NEUROPHYSIOL, V81, P3021, DOI 10.1152/jn.1999.81.6.3021; REDLICH AN, 1993, NEURAL COMPUT, V5, P289, DOI 10.1162/neco.1993.5.2.289; Shannon C.E., 1963, MATH THEORY COMMUNIC; Smirnakis SM, 1997, NATURE, V386, P69, DOI 10.1038/386069a0; Storer J.A., 1988, DATA COMPRESSION MET; Usrey WM, 1999, ANNU REV PHYSIOL, V61, P435, DOI 10.1146/annurev.physiol.61.1.435; Usrey WM, 2000, J NEUROSCI, V20, P5461, DOI 10.1523/JNEUROSCI.20-14-05461.2000; Wandell B.A., 1995, FDN VISION; Warland DK, 1997, J NEUROPHYSIOL, V78, P2336, DOI 10.1152/jn.1997.78.5.2336; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520	40	131	161	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 6	2003	37	3					499	511		10.1016/S0896-6273(03)00004-7	http://dx.doi.org/10.1016/S0896-6273(03)00004-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	647FF	12575956	Bronze			2022-12-24	WOS:000181081600014
J	Banke, TG; Traynelis, SF				Banke, TG; Traynelis, SF			Activation of NR1/NR2B NMDA receptors	NATURE NEUROSCIENCE			English	Article							GLUTAMATE-RECEPTOR; OPEN PROBABILITY; PROTEIN-KINASE; BINDING-SITE; CHANNEL; PATCH; DEPENDENCE; KINETICS; NUMBER; MUTANT	N-methyl-D-aspartate (NMDA) receptors are highly expressed in the central nervous system and are involved in excitatory synaptic transmission as well as synaptic plasticity. Despite considerable structural and biophysical research, the mechanism behind activation of the NMDA receptor is still poorly understood. By analyzing patch clamp recordings of one channel activated by glutamate, we determined the burst structure and open probability for recombinant rat NR1/NR2B receptors. We used partial agonists at the glutamate and glycine binding sites to show that at least two kinetically distinct subunit-associated conformational changes link co-agonist binding to the opening of the NMDA receptor pore. These data suggest that NR1 and NR2B subunits, respectively, undergo a fast and slow agonist-dependent conformational change that precedes opening of the pore. We propose a new working model of receptor activation that can account for macroscopic as well as microscopic NMDA receptor properties.	Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA	Emory University	Banke, TG (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, 1510 Clifton Rd, Atlanta, GA 30322 USA.	tbanke@pharm.emory.edu		Banke, Tue/0000-0001-8417-4400	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS036654, R01NS036654] Funding Source: NIH RePORTER; NINDS NIH HHS [NS36654] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akk G, 1999, BIOPHYS J, V76, P207, DOI 10.1016/S0006-3495(99)77190-0; Anson LC, 2000, J PHYSIOL-LONDON, V527, P225, DOI 10.1111/j.1469-7793.2000.00225.x; ANTOINE R, 2001, J NEUROSCI, V21, P5574; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; BENVENISTE M, 1995, J PHYSIOL-LONDON, V483, P367, DOI 10.1113/jphysiol.1995.sp020591; CAREAGA CL, 1995, BIOCHEMISTRY-US, V34, P3048, DOI 10.1021/bi00009a036; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen NS, 1999, J NEUROSCI, V19, P6844, DOI 10.1523/JNEUROSCI.19-16-06844.1999; COLQUHOUN D, 1990, PROC R SOC SER B-BIO, V240, P453, DOI 10.1098/rspb.1990.0048; Colquhoun David, 1995, P483; Dingledine R, 1999, PHARMACOL REV, V51, P7; EDMONDS B, 1992, P ROY SOC B-BIOL SCI, V250, P279, DOI 10.1098/rspb.1992.0160; GIBB AJ, 1992, J PHYSIOL-LONDON, V456, P143, DOI 10.1113/jphysiol.1992.sp019331; HORN R, 1991, BIOPHYS J, V60, P433, DOI 10.1016/S0006-3495(91)82069-0; JAHR CE, 1992, SCIENCE, V255, P470, DOI 10.1126/science.1346477; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jones KS, 2002, J NEUROSCI, V22, P2044, DOI 10.1523/JNEUROSCI.22-06-02044.2002; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; LESTER RAJ, 1992, J NEUROSCI, V12, P635; Mansour M, 2001, NEURON, V32, P841, DOI 10.1016/S0896-6273(01)00520-7; Perozo E, 2002, STRUCTURE, V10, P1027, DOI 10.1016/S0969-2126(02)00812-2; Perozo E, 1999, SCIENCE, V285, P73, DOI 10.1126/science.285.5424.73; Premkumar LS, 1997, J GEN PHYSIOL, V109, P181, DOI 10.1085/jgp.109.2.181; Qin F, 1996, BIOPHYS J, V70, P264, DOI 10.1016/S0006-3495(96)79568-1; Qin F, 1997, P ROY SOC B-BIOL SCI, V264, P375, DOI 10.1098/rspb.1997.0054; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; ROSENMUND C, 1995, J NEUROSCI, V15, P2788; Schneggenburger R, 1997, NEURON, V18, P167, DOI 10.1016/S0896-6273(01)80055-6; Sobolevsky AI, 2002, NEURON, V33, P75, DOI 10.1016/S0896-6273(01)00560-8; Sobolevsky AI, 2002, BIOPHYS J, V83, P3304, DOI 10.1016/S0006-3495(02)75331-9; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Traynelis SF, 1997, J PHYSIOL-LONDON, V503, P513, DOI 10.1111/j.1469-7793.1997.513bg.x; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978	34	176	179	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2003	6	2					144	152		10.1038/nn1000	http://dx.doi.org/10.1038/nn1000			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	640CL	12524545	Green Published			2022-12-24	WOS:000180669100014
J	Esteban, JA; Shi, SH; Wilson, C; Nuriya, M; Huganir, RL; Malinow, R				Esteban, JA; Shi, SH; Wilson, C; Nuriya, M; Huganir, RL; Malinow, R			PKA phosphorylation of AMPA receptor subunits controls synaptic trafficking underlying plasticity	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; DEPENDENT PROTEIN-KINASE; CYCLIC-AMP; FREQUENCY STIMULATION; ACTIVATION INCREASES; HIPPOCAMPAL SYNAPSES; GLUTAMATE RECEPTORS; LATE-PHASE; AREA CA1; LTP	The regulated incorporation of AMPA receptors into synapses is important for synaptic plasticity. Here we examine the role of protein kinase A (PKA) in this process. We found that PKA phosphorylation of the AMPA receptor subunits GluR4 and GluR1 directly controlled the synaptic incorporation of AMPA receptors in organotypic slices from rat hippocampus. Activity-driven PKA phosphorylation of GluR4 was necessary and sufficient to relieve a retention interaction and drive receptors into synapses. In contrast, PKA phosphorylation of GluR1 and the activity of calcium/calmodulin-dependent kinase II (CaMKII) were both necessary for receptor incorporation. Thus, PKA phosphorylation of AMPA receptor subunits contributes to diverse mechanisms underlying synaptic plasticity.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21205 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Howard Hughes Medical Institute; Johns Hopkins University; Cold Spring Harbor Laboratory	Esteban, JA (corresponding author), Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA.	estebanj@umich.edu; malinow@cshl.org	Esteban, Jose/L-4944-2014; Nuriya, Mutsuo/J-5928-2013	Esteban, Jose/0000-0002-3759-3300; Nuriya, Mutsuo/0000-0002-5689-8222	NINDS NIH HHS [R01 NS036715, NS32827, NS36715] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036715, R01NS032827] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; Bear MF, 1999, J NEUROBIOL, V41, P83, DOI 10.1002/(SICI)1097-4695(199910)41:1<83::AID-NEU11>3.0.CO;2-Z; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; Bolshakov VY, 1997, NEURON, V19, P635, DOI 10.1016/S0896-6273(00)80377-3; Brandon EP, 1997, CURR OPIN NEUROBIOL, V7, P397, DOI 10.1016/S0959-4388(97)80069-4; Brown GP, 2000, J NEUROSCI, V20, P7880; Carvalho AL, 1999, J NEUROSCI, V19, P4748; Chao SZ, 2002, J NEUROCHEM, V81, P984, DOI 10.1046/j.1471-4159.2002.00877.x; CHETKOVICH DM, 1993, J NEUROCHEM, V61, P1933, DOI 10.1111/j.1471-4159.1993.tb09836.x; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Gurden H, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0003.2000; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Jordan JD, 1998, BIOCHEM PHARMACOL, V55, P1347; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MALINOW R, 1999, IMAGING LIVING CELLS; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Moita MAP, 2002, NAT NEUROSCI, V5, P837, DOI 10.1038/nn901; Otmakhova NA, 1996, J NEUROSCI, V16, P7478; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Price CJ, 1999, J NEUROCHEM, V73, P2441, DOI 10.1046/j.1471-4159.1999.0732441.x; Reed TM, 2002, J NEUROSCI, V22, P5188, DOI 10.1523/JNEUROSCI.22-12-05188.2002; Roberson ED, 1996, J BIOL CHEM, V271, P30436, DOI 10.1074/jbc.271.48.30436; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Salin PA, 1996, NEURON, V16, P797, DOI 10.1016/S0896-6273(00)80099-9; Sanes JR, 1999, NAT NEUROSCI, V2, P597, DOI 10.1038/10154; Sheng M, 2001, CELL, V105, P825, DOI 10.1016/S0092-8674(01)00406-8; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Snyder GL, 2000, J NEUROSCI, V20, P4480, DOI 10.1523/JNEUROSCI.20-12-04480.2000; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Thomas MJ, 1996, NEURON, V17, P475, DOI 10.1016/S0896-6273(00)80179-8; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; Yasuda H, 2003, NAT NEUROSCI, V6, P15, DOI 10.1038/nn985; Zhu JJ, 2002, NAT NEUROSCI, V5, P513, DOI 10.1038/nn0602-850; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614	48	634	657	3	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2003	6	2					136	143		10.1038/nn997	http://dx.doi.org/10.1038/nn997			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	640CL	12536214				2022-12-24	WOS:000180669100013
J	Pawlak, R; Magarinos, AM; Melchor, J; McEwen, B; Strickland, S				Pawlak, R; Magarinos, AM; Melchor, J; McEwen, B; Strickland, S			Tissue plasminogen activator in the amygdala is critical for stress-induced anxiety-like behavior	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; HIPPOCAMPAL PLASTICITY; LATE-PHASE; GENE; EXPRESSION; RELEASE; MICE; DEGRADATION; PATHWAY; LAMININ	Although neuronal stress circuits have been identified, little is known about the mechanisms that underlie the stress-induced neuronal plasticity leading to fear and anxiety. Here we found that the serine protease tissue-plasminogen activator (tPA) was upregulated in the central and medial amygdala by acute restraint stress, where it promoted stress-related neuronal remodeling and was subsequently inhibited by plasminogen activator inhibitor-1 (PAI-1). These events preceded stress-induced increases in anxiety-like behavior of mice. Mice in which the tPA gene has been disrupted did not show anxiety after up to three weeks of daily restraint and showed attenuated neuronal remodeling as well as a maladaptive hormonal response. These studies support the idea that tPA is critical for the development of anxiety-like behavior after stress.	Rockefeller Univ, Neurobiol Lab, New York, NY 10021 USA; Rockefeller Univ, Neuroendocrinol Lab, New York, NY 10021 USA	Rockefeller University; Rockefeller University	Strickland, S (corresponding author), Rockefeller Univ, Neurobiol Lab, 1230 York Ave, New York, NY 10021 USA.	strickland@rockefeller.edu	McEwen, Bruce/Z-1630-2019	Strickland, Sidney/0000-0002-3072-9244	NINDS NIH HHS [NS-35704, NS-38472] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038472, R01NS035704] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams JP, 2002, ANNU REV PHARMACOL, V42, P135, DOI 10.1146/annurev.pharmtox.42.082701.145401; ALLEN JP, 1974, NEUROENDOCRINOLOGY, V15, P220, DOI 10.1159/000122310; Baranes D, 1998, NEURON, V21, P813, DOI 10.1016/S0896-6273(00)80597-8; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; CHAPMAN PF, 2000, AMYGDALA FUNCTIONAL, P117; CHEN ZL, 1995, J NEUROSCI, V15, P5088; Chen ZL, 1997, CELL, V91, P917, DOI 10.1016/S0092-8674(00)80483-3; Davis S, 2000, J NEUROSCI, V20, P4563, DOI 10.1523/JNEUROSCI.20-12-04563.2000; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Frey U, 1996, J NEUROSCI, V16, P2057; GLOWINSKI J, 1966, BIOCHEM PHARMACOL, V15, P977, DOI 10.1016/0006-2952(66)90175-4; GRAY TS, 1989, NEUROENDOCRINOLOGY, V50, P433, DOI 10.1159/000125260; Gualandris A, 1996, J NEUROSCI, V16, P2220; Hastings GA, 1997, J BIOL CHEM, V272, P33062, DOI 10.1074/jbc.272.52.33062; Herman JP, 1996, CRIT REV NEUROBIOL, V10, P371, DOI 10.1615/CritRevNeurobiol.v10.i3-4.50; Holsboer F, 1999, J PSYCHIATR RES, V33, P181, DOI 10.1016/S0022-3956(98)90056-5; Horsell A, 1999, NEUROREPORT, V10, P3003, DOI 10.1097/00001756-199909290-00024; Huang YY, 1996, P NATL ACAD SCI USA, V93, P8699, DOI 10.1073/pnas.93.16.8699; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; Kim YH, 1999, SCIENCE, V284, P647, DOI 10.1126/science.284.5414.647; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; LUITEN PGM, 1985, BRAIN RES, V332, P283, DOI 10.1016/0006-8993(85)90597-9; Madani R, 1999, EMBO J, V18, P3007, DOI 10.1093/emboj/18.11.3007; Magarinos AM, 1997, P NATL ACAD SCI USA, V94, P14002, DOI 10.1073/pnas.94.25.14002; MARS WM, 1993, AM J PATHOL, V143, P949; McEwen BS, 2002, PSYCHIAT CLIN N AM, V25, P469, DOI 10.1016/S0193-953X(01)00009-0; MCEWEN BS, 1994, ANN NY ACAD SCI, V746, P134; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Nakagami Y, 2000, J NEUROSCI, V20, P2003; Neuhoff H, 1999, EUR J NEUROSCI, V11, P4241, DOI 10.1046/j.1460-9568.1999.00856.x; Nicole O, 2001, NAT MED, V7, P59, DOI 10.1038/83358; Parmer RJ, 1997, J BIOL CHEM, V272, P1976, DOI 10.1074/jbc.272.3.1976; QIAN Z, 1993, NATURE, V361, P453, DOI 10.1038/361453a0; Rogan MT, 1996, CELL, V85, P469, DOI 10.1016/S0092-8674(00)81247-7; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Salles FJ, 2002, J NEUROSCI, V22, P2125, DOI 10.1523/JNEUROSCI.22-06-02125.2002; SAPPINO AP, 1993, J CLIN INVEST, V92, P679, DOI 10.1172/JCI116637; Schafe GE, 2000, J NEUROSCI, V20, P8177; Selye H, 1936, NATURE, V138, P32, DOI 10.1038/138032a0; TSIRKA SE, 1995, NATURE, V377, P340, DOI 10.1038/377340a0; Tsirka SE, 1996, NATURE, V384, P123, DOI 10.1038/384123b0; Vyas A, 2002, J NEUROSCI, V22, P6810; Yamamoto K, 2002, P NATL ACAD SCI USA, V99, P890, DOI 10.1073/pnas.022608799; Yepes M, 2002, J CLIN INVEST, V109, P1571, DOI 10.1172/JCI200214308; Zhuo M, 2000, J NEUROSCI, V20, P542, DOI 10.1523/JNEUROSCI.20-02-00542.2000	46	205	217	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2003	6	2					168	174		10.1038/nn998	http://dx.doi.org/10.1038/nn998			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	640CL	12524546				2022-12-24	WOS:000180669100017
J	Glossop, NRJ; Houl, JH; Zheng, H; Ng, FS; Dudek, SM; Hardin, PE				Glossop, NRJ; Houl, JH; Zheng, H; Ng, FS; Dudek, SM; Hardin, PE			VRILLE feeds back to control circadian transcription of Clock in the Drosophila circadian oscillator	NEURON			English	Article							INTERLOCKED FEEDBACK LOOPS; GENE-EXPRESSION; PERIOD PROTEIN; NUCLEAR ENTRY; BZIP FAMILY; DOUBLE-TIME; CRYPTOCHROME; MUTATION; RHYTHMS; PHOTORECEPTOR	The Drosophila circadian oscillator consists of interlocked period (per)/timeless (tim) and Clock (Clk) transcriptional/translational feedback loops. Within these feedback loops, CLK and CYCLE (CYC) activate per and tim transcription at the same time as they repress Clk transcription, thus controlling the opposite cycling phases of these transcripts. CLK-CYC directly bind E box elements to activate transcription, but the mechanism of CLK-CYC-dependent repression is not known. Here we show that a CLK-CYC-activated gene, vrille (vri), encodes a repressor of Clk transcription, thereby identifying vri as a key negative component of the Clk feedback loop in Drosophila's circadian oscillator. The blue light photoreceptor encoding cryptochrome (cry) gene is also a target for VRI repression, suggesting a broader role for VRI in the rhythmic repression of output genes that cycle in phase with Clk.	Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA	University of Houston System; University of Houston	Hardin, PE (corresponding author), Univ Houston, Dept Biol & Biochem, 369 Sci & Res Bldg 2, Houston, TX 77204 USA.	phardin@uh.edu		Hardin, Paul/0000-0002-3370-9011	NIMH NIH HHS [MH61423] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061423] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Bae K, 2000, J NEUROSCI, V20, P1746; Bae K, 1998, MOL CELL BIOL, V18, P6142, DOI 10.1128/MCB.18.10.6142; Blau J, 1999, CELL, V99, P661, DOI 10.1016/S0092-8674(00)81554-8; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cheng P, 2001, P NATL ACAD SCI USA, V98, P7408, DOI 10.1073/pnas.121170298; Claridge-Chang A, 2001, NEURON, V32, P657, DOI 10.1016/S0896-6273(01)00515-3; COWELL IG, 1992, MOL CELL BIOL, V12, P3070, DOI 10.1128/MCB.12.7.3070; CURTIN KD, 1995, NEURON, V14, P365, DOI 10.1016/0896-6273(95)90292-9; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Egan ES, 1999, J NEUROSCI, V19, P3665; Emery P, 2000, NEURON, V26, P493, DOI 10.1016/S0896-6273(00)81181-2; Emery P, 2000, NATURE, V404, P456, DOI 10.1038/35006558; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; George H, 1997, GENETICS, V146, P1345; Glossop NRJ, 1999, SCIENCE, V286, P766, DOI 10.1126/science.286.5440.766; Glossop NRJ, 2002, J CELL SCI, V115, P3369; Hao HP, 1997, MOL CELL BIOL, V17, P3687, DOI 10.1128/MCB.17.7.3687; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; Hassan BA, 2000, NEURON, V25, P549, DOI 10.1016/S0896-6273(00)81059-4; HURST HC, 1994, PROTEIN PROFILE, V1, P123; Ishikawa T, 1999, GENES CELLS, V4, P57, DOI 10.1046/j.1365-2443.1999.00237.x; Ivanchenko M, 2001, J BIOL RHYTHM, V16, P205, DOI 10.1177/074873001129001917; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; JOHNSON AD, 1995, CELL, V81, P655, DOI 10.1016/0092-8674(95)90524-3; Kaneko M, 2000, J COMP NEUROL, V422, P66, DOI 10.1002/(SICI)1096-9861(20000619)422:1<66::AID-CNE5>3.0.CO;2-2; Kim EY, 2002, NEURON, V34, P69, DOI 10.1016/S0896-6273(02)00639-6; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; Krishnan B, 2001, NATURE, V411, P313, DOI 10.1038/35077094; Lee C, 1999, MOL CELL BIOL, V19, P5316; Lee CG, 1998, NEURON, V21, P857, DOI 10.1016/S0896-6273(00)80601-7; Lin FJ, 2001, MOL CELL BIOL, V21, P7287, DOI 10.1128/MCB.21.21.7287-7294.2001; Lin Y, 2002, P NATL ACAD SCI USA, V99, P9562, DOI 10.1073/pnas.132269699; Maldonado E, 1999, CELL, V99, P455, DOI 10.1016/S0092-8674(00)81533-0; Martinek S, 2001, CELL, V105, P769, DOI 10.1016/S0092-8674(01)00383-X; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Mitsui S, 2001, GENE DEV, V15, P995, DOI 10.1101/gad.873501; PIROTTA V, 1988, SURVEY MOL CLONING V, P437; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; PRICE JL, 1995, EMBO J, V14, P4044, DOI 10.1002/j.1460-2075.1995.tb00075.x; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; Saez L, 1996, NEURON, V17, P911, DOI 10.1016/S0896-6273(00)80222-6; So WV, 2000, MOL CELL BIOL, V20, P6935, DOI 10.1128/MCB.20.18.6935-6944.2000; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Ueda HR, 2002, J BIOL CHEM, V277, P14048, DOI 10.1074/jbc.C100765200; VOSSHALL LB, 1994, SCIENCE, V263, P1606, DOI 10.1126/science.8128247; Williams JA, 2001, ANNU REV PHYSIOL, V63, P729, DOI 10.1146/annurev.physiol.63.1.729; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576	52	216	220	3	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 23	2003	37	2					249	261		10.1016/S0896-6273(03)00002-3	http://dx.doi.org/10.1016/S0896-6273(03)00002-3			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	646UX	12546820	Bronze			2022-12-24	WOS:000181054900010
J	Paul, S; Nairn, AC; Wang, P; Lombroso, PJ				Paul, S; Nairn, AC; Wang, P; Lombroso, PJ			NMDA-mediated activation of the tyrosine phosphatase STEP regulates the duration of ERK signaling	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE CASCADE; DUAL-SPECIFICITY PHOSPHATASES; LONG-TERM POTENTIATION; MAP KINASE; DEPENDENT PATHWAY; STRIATAL NEURONS; IN-VIVO; PHOSPHORYLATION; RECEPTOR; HIPPOCAMPAL	The intracellular mechanism(s) by which a cell determines the duration of extracellular signal-regulated kinase (ERK) activation is not well understood. We have investigated the role of STEP, a striatal-enriched tyrosine phosphatase, in the regulation of ERK activity in rat neurons. Glutamate-mediated activation of NMDA receptors leads to the rapid but transient phosphorylation of ERK in cultured neurons. Here we show that activation of NMDA receptors led to activation of STEP, which limited the duration of ERK activity as well as its translocation to the nucleus and its subsequent downstream nuclear signaling. In neurons, STEP is phosphorylated and inactive under basal conditions. NMDA-mediated influx of Ca2+, but not increased intracellular Ca2+ from other sources, leads to activation of the Ca2+-dependent phosphatase calcineurin and the dephosphorylation and activation of STEP. We have identified an important mechanism involved in the regulation of ERK activity in neurons that highlights the complex interplay between serine/threonine and tyrosine kinases and phosphatases.	Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA; Rockefeller Univ, New York, NY 10021 USA	Yale University; Yale University; Rockefeller University	Lombroso, PJ (corresponding author), Yale Univ, Sch Med, Ctr Child Study, 230 S Frontage Rd, New Haven, CT 06520 USA.			Nairn, Angus/0000-0002-7075-0195	NIDA NIH HHS [P01 DA010044, DA10044] Funding Source: Medline; NIMH NIH HHS [MH40899, MH01527, MH52711] Funding Source: Medline; NINDS NIH HHS [NS35989] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH052711, R01MH052711, P01MH040899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Abe K, 2000, NEUROSCI LETT, V292, P1, DOI 10.1016/S0304-3940(00)01415-4; ALESSI DR, 1995, CURR BIOL, V5, P283, DOI 10.1016/S0960-9822(95)00059-5; ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Blum S, 1999, J NEUROSCI, V19, P3535; BOULANGER LM, 1995, J NEUROSCI, V15, P1532; Bult A, 1996, J NEUROSCI, V16, P7821; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; Cepeda C, 1998, DEV NEUROSCI-BASEL, V20, P1, DOI 10.1159/000017294; Charpier S, 1997, P NATL ACAD SCI USA, V94, P7036, DOI 10.1073/pnas.94.13.7036; Coogan AN, 1999, J NEUROPHYSIOL, V81, P103, DOI 10.1152/jn.1999.81.1.103; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; Grewal SS, 1999, CURR OPIN NEUROBIOL, V9, P544, DOI 10.1016/S0959-4388(99)00010-0; Grewal SS, 2000, J BIOL CHEM, V275, P3722, DOI 10.1074/jbc.275.5.3722; Groom LA, 1996, EMBO J, V15, P3621, DOI 10.1002/j.1460-2075.1996.tb00731.x; Han BH, 2000, J NEUROSCI, V20, P5775, DOI 10.1523/jneurosci.20-15-05775.2000; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Kornhauser JM, 1997, NEURON, V18, P839, DOI 10.1016/S0896-6273(00)80322-0; KOTTER R, 1994, PROG NEUROBIOL, V44, P163, DOI 10.1016/0301-0082(94)90037-X; Kuroki Y, 2001, EUR J NEUROSCI, V13, P472, DOI 10.1046/j.0953-816x.2000.01409.x; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Muda M, 1996, J BIOL CHEM, V271, P27205, DOI 10.1074/jbc.271.44.27205; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Nguyen TH, 2002, J BIOL CHEM, V277, P24274, DOI 10.1074/jbc.M111683200; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; Paul S, 2000, J NEUROSCI, V20, P5630, DOI 10.1523/JNEUROSCI.20-15-05630.2000; Pelkey KA, 2002, NEURON, V34, P127, DOI 10.1016/S0896-6273(02)00633-5; Pulido R, 1998, EMBO J, V17, P7337, DOI 10.1093/emboj/17.24.7337; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Runden E, 1998, J NEUROSCI, V18, P7296; Sala C, 2000, J NEUROSCI, V20, P3529, DOI 10.1523/JNEUROSCI.20-10-03529.2000; Saxena M, 1999, NAT CELL BIOL, V1, P305, DOI 10.1038/13024; Schwarzschild MA, 1999, J NEUROCHEM, V72, P2248, DOI 10.1046/j.1471-4159.1999.0722248.x; Sgambato V, 1998, J NEUROSCI, V18, P8814; Stanciu M, 2002, J BIOL CHEM, V277, P4010, DOI 10.1074/jbc.M104479200; Stanciu M, 2000, J BIOL CHEM, V275, P12200, DOI 10.1074/jbc.275.16.12200; Vanhoutte P, 1999, MOL CELL BIOL, V19, P136; Vincent SR, 1998, SYNAPSE, V29, P29, DOI 10.1002/(SICI)1098-2396(199805)29:1<29::AID-SYN3>3.3.CO;2-T; Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Xia ZG, 1996, J NEUROSCI, V16, P5425; Yan Z, 1999, P NATL ACAD SCI USA, V96, P11607, DOI 10.1073/pnas.96.20.11607; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; Yun HY, 1999, DIABETES RES CLIN PR, V45, P113, DOI 10.1016/S0168-8227(99)00039-X; Zanassi P, 2001, J BIOL CHEM, V276, P11487, DOI 10.1074/jbc.M007631200; Zhou B, 2002, J BIOL CHEM, V277, P31818, DOI 10.1074/jbc.M203969200	49	261	269	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2003	6	1					34	42		10.1038/nn989	http://dx.doi.org/10.1038/nn989			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	630CE	12483215				2022-12-24	WOS:000180089300013
J	Akerman, CJ; Smyth, D; Thompson, ID				Akerman, CJ; Smyth, D; Thompson, ID			Visual experience before eye-opening and the development of the retinogeniculate pathway	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; RETINAL GANGLION-CELLS; DEVELOPING MAMMALIAN RETINA; ACTION-POTENTIAL ACTIVITY; RECEPTIVE-FIELDS; ORIENTATION SELECTIVITY; NEURONAL-ACTIVITY; CORTEX; FERRET; DEPRIVATION	Visual experience before eye-opening is not usually thought to have any developmental significance. Here we show that naturalistic visual stimuli presented through unopened eyelids robustly activate neurons in the ferret dorsal lateral geniculate nucleus. Further, dark-rearing prior to natural eye-opening has striking effects upon geniculate physiology. Receptive field maps after dark-rearing show increased convergence of On- and Off-center responses, and neurons frequently respond to both bright and dark phases of drifting gratings. There is also increased selectivity for the orientation of the gratings. These abnormalities of On-Off segregation can be explained by the finding that the responses of immature On and Off cells to naturalistic stimuli are strongly anticorrelated.	Univ Oxford, Physiol Lab, Oxford OX1 3PT, England	University of Oxford	Thompson, ID (corresponding author), Univ Oxford, Physiol Lab, Parks Rd, Oxford OX1 3PT, England.		Thompson, Ian D/C-5785-2009					BLAKEMORE C, 1975, J PHYSIOL-LONDON, V248, P663, DOI 10.1113/jphysiol.1975.sp010995; BODNARENKO SR, 1993, NATURE, V364, P144, DOI 10.1038/364144a0; Bodnarenko SR, 1999, NEUROREPORT, V10, P2955, DOI 10.1097/00001756-199909290-00015; CHAPMAN B, 1993, J NEUROSCI, V13, P5251, DOI 10.1523/JNEUROSCI.13-12-05251.1993; Crair MC, 1999, CURR OPIN NEUROBIOL, V9, P88, DOI 10.1016/S0959-4388(99)80011-7; Cramer KS, 1997, DEV BRAIN RES, V98, P287, DOI 10.1016/S0165-3806(96)00188-5; DANIELS JD, 1978, J NEUROPHYSIOL, V41, P1373, DOI 10.1152/jn.1978.41.6.1373; DUBIN MW, 1986, J NEUROSCI, V6, P1021; Eglen SJ, 1999, PHILOS T ROY SOC B, V354, P497, DOI 10.1098/rstb.1999.0400; Feller MB, 1997, NEURON, V19, P293, DOI 10.1016/S0896-6273(00)80940-X; Hahm JO, 1999, J COMP NEUROL, V411, P327, DOI 10.1002/(SICI)1096-9861(19990823)411:2<327::AID-CNE12>3.0.CO;2-#; HAHM JO, 1991, NATURE, V351, P568, DOI 10.1038/351568a0; HUTTENLOCHER PR, 1967, EXP NEUROL, V17, P247, DOI 10.1016/0014-4886(67)90104-5; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Krug K, 2001, J NEUROPHYSIOL, V85, P1436, DOI 10.1152/jn.2001.85.4.1436; LAU KC, 1990, J COMP NEUROL, V300, P583, DOI 10.1002/cne.903000411; LEVENTHAL AG, 1983, J NEUROSCI, V3, P332; LINDEN DC, 1981, J COMP NEUROL, V203, P189, DOI 10.1002/cne.902030204; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; Myhr KL, 2001, J NEUROSCI, V21, P8664, DOI 10.1523/JNEUROSCI.21-21-08664.2001; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Porter V, 1985, COMPLETE BOOK FERRET; Sernagor E, 1996, CURR BIOL, V6, P1503, DOI 10.1016/S0960-9822(96)00755-5; SHATZ CJ, 1988, SCIENCE, V242, P87, DOI 10.1126/science.3175636; STARK LA, 1986, VISION RES, V26, P409, DOI 10.1016/0042-6989(86)90183-5; Stellwagen D, 2002, NEURON, V33, P357, DOI 10.1016/S0896-6273(02)00577-9; Tavazoie SF, 2000, NAT NEUROSCI, V3, P608, DOI 10.1038/75786; Usrey WM, 1998, NATURE, V395, P384, DOI 10.1038/26487; Wang GY, 2001, J NEUROSCI, V21, P4310, DOI 10.1523/JNEUROSCI.21-12-04310.2001; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599; White LE, 2001, NATURE, V411, P1049, DOI 10.1038/35082568; Wong ROL, 1996, NEURON, V16, P1087, DOI 10.1016/S0896-6273(00)80135-X; WONG ROL, 1991, J NEUROBIOL, V22, P685, DOI 10.1002/neu.480220704; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29; WORGOTTER F, 1987, BIOL CYBERN, V57, P349, DOI 10.1007/BF00354980; ZHOU YF, 1995, J NEUROSCI, V15, P689	37	79	82	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 5	2002	36	5					869	879		10.1016/S0896-6273(02)01010-3	http://dx.doi.org/10.1016/S0896-6273(02)01010-3			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	622VL	12467590	Bronze			2022-12-24	WOS:000179667800011
J	Freeman, TCB; Durand, S; Kiper, DC; Carandini, M				Freeman, TCB; Durand, S; Kiper, DC; Carandini, M			Suppression without inhibition in visual cortex	NEURON			English	Article							CAT STRIATE CORTEX; LATERAL GENICULATE-NUCLEUS; CROSS-ORIENTATION INHIBITION; NEUROTRANSMITTER RELEASE PROBABILITY; UNDERLYING CONTRAST ADAPTATION; RETINAL GANGLION-CELLS; CORTICAL-NEURONS; TEMPORAL INTERACTIONS; GAIN-CONTROL; AREA 17	Neurons in primary visual cortex (V1) are thought to receive inhibition from other V1 neurons selective for a variety of orientations. Evidence for this inhibition is commonly found in cross-orientation suppression: responses of a V1 neuron to optimally oriented bars are suppressed by superimposed mask bars of different orientation. We show, however, that suppression is unlikely to result from intracortical inhibition. First, suppression can be obtained with masks drifting too rapidly to elicit much of a response in cortex. Second, suppression is immune to hyperpolarization (through visual adaptation) of cortical neurons responding to the mask. Signals mediating suppression might originate in thalamus, rather than in cortex. Thalamic neurons exhibit some suppression; additional suppression might arise from depression at thalamocortical synapses. The mechanisms of suppression are subcortical and possibly include the very first synapse into cortex.	Univ Zurich, Inst Neuroinformat, CH-8057 Zurich, Switzerland; Swiss Fed Inst Technol, CH-8057 Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Carandini, M (corresponding author), Univ Zurich, Inst Neuroinformat, Winterthurerstr 190, CH-8057 Zurich, Switzerland.		freeman, tobe/GZN-0356-2022; Carandini, Matteo/C-1922-2008; Carandini, Matteo/ABD-8296-2021	freeman, tobe/0000-0002-1883-958X; Carandini, Matteo/0000-0003-4880-7682; Carandini, Matteo/0000-0003-4880-7682				Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; ALBRECHT DG, 1984, J PHYSIOL-LONDON, V347, P713, DOI 10.1113/jphysiol.1984.sp015092; ALBRECHT DG, 1991, VISUAL NEUROSCI, V7, P531, DOI 10.1017/S0952523800010336; Allison JD, 2001, VISUAL NEUROSCI, V18, P941, DOI 10.1017/S0952523801186116; Alonso JM, 2001, J NEUROSCI, V21, P4002, DOI 10.1523/JNEUROSCI.21-11-04002.2001; Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Anderson JS, 2001, J NEUROSCI, V21, P2104, DOI 10.1523/JNEUROSCI.21-06-02104.2001; BAUMAN LA, 1991, VISION RES, V31, P933, DOI 10.1016/0042-6989(91)90201-F; BENEVENTO LA, 1972, NATURE-NEW BIOL, V238, P124, DOI 10.1038/newbio238124a0; Blake R., 2001, BRAIN MIND, V2, P5, DOI [https://doi.org/10.1023/A:1017925416289, DOI 10.1023/A:1017925416289, 10.1023/A:1017925416289]; BLAKEMORE C, 1972, EXP BRAIN RES, V15, P439; BOLZ J, 1986, NATURE, V320, P362, DOI 10.1038/320362a0; BONDS AB, 1989, VISUAL NEUROSCI, V2, P41, DOI 10.1017/S0952523800004314; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Boynton GM, 1999, VISION RES, V39, P1641, DOI 10.1016/S0042-6989(98)00199-0; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; CARANDINI M, 1994, SCIENCE, V264, P1333, DOI 10.1126/science.8191289; Carandini M, 1997, J NEUROSCI, V17, P8621; Carandini M, 1998, NEUROPHARMACOLOGY, V37, P501, DOI 10.1016/S0028-3908(98)00069-0; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; CHAGNACAMITAI Y, 1989, J NEUROPHYSIOL, V61, P747, DOI 10.1152/jn.1989.61.4.747; Chance FS, 1998, J NEUROSCI, V18, P4785; Chung S, 2002, NEURON, V34, P437, DOI 10.1016/S0896-6273(02)00659-1; Cohen I, 2000, J PHYSIOL-LONDON, V524, P485, DOI 10.1111/j.1469-7793.2000.00485.x; Crook JM, 1998, EUR J NEUROSCI, V10, P2056, DOI 10.1046/j.1460-9568.1998.00218.x; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1091, DOI 10.1152/jn.1993.69.4.1091; DEANGELIS GC, 1992, J NEUROPHYSIOL, V68, P144, DOI 10.1152/jn.1992.68.1.144; DEANGELIS GC, 1994, J NEUROPHYSIOL, V71, P347, DOI 10.1152/jn.1994.71.1.347; DOUGLAS RJ, 1988, NATURE, V332, P642, DOI 10.1038/332642a0; EYSEL UT, 1990, EXP BRAIN RES, V80, P626; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; FERSTER D, 1985, J PHYSIOL-LONDON, V367, P217, DOI 10.1113/jphysiol.1985.sp015821; FERSTER D, 1988, J NEUROSCI, V8, P1172; Foley John M., 1997, Vision Research, V37, P2779, DOI 10.1016/S0042-6989(97)00081-3; GILBERT CD, 1975, J COMP NEUROL, V163, P81, DOI 10.1002/cne.901630106; GRIEVE KL, 1991, EXP BRAIN RES, V87, P521; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Hirsch JA, 1998, J NEUROSCI, V18, P9517; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P229, DOI 10.1152/jn.1965.28.2.229; IKEDA H, 1975, EXP BRAIN RES, V22, P363; Kayser A, 2001, J NEUROPHYSIOL, V85, P2130, DOI 10.1152/jn.2001.85.5.2130; KOCH C, 1983, P NATL ACAD SCI-BIOL, V80, P2799, DOI 10.1073/pnas.80.9.2799; Lauritzen TZ, 2001, J NEUROPHYSIOL, V86, P1803, DOI 10.1152/jn.2001.86.4.1803; LI CY, 1994, VISION RES, V34, P2337, DOI 10.1016/0042-6989(94)90280-1; MAFFEI L, 1973, SCIENCE, V182, P1036, DOI 10.1126/science.182.4116.1036; Martinez LM, 2002, J PHYSIOL-LONDON, V540, P321, DOI 10.1113/jphysiol.2001.012776; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; MEIER L, 2002, J VISION; MORRONE MC, 1982, PROC R SOC SER B-BIO, V216, P335, DOI 10.1098/rspb.1982.0078; MORRONE MC, 1987, EXP BRAIN RES, V67, P635; MOVSHON JA, 1979, NATURE, V278, P850, DOI 10.1038/278850a0; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P101, DOI 10.1113/jphysiol.1978.sp012490; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; Muller JR, 2001, J NEUROSCI, V21, P6978, DOI 10.1523/JNEUROSCI.21-17-06978.2001; MURPHY PC, 1987, NATURE, V329, P727, DOI 10.1038/329727a0; Murphy PC, 1999, SCIENCE, V286, P1552, DOI 10.1126/science.286.5444.1552; NELSON S, 1994, SCIENCE, V265, P774, DOI 10.1126/science.8047882; NELSON SB, 1991, J NEUROSCI, V11, P344; NELSON SB, 1991, J NEUROSCI, V11, P357; NELSON SB, 1991, J NEUROSCI, V11, P369; OHZAWA I, 1985, J NEUROPHYSIOL, V54, P651, DOI 10.1152/jn.1985.54.3.651; PALMER LA, 1981, J NEUROPHYSIOL, V46, P260, DOI 10.1152/jn.1981.46.2.260; Payne BR, 2002, CAT PRIMARY VISUAL C, P1, DOI [10.1016/b978-012552104-8/50002-x, DOI 10.1016/B978-012552104-8/50002-X]; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; ROBINSON DA, 1968, PR INST ELECTR ELECT, V56, P1065, DOI 10.1109/PROC.1968.6458; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; SAUL AB, 1990, J NEUROPHYSIOL, V64, P206, DOI 10.1152/jn.1990.64.1.206; SAUL AB, 1992, VISUAL NEUROSCI, V8, P365, DOI 10.1017/S0952523800005101; SCLAR G, 1990, VISION RES, V30, P1, DOI 10.1016/0042-6989(90)90123-3; Sengpiel F, 1998, VISION RES, V38, P2067, DOI 10.1016/S0042-6989(97)00413-6; SENGPIEL F, 1995, VISION RES, V35, P179, DOI 10.1016/0042-6989(94)00125-6; SENGPIEL F, 1994, NATURE, V368, P847, DOI 10.1038/368847a0; Senn W, 2001, NEURAL COMPUT, V13, P35, DOI 10.1162/089976601300014628; SHAPLEY RM, 1981, J PHYSIOL-LONDON, V318, P161; SHAPLEY RM, 1978, J PHYSIOL-LONDON, V285, P275, DOI 10.1113/jphysiol.1978.sp012571; Shou TD, 1996, VISUAL NEUROSCI, V13, P605, DOI 10.1017/S0952523800008518; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P304; SMITH MA, 2001, J VISION; Sompolinsky H, 1997, CURR OPIN NEUROBIOL, V7, P514, DOI 10.1016/S0959-4388(97)80031-1; Stratford KJ, 1996, NATURE, V382, P258, DOI 10.1038/382258a0; Thomson AM, 1997, CEREB CORTEX, V7, P510, DOI 10.1093/cercor/7.6.510; TOLHURST DJ, 1980, EXP BRAIN RES, V38, P431; TOLHURST DJ, 1987, EXP BRAIN RES, V66, P607, DOI 10.1007/BF00270694; Troyer TW, 1998, J NEUROSCI, V18, P5908; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Varela JA, 1997, J NEUROSCI, V17, P7926; Vidyasagar TR, 1996, TRENDS NEUROSCI, V19, P272, DOI 10.1016/S0166-2236(96)20027-X; Walker GA, 1998, J NEUROPHYSIOL, V79, P227, DOI 10.1152/jn.1998.79.1.227	91	162	162	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 15	2002	35	4					759	771		10.1016/S0896-6273(02)00819-X	http://dx.doi.org/10.1016/S0896-6273(02)00819-X			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	585JE	12194874	Bronze			2022-12-24	WOS:000177521000015
J	Desai, NS; Cudmore, RH; Nelson, SB; Turrigiano, GG				Desai, NS; Cudmore, RH; Nelson, SB; Turrigiano, GG			Critical periods for experience-dependent synaptic scaling in visual cortex	NATURE NEUROSCIENCE			English	Article							MONOCULAR DEPRIVATION; QUANTAL AMPLITUDE; NMDA-RECEPTOR; PLASTICITY; RAT; EXPRESSION; SYNAPSES; AMPA; MECHANISMS; ZIF268	The mechanisms underlying experience-dependent plasticity and refinement of central circuits are not yet fully understood. A non-Hebbian form of synaptic plasticity, which scales synaptic strengths up or down to stabilize firing rates, has recently been discovered in cultured neuronal networks. Here we demonstrate the existence of a similar mechanism in the intact rodent visual cortex. The frequency of miniature excitatory postsynaptic currents (mEPSCs) in principal neurons increased steeply between post-natal days 12 and 23. There was a concomitant decrease in mEPSC amplitude, which was prevented by rearing rats in complete darkness from 12 days of age. In addition, as little as two days of monocular deprivation scaled up mEPSC amplitude in a layer- and age-dependent manner. These data indicate that mEPSC amplitudes can be globally scaled up or down as a function of development and sensory experience, and suggest that synaptic scaling may be involved in the activity-dependent refinement of cortical connectivity.	Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Brandeis Univ, Volen Natl Ctr Complex Syst, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Turrigiano, GG (corresponding author), Brandeis Univ, Dept Biol, MS 008,415 South St, Waltham, MA 02454 USA.	turrigiano@brandeis.edu		Nelson, Sacha/0000-0002-0108-8599; Cudmore, Robert/0000-0002-0440-1704	NATIONAL EYE INSTITUTE [R01EY011116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036853] Funding Source: NIH RePORTER; NEI NIH HHS [EY 11116] Funding Source: Medline; NINDS NIH HHS [R01 NS 36853] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott LF, 2001, NAT NEUROSCI, V4, P115, DOI 10.1038/83920; Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; BLUE ME, 1983, J NEUROCYTOL, V12, P599, DOI 10.1007/BF01181526; Caleo M, 1999, NEUROSCIENCE, V91, P1017, DOI 10.1016/S0306-4522(98)00682-4; Caleo M, 1999, EUR J NEUROSCI, V11, P2979, DOI 10.1046/j.1460-9568.1999.00737.x; CHANGNACAMITAI Y, 1989, J NEUROPHYSIOL, V62, P1149; Colman H, 1997, SCIENCE, V275, P356, DOI 10.1126/science.275.5298.356; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; Crowley JC, 1999, NAT NEUROSCI, V2, P1125, DOI 10.1038/16051; CYNADER M, 1980, J NEUROPHYSIOL, V43, P1026, DOI 10.1152/jn.1980.43.4.1026; Davis GW, 1998, CURR OPIN NEUROBIOL, V8, P149, DOI 10.1016/S0959-4388(98)80018-4; Davis GW, 1998, NATURE, V392, P82, DOI 10.1038/32176; DAW NW, 1992, J NEUROPHYSIOL, V67, P197, DOI 10.1152/jn.1992.67.1.197; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; DIAMOND ME, 1993, P NATL ACAD SCI USA, V90, P2082, DOI 10.1073/pnas.90.5.2082; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Feller MB, 1999, NEURON, V22, P653, DOI 10.1016/S0896-6273(00)80724-2; FOX K, 1992, J NEUROSCI, V12, P1826; Gilbert CD, 1998, PHYSIOL REV, V78, P467, DOI 10.1152/physrev.1998.78.2.467; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Gordon JA, 1996, J NEUROSCI, V16, P3274; Guire ES, 1999, J NEUROPHYSIOL, V81, P121, DOI 10.1152/jn.1999.81.1.121; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KIRKWOOD A, 1994, J NEUROSCI, V14, P1634, DOI 10.1523/JNEUROSCI.14-03-01634.1994; Leslie KR, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-19-j0005.2001; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; LIU GS, 1995, NATURE, V375, P404, DOI 10.1038/375404a0; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; McCormick DA, 1999, SCIENCE, V285, P541, DOI 10.1126/science.285.5427.541; Micheva KD, 1996, J COMP NEUROL, V373, P340, DOI 10.1002/(SICI)1096-9861(19960923)373:3<340::AID-CNE3>3.0.CO;2-2; Miller KD, 1996, NEURON, V17, P371, DOI 10.1016/S0896-6273(00)80169-5; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; REID SNM, 1991, BRAIN RES, V563, P293, DOI 10.1016/0006-8993(91)91549-G; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P305, DOI 10.1113/jphysiol.1975.sp011056; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; van Rossum MCW, 2000, J NEUROSCI, V20, P8812; Varela JA, 1999, J NEUROSCI, V19, P4293; Watt AJ, 2000, NEURON, V26, P659, DOI 10.1016/S0896-6273(00)81202-7; WORLEY PF, 1991, P NATL ACAD SCI USA, V88, P5106, DOI 10.1073/pnas.88.12.5106; ZILLES K, 1984, J COMP NEUROL, V226, P391, DOI 10.1002/cne.902260308	49	416	428	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2002	5	8					783	789		10.1038/nn878	http://dx.doi.org/10.1038/nn878			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	577XT	12080341				2022-12-24	WOS:000177088900022
J	Yao, HS; Li, CY				Yao, HS; Li, CY			Clustered organization of neurons with similar extra-receptive field properties in the primary visual cortex	NEURON			English	Article							MACAQUE MONKEY; FUNCTIONAL ARCHITECTURE; INTRINSIC CONNECTIONS; CORTICAL DYNAMICS; SPATIAL SUMMATION; CAT; INTEGRATION; INHIBITION; DIRECTION; AREA-17	The primary visual cortex is organized into clusters of cells having similar classical receptive field (CRF) properties. Nonclassical, extra-receptive fields (ERFs) can either inhibit or facilitate the response elicited by stimulation within the CRF. Here, we report that in the primary visual cortex of cat, neurons with similar inhibitory or facilitatory ERF properties are also grouped into clusters. These clusters are randomly distributed in all cortical layers, with no detectable relationship with orientation and ocular dominance columns. This functional organization of neurons with respect to ERF properties may allow an efficient processing of global visual information.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Li, CY (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China.							ALLMAN J, 1985, ANNU REV NEUROSCI, V8, P407, DOI 10.1146/annurev.ne.08.030185.002203; AMIR Y, 1993, J COMP NEUROL, V334, P19, DOI 10.1002/cne.903340103; BLAKEMORE C, 1972, EXP BRAIN RES, V15, P439; Born RT, 2000, J NEUROPHYSIOL, V84, P2658, DOI 10.1152/jn.2000.84.5.2658; Das A, 1999, NATURE, V399, P655, DOI 10.1038/21371; DeAngelis GC, 1999, J NEUROSCI, V19, P4046; DEANGELIS GC, 1994, J NEUROPHYSIOL, V71, P347, DOI 10.1152/jn.1994.71.1.347; DeAngelis GC, 1999, J NEUROSCI, V19, P1398; GILBERT CD, 1992, NEURON, V9, P1, DOI 10.1016/0896-6273(92)90215-Y; Gilbert CD, 1998, PHYSIOL REV, V78, P467, DOI 10.1152/physrev.1998.78.2.467; GILBERT CD, 1990, VISION RES, V30, P1689, DOI 10.1016/0042-6989(90)90153-C; GILBERT CD, 1977, J PHYSIOL-LONDON, V268, P391, DOI 10.1113/jphysiol.1977.sp011863; GULYAS B, 1987, J NEUROPHYSIOL, V57, P1767, DOI 10.1152/jn.1987.57.6.1767; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; Jones HE, 2001, J NEUROPHYSIOL, V86, P2011, DOI 10.1152/jn.2001.86.4.2011; Kapadia MK, 1999, P NATL ACAD SCI USA, V96, P12073, DOI 10.1073/pnas.96.21.12073; LEVAY S, 1988, VISUAL NEUROSCI, V1, P395, DOI 10.1017/S0952523800004168; Levitt JB, 1997, NATURE, V387, P73, DOI 10.1038/387073a0; LI CY, 1995, J NEUROSCI METH, V57, P217, DOI 10.1016/0165-0270(94)00151-6; Li CY, 1996, NEWS PHYSIOL SCI, V11, P181; LI CY, 1994, VISION RES, V34, P2337, DOI 10.1016/0042-6989(94)90280-1; Li CY, 1999, P NATL ACAD SCI USA, V96, P4052, DOI 10.1073/pnas.96.7.4052; LUND JS, 1979, J COMP NEUROL, V184, P599, DOI 10.1002/cne.901840402; MAFFEI L, 1976, NATURE, V264, P754, DOI 10.1038/264754a0; MALACH R, 1993, P NATL ACAD SCI USA, V90, P10469, DOI 10.1073/pnas.90.22.10469; MCGUIRE BA, 1991, J COMP NEUROL, V305, P370, DOI 10.1002/cne.903050303; NELSON JI, 1978, BRAIN RES, V139, P359, DOI 10.1016/0006-8993(78)90937-X; PAYNE BR, 1981, BRAIN RES, V211, P445, DOI 10.1016/0006-8993(81)90971-9; ROCKLAND KS, 1983, J COMP NEUROL, V216, P303, DOI 10.1002/cne.902160307; Sceniak MP, 1999, NAT NEUROSCI, V2, P733, DOI 10.1038/11197; Sengpiel F, 1997, EXP BRAIN RES, V116, P216, DOI 10.1007/PL00005751; Shmuel A, 1996, J NEUROSCI, V16, P6945; Shoham D, 1997, NATURE, V385, P529, DOI 10.1038/385529a0; Swindale NV, 2000, NAT NEUROSCI, V3, P822, DOI 10.1038/77731; TOLHURST DJ, 1981, PROC R SOC SER B-BIO, V213, P183, DOI 10.1098/rspb.1981.0061; TOOTELL RB, 1981, SCIENCE, V214, P813, DOI 10.1126/science.7292014; Walker GA, 2000, VISUAL NEUROSCI, V17, P369, DOI 10.1017/S0952523800173055; Weliky M, 1996, NATURE, V379, P725, DOI 10.1038/379725a0	38	44	50	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 1	2002	35	3					547	553		10.1016/S0896-6273(02)00782-1	http://dx.doi.org/10.1016/S0896-6273(02)00782-1			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	582CB	12165475	Bronze			2022-12-24	WOS:000177331200014
J	Tobin, DM; Madsen, DM; Kahn-Kirby, A; Peckol, EL; Moulder, G; Barstead, R; Maricq, AV; Bargmann, CI				Tobin, DM; Madsen, DM; Kahn-Kirby, A; Peckol, EL; Moulder, G; Barstead, R; Maricq, AV; Bargmann, CI			Combinatorial expression of TRPV channel proteins defines their sensory functions and subcellular localization in C-elegans neurons	NEURON			English	Article							NUCLEOTIDE-GATED CHANNEL; PDZ-DOMAIN PROTEIN; CAENORHABDITIS-ELEGANS; CATION CHANNEL; CA2+ CHANNEL; SIGNALING COMPLEXES; GLUTAMATE; INAD; ADAPTATION; OLFACTION	C. elegans OSM-9 is a TRPV channel protein involved in sensory transduction and adaptation. Here, we show that distinct sensory functions arise from different combinations of OSM-9 and related OCR TRPV proteins. Both OSM-9 and OCR-2 are essential for several forms of sensory transduction, including olfaction, osmosensation, mechanosensation, and chemosensation. In neurons that express both OSM-9 and OCR-2, tagged OCR-2 and OSM-9 proteins reside in sensory cilia and promote each other's localization to cilia. In neurons that express only OSM-9, tagged OSM-9 protein resides in the cell body and acts in sensory adaptation rather than sensory transduction. Thus, alternative combinations of TRPV proteins may direct different functions in distinct subcellular locations. Animals expressing the mammalian TRPV1 (VR1) channel in ASH nociceptor neurons avoid the TRPV1 ligand capsaicin, allowing selective, drug-inducible activation of a specific behavior.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Dev Biol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Genet Program, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Utah System of Higher Education; University of Utah; Oklahoma Medical Research Foundation	Bargmann, CI (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	cori@itsa.ucsf.edu		Tobin, David/0000-0003-3465-5518; Bargmann, Cornelia/0000-0002-8484-0618				Bahner M, 2002, NEURON, V34, P83, DOI 10.1016/S0896-6273(02)00630-X; Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Bellocchio EE, 2000, SCIENCE, V289, P957, DOI 10.1126/science.289.5481.957; BERRIDGE MJ, 1995, BIOCHEM J, V312, P1, DOI 10.1042/bj3120001; Birnby DA, 2000, GENETICS, V155, P85; BRENNER S, 1974, GENETICS, V77, P71; Brockie PJ, 2001, J NEUROSCI, V21, P1510, DOI 10.1523/JNEUROSCI.21-05-01510.2001; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Chevesich J, 1997, NEURON, V18, P95, DOI 10.1016/S0896-6273(01)80049-0; Chyb S, 1999, NATURE, V397, P255, DOI 10.1038/16703; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; CLARK SG, 1994, GENETICS, V137, P987; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; COLBERT HA, 1995, NEURON, V14, P803, DOI 10.1016/0896-6273(95)90224-4; Colbert HA, 1997, J NEUROSCI, V17, P8259; Dernburg AF, 1998, CELL, V94, P387, DOI 10.1016/S0092-8674(00)81481-6; Fukushige T, 1998, DEV BIOL, V198, P286, DOI 10.1016/S0012-1606(98)80006-7; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; Hart AC, 1999, J NEUROSCI, V19, P1952; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; Hilliard MA, 2002, CURR BIOL, V12, P730, DOI 10.1016/S0960-9822(02)00813-8; Hoenderop JGJ, 1999, J BIOL CHEM, V274, P8375, DOI 10.1074/jbc.274.13.8375; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Huber A, 1996, EMBO J, V15, P7036, DOI 10.1002/j.1460-2075.1996.tb01095.x; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; Komatsu H, 1999, BRAIN RES, V821, P160, DOI 10.1016/S0006-8993(99)01111-7; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; Lee RYN, 1999, J NEUROSCI, V19, P159, DOI 10.1523/JNEUROSCI.19-01-00159.1999; Li HS, 2000, J CELL BIOL, V150, P1411, DOI 10.1083/jcb.150.6.1411; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Ma D, 2002, NEURON, V33, P715, DOI 10.1016/S0896-6273(02)00614-1; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; MONTELL C, 1985, SCIENCE, V230, P1040, DOI 10.1126/science.3933112; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Niemeyer BA, 1996, CELL, V85, P651, DOI 10.1016/S0092-8674(00)81232-5; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; PHILLIPS AM, 1992, NEURON, V8, P631, DOI 10.1016/0896-6273(92)90085-R; RANGANATHAN R, 1995, ANNU REV NEUROSCI, V18, P283; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; Scott K, 1997, CELL, V91, P375, DOI 10.1016/S0092-8674(00)80421-3; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shieh BH, 1996, NEURON, V16, P991, DOI 10.1016/S0896-6273(00)80122-1; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Tsunoda S, 2001, J NEUROSCI, V21, P150, DOI 10.1523/JNEUROSCI.21-01-00150.2001; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; Wittenburg N, 1999, P NATL ACAD SCI USA, V96, P10477, DOI 10.1073/pnas.96.18.10477; Xu XZS, 2000, NEURON, V26, P647, DOI 10.1016/S0896-6273(00)81201-5; YANDELL MD, 1994, P NATL ACAD SCI USA, V91, P1381, DOI 10.1073/pnas.91.4.1381; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8; Zheng Y, 1999, NEURON, V24, P347, DOI 10.1016/S0896-6273(00)80849-1; ZWAAL RR, 1993, P NATL ACAD SCI USA, V90, P7431, DOI 10.1073/pnas.90.16.7431; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	64	316	353	6	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 18	2002	35	2					307	318		10.1016/S0896-6273(02)00757-2	http://dx.doi.org/10.1016/S0896-6273(02)00757-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	576YF	12160748	Bronze			2022-12-24	WOS:000177034200010
J	Broihier, HT; Skeath, JB				Broihier, HT; Skeath, JB			Drosophila homeodomain protein dHb9 directs neuronal fate via crossrepressive and cell-nonautonomous mechanisms	NEURON			English	Article							VENTRAL NEURAL-TUBE; MOTOR AXON GUIDANCE; SPINAL-CORD; EMBRYONIC NEUROBLASTS; GENE-EXPRESSION; NERVOUS-SYSTEM; IDENTITY; SPECIFICATION; CNS; TRANSPOSITION	Here we present the identification and characterization of dHb9, the Drosophila homolog of vertebrate Hb9, which encodes a factor central to motorneuron (MN) development. We show that dHb9 regulates neuronal fate by restricting expression of Lim3 and Even-skipped (Eve), two homeodomain (HD) proteins required for development of distinct neuronal classes. Also, dHb9 and Lim3 are activated independently of each other in a virtually identical population of ventrally and laterally projecting MNs. Surprisingly, dHb9 represses Lim3 cell nonautonomously in a subset of dorsally projecting MNs, revealing a novel role for intercellular signaling in the establishment of neuronal fate in Drosophila. Lastly, we provide evidence that dHb9 and Eve regulate each other's expression through Groucho-dependent crossrepression. This mutually antagonistic relationship bears similarity to the crossrepressive relationships between pairs of HD proteins that pattern the vertebrate neural tube.	Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL)	Skeath, JB (corresponding author), Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA.			Broihier, Heather/0000-0003-1363-3088	NINDS NIH HHS [R01-NS-36570] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036570] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Appel B, 1995, DEVELOPMENT, V121, P4117; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Bossing T, 1996, DEV BIOL, V179, P41, DOI 10.1006/dbio.1996.0240; BRAND AH, 1993, DEVELOPMENT, V118, P401; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Desai CJ, 1996, CELL, V84, P599, DOI 10.1016/S0092-8674(00)81035-1; DOE CQ, 1988, NATURE, V333, P376, DOI 10.1038/333376a0; Fujioka M, 1999, DEVELOPMENT, V126, P2527; Goodman Corey S., 1993, P1131; HUFF R, 1989, DEV BIOL, V134, P146, DOI 10.1016/0012-1606(89)90085-7; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Jimenez G, 1997, GENE DEV, V11, P3072, DOI 10.1101/gad.11.22.3072; Kobayashi M, 2001, DEVELOPMENT, V128, P1805; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; Krueger NX, 1996, CELL, V84, P611, DOI 10.1016/S0092-8674(00)81036-3; Landgraf M, 1999, NEURON, V22, P43, DOI 10.1016/S0896-6273(00)80677-7; Landgraf M, 1997, J NEUROSCI, V17, P9642; LUNDELL MJ, 1994, DEV BIOL, V165, P385, DOI 10.1006/dbio.1994.1261; Moran-Rivard L, 2001, NEURON, V29, P385, DOI 10.1016/S0896-6273(01)00213-6; Muhr J, 2001, CELL, V104, P861, DOI 10.1016/S0092-8674(01)00283-5; PATEL NH, 1989, GENE DEV, V3, P890, DOI 10.1101/gad.3.6.890; Sagasti A, 2001, CELL, V105, P221, DOI 10.1016/S0092-8674(01)00313-0; Saha MS, 1997, DEV BIOL, V187, P209, DOI 10.1006/dbio.1997.8625; Schmid A, 1999, DEVELOPMENT, V126, P4653; Sepp KJ, 1999, GENETICS, V151, P1093; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Skeath JB, 1998, DEVELOPMENT, V125, P1857; SPANA EP, 1995, DEVELOPMENT, V121, P3489; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1; Thor S, 1999, NATURE, V397, P76, DOI 10.1038/16275; Thor S, 1997, NEURON, V18, P397, DOI 10.1016/S0896-6273(00)81241-6; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; ZHANG P, 1993, GENETICS, V133, P361	35	108	109	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 3	2002	35	1					39	50		10.1016/S0896-6273(02)00743-2	http://dx.doi.org/10.1016/S0896-6273(02)00743-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	569KP	12123607	Bronze			2022-12-24	WOS:000176601800009
J	Swiercz, JM; Kuner, R; Behrens, J; Offermanns, S				Swiercz, JM; Kuner, R; Behrens, J; Offermanns, S			Plexin-B1 directly interacts with PDZ-RhoGEF/LARG to regulate RhoA and growth cone morphology	NEURON			English	Article							NUCLEOTIDE EXCHANGE FACTOR; AXONAL GUIDANCE; ACTIVE RAC; DBL FAMILY; SEMAPHORIN RECEPTORS; NEURITE RETRACTION; G-PROTEINS; GTPASES; ACTIVATION; CELLS	Plexins are widely expressed transmembrane proteins that, in the nervous system, mediate repulsive signals of semaphorins.However, the molecular nature of plexin-mediated signal transduction remains poorly understood. Here, we demonstrate that plexin-B family members associate through their C termini with the Rho guanine nucleotide exchange factors PDZ-RhoGEF and LARG. Activation of plexin-B1 by semaphorin 4D regulates PDZ-RhoGEF/LARG activity leading to RhoA activation. In addition, a dominant-negative form of PDZ-RhoGEF blocks semaphorin 4D-induced growth cone collapse in primary hippocampal neurons. Our study indicates that the interaction of mammalian plexin-B family members with the multidomain proteins PDZ-RhoGEF and LARG represents an essential molecular link between plexin-B and localized, Rho-mediated downstream signaling events which underly various plexin-mediated cellular phenomena including axonal growth cone collapse.	Heidelberg Univ, Inst Pharmacol, D-69120 Heidelberg, Germany; Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr, D-91054 Erlangen, Germany	Ruprecht Karls University Heidelberg; University of Erlangen Nuremberg	Offermanns, S (corresponding author), Heidelberg Univ, Inst Pharmacol, Neuenheimer Feld 366, D-69120 Heidelberg, Germany.	stefan.offermanns@urz.uni-heidelberg.de	Kuner, Rohini/AGU-0204-2022; Offermanns, Stefan/L-3313-2017	Offermanns, Stefan/0000-0001-8676-6805				Bateman J, 2001, J CELL SCI, V114, P1973; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Brouns MR, 2001, NAT CELL BIOL, V3, P361, DOI 10.1038/35070042; BUHL AM, 1995, J BIOL CHEM, V270, P24631, DOI 10.1074/jbc.270.42.24631; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Culotti JG, 1996, CURR OPIN NEUROBIOL, V6, P81, DOI 10.1016/S0959-4388(96)80012-2; Dickson BJ, 2001, CURR OPIN NEUROBIOL, V11, P103, DOI 10.1016/S0959-4388(00)00180-X; Driessens MHE, 2001, CURR BIOL, V11, P339, DOI 10.1016/S0960-9822(01)00092-6; Elhabazi A, 2001, J IMMUNOL, V166, P4341, DOI 10.4049/jimmunol.166.7.4341; Fromm C, 1997, P NATL ACAD SCI USA, V94, P10098, DOI 10.1073/pnas.94.19.10098; Fukuhara S, 2001, ONCOGENE, V20, P1661, DOI 10.1038/sj.onc.1204182; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; Girkontaite I, 2001, NAT IMMUNOL, V2, P855, DOI 10.1038/ni0901-855; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hormuzdi SG, 2001, NEURON, V31, P487, DOI 10.1016/S0896-6273(01)00387-7; Hu HL, 2001, NEURON, V32, P39, DOI 10.1016/S0896-6273(01)00453-6; ISHIKAWA K, 1997, DNA RES, V31, P307; Jackson M, 2001, NATURE, V410, P89, DOI 10.1038/35065091; Jin Z, 1997, J NEUROSCI, V17, P6256; Katoh H, 1998, J BIOL CHEM, V273, P28700, DOI 10.1074/jbc.273.44.28700; Kornau HC, 1997, CURR OPIN NEUROBIOL, V7, P368, DOI 10.1016/S0959-4388(97)80064-5; Kourlas PJ, 2000, P NATL ACAD SCI USA, V97, P2145, DOI 10.1073/pnas.040569197; Kranenburg O, 1999, MOL BIOL CELL, V10, P1851, DOI 10.1091/mbc.10.6.1851; Kuhn TB, 2000, J NEUROBIOL, V44, P126, DOI 10.1002/1097-4695(200008)44:2<126::AID-NEU4>3.0.CO;2-Z; Kuhn TB, 1999, J NEUROSCI, V19, P1965; Kumanogoh A, 2001, TRENDS IMMUNOL, V22, P670, DOI 10.1016/S1471-4906(01)02087-7; Liu BP, 2001, CURR OPIN CELL BIOL, V13, P619, DOI 10.1016/S0955-0674(00)00260-X; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Mack TGA, 2000, MOL CELL NEUROSCI, V15, P51, DOI 10.1006/mcne.1999.0802; Maestrini E, 1996, P NATL ACAD SCI USA, V93, P674, DOI 10.1073/pnas.93.2.674; Mueller BK, 1999, ANNU REV NEUROSCI, V22, P351, DOI 10.1146/annurev.neuro.22.1.351; Nagase T, 1999, DNA Res, V6, P337, DOI 10.1093/dnares/6.5.337; Nagase T, 1997, DNA Res, V4, P141, DOI 10.1093/dnares/4.2.141; Nakamura F, 2000, J NEUROBIOL, V44, P219, DOI 10.1002/1097-4695(200008)44:2<219::AID-NEU11>3.0.CO;2-W; Puschel AW, 1996, EUR J NEUROSCI, V8, P1317, DOI 10.1111/j.1460-9568.1996.tb01593.x; Raper JA, 2000, CURR OPIN NEUROBIOL, V10, P88, DOI 10.1016/S0959-4388(99)00057-4; Ren XD, 2000, METHOD ENZYMOL, V325, P264; Reuther GW, 2001, J BIOL CHEM, V276, P27145, DOI 10.1074/jbc.M103565200; Rohm B, 2000, MECH DEVELOP, V93, P95, DOI 10.1016/S0925-4773(00)00269-0; Sah VP, 2000, ANNU REV PHARMACOL, V40, P459, DOI 10.1146/annurev.pharmtox.40.1.459; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Symons M, 2000, TRENDS CELL BIOL, V10, P415, DOI 10.1016/S0962-8924(00)01832-8; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Tamagnone L, 2000, TRENDS CELL BIOL, V10, P377, DOI 10.1016/S0962-8924(00)01816-X; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Togashi H, 2000, J BIOL CHEM, V275, P29570, DOI 10.1074/jbc.M003726200; Vastrik I, 1999, CURR BIOL, V9, P991, DOI 10.1016/S0960-9822(99)80447-3; Vikis HG, 2000, P NATL ACAD SCI USA, V97, P12457, DOI 10.1073/pnas.220421797; Vikis HG, 2002, GENE DEV, V16, P836, DOI 10.1101/gad.966402; Vojtek AB, 1997, ADV MOLEC BIOL, P29; Wang XS, 2001, BLOOD, V97, P3498, DOI 10.1182/blood.V97.11.3498; Whitehead IP, 1996, J BIOL CHEM, V271, P18643, DOI 10.1074/jbc.271.31.18643; Zheng Y, 2001, TRENDS BIOCHEM SCI, V26, P724, DOI 10.1016/S0968-0004(01)01973-9	56	296	307	1	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 3	2002	35	1					51	63		10.1016/S0896-6273(02)00750-X	http://dx.doi.org/10.1016/S0896-6273(02)00750-X			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	569KP	12123608	Bronze			2022-12-24	WOS:000176601800010
J	Vaillant, AR; Zanassi, P; Walsh, GS; Aumont, A; Alonso, A; Miller, FD				Vaillant, AR; Zanassi, P; Walsh, GS; Aumont, A; Alonso, A; Miller, FD			Signaling mechanisms underlying reversible, activity-dependent dendrite formation	NEURON			English	Article							MICROTUBULE-ASSOCIATED PROTEIN-2; SUPERIOR CERVICAL-GANGLION; NERVE GROWTH-FACTOR; SYMPATHETIC NEURONS; STRUCTURAL-CHANGES; CELL MORPHOLOGY; KINASE-II; IN-VITRO; PHOSPHORYLATION; MAP2	Neuronal activity and neurotrophins play a central role in the formation, maintenance, and plasticity of dendritic arbors. Here, we show that neuronal activity, mediated by electrical stimulation, KCl depolarization, or cholinergic receptor activation, promotes reversible dendrite formation in sympathetic neurons and that this effect is enhanced by NGF. Activity-dependent dendrite formation is accompanied by increased association of HMW MAP2 with microtubules and increased microtubule stability. Inhibition of either CaMKII or the MEK-ERK pathway, both of which phosphorylate MAP2, inhibits dendrite formation, but inhibition of both pathways simultaneously is required for dendrites to retract. These data indicate that neuronal activity signals via CamKII and the ERKs to regulate MAP2:microtubule interactions and hence reversible dendrite stability, and to provide a mechanism whereby activity and neurotrophins converge intracellularly to dynamically regulate dendritic morphology.	McGill Univ, Montreal Neurol Inst, Ctr Neuronal Survival, Brain Tumor Res Ctr, Montreal, PQ H3A 2B4, Canada; McGill Univ, Montreal Neurol Inst, Grp Cell Biol Excitable Tissues, Montreal, PQ H3A 2B4, Canada	McGill University; McGill University	Miller, FD (corresponding author), McGill Univ, Montreal Neurol Inst, Ctr Neuronal Survival, Brain Tumor Res Ctr, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.	freda.miller@mcgill.ca		VAILLANT, Andrew/0000-0002-1433-0700				ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; [Anonymous], [No title captured]; Atwal JK, 2000, NEURON, V27, P265, DOI 10.1016/S0896-6273(00)00035-0; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; BERNHARDT R, 1984, J COMP NEUROL, V226, P203, DOI 10.1002/cne.902260205; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; Brosenitsch TA, 2001, J NEUROSCI, V21, P2571, DOI 10.1523/JNEUROSCI.21-08-02571.2001; BRUGG B, 1991, J CELL BIOL, V114, P735, DOI 10.1083/jcb.114.4.735; CACERES A, 1984, DEV BRAIN RES, V13, P314, DOI 10.1016/0165-3806(84)90167-6; CACERES A, 1990, NATURE, V343, P461, DOI 10.1038/343461a0; Causing CG, 1997, NEURON, V18, P257, DOI 10.1016/S0896-6273(00)80266-4; COLLINS CA, 1987, J CELL BIOL, V105, P2847, DOI 10.1083/jcb.105.6.2847; DIAZNIDO J, 1993, EUR J NEUROSCI, V5, P818, DOI 10.1111/j.1460-9568.1993.tb00933.x; FRANKLIN JL, 1995, J NEUROSCI, V15, P643; Gamblin TC, 1996, BIOCHEMISTRY-US, V35, P12576, DOI 10.1021/bi961135d; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; ISHIDA A, 1995, BIOCHEM BIOPH RES CO, V212, P806, DOI 10.1006/bbrc.1995.2040; JAMESON L, 1981, P NATL ACAD SCI-BIOL, V78, P3413, DOI 10.1073/pnas.78.6.3413; JOSHI HC, 1989, J CELL BIOL, V109, P663, DOI 10.1083/jcb.109.2.663; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; KATZ LC, 1989, J NEUROSCI, V9, P1389; LECLERC N, 1993, P NATL ACAD SCI USA, V90, P6223, DOI 10.1073/pnas.90.13.6223; LEE JC, 1978, BIOCHEMISTRY-US, V17, P2783, DOI 10.1021/bi00607a013; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; LEIN P, 1995, NEURON, V15, P597, DOI 10.1016/0896-6273(95)90148-5; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; MADERDRUT JL, 1988, BRAIN RES, V444, P189, DOI 10.1016/0006-8993(88)90928-6; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Niblock MM, 2000, J NEUROSCI, V20, P4165; OBAR RA, 1989, NEURON, V3, P639, DOI 10.1016/0896-6273(89)90274-2; PURVES D, 1986, J NEUROSCI, V6, P1051; PURVES D, 1975, J PHYSIOL-LONDON, V252, P429, DOI 10.1113/jphysiol.1975.sp011151; PURVES D, 1988, NATURE, V336, P123, DOI 10.1038/336123a0; Quinlan EM, 1996, NEURON, V16, P357, DOI 10.1016/S0896-6273(00)80053-7; RAY LB, 1987, P NATL ACAD SCI USA, V84, P1502, DOI 10.1073/pnas.84.6.1502; RUBIN E, 1985, J NEUROSCI, V5, P673; RUBIN E, 1985, J NEUROSCI, V5, P697; RUBINO HM, 1989, NEURON, V3, P631, DOI 10.1016/0896-6273(89)90273-0; RUIT KG, 1990, J NEUROSCI, V10, P2412; RUIT KG, 1991, J COMP NEUROL, V314, P106, DOI 10.1002/cne.903140110; Sanchez C, 2000, PROG NEUROBIOL, V61, P133, DOI 10.1016/S0301-0082(99)00046-5; SCHULMAN H, 1984, J CELL BIOL, V99, P11, DOI 10.1083/jcb.99.1.11; SNIDER WD, 1988, J NEUROSCI, V8, P2628; THROWER D, 1991, J IMMUNOL METHODS, V136, P45, DOI 10.1016/0022-1759(91)90248-E; TOKUMITSU H, 1990, J BIOL CHEM, V265, P4315; Vaillant AR, 1998, J BIOL CHEM, V273, P13973, DOI 10.1074/jbc.273.22.13973; Vaillant AR, 1999, J CELL BIOL, V146, P955, DOI 10.1083/jcb.146.5.955; VOLKMAR FR, 1972, SCIENCE, V176, P1445, DOI 10.1126/science.176.4042.1445; VOYVODIC JT, 1989, J NEUROSCI, V9, P1997; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976; Xu BJ, 2000, NEURON, V26, P233, DOI 10.1016/S0896-6273(00)81153-8; YAWO H, 1987, J NEUROSCI, V7, P3703	54	194	198	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 13	2002	34	6					985	998		10.1016/S0896-6273(02)00717-1	http://dx.doi.org/10.1016/S0896-6273(02)00717-1			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	563HF	12086645	Bronze			2022-12-24	WOS:000176249700015
J	Lee, TS; Yang, CF; Romero, RD; Mumford, D				Lee, TS; Yang, CF; Romero, RD; Mumford, D			Neural activity in early visual cortex reflects behavioral experience and higher-order perceptual saliency	NATURE NEUROSCIENCE			English	Article							INTERACTIVE ACTIVATION; CONTEXTUAL MODULATION; MACAQUE MONKEY; AREAS V1; ATTENTION; TEXTURE; SHAPE; MECHANISMS; RESPONSES; VISION	We report here that shape-from-shading stimuli evoked a long-latency contextual pop-out response in V1 and V2 neurons of macaque monkeys, particularly after the monkeys had used the stimuli in a behavioral task. The magnitudes of the pop-out responses were correlated to the monkeys' behavioral performance, suggesting that these signals are neural correlates of perceptual pop-out saliency. The signals changed with the animal's behavioral adaptation to stimulus contingencies, indicating that perceptual saliency is also a function of experience and behavioral relevance. The evidence that higher-order stimulus attributes and task experience can influence early visual processing supports the notion that perceptual computation is an interactive and plastic process involving multiple cortical areas.	Carnegie Mellon Univ, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA; Carnegie Mellon Univ, Dept Comp Sci, Pittsburgh, PA 15213 USA; Brown Univ, Div Appl Math, Providence, RI 02912 USA	Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University; Brown University	Lee, TS (corresponding author), Carnegie Mellon Univ, Ctr Neural Basis Cognit, 4400 5th Ave, Pittsburgh, PA 15213 USA.	tai@cnbc.cmu.edu		Yang, Cindy/0000-0001-6144-4658	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR006009] Funding Source: NIH RePORTER; NCRR NIH HHS [2P41RR06009-11] Funding Source: Medline; NEI NIH HHS [EY08298] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Ahissar M, 1997, NATURE, V387, P401, DOI 10.1038/387401a0; Ahissar M, 2001, PSYCHOL SCI, V12, P56, DOI 10.1111/1467-9280.00310; Bakin JS, 2000, J NEUROSCI, V20, P8188; Bichot NP, 1999, NAT NEUROSCI, V2, P549, DOI 10.1038/9205; BRAUN J, 1993, SPATIAL VISION, V7, P311, DOI 10.1163/156856893X00469; Crist RE, 2001, NAT NEUROSCI, V4, P519, DOI 10.1038/87470; DECO G, IN PRESS NEUROCOMPUT; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; GROSSBERG S, 1987, COGNITIVE SCI, V11, P23, DOI 10.1111/j.1551-6708.1987.tb00862.x; Hupe JM, 2001, J NEUROPHYSIOL, V85, P134, DOI 10.1152/jn.2001.85.1.134; Ito M, 1999, NEURON, V22, P593, DOI 10.1016/S0896-6273(00)80713-8; Joseph JS, 1997, NATURE, V387, P805, DOI 10.1038/42940; JULESZ B, 1975, SCI AM, V232, P34, DOI 10.1038/scientificamerican0475-34; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961, DOI 10.1152/jn.1992.67.4.961; LAMME VAF, 1995, J NEUROSCI, V10, P649; Lee TS, 2001, P NATL ACAD SCI USA, V98, P1907, DOI 10.1073/pnas.031579998; Lee TS, 1998, VISION RES, V38, P2429, DOI 10.1016/S0042-6989(97)00464-1; Leopold DA, 1998, EXP BRAIN RES, V123, P341, DOI 10.1007/s002210050577; Levitt JB, 1997, NATURE, V387, P73, DOI 10.1038/387073a0; Li ZP, 1999, NETWORK-COMP NEURAL, V10, P187, DOI 10.1088/0954-898X/10/2/305; Logothetis N, 1998, CURR OPIN NEUROBIOL, V8, P536; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; MCCLELLAND JL, 1981, PSYCHOL REV, V88, P375, DOI 10.1037/0033-295X.88.5.375; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; MUMFORD D, 1992, BIOL CYBERN, V66, P241, DOI 10.1007/BF00198477; Nothdurft HC, 1999, VISUAL NEUROSCI, V16, P15, DOI 10.1017/S0952523899156189; Pollen DA, 1999, CEREB CORTEX, V9, P4, DOI 10.1093/cercor/9.1.4; RAMACHANDRAN VS, 1988, NATURE, V331, P163, DOI 10.1038/331163a0; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Rossi AF, 2001, J NEUROSCI, V21, P1698, DOI 10.1523/JNEUROSCI.21-05-01698.2001; STEMMLER M, 1995, SCIENCE, V269, P1877, DOI 10.1126/science.7569930; Sun J, 1996, NATURE, V379, P165, DOI 10.1038/379165a0; Super H, 2001, NAT NEUROSCI, V4, P304, DOI 10.1038/85170; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; WURTZ RH, 1969, J NEUROPHYSIOL, V32, P975, DOI 10.1152/jn.1969.32.6.975; Zipser K, 1996, J NEUROSCI, V16, P7376	37	159	161	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2002	5	6					589	597		10.1038/nn860	http://dx.doi.org/10.1038/nn860			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	556XQ	12021764				2022-12-24	WOS:000175874600020
J	Aizenman, CD; Munoz-Elias, G; Cline, HT				Aizenman, CD; Munoz-Elias, G; Cline, HT			Visually driven modulation of glutamatergic synaptic transmission is mediated by the regulation of intracellular polyamines	NEURON			English	Article							CALCIUM-PERMEABLE AMPA; LONG-TERM POTENTIATION; DEVELOPING RETINOTECTAL SYNAPSES; RECEPTOR CHANNELS; RAT-BRAIN; IN-VIVO; ORNITHINE DECARBOXYLASE; SUBUNIT COMPOSITION; KAINATE RECEPTORS; CA2+ PERMEABILITY	Ca2+-permeable AMPARs are inwardly rectifying due to block by intracellular polyamines. Neuronal activity regulates polyamine synthesis, yet whether this affects Ca2+-AMPAR-mediated synaptic transmission is unknown. We test whether 4 hr of increased visual stimulation regulates glutamatergic retino-tectal synapses in Xenopus tadpoles. Tectal neurons containing Ca2+-AMPARs form a gradient along the rostro-caudal developmental axis. These neurons had inwardly rectifying AMPAR-mediated EPSCs. Four hours of visual stimulation or addition of intracellular spermine increased rectification in immature neurons. Polyamine synthesis inhibitors blocked the effect of visual stimulation, suggesting that visual activity regulates AMPARs via the polyamine synthesis pathway. This modulation resulted in changes in the integrative properties of tectal neurons. Regulation of polyamine synthesis by physiological stimuli is a novel form of modulation of synaptic transmission important for understanding the short-term effects of enhanced sensory experience during development.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Cline, HT (corresponding author), Cold Spring Harbor Lab, Beckman Bldg,1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.							Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; BAUDRY M, 1994, NEUROSCI LETT, V171, P151, DOI 10.1016/0304-3940(94)90627-0; BOCHET P, 1994, NEURON, V12, P383, DOI 10.1016/0896-6273(94)90279-8; Bollmann JH, 1998, J NEUROSCI, V18, P10409; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; Bowie D, 1998, J NEUROSCI, V18, P8175; Burnashev N, 1996, J PHYSIOL-LONDON, V496, P165, DOI 10.1113/jphysiol.1996.sp021674; BURNASHEV N, 1992, SCIENCE, V256, P1566, DOI 10.1126/science.1317970; Cantallops I, 2000, NAT NEUROSCI, V3, P1004, DOI 10.1038/79823; Carvalho AL, 2000, NEUROCHEM RES, V25, P1245, DOI 10.1023/A:1007644128886; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; Cline HT, 1996, COLD SPRING HARB SYM, V61, P95; Constantine-Paton M, 1998, CURR OPIN NEUROBIOL, V8, P139, DOI 10.1016/S0959-4388(98)80017-2; Crair MC, 1999, CURR OPIN NEUROBIOL, V9, P88, DOI 10.1016/S0959-4388(99)80011-7; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; DONEVAN SD, 1995, P NATL ACAD SCI USA, V92, P9298, DOI 10.1073/pnas.92.20.9298; Estabel J, 1999, LIFE SCI, V64, P607, DOI 10.1016/S0024-3205(98)00603-1; Fox K, 2000, CURR OPIN NEUROBIOL, V10, P494, DOI 10.1016/S0959-4388(00)00112-4; FOX K, 1992, J NEUROSCI, V12, P1826; Furuta A, 1999, J NEUROBIOL, V39, P67, DOI 10.1002/(SICI)1097-4695(199904)39:1<67::AID-NEU6>3.0.CO;2-7; Gimenez-Llort L, 1998, NEUROREPORT, V9, P937, DOI 10.1097/00001756-199803300-00032; Gu JG, 1996, NATURE, V381, P793, DOI 10.1038/381793a0; HAYASHI Y, 1993, NEUROSCI LETT, V149, P63, DOI 10.1016/0304-3940(93)90348-O; HAYASHI Y, 1992, J NEUROCHEM, V58, P562, DOI 10.1111/j.1471-4159.1992.tb09756.x; HERBERG LJ, 1992, EPILEPSY RES, V11, P3, DOI 10.1016/0920-1211(92)90015-L; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; JONAS P, 1994, NEURON, V12, P1281, DOI 10.1016/0896-6273(94)90444-8; KAMBOJ SK, 1995, J PHYSIOL-LONDON, V486, P297, DOI 10.1113/jphysiol.1995.sp020812; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Knudsen EI, 1999, J COMP PHYSIOL A, V185, P305, DOI 10.1007/s003590050391; KOH DS, 1995, J PHYSIOL-LONDON, V486, P305, DOI 10.1113/jphysiol.1995.sp020813; Lawrence JJ, 2000, J NEUROSCI, V20, P4864; Linden DJ, 1999, NEURON, V22, P661, DOI 10.1016/S0896-6273(00)80726-6; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Mahanty NK, 1998, NATURE, V394, P683, DOI 10.1038/29312; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; MCBAIN CJ, 1993, J PHYSIOL-LONDON, V462, P373, DOI 10.1113/jphysiol.1993.sp019560; NAJM I, 1992, DEV BRAIN RES, V69, P11, DOI 10.1016/0165-3806(92)90117-F; OTIS TS, 1995, J PHYSIOL-LONDON, V482, P309, DOI 10.1113/jphysiol.1995.sp020519; PATERNAIN AV, 1995, NEURON, V14, P185, DOI 10.1016/0896-6273(95)90253-8; PELLEGRINIGIAMPIETRO DE, 1992, NEUROSCI LETT, V144, P65, DOI 10.1016/0304-3940(92)90717-L; PellegriniGiampietro DE, 1997, TRENDS NEUROSCI, V20, P464, DOI 10.1016/S0166-2236(97)01100-4; Pickard L, 2000, J NEUROSCI, V20, P7922; PRUSS RM, 1991, NEURON, V7, P509, DOI 10.1016/0896-6273(91)90302-G; Rajan I, 1998, J NEUROSCI, V18, P7836; Rozov A, 1999, NATURE, V401, P594, DOI 10.1038/44151; Rozov A, 1998, J PHYSIOL-LONDON, V511, P361, DOI 10.1111/j.1469-7793.1998.361bh.x; Standley S, 1998, DEV BRAIN RES, V107, P277, DOI 10.1016/S0165-3806(98)00036-4; STRAZNICKY K, 1972, J EMBRYOL EXP MORPH, V28, P87; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; Washburn MS, 1997, J NEUROSCI, V17, P9393; WIESEL TN, 1965, J NEUROPHYSIOL, V28, P1029, DOI 10.1152/jn.1965.28.6.1029; Williams K, 1997, CELL SIGNAL, V9, P1, DOI 10.1016/S0898-6568(96)00089-7; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Wu GY, 1999, J NEUROSCI, V19, P4472; ZAWIA NH, 1990, MOL BRAIN RES, V7, P243, DOI 10.1016/0169-328X(90)90034-B; ZAWIA NH, 1993, DEV BRAIN RES, V71, P53, DOI 10.1016/0165-3806(93)90104-I; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665; Zhang LI, 2000, NAT NEUROSCI, V3, P708, DOI 10.1038/76665	61	81	81	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 16	2002	34	4					623	634		10.1016/S0896-6273(02)00674-8	http://dx.doi.org/10.1016/S0896-6273(02)00674-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	553FT	12062045	Bronze			2022-12-24	WOS:000175665700015
J	Nakamura, W; Honma, S; Shirakawa, T; Honma, K				Nakamura, W; Honma, S; Shirakawa, T; Honma, K			Clock mutation lengthens the circadian period without damping rhythms in individual SCN neurons	NATURE NEUROSCIENCE			English	Article							GENE; BEHAVIOR		Hokkaido Univ, Grad Sch Med, Dept Physiol, Sapporo, Hokkaido 0608638, Japan; Hokkaido Univ, Grad Sch Dent, Dept Oral Funct Sci, Sapporo, Hokkaido 0608586, Japan	Hokkaido University; Hokkaido University	Honma, S (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Physiol, Sapporo, Hokkaido 0608638, Japan.							Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Herzog ED, 1998, NAT NEUROSCI, V1, P708, DOI 10.1038/3708; Honma S, 1998, NEUROSCI LETT, V250, P157, DOI 10.1016/S0304-3940(98)00464-9; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; Klein D.C., 1991, SUPRACHIASMATIC NUCL; Low-Zeddies SS, 2001, CELL, V105, P25, DOI 10.1016/S0092-8674(01)00294-X; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7	10	104	106	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2002	5	5					399	400		10.1038/nn843	http://dx.doi.org/10.1038/nn843			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	546JY	11953751				2022-12-24	WOS:000175272000007
J	Tanemoto, M; Fujita, A; Higashi, K; Kurachi, Y				Tanemoto, M; Fujita, A; Higashi, K; Kurachi, Y			PSD-95 mediates formation of a functional homomeric Kir5.1 channel in the brain	NEURON			English	Article							RECTIFIER K+-CHANNEL; PROTEIN-KINASE; SULFONYLUREA RECEPTOR; POTASSIUM CHANNELS; PDZ PROTEINS; FAMILY; PHOSPHORYLATION; EXPRESSION; DOMAIN; LOCALIZATION	Homomeric assembly of Kir5.1, an inward-rectifying K+ channel subunit, is believed to be nonfunctional, although the subunit exists abundantly in the brain. We show that HEK293T cells cotransfected with Kir5.1 and PSD-95 exhibit a Ball-sensitive inward-rectifying K+ current. Kir5.1 coexpressed with PSD-95 located on the plasma membrane in a clustered manner, while the Kir5.1 subunit expressed alone distributed mostly in cytoplasm, probably due to rapid internalization. The binding of Kir5.1 with PSD-95 was prevented by protein kinase A (PKA)-mediated phosphorylation of its carboxyl terminus. The currents flowing through Kir5.1/PSD-95 were suppressed promptly and reversibly by PKA activation. Because the Kir5.1/PSD-95 complex was detected in the brain, this functional brain K+ channel is potentially a novel physiological target of PKA-mediated signaling.	Osaka Univ, Grad Sch Med A7, Dept Pharmacol 2, Suita, Osaka 5650871, Japan	Osaka University	Kurachi, Y (corresponding author), Osaka Univ, Grad Sch Med A7, Dept Pharmacol 2, Yamadaoka 2-2, Suita, Osaka 5650871, Japan.							BOND CT, 1994, RECEPTOR CHANNEL, V2, P183; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Cohen NA, 1996, NEURON, V17, P759, DOI 10.1016/S0896-6273(00)80207-X; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Craven SE, 1998, CELL, V93, P495, DOI 10.1016/S0092-8674(00)81179-4; Fraser IDC, 1999, NEURON, V23, P423, DOI 10.1016/S0896-6273(00)80795-3; Hibino H, 2000, EMBO J, V19, P78, DOI 10.1093/emboj/19.1.78; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Inanobe A, 1999, J NEUROSCI, V19, P1006; Isomoto S, 1997, JPN J PHYSIOL, V47, P11, DOI 10.2170/jjphysiol.47.11; Jan LY, 1997, ANNU REV NEUROSCI, V20, P91, DOI 10.1146/annurev.neuro.20.1.91; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Nehring RB, 2000, J NEUROSCI, V20, P156, DOI 10.1523/JNEUROSCI.20-01-00156.2000; Niethammer M, 1998, NEURON, V20, P693, DOI 10.1016/S0896-6273(00)81009-0; Pearson WL, 1999, J PHYSIOL-LONDON, V514, P639, DOI 10.1111/j.1469-7793.1999.639ad.x; Pessia M, 1996, EMBO J, V15, P2980, DOI 10.1002/j.1460-2075.1996.tb00661.x; Salvatore L, 1999, FEBS LETT, V449, P146, DOI 10.1016/S0014-5793(99)00420-2; Sheng M, 2001, P NATL ACAD SCI USA, V98, P7058, DOI 10.1073/pnas.111146298; Simpson F, 1999, NAT CELL BIOL, V1, P119, DOI 10.1038/10091; Tanemoto M, 2000, J PHYSIOL-LONDON, V525, P587, DOI 10.1111/j.1469-7793.2000.00587.x; Tucker SJ, 2000, J BIOL CHEM, V275, P16404, DOI 10.1074/jbc.C000127200; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; Wang SS, 2000, CELL, V103, P169, DOI 10.1016/S0092-8674(00)00096-9; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93; Wischmeyer E, 1996, P NATL ACAD SCI USA, V93, P5819, DOI 10.1073/pnas.93.12.5819; Xu HX, 2000, J PHYSIOL-LONDON, V524, P725, DOI 10.1111/j.1469-7793.2000.00725.x; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	29	56	59	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 25	2002	34	3					387	397		10.1016/S0896-6273(02)00675-X	http://dx.doi.org/10.1016/S0896-6273(02)00675-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	545JW	11988170	Bronze			2022-12-24	WOS:000175214700010
J	Krekelberg, B; Kubischik, M; Hoffmann, KP; Bremmer, F				Krekelberg, B; Kubischik, M; Hoffmann, KP; Bremmer, F			Neural correlates of visual localization and perisaccadic mislocalization	NEURON			English	Article							SACCADIC EYE-MOVEMENTS; PARIETAL CORTEX; APPARENT POSITION; RECEPTIVE-FIELDS; MOVING-OBJECTS; MONKEY; NEURONS; REPRESENTATION; SPACE; MT	While reading this text, your eyes jump from word to word. Yet you are unaware of the motion this causes on your retina; the brain somehow compensates for these displacements and creates a stable percept of the world. This compensation is not perfect; perisaccadically, perceptual space is distorted. We show that this distortion can be traced to a representation of retinal position in the medial temporal and medial superior temporal areas. These cells accurately represent retinal position during fixation, but perisaccadically, the same cells distort the representation of space. The time course and magnitude of this distortion are similar to the mislocalization found psychophysically in humans. This challenges the assumption in many psychophysical studies that the perisaccadic retinal position signal is veridical.	Ruhr Univ Bochum, Dept Gen Zool & Neurobiol, D-44780 Bochum, Germany	Ruhr University Bochum	Krekelberg, B (corresponding author), Salk Inst Biol Studies, Vis Ctr Lab, 10100 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Krekelberg, Bart/N-7938-2019; Bremmer, Frank/F-3268-2012	Krekelberg, Bart/0000-0003-1083-6103; Bremmer, Frank/0000-0003-1597-7407				BISCHOF N, 1968, PSYCHOL FORSCH, V32, P185, DOI 10.1007/BF00418660; Bremmer F, 1997, J NEUROPHYSIOL, V77, P944, DOI 10.1152/jn.1997.77.2.944; BURR DC, 1994, NATURE, V371, P511, DOI 10.1038/371511a0; DASSONVILLE P, 1992, VISUAL NEUROSCI, V9, P261, DOI 10.1017/S0952523800010671; Diamond MR, 2000, J NEUROSCI, V20, P3449, DOI 10.1523/JNEUROSCI.20-09-03449.2000; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Duhamel JR, 1997, NATURE, V389, P845, DOI 10.1038/39865; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; Holt EB, 1903, PSYCHOL REV-MONOGR S, V4, P3; HONDA H, 1991, VISION RES, V31, P1915, DOI 10.1016/0042-6989(91)90186-9; HONDA H, 1993, VISION RES, V33, P709, DOI 10.1016/0042-6989(93)90190-8; Krekelberg B, 2001, TRENDS NEUROSCI, V24, P335, DOI 10.1016/S0166-2236(00)01795-1; Krekelberg B, 2000, VISION RES, V40, P201, DOI 10.1016/S0042-6989(99)00168-6; Kubischik M., 1999, Society for Neuroscience Abstracts, V25, P1164; Lappe M, 2000, NATURE, V403, P892, DOI 10.1038/35002588; MACKAY DM, 1970, NATURE, V227, P731, DOI 10.1038/227731a0; MATEEFF S, 1978, PERCEPT PSYCHOPHYS, V24, P215, DOI 10.3758/BF03206092; MATIN L, 1965, SCIENCE, V148, P1485, DOI 10.1126/science.148.3676.1485; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; MISHKIN M, 1983, TRENDS NEUROSCI, V6, P414, DOI 10.1016/0166-2236(83)90190-X; Morrone MC, 1997, J NEUROSCI, V17, P7941; OREGAN JK, 1984, PERCEPT PSYCHOPHYS, V36, P1, DOI 10.3758/BF03206348; Recanzone GH, 1999, J NEUROPHYSIOL, V82, P1710, DOI 10.1152/jn.1999.82.4.1710; Ross J, 2001, TRENDS NEUROSCI, V24, P113, DOI 10.1016/S0166-2236(00)01685-4; Ross J, 1997, NATURE, V386, P598, DOI 10.1038/386598a0; Schlag J, 2002, NAT REV NEUROSCI, V3, P191, DOI 10.1038/nrn750; Schmolesky MT, 1998, J NEUROPHYSIOL, V79, P3272, DOI 10.1152/jn.1998.79.6.3272; Snyder LH, 2000, CURR OPIN NEUROBIOL, V10, P747, DOI 10.1016/S0959-4388(00)00152-5; Thiele A, 2002, SCIENCE, V295, P2460, DOI 10.1126/science.1068788; Tolias AS, 2001, NEURON, V29, P757, DOI 10.1016/S0896-6273(01)00250-1; Umeno MM, 1997, J NEUROPHYSIOL, V78, P1373, DOI 10.1152/jn.1997.78.3.1373; WALKER MF, 1995, J NEUROPHYSIOL, V73, P1988, DOI 10.1152/jn.1995.73.5.1988; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0	33	66	66	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 6	2003	37	3					537	545		10.1016/S0896-6273(03)00003-5	http://dx.doi.org/10.1016/S0896-6273(03)00003-5			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	647FF	12575959	Bronze			2022-12-24	WOS:000181081600017
J	Murthy, M; Garza, D; Scheller, RH; Schwarz, TL				Murthy, M; Garza, D; Scheller, RH; Schwarz, TL			Mutations in the exocyst component Sec5 disrupt neuronal membrane traffic, but neurotransmitter release persists	NEURON			English	Article							CULTURED HIPPOCAMPAL-NEURONS; SYNAPTIC VESICLE BIOGENESIS; YEAST SECRETORY PATHWAY; TRANS-GOLGI NETWORK; SACCHAROMYCES-CEREVISIAE; DROSOPHILA-MELANOGASTER; NEURITE OUTGROWTH; BINDING-PROTEIN; PLASMA-MEMBRANE; SEC6/8 COMPLEX	The exocyst (Sec6/8) complex is necessary for secretion in yeast and has been postulated to establish polarity by directing vesicle fusion to specific sites along the plasma membrane. The complex may also function in the nervous system, but its precise role is unknown. We have investigated exocyst function in Drosophila with mutations in one member of the complex, sec5. Null alleles die as growth-arrested larvae, whose neuromuscular junctions fall to expand. In culture, neurite outgrowth fails in sec5 mutants once maternal Sec5 is exhausted. Using a trafficking assay, we found impairments in the membrane addition of newly synthesized proteins. In contrast, synaptic vesicle fusion was not impaired. Thus, Sec5 differentiates between two forms of vesicle trafficking: trafficking for cell growth and membrane protein insertion depend on sec5, whereas transmitter secretion does not. In this regard, sec5 differs from the homologs of other yeast exocytosis genes that are required for both neuronal trafficking pathways.	Stanford Univ, Howard Hughes Med Inst, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; Florida State Univ, Dept Biol Sci, Tallahassee, FL 32312 USA; Harvard Univ, Childrens Hosp, Sch Med, Div Neurosci, Boston, MA 02115 USA	Howard Hughes Medical Institute; Stanford University; State University System of Florida; Florida State University; Harvard University; Boston Children's Hospital; Harvard Medical School	Schwarz, TL (corresponding author), Stanford Univ, Howard Hughes Med Inst, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH048108, T32MH020016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041062] Funding Source: NIH RePORTER; NIMH NIH HHS [5T32 MH20016-04, MH48108] Funding Source: Medline; NINDS NIH HHS [NS41062] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BASHAW GJ, 1995, DEVELOPMENT, V121, P3245; BRAY D, 1970, P NATL ACAD SCI USA, V65, P905, DOI 10.1073/pnas.65.4.905; BURGESS TL, 1987, ANNU REV CELL BIOL, V3, P243, DOI 10.1146/annurev.cellbio.3.1.243; Calakos N, 1996, PHYSIOL REV, V76, P1; Chou TB, 1996, GENETICS, V144, P1673; CRAIG AM, 1995, NATURE, V375, P592, DOI 10.1038/375592a0; DOTTI CG, 1990, CELL, V62, P63, DOI 10.1016/0092-8674(90)90240-F; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Finger FP, 1998, J CELL BIOL, V142, P609, DOI 10.1083/jcb.142.3.609; Finger FP, 1998, CELL, V92, P559, DOI 10.1016/S0092-8674(00)80948-4; Finger FP, 1997, MOL BIOL CELL, V8, P647, DOI 10.1091/mbc.8.4.647; Friedrich GA, 1997, DEV BIOL, V192, P364, DOI 10.1006/dbio.1997.8727; Grindstaff KK, 1998, CELL, V93, P731, DOI 10.1016/S0092-8674(00)81435-X; Grote E, 2000, J CELL BIOL, V151, P439, DOI 10.1083/jcb.151.2.439; Guo W, 1999, J BIOL CHEM, V274, P23558, DOI 10.1074/jbc.274.33.23558; Guo W, 1999, EMBO J, V18, P1071, DOI 10.1093/emboj/18.4.1071; Hannah MJ, 1999, ANNU REV CELL DEV BI, V15, P733, DOI 10.1146/annurev.cellbio.15.1.733; Hazuka CD, 1999, J NEUROSCI, V19, P1324; Hsu SC, 1996, NEURON, V17, P1209, DOI 10.1016/S0896-6273(00)80251-2; Jantti J, 1999, P NATL ACAD SCI USA, V96, P909, DOI 10.1073/pnas.96.3.909; Jareb M, 1998, NEURON, V20, P855, DOI 10.1016/S0896-6273(00)80468-7; Kee Y, 1997, P NATL ACAD SCI USA, V94, P14438, DOI 10.1073/pnas.94.26.14438; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; Lin RC, 2000, ANNU REV CELL DEV BI, V16, P19, DOI 10.1146/annurev.cellbio.16.1.19; Lipschutz JH, 2000, MOL BIOL CELL, V11, P4259, DOI 10.1091/mbc.11.12.4259; MATTEOLI M, 1992, J CELL BIOL, V117, P849, DOI 10.1083/jcb.117.4.849; Moskalenko S, 2002, NAT CELL BIOL, V4, P66, DOI 10.1038/ncb728; NOVICK P, 1981, CELL, V25, P461, DOI 10.1016/0092-8674(81)90064-7; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; REGNIERVIGOUROUX A, 1993, NEUROCHEM RES, V18, P59, DOI 10.1007/BF00966923; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; SALMINEN A, 1989, J CELL BIOL, V109, P1023, DOI 10.1083/jcb.109.3.1023; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; Stewart BA, 2000, P NATL ACAD SCI USA, V97, P13955, DOI 10.1073/pnas.250491397; Stowers RS, 1999, GENETICS, V152, P1631; Sudhof TC, 2000, NEURON, V28, P317, DOI 10.1016/S0896-6273(00)00109-4; TERBUSH DR, 1995, J CELL BIOL, V130, P299, DOI 10.1083/jcb.130.2.299; Ueda A, 1996, INVERTEBR NEUROSCI, V1, P315, DOI 10.1007/BF02211911; Vega IE, 2001, J NEUROSCI, V21, P3839, DOI 10.1523/JNEUROSCI.21-11-03839.2001; WU CF, 1983, J NEUROSCI, V3, P1888; Yeaman C, 2001, J CELL BIOL, V155, P593, DOI 10.1083/jcb.200107088; Zhang YQ, 2002, GENESIS, V34, P142, DOI 10.1002/gene.10144	43	156	159	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 6	2003	37	3					433	447		10.1016/S0896-6273(03)00031-X	http://dx.doi.org/10.1016/S0896-6273(03)00031-X			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	647FF	12575951	Bronze			2022-12-24	WOS:000181081600009
J	Csicsvari, J; Jamieson, B; Wise, KD; Buzsaki, G				Csicsvari, J; Jamieson, B; Wise, KD; Buzsaki, G			Mechanisms of gamma oscillations in the hippocampus of the behaving rat	NEURON			English	Article							NETWORK OSCILLATIONS; GAP-JUNCTIONS; NEURONAL SYNCHRONIZATION; CHOLINERGIC INDUCTION; GABAERGIC MODULATION; SYNAPTIC INHIBITION; ENTORHINAL CORTEX; PYRAMIDAL CELLS; VISUAL-CORTEX; BETA RHYTHMS	Gamma frequency oscillations (30-100 Hz) have been suggested to underlie various cognitive and motor functions. Here, we examine the generation of gamma oscillation currents in the hippocampus, using two-dimensional, 96-site silicon probes. Two gamma generators were identified, one in the dentate gyrus and another in the CA3-CA1 regions. The coupling strength between the two oscillators varied during both theta and nontheta states. Both pyramidal cells and interneurons were phase-locked to gamma waves. Anatomical connectivity, rather than physical distance, determined the coupling strength of the oscillating neurons. CA3 pyramidal neurons discharged CA3 and CA1 interneurons at latencies indicative of monosynaptic connections. Intrahippocampal gamma oscillation emerges in the CA3 recurrent system, which entrains the CA1 region via its interneurons.	Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA; Univ Michigan, Dept Elect Engn & Comp Sci, Ann Arbor, MI 48109 USA	Rutgers State University Newark; Rutgers State University New Brunswick; University of Michigan System; University of Michigan	Buzsaki, G (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, 197 Univ Ave, Newark, NJ 07102 USA.	buzsaki@axon.rutgers.edu		Buzsaki, Gyorgy/0000-0002-3100-4800	NCRR NIH HHS [1P41RR09754] Funding Source: Medline; NIMH NIH HHS [MH54671] Funding Source: Medline; NINDS NIH HHS [NS43157, NS34994] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR009754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034994, R01NS043157] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ali AB, 1998, J PHYSIOL-LONDON, V507, P201, DOI 10.1111/j.1469-7793.1998.201bu.x; Bartos M, 2002, P NATL ACAD SCI USA, V99, P13222, DOI 10.1073/pnas.192233099; Bracci E, 1999, J NEUROSCI, V19, P8104; BRAGIN A, 1995, J NEUROSCI, V15, P47; BULLOCK TH, 1989, ELECTROEN CLIN NEURO, V73, P479, DOI 10.1016/0013-4694(89)90258-7; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; Buzsaki G., 1994, TEMPORAL CODING BRAI; CHARPAK S, 1995, EUR J NEUROSCI, V7, P1548, DOI 10.1111/j.1460-9568.1995.tb01150.x; Chow CC, 1998, J COMPUT NEUROSCI, V5, P407, DOI 10.1023/A:1008889328787; Chrobak JJ, 1998, J NEUROSCI, V18, P388; Colling SB, 1998, J NEUROPHYSIOL, V80, P155, DOI 10.1152/jn.1998.80.1.155; Csicsvari J, 2000, NEURON, V28, P585, DOI 10.1016/S0896-6273(00)00135-5; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; Deans MR, 2001, NEURON, V31, P477, DOI 10.1016/S0896-6273(01)00373-7; ECKHORN R, 1994, PROG BRAIN RES, V102, P405; EECKMAN FH, 1990, BRAIN RES, V528, P238, DOI 10.1016/0006-8993(90)91663-2; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fell J, 2001, NAT NEUROSCI, V4, P1259, DOI 10.1038/nn759; Fellous JM, 2000, HIPPOCAMPUS, V10, P187, DOI 10.1002/(SICI)1098-1063(2000)10:2<187::AID-HIPO8>3.3.CO;2-D; Fetz EE, 2000, J PHYSIOLOGY-PARIS, V94, P323, DOI 10.1016/S0928-4257(00)01089-5; Fisahn A, 2002, NEURON, V33, P615, DOI 10.1016/S0896-6273(02)00587-1; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Fisher NI, 1995, STAT ANAL CIRCULAR D; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Fries P, 2001, NAT NEUROSCI, V4, P194, DOI 10.1038/84032; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Gray C M, 1994, J Comput Neurosci, V1, P11, DOI 10.1007/BF00962716; Gray CM, 1995, J NEUROSCI METH, V63, P43, DOI 10.1016/0165-0270(95)00085-2; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Hasselmo ME, 1996, HIPPOCAMPUS, V6, P693, DOI 10.1002/(SICI)1098-1063(1996)6:6<693::AID-HIPO12>3.0.CO;2-W; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; Hirai N, 1999, NEUROSCIENCE, V90, P1149, DOI 10.1016/S0306-4522(98)00513-2; Hirase H, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-10-j0003.2001; HOLSHEIMER J, 1987, EXP BRAIN RES, V67, P402; Hormuzdi SG, 2001, NEURON, V31, P487, DOI 10.1016/S0896-6273(01)00387-7; ISHIZUKA N, 1990, J COMP NEUROL, V295, P580, DOI 10.1002/cne.902950407; Jensen O, 1996, LEARN MEMORY, V3, P264, DOI 10.1101/lm.3.2-3.264; Kanji G., 1999, 100 STAT TESTS; KATSUMARU H, 1988, EXP BRAIN RES, V72, P363; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; LEUNG LS, 1979, J NEUROPHYSIOL, V42, P1571, DOI 10.1152/jn.1979.42.6.1571; Leung LS, 1998, NEUROSCI BIOBEHAV R, V22, P275; LEUNG LWS, 1987, BRAIN RES, V419, P173, DOI 10.1016/0006-8993(87)90581-6; LEUNG LWS, 1992, HIPPOCAMPUS, V2, P93, DOI 10.1002/hipo.450020202; LEUNG LWS, 1982, J NEUROPHYSIOL, V47, P845, DOI 10.1152/jn.1982.47.5.845; LI XM, 1994, POTENTIAL ANAL, V3, P339, DOI 10.1007/BF01049807; Lisman J, 1998, NATURE, V394, P132, DOI 10.1038/28061; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Llinas R, 1998, PHILOS T ROY SOC B, V353, P1841, DOI 10.1098/rstb.1998.0336; Marshall L, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-02-j0001.2002; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; MIZUMORI SJY, 1989, J NEUROPHYSIOL, V61, P15, DOI 10.1152/jn.1989.61.1.15; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Orban G, 2001, BIOL CYBERN, V84, P123, DOI 10.1007/s004220000199; Penttonen M, 1998, EUR J NEUROSCI, V10, P718, DOI 10.1046/j.1460-9568.1998.00096.x; Redish AD, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-05-j0004.2001; Roelfsema PR, 1997, NATURE, V385, P157, DOI 10.1038/385157a0; Rolls ET, 1996, HIPPOCAMPUS, V6, P601, DOI 10.1002/(SICI)1098-1063(1996)6:6<601::AID-HIPO5>3.0.CO;2-J; SINGER W, 1993, ANNU REV PHYSIOL, V55, P349, DOI 10.1146/annurev.physiol.55.1.349; SOLTESZ I, 1993, J NEUROPHYSIOL, V70, P97, DOI 10.1152/jn.1993.70.1.97; Stanford IM, 1998, J NEUROPHYSIOL, V80, P162, DOI 10.1152/jn.1998.80.1.162; Stenkamp K, 2001, J NEUROPHYSIOL, V85, P2063, DOI 10.1152/jn.2001.85.5.2063; STUMPF C., 1965, INT REV NEUROBIOL, V8, P77, DOI 10.1016/S0074-7742(08)60756-4; Szabo I, 2001, J NEUROSCI METH, V105, P105, DOI 10.1016/S0165-0270(00)00362-9; TAMAMAKI N, 1993, HIPPOCAMPUS, V3, P471, DOI 10.1002/hipo.450030408; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; Tiesinga PHE, 2001, HIPPOCAMPUS, V11, P251, DOI 10.1002/hipo.1041; Towers SK, 2002, J NEUROPHYSIOL, V87, P1165, DOI 10.1152/jn.00495.2001; Traub RD, 1997, J COMPUT NEUROSCI, V4, P141, DOI 10.1023/A:1008839312043; Traub RD, 2001, J NEUROSCI, V21, P9478, DOI 10.1523/JNEUROSCI.21-23-09478.2001; Traub RD, 1996, NATURE, V383, P621, DOI 10.1038/383621a0; Traub RD, 2000, EUR J NEUROSCI, V12, P4093, DOI 10.1046/j.1460-9568.2000.00300.x; Traub RD, 1999, FAST OSCILLATIONS CO; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Wallenstein GV, 1997, J NEUROPHYSIOL, V78, P393, DOI 10.1152/jn.1997.78.1.393; Wang XJ, 1996, J NEUROSCI, V16, P6402; White JA, 1998, J COMPUT NEUROSCI, V5, P5, DOI 10.1023/A:1008841325921; Whittington MA, 1997, P NATL ACAD SCI USA, V94, P12198, DOI 10.1073/pnas.94.22.12198; Whittington MA, 2001, J NEUROSCI, V21, P1727, DOI 10.1523/JNEUROSCI.21-05-01727.2001; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0	84	690	701	1	62	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 23	2003	37	2					311	322		10.1016/S0896-6273(02)01169-8	http://dx.doi.org/10.1016/S0896-6273(02)01169-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	646UX	12546825	Bronze			2022-12-24	WOS:000181054900015
J	Otten, LJ; Henson, RNA; Rugg, MD				Otten, LJ; Henson, RNA; Rugg, MD			State-related and item-related neural correlates of successful memory encoding	NATURE NEUROSCIENCE			English	Article							RECOGNITION MEMORY; BRAIN ACTIVITY; ACQUISITION; PERFORMANCE; EXPERIENCE; RETRIEVAL; PREDICTS; TASK	Neuroimaging studies show that the efficacy of long-term memory encoding of a stimulus is indexed by transient neural activity elicited by that stimulus. Here, we show that successful memory encoding is also indexed by neural activity that is tonically maintained throughout a study task. Using functional magnetic resonance imaging (fMRI), transient and sustained neural activity were dissociated with a mixed event-related and blocked design. In a series of short task blocks, human subjects made semantic or phonological decisions about visually presented words. After statistically removing item-related activity, we found that the mean level of activity across a task block was correlated with the number of words subsequently remembered from that block. These correlations were found in inferior medial parietal and left prefrontal cortex for the semantic task, and in superior medial parietal cortex for the phonological task. Our findings suggest that state-related activity in these brain regions is involved in memory encoding.	Inst Cognit Neurosci, London WC1N 3AR, England; UCL, Dept Psychol, London WC1H 0AP, England; Wellcome Dept Imaging Neurosci, London WC1N 3BG, England	University of London; University College London; University of London; University College London; University of London; University College London	Otten, LJ (corresponding author), Inst Cognit Neurosci, 17 Queen Sq, London WC1N 3AR, England.	l.otten@ucl.ac.uk	Henson, Richard/H-8822-2019; Otten, Leun/C-6036-2008	Henson, Richard/0000-0002-0712-2639; 				Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Bernstein LJ, 2002, NEUROPSYCHOLOGIA, V40, P86, DOI 10.1016/S0028-3932(01)00070-7; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Buckner RL, 1999, NAT NEUROSCI, V2, P311, DOI 10.1038/7221; Buckner RL, 2001, J COGNITIVE NEUROSCI, V13, P406, DOI 10.1162/08989290151137430; Chawla D, 1999, NAT NEUROSCI, V2, P671, DOI 10.1038/10230; Cocosco C. A., 1997, NEUROIMAGE, V5, P425; Davachi L, 2001, J COGNITIVE NEUROSCI, V13, P1059, DOI 10.1162/089892901753294356; Donaldson DI, 2001, NEUROIMAGE, V13, P129, DOI 10.1006/nimg.2000.0664; Fernandez G, 1999, HIPPOCAMPUS, V9, P35, DOI 10.1002/(SICI)1098-1063(1999)9:1<35::AID-HIPO4>3.0.CO;2-Z; Fernandez G, 2001, BRAIN RES BULL, V55, P1, DOI 10.1016/S0361-9230(01)00494-4; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Friston KJ, 1997, TRENDS COGN SCI, V1, P21, DOI 10.1016/S1364-6613(97)01001-2; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Henson R, 2001, NEUROIMAGE, V13, pS149; Henson RNA, 1999, J NEUROSCI, V19, P3962; Holmes AP, 1998, NEUROIMAGE, V7, pS754, DOI [10.1016/S1053-8119(18)31587-8, DOI 10.1016/S1053-8119(18)31587-8]; Josephs O, 1999, PHILOS T R SOC B, V354, P1215, DOI 10.1098/rstb.1999.0475; Kucera H., 1967, COMPUTATIONAL ANAL P; Otten LJ, 2001, CEREB CORTEX, V11, P1150, DOI 10.1093/cercor/11.12.1150; Otten LJ, 2001, BRAIN, V124, P399, DOI 10.1093/brain/124.2.399; Otten LJ, 2001, CURR BIOL, V11, P1528, DOI 10.1016/S0960-9822(01)00454-7; Paller KA, 2002, TRENDS COGN SCI, V6, P93, DOI 10.1016/S1364-6613(00)01845-3; Pashler H, 2001, ANNU REV PSYCHOL, V52, P629, DOI 10.1146/annurev.psych.52.1.629; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Rosen BR, 1998, P NATL ACAD SCI USA, V95, P773, DOI 10.1073/pnas.95.3.773; Rugg MD, 2002, PHILOS T R SOC B, V357, P1097, DOI 10.1098/rstb.2002.1102; RUGG MD, IN PRESS HDB MEMORY; SHALLICE T, 1994, NATURE, V368, P633, DOI 10.1038/368633a0; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188	32	158	161	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2002	5	12					1339	1344		10.1038/nn967	http://dx.doi.org/10.1038/nn967			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	618ZE	12402040				2022-12-24	WOS:000179447500018
J	Lenzi, D; Crum, J; Ellisman, MH; Roberts, WM				Lenzi, D; Crum, J; Ellisman, MH; Roberts, WM			Depolarization redistributes synaptic membrane and creates a gradient of vesicles on the synaptic body at a ribbon synapse	NEURON			English	Article							SACCULAR HAIR-CELLS; TEMPORARY THRESHOLD SHIFT; RETINAL BIPOLAR NEURONS; GATED CA2+ CHANNELS; NEUROMUSCULAR-JUNCTION; AFFERENT SYNAPSE; ACTIVE ZONES; ALPHA(1D) SUBUNIT; GLUTAMATE RELEASE; CHICKENS COCHLEA	We used electron tomography of frog saccular hair cells to reconstruct presynaptic ultrastructure at synapses specialized for sustained transmitter release. Synaptic vesicles at inhibited synapses were abundant in the cytoplasm and covered the synaptic body at high density. Continuous maximal stimulation depleted 73% of the vesicles within 800 nm of the synapse, with a concomitant increase in surface area of intracellular cisterns and plasmalemmal infoldings. Docked vesicles were depleted 60%-80% regardless of their distance from the active zone. Vesicles on the synaptic body were depleted primarily in the hemisphere facing the plasmalemma, creating a gradient of vesicles on its surface. We conclude that formation of new synaptic vesicles from cisterns is rate limiting in the vesicle cycle.	Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA; Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	University of Oregon; University of California System; University of California San Diego; University of California System; University of California San Diego	Roberts, WM (corresponding author), Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA.	roberts@uoneuro.uoregon.edu	Crum, John/B-2477-2009	Lenzi, David/0000-0003-4802-1444; Roberts, William/0000-0001-9762-4255	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027142, R29NS027142] Funding Source: NIH RePORTER; NCRR NIH HHS [RR04050] Funding Source: Medline; NINDS NIH HHS [NS36069, NS27142] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Armstrong CE, 1998, J NEUROSCI, V18, P2962; Beutner D, 2001, NEURON, V29, P681, DOI 10.1016/S0896-6273(01)00243-4; Brodin L, 2000, CURR OPIN NEUROBIOL, V10, P312, DOI 10.1016/S0959-4388(00)00097-0; Brunger AT, 2000, CURR OPIN NEUROBIOL, V10, P293, DOI 10.1016/S0959-4388(00)00098-2; BUNT AH, 1971, BRAIN RES, V25, P571, DOI 10.1016/0006-8993(71)90461-6; FURUKAWA T, 1982, J PHYSIOL-LONDON, V322, P181, DOI 10.1113/jphysiol.1982.sp014031; Gad H, 1998, NEURON, V21, P607, DOI 10.1016/S0896-6273(00)80570-X; Glowatzki E, 2002, NAT NEUROSCI, V5, P147, DOI 10.1038/nn796; GRAY EG, 1971, BRAIN RES, V35, P1, DOI 10.1016/0006-8993(71)90591-9; Griesinger CB, 2002, J NEUROSCI, V22, P3939, DOI 10.1523/JNEUROSCI.22-10-03939.2002; HAMA K, 1977, J NEUROCYTOL, V6, P361, DOI 10.1007/BF01178223; Harlow M, 1998, J PHYSIOL-PARIS, V92, P75, DOI 10.1016/S0928-4257(98)80141-1; Harlow ML, 2001, NATURE, V409, P479, DOI 10.1038/35054000; Heidelberger R, 1998, J GEN PHYSIOL, V111, P225, DOI 10.1085/jgp.111.2.225; HENRY WR, 1995, HEARING RES, V84, P81, DOI 10.1016/0378-5955(95)00014-U; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Hibino H, 2002, NEURON, V34, P411, DOI 10.1016/S0896-6273(02)00667-0; JACOBS RA, 1990, COLD SPRING HARB SYM, V55, P547; Juusola M, 1996, TRENDS NEUROSCI, V19, P292, DOI 10.1016/S0166-2236(96)10028-X; Kollmar R, 1997, P NATL ACAD SCI USA, V94, P14889, DOI 10.1073/pnas.94.26.14889; Kollmar R, 1997, P NATL ACAD SCI USA, V94, P14883, DOI 10.1073/pnas.94.26.14883; Koschak A, 2001, J BIOL CHEM, V276, P22100, DOI 10.1074/jbc.M101469200; Lagnado L, 1996, NEURON, V17, P957, DOI 10.1016/S0896-6273(00)80226-3; Leenders AGM, 2002, NEUROSCIENCE, V109, P195, DOI 10.1016/S0306-4522(01)00450-X; Lenzi D, 1999, J NEUROSCI, V19, P119, DOI 10.1523/JNEUROSCI.19-01-00119.1999; Lenzi D, 2001, BIOESSAYS, V23, P831, DOI 10.1002/bies.1118; Li J, 1999, PHILOS T ROY SOC B, V354, P299, DOI 10.1098/rstb.1999.0381; Matsubara A, 1996, J NEUROSCI, V16, P4457; Mennerick S, 1996, NEURON, V17, P1241, DOI 10.1016/S0896-6273(00)80254-8; Morgans CW, 2000, IMMUNOL CELL BIOL, V78, P442, DOI 10.1046/j.1440-1711.2000.00923.x; Moser T, 2000, P NATL ACAD SCI USA, V97, P883, DOI 10.1073/pnas.97.2.883; MULROY MJ, 1990, HEARING RES, V49, P79, DOI 10.1016/0378-5955(90)90096-8; Muresan V, 1999, J NEUROSCI, V19, P1027; Murthy VN, 1999, NAT NEUROSCI, V2, P503, DOI 10.1038/9149; NADOL JB, 1990, J ELECTRON MICR TECH, V15, P187, DOI 10.1002/jemt.1060150210; PARSONS TD, 1994, NEURON, V13, P875, DOI 10.1016/0896-6273(94)90253-4; Richards DA, 2000, NEURON, V27, P551, DOI 10.1016/S0896-6273(00)00065-9; ROBERTS WM, 1994, J NEUROSCI, V14, P3246; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; Rouze NC, 1998, J NEUROSCI, V18, P8614; SCHACHER S, 1976, J CELL BIOL, V70, P178, DOI 10.1083/jcb.70.1.178; SCHACHER SM, 1974, NATURE, V249, P261, DOI 10.1038/249261a0; SCHAEFFER SF, 1978, J CELL BIOL, V79, P802, DOI 10.1083/jcb.79.3.802; Schikorski T, 1997, J NEUROSCI, V17, P5858; Schmitz F, 2000, NEURON, V28, P857, DOI 10.1016/S0896-6273(00)00159-8; Schmitz F, 1996, J NEUROSCI, V16, P7109; SIEGEL JH, 1986, J NEUROCYTOL, V15, P311, DOI 10.1007/BF01611434; Spassova M, 2001, J PHYSIOL-LONDON, V535, P689, DOI 10.1111/j.1469-7793.2001.00689.x; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; Vollrath L, 1996, MICROSC RES TECHNIQ, V35, P472, DOI 10.1002/(SICI)1097-0029(19961215)35:6<472::AID-JEMT6>3.0.CO;2-K; von Gersdorff H, 1998, NEURON, V21, P1177, DOI 10.1016/S0896-6273(00)80634-0; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; vonGersdorff H, 1997, J NEUROSCI, V17, P1919; Wagner HJ, 1997, CELL TISSUE RES, V287, P435, DOI 10.1007/s004410050768; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500; ZUCCA G, 1992, HEARING RES, V63, P52, DOI 10.1016/0378-5955(92)90073-V	58	127	129	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 14	2002	36	4					649	659		10.1016/S0896-6273(02)01025-5	http://dx.doi.org/10.1016/S0896-6273(02)01025-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	616PX	12441054	Bronze			2022-12-24	WOS:000179313100012
J	Lorincz, A; Notomi, T; Tamas, G; Shigemoto, R; Nusser, Z				Lorincz, A; Notomi, T; Tamas, G; Shigemoto, R; Nusser, Z			Polarized and compartment-dependent distribution of HCN1 in pyramidal cell dendrites	NATURE NEUROSCIENCE			English	Article							HYPERPOLARIZATION-ACTIVATED CHANNEL; CYCLIC-NUCLEOTIDE; RAT HIPPOCAMPUS; GLUTAMATE RECEPTORS; GABA(A) RECEPTORS; I-H; ACTION-POTENTIALS; APICAL DENDRITE; CATION CHANNELS; CA2+ CHANNELS	An ion channel's function depends largely on its location and density on neurons. Here we used high-resolution immunolocalization to determine the subcellular distribution of the hyperpolarization-activated and cyclic-nucleotide-gated channel subunit 1 (HCN1) in rat brain. Light microscopy revealed graded HCN1 immunoreactivity in apical dendrites of hippocampal, subicular and neocortical layer-5 pyramidal cells. Quantitative comparison of immunogold densities showed a 60-fold increase from somatic to distal apical dendritic membranes. Distal dendritic shafts had 16 times more HCN1 labeling than proximal dendrites of similar diameters. At the same distance from the soma, the density of HCN1 was significantly higher in dendritic shafts than in spines. Our results reveal the complex cell surface distribution of voltage-gated ion-channels, and predict its role in increasing the computational power of single neurons via subcellular domain and input-specific mechanisms.	Hungarian Acad Sci, Inst Expt Med, Lab Cellular Neurophysiol, H-1083 Budapest, Hungary; Univ Szeged, Dept Comparat Physiol, H-6726 Szeged, Hungary; Grad Univ Adv Studies, Sch Life Sci, Natl Inst Physiol Sci, Div Cerebral Struct, Okazaki, Aichi, Japan; Japan Sci & Technol Corp, CREST, Okazaki, Aichi 4448585, Japan	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Szeged University; Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Japan Science & Technology Agency (JST)	Nusser, Z (corresponding author), Hungarian Acad Sci, Inst Expt Med, Lab Cellular Neurophysiol, Szigony St 43, H-1083 Budapest, Hungary.		Tamas, Gabor/AAG-9305-2020; Nusser, Zoltan/K-8587-2014; Shigemoto, Ryuichi/E-3628-2013	Tamas, Gabor/0000-0002-7905-6001; Shigemoto, Ryuichi/0000-0001-8761-9444; Nusser, Zoltan/0000-0001-7004-4111				BAUDE A, 1995, NEUROSCIENCE, V69, P1031, DOI 10.1016/0306-4522(95)00350-R; Bender RA, 2001, NEUROSCIENCE, V106, P689, DOI 10.1016/S0306-4522(01)00314-1; Berger T, 2001, J NEUROPHYSIOL, V85, P855, DOI 10.1152/jn.2001.85.2.855; BISCHOFBERGER J, 1995, J PHYSIOL-LONDON, V487, P305, DOI 10.1113/jphysiol.1995.sp020881; Chen C, 2001, J GEN PHYSIOL, V117, P491, DOI 10.1085/jgp.117.5.491; CHRISTIE BR, 1995, J NEUROPHYSIOL, V73, P2553, DOI 10.1152/jn.1995.73.6.2553; Colbert CM, 1996, J NEUROSCI, V16, P6676; Conti F, 1999, TRENDS NEUROSCI, V22, P451, DOI 10.1016/S0166-2236(99)01445-9; Craig AM, 2001, NAT NEUROSCI, V4, P569, DOI 10.1038/88388; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Fritschy JM, 1998, J COMP NEUROL, V390, P194; Gauss R, 1998, NATURE, V393, P583, DOI 10.1038/31248; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Hoffman DA, 1998, J NEUROSCI, V18, P3521; Hu H, 2001, J NEUROSCI, V21, P9585, DOI 10.1523/JNEUROSCI.21-24-09585.2001; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Magee J, 1998, ANNU REV PHYSIOL, V60, P327, DOI 10.1146/annurev.physiol.60.1.327; MAGEE JC, 1995, J PHYSIOL-LONDON, V487, P67, DOI 10.1113/jphysiol.1995.sp020862; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Magee JC, 1998, J NEUROSCI, V18, P7613; Monteggia LM, 2000, MOL BRAIN RES, V81, P129, DOI 10.1016/S0169-328X(00)00155-8; Moosmang S, 1999, BIOL CHEM, V380, P975, DOI 10.1515/BC.1999.121; Nusser Z, 1998, J NEUROSCI, V18, P1693; Nusser Z, 1997, NEURON, V19, P697, DOI 10.1016/S0896-6273(00)80382-7; Nusser Z, 1996, P NATL ACAD SCI USA, V93, P11939, DOI 10.1073/pnas.93.21.11939; Nusser Z, 1998, NATURE, V395, P172, DOI 10.1038/25999; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; NUSSER Z, 1995, EUR J NEUROSCI, V7, P630, DOI 10.1111/j.1460-9568.1995.tb00667.x; Nyiri G, 2001, EUR J NEUROSCI, V13, P428, DOI 10.1046/j.1460-9568.2001.01407.x; Ottersen OP, 1997, EUR J NEUROSCI, V9, P2219, DOI 10.1111/j.1460-9568.1997.tb01640.x; Petralia RS, 1998, CELL BIOL INT, V22, P603, DOI 10.1006/cbir.1998.0385; Rubio ME, 1997, NEURON, V18, P939, DOI 10.1016/S0896-6273(00)80333-5; Santoro B, 1997, P NATL ACAD SCI USA, V94, P14815, DOI 10.1073/pnas.94.26.14815; Schwindt PC, 1997, J NEUROPHYSIOL, V78, P187, DOI 10.1152/jn.1997.78.1.187; Seifert R, 1999, P NATL ACAD SCI USA, V96, P9391, DOI 10.1073/pnas.96.16.9391; Shigemoto R, 1997, J NEUROSCI, V17, P7503, DOI 10.1523/jneurosci.17-19-07503.1997; Sloviter RS, 2001, J COMP NEUROL, V430, P283; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; SOMOGYI P, 1998, PRECISION VARIABILIT, P82; STUART G, 1994, NEURON, V13, P703, DOI 10.1016/0896-6273(94)90037-X; Stuart G, 1998, J NEUROSCI, V18, P3501; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Tsubokawa H, 1999, J PHYSIOL-LONDON, V517, P135, DOI 10.1111/j.1469-7793.1999.0135z.x; Watanabe M, 1998, EUR J NEUROSCI, V10, P478, DOI 10.1046/j.1460-9568.1998.00063.x; Williams SR, 2000, J NEUROPHYSIOL, V83, P3177, DOI 10.1152/jn.2000.83.5.3177; Yuste R, 1996, NEURON, V16, P701, DOI 10.1016/S0896-6273(00)80091-4	48	324	329	0	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1185	1193		10.1038/nn962	http://dx.doi.org/10.1038/nn962			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	609CG	12389030				2022-12-24	WOS:000178884600022
J	Minichiello, L; Calella, AM; Medina, DL; Bonhoeffer, T; Klein, R; Korte, M				Minichiello, L; Calella, AM; Medina, DL; Bonhoeffer, T; Klein, R; Korte, M			Mechanism of TrkB-mediated hippocampal long-term potentiation	NEURON			English	Article							ACTIVATED PROTEIN-KINASE; NEUROTROPHIC FACTOR; SYNAPTIC-TRANSMISSION; TRANSCRIPTION FACTOR; UP-REGULATION; MICE LACKING; LATE-PHASE; BDNF; CREB; EXPRESSION	The TrkB receptor tyrosine kinase and its ligand, BDNF, have an essential role in certain forms of synaptic plasticity. However, the downstream pathways required to mediate these functions are unknown. We have studied mice with a targeted mutation in either the Shc or the phospholipase Cgamma (PLCgamma) docking sites of TrkB (trkB(SHC/SHC) and trkB(PLC/PLC) mice). We found that hippocampal long-term potentiation was impaired in trkB(PLC/PLC) mice, but not trkB(SHC/SHC) mice. BDNF stimulation of primary neurons derived from trkB(PLC/PLC) mice fully retained their ability to activate MAP kinases, whereas induction of CREB and CaMKIV phosphorylation was strongly impaired. The opposite effect was observed in trkB(SHC/SHC) neurons, suggesting that MAPKs and CREB act in parallel pathways. Our results provide genetic evidence that TrkB mediates hippocampal plasticity via recruitment of PLCgamma, and by subsequent phosphorylation of CaMKIV and CREB.	European Mol Biol Lab, I-00016 Monterotondo, Italy; Max Planck Inst Neurobiol, D-82152 Martinsried, Germany	European Molecular Biology Laboratory (EMBL); Max Planck Society	Minichiello, L (corresponding author), European Mol Biol Lab, Via Ramarini 32, I-00016 Monterotondo, Italy.	mini@embl-monterotondo.it; rklein@neuro.mpg.de	Medina, Diego/AAC-9622-2020; Bonhoeffer, Tobias/B-9481-2009; Minichiello, Liliana/AAA-7190-2022; Klein, Ruediger/C-6147-2008	Medina, Diego/0000-0002-7347-2645; Bonhoeffer, Tobias/0000-0001-7897-6634; Klein, Ruediger/0000-0002-3109-0163				Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Blendy JA, 1996, EMBO J, V15, P1098, DOI 10.1002/j.1460-2075.1996.tb00447.x; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; Canossa M, 2001, EMBO J, V20, P1640, DOI 10.1093/emboj/20.7.1640; Cash S, 1996, NEURON, V16, P745, DOI 10.1016/S0896-6273(00)80095-1; DOTTI CG, 1987, NEUROSCIENCE, V23, P121, DOI 10.1016/0306-4522(87)90276-4; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; English JD, 1996, J BIOL CHEM, V271, P24329, DOI 10.1074/jbc.271.40.24329; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Gass P, 1998, LEARN MEMORY, V5, P274; HANKS M, 1995, SCIENCE, V269, P679, DOI 10.1126/science.7624797; Hartmann M, 2001, EMBO J, V20, P5887, DOI 10.1093/emboj/20.21.5887; Hosaka M, 1999, NEURON, V24, P377, DOI 10.1016/S0896-6273(00)80851-X; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; JANSSENTIMMEN U, 1989, GENE, V80, P325, DOI 10.1016/0378-1119(89)90296-5; JONES KR, 1994, CELL, V76, P989, DOI 10.1016/0092-8674(94)90377-8; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Kafitz KW, 1999, NATURE, V401, P918, DOI 10.1038/44847; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; Kang HJ, 2001, CELL, V106, P771, DOI 10.1016/S0092-8674(01)00497-4; KLEIN R, 1993, CELL, V75, P113, DOI 10.1016/0092-8674(93)90683-H; KLEIN R, 1989, EMBO J, V8, P3701, DOI 10.1002/j.1460-2075.1989.tb08545.x; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Korte M, 2000, NEUROPHARMACOLOGY, V39, P717, DOI 10.1016/S0028-3908(99)00273-7; Korte M, 1998, NEUROPHARMACOLOGY, V37, P553, DOI 10.1016/S0028-3908(98)00035-5; Korte M, 1996, P NATL ACAD SCI USA, V93, P12547, DOI 10.1073/pnas.93.22.12547; LESSMANN V, 1994, NEUROREPORT, V6, P21; Li YX, 1998, J NEUROSCI, V18, P10231; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Minichiello L, 1998, NEURON, V21, P335, DOI 10.1016/S0896-6273(00)80543-7; Minichiello L, 1996, GENE DEV, V10, P2849, DOI 10.1101/gad.10.22.2849; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Patterson SL, 2001, NEURON, V32, P123, DOI 10.1016/S0896-6273(01)00443-3; Pittenger C, 2002, NEURON, V34, P447, DOI 10.1016/S0896-6273(02)00684-0; Pozzo-Miller LD, 1999, J NEUROSCI, V19, P4972; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Rudolph D, 1998, P NATL ACAD SCI USA, V95, P4481, DOI 10.1073/pnas.95.8.4481; Schinder AF, 2000, TRENDS NEUROSCI, V23, P639, DOI 10.1016/S0166-2236(00)01672-6; Schuman EM, 1999, CURR OPIN NEUROBIOL, V9, P105, DOI 10.1016/S0959-4388(99)80013-0; Schwartz PM, 1997, NEURON, V19, P269, DOI 10.1016/S0896-6273(00)80938-1; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; Soderling TR, 2000, CURR OPIN NEUROBIOL, V10, P375, DOI 10.1016/S0959-4388(00)00090-8; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Xu BJ, 2000, J NEUROSCI, V20, P6888, DOI 10.1523/JNEUROSCI.20-18-06888.2000; Ying SW, 2002, J NEUROSCI, V22, P1532, DOI 10.1523/JNEUROSCI.22-05-01532.2002; Yoo J, 2002, J BIOL CHEM, V277, P11904, DOI 10.1074/jbc.M111788200; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805	59	330	348	2	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 26	2002	36	1					121	137		10.1016/S0896-6273(02)00942-X	http://dx.doi.org/10.1016/S0896-6273(02)00942-X			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	598UP	12367511	Bronze			2022-12-24	WOS:000178295100012
J	Capela, A; Temple, S				Capela, A; Temple, S			LeX/ssea-1 is expressed by adult mouse CNS stem cells, identifying them as nonependymal	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; EMBRYONIC ANTIGEN SSEA-1; PRIMORDIAL GERM-CELLS; RAT CEREBRAL-CORTEX; MAMMALIAN FOREBRAIN; IN-VIVO; SUBEPENDYMAL CELLS; PROGENITOR CELLS; SELF-RENEWAL; SPINAL-CORD	Adult neural stem cells are rare, and little is known about their unique characteristics, leaving their in vivo identity enigmatic. We show that Lewis X (LeX), a carbohydrate expressed by embryonic pluripotent stem cells, is made by adult mouse subventricular zone (SVZ) stem cells and shed into their environment. Only 4% of acutely isolated SVZ cells are LeX(+); this subpopulation, purified by FACS, contains the SVZ stem cells. Ependymal cells are LeX(-), and purified ependymal cells do not make neurospheres, resolving the controversial claim that these are stem cells. Thus, LeX expression by adult CNS stem cells aids their in vivo identification, allows their enrichment, and raises new questions about the role of this unusual carbohydrate in stem cell biology.	Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA	Albany Medical College	Temple, S (corresponding author), Stemcells Inc, 3155 Porter Dr, Palo Alto, CA 94304 USA.				NINDS NIH HHS [R01 NS33529] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033529] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allendoerfer KL, 1999, DEV BIOL, V211, P208, DOI 10.1006/dbio.1999.9308; ALLENDOERFER KL, 1995, MOL CELL NEUROSCI, V6, P381, DOI 10.1006/mcne.1995.1029; Ashwell KWS, 1997, CELL TISSUE RES, V289, P17, DOI 10.1007/s004410050848; Bach SP, 2000, CARCINOGENESIS, V21, P469, DOI 10.1093/carcin/21.3.469; BARTSCH D, 1991, CELL TISSUE RES, V263, P353, DOI 10.1007/BF00318777; BIRD JM, 1984, DEV BIOL, V104, P449, DOI 10.1016/0012-1606(84)90101-5; Calaora V, 1996, NEUROSCIENCE, V73, P581, DOI 10.1016/0306-4522(96)00042-5; CAMPOSORTEGA JA, 1995, MOL NEUROBIOL, V10, P75, DOI 10.1007/BF02740668; Cao QL, 2001, EXP NEUROL, V167, P48, DOI 10.1006/exnr.2000.7536; Chiasson BJ, 1999, J NEUROSCI, V19, P4462; DAVIS AA, 1994, NATURE, V372, P263, DOI 10.1038/372263a0; DODD J, 1986, J EXP BIOL, V124, P225; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Dvorak P, 1998, J CELL SCI, V111, P2945; FOX N, 1981, DEV BIOL, V83, P391, DOI 10.1016/0012-1606(81)90487-5; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gocht A, 1996, HISTOL HISTOPATHOL, V11, P1007; GOMPERTS M, 1994, DEVELOPMENT, V120, P135; GOOI HC, 1981, NATURE, V292, P156, DOI 10.1038/292156a0; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; Gritti A, 2002, J NEUROSCI, V22, P437, DOI 10.1523/JNEUROSCI.22-02-00437.2002; Gritti A, 1996, J NEUROSCI, V16, P1091; HAKOMORI SI, 1992, HISTOCHEM J, V24, P771, DOI 10.1007/BF01046348; JESSELL TM, 1990, ANNU REV NEUROSCI, V13, P227, DOI 10.1146/annurev.ne.13.030190.001303; Jirmanova L, 1999, INT J DEV BIOL, V43, P555; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; JONES PH, 1995, CELL, V80, P83, DOI 10.1016/0092-8674(95)90453-0; Kato M, 1998, NAT MED, V4, P691, DOI 10.1038/nm0698-691; Kawaguchi A, 2001, MOL CELL NEUROSCI, V17, P259, DOI 10.1006/mcne.2000.0925; Kempermann G, 1997, P NATL ACAD SCI USA, V94, P10409, DOI 10.1073/pnas.94.19.10409; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Laywell ED, 2000, P NATL ACAD SCI USA, V97, P13883, DOI 10.1073/pnas.250471697; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Mai JK, 1998, EUR J NEUROSCI, V10, P746, DOI 10.1046/j.1460-9568.1998.00029.x; MARANI E, 1986, ACTA MORPHOL NEER SC, V24, P103; MARANI E, 1983, HISTOCHEMISTRY, V78, P157, DOI 10.1007/BF00489494; Marmur R, 1998, DEV BIOL, V204, P577, DOI 10.1006/dbio.1998.9099; Milev P, 1998, J BIOL CHEM, V273, P21439, DOI 10.1074/jbc.273.34.21439; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Muramatsu T, 1994, Nagoya J Med Sci, V57, P95; Nowakowski R S, 2000, Science, V288, P771; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Reynolds R, 1997, J NEUROSCI RES, V47, P455, DOI 10.1002/(SICI)1097-4547(19970301)47:5<455::AID-JNR1>3.0.CO;2-G; Rietze RL, 2001, NATURE, V412, P736, DOI 10.1038/35089085; Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130; Seaberg RM, 2002, J NEUROSCI, V22, P1784, DOI 10.1523/JNEUROSCI.22-05-01784.2002; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; TOLE S, 1995, J NEUROSCI, V15, P957; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Weiss S, 1996, J NEUROSCI, V16, P7599; Winkler C, 1998, MOL CELL NEUROSCI, V11, P99, DOI 10.1006/mcne.1998.0674; YAMAMOTO M, 1985, P NATL ACAD SCI USA, V82, P3045, DOI 10.1073/pnas.82.9.3045	58	530	570	0	17	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 29	2002	35	5					865	875		10.1016/S0896-6273(02)00835-8	http://dx.doi.org/10.1016/S0896-6273(02)00835-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	589UY	12372282	Bronze			2022-12-24	WOS:000177779800010
J	Lee, CJ; Bardoni, R; Tong, CK; Engelman, HS; Joseph, DJ; Magherini, PC; MacDermott, AB				Lee, CJ; Bardoni, R; Tong, CK; Engelman, HS; Joseph, DJ; Magherini, PC; MacDermott, AB			Functional expression of AMPA receptors on central terminals of rat dorsal root ganglion neurons and presynaptic inhibition of glutamate release	NEURON			English	Article							NON-NMDA RECEPTORS; SPINAL-CORD; KAINATE RECEPTORS; DRG NEURONS; IMMUNOCYTOCHEMICAL LOCALIZATION; SYNAPTIC TRANSMISSION; HIPPOCAMPAL-NEURONS; PRIMARY AFFERENTS; ACTION-POTENTIALS; HORN NEURONS	No direct evidence has been found for expression of functional AMPA receptors by dorsal root ganglion neurons despite immunocytochemical evidence suggesting they are present. Here we report evidence for expression of functional AMPA receptors by a subpopulation of dorsal root ganglion neurons. The AMPA receptors are most prominently located near central terminals of primary afferent fibers. AMPA and kainate receptors were detected by recording receptor-mediated depolarization of the central terminals under selective pharmacological conditions. We demonstrate that activation of presynaptic AMPA receptors by exogenous agonists causes inhibition of glutamate release from the terminals, possibly via primary afferent depolarization (PAD). These results challenge the traditional view that GABA and GABA(A) receptors exclusively mediate PAD, and indicate that PAD is also mediated by glutamate acting on presynaptically localized AMPA and kainate receptors.	Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA; Univ Modena & Reggio Emilia, Dept Biomed Sci, I-41100 Modena, Italy	Columbia University; Columbia University; Universita di Modena e Reggio Emilia	MacDermott, AB (corresponding author), Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA.		Bardoni, Rita/AAE-2255-2020; Bardoni, Rita/C-1109-2016	Bardoni, Rita/0000-0002-0959-9983; Lee, C Justin/0000-0002-3555-0980	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029797] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 29797] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AGRAWAL SG, 1986, BRIT J PHARMACOL, V87, P345, DOI 10.1111/j.1476-5381.1986.tb10823.x; AULT B, 1993, J PHARMACOL EXP THER, V265, P927; Bureau I, 1998, J PHYSIOL-LONDON, V509, P817, DOI 10.1111/j.1469-7793.1998.817bm.x; Cochilla AJ, 1997, J PHYSIOL-LONDON, V499, P443, DOI 10.1113/jphysiol.1997.sp021940; Coggeshall RE, 1998, J COMP NEUROL, V391, P78; DESARMENIEN M, 1984, BRIT J PHARMACOL, V81, P327, DOI 10.1111/j.1476-5381.1984.tb10082.x; DODD J, 1985, J NEUROSCI, V5, P3278; Donevan SD, 1998, J PHARMACOL EXP THER, V285, P539; ECCLES JC, 1963, J PHYSIOL-LONDON, V168, P500, DOI 10.1113/jphysiol.1963.sp007205; EVANS RH, 1989, NEUROSCI LETT, V100, P231, DOI 10.1016/0304-3940(89)90690-3; FITZGERALD M, 1994, J COMP NEUROL, V348, P225, DOI 10.1002/cne.903480205; FITZGERALD M, 1981, J PHYSIOL-LONDON, V318, P25; Goldstein ME, 1996, NEUROSCIENCE, V71, P243, DOI 10.1016/0306-4522(95)00404-1; GOLDSTEIN ME, 1991, J NEUROSCI RES, V30, P92, DOI 10.1002/jnr.490300111; GRAHAM B, 1994, J NEUROPHYSIOL, V71, P538, DOI 10.1152/jn.1994.71.2.538; Grosshans DR, 2002, NAT NEUROSCI, V5, P27, DOI 10.1038/nn779; Gu JG, 1996, NATURE, V381, P793, DOI 10.1038/381793a0; Gu JGG, 1997, NATURE, V389, P749, DOI 10.1038/39639; Guo A, 1999, EUR J NEUROSCI, V11, P946, DOI 10.1046/j.1460-9568.1999.00503.x; Hackman JC, 1997, NEUROSCIENCE, V81, P1079, DOI 10.1016/S0306-4522(97)00234-0; HUETTNER JE, 1990, NEURON, V5, P255, DOI 10.1016/0896-6273(90)90163-A; Huettner JE, 1998, NEUROPHARMACOLOGY, V37, P1239, DOI 10.1016/S0028-3908(98)00082-3; Hwang SJ, 2001, J COMP NEUROL, V436, P275; Kerchner GA, 2001, NEURON, V32, P477, DOI 10.1016/S0896-6273(01)00479-2; Kerchner GA, 2001, J NEUROSCI, V21, P59, DOI 10.1523/JNEUROSCI.21-01-00059.2001; KYROZIS A, 1995, J PHYSIOL-LONDON, V485, P373, DOI 10.1113/jphysiol.1995.sp020736; Lee CJ, 2001, J NEUROSCI, V21, P4572, DOI 10.1523/JNEUROSCI.21-13-04572.2001; Lerma J, 2001, PHYSIOL REV, V81, P971, DOI 10.1152/physrev.2001.81.3.971; LIU H, 1994, P NATL ACAD SCI USA, V91, P8383, DOI 10.1073/pnas.91.18.8383; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; MIRNICS K, 1995, J COMP NEUROL, V355, P601, DOI 10.1002/cne.903550409; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; PATNEAU DK, 1993, J NEUROSCI, V13, P3496; Pelkey KA, 1998, CAN J PHYSIOL PHARM, V76, P900, DOI 10.1139/cjpp-76-9-900; PIGNATELLI D, 1989, BRAIN RES, V491, P33, DOI 10.1016/0006-8993(89)90085-1; POOK P, 1993, BRIT J PHARMACOL, V108, P179, DOI 10.1111/j.1476-5381.1993.tb13459.x; REICHLING DB, 1991, J PHYSIOL-LONDON, V441, P199, DOI 10.1113/jphysiol.1991.sp018746; RIBEIRODASILVA A, 1985, J NEUROCYTOL, V14, P203, DOI 10.1007/BF01258448; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; Rudomin P, 1999, EXP BRAIN RES, V129, P1, DOI 10.1007/s002210050933; Russo RE, 2000, J PHYSIOL-LONDON, V528, P115, DOI 10.1111/j.1469-7793.2000.00115.x; Satake S, 2000, NAT NEUROSCI, V3, P551, DOI 10.1038/75718; SATO K, 1993, NEUROREPORT, V4, P1263, DOI 10.1097/00001756-199309000-00013; SEGEV I, 1990, J NEUROPHYSIOL, V63, P987, DOI 10.1152/jn.1990.63.5.987; Stucky CL, 1999, J NEUROSCI, V19, P6497; SUR C, 1995, NEUROSCIENCE, V66, P697, DOI 10.1016/0306-4522(94)00579-T; TACHIBANA M, 1994, J COMP NEUROL, V344, P431, DOI 10.1002/cne.903440307; Uchida I, 1996, EUR J PHARMACOL, V307, P89, DOI 10.1016/0014-2999(96)00156-2; Willis WD, 1999, EXP BRAIN RES, V124, P395, DOI 10.1007/s002210050637; WONG LA, 1993, MOL PHARMACOL, V44, P504; Zhou LM, 1997, J PHARMACOL EXP THER, V280, P422	51	88	91	1	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 3	2002	35	1					135	146		10.1016/S0896-6273(02)00729-8	http://dx.doi.org/10.1016/S0896-6273(02)00729-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	569KP	12123614	Bronze			2022-12-24	WOS:000176601800016
J	Gross, MK; Dottori, M; Goulding, M				Gross, MK; Dottori, M; Goulding, M			Lbx1 specifies somatosensory association Interneurons in the dorsal spinal cord	NEURON			English	Article							COMMISSURAL INTERNEURONS; NEURONS; IDENTITY; PATHWAY; MATH1; MOUSE; FATE; RAT; SPECIFICATION; EXPRESSION	Association and relay neurons that are generated in the dorsal spinal cord play essential roles in transducing somatosensory information. During development, these two major neuronal classes are delineated by the expression of the homeodomain transcription factor Lbx1. Lbx1 is expressed in and required for the correct specification of three early dorsal interneuron populations and late-born neurons that form the substantia gelatinosa. In mice lacking Lbx1, cells types that arise in the ventral alar plate acquire more dorsal identities. This results in the loss of dorsal horn association interneurons, excess production of commissural neurons, and disrupted sensory afferent innervation of the dorsal horn. Lbx1, therefore, plays a critical role in the development of sensory pathways in the spinal cord that relay pain and touch.	Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA	Salk Institute	Goulding, M (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.			Dottori, Mirella/0000-0003-0598-4195				ANTAL M, 1991, J COMP NEUROL, V314, P114, DOI 10.1002/cne.903140111; Bermingham NA, 2001, NEURON, V30, P411, DOI 10.1016/S0896-6273(01)00305-1; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Brown AG, 1981, ORG SPINAL CORD; Burrill JD, 1997, DEVELOPMENT, V124, P4493; Chen ZF, 2001, NEURON, V31, P59, DOI 10.1016/S0896-6273(01)00341-5; Dottori M, 2001, DEVELOPMENT, V128, P4127; GOULDING MD, 1993, DEVELOPMENT, V117, P1001; Gowan K, 2001, NEURON, V31, P219, DOI 10.1016/S0896-6273(01)00367-1; Gross MK, 2000, DEVELOPMENT, V127, P413; Helms AW, 1998, DEVELOPMENT, V125, P919; HOLLEY JA, 1982, J COMP NEUROL, V205, P371, DOI 10.1002/cne.902050406; JAGLA K, 1995, MECH DEVELOP, V53, P345, DOI 10.1016/0925-4773(95)00450-5; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Lee KJ, 1998, GENE DEV, V12, P3394, DOI 10.1101/gad.12.21.3394; Li YQ, 1999, BRAIN RES, V840, P179, DOI 10.1016/S0006-8993(99)01794-1; Liem KF, 1997, CELL, V91, P127, DOI 10.1016/S0092-8674(01)80015-5; Malmberg AB, 1997, SCIENCE, V278, P279, DOI 10.1126/science.278.5336.279; Mansouri A, 1998, MECH DEVELOP, V78, P171, DOI 10.1016/S0925-4773(98)00168-3; Moran-Rivard L, 2001, NEURON, V29, P385, DOI 10.1016/S0896-6273(01)00213-6; Muller T, 2002, NEURON, V34, P551, DOI 10.1016/S0896-6273(02)00689-X; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; Pierani A, 2001, NEURON, V29, P367, DOI 10.1016/S0896-6273(01)00212-4; Pierani A, 1999, CELL, V97, P903, DOI 10.1016/S0092-8674(00)80802-8; PITUELLO F, 1995, P NATL ACAD SCI USA, V92, P6952, DOI 10.1073/pnas.92.15.6952; Polgar E, 1999, J NEUROSCI, V19, P2637; REXED B, 1952, J COMP NEUROL, V96, P415, DOI 10.1002/cne.900960303; SAITO T, 1995, MOL CELL NEUROSCI, V6, P280, DOI 10.1006/mcne.1995.1022; Schubert FR, 2001, MECH DEVELOP, V101, P181, DOI 10.1016/S0925-4773(00)00537-2; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; Shirasawa S, 2000, NAT GENET, V24, P287, DOI 10.1038/73516; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; SZENTAGOTHAI J, 1964, J COMP NEUROL, V122, P219, DOI 10.1002/cne.901220207; Tracey D, 1985, RAT NERVOUS SYSTEM, P129; Wang SS, 1997, J NEUROSCI, V17, P4149; Willis Jr W. D., 1991, SENSORY MECH SPINAL	36	290	293	0	16	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 16	2002	34	4					535	549		10.1016/S0896-6273(02)00690-6	http://dx.doi.org/10.1016/S0896-6273(02)00690-6			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	553FT	12062038	Bronze			2022-12-24	WOS:000175665700008
J	Hughes, SW; Cope, DW; Blethyn, KL; Crunelli, V				Hughes, SW; Cope, DW; Blethyn, KL; Crunelli, V			Cellular mechanisms of the slow (< 1 Hz) oscillation in thalamocortical neurons in vitro	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; LOW-FREQUENCY RHYTHMS; IN-VITRO; CORTICOTHALAMIC NETWORKS; SYNCHRONIZED OSCILLATIONS; DELTA-WAVES; SLEEP; RAT; CAT; ACTIVATION	The slow (<1 Hz) rhythm is a defining feature of the electroencephalogram during sleep. Since cortical circuits can generate this rhythm in isolation, it is assumed that the accompanying slow oscillation in thalamocortical (TC) neurons is largely a passive reflection of neocortical activity. Here we show, however, that by activating the metabotropic glutamate receptor (mGluR), mGluR1a, cortical inputs can recruit intricate cellular mechanisms that enable the generation of an intrinsic slow oscillation in TC neurons in vitro with identical properties to those observed in vivo. These mechanisms rely on the "window" component of the T-type Ca2+ current and a Ca2+-activated, nonselective cation current. These results suggest an active role for the thalamus in shaping the slow (<1 Hz) sleep rhythm.	Cardiff Univ, Sch Biosci, Cardiff CF10 3US, S Glam, Wales	Cardiff University	Crunelli, V (corresponding author), Cardiff Univ, Sch Biosci, Museum Ave, Cardiff CF10 3US, S Glam, Wales.		Crunelli, Vincenzo/A-7258-2010	Crunelli, Vincenzo/0000-0001-7154-9752; Hughes, Stuart/0000-0003-0423-777X				Achermann P, 1997, NEUROSCIENCE, V81, P213, DOI 10.1016/S0306-4522(97)00186-3; Amzica F, 1997, NEUROLOGY, V49, P952, DOI 10.1212/WNL.49.4.952; AMZICA F, 1995, J NEUROSCI, V15, P4658; Bal T, 1996, NEURON, V17, P297, DOI 10.1016/S0896-6273(00)80161-0; BAL T, 1993, J PHYSIOL-LONDON, V468, P669, DOI 10.1113/jphysiol.1993.sp019794; Chuang SC, 2000, J NEUROPHYSIOL, V83, P2844, DOI 10.1152/jn.2000.83.5.2844; Contreras D, 1996, J PHYSIOL-LONDON, V494, P251, DOI 10.1113/jphysiol.1996.sp021488; Contreras D, 1997, NEUROSCIENCE, V76, P25; Contreras D, 1997, NEUROSCIENCE, V76, P11; CONTRERAS D, 1995, J NEUROSCI, V15, P604; CRUNELLI V, 1989, J PHYSIOL-LONDON, V413, P543, DOI 10.1113/jphysiol.1989.sp017668; Destexhe A, 1996, J NEUROPHYSIOL, V76, P2049, DOI 10.1152/jn.1996.76.3.2049; Godwin DW, 1996, J NEUROSCI, V16, P8181; Gutierrez C, 2001, J NEUROSCI, V21, P1022, DOI 10.1523/JNEUROSCI.21-03-01022.2001; Hughes SW, 1999, J PHYSIOL-LONDON, V517, P805, DOI 10.1111/j.1469-7793.1999.0805s.x; Lee KH, 1997, NEUROSCIENCE, V77, P335, DOI 10.1016/S0306-4522(96)00481-2; LERESCHE N, 1991, J PHYSIOL-LONDON, V441, P155, DOI 10.1113/jphysiol.1991.sp018744; Luthi A, 1998, NEURON, V20, P553, DOI 10.1016/S0896-6273(00)80994-0; MCCORMICK DA, 1990, J PHYSIOL-LONDON, V431, P291, DOI 10.1113/jphysiol.1990.sp018331; MCCORMICK DA, 1992, P NATL ACAD SCI USA, V89, P2774, DOI 10.1073/pnas.89.7.2774; Pakhotin PI, 1997, NEUROREPORT, V8, P1755, DOI 10.1097/00001756-199705060-00037; PARTRIDGE LD, 1988, TRENDS NEUROSCI, V11, P69, DOI 10.1016/0166-2236(88)90167-1; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Simon NR, 2000, BRAIN RES, V860, P64, DOI 10.1016/S0006-8993(00)01974-0; SOLTESZ I, 1991, J PHYSIOL-LONDON, V441, P175, DOI 10.1113/jphysiol.1991.sp018745; STERIADE M, 1993, J NEUROSCI, V13, P3284; STERIADE M, 1993, J NEUROSCI, V13, P3266; STERIADE M, 1991, J NEUROSCI, V11, P3200; Steriade M, 1996, J NEUROSCI, V16, P2788; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; STERIADE M, 1993, J NEUROSCI, V13, P3253; Tennigkeit F, 1999, J NEUROPHYSIOL, V82, P718, DOI 10.1152/jn.1999.82.2.718; Timofeev I, 1996, J NEUROPHYSIOL, V76, P4152, DOI 10.1152/jn.1996.76.6.4152; TOKIMASA T, 1985, BRAIN RES, V337, P386, DOI 10.1016/0006-8993(85)90081-2; Toth TI, 1998, NEUROSCIENCE, V87, P519, DOI 10.1016/S0306-4522(98)00118-3; Turner JP, 1998, J PHYSIOL-LONDON, V510, P829, DOI 10.1111/j.1469-7793.1998.829bj.x; Turner JP, 2000, NEUROSCIENCE, V100, P493, DOI 10.1016/S0306-4522(00)00280-3; Von Krosigk M, 1999, NEUROSCIENCE, V91, P7, DOI 10.1016/S0306-4522(98)00557-0; Williams SR, 1997, J PHYSIOL-LONDON, V505, P689, DOI 10.1111/j.1469-7793.1997.689ba.x; Zhan XJ, 2000, J NEUROSCI, V20, P3909, DOI 10.1523/JNEUROSCI.20-10-03909.2000; Zhu JJ, 1999, NEUROSCIENCE, V91, P1445, DOI 10.1016/S0306-4522(98)00665-4	42	177	181	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 14	2002	33	6					947	958		10.1016/S0896-6273(02)00623-2	http://dx.doi.org/10.1016/S0896-6273(02)00623-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	530ZK	11906700	Bronze			2022-12-24	WOS:000174389600011
J	Derjean, D; Bertrand, S; Le Masson, G; Landry, M; Morisset, V; Nagy, F				Derjean, D; Bertrand, S; Le Masson, G; Landry, M; Morisset, V; Nagy, F			Dynamic balance of metabotropic inputs causes dorsal horn neurons to switch functional states	NATURE NEUROSCIENCE			English	Article							TURTLE SPINAL-CORD; PLATEAU POTENTIALS; RECEPTOR ACTIVATION; GLUTAMATE RECEPTORS; RESPONSE PROPERTIES; INHIBITORY CONTROL; GABA(B) RECEPTOR; NUCLEUS NEURONS; IN-VITRO; RAT	Sensory relay structures in the spinal cord dorsal horn are now thought to be active processing structures that function before supraspinal sensory integration. Dorsal horn neurons directly receive nociceptive (pain) signals from the periphery, express a high degree of functional plasticity and are involved in long-term sensitization and chronic pain. We show here that deep dorsal horn neurons (DHNs) in Wistar rats can switch their intrinsic firing properties from tonic to plateau or endogenous bursting patterns, depending upon the balance of control by metabotropic glutamate (mGlu) and GABA(B) receptors. We further show that this modulation acts on at least one common target, the inwardly rectifying potassium channel (Kir3). Finally, we found that these firing modes correspond to specific functional states of information transfer in which dorsal horn neurons can faithfully transmit, greatly enhance or block the transfer of nociceptive information.	Univ Bordeaux 2, INSERM E0358, Inst Francois Magendie, F-33076 Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Nagy, F (corresponding author), Univ Bordeaux 2, INSERM E0358, Inst Francois Magendie, F-33076 Bordeaux, France.		Bertrand, Sandrine/P-9290-2015	Bertrand, Sandrine S/0000-0002-3020-7980				ADRIAENSEN H, 1983, J NEUROPHYSIOL, V49, P111, DOI 10.1152/jn.1983.49.1.111; Asada H, 1996, NEUROSCI LETT, V213, P99, DOI 10.1016/0304-3940(96)12844-5; Baranauskas G, 1998, PROG NEUROBIOL, V54, P349, DOI 10.1016/S0301-0082(97)00067-1; Bettler B, 1998, CURR OPIN NEUROBIOL, V8, P345, DOI 10.1016/S0959-4388(98)80059-7; Beurrier C, 1999, J NEUROSCI, V19, P599, DOI 10.1523/jneurosci.19-02-00599.1999; CALVINO B, 1987, PAIN, V28, P81, DOI 10.1016/0304-3959(87)91063-3; COOK AJ, 1987, NATURE, V325, P151, DOI 10.1038/325151a0; Couve A, 2000, MOL CELL NEUROSCI, V16, P296, DOI 10.1006/mcne.2000.0908; Dascal N, 1997, CELL SIGNAL, V9, P551, DOI 10.1016/S0898-6568(97)00095-8; DE KONINCK Y, 1991, P NATL ACAD SCI USA, V88, P11344, DOI 10.1073/pnas.88.24.11344; DelgadoLezama R, 1997, J PHYSIOL-LONDON, V504, P97, DOI 10.1111/j.1469-7793.1997.097bf.x; Destexhe A, 1994, J Comput Neurosci, V1, P195, DOI 10.1007/BF00961734; DiPrisco GV, 1997, SCIENCE, V278, P1122, DOI 10.1126/science.278.5340.1122; HAO JX, 1992, J NEUROPHYSIOL, V68, P392, DOI 10.1152/jn.1992.68.2.392; Herrero JF, 2000, PROG NEUROBIOL, V61, P169, DOI 10.1016/S0301-0082(99)00051-9; Herzog E, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-22-j0001.2001; INOKUCHI H, 1992, NEUROSCIENCE, V46, P657, DOI 10.1016/0306-4522(92)90152-R; JIANG MC, 1995, J NEUROPHYSIOL, V74, P1819, DOI 10.1152/jn.1995.74.5.1819; Jiang MC, 1999, J NEUROPHYSIOL, V81, P3078, DOI 10.1152/jn.1999.81.6.3078; KANGRGA I, 1991, BRAIN RES, V562, P265, DOI 10.1016/0006-8993(91)90630-E; Kawasaki H, 1999, J NEUROPHYSIOL, V82, P2590, DOI 10.1152/jn.1999.82.5.2590; Le Masson G, 2002, NATURE, V417, P854, DOI 10.1038/nature00825; LeMasson G, 1995, PROG BIOPHYS MOL BIO, V64, P201, DOI 10.1016/S0079-6107(96)00004-1; Levine MW, 1998, BIOSYSTEMS, V48, P139, DOI 10.1016/S0303-2647(98)00059-8; Lin Q, 1996, J NEUROPHYSIOL, V75, P109, DOI 10.1152/jn.1996.75.1.109; Lo FS, 2002, J NEUROPHYSIOL, V88, P794, DOI 10.1152/jn.2002.88.2.794; LOMBARD MC, 1983, ADV PAIN RES THER, P147; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; Millan MJ, 1999, PROG NEUROBIOL, V57, P1, DOI 10.1016/S0301-0082(98)00048-3; Morisset V, 2000, EUR J NEUROSCI, V12, P3087, DOI 10.1046/j.1460-9568.2000.00188.x; Morisset V, 1999, J NEUROSCI, V19, P7309, DOI 10.1523/JNEUROSCI.19-17-07309.1999; Morisset V, 1998, EUR J NEUROSCI, V10, P3642, DOI 10.1046/j.1460-9568.1998.00370.x; Neugebauer V, 2002, PAIN, V98, P1, DOI 10.1016/S0304-3959(02)00140-9; RUSSO RE, 1994, NEUROSCIENCE, V61, P191, DOI 10.1016/0306-4522(94)90222-4; Russo RE, 1998, J PHYSIOL-LONDON, V506, P795, DOI 10.1111/j.1469-7793.1998.795bv.x; Russo RE, 1999, PROG BIOPHYS MOL BIO, V72, P329, DOI 10.1016/S0079-6107(99)00011-5; Russo RE, 1996, J PHYSIOL-LONDON, V493, P39, DOI 10.1113/jphysiol.1996.sp021363; Russo RE, 1997, J PHYSIOL-LONDON, V499, P459, DOI 10.1113/jphysiol.1997.sp021941; Schneider SP, 1998, J NEUROPHYSIOL, V80, P2954, DOI 10.1152/jn.1998.80.6.2954; Sharon D, 1997, J GEN PHYSIOL, V109, P477, DOI 10.1085/jgp.109.4.477; SHARP AA, 1993, J NEUROPHYSIOL, V69, P992, DOI 10.1152/jn.1993.69.3.992; Sodickson DL, 1996, J NEUROSCI, V16, P6374; SOTGIU ML, 1995, NEUROREPORT, V6, P1021, DOI 10.1097/00001756-199505090-00018; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; Tennigkeit F, 1999, J NEUROPHYSIOL, V82, P718, DOI 10.1152/jn.1999.82.2.718; URBAN L, 1994, TRENDS NEUROSCI, V17, P432, DOI 10.1016/0166-2236(94)90018-3; Usrey WM, 2002, CURR OPIN NEUROBIOL, V12, P411, DOI 10.1016/S0959-4388(02)00339-2; Willis Jr W. D., 1991, SENSORY MECH SPINAL; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; WOOLF CJ, 1989, J NEUROPHYSIOL, V62, P907, DOI 10.1152/jn.1989.62.4.907	50	96	104	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2003	6	3					274	281		10.1038/nn1016	http://dx.doi.org/10.1038/nn1016			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	648YB	12592405				2022-12-24	WOS:000181178300016
J	Dyer, JR; Michel, S; Lee, W; Castellucci, VF; Wayne, NL; Sossin, WS				Dyer, JR; Michel, S; Lee, W; Castellucci, VF; Wayne, NL; Sossin, WS			An activity-dependent switch to cap-independent translation triggered by eIF4E dephosphorylation	NATURE NEUROSCIENCE			English	Article							INITIATION-FACTOR 4E; NERVOUS-SYSTEM; APLYSIA; PHOSPHORYLATION; FACILITATION		McGill Univ, Dept Neurol & Neurosurg, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; Univ Calif Los Angeles, Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; Univ Montreal, Dept Physiol, Montreal, PQ H3C 3J7, Canada	McGill University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Universite de Montreal	Sossin, WS (corresponding author), McGill Univ, Dept Neurol & Neurosurg, Montreal Neurol Inst, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033548] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS 33548] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Dyer JR, 2000, J NEUROCHEM, V75, P872, DOI 10.1046/j.1471-4159.2000.0750872.x; GHIRARDI M, 1995, NEURON, V14, P413, DOI 10.1016/0896-6273(95)90297-X; Lachance PED, 2002, MOL CELL BIOL, V22, P1656, DOI 10.1128/MCB.22.6.1656-1663.2002; Lee WJ, 1998, ENDOCRINOLOGY, V139, P5109, DOI 10.1210/en.139.12.5109; MAHON AC, 1985, J NEUROSCI, V5, P1872; Manseau F, 2001, J NEUROSCI, V21, P1247; Pinkstaff JK, 2001, P NATL ACAD SCI USA, V98, P2770, DOI 10.1073/pnas.051623398; Pyronnet S, 2001, GENE DEV, V15, P2083, DOI 10.1101/gad.889201; Scheper GC, 2002, J BIOL CHEM, V277, P3303, DOI 10.1074/jbc.M103607200; Yanow SK, 1998, J NEUROCHEM, V70, P572	10	53	54	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2003	6	3					219	220		10.1038/nn1018	http://dx.doi.org/10.1038/nn1018			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	648YB	12592407				2022-12-24	WOS:000181178300008
J	Das, T; Payer, B; Cayouette, M; Harris, WA				Das, T; Payer, B; Cayouette, M; Harris, WA			In vivo time-lapse imaging of cell divisions during neurogenesis in the developing zebrafish retina	NEURON			English	Article							MOUSE CORTICAL NEUROGENESIS; ASYMMETRIC INHERITANCE; NEUROEPITHELIAL CELLS; NERVOUS-SYSTEM; XENOPUS RETINA; MAMMALIAN NUMB; GLIAL-CELLS; DIFFERENTIATION; NEURONS; LINEAGE	Two-photon excitation microscopy was used to reconstruct cell divisions in living zebrafish embryonic retinas. Contrary to proposed models for vertebrate asymmetric divisions, no apico-basal cell divisions take place in the zebrafish retina during the generation of postmitotic neurons. However, a surprising shift in the orientation of cell division from central-peripheral to circumferential occurs within the plane of the ventricular surface. In the sonic you (syu) and lakritz (lak) mutants, the shift from central-peripheral to circumferential divisions is absent or delayed, correlating with the delay in neuronal differentiation and neurogenesis in these mutants. The reconstructions here show that mitotic cells always remain in contact with the opposite basal surface by means of a thin basal process that can be inherited asymmetrically.	Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England; Univ Oxford New Coll, Oxford OX1 3BN, England; Wellcome Trust Canc Res UK Inst Canc & Dev Biol, Cambridge CB2 1QR, England; UCL, MRC, Mol Cell Biol Lab, London WC1E 6BT, England	University of Cambridge; University of Oxford; University of London; University College London	Harris, WA (corresponding author), Univ Cambridge, Dept Anat, Downing St, Cambridge CB2 3DY, England.	harris@mole.bio.cam.ac.uk	Payer, Bernhard/F-7353-2010; Das, Tilak/AAY-5310-2020	Payer, Bernhard/0000-0002-4694-2082; Das, Tilak/0000-0003-0655-412X; Cayouette, Michel/0000-0003-4655-9048				Adams RJ, 1996, J NEUROSCI, V16, P7610; Bellaiche Y, 2001, NAT CELL BIOL, V3, P50, DOI 10.1038/35050558; Cayouette M, 2001, J NEUROSCI, V21, P5643, DOI 10.1523/JNEUROSCI.21-15-05643.2001; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Doe CQ, 2001, CURR OPIN CELL BIOL, V13, P68, DOI 10.1016/S0955-0674(00)00176-9; Dowling J. E., 1987, RETINA APPROACHABLE; Gho M, 1998, NATURE, V393, P178, DOI 10.1038/30265; HINDS JW, 1979, J COMP NEUROL, V187, P495, DOI 10.1002/cne.901870303; HINDS JW, 1974, DEV BIOL, V37, P381, DOI 10.1016/0012-1606(74)90156-0; HOLT CE, 1988, NEURON, V1, P15, DOI 10.1016/0896-6273(88)90205-X; Horne-Badovinac S, 2001, CURR BIOL, V11, P1492, DOI 10.1016/S0960-9822(01)00458-4; Hu M, 1999, DEV BIOL, V207, P309, DOI 10.1006/dbio.1998.9031; Huttner WB, 1997, CURR OPIN NEUROBIOL, V7, P29, DOI 10.1016/S0959-4388(97)80117-1; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kay JN, 2001, NEURON, V30, P725, DOI 10.1016/S0896-6273(01)00312-9; Kelsh RN, 1996, DEVELOPMENT, V123, P369; Knoblich JA, 2001, NAT REV MOL CELL BIO, V2, P11, DOI 10.1038/35048085; Laessing U, 1996, J NEUROBIOL, V29, P65, DOI 10.1002/(SICI)1097-4695(199601)29:1<65::AID-NEU5>3.0.CO;2-5; Li Z, 2000, DEV DYNAM, V218, P175, DOI 10.1002/(SICI)1097-0177(200005)218:1<175::AID-DVDY15>3.0.CO;2-K; Li Z, 2000, DEV DYNAM, V219, P391, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1063>3.0.CO;2-G; Lu BW, 2000, ANNU REV NEUROSCI, V23, P531, DOI 10.1146/annurev.neuro.23.1.531; Masai I, 2000, NEURON, V27, P251, DOI 10.1016/S0896-6273(00)00034-9; McFarlane S, 1998, DEVELOPMENT, V125, P3967; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; NAWROCKI LW, 1985, DEV NEURAL RETINA ZE; Neumann CJ, 2000, SCIENCE, V289, P2137, DOI 10.1126/science.289.5487.2137; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Ohnuma S, 1999, CELL, V99, P499, DOI 10.1016/S0092-8674(00)81538-X; Piston DW, 1999, TRENDS CELL BIOL, V9, P66, DOI 10.1016/S0962-8924(98)01432-9; RAKIC P, 1995, TRENDS NEUROSCI, V18, P383, DOI 10.1016/0166-2236(95)93934-P; Roegiers F, 2001, NAT CELL BIOL, V3, P58, DOI 10.1038/35050568; SCHMITT EA, 1994, J COMP NEUROL, V344, P532, DOI 10.1002/cne.903440404; Silva AO, 2002, J NEUROSCI, V22, P7518; TURNER DL, 1990, NEURON, V4, P833, DOI 10.1016/0896-6273(90)90136-4; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; Wakamatsu Y, 1999, NEURON, V23, P71, DOI 10.1016/S0896-6273(00)80754-0; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Wolf E, 1996, J COMP NEUROL, V367, P623; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215; Zhong WM, 1997, DEVELOPMENT, V124, P1887; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2	42	156	158	1	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 20	2003	37	4					597	609		10.1016/S0896-6273(03)00066-7	http://dx.doi.org/10.1016/S0896-6273(03)00066-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	648EH	12597858	Bronze			2022-12-24	WOS:000181136500009
J	Vermeren, M; Maro, GS; Bron, R; McGonnell, IM; Charnay, P; Topilko, P; Cohen, J				Vermeren, M; Maro, GS; Bron, R; McGonnell, IM; Charnay, P; Topilko, P; Cohen, J			Integrity of developing spinal motor columns is regulated by neural crest derivatives at motor exit points	NEURON			English	Article							HOMEOBOX GENE ISLET-1; CHICK-EMBRYO; CELL-MIGRATION; NERVOUS-SYSTEM; MUTANT MOUSE; TUBE CELLS; EXPRESSION; IDENTITY; SPLOTCH; NERVES	Spinal motor neurons must extend their axons into the periphery through motor exit points (MEPs), but their cell bodies remain within spinal motor columns. It is not known how this partitioning is established in development. We show here that motor neuron somata are confined to the CNS by interactions with a neural crest subpopulation, boundary cap (BC) cells that prefigure the sites of spinal MEPs. Elimination of BC cells by surgical or targeted genetic ablation does not perturb motor axon outgrowth but results in motor neuron somata migrating out of the spinal cord by translocating along their axons. Heterologous neural crest grafts in crest-ablated embryos stop motor neuron emigration. Thus, before the formation of a mature transitional zone at the MEP, BC cells maintain a cell-tight boundary that allows motor axons to cross but blocks neuron migration.	Kings Coll London, MRC, Ctr Dev Neurobiol, London SE1 1UL, England; Ecole Normale Super, INSERM, U368, F-75230 Paris 05, France	University of London; King's College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Cohen, J (corresponding author), Kings Coll London, MRC, Ctr Dev Neurobiol, Guys Campus, London SE1 1UL, England.	james.cohen@kci.ac.uk	McGonnell, Imelda/AGG-3394-2022	McGonnell, Imelda/0000-0002-9800-7248; Vermeren, Matthieu/0000-0003-3584-0387; Charnay, Patrick/0000-0002-3847-6042				ALTMAN J, 1984, ADV ANAT EMBRYOL CEL, V85, P1; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; AUERBACH R, 1954, J EXP ZOOL, V127, P305, DOI 10.1002/jez.1401270206; BASLER K, 1993, CELL, V73, P687, DOI 10.1016/0092-8674(93)90249-P; BHATTACHARYYA A, 1994, DEVELOPMENT, V120, P1411; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; CARPENTER EM, 1992, DEV BIOL, V150, P144, DOI 10.1016/0012-1606(92)90014-8; ERICSON J, 1992, SCIENCE, V256, P1555, DOI 10.1126/science.1350865; FRANZ T, 1990, ACTA ANAT, V138, P246; Gilmour DT, 2002, NEURON, V34, P577, DOI 10.1016/S0896-6273(02)00683-9; GILTHORPE JD, 2002, IN PRESS DEVELOPMENT, V129; Golding JP, 1997, MOL CELL NEUROSCI, V9, P381, DOI 10.1006/mcne.1997.0647; Henderson DJ, 1997, MECH DEVELOP, V69, P39, DOI 10.1016/S0925-4773(97)00151-2; Itasaki N, 1999, NAT CELL BIOL, V1, pE203, DOI 10.1038/70231; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; LEDOUARIN N, 1991, GLIA, V4, P175; LORING JF, 1987, DEV BIOL, V121, P220, DOI 10.1016/0012-1606(87)90154-0; LUNN ER, 1987, DEVELOPMENT, V101, P247; Mansouri A, 2001, DEVELOPMENT, V128, P1995; McGonnell IM, 2002, CURR BIOL, V12, P767, DOI 10.1016/S0960-9822(02)00818-7; Meyer D, 1997, DEVELOPMENT, V124, P3575; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; NAKAGAWA S, 1995, DEVELOPMENT, V121, P1321; Niederlander C, 1996, DEVELOPMENT, V122, P2367; Price SR, 2002, CELL, V109, P205, DOI 10.1016/S0092-8674(02)00695-5; RICKMANN M, 1985, J EMBRYOL EXP MORPH, V90, P437; SCHNEIDERMAUNOURY S, 1993, CELL, V75, P1199, DOI 10.1016/0092-8674(93)90329-O; Schubert FR, 2001, DEV DYNAM, V222, P506, DOI 10.1002/dvdy.1211; Serbedzija GN, 1997, DEV BIOL, V185, P139, DOI 10.1006/dbio.1997.8551; SERBEDZIJA GN, 1989, DEVELOPMENT, V106, P809; Sockanathan S, 1998, CELL, V94, P503, DOI 10.1016/S0092-8674(00)81591-3; Sohal GS, 1996, INT J DEV NEUROSCI, V14, P419, DOI 10.1016/S0736-5748(96)00002-0; Sohal GS, 1998, INT J DEV NEUROSCI, V16, P477, DOI 10.1016/S0736-5748(98)00049-5; Sohal GS, 1998, BIOCHEM BIOPH RES CO, V252, P675, DOI 10.1006/bbrc.1998.9715; Sonnenberg-Riethmacher E, 2001, MECH DEVELOP, V109, P253, DOI 10.1016/S0925-4773(01)00547-0; STERN HM, 1995, DEVELOPMENT, V121, P3675; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; WESTON JA, 1963, DEV BIOL, V6, P279, DOI 10.1016/0012-1606(63)90016-2; WILKINSON DG, 1989, NATURE, V337, P461, DOI 10.1038/337461a0; Wingate RJT, 1999, DEVELOPMENT, V126, P4395; Yaneza M, 2002, DEV DYNAM, V223, P163, DOI 10.1002/dvdy.1241	44	100	100	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 6	2003	37	3					403	415		10.1016/S0896-6273(02)01188-1	http://dx.doi.org/10.1016/S0896-6273(02)01188-1			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	647FF	12575949	Bronze			2022-12-24	WOS:000181081600007
J	Yu, TW; Hao, JC; Lim, W; Tessier-Lavigne, M; Bargmann, CI				Yu, TW; Hao, JC; Lim, W; Tessier-Lavigne, M; Bargmann, CI			Shared receptors in axon guidance: SAX-3/Robo signals via UNC-34/enabled and a Netrin-independent UNC-40/DCC function	NATURE NEUROSCIENCE			English	Article							GROWTH CONE MIGRATIONS; C-ELEGANS; CAENORHABDITIS-ELEGANS; LISTERIA-MONOCYTOGENES; COLORECTAL-CANCER; TYROSINE KINASE; SLIT PROTEINS; CNS MIDLINE; DROSOPHILA; GENES	The C. elegans SAX-3/Robo receptor acts in anterior-posterior, dorsal-ventral and midline guidance decisions. Here we show that SAX-3 signaling involves the C. elegans Enabled protein UNC-34 and an unexpected Netrin-independent function of the Netrin receptor UNC-40/DCC. Genetic interactions with gain- and loss-of-function mutations suggest that unc-34 and unc-40 act together with sax-3 in several guidance decisions, but the C. elegans Netrin gene unc-6 does not act in the same genetic pathways. Within the migrating axon, sax-3, unc-34 and unc-40 all act cell-autonomously. Our results support a role for UNC-34/Enabled proteins in SAX-3-mediated repulsion, and show that UNC-40/DCC can potentiate SAX-3/Robo signaling via a mechanism that may involve direct binding of the two guidance receptors. A combinatorial logic dictates alternative functions for UNC-40/DCC, which can act in attraction to UNC-6/Netrin, repulsion from Netrin (with UNC-5), or repulsion from Slit (with SAX-3).	Univ Calif San Francisco, Dept Anat, Program Neurosci, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bargmann, CI (corresponding author), Univ Calif San Francisco, Dept Anat, Program Neurosci, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	cori@itsa.ucsf.edu	Yu, Timothy W./AAF-5738-2019	Yu, Timothy W./0000-0003-2988-7701; Bargmann, Cornelia/0000-0002-8484-0618				Bagri A, 2002, NEURON, V33, P233, DOI 10.1016/S0896-6273(02)00561-5; Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Bashaw GJ, 1999, CELL, V97, P917, DOI 10.1016/S0092-8674(00)80803-X; Bear JE, 2000, CELL, V101, P717, DOI 10.1016/S0092-8674(00)80884-3; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Brose K, 2000, CURR OPIN NEUROBIOL, V10, P95, DOI 10.1016/S0959-4388(99)00066-5; CHAKRABORTY T, 1995, EMBO J, V14, P1314, DOI 10.1002/j.1460-2075.1995.tb07117.x; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; Colavita A, 1998, DEV BIOL, V194, P72, DOI 10.1006/dbio.1997.8790; Culotti JG, 1998, CURR OPIN CELL BIOL, V10, P609, DOI 10.1016/S0955-0674(98)80036-7; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Flanagan JG, 1998, CELL, V92, P429, DOI 10.1016/S0092-8674(00)80935-6; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Forrester WC, 1997, DEVELOPMENT, V124, P1831; Fricke C, 2001, SCIENCE, V292, P507, DOI 10.1126/science.1059496; Fritz JL, 2000, DEVELOPMENT, V127, P1991; Gallo G, 1999, CURR BIOL, V9, pR490, DOI 10.1016/S0960-9822(99)80304-2; GERTLER FB, 1990, SCIENCE, V248, P857, DOI 10.1126/science.2188361; GERTLER FB, 1995, GENE DEV, V9, P521, DOI 10.1101/gad.9.5.521; Guthrie S, 2001, CURR BIOL, V11, pR300, DOI 10.1016/S0960-9822(01)00169-5; HAMELIN M, 1992, EMBO J, V11, P2885, DOI 10.1002/j.1460-2075.1992.tb05357.x; HAMELIN M, 1993, NATURE, V364, P327, DOI 10.1038/364327a0; Hao JC, 2001, NEURON, V32, P25, DOI 10.1016/S0896-6273(01)00448-2; HEDGECOCK EM, 1987, DEVELOPMENT, V100, P365; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Hiramoto M, 2000, NATURE, V406, P886, DOI 10.1038/35022571; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Honigberg L, 2000, DEVELOPMENT, V127, P4655; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kidd T, 1998, NEURON, V20, P25, DOI 10.1016/S0896-6273(00)80431-6; Kim S, 1999, DEVELOPMENT, V126, P3881; Laurent V, 1999, J CELL BIOL, V144, P1245, DOI 10.1083/jcb.144.6.1245; Lin MZ, 2000, CELL, V101, P239, DOI 10.1016/S0092-8674(00)80833-8; MCINTIRE SL, 1992, NEURON, V8, P307, DOI 10.1016/0896-6273(92)90297-Q; Merz DC, 2000, J NEUROBIOL, V44, P281, DOI 10.1002/1097-4695(200008)44:2&lt;281::AID-NEU16&gt;3.0.CO;2-4; Nakamura F, 2000, J NEUROBIOL, V44, P219, DOI 10.1002/1097-4695(200008)44:2<219::AID-NEU11>3.0.CO;2-W; Plump AS, 2002, NEURON, V33, P219, DOI 10.1016/S0896-6273(01)00586-4; Stein E, 2001, SCIENCE, V291, P1976, DOI 10.1126/science.1059391; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Sun Q, 2000, DEVELOPMENT, V127, P801; Tear G, 1993, Perspect Dev Neurobiol, V1, P183; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wills Z, 1999, NEURON, V22, P301, DOI 10.1016/S0896-6273(00)81091-0; Zallen JA, 1999, DEVELOPMENT, V126, P3679; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	50	122	132	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1147	1154		10.1038/nn956	http://dx.doi.org/10.1038/nn956			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	609CG	12379860				2022-12-24	WOS:000178884600017
J	Benn, SC; Perrelet, D; Kato, AC; Scholz, J; Decosterd, I; Mannion, RJ; Bakowska, JC; Woolf, CJ				Benn, SC; Perrelet, D; Kato, AC; Scholz, J; Decosterd, I; Mannion, RJ; Bakowska, JC; Woolf, CJ			Hsp27 upregulation and phosphorylation is required for injured sensory and motor neuron survival	NEURON			English	Article							BACTERIAL ARTIFICIAL CHROMOSOME; PERIPHERAL-NERVE INJURY; C-DEPENDENT ACTIVATION; PROGRAMMED CELL-DEATH; HEAT-SHOCK PROTEINS; IAP FAMILY PROTEINS; CYTOCHROME-C; DEVELOPING MOTONEURONS; SCIATIC-NERVE; IN-VIVO	Peripheral nerve transection results in the rapid death by apoptosis of neonatal but not adult sensory and motor neurons. We show that this is due to induction and phosphorylation in all adult axotomized neurons of the small heat shock protein Hsp27 and the failure of such induction in most neonatal neurons. In vivo delivery of human Hsp27 but not a nonphosphorylatable mutant prevents neonatal rat motor neurons from nerve injury-induced death, while knockdown in vitro and in vivo of Hsp27 in adult injured sensory neurons results in apoptosis. Hsp27's neuroprotective action is downstream of cytochrome c release from mitochondria and upstream of caspase-3 activation. Transcriptional and posttranslational regulation of Hsp27 is necessary for sensory and motor neuron survival following peripheral nerve injury.	Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Neural Plast Res Grp, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Dept Neurol, Mol Neurogenet Unit, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Dept Radiol, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA; CHU Vaudois, Dept Anesthesiol, CH-1011 Lausanne, Switzerland; CHU Vaudois, Dept Expt Surg, CH-1011 Lausanne, Switzerland; Ctr Med Univ Geneva, Fac Med, Dept Anesthesiol Pharmacol & Surg Intens Care, CH-1211 Geneva 4, Switzerland	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Geneva	Woolf, CJ (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Neural Plast Res Grp, Charlestown, MA 02129 USA.	woolf.clifford@mgh.harvard.edu	Woolf, Clifford/A-9784-2010		NICHD NIH HHS [HD38533] Funding Source: Medline; NINDS NIH HHS [NS38253] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038253] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARRIGO AP, 1994, BIOL HEAT SHOCK PROT; Benjamin IJ, 1998, CIRC RES, V83, P117, DOI 10.1161/01.RES.83.2.117; Benn SC, 2001, J NEUROSCI, V21, P6077, DOI 10.1523/JNEUROSCI.21-16-06077.2001; BENNDORF R, 1994, J BIOL CHEM, V269, P20780; Bruey JM, 2000, NAT CELL BIOL, V2, P645, DOI 10.1038/35023595; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Carper SW, 1997, J CELL BIOCHEM, V66, P153, DOI 10.1002/(SICI)1097-4644(19970801)66:2<153::AID-JCB3>3.3.CO;2-N; Charette SJ, 2000, MOL CELL BIOL, V20, P7602, DOI 10.1128/MCB.20.20.7602-7612.2000; CLARKE PGH, 1995, METHOD CELL BIOL, V46, P277; Concannon CG, 2001, GENE EXPRESSION, V9, P195, DOI 10.3727/000000001783992605; Costigan M, 1998, J NEUROSCI, V18, P5891; DECHIARA TM, 1995, CELL, V83, P313, DOI 10.1016/0092-8674(95)90172-8; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; DUBOISDAUPHIN M, 1994, P NATL ACAD SCI USA, V91, P3309, DOI 10.1073/pnas.91.8.3309; Garces A, 2000, J NEUROSCI, V20, P4992; Garrido C, 1999, FASEB J, V13, P2061, DOI 10.1096/fasebj.13.14.2061; Guay J, 1997, J CELL SCI, V110, P357; Hedges JC, 1999, J BIOL CHEM, V274, P24211, DOI 10.1074/jbc.274.34.24211; Henderson CE, 1996, NEURON, V17, P579, DOI 10.1016/S0896-6273(00)80191-9; Houenou LJ, 1996, J NEUROPATH EXP NEUR, V55, P698, DOI 10.1097/00005072-199606000-00003; Huot J, 1996, CANCER RES, V56, P273; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Kalmar B, 2002, EXP NEUROL, V176, P87, DOI 10.1006/exnr.2002.7945; Kato K, 2001, CELL STRESS CHAPERON, V6, P16, DOI 10.1379/1466-1268(2001)006<0016:PKICSS>2.0.CO;2; Konishi H, 1997, FEBS LETT, V410, P493, DOI 10.1016/S0014-5793(97)00541-3; Krueger-Naug AMR, 2002, NEUROSCIENCE, V110, P653, DOI 10.1016/S0306-4522(01)00453-5; Lambert H, 1999, J BIOL CHEM, V274, P9378, DOI 10.1074/jbc.274.14.9378; Landry J, 1999, BIOCHEM SOC SYMP, P79; Lewis SE, 1999, J NEUROSCI, V19, P8945, DOI 10.1523/JNEUROSCI.19-20-08945.1999; Li L, 2001, J NEUROBIOL, V46, P249, DOI 10.1002/1097-4695(200103)46:4<249::AID-NEU1006>3.0.CO;2-G; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu X, 2000, DEV DYNAM, V218, P94, DOI 10.1002/(SICI)1097-0177(200005)218:1<94::AID-DVDY8>3.0.CO;2-Z; Livesey FJ, 1997, NATURE, V390, P614, DOI 10.1038/37615; Ma JJ, 2001, EXP BRAIN RES, V139, P216, DOI 10.1007/s002210100769; MARTINOU JC, 1994, NEURON, V13, P1017, DOI 10.1016/0896-6273(94)90266-6; Mehlen P, 1997, J BIOL CHEM, V272, P31657, DOI 10.1074/jbc.272.50.31657; Murashov AK, 2001, MOL BRAIN RES, V93, P199, DOI 10.1016/S0169-328X(01)00212-1; Namikawa K, 2000, J NEUROSCI, V20, P2875; Nishimune H, 2000, NAT CELL BIOL, V2, P906, DOI 10.1038/35046558; Oliveira ALR, 1997, NEUROREPORT, V8, P2837; Oppenheim RW, 2001, J NEUROSCI, V21, P1283; Oppenheim RW, 1996, NEURON, V17, P195, DOI 10.1016/S0896-6273(00)80151-8; Pandey P, 2000, ONCOGENE, V19, P1975, DOI 10.1038/sj.onc.1203531; Parsadanian AS, 1998, J NEUROSCI, V18, P1009; Paul C, 2002, MOL CELL BIOL, V22, P816, DOI 10.1128/MCB.22.3.816-834.2002; Perrelet D, 2000, EUR J NEUROSCI, V12, P2059, DOI 10.1046/j.1460-9568.2000.00098.x; Pettmann B, 1998, NEURON, V20, P633, DOI 10.1016/S0896-6273(00)81004-1; Pieri I, 2001, J NEUROSCI RES, V65, P247, DOI 10.1002/jnr.1148; Raoul C, 1999, J CELL BIOL, V147, P1049, DOI 10.1083/jcb.147.5.1049; Rogalla T, 1999, J BIOL CHEM, V274, P18947, DOI 10.1074/jbc.274.27.18947; Saeki Y, 1998, HUM GENE THER, V9, P2787, DOI 10.1089/hum.1998.9.18-2787; Saeki Y, 2001, MOL THER, V3, P591, DOI 10.1006/mthe.2001.0294; Sendtner M, 2000, CELL TISSUE RES, V301, P71, DOI 10.1007/s004410000217; Tandrup T, 2000, J COMP NEUROL, V422, P172, DOI 10.1002/(SICI)1096-9861(20000626)422:2<172::AID-CNE2>3.0.CO;2-H; Tsujino H, 2000, MOL CELL NEUROSCI, V15, P170, DOI 10.1006/mcne.1999.0814; Valentine B, 2001, J ACAD LIBR, V27, P107, DOI 10.1016/S0099-1333(00)00182-8; VEJSADA R, 1995, EUR J NEUROSCI, V7, P108, DOI 10.1111/j.1460-9568.1995.tb01025.x; Wagstaff MJD, 1999, J BIOL CHEM, V274, P5061, DOI 10.1074/jbc.274.8.5061; Wiese S, 1999, EUR J NEUROSCI, V11, P1668, DOI 10.1046/j.1460-9568.1999.00585.x; Yamada M, 2001, EXP NEUROL, V168, P225, DOI 10.1006/exnr.2000.7597; Yokoyama A, 2001, INVEST OPHTH VIS SCI, V42, P3283	62	209	218	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 26	2002	36	1					45	56		10.1016/S0896-6273(02)00941-8	http://dx.doi.org/10.1016/S0896-6273(02)00941-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	598UP	12367505	Bronze			2022-12-24	WOS:000178295100006
J	Shahbazian, MD; Young, JI; Yuva-Paylor, LA; Spencer, CM; Antalffy, BA; Noebels, JL; Armstrong, DL; Paylor, R; Zoghbi, HY				Shahbazian, MD; Young, JI; Yuva-Paylor, LA; Spencer, CM; Antalffy, BA; Noebels, JL; Armstrong, DL; Paylor, R; Zoghbi, HY			Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3	NEURON			English	Article							CPG-BINDING PROTEIN-2; LINKED MENTAL-RETARDATION; TRANSCRIPTIONAL REPRESSION; CHROMOSOMAL PROTEIN; DNA METHYLATION; MUTATIONS; LOCALIZATION; GENE; DEACETYLATION; PHENOTYPES	Mutations in the methyl-CpG binding protein 2 (MECP2) gene cause Rett syndrome (RTT), a neurodevelopmental disorder characterized by the loss of language and motor skills during early childhood. We generated mice with a truncating mutation similar to those found in RTT patients. These mice appeared normal and exhibited normal motor function for about 6 weeks, but then developed a progressive neurological disease that includes many features of RTT: tremors, motor impairments, hypoactivity, increased anxiety-related behavior, seizures, kyphosis, and stereotypic forelimb motions. Additionally, we show that although the truncated MeCP2 protein in these mice localizes normally to heterochromatic domains in vivo, histone H3 is hyperacetylated, providing evidence that the chromatin architecture is abnormal and that gene expression may be misregulated in this model of Rett syndrome.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute	Zoghbi, HY (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza, Houston, TX 77030 USA.			Zoghbi, Huda/0000-0002-0700-3349; Noebels, Jeffrey/0000-0002-2887-0839	NICHD NIH HHS [P01 HD40301, HD24064] Funding Source: Medline; NIMH NIH HHS [MH12555-02] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD040301] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Amir RE, 2000, ANN NEUROL, V47, P670, DOI 10.1002/1531-8249(200005)47:5<670::AID-ANA20>3.3.CO;2-6; ARMSTRONG D, 1995, J NEUROPATH EXP NEUR, V54, P195, DOI 10.1097/00005072-199503000-00006; Bienvenu T, 2000, HUM MOL GENET, V9, P1377, DOI 10.1093/hmg/9.9.1377; Bjerling P, 2002, MOL CELL BIOL, V22, P2170, DOI 10.1128/MCB.22.7.2170-2181.2002; Bourdon V, 2001, HUM GENET, V108, P43, DOI 10.1007/s004390000422; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Cohen D, 2002, AM J PSYCHIAT, V159, P148, DOI 10.1176/appi.ajp.159.1.148-a; Glaze DG, 1998, ELECTROEN CLIN NEURO, V106, P79, DOI 10.1016/S0013-4694(97)00084-9; Gregory RI, 2001, MOL CELL BIOL, V21, P5426, DOI 10.1128/MCB.21.16.5426-5436.2001; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; HAGBERG B, 1983, ANN NEUROL, V14, P471, DOI 10.1002/ana.410140412; HAGBERG BA, 1994, PEDIATR NEUROL, V11, P5, DOI 10.1016/0887-8994(94)90082-5; Hoffbuhr K, 2001, NEUROLOGY, V56, P1486, DOI 10.1212/WNL.56.11.1486; Imessaoudene B, 2001, J MED GENET, V38, P171, DOI 10.1136/jmg.38.3.171; Kokura K, 2001, J BIOL CHEM, V276, P34115, DOI 10.1074/jbc.M105747200; LaSalle JM, 2001, HUM MOL GENET, V10, P1729, DOI 10.1093/hmg/10.17.1729; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; LINDZEY G, 1961, NATURE, V191, P474, DOI 10.1038/191474a0; Lorincz MC, 2001, MOL CELL BIOL, V21, P7913, DOI 10.1128/MCB.21.23.7913-7922.2001; Meloni I, 2000, AM J HUM GENET, V67, P982, DOI 10.1086/303078; MICZEK KA, 1979, PSYCHOPHARMACOLOGY, V60, P253, DOI 10.1007/BF00426664; Nan XS, 1996, MOL CELL BIOL, V16, P414; NAN XS, 1993, NUCLEIC ACIDS RES, V21, P4886, DOI 10.1093/nar/21.21.4886; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nguyen CT, 2001, NUCLEIC ACIDS RES, V29, P4598, DOI 10.1093/nar/29.22.4598; Orrico A, 2000, FEBS LETT, V481, P285, DOI 10.1016/S0014-5793(00)01994-3; Paylor R, 1998, LEARN MEMORY, V5, P302; Schanen C, 1998, AM J HUM GENET, V63, P267, DOI 10.1086/301932; Shahbazian MD, 2002, HUM MOL GENET, V11, P115, DOI 10.1093/hmg/11.2.115; Shahbazian MD, 2001, CURR OPIN NEUROL, V14, P171, DOI 10.1097/00019052-200104000-00006; Steffenburg U, 2001, ACTA PAEDIATR, V90, P34; TREVATHAN E, 1988, ANN NEUROL, V23, P425; Vacca M, 2001, J MOL MED, V78, P648, DOI 10.1007/s001090000155; Van den Veyver IB, 2001, BRAIN DEV-JPN, V23, pS147, DOI 10.1016/S0387-7604(01)00376-X; Villard L, 2000, NEUROLOGY, V55, P1188, DOI 10.1212/WNL.55.8.1188; Wan MM, 2001, HUM MOL GENET, V10, P1085, DOI 10.1093/hmg/10.10.1085; Wan MM, 1999, AM J HUM GENET, V65, P1520, DOI 10.1086/302690; Zappella M, 2001, AM J MED GENET, V104, P14, DOI 10.1002/ajmg.10005	40	585	597	2	22	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 18	2002	35	2					243	254		10.1016/S0896-6273(02)00768-7	http://dx.doi.org/10.1016/S0896-6273(02)00768-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	576YF	12160743	Bronze			2022-12-24	WOS:000177034200005
J	Born, J; Lange, T; Kern, W; McGregor, GP; Bickel, U; Fehm, HL				Born, J; Lange, T; Kern, W; McGregor, GP; Bickel, U; Fehm, HL			Sniffing neuropeptides: a transnasal approach to the human brain	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; CEREBROSPINAL-FLUID; INSULIN; TRANSPORT; BARRIER; PLASMA		Univ Lubeck, Dept Neuroendocrinol, D-23538 Lubeck, Germany; Univ Lubeck, Dept Internal Med, D-23538 Lubeck, Germany; Univ Marburg, Dept Physiol, D-35037 Marburg, Germany; Texas Tech Univ, Hlth Sci Ctr, Dept Pharmaceut Sci, Amarillo, TX 79106 USA	University of Lubeck; University of Lubeck; Philipps University Marburg; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo	Born, J (corresponding author), Univ Lubeck, Dept Neuroendocrinol, Ratzeburger Allee 160, D-23538 Lubeck, Germany.		Born, Jan/K-2596-2016; Bickel, Ulrich/AAZ-1553-2020; Lange, Tanja/Z-1688-2018	Born, Jan/0000-0002-1847-6248; Bickel, Ulrich/0000-0002-2721-299X; mcgregor, gerard/0000-0003-3087-0018; Lange, Tanja/0000-0001-8309-2112				BICKEL U, 1988, EUR J CLIN PHARMACOL, V35, P371, DOI 10.1007/BF00561367; Chen Xue-Qing, 1998, J Alzheimers Dis, V1, P35; de Wied D, 1976, Prog Brain Res, V45, P181, DOI 10.1016/S0079-6123(08)60990-5; Fehm HL, 2000, EUR J PHARMACOL, V405, P43, DOI 10.1016/S0014-2999(00)00540-9; Fehm HL, 2001, J CLIN ENDOCR METAB, V86, P1144, DOI 10.1210/jc.86.3.1144; Illum L, 2000, EUR J PHARM SCI, V11, P1, DOI 10.1016/S0928-0987(00)00087-7; Kern W, 1999, DIABETES, V48, P557, DOI 10.2337/diabetes.48.3.557; Pardridge WM, 1999, J NEUROVIROL, V5, P556, DOI 10.3109/13550289909021285; RIEKKINEN P, 1987, PEPTIDES, V8, P261, DOI 10.1016/0196-9781(87)90101-X; SCHWARTZ MW, 1991, J CLIN INVEST, V88, P1272, DOI 10.1172/JCI115431; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Sigurdsson P, 1997, DRUG DELIV, V4, P195, DOI 10.3109/10717549709051892; Strand FL, 1999, NEUROPEPTIDES REGULA; THORNE RG, 1995, BRAIN RES, V692, P278, DOI 10.1016/0006-8993(95)00637-6; WALLUM BJ, 1987, J CLIN ENDOCR METAB, V64, P190, DOI 10.1210/jcem-64-1-190	15	996	1044	0	86	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2002	5	6					514	516		10.1038/nn849	http://dx.doi.org/10.1038/nn849			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	556XQ	11992114				2022-12-24	WOS:000175874600009
J	Obici, S; Feng, ZH; Karkanias, G; Baskin, DG; Rossetti, L				Obici, S; Feng, ZH; Karkanias, G; Baskin, DG; Rossetti, L			Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; Y MESSENGER-RNA; GENE-EXPRESSION; FOOD-INTAKE; VISCERAL ADIPOSITY; ARCUATE NUCLEUS; DIABETIC RATS; BODY-WEIGHT; LEPTIN; BRAIN	We investigated the role of hypothalamic insulin signaling in the regulation of energy balance and insulin action in rats through selective decreases in insulin receptor expression in discrete hypothalamic nuclei. We generated an antisense oligodeoxynucleotide directed against the insulin receptor precursor protein and administered this directly into the third cerebral ventricle. Immunostaining of rat brains after 7-day administration of the oligodeoxynucleotide showed a selective decrease of insulin receptor protein within cells in the medial portion of the arcuate nucleus (decreased by similar to80% as compared to rats treated with a control oligodeoxynucleotide). Insulin receptors in other hypothalamic and extra-hypothalamic areas were not affected. This selective decrease in hypothalamic insulin receptor protein was accompanied by rapid onset of hyperphagia and increased fat mass. During insulin-clamp studies, physiological hyperinsulinemia decreased glucose production by 55% in rats treated with control oligodeoxynucleotides but by only 25% in rats treated with insulin receptor antisense oligodeoxynucleotides. Thus, insulin receptors in discrete areas of the hypothalamus have a physiological role in the control of food intake, fat mass and hepatic action of insulin.	Yeshiva Univ Albert Einstein Coll Med, Bronx, NY 10461 USA; VA Puget Sound Hlth Care Syst, Seattle, WA 98108 USA; Univ Washington, Seattle, WA 98108 USA	Yeshiva University; Albert Einstein College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle	Rossetti, L (corresponding author), Yeshiva Univ Albert Einstein Coll Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047, R01DK048321, P60DK020541, R37DK048321, R29DK045024, R01DK045024] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 17047, DK 20541, DK 45024, DK 48321] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Air EL, 2002, NAT MED, V8, P179, DOI 10.1038/nm0202-179; Barzilai N, 1999, AM J PHYSIOL-ENDOC M, V277, pE291, DOI 10.1152/ajpendo.1999.277.2.E291; Barzilai N, 1997, J CLIN INVEST, V100, P3105, DOI 10.1172/JCI119865; BASKIN DG, 1987, ANNU REV PHYSIOL, V49, P335, DOI 10.1146/annurev.ph.49.030187.002003; Baskin DG, 1999, J HISTOCHEM CYTOCHEM, V47, P353, DOI 10.1177/002215549904700309; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Burry RW, 2000, J HISTOCHEM CYTOCHEM, V48, P163, DOI 10.1177/002215540004800201; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; CHIANG MY, 1991, J BIOL CHEM, V266, P18162; COLEMAN DL, 1978, DIABETOLOGIA, V14, P141, DOI 10.1007/BF00429772; DAVIS SN, 1995, J CLIN INVEST, V95, P593, DOI 10.1172/JCI117703; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; HAVRANKOVA J, 1978, NATURE, V272, P827, DOI 10.1038/272827a0; HEIDENREICH KA, 1993, ANN NY ACAD SCI, V692, P72; Jonas EA, 1997, NATURE, V385, P343, DOI 10.1038/385343a0; KENNEDY GC, 1953, PROC R SOC SER B-BIO, V140, P578, DOI 10.1098/rspb.1953.0009; Liu LS, 1998, J BIOL CHEM, V273, P31160, DOI 10.1074/jbc.273.47.31160; LUZI L, 1992, DIABETES, V41, P1632, DOI 10.2337/diabetes.41.12.1632; Niswender KD, 2001, NATURE, V413, P794, DOI 10.1038/35101657; Obici S, 2001, J CLIN INVEST, V108, P1079, DOI 10.1172/JCI200112954; PALKOVITS M, 1973, BRAIN RES, V59, P449, DOI 10.1016/0006-8993(73)90290-4; Paxinos G., 1998, RAT BRAIN STEROTAXIC; ROBINSON LJ, 1994, ENDOCRINOLOGY, V135, P2568, DOI 10.1210/en.135.6.2568; ROSSETTI L, 1990, J CLIN INVEST, V85, P1785, DOI 10.1172/JCI114636; ROSSETTI L, 1987, J CLIN INVEST, V79, P1510, DOI 10.1172/JCI112981; SCHWARTZ MW, 1992, ENDOCR REV, V13, P387, DOI 10.1210/er.13.3.387; SCHWARTZ MW, 1991, ENDOCRINOLOGY, V128, P2645, DOI 10.1210/endo-128-5-2645; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; SCHWARTZ MW, 1992, ENDOCRINOLOGY, V130, P3608, DOI 10.1210/en.130.6.3608; SIPOLS AJ, 1995, DIABETES, V44, P147, DOI 10.2337/diabetes.44.2.147; Wan Q, 1997, NATURE, V388, P686, DOI 10.1038/41792; Wang JL, 1999, NAT MED, V5, P895, DOI 10.1038/11335; Wang JL, 1998, NATURE, V393, P684, DOI 10.1038/31474; WOODS SC, 1984, AM J PHYSIOL, V247, pR393, DOI 10.1152/ajpregu.1984.247.2.R393; WOODS SC, 1979, NATURE, V282, P503, DOI 10.1038/282503a0; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	36	530	546	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2002	5	6					566	572		10.1038/nn861	http://dx.doi.org/10.1038/nn861			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	556XQ	12021765				2022-12-24	WOS:000175874600017
J	Fraser, C; Power, M; Hamdy, S; Rothwell, J; Hobday, D; Hollander, I; Tyrell, P; Hobson, A; Williams, S; Thompson, D				Fraser, C; Power, M; Hamdy, S; Rothwell, J; Hobday, D; Hollander, I; Tyrell, P; Hobson, A; Williams, S; Thompson, D			Driving plasticity in human adult motor cortex is associated with improved motor function after brain injury	NEURON			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; ACUTE STROKE; REORGANIZATION; RECOVERY; FMRI; EXCITABILITY; ACTIVATION; ASPIRATION; DYSPHAGIA; MRI	Changes in somatosensory input can remodel human cortical motor organization, yet the input characteristics that promote reorganization and their functional significance have not been explored. Here we show with transcranial magnetic stimulation that sensory-driven reorganization of human motor cortex is highly dependent upon the frequency, intensity, and duration of stimulus applied. Those patterns of input associated with enhanced excitability (5 Hz, 75% maximal tolerated intensity for 10 min) induce stronger cortical activation to fMRI. When applied to acutely dysphagic stroke patients, swallowing corticobulbar excitability is increased mainly in the undamaged hemisphere, being strongly correlated with an improvement in swallowing function. Thus, input to the human adult brain can be programmed to promote beneficial changes in neuroplasticity and function after cerebral injury.	Hope Hosp, Univ Dept Gastroenterol, Salford M6 8HD, Lancs, England; Hope Hosp, Univ Dept Stroke Med, Salford M6 8HD, Lancs, England; Inst Neurol, Sobell Dept Neurophysiol, London WC1N 3BG, England; Univ Manchester, Dept Imaging Sci & Biomed Engn, Manchester M13 9PL, Lancs, England	University of London; University College London; University of Manchester	Hamdy, S (corresponding author), Hope Hosp, Univ Dept Gastroenterol, Salford M6 8HD, Lancs, England.		Williams, Steve R/C-8945-2011; Williams, Steve C/D-6979-2011; Hamdy, Shaheen/O-5039-2014	Williams, Steve R/0000-0001-5940-1675; Williams, Steve C/0000-0003-4299-1941; Hamdy, Shaheen/0000-0001-9640-7427; Rothwell, John/0000-0003-1367-6467				BENECKE R, 1991, EXP BRAIN RES, V83, P419; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Classen J, 1998, J NEUROPHYSIOL, V79, P1117, DOI 10.1152/jn.1998.79.2.1117; Cohen LG, 1998, J CLIN NEUROPHYSIOL, V15, P305, DOI 10.1097/00004691-199807000-00003; Cohen LG, 1997, NATURE, V389, P180, DOI 10.1038/38278; Cook IJ, 1999, GASTROENTEROLOGY, V116, P455, DOI 10.1016/S0016-5085(99)70144-7; DONOGHUE JP, 1996, SUBSTRATES MECH LEAR; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Friston K.J., 1994, HUM BRAIN MAPP, V1, P153, DOI DOI 10.1002/HBM.460010207; GORDON C, 1987, BRIT MED J, V295, P411, DOI 10.1136/bmj.295.6595.411; Hallett M, 2000, NATURE, V406, P147, DOI 10.1038/35018000; Hamdy S, 1999, AM J PHYSIOL-GASTR L, V277, pG219, DOI 10.1152/ajpgi.1999.277.1.G219; Hamdy S, 1996, NAT MED, V2, P1217, DOI 10.1038/nm1196-1217; Hamdy S, 1997, AM J PHYSIOL-GASTR L, V272, pG802, DOI 10.1152/ajpgi.1997.272.4.G802; Hamdy S, 1998, GASTROENTEROLOGY, V115, P1104, DOI 10.1016/S0016-5085(98)70081-2; Hamdy S, 1998, NAT NEUROSCI, V1, P64, DOI 10.1038/264; Hobday DI, 2001, BRAIN, V124, P361, DOI 10.1093/brain/124.2.361; KIDD D, 1995, QJM-MON J ASSOC PHYS, V88, P409; Liepert J, 2000, STROKE, V31, P1210, DOI 10.1161/01.STR.31.6.1210; MAHONEY F I, 1965, Md State Med J, V14, P61; Medical research council of the United Kingdom, 1976, AIDS EX PER NERV SYS; Muellbacher W, 2000, CLIN NEUROPHYSIOL, V111, P1002, DOI 10.1016/S1388-2457(00)00284-4; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; Ridding MC, 2000, EXP BRAIN RES, V131, P135, DOI 10.1007/s002219900269; Ridding MC, 1997, ELECTROMYOGR MOTOR C, V105, P340, DOI 10.1016/S0924-980X(97)00041-6; Rosenbek JC, 1996, DYSPHAGIA, V11, P93, DOI 10.1007/BF00417897; Stefan K, 2000, BRAIN, V123, P572, DOI 10.1093/brain/123.3.572; Thacker NA, 1999, JMRI-J MAGN RESON IM, V10, P582, DOI 10.1002/(SICI)1522-2586(199910)10:4<582::AID-JMRI12>3.0.CO;2-X; Thacker NA, 1999, PHYSIOL MEAS, V20, P251, DOI 10.1088/0967-3334/20/3/303; Thulborn KR, 1999, STROKE, V30, P749, DOI 10.1161/01.STR.30.4.749; Vokurka EA, 1999, JMRI-J MAGN RESON IM, V10, P550, DOI 10.1002/(SICI)1522-2586(199910)10:4<550::AID-JMRI8>3.0.CO;2-Q; WEILLER C, 1995, ANN NEUROL, V37, P723, DOI 10.1002/ana.410370605	32	263	294	2	31	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 30	2002	34	5					831	840		10.1016/S0896-6273(02)00705-5	http://dx.doi.org/10.1016/S0896-6273(02)00705-5			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	558DV	12062028	Bronze			2022-12-24	WOS:000175951800016
J	Mazzucchelli, C; Vantaggiato, C; Ciamei, A; Fasano, S; Pakhotin, P; Krezel, W; Welzl, H; Wolfer, DP; Pages, G; Valverde, O; Marowsky, A; Porrazzo, A; Orban, PC; Maldonado, R; Ehrengruber, MU; Cestari, V; Lipp, HP; Chapman, PF; Pouyssegur, J; Brambilla, R				Mazzucchelli, C; Vantaggiato, C; Ciamei, A; Fasano, S; Pakhotin, P; Krezel, W; Welzl, H; Wolfer, DP; Pages, G; Valverde, O; Marowsky, A; Porrazzo, A; Orban, PC; Maldonado, R; Ehrengruber, MU; Cestari, V; Lipp, HP; Chapman, PF; Pouyssegur, J; Brambilla, R			Knockout of ERK1 MAP kinase enhances synaptic plasticity in the striatum and facilitates striatal-mediated learning and memory	NEURON			English	Article							ACTIVATED PROTEIN-KINASE; LONG-TERM POTENTIATION; RECEPTOR MUTANT MICE; NUCLEUS-ACCUMBENS; MOLECULAR MECHANISMS; SIGNALING PATHWAY; DOPAMINE; COCAINE; RAS; EXPRESSION	Extracellular signal-regulated kinases (ERK1 and 2) are synaptic signaling components necessary for several forms of learning. In mice lacking ERK1, we observe a dramatic enhancement of striatum-dependent long-term memory, which correlates with a facilitation of long-term potentiation in the nucleus accumbens. At the cellular level, we find that ablation of ERK1 results in a stimulus-dependent increase of ERK2 signaling, likely due to its enhanced interaction with the upstream kinase MEK. Consistently, such activity change is responsible for the hypersensitivity of ERK1 mutant mice to the rewarding properties of morphine. Our results reveal an unexpected complexity of ERK-dependent signaling in the brain and a critical regulatory role for ERK1 in the long-term adaptive changes underlying striatum-dependent behavioral plasticity and drug addiction.	San Raffaele Res Inst, I-20132 Milan, Italy; Univ Milan, I-20132 Milan, Italy; Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3US, S Glam, Wales; Univ Zurich, Inst Anat, CH-8057 Zurich, Switzerland; CNR, Ist Neurosci, Sez Psicobiol & Psicofarmacol, I-00137 Rome, Italy; Ctr Antoine Lacassagne, Inst Signaling Dev Biol & Canc Res, CNRS, UMR 6543, F-06189 Nice, France; Univ Pompeu Fabra, Fac Ciencies Salut & Vida, Barcelona 08003, Spain; Univ Zurich, Inst Brain Res, CH-8057 Zurich, Switzerland	University of Milan; Cardiff University; University of Zurich; Consiglio Nazionale delle Ricerche (CNR); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; UNICANCER; Centre Antoine Lacassagne; Pompeu Fabra University; University of Zurich	Brambilla, R (corresponding author), San Raffaele Res Inst, Via Olgettina 58, I-20132 Milan, Italy.		Vantaggiato, Chiara/AAH-5702-2019; KREZEL, Wojciech/S-8331-2019; Valverde, Olga/D-8654-2012; Brambilla, Riccardo/A-6082-2010; Maldonado, Rafael/F-5657-2014; Krezel, Wojciech/I-7886-2016; Krezel, Wojciech/H-9080-2017; Wolfer, David P/B-3293-2016	Vantaggiato, Chiara/0000-0002-3910-6836; Valverde, Olga/0000-0003-2264-7852; Maldonado, Rafael/0000-0002-4359-8773; Krezel, Wojciech/0000-0003-1605-3185; Krezel, Wojciech/0000-0003-1605-3185; Wolfer, David P/0000-0002-5957-1401; Brambilla, Riccardo/0000-0003-3569-5706; Cestari, Vincenzo/0000-0002-9623-157X; Fasano, Stefania/0000-0002-3696-7139				Abel T, 2001, CURR OPIN NEUROBIOL, V11, P180, DOI 10.1016/S0959-4388(00)00194-X; Adams JP, 2002, ANNU REV PHARMACOL, V42, P135, DOI 10.1146/annurev.pharmtox.42.082701.145401; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Brambilla R, 1997, NATURE, V390, P281, DOI 10.1038/36849; CLINCKE GHC, 1993, BEHAV NEUROSCIENCE, V1; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; English JD, 1996, J BIOL CHEM, V271, P24329, DOI 10.1074/jbc.271.40.24329; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; FOULKES NS, 1991, CELL, V64, P739, DOI 10.1016/0092-8674(91)90503-Q; Graybiel AM, 1995, CURR OPIN NEUROBIOL, V5, P733, DOI 10.1016/0959-4388(95)80100-6; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; Izquierdo I, 1997, EUR J NEUROSCI, V9, P786, DOI 10.1111/j.1460-9568.1997.tb01427.x; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Krezel W, 2001, P NATL ACAD SCI USA, V98, P12278, DOI 10.1073/pnas.221451898; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lundstrom K, 2001, HISTOCHEM CELL BIOL, V115, P83, DOI 10.1007/s004180000223; Maldonado R, 1997, NATURE, V388, P586, DOI 10.1038/41567; Martin M, 2000, EUR J NEUROSCI, V12, P4038, DOI 10.1046/j.1460-9568.2000.00287.x; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Mayford M, 1999, TRENDS GENET, V15, P463, DOI 10.1016/S0168-9525(99)01846-6; Mazzucchelli C, 2000, CELL MOL LIFE SCI, V57, P604, DOI 10.1007/PL00000722; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; OLANOW CW, 2000, TRENDS NEUROSCI S, V23; Orban PC, 1999, TRENDS NEUROSCI, V22, P38, DOI 10.1016/S0166-2236(98)01306-X; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; ROOZENDAAL B, 1993, BEHAV NEURAL BIOL, V59, P143, DOI 10.1016/0163-1047(93)90873-G; SAHGAL A, 1993, BEHAV NEUROSCIENCE, V1; SALAMONE JD, 1994, BEHAV BRAIN RES, V61, P117, DOI 10.1016/0166-4328(94)90153-8; SCHMUED LC, 1990, J HISTOCHEM CYTOCHEM, V38, P721, DOI 10.1177/38.5.2332627; SCHUTZ RA, 1979, PHYSIOL BEHAV, V23, P97, DOI 10.1016/0031-9384(79)90128-8; Schwarzschild MA, 1999, J NEUROCHEM, V72, P2248, DOI 10.1046/j.1471-4159.1999.0722248.x; Selcher JC, 2001, LEARN MEMORY, V8, P11, DOI 10.1101/lm.37001; Shields JM, 2000, TRENDS CELL BIOL, V10, P147, DOI 10.1016/S0962-8924(00)01740-2; Sweatt JD, 1999, LEARN MEMORY, V6, P399, DOI 10.1101/lm.6.5.399; TAGHZOUTI K, 1985, BRAIN RES, V344, P9, DOI 10.1016/0006-8993(85)91184-9; Valjent E, 2000, J NEUROSCI, V20, P8701; Winder DG, 1999, NEURON, V24, P715, DOI 10.1016/S0896-6273(00)81124-1; XU M, 1994, CELL, V79, P945, DOI 10.1016/0092-8674(94)90026-4; XU M, 1994, CELL, V79, P729, DOI 10.1016/0092-8674(94)90557-6	41	375	387	0	22	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 30	2002	34	5					807	820		10.1016/S0896-6273(02)00716-X	http://dx.doi.org/10.1016/S0896-6273(02)00716-X			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	558DV	12062026	Bronze			2022-12-24	WOS:000175951800014
J	Dodart, JC; Bales, KR; Gannon, KS; Greene, SJ; DeMattos, RB; Mathis, C; DeLong, CA; Wu, S; Wu, X; Holtzman, DM; Paul, SM				Dodart, JC; Bales, KR; Gannon, KS; Greene, SJ; DeMattos, RB; Mathis, C; DeLong, CA; Wu, S; Wu, X; Holtzman, DM; Paul, SM			Immunization reverses memory deficits without reducing brain A beta burden in Alzheimer's disease model	NATURE NEUROSCIENCE			English	Article							AMYLOID PRECURSOR PROTEIN; APP(V717F) TRANSGENIC MICE; MOUSE MODEL; APOLIPOPROTEIN-E; PEPTIDE; PATHOLOGY; HYPOTHESIS; PLAQUES	We have previously shown that chronic treatment with the monoclonal antibody m266, which is specific for amyloid beta-peptide (Abeta), increases plasma concentrations of Abeta and reduces Abeta burden in the PDAPP transgenic mouse model of Alzheimer's disease (AD). We now report that administration of m266 to PDAPP mice can rapidly reverse memory deficits in both an object recognition task and a holeboard learning and memory task, but without altering brain Abeta burden. We also found that an Abeta/antibody complex was present in both the plasma and the cerebrospinal fluid of m266-treated mice. Our data indicate that passive immunization with this anti-Abeta monoclonal antibody can very rapidly reverse memory impairment in certain learning and memory tasks in the PDAPP mouse model of AD, owing perhaps to enhanced peripheral clearance and (or) sequestration of a soluble brain Abeta species.	Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Neurosci Discovery Res, Indianapolis, IN 46285 USA; Washington Univ, Sch Med, Ctr Study Nervous Syst Injury, Alzheimers Dis Res Ctr,Dept Neurol Mol Biol & Pha, St Louis, MO 63110 USA; Univ Strasbourg 1, CNRS, UMR 7521, F-67000 Strasbourg, France	Eli Lilly; Washington University (WUSTL); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Paul, SM (corresponding author), Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Neurosci Discovery Res, Indianapolis, IN 46285 USA.		MATHIS, CHANTAL mb/B-6399-2013; Paul, Steve/ABE-5400-2020	MATHIS, CHANTAL mb/0000-0002-6663-5282; 				Bales KR, 1999, P NATL ACAD SCI USA, V96, P15233, DOI 10.1073/pnas.96.26.15233; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; Dodart JC, 2000, NEUROBIOL DIS, V7, P71, DOI 10.1006/nbdi.1999.0278; Dodart JC, 1997, NEUROREPORT, V8, P1173, DOI 10.1097/00001756-199703240-00023; Dodart JC, 2000, REV NEUROSCIENCE, V11, P75; Dodart JC, 1999, BEHAV NEUROSCI, V113, P982, DOI 10.1037/0735-7044.113.5.982; Dodart JC, 2000, NEUROREPORT, V11, P603, DOI 10.1097/00001756-200002280-00034; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Johnson D, 1997, EDN, V42, P94; Koistinaho M, 2001, P NATL ACAD SCI USA, V98, P14675, DOI 10.1073/pnas.261562998; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Neve RL, 1998, TRENDS NEUROSCI, V21, P15, DOI 10.1016/S0166-2236(97)01168-5; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; Sigurdsson EM, 2001, AM J PATHOL, V159, P439, DOI 10.1016/S0002-9440(10)61715-4; Weiner HL, 2000, ANN NEUROL, V48, P567, DOI 10.1002/1531-8249(200010)48:4<567::AID-ANA3>3.3.CO;2-N	22	747	843	0	58	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2002	5	5					452	457		10.1038/nn842	http://dx.doi.org/10.1038/nn842			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	546JY	11941374				2022-12-24	WOS:000175272000016
J	Pittenger, C; Huang, YY; Paletzki, RF; Bourtchouladze, R; Scanlin, H; Vronskaya, S; Kandel, ER				Pittenger, C; Huang, YY; Paletzki, RF; Bourtchouladze, R; Scanlin, H; Vronskaya, S; Kandel, ER			Reversible inhibition of CREB/ATF transcription factors in region CA1 of the dorsal hippocampus disrupts hippocampus-dependent spatial memory	NEURON			English	Article							LONG-TERM-MEMORY; ELEMENT-BINDING PROTEIN; MEDIATED GENE-EXPRESSION; LATE-PHASE; SYNAPTIC PLASTICITY; NUCLEAR TRANSLOCATION; TARGETED MUTATION; UP-REGULATION; MAP KINASE; POTENTIATION	CREB is critical for long-lasting synaptic and behavioral plasticity in invertebrates. Its role in the mammalian hippocampus is less clear. We have interfered with CREB family transcription factors in region CA1 of the dorsal hippocampus. This impairs learning in the Morris water maze, which specifically requires the dorsal hippocampus, but not context conditioning, which does not. The deficit is specific to long-term memory, as shown in an object recognition task. Several forms of late-phase LTP are normal, but forskolin-induced and dopamine-regulated potentiation are disrupted. These experiments represent the first targeting of the dorsal hippocampus in genetically modified mice and confirm a role for CREB in hippocampus-dependent learning. Nevertheless, they suggest that some experimental forms of plasticity bypass the requirement for CREB.	Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA; NINCDS, Mol Plast Sect, NIH, Bethesda, MD 20892 USA	Columbia University; Columbia University; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Kandel, ER (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, 1051 Riverside Dr, New York, NY 10032 USA.		Pittenger, Christopher/G-8402-2012	Pittenger, Christopher/0000-0003-2117-9321	NIMH NIH HHS [MH 12956-01] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Ahn S, 1999, NEURON, V23, P559, DOI 10.1016/S0896-6273(00)80808-9; ALBERINI CM, 1994, CELL, V76, P1099, DOI 10.1016/0092-8674(94)90386-7; Amaral D.G., 1995, RAT NERVOUS SYSTEM; ANDERSEN P, 1971, EXP BRAIN RES, V13, P222; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; Bailey CH, 2000, NAT REV NEUROSCI, V1, P11, DOI 10.1038/35036191; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; Barth AL, 2000, J NEUROSCI, V20, P4206; Bartsch D, 2000, CELL, V103, P595, DOI 10.1016/S0092-8674(00)00163-X; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; Bartsch D, 1998, CELL, V95, P211, DOI 10.1016/S0092-8674(00)81752-3; Blendy JA, 1996, EMBO J, V15, P1098, DOI 10.1002/j.1460-2075.1996.tb00447.x; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; CHAVEZNORIEGA LE, 1992, BRAIN RES, V574, P85, DOI 10.1016/0006-8993(92)90803-H; CRAIG JC, 2000, J BIOL CHEM, V27, P27; Crawley Jacqueline N., 2007, WHATS WRONG MY MOUSE; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037/0735-7044.112.4.863; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; GALLAGHER M, 1993, BEHAV NEUROSCI, V107, P618, DOI 10.1037/0735-7044.107.4.618; Gass P, 1998, LEARN MEMORY, V5, P274; GERFEN CR, 1991, J NEUROSCI, V11, P1016; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; HU GY, 1987, NATURE, V328, P426, DOI 10.1038/328426a0; HUANG JY, 1995, LASER SPECTROSCOPY P, V1, P5; Huang YY, 1996, LEARN MEMORY, V3, P74, DOI 10.1101/lm.3.2-3.74; Huang YY, 2000, J NEUROSCI, V20, P6317, DOI 10.1523/JNEUROSCI.20-17-06317.2000; HUMMLER E, 1994, P NATL ACAD SCI USA, V91, P5647, DOI 10.1073/pnas.91.12.5647; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; IRWIN S, 1968, PSYCHOPHARMACOLOGIA, V13, P222, DOI 10.1007/BF00401402; Jean D, 1998, J BIOL CHEM, V273, P24884, DOI 10.1074/jbc.273.38.24884; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Josselyn SA, 2001, J NEUROSCI, V21, P2404, DOI 10.1523/JNEUROSCI.21-07-02404.2001; Kandel ER, 1999, PHILOS T R SOC B, V354, P2027, DOI 10.1098/rstb.1999.0542; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; KIDA S, 2002, IN PRESS NAT NEUROSC; Kogan JH, 2000, HIPPOCAMPUS, V10, P47, DOI 10.1002/(SICI)1098-1063(2000)10:1<47::AID-HIPO5>3.0.CO;2-6; KONRADI C, 1993, P NATL ACAD SCI USA, V90, P7005, DOI 10.1073/pnas.90.15.7005; KONRADI C, 1995, J NEUROCHEM, V65, P1007; LORIAUX MM, 1993, P NATL ACAD SCI USA, V90, P9046, DOI 10.1073/pnas.90.19.9046; LOVINGER DM, 1987, BRAIN RES, V436, P177, DOI 10.1016/0006-8993(87)91573-3; Mansuy IM, 1998, CELL, V92, P39, DOI 10.1016/S0092-8674(00)80897-1; Maren S, 1997, BEHAV BRAIN RES, V88, P261, DOI 10.1016/S0166-4328(97)00088-0; Martin KC, 1997, NEURON, V18, P899, DOI 10.1016/S0896-6273(00)80330-X; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Moser MB, 1998, HIPPOCAMPUS, V8, P608, DOI 10.1002/(SICI)1098-1063(1998)8:6<608::AID-HIPO3>3.0.CO;2-7; Nguyen PV, 1996, J NEUROSCI, V16, P3189; Patterson SL, 2001, NEURON, V32, P123, DOI 10.1016/S0896-6273(01)00443-3; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Pittenger C, 1998, CR ACAD SCI III-VIE, V321, P91, DOI 10.1016/S0764-4469(97)89807-1; PITTENGER C, 2002, THESIS COLUMBIA U NE; Rammes G, 2000, EUR J NEUROSCI, V12, P2534, DOI 10.1046/j.1460-9568.2000.00108.x; Reusch JEB, 2000, MOL CELL BIOL, V20, P1008, DOI 10.1128/MCB.20.3.1008-1020.2000; Richmond MA, 1999, BEHAV NEUROSCI, V113, P1189, DOI 10.1037/0735-7044.113.6.1189; Sanes JR, 1999, NAT NEUROSCI, V2, P597, DOI 10.1038/10154; Sgambato V, 1998, J NEUROSCI, V18, P8814; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Steckler T, 1998, PROG NEUROBIOL, V54, P313, DOI 10.1016/S0301-0082(97)00061-0; Taubenfeld SM, 1999, NAT NEUROSCI, V2, P309, DOI 10.1038/7217; WALTON KM, 1992, MOL ENDOCRINOL, V6, P647, DOI 10.1210/me.6.4.647; Zha XM, 2001, HEARING RES, V156, P53, DOI 10.1016/S0378-5955(01)00267-2	65	390	417	2	21	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 25	2002	34	3					447	462		10.1016/S0896-6273(02)00684-0	http://dx.doi.org/10.1016/S0896-6273(02)00684-0			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	545JW	11988175	Bronze			2022-12-24	WOS:000175214700015
J	Knott, GW; Quairiaux, C; Genoud, C; Welker, E				Knott, GW; Quairiaux, C; Genoud, C; Welker, E			Formation of dendritic spines with GABAergic synapses by whisker stimulation in induced adult mice	NEURON			English	Article							RAT BARREL CORTEX; EXPERIENCE-DEPENDENT PLASTICITY; MONKEY STRIATE CORTEX; CAT VISUAL-CORTEX; SYNAPTIC PLASTICITY; SENSORY STIMULATION; CLUTCH CELLS; FIELD CORTEX; LAYER-IV; MOUSE	During development, alterations in sensory experience modify the structure of cortical neurons, particularly at the level of the dendritic spine. Are similar adaptations involved in plasticity of the adult cortex? Here we show that a 24 hr period of single whisker stimulation in freely moving adult mice increases, by 36%, the total synaptic density in the corresponding cortical barrel. This is due to an increase in both excitatory and inhibitory synapses found on spines. Four days after stimulation, the inhibitory inputs to the spines remain despite total synaptic density returning to pre-stimulation levels. Functional analysis of layer IV cells demonstrated altered response properties, immediately after stimulation, as well as four days later. These results indicate activity-dependent alterations in synaptic circuitry in adulthood, modifying the flow of sensory information into the cerebral cortex.	Univ Lausanne, Inst Biol Cellulaire & Morphol, CH-1005 Lausanne, Switzerland	University of Lausanne	Welker, E (corresponding author), Univ Lausanne, Inst Biol Cellulaire & Morphol, Rue Bugnon 9, CH-1005 Lausanne, Switzerland.			Knott, Graham W/0000-0002-2956-9052; Quairiaux, Charles/0000-0003-3770-8232				ARMSTRONGJAMES M, 1992, J NEUROPHYSIOL, V68, P1345, DOI 10.1152/jn.1992.68.4.1345; CAJAL SRY, 1891, CAJAL CEREBRAL CORTE, P23; CHANG FLF, 1982, BRAIN RES, V232, P283, DOI 10.1016/0006-8993(82)90274-8; DEAN JB, 1989, NEUROSCI RES, V6, P487, DOI 10.1016/0168-0102(89)90012-6; DEHAY C, 1991, J PHYSIOL-LONDON, V440, P723, DOI 10.1113/jphysiol.1991.sp018732; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fan YP, 2000, J NEUROPHYSIOL, V84, P2896, DOI 10.1152/jn.2000.84.6.2896; GREENOUGH WT, 1985, P NATL ACAD SCI USA, V82, P4549, DOI 10.1073/pnas.82.13.4549; Grenier F, 1998, P NATL ACAD SCI USA, V95, P13929, DOI 10.1073/pnas.95.23.13929; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Huguenard JR, 1996, ANNU REV PHYSIOL, V58, P329, DOI 10.1146/annurev.physiol.58.1.329; JONES EG, 1969, J CELL SCI, V5, P509; Jones TA, 1996, BRAIN RES, V733, P142, DOI 10.1016/0006-8993(96)00792-5; Kirov SA, 1999, J NEUROSCI, V19, P2876; KISVARDAY ZF, 1986, NEUROSCIENCE, V19, P741, DOI 10.1016/0306-4522(86)90296-4; KISVARDAY ZF, 1985, J COMP NEUROL, V241, P111, DOI 10.1002/cne.902410202; Kleim JA, 1998, NEUROBIOL LEARN MEM, V69, P274, DOI 10.1006/nlme.1998.3827; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; MELZER P, 1985, BRAIN RES, V348, P229, DOI 10.1016/0006-8993(85)90441-X; MICHEVA KD, 1995, P NATL ACAD SCI USA, V92, P11834, DOI 10.1073/pnas.92.25.11834; Peters A, 1997, J NEUROCYTOL, V26, P779, DOI 10.1023/A:1018518515982; Rocamora N, 1996, J NEUROSCI, V16, P4411; SOMOGYI P, 1986, NEUROSCIENCE, V19, P1051, DOI 10.1016/0306-4522(86)90122-3; STAFSTROM CE, 1984, J NEUROPHYSIOL, V52, P244, DOI 10.1152/jn.1984.52.2.244; Staiger JF, 1996, EUR J NEUROSCI, V8, P2273, DOI 10.1111/j.1460-9568.1996.tb01191.x; Steriade M, 1997, J NEUROSCI, V17, P3778; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; Tamas G, 1997, J PHYSIOL-LONDON, V500, P715, DOI 10.1113/jphysiol.1997.sp022054; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; VANDERLOOS H, 1986, J HERED, V77, P66, DOI 10.1093/oxfordjournals.jhered.a110201; Vees AM, 1998, J COMP NEUROL, V400, P110; WELKER E, 1993, EUR J NEUROSCI, V5, P691, DOI 10.1111/j.1460-9568.1993.tb00534.x; WELKER E, 1989, EXP BRAIN RES, V78, P659, DOI 10.1007/BF00230256; WELKER E, 1992, J NEUROSCI, V12, P153; WHITE EL, 1993, J COMP NEUROL, V334, P86, DOI 10.1002/cne.903340107; WOOLSEY TA, 1975, P NATL ACAD SCI USA, V72, P2165, DOI 10.1073/pnas.72.6.2165; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X	38	339	348	1	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 11	2002	34	2					265	273		10.1016/S0896-6273(02)00663-3	http://dx.doi.org/10.1016/S0896-6273(02)00663-3			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	541GE	11970868	Bronze			2022-12-24	WOS:000174976200012
J	Kornhauser, JM; Cowan, CW; Shaywitz, AJ; Dolmetsch, RE; Griffith, EC; Hu, LS; Haddad, C; Xia, ZG; Greenberg, ME				Kornhauser, JM; Cowan, CW; Shaywitz, AJ; Dolmetsch, RE; Griffith, EC; Hu, LS; Haddad, C; Xia, ZG; Greenberg, ME			CREB transcriptional activity in neurons is regulated by multiple, calcium-specific phosphorylation events	NEURON			English	Article							BINDING PROTEIN CREB; GLYCOGEN-SYNTHASE KINASE-3; FACTOR-DEPENDENT MECHANISM; GENE-EXPRESSION; MEMBRANE DEPOLARIZATION; SIGNALING PATHWAY; COMPLEX-FORMATION; CELL-SURVIVAL; CBP; ACTIVATION	The transcription factor CREB mediates diverse responses in the nervous system. It is not known how CREB induces specific patterns of gene expression in response to different extracellular stimuli. We find that Ca2+ influx into neurons induces CREB phosphorylation at Ser133 and two additional sites, Ser142 and Ser143. While CREB Ser133 phosphorylation is induced by many stimuli, phosphorylation at Ser142 and Ser143 is selectively activated by Ca2+ influx. The triple phosphorylation of CREB is required for effective Ca2+ stimulation of CREB-dependent transcription, but the phosphorylation of Ser142 and Ser143, in addition to Ser133, disrupts the interaction of CREB with its cofactor CBP. These results suggest that Ca2+ influx triggers a specific program of gene expression in neurons by selectively regulating CREB phosphorylation.	Harvard Univ, Sch Med, Div Neurosci, Childrens Hosp, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Neurobiol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard University; Harvard Medical School	Greenberg, ME (corresponding author), Harvard Univ, Sch Med, Div Neurosci, Childrens Hosp, Cambridge, MA 02138 USA.	michael.greenberg@tch.harvard.edu	Cowan, Christopher W/I-2497-2014	Griffith, Eric/0000-0003-0428-3215	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS028829, F32NS009933, R01NS028829] Funding Source: NIH RePORTER; NICHD NIH HHS [P30 HD18655] Funding Source: Medline; NINDS NIH HHS [F32 NS09933, NS28829] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; BONNI A, 1995, MOL CELL NEUROSCI, V6, P168, DOI 10.1006/mcne.1995.1015; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Bullock BP, 1998, BIOCHEMISTRY-US, V37, P3795, DOI 10.1021/bi970982t; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; DEGROOT RP, 1993, EMBO J, V12, P3903, DOI 10.1002/j.1460-2075.1993.tb06068.x; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; ENSLEN H, 1994, J BIOL CHEM, V269, P15520; FIOL CJ, 1994, J BIOL CHEM, V269, P32187; FRANK DA, 1994, CELL, V79, P5, DOI 10.1016/0092-8674(94)90394-8; Gau D, 2002, NEURON, V34, P245, DOI 10.1016/S0896-6273(02)00656-6; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; Goldman PS, 1997, RECENT PROG HORM RES, V52, P103; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; Hu SC, 1999, NEURON, V22, P799, DOI 10.1016/S0896-6273(00)80738-2; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; Moore AN, 1996, J BIOL CHEM, V271, P14214, DOI 10.1074/jbc.271.24.14214; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; Parker D, 1996, MOL CELL BIOL, V16, P694; Parker D, 1998, MOL CELL, V2, P353, DOI 10.1016/S1097-2765(00)80279-8; PLANASSILVA MD, 1992, EMBO J, V11, P507, DOI 10.1002/j.1460-2075.1992.tb05081.x; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; Sasaki M, 2000, P NATL ACAD SCI USA, V97, P8617, DOI 10.1073/pnas.97.15.8617; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; SHENG M, 1988, MOL CELL BIOL, V8, P2787, DOI 10.1128/MCB.8.7.2787; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; Soderling TR, 2001, J BIOL CHEM, V276, P3719, DOI 10.1074/jbc.R000013200; SUN PQ, 1995, J BIOL CHEM, V270, P7041, DOI 10.1074/jbc.270.13.7041; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Walton M, 1999, J NEUROCHEM, V73, P1836; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198; Wu XL, 2001, J BIOL CHEM, V276, P1735, DOI 10.1074/jbc.M006727200; Xia ZG, 1996, J NEUROSCI, V16, P5425; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0	45	227	232	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 11	2002	34	2					221	233		10.1016/S0896-6273(02)00655-4	http://dx.doi.org/10.1016/S0896-6273(02)00655-4			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	541GE	11970864	Bronze			2022-12-24	WOS:000174976200008
J	Melyan, Z; Wheal, HV; Lancaster, B				Melyan, Z; Wheal, HV; Lancaster, B			Metabotropic-mediated kainate receptor regulation of I(sAHP) and excitability in pyramidal cells	NEURON			English	Article							HIPPOCAMPAL-NEURONS INVITRO; GLUTAMATE RECEPTORS; SYNAPTIC ACTIVATION; K+ CURRENT; POTASSIUM CONDUCTANCES; EPILEPTIFORM ACTIVITY; SYMPATHETIC NEURONS; CALCIUM CHANNELS; G-PROTEINS; RAT	Kainate receptors (KARs) on CA1 pyramidal cells make no detectable contribution to EPSCs. We report that these receptors have a metabotropic function, as shown previously for CA1 interneurons. Brief kainate exposure caused long-lasting inhibition of a postspike potassium current (1(sAHP)) in CA1 pyramidal cells. The pharmacological profile was independent of AMPA receptors or the GluR5 subunit, indicating a possible role for the GluR6 subunit. KAR inhibition of I(sAHP) did not require ionotropic action or network activity, but was blocked by the inhibitor of pertussis toxin-sensitive G proteins, N-ethylmaleimide (NEM), or the PKC inhibitor calphostin C. These data suggest how KARs, putatively containing GluR6, directly increase excitability of CA1 pyramidal cells and help explain the propensity for seizure activity following KAR activation.	Univ Southampton, Ctr Neurosci, Southampton SO16 7PX, Hants, England; UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England	University of Southampton; University of London; University College London	Wheal, HV (corresponding author), Univ Southampton, Ctr Neurosci, Bassett Crescent E, Southampton SO16 7PX, Hants, England.	h.v.wheal@soton.ac.uk			Wellcome Trust [WT069189] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AbdulGhani MA, 1996, J NEUROPHYSIOL, V76, P2691, DOI 10.1152/jn.1996.76.4.2691; ASHWOOD TJ, 1986, EXP BRAIN RES, V62, P189; Ben-Ari Y, 2000, TRENDS NEUROSCI, V23, P580, DOI 10.1016/S0166-2236(00)01659-3; Bleakman D, 1996, NEUROPHARMACOLOGY, V35, P1689, DOI 10.1016/S0028-3908(96)00156-6; Buhl EH, 1998, J PHYSIOL-LONDON, V513, P117, DOI 10.1111/j.1469-7793.1998.117by.x; Bureau I, 1999, J NEUROSCI, V19, P653; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; CHARPAK S, 1990, NATURE, V347, P765, DOI 10.1038/347765a0; Clarke VRJ, 1997, NATURE, V389, P599, DOI 10.1038/39315; COLE AE, 1984, J PHYSIOL-LONDON, V352, P173, DOI 10.1113/jphysiol.1984.sp015285; Cossart R, 1998, NAT NEUROSCI, V1, P470, DOI 10.1038/2185; DEBONNEL G, 1989, CAN J PHYSIOL PHARM, V67, P29, DOI 10.1139/y89-005; Delmas P, 1997, J PHYSIOL-LONDON, V498, P627, DOI 10.1113/jphysiol.1997.sp021888; Engisch KL, 1996, HIPPOCAMPUS, V6, P183, DOI 10.1002/(SICI)1098-1063(1996)6:2<183::AID-HIPO8>3.0.CO;2-Q; FISHER RS, 1984, J NEUROSCI, V4, P1312; Frerking M, 1998, NAT NEUROSCI, V1, P479, DOI 10.1038/2194; Frerking M, 2000, CURR OPIN NEUROBIOL, V10, P342, DOI 10.1016/S0959-4388(00)00094-5; Frerking M, 2001, J NEUROSCI, V21, P2958, DOI 10.1523/JNEUROSCI.21-09-02958.2001; GHO M, 1986, BRAIN RES, V385, P411, DOI 10.1016/0006-8993(86)91093-0; GRAY R, 1987, NATURE, V327, P620, DOI 10.1038/327620a0; Heuss C, 1999, NAT NEUROSCI, V2, P1070, DOI 10.1038/15996; Jane DE, 1997, J MED CHEM, V40, P3645, DOI 10.1021/jm9702387; KNOPFEL T, 1990, P NATL ACAD SCI USA, V87, P4083, DOI 10.1073/pnas.87.11.4083; Kohler M, 1996, SCIENCE, V273, P1709, DOI 10.1126/science.273.5282.1709; LANCASTER B, 1986, J NEUROPHYSIOL, V55, P1268, DOI 10.1152/jn.1986.55.6.1268; LANCASTER B, 2000, J PHYSL, V495, P449; Lerma J, 2001, PHYSIOL REV, V81, P971, DOI 10.1152/physrev.2001.81.3.971; MADISON DV, 1984, J PHYSIOL-LONDON, V354, P319, DOI 10.1113/jphysiol.1984.sp015378; MADISON DV, 1986, J PHYSIOL-LONDON, V372, P221, DOI 10.1113/jphysiol.1986.sp016006; MALENKA RC, 1986, J NEUROSCI, V6, P475; Min MY, 1999, P NATL ACAD SCI USA, V96, P9932, DOI 10.1073/pnas.96.17.9932; MULLER W, 1992, J NEUROPHYSIOL, V68, P2264, DOI 10.1152/jn.1992.68.6.2264; NICOLL RA, 1988, SCIENCE, V241, P545, DOI 10.1126/science.2456612; NISTRI A, 1991, J PHYSIOL-LONDON, V435, P465, DOI 10.1113/jphysiol.1991.sp018519; PATERNAIN AV, 1995, NEURON, V14, P185, DOI 10.1016/0896-6273(95)90253-8; Pedarzani P, 1996, PFLUG ARCH EUR J PHY, V431, P723, DOI 10.1007/s004240050057; PEDARZANI P, 1993, NEURON, V11, P1023, DOI 10.1016/0896-6273(93)90216-E; Robinson I. K., 1991, HDB SYNCHROTRON RAD, V3, P221; Rodriguez-Moreno A, 1998, NEURON, V20, P1211, DOI 10.1016/S0896-6273(00)80501-2; RodriguezMoreno A, 1997, NEURON, V19, P893, DOI 10.1016/S0896-6273(00)80970-8; Schmitz D, 2000, NEURON, V27, P327, DOI 10.1016/S0896-6273(00)00040-4; Semyanov A, 2001, NAT NEUROSCI, V4, P718, DOI 10.1038/89506; SHAPIRO MS, 1994, J NEUROSCI, V14, P7109; Stocker M, 1999, P NATL ACAD SCI USA, V96, P4662, DOI 10.1073/pnas.96.8.4662; TRAUB RD, 1993, J PHYSIOL-LONDON, V461, P525, DOI 10.1113/jphysiol.1993.sp019527; Viana F, 1996, J NEUROSCI, V16, P6000; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; WESTBROOK GL, 1983, BRAIN RES, V273, P97, DOI 10.1016/0006-8993(83)91098-3; WONG LA, 1994, J NEUROSCI, V14, P3881; ZHANG L, 1994, PFLUG ARCH EUR J PHY, V426, P247, DOI 10.1007/BF00374778	50	159	164	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAR 28	2002	34	1					107	114		10.1016/S0896-6273(02)00624-4	http://dx.doi.org/10.1016/S0896-6273(02)00624-4			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536HR	11931745	Bronze			2022-12-24	WOS:000174695100013
J	Xiong, WH; Chen, WR				Xiong, WH; Chen, WR			Dynamic gating of spike propagation in the mitral cell lateral dendrites	NEURON			English	Article							RAT OLFACTORY-BULB; ACTION-POTENTIALS; TUFTED CELLS; DENDRODENDRITIC INHIBITION; FUNCTIONAL EXPRESSION; RECIPROCAL SYNAPSES; NEURAL ASSEMBLIES; PYRAMIDAL NEURONS; NMDA RECEPTORS; ODOR	A unique feature of the olfactory bulb circuit is the long projection of the mitral cell lateral dendrites. Through dendrodendritic reciprocal synapses, these dendrites connect one olfactory glomerular module to hundreds of others; but the functional principles governing these extensive lateral interactions remain largely unknown. Here we report that the spatial extent of action potential propagation in these dendrites is dynamically regulated by inhibitory synapses distributed along the dendrites. The extent of propagation determines the spatial pattern of Ca2+ influx and thus the range and number of dendrodendritic synapses to be activated. Accordingly, network control of spike traffic in the mitral cell lateral dendrites can mediate dynamic interaction with different combinations of glomerular modules in response to different odorants.	Yale Univ, Dept Neurobiol, New Haven, CT 06520 USA	Yale University	Chen, WR (corresponding author), Yale Univ, Dept Neurobiol, 333 Cedar St,C303 SHM, New Haven, CT 06520 USA.				NIDCD NIH HHS [R01 DC 03918] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003918] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Bischofberger J, 1997, J PHYSIOL-LONDON, V504, P359, DOI 10.1111/j.1469-7793.1997.359be.x; BUONVISO N, 1990, J NEUROPHYSIOL, V63, P447, DOI 10.1152/jn.1990.63.3.447; BUONVISO N, 1992, J NEUROPHYSIOL, V68, P417, DOI 10.1152/jn.1992.68.2.417; Carlson GC, 2000, J NEUROSCI, V20, P2011; Charpak S, 2001, P NATL ACAD SCI USA, V98, P1230, DOI 10.1073/pnas.021422798; Chen WR, 1997, BRAIN RES, V745, P189, DOI 10.1016/S0006-8993(96)01150-X; Chen WR, 1997, SCIENCE, V278, P463, DOI 10.1126/science.278.5337.463; Chen WR, 2000, NEURON, V25, P625, DOI 10.1016/S0896-6273(00)81065-X; EZEH PI, 1993, J NEUROPHYSIOL, V70, P263, DOI 10.1152/jn.1993.70.1.263; Friedman D, 2000, J NEUROPHYSIOL, V84, P39, DOI 10.1152/jn.2000.84.1.39; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; HAMILTON KA, 1989, J NEUROPHYSIOL, V62, P609, DOI 10.1152/jn.1989.62.3.609; HAUSSER M, 1995, NEURON, V15, P637, DOI 10.1016/0896-6273(95)90152-3; Isaacson JS, 1998, NEURON, V20, P749, DOI 10.1016/S0896-6273(00)81013-2; JAHR CE, 1982, J PHYSIOL-LONDON, V326, P213, DOI 10.1113/jphysiol.1982.sp014187; Johnson BA, 2000, J COMP NEUROL, V422, P496, DOI 10.1002/1096-9861(20000710)422:4<496::AID-CNE2>3.0.CO;2-4; Kashiwadani H, 1999, J NEUROPHYSIOL, V82, P1786, DOI 10.1152/jn.1999.82.4.1786; KATOH K, 1993, J NEUROPHYSIOL, V70, P2161, DOI 10.1152/jn.1993.70.5.2161; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; LANCASTER B, 1987, J PHYSIOL-LONDON, V389, P187, DOI 10.1113/jphysiol.1987.sp016653; Larkum ME, 1996, J NEUROPHYSIOL, V75, P154, DOI 10.1152/jn.1996.75.1.154; Laurent G, 1996, TRENDS NEUROSCI, V19, P489, DOI 10.1016/S0166-2236(96)10054-0; LEVETEAU J, 1966, SCIENCE, V153, P175, DOI 10.1126/science.153.3732.175; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P197, DOI 10.1113/jphysiol.1980.sp013358; Luo M, 2001, NEURON, V32, P1165, DOI 10.1016/S0896-6273(01)00537-2; MacLeod K, 1996, SCIENCE, V274, P976, DOI 10.1126/science.274.5289.976; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Margrie TW, 2001, P NATL ACAD SCI USA, V98, P319, DOI 10.1073/pnas.011523098; Martina M, 2000, SCIENCE, V287, P295, DOI 10.1126/science.287.5451.295; Meister M, 2001, J NEUROSCI, V21, P1351; MEREDITH M, 1986, J NEUROPHYSIOL, V56, P572, DOI 10.1152/jn.1986.56.3.572; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; MORI K, 1983, J COMP NEUROL, V219, P339, DOI 10.1002/cne.902190308; Nickell WT, 1996, BRAIN RES BULL, V39, P57, DOI 10.1016/0361-9230(95)02042-X; ONODA N, 1980, J NEUROPHYSIOL, V44, P29, DOI 10.1152/jn.1980.44.1.29; ORONA E, 1984, J COMP NEUROL, V226, P346, DOI 10.1002/cne.902260305; Pare D, 1998, NEUROSCIENCE, V84, P377, DOI 10.1016/S0306-4522(97)00530-7; PRICE JL, 1970, J CELL SCI, V7, P631; RALL W, 1968, J NEUROPHYSIOL, V31, P884, DOI 10.1152/jn.1968.31.6.884; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Schoppa NE, 2001, NEURON, V31, P639, DOI 10.1016/S0896-6273(01)00389-0; Schoppa NE, 1998, J NEUROSCI, V18, P6790; Shepherd G.M., 1998, SYNAPTIC ORG BRAIN, P159; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; STEWART WB, 1979, J COMP NEUROL, V185, P715, DOI 10.1002/cne.901850407; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Tsubokawa H, 1996, J NEUROPHYSIOL, V76, P2896, DOI 10.1152/jn.1996.76.5.2896; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; WELLIS DP, 1989, J NEUROPHYSIOL, V61, P1161, DOI 10.1152/jn.1989.61.6.1161; Williams SR, 2000, J NEUROSCI, V20, P1307; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371; Zhao HQ, 1998, SCIENCE, V279, P237, DOI 10.1126/science.279.5348.237	55	112	113	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 28	2002	34	1					115	126		10.1016/S0896-6273(02)00628-1	http://dx.doi.org/10.1016/S0896-6273(02)00628-1			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536HR	11931746	Bronze			2022-12-24	WOS:000174695100014
J	Hernandez, A; Zainos, A; Romo, R				Hernandez, A; Zainos, A; Romo, R			Temporal evolution of a decision-making process in medial premotor cortex	NEURON			English	Article							CONTRASTING NEURONAL-ACTIVITY; PRESUPPLEMENTARY MOTOR AREAS; WORKING-MEMORY; PSYCHOPHYSICAL MEASUREMENTS; SENSORY DISCRIMINATION; CORTICOCORTICAL CONNECTIONS; CUTANEOUS REPRESENTATIONS; PERCEPTUAL DECISION; PARIETAL CORTEX; LATERAL SULCUS	The events linking sensory discrimination to motor action remain unclear. It is not known, for example, whether the motor areas of the frontal lobe receive the result of the discrimination process from other areas or whether they actively participate in it. To investigate this, we trained monkeys to discriminate between two mechanical vibrations applied sequentially to the fingertips; here subjects had to recall the first vibration, compare it to the second one, and indicate with a hand/arm movement which of the two vibrations had the higher frequency. We recorded the activity of single neurons in medial premotor cortex (MPC) and found that their responses correlate with the diverse stages of the discrimination process. Thus, activity in MPC reflects the temporal evolution of the decision-making process leading to action selection during this perceptual task.	Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Romo, R (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico.	rromo@ifisiol.unam.mx		romo, ranulfo/0000-0003-3529-3635; zainos, antonio/0000-0001-6137-1794				BRITTEN KH, 1992, J NEUROSCI, V12, P4745; BURTON H, 1995, J COMP NEUROL, V355, P539, DOI 10.1002/cne.903550405; BURTON H, 1995, J COMP NEUROL, V355, P508, DOI 10.1002/cne.903550404; CHEN YC, 1995, EXP BRAIN RES, V102, P461; Cipolloni PB, 1999, J COMP NEUROL, V403, P431; Dodd JV, 2001, J NEUROSCI, V21, P4809, DOI 10.1523/JNEUROSCI.21-13-04809.2001; FALZETT M, 1985, BRAIN RES, V347, P127, DOI 10.1016/0006-8993(85)90898-4; Fuster JM, 1997, TRENDS NEUROSCI, V20, P451, DOI 10.1016/S0166-2236(97)01128-4; Gold JI, 2000, NATURE, V404, P390, DOI 10.1038/35006062; Hernandez A, 1997, J NEUROSCI, V17, P6391; Hernandez A, 2000, P NATL ACAD SCI USA, V97, P6191, DOI 10.1073/pnas.120018597; Horwitz GD, 1999, SCIENCE, V284, P1158, DOI 10.1126/science.284.5417.1158; JOHNSON KO, 1980, J NEUROPHYSIOL, V43, P1771, DOI 10.1152/jn.1980.43.6.1771; JOHNSON KO, 1980, J NEUROPHYSIOL, V43, P1793, DOI 10.1152/jn.1980.43.6.1793; JONES EG, 1978, J COMP NEUROL, V181, P291, DOI 10.1002/cne.901810206; JONES EG, 1969, BRAIN, V92, P477, DOI 10.1093/brain/92.3.477; JURGENS U, 1984, BRAIN RES, V300, P63, DOI 10.1016/0006-8993(84)91341-6; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; KRUBITZER L, 1995, J NEUROSCI, V15, P3821; KURATA K, 1985, J NEUROPHYSIOL, V53, P142, DOI 10.1152/jn.1985.53.1.142; LaBar KS, 1999, NEUROIMAGE, V10, P695, DOI 10.1006/nimg.1999.0503; LAMOTTE RH, 1975, J NEUROPHYSIOL, V38, P539, DOI 10.1152/jn.1975.38.3.539; Leon MI, 1998, NEURON, V21, P669, DOI 10.1016/S0896-6273(00)80584-X; LUPPINO G, 1993, J COMP NEUROL, V338, P114, DOI 10.1002/cne.903380109; MATSUZAKA Y, 1992, J NEUROPHYSIOL, V68, P653, DOI 10.1152/jn.1992.68.3.653; Merchant H, 1997, J NEUROPHYSIOL, V77, P1132, DOI 10.1152/jn.1997.77.3.1132; MOUNTCASTLE VB, 1990, J NEUROSCI, V10, P3032; MOUNTCASTLE VB, 1992, CEREB CORTEX, V2, P277, DOI 10.1093/cercor/2.4.277; MOUNTCASTLE VB, 1991, J NEUROSCI METH, V36, P77, DOI 10.1016/0165-0270(91)90140-U; PANDYA DN, 1969, BRAIN RES, V13, P13, DOI 10.1016/0006-8993(69)90141-3; Petit L, 1998, J NEUROSCI, V18, P9429; Pollmann S, 2000, EXP BRAIN RES, V133, P12, DOI 10.1007/s002210000396; PONS TP, 1987, SCIENCE, V237, P417, DOI 10.1126/science.3603028; PONS TP, 1992, J NEUROPHYSIOL, V68, P518, DOI 10.1152/jn.1992.68.2.518; ROMO R, 1993, J NEUROPHYSIOL, V70, P2690, DOI 10.1152/jn.1993.70.6.2690; Romo R, 1998, NATURE, V392, P387, DOI 10.1038/32891; Romo R, 2000, NEURON, V26, P273, DOI 10.1016/S0896-6273(00)81156-3; Romo R, 2001, ANNU REV NEUROSCI, V24, P107, DOI 10.1146/annurev.neuro.24.1.107; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; ROMO R, 1992, EXP BRAIN RES, V91, P396, DOI 10.1007/BF00227836; Romo R, 1997, CEREB CORTEX, V7, P317, DOI 10.1093/cercor/7.4.317; ROMO R, 1987, EXP BRAIN RES, V67, P656; Salinas E, 2000, J NEUROSCI, V20, P5503, DOI 10.1523/JNEUROSCI.20-14-05503.2000; Salinas E, 1998, J NEUROSCI, V18, P499; Schall JD, 2001, NAT REV NEUROSCI, V2, P33, DOI 10.1038/35049054; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Shen LM, 1997, J NEUROPHYSIOL, V77, P1195, DOI 10.1152/jn.1997.77.3.1195; Shima K, 1998, J NEUROPHYSIOL, V80, P3247, DOI 10.1152/jn.1998.80.6.3247; Shima K, 2000, J NEUROPHYSIOL, V84, P2148, DOI 10.1152/jn.2000.84.4.2148; Tanji J, 1996, CURR OPIN NEUROBIOL, V6, P782, DOI 10.1016/S0959-4388(96)80028-6; TANJI J, 1985, J NEUROPHYSIOL, V53, P129, DOI 10.1152/jn.1985.53.1.129; THALER D, 1995, EXP BRAIN RES, V102, P445; Zhang J, 1997, J NEUROSCI, V17, P2227; Zhang J, 1997, J MATH PSYCHOL, V41, P219, DOI 10.1006/jmps.1997.1168; [No title captured]	56	190	190	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 14	2002	33	6					959	972		10.1016/S0896-6273(02)00613-X	http://dx.doi.org/10.1016/S0896-6273(02)00613-X			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	530ZK	11906701	Bronze, Green Submitted			2022-12-24	WOS:000174389600012
J	Gulledge, AT; Stuart, GJ				Gulledge, AT; Stuart, GJ			Excitatory actions of GABA in the cortex	NEURON			English	Article							HIPPOCAMPAL PYRAMIDAL CELLS; RECEPTOR-MEDIATED RESPONSES; RAT NEOCORTICAL NEURONS; GAMMA-AMINOBUTYRIC ACID; CONDUCTANCE; CHLORIDE; CL; BICARBONATE; DENDRITES; CA1	Little is known about how GABAergic inputs interact with excitatory inputs under conditions that maintain physiological concentrations of intracellular anions. Using extracellular and gramicidin perforated-patch recording, we show that somatic and dendritic GABA responses in mature cortical pyramidal neurons are depolarizing from rest and can facilitate action potential generation when combined with proximal excitatory input. Dendritic GABA responses were excitatory regardless of timing, whereas somatic GABA responses were inhibitory when coincident with excitatory input but excitatory at earlier times. These excitatory actions of GABA occur even though the GABA reversal potential is below action potential threshold and largely uniform across the somato-dendritic axis, and arise when GABAergic inputs are temporally or spatially isolated from concurrent excitation. Our findings demonstrate that under certain circumstances GABA will have an excitatory role in synaptic integration in the cortex.	Australian Natl Univ, John Curtin Sch Med Res, Div Neurosci, Canberra, ACT 0200, Australia	Australian National University; John Curtin School of Medical Research	Stuart, GJ (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Div Neurosci, Mills Rd, Canberra, ACT 0200, Australia.		stuart, greg j/F-7328-2011; Gulledge, Allan T/C-2733-2008	Gulledge, Allan T/0000-0002-5721-374X; stuart, greg/0000-0001-9395-2219				ABE Y, 1994, J NEUROPHYSIOL, V72, P1530, DOI 10.1152/jn.1994.72.4.1530; Akaike N, 1996, PROG BIOPHYS MOL BIO, V65, P251, DOI 10.1016/S0079-6107(96)00013-2; ALGER BE, 1979, NATURE, V281, P315, DOI 10.1038/281315a0; ALGER BE, 1982, J PHYSIOL-LONDON, V328, P125, DOI 10.1113/jphysiol.1982.sp014256; ANDERSEN P, 1980, J PHYSIOL-LONDON, V305, P279, DOI 10.1113/jphysiol.1980.sp013363; Archer DP, 2001, ANESTH ANALG, V93, P1521, DOI 10.1097/00000539-200112000-00038; BARKER JL, 1978, J PHYSIOL-LONDON, V280, P331, DOI 10.1113/jphysiol.1978.sp012387; CONNORS BW, 1988, J PHYSIOL-LONDON, V406, P443, DOI 10.1113/jphysiol.1988.sp017390; DJORUP A, 1981, BRAIN RES, V219, P196, DOI 10.1016/0006-8993(81)90282-1; ELBEHEIRY H, 1990, NEUROSCI LETT, V119, P83, DOI 10.1016/0304-3940(90)90761-W; Gao XB, 1998, J NEUROPHYSIOL, V79, P716, DOI 10.1152/jn.1998.79.2.716; GROVER LM, 1993, J NEUROPHYSIOL, V69, P1541, DOI 10.1152/jn.1993.69.5.1541; HARA M, 1992, NEUROSCI LETT, V143, P135, DOI 10.1016/0304-3940(92)90250-B; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; KAILA K, 1994, PROG NEUROBIOL, V42, P489, DOI 10.1016/0301-0082(94)90049-3; KAILA K, 1987, NATURE, V330, P163, DOI 10.1038/330163a0; KAILA K, 1993, J PHYSIOL-LONDON, V464, P273, DOI 10.1113/jphysiol.1993.sp019634; Kaila K, 1997, J NEUROSCI, V17, P7662; Kakazu Y, 2000, J NEUROPHYSIOL, V84, P281, DOI 10.1152/jn.2000.84.1.281; KOCH C, 1990, J NEUROSCI, V10, P1728; Kuner T, 2000, NEURON, V27, P447, DOI 10.1016/S0896-6273(00)00056-8; LAMBERT NA, 1991, J NEUROPHYSIOL, V66, P1538, DOI 10.1152/jn.1991.66.5.1538; Lewis BL, 2000, CEREB CORTEX, V10, P1168, DOI 10.1093/cercor/10.12.1168; LUHMANN HJ, 1991, J NEUROPHYSIOL, V65, P247, DOI 10.1152/jn.1991.65.2.247; Mainen ZF, 1995, NEURON, V15, P1427, DOI 10.1016/0896-6273(95)90020-9; Martina M, 2001, J NEUROPHYSIOL, V86, P2887, DOI 10.1152/jn.2001.86.6.2887; NEWBERRY NR, 1985, J PHYSIOL-LONDON, V360, P161, DOI 10.1113/jphysiol.1985.sp015610; Owens DF, 1996, J NEUROSCI, V16, P6414; Perkins KL, 1999, J NEUROPHYSIOL, V82, P768, DOI 10.1152/jn.1999.82.2.768; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; ROBINSON HPC, 1993, J NEUROSCI METH, V49, P157, DOI 10.1016/0165-0270(93)90119-C; SCHARFMAN HE, 1985, BRAIN RES, V358, P385, DOI 10.1016/0006-8993(85)90990-4; SEGEV I, 1983, BIOPHYS J, V41, P41, DOI 10.1016/S0006-3495(83)84404-X; Staley KJ, 1999, J PHYSIOL-LONDON, V519, P693, DOI 10.1111/j.1469-7793.1999.0693n.x; STALEY KJ, 1992, J NEUROPHYSIOL, V68, P197, DOI 10.1152/jn.1992.68.1.197; STALEY KJ, 1995, SCIENCE, V269, P977, DOI 10.1126/science.7638623; Stuart G, 1998, J NEUROSCI, V18, P3501; Taira T, 1997, J NEUROPHYSIOL, V77, P2213, DOI 10.1152/jn.1997.77.4.2213; THALMANN RH, 1981, NEUROSCI LETT, V21, P319, DOI 10.1016/0304-3940(81)90224-X; van Brederode JFM, 2001, J PHYSIOL-LONDON, V533, P711, DOI 10.1111/j.1469-7793.2001.00711.x; WONG RKS, 1982, J NEUROPHYSIOL, V48, P938, DOI 10.1152/jn.1982.48.4.938	41	299	304	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 23	2003	37	2					299	309		10.1016/S0896-6273(02)01146-7	http://dx.doi.org/10.1016/S0896-6273(02)01146-7			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	646UX	12546824	Bronze			2022-12-24	WOS:000181054900014
J	Wu, HH; Ivkovic, S; Murray, RC; Jaramillo, S; Lyons, KM; Johnson, JE; Calof, AL				Wu, HH; Ivkovic, S; Murray, RC; Jaramillo, S; Lyons, KM; Johnson, JE; Calof, AL			Autoregulation of neurogenesis by GDF11	NEURON			English	Article							MOUSE OLFACTORY EPITHELIUM; CELL-PROLIFERATION; BETA SUPERFAMILY; PROGENITOR CELLS; STEM-CELLS; IN-VITRO; EXPRESSION; DIFFERENTIATION; ACTIVIN; GROWTH	In the olfactory epithelium (OE), generation of new neurons by neuronal progenitors is inhibited by a signal from neurons themselves. Here we provide evidence that this feedback inhibitory signal is growth and differentiation factor 11 (GDF11). Both GDF11 and its receptors are expressed by OE neurons and progenitors, and GDF11 inhibits OE neurogenesis in vitro by inducing p27(Kip1) and reversible cell cycle arrest in progenitors. Mice lacking functional GDF11 have more progenitors and neurons in the OE, whereas mice lacking follistatin, a GDF11 antagonist, show dramatically decreased neurogenesis. This negative autoregulatory action of GDF11 is strikingly like that of its homolog, GDF8/myostatin, in skeletal muscle, suggesting that similar strategies establish and maintain proper cell number during neural and muscular development.	Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA; Univ Calif Irvine, Ctr Dev Biol, Irvine, CA 92697 USA; Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75390 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Los Angeles; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Calof, AL (corresponding author), Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA.	alcalof@uci.edu	Johnson, Jane/F-8881-2010; Calof, Anne/A-8644-2013	Calof, Anne/0000-0003-3676-2499; Ivkovic, Sanja/0000-0002-7977-3166; Ivkovic, Sanja/0000-0001-7089-3615	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD038761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003583] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR44528] Funding Source: Medline; NICHD NIH HHS [HD38761] Funding Source: Medline; NIDCD NIH HHS [DC03583] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ALBANO RM, 1994, DEVELOPMENT, V120, P803; BULLOUGH WS, 1965, CANCER RES, V25, P1683; Calof AL, 1998, J NEUROBIOL, V36, P190, DOI 10.1002/(SICI)1097-4695(199808)36:2<190::AID-NEU7>3.0.CO;2-X; Calof AL, 2002, MICROSC RES TECHNIQ, V58, P176, DOI 10.1002/jemt.10147; CALOF AL, 1989, NEURON, V3, P115, DOI 10.1016/0896-6273(89)90120-7; Calof AL, 1996, J NEUROBIOL, V30, P67; Calof AL, 1996, CIBA F SYMP, V196, P188; Cau E, 1997, DEVELOPMENT, V124, P1611; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; Chen P, 1999, DEVELOPMENT, V126, P1581; CLEGG CH, 1987, J CELL BIOL, V105, P949, DOI 10.1083/jcb.105.2.949; DEHAMER MK, 1994, NEURON, V13, P1083, DOI 10.1016/0896-6273(94)90047-7; Doetsch F, 2002, J NEUROSCI, V22, P2255, DOI 10.1523/JNEUROSCI.22-06-02255.2002; Dyer MA, 2001, J NEUROSCI, V21, P4259, DOI 10.1523/JNEUROSCI.21-12-04259.2001; Federman SM, 2000, J BONE MINER RES, V15, pS463; FEIJEN A, 1994, DEVELOPMENT, V120, P3621; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Gamer LW, 1999, DEV BIOL, V208, P222, DOI 10.1006/dbio.1998.9191; GORDON MK, 1995, MOL CELL NEUROSCI, V6, P363, DOI 10.1006/mcne.1995.1028; Gowan K, 2001, NEURON, V31, P219, DOI 10.1016/S0896-6273(01)00367-1; GUILLEMOT F, 1993, MECH DEVELOP, V42, P171, DOI 10.1016/0925-4773(93)90006-J; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; HALL PA, 1989, DEVELOPMENT, V106, P619; Hogan B, 1994, MANIPULATING MOUSE E; HOLCOMB JD, 1995, DEV BIOL, V172, P307, DOI 10.1006/dbio.1995.0025; KAUFFMAN SL, 1968, EXP CELL RES, V49, P420, DOI 10.1016/0014-4827(68)90191-2; Kawauchi S, 1999, J BIOL CHEM, V274, P19254, DOI 10.1074/jbc.274.27.19254; Lee SJ, 1999, CURR OPIN GENET DEV, V9, P604, DOI 10.1016/S0959-437X(99)00004-0; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Legrier ME, 2001, CELL GROWTH DIFFER, V12, P591; Levine EM, 2000, DEV BIOL, V219, P299, DOI 10.1006/dbio.2000.9622; Li WW, 1998, J NEUROSCI, V18, P8853; Lo PCH, 1999, MECH DEVELOP, V86, P171, DOI 10.1016/S0925-4773(99)00108-2; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; MATZUK MM, 1995, NATURE, V374, P360, DOI 10.1038/374360a0; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1999, NAT GENET, V22, P260, DOI 10.1038/10320; Miller JB, 1999, CURR TOP DEV BIOL, V43, P191; Miyazawa K, 2000, J NEUROSCI, V20, P5756, DOI 10.1523/JNEUROSCI.20-15-05756.2000; Mumm JS, 1996, P NATL ACAD SCI USA, V93, P11167, DOI 10.1073/pnas.93.20.11167; MURRAY RC, 2003, IN PRESS J NEUROSCI; NAKAMURA T, 1990, SCIENCE, V247, P836, DOI 10.1126/science.2106159; Nakashima M, 1999, MECH DEVELOP, V80, P185, DOI 10.1016/S0925-4773(98)00205-6; Newfeld SJ, 1999, GENETICS, V152, P783; Oh SP, 1997, GENE DEV, V11, P1812, DOI 10.1101/gad.11.14.1812; Parent JM, 1997, J NEUROSCI, V17, P3727; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; ROBERTS VJ, 1994, ENDOCRINOLOGY, V134, P914, DOI 10.1210/en.134.2.914; Scheufler C, 1999, J MOL BIOL, V287, P103, DOI 10.1006/jmbi.1999.2590; SCHNEYER AL, 1994, ENDOCRINOLOGY, V135, P667, DOI 10.1210/en.135.2.667; Shou J, 1999, NAT NEUROSCI, V2, P339, DOI 10.1038/7251; Shou JY, 2000, DEVELOPMENT, V127, P5403; Sloviter RS, 1996, J COMP NEUROL, V366, P516, DOI 10.1002/(SICI)1096-9861(19960311)366:3<516::AID-CNE10>3.0.CO;2-N; Taylor WE, 2001, AM J PHYSIOL-ENDOC M, V280, pE221, DOI 10.1152/ajpendo.2001.280.2.E221; Thomas M, 2000, J BIOL CHEM, V275, P40235, DOI 10.1074/jbc.M004356200; Williams RW, 2000, RES PRO CEL, V30, P21	57	258	293	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 23	2003	37	2					197	207		10.1016/S0896-6273(02)01172-8	http://dx.doi.org/10.1016/S0896-6273(02)01172-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	646UX	12546816	Green Published, Bronze			2022-12-24	WOS:000181054900006
J	Antonov, I; Antonova, I; Kandel, ER; Hawkins, RD				Antonov, I; Antonova, I; Kandel, ER; Hawkins, RD			Activity-dependent presynaptic facilitation and Hebbian LTP are both required and interact during classical conditioning in Aplysia	NEURON			English	Article							LONG-TERM POTENTIATION; SIPHON-WITHDRAWAL REFLEX; RELATING CELLULAR EVENTS; MOTOR NEURON SYNAPSES; SENSORY NEURONS; SENSORIMOTOR SYNAPSES; SYNAPTIC PLASTICITY; GILL-WITHDRAWAL; POSTSYNAPTIC MECHANISMS; INTERSTIMULUS-INTERVAL	Using a simplified preparation of the Aplysia siphon-withdrawal reflex, we previously found that associative plasticity at synapses between sensory neurons and motor neurons contributes importantly to classical conditioning of the reflex. We have now tested the roles in that plasticity of two associative cellular mechanisms: activity-dependent enhancement of presynaptic facilitation and postsynaptically induced longterm potentiation. By perturbing molecular signaling pathways in individual neurons, we have provided the most direct evidence to date that each of these mechanisms contributes to behavioral learning. In addition, our results suggest that the two mechanisms are not independent but rather interact through retrograde signaling.	Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, New York, NY 10032 USA; Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; New York State Psychiatry Institute; Howard Hughes Medical Institute	Hawkins, RD (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, 1051 Riverside Dr, New York, NY 10032 USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH026212] Funding Source: NIH RePORTER; NIMH NIH HHS [MH26212] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abrams TW, 1998, LEARN MEMORY, V4, P496, DOI 10.1101/lm.4.6.496; Antonov I, 2001, J NEUROSCI, V21, P6413, DOI 10.1523/JNEUROSCI.21-16-06413.2001; Antonov I, 1999, J NEUROSCI, V19, P10438; Arancio O, 2001, J NEUROSCI, V21, P143, DOI 10.1523/JNEUROSCI.21-01-00143.2001; Bailey CH, 2000, NAT REV NEUROSCI, V1, P11, DOI 10.1038/35036191; BAILEY CH, 1979, J NEUROPHYSIOL, V42, P530, DOI 10.1152/jn.1979.42.2.530; Bao JX, 1998, J NEUROSCI, V18, P458; Bao JX, 1997, SCIENCE, V275, P969, DOI 10.1126/science.275.5302.969; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BYRNE J, 1974, J NEUROPHYSIOL, V37, P1041, DOI 10.1152/jn.1974.37.5.1041; BYRNE J, 1987, PHYSIOL REV, V6, P329; Byrne JH, 1996, J NEUROSCI, V16, P425; CAREW TJ, 1986, ANNU REV NEUROSCI, V9, P435, DOI 10.1146/annurev.ne.09.030186.002251; CAREW TJ, 1984, J NEUROSCI, V4, P1217; CAREW TJ, 1981, J NEUROSCI, V1, P1426; CAREW TJ, 1983, SCIENCE, V219, P397, DOI 10.1126/science.6681571; CLARK GA, 1994, LEARN MEMORY, V1, P243; Cohen TE, 1997, J NEUROSCI, V17, P2886; COLWILL RM, 1988, J NEUROSCI, V8, P4440; COLWILL RM, 1988, J NEUROSCI, V8, P4434; Conrad P, 1999, J NEUROBIOL, V39, P237, DOI 10.1002/(SICI)1097-4695(199905)39:2<237::AID-NEU8>3.3.CO;2-S; Contractor A, 2002, SCIENCE, V296, P1864, DOI 10.1126/science.1069081; DALE N, 1993, P NATL ACAD SCI USA, V90, P7163, DOI 10.1073/pnas.90.15.7163; ELIOT LS, 1994, J NEUROSCI, V14, P368; Frost L, 1997, J NEUROSCI, V17, P2900; FROST WN, 1995, J NEUROPHYSIOL, V73, P2413, DOI 10.1152/jn.1995.73.6.2413; Ganguly K, 2000, NAT NEUROSCI, V3, P1018, DOI 10.1038/79838; GLANZMAN DL, 1994, J NEUROBIOL, V25, P666, DOI 10.1002/neu.480250608; Hawkins RD, 1998, BEHAV NEUROSCI, V112, P24, DOI 10.1037/0735-7044.112.1.24; Hawkins RD, 1998, PROG BRAIN RES, V118, P155; HAWKINS RD, 1983, SCIENCE, V219, P400, DOI 10.1126/science.6294833; HAWKINS RD, 1986, J NEUROSCI, V6, P1695; HAWKINS RD, 1989, P NATL ACAD SCI USA, V86, P7620, DOI 10.1073/pnas.86.19.7620; Hawkins RD, 1997, BEHAV BRAIN SCI, V20, P620, DOI 10.1017/S0140525X97301599; HAWKINS RD, 1989, J NEUROSCI, V9, P4236; Hawkins RD, 1998, BEHAV NEUROSCI, V112, P636, DOI 10.1037/0735-7044.112.3.636; HAWKINS RD, 1993, ANNU REV NEUROSCI, V16, P625, DOI 10.1146/annurev.ne.16.030193.003205; Hickie C, 1997, EUR J NEUROSCI, V9, P627, DOI 10.1111/j.1460-9568.1997.tb01411.x; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; Huang YY, 1998, NEURON, V21, P169, DOI 10.1016/S0896-6273(00)80524-3; ILLICH PA, 1994, BEHAV NEUROSCI, V108, P614; KANDEL ER, 1983, COLD SPRING HARB SYM, V48, P821, DOI 10.1101/SQB.1983.048.01.085; KELSO SR, 1986, P NATL ACAD SCI USA, V83, P5326, DOI 10.1073/pnas.83.14.5326; LIN XY, 1994, P ROY SOC B-BIOL SCI, V255, P113, DOI 10.1098/rspb.1994.0016; LIN XY, 1994, P ROY SOC B-BIOL SCI, V255, P215, DOI 10.1098/rspb.1994.0031; Lin XY, 1997, J NEUROPHYSIOL, V77, P667, DOI 10.1152/jn.1997.77.2.667; MACKEY SL, 1989, J NEUROSCI, V9, P4227; MACKEY SL, 1987, P NATL ACAD SCI USA, V84, P8730, DOI 10.1073/pnas.84.23.8730; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Murphy GG, 1997, SCIENCE, V278, P467, DOI 10.1126/science.278.5337.467; Murphy GG, 1996, P NATL ACAD SCI USA, V93, P9931, DOI 10.1073/pnas.93.18.9931; Murphy GG, 1999, J NEUROSCI, V19, P10595; OCORR KA, 1985, P NATL ACAD SCI USA, V82, P2548, DOI 10.1073/pnas.82.8.2548; Oda Y, 1998, NATURE, V394, P182, DOI 10.1038/28172; Pavlidis P, 2000, J NEUROSCI, V20, P4497, DOI 10.1523/JNEUROSCI.20-12-04497.2000; PERLMAN AJ, 1979, J NEUROPHYSIOL, V42, P510, DOI 10.1152/jn.1979.42.2.510; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Schacher S, 1997, J NEUROSCI, V17, P597; TRUDEAU LE, 1993, J NEUROPHYSIOL, V70, P1221, DOI 10.1152/jn.1993.70.3.1221; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Tsvetkov E, 2002, NEURON, V34, P289, DOI 10.1016/S0896-6273(02)00645-1; WALTERS ET, 1983, SCIENCE, V219, P405, DOI 10.1126/science.6294834; WALTERS ET, 1989, P NATL ACAD SCI USA, V86, P7616, DOI 10.1073/pnas.86.19.7616; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; WIGSTROM H, 1986, ACTA PHYSIOL SCAND, V126, P317, DOI 10.1111/j.1748-1716.1986.tb07822.x; Winer B.J., 1991, STAT PRINCIPLES EXPT; Yeckel MF, 1999, NAT NEUROSCI, V2, P625, DOI 10.1038/10180; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805	69	128	132	0	21	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 9	2003	37	1					135	147		10.1016/S0896-6273(02)01129-7	http://dx.doi.org/10.1016/S0896-6273(02)01129-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	646UV	12526779	Bronze			2022-12-24	WOS:000181054700016
J	Lai, K; Kaspar, BK; Gage, FH; Schaffer, DV				Lai, K; Kaspar, BK; Gage, FH; Schaffer, DV			Sonic hedgehog regulates adult neural progenitor proliferation in vitro and in vivo	NATURE NEUROSCIENCE			English	Article							CNS STEM-CELLS; SUBVENTRICULAR ZONE; DENTATE GYRUS; MAMMALIAN FOREBRAIN; RAT HIPPOCAMPUS; NERVOUS-SYSTEM; SPINAL-CORD; NEURONS; NEUROGENESIS; SIGNALS	Neural stem cells exist in the developing and adult nervous systems of all mammals, but the basic mechanisms that control their behavior are not yet well understood. Here, we investigated the role of Sonic hedgehog (Shh), a factor vital for neural development, in regulating adult hippocampal neural stem cells. We found high expression of the Shh receptor Patched in both the adult rat hippocampus and neural progenitor cells isolated from this region. In addition, Shh elicited a strong, dose-dependent proliferative response in progenitors in vitro. Furthermore, adeno-associated viral vector delivery of shh cDNA to the hippocampus elicited a 3.3-fold increase in cell proliferation. Finally, the pharmacological inhibitor of Shh signaling cyclopamine reduced hippocampal neural progenitor proliferation in vivo. This work identifies Shh as a regulator of adult hippocampal neural stem cells.	Univ Calif Berkeley, Dept Chem Engn, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; Salk Inst Biol Studies, Genet Lab, San Diego, CA 92186 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Salk Institute	Schaffer, DV (corresponding author), Univ Calif Berkeley, Dept Chem Engn, 201 Gilman Hall, Berkeley, CA 94720 USA.		Kaspar, Brian/E-6490-2010; Kaspar, Brian/E-3349-2011					Aberg MAI, 2000, J NEUROSCI, V20, P2896; Altar CA, 1998, TRENDS NEUROSCI, V21, P433, DOI 10.1016/S0166-2236(98)01273-9; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; AMARAL DG, 1985, J COMP NEUROL, V240, P37, DOI 10.1002/cne.902400104; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Britto J, 2002, NAT NEUROSCI, V5, P103, DOI 10.1038/nn797; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Conover JC, 2000, NAT NEUROSCI, V3, P1091, DOI 10.1038/80606; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Dahmane N, 2001, DEVELOPMENT, V128, P5201; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; ERICSON J, 1995, CELL, V81, P747, DOI 10.1016/0092-8674(95)90536-7; Gage FH, 1998, J NEUROBIOL, V36, P249, DOI 10.1002/(SICI)1097-4695(199808)36:2<249::AID-NEU11>3.0.CO;2-9; Gould E, 1997, J NEUROSCI, V17, P2492; Hahn H, 2000, J BIOL CHEM, V275, P28341, DOI 10.1074/jbc.C000352200; Hitoshi S, 2002, DEVELOPMENT, V129, P233; Huang Z, 1998, DEVELOPMENT, V125, P3753; HYNES M, 1995, NEURON, V15, P35, DOI 10.1016/0896-6273(95)90062-4; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Jin KL, 2002, J NEUROSCI, V22, P5365; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; Kaspar BK, 2002, P NATL ACAD SCI USA, V99, P2320, DOI 10.1073/pnas.042678699; Kaspar BK, 2002, MOL THER, V5, P50, DOI 10.1006/mthe.2001.0520; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Palmer TD, 1999, J NEUROSCI, V19, P8487; Pola R, 2001, NAT MED, V7, P706, DOI 10.1038/89083; Poncet C, 1996, MECH DEVELOP, V60, P13, DOI 10.1016/S0925-4773(96)00595-3; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; ROSENBERG MB, 1988, SCIENCE, V242, P1575, DOI 10.1126/science.3201248; Rowitch DH, 1999, J NEUROSCI, V19, P8954, DOI 10.1523/JNEUROSCI.19-20-08954.1999; RUIZ IAA, 2002, NAT REV NEUROSCI, V3, P24, DOI DOI 10.1038/NRN704; Sakurada K, 1999, DEVELOPMENT, V126, P4017; SAMULSKI RJ, 1989, J VIROL, V63, P3822, DOI 10.1128/JVI.63.9.3822-3828.1989; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Tanigaki K, 2001, NEURON, V29, P45, DOI 10.1016/S0896-6273(01)00179-9; Taupin P, 2000, NEURON, V28, P385, DOI 10.1016/S0896-6273(00)00119-7; Traiffort E, 1999, EUR J NEUROSCI, V11, P3199, DOI 10.1046/j.1460-9568.1999.00777.x; Traiffort E, 2001, EUR J NEUROSCI, V14, P839, DOI 10.1046/j.0953-816x.2001.01708.x; Uekama K, 1998, CHEM REV, V98, P2045, DOI 10.1021/cr970025p; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Weiss S, 1996, J NEUROSCI, V16, P7599; Weiss S, 1996, TRENDS NEUROSCI, V19, P387, DOI 10.1016/S0166-2236(96)10035-7; Xie JW, 2001, P NATL ACAD SCI USA, V98, P9255, DOI 10.1073/pnas.151173398; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3	50	625	678	2	40	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2003	6	1					21	27		10.1038/nn983	http://dx.doi.org/10.1038/nn983			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	630CE	12469128				2022-12-24	WOS:000180089300011
J	Stevens, B; Porta, S; Haak, LL; Gallo, V; Fields, RD				Stevens, B; Porta, S; Haak, LL; Gallo, V; Fields, RD			Adenosine: A neuron-glial transmitter promoting myelination in the CNS in response to action potentials	NEURON			English	Article							OLIGODENDROCYTE PRECURSOR CELLS; THYROID-HORMONE; OPTIC-NERVE; RETINOIC ACID; SCHWANN-CELLS; SPINAL-CORD; LINEAGE; DIFFERENTIATION; PROLIFERATION; ACTIVATION	Neuronal activity influences myelination of the brain, but the molecular mechanisms involved are largely unknown. Here, we report that oligodendrocyte progenitor cells (OPCs) express functional adenosine receptors, which are activated in response to action potential firing. Adenosine acts as a potent neuronglial transmitter to inhibit OPC proliferation, stimulate differentiation, and promote the formation of myelin. This neuron-glial signal provides a molecular mechanism for promoting oligodendrocyte development and myelination in response to impulse activity and may help resolve controversy on the opposite effects of impulse activity on myelination in the central and peripheral nervous systems.	NICHD, Lab Cellular & Synapt Neurophysiol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Fields, RD (corresponding author), NICHD, Lab Cellular & Synapt Neurophysiol, NIH, Bethesda, MD 20892 USA.	fields@helix.nih.gov	Messier, Claude/A-2322-2008; Haak, Laurel L./C-4986-2008	Messier, Claude/0000-0002-4791-1763; Haak, Laurel L./0000-0001-5109-3700	NICHD NIH HHS [Z01 HD000713-11] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000713] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000713, K04HD000713] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Baas D, 2002, P NATL ACAD SCI USA, V99, P2907, DOI 10.1073/pnas.052482299; Barres BA, 1999, J CELL BIOL, V147, P1123, DOI 10.1083/jcb.147.6.1123; BARRES BA, 1993, NATURE, V361, P258, DOI 10.1038/361258a0; BARRES BA, 1994, DEVELOPMENT, V120, P1097; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Belachew S, 2001, DEV NEUROSCI-BASEL, V23, P287, DOI 10.1159/000048712; Bernstein M, 1996, J NEUROSCI RES, V46, P152, DOI 10.1002/(SICI)1097-4547(19961015)46:2<152::AID-JNR3>3.0.CO;2-G; Bunge RP, 1987, PROG BRAIN RES <D>, V71, P143; Burnstock G, 1997, NEUROPHARMACOLOGY, V36, P1127, DOI 10.1016/S0028-3908(97)00125-1; Calaora V, 2001, J NEUROSCI, V21, P4740, DOI 10.1523/JNEUROSCI.21-13-04740.2001; Calza L, 2002, P NATL ACAD SCI USA, V99, P3258, DOI 10.1073/pnas.052704499; Canoll PD, 1999, MOL CELL NEUROSCI, V13, P79, DOI 10.1006/mcne.1998.0733; Canoll PD, 1996, NEURON, V17, P229, DOI 10.1016/S0896-6273(00)80155-5; Demerens C, 1996, P NATL ACAD SCI USA, V93, P9887, DOI 10.1073/pnas.93.18.9887; Fields R. Douglas, 1992, P67; Fields RD, 2000, TRENDS NEUROSCI, V23, P625, DOI 10.1016/S0166-2236(00)01674-X; FIELDS RD, 1997, CURRENT PROTOCOLS NE; FITZGERALD M, 1987, NATURE, V326, P603, DOI 10.1038/326603a0; Gallo V, 1996, J NEUROSCI, V16, P2659, DOI 10.1523/jneurosci.16-08-02659.1996; Gallo V, 2000, TRENDS PHARMACOL SCI, V21, P252, DOI 10.1016/S0165-6147(00)01494-2; GALLO V, 1995, J NEUROSCI, V15, P394; Gao FB, 1998, DEV BIOL, V197, P54, DOI 10.1006/dbio.1998.8877; Ghiani CA, 1999, DEVELOPMENT, V126, P1077; GYLLENSTEN L, 1963, J EMBRYOL EXP MORPH, V11, P255; HE MH, 1994, J NEUROCHEM, V63, P501; ITOH K, 1995, SCIENCE, V270, P1369, DOI 10.1126/science.270.5240.1369; KASTRITSIS CH, 1993, GLIA, V8, P106, DOI 10.1002/glia.440080206; KIRISCHUK S, 1995, J PHYSIOL-LONDON, V483, P41, DOI 10.1113/jphysiol.1995.sp020566; Kreisberg MS, 1997, AM J PHYSIOL-HEART C, V272, pH1231, DOI 10.1152/ajpheart.1997.272.3.H1231; KRIEGLER S, 1993, J NEUROSCI, V13, P4229, DOI 10.1523/jneurosci.13-10-04229.1993; KUPERMAN AS, 1964, NATURE, V204, P1000, DOI 10.1038/2041000a0; Li MX, 1996, J NEUROPHYSIOL, V76, P2595, DOI 10.1152/jn.1996.76.4.2595; LUBETZKI C, 1993, P NATL ACAD SCI USA, V90, P6820, DOI 10.1073/pnas.90.14.6820; MAIRE JC, 1984, J PHYSIOL-LONDON, V357, P67, DOI 10.1113/jphysiol.1984.sp015489; Mayer C, 1998, GLIA, V23, P374, DOI 10.1002/(SICI)1098-1136(199808)23:4<374::AID-GLIA9>3.0.CO;2-2; Mirsky R, 1996, CURR OPIN NEUROBIOL, V6, P89, DOI 10.1016/S0959-4388(96)80013-4; Omlin FX, 1997, BRAIN RES BULL, V44, P627, DOI 10.1016/S0361-9230(97)00283-9; Park SK, 2001, DEV NEUROSCI-BASEL, V23, P327, DOI 10.1159/000048716; Park SK, 2001, J CELL BIOL, V154, P1245, DOI 10.1083/jcb.200104025; Rogister B, 1999, MOL CELL NEUROSCI, V14, P287, DOI 10.1006/mcne.1999.0790; SCOTT S, 1992, SENSORY NEURONS; SEILHEIMER B, 1989, J CELL BIOL, V109, P3095, DOI 10.1083/jcb.109.6.3095; Stevens B, 1998, J NEUROSCI, V18, P9303; Stevens B, 2000, SCIENCE, V287, P2267, DOI 10.1126/science.287.5461.2267; STEWART HJS, 1993, EUR J NEUROSCI, V5, P1136, DOI 10.1111/j.1460-9568.1993.tb00968.x; TAKEDA M, 1995, GLIA, V14, P225, DOI 10.1002/glia.440140308; TAUBER H, 1980, NEUROSCI LETT, V16, P235, DOI 10.1016/0304-3940(80)90003-8; Tokumoto YM, 1999, DEV BIOL, V213, P327, DOI 10.1006/dbio.1999.9397; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; WOOD PM, 1990, J NEUROSCI, V10, P3635; Yuan XQ, 2002, J NEUROSCI RES, V70, P529, DOI 10.1002/jnr.10368; Yuan XQ, 1998, DEVELOPMENT, V125, P2901; Zalc B, 2000, NEUROSCIENTIST, V6, P5, DOI 10.1177/107385840000600109; Zimmermann H, 1998, NEUROCHEM INT, V32, P421, DOI 10.1016/S0197-0186(97)00126-5	54	416	429	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 5	2002	36	5					855	868		10.1016/S0896-6273(02)01067-X	http://dx.doi.org/10.1016/S0896-6273(02)01067-X			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	622VL	12467589	Green Accepted, Bronze			2022-12-24	WOS:000179667800010
J	Lee, SH; Liu, LD; Wang, YT; Sheng, M				Lee, SH; Liu, LD; Wang, YT; Sheng, M			Clathrin adaptor AP2 and NSF interact with overlapping sites of GluR2 and play distinct roles in AMPA receptor trafficking and hippocampal LTD	NEURON			English	Article							LONG-TERM DEPRESSION; DOMAIN-CONTAINING PROTEINS; SYNAPTIC TRANSMISSION; ENDOCYTOTIC PATHWAYS; SUBUNIT; NEURONS; PHOSPHORYLATION; PLASTICITY; BINDING; EXPRESSION	Proteins that bind to the cytoplasmic tails of AMPA receptors control receptor trafficking and thus the strength of postsynaptic responses. Here we show that AP2, a clathrin adaptor complex important for endocytosis, associates with a region of GluR2 that overlaps the NSF binding site. Peptides used previously to interfere with NSF binding also antagonize GluR2-AP2 interaction. Using GluR2 mutants and peptide variants that dissociate NSF and AP2 interaction, we find that AP2 is involved specifically in NMDA receptor-induced (but not ligand-dependent) internalization of AMPA receptors, and is essential for hippocampal long-term depression (LTD). NSF function, on the other hand, is needed to maintain synaptic AMPA receptor responses, but is not directly required for NMDA receptor-mediated internalization and LTD.	MIT, Picower Ctr Learning & Memory, RIKEN, Howard Hughes Med Inst,Neurisci Res Ctr, Cambridge, MA 02139 USA; Univ Toronto, Hosp Sick Children, Brain & Behav Program, Toronto, ON M5G 1X8, Canada; Univ British Columbia, Dept Med, Vancouver Hosp & Hlth Sci Ctr, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Brain Res Ctr, Vancouver Hosp & Hlth Sci Ctr, Vancouver, BC V6T 1Z3, Canada	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); RIKEN; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of British Columbia; University of British Columbia	Sheng, M (corresponding author), MIT, Picower Ctr Learning & Memory, RIKEN, Howard Hughes Med Inst,Neurisci Res Ctr, Cambridge, MA 02139 USA.		Wang, Yu Tian/A-4729-2008; Wang, Yu Tian/J-8255-2015; Lee, Sang/R-7518-2019	Sheng, Morgan/0000-0002-8703-5366; Liu, Lidong/0000-0002-7026-690X; Lee, Sang H./0000-0001-5467-0331	NINDS NIH HHS [NS35050] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035050] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AROETI B, 1994, EMBO J, V13, P2297, DOI 10.1002/j.1460-2075.1994.tb06513.x; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Borgdorff AJ, 2002, NATURE, V417, P649, DOI 10.1038/nature00780; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Chapman ER, 1998, J BIOL CHEM, V273, P32966, DOI 10.1074/jbc.273.49.32966; CHEN H, 1997, J BIOL CHEM, V274, P25963; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chung HJ, 2000, J NEUROSCI, V20, P7258; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Dryga SA, 1997, VIROLOGY, V228, P74, DOI 10.1006/viro.1996.8364; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; GALLO V, 1992, J NEUROSCI, V12, P1010; Haucke V, 2000, EMBO J, V19, P6011, DOI 10.1093/emboj/19.22.6011; Hay JC, 1997, CURR OPIN CELL BIOL, V9, P505, DOI 10.1016/S0955-0674(97)80026-9; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Kirchhausen T, 1999, ANNU REV CELL DEV BI, V15, P705, DOI 10.1146/annurev.cellbio.15.1.705; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lee SH, 2001, NEUROPHARMACOLOGY, V41, P680, DOI 10.1016/S0028-3908(01)00124-1; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Matsuda S, 2000, EMBO J, V19, P2765, DOI 10.1093/emboj/19.12.2765; Morishita W, 2001, NEURON, V32, P1133, DOI 10.1016/S0896-6273(01)00554-2; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; NIETHAMMER M, 1999, METHOD ENZYMOL, P102; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Sala C, 2000, J NEUROSCI, V20, P3529, DOI 10.1523/JNEUROSCI.20-10-03529.2000; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; Schweizer FE, 1998, SCIENCE, V279, P1203, DOI 10.1126/science.279.5354.1203; Sheng M, 2000, ANNU REV PHYSIOL, V62, P755, DOI 10.1146/annurev.physiol.62.1.755; Sheng M, 2001, CELL, V105, P825, DOI 10.1016/S0092-8674(01)00406-8; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Slepnev VI, 1998, SCIENCE, V281, P821, DOI 10.1126/science.281.5378.821; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Wan Q, 1997, NATURE, V388, P686, DOI 10.1038/41792; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Wilde A, 1996, J CELL BIOL, V135, P635, DOI 10.1083/jcb.135.3.635; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8	56	317	334	1	22	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 14	2002	36	4					661	674		10.1016/S0896-6273(02)01024-3	http://dx.doi.org/10.1016/S0896-6273(02)01024-3			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	616PX	12441055	Bronze			2022-12-24	WOS:000179313100013
J	Diaz, E; Ge, YC; Yang, YH; Loh, KC; Serafini, TA; Okazaki, Y; Hayashizaki, Y; Speed, TP; Ngai, J; Scheiffele, P				Diaz, E; Ge, YC; Yang, YH; Loh, KC; Serafini, TA; Okazaki, Y; Hayashizaki, Y; Speed, TP; Ngai, J; Scheiffele, P			Molecular analysis of gene expression in the developing pontocerebellar projection system	NEURON			English	Article							CEREBELLAR GRANULE NEURONS; WEAVER MUTANT MICE; PURKINJE-CELLS; MOUSE CEREBELLUM; SONIC HEDGEHOG; STOP SIGNAL; IN-VITRO; DIFFERENTIATION; RECEPTOR; PRECURSORS	As an approach toward understanding the molecular mechanisms of neuronal differentiation, we utilized DNA microarrays to elucidate global patterns of gene expression during pontocerebellar development. Through this analysis, we identified groups of genes specific to neuronal precursor cells, associated with axon outgrowth, and regulated in response to contact with synaptic target cells. In the cerebellum, we identified a phase of granule cell differentiation that is independent of interactions with other cerebellar cell types. Analysis of pontine gene expression revealed that distinct programs of gene expression, correlated with axon outgrowth and synapse formation, can be decoupled and are likely influenced by different cells in the cerebellar target environment. Our approach provides insight into the genetic programs underlying the differentiation of specific cell types in the pontocerebellar projection system.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Funct Genom Lab, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; Riken Genom Sci Ctr, Genome Explorat Res Grp, Kanagawa 2300045, Japan; Walter & Eliza Hall Inst Med Res, Div Genet & Bioinformat, Parkville, Vic 3050, Australia	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; RIKEN; Walter & Eliza Hall Institute	Ngai, J (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.		Hayashizaki, Yoshihide/N-6590-2015; Speed, Terence P/B-8085-2009; Ge, Yongchao/AAG-9317-2021; Yang, Jean YH/D-2920-2015	Speed, Terence P/0000-0002-5403-7998; Ge, Yongchao/0000-0001-6448-5703; Yang, Jean YH/0000-0002-5271-2603; Okazaki, Yasushi/0000-0003-3241-5502				Anderson DJ, 1997, COLD SPRING HARB SYM, V62, P493; ARAKI K, 1993, BIOCHEM BIOPH RES CO, V197, P1267, DOI 10.1006/bbrc.1993.2614; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Bach I, 1997, GENE DEV, V11, P1370, DOI 10.1101/gad.11.11.1370; BAIRD DH, 1992, J NEUROSCI, V12, P619; BAPTISTA CA, 1994, NEURON, V12, P243, DOI 10.1016/0896-6273(94)90268-2; Barth AL, 1997, NEURON, V19, P359, DOI 10.1016/S0896-6273(00)80945-9; BenArie N, 1997, NATURE, V390, P169, DOI 10.1038/36579; BJERREGAARD A, 1994, NEUROCHEM RES, V19, P789, DOI 10.1007/BF00967445; CADDY KWT, 1979, PHILOS T ROY SOC B, V287, P167, DOI 10.1098/rstb.1979.0055; Campagna JA, 1995, NEURON, V15, P1365, DOI 10.1016/0896-6273(95)90014-4; Cantallops I, 2000, NAT NEUROSCI, V3, P1004, DOI 10.1038/79823; Copani A, 2001, TRENDS NEUROSCI, V24, P25, DOI 10.1016/S0166-2236(00)01663-5; Dodds DC, 1997, J BIOL CHEM, V272, P21488, DOI 10.1074/jbc.272.34.21488; Dudoit S, 2002, STAT SINICA, V12, P111; DUMESNILBOUSEZ N, 1992, J NEUROCYTOL, V21, P506, DOI 10.1007/BF01186954; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eisen MB, 1999, METHOD ENZYMOL, V303, P179; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Hatten ME, 1997, CURR OPIN NEUROBIOL, V7, P40, DOI 10.1016/S0959-4388(97)80118-3; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; HATTEN ME, 1986, J NEUROSCI, V6, P2676; Heintz N, 2000, ANNU REV PHYSIOL, V62, P779, DOI 10.1146/annurev.physiol.62.1.779; Hess EJ, 1996, NEURON, V16, P1073, DOI 10.1016/S0896-6273(00)80133-6; Huard JMT, 1999, DEVELOPMENT, V126, P1927; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Jensen P, 1999, J NEUROSCI, V19, P7991; JOHNSON JE, 1990, NATURE, V346, P858, DOI 10.1038/346858a0; KATO K, 1990, J MOL BIOL, V214, P619, DOI 10.1016/0022-2836(90)90276-R; Kenney AM, 2000, MOL CELL BIOL, V20, P9055, DOI 10.1128/MCB.20.23.9055-9067.2000; Kofuji P, 1996, NEURON, V16, P941, DOI 10.1016/S0896-6273(00)80117-8; Lankford K, 1990, CURR OPIN CELL BIOL, V2, P80, DOI 10.1016/S0955-0674(05)80035-3; LEID M, 1992, CELL, V68, P377, DOI 10.1016/0092-8674(92)90478-U; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Matoba R, 2000, GENE, V241, P125, DOI 10.1016/S0378-1119(99)00457-6; Matoba R, 2000, PHYSIOL GENOMICS, V4, P155, DOI 10.1152/physiolgenomics.2000.4.2.155; Migheli A, 1999, AM J PATHOL, V155, P365, DOI 10.1016/S0002-9440(10)65133-4; Miki R, 2001, P NATL ACAD SCI USA, V98, P2199, DOI 10.1073/pnas.041605498; Naeve GS, 1997, P NATL ACAD SCI USA, V94, P2648, DOI 10.1073/pnas.94.6.2648; Nedivi E, 1998, SCIENCE, V281, P1863, DOI 10.1126/science.281.5384.1863; PATIL N, 1995, NAT GENET, V11, P126, DOI 10.1038/ng1095-126; Plunkett JA, 1998, J NEUROSCI, V18, P5832; Pons S, 2001, DEVELOPMENT, V128, P1481; PORTER BE, 1995, NEURON, V14, P549, DOI 10.1016/0896-6273(95)90311-9; Rabacchi SA, 1999, J NEUROSCI, V19, P4437; RAKIC P, 1973, J COMP NEUROL, V152, P133, DOI 10.1002/cne.901520203; RAKIC P, 1973, J COMP NEUROL, V152, P103, DOI 10.1002/cne.901520202; Ross ME, 1996, J NEUROSCI, V16, P210; SALINAS PC, 1994, DEVELOPMENT, V120, P1277; Schacher S, 1999, J NEUROSCI, V19, P6338; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Slesinger PA, 1996, NEURON, V16, P321, DOI 10.1016/S0896-6273(00)80050-1; Solecki DJ, 2001, NEURON, V31, P557, DOI 10.1016/S0896-6273(01)00395-6; SOTELO C, 1990, J EXP BIOL, V153, P225; Sugiura Y, 1995, DEV BRAIN RES, V90, P73, DOI 10.1016/0165-3806(96)83488-2; SWISHER DA, 1977, J COMP NEUROL, V173, P205, DOI 10.1002/cne.901730112; Torii MA, 1999, DEVELOPMENT, V126, P443; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yang YH, 2002, NAT REV GENET, V3, P579, DOI 10.1038/nrg863; YANG YH, 2002, IN PRESS J COMPUT GR; YANG YH, 2001, P SPIE, V4266; Zhao Q, 2002, P NATL ACAD SCI USA, V99, P5704, DOI 10.1073/pnas.082092399; Zuo J, 1997, NATURE, V388, P769, DOI 10.1038/42009	67	75	76	1	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 24	2002	36	3					417	434		10.1016/S0896-6273(02)01016-4	http://dx.doi.org/10.1016/S0896-6273(02)01016-4			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	608ZE	12408845	Bronze			2022-12-24	WOS:000178877700011
J	Miller, S; Yasuda, M; Coats, JK; Jones, Y; Martone, ME; Mayford, M				Miller, S; Yasuda, M; Coats, JK; Jones, Y; Martone, ME; Mayford, M			Disruption of dendritic translation of CaMKII alpha impairs stabilization of synaptic plasticity and memory consolidation	NEURON			English	Article							LONG-TERM POTENTIATION; DEPENDENT PROTEIN-KINASE; POSTSYNAPTIC DENSITY FRACTION; II MUTANT MICE; MESSENGER-RNA; CYTOPLASMIC POLYADENYLATION; HIPPOCAMPAL-NEURONS; RAT-BRAIN; IN-VIVO; SYNAPSES	Local protein translation in dendrites could be a means for delivering synaptic proteins to their sites of action, perhaps in a spatially regulated fashion that could contribute to plasticity. To directly test the functional role of dendritic translation of calcium/calmodulin-dependent protein kinase IIalpha (CaMIKIIalpha) in vivo, we mutated the endogenous gene to disrupt the dendritic localization signal in the mRNA. In this mutant mouse, the protein-coding region of CaMKIIalpha. is intact, but mRNA is restricted to the soma. Removal of dendritic mRNA produced a dramatic reduction of CaMKII(x in postsynaptic densities (PSDs), a reduction in late-phase long-term potentiation (LTP), and impairments in spatial memory, associative fear conditioning, and object recognition memory. These results demonstrate that local translation is important for synaptic delivery of the kinase and that local translation contributes to synaptic and behavioral plasticity.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Inst Childhood & Neglected Dis, La Jolla, CA 92037 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA	Scripps Research Institute; Scripps Research Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Miller, S (corresponding author), Scripps Res Inst, Dept Cell Biol, 10550 N Torrey Pines Rd,ICND 202, La Jolla, CA 92037 USA.	stephanm@scripps.edu		Mayford, Mark/0000-0002-9001-5024				Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; BENNETT MK, 1983, J BIOL CHEM, V258, P2735; Blichenberg A, 2001, EUR J NEUROSCI, V13, P1881, DOI 10.1046/j.0953-816x.2001.01565.x; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Brocke L, 1999, J BIOL CHEM, V274, P22713, DOI 10.1074/jbc.274.32.22713; BURGIN KE, 1990, J NEUROSCI, V10, P1788; CHAPMAN PF, 1995, NEURON, V14, P591, DOI 10.1016/0896-6273(95)90315-1; CHEN C, 1994, SCIENCE, V266, P291, DOI 10.1126/science.7939668; Chen HX, 2001, J NEUROPHYSIOL, V85, P1368, DOI 10.1152/jn.2001.85.4.1368; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Clark RE, 2000, J NEUROSCI, V20, P8853; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Feng TP, 1995, PROG BRAIN RES, V105, P55; Frankland PW, 2001, NATURE, V411, P309, DOI 10.1038/35077089; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; GALLAGHER M, 1993, BEHAV NEUROSCI, V107, P618, DOI 10.1037/0735-7044.107.4.618; Gerlai R, 2001, BEHAV BRAIN RES, V125, P13, DOI 10.1016/S0166-4328(01)00282-0; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hebb Donald O., 1949, ORG BEHAV; Hinds HL, 1998, LEARN MEMORY, V5, P344; Huang YY, 1996, LEARN MEMORY, V3, P74, DOI 10.1101/lm.3.2-3.74; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; HVALBY O, 1994, P NATL ACAD SCI USA, V91, P4761, DOI 10.1073/pnas.91.11.4761; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; KENNEDY MB, 1983, P NATL ACAD SCI-BIOL, V80, P7357, DOI 10.1073/pnas.80.23.7357; Koh YH, 1999, CELL, V98, P353, DOI 10.1016/S0092-8674(00)81964-9; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lisman JE, 2001, NEURON, V31, P191, DOI 10.1016/S0896-6273(01)00364-6; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Mayford M, 1996, P NATL ACAD SCI USA, V93, P13250, DOI 10.1073/pnas.93.23.13250; MCCLELLAND JL, 1994, REV NEUROL, V150, P570; MILLER SG, 1985, J BIOL CHEM, V260, P9039; Mori Y, 2000, NAT NEUROSCI, V3, P1079, DOI 10.1038/80591; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Otmakhov N, 1997, J NEUROSCI, V17, P5357; Ouyang Y, 1999, J NEUROSCI, V19, P7823; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Rongo C, 1999, NATURE, V402, P195, DOI 10.1038/46065; Scheetz AJ, 2000, NAT NEUROSCI, V3, P211, DOI 10.1038/72915; Shen K, 1998, NEURON, V21, P593, DOI 10.1016/S0896-6273(00)80569-3; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; Silva AJ, 1996, CURR BIOL, V6, P1509, DOI 10.1016/S0960-9822(96)00756-7; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Steward O, 1996, J NEUROCYTOL, V25, P717, DOI 10.1007/BF02284837; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Wells DG, 2001, J NEUROSCI, V21, P9541, DOI 10.1523/JNEUROSCI.21-24-09541.2001; WILLOTT JF, 1986, J NEUROPHYSIOL, V56, P391, DOI 10.1152/jn.1986.56.2.391; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3	54	380	395	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 24	2002	36	3					507	519		10.1016/S0896-6273(02)00978-9	http://dx.doi.org/10.1016/S0896-6273(02)00978-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	608ZE	12408852	Bronze			2022-12-24	WOS:000178877700018
J	Koulakov, AA; Raghavachari, S; Kepecs, A; Lisman, JE				Koulakov, AA; Raghavachari, S; Kepecs, A; Lisman, JE			Model for a robust neural integrator	NATURE NEUROSCIENCE			English	Article							OCULOMOTOR SYSTEM; WORKING-MEMORY; PERSISTENT ACTIVITY; EYE-POSITION; PARIETAL CORTEX; HEAD-DIRECTION; NMDA RECEPTORS; NEURONS; NETWORK; CAT	Integrator circuits in the brain show persistent firing that reflects the sum of previous excitatory and inhibitory inputs from external sources. Integrator circuits have been implicated in parametric working memory, decision making and motor control. Previous work has shown that stable integrator function can be achieved by an excitatory recurrent neural circuit, provided synaptic strengths are tuned with extreme precision (better than 1% accuracy). Here we show that integrator circuits can function without fine tuning if the neuronal units have bistable properties. Two specific mechanisms of bistability are analyzed, one based on local recurrent excitation, and the other on the voltage-dependence of the NMDA (N-methyl-D-aspartate) channel. Neither circuit requires fine tuning to perform robust integration, and the latter actually exploits the variability of neuronal conductances.	Salk Inst Biol Studies, La Jolla, CA 92037 USA; Univ Utah, Dept Phys, Salt Lake City, UT 84112 USA; Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02454 USA	Salk Institute; Utah System of Higher Education; University of Utah; Brandeis University	Koulakov, AA (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.			Kepecs, Adam/0000-0003-0049-8120	PHS HHS [461434] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Aksay E, 2000, J NEUROPHYSIOL, V84, P1035, DOI 10.1152/jn.2000.84.2.1035; Aksay E, 2001, NAT NEUROSCI, V4, P184, DOI 10.1038/84023; ARNOLD DB, 1991, BIOL CYBERN, V64, P447, DOI 10.1007/BF00202608; BLAIR HT, 1995, J NEUROSCI, V15, P6260; CANNON SC, 1983, BIOL CYBERN, V49, P127, DOI 10.1007/BF00320393; CIMINO A, 1990, FEBS LETT, V263, P199, DOI 10.1016/0014-5793(90)81373-V; DeSouza JFX, 2000, J NEUROSCI, V20, P5835, DOI 10.1523/JNEUROSCI.20-15-05835.2000; FUKUSHIMA K, 1992, PROG NEUROBIOL, V39, P609, DOI 10.1016/0301-0082(92)90016-8; Fuster JM, 1995, MEMORY CEREBRAL CORT; GNADT JW, 1988, EXP BRAIN RES, V70, P216; GODAUX E, 1990, NEUROSCI LETT, V116, P162, DOI 10.1016/0304-3940(90)90403-V; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; KEPECS A, 2002, ADV NEURAL INFORMATI, V14; Koulakov AA, 2001, NETWORK-COMP NEURAL, V12, P47, DOI 10.1088/0954-898X/12/1/304; LISMAN JE, 1985, P NATL ACAD SCI USA, V82, P3055, DOI 10.1073/pnas.82.9.3055; Lisman JE, 1998, NAT NEUROSCI, V1, P273, DOI 10.1038/1086; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; McAdams HH, 1998, ANNU REV BIOPH BIOM, V27, P199, DOI 10.1146/annurev.biophys.27.1.199; METTENS P, 1994, NEUROREPORT, V5, P1333, DOI 10.1097/00001756-199406270-00009; MIYASHITA Y, 1988, NATURE, V331, P68, DOI 10.1038/331068a0; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Petersen CCH, 1998, P NATL ACAD SCI USA, V95, P4732, DOI 10.1073/pnas.95.8.4732; Pinsky P F, 1994, J Comput Neurosci, V1, P39, DOI 10.1007/BF00962717; Priesol AJ, 2000, BRAIN RES, V857, P252, DOI 10.1016/S0006-8993(99)02441-5; ROBINSON DA, 1989, ANNU REV NEUROSCI, V12, P33, DOI 10.1146/annurev.neuro.12.1.33; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; Schiller J, 2001, CURR OPIN NEUROBIOL, V11, P343, DOI 10.1016/S0959-4388(00)00217-8; SEGEL LA, 1995, IMMUNOL TODAY, V16, P80, DOI 10.1016/0167-5699(95)80093-X; Seung HS, 2000, J COMPUT NEUROSCI, V9, P171, DOI 10.1023/A:1008971908649; Seung HS, 1996, P NATL ACAD SCI USA, V93, P13339, DOI 10.1073/pnas.93.23.13339; Seung HS, 2000, NEURON, V26, P259, DOI 10.1016/S0896-6273(00)81155-1; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; TAUBE JS, 1990, J NEUROSCI, V10, P420; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; Wang XJ, 1999, J NEUROSCI, V19, P9587; WILSON HR, 1972, BIOPHYS J, V12, P1, DOI 10.1016/S0006-3495(72)86068-5	38	212	215	1	19	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2002	5	8					775	782		10.1038/nn893	http://dx.doi.org/10.1038/nn893			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	577XT	12134153				2022-12-24	WOS:000177088900021
J	Noesselt, T; Hillyard, SA; Woldorff, MG; Schoenfeld, A; Hagner, T; Jancke, L; Tempelmann, C; Hinrichs, H; Heinze, HJ				Noesselt, T; Hillyard, SA; Woldorff, MG; Schoenfeld, A; Hagner, T; Jancke, L; Tempelmann, C; Hinrichs, H; Heinze, HJ			Delayed striate cortical activation during spatial attention	NEURON			English	Article							PRIMARY VISUAL-CORTEX; BILATERAL STIMULUS ARRAYS; INDEX FOCUSED ATTENTION; SELECTIVE ATTENTION; RETINOTOPIC ORGANIZATION; EXPERIMENTAL-DESIGNS; BRAIN ACTIVITY; AREAS V1; EXTRASTRIATE; POTENTIALS	Recordings of event-related potentials (ERPs) and event-related magnetic fields (ERMFs) were combined with functional magnetic resonance imaging (fMRI) to study visual cortical activity in humans during spatial attention. While subjects attended selectively to stimulus arrays in one visual field, fMRI revealed stimulus-related activations in the contralateral primary visual cortex and in multiple extrastriate areas. ERP and ERMF recordings showed that attention did not affect the initial evoked response at 60-90 ms poststimulus that was localized to primary cortex, but a similarly localized late response at 140-250 ms was enhanced to attended stimuli. These findings provide evidence that the primary visual cortex participates in the selective processing of attended stimuli by means of delayed feedback from higher visual-cortical areas.	Otto von Guericke Univ, Dept Neurol 2, D-39120 Magdeburg, Germany; Otto von Guericke Univ, Inst Gen Psychol, D-39120 Magdeburg, Germany; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Duke Univ, Ctr Cognit Neurosci, Durham, NC 27708 USA; Duke Univ, Dept Psychol & Brain Sci, Durham, NC 27708 USA	Otto von Guericke University; Otto von Guericke University; University of California System; University of California San Diego; Duke University; Duke University	Noesselt, T (corresponding author), Otto von Guericke Univ, Dept Neurol 2, D-39120 Magdeburg, Germany.	toemme@neuro2.med.uni-magdeburg.de	Jäncke, Lutz/C-3792-2009; Jancke, Lutz/D-2910-2013	Jäncke, Lutz/0000-0002-8115-4890; Schoenfeld, Mircea Ariel/0000-0001-9003-4092; Tempelmann, Claus/0000-0001-8570-4960; Jancke, Lutz/0000-0003-2110-9067; Noesselt, Toemme/0000-0002-9611-9713; Woldorff, Marty/0000-0002-2683-4551	NIMH NIH HHS [MH-25594] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH025594, R01MH025594] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aine C J, 1995, Int J Neurosci, V80, P79, DOI 10.3109/00207459508986095; Aine CJ, 1996, CEREB CORTEX, V6, P354, DOI 10.1093/cercor/6.3.354; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; Burock MA, 1998, NEUROREPORT, V9, P3735, DOI 10.1097/00001756-199811160-00030; Burock MA, 2000, HUM BRAIN MAPP, V11, P249, DOI 10.1002/1097-0193(200012)11:4<249::AID-HBM20>3.3.CO;2-X; Clark V.P., 1994, HUMAN BRAIN MAPPING, V2, P170, DOI [10.1002/hbm.460020306, DOI 10.1002/HBM.460020306]; Clark VP, 1996, J COGNITIVE NEUROSCI, V8, P387, DOI 10.1162/jocn.1996.8.5.387; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; Desimone R, 1998, PHILOS T R SOC B, V353, P1245, DOI 10.1098/rstb.1998.0280; Di Russo F, 2002, HUM BRAIN MAPP, V15, P95, DOI 10.1002/hbm.10010; Fuchs M, 1999, J CLIN NEUROPHYSIOL, V16, P267, DOI 10.1097/00004691-199905000-00006; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; Gratton G, 1997, NEUROREPORT, V8, P1749, DOI 10.1097/00001756-199705060-00036; HEINZE HJ, 1990, ELECTROEN CLIN NEURO, V75, P511, DOI 10.1016/0013-4694(90)90138-A; HEINZE HJ, 1994, NATURE, V372, P543, DOI 10.1038/372543a0; Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781; Hinrichs H, 2000, J COGNITIVE NEUROSCI, V12, P76, DOI 10.1162/089892900564082; Ilmoniemi R J, 1993, Brain Topogr, V5, P331, DOI 10.1007/BF01128686; Ito M, 1999, NEURON, V22, P593, DOI 10.1016/S0896-6273(00)80713-8; Josephs O, 1999, PHILOS T R SOC B, V354, P1215, DOI 10.1098/rstb.1999.0475; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; LAMME VAF, 2000, NEW COGNITIVE NEUROS, P279; Lange JJ, 1998, BIOL PSYCHOL, V48, P153, DOI 10.1016/S0301-0511(98)00011-8; LUCK SJ, 1990, ELECTROEN CLIN NEURO, V75, P528, DOI 10.1016/0013-4694(90)90139-B; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Mangun GR, 1997, HUM BRAIN MAPP, V5, P273, DOI 10.1002/(SICI)1097-0193(1997)5:4<273::AID-HBM12>3.0.CO;2-F; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; Martinez A, 2001, VISION RES, V41, P1437, DOI 10.1016/S0042-6989(00)00267-4; Maunsell J., 2000, NEW COGNITIVE NEUROS, P315; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; Mehta SD, 2000, CEREB CORTEX, V10, P343, DOI 10.1093/cercor/10.4.343; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Poline JB, 1997, NEUROIMAGE, V5, P83, DOI 10.1006/nimg.1996.0248; Posner MI, 1999, P NATL ACAD SCI USA, V96, P2585, DOI 10.1073/pnas.96.6.2585; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; Robinson SE, 1989, ADV BIOMAGNETISM, P721, DOI [10.1007/978-1-4613-0581-1_162, DOI 10.1007/978-1-4613-0581-1_162]; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Sengpiel F, 1999, CURR BIOL, V9, pR318, DOI 10.1016/S0960-9822(99)80202-4; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; Super H, 2001, NAT NEUROSCI, V4, P304, DOI 10.1038/85170; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; Tootell RBH, 1997, J NEUROSCI, V17, P7060; Vidyasagar TR, 1998, NEUROREPORT, V9, P1947, DOI 10.1097/00001756-199806220-00006; Vidyasagar TR, 1999, BRAIN RES REV, V30, P66, DOI 10.1016/S0165-0173(99)00005-3; Wijers AA, 1997, PSYCHOPHYSIOLOGY, V34, P553, DOI 10.1111/j.1469-8986.1997.tb01742.x; Woldorff MG, 1997, HUM BRAIN MAPP, V5, P280, DOI 10.1002/(SICI)1097-0193(1997)5:4<280::AID-HBM13>3.0.CO;2-I; WOLDORFF MG, 1993, PSYCHOPHYSIOLOGY, V30, P98, DOI 10.1111/j.1469-8986.1993.tb03209.x	49	214	224	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 1	2002	35	3					575	587		10.1016/S0896-6273(02)00781-X	http://dx.doi.org/10.1016/S0896-6273(02)00781-X			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	582CB	12165478	Bronze			2022-12-24	WOS:000177331200017
J	Formisano, E; Linden, DEJ; Di Salle, F; Trojano, L; Esposito, F; Sack, AT; Grossi, D; Zanella, FE; Goebel, R				Formisano, E; Linden, DEJ; Di Salle, F; Trojano, L; Esposito, F; Sack, AT; Grossi, D; Zanella, FE; Goebel, R			Tracking the mind's image in the brain I: Time-resolved fMRI during visuospatila mental imagery	NEURON			English	Article							CORTICAL ACTIVATION; FUNCTIONAL-ANATOMY; TARGET DETECTION; VISUAL-IMAGERY; ATTENTION; NEUROPSYCHOLOGY; GENERATION; NETWORKS; ROTATION	Mental imagery, the generation and manipulation of mental representations in the absence of sensory stimulation, is a core element of numerous cognitive processes. We investigate the cortical mechanisms underlying imagery and spatial analysis in the visual domain using event-related functional magnetic resonance imaging during the mental clock task. The time-resolved analysis of cortical activation from auditory perception to motor response reveals a sequential activation of the left and right posterior parietal cortex, suggesting that these regions perform distinct functions in this imagery task. This is confirmed by a trial-by-trial analysis of correlations between reaction time and onset, width, and amplitude of the hemodynamic response. These findings pose neurophysiological constraints on cognitive models of mental imagery.	Univ Maastricht, Fac Psychol, Dept Cognit Neurosci, NL-6200 MD Maastricht, Netherlands; Max Planck Inst Hirnforsch, D-60528 Frankfurt, Germany; Univ Frankfurt Klinikum, Dept Psychiat, Lab Neuroimaging & Neurophysiol, D-60590 Frankfurt, Germany; Univ Frankfurt Klinikum, Dept Neuroradiol, D-60590 Frankfurt, Germany; Salvatore Maugeri Fdn, IRCCS, Ctr Telese, Loc S Stefano Lanterria, I-82037 Telese Terme, BN, Italy; Univ Naples 2, Inst Neurol Sci, I-80138 Naples, Italy; Univ Naples 2, Dept Psychol, Caserta, Italy; Univ Naples Federico II, Nuovo Policlin, Dept Neuroradiol, I-80131 Naples, Italy	Maastricht University; Max Planck Society; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Istituti Clinici Scientifici Maugeri IRCCS; Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; University of Naples Federico II	Goebel, R (corresponding author), Univ Maastricht, Fac Psychol, Dept Cognit Neurosci, Postbus 616, NL-6200 MD Maastricht, Netherlands.	r.goebel@psychology.unimaas.nl	Linden, David/S-9948-2019; Linden, David E J/C-7355-2013; Trojano, Luigi/F-2396-2016; Esposito, Fabrizio/M-8555-2015	Linden, David/0000-0002-5638-9292; Linden, David E J/0000-0002-5638-9292; Trojano, Luigi/0000-0002-0328-9642; Esposito, Fabrizio/0000-0002-5099-9786; Di Salle, Francesco/0000-0002-0226-8460; Goebel, Rainer/0000-0003-1780-2467; Sack, Alexander/0000-0002-1471-0885; Formisano, Elia/0000-0001-5008-2460				Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Chee MWL, 1999, HUM BRAIN MAPP, V7, P15, DOI 10.1002/(SICI)1097-0193(1999)7:1<15::AID-HBM2>3.3.CO;2-Y; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Cohen MS, 1996, BRAIN, V119, P89, DOI 10.1093/brain/119.1.89; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Culham JC, 2001, CURR OPIN NEUROBIOL, V11, P157, DOI 10.1016/S0959-4388(00)00191-4; Dierks T, 1999, NEURON, V22, P615, DOI 10.1016/S0896-6273(00)80715-1; FARAH MJ, 1988, BRAIN COGNITION, V8, P147, DOI 10.1016/0278-2626(88)90046-2; FARAH MJ, 1995, NEUROPSYCHOLOGIA, V33, P1455, DOI 10.1016/0028-3932(95)00075-E; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Goebel R, 1998, NEUROREPORT, V9, P713, DOI 10.1097/00001756-199803090-00028; Goebel R, 2001, VISION RES, V41, P1459, DOI 10.1016/S0042-6989(01)00069-4; GROSSI D, 1989, BRAIN COGNITION, V10, P18, DOI 10.1016/0278-2626(89)90072-9; HILLYARD SA, 1993, CURR OPIN NEUROBIOL, V3, P217, DOI 10.1016/0959-4388(93)90213-I; Kanwisher N, 2000, NAT REV NEUROSCI, V1, P91, DOI 10.1038/35039043; Knauff M, 2000, NEUROREPORT, V11, P3957, DOI 10.1097/00001756-200012180-00011; Kosslyn S.M., 1994, IMAGE BRAIN RESOLUTI; KOSSLYN SM, 1995, NEUROPSYCHOLOGIA, V33, P1485, DOI 10.1016/0028-3932(95)00077-G; Kosslyn SM, 1997, NEUROIMAGE, V6, P320, DOI 10.1006/nimg.1997.0295; Kriegeskorte N, 2001, NEUROIMAGE, V14, P329, DOI 10.1006/nimg.2001.0831; LaBar KS, 1999, NEUROIMAGE, V10, P695, DOI 10.1006/nimg.1999.0503; Linden DEJ, 1999, CEREB CORTEX, V9, P815, DOI 10.1093/cercor/9.8.815; Mellet E, 2000, J COGNITIVE NEUROSCI, V12, P98, DOI 10.1162/08989290051137620; Menon RS, 1998, P NATL ACAD SCI USA, V95, P10902, DOI 10.1073/pnas.95.18.10902; Menon RS, 1999, TRENDS COGN SCI, V3, P207, DOI 10.1016/S1364-6613(99)01329-7; MUNK MHJ, 2002, IN PRESS CEREB CORTE; PAIVIO A, 1978, J EXP PSYCHOL HUMAN, V4, P61, DOI 10.1037/0096-1523.4.1.61; Posner M.I., 1978, CHRONOMETRIC EXPLORA; Raij T, 1999, J COGNITIVE NEUROSCI, V11, P282, DOI 10.1162/089892999563391; RENAULT B, 1982, SCIENCE, V215, P1413, DOI 10.1126/science.7063853; Richter W, 2000, J COGNITIVE NEUROSCI, V12, P310, DOI 10.1162/089892900562129; Rowe JB, 2000, SCIENCE, V288, P1656, DOI 10.1126/science.288.5471.1656; Sack AT, 2002, NEURON, V35, P195, DOI 10.1016/S0896-6273(02)00745-6; SERGENT J, 1990, BRAIN COGNITION, V13, P98, DOI 10.1016/0278-2626(90)90043-N; Shepard RN., 1982, J HIST BEHAV SCI, V19, P301, DOI 10.2307/1422825; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; STANGALINO C, 1995, NEUROPSYCHOLOGIA, V33, P1473, DOI 10.1016/0028-3932(95)00076-F; Talairach J., 1988, COPLANAR STEREOTAXIC; TROJANO L, 1994, BRAIN COGNITION, V24, P213, DOI 10.1006/brcg.1994.1012; Trojano L, 2000, CEREB CORTEX, V10, P473, DOI 10.1093/cercor/10.5.473; Wojciulik E, 1999, NEURON, V23, P747, DOI 10.1016/S0896-6273(01)80033-7	42	186	188	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 3	2002	35	1					185	194		10.1016/S0896-6273(02)00747-X	http://dx.doi.org/10.1016/S0896-6273(02)00747-X			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	569KP	12123618	Green Published, Bronze			2022-12-24	WOS:000176601800020
J	Li, Z; Aizenman, CD; Cline, HT				Li, Z; Aizenman, CD; Cline, HT			Regulation of rho GTPases by crosstalk and neuronal activity in vivo	NEURON			English	Article							WISKOTT-ALDRICH SYNDROME; BINDING PROTEIN-RHO; IN-VIVO; SERINE/THREONINE KINASE; DENDRITIC SPINES; AXON OUTGROWTH; FAMILY GTPASES; RAC; CDC42; GROWTH	Proper development of neurons depends on synaptic activity, but the mechanisms of activity-dependent neuronal growth are not well understood. The small GTPases, RhoA, Rac, and Cdc42, regulate neuronal morphogenesis by controlling the assembly and stability of the actin cytoskeleton. We report an in situ method to determine endogenous Rho GTPase activity In intact Xenopus brain. We use this method to provide evidence for crosstalk between Rho GTPases in optic tectal cells. Moreover, crosstalk between the Rho GTPases appears to affect dendritic arbor development in vivo. Finally, we demonstrate that optic nerve stimulation regulates Rho GTPase activity in a glutamate receptor-dependent manner. These data suggest a link between glutamate receptor function, Rho GTPase activity, and dendritic arbor growth in the intact animal.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Cline, HT (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.		Li, Zheng/I-8016-2014	Li, Zheng/0000-0002-2978-2531				Aspenstrom P, 1996, CURR BIOL, V6, P70, DOI 10.1016/S0960-9822(02)00423-2; BAGRODIA S, 1995, J BIOL CHEM, V270, P22731, DOI 10.1074/jbc.270.39.22731; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bito H, 2000, NEURON, V26, P431, DOI 10.1016/S0896-6273(00)81175-7; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; CLINE HT, 1999, IMAGING LAB MANUAL; Dickson BJ, 2001, CURR OPIN NEUROBIOL, V11, P103, DOI 10.1016/S0959-4388(00)00180-X; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Foa L, 2001, NAT NEUROSCI, V4, P499, DOI 10.1038/87447; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hirose M, 1998, J CELL BIOL, V141, P1625, DOI 10.1083/jcb.141.7.1625; Ho YD, 1999, J BIOL CHEM, V274, P464, DOI 10.1074/jbc.274.1.464; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; Kim SH, 2000, J BIOL CHEM, V275, P36999, DOI 10.1074/jbc.M003430200; Kjoller L, 1999, EXP CELL RES, V253, P166, DOI 10.1006/excr.1999.4674; Kolluri R, 1996, P NATL ACAD SCI USA, V93, P5615, DOI 10.1073/pnas.93.11.5615; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; LEUNG T, 1995, J BIOL CHEM, V270, P29051, DOI 10.1074/jbc.270.49.29051; Li Z, 2000, NAT NEUROSCI, V3, P217, DOI 10.1038/72920; Liu BP, 2000, MOL CELL BIOL, V20, P7160, DOI 10.1128/MCB.20.19.7160-7169.2000; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Luo LQ, 1996, PERSPECT DEV NEUROBI, V4, P199; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Moore K D, 1999, Health Forum J, V42, P22; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Rajan I, 1998, J NEUROSCI, V18, P7836; Reid T, 1996, J BIOL CHEM, V271, P13556, DOI 10.1074/jbc.271.23.13556; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ruchhoeft ML, 1999, J NEUROSCI, V19, P8454; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; VAN AL, 1997, GENE DEV, V11, P2295; vanLeeuwen FN, 1997, J CELL BIOL, V139, P797, DOI 10.1083/jcb.139.3.797; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Wong WT, 2000, J NEUROSCI, V20, P5024; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222; Yamaguchi Y, 2001, J BIOL CHEM, V276, P18977, DOI 10.1074/jbc.M100254200; Yamashita T, 1999, NEURON, V24, P585, DOI 10.1016/S0896-6273(00)81114-9	50	179	182	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 28	2002	33	5					741	750		10.1016/S0896-6273(02)00621-9	http://dx.doi.org/10.1016/S0896-6273(02)00621-9			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	529EC	11879651	Bronze			2022-12-24	WOS:000174286200010
J	Spehr, M; Wetzel, CH; Hatt, H; Ache, BW				Spehr, M; Wetzel, CH; Hatt, H; Ache, BW			3-Phosphoinositides modulate cyclic nucleotide signaling in olfactory receptor neurons	NEURON			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; PLASMA-MEMBRANE; PHOSPHOINOSITIDE 3-KINASE; RESPONSE PROPERTIES; RAT; TRANSDUCTION; CHANNELS; EXPRESSION; ODORANTS; BETA	Phosphatidylinositol 3-kinase (PI3K)-dependent phosphoinositide signaling has been implicated in diverse cellular systems coupled to receptors for many different ligands, but the extent to which it functions in sensory transduction is yet to be determined. We now report that blocking PI3K activity increases odorant-evoked, cyclic nucleotide-dependent elevation of [Ca2+](i) in acutely dissociated rat olfactory receptor neurons and does so in an odorant-specific manner. These findings imply that 3-phosphoinositide signaling acts in vertebrate olfactory transduction to inhibit cyclic nucleotide-dependent excitation of the cells and that the interaction of the two signaling pathways is important in odorant coding, indicating that 3-phosphoinositide signaling can play a role in sensory transduction.	Univ Florida, Ctr Smell & Taste, Dept Zool, Whitney Lab, Gainesville, FL 32610 USA; Univ Florida, Ctr Smell & Taste, Dept Neurosci, Whitney Lab, Gainesville, FL 32610 USA; Univ Florida, McKnight Brain Inst, Gainesville, FL 32610 USA; Ruhr Univ Bochum, Dept Cell Physiol, D-44780 Bochum, Germany	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Ruhr University Bochum	Ache, BW (corresponding author), Univ Florida, Ctr Smell & Taste, Dept Zool, Whitney Lab, Gainesville, FL 32610 USA.	bwa@whitney.ufl.edu	Wetzel, Christian/F-1366-2018; Spehr, Marc/AAK-3162-2021; Spehr, Marc/B-3140-2011; Wetzel, Christian H/N-9880-2017; Wetzel, Christian/C-2501-2009	Spehr, Marc/0000-0001-6616-4196; Spehr, Marc/0000-0001-6616-4196; Wetzel, Christian H/0000-0002-5762-0003; Wetzel, Christian/0000-0002-5762-0003	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001655] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC01655] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ACHE BW, 1995, CURR OPIN NEUROBIOL, V5, P461, DOI 10.1016/0959-4388(95)80006-9; Araneda RC, 2000, NAT NEUROSCI, V3, P1248, DOI 10.1038/81774; Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; Bozza TC, 1998, J NEUROSCI, V18, P4560; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; Chen S, 2000, J NEUROPHYSIOL, V84, P575, DOI 10.1152/jn.2000.84.1.575; CUNNINGHAM AM, 1993, NEUROSCIENCE, V57, P339, DOI 10.1016/0306-4522(93)90067-P; Duchamp-Viret P, 1999, SCIENCE, V284, P2171, DOI 10.1126/science.284.5423.2171; FADOOL DA, 1992, NEURON, V9, P907, DOI 10.1016/0896-6273(92)90243-7; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; FULLE HJ, 1995, P NATL ACAD SCI USA, V92, P3571, DOI 10.1073/pnas.92.8.3571; Gold GH, 1999, ANNU REV PHYSIOL, V61, P857, DOI 10.1146/annurev.physiol.61.1.857; Gomez G, 2000, NEUROSCIENCE, V98, P181, DOI 10.1016/S0306-4522(00)00112-3; GUELLAEN G, 1977, BIOCHIM BIOPHYS ACTA, V484, P465, DOI 10.1016/0005-2744(77)90102-4; HAWKINS PT, 1992, NATURE, V358, P157, DOI 10.1038/358157a0; Jiang T, 1998, J BIOL CHEM, V273, P11017, DOI 10.1074/jbc.273.18.11017; KAPELLER R, 1994, BIOESSAYS, V16, P565, DOI 10.1002/bies.950160810; KURAHASHI T, 1994, SCIENCE, V265, P118, DOI 10.1126/science.8016645; LeindersZufall T, 1997, J NEUROSCI, V17, P4136; Lischka FW, 1999, BIOPHYS J, V76, P1410, DOI 10.1016/S0006-3495(99)77302-9; Maier U, 1999, J BIOL CHEM, V274, P29311, DOI 10.1074/jbc.274.41.29311; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; MORALES B, 2000, BIOL RES, V29, P333; Munger SD, 2000, J BIOL CHEM, V275, P20450, DOI 10.1074/jbc.M001989200; Noe J, 1998, J NEUROCHEM, V71, P2286; OKADA Y, 1994, J NEUROPHYSIOL, V71, P595, DOI 10.1152/jn.1994.71.2.595; Rawson NE, 2000, J NEUROCHEM, V75, P185, DOI 10.1046/j.1471-4159.2000.0750185.x; SANHUEZA M, 2000, AM J PHYSIOL, V279, P31; Schandar M, 1998, J BIOL CHEM, V273, P16669, DOI 10.1074/jbc.273.27.16669; Schild D, 1998, PHYSIOL REV, V78, P429, DOI 10.1152/physrev.1998.78.2.429; Serizawa S, 2000, NAT NEUROSCI, V3, P687, DOI 10.1038/76641; Tang XW, 1997, J BIOL CHEM, V272, P14193, DOI 10.1074/jbc.272.22.14193; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; Vargas G, 1999, CHEM SENSES, V24, P211, DOI 10.1093/chemse/24.2.211; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Vogl A, 2000, EUR J BIOCHEM, V267, P4529, DOI 10.1046/j.1432-1327.2000.01503.x; Wetzel CH, 1999, J NEUROSCI, V19, P7426, DOI 10.1523/JNEUROSCI.19-17-07426.1999; Wymann MP, 1996, MOL CELL BIOL, V16, P1722; Yang F, 2001, NAT NEUROSCI, V4, P19, DOI 10.1038/82858; YULE DI, 1992, J BIOL CHEM, V267, P13830; Zhainazarov AB, 2001, J NEUROPHYSIOL, V85, P2537, DOI 10.1152/jn.2001.85.6.2537; Zhang XL, 1998, SEMIN CELL DEV BIOL, V9, P153, DOI 10.1006/scdb.1997.0220; Zhao H, 2001, CHEM SENSES, V26, P1110; Zufall F, 2000, J NEUROPHYSIOL, V83, P501, DOI 10.1152/jn.2000.83.1.501	44	93	95	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 28	2002	33	5					731	739		10.1016/S0896-6273(02)00610-4	http://dx.doi.org/10.1016/S0896-6273(02)00610-4			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	529EC	11879650	Bronze			2022-12-24	WOS:000174286200009
J	Azouz, R; Gray, CM				Azouz, R; Gray, CM			Adaptive coincidence detection and dynamic gain control in visual cortical neurons in vivo	NEURON			English	Article							ORIENTATION SELECTIVITY; POSTSYNAPTIC POTENTIALS; NEOCORTICAL NEURONS; FEATURE INTEGRATION; PYRAMIDAL CELLS; CAT; OSCILLATIONS; THRESHOLD; SPIKING; CORTEX	Several theories have proposed a functional role for response synchronization in sensory perception. Critics of these theories have argued that selective synchronization is physiologically implausible when cortical networks operate at high levels of activity. Using intracellular recordings from visual cortex in vivo, in combination with numerical simulations, we find dynamic changes in spike threshold that reduce cellular sensitivity to slow depolarizations and concurrently increase the relative sensitivity to rapid depolarizations. Consistent with this, we find that spike activity and high-frequency fluctuations in membrane potential are closely correlated and that both are more tightly tuned for stimulus orientation than the mean membrane potential. These findings suggest that under high-input conditions the spike-generating mechanism adaptively enhances the sensitivity to synchronous inputs while simultaneously decreasing the sensitivity to temporally uncorrelated inputs.	Montana State Univ, Ctr Computat Biol, Bozeman, MT 59717 USA; Montana State Univ, Dept Cell Biol & Neurosci, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Gray, CM (corresponding author), Montana State Univ, Ctr Computat Biol, Bozeman, MT 59717 USA.	cmgray@nervana.montana.edu						Abeles M., 1982, LOCAL CORTICAL CIRCU; ALBRECHT DG, 1982, J NEUROPHYSIOL, V48, P217, DOI 10.1152/jn.1982.48.1.217; Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; ANDERSEN P, 1987, J PHYSIOL-LONDON, V383, P509; Anderson J, 2000, NAT NEUROSCI, V3, P617, DOI 10.1038/75797; Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; Azouz R, 2000, P NATL ACAD SCI USA, V97, P8110, DOI 10.1073/pnas.130200797; Azouz R, 1999, J NEUROSCI, V19, P2209; Azouz R, 1997, CEREB CORTEX, V7, P534, DOI 10.1093/cercor/7.6.534; BELLUZZI O, 1991, PROG BIOPHYS MOL BIO, V55, P1, DOI 10.1016/0079-6107(91)90009-H; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; BRINGUIER V, 1996, J PHYSL, V500, P751; BUZSAKI G, 1995, CURR OPIN NEUROBIOL, V5, P504, DOI 10.1016/0959-4388(95)80012-3; Cantrell AR, 2001, NAT REV NEUROSCI, V2, P397, DOI 10.1038/35077553; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Carandini M, 1996, J NEUROPHYSIOL, V76, P3425, DOI 10.1152/jn.1996.76.5.3425; Carr DB, 2002, J NEUROSCI, V22, P6846; Destexhe A, 1999, J NEUROPHYSIOL, V81, P1531, DOI 10.1152/jn.1999.81.4.1531; Diesmann M, 1999, NATURE, V402, P529, DOI 10.1038/990101; Fleidervish IA, 1996, J PHYSIOL-LONDON, V493, P83, DOI 10.1113/jphysiol.1996.sp021366; Fricker D, 1999, J PHYSIOL-LONDON, V517, P791, DOI 10.1111/j.1469-7793.1999.0791s.x; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Gray C M, 1994, J Comput Neurosci, V1, P11, DOI 10.1007/BF00962716; Gray CM, 1999, NEURON, V24, P31, DOI 10.1016/S0896-6273(00)80820-X; Gray CM, 1996, SCIENCE, V274, P109, DOI 10.1126/science.274.5284.109; GRAY CM, 1990, EUR J NEUROSCI, V2, P607, DOI 10.1111/j.1460-9568.1990.tb00450.x; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; Hamill OP, 1991, CEREB CORTEX, V1, P48, DOI 10.1093/cercor/1.1.48; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Henze DA, 2001, NEUROSCIENCE, V105, P121, DOI 10.1016/S0306-4522(01)00167-1; HINES M, 1989, INT J BIOMED COMPUT, V24, P55, DOI 10.1016/0020-7101(89)90007-X; Hirsch JA, 1998, J NEUROSCI, V18, P9517; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P497, DOI 10.1113/jphysiol.1952.sp004719; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HUGUENARD JR, 1988, J NEUROPHYSIOL, V59, P778, DOI 10.1152/jn.1988.59.3.778; JAGADEESH B, 1992, SCIENCE, V257, P552, DOI 10.1126/science.1636094; Margulis M, 1998, J NEUROPHYSIOL, V79, P2809, DOI 10.1152/jn.1998.79.5.2809; MILNER PM, 1974, PSYCHOL REV, V81, P521, DOI 10.1037/h0037149; NELSON S, 1994, SCIENCE, V265, P774, DOI 10.1126/science.8047882; NOBLE D, 1966, PHYSIOL REV, V46, P1; Nowak LG, 1997, CEREB CORTEX, V7, P487, DOI 10.1093/cercor/7.6.487; Pare D, 1998, J NEUROPHYSIOL, V79, P1450, DOI 10.1152/jn.1998.79.3.1450; PEI X, 1994, J NEUROSCI, V14, P7130; SCHWINDT PC, 1995, J NEUROPHYSIOL, V74, P2220, DOI 10.1152/jn.1995.74.5.2220; Shadlen MN, 1999, NEURON, V24, P67, DOI 10.1016/S0896-6273(00)80822-3; Shadlen MN, 1998, J NEUROSCI, V18, P3870; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; Steinmetz PN, 2000, NATURE, V404, P187, DOI 10.1038/35004588; STUART G, 1995, NEURON, V15, P1065, DOI 10.1016/0896-6273(95)90095-0; Usrey WM, 1999, ANNU REV PHYSIOL, V61, P435, DOI 10.1146/annurev.physiol.61.1.435; Volgushev M, 2000, EUR J NEUROSCI, V12, P257, DOI 10.1046/j.1460-9568.2000.00909.x; von der Malsburg C, 1981, CORRELATION THEORY B; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0	55	206	207	3	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 6	2003	37	3					513	523		10.1016/S0896-6273(02)01186-8	http://dx.doi.org/10.1016/S0896-6273(02)01186-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	647FF	12575957	Bronze			2022-12-24	WOS:000181081600015
J	L'Etoile, ND; Coburn, CM; Eastham, J; Kistler, A; Gallegos, G; Bargmann, CI				L'Etoile, ND; Coburn, CM; Eastham, J; Kistler, A; Gallegos, G; Bargmann, CI			The cyclic GMP-dependent protein kinase EGL-4 regulates olfactory adaptation in C-elegans	NEURON			English	Article							NUCLEOTIDE-GATED CHANNEL; NEMATODE CAENORHABDITIS-ELEGANS; ODOR ADAPTATION; CHEMOSENSORY RECEPTORS; CHEMORECEPTOR GENES; SIGNALING COMPLEX; NEURONS; EXPRESSION; DISCRIMINATION; IDENTIFICATION	Prolonged odor exposure causes a specific, reversible adaptation of olfactory responses. A genetic screen for negative regulators of olfaction uncovered mutations in the cGMP-dependent protein kinase EGL-4 that disrupt olfactory adaptation in C. elegans. G protein-coupled olfactory receptors within the AWC olfactory neuron signal through cGMP and a cGMP-gated channel. The cGMP-dependent kinase functions in AWC neurons during odor exposure to direct adaptation to AWC-sensed odors, suggesting that adaptation is a cell intrinsic process initiated by cGMP. A predicted phosphorylation site on the beta subunit of the cGMP-gated channel is required for adaptation after short odor exposure, suggesting that phosphorylation of signaling molecules generates adaptation at early time points. A predicted nuclear localization signal within EGL-4 is required for adaptation after longer odor exposure, suggesting that nuclear translocation of EGL-4 triggers late forms of adaptation.	Univ Calif San Francisco, Howard Hughes Med Inst, Program Dev Biol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Program Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Genet Program, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; Univ Calif Davis, Dept Biochem & Mol Biol, Davis, CA 95616 USA; Univ Calif Davis, Dept Psychiat & Behav Sci, Sacramento, CA 95817 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Bargmann, CI (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Program Dev Biol, San Francisco, CA 94143 USA.			Bargmann, Cornelia/0000-0002-8484-0618				Bargmann C. I., 1997, C ELEGANS, P717; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Bear MF, 2001, SYNAPSES, P455; Birnby DA, 2000, GENETICS, V155, P85; Bradley J, 2001, SCIENCE, V294, P2176, DOI 10.1126/science.1063415; BRENNER S, 1974, GENETICS, V77, P71; CHEN TY, 1994, NATURE, V368, P545, DOI 10.1038/368545a0; Coburn CM, 1998, DEVELOPMENT, V125, P249; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; Colbert HA, 1997, LEARN MEMORY, V4, P179, DOI 10.1101/lm.4.2.179; COLBERT HA, 1995, NEURON, V14, P803, DOI 10.1016/0896-6273(95)90224-4; Dalton P, 2000, CHEM SENSES, V25, P487, DOI 10.1093/chemse/25.4.487; Daniels SA, 2000, GENETICS, V156, P123; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; Fujiwara M, 2002, NEURON, V36, P1091, DOI 10.1016/S0896-6273(02)01093-0; Gu T, 1998, MOL CELL BIOL, V18, P4556, DOI 10.1128/MCB.18.8.4556; Gudi T, 1997, MOL CELL BIOL, V17, P5244, DOI 10.1128/MCB.17.9.5244; Huber A, 1996, EMBO J, V15, P7036, DOI 10.1002/j.1460-2075.1996.tb01095.x; Komatsu H, 1999, BRAIN RES, V821, P160, DOI 10.1016/S0006-8993(99)01111-7; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; Kramer RH, 2001, J EXP BIOL, V204, P2921; Kuhara A, 2002, NEURON, V33, P751, DOI 10.1016/S0896-6273(02)00607-4; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; Mello C, 1995, METHOD CELL BIOL, V48, P451; Munger SD, 2001, SCIENCE, V294, P2172, DOI 10.1126/science.1063224; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; Peckol EL, 2001, P NATL ACAD SCI USA, V98, P11032, DOI 10.1073/pnas.191352498; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Pugh EN, 1999, CURR OPIN NEUROBIOL, V9, P410, DOI 10.1016/S0959-4388(99)80062-2; Riddle DL, 1997, C ELEGANS, P739; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; Robertson HM, 2000, GENOME RES, V10, P192, DOI 10.1101/gr.10.2.192; Robertson HM, 1998, GENOME RES, V8, P449, DOI 10.1101/gr.8.5.449; Saeki S, 2001, J EXP BIOL, V204, P1757; Schackwitz WS, 1996, NEURON, V17, P719, DOI 10.1016/S0896-6273(00)80203-2; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; Stansberry J, 2001, J NEUROCHEM, V76, P1177, DOI 10.1046/j.1471-4159.2001.00131.x; STRINGHAM EG, 1992, MOL BIOL CELL, V3, P221, DOI 10.1091/mbc.3.2.221; Sulston J., 1988, METHODS NEMATODE CAE, P587; TRENT C, 1983, GENETICS, V104, P619; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; TROEMEL ER, 1999, THESIS U CALIFORNIA; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; Wes PD, 2001, NATURE, V410, P698, DOI 10.1038/35070581; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wingrove JA, 1999, CELL, V98, P105, DOI 10.1016/S0092-8674(00)80610-8; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384; ZHENG JH, 1993, BIOCHEMISTRY-US, V32, P2154, DOI 10.1021/bi00060a005; Zufall F, 2000, CHEM SENSES, V25, P473, DOI 10.1093/chemse/25.4.473; Zufall F, 1997, J NEUROSCI, V17, P2703	50	141	160	0	16	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 19	2002	36	6					1079	1089		10.1016/S0896-6273(02)01066-8	http://dx.doi.org/10.1016/S0896-6273(02)01066-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	628TA	12495623	Bronze			2022-12-24	WOS:000180011600011
J	Deans, MR; Volgyi, B; Goodenough, DA; Bloomfield, SA; Paul, DL				Deans, MR; Volgyi, B; Goodenough, DA; Bloomfield, SA; Paul, DL			Connexin36 is essential for transmission of rod-mediated visual signals in the mammalian retina	NEURON			English	Article							AII AMACRINE CELLS; CONE BIPOLAR CELLS; GANGLION-CELLS; RABBIT RETINA; MOUSE RETINA; GAP-JUNCTIONS; CAT RETINA; FUNCTIONAL ARCHITECTURE; ALTERNATIVE PATHWAY; RESPONSE PROPERTIES	To examine the functions of electrical synapses in the transmission of signals from rod photoreceptors to ganglion cells, we generated connexin36 knockout mice. Reporter expression indicated that connexin36 was present in multiple retinal neurons including rod photoreceptors, cone bipolar cells, and All amacrine cells. Disruption of electrical synapses between adjacent Ails and between Ails and ON cone bipolars was demonstrated by intracellular injection of Neurobiotin. In addition, extracellular recording in the knockout revealed the complete elimination of rod-mediated, on-center responses at the ganglion cell level. These data represent direct proof that electrical synapses are critical for the propagation of rod signals across the mammalian retina, and they demonstrate the existence of multiple rod pathways, each of which is dependent on electrical synapses.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; NYU, Sch Med, Dept Ophthalmol, New York, NY 10016 USA; NYU, Sch Med, Dept Physiol & Neurosci, New York, NY 10016 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; New York University; New York University	Paul, DL (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 200 Longwood Ave, Boston, MA 02115 USA.	dpaul@hms.harvard-edu	Volgyi, Bela/A-9079-2013; Volgyi, Bela/C-3101-2009; Volgyi, Bela/B-1016-2011	Volgyi, Bela/0000-0001-7481-390X; 	NEI NIH HHS [R01 EY007360, R01 EY014127, R01 EY014127-01A2, R01 EY014127-02, R01 EY014127-03, EY07360, R01 EY014127-04] Funding Source: Medline; NICHD NIH HHS [P30-HD18655, P30 HD018655] Funding Source: Medline; NIGMS NIH HHS [R01 GM037751-21, R01 GM037751-18, GM37751, R01 GM037751-22, R01 GM037751-23, R01 GM037751-15, R01 GM018974, R01 GM037751-17, R01 GM037751-19, R01 GM037751-16, R01 GM037751-13, R01 GM037751-14, R01 GM037751, R01 GM037751-20, GM18974] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY014127, R01EY007360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM018974, R01GM037751, R37GM018974] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aguilar M., 1954, OPT ACTA, V1, DOI [10.1080/713818657, DOI 10.1080/713818657]; BALKEMA GW, 1982, J NEUROPHYSIOL, V48, P968, DOI 10.1152/jn.1982.48.4.968; Barlow H B, 1971, Vision Res, VSuppl 3, P87; BAYLOR DA, 1974, J PHYSIOL-LONDON, V242, P685, DOI 10.1113/jphysiol.1974.sp010731; Bloomfield SA, 1997, VISUAL NEUROSCI, V14, P565, DOI 10.1017/S0952523800012220; BLOOMFIELD SA, 1982, J COMP NEUROL, V208, P288, DOI 10.1002/cne.902080306; Bloomfield SA, 1997, VISUAL NEUROSCI, V14, P1153, DOI 10.1017/S0952523800011846; Bloomfield SA, 2001, PROG RETIN EYE RES, V20, P351, DOI 10.1016/S1350-9462(00)00031-8; BUNTMILAM AH, 1983, J CELL BIOL, V97, P703, DOI 10.1083/jcb.97.3.703; CALDWELL JH, 1978, J PHYSIOL-LONDON, V276, P257, DOI 10.1113/jphysiol.1978.sp012232; COHEN E, 1986, J COMP NEUROL, V250, P1, DOI 10.1002/cne.902500102; Deans MR, 2001, CELL COMMUN ADHES, V8, P361, DOI 10.3109/15419060109080754; Deans MR, 2001, NEURON, V31, P477, DOI 10.1016/S0896-6273(01)00373-7; DEVRIES SH, 1995, P NATL ACAD SCI USA, V92, P10658, DOI 10.1073/pnas.92.23.10658; EULER T, 1995, J COMP NEUROL, V361, P461, DOI 10.1002/cne.903610310; FAMIGLIETTI EV, 1975, BRAIN RES, V84, P293, DOI 10.1016/0006-8993(75)90983-X; Feigenspan A, 2001, J NEUROSCI, V21, P230, DOI 10.1523/JNEUROSCI.21-01-00230.2001; Guldenagel M, 2001, J NEUROSCI, V21, P6036, DOI 10.1523/JNEUROSCI.21-16-06036.2001; Hack I, 1999, P NATL ACAD SCI USA, V96, P14130, DOI 10.1073/pnas.96.24.14130; HAMPSON ECGM, 1992, J NEUROSCI, V12, P4911; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Hu EH, 2000, J NEUROSCI METH, V103, P209, DOI 10.1016/S0165-0270(00)00319-8; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Krishna VR, 2002, J NEUROPHYSIOL, V87, P42, DOI 10.1152/jn.00489.2001; Krizaj D, 1998, J COMP NEUROL, V398, P529; LEVICK WR, 1967, J PHYSIOL-LONDON, V188, P285, DOI 10.1113/jphysiol.1967.sp008140; Lyubarsky AL, 1996, J NEUROSCI, V16, P563, DOI 10.1523/jneurosci.16-02-00563.1996; Mills SL, 2001, J COMP NEUROL, V436, P336; MILLS SL, 1995, NATURE, V377, P734, DOI 10.1038/377734a0; MULLER F, 1988, J NEUROPHYSIOL, V59, P1657, DOI 10.1152/jn.1988.59.6.1657; NAKA KI, 1966, J PHYSIOL-LONDON, V185, P556, DOI 10.1113/jphysiol.1966.sp008002; NELSON R, 1977, J COMP NEUROL, V172, P109, DOI 10.1002/cne.901720106; PENN JS, 1984, VISION RES, V24, P1673, DOI 10.1016/0042-6989(84)90325-0; RAVIOLA E, 1973, P NATL ACAD SCI USA, V70, P1677, DOI 10.1073/pnas.70.6.1677; RAVIOLA E, 1975, J CELL BIOL, V65, P192, DOI 10.1083/jcb.65.1.192; SCHNEEWEIS DM, 1995, SCIENCE, V268, P1053, DOI 10.1126/science.7754386; SCHWARTZ EA, 1975, J PHYSIOL-LONDON, V246, P639, DOI 10.1113/jphysiol.1975.sp010908; Sharpe LT, 1999, TRENDS NEUROSCI, V22, P497, DOI 10.1016/S0166-2236(99)01458-7; SMITH RG, 1986, J NEUROSCI, V6, P3505; Soucy E, 1998, NEURON, V21, P481, DOI 10.1016/S0896-6273(00)80560-7; STONE C, 1993, VISUAL NEUROSCI, V10, P31, DOI 10.1017/S0952523800003205; THIBOS LN, 1978, J PHYSIOL-LONDON, V278, P101, DOI 10.1113/jphysiol.1978.sp012295; Tsukamoto Y, 2001, J NEUROSCI, V21, P8616, DOI 10.1523/JNEUROSCI.21-21-08616.2001; Vaney DI, 1997, INVEST OPHTH VIS SCI, V38, P267; VANEY DI, 1991, NEUROSCI LETT, V125, P187, DOI 10.1016/0304-3940(91)90024-N; Vaney DI, 1998, J NEUROSCI, V18, P10594; Vaney DI, 2000, BRAIN RES REV, V32, P115, DOI 10.1016/S0165-0173(99)00070-3; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; White TW, 1999, ANNU REV PHYSIOL, V61, P283, DOI 10.1146/annurev.physiol.61.1.283; Xin DY, 1997, J COMP NEUROL, V383, P512, DOI 10.1002/(SICI)1096-9861(19970714)383:4<512::AID-CNE8>3.0.CO;2-5; YANG XL, 1989, SCIENCE, V244, P352, DOI 10.1126/science.2711185	51	329	336	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 14	2002	36	4					703	712		10.1016/S0896-6273(02)01046-2	http://dx.doi.org/10.1016/S0896-6273(02)01046-2			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	616PX	12441058	Green Accepted, Bronze			2022-12-24	WOS:000179313100016
J	Southwood, CM; Garbern, J; Jiang, W; Gow, A				Southwood, CM; Garbern, J; Jiang, W; Gow, A			The unfolded protein response modulates disease severity in Pelizaeus-Merzbacher disease	NEURON			English	Article							MYELIN PROTEOLIPID PROTEIN; I HISTOCOMPATIBILITY MOLECULES; ENDOPLASMIC-RETICULUM; TRANSGENIC MICE; CNS MYELIN; CELL-DEATH; OLIGODENDROCYTE APOPTOSIS; INTRACELLULAR-TRANSPORT; GENE-EXPRESSION; SPINAL-CORD	The unfolded protein response (UPR) is a eukaryotic signaling pathway linking protein flux through the endoplasmic reticulum to transcription and translational repression. Herein, we demonstrate UPR activation in the leukodystrophy Pelizaeus-Merzbacher disease (PMD) as well as in three mouse models of this disease and transfected fibroblasts expressing mutant protein. The CHOP protein, widely known as a proapoptotic transcription factor, modulates pathogenesis in the mouse models of PMD; however, this protein exhibits antiapoptotic activity. Together, these data show that the UPR has the potential to modulate disease severity in many cells expressing mutant secretory pathway proteins. Thus, PMD represents the first member of a novel class of disparate degenerative diseases for which UPR activation and signaling is the common pathogenic mechanism.	Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48201 USA; Wayne State Univ, Sch Med, Dept Pediat, Detroit, MI 48201 USA; Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA	Wayne State University; Wayne State University; Wayne State University	Gow, A (corresponding author), Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48201 USA.	agow@genetics.wayne.edu		gow, alexander/0000-0001-7446-8990	NINDS NIH HHS [R01 NS43783, R01 NS043783] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043783] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLISON J, 1988, NATURE, V333, P529, DOI 10.1038/333529a0; Aridor M, 1999, NAT MED, V5, P745, DOI 10.1038/10466; Baerwald KD, 2000, J NEUROSCI RES, V59, P160, DOI 10.1002/(SICI)1097-4547(20000115)59:2<160::AID-JNR2>3.3.CO;2-B; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DUNCAN ID, 1990, ANN NY ACAD SCI, V605, P110, DOI 10.1111/j.1749-6632.1990.tb42386.x; DYCAICO MJ, 1988, SCIENCE, V242, P1409, DOI 10.1126/science.3264419; FANARRAGA ML, 1992, GLIA, V5, P161, DOI 10.1002/glia.440050302; Garbern J, 1999, ARCH NEUROL-CHICAGO, V56, P1210, DOI 10.1001/archneur.56.10.1210; GENCIC S, 1990, J NEUROSCI, V10, P117; Gow A, 1998, J CELL BIOL, V140, P925, DOI 10.1083/jcb.140.4.925; Gow A, 1997, J NEUROSCI, V17, P181, DOI 10.1523/JNEUROSCI.17-01-00181.1997; GOW A, 1994, J NEUROSCI RES, V37, P563, DOI 10.1002/jnr.490370503; GOW A, 1994, J NEUROSCI RES, V37, P574, DOI 10.1002/jnr.490370504; Gow A, 1996, NAT GENET, V13, P422, DOI 10.1038/ng0896-422; Gow A, 1999, CELL, V99, P649, DOI 10.1016/S0092-8674(00)81553-6; GOW A, 2002, NEUROGENETICS METHOD, P263; Griffiths I, 1998, SCIENCE, V280, P1610, DOI 10.1126/science.280.5369.1610; GRIFFITHS IR, 1990, J NEUROCYTOL, V19, P273, DOI 10.1007/BF01217305; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hobson GM, 2000, NEUROLOGY, V55, P1089, DOI 10.1212/WNL.55.8.1089; HUDSON LD, 1987, P NATL ACAD SCI USA, V84, P1454, DOI 10.1073/pnas.84.5.1454; IKENAKA K, 1995, DEV NEUROSCI-BASEL, V17, P127, DOI 10.1159/000111281; KAGAWA T, 1994, NEURON, V13, P427, DOI 10.1016/0896-6273(94)90358-1; Katayama T, 1999, NAT CELL BIOL, V1, P479, DOI 10.1038/70265; Klugmann M, 1997, NEURON, V18, P59, DOI 10.1016/S0896-6273(01)80046-5; KNAPP PE, 1986, J NEUROSCI, V6, P2813; KOBAYASHI H, 1994, NAT GENET, V7, P351, DOI 10.1038/ng0794-351; LORENCE MC, 1990, ENDOCRINOLOGY, V126, P2493, DOI 10.1210/endo-126-5-2493; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Ma YJ, 2001, CELL, V107, P827, DOI 10.1016/S0092-8674(01)00623-7; Niwa M, 1999, CELL, V99, P691, DOI 10.1016/S0092-8674(00)81667-0; OKADA T, 2002, BIOCH J, V16; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Power C, 1996, J NEUROSCI RES, V44, P165, DOI 10.1002/(SICI)1097-4547(19960415)44:2<165::AID-JNR9>3.0.CO;2-B; READHEAD C, 1994, NEURON, V12, P583, DOI 10.1016/0896-6273(94)90214-3; Rosenbluth J, 1996, J COMP NEUROL, V371, P336, DOI 10.1002/(SICI)1096-9861(19960722)371:2<336::AID-CNE12>3.0.CO;2-Q; Sato N, 2000, NAT CELL BIOL, V2, P863, DOI 10.1038/35046500; SCHNEIDER A, 1995, P NATL ACAD SCI USA, V92, P4447, DOI 10.1073/pnas.92.10.4447; SCHNEIDER A, 1992, NATURE, V358, P758, DOI 10.1038/358758a0; Simons M, 2002, J CELL BIOL, V157, P327, DOI 10.1083/jcb.200110138; Southwood C, 2001, MICROSC RES TECHNIQ, V52, P700, DOI 10.1002/jemt.1054; Stecca B, 2000, J NEUROSCI, V20, P4002; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; TURNLEY AM, 1991, NATURE, V353, P566, DOI 10.1038/353566a0; Wang XZ, 1998, EMBO J, V17, P3619, DOI 10.1093/emboj/17.13.3619; Williams WC, 1997, J NEUROSCI RES, V50, P177, DOI 10.1002/(SICI)1097-4547(19971015)50:2<177::AID-JNR7>3.0.CO;2-C; Yamamoto T, 1998, AM J MED GENET, V75, P439, DOI 10.1002/(SICI)1096-8628(19980203)75:4<439::AID-AJMG19>3.0.CO;2-P; YAMAMURA T, 1991, J NEUROCHEM, V57, P1671, DOI 10.1111/j.1471-4159.1991.tb06367.x; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	50	217	228	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	NOV 14	2002	36	4					585	596		10.1016/S0896-6273(02)01045-0	http://dx.doi.org/10.1016/S0896-6273(02)01045-0			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	616PX	12441049	Bronze, Green Accepted			2022-12-24	WOS:000179313100007
J	Li, JYH; Lao, ZM; Joyner, AL				Li, JYH; Lao, ZM; Joyner, AL			Changing requirements for gbx2 in development of the cerebellum and maintenance of the mid/hindbrain organizer	NEURON			English	Article							MOUSE OTX2; ANTERIOR NEUROECTODERM; EXPRESSION; FGF8; GENE; SPECIFICATION; HINDBRAIN; MIDBRAIN; REGIONS; MESODERM	We examined whether Gbx2 is required after embryonic day 9 (E9) to repress Otx2 in the cerebellar anlage and position the midbrain/hindbrain organizer. In contrast to Gbx2 null mutants, mice lacking Gbx2 in rhombomere 1 (r1) after E9 (Gbx2-CKO) are viable and develop a cerebellum. A Gbx2-independent pathway can repress Otx2 in r1 after E9. Mid/hindbrain organizer gene expression, however, continues to be dependent on Gbx2. We found that Fgf8 expression normally correlates with the isthmus where cells undergo low proliferation and that in Gbx2-CKO mutants this domain is expanded. We propose that Fgf8 permits lateral cerebellar development through repression of Otx2 and also suppresses medial cerebellar growth in Gbx2-CKO embryos. Our work has uncovered distinct requirements for Gbx2 during cerebellum formation and provided a model for how a transcription factor can play multiple roles during development.	NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; NYU, Sch Med, Skirball Inst Biomol Med, Dev Genet Program, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; NYU, Sch Med, Dept Physiol & Neurosci, New York, NY 10016 USA	Howard Hughes Medical Institute; New York University; New York University; New York University; New York University	Joyner, AL (corresponding author), NYU, Sch Med, Howard Hughes Med Inst, 540 1st Ave, New York, NY 10016 USA.	joyner@saturn.med.nyu.edu; joyner@saturn.med.nyu.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS041702] Funding Source: NIH RePORTER; NINDS NIH HHS [F32 NS041702-02, F32 NS041702] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ACAMPORA D, 1995, DEVELOPMENT, V121, P3279; ALTMAN J, 1997, DEV CERBELLAR SYSTEM; ANG SL, 1994, DEVELOPMENT, V120, P2979; Ang SL, 1996, DEVELOPMENT, V122, P243; Auerbach W, 2000, BIOTECHNIQUES, V29, P1024, DOI 10.2144/00295st04; BOUILLET P, 1995, DEV DYNAM, V204, P372, DOI 10.1002/aja.1002040404; Broccoli V, 1999, NATURE, V401, P164, DOI 10.1038/43670; Castanon I, 2001, DEVELOPMENT, V128, P3145; Chapman G, 1997, GENOMICS, V46, P223, DOI 10.1006/geno.1997.4969; Crossley PH, 1996, NATURE, V380, P66, DOI 10.1038/380066a0; Crossley PH, 2001, NEUROSCIENCE, V108, P183, DOI 10.1016/S0306-4522(01)00411-0; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; Donoghue MJ, 1996, MOL CELL NEUROSCI, V8, P185, DOI 10.1006/mcne.1996.0056; Flenniken AM, 1996, DEV BIOL, V179, P382, DOI 10.1006/dbio.1996.0269; Garda AL, 2001, MECH DEVELOP, V101, P111, DOI 10.1016/S0925-4773(00)00567-0; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; Hogan B, 1994, MANIPULATING MOUSE E; Joyner AL, 2000, CURR OPIN CELL BIOL, V12, P736, DOI 10.1016/S0955-0674(00)00161-7; Katahira T, 2000, MECH DEVELOP, V91, P43, DOI 10.1016/S0925-4773(99)00262-2; Kimmel RA, 2000, GENE DEV, V14, P1377; Li JYH, 2001, DEVELOPMENT, V128, P4979; Liu AM, 2001, ANNU REV NEUROSCI, V24, P869, DOI 10.1146/annurev.neuro.24.1.869; Liu AM, 1999, DEVELOPMENT, V126, P4827; MACARTHUR CA, 1995, DEVELOPMENT, V121, P3603; Martinez S, 1999, DEVELOPMENT, V126, P1189; Martinez-Barbera JP, 2001, DEVELOPMENT, V128, P4789; Matise MP, 2000, PRACT APPROACH SER, V212, P101; MATSUO I, 1995, GENE DEV, V9, P2646, DOI 10.1101/gad.9.21.2646; MILLEN KJ, 1994, DEVELOPMENT, V120, P695; Millett S, 1999, NATURE, V401, P161, DOI 10.1038/43664; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; PARR BA, 1993, DEVELOPMENT, V119, P247; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Sato T, 2001, DEVELOPMENT, V128, P2461; Shamim H, 1999, DEVELOPMENT, V126, P945; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Sugiyama S, 2000, DEV BIOL, V221, P168, DOI 10.1006/dbio.2000.9643; Wassarman KM, 1997, DEVELOPMENT, V124, P2923; WILKINSON DG, 1989, NATURE, V341, P405, DOI 10.1038/341405a0; Wingate RJT, 2001, CURR OPIN NEUROBIOL, V11, P82, DOI 10.1016/S0959-4388(00)00177-X; Ye WL, 2001, NAT NEUROSCI, V4, P1175, DOI 10.1038/nn761	41	101	101	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 26	2002	36	1					31	43		10.1016/S0896-6273(02)00935-2	http://dx.doi.org/10.1016/S0896-6273(02)00935-2			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	598UP	12367504	Bronze			2022-12-24	WOS:000178295100005
J	Hebert, JM; Mishina, Y; McConnell, SK				Hebert, JM; Mishina, Y; McConnell, SK			BMP signaling is required locally to pattern the dorsal telencephalic midline	NEURON			English	Article							BONE MORPHOGENETIC PROTEINS; CEREBRAL-CORTEX; MOUSE EMBRYOGENESIS; VENTRICULAR ZONE; EXPRESSION; MICE; RECEPTORS; FOREBRAIN; EYE; CRE	BMPs have been proposed to pattern the medial-lateral axis of the telencephalon in a concentration-dependent manner, thus helping to subdivide the embryonic telencephalon into distinct forebrain regions. Using a CRE/1oxP genetic approach, we tested this hypothesis by disrupting the Bmpr1a gene in the telencephalon. In mutants, BMP signaling was compromised throughout the dorsal telencephalon, but only the most dorsalmedial derivative, the choroid plexus, failed to be specified or differentiate. Choroid plexus precursors remained proliferative and did not adopt the fate of their lateral telencephalic neighbors. These results demonstrate that BMP signaling is required for the formation of the most dorsal telencephalic derivative, the choroid plexus, and that BMP signaling plays an essential role in locally patterning the dorsal midline. Our data fall to support a more global, concentration-dependent role in specifying telencephalic cell fates.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; NIEHS, NIH, Res Triangle Pk, NC 27709 USA	Stanford University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	McConnell, SK (corresponding author), Stanford Univ, Dept Biol Sci, 385 Serra Mall, Stanford, CA 94305 USA.				NIMH NIH HHS [MH51864] Funding Source: Medline; NINDS NIH HHS [NS12151] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES071003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH051864, R01MH051864] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS012151, P01NS012151] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bulchand S, 2001, MECH DEVELOP, V100, P165, DOI 10.1016/S0925-4773(00)00515-3; BULFONE A, 1995, NEURON, V15, P63, DOI 10.1016/0896-6273(95)90065-9; DEWULF N, 1995, ENDOCRINOLOGY, V136, P2652, DOI 10.1210/en.136.6.2652; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; FRANTZ GD, 1994, J NEUROSCI, V14, P5725; Fukuchi-Shimogori T, 2001, SCIENCE, V294, P1071, DOI 10.1126/science.1064252; Furuta Y, 1997, DEVELOPMENT, V124, P2203; Grove EA, 1998, DEVELOPMENT, V125, P2315; Hebert JM, 2000, DEV BIOL, V222, P296, DOI 10.1006/dbio.2000.9732; KINGSLEY DM, 1992, CELL, V71, P399, DOI 10.1016/0092-8674(92)90510-J; Lee KJ, 1998, GENE DEV, V12, P3394, DOI 10.1101/gad.12.21.3394; Li WW, 1998, J NEUROSCI, V18, P8853; Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798; LUO G, 1995, GENE DEV, V9, P2808, DOI 10.1101/gad.9.22.2808; Massague J, 1996, CELL, V85, P947, DOI 10.1016/S0092-8674(00)81296-9; Mehler MF, 2000, DEV NEUROSCI-BASEL, V22, P74, DOI 10.1159/000017429; Mishina Y, 2002, GENESIS, V32, P69, DOI 10.1002/gene.10038; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; Monuki ES, 2001, NEURON, V32, P591, DOI 10.1016/S0896-6273(01)00504-9; ORourke NA, 1997, DEVELOPMENT, V124, P997; Panchision DM, 2001, GENE DEV, V15, P2094, DOI 10.1101/gad.894701; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; Podos SD, 1999, TRENDS GENET, V15, P396, DOI 10.1016/S0168-9525(99)01854-5; Porter FD, 1997, DEVELOPMENT, V124, P2935; Ragsdale CW, 2001, CURR OPIN NEUROBIOL, V11, P50, DOI 10.1016/S0959-4388(00)00173-2; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; Schmidt EE, 2000, P NATL ACAD SCI USA, V97, P13702, DOI 10.1073/pnas.240471297; Shimamura K, 1997, DEVELOPMENT, V124, P2709; Solloway MJ, 1998, DEV GENET, V22, P321, DOI 10.1002/(SICI)1520-6408(1998)22:4<321::AID-DVG3>3.3.CO;2-7; Solloway MJ, 1999, DEVELOPMENT, V126, P1753; STURROCK RR, 1979, J ANAT, V129, P777; THOMAS T, 1988, DEV BIOL, V128, P415, DOI 10.1016/0012-1606(88)90303-X; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; XUAN SH, 1995, NEURON, V14, P1141, DOI 10.1016/0896-6273(95)90262-7; Yi SE, 2000, DEVELOPMENT, V127, P621; ZAKI W, 1981, Z MIKROSK ANAT FORSC, V95, P919; Zhang HB, 1996, DEVELOPMENT, V122, P2977	37	195	202	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 12	2002	35	6					1029	1041		10.1016/S0896-6273(02)00900-5	http://dx.doi.org/10.1016/S0896-6273(02)00900-5			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	594GC	12354394	Bronze			2022-12-24	WOS:000178040000005
J	Ostroff, LE; Fiala, JC; Allwardt, B; Harris, KM				Ostroff, LE; Fiala, JC; Allwardt, B; Harris, KM			Polyribosomes redistribute from dendritic shafts into spines with enlarged synapses during LTP in developing rat hippocampal slices	NEURON			English	Article							LONG-TERM POTENTIATION; LOCAL PROTEIN-SYNTHESIS; SYNAPTIC ACTIVATION CAUSES; MESSENGER-RNA; DENTATE GYRUS; AREA CA1; POSTSYNAPTIC SITES; GRANULE CELLS; LATE-PHASE; KINASE-II	The presence of polyribosomes in dendritic spines suggests a potential involvement of local protein synthesis in the modification of synapses. Dendritic spine and synapse ultrastructure were compared after low-frequency control or tetanic stimulation in hippocampal slices from postnatal day (P)15 rats. The percentage of spines containing polyribosomes increased from 12% +/- 4% after control stimulation to 39% +/- 4% after tetanic stimulation, with a commensurate loss of polyribosomes from dendritic shafts at 2 hr posttetanus. Postsynaptic densities on spines containing polyribosomes were larger after tetanic stimulation. Local protein synthesis might therefore serve to stabilize stimulation-induced growth of the postsynaptic density. Furthermore, coincident polyribosomes and synapse enlargement might indicate spines that are expressing long-term potentiation induced by tetanic stimulation.	Boston Univ, Dept Biol, Program Neurosci, Boston, MA 02215 USA	Boston University	Harris, KM (corresponding author), Boston Univ, Dept Biol, Program Neurosci, 5 Cummington St, Boston, MA 02215 USA.			Ostroff, Linnaea/0000-0002-3348-342X; Harris, Kristen/0000-0002-1943-4744	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033574] Funding Source: NIH RePORTER; NIDA NIH HHS [DA 57351] Funding Source: Medline; NINDS NIH HHS [NS 33574] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; CHANG FLF, 1984, BRAIN RES, V309, P35, DOI 10.1016/0006-8993(84)91008-4; CHICUREL ME, 1992, J COMP NEUROL, V325, P169, DOI 10.1002/cne.903250204; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; DESMOND NL, 1990, SYNAPSE, V5, P139, DOI 10.1002/syn.890050208; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fiala JC, 2002, NAT NEUROSCI, V5, P297, DOI 10.1038/nn830; Fiala JC, 2001, J MICROSC-OXFORD, V202, P468, DOI 10.1046/j.1365-2818.2001.00926.x; Fiala JC, 2001, J AM MED INFORM ASSN, V8, P1; Fiala JC, 1998, J NEUROSCI, V18, P8900; FIFKOVA E, 1982, J NEUROCYTOL, V11, P183, DOI 10.1007/BF01258243; FREY U, 1989, NEUROSCI LETT, V97, P135, DOI 10.1016/0304-3940(89)90152-3; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; Greenberg ME, 2001, SYNAPSES, P357; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; HARRIS KM, 1992, J NEUROSCI, V12, P2685; HARRIS KM, 1984, J PHYSIOL-LONDON, V346, P27, DOI 10.1113/jphysiol.1984.sp015005; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; JACKSON PS, 1993, J NEUROPHYSIOL, V70, P1412, DOI 10.1152/jn.1993.70.4.1412; JENSEN FE, 1989, J NEUROSCI METH, V29, P217, DOI 10.1016/0165-0270(89)90146-5; Job C, 2001, P NATL ACAD SCI USA, V98, P13037, DOI 10.1073/pnas.231485698; Job C, 2001, NAT REV NEUROSCI, V2, P889, DOI 10.1038/35104069; Kaech S, 2001, P NATL ACAD SCI USA, V98, P7086, DOI 10.1073/pnas.111146798; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Kirov SA, 1999, J NEUROSCI, V19, P2876; Knowles RB, 1996, J NEUROSCI, V16, P7812; Kohrmann M, 1999, MOL BIOL CELL, V10, P2945, DOI 10.1091/mbc.10.9.2945; Krichevsky AM, 2001, NEURON, V32, P683, DOI 10.1016/S0896-6273(01)00508-6; LEE KS, 1980, J NEUROPHYSIOL, V44, P247, DOI 10.1152/jn.1980.44.2.247; Long RM, 1997, SCIENCE, V277, P383, DOI 10.1126/science.277.5324.383; Luscher C, 2001, TRENDS NEUROSCI, V24, P665, DOI 10.1016/S0166-2236(00)01959-7; MACKLER SA, 1992, NEURON, V9, P539, DOI 10.1016/0896-6273(92)90191-F; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Marrs GS, 2001, NAT NEUROSCI, V4, P1006, DOI 10.1038/nn717; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; OTANI S, 1989, NEUROSCIENCE, V28, P519, DOI 10.1016/0306-4522(89)90001-8; Ouyang Y, 1999, J NEUROSCI, V19, P7823; RAO A, 1991, J NEUROSCI, V11, P2881; Roberts LA, 1998, MOL BRAIN RES, V56, P38, DOI 10.1016/S0169-328X(98)00026-6; Scheetz AJ, 2000, NAT NEUROSCI, V3, P211, DOI 10.1038/72915; Sheng M, 2001, P NATL ACAD SCI USA, V98, P7058, DOI 10.1073/pnas.111146298; Sorra KE, 1998, J NEUROSCI, V18, P658; STEWARD O, 1988, J NEUROSCI, V8, P176; Steward O, 2001, NEURON, V30, P227, DOI 10.1016/S0896-6273(01)00275-6; Steward O, 1999, J NEUROSCI, V19, P7834; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; STEWARD O, 1983, COLD SPRING HARB SYM, V48, P745, DOI 10.1101/SQB.1983.048.01.077; STEWARD O, 1991, J COMP NEUROL, V314, P545, DOI 10.1002/cne.903140311; STEWARD O, 1982, J NEUROSCI, V2, P284; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; SUNDELL CL, 1991, SCIENCE, V253, P1275, DOI 10.1126/science.1891715; Tang SJ, 2001, NEURON, V32, P463, DOI 10.1016/S0896-6273(01)00493-7; TEYLER TJ, 1985, NEUROSCI BIOBEHAV RE, V9, P337; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; TORRE ER, 1992, J NEUROSCI, V12, P762; VANHARREVELD A, 1975, EXP NEUROL, V49, P736, DOI 10.1016/0014-4886(75)90055-2; WEILER I J, 1991, Molecular and Cellular Neuroscience, V2, P305, DOI 10.1016/1044-7431(91)90060-2; Wells DG, 2000, CURR OPIN NEUROBIOL, V10, P132, DOI 10.1016/S0959-4388(99)00050-1; Wells DG, 2001, J NEUROSCI, V21, P9541, DOI 10.1523/JNEUROSCI.21-24-09541.2001; YISRAELI JK, 1990, DEVELOPMENT, V108, P289; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071	66	323	329	1	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 1	2002	35	3					535	545		10.1016/S0896-6273(02)00785-7	http://dx.doi.org/10.1016/S0896-6273(02)00785-7			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	582CB	12165474	Bronze			2022-12-24	WOS:000177331200013
J	Markus, A; Zhong, J; Snider, WD				Markus, A; Zhong, J; Snider, WD			Raf and akt mediate distinct aspects of sensory axon growth	NEURON			English	Article							BAX-DEFICIENT MICE; PROTEIN-KINASE-B; NERVE GROWTH; PC12 CELLS; SYMPATHETIC NEURONS; NEURITE OUTGROWTH; PHOSPHOINOSITIDE 3-KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNAL-TRANSDUCTION; SURVIVAL SIGNALS	Nerve growth factor (NGF) induces dramatic axon growth from responsive embryonic peripheral neurons. However, the roles of the various NGF-triggered signaling cascades in determining specific axon morphological features remain unknown. Here, we transfected activated and inhibitory mutants of Trk effectors into sensory neurons lacking the proapoptotic protein Bax. This allowed axon growth to be studied in the absence of NGF, enabling us to observe the contributions of individual signaling mediators. While Ras was both necessary and sufficient for NGF-stimulated axon growth, the Ras effectors Raf and Akt induced distinct morphologies. Activated Raf-1 caused axon lengthening comparable to NGF, while active Akt increased axon caliber and branching. Our results suggest that the different Trk effector pathways mediate distinct morphological aspects of developing neurons.	Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Snider, WD (corresponding author), Univ N Carolina, Ctr Neurosci, 103 Mason Farm Rd, Chapel Hill, NC 27599 USA.	wsnider@med.unc.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031768] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS31768] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ashcroft M, 1999, ONCOGENE, V18, P4586, DOI 10.1038/sj.onc.1202814; Atwal JK, 2000, NEURON, V27, P265, DOI 10.1016/S0896-6273(00)00035-0; Bang OS, 2001, J CELL SCI, V114, P81; BARSAGI D, 1985, CELL, V42, P841, DOI 10.1016/0092-8674(85)90280-6; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; BORASIO GD, 1989, NEURON, V2, P1087; BORASIO GD, 1993, J CELL BIOL, V121, P665, DOI 10.1083/jcb.121.3.665; Chen DF, 1997, NATURE, V385, P434, DOI 10.1038/385434a0; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; CLEVELAND DW, 1991, CELL, V67, P453, DOI 10.1016/0092-8674(91)90518-4; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Crowder RJ, 1998, J NEUROSCI, V18, P2933; Daniels RH, 1998, EMBO J, V17, P754, DOI 10.1093/emboj/17.3.754; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Edsjo A, 2001, CELL GROWTH DIFFER, V12, P39; Fambrough D, 1999, CELL, V97, P727, DOI 10.1016/S0092-8674(00)80785-0; Farinas I, 1998, NEURON, V21, P325, DOI 10.1016/S0896-6273(00)80542-5; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; Fukumoto S, 2001, J BIOL CHEM, V276, P17479, DOI 10.1074/jbc.C000880200; GOLD BG, 1991, J NEUROSCI, V11, P943; Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; GREEN SH, 1986, J CELL BIOL, V102, P830, DOI 10.1083/jcb.102.3.830; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Hilton M, 1997, CURR BIOL, V7, P798, DOI 10.1016/S0960-9822(06)00339-3; Hing H, 1999, CELL, V97, P853, DOI 10.1016/S0092-8674(00)80798-9; Howe CL, 2001, NEURON, V32, P801, DOI 10.1016/S0896-6273(01)00526-8; Huser M, 2001, EMBO J, V20, P1940, DOI 10.1093/emboj/20.8.1940; Jackson TR, 1996, J CELL SCI, V109, P289; Jaiswal RK, 1996, J BIOL CHEM, V271, P23626, DOI 10.1074/jbc.271.39.23626; JAISWAL RK, 1994, MOL CELL BIOL, V14, P6944, DOI 10.1128/MCB.14.10.6944; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Keller-Peck CR, 2001, J NEUROSCI, V21, P6136, DOI 10.1523/JNEUROSCI.21-16-06136.2001; Klesse LJ, 1999, ONCOGENE, V18, P2055, DOI 10.1038/sj.onc.1202524; Klesse LJ, 1998, J NEUROSCI, V18, P10420; Klinz FJ, 1996, J NEUROSCI RES, V46, P720, DOI 10.1002/(SICI)1097-4547(19961215)46:6<720::AID-JNR8>3.0.CO;2-H; Klippel A, 1996, MOL CELL BIOL, V16, P4117; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Kohn AD, 1996, J BIOL CHEM, V271, P21920, DOI 10.1074/jbc.271.36.21920; Korhonen JM, 1999, J BIOL CHEM, V274, P37307, DOI 10.1074/jbc.274.52.37307; KORSCHING S, 1983, P NATL ACAD SCI-BIOL, V80, P3513, DOI 10.1073/pnas.80.11.3513; KOTANI K, 1994, EMBO J, V13, P2313, DOI 10.1002/j.1460-2075.1994.tb06515.x; Kuruvilla R, 2000, NEURON, V27, P499, DOI 10.1016/S0896-6273(00)00061-1; Kwon T, 2000, J BIOL CHEM, V275, P423, DOI 10.1074/jbc.275.1.423; Lee MK, 1996, ANNU REV NEUROSCI, V19, P187, DOI 10.1146/annurev.ne.19.030196.001155; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; Lentz SI, 1999, J NEUROSCI, V19, P1038; Liu RY, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-17-j0003.2001; Markus A, 1997, DEV BIOL, V191, P306, DOI 10.1006/dbio.1997.8771; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Munson JB, 1997, J NEUROSCI, V17, P470, DOI 10.1523/JNEUROSCI.17-01-00470.1997; Munson JB, 1997, EUR J NEUROSCI, V9, P1126, DOI 10.1111/j.1460-9568.1997.tb01465.x; Namikawa K, 2000, J NEUROSCI, V20, P2875; NOBES CD, 1995, EUR J NEUROSCI, V7, P344, DOI 10.1111/j.1460-9568.1995.tb01069.x; Patel TD, 2000, NEURON, V25, P345, DOI 10.1016/S0896-6273(00)80899-5; Pearson G, 2000, J BIOL CHEM, V275, P37303, DOI 10.1074/jbc.C000570200; Resh MD, 1996, CELL SIGNAL, V8, P403, DOI 10.1016/S0898-6568(96)00088-5; Reusch HP, 2001, J BIOL CHEM, V276, P33630, DOI 10.1074/jbc.M105322200; Robinson MJ, 1998, CURR BIOL, V8, P1141, DOI 10.1016/S0960-9822(07)00485-X; Rommel C, 1999, SCIENCE, V286, P1738, DOI 10.1126/science.286.5445.1738; Roux PP, 2001, J BIOL CHEM, V276, P23097, DOI 10.1074/jbc.M011520200; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; Shioi T, 2000, EMBO J, V19, P2537, DOI 10.1093/emboj/19.11.2537; Stocker H, 2000, CURR OPIN GENET DEV, V10, P529, DOI 10.1016/S0959-437X(00)00123-4; STOKOE D, 1994, SCIENCE, V264, P1463, DOI 10.1126/science.7811320; Tang Y, 2000, J BIOL CHEM, V275, P9106, DOI 10.1074/jbc.275.13.9106; Teruel MN, 1999, J NEUROSCI METH, V93, P37, DOI 10.1016/S0165-0270(99)00112-0; Tsui-Pierchala BA, 2000, J NEUROSCI, V20, P7228; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Ulupinar E, 2000, J COMP NEUROL, V425, P202, DOI 10.1002/1096-9861(20000918)425:2<202::AID-CNE4>3.0.CO;2-T; White FA, 1998, J NEUROSCI, V18, P1428; Wiese S, 2001, NAT NEUROSCI, V4, P137, DOI 10.1038/83960; WOOD KW, 1993, P NATL ACAD SCI USA, V90, P5016, DOI 10.1073/pnas.90.11.5016; Wright DE, 1997, NEURON, V19, P503, DOI 10.1016/S0896-6273(00)80367-0; York RD, 2000, MOL CELL BIOL, V20, P8069, DOI 10.1128/MCB.20.21.8069-8083.2000; Zhang YZ, 2000, J NEUROSCI, V20, P5671, DOI 10.1523/JNEUROSCI.20-15-05671.2000; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741	80	266	277	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 3	2002	35	1					65	76		10.1016/S0896-6273(02)00752-3	http://dx.doi.org/10.1016/S0896-6273(02)00752-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	569KP	12123609	Bronze, Green Published			2022-12-24	WOS:000176601800011
J	Walker, HC; Lawrence, JJ; McBain, CJ				Walker, HC; Lawrence, JJ; McBain, CJ			Activation of kinetically distinct synaptic conductances on inhibitory interneurons by electrotonically overlapping afferents	NEURON			English	Article							TARGET-SPECIFIC EXPRESSION; PYRAMIDAL CELLS; GLUTAMATE RECEPTORS; SUBUNIT COMPOSITION; NMDA RECEPTORS; AMPA RECEPTORS; MOSSY FIBERS; TIME-COURSE; TRANSMISSION; NEURONS	Mossy fiber (MF) and CA3 collateral (CL) axons activate common interneurons via synapses comprised of different AMPA receptors to provide feedforward and feedback inhibitory control of the CA3 hippocampal network. Because synapses potentially occur over variable electrotonic distances that distort somatically recorded synaptic currents, it is not known whether the underlying afferent-specific synaptic conductances are associated with different time courses. Using a somatic voltage jump technique to alter the driving force at the site of the synapse, we demonstrate that MF and CL synapses overlap in electrotonic location yet differ in conductance time course. Thus, afferent-specific conductance time courses allow single interneurons to differentially integrate feedforward and feedback information without the need to segregate distinct AMPA receptor subunits to different electrotonic domains.	NICHHD, Lab Cellular & Synapt Neurophysiol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	McBain, CJ (corresponding author), NICHHD, Lab Cellular & Synapt Neurophysiol, NIH, Bethesda, MD 20892 USA.	mcbainc@mail.nih.gov			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001205] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001205] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Acsady L, 1998, J NEUROSCI, V18, P3386; AMARAL DG, 1981, J COMP NEUROL, V195, P51, DOI 10.1002/cne.901950106; Banks MI, 2000, J NEUROSCI, V20, P937, DOI 10.1523/JNEUROSCI.20-03-00937.2000; BLASCHKE M, 1993, P NATL ACAD SCI USA, V90, P6528, DOI 10.1073/pnas.90.14.6528; Brenowitz S, 2001, J NEUROSCI, V21, P1857, DOI 10.1523/JNEUROSCI.21-06-01857.2001; CLAIBORNE BJ, 1993, HIPPOCAMPUS, V3, P115, DOI 10.1002/hipo.450030202; Craig AM, 2001, NAT NEUROSCI, V4, P569, DOI 10.1038/88388; Dingledine R, 1999, PHARMACOL REV, V51, P7; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Fricker D, 2000, NEURON, V28, P559, DOI 10.1016/S0896-6273(00)00133-1; Fuchs EC, 2001, P NATL ACAD SCI USA, V98, P3571, DOI 10.1073/pnas.051631898; Gardner SM, 2001, J NEUROSCI, V21, P7428, DOI 10.1523/JNEUROSCI.21-18-07428.2001; Geiger JRP, 1999, HANDB EXP PHARM, V141, P363; Geiger JRP, 1997, NEURON, V18, P1009, DOI 10.1016/S0896-6273(00)80339-6; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; GULYAS AI, 1993, NATURE, V366, P683, DOI 10.1038/366683a0; Hausser M, 1997, J NEUROSCI, V17, P7606; Henze DA, 2000, NEUROSCIENCE, V98, P407, DOI 10.1016/S0306-4522(00)00146-9; HERLITZE S, 1993, NEURON, V10, P1131, DOI 10.1016/0896-6273(93)90061-U; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; Jonas Peter, 1994, Current Opinion in Neurobiology, V4, P366, DOI 10.1016/0959-4388(94)90098-1; Kamiya H, 1996, J PHYSIOL-LONDON, V493, P447, DOI 10.1113/jphysiol.1996.sp021395; Kapur A, 1998, J NEUROPHYSIOL, V79, P2181, DOI 10.1152/jn.1998.79.4.2181; Kumar SS, 2001, J NEUROPHYSIOL, V86, P2973, DOI 10.1152/jn.2001.86.6.2973; Lawrence JJ, 2000, J NEUROSCI, V20, P4864; Lei SB, 2002, NEURON, V33, P921, DOI 10.1016/S0896-6273(02)00608-6; Maccaferri G, 1998, SCIENCE, V279, P1368, DOI 10.1126/science.279.5355.1368; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; MANZONI OJ, 1995, NEUROPHARMACOLOGY, V34, P965, DOI 10.1016/0028-3908(95)00060-J; Martina M, 2000, SCIENCE, V287, P295, DOI 10.1126/science.287.5451.295; Monyer H, 1999, HANDB EXP PHARM, V141, P309; MOSBACHER J, 1994, SCIENCE, V266, P1059, DOI 10.1126/science.7973663; Partin KM, 1996, J NEUROSCI, V16, P6634, DOI 10.1523/jneurosci.16-21-06634.1996; PEARCE RA, 1993, NEURON, V10, P189, DOI 10.1016/0896-6273(93)90310-N; RALL W, 1969, BIOPHYS J, V9, P1483, DOI 10.1016/S0006-3495(69)86467-2; Rubio ME, 1997, NEURON, V18, P939, DOI 10.1016/S0896-6273(00)80333-5; Silver R. A., 1999, DENDRITES, P114; Spruston N, 1997, J COMP NEUROL, V385, P427; STUART G, 1995, CURR OPIN NEUROBIOL, V5, P389, DOI 10.1016/0959-4388(95)80053-0; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; Toth K, 1998, NAT NEUROSCI, V1, P572, DOI 10.1038/2807; Toth K, 2000, J PHYSIOL-LONDON, V525, P41, DOI 10.1111/j.1469-7793.2000.00041.x; Toth K, 2000, J NEUROSCI, V20, P8279, DOI 10.1523/JNEUROSCI.20-22-08279.2000; Tovar KR, 1999, J NEUROSCI, V19, P4180; Trussell L, 1998, PROG BRAIN RES, V116, P59, DOI 10.1016/S0079-6123(08)60430-6; VYKLICKY L, 1991, NEURON, V7, P971, DOI 10.1016/0896-6273(91)90342-W; Washburn MS, 1996, J PHARMACOL EXP THER, V278, P669; Yeckel MF, 1999, NAT NEUROSCI, V2, P625, DOI 10.1038/10180; ZHANG S, 1994, J PHYSIOL-LONDON, V480, P123, DOI 10.1113/jphysiol.1994.sp020346	50	34	34	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 3	2002	35	1					161	171		10.1016/S0896-6273(02)00734-1	http://dx.doi.org/10.1016/S0896-6273(02)00734-1			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	569KP	12123616	Bronze			2022-12-24	WOS:000176601800018
J	Attwell, PJE; Cooke, SF; Yeo, CH				Attwell, PJE; Cooke, SF; Yeo, CH			Cerebellar function in consolidation of a motor memory	NEURON			English	Article							NICTITATING-MEMBRANE RESPONSE; CONDITIONED EYELID RESPONSES; CLIMBING FIBER ACTIVATION; INFERIOR OLIVE; PURKINJE-CELLS; MOSSY FIBER; REVERSIBLE INACTIVATIONS; LOBULE HVI; RABBIT; ACQUISITION	Several forms of motor learning, including classical conditioning of the eyeblink and nictitating membrane response (NMR), are dependent upon the cerebellum, but it is not known how motor memories are stored within the cerebellar circuitry. Localized infusions of the GABA(A) agonist muscimol were used to target putative consolidation processes by producing reversible inactivations after NMR conditioning sessions. Post-training inactivations of eyeblink control regions in cerebellar cortical lobule HVI completely prevented conditioning from developing over four sessions. In contrast, similar inactivations of eyeblink control regions in the cerebellar nuclei allowed conditioning to develop normally. These findings provide evidence that there are critical posttraining memory consolidation processes for eyeblink conditioning mediated by the cerebellar cortex.	UCL, Dept Anat & Dev Biol, London WC1E 6BT, England	University of London; University College London	Yeo, CH (corresponding author), UCL, Dept Anat & Dev Biol, Gower St, London WC1E 6BT, England.	c.yeo@ucl.ac.uk		cooke, samuel/0000-0002-4876-6502				ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; ANDERSSON G, 1987, EXP BRAIN RES, V67, P533; ANDERSSON G, 1988, EXP BRAIN RES, V72, P450; ANDERSSON G, 1987, EXP BRAIN RES, V67, P523; Attwell PJE, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-24-j0003.1999; Attwell PJE, 2001, J NEUROSCI, V21, P5715, DOI 10.1523/JNEUROSCI.21-15-05715.2001; Bao SW, 2002, P NATL ACAD SCI USA, V99, P1592, DOI 10.1073/pnas.032655399; BENEDETTI F, 1983, J PHYSIOL-LONDON, V340, P195, DOI 10.1113/jphysiol.1983.sp014758; Bracha V, 1998, BRAIN RES, V788, P169, DOI 10.1016/S0006-8993(97)01535-7; BRIONI JD, 1989, BRAIN RES, V487, P105, DOI 10.1016/0006-8993(89)90945-1; COLIN F, 1980, BRAIN RES, V187, P3, DOI 10.1016/0006-8993(80)90491-6; D'Angelo E, 2001, J NEUROSCI, V21, P759, DOI 10.1523/JNEUROSCI.21-03-00759.2001; Garcia KS, 1998, NEUROPHARMACOLOGY, V37, P471, DOI 10.1016/S0028-3908(98)00055-0; GILBERT P, 1975, NATURE, V254, P688, DOI 10.1038/254688a0; GORMEZANO I, 1962, SCIENCE, V138, P33, DOI 10.1126/science.138.3536.33; GRUART A, 1995, EXP BRAIN RES, V104, P431; Hansel C, 2001, NAT NEUROSCI, V4, P467, DOI 10.1038/87419; Hardiman MJ, 1996, EXP BRAIN RES, V110, P235; HARDIMAN MJ, 1992, EUR J NEUROSCI, V4, P966, DOI 10.1111/j.1460-9568.1992.tb00123.x; HERNANDEZ LL, 1983, BEHAV NEUROSCI, V97, P478, DOI 10.1037/0735-7044.97.3.478; Hesslow G, 1999, NEURON, V24, P179, DOI 10.1016/S0896-6273(00)80831-4; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; ITO M, 1982, ANNU REV NEUROSCI, V5, P275, DOI 10.1146/annurev.ne.05.030182.001423; Ito M, 1998, TRENDS COGN SCI, V2, P313, DOI 10.1016/S1364-6613(98)01222-4; IZQUIERDO I, 1990, BEHAV NEURAL BIOL, V54, P105, DOI 10.1016/0163-1047(90)91282-G; JOMTELL H, 2002, NEURON, V34, P797; KEHOE EJ, 1974, B PSYCHONOMIC SOC, V4, P434, DOI 10.3758/BF03336746; Kim JJ, 1997, TRENDS NEUROSCI, V20, P177, DOI 10.1016/S0166-2236(96)10081-3; KRUPA DJ, 1995, P NATL ACAD SCI USA, V92, P5097, DOI 10.1073/pnas.92.11.5097; KRUPA DJ, 1993, SCIENCE, V260, P989, DOI 10.1126/science.8493536; Lisberger SG, 1998, CELL, V92, P701, DOI 10.1016/S0092-8674(00)81397-5; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; MATTHIES H, 1989, PROG NEUROBIOL, V32, P277, DOI 10.1016/0301-0082(89)90024-5; MCCORMICK DA, 1984, SCIENCE, V223, P296, DOI 10.1126/science.6701513; MCCORMICK DA, 1985, BRAIN RES, V359, P120, DOI 10.1016/0006-8993(85)91419-2; MCGAUGH JL, 1966, SCIENCE, V153, P1351, DOI 10.1126/science.153.3742.1351; Medina JF, 2000, NAT NEUROSCI, V3, P1205, DOI 10.1038/81486; Medina JF, 1999, J NEUROSCI, V19, P7140, DOI 10.1523/JNEUROSCI.19-16-07140.1999; MONTAROLO PG, 1982, J PHYSIOL-LONDON, V332, P187, DOI 10.1113/jphysiol.1982.sp014409; PERRETT SP, 1995, J NEUROSCI, V15, P2074, DOI 10.1523/JNEUROSCI.15-03-02074.1995; Ramnani N, 1996, J PHYSIOL-LONDON, V495, P159, DOI 10.1113/jphysiol.1996.sp021581; Raymond JL, 1996, SCIENCE, V272, P1126, DOI 10.1126/science.272.5265.1126; SCAVIO MJ, 1992, BEHAV NEUROSCI, V106, P900, DOI 10.1037/0735-7044.106.6.900; Shadmehr R, 1997, J NEUROSCI, V17, P409, DOI 10.1523/JNEUROSCI.17-01-00409.1997; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; Vazdarjanova A, 1999, J NEUROSCI, V19, P6615; Welsh JP, 1998, EUR J NEUROSCI, V10, P3321, DOI 10.1046/j.1460-9568.1998.00400.x; YEO CH, 1985, EXP BRAIN RES, V60, P114, DOI 10.1007/BF00237024; Yeo CH, 1998, TRENDS COGN SCI, V2, P322, DOI 10.1016/S1364-6613(98)01219-4; YEO CH, 1992, EXP BRAIN RES, V88, P623; YEO CH, 1985, EXP BRAIN RES, V60, P87, DOI 10.1007/BF00237022; YEO CH, 1985, EXP BRAIN RES, V60, P99, DOI 10.1007/BF00237023; Yeo CH, 1997, LEARN MEMORY, V3, P557, DOI 10.1101/lm.3.6.557; YEO CH, 1986, EXP BRAIN RES, V63, P81	54	115	117	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUN 13	2002	34	6					1011	1020		10.1016/S0896-6273(02)00719-5	http://dx.doi.org/10.1016/S0896-6273(02)00719-5			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	563HF	12086647	Bronze			2022-12-24	WOS:000176249700017
J	Delmas, P; Wanaverbecq, N; Abogadie, FC; Mistry, M; Brown, DA				Delmas, P; Wanaverbecq, N; Abogadie, FC; Mistry, M; Brown, DA			Signaling microdomains define the specificity of receptor-mediated InsP(3) pathways in neurons	NEURON			English	Article							RAT SYMPATHETIC NEURONS; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; INTRACELLULAR CA2+ STORES; M-CURRENT INHIBITION; PROTEIN-KINASE-C; MUSCARINIC INHIBITION; PHOSPHOLIPASE-C; POTENTIAL TRP; CALCIUM-ENTRY; CHANNELS	M-1 muscarinic (M(1)AChRs) and B-2 bradykinin (B(2)Rs) receptors are two PLCbeta-coupled receptors that mobilize Ca2+ in nonexcitable cells. In many neurons, however, B(2)Rs but not M(1)AChRs mobilize intracellular Ca2+. We have studied the membrane organization and dynamics underlying this coupling specificity by using Trp channels as biosensors for real-time detection of PLCbeta products. We found that, in sympathetic neurons, although both receptors rapidly produced DAG and InsP(3) as messengers, only InsP(3) formed by B(2)Rs has the ability to activate IP(3)Rs. This exclusive coupling results from spatially restricted complexes linking B(2)Rs to IP(3)Rs, a missing partnership for M(1)AChRs. These complexes allow fast and localized rises of InsP(3), necessary to activate the low-affinity neuronal IP3R. Thus, these signaling microdomains are of critical importance for the induction of selective responses, discriminating proinflammatory information associated with B(2)Rs from cholinergic neurotransmission.	UCL, Dept Pharmacol, Wellcome Lab Mol Pharmacol, London WC1E 6BT, England; CNRS, F-13402 Marseille, France	University of London; University College London; Centre National de la Recherche Scientifique (CNRS)	Delmas, P (corresponding author), UCL, Dept Pharmacol, Wellcome Lab Mol Pharmacol, Gower St, London WC1E 6BT, England.	delmas@irlnb.cnrs-mrs.fr	Brown, David A/J-9019-2012	Wanaverbecq, Nicolas/0000-0001-5486-2771				BERHNEIM L, 1992, P NATL ACAD SCI USA, V89, P9544; BERRIDGE MJ, 1993, NATURE, V365, P388, DOI 10.1038/365388a0; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Boulay G, 1999, P NATL ACAD SCI USA, V96, P14955, DOI 10.1073/pnas.96.26.14955; Boulay G, 1997, J BIOL CHEM, V272, P29672, DOI 10.1074/jbc.272.47.29672; BOURGUIGNON LYW, 1993, CELL BIOL INT, V17, P751, DOI 10.1006/cbir.1993.1136; Brown DA, 1997, LIFE SCI, V60, P1137, DOI 10.1016/S0024-3205(97)00058-1; CAULFIELD MP, 1993, PHARMACOL THERAPEUT, V58, P319, DOI 10.1016/0163-7258(93)90027-B; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Cruzblanca H, 1998, P NATL ACAD SCI USA, V95, P7151, DOI 10.1073/pnas.95.12.7151; del Rio E, 1999, J PHYSIOL-LONDON, V520, P101, DOI 10.1111/j.1469-7793.1999.00101.x; Delmas P, 1999, J PHYSIOL-LONDON, V518, P23, DOI 10.1111/j.1469-7793.1999.0023r.x; Delmas P, 2000, NAT NEUROSCI, V3, P670, DOI 10.1038/76621; Delmas P, 1998, EUR J NEUROSCI, V10, P1654, DOI 10.1046/j.1460-9568.1998.00170.x; Delmas P, 1998, J PHYSIOL-LONDON, V506, P319, DOI 10.1111/j.1469-7793.1998.319bw.x; Dray A, 1997, CAN J PHYSIOL PHARM, V75, P704, DOI 10.1139/cjpp-75-6-704; DRAY A, 1993, TRENDS NEUROSCI, V16, P99, DOI 10.1016/0166-2236(93)90133-7; Fagni L, 2000, TRENDS NEUROSCI, V23, P80, DOI 10.1016/S0166-2236(99)01492-7; FELDER CC, 1995, FASEB J, V9, P619, DOI 10.1096/fasebj.9.8.7768353; Fink CC, 2000, BIOPHYS J, V79, P163, DOI 10.1016/S0006-3495(00)76281-3; FUKUDA K, 1988, NATURE, V335, P355, DOI 10.1038/335355a0; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Haley JE, 2000, J NEUROSCI, V20, P3973; Haley JE, 1998, J NEUROSCI, V18, P4521; HALEY JE, 2000, J NEUROSCI, V20, P1; Hamilton SE, 1997, P NATL ACAD SCI USA, V94, P13311, DOI 10.1073/pnas.94.24.13311; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; Hirose K, 1999, SCIENCE, V284, P1527, DOI 10.1126/science.284.5419.1527; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; JONES S, 1995, NEURON, V14, P399, DOI 10.1016/0896-6273(95)90295-3; KHODAKHAH K, 1993, P NATL ACAD SCI USA, V90, P4976, DOI 10.1073/pnas.90.11.4976; LEE SB, 1995, CURR OPIN CELL BIOL, V7, P183, DOI 10.1016/0955-0674(95)80026-3; Lin RW, 2001, P NATL ACAD SCI USA, V98, P5258, DOI 10.1073/pnas.011538198; Lockwich TP, 2000, J BIOL CHEM, V275, P11934, DOI 10.1074/jbc.275.16.11934; Ma HT, 2000, SCIENCE, V287, P1647, DOI 10.1126/science.287.5458.1647; MARRION NV, 1989, BRIT J PHARMACOL, V98, P557, DOI 10.1111/j.1476-5381.1989.tb12630.x; MARSH SJ, 1995, NEURON, V15, P729, DOI 10.1016/0896-6273(95)90160-4; Michikawa T, 1999, NEURON, V23, P799, DOI 10.1016/S0896-6273(01)80037-4; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; Patterson RL, 1999, CELL, V98, P487, DOI 10.1016/S0092-8674(00)81977-7; Putney JW, 1999, P NATL ACAD SCI USA, V96, P14669, DOI 10.1073/pnas.96.26.14669; Rich TC, 2000, J GEN PHYSIOL, V116, P147, DOI 10.1085/jgp.116.2.147; ROBBINS J, 1993, J PHYSIOL-LONDON, V469, P153, DOI 10.1113/jphysiol.1993.sp019809; Rosado JA, 2000, BIOCHEM J, V350, P631, DOI 10.1042/0264-6021:3500631; ROSSIER MF, 1991, BIOCHEM J, V274, P643, DOI 10.1042/bj2740643; Sakmann B., 1995, SINGLE CHANNEL RECOR; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Xiao B, 2000, CURR OPIN NEUROBIOL, V10, P370, DOI 10.1016/S0959-4388(00)00087-8; Zhu X, 1996, CELL, V85, P661, DOI 10.1016/S0092-8674(00)81233-7	52	222	228	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	APR 11	2002	34	2					209	220		10.1016/S0896-6273(02)00641-4	http://dx.doi.org/10.1016/S0896-6273(02)00641-4			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	541GE	11970863	Bronze			2022-12-24	WOS:000174976200007
J	Veruki, ML; Hartveit, E				Veruki, ML; Hartveit, E			All (rod) amacrine cells form a network of electrically coupled Interneurons in the mammalian retina	NEURON			English	Article							SLICE PREPARATION; NEURONS; CURRENTS; PATHWAYS; SYNAPSES; AII	All (rod) amacrine cells in the mammalian retina are reciprocally connected via gap junctions, but there is no physiological evidence that demonstrates a proposed function as electrical synapses. In whole-cell recordings from pairs of All amacrine cells in a slice preparation of the rat retina, bidirectional, nonrectifying electrical coupling was observed in all pairs with overlapping dendritic trees (average conductance similar to700 pS). Coupling displayed characteristics of a low-pass filter, with no evidence for amplification of spike-evoked electrical postsynaptic potentials by active conductances. Coincidence detection, as well as precise temporal synchronization of subthreshold membrane potential oscillations and TTX-sensitive spiking, was commonly observed. These results indicate a unique mode of operation and integrative capability of the network of All amacrine cells.	Univ Bergen, Dept Anat & Cell Biol, N-5009 Bergen, Norway	University of Bergen	Hartveit, E (corresponding author), Univ Bergen, Dept Anat & Cell Biol, Arstadveien 19, N-5009 Bergen, Norway.			Hartveit, Espen/0000-0003-1798-1901; Veruki, Margaret/0000-0002-0532-144X				Bartos M, 2001, J NEUROSCI, V21, P2687, DOI 10.1523/JNEUROSCI.21-08-02687.2001; BOOS R, 1993, J NEUROSCI, V13, P2874; Brivanlou IH, 1998, NEURON, V20, P527, DOI 10.1016/S0896-6273(00)80992-7; Feigenspan A, 2001, J NEUROSCI, V21, P230, DOI 10.1523/JNEUROSCI.21-01-00230.2001; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Galarreta M, 2001, NAT REV NEUROSCI, V2, P425, DOI 10.1038/35077566; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Hartveit E, 1996, J NEUROPHYSIOL, V76, P401, DOI 10.1152/jn.1996.76.1.401; KOLB H, 1974, SCIENCE, V186, P47, DOI 10.1126/science.186.4158.47; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; Loewenstein Y, 2001, P NATL ACAD SCI USA, V98, P8095, DOI 10.1073/pnas.131116898; Mann-Metzer P, 1999, J NEUROSCI, V19, P3298; Martina M, 2000, SCIENCE, V287, P295, DOI 10.1126/science.287.5451.295; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; Mills SL, 2001, J COMP NEUROL, V436, P336; Nolan MF, 1999, J PHYSIOL-LONDON, V519, P753, DOI 10.1111/j.1469-7793.1999.0753n.x; SMITH RG, 1995, VISUAL NEUROSCI, V12, P851, DOI 10.1017/S095252380000941X; STRETTOI E, 1992, J COMP NEUROL, V325, P152, DOI 10.1002/cne.903250203; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Teubner B, 2000, J MEMBRANE BIOL, V176, P249, DOI 10.1007/s002320001094; Van Rijen HVM, 1998, PFLUG ARCH EUR J PHY, V436, P141, DOI 10.1007/s004240050615; Vaney DI, 1997, INVEST OPHTH VIS SCI, V38, P267	22	125	127	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 14	2002	33	6					935	946		10.1016/S0896-6273(02)00609-8	http://dx.doi.org/10.1016/S0896-6273(02)00609-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	530ZK	11906699	Bronze			2022-12-24	WOS:000174389600010
J	Pillow, J; Rubin, N				Pillow, J; Rubin, N			Perceptual completion across the vertical meridian and the role of early visual cortex	NEURON			English	Article							ILLUSORY CONTOURS; CALLOSAL CONNECTIONS; AREAS V1; DYNAMICS; MONKEY; REPRESENTATION; ORGANIZATION; MECHANISMS; SALIENT; FIELDS	Perceptual completion can link widely separated contour fragments and interpolate illusory contours (ICs) between them. The mechanisms underlying such long-range linking are not well understood. Here we report that completion is much poorer when ICs cross the vertical meridian than when they reside entirely within the left or right visual hemifield. This deficit reflects limitations in cross-hemispheric integration. We also show that the sensitivity to the interhemispheric divide is unique to perceptual completion: a comparable task which did not require completion showed no across-meridian impairment. We propose that these findings support the existence of specialized completion mechanisms in early visual cortical areas (V1/V2), since those areas are likely to be more sensitive to the interhemispheric divide.	NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University	Rubin, N (corresponding author), NYU, Ctr Neural Sci, 4 Washington Pl, New York, NY 10003 USA.	nava@cns.nyu.edu	Rubin, Nava/J-5189-2012	Pillow, Jonathan/0000-0002-3638-8831				ANDERSON BL, 1994, NATURE, V367, P365, DOI 10.1038/367365a0; Bakin JS, 2000, J NEUROSCI, V20, P8188; BIEDERMAN I, 1974, J EXP PSYCHOL, V103, P597, DOI 10.1037/h0037158; Blake Randolph, 1995, P17; CLARKE S, 1990, J COMP NEUROL, V298, P188, DOI 10.1002/cne.902980205; Ellis A, 1988, HUMAN COGNITIVE NEUR; FIELD DJ, 1993, VISION RES, V33, P173, DOI 10.1016/0042-6989(93)90156-Q; Fodor J. A, 1983, MODULARITY MIND; Geiger D, 1998, PROC CVPR IEEE, P118, DOI 10.1109/CVPR.1998.698597; GILBERT CD, 1985, VISION RES, V25, P365, DOI 10.1016/0042-6989(85)90061-6; Gillam B, 1987, PERCEPTION ILLUSORY, P268; Gold JM, 2000, CURR BIOL, V10, P663, DOI 10.1016/S0960-9822(00)00523-6; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Grill-Spector K, 1998, HUM BRAIN MAPP, V6, P316, DOI 10.1002/(SICI)1097-0193(1998)6:4<316::AID-HBM9>3.0.CO;2-6; GROSOF DH, 1993, NATURE, V365, P550, DOI 10.1038/365550a0; GROSS CG, 1977, BRAIN RES, V131, P227, DOI 10.1016/0006-8993(77)90517-0; Grossberg S, 1997, PSYCHOL REV, V104, P618, DOI 10.1037/0033-295X.104.3.618; HEITGER F, 1992, VISION RES, V32, P963, DOI 10.1016/0042-6989(92)90039-L; Innocenti GM., 1986, GEN ORG CALLOSAL CON, P291, DOI [10.1007/978-1-4613-2149-1_9, DOI 10.1007/978-1-4613-2149-1_9]; KANIZSA G, 1976, SCI AM, V234, P48, DOI 10.1038/scientificamerican0476-48; Kanizsa G., 1955, RIV PSICOL, V49, P7; Kellman PJ, 1998, J EXP PSYCHOL HUMAN, V24, P859, DOI 10.1037/0096-1523.24.3.859; KELLMAN PJ, 1991, COGNITIVE PSYCHOL, V23, P141, DOI 10.1016/0010-0285(91)90009-D; KENNEDY H, 1986, J COMP NEUROL, V247, P398, DOI 10.1002/cne.902470309; Lee TS, 2001, P NATL ACAD SCI USA, V98, P1907, DOI 10.1073/pnas.031579998; Lee TS, 1998, VISION RES, V38, P2429, DOI 10.1016/S0042-6989(97)00464-1; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Mendola JD, 1999, J NEUROSCI, V19, P8560; MINGUZZI GF, 1987, PERCEPTION ILLUSORY, P71; MUMFORD D, 1994, LARGE SCALE NEURONAL, P125; MURRAY MM, 2002, IN PRESS J NEUROSCI; Murray RF, 2001, INVEST OPHTH VIS SCI, V42, pS723; NAKAYAMA K, 1990, VISION RES, V30, P1811, DOI 10.1016/0042-6989(90)90161-D; NEWSOME WT, 1980, J COMP NEUROL, V194, P209, DOI 10.1002/cne.901940111; PETERHANS E, 1989, J NEUROSCI, V9, P1749; PETERSON MA, 1994, CURR DIR PSYCHOL SCI, V3, P105, DOI 10.1111/1467-8721.ep10770552; POTTER MC, 1975, SCIENCE, V187, P965, DOI 10.1126/science.1145183; RINGO JL, 1994, CEREB CORTEX, V4, P331, DOI 10.1093/cercor/4.4.331; Rock I., 1987, PERCEPTION ILLUSORY, P62, DOI [10.1007/978-1-4612-4760-9_6, DOI 10.1007/978-1-4612-4760-9_6]; Rubin N, 1996, SCIENCE, V271, P651, DOI 10.1126/science.271.5249.651; Rubin N, 2001, PERCEPTION, V30, P339, DOI 10.1068/p3173; Rubin N, 1997, CURR BIOL, V7, P461, DOI 10.1016/S0960-9822(06)00217-X; Saron CD, 2002, IS CL CO NE, P171; Seghier M, 2000, CEREB CORTEX, V10, P663, DOI 10.1093/cercor/10.7.663; Sugita Y, 1999, NATURE, V401, P269, DOI 10.1038/45785; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P818, DOI 10.1073/pnas.95.3.818; ULLMAN S, 1976, BIOL CYBERN, V25, P1; Ullman S., 1988, P 2 INT C COMP VIS, P321, DOI DOI 10.1109/CCV.1988.590008; VONDERHEYDT R, 1984, SCIENCE, V224, P1260, DOI 10.1126/science.6539501; WALLACH H, 1988, PERCEPT PSYCHOPHYS, V43, P101, DOI 10.3758/BF03214186; Williams LR, 1997, NEURAL COMPUT, V9, P837, DOI 10.1162/neco.1997.9.4.837; Wilson HR, 2001, NATURE, V412, P907, DOI 10.1038/35091066; Yen SC, 1998, VISION RES, V38, P719, DOI 10.1016/S0042-6989(97)00197-1	53	73	74	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 28	2002	33	5					805	813		10.1016/S0896-6273(02)00605-0	http://dx.doi.org/10.1016/S0896-6273(02)00605-0			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	529EC	11879656	Bronze, Green Submitted			2022-12-24	WOS:000174286200015
J	Weliky, M; Fiser, J; Hunt, RH; Wagner, DN				Weliky, M; Fiser, J; Hunt, RH; Wagner, DN			Coding of natural scenes in primary visual cortex	NEURON			English	Article							CLASSICAL RECEPTIVE-FIELD; STRIATE CORTEX; CELLS; CAT; SUPPRESSION; INHIBITION; RESPONSES; NEURONS; STIMULI; REPRESENTATION	Natural scene coding in ferret visual cortex was investigated using a new technique for multi-site recording of neuronal activity from the cortical surface. Surface recordings accurately reflected radially aligned layer 2/3 activity. At individual sites, evoked activity to natural scenes was weakly correlated with the local image contrast structure failing within the cells' classical receptive field. However, a population code, derived from activity integrated across cortical sites having retinotopically overlapping receptive fields, correlated strongly with the local image contrast structure. Cell responses demonstrated high lifetime sparseness, population sparseness, and high dispersal values, implying efficient neural coding in terms of information processing. These results indicate that while cells at an individual cortical site do not provide a reliable estimate of the local contrast structure in natural scenes, cell activity integrated across distributed cortical sites is closely related to this structure in the form of a sparse and dispersed code.	Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA	University of Rochester	Weliky, M (corresponding author), Univ Rochester, Dept Brain & Cognit Sci, Meliora Hall, Rochester, NY 14627 USA.	weliky@cvs.rochester.edu	Fiser, József/A-2877-2009					ALBRECHT DG, 1982, J NEUROPHYSIOL, V48, P217, DOI 10.1152/jn.1982.48.1.217; ALLMAN J, 1985, ANNU REV NEUROSCI, V8, P407, DOI 10.1146/annurev.ne.08.030185.002203; Barlow HB, 1989, NEURAL COMPUT, V1, P295, DOI 10.1162/neco.1989.1.3.295; BLAKEMORE C, 1972, EXP BRAIN RES, V15, P439; Bringuier V, 1999, SCIENCE, V283, P695, DOI 10.1126/science.283.5402.695; DEANGELIS GC, 1992, J NEUROPHYSIOL, V68, P144, DOI 10.1152/jn.1992.68.1.144; DeAngelis GC, 1998, NATURE, V394, P677, DOI 10.1038/29299; DEVALOIS KK, 1983, J PHYSIOL-LONDON, V336, P359, DOI 10.1113/jphysiol.1983.sp014586; DEVALOIS RL, 1982, VISION RES, V22, P545, DOI 10.1016/0042-6989(82)90113-4; FIELD DJ, 1994, NEURAL COMPUT, V6, P559, DOI 10.1162/neco.1994.6.4.559; Fries P, 1997, P NATL ACAD SCI USA, V94, P12699, DOI 10.1073/pnas.94.23.12699; Gabor D., 1946, J I ELECT ENG LOND, V93, P429, DOI DOI 10.1049/JI-3-2.1946.0074; GILBERT CD, 1990, VISION RES, V30, P1689, DOI 10.1016/0042-6989(90)90153-C; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; LADES M, 1993, IEEE T COMPUT, V42, P300, DOI 10.1109/12.210173; Levitt JB, 1997, NATURE, V387, P73, DOI 10.1038/387073a0; LI CY, 1994, VISION RES, V34, P2337, DOI 10.1016/0042-6989(94)90280-1; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; NELSON JI, 1978, BRAIN RES, V139, P359, DOI 10.1016/0006-8993(78)90937-X; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Polat U, 1998, NATURE, V391, P580, DOI 10.1038/35372; ROLLS ET, 1995, J NEUROPHYSIOL, V73, P713, DOI 10.1152/jn.1995.73.2.713; Rossi AF, 1996, SCIENCE, V273, P1104, DOI 10.1126/science.273.5278.1104; SILLITO AM, 1995, NATURE, V378, P492, DOI 10.1038/378492a0; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; TREVES A, 1991, NETWORK-COMP NEURAL, V2, P371, DOI 10.1088/0954-898X/2/4/004; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Walker GA, 1999, J NEUROSCI, V19, P10536; Walker GA, 2000, VISUAL NEUROSCI, V17, P369, DOI 10.1017/S0952523800173055; Weliky M, 1997, NATURE, V386, P680, DOI 10.1038/386680a0; White LE, 1999, J NEUROSCI, V19, P7089, DOI 10.1523/JNEUROSCI.19-16-07089.1999; Willmore B, 2000, PERCEPTION, V29, P1017, DOI 10.1068/p2963; Willmore B, 2001, NETWORK-COMP NEURAL, V12, P255, DOI 10.1088/0954-898X/12/3/302	33	95	97	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 20	2003	37	4					703	718		10.1016/S0896-6273(03)00022-9	http://dx.doi.org/10.1016/S0896-6273(03)00022-9			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	648EH	12597866	Bronze			2022-12-24	WOS:000181136500017
J	Anderson, AK; Christoff, K; Stappen, I; Panitz, D; Ghahremani, DG; Glover, G; Gabrieli, JDE; Sobel, N				Anderson, AK; Christoff, K; Stappen, I; Panitz, D; Ghahremani, DG; Glover, G; Gabrieli, JDE; Sobel, N			Dissociated neural representations of intensity and valence in human olfaction	NATURE NEUROSCIENCE			English	Article							EVENT-RELATED POTENTIALS; HUMAN AMYGDALA; ORBITOFRONTAL CORTEX; EMOTIONAL AROUSAL; PREFRONTAL CORTEX; ODOR PLEASANTNESS; MOOD DISORDERS; TEMPORAL-LOBE; ACTIVATION; STIMULI	Affective experience has been described in terms of two primary dimensions: intensity and valence. In the human brain, it is intrinsically difficult to dissociate the neural coding of these affective dimensions for visual and auditory stimuli, but such dissociation is more readily achieved in olfaction, where intensity and valence can be manipulated independently. Using event-related functional magnetic resonance imaging (fMRI), we found amygdala activation to be associated with intensity, and not valence, of odors. Activity in regions of orbitofrontal cortex, in contrast, were associated with valence independent of intensity. These findings show that distinct olfactory regions subserve the analysis of the degree and quality of olfactory stimulation, suggesting that the affective representations of intensity and valence draw upon dissociable neural substrates.	Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; Univ Vienna, Inst Pharmaceut Chem, A-1090 Vienna, Austria; Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Stanford University; University of Vienna; Stanford University; University of California System; University of California Berkeley	Anderson, AK (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, 349 Mulford Hall, Berkeley, CA 94720 USA.	adam.k.anderson@stanford.edu; nsobel@socrates.berkeley.edu	Gabrieli, John/AAJ-2869-2020	Sobel, Noam/0000-0002-3232-9391				Adolphs R, 1999, PSYCHOL SCI, V10, P167, DOI 10.1111/1467-9280.00126; Anderson AK, 2001, NATURE, V411, P305, DOI 10.1038/35077083; Anderson AK, 2002, J COGNITIVE NEUROSCI, V14, P709, DOI 10.1162/08989290260138618; Barrett LF, 1999, CURR DIR PSYCHOL SCI, V8, P10, DOI 10.1111/1467-8721.00003; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bensafi M, 2002, CHEM SENSES, V27, P703, DOI 10.1093/chemse/27.8.703; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; Cahill L, 1998, TRENDS NEUROSCI, V21, P294, DOI 10.1016/S0166-2236(97)01214-9; CAIN WS, 1978, PERCEPTION, V7, P459, DOI 10.1068/p070459; Canli T, 1998, NEUROREPORT, V9, P3233, DOI 10.1097/00001756-199810050-00019; Carretie L, 2001, INT J PSYCHOPHYSIOL, V41, P75, DOI 10.1016/S0167-8760(00)00195-1; Davidson RJ, 1999, TRENDS COGN SCI, V3, P11, DOI 10.1016/S1364-6613(98)01265-0; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; DOTY RL, 1975, PERCEPT PSYCHOPHYS, V17, P492, DOI 10.3758/BF03203300; Dravnieks A., 1985, ATLAS ODOR CHARACTER; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; Duchamp-Viret P, 2000, J NEUROSCI, V20, P2383; Gallagher M, 2000, AMYGDALA FUNCTIONAL, P311; Hamann SB, 1999, NAT NEUROSCI, V2, P289, DOI 10.1038/6404; Hamann SB, 2002, PSYCHOL SCI, V13, P135, DOI 10.1111/1467-9280.00425; HENION KE, 1971, J EXP PSYCHOL, V90, P275, DOI 10.1037/h0031549; Irwin W, 1996, NEUROREPORT, V7, P1765, DOI 10.1097/00001756-199607290-00014; JonesGotman M, 1997, BRAIN, V120, P1845, DOI 10.1093/brain/120.10.1845; LaBar KS, 1998, PSYCHOL SCI, V9, P490, DOI 10.1111/1467-9280.00090; Lane RD, 1997, NEUROPSYCHOLOGIA, V35, P1437, DOI 10.1016/S0028-3932(97)00070-5; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; Lazarus R.S., 1991, EMOTION ADAPTATION; LEDOUX JE, 1995, ANNU REV PSYCHOL, V46, P209, DOI 10.1146/annurev.ps.46.020195.001233; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; MOSKOWITZ HR, 1976, PERCEPT PSYCHOPHYS, V19, P122, DOI 10.3758/BF03204218; O'Doherty J, 2000, NEUROREPORT, V11, P893, DOI 10.1097/00001756-200003200-00046; Pause BM, 1997, CHEM SENSES, V22, P9, DOI 10.1093/chemse/22.1.9; Price JL, 1999, ANN NY ACAD SCI, V877, P383, DOI 10.1111/j.1749-6632.1999.tb09278.x; Price JL, 1990, HUMAN NERVOUS SYSTEM, P979; ROBINSON RG, 1984, BRAIN, V107, P81, DOI 10.1093/brain/107.1.81; Rolls ET, 2001, CHEM SENSES, V26, P595, DOI 10.1093/chemse/26.5.595; Royet JP, 2000, J NEUROSCI, V20, P7752; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; SAKAMOTO N, 1999, HDB CHEM NEUROANATOM, V15, P15; Savic I, 2000, NEURON, V26, P735, DOI 10.1016/S0896-6273(00)81209-X; Sobel N, 1998, NATURE, V392, P282, DOI 10.1038/32654; Sobel N, 2000, J NEUROPHYSIOL, V83, P537, DOI 10.1152/jn.2000.83.1.537; Wilson DA, 1997, J NEUROPHYSIOL, V78, P160, DOI 10.1152/jn.1997.78.1.160; Zald DH, 1998, J CEREBR BLOOD F MET, V18, P896, DOI 10.1097/00004647-199808000-00010; Zald DH, 1997, P NATL ACAD SCI USA, V94, P4119, DOI 10.1073/pnas.94.8.4119; Zatorre RJ, 2000, NEUROREPORT, V11, P2711, DOI 10.1097/00001756-200008210-00021; ZATORRE RJ, 1992, NATURE, V360, P339, DOI 10.1038/360339a0; Zou ZH, 2001, NATURE, V414, P173, DOI 10.1038/35102506	48	786	796	3	93	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2003	6	2					196	202		10.1038/nn1001	http://dx.doi.org/10.1038/nn1001			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	640CL	12536208				2022-12-24	WOS:000180669100021
J	Aron, AR; Fletcher, PC; Bullmore, ET; Sahakian, BJ; Robbins, TW				Aron, AR; Fletcher, PC; Bullmore, ET; Sahakian, BJ; Robbins, TW			Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans	NATURE NEUROSCIENCE			English	Article							FUNCTIONAL MRI		Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England; Univ Cambridge, Dept Psychiat, Brain Mapping Unit, Cambridge CB2 2QQ, England	University of Cambridge; University of Cambridge	Robbins, TW (corresponding author), Univ Cambridge, Dept Expt Psychol, Downing St, Cambridge CB2 3EB, England.	twr2@cam.ac.uk	Sahakian, Barbara/AAW-1198-2020; Robbins, Trevor W/A-7551-2008; Bullmore, Ed/C-1706-2012; Li, Chong/F-4265-2015; Fletcher, Paul/F-5380-2011	Sahakian, Barbara/0000-0001-7352-1745; Bullmore, Ed/0000-0002-8955-8283; Robbins, Trevor/0000-0003-0642-5977; Fletcher, Paul/0000-0001-8257-1517	Wellcome Trust [064351] Funding Source: Medline; ESRC [ES/F028814/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Brett M, 2001, NEUROIMAGE, V14, P486, DOI 10.1006/nimg.2001.0845; Bunge SA, 2002, NEURON, V33, P301, DOI 10.1016/S0896-6273(01)00583-9; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; GoldmanRakic PS, 1996, PHILOS T ROY SOC B, V351, P1445, DOI 10.1098/rstb.1996.0129; Konishi S, 1999, BRAIN, V122, P981, DOI 10.1093/brain/122.5.981; Konishi S, 1998, EUR J NEUROSCI, V10, P1209, DOI 10.1046/j.1460-9568.1998.00167.x; Logan G. D., 2000, ATTENTION PERFORM, P653; Logan Gordon D., 1994, P189; Menon V, 2001, HUM BRAIN MAPP, V12, P131, DOI 10.1002/1097-0193(200103)12:3<131::AID-HBM1010>3.0.CO;2-C; Rubia K, 1999, AM J PSYCHIAT, V156, P891, DOI 10.1176/ajp.156.6.891; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; WILLIAMS EJ, 1959, J ROY STAT SOC B, V21, P396	13	1198	1223	5	114	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2003	6	2					115	116		10.1038/nn1003	http://dx.doi.org/10.1038/nn1003			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	640CL	12536210				2022-12-24	WOS:000180669100009
J	Izzo, E; Martin-Fardon, R; Koob, GF; Weiss, F; Sanna, PP				Izzo, E; Martin-Fardon, R; Koob, GF; Weiss, F; Sanna, PP			Neural plasticity and addiction: PI3-kinase and cocaine behavioral sensitization	NATURE NEUROSCIENCE			English	Article							CONTEXT; PATHWAY; DRUG		Scripps Res Inst, Dept Neuropharmacol, San Diego, CA 92103 USA	Scripps Research Institute	Sanna, PP (corresponding author), Scripps Res Inst, Dept Neuropharmacol, 10550 N Torrey Pines Rd, San Diego, CA 92103 USA.	psanna@scripps.edu	Martin-Fardon, R/ABB-7865-2020		NIDA NIH HHS [DA04398, DA13821, DA08467] Funding Source: Medline; NIMH NIH HHS [MH62140] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH062140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA008467, R01DA004398, R01DA013821] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Bell K, 1996, PSYCHOPHARMACOLOGY, V127, P377, DOI 10.1007/BF02806018; Jackson A, 1998, BEHAV PHARMACOL, V9, P457, DOI 10.1097/00008877-199809000-00009; Koob GF, 1998, NEURON, V21, P467, DOI 10.1016/S0896-6273(00)80557-7; Lin CH, 2001, NEURON, V31, P841, DOI 10.1016/S0896-6273(01)00433-0; MISCRENDINO MJ, 1995, BRAIN RES, V674, P299; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Pierce RC, 1998, J PHARMACOL EXP THER, V286, P1171; Pierce RC, 1999, J NEUROSCI, V19, P8685; POST RM, 1987, PSYCHOPHARMACOL BULL, V23, P425; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Sanna PP, 2002, J NEUROSCI, V22, P3359; Vaillant AR, 1999, J CELL BIOL, V146, P955, DOI 10.1083/jcb.146.5.955; Wymann MP, 1998, BBA-MOL CELL BIOL L, V1436, P127, DOI 10.1016/S0005-2760(98)00139-8	13	51	52	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2002	5	12					1263	1264		10.1038/nn977	http://dx.doi.org/10.1038/nn977			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	618ZE	12436114				2022-12-24	WOS:000179447500007
J	Nguyen, QT; Sanes, JR; Lichtman, JW				Nguyen, QT; Sanes, JR; Lichtman, JW			Pre-existing pathways promote precise projection patterns	NATURE NEUROSCIENCE			English	Article							PERIPHERAL-NERVE REGENERATION; DIFFERENT SEGMENTAL LEVELS; GROWTH CONE GUIDANCE; NEUROMUSCULAR-JUNCTIONS; SELECTIVE REINNERVATION; INVIVO VISUALIZATION; POSTSYNAPTIC CHANGES; INTERCOSTAL MUSCLES; SYNAPSE ELIMINATION; TRANSGENIC MICE	A large body of evidence shows that molecular cues promote specific synapse formation by guiding axons and by mediating their association with targets, but much less is known about the contribution of physical cues (such as mechanical constraints) to these processes. Here we used the peripheral motor system to investigate the latter issue. In living mice, we viewed individual motor axons bearing a fluorescent reporter, and mapped the cohort of muscle fibers that they innervated both before and after nerve damage. When gross trauma was minimized (by a nerve-crushing rather than nerve-cutting procedure), regenerating axons retraced their former pathways, bifurcated at original branch points, and formed neuromuscular junctions on the same fibers that they originally innervated. Axonal growth through tubes of non-neural cells seemed to account for this specificity, and specificity degraded when the tubes were cut. These results suggest that nonspecific guidance cues can be sufficient to generate specific synaptic circuitry.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Lichtman, JW (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.							Akaaboune M, 1999, SCIENCE, V286, P503, DOI 10.1126/science.286.5439.503; [Anonymous], [No title captured]; BALICEGORDON RJ, 1990, J NEUROSCI, V10, P894; BALICEGORDON RJ, 1993, J NEUROSCI, V13, P834; Bastmeyer M, 1998, J COMP NEUROL, V392, P1, DOI 10.1002/(SICI)1096-9861(19980302)392:1<1::AID-CNE1>3.0.CO;2-6; Benson DL, 2001, NAT REV NEUROSCI, V2, P899, DOI 10.1038/35104078; BERNSTEIN J, 1961, EXP NEUROL, V4, P262, DOI 10.1016/0014-4886(61)90047-4; BROWN MC, 1987, BRAIN, V110, P695, DOI 10.1093/brain/110.3.695; BROWN MC, 1981, ANNU REV NEUROSCI, V4, P17, DOI 10.1146/annurev.ne.04.030181.000313; BRUSHART TM, 1980, SCIENCE, V208, P603, DOI 10.1126/science.7367884; BRUSHART TM, 1981, NEUROSCIENCE, V6, P2053, DOI 10.1016/0306-4522(81)90043-9; CAJAL SRY, 1928, DEGENERATION REGENER, V1, P66; Carlstedt T, 2000, CURR OPIN NEUROL, V13, P683, DOI 10.1097/00019052-200012000-00012; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; DESANTIS M, 1992, EXP NEUROL, V116, P229, DOI 10.1016/0014-4886(92)90002-8; DESANTIS M, 1993, J COMP NEUROL, V336, P66, DOI 10.1002/cne.903360106; DIAMOND J, 1992, J NEUROSCI, V12, P1467; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Feng GP, 2000, NEURON, V25, P295, DOI 10.1016/S0896-6273(00)80895-8; Fu SY, 1997, MOL NEUROBIOL, V14, P67, DOI 10.1007/BF02740621; Gutmann E, 1944, J ANAT, V78, P15; HARDMAN VJ, 1987, J NEUROSCI, V7, P1031; HENDRY IA, 1986, BRAIN RES, V376, P292, DOI 10.1016/0006-8993(86)90192-7; Ide C, 1996, NEUROSCI RES, V25, P101; Keller-Peck CR, 2001, NEURON, V31, P381, DOI 10.1016/S0896-6273(01)00383-X; Keller-Peck CR, 2001, J NEUROSCI, V21, P6136, DOI 10.1523/JNEUROSCI.21-16-06136.2001; Kiefer R, 2001, PROG NEUROBIOL, V64, P109, DOI 10.1016/S0301-0082(00)00060-5; KUGELBERG E, 1970, J NEUROL NEUROSUR PS, V33, P319, DOI 10.1136/jnnp.33.3.319; Langley J N, 1897, J Physiol, V22, P215; Laskowski MB, 1998, J NEUROSCI, V18, P7328; LASKOWSKI MB, 1988, J NEUROSCI, V8, P3094; LINGLE CJ, 1988, INT ANESTHESIOL CLIN, V26, P288, DOI 10.1097/00004311-198802640-00007; Melancon E, 1997, J NEUROSCI, V17, P7796; Mueller BK, 1999, ANNU REV NEUROSCI, V22, P351, DOI 10.1146/annurev.neuro.22.1.351; NJA A, 1977, J PHYSIOL-LONDON, V272, P633, DOI 10.1113/jphysiol.1977.sp012064; RICH MM, 1989, J NEUROSCI, V9, P1781, DOI 10.1523/jneurosci.09-05-01781.1989; SALONEN V, 1988, ACTA NEUROPATHOL, V75, P331, DOI 10.1007/BF00687785; SANES JR, 1978, J CELL BIOL, V78, P176, DOI 10.1083/jcb.78.1.176; SCHERER SS, 1984, J NEUROCYTOL, V13, P519, DOI 10.1007/BF01148079; Stankovic N, 1996, CELL TISSUE RES, V284, P161, DOI 10.1007/s004410050576; Sunderland S, 1978, NERVES NERVE INJURIE, P69; THOMAS GJ, 1993, ADV BIOPHYS CHEM, V3, P1; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Weiss P, 1934, J EXP ZOOL, V68, P393, DOI 10.1002/jez.1400680304; WESTERFIELD M, 1987, J EXP BIOL, V132, P161; WIGSTON DJ, 1985, J NEUROSCI, V5, P1208; WIGSTON DJ, 1982, NATURE, V299, P464, DOI 10.1038/299464a0; WIGSTON DJ, 1986, J NEUROSCI, V6, P2757; Young JZ, 1942, PHYSIOL REV, V22, P0318, DOI 10.1152/physrev.1942.22.4.318	49	229	236	0	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2002	5	9					861	867		10.1038/nn905	http://dx.doi.org/10.1038/nn905			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587RL	12172551				2022-12-24	WOS:000177656300016
J	Suh, BC; Hille, B				Suh, BC; Hille, B			Recovery from muscarinic modulation of M current channels requires phosphatidylinositol 4,5-bisphosphate synthesis	NEURON			English	Article							LIGHT-CHAIN KINASE; RAT SYMPATHETIC NEURONS; POTASSIUM CURRENT; PHOSPHOINOSITIDE TURNOVER; PHOSPHOLIPASE-C; SENSITIVE POOLS; CA2+ CHANNELS; SMOOTH-MUSCLE; G-PROTEINS; INHIBITION	Suppression of M current channels by muscarinic receptors enhances neuronal excitability. Little is known about the molecular mechanism of this inhibition except the requirement for a specific G protein and the involvement of an unidentified diffusible second messenger. We demonstrate here that intracellular ATP is required for recovery of KCNQ2/KCNQ3 current from muscarinic suppression, with an EC50 of similar to0.5 mM. Substitution of nonhydrolyzable ATP analogs for ATP slowed or prevented recovery. ADPbetaS but not ADP also prevented the recovery. Receptor-mediated inhibition was irreversible when recycling of agonist-sensitive pools of phosphatidylinositol-4,5-bisphosphate (PIP2) was blocked by lipid kinase inhibitors. Lipid phosphorylation by PI4-kinase is required for recovery from muscarinic modulation of M current.	Univ Washington, Sch Med, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Hille, B (corresponding author), Univ Washington, Sch Med, Dept Physiol & Biophys, Seattle, WA 98195 USA.	hille@u.washington.edu	Oka, Yoshitaka/C-9670-2010	Oka, Yoshitaka/0000-0002-3482-3051	NIDA NIH HHS [DA 00286] Funding Source: Medline; NINDS NIH HHS [NS 08174] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS008174] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKASU T, 1993, NEURON, V11, P1133, DOI 10.1016/0896-6273(93)90226-H; Aromolaran AS, 2000, J PHYSIOL-LONDON, V524, P853, DOI 10.1111/j.1469-7793.2000.00853.x; Balla T, 1998, BBA-MOL CELL BIOL L, V1436, P69, DOI 10.1016/S0005-2760(98)00134-9; BEECH DJ, 1991, P NATL ACAD SCI USA, V88, P652, DOI 10.1073/pnas.88.2.652; BOSMA MM, 1989, P NATL ACAD SCI USA, V86, P2943, DOI 10.1073/pnas.86.8.2943; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; CAULFIELD MP, 1994, J PHYSIOL-LONDON, V477, P415, DOI 10.1113/jphysiol.1994.sp020203; CHEN HY, 1992, BRIT J PHARMACOL, V105, P329, DOI 10.1111/j.1476-5381.1992.tb14254.x; Choi S, 1996, J NEUROSCI, V16, P36; Cruzblanca H, 1998, P NATL ACAD SCI USA, V95, P7151, DOI 10.1073/pnas.95.12.7151; del Rio E, 1999, J PHYSIOL-LONDON, V520, P101, DOI 10.1111/j.1469-7793.1999.00101.x; Delmas P, 2002, NEURON, V34, P209, DOI 10.1016/S0896-6273(02)00641-4; DHAND R, 1994, EMBO J, V13, P511, DOI 10.1002/j.1460-2075.1994.tb06289.x; ECKSTEIN F, 1976, BIOCHEMISTRY-US, V15, P1685, DOI 10.1021/bi00653a015; Fan Z, 1997, J BIOL CHEM, V272, P5388, DOI 10.1074/jbc.272.9.5388; Haley JE, 1998, J NEUROSCI, V18, P4521; Haley JE, 2000, J NEUROSCI, V20; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; HILLE B, 1994, TRENDS NEUROSCI, V17, P531, DOI 10.1016/0166-2236(94)90157-0; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; JENKINSON S, 1994, MOL PHARMACOL, V46, P1138; JONES S, 1995, NEURON, V14, P399, DOI 10.1016/0896-6273(95)90295-3; Lamas JA, 1997, EUR J NEUROSCI, V9, P605, DOI 10.1111/j.1460-9568.1997.tb01637.x; Linseman DA, 1999, J NEUROCHEM, V73, P1933; Marrion NV, 1997, ANNU REV PHYSIOL, V59, P483, DOI 10.1146/annurev.physiol.59.1.483; MARRION NV, 1993, NEURON, V11, P77, DOI 10.1016/0896-6273(93)90272-S; Meyers R, 1997, J BIOL CHEM, V272, P4384, DOI 10.1074/jbc.272.7.4384; NAKANISHI S, 1988, J BIOL CHEM, V263, P6215; NAKANISHI S, 1995, P NATL ACAD SCI USA, V92, P5317, DOI 10.1073/pnas.92.12.5317; OKADA T, 1994, J BIOL CHEM, V269, P3563; PFAFFINGER PJ, 1988, NEURON, V1, P477, DOI 10.1016/0896-6273(88)90178-X; Pfitzer G, 2001, J APPL PHYSIOL, V91, P497, DOI 10.1152/jappl.2001.91.1.497; Poser S, 2000, EMBO J, V19, P4955, DOI 10.1093/emboj/19.18.4955; Samizo K, 1999, BIOCHEM BIOPH RES CO, V261, P95, DOI 10.1006/bbrc.1999.0956; SCHAEFER T, 1994, ANN NY ACAD SCI, V710, P356, DOI 10.1111/j.1749-6632.1994.tb26642.x; SELYANKO AA, 1992, P ROY SOC B-BIOL SCI, V250, P119, DOI 10.1098/rspb.1992.0139; Shapiro MS, 2000, J NEUROSCI, V20, P1710; SHAPIRO MS, 1994, NEURON, V12, P1319, DOI 10.1016/0896-6273(94)90447-2; SHAPIRO MS, 1994, J NEUROSCI, V14, P7109; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; SIMMONS MA, 1994, J PHARMACOL EXP THER, V271, P581; Simmons MA, 1998, J NEUROSCI, V18, P6254; SIMMONS MA, 1990, NEURON, V4, P557, DOI 10.1016/0896-6273(90)90113-T; Sorensen SD, 1998, MOL PHARMACOL, V53, P827; SUH BC, 1995, J NEUROCHEM, V65, P2124; Sui JL, 1998, P NATL ACAD SCI USA, V95, P1307, DOI 10.1073/pnas.95.3.1307; TOKIMASA T, 1995, BRIT J PHARMACOL, V114, P489, DOI 10.1111/j.1476-5381.1995.tb13253.x; TOKIMASA T, 1990, J PHYSIOL-LONDON, V426, P241, DOI 10.1113/jphysiol.1990.sp018136; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; WANG HS, 1995, J PHYSIOL-LONDON, V485, P319, DOI 10.1113/jphysiol.1995.sp020732; Watanabe H, 1998, FASEB J, V12, P341, DOI 10.1096/fasebj.12.3.341; Wiedemann C, 1996, EMBO J, V15, P2094, DOI 10.1002/j.1460-2075.1996.tb00563.x; Willars GB, 1998, J BIOL CHEM, V273, P5037, DOI 10.1074/jbc.273.9.5037; Xie LH, 1999, P NATL ACAD SCI USA, V96, P15292, DOI 10.1073/pnas.96.26.15292; Yu SP, 1998, J NEUROSCI RES, V52, P612, DOI 10.1002/(SICI)1097-4547(19980601)52:5<612::AID-JNR13>3.0.CO;2-3; Yue JC, 2001, J BIOL CHEM, V276, P49093, DOI 10.1074/jbc.M101328200	57	369	379	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 1	2002	35	3					507	520		10.1016/S0896-6273(02)00790-0	http://dx.doi.org/10.1016/S0896-6273(02)00790-0			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	582CB	12165472	Bronze			2022-12-24	WOS:000177331200011
J	Samson, AO; Scherf, T; Eisenstein, M; Chill, JH; Anglister, J				Samson, AO; Scherf, T; Eisenstein, M; Chill, JH; Anglister, J			The mechanism for acetylcholine receptor inhibition by alpha-neurotoxins and species-specific resistance to alpha-bungarotoxin revealed by NMR	NEURON			English	Article							BINDING-SITE; NICOTINIC RECEPTORS; LIGAND-BINDING; HIGH-AFFINITY; SUBUNIT; RESIDUES; PEPTIDE; COMPLEX; SENSITIVITY; PROTEIN	The structure of a peptide corresponding to residues 182-202 of the acetylcholine receptor alpha1 subunit in complex with alpha-bungarotoxin was solved using NMR spectroscopy. The peptide contains the complete sequence of the major determinant of AChR involved in alpha-bungarotoxin binding. One face of the long beta hairpin formed by the AChR peptide consists of exposed nonconserved residues, which interact extensively with the toxin. Mutations of these receptor residues confer resistance to the toxin. Conserved AChR residues form the opposite face of the beta hairpin, which creates the inner and partially hidden pocket for acetylcholine. An NMR-derived model for the receptor complex with two alpha-bungarotoxin molecules shows that this pocket is occupied by the conserved alpha-neurotoxin residue R36, which forms cation-pi interactions with both (alpha)W149 and (gamma)W55/(delta)W57 of the receptor and mimics acetylcholine.	Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Chem Serv, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Anglister, J (corresponding author), Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel.	jacob.anglister@weizmann.ac.il	Chill, Jordan/W-5048-2018	Chill, Jordan/0000-0002-9518-824X				Ariel S, 1998, ANN NY ACAD SCI, V841, P93, DOI 10.1111/j.1749-6632.1998.tb10912.x; ARONHEIM A, 1988, J BIOL CHEM, V263, P9933; BARCHAN D, 1995, BIOCHEMISTRY-US, V34, P9172, DOI 10.1021/bi00028a029; BARCHAN D, 1992, P NATL ACAD SCI USA, V89, P7717, DOI 10.1073/pnas.89.16.7717; BASU AK, 1988, CHEM RES TOXICOL, V1, P1, DOI 10.1021/tx00001a001; BASUS VJ, 1993, BIOCHEMISTRY-US, V32, P12290, DOI 10.1021/bi00097a004; BLOUNT P, 1989, NEURON, V3, P349, DOI 10.1016/0896-6273(89)90259-6; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHATURVEDI V, 1993, BIOCHEMISTRY-US, V32, P9570, DOI 10.1021/bi00088a008; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Grutter T, 2001, TRENDS BIOCHEM SCI, V26, P459, DOI 10.1016/S0968-0004(01)01921-1; HAGGERTY JG, 1981, J BIOL CHEM, V256, P8294; Harel M, 2001, NEURON, V32, P265, DOI 10.1016/S0896-6273(01)00461-5; HAREL M, 1993, P NATL ACAD SCI USA, V90, P9031, DOI 10.1073/pnas.90.19.9031; KAO PN, 1986, J BIOL CHEM, V261, P8085; Karlin A, 1993, Curr Opin Neurobiol, V3, P299, DOI 10.1016/0959-4388(93)90121-E; Kasher R, 2001, CHEM BIOL, V8, P147, DOI 10.1016/S1074-5521(00)90063-2; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Levandoski MM, 1999, J BIOL CHEM, V274, P26113, DOI 10.1074/jbc.274.37.26113; Malany S, 2000, BIOCHEMISTRY-US, V39, P15388, DOI 10.1021/bi001825o; Moise L, 2002, J BIOL CHEM, V277, P12406, DOI 10.1074/jbc.M110320200; NEIDIG KP, 1995, J BIOMOL NMR, V6, P255, DOI 10.1007/BF00197807; OHANA B, 1990, BIOCHEMISTRY-US, V29, P6409, DOI 10.1021/bi00479a011; Osaka H, 2000, J BIOL CHEM, V275, P5478, DOI 10.1074/jbc.275.8.5478; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Roberts G.C.K., 1993, NMR MACROMOLECULES; Samson AO, 2001, BIOCHEMISTRY-US, V40, P5464, DOI 10.1021/bi0022689; Scarselli M, 2002, BIOCHEMISTRY-US, V41, P1457, DOI 10.1021/bi011012f; Scherf T, 1997, P NATL ACAD SCI USA, V94, P6059, DOI 10.1073/pnas.94.12.6059; Scherf T, 2001, P NATL ACAD SCI USA, V98, P6629, DOI 10.1073/pnas.111164298; Servent D, 1998, TOXICOL LETT, V103, P199, DOI 10.1016/S0378-4274(98)00307-5; SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098; Spura A, 1999, BIOCHEMISTRY-US, V38, P4912, DOI 10.1021/bi982656z; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TRONCONI BMC, 1991, BIOCHEMISTRY-US, V30, P2575; Tsetlin V, 1999, EUR J BIOCHEM, V264, P281, DOI 10.1046/j.1432-1327.1999.00623.x; WAGNER G, 1987, J MOL BIOL, V196, P611, DOI 10.1016/0022-2836(87)90037-4; WILSON PT, 1988, MOL PHARMACOL, V34, P643; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Zeng HY, 2001, J BIOL CHEM, V276, P22930, DOI 10.1074/jbc.M102300200; Zhong WG, 1998, P NATL ACAD SCI USA, V95, P12088, DOI 10.1073/pnas.95.21.12088	42	60	65	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 18	2002	35	2					319	332		10.1016/S0896-6273(02)00773-0	http://dx.doi.org/10.1016/S0896-6273(02)00773-0			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	576YF	12160749	Bronze			2022-12-24	WOS:000177034200011
J	Hiyama, TY; Watanabe, E; Ono, K; Inenaga, K; Tamkun, MM; Yoshida, S; Noda, M				Hiyama, TY; Watanabe, E; Ono, K; Inenaga, K; Tamkun, MM; Yoshida, S; Noda, M			Na-x channel involved in CNS sodium-level sensing	NATURE NEUROSCIENCE			English	Article							NEURONS		Natl Inst Basic Biol, Div Mol Neurobiol, Okazaki, Aichi 4448585, Japan; Natl Inst Basic Biol, Ctr Transgen Anim & Plants, Okazaki, Aichi 4448585, Japan; Grad Univ Adv Studies, Dept Mol Biomech, Okazaki, Aichi 4448585, Japan; Kyushu Dent Coll, Dept Physiol, Kokurakita Ku, Kitakyushu, Fukuoka 8038580, Japan; Colorado State Univ, Dept Physiol, Ft Collins, CO 80523 USA; Natl Inst Physiol Sci, Lab Intracellular Metab, Okazaki, Aichi 4448585, Japan; Nagasaki Univ, Sch Med, Dept Physiol, Nagasaki 8528523, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; Kyushu Dental University; Colorado State University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Nagasaki University	Noda, M (corresponding author), Natl Inst Basic Biol, Div Mol Neurobiol, Okazaki, Aichi 4448585, Japan.		Ono, Kentaro/AAV-5616-2021; Noda, Masaharu/D-7146-2016; Hiyama, Takeshi/X-4134-2018	Ono, Kentaro/0000-0003-0891-7705; Noda, Masaharu/0000-0002-3796-524X; Hiyama, Takeshi/0000-0001-8612-8707; Watanabe, Eiji/0000-0001-9089-8122				Denton DA, 1996, P NATL ACAD SCI USA, V93, P7397, DOI 10.1073/pnas.93.14.7397; Goldin AL, 2000, NEURON, V28, P365, DOI 10.1016/S0896-6273(00)00116-1; Goldin AL, 2001, ANNU REV PHYSIOL, V63, P871, DOI 10.1146/annurev.physiol.63.1.871; JOHNSON AK, 1990, CURRENT TOPICS NEURO, V10, P149; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; MINTA A, 1989, J BIOL CHEM, V264, P19449; NOSE H, 1992, J APPL PHYSIOL, V73, P1419, DOI 10.1152/jappl.1992.73.4.1419; OLIET SHR, 1993, NATURE, V364, P341, DOI 10.1038/364341a0; WAKERLEY JB, 1978, BRAIN RES, V148, P425, DOI 10.1016/0006-8993(78)90730-8; Watanabe E, 2000, J NEUROSCI, V20, P7743; Wells T, 1998, MOL CELL ENDOCRINOL, V136, P103, DOI 10.1016/S0303-7207(97)00219-0	11	136	137	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2002	5	6					511	512		10.1038/nn856	http://dx.doi.org/10.1038/nn856			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	556XQ	11992118				2022-12-24	WOS:000175874600007
J	Okazawa, H; Rich, T; Chang, A; Lin, X; Waragai, M; Kajikawa, M; Enokido, Y; Komuro, A; Kato, S; Shibata, M; Hatanaka, H; Mouradian, MM; Sudol, M; Kanazawa, I				Okazawa, H; Rich, T; Chang, A; Lin, X; Waragai, M; Kajikawa, M; Enokido, Y; Komuro, A; Kato, S; Shibata, M; Hatanaka, H; Mouradian, MM; Sudol, M; Kanazawa, I			Interaction between mutant ataxin-1 and POBP-1 affects transcription and cell death	NEURON			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; EXPANDED POLYGLUTAMINE PROTEIN; CREB-BINDING PROTEIN; RNA-POLYMERASE-II; NUCLEAR INCLUSIONS; TRACT-BINDING; WW DOMAIN; DISEASE; AGGREGATION; IDENTIFICATION	PQBP-1 was isolated on the basis of its interaction with polyglutamine tracts. In this study, using in vitro and in vivo assays, we show that the association between ataxin-1 and PQBP-1 is positively influenced by expanded polyglutamine sequences. In cell lines, interaction between the two molecules induces apoptotic cell death. As a possible mechanism underlying this phenomenon, we found that mutant ataxin-1 enhances binding of PQBP-1 to the C-terminal domain of RNA polymerase II large subunit (Pol II). This reduces the level of phosphorylated Pol II and transcription. Our results suggest the involvement of PQBP-1 in the pathology of spinocerebellar ataxia type 1 (SCA1) and support the idea that modified transcription underlies polyglutamine-mediated pathology.	Univ Tokyo, Grad Sch med, Dept Neurol, Bunkyo Ku, Tokyo 1138655, Japan; MBL Co Ltd, Dept Pharmaceut Dev, Nagano 3960002, Japan; Osaka Univ, Inst Prot Res, Div Prot Biosynth, Suita, Osaka 5650871, Japan; JST, ERATO, Sagami Chem Res Ctr, Kanagawa 2290012, Japan; Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; Mt Sinai Med Ctr, Dept Med, New York, NY 10029 USA; Baylor Coll Med, Howard Hughes Med Inst, Dept Pediat Neurol Neurosci & Mol Genet, Houston, TX 77030 USA; NINCDS, Expt Therapeut Branch, NIH, Bethesda, MD 20892 USA	University of Tokyo; Osaka University; Japan Science & Technology Agency (JST); University of Cambridge; Icahn School of Medicine at Mount Sinai; Baylor College of Medicine; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Okazawa, H (corresponding author), Tokyo Metropolitan Inst Neurosci, Dept Mol Therapeut, 2-6 Musashidai, Tokyo 1838526, Japan.	okazawa@tmin.ac.jp		Enokido, Yasushi/0000-0003-3252-504X; Mouradian, M. Maral/0000-0002-9937-412X; Chang, Alex/0000-0001-8584-2984	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002826] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BANFI S, 1994, NAT GENET, V7, P513, DOI 10.1038/ng0894-513; Berry LD, 1997, J CELL BIOL, V137, P1337, DOI 10.1083/jcb.137.6.1337; Boutell JM, 1999, HUM MOL GENET, V8, P1647, DOI 10.1093/hmg/8.9.1647; Chai YH, 1999, HUM MOL GENET, V8, P673, DOI 10.1093/hmg/8.4.673; Chang A, 2000, J BIOL CHEM, V275, P20562, DOI 10.1074/jbc.M002479200; Cummings CJ, 1999, NEURON, V24, P879, DOI 10.1016/S0896-6273(00)81035-1; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Davidson JD, 2000, HUM MOL GENET, V9, P2305, DOI 10.1093/oxfordjournals.hmg.a018922; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Diamond MI, 2000, P NATL ACAD SCI USA, V97, P657, DOI 10.1073/pnas.97.2.657; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Gall JG, 1999, MOL BIOL CELL, V10, P4385, DOI 10.1091/mbc.10.12.4385; Gilman S, 1996, ANN NEUROL, V39, P241, DOI 10.1002/ana.410390214; Goldberg YP, 1996, NAT GENET, V13, P442, DOI 10.1038/ng0896-442; Hirose Y, 2000, GENE DEV, V14, P1415; Hsiao PW, 1999, J BIOL CHEM, V274, P20229, DOI 10.1074/jbc.274.29.20229; Iwamoto K, 2000, GENE, V259, P69, DOI 10.1016/S0378-1119(00)00437-6; Kazantsev A, 1999, P NATL ACAD SCI USA, V96, P11404, DOI 10.1073/pnas.96.20.11404; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Kobayashi Y, 1998, BIOCHEM BIOPH RES CO, V252, P145, DOI 10.1006/bbrc.1998.9624; Koide R, 1999, HUM MOL GENET, V8, P2047, DOI 10.1093/hmg/8.11.2047; Komuro A, 1999, NUCLEIC ACIDS RES, V27, P1957, DOI 10.1093/nar/27.9.1957; Komuro A, 1999, J BIOL CHEM, V274, P36513, DOI 10.1074/jbc.274.51.36513; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Lin X, 2000, NAT NEUROSCI, V3, P157, DOI 10.1038/72101; Lunkes A, 1997, NAT MED, V3, P1201, DOI 10.1038/nm1197-1201; McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; OKAMOTO K, 1990, CELL, V60, P461, DOI 10.1016/0092-8674(90)90597-8; Okazawa H, 1996, P NATL ACAD SCI USA, V93, P11933, DOI 10.1073/pnas.93.21.11933; Okazawa H, 2001, BRAIN RES BULL, V56, P273, DOI 10.1016/S0361-9230(01)00579-2; Okazawa H, 1996, J CELL BIOL, V132, P955, DOI 10.1083/jcb.132.5.955; Ona VO, 1999, NATURE, V399, P263, DOI 10.1038/20446; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; Reuter K, 1999, J MOL BIOL, V294, P515, DOI 10.1006/jmbi.1999.3258; Rich T, 1999, HUM MOL GENET, V8, P2451, DOI 10.1093/hmg/8.13.2451; Sanchez I, 1999, NEURON, V22, P623, DOI 10.1016/S0896-6273(00)80716-3; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Sawa A, 1999, NAT MED, V5, P1194, DOI 10.1038/13518; SERVADIO A, 1995, NAT GENET, V10, P94, DOI 10.1038/ng0595-94; Shibata H, 2000, HUM MOL GENET, V9, P1303, DOI 10.1093/hmg/9.9.1303; Shimohata T, 2000, NAT GENET, V26, P29, DOI 10.1038/79139; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Stenoien DL, 1999, HUM MOL GENET, V8, P731, DOI 10.1093/hmg/8.5.731; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; Wanker EE, 2000, MOL MED TODAY, V6, P387, DOI 10.1016/S1357-4310(00)01761-5; Waragai M, 1999, HUM MOL GENET, V8, P977, DOI 10.1093/hmg/8.6.977; Waragai M, 2000, BIOCHEM BIOPH RES CO, V273, P592, DOI 10.1006/bbrc.2000.2992; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; Yanagisawa H, 2000, HUM MOL GENET, V9, P1433, DOI 10.1093/hmg/9.9.1433; Yue S, 2001, HUM MOL GENET, V10, P25, DOI 10.1093/hmg/10.1.25; Zhang JW, 2000, THIN WALL STRUCT, V38, P1, DOI 10.1016/S0263-8231(00)00027-6	56	149	156	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 30	2002	34	5					701	713		10.1016/S0896-6273(02)00697-9	http://dx.doi.org/10.1016/S0896-6273(02)00697-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	558DV	12062018	Bronze			2022-12-24	WOS:000175951800006
J	Lonze, BE; Riccio, A; Cohen, S; Ginty, DD				Lonze, BE; Riccio, A; Cohen, S; Ginty, DD			Apoptosis, axonal growth defects, and degeneration of peripheral neurons in mice lacking CREB	NEURON			English	Article							ELEMENT-BINDING PROTEIN; FAMILY TRANSCRIPTION FACTOR; BAX-DEFICIENT MICE; SYMPATHETIC NEURONS; CELL-DEATH; SIGNAL-TRANSDUCTION; NEURITE OUTGROWTH; BCL-2 EXPRESSION; GENE-EXPRESSION; PRECURSOR CELLS	CRE-binding protein (CREB) belongs to a family of transcription factors that mediates stimulus-dependent gene expression in neuronal and non-neuronal cells. Here we show that CREB is phosphorylated on its transcriptional regulatory site, Ser-133, in vivo in a neurotrophin-dependent manner. In mice harboring a null mutation in the Creb gene, sensory neurons exhibit excess apoptosis and degeneration, and display impaired axonal growth and projections. Interestingly, excess apoptosis is not observed in the central nervous system. CREB is required within sensory and sympathetic neurons for survival and axon extension since both of these neurotrophin-dependent processes are compromised in cultured neurons from CREB null mice. Thus, during their period of neurotrophin dependency, peripheral neurons require CREB-mediated gene expression for both survival and growth in vivo.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University	Ginty, DD (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21205 USA.	dginty@jhmi.edu		Lonze, Bonnie/0000-0002-0973-1657	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS034814, R01NS034814, R37NS034814] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 34814] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Angelastro JM, 2000, P NATL ACAD SCI USA, V97, P10424, DOI 10.1073/pnas.97.19.10424; BONNI A, 1995, MOL CELL NEUROSCI, V6, P168, DOI 10.1006/mcne.1995.1015; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; BURSTEIN DE, 1978, P NATL ACAD SCI USA, V75, P6059, DOI 10.1073/pnas.75.12.6059; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Cowan WM, 2001, ANNU REV NEUROSCI, V24, P551, DOI 10.1146/annurev.neuro.24.1.551; DAVIES AM, 1987, NATURE, V326, P353, DOI 10.1038/326353a0; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; ElShamy WM, 1998, NEURON, V21, P1003, DOI 10.1016/S0896-6273(00)80619-4; ElShamy WM, 1996, NEURON, V16, P963, DOI 10.1016/S0896-6273(00)80119-1; ElShamy WM, 1996, DEVELOPMENT, V122, P2405; Elshamy WM, 1996, DEVELOPMENT, V122, P491; Enomoto H, 2001, DEVELOPMENT, V128, P3963; Fagan AM, 1996, J NEUROSCI, V16, P6208; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; Fitzli D, 2000, J CELL BIOL, V149, P951, DOI 10.1083/jcb.149.4.951; Francis N, 1999, DEV BIOL, V210, P411, DOI 10.1006/dbio.1999.9269; GARCIA I, 1992, SCIENCE, V258, P302, DOI 10.1126/science.1411528; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; GINTY DD, 1994, CELL, V77, P713, DOI 10.1016/0092-8674(94)90055-8; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; GOPALAKRISHNAN L, 1994, J BIOL CHEM, V269, P105; GREENLUND LJS, 1995, NEURON, V15, P649, DOI 10.1016/0896-6273(95)90153-1; HALEGOUA S, 1991, CURR TOP MICROBIOL, V165, P119; Herzig RP, 2000, J BIOL CHEM, V275, P13134, DOI 10.1074/jbc.275.17.13134; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; HUMMLER E, 1994, P NATL ACAD SCI USA, V91, P5647, DOI 10.1073/pnas.91.12.5647; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Kazantsev A, 1999, P NATL ACAD SCI USA, V96, P11404, DOI 10.1073/pnas.96.20.11404; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Kuruvilla R, 2000, NEURON, V27, P499, DOI 10.1016/S0896-6273(00)00061-1; LEVIMONTALCINI R, 1956, P NATL ACAD SCI USA, V42, P695, DOI 10.1073/pnas.42.9.695; Lewis J, 1999, NAT MED, V5, P832, DOI 10.1038/10556; Liu RY, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-17-j0003.2001; Liu YZ, 1999, NUCLEIC ACIDS RES, V27, P2086, DOI 10.1093/nar/27.10.2086; Long FX, 2001, DEVELOPMENT, V128, P541; LUMSDEN AGS, 1983, NATURE, V306, P786, DOI 10.1038/306786a0; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Michaelidis TM, 1996, NEURON, V17, P75, DOI 10.1016/S0896-6273(00)80282-2; MOBLEY WC, 1976, BIOCHEMISTRY-US, V15, P5543, DOI 10.1021/bi00670a019; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; O'Connor R, 1999, NEURON, V24, P165, DOI 10.1016/S0896-6273(00)80830-2; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Patel TD, 2000, NEURON, V25, P345, DOI 10.1016/S0896-6273(00)80899-5; Pugazhenthi S, 1999, J BIOL CHEM, V274, P27529, DOI 10.1074/jbc.274.39.27529; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; Qian XZ, 1998, NEURON, V21, P1017, DOI 10.1016/S0896-6273(00)80620-0; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; Rudolph D, 1998, P NATL ACAD SCI USA, V95, P4481, DOI 10.1073/pnas.95.8.4481; Sakai R, 2000, NEURON, V28, P819, DOI 10.1016/S0896-6273(00)00156-2; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; STRUTHERS RS, 1991, NATURE, V350, P622, DOI 10.1038/350622a0; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; Watson FL, 1999, J NEUROSCI, V19, P7889; Watson FL, 2001, NAT NEUROSCI, V4, P981, DOI 10.1038/nn720; White FA, 1996, J NEUROSCI, V16, P4662; White FA, 1998, J NEUROSCI, V18, P1428; Wilson BE, 1996, MOL CELL BIOL, V16, P5546; Yip PM, 1998, MOL BIOL CELL, V9, P277, DOI 10.1091/mbc.9.2.277	66	265	273	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 25	2002	34	3					371	385		10.1016/S0896-6273(02)00686-4	http://dx.doi.org/10.1016/S0896-6273(02)00686-4			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	545JW	11988169	Bronze			2022-12-24	WOS:000175214700009
J	Hendricks, TJ; Fyodorov, DV; Wegman, LJ; Lelutiu, NB; Pehek, EA; Yamamoto, B; Silver, J; Weeber, EJ; Sweatt, JD; Deneris, ES				Hendricks, TJ; Fyodorov, DV; Wegman, LJ; Lelutiu, NB; Pehek, EA; Yamamoto, B; Silver, J; Weeber, EJ; Sweatt, JD; Deneris, ES			Pet-1 ETS gene plays a critical role in 5-HT neuron development and is required for normal anxiety-like and aggressive behavior	NEURON			English	Article							TRANSPORTER MESSENGER-RNA; CENTRAL-NERVOUS-SYSTEM; MICE LACKING; SEROTONIN TRANSPORTER; TRANSCRIPTION FACTORS; HOMEODOMAIN PROTEIN; KNOCKOUT MICE; DOMAIN FACTOR; RAT-BRAIN; EXPRESSION	The central serotonin (5-HT) neurotransmitter system is an important modulator of diverse physiological processes and behaviors; however, the transcriptional mechanisms controlling its development are largely unknown. The Pet-1 ETS factor is a precise marker of developing and adult 5-HT neurons and is expressed shortly before 5-HT appears in the hindbrain. Here we show that in mice lacking Pet-1, the majority of 5-HT neurons fail to differentiate. Remaining ones show deficient expression of genes required for 5-HT synthesis, uptake, and storage. Significantly, defective development of the 5-HT system is followed by heightened anxiety-like and aggressive behavior in adults. These findings indicate that Pet-1 is a critical determinant of 5-HT neuron identity and implicate a Pet-1-dependent program in serotonergic modulation of behavior.	Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Dept Psychiat, Cleveland, OH 44106 USA; Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA	Case Western Reserve University; Case Western Reserve University; Baylor College of Medicine	Deneris, ES (corresponding author), Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA.	esd@po.cwru.edu	Yamamoto, Bryan/Z-1050-2019; Weeber, Edwin J/A-5396-2012	Sweatt, J. David/0000-0003-3567-485X	NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH058926, R01MH062723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029123] Funding Source: NIH RePORTER; NIMH NIH HHS [MH58926, MH62723] Funding Source: Medline; NINDS NIH HHS [NS29123] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALTMAN J, 1981, J COMP NEUROL, V198, P677, DOI 10.1002/cne.901980409; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Barnes NM, 1999, NEUROPHARMACOLOGY, V38, P1083, DOI 10.1016/S0028-3908(99)00010-6; Bartel FO, 2000, ONCOGENE, V19, P6443, DOI 10.1038/sj.onc.1204038; Bassuk AG, 1997, ADV IMMUNOL, V64, P65, DOI 10.1016/S0065-2776(08)60887-1; BLAKELY RD, 1991, NATURE, V354, P66, DOI 10.1038/354066a0; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Chiavegatto S, 2001, P NATL ACAD SCI USA, V98, P1277, DOI 10.1073/pnas.031487198; DAHLSTROM A, 1964, ACTA PHYSIOL SCAND, V62, P1; Davidson RJ, 2000, SCIENCE, V289, P591, DOI 10.1126/science.289.5479.591; Duxon MS, 1997, NEUROPHARMACOLOGY, V36, P601, DOI 10.1016/S0028-3908(97)00042-7; Eastman C, 1999, J NEUROSCI, V19, P6225; Fyodorov D, 1998, J NEUROBIOL, V34, P151, DOI 10.1002/(SICI)1097-4695(19980205)34:2<151::AID-NEU5>3.0.CO;2-1; Gingrich JA, 2001, PSYCHOPHARMACOLOGY, V155, P1, DOI 10.1007/s002130000573; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; Hansson SR, 1998, NEUROSCIENCE, V83, P1185, DOI 10.1016/S0306-4522(97)00444-2; Heisler LK, 1998, P NATL ACAD SCI USA, V95, P15049, DOI 10.1073/pnas.95.25.15049; Hendricks T, 1999, J NEUROSCI, V19, P10348; Hynes M, 1999, CURR OPIN NEUROBIOL, V9, P26, DOI 10.1016/S0959-4388(99)80004-X; JACOBS BL, 1992, PHYSIOL REV, V72, P165, DOI 10.1152/physrev.1992.72.1.165; Kamali M, 2001, DEPRESS ANXIETY, V14, P164, DOI 10.1002/da.1062; Kim HS, 1998, J NEUROSCI, V18, P8247; Kroeze Wesley K., 2002, Current Topics in Medicinal Chemistry, V2, P507, DOI 10.2174/1568026023393796; LIDOV HGW, 1982, BRAIN RES BULL, V9, P559, DOI 10.1016/0361-9230(82)90164-2; Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2; Lo LC, 1999, NEURON, V22, P693, DOI 10.1016/S0896-6273(00)80729-1; Lucki I, 1998, BIOL PSYCHIAT, V44, P151, DOI 10.1016/S0006-3223(98)00139-5; Lyons WE, 1999, P NATL ACAD SCI USA, V96, P15239, DOI 10.1073/pnas.96.26.15239; Mann JJ, 2001, NEUROPSYCHOPHARMACOL, V24, P467, DOI 10.1016/S0893-133X(00)00228-1; Matise MP, 1998, DEVELOPMENT, V125, P2759; McGeer P L, 1973, Prog Neurobiol, V2, P69, DOI 10.1016/0301-0082(73)90007-5; Menard J, 1999, NEUROSCI BIOBEHAV R, V23, P591, DOI 10.1016/S0149-7634(98)00056-6; Naughton M, 2000, HUM PSYCHOPHARM CLIN, V15, P397, DOI 10.1002/1099-1077(200008)15:6<397::AID-HUP212>3.3.CO;2-C; Nelson RJ, 2001, TRENDS NEUROSCI, V24, P713, DOI 10.1016/S0166-2236(00)01996-2; Parks CL, 1998, P NATL ACAD SCI USA, V95, P10734, DOI 10.1073/pnas.95.18.10734; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; Pfaar H, 2002, DEV GENES EVOL, V212, P43, DOI 10.1007/s00427-001-0208-x; Ramboz S, 1998, P NATL ACAD SCI USA, V95, P14476, DOI 10.1073/pnas.95.24.14476; Rattray M, 1999, NEUROSCIENCE, V88, P169, DOI 10.1016/S0306-4522(98)00231-0; Ressler KJ, 2000, DEPRESS ANXIETY, V12, P2, DOI 10.1002/1520-6394(2000)12:1+<2::AID-DA2>3.3.CO;2-W; Rind HB, 2000, NEUROSCIENCE, V101, P665, DOI 10.1016/S0306-4522(00)00402-4; SAUDOU F, 1994, SCIENCE, V265, P1875, DOI 10.1126/science.8091214; SIJBESMA H, 1991, PHARMACOL BIOCHEM BE, V38, P447, DOI 10.1016/0091-3057(91)90305-L; Stanke M, 1999, DEVELOPMENT, V126, P4087; STEINBUSCH HWM, 1981, NEUROSCIENCE, V6, P557, DOI 10.1016/0306-4522(81)90146-9; Swanson DJ, 1997, J BIOL CHEM, V272, P27382, DOI 10.1074/jbc.272.43.27382; Sze JY, 2002, DEVELOPMENT, V129, P3901; TORK I, 1990, ANN NY ACAD SCI, V600, P9; Van Praag HM, 2001, PROG NEURO-PSYCHOPH, V25, P893, DOI 10.1016/S0278-5846(01)00151-8; vansDoornick J. H., 1999, J NEUROSCI, V19, P1; WALLACE JA, 1983, BRAIN RES BULL, V10, P459, DOI 10.1016/0361-9230(83)90144-2; Weihe E, 2000, FASEB J, V14, P2435, DOI 10.1096/fj.00-0202rev; WhitakerAzmitia PM, 1996, BEHAV BRAIN RES, V73, P19; Yamamoto BK, 1998, J NEUROCHEM, V71, P274; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3; Young SN, 2002, PHARMACOL BIOCHEM BE, V71, P857, DOI 10.1016/S0091-3057(01)00670-0; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3; Zhuang XX, 1999, NEUROPSYCHOPHARMACOL, V21, pS52, DOI 10.1016/S0893-133X(99)00047-0	58	348	356	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 23	2003	37	2					233	247		10.1016/S0896-6273(02)01167-4	http://dx.doi.org/10.1016/S0896-6273(02)01167-4			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	646UX	12546819	Bronze			2022-12-24	WOS:000181054900009
J	Hummel, T; Vasconcelos, ML; Clemens, JC; Fishilevich, Y; Vosshall, LB; Zipursky, SL				Hummel, T; Vasconcelos, ML; Clemens, JC; Fishilevich, Y; Vosshall, LB; Zipursky, SL			Axonal targeting of olfactory receptor neurons in Drosophila is controlled by Dscam	NEURON			English	Article							ODORANT RECEPTORS; ANTENNAL LOBE; SENSORY MAP; GUIDANCE; FAMILY; CELL; MELANOGASTER; SYSTEM; EXPRESSION; DIVERSITY	Different classes of olfactory receptor neurons (ORNs) in Drosophila innervate distinct targets, or glomeruli, in the antennal lobe of the brain. Here we demonstrate that specific ORN classes require the cell surface protein Dscam (Down Syndrome Cell Adhesion Molecule) to synapse in the correct glomeruli. Dscam mutant ORNs frequently terminated in ectopic sites both within and outside the antennal lobe. The morphology of Dscam mutant axon terminals in either ectopic or cognate targets was abnormal. Target specificity for other ORNs was not altered in Dscam mutants, suggesting that different ORNs use different strategies to regulate wiring. Multiple forms of Dscam RNA were detected in the developing antenna, and Dscam protein was localized to developing ORN axons. We propose a role for Dscam protein diversity in regulating ORN target specificity.	Univ Calif Los Angeles, David Geffen Sch Med, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA; Rockefeller Univ, Neurogenet Lab, New York, NY 10021 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Rockefeller University	Zipursky, SL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA.			Zipursky, Stephen/0000-0001-5630-7181; Vosshall, Leslie/0000-0002-6060-8099; Vasconcelos, Maria Luisa/0000-0001-6248-3667				Agarwala KL, 2001, BIOCHEM BIOPH RES CO, V285, P760, DOI 10.1006/bbrc.2001.5214; Ashburner M., 2004, DROSOPHILA LAB MANUA, V2nd; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Elmore T, 2001, INSECT BIOCHEM MOLEC, V31, P791, DOI 10.1016/S0965-1748(00)00184-3; Estes PS, 2000, J NEUROGENET, V13, P233, DOI 10.3109/01677060009084496; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; GRIGLIATTI T, 1986, DROSOPHILA PRACTICAL; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; Laissue PP, 1999, J COMP NEUROL, V405, P543; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Newsome TP, 2000, DEVELOPMENT, V127, P851; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; STORTKUHL KF, 1994, CELL TISSUE RES, V275, P27, DOI 10.1007/BF00305373; Sullivan W., 2000, DROSOPHILA PROTOCOLS; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; VANVACTOR DL, 1991, CELL, V67, P1145, DOI 10.1016/0092-8674(91)90291-6; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; Winberg ML, 1998, CELL, V93, P581, DOI 10.1016/S0092-8674(00)81187-3; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Yamakawa K, 1998, HUM MOL GENET, V7, P227, DOI 10.1093/hmg/7.2.227; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748	35	158	160	0	22	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 23	2003	37	2					221	231		10.1016/S0896-6273(02)01183-2	http://dx.doi.org/10.1016/S0896-6273(02)01183-2			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	646UX	12546818	Bronze			2022-12-24	WOS:000181054900008
J	Rusakov, DA; Fine, A				Rusakov, DA; Fine, A			Extracellular Ca(2+) depletion contributes to fast activity-dependent modulation of synaptic transmission in the brain	NEURON			English	Article							QUANTITATIVE ULTRASTRUCTURAL ANALYSIS; PAIRED-PULSE DEPRESSION; RAT HIPPOCAMPAL SLICES; SHORT-TERM PLASTICITY; PRESYNAPTIC CALCIUM; TRANSMITTER RELEASE; GLUTAMATE DIFFUSION; MICRO-ENVIRONMENT; CENTRAL SYNAPSES; RECEPTORS	Synaptic activation is associated with rapid changes in intracellular Call, while the extracellular Ca(2+) level is generally assumed to be constant. Here, using a novel optical method to measure changes in extracellular Call at high spatial and temporal resolution, we find that brief trains of synaptic transmission in hippocampal area CA1 induce transient depletion of extracellular Ca(2+). We show that this depletion, which depends on postsynaptic NMDA receptor activation, decreases the Ca(2+) available to enter individual presynaptic boutons of CA3 pyramidal cells. This in turn reduces the probability of consecutive synaptic releases at CA3-CA1 synapses and therefore contributes to short-term paired-pulse depression of minimal responses. This activity-dependent depletion of extracellular Ca(2+) represents a novel form of fast retrograde synaptic signaling that can modulate glutamatergic information transfer in the brain.	Natl Inst Med Res, Div Neurophysiol, London NW7 1AA, England; UCL, Inst Neurol, London WC1N 3BG, England; Dalhousie Univ, Dept Physiol & Biophys, Halifax, NS B3H 4H7, Canada	MRC National Institute for Medical Research; University of London; University College London; Dalhousie University	Rusakov, DA (corresponding author), Natl Inst Med Res, Div Neurophysiol, Mill Hill, London NW7 1AA, England.	d.rusakov@ion.ucl.ac.uk; afine@nimr.mrc.ac.uk	Fine, Alan/P-5936-2014; Rusakov, Dmitri/AAH-4529-2021; Rusakov, Dmitri A/E-1987-2011	Fine, Alan/0000-0002-4960-6973; Rusakov, Dmitri/0000-0001-9539-9947; Rusakov, Dmitri A/0000-0001-9539-9947	Medical Research Council [G0400627(76527), G0400627, G0400627(71256)] Funding Source: Medline; Wellcome Trust [071179] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		BASKYS A, 1991, J PHYSIOL-LONDON, V444, P687, DOI 10.1113/jphysiol.1991.sp018901; Bellingham MC, 1999, NEURON, V23, P159, DOI 10.1016/S0896-6273(00)80762-X; Berretta N, 2000, NEUROPHARMACOLOGY, V39, P2288, DOI 10.1016/S0028-3908(00)00076-9; Borst JGG, 1999, J PHYSIOL-LONDON, V521, P123, DOI 10.1111/j.1469-7793.1999.00123.x; BROWN EM, 1995, CELL, V83, P679, DOI 10.1016/0092-8674(95)90180-9; Carter AG, 2002, J NEUROSCI, V22, P21, DOI 10.1523/JNEUROSCI.22-01-00021.2002; Casado M, 2000, P NATL ACAD SCI USA, V97, P11593, DOI 10.1073/pnas.200354297; CLARK KA, 1994, EXP BRAIN RES, V101, P272, DOI 10.1007/BF00228747; Cochilla AJ, 1999, J NEUROSCI, V19, P193, DOI 10.1523/JNEUROSCI.19-01-00193.1999; Dobrunz LE, 1997, P NATL ACAD SCI USA, V94, P14843, DOI 10.1073/pnas.94.26.14843; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; Egelman DM, 1998, J NEUROSCI, V18, P8580; Egelman DM, 1999, BIOPHYS J, V76, P1856, DOI 10.1016/S0006-3495(99)77345-5; EllisDavies GCR, 1996, BIOPHYS J, V70, P1006, DOI 10.1016/S0006-3495(96)79644-3; Emptage N, 1999, NEURON, V22, P115, DOI 10.1016/S0896-6273(00)80683-2; Emptage NJ, 2001, NEURON, V29, P197, DOI 10.1016/S0896-6273(01)00190-8; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; KAMIYA H, 1994, NATURE, V371, P603, DOI 10.1038/371603a0; King RD, 2001, J NEUROPHYSIOL, V85, P1952, DOI 10.1152/jn.2001.85.5.1952; Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596; Kojima H, 2001, ANAL CHEM, V73, P1967, DOI 10.1021/ac001136i; KRISHTAL OA, 1987, BRAIN RES, V436, P352, DOI 10.1016/0006-8993(87)91678-7; KRNJEVIC K, 1982, CAN J PHYSIOL PHARM, V60, P1658, DOI 10.1139/y82-244; Liu HT, 1997, NATURE, V386, P721, DOI 10.1038/386721a0; MANZONI OJ, 1994, SCIENCE, V265, P2098, DOI 10.1126/science.7916485; Maravall M, 2000, BIOPHYS J, V78, P2655, DOI 10.1016/S0006-3495(00)76809-3; Min MY, 1998, NEURON, V21, P561, DOI 10.1016/S0896-6273(00)80566-8; MODY I, 1986, NEUROSCI LETT, V69, P137, DOI 10.1016/0304-3940(86)90592-6; NEWMAN GC, 1995, J NEUROSCI METH, V61, P33, DOI 10.1016/0165-0270(95)00020-U; NICHOLSON C, 1978, J NEUROPHYSIOL, V41, P1026, DOI 10.1152/jn.1978.41.4.1026; NICHOLSON C, 1981, J PHYSIOL-LONDON, V321, P225, DOI 10.1113/jphysiol.1981.sp013981; NICHOLSON C, 1987, CAN J PHYSIOL PHARM, V65, P1086, DOI 10.1139/y87-170; Perrais D, 2000, EUR J NEUROSCI, V12, P400, DOI 10.1046/j.1460-9568.2000.00957.x; Platt B, 1997, BRAIN RES, V777, P131; Rusakov DA, 2001, BIOPHYS J, V81, P1947, DOI 10.1016/S0006-3495(01)75846-8; Rusakov DA, 1998, NEUROPHARMACOLOGY, V37, P513, DOI 10.1016/S0028-3908(98)00023-9; Rusakov DA, 1998, J NEUROSCI, V18, P3158; Rusakov DA, 1999, TRENDS NEUROSCI, V22, P382, DOI 10.1016/S0166-2236(99)01425-3; Sabatini BL, 1998, BIOPHYS J, V74, P1549, DOI 10.1016/S0006-3495(98)77867-1; Schikorski T, 1997, J NEUROSCI, V17, P5858; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; Stanley EF, 2000, J NEUROPHYSIOL, V83, P477, DOI 10.1152/jn.2000.83.1.477; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; Stevens CF, 1999, NEURON, V24, P1017, DOI 10.1016/S0896-6273(00)81047-8; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tamura K, 1998, NEURON, V20, P1153, DOI 10.1016/S0896-6273(00)80496-1; THIES RE, 1965, J NEUROPHYSIOL, V28, P427, DOI 10.1152/jn.1965.28.3.427; Vassilev PM, 1997, BIOPHYS J, V72, P2103, DOI 10.1016/S0006-3495(97)78853-2; Watanabe T, 1996, MAGNET RESON MED, V35, P697, DOI 10.1002/mrm.1910350511; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; YAMAMOTO N, 1989, SCIENCE, V245, P192, DOI 10.1126/science.2749258; Zucker RS, 1996, NEURON, V17, P1049, DOI 10.1016/S0896-6273(00)80238-X	53	157	158	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JAN 23	2003	37	2					287	297		10.1016/S0896-6273(03)00025-4	http://dx.doi.org/10.1016/S0896-6273(03)00025-4			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	646UX	12546823	Bronze, Green Accepted			2022-12-24	WOS:000181054900013
J	Manns, JR; Hopkins, RO; Reed, JM; Kitchener, EG; Squire, LR				Manns, JR; Hopkins, RO; Reed, JM; Kitchener, EG; Squire, LR			Recognition memory and the human hippocampus	NEURON			English	Article							TEMPORAL-LOBE; RECOLLECTIVE EXPERIENCE; OBJECT-RECOGNITION; DECLARATIVE MEMORY; PERIRHINAL CORTEX; DAMAGE; IMPAIRMENT; AMNESIA; ITEM; DISSOCIATION	The capacity for declarative memory depends on the hippocampal region and adjacent cortex within the medial temporal lobe. One of the most widely studied examples of declarative memory is the capacity to recognize recently encountered material as familiar, but uncertainty remains about whether intact recognition memory depends on the hippocampal region itself and, if so, what the nature of the hippocampal contribution might be. Seven patients with bilateral damage thought to be limited primarily to the hippocampal region were impaired on three standard tests of recognition memory. In addition, the patients were impaired to a similar extent at Remembering and Knowing, measures of the two processes thought to support recognition performance: the ability to remember the learning episode (episodic recollection) and the capacity for judging items as familiar (familiarity).	Univ Calif San Diego, La Jolla, CA 92093 USA; Brigham Young Univ, Provo, UT 84602 USA; LDS Hosp, Salt Lake City, UT 84143 USA; E Carolina Univ, Greenville, NC 27858 USA; Vet Adm Med Ctr, San Diego, CA 92161 USA	University of California System; University of California San Diego; Brigham Young University; University of North Carolina; East Carolina University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Squire, LR (corresponding author), Univ Calif San Diego, La Jolla, CA 92093 USA.	lsquire@ucsd.edu			PHS HHS [24600] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Aggleton JP, 1996, NEUROPSYCHOLOGIA, V34, P51, DOI 10.1016/0028-3932(95)00150-6; Amaral DG, 1990, HUMAN NERVOUS SYSTEM, P711; Baddeley A.D., 1994, DOORS PEOPLE TEST TE; Baddeley AD, 2001, J COGNITIVE NEUROSCI, V13, P357, DOI 10.1162/08989290151137403; Baker KB, 2002, LEARN MEMORY, V9, P58, DOI 10.1101/lm.46102; Beason-Held LL, 1999, HIPPOCAMPUS, V9, P562, DOI 10.1002/(SICI)1098-1063(1999)9:5<562::AID-HIPO10>3.0.CO;2-X; BROADBENT NJ, 2002, NEUROPSYCHOLOGY MEMO, P3; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Buffalo EA, 1999, LEARN MEMORY, V6, P572, DOI 10.1101/lm.6.6.572; Clark RE, 2001, HIPPOCAMPUS, V11, P176, DOI 10.1002/hipo.1035; Curran T, 2000, MEM COGNITION, V28, P923, DOI 10.3758/BF03209340; Davachi L, 2002, J NEUROPHYSIOL, V88, P982, DOI 10.1152/jn.2002.88.2.982; Davidson PSR, 2002, COGN AFFECT BEHAV NE, V2, P174, DOI 10.3758/CABN.2.2.174; Donaldson W, 1996, MEM COGNITION, V24, P523, DOI 10.3758/BF03200940; ELCHENBAUM H, 2001, CONDITIONING CONSCIO; Eldridge LL, 2000, NAT NEUROSCI, V3, P1149, DOI 10.1038/80671; Fernandez G, 2002, HIPPOCAMPUS, V12, P514, DOI 10.1002/hipo.10050; Fried I, 1997, NEURON, V18, P753, DOI 10.1016/S0896-6273(00)80315-3; GARDINER JM, 1990, MEM COGNITION, V18, P579, DOI 10.3758/BF03197100; Gardiner JM, 2002, MEMORY, V10, P83, DOI 10.1080/09658210143000281; GILBERT JG, 1968, PERCEPT MOTOR SKILL, V27, P277, DOI 10.2466/pms.1968.27.1.277; Green DM, 1966, SIGNAL DETECTION THE; Grubb NR, 2000, STROKE, V31, P1509, DOI 10.1161/01.STR.31.7.1509; Henke K, 1997, HIPPOCAMPUS, V7, P249, DOI 10.1002/(SICI)1098-1063(1997)7:3<249::AID-HIPO1>3.0.CO;2-G; Henson RNA, 1999, J NEUROSCI, V19, P3962; Holdstock JS, 2002, HIPPOCAMPUS, V12, P341, DOI 10.1002/hipo.10011; Hopkins R O, 1995, J Int Neuropsychol Soc, V1, P501; HOPKINS RO, 1995, BRAIN COGNITION, V27, P180, DOI 10.1006/brcg.1995.1016; Insausti R, 1998, AM J NEURORADIOL, V19, P659; JANOWSKY JS, 1989, NEUROPSYCHOLOGIA, V27, P1043, DOI 10.1016/0028-3932(89)90184-X; KESNER RP, 1994, NEUROPSYCHOLOGIA, V32, P881, DOI 10.1016/0028-3932(94)90040-X; KNOWLTON BJ, 1995, J EXP PSYCHOL LEARN, V21, P699, DOI 10.1037/0278-7393.21.3.699; Kopelman MD, 1997, NEUROPSYCHOLOGIA, V35, P1533, DOI 10.1016/S0028-3932(97)00076-6; MANDLER G, 1980, PSYCHOL REV, V87, P252, DOI 10.1037/0033-295X.87.3.252; Manns JR, 1999, HIPPOCAMPUS, V9, P495, DOI 10.1002/(SICI)1098-1063(1999)9:5<495::AID-HIPO2>3.0.CO;2-O; Mayes AR, 2002, HIPPOCAMPUS, V12, P325, DOI 10.1002/hipo.1111; MILNER B, 1991, NEUROPSYCHOLOGIA, V29, P601, DOI 10.1016/0028-3932(91)90013-X; MISHKIN M, 1994, CURR OPIN NEUROBIOL, V4, P200, DOI 10.1016/0959-4388(94)90073-6; Mumby DG, 2002, LEARN MEMORY, V9, P49, DOI 10.1101/lm.41302; Mumby DG, 2001, BEHAV BRAIN RES, V127, P159, DOI 10.1016/S0166-4328(01)00367-9; Murray EA, 1998, J NEUROSCI, V18, P6568; Olichney JM, 2000, BRAIN, V123, P1948, DOI 10.1093/brain/123.9.1948; Osterrieth PA, 1944, ARCH PSYCHOLOGIE, V30, P205; PARKIN AJ, 1992, PSYCHOL AGING, V7, P290, DOI 10.1037/0882-7974.7.2.290; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; Reed JM, 1999, BEHAV NEUROSCI, V113, P411, DOI 10.1037/0735-7044.113.3.411; Reed JM, 1997, BEHAV NEUROSCI, V111, P667, DOI 10.1037/0735-7044.111.4.667; RempelClower NL, 1996, J NEUROSCI, V16, P5233; Rey A, 1964, LEXAMEN CLINIQUE PSY; Rugg MD, 1998, NATURE, V392, P595, DOI 10.1038/33396; Schacter D. L., 1994, MEMORY SYSTEMS 1994; SCHACTER DL, 1987, PSYCHOBIOLOGY, V15, P21; Schmolck H, 2002, HIPPOCAMPUS, V12, P520, DOI 10.1002/hipo.10039; SHIMAMURA AP, 1987, J EXP PSYCHOL LEARN, V13, P464, DOI 10.1037/0278-7393.13.3.464; SMITH ME, 1993, J COGNITIVE NEUROSCI, V5, P1, DOI 10.1162/jocn.1993.5.1.1; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; SQUIRE LR, 1989, EXP NEUROL, V105, P23, DOI 10.1016/0014-4886(89)90168-4; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; SQUIRE LR, 1986, BEHAV NEUROSCI, V100, P866, DOI 10.1037/0735-7044.100.6.866; Stark CEL, 2001, LEARN MEMORY, V8, P190, DOI 10.1101/lm.40701; Stark CEL, 2002, LEARN MEMORY, V9, P238, DOI 10.1101/lm.51802; Stark CEL, 2000, J NEUROSCI, V20, P7776; Suzuki WA, 2000, ANN NY ACAD SCI, V911, P175; SUZUKI WA, 1994, J NEUROSCI, V14, P1856, DOI 10.1523/JNEUROSCI.14-03-01856.1994; Tulving E, 1998, HIPPOCAMPUS, V8, P198, DOI 10.1002/(SICI)1098-1063(1998)8:3<198::AID-HIPO2>3.3.CO;2-J; TULVING E, 1985, CAN PSYCHOL, V26, P1, DOI 10.1037/h0080017; Vargha-Khadem F, 2001, PHILOS T R SOC B, V356, P1435, DOI 10.1098/rstb.2001.0951; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Verfaellie, 2002, NEUROPSYCHOLOGY MEMO, P35; WARRINGTON EK, 1984, RECOGNITION MEMORY; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864; Yonelinas AP, 1998, NEUROPSYCHOLOGY, V12, P323, DOI 10.1037/0894-4105.12.3.323; Yonelinas AP, 2002, NAT NEUROSCI, V5, P1236, DOI 10.1038/nn961; Yonelinas AP, 2001, NEUROREPORT, V12, P359, DOI 10.1097/00001756-200102120-00035; Zola SM, 2000, J NEUROSCI, V20, P451, DOI 10.1523/JNEUROSCI.20-01-00451.2000; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950	77	340	344	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 9	2003	37	1					171	180		10.1016/S0896-6273(02)01147-9	http://dx.doi.org/10.1016/S0896-6273(02)01147-9			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	646UV	12526782	Bronze, Green Published			2022-12-24	WOS:000181054700019
J	Naito, E; Roland, PE; Ehrsson, HH				Naito, E; Roland, PE; Ehrsson, HH			I feel my hand moving: A new role of the primary motor cortex in somatic perception of limb movement	NEURON			English	Article							THRESHOLD MUSCLE AFFERENTS; SOMATOSENSORY CORTEX; PRECENTRAL NEURONS; PASSIVE MOVEMENTS; TENDON VIBRATION; CEREBRAL-CORTEX; INTERINDIVIDUAL VARIABILITY; ELECTRICAL-STIMULATION; SUPPLEMENTARY MOTOR; CONSCIOUS MONKEYS	The primary motor cortex (MI) is regarded as the site for motor control. Occasional reports that MI neurons react to sensory stimuli have either been ignored or attributed to guidance of voluntary movements. Here, we show that MI activation is necessary for the somatic perception of movement of our limbs. We made use of an illusion: when the wrist tendon of one hand is vibrated, it is perceived as the hand moving. If the vibrated hand has skin contact with the other hand, it is perceived as both hands bending. Using fMRI and TMS, we show that the activation in MI controlling the nonvibrated hand is compulsory for the somatic perception of the hand movement. This novel function of MI contrasts with its traditional role as the executive locus of voluntary limb movement.	Karolinska Inst, Dept Neurosci, Div Human Brain Res, S-17177 Stockholm, Sweden; Kyoto Univ, Fac Human Studies, Sakyo Ku, Kyoto 6068501, Japan; Karolinska Hosp, Dept Woman & Child Hlth, Motor Control Lab, Stockholm, Sweden	Karolinska Institutet; Kyoto University; Karolinska Institutet; Karolinska University Hospital	Naito, E (corresponding author), Karolinska Inst, Dept Neurosci, Div Human Brain Res, S-17177 Stockholm, Sweden.	eiichi.naito@neuro.ki.se						Bodegard A, 2001, NEURON, V31, P317, DOI 10.1016/S0896-6273(01)00362-2; BURKE D, 1976, J PHYSIOL-LONDON, V261, P673, DOI 10.1113/jphysiol.1976.sp011580; CLARK FJ, 1985, J NEUROPHYSIOL, V54, P1529, DOI 10.1152/jn.1985.54.6.1529; COLEBATCH JG, 1990, ELECTROEN CLIN NEURO, V75, P44, DOI 10.1016/0013-4694(90)90151-9; Collins DF, 1996, J PHYSIOL-LONDON, V496, P857, DOI 10.1113/jphysiol.1996.sp021733; CRASKE B, 1977, SCIENCE, V196, P71, DOI 10.1126/science.841342; DARIANSMITH C, 1993, J COMP NEUROL, V335, P200, DOI 10.1002/cne.903350205; Ehrsson HH, 2000, EUR J NEUROSCI, V12, P3385, DOI 10.1046/j.1460-9568.2000.00209.x; FETZ EE, 1980, J NEUROPHYSIOL, V43, P1070, DOI 10.1152/jn.1980.43.4.1070; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; GANDEVIA SC, 1985, BRAIN, V108, P965, DOI 10.1093/brain/108.4.965; Geyer S, 1999, NEUROIMAGE, V10, P63, DOI 10.1006/nimg.1999.0440; Geyer S, 1996, NATURE, V382, P805, DOI 10.1038/382805a0; GOODWIN GM, 1972, SCIENCE, V175, P1382, DOI 10.1126/science.175.4028.1382; GOODWIN GM, 1972, BRAIN, V95, P705, DOI 10.1093/brain/95.4.705; GOULD HJ, 1986, J COMP NEUROL, V247, P297, DOI 10.1002/cne.902470303; Grefkes C, 2001, NEUROIMAGE, V14, P617, DOI 10.1006/nimg.2001.0858; IWAMURA Y, 1983, EXP BRAIN RES, V51, P315; IWAMURA Y, 1994, NATURE, V369, P554, DOI 10.1038/369554a0; IWAMURA Y, 1993, EXP BRAIN RES, V92, P360; JENNY AB, 1979, J COMP NEUROL, V188, P137, DOI 10.1002/cne.901880111; JONES EG, 1979, J COMP NEUROL, V188, P113, DOI 10.1002/cne.901880110; LACKNER JR, 1988, BRAIN, V111, P281, DOI 10.1093/brain/111.2.281; LACKNER JR, 1983, J NEUROSCI, V3, P2280; LANDGREN S, 1970, Acta Physiologica Scandinavica, V80, p10A, DOI 10.1111/j.1748-1716.1970.tb04834.x; LANDGREN S, 1969, J PHYSIOL-LONDON, V200, P353, DOI 10.1113/jphysiol.1969.sp008698; LANDGREN S, 1971, J PHYSIOL-LONDON, V218, P551, DOI 10.1113/jphysiol.1971.sp009633; LEMON RN, 1981, J PHYSIOL-LONDON, V311, P497, DOI 10.1113/jphysiol.1981.sp013601; LEMON RN, 1976, PROC R SOC SER B-BIO, V194, P313, DOI 10.1098/rspb.1976.0082; LEMON RN, 1976, PROC R SOC SER B-BIO, V194, P341, DOI 10.1098/rspb.1976.0083; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; MOUNTCASTLE VB, 1959, B JOHNS HOPKINS HOSP, V105, P173; Naito E, 1999, J NEUROSCI, V19, P6134, DOI 10.1523/JNEUROSCI.19-14-06134.1999; Naito E, 2002, J NEUROSCI, V22, P3683; Naito E, 2001, NEUROREPORT, V12, P3805, DOI 10.1097/00001756-200112040-00041; NAITO E, 1994, COGNITIVE BRAIN RES, V2, P131, DOI 10.1016/0926-6410(94)90009-4; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PHILLIPS CG, 1971, J PHYSIOL-LONDON, V217, P419, DOI 10.1113/jphysiol.1971.sp009579; PONS TP, 1992, J NEUROPHYSIOL, V68, P518, DOI 10.1152/jn.1992.68.2.518; PORTER R, 1993, CORTICOSPINAL FUNCTI, P247; Roland P, 2001, TRENDS NEUROSCI, V24, P562, DOI 10.1016/S0166-2236(00)01924-X; Roland PE, 1998, BRAIN RES REV, V26, P87, DOI 10.1016/S0165-0173(97)00058-1; Roland PE, 2002, TRENDS NEUROSCI, V25, P183, DOI 10.1016/S0166-2236(00)02125-1; ROLL JP, 1982, EXP BRAIN RES, V47, P177; ROLL JP, 1989, EXP BRAIN RES, V76, P213; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; ROUILLER EM, 1994, EXP BRAIN RES, V102, P227; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Schleicher A, 1999, NEUROIMAGE, V9, P165, DOI 10.1006/nimg.1998.0385; Schormann T, 1998, HUM BRAIN MAPP, V6, P339, DOI 10.1002/(SICI)1097-0193(1998)6:5/6<339::AID-HBM3>3.3.CO;2-H; STEPNIEWSKA I, 1993, J COMP NEUROL, V330, P238, DOI 10.1002/cne.903300207; STRICK PL, 1982, J NEUROPHYSIOL, V48, P150, DOI 10.1152/jn.1982.48.1.150; Weiller C, 1996, NEUROIMAGE, V4, P105, DOI 10.1006/nimg.1996.0034	54	155	157	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 5	2002	36	5					979	988		10.1016/S0896-6273(02)00980-7	http://dx.doi.org/10.1016/S0896-6273(02)00980-7			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	622VL	12467600	Bronze			2022-12-24	WOS:000179667800021
J	Nery, S; Fishell, G; Corbin, JG				Nery, S; Fishell, G; Corbin, JG			The caudal ganglionic eminence is a source of distinct cortical and subcortical cell populations	NATURE NEUROSCIENCE			English	Article							IN-SITU HYBRIDIZATION; GABAERGIC NEURONS; BASAL FOREBRAIN; MAMMALIAN FOREBRAIN; PROJECTION NEURONS; CEREBRAL-CORTEX; HOMEOBOX GENE; TELENCEPHALON; MIGRATION; ORIGIN	During development, the mammalian ventral telencephalon is comprised of three major proliferative zones: the medial (MGE), lateral (LGE) and caudal (CGE) ganglionic eminences. Through gene expression studies, in vitro migration assays, genetic mutant analysis and in vivo fate mapping in mice, we found that the CGE is a progenitor region that is distinct from both the MGE and LGE. Notably, CGE cells showed a unique in vivo pattern of migration, and the CGE contributed cells to nuclei distinct from those populated by the MGE and LGE. Moreover, we report that the migratory fate of cells from the CGE is intrinsically determined by embryonic day 13.5 (E13.5). Together, these results provide the first insights into the development and fate of the CGE.	NYU, Med Ctr, Skirball Inst Biomol Med, Dev Genet Program, New York, NY 10016 USA; NYU, Med Ctr, Skirball Inst Biomol Med, Dept Cell Biol, New York, NY 10016 USA	New York University; New York University	Fishell, G (corresponding author), NYU, Med Ctr, Skirball Inst Biomol Med, Dev Genet Program, 540 1st Ave, New York, NY 10016 USA.	fishell@saturn.med.nyu.edu	Nery, Susana Vaz/P-4518-2014	Fishell, Gordon/0000-0002-9640-9278; Vaz Nery, Susana/0000-0002-2399-7785	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039007] Funding Source: NIH RePORTER; NINDS NIH HHS [NS10962-03, R01 NS39007-03] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Anderson SA, 2001, DEVELOPMENT, V128, P353; Anderson SA, 1997, NEURON, V19, P27, DOI 10.1016/S0896-6273(00)80345-1; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Casarosa S, 1999, DEVELOPMENT, V126, P525; Corbin JG, 2000, DEVELOPMENT, V127, P5007; Corbin JG, 2001, NAT NEUROSCI, V4, P1177, DOI 10.1038/nn749; DeCarlos JA, 1996, J NEUROSCI, V16, P6146; DEFELIPE J, 1993, CEREB CORTEX, V3, P273, DOI 10.1093/cercor/3.4.273; Deprimo SE, 1996, TRANSGENIC RES, V5, P459, DOI 10.1007/BF01980211; FENTRESS JC, 1981, ANAT EMBRYOL, V163, P275, DOI 10.1007/BF00315705; Gaiano N, 1999, NAT NEUROSCI, V2, P812, DOI 10.1038/12186; Garel S, 1999, DEVELOPMENT, V126, P5285; Gonchar Y, 1997, CEREB CORTEX, V7, P347, DOI 10.1093/cercor/7.4.347; He WL, 2001, J NEUROSCI, V21, P8854, DOI 10.1523/JNEUROSCI.21-22-08854.2001; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Kim AS, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-05-j0002.2001; KUBOTA Y, 1994, BRAIN RES, V649, P159, DOI 10.1016/0006-8993(94)91060-X; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Liu AM, 1998, MECH DEVELOP, V75, P107, DOI 10.1016/S0925-4773(98)00090-2; Marin O, 2000, J NEUROSCI, V20, P6063; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; Martin J., 1989, NEUROANATOMY TEXT AT; MCCONNELL SK, 1991, SCIENCE, V254, P282, DOI 10.1126/science.1925583; Nery S, 2001, DEVELOPMENT, V128, P527; Olivier C, 2001, DEVELOPMENT, V128, P1757; Olsson M, 1998, NEUROSCIENCE, V84, P867, DOI 10.1016/S0306-4522(97)00532-0; OLSSON M, 1995, NEUROSCIENCE, V69, P1169, DOI 10.1016/0306-4522(95)00325-D; OUIMET CC, 1984, J NEUROSCI, V4, P111; Parnavelas JG, 2000, TRENDS NEUROSCI, V23, P126, DOI 10.1016/S0166-2236(00)01553-8; Paxinos G, 1995, RAT NERVOUS SYSTEM, V2nd; Pleasure SJ, 2000, NEURON, V28, P727, DOI 10.1016/S0896-6273(00)00149-5; Puelles L, 2000, J COMP NEUROL, V424, P409, DOI 10.1002/1096-9861(20000828)424:3<409::AID-CNE3>3.0.CO;2-7; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schuurmans C, 2002, CURR OPIN NEUROBIOL, V12, P26, DOI 10.1016/S0959-4388(02)00286-6; SMART IHM, 1979, NEOSTRIATUM, P127; Spassky N, 1998, J NEUROSCI, V18, P8331; Sussel L, 1999, DEVELOPMENT, V126, P3359; Szucsik JC, 1997, DEV BIOL, V191, P230, DOI 10.1006/dbio.1997.8733; Tamamaki N, 1997, J NEUROSCI, V17, P8313; Toresson H, 2000, DEVELOPMENT, V127, P4361; Toresson H, 1999, DEVELOPMENT, V126, P1317; Villegas EMP, 1999, DEV BIOL, V216, P98, DOI 10.1006/dbio.1999.9438; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Wichterle H, 1999, NAT NEUROSCI, V2, P461, DOI 10.1038/8131; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; Yun K, 2001, DEVELOPMENT, V128, P193	47	408	417	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2002	5	12					1279	1287		10.1038/nn971	http://dx.doi.org/10.1038/nn971			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	618ZE	12411960				2022-12-24	WOS:000179447500010
J	Wei, F; Qiu, CS; Kim, SJ; Muglia, L; Maas, JW; Pineda, VV; Xu, HM; Chen, ZF; Storm, DR; Muglia, LJ; Zhuo, M				Wei, F; Qiu, CS; Kim, SJ; Muglia, L; Maas, JW; Pineda, VV; Xu, HM; Chen, ZF; Storm, DR; Muglia, LJ; Zhuo, M			Genetic elimination of behavioral sensitization in mice lacking calmodulin-stimulated adenylyl cyclases	NEURON			English	Article							ANTERIOR CINGULATE CORTEX; LONG-TERM-MEMORY; DEPENDENT PROTEIN-KINASE; CYCLIC-AMP; SOMATOSENSORY CORTEX; NOCICEPTIVE NEURONS; HIPPOCAMPAL-NEURONS; INFLAMMATORY PAIN; TARGETED MUTATION; MOLECULAR-BIOLOGY	Adenylyl cyclase types 1 (AC1) and 8 (AC8), the two major calmodulin-stimulated adenylyl cyclases in the brain, couple NMDA receptor activation to cAMP signaling pathways. Cyclic AMP signaling pathways are important for many brain functions, such as learning and memory, drug addiction, and development. Here we show that wild-type, AC1, AC8, or AC1&8 double knockout (DKO) mice were indistinguishable in tests of acute pain, whereas behavioral responses to peripheral injection of two inflammatory stimuli, formalin and complete Freund's adjuvant, were reduced or abolished in AC1&8 DKO mice. AC1 and AC8 are highly expressed in the anterior cingulate cortex (ACC), and contribute to inflammation-induced activation of CREB. Intra-ACC administration of forskolin rescued behavioral allodynia defective in the AC1&8 DKO mice. Our studies suggest that AC1 and AC8 in the ACC selectively contribute to behavioral allodynia.	Washington Univ, Washington Univ Pain Ctr, Dept Anesthesiol, St Louis, MO 63108 USA; Washington Univ, Washington Univ Pain Ctr, Dept Psychiat & Anat, St Louis, MO 63108 USA; Washington Univ, Washington Univ Pain Ctr, Dept Neurobiol, St Louis, MO 63108 USA; Washington Univ, Washington Univ Pain Ctr, Dept Pediat, St Louis, MO 63108 USA; Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Washington; University of Washington Seattle	Zhuo, M (corresponding author), Washington Univ, Washington Univ Pain Ctr, Dept Anesthesiol, St Louis, MO 63108 USA.		Zhuo, Min/A-2072-2008; Xu, Haiming/A-2238-2014	Zhuo, Min/0000-0001-9062-3241; 				Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Aley KO, 1999, J NEUROSCI, V19, P2181; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Bushnell MC, 1999, P NATL ACAD SCI USA, V96, P7705, DOI 10.1073/pnas.96.14.7705; Calejesan AA, 2000, EUR J PAIN, V4, P83, DOI 10.1053/eujp.1999.0158; Cali JJ, 1996, J BIOL CHEM, V271, P1089, DOI 10.1074/jbc.271.2.1089; Casey KL, 1999, P NATL ACAD SCI USA, V96, P7668, DOI 10.1073/pnas.96.14.7668; CHETKOVICH DM, 1993, J NEUROCHEM, V61, P1933, DOI 10.1111/j.1471-4159.1993.tb09836.x; Craig AD, 1996, NATURE, V384, P258, DOI 10.1038/384258a0; Davidson RJ, 2000, SCIENCE, V289, P591, DOI 10.1126/science.289.5479.591; Derbyshire SWG, 1998, EXP BRAIN RES, V118, P52, DOI 10.1007/s002210050254; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; DUBUISSON D, 1977, PAIN, V4, P161, DOI 10.1016/0304-3959(77)90130-0; FOSTER JL, 1984, J BIOL CHEM, V259, P3049; Gilbert CD, 1996, CURR OPIN NEUROBIOL, V6, P269, DOI 10.1016/S0959-4388(96)80083-3; HALEY JE, 1990, BRAIN RES, V518, P218, DOI 10.1016/0006-8993(90)90975-H; Hutchison WD, 1999, NAT NEUROSCI, V2, P403, DOI 10.1038/8065; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Ji RR, 1997, J NEUROSCI, V17, P1776; Johansen JP, 2001, P NATL ACAD SCI USA, V98, P8077, DOI 10.1073/pnas.141218998; KAAS JH, 1991, ANNU REV NEUROSCI, V14, P137, DOI 10.1146/annurev.neuro.14.1.137; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Koyama T, 1998, NEUROREPORT, V9, P2663, DOI 10.1097/00001756-199808030-00044; Lee DE, 1999, BRAIN RES, V845, P117, DOI 10.1016/S0006-8993(99)01956-3; LIVINGSTONE MS, 1984, CELL, V37, P205, DOI 10.1016/0092-8674(84)90316-7; Malmberg AB, 1997, J NEUROSCI, V17, P7462; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; MOSS SJ, 1992, SCIENCE, V257, P661, DOI 10.1126/science.1323140; Muglia LM, 1999, J NEUROSCI, V19, P2051; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Pastoriza LN, 1996, PAIN, V64, P11, DOI 10.1016/0304-3959(95)00070-4; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; RAMACHANDRAN VS, 1993, P NATL ACAD SCI USA, V90, P10413, DOI 10.1073/pnas.90.22.10413; RANKLIN KBJ, 1997, MOUSE BRAIN STEREOTA; ROSENMUND C, 1994, NATURE, V368, P853, DOI 10.1038/368853a0; SAH P, 1991, J PHYSIOL-LONDON, V433, P615, DOI 10.1113/jphysiol.1991.sp018446; Schaefer ML, 2000, J NEUROSCI, V20, P4809; Schafe GE, 2000, J NEUROSCI, V20, P8177; Schafe GE, 2001, TRENDS NEUROSCI, V24, P540, DOI 10.1016/S0166-2236(00)01969-X; SELTZER Z, 1990, PAIN, V43, P205, DOI 10.1016/0304-3959(90)91074-S; SIKES RW, 1992, J NEUROPHYSIOL, V68, P1720, DOI 10.1152/jn.1992.68.5.1720; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Sluka KA, 1997, BRIT J PHARMACOL, V122, P1165, DOI 10.1038/sj.bjp.0701486; Soderling TR, 2000, CURR OPIN NEUROBIOL, V10, P375, DOI 10.1016/S0959-4388(00)00090-8; TAIWO YO, 1991, NEUROSCIENCE, V44, P131, DOI 10.1016/0306-4522(91)90255-M; TALBOT JD, 1991, SCIENCE, V251, P1355, DOI 10.1126/science.2003220; TANAKA E, 1994, J NEUROSCI, V14, P1106, DOI 10.1523/JNEUROSCI.14-03-01106.1994; Trudeau LE, 1996, NEURON, V17, P789, DOI 10.1016/S0896-6273(00)80210-X; Tully T, 1998, NAT NEUROSCI, V1, P543, DOI 10.1038/2780; Villacres EC, 1998, J NEUROSCI, V18, P3186; Vogt BA, 1996, EUR J NEUROSCI, V8, P1461, DOI 10.1111/j.1460-9568.1996.tb01608.x; Wei F, 2001, NAT NEUROSCI, V4, P164, DOI 10.1038/83993; Wei F, 1999, J NEUROSCI, V19, P9346; Wei F, 2002, NAT NEUROSCI, V5, P573, DOI 10.1038/nn0602-855; Wei F, 2001, J PHYSIOL-LONDON, V532, P823, DOI 10.1111/j.1469-7793.2001.0823e.x; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; XIA ZG, 1993, J NEUROCHEM, V60, P305, DOI 10.1111/j.1471-4159.1993.tb05852.x; Xia ZG, 1997, CURR OPIN NEUROBIOL, V7, P391, DOI 10.1016/S0959-4388(97)80068-2; XIA ZG, 1991, NEURON, V6, P431, DOI 10.1016/0896-6273(91)90251-T; YARNITSKY D, 1988, PAIN, V32, P285, DOI 10.1016/0304-3959(88)90040-1; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; Zhuo M, 2002, DRUG DISCOV TODAY, V7, P259, DOI 10.1016/S1359-6446(01)02138-9	75	197	207	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 14	2002	36	4					713	726		10.1016/S0896-6273(02)01019-X	http://dx.doi.org/10.1016/S0896-6273(02)01019-X			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	616PX	12441059	Bronze			2022-12-24	WOS:000179313100017
J	Wang, J; Chen, S; Nolan, MF; Siegelbaum, SA				Wang, J; Chen, S; Nolan, MF; Siegelbaum, SA			Activity-dependent regulation of HCN pacemaker channels by cyclic AMP: Signaling through dynamic allosteric coupling	NEURON			English	Article							NUCLEOTIDE-GATED CHANNELS; UNDERLYING SYNCHRONIZED OSCILLATIONS; HYPERPOLARIZATION-ACTIVATED CHANNEL; MOLECULAR MECHANISM; CAMP MODULATION; K+ CHANNEL; VOLTAGE; NEURONS; MODEL; IDENTIFICATION	Signal transduction in neurons is a dynamic process, generally thought to be driven by transient changes in the concentration of second messengers. Here we describe a novel regulatory mechanism in which the dynamics of signaling through cyclic AMP are mediated by activity-dependent changes in the affinity of the hyperpolarization-activated, cation nonselective (HCN) channels for cAMP, rather than by changes in cAMP concentration. Due to the allosteric coupling of channel opening and ligand binding, changes in cellular electrical activity that alter the opening of the HCN channels modify the binding of static, basal levels of cAMP. These changes in ligand binding produce long-lasting changes in channel function which can contribute to the regulation of rhythmic firing patterns.	Columbia Univ, Integrated Program Cellular Mol & Biophys Studies, New York, NY 10032 USA; Columbia Univ, Dept Pharmacol, New York, NY 10032 USA; Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute	Siegelbaum, SA (corresponding author), Columbia Univ, Integrated Program Cellular Mol & Biophys Studies, 722 W 168th St, New York, NY 10032 USA.		Nolan, Matthew/A-1356-2009	Nolan, Matthew/0000-0003-1062-6501	NINDS NIH HHS [NS 36658] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036658] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Altomare C, 2001, J GEN PHYSIOL, V117, P519, DOI 10.1085/jgp.117.6.519; BAL T, 1995, J PHYSIOL-LONDON, V483, P641, DOI 10.1113/jphysiol.1995.sp020612; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Chen M, 2001, ENVIRON FORENSICS, V2, P117, DOI 10.1006/enfo.2001.0050; Colquhoun David, 1995, P589; Cox DH, 1997, J GEN PHYSIOL, V110, P257, DOI 10.1085/jgp.110.3.257; Cui J, 2000, CURR BIOL, V10, P671, DOI 10.1016/S0960-9822(00)00516-9; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; Destexhe A, 1996, J NEUROPHYSIOL, V76, P2049, DOI 10.1152/jn.1996.76.3.2049; DiFrancesco D, 1999, J PHYSIOL-LONDON, V515, P367, DOI 10.1111/j.1469-7793.1999.367ac.x; DIFRANCESCO D, 1993, ANNU REV PHYSIOL, V55, P455, DOI 10.1146/annurev.physiol.55.1.455; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; Gauss R, 1998, NATURE, V393, P583, DOI 10.1038/31248; GOULDING EH, 1994, NATURE, V372, P369, DOI 10.1038/372369a0; Hines ML, 2000, NEURAL COMPUT, V12, P995, DOI 10.1162/089976600300015475; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Kaupp UB, 2001, ANNU REV PHYSIOL, V63, P235, DOI 10.1146/annurev.physiol.63.1.235; Liu DT, 1998, NEURON, V21, P235, DOI 10.1016/S0896-6273(00)80530-9; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Luthi A, 1998, NEURON, V21, P9, DOI 10.1016/S0896-6273(00)80509-7; Luthi A, 1999, NAT NEUROSCI, V2, P634, DOI 10.1038/10189; Luthi A, 1998, NEURON, V20, P553, DOI 10.1016/S0896-6273(00)80994-0; Marx SO, 2002, SCIENCE, V295, P496, DOI 10.1126/science.1066843; MCCORMICK DA, 1992, J NEUROPHYSIOL, V68, P1384, DOI 10.1152/jn.1992.68.4.1384; Michel JJC, 2002, ANNU REV PHARMACOL, V42, P235, DOI 10.1146/annurev.pharmtox.42.083101.135801; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; Robison G.A., 1971, CYCLIC AMP, DOI [10.1146/annurev.bi.37.070168.001053, DOI 10.1146/ANNUREV.BI.37.070168.001053]; Ruiz M, 1997, NATURE, V389, P389, DOI 10.1038/38744; Santoro B, 1999, ANN NY ACAD SCI, V868, P741, DOI 10.1111/j.1749-6632.1999.tb11353.x; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Seifert R, 1999, P NATL ACAD SCI USA, V96, P9391, DOI 10.1073/pnas.96.16.9391; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Tibbs GR, 1997, NATURE, V386, P612, DOI 10.1038/386612a0; Ulens C, 2001, J BIOL CHEM, V276, P6069, DOI 10.1074/jbc.C000738200; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Wang J, 2001, J GEN PHYSIOL, V118, P237, DOI 10.1085/jgp.118.3.237; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315	41	99	103	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 24	2002	36	3					451	461		10.1016/S0896-6273(02)00968-6	http://dx.doi.org/10.1016/S0896-6273(02)00968-6			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	608ZE	12408847	Bronze			2022-12-24	WOS:000178877700013
J	Ingram, SL; Prasad, BM; Amara, SG				Ingram, SL; Prasad, BM; Amara, SG			Dopamine transporter-mediated conductances increase excitability of midbrain dopamine neurons	NATURE NEUROSCIENCE			English	Article							CULTURED HIPPOCAMPAL-NEURONS; SUBSTANTIA-NIGRA NEURONS; CHLORIDE CHANNEL; GLUTAMATE TRANSPORTER; D-AMPHETAMINE; RAT; RELEASE; RECEPTORS; COCAINE; BRAIN	Uptake by Na+/Cl- -dependent neurotransmitter transporters is the principal mechanism by which extracellular biogenic amine concentrations are regulated. In addition to uptake, the cloned transporter proteins also elicit ion channel-like currents, but the physiological consequences of these currents are unknown. Here, whole-cell patch clamp and perforated-patch recordings show that substrates of the dopamine transporter (DAT), such as dopamine (DA) and amphetamine, increase the firing activity of rat DA neurons in culture. We found that these substrates elicit inward currents that are Na+-dependent and blocked by cocaine. These currents are primarily comprised of anions and result in an excitatory response in DA neurons at lower DA concentrations than are required for D2 autoreceptor activation. Thus, in addition to clearing extracellular DA, our results suggest that the currents associated with DAT modulate excitability and may regulate release of neurotransmitter from midbrain DA neurons.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97201 USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University	Amara, SG (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.		Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X; Amara, Susan/0000-0001-8914-1106	NATIONAL INSTITUTE ON DRUG ABUSE [R01DA007595, R37DA007595] Funding Source: NIH RePORTER; NIDA NIH HHS [DAO07595] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Ali DW, 1998, J PHYSIOL-LONDON, V509, P211, DOI 10.1111/j.1469-7793.1998.211bo.x; Backus KH, 1998, J PHYSIOL-LONDON, V507, P783, DOI 10.1111/j.1469-7793.1998.783bs.x; Benoit-Marand M, 2001, J NEUROSCI, V21, P9134, DOI 10.1523/JNEUROSCI.21-23-09134.2001; BRUNS D, 1993, NEURON, V10, P559, DOI 10.1016/0896-6273(93)90159-O; BUNNEY BS, 1978, N-S ARCH PHARMACOL, V304, P255, DOI 10.1007/BF00507966; Cao YW, 1997, J NEUROSCI, V17, P2257; CILIAX BJ, 1995, J NEUROSCI, V15, P1714, DOI 10.1523/JNEUROSCI.15-03-01714.1995; Cragg SJ, 1997, J NEUROPHYSIOL, V77, P863, DOI 10.1152/jn.1997.77.2.863; DeFelice LJ, 1996, BIOPHYS J, V70, P579, DOI 10.1016/S0006-3495(96)79604-2; EBIHARA S, 1995, J PHYSIOL-LONDON, V484, P77, DOI 10.1113/jphysiol.1995.sp020649; Eliasof S, 1996, P NATL ACAD SCI USA, V93, P4153, DOI 10.1073/pnas.93.9.4153; ESHLEMAN AJ, 1994, MOL PHARMACOL, V45, P312; Falkenburger BH, 2001, SCIENCE, V293, P2465, DOI 10.1126/science.1060645; FATIMASHAD K, 1993, P ROY SOC B-BIOL SCI, V253, P69, DOI 10.1098/rspb.1993.0083; FRANCIOLINI F, 1987, J GEN PHYSIOL, V90, P453, DOI 10.1085/jgp.90.4.453; GALLI A, 1995, J EXP BIOL, V198, P2197; Galli A, 1998, P NATL ACAD SCI USA, V95, P13260, DOI 10.1073/pnas.95.22.13260; GEFFEN LB, 1976, NATURE, V260, P258, DOI 10.1038/260258a0; GU H, 1994, J BIOL CHEM, V269, P7124; Hoffman AF, 1998, J PHARMACOL EXP THER, V287, P487; Jaffe EH, 1998, J NEUROSCI, V18, P3548; Jayanthi LD, 2002, BRIT J PHARMACOL, V135, P1927, DOI 10.1038/sj.bjp.0704658; KIM KM, 1995, NEUROSCIENCE, V69, P1145, DOI 10.1016/0306-4522(95)00326-E; KRUEGER BK, 1990, J NEUROCHEM, V55, P260, DOI 10.1111/j.1471-4159.1990.tb08847.x; Kuner T, 2000, NEURON, V27, P447, DOI 10.1016/S0896-6273(00)00056-8; LACEY MG, 1990, BRIT J PHARMACOL, V99, P731, DOI 10.1111/j.1476-5381.1990.tb12998.x; LESTER HA, 1994, ANNU REV PHARMACOL, V34, P219; MAGER S, 1994, NEURON, V12, P845, DOI 10.1016/0896-6273(94)90337-9; MERCURI NB, 1989, BRIT J PHARMACOL, V98, P127, DOI 10.1111/j.1476-5381.1989.tb16872.x; NICHOLSON LFB, 1992, NEUROSCIENCE, V50, P355, DOI 10.1016/0306-4522(92)90429-6; Nirenberg MJ, 1996, J NEUROSCI, V16, P436; Otis TS, 1997, SCIENCE, V277, P1515, DOI 10.1126/science.277.5331.1515; Paladini CA, 2001, NAT NEUROSCI, V4, P275, DOI 10.1038/85124; Paladini CA, 1999, BRAIN RES, V832, P145, DOI 10.1016/S0006-8993(99)01484-5; Prasad BM, 2001, J NEUROSCI, V21, P7561, DOI 10.1523/JNEUROSCI.21-19-07561.2001; RITZ MC, 1987, SCIENCE, V237, P1219, DOI 10.1126/science.2820058; Saunders C, 2000, P NATL ACAD SCI USA, V97, P6850, DOI 10.1073/pnas.110035297; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Shi WX, 2000, J NEUROSCI, V20, P3504, DOI 10.1523/JNEUROSCI.20-09-03504.2000; Sitte HH, 1998, J NEUROCHEM, V71, P1289; Sonders MS, 1997, J NEUROSCI, V17, P960; Sonders MS, 1996, CURR OPIN NEUROBIOL, V6, P294, DOI 10.1016/S0959-4388(96)80111-5; Staley KJ, 1999, J PHYSIOL-LONDON, V519, P693, DOI 10.1111/j.1469-7793.1999.0693n.x; SULZER D, 1993, J NEUROCHEM, V60, P527, DOI 10.1111/j.1471-4159.1993.tb03181.x; TRENT F, 1991, EUR J PHARMACOL, V204, P265, DOI 10.1016/0014-2999(91)90851-G; Volkow ND, 1999, J PHARMACOL EXP THER, V291, P409; Wadiche JI, 1998, J NEUROSCI, V18, P7650; WISE RA, 1987, PSYCHOL REV, V94, P469, DOI 10.1037/0033-295X.94.4.469	48	173	175	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2002	5	10					971	978		10.1038/nn920	http://dx.doi.org/10.1038/nn920			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	597VV	12352983				2022-12-24	WOS:000178242200016
J	Matulef, K; Zagotta, WN				Matulef, K; Zagotta, WN			Multimerization of the ligand binding domains of cyclic nucleotide-gated channels	NEURON			English	Article							ION CHANNELS; SUBUNIT STOICHIOMETRY; ACTIVATED CHANNELS; ROD PHOTORECEPTORS; MEMBRANE PATCHES; SITE; GMP; PROTEIN; CONDUCTANCE; RECEPTOR	Cyclic nucleotide-gated (CNG) channels comprise four subunits and are activated by the direct binding of cyclic nucleotide to an intracellular domain on each subunit. This ligand binding domain is thought to contain a beta roll followed by two alpha helices, designated the B and C helices. To examine the quaternary structure of CNG channels and how it changes during ion channel gating, we introduced single cysteines along the C helix of each subunit in an otherwise cysteineless channel. We found that cysteines on the C helices could form intersubunit disulfide bonds, even between diagonal subunits. Disulfide bond formation occurred primarily in closed channels and inhibited channel opening. These data suggest that the C helices from all four channel subunits are in close proximity in the closed state and move apart during channel opening.	Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA; Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Zagotta, WN (corresponding author), Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA.				NATIONAL EYE INSTITUTE [T32EY007031, R01EY010329] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY010329, R01 EY010329-09, EY 10329, T32 EY07031] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		[Anonymous], 1973, CHEM BIOCH SULFHYDRY; Brown RL, 2000, BIOCHEMISTRY-US, V39, P432, DOI 10.1021/bi9920735; CAREAGA CL, 1992, BIOPHYS J, V62, P209, DOI 10.1016/S0006-3495(92)81806-4; FALKE JJ, 1987, SCIENCE, V237, P1596, DOI 10.1126/science.2820061; FESENKO EE, 1985, NATURE, V313, P310, DOI 10.1038/313310a0; GORDON SE, 1995, P NATL ACAD SCI USA, V92, P10222, DOI 10.1073/pnas.92.22.10222; Gordon SE, 1997, NEURON, V19, P431, DOI 10.1016/S0896-6273(00)80951-4; GORDON SE, 1995, NEURON, V14, P857, DOI 10.1016/0896-6273(95)90229-5; GORDON SE, 1995, NEURON, V14, P177; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HENN DK, 1995, P NATL ACAD SCI USA, V92, P7425, DOI 10.1073/pnas.92.16.7425; JAN LY, 1990, NATURE, V345, P672, DOI 10.1038/345672a0; KARPEN JW, 1988, P NATL ACAD SCI USA, V85, P1287, DOI 10.1073/pnas.85.4.1287; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; KOBASHI K, 1968, BIOCHIM BIOPHYS ACTA, V158, P239, DOI 10.1016/0304-4165(68)90136-0; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Liu DT, 1998, NEURON, V21, P235, DOI 10.1016/S0896-6273(00)80530-9; Liu DT, 1996, NEURON, V16, P983, DOI 10.1016/S0896-6273(00)80121-X; Matulef K, 1999, NEURON, V24, P443, DOI 10.1016/S0896-6273(00)80857-0; MOLDAY RS, 1991, J BIOL CHEM, V266, P21917; Molokanova E, 1997, J NEUROSCI, V17, P9068; Molokanova E, 1999, J GEN PHYSIOL, V113, P45, DOI 10.1085/jgp.113.1.45; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; Rho SH, 2000, FEBS LETT, V478, P246, DOI 10.1016/S0014-5793(00)01863-9; Rosenbaum T, 2002, NEURON, V33, P703, DOI 10.1016/S0896-6273(02)00599-8; Scott SP, 2001, BIOCHEMISTRY-US, V40, P7464, DOI 10.1021/bi002804x; SHABB JB, 1992, J BIOL CHEM, V267, P5723; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; Sunderman ER, 1999, J GEN PHYSIOL, V113, P601, DOI 10.1085/jgp.113.5.601; Tibbs GR, 1998, J BIOL CHEM, V273, P4497, DOI 10.1074/jbc.273.8.4497; Varnum MD, 1996, BIOPHYS J, V70, P2667, DOI 10.1016/S0006-3495(96)79836-3; VARNUM MD, 1995, NEURON, V15, P619, DOI 10.1016/0896-6273(95)90150-7; WEBER IT, 1987, J BIOL CHEM, V262, P5630; Weber K, 1972, Methods Enzymol, V26, P3; WOHLFART P, 1992, J BIOL CHEM, V267, P644; YAU KW, 1989, ANNU REV NEUROSCI, V12, P289, DOI 10.1146/annurev.ne.12.030189.001445; ZAGOTTA WN, 1989, P NATL ACAD SCI USA, V86, P7243, DOI 10.1073/pnas.86.18.7243; ZIMMERMAN AL, 1988, BIOPHYS J, V54, P351, DOI 10.1016/S0006-3495(88)82966-7; ZUFALL F, 1994, ANNU REV BIOPH BIOM, V23, P577, DOI 10.1146/annurev.bb.23.060194.003045	40	28	30	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 26	2002	36	1					93	103		10.1016/S0896-6273(02)00878-4	http://dx.doi.org/10.1016/S0896-6273(02)00878-4			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	598UP	12367509	Bronze			2022-12-24	WOS:000178295100010
J	Zakharenko, SS; Zablow, L; Siegelbaum, SA				Zakharenko, SS; Zablow, L; Siegelbaum, SA			Altered presynaptic vesicle release and cycling during mGluR-dependent LTD	NEURON			English	Article							LONG-TERM DEPRESSION; FROG NEUROMUSCULAR-JUNCTION; HIPPOCAMPAL PYRAMIDAL CELLS; MOTOR-NERVE TERMINALS; SILENT SYNAPSES; TRANSMITTER RELEASE; SYNAPTIC PLASTICITY; RECEPTOR ACTIVATION; PROTEIN-SYNTHESIS; ARACHIDONIC-ACID	The site of modification of synaptic transmission during long-term plasticity in the mammalian hippocampus remains controversial. Here we used a fluorescent marker of presynaptic activity, FM 1-43, to directly image presynaptic function during metabotropic glutamate receptor-dependent long-term depression (mGluR-LTD) at CA3-CA1 excitatory synapses in acute hippocampal slices. We found a significant decrease in the rate of FM 1-43 release in response to synaptic stimulation following induction of mGluR-LTD, providing direct evidence for altered presynaptic function. Moreover, we found that mGluR-LTD causes several changes in FM dye release properties that are consistent with a change in the mode of vesicle cycling, possibly involving a switch from a full fusion mode of release to a "kiss-and-run" mode of release through the transient opening of a fusion pore.	Columbia Univ, Howard Hughes Med Inst, Dept Pharmacol, Ctr Neurobiol & Behav, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Siegelbaum, SA (corresponding author), Columbia Univ, Howard Hughes Med Inst, Dept Pharmacol, Ctr Neurobiol & Behav, 722 W 168th St, New York, NY 10032 USA.		Zakharenko, Stanislav/D-3287-2013	Zakharenko, Stanislav/0000-0001-8115-202X	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH050733] Funding Source: NIH RePORTER; NIMH NIH HHS [MH-50733] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Atwood HL, 1999, LEARN MEMORY, V6, P542, DOI 10.1101/lm.6.6.542; Becherer U, 2001, J NEUROSCI, V21, P782, DOI 10.1523/JNEUROSCI.21-03-00782.2001; BETZ WJ, 1993, J PHYSIOL-LONDON, V460, P287, DOI 10.1113/jphysiol.1993.sp019472; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; BOLSHAKOV VY, 1995, NEUROPHARMACOLOGY, V34, P1581, DOI 10.1016/0028-3908(95)00127-R; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; Bolshakov VY, 2000, NAT NEUROSCI, V3, P1107, DOI 10.1038/80624; Braunewell KH, 2001, REV NEUROSCIENCE, V12, P121; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Choi S, 2000, NAT NEUROSCI, V3, P330, DOI 10.1038/73895; DETOLEDO GA, 1993, NATURE, V363, P554, DOI 10.1038/363554a0; Fitzjohn SM, 1999, NEUROPHARMACOLOGY, V38, P1577, DOI 10.1016/S0028-3908(99)00123-9; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Henkel AW, 1995, J NEUROSCI, V15, P8246; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; KATZ B, 1971, SCIENCE, V173, P123, DOI 10.1126/science.173.3992.123; Kauderer BS, 2000, P NATL ACAD SCI USA, V97, P13342, DOI 10.1073/pnas.97.24.13342; Kay AR, 1999, NEURON, V24, P809, DOI 10.1016/S0896-6273(00)81029-6; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Klyachko VA, 2002, NATURE, V418, P89, DOI 10.1038/nature00852; KULLMANN DM, 1994, NEURON, V12, P1111, DOI 10.1016/0896-6273(94)90318-2; KULLMANN DM, 1995, NEURON, V15, P997, DOI 10.1016/0896-6273(95)90089-6; KULLMANN DM, 1992, NATURE, V357, P240, DOI 10.1038/357240a0; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MALGAROLI A, 1995, SCIENCE, V268, P1624, DOI 10.1126/science.7777862; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; MALINOW R, 1991, SCIENCE, V252, P722, DOI 10.1126/science.1850871; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Nicoll RA, 1999, ANN NY ACAD SCI, V868, P515, DOI 10.1111/j.1749-6632.1999.tb11320.x; Normandin M, 1996, BRAIN RES, V730, P40; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; Pyle JL, 1999, NEURON, V24, P803, DOI 10.1016/S0896-6273(00)81028-4; Renger JJ, 2001, NEURON, V29, P469, DOI 10.1016/S0896-6273(01)00219-7; Rouze NC, 1998, J NEUROSCI, V18, P8614; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Sankaranarayanan S, 2001, NAT NEUROSCI, V4, P129, DOI 10.1038/83949; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Stanton PK, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-19-j0002.2001; Stevens CF, 2000, P NATL ACAD SCI USA, V97, P12828, DOI 10.1073/pnas.230438697; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; Sun JY, 2002, NATURE, V417, P555, DOI 10.1038/417555a; Wang CT, 2001, SCIENCE, V294, P1111, DOI 10.1126/science.1064002; Watabe AM, 2002, J NEUROPHYSIOL, V87, P1395, DOI 10.1152/jn.00723.2001; Zakharenko SS, 2001, NAT NEUROSCI, V4, P711, DOI 10.1038/89498	51	109	111	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 12	2002	35	6					1099	1110		10.1016/S0896-6273(02)00898-X	http://dx.doi.org/10.1016/S0896-6273(02)00898-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	594GC	12354399	Bronze			2022-12-24	WOS:000178040000010
J	Moita, MAP; Lamprecht, R; Nader, K; LeDoux, JE				Moita, MAP; Lamprecht, R; Nader, K; LeDoux, JE			A-kinase anchoring proteins in amygdala are involved in auditory fear memory	NATURE NEUROSCIENCE			English	Article							AKAP; RECEPTORS; COMPLEX; NEURONS; PKA		NYU, Ctr Neural Sci, WM Keck Fdn Lab Neurobiol, New York, NY 10003 USA	New York University	LeDoux, JE (corresponding author), NYU, Ctr Neural Sci, WM Keck Fdn Lab Neurobiol, New York, NY 10003 USA.			Moita, Marta/0000-0002-5144-6905	NIMH NIH HHS [MH00956, MH38774, MH46516] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH000956, R37MH038774, R01MH038774, R01MH046516] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Colledge M, 1999, TRENDS CELL BIOL, V9, P216, DOI 10.1016/S0962-8924(99)01558-5; Dodge K, 2000, FEBS LETT, V476, P58, DOI 10.1016/S0014-5793(00)01671-9; Dodge KL, 1999, MOL ENDOCRINOL, V13, P1977, DOI 10.1210/me.13.12.1977; Feliciello A, 1997, CURR BIOL, V7, P1011, DOI 10.1016/S0960-9822(06)00424-6; Feliciello A, 2001, J MOL BIOL, V308, P99, DOI 10.1006/jmbi.2001.4585; Fraser IDC, 2000, CURR BIOL, V10, P409, DOI 10.1016/S0960-9822(00)00419-X; GLANTZ SB, 1992, MOL BIOL CELL, V3, P1215, DOI 10.1091/mbc.3.11.1215; Herberg FW, 2000, J MOL BIOL, V298, P329, DOI 10.1006/jmbi.2000.3662; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; ROSENMUND C, 1994, NATURE, V368, P853, DOI 10.1038/368853a0; Schafe GE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-18-j0003.2000; Schafe GE, 2001, TRENDS NEUROSCI, V24, P540, DOI 10.1016/S0166-2236(00)01969-X; Vijayaraghavan S, 1997, J BIOL CHEM, V272, P4747, DOI 10.1074/jbc.272.8.4747; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93	15	66	67	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2002	5	9					837	838		10.1038/nn901	http://dx.doi.org/10.1038/nn901			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587RL	12172550				2022-12-24	WOS:000177656300010
J	Golestani, N; Paus, T; Zatorre, RJ				Golestani, N; Paus, T; Zatorre, RJ			Anatomical correlates of learning novel speech sounds	NEURON			English	Article							AUDITORY-CORTEX; PERCEPTUAL REORGANIZATION; DEVELOPMENTAL DYSLEXIA; STATISTICAL-ANALYSIS; TEMPORAL PERCEPTION; PLANUM-TEMPORALE; WHITE-MATTER; HUMAN BRAIN; MRI; DISCRIMINATION	We examined the relationship between brain anatomy and the ability to learn nonnative speech sounds, as well as rapidly changing and steady-state nonlinguistic sounds, using voxel-based morphometry in 59 healthy adults. Faster phonetic learners appeared to have more white matter in parietal regions, especially in the left hemisphere. The pattern of results was similar for the rapidly changing but not for the steady-state nonlinguistic stimuli, suggesting that morphological correlates of phonetic learning are related to the ability to process rapid temporal variation. Greater asymmetry in the amount of white matter in faster learners may be related to greater myelination allowing more efficient neural processing, which is critical for the ability to process certain speech sounds.	McGill Univ, Montreal Neurol Inst, Cognit Neurosci Unit, Montreal, PQ H3A 2B4, Canada	McGill University	Golestani, N (corresponding author), McGill Univ, Montreal Neurol Inst, Cognit Neurosci Unit, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.	narlyg@bic.mni.mcgill.ca	Golestani, Narly/C-4879-2009	Golestani, Narly/0000-0001-7388-4714				Anderson B, 1999, NEUROPSY NEUROPSY BE, V12, P247; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Belin P, 1998, J COGNITIVE NEUROSCI, V10, P536, DOI 10.1162/089892998562834; Benasich AA, 1996, INFANT BEHAV DEV, V19, P339, DOI 10.1016/S0163-6383(96)90033-8; Bermudez P, 2001, NEUROIMAGE, V13, P1121, DOI 10.1006/nimg.2001.0772; BEST CT, 1988, J EXP PSYCHOL HUMAN, V14, P345, DOI 10.1037/0096-1523.14.3.345; Binder JR, 1996, BRAIN, V119, P1239, DOI 10.1093/brain/119.4.1239; BINDER JR, 1994, ANN NEUROL, V35, P662, DOI 10.1002/ana.410350606; Binder JR, 1997, J NEUROSCI, V17, P353, DOI 10.1523/JNEUROSCI.17-01-00353.1997; BURNHAM DK, 1986, APPL PSYCHOLINGUIST, V7, P207, DOI 10.1017/S0142716400007542; Burton MW, 2000, J COGNITIVE NEUROSCI, V12, P679, DOI 10.1162/089892900562309; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Collins DL, 1995, HUM BRAIN MAPP, V3, P190, DOI 10.1002/hbm.460030304; Collins DL, 1997, INT J PATTERN RECOGN, V11, P1271, DOI 10.1142/S0218001497000597; COLLINS DL, 1999, P 16 INT C INF P MED; DELACOSTE MC, 1985, J NEUROPATH EXP NEUR, V44, P578, DOI 10.1097/00005072-198511000-00004; DEMONET JF, 1994, NEUROSCI LETT, V182, P25, DOI 10.1016/0304-3940(94)90196-1; DEMONET JF, 1992, BRAIN, V115, P1753, DOI 10.1093/brain/115.6.1753; DUARA R, 1991, ARCH NEUROL-CHICAGO, V48, P410, DOI 10.1001/archneur.1991.00530160078018; EFRON R, 1963, BRAIN, V86, P403, DOI 10.1093/brain/86.3.403; FIEZ JA, 1995, J COGNITIVE NEUROSCI, V7, P357, DOI 10.1162/jocn.1995.7.3.357; HENKE WL, 1990, MITSYN SYNERGISTIC F; Horwitz B, 1998, P NATL ACAD SCI USA, V95, P8939, DOI 10.1073/pnas.95.15.8939; HYND GW, 1990, ARCH NEUROL-CHICAGO, V47, P919, DOI 10.1001/archneur.1990.00530080107018; Isaacs EB, 2001, BRAIN, V124, P1701, DOI 10.1093/brain/124.9.1701; JAMIESON DG, 1986, PERCEPT PSYCHOPHYS, V40, P205, DOI 10.3758/BF03211500; Jancke L, 1998, NEUROPSYCHOLOGIA, V36, P875, DOI 10.1016/S0028-3932(98)00019-0; Jenkins JamesJ., 1995, ASSESSING INDIVIDUAL, P297; JERNIGAN TL, 1991, ARCH NEUROL-CHICAGO, V48, P539, DOI 10.1001/archneur.1991.00530170103028; Johnsrude IS, 2000, BRAIN, V123, P155, DOI 10.1093/brain/123.1.155; Johnsrude IS, 1997, NEUROREPORT, V8, P1761, DOI 10.1097/00001756-199705060-00038; Klingberg T, 2000, NEURON, V25, P493, DOI 10.1016/S0896-6273(00)80911-3; KUHL PK, 1992, SCIENCE, V255, P606, DOI 10.1126/science.1736364; KUSHCH A, 1993, NEUROPSYCHOLOGIA, V31, P811, DOI 10.1016/0028-3932(93)90130-R; LARSEN JP, 1990, BRAIN LANG, V39, P289, DOI 10.1016/0093-934X(90)90015-9; Liegeois-Chauvel C, 1999, CEREB CORTEX, V9, P484, DOI 10.1093/cercor/9.5.484; Liegeois-Chauvel C, 2001, ANN NY ACAD SCI, V930, P117, DOI 10.1111/j.1749-6632.2001.tb05728.x; MacDonald D, 1994, P SOC PHOTO-OPT INS, V2359, P160; MAZOYER BM, 1993, J COGNITIVE NEUROSCI, V5, P467, DOI 10.1162/jocn.1993.5.4.467; MOROSAN DE, 1986, P 12 INT C AC CAN AC; Mummery CJ, 1999, J ACOUST SOC AM, V106, P449, DOI 10.1121/1.427068; Nicholls MER, 1999, NEUROPSY NEUROPSY BE, V12, P11; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; Paus T, 1999, SCIENCE, V283, P1908, DOI 10.1126/science.283.5409.1908; Penhune VB, 1996, CEREB CORTEX, V6, P661, DOI 10.1093/cercor/6.5.661; Petersen S E, 1989, J Cogn Neurosci, V1, P153, DOI 10.1162/jocn.1989.1.2.153; PETERSEN SE, 1988, NATURE, V331, P585, DOI 10.1038/331585a0; PLANTE E, 1991, BRAIN LANG, V41, P52, DOI 10.1016/0093-934X(91)90110-M; POLKA L, 1991, J ACOUST SOC AM, V89, P2961, DOI 10.1121/1.400734; POLKA L, 1994, J EXP PSYCHOL HUMAN, V20, P421, DOI 10.1037/0096-1523.20.2.421; Pruitt J. S., 1990, J ACOUST SOC AM, V87, pS72; PUJOL J, 2002, IN PRESS NEUROIMAGE; RACK JP, 1992, READ RES QUART, V27, P28, DOI 10.2307/747832; ROBIN DA, 1990, BRAIN LANG, V39, P539, DOI 10.1016/0093-934X(90)90161-9; Rohen J. W., 1983, COLOR ATLAS ANATOMY; RUMSEY JM, 1986, ARCH NEUROL-CHICAGO, V43, P1045, DOI 10.1001/archneur.1986.00520100053014; Rumsey JM, 1999, BRAIN LANG, V70, P187, DOI 10.1006/brln.1999.2158; RUMSEY JM, 1992, ARCH NEUROL-CHICAGO, V49, P527, DOI 10.1001/archneur.1992.00530290115020; SCHWARTZ J, 1980, SCIENCE, V207, P1380, DOI 10.1126/science.7355297; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Stevens Kenneth N., 1975, J PHONETICS, V3, P215, DOI [10.1016/s0095-4470(19)31431-7, DOI 10.1016/S0095-4470(19)31431-7]; Talairach J, 1993, REFERENTIALLY ORIENT; Talairach J., 1988, COPLANAR STEREOTAXIC; TALLAL P, 1980, BRAIN LANG, V9, P182, DOI 10.1016/0093-934X(80)90139-X; TALLAL P, 1973, NATURE, V241, P468, DOI 10.1038/241468a0; TALLAL P, 1993, ANN NY ACAD SCI, V682, P27, DOI 10.1111/j.1749-6632.1993.tb22957.x; TEES RC, 1984, CAN J PSYCHOL, V38, P579, DOI 10.1037/h0080868; Temple E, 2000, P NATL ACAD SCI USA, V97, P13907, DOI 10.1073/pnas.240461697; TERRACE HS, 1963, J EXP ANAL BEHAV, V6, P1, DOI 10.1901/jeab.1963.6-1; Thompson PM, 2001, P NATL ACAD SCI USA, V98, P11650, DOI 10.1073/pnas.201243998; Vargha-Khadem F, 1998, P NATL ACAD SCI USA, V95, P12695, DOI 10.1073/pnas.95.21.12695; Waddington MM, 1984, ATLAS HUMAN INTRACRA; Watkins KE, 2001, CEREB CORTEX, V11, P868, DOI 10.1093/cercor/11.9.868; WERKER JF, 1984, INFANT BEHAV DEV, V7, P49, DOI 10.1016/S0163-6383(84)80022-3; WERKER JF, 1988, DEV PSYCHOL, V24, P672, DOI 10.1037/0012-1649.24.5.672; WERKER JF, 1984, J ACOUST SOC AM, V75, P1866, DOI 10.1121/1.390988; WERKER JF, 1983, CAN J PSYCHOL, V37, P278, DOI 10.1037/h0080725; WERKER JF, 1985, PERCEPT PSYCHOPHYS, V37, P35, DOI 10.3758/BF03207136; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Wright IC, 1995, NEUROIMAGE, V2, P244, DOI 10.1006/nimg.1995.1032; Zatorre RJ, 2001, ANN NY ACAD SCI, V930, P193, DOI 10.1111/j.1749-6632.2001.tb05734.x; ZATORRE RJ, 1994, J NEUROSCI, V14, P1908, DOI 10.1523/jneurosci.14-04-01908.1994; Zatorre RJ, 1996, CEREB CORTEX, V6, P21, DOI 10.1093/cercor/6.1.21; ZATORRE RJ, 1992, SCIENCE, V256, P846, DOI 10.1126/science.1589767; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7; ZIJDENBOS AP, 1998, P 1 INT C MED IM COM, P439	87	180	184	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 29	2002	35	5					997	1010		10.1016/S0896-6273(02)00862-0	http://dx.doi.org/10.1016/S0896-6273(02)00862-0			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	589UY	12372292	Bronze			2022-12-24	WOS:000177779800020
J	Haase, G; Dessaud, E; Garces, A; de Bovis, B; Birling, MC; Filippi, P; Schmalbruch, H; Arber, S; deLapeyriere, O				Haase, G; Dessaud, E; Garces, A; de Bovis, B; Birling, MC; Filippi, P; Schmalbruch, H; Arber, S; deLapeyriere, O			GDNF acts through PEA3 to regulate cell body positioning and muscle innervation of specific motor neuron pools	NEURON			English	Article							DEVELOPING SPINAL-CORD; LIM HOMEOBOX GENES; MICE LACKING GDNF; NEUROTROPHIC FACTOR; SUBTYPE IDENTITY; NERVOUS-SYSTEM; MOTONEURON DIFFERENTIATION; PERIPHERAL-NERVE; SENSORY NEURONS; SURVIVAL FACTOR	Target innervation by specific neuronal populations involves still incompletely understood interactions between central and peripheral factors. We show that glial cell line-derived neurotrophic factor (GDNF), initially characterized for its role as a survival factor, is present early in the plexus of the developing forelimb and later in two muscles: the cutaneus maximus and latissimus dorsi. In the absence of GDNF signaling, motor neurons that normally innervate these muscles are mispositioned within the spinal cord and muscle invasion by their axons is dramatically reduced. The ETS transcription factor PEA3 is normally expressed by these motor neurons and fails to be induced in most of them in GDNF signaling mutants. Thus, GDNF acts as a peripheral signal to induce PEA3 expression in specific motor neuron pools thereby regulating both cell body position and muscle innervation.	Univ Basel, Bioctr, Dept Cell Biol, CH-4056 Basel, Switzerland; Univ Mediterranee, Dev Biol Inst Marseille, CNRS, INSERM,U382, F-13288 Marseille 9, France; Univ Copenhagen, Dept Med Physiol, Div Neurophysiol, DK-2200 Copenhagen, Denmark; Friedrich Miescher Inst, CH-4058 Basel, Switzerland	University of Basel; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of Copenhagen; Friedrich Miescher Institute for Biomedical Research	deLapeyriere, O (corresponding author), Univ Basel, Bioctr, Dept Cell Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.			Garces, Alain/0000-0001-6252-9995; Birling, Marie-Christine/0000-0002-3372-8108; Dessaud, Eric/0000-0001-9723-6658; Arber, Silvia/0000-0002-6261-250X				Airaksinen MS, 1999, MOL CELL NEUROSCI, V13, P313, DOI 10.1006/mcne.1999.0754; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; BAULAC M, 1981, ACTA ANAT, V109, P209; Brophy PD, 2001, DEVELOPMENT, V128, P4747; Cacalano G, 1998, NEURON, V21, P53, DOI 10.1016/S0896-6273(00)80514-0; Carpenter EM, 1997, DEVELOPMENT, V124, P4505; Carroll P, 2001, MOL CELL NEUROSCI, V17, P611, DOI 10.1006/mcne.2001.0966; deLapeyriere O, 1997, CURR OPIN GENET DEV, V7, P642, DOI 10.1016/S0959-437X(97)80012-3; Dou CL, 1997, NEURON, V18, P539, DOI 10.1016/S0896-6273(00)80296-2; Ebens A, 1996, NEURON, V17, P1157, DOI 10.1016/S0896-6273(00)80247-0; Eisen JS, 1999, TRENDS NEUROSCI, V22, P321, DOI 10.1016/S0166-2236(98)01370-8; Ensini M, 1998, DEVELOPMENT, V125, P969; Farinas I, 1996, NEURON, V17, P1065, DOI 10.1016/S0896-6273(00)80240-8; Garces A, 2001, DEV DYNAM, V220, P189, DOI 10.1002/1097-0177(20010301)220:3<189::AID-DVDY1106>3.0.CO;2-I; Garces A, 2000, J NEUROSCI, V20, P4992; Golden JP, 1999, EXP NEUROL, V158, P504, DOI 10.1006/exnr.1999.7127; Greene E.C., 1963, ANATOMY RAT, V27; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; Keller-Peck CR, 2001, J NEUROSCI, V21, P6136, DOI 10.1523/JNEUROSCI.21-16-06136.2001; KELLY R, 1995, J CELL BIOL, V129, P383, DOI 10.1083/jcb.129.2.383; Kume T, 2000, DEVELOPMENT, V127, P1387; LANCEJONES C, 1981, PROC R SOC SER B-BIO, V214, P1, DOI 10.1098/rspb.1981.0079; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P391, DOI 10.1113/jphysiol.1978.sp012546; Landmesser LT, 2001, INT J DEV NEUROSCI, V19, P175, DOI 10.1016/S0736-5748(00)00090-3; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Liu JP, 2001, NEURON, V32, P997, DOI 10.1016/S0896-6273(01)00544-X; Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2; Maina F, 1997, GENE DEV, V11, P3341, DOI 10.1101/gad.11.24.3341; Milner LD, 1999, J NEUROSCI, V19, P3007; Milner LD, 1998, J NEUROSCI, V18, P3297; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Nguyen QT, 1998, SCIENCE, V279, P1725, DOI 10.1126/science.279.5357.1725; Oppenheim RW, 2000, J NEUROSCI, V20, P5001; Oppenheim RW, 1996, NEURON, V17, P195, DOI 10.1016/S0896-6273(00)80151-8; PACHNIS V, 1993, DEVELOPMENT, V119, P1005; Price SR, 2002, CELL, V109, P205, DOI 10.1016/S0092-8674(02)00695-5; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; Sockanathan S, 1998, CELL, V94, P503, DOI 10.1016/S0092-8674(00)81591-3; Sorensen J, 1998, ANN NEUROL, V43, P205, DOI 10.1002/ana.410430210; Taraviras S, 1999, DEVELOPMENT, V126, P2785; THERIAULT E, 1988, J NEUROPHYSIOL, V60, P463, DOI 10.1152/jn.1988.60.2.463; Tiret L, 1998, DEVELOPMENT, V125, P279; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Wang H, 1999, NATURE, V401, P765, DOI 10.1038/44521; Wright DE, 1996, CELL TISSUE RES, V286, P209, DOI 10.1007/s004410050689; YAMADA T, 1993, CELL, V73, P673, DOI 10.1016/0092-8674(93)90248-O; Yamamoto Y, 1997, DEVELOPMENT, V124, P2903; Zurn AD, 1996, J NEUROSCI RES, V44, P133, DOI 10.1002/(SICI)1097-4547(19960415)44:2<133::AID-JNR5>3.0.CO;2-E	53	150	151	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 29	2002	35	5					893	905		10.1016/S0896-6273(02)00864-4	http://dx.doi.org/10.1016/S0896-6273(02)00864-4			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	589UY	12372284	Bronze			2022-12-24	WOS:000177779800012
J	James, TW; Humphrey, GK; Gati, JS; Menon, RS; Goodale, MA				James, TW; Humphrey, GK; Gati, JS; Menon, RS; Goodale, MA			Differential effects of viewpoint on object-driven activation in dorsal and ventral streams	NEURON			English	Article							POSITRON EMISSION TOMOGRAPHY; EVENT-RELATED FMRI; FUNCTIONAL-ANATOMY; VISUAL RECOGNITION; FACE RECOGNITION; HUMANS; CORTEX; BRAIN; MECHANISMS; MEMORY	Using fMRI, we showed that an area in the ventral temporo-occipital cortex (area vTO), which is part of the human homolog of the ventral stream of visual processing, exhibited priming for both identical and depth-rotated images of objects. This pattern of activation in area vTO corresponded to performance in a behavioral matching task. An area in the caudal part of the intraparietal sulcus (area cIPS) also showed priming, but only with identical images of objects. This dorsal-stream area treated rotated images as new objects. The difference in the pattern of priming-related activation in the two areas may reflect the respective roles of the ventral and dorsal streams in object recognition and object-directed action.	Univ Western Ontario, Dept Psychol, CIHR Grp Act & Percept, London, ON N6A 5C2, Canada	Western University (University of Western Ontario)	Goodale, MA (corresponding author), Univ Western Ontario, Dept Psychol, CIHR Grp Act & Percept, London, ON N6A 5C2, Canada.		Menon, Ravi/ABA-8654-2020; Menon, Ravi S/K-5500-2013; Goodale, Melvyn A/M-5907-2013; Gati, Joseph S/K-5476-2013	Menon, Ravi/0000-0002-7916-0263; Menon, Ravi S/0000-0002-7916-0263; Goodale, Melvyn A/0000-0001-6748-0561; 				Badgaiyan RD, 2000, HUM BRAIN MAPP, V10, P197, DOI 10.1002/1097-0193(200008)10:4<197::AID-HBM50>3.0.CO;2-B; Biederman I, 1997, PHILOS T ROY SOC B, V352, P1203, DOI 10.1098/rstb.1997.0103; BIEDERMAN I, 1993, J EXP PSYCHOL HUMAN, V19, P1162, DOI 10.1037/0096-1523.19.6.1162; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; CORBETTA M, 1991, J NEUROSCI, V11, P2383; Craighero L, 1996, NEUROREPORT, V8, P347, DOI 10.1097/00001756-199612200-00068; Culham JC, 2001, CURR OPIN NEUROBIOL, V11, P157, DOI 10.1016/S0959-4388(00)00191-4; Dale AM, 2000, NEURON, V26, P55, DOI 10.1016/S0896-6273(00)81138-1; ELLIS R, 1989, Q J EXP PSYCHOL-A, V41, P775, DOI 10.1080/14640748908402393; Faillenot I, 1997, CEREB CORTEX, V7, P77, DOI 10.1093/cercor/7.1.77; Gauthier I, 1997, VISION RES, V37, P1673, DOI 10.1016/S0042-6989(96)00286-6; Gauthier I, 1997, CURR BIOL, V7, P645, DOI 10.1016/S0960-9822(06)00291-0; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 1998, HUM BRAIN MAPP, V6, P316, DOI 10.1002/(SICI)1097-0193(1998)6:4<316::AID-HBM9>3.0.CO;2-6; Grill-Spector K, 2000, NAT NEUROSCI, V3, P837, DOI 10.1038/77754; Halgren E, 1999, HUM BRAIN MAPP, V7, P29; Henson R, 2000, SCIENCE, V287, P1269, DOI 10.1126/science.287.5456.1269; James TW, 2000, CURR BIOL, V10, P1017, DOI 10.1016/S0960-9822(00)00655-2; James TW, 2002, NEUROPSYCHOLOGIA, V40, P1706, DOI 10.1016/S0028-3932(02)00017-9; Jiang Y, 2000, SCIENCE, V287, P643, DOI 10.1126/science.287.5453.643; JOLICOEUR P, 1998, PERCEPTUAL CONSTANCY, P69; Kanwisher N, 1996, COGNITIVE BRAIN RES, V5, P55, DOI 10.1016/S0926-6410(96)00041-9; Kraut M, 1997, NEUROLOGY, V48, P1416, DOI 10.1212/WNL.48.5.1416; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; OGAWA S, 1993, BIOPHYS J, V64, P803, DOI 10.1016/S0006-3495(93)81441-3; Price CJ, 1996, P ROY SOC B-BIOL SCI, V263, P1501, DOI 10.1098/rspb.1996.0219; Sakata H, 1997, TRENDS NEUROSCI, V20, P350, DOI 10.1016/S0166-2236(97)01067-9; Schacter DL, 1998, NEURON, V20, P185, DOI 10.1016/S0896-6273(00)80448-1; SCHACTER DL, 1995, NATURE, V376, P587, DOI 10.1038/376587a0; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; Shikata E, 2001, J NEUROPHYSIOL, V85, P1309, DOI 10.1152/jn.2001.85.3.1309; SQUIRE LR, 1992, P NATL ACAD SCI USA, V89, P1837, DOI 10.1073/pnas.89.5.1837; Talairach J., 1988, COPLANAR STEREOTAXIC; Tarr MJ, 1998, COGNITION, V67, P1, DOI 10.1016/S0010-0277(98)00026-2; van Turennout M, 2000, NAT NEUROSCI, V3, P1329, DOI 10.1038/81873; Vuilleumier P, 2002, NAT NEUROSCI, V5, P491, DOI 10.1038/nn839; Wallis G, 1999, TRENDS COGN SCI, V3, P22, DOI 10.1016/S1364-6613(98)01261-3; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X; Williams P, 1999, PERCEPT PSYCHOPHYS, V61, P963, DOI 10.3758/BF03206910	41	191	195	1	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 15	2002	35	4					793	801		10.1016/S0896-6273(02)00803-6	http://dx.doi.org/10.1016/S0896-6273(02)00803-6			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	585JE	12194877	Bronze			2022-12-24	WOS:000177521000018
J	Higuchi, M; Ishihara, T; Zhang, B; Hong, M; Andreadis, A; Trojanowski, JQ; Lee, VMY				Higuchi, M; Ishihara, T; Zhang, B; Hong, M; Andreadis, A; Trojanowski, JQ; Lee, VMY			Transgenic mouse model of tauopathies with glial pathology and nervous system degeneration	NEURON			English	Article							PAIRED HELICAL FILAMENTS; PROGRESSIVE SUPRANUCLEAR PALSY; TAU-POSITIVE GLIA; HUMAN BRAIN TAU; ALZHEIMERS-DISEASE; FRONTOTEMPORAL DEMENTIA; PICKS-DISEASE; CORTICOBASAL DEGENERATION; MONOCLONAL-ANTIBODIES; NEUROFIBRILLARY TANGLES	Frontotemporal dementias (FTDs), including cortico-basal degeneration (CBD) and progressive supranuclear palsy (PSP), are neurodegenerative tauopathies characterized by widespread CNS neuronal and glial tau pathologies, but there are no tau transgenic (Tg) mice that model neurodegeneration with glia tau lesions. Thus, we generated Tg mice overexpressing human tau in neurons and glia. No neuronal tau aggregates were detected, but old mice developed Thioflavin S- and Gallyas-positive glial tau pathology resembling CBD astrocytic plaques. Tau-immunoreactive and Gallyas-positive oligodendroglial coiled bodies (similar to CBD and PSP), glial degeneration, and motor deficits were associated with age-dependent accumulations of insoluble hyperphosphorylated human tau and tau immunopositive filaments in degenerating glial cells. Thus, tau-positive glial lesions similar to human FTDs occur in these Tg mice, and these pathologies are linked to glial and axonal degeneration.	Univ Penn, Sch Med, Dept Pathol & Lab Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA; Eunice Kennedy Shriver Ctr Mental Retardat Inc, Dept Biomed Sci, Waltham, MA 02254 USA	University of Pennsylvania; Pennsylvania Medicine	Lee, VMY (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA.							BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; BRAMBLETT GT, 1992, LAB INVEST, V66, P212; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; Brion JP, 1999, AM J PATHOL, V154, P255, DOI 10.1016/S0002-9440(10)65272-8; CARDEN MJ, 1987, J NEUROSCI, V7, P3489; Chin SSM, 1996, J NEUROPATH EXP NEUR, V55, P499; Clark LN, 1998, P NATL ACAD SCI USA, V95, P13103, DOI 10.1073/pnas.95.22.13103; D'Souza I, 1999, P NATL ACAD SCI USA, V96, P5598, DOI 10.1073/pnas.96.10.5598; Dawson HN, 2001, J CELL SCI, V114, P1179; DELISLE MB, 1999, ACTA NEUROPATHOL BER, V96, P8229; Dickson DW, 1996, J NEURAL TRANSM-SUPP, P31; Feany MB, 1996, J NEUROPATH EXP NEUR, V55, P53, DOI 10.1097/00005072-199601000-00006; FEANY MB, 1995, AM J PATHOL, V146, P1388; Forman MS, 2002, AM J PATHOL, V160, P2045, DOI 10.1016/S0002-9440(10)61154-6; GALLYAS F, 1971, ACTA MORPHOL HUNG, V19, P1; Gleckman AM, 1999, ACTA NEUROPATHOL, V98, P55, DOI 10.1007/s004010051051; GLOSTER A, 1994, J NEUROSCI, V14, P7319; GOEDERT M, 1994, BIOCHEM J, V301, P871, DOI 10.1042/bj3010871; Goedert M, 1999, NAT MED, V5, P454, DOI 10.1038/7454; GOTZ J, 1995, EMBO J, V14, P1304, DOI 10.1002/j.1460-2075.1995.tb07116.x; Gotz J, 2001, EUR J NEUROSCI, V13, P2131, DOI 10.1046/j.0953-816x.2001.01604.x; Gotz J, 2001, J BIOL CHEM, V276, P529, DOI 10.1074/jbc.M006531200; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; Hoffmann R, 1997, BIOCHEMISTRY-US, V36, P8114, DOI 10.1021/bi970380+; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Iseki E, 2001, ACTA NEUROPATHOL, V102, P285; Ishihara T, 1999, NEURON, V24, P751, DOI 10.1016/S0896-6273(00)81127-7; Ishihara T, 2001, AM J PATHOL, V158, P555, DOI 10.1016/S0002-9440(10)63997-1; IWATSUBO T, 1994, ACTA NEUROPATHOL, V88, P129; KIM KS, 1990, NEUROSCI RES COMMUN, V7, P113; Komori T, 1999, BRAIN PATHOL, V9, P663; Komori T, 1998, ACTA NEUROPATHOL, V96, P401, DOI 10.1007/s004010050911; KOSIK KS, 1988, NEURON, V1, P817, DOI 10.1016/0896-6273(88)90129-8; LANG E, 1992, BIOCHEM BIOPH RES CO, V187, P783, DOI 10.1016/0006-291X(92)91264-Q; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; LEE VMY, 1984, J NEUROCHEM, V42, P25, DOI 10.1111/j.1471-4159.1984.tb09692.x; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; LI J, 1997, J CHEM IND ENG, V48, P517; Matsuo A, 1998, AM J PATHOL, V153, P735, DOI 10.1016/S0002-9440(10)65617-9; MATSUO ES, 1994, NEURON, V13, P989, DOI 10.1016/0896-6273(94)90264-X; MAWALDEWAN M, 1994, J BIOL CHEM, V269, P30981; McKhann GM, 2001, ARCH NEUROL-CHICAGO, V58, P1803, DOI 10.1001/archneur.58.11.1803; NISHIMURA M, 1995, AM J PATHOL, V146, P1052; NISHIMURA M, 1992, NEUROSCI LETT, V143, P35, DOI 10.1016/0304-3940(92)90227-X; OTVOS L, 1994, J NEUROSCI RES, V39, P669, DOI 10.1002/jnr.490390607; Oyanagi K, 1997, J NEUROPATH EXP NEUR, V56, P308, DOI 10.1097/00005072-199703000-00010; Piao YS, 2002, ACTA NEUROPATHOL, V103, P469, DOI 10.1007/s00401-001-0488-2; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Probst A, 2000, ACTA NEUROPATHOL, V99, P469, DOI 10.1007/s004010051148; Reed LA, 1997, ANN NEUROL, V42, P564, DOI 10.1002/ana.410420406; Richter-Landsberg C, 2001, MICROSC RES TECHNIQ, V52, P628, DOI 10.1002/jemt.1047; SEUBERT P, 1995, J BIOL CHEM, V270, P18917, DOI 10.1074/jbc.270.32.18917; Spillantini MG, 1998, AM J PATHOL, V153, P1359, DOI 10.1016/S0002-9440(10)65721-5; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Spittaels K, 1999, AM J PATHOL, V155, P2153, DOI 10.1016/S0002-9440(10)65533-2; SUZUKI N, 1994, AM J PATHOL, V145, P452; SZENDREI GI, 1993, J NEUROSCI RES, V34, P243, DOI 10.1002/jnr.490340212; Szendrei GI, 1996, INT J PEPT PROT RES, V47, P289; TU PH, 1995, J CELL BIOL, V129, P1629, DOI 10.1083/jcb.129.6.1629; Tu PH, 1998, ANN NEUROL, V44, P415, DOI 10.1002/ana.410440324; YAMADA T, 1992, NEUROSCI LETT, V135, P99, DOI 10.1016/0304-3940(92)90145-W; YAMAZAKI M, 1994, ACTA NEUROPATHOL, V88, P587; Zhukareva V, 2002, ANN NEUROL, V51, P730, DOI 10.1002/ana.10222	65	109	113	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 1	2002	35	3					433	446		10.1016/S0896-6273(02)00789-4	http://dx.doi.org/10.1016/S0896-6273(02)00789-4			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	582CB	12165467	Bronze			2022-12-24	WOS:000177331200006
J	Pesaran, B; Pezaris, JS; Sahani, M; Mitra, PP; Andersen, RA				Pesaran, B; Pezaris, JS; Sahani, M; Mitra, PP; Andersen, RA			Temporal structure in neuronal activity during working memory in macaque parietal cortex	NATURE NEUROSCIENCE			English	Article							CAT VISUAL-CORTEX; LATERAL INTRAPARIETAL AREA; SHORT-TERM-MEMORY; PREFRONTAL CORTEX; UNIT-ACTIVITY; SYNCHRONIZATION; OSCILLATIONS; MONKEY; ATTENTION; AWAKE	Many cortical structures have elevated firing rates during working memory, but it is not known how the activity is maintained. To investigate whether reverberating activity is important, we studied the temporal structure of local field potential (LFP) activity and spiking from area LIP in two awake macaques during a memory-saccade task. Using spectral analysis, we found spatially tuned elevated power in the gamma band (25-90 Hz) in LFP and spiking activity during the memory period. Spiking and LFP activity were also coherent in the gamma band but not at lower frequencies. Finally, we decoded LFP activity on a single-trial basis and found that LFP activity in parietal cortex discriminated between preferred and anti-preferred direction with approximately the same accuracy as the spike rate and predicted the time of a planned movement with better accuracy than the spike rate. This finding could accelerate the development of a cortical neural prosthesis.	CALTECH, Computat & Neural Syst Program, Pasadena, CA 91125 USA; CALTECH, Div Phys Math & Astron, Pasadena, CA 91125 USA; Bell Labs, Lucent Technol, Murray Hill, NJ 07974 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; Alcatel-Lucent; Lucent Technologies; AT&T; California Institute of Technology	Andersen, RA (corresponding author), CALTECH, Computat & Neural Syst Program, Pasadena, CA 91125 USA.			Pesaran, Bijan/0000-0003-4116-0038; Mitra, Partha/0000-0001-8818-6804	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062528] Funding Source: NIH RePORTER; NEI NIH HHS [EY05522-21] Funding Source: Medline; NIMH NIH HHS [MH62528-01] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AMIT DJ, 1995, BEHAV BRAIN SCI, V18, P617, DOI 10.1017/S0140525X00040164; ANDERSEN RA, 1995, CEREB CORTEX, V5, P457, DOI 10.1093/cercor/5.5.457; BLATT GJ, 1990, J COMP NEUROL, V299, P421, DOI 10.1002/cne.902990404; BRESSLER SL, 1993, NATURE, V366, P153, DOI 10.1038/366153a0; BRILLINGER DR, 1974, TIME SERIES; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; Chafee MV, 1998, J NEUROPHYSIOL, V79, P2919, DOI 10.1152/jn.1998.79.6.2919; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Donoghue JP, 1998, J NEUROPHYSIOL, V79, P159, DOI 10.1152/jn.1998.79.1.159; ECKHORN R, 1993, NEUROREPORT, V4, P243, DOI 10.1097/00001756-199303000-00004; Efron B., 1994, INTRO BOOTSTRAP; ENGEL AK, 1990, EUR J NEUROSCI, V2, P588, DOI 10.1111/j.1460-9568.1990.tb00449.x; EPRCIVAL DB, 1993, SPECTRAL ANAL PHYSIC; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Fuster JM, 1995, MEMORY CEREBRAL CORT; GNADT JW, 1988, EXP BRAIN RES, V70, P216; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Hebb Donald O., 1949, ORG BEHAV; Jarvis MR, 2001, NEURAL COMPUT, V13, P717, DOI 10.1162/089976601300014312; KOCH KW, 1989, EXP BRAIN RES, V76, P292; Kreiter AK, 1996, J NEUROSCI, V16, P2381; Lebedev MA, 2000, EXP BRAIN RES, V130, P195, DOI 10.1007/s002210050022; Mazzoni P, 1996, J NEUROPHYSIOL, V76, P1439, DOI 10.1152/jn.1996.76.3.1439; Miller EK, 1996, J NEUROSCI, V16, P5154; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; Murthy VN, 1996, J NEUROPHYSIOL, V76, P3949, DOI 10.1152/jn.1996.76.6.3949; NAKAMURA K, 1992, NEUROREPORT, V3, P117, DOI 10.1097/00001756-199201000-00031; Pezaris JS, 1999, NEUROCOMPUTING, V26-7, P471, DOI 10.1016/S0925-2312(99)00053-3; PEZARIS JS, 1996, COMPUTATIONAL NEUROS, P937; Ripley B. D., 1996, PATTERN RECOGNITION; Roelfsema PR, 1997, NATURE, V385, P157, DOI 10.1038/385157a0; ROUGEUL A, 1979, ELECTROEN CLIN NEURO, V46, P310, DOI 10.1016/0013-4694(79)90205-0; Sahani M, 1998, ADV NEUR IN, V10, P222; Seung HS, 1996, P NATL ACAD SCI USA, V93, P13339, DOI 10.1073/pnas.93.23.13339; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Steinmetz PN, 2000, NATURE, V404, P187, DOI 10.1038/35004588; Tallon-Baudry C, 1998, J NEUROSCI, V18, P4244; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; Thomson DJ, 1991, ADV SPECTRUM ANAL AR; Wang XJ, 1999, J NEUROSCI, V19, P9587; Wehr M, 1996, NATURE, V384, P162, DOI 10.1038/384162a0; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582	47	702	712	3	49	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2002	5	8					805	811		10.1038/nn890	http://dx.doi.org/10.1038/nn890			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	577XT	12134152	Green Submitted			2022-12-24	WOS:000177088900025
J	Ahmed, SH; Kenny, PJ; Koob, GF; Markou, A				Ahmed, SH; Kenny, PJ; Koob, GF; Markou, A			Neurobiological evidence for hedonic allostasis associated with escalating cocaine use	NATURE NEUROSCIENCE			English	Article							DRUG-ADDICTION; REWARD; BRAIN; WITHDRAWAL; DEPRESSION		Univ Bordeaux 2, CNRS, UMR 5541, Lab Neuropsychobiol Desadaptat, F-33076 Bordeaux, France; Scripps Res Inst, Res Inst, Dept Neuropharmacol, La Jolla, CA 92037 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Scripps Research Institute	Ahmed, SH (corresponding author), Univ Bordeaux 2, CNRS, UMR 5541, Lab Neuropsychobiol Desadaptat, 146 Rue Leo Saignat, F-33076 Bordeaux, France.		AHMED, Serge H/D-5236-2014	Ahmed, Serge/0000-0002-1225-9234	NIDA NIH HHS [R56 DA011946, DA11946, DA04398] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R56DA011946, R01DA004398, R01DA011946] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Ahmed SH, 1998, SCIENCE, V282, P298, DOI 10.1126/science.282.5387.298; Ahmed SH, 2000, NEUROPSYCHOPHARMACOL, V22, P413, DOI 10.1016/S0893-133X(99)00133-5; Epping-Jordan MP, 1998, NATURE, V393, P76, DOI 10.1038/30001; Koob GF, 2001, NEUROPSYCHOPHARMACOL, V24, P97, DOI 10.1016/S0893-133X(00)00195-0; Koob GF, 1996, NEURON, V16, P893, DOI 10.1016/S0896-6273(00)80109-9; KORNETSKY C, 1979, FED PROC, V38, P2473; LEITH NJ, 1976, PSYCHOPHARMACOLOGIA, V46, P19, DOI 10.1007/BF00421544; MARKOU A, 1992, PHYSIOL BEHAV, V51, P111, DOI 10.1016/0031-9384(92)90211-J; MARKOU A, 1991, NEUROPSYCHOPHARMACOL, V4, P17; Markou A, 1998, NEUROPSYCHOPHARMACOL, V18, P135, DOI 10.1016/S0893-133X(97)00113-9; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; SCHULTEIS G, 1995, P NATL ACAD SCI USA, V92, P5880, DOI 10.1073/pnas.92.13.5880; Wise RA, 1996, ANNU REV NEUROSCI, V19, P319, DOI 10.1146/annurev.ne.19.030196.001535	13	270	279	0	16	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2002	5	7					625	626		10.1038/nn872	http://dx.doi.org/10.1038/nn872			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	566EP	12055635				2022-12-24	WOS:000176414300007
J	Morales, J; Hiesinger, PR; Schroeder, AJ; Kume, K; Verstreken, P; Jackson, FR; Nelson, DL; Hassan, BA				Morales, J; Hiesinger, PR; Schroeder, AJ; Kume, K; Verstreken, P; Jackson, FR; Nelson, DL; Hassan, BA			Drosophila fragile X protein, DFXR, regulates neuronal morphology and function in the brain	NEURON			English	Article							MENTAL-RETARDATION PROTEIN; HUMAN HOMOLOG; P190 RHOGAP; DENDRITIC SPINES; MESSENGER-RNAS; CGG REPEAT; FMR-1 GENE; EXPRESSION; RHYTHMS; IDENTIFICATION	Mental retardation is a pervasive societal problem, 25 times more common than blindness for example. Fragile X syndrome, the most common form of inherited mental retardation, is caused by mutations in the FMR1 gene. Fragile X patients display neurite morphology defects in the brain, suggesting that this may be the basis of their mental retardation. Drosophila contains a single homolog of FMR1, dfxr (also called dfmr1). We analyzed the role of dfxr in neurite development in three distinct neuronal classes. We find that DFXR is required for normal neurite extension, guidance, and branching. dfxr mutants also display strong eclosion failure and circadian rhythm defects. Interestingly, distinct neuronal cell types show different phenotypes, suggesting that dfxr differentially regulates diverse targets in the brain.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA; Flanders Interuniv Inst Biotechnol VIB, Neurogenet Lab, Ctr Human Genet, B-3000 Louvain, Belgium	Baylor College of Medicine; Baylor College of Medicine; Tufts University; Flanders Institute for Biotechnology (VIB)	Hassan, BA (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	bassem.hassan@med.kuleuven.ac.be	Verstreken, Patrik/AAC-7591-2022; Hassan, Bassem A/D-5221-2012	Verstreken, Patrik/0000-0002-5073-5393; Hassan, Bassem A/0000-0001-9533-4908; Schroeder, Andrew/0000-0002-5824-7917; Morales, Joannella/0000-0002-8121-9797; Kume, Kazuhiko/0000-0003-4232-1657	NHLBI NIH HHS [R01 HL059873-05, R01 HL059873-07, R01 HL059873-08, R01 HL059873-06, R01 HL059873, R01 HL59873] Funding Source: Medline; NICHD NIH HHS [R01 HD29256] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029256] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059873] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABITBOL M, 1993, NAT GENET, V4, P147, DOI 10.1038/ng0693-147; Baker JD, 1999, J EXP BIOL, V202, P3037; Billuart P, 1998, PATHOL BIOL, V46, P678; Billuart P, 2001, CELL, V107, P195, DOI 10.1016/S0092-8674(01)00522-0; Brouns MR, 2000, DEVELOPMENT, V127, P4891; Brouns MR, 2001, NAT CELL BIOL, V3, P361, DOI 10.1038/35070042; Brown V, 1998, J BIOL CHEM, V273, P15521, DOI 10.1074/jbc.273.25.15521; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Chen HM, 1997, HUM GENET, V99, P262, DOI 10.1007/s004390050350; CHEN KS, 1995, AM J HUM GENET, V56, P175; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; DEBOULLE K, 1993, NAT GENET, V3, P31, DOI 10.1038/ng0193-31; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; Eberhart DE, 1996, HUM MOL GENET, V5, P1083, DOI 10.1093/hmg/5.8.1083; EWER J, 1992, J NEUROSCI, V12, P3321; Gould EL, 2000, AM J MED GENET, V95, P307; GU YH, 1994, HUM MOL GENET, V3, P1705, DOI 10.1093/hmg/3.9.1705; Guimera J, 1996, HUM MOL GENET, V5, P1305, DOI 10.1093/hmg/5.9.1305; Hagerman RJ, 1996, FRAGILE X SYNDROME D; Hassan BA, 2000, NEURON, V25, P549, DOI 10.1016/S0896-6273(00)81059-4; HEISENBERG M, 1971, J EXP BIOL, V55, P85; Helfrich-Forster C, 2000, J NEUROSCI, V20, P3339, DOI 10.1523/JNEUROSCI.20-09-03339.2000; HERGERSBERG M, 1995, HUM MOL GENET, V4, P359, DOI 10.1093/hmg/4.3.359; HINTON VJ, 1991, AM J MED GENET, V41, P289, DOI 10.1002/ajmg.1320410306; Irwin SA, 2000, CEREB CORTEX, V10, P1038, DOI 10.1093/cercor/10.10.1038; Irwin SA, 2001, AM J MED GENET, V98, P161, DOI 10.1002/1096-8628(20010115)98:2<161::AID-AJMG1025>3.0.CO;2-B; Kutsche K, 2000, NAT GENET, V26, P247, DOI 10.1038/80002; Lee CG, 1998, NEURON, V21, P857, DOI 10.1016/S0896-6273(00)80601-7; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; LEVINE JD, 1994, NEURON, V13, P967, DOI 10.1016/0896-6273(94)90262-3; Levine JD, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-1; LUGENBEEL KA, 1995, NAT GENET, V10, P483, DOI 10.1038/ng0895-483; MEIJER H, 1994, HUM MOL GENET, V3, P615; Morton JE, 1997, J MED GENET, V34, P1, DOI 10.1136/jmg.34.1.1; NEWBY LM, 1991, GENETICS, V128, P571; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; O'Brien G, 2000, J ROY SOC MED, V93, P618, DOI 10.1177/014107680009301204; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Peier AM, 2000, HUM MOL GENET, V9, P1145, DOI 10.1093/hmg/9.8.1145; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; RUDELLI RD, 1985, ACTA NEUROPATHOL, V67, P289, DOI 10.1007/BF00687814; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; Tamanini F, 1997, HUM MOL GENET, V6, P1315, DOI 10.1093/hmg/6.8.1315; Turner G, 1996, AM J MED GENET, V64, P196, DOI 10.1002/(SICI)1096-8628(19960712)64:1<196::AID-AJMG35>3.0.CO;2-G; Van Vactor D, 1999, CURR BIOL, V9, pR201; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Wan LL, 2000, MOL CELL BIOL, V20, P8536, DOI 10.1128/MCB.20.22.8536-8547.2000; WISNIEWSKI KE, 1991, AM J MED GENET, V38, P476, DOI 10.1002/ajmg.1320380267; Wittwer F, 2001, DEVELOPMENT, V128, P791; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X	52	196	201	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 13	2002	34	6					961	972		10.1016/S0896-6273(02)00731-6	http://dx.doi.org/10.1016/S0896-6273(02)00731-6			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	563HF	12086643	Bronze			2022-12-24	WOS:000176249700013
J	Qiu, J; Cai, CM; Dai, HN; McAtee, M; Hoffman, PN; Bregman, BS; Filbin, MT				Qiu, J; Cai, CM; Dai, HN; McAtee, M; Hoffman, PN; Bregman, BS; Filbin, MT			Spinal axon regeneration induced by elevation of cyclic AMP	NEURON			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; ADULT NEURONS; CORD INJURY; GROWTH; CNS; SURVIVAL; PROMOTE; CELLS; RATS	Myelin inhibitors, including MAG, are major impediments to CNS regeneration. However, CNS axons of DRGs regenerate if the peripheral branch of these neurons is lesioned first. We show that 1 day post-peripheral-lesion, DRG-cAMP levels triple and MAG/myelin no longer inhibit growth, an effect that is PKA dependent. By 1 week post-lesion, DRG-cAMP returns to control, but growth on MAG/myelin improves and is now PKA independent. Inhibiting PKA in vivo blocks the post-lesion growth on MAG/myelin at 1 day and attenuates it at I week. Alone, injection of db-cAMP into the DRG mimics completely a conditioning lesion as DRGs grow on MAG/myelin, initially, in a PKA-dependent manner that becomes PKA independent. Importantly, DRG injection of db-cAMP results in extensive regeneration of dorsal column axons lesioned 1 week later. These results may be relevant to developing therapies for spinal cord injury.	CUNY Hunter Coll, Dept Biol Sci, New York, NY 10021 USA; Georgetown Univ, Sch Med, Dept Neurosci, Washington, DC 20007 USA; Johns Hopkins Univ, Dept Neurol, Sch Med, Baltimore, MD 21218 USA	City University of New York (CUNY) System; Hunter College (CUNY); Georgetown University; Johns Hopkins University	Filbin, MT (corresponding author), CUNY Hunter Coll, Dept Biol Sci, 695 Pk Ave, New York, NY 10021 USA.			Cai, Dongming/0000-0002-0601-6826	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS041073, R37NS037060, R01NS037060, R01NS019259] Funding Source: NIH RePORTER; NINDS NIH HHS [NS41073, NS 37060, NS19259] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bomze HM, 2001, NAT NEUROSCI, V4, P38, DOI 10.1038/82881; Bradbury EJ, 2000, TRENDS PHARMACOL SCI, V21, P389, DOI 10.1016/S0165-6147(00)01536-4; BREGMAN BS, 1993, EXP NEUROL, V123, P3, DOI 10.1006/exnr.1993.1136; Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001; Cai DM, 1999, NEURON, V22, P89, DOI 10.1016/S0896-6273(00)80681-9; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; DeBellard ME, 1996, MOL CELL NEUROSCI, V7, P89, DOI 10.1006/mcne.1996.0007; Filbin MT, 1999, NEURON, V23, P2, DOI 10.1016/S0896-6273(00)80744-8; Fitch MT, 1999, CNS REGENERATION BAS, P55; Hanson MG, 1998, J NEUROSCI, V18, P7361; Huang DW, 1999, NEURON, V24, P639, DOI 10.1016/S0896-6273(00)81118-6; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999; MCKEON RJ, 1995, EXP NEUROL, V136, P32, DOI 10.1006/exnr.1995.1081; MESULAM MM, 1976, J HISTOCHEM CYTOCHEM, V24, P1273, DOI 10.1177/24.12.63512; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; Porreca F, 1999, P NATL ACAD SCI USA, V96, P7640, DOI 10.1073/pnas.96.14.7640; RICHARDSON PM, 1980, NATURE, V284, P264, DOI 10.1038/284264a0; Scherer S.S., 1996, GLIAL CELL DEV, P165; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Smith DS, 1997, J NEUROSCI, V17, P646; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Wiemelt AP, 1997, J BIOL CHEM, V272, P31489, DOI 10.1074/jbc.272.50.31489	26	530	548	4	27	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 13	2002	34	6					895	903		10.1016/S0896-6273(02)00730-4	http://dx.doi.org/10.1016/S0896-6273(02)00730-4			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	563HF	12086638	Bronze			2022-12-24	WOS:000176249700008
J	Taha, S; Stryker, MP				Taha, S; Stryker, MP			Rapid ocular dominance plasticity requires cortical but not geniculate protein synthesis	NEURON			English	Article							DEVELOPING VISUAL-CORTEX; LONG-TERM POTENTIATION; EXPERIENCE-DEPENDENT PLASTICITY; TISSUE-PLASMINOGEN ACTIVATOR; FACTOR MESSENGER-RNA; MONOCULAR DEPRIVATION; LATE-PHASE; SYNAPTIC PLASTICITY; NEUROTROPHIC FACTOR; STRUCTURAL-CHANGES	Synaptic plasticity is a multistep process in which rapid, early phases eventually give way to slower, more enduring stages. Diverse forms of synaptic change share a common requirement for protein synthesis in the late stages of plasticity, which are often associated with structural rearrangements. Ocular dominance plasticity in the primary visual cortex (V1) is a long-lasting form of activity-dependent plasticity comprised of well-defined physiological and anatomical stages. The molecular events underlying these stages remain poorly understood. Using the protein synthesis inhibitor cycloheximide, we investigated a role for protein synthesis in ocular dominance plasticity. Suppression of cortical, but not geniculate, protein synthesis impaired rapid ocular dominance plasticity, while leaving neuronal responsiveness intact. These findings suggest that structural changes underlying ocular dominance plasticity occur rapidly following monocular occlusion, and cortical changes guide subsequent alterations in thalamocortical afferents.	Univ Calif San Francisco, WM Keck Fdn Ctr Integrat Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Stryker, MP (corresponding author), Univ Calif San Francisco, WM Keck Fdn Ctr Integrat Neurosci, San Francisco, CA 94143 USA.	stryker@phy.ucsf.edu		Stryker, Michael/0000-0003-1546-5831	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS016033, P50NS016033] Funding Source: NIH RePORTER; NINDS NIH HHS [P01 NS016033-210017, P01 NS016033, NS 16033] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AndroutsellisTheotokis A, 1996, BRAIN RES, V743, P40, DOI 10.1016/S0006-8993(96)00981-X; Antonini A, 1999, J NEUROSCI, V19, P4388; ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; BAILEY CH, 1992, NEURON, V9, P749, DOI 10.1016/0896-6273(92)90037-E; BAILEY CH, 1989, J NEUROSCI, V9, P1774; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; Barea-Rodriguez EJ, 2000, J NEUROSCI, V20, P8528, DOI 10.1523/JNEUROSCI.20-22-08528.2000; BEAR MF, 1990, J NEUROSCI, V10, P909; Bozdagi O, 2000, NEURON, V28, P245, DOI 10.1016/S0896-6273(00)00100-8; CABELLI RJ, 1995, SCIENCE, V267, P1662, DOI 10.1126/science.7886458; DAW NW, 1993, ANNU REV NEUROSCI, V16, P207, DOI 10.1146/annurev.ne.16.030193.001231; Dubnau J, 1998, ANNU REV NEUROSCI, V21, P407, DOI 10.1146/annurev.neuro.21.1.407; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; FLEXNER JB, 1963, SCIENCE, V141, P57, DOI 10.1126/science.141.3575.57; Frank MG, 2001, NEURON, V30, P275, DOI 10.1016/S0896-6273(01)00279-3; FREEMAN RD, 1982, J NEUROPHYSIOL, V47, P139, DOI 10.1152/jn.1982.47.2.139; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; Gillespie DC, 2000, J NEUROSCI, V20, P9174; Gordon JA, 1996, NEURON, V17, P491, DOI 10.1016/S0896-6273(00)80181-6; Gordon JA, 1996, J NEUROSCI, V16, P3274; Hanover JL, 1999, J NEUROSCI, V19, part. no.; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; KENNEDY C, 1981, P NATL ACAD SCI-BIOL, V78, P3950, DOI 10.1073/pnas.78.6.3950; KRUG M, 1984, BRAIN RES BULL, V13, P39, DOI 10.1016/0361-9230(84)90005-4; Kurotani T, 1996, NEUROREPORT, V8, P35, DOI 10.1097/00001756-199612200-00008; Lein ES, 2000, J NEUROSCI, V20, P1470; Levenes C, 1998, PROG NEUROBIOL, V55, P79, DOI 10.1016/S0301-0082(97)00096-8; Linden DJ, 1996, NEURON, V17, P483, DOI 10.1016/S0896-6273(00)80180-4; Mayford M, 1999, TRENDS GENET, V15, P463, DOI 10.1016/S0168-9525(99)01846-6; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; MOVSHON JA, 1977, J NEUROPHYSIOL, V40, P1255, DOI 10.1152/jn.1977.40.6.1255; Muller CM, 1998, NAT NEUROSCI, V1, P47, DOI 10.1038/248; OLSON CR, 1980, EXP BRAIN RES, V38, P53; Pham TA, 1999, NEURON, V22, P63, DOI 10.1016/S0896-6273(00)80679-0; Porciatti V, 1999, VISION RES, V39, P3071, DOI 10.1016/S0042-6989(99)00022-X; QIAN Z, 1993, NATURE, V361, P453, DOI 10.1038/361453a0; REITER HO, 1986, EXP BRAIN RES, V65, P182; REITER HO, 1988, P NATL ACAD SCI USA, V85, P3623, DOI 10.1073/pnas.85.10.3623; Roberts EB, 1998, J NEUROPHYSIOL, V80, P1021, DOI 10.1152/jn.1998.80.3.1021; Rose SPR, 1999, BEHAV BRAIN RES, V98, P237, DOI 10.1016/S0166-4328(98)00089-8; SCHOUPS AA, 1995, DEV BRAIN RES, V86, P326, DOI 10.1016/0165-3806(95)00043-D; SHAW C, 1984, NATURE, V308, P731, DOI 10.1038/308731a0; Silver MA, 1999, J NEUROSCI, V19, P10829, DOI 10.1523/JNEUROSCI.19-24-10829.1999; Soderling TR, 2000, CURR OPIN NEUROBIOL, V10, P375, DOI 10.1016/S0959-4388(00)00090-8; Trachtenberg JT, 2000, SCIENCE, V287, P2029, DOI 10.1126/science.287.5460.2029; Trachtenberg JT, 2001, J NEUROSCI, V21, P3476, DOI 10.1523/JNEUROSCI.21-10-03476.2001; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3; ZAFRA F, 1992, J NEUROSCI, V12, P4793	52	75	76	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 25	2002	34	3					425	436		10.1016/S0896-6273(02)00673-6	http://dx.doi.org/10.1016/S0896-6273(02)00673-6			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	545JW	11988173	Bronze			2022-12-24	WOS:000175214700013
J	Stepanyants, A; Hof, PR; Chklovskii, DB				Stepanyants, A; Hof, PR; Chklovskii, DB			Geometry and structural plasticity of synaptic connectivity	NEURON			English	Article							LONG-TERM POTENTIATION; MONKEY VISUAL-CORTEX; CA1 PYRAMIDAL CELLS; DENDRITES IN-VIVO; MACAQUE MONKEY; CEREBRAL-CORTEX; 3-DIMENSIONAL STRUCTURE; NEUROFILAMENT PROTEIN; HIPPOCAMPAL SLICES; PROJECTION NEURONS	Changes in synaptic connectivity patterns through the formation and elimination of dendritic spines may contribute to structural plasticity in the brain. We characterize this contribution quantitatively by estimating the number of different synaptic connectivity patterns attainable without major arbor remodeling. This number depends on the ratio of the synapses on a dendrite to the axons that pass within a spine length of that dendrite. We call this ratio the filling fraction and calculate it from geometrical analysis and anatomical data. The filling fraction is 0.26 in mouse neocortex, 0.22-0.34 in rat hippocampus. In the macaque visual cortex, the filling fraction increases by a factor of 1.6-1.8 from area V1 to areas V2, V4, and 7a. Since the filling fraction is much smaller than 1, spine remodeling can make a large contribution to structural plasticity.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; CUNY Mt Sinai Sch Med, Fishberg Res Ctr Neurobiol, Kastor Neurobiol Aging Labs, Computat Neurobiol & Imaging Ctr,Adv Imaging Prog, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Geriatr & Adult Dev, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Ophthalmol, New York, NY 10029 USA	Cold Spring Harbor Laboratory; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Chklovskii, DB (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	mitya@cshl.org			NIA NIH HHS [AG05138] Funding Source: Medline; NIMH NIH HHS [MH58911] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH058911] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AMARAL DG, 1990, PROG BRAIN RES, V83, P1; AMIR Y, 1993, J COMP NEUROL, V334, P19, DOI 10.1002/cne.903340103; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Baker RE, 1997, DEV BRAIN RES, V98, P21, DOI 10.1016/S0165-3806(96)00163-0; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BRAITENBERG V, 1998, CORTEX STAT GENOMETR; Budd JML, 1998, P ROY SOC B-BIOL SCI, V265, P1037, DOI 10.1098/rspb.1998.0396; CAJAL SRY, 1891, CELLULE, V7, P125; Cash S, 1999, NEURON, V22, P383, DOI 10.1016/S0896-6273(00)81098-3; Chklovskii DB, 2000, J NEUROPHYSIOL, V83, P2113, DOI 10.1152/jn.2000.83.4.2113; CHKLOVSKII DB, 2002, IN PRESS NEURON; Dailey ME, 1996, J NEUROSCI, V16, P2983; Denk W, 1996, CURR OPIN NEUROBIOL, V6, P372, DOI 10.1016/S0959-4388(96)80122-X; Elston GN, 1997, CEREB CORTEX, V7, P432, DOI 10.1093/cercor/7.5.432; Elston GN, 1998, CEREB CORTEX, V8, P278, DOI 10.1093/cercor/8.3.278; Elston GN, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-18-j0002.2000; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Feldmeyer D, 1999, J PHYSIOL-LONDON, V521, P169, DOI 10.1111/j.1469-7793.1999.00169.x; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; GREENOUGH WT, 1985, BEHAV NEURAL BIOL, V44, P301, DOI 10.1016/S0163-1047(85)90310-3; GUSTAFSSON B, 1990, PROG BRAIN RES, V83, P223; HARRIS KM, 1989, J NEUROSCI, V9, P2982; HARRIS RM, 1981, J COMP NEUROL, V196, P357, DOI 10.1002/cne.901960302; HELLWIG B, 1994, BIOL CYBERN, V71, P1, DOI 10.1007/BF00198906; Hof PR, 1996, J COMP NEUROL, V376, P112; HOF PR, 1995, J COMP NEUROL, V352, P161, DOI 10.1002/cne.903520202; IKARI K, 1981, FOLIA PSYCHIAT NEU J, V35, P477; Jones TA, 1999, J COMP NEUROL, V414, P57; KOCH C, 1993, J NEUROSCI, V13, P413; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; Lewis JW, 2000, J COMP NEUROL, V428, P79, DOI 10.1002/1096-9861(20001204)428:1<79::AID-CNE7>3.0.CO;2-Q; MADISON DV, 1991, ANNU REV NEUROSCI, V14, P379, DOI 10.1146/annurev.ne.14.030191.002115; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Nimchinsky EA, 1996, J COMP NEUROL, V374, P136; OROURKE NA, 1990, NEURON, V5, P159, DOI 10.1016/0896-6273(90)90306-Z; Page TL, 2002, NEUROSCI LETT, V317, P37, DOI 10.1016/S0304-3940(01)02428-4; PETERS A, 1970, AM J ANAT, V127, P321, DOI 10.1002/aja.1001270402; PETIT TL, 1988, DEV BRAIN RES, V41, P209, DOI 10.1016/0165-3806(88)90183-6; Poirazi P, 2001, NEURON, V29, P779, DOI 10.1016/S0896-6273(01)00252-5; PURVES D, 1986, J NEUROSCI, V6, P1051; PURVES D, 1985, NATURE, V315, P404, DOI 10.1038/315404a0; Rajan I, 1998, J NEUROSCI, V18, P7836; Rajan I, 1999, J NEUROBIOL, V38, P357, DOI 10.1002/(SICI)1097-4695(19990215)38:3<357::AID-NEU5>3.0.CO;2-#; Ramon y Cajal S, 1893, ARCH ANAT PHYSL, P319; Rieke F., 1997, SPIKES EXPLORING NEU; SCHUZ A, 1989, J COMP NEUROL, V286, P442, DOI 10.1002/cne.902860404; Shannon C., 1964, MATH THEORY COMMUNIC; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; SHEPHERD GMG, 2002, IN PRESS P NATL ACAD; SORRA KE, 1993, J NEUROSCI, V13, P3736; SPACEK J, 1983, ANAT EMBRYOL, V167, P289, DOI 10.1007/BF00298517; Stern JE, 1998, J NEUROSCI, V18, P841; SWINDALE NV, 1981, TRENDS NEUROSCI, V4, P240, DOI 10.1016/0166-2236(81)90075-8; Tanzi E., 1893, RIV SPER FRENIAT MED, V19, P419; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; TROMMALD M, 1995, J COMP NEUROL, V353, P260, DOI 10.1002/cne.903530208; VALVERDE F, 1978, ANAT EMBRYOL, V154, P305, DOI 10.1007/BF00345659; WEST MJ, 1978, CELL TISSUE RES, V188, P345; Witte S, 1996, J NEUROBIOL, V31, P219, DOI 10.1002/(SICI)1097-4695(199610)31:2<219::AID-NEU7>3.0.CO;2-E; Wong WT, 2000, J NEUROSCI, V20, P5024; WOOLLEY CS, 1999, DENDRITES, P339; Yankova M, 2001, P NATL ACAD SCI USA, V98, P3525, DOI 10.1073/pnas.051624598	66	235	236	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 11	2002	34	2					275	288		10.1016/S0896-6273(02)00652-9	http://dx.doi.org/10.1016/S0896-6273(02)00652-9			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	541GE	11970869	Bronze			2022-12-24	WOS:000174976200013
J	Nadal, MS; Ozaita, A; Amarillo, Y; Vega-Saenz de Miera, E; Ma, YL; Mo, WJ; Goldberg, EM; Misumi, Y; Ikehara, Y; Neubert, TA; Rudy, B				Nadal, MS; Ozaita, A; Amarillo, Y; Vega-Saenz de Miera, E; Ma, YL; Mo, WJ; Goldberg, EM; Misumi, Y; Ikehara, Y; Neubert, TA; Rudy, B			The CD26-related dipeptidyl aminopeptidase-like protein DPPX is a critical component of neuronal A-type K+ channels	NEURON			English	Article							HIPPOCAMPAL PYRAMIDAL NEURONS; TRANSIENT POTASSIUM CURRENT; SUBTHRESHOLD POTENTIALS; DIFFERENTIAL EXPRESSION; CA2+-BINDING PROTEIN; OUTWARD CURRENTS; SODIUM-CHANNELS; GRANULE CELLS; PEPTIDASE-IV; GUINEA-PIG	Subthreshold-activating somatodendritic A-type potassium channels have fundamental roles in neuronal signaling and plasticity which depend on their unique cellular localization, voltage dependence, and kinetic properties. Some of the components of A-type K+ channels have been identified; however, these do not reproduce the properties of the native channels, indicating that key molecular factors have yet to be unveiled. We purified A-type K+ channel complexes from rat brain membranes and found that DPPX, a protein of unknown function that is structurally related to the dipeptidyl aminopeptidase and cell adhesion protein CD26, is a novel component of A-type K+ channels. DPPX associates with the channels' pore-forming subunits, facilitates their trafficking and membrane targeting, reconstitutes the properties of the native channels in heterologous expression systems, and is coexpressed with the pore-forming subunits in the somatodendritic compartment of CNS neurons.	NYU, Sch Med, Dept Physiol & Neurosci, New York, NY 10016 USA; NYU, Sch Med, Dept Biochem, New York, NY 10016 USA; NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA; NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA; Fukuoka Univ, Sch Med, Dept Biochem, Jonan Ku, Fukuoka 81401, Japan	New York University; New York University; New York University; New York University; Fukuoka University	Rudy, B (corresponding author), NYU, Sch Med, Dept Physiol & Neurosci, 550 1st Ave, New York, NY 10016 USA.	rudyb0l@med.nyu.edu	Amarillo, Yimy/H-8258-2019; Ozaita, Andres/H-3411-2015; Goldberg, Ethan/J-8332-2012	Amarillo, Yimy/0000-0002-1247-4380; Ozaita, Andres/0000-0002-2239-7403; Goldberg, Ethan/0000-0002-7404-735X; Rudy, Bernardo/0000-0001-5748-6900	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS044184] Funding Source: NIH RePORTER; NINDS NIH HHS [1R21NS44184] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alonso G, 1997, NEUROSCIENCE, V77, P617; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Anderson JM, 1996, CURR BIOL, V6, P382, DOI 10.1016/S0960-9822(02)00501-8; BALDWIN TJ, 1991, NEURON, V7, P471, DOI 10.1016/0896-6273(91)90299-F; Banks MI, 1996, J NEUROSCI, V16, P3862; BARDONI R, 1993, J NEUROPHYSIOL, V69, P2222, DOI 10.1152/jn.1993.69.6.2222; Baxter D A, 1991, Curr Opin Neurobiol, V1, P105, DOI 10.1016/0959-4388(91)90017-2; Campomanes CR, 2002, J BIOL CHEM, V277, P8298, DOI 10.1074/jbc.M110276200; Cheng HYM, 2002, CELL, V108, P31, DOI 10.1016/S0092-8674(01)00629-8; CONNOR JA, 1971, J PHYSIOL-LONDON, V213, P31, DOI 10.1113/jphysiol.1971.sp009366; CULLCANDY SG, 1989, J PHYSIOL-LONDON, V414, P179, DOI 10.1113/jphysiol.1989.sp017683; De Meester I, 1999, IMMUNOL TODAY, V20, P367, DOI 10.1016/S0167-5699(99)01486-3; DELECEA L, 1994, MOL BRAIN RES, V25, P286, DOI 10.1016/0169-328X(94)90164-3; Gharahdaghi F, 1999, ELECTROPHORESIS, V20, P601, DOI 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO;2-6; Gorrell MD, 2001, SCAND J IMMUNOL, V54, P249, DOI 10.1046/j.1365-3083.2001.00984.x; Hildebrandt M, 2000, CLIN SCI, V99, P93, DOI 10.1042/CS19990368; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Hough RB, 1998, P NATL ACAD SCI USA, V95, P13800, DOI 10.1073/pnas.95.23.13800; HSIAO CF, 1995, BRAIN RES, V695, P217, DOI 10.1016/0006-8993(95)00796-S; Hsueh YP, 2000, NATURE, V404, P298, DOI 10.1038/35005118; HUGUENARD JR, 1991, J NEUROPHYSIOL, V66, P1304, DOI 10.1152/jn.1991.66.4.1304; Isom LL, 2002, FRONT BIOSCI, V7, P12; ISOM LL, 1995, CELL, V83, P433, DOI 10.1016/0092-8674(95)90121-3; Jo DG, 2001, FASEB J, V15, P589; Johns DC, 1997, J BIOL CHEM, V272, P31598, DOI 10.1074/jbc.272.50.31598; Johnston D, 2000, J PHYSIOL-LONDON, V525, P75, DOI 10.1111/j.1469-7793.2000.00075.x; Kin Y, 2001, J BIOCHEM-TOKYO, V129, P289, DOI 10.1093/oxfordjournals.jbchem.a002856; KLEE R, 1995, J NEUROPHYSIOL, V74, P1982, DOI 10.1152/jn.1995.74.5.1982; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; Kuo HC, 2001, CELL, V107, P801, DOI 10.1016/S0092-8674(01)00588-8; Lilliehook C, 2002, MOL CELL NEUROSCI, V19, P552, DOI 10.1006/mcne.2001.1096; Liss B, 2001, EMBO J, V20, P5715, DOI 10.1093/emboj/20.20.5715; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; MALETICSAVATIC M, 1995, J NEUROSCI, V15, P3840; Malin SA, 2000, J NEUROSCI, V20, P5191, DOI 10.1523/JNEUROSCI.20-14-05191.2000; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Martina M, 1998, J NEUROSCI, V18, P8111; MCCORMACK T, 1994, CELL, V79, P1133, DOI 10.1016/0092-8674(94)90004-3; Nadal MS, 2001, J PHYSIOL-LONDON, V537, P801; Nakamura TY, 2001, P NATL ACAD SCI USA, V98, P12808, DOI 10.1073/pnas.221168498; Nakamura TY, 2001, FEBS LETT, V499, P205, DOI 10.1016/S0014-5793(01)02560-1; NUMANN RE, 1987, J PHYSIOL-LONDON, V393, P331, DOI 10.1113/jphysiol.1987.sp016826; Ozaita A, 2002, J NEUROPHYSIOL, V88, P394, DOI 10.1152/jn.2002.88.1.394; Ratcliffe CF, 2001, J CELL BIOL, V154, P427, DOI 10.1083/jcb.200102086; RUDY B, 1988, NEURON, V1, P649, DOI 10.1016/0896-6273(88)90164-X; RUDY B, 1988, NEUROSCIENCE, V25, P729, DOI 10.1016/0306-4522(88)90033-4; RUSH ME, 1995, B MATH BIOL, V57, P899, DOI 10.1016/S0092-8240(95)80006-9; Schoppa NE, 1999, NAT NEUROSCI, V2, P1106, DOI 10.1038/16033; Serodio P, 1998, J NEUROPHYSIOL, V79, P1081, DOI 10.1152/jn.1998.79.2.1081; SERODIO P, 1994, J NEUROPHYSIOL, V72, P1516, DOI 10.1152/jn.1994.72.4.1516; Serodio P, 1996, J NEUROPHYSIOL, V75, P2174, DOI 10.1152/jn.1996.75.5.2174; SHENG M, 1993, NATURE, V365, P72, DOI 10.1038/365072a0; SHENG M, 1992, NEURON, V9, P271, DOI 10.1016/0896-6273(92)90166-B; Shevchenko A, 1996, BIOCHEM SOC T, V24, P893, DOI 10.1042/bst0240893; Shibata R, 2000, J NEUROSCI, V20, P4145; Srinivasan J, 1998, P NATL ACAD SCI USA, V95, P15753, DOI 10.1073/pnas.95.26.15753; SURMEIER DJ, 1989, NEUROSCI LETT, V103, P331; SURMEIER DJ, 1988, BRAIN RES, V473, P187, DOI 10.1016/0006-8993(88)90334-4; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; Tkatch T, 2000, J NEUROSCI, V20, P579, DOI 10.1523/JNEUROSCI.20-02-00579.2000; TSUNODA S, 1995, J NEUROSCI, V15, P1741, DOI 10.1523/JNEUROSCI.15-03-01741.1995; WADA K, 1992, P NATL ACAD SCI USA, V89, P197, DOI 10.1073/pnas.89.1.197; WANG Y, 1991, BRAIN RES, V567, P153, DOI 10.1016/0006-8993(91)91449-B; Watanabe S, 2002, P NATL ACAD SCI USA, V99, P8366, DOI 10.1073/pnas.122210599; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; ZHANG L, 1995, J PHYSIOL-LONDON, V488, P661, DOI 10.1113/jphysiol.1995.sp020998	68	286	292	0	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 6	2003	37	3					449	461		10.1016/S0896-6273(02)01185-6	http://dx.doi.org/10.1016/S0896-6273(02)01185-6			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	647FF	12575952	Bronze			2022-12-24	WOS:000181081600010
J	Foster, KA; Kreitzer, AC; Regehr, WG				Foster, KA; Kreitzer, AC; Regehr, WG			Interaction of postsynaptic receptor saturation with presynaptic mechanisms produces a reliable synapse	NEURON			English	Article							PURKINJE-CELL SYNAPSES; SQUID GIANT SYNAPSE; CLIMBING FIBER; TRANSMITTER RELEASE; NEUROTRANSMITTER RELEASE; CALCIUM-DEPENDENCE; CEREBELLAR SYNAPSE; TIME-COURSE; DEPRESSION; TRANSMISSION	Synapses that reliably activate their postsynaptic targets typically release neurotransmitter with high probability, are not very sensitive to changes in calcium entry, and depress. We have determined the mechanisms that give rise to these characteristic features at the climbing fiber to Purkinje cell synapse. We find that saturation of presynaptic calcium entry, of presynaptic release, and of postsynaptic receptors combine to produce a postsynaptic response that is near maximal. Postsynaptic receptor saturation also accelerates recovery from depression, in part by accentuating a rapid calcium-dependent recovery phase. Thus, postsynaptic receptor saturation interacts with presynaptic mechanisms to produce highly reliable synapses that can effectively drive their targets even during sustained activation.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Regehr, WG (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.				NIMH NIH HHS [MH/NS32405-01] Funding Source: Medline; NINDS NIH HHS [R01-NS32405-01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032405] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; ADLER EM, 1991, J NEUROSCI, V11, P1496; ARMSTRONG DM, 1979, J PHYSIOL-LONDON, V289, P425, DOI 10.1113/jphysiol.1979.sp012745; Atluri PP, 1996, J NEUROSCI, V16, P5661; BETZ WJ, 1970, J PHYSIOL-LONDON, V206, P629, DOI 10.1113/jphysiol.1970.sp009034; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; Brenowitz S, 2001, J NEUROSCI, V21, P9487, DOI 10.1523/JNEUROSCI.21-23-09487.2001; Cajal S. R., 1911, HISTOLOGIE SYSTEME N, V2; Chen CF, 1999, J NEUROSCI, V19, P6257; Chung S, 2002, NEURON, V34, P437, DOI 10.1016/S0896-6273(02)00659-1; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; Diamond JS, 1997, J NEUROSCI, V17, P4672; Dittman JS, 1998, J NEUROSCI, V18, P6147; Dittman JS, 1996, J NEUROSCI, V16, P1623; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; ECCLES JC, 1966, J PHYSIOL-LONDON, V182, P297, DOI 10.1113/jphysiol.1966.sp007825; ECCLES JC, 1966, J PHYSIOL-LONDON, V182, P268, DOI 10.1113/jphysiol.1966.sp007824; ECCLES JC, 1941, J PHYSL, V124, P574; Feng T.P., 1941, CHINESE J PHYSIOL, V16, P341; FOGELSON AL, 1985, BIOPHYS J, V48, P1003, DOI 10.1016/S0006-3495(85)83863-7; GRANIT R, 1956, J PHYSIOL-LONDON, V133, P520, DOI 10.1113/jphysiol.1956.sp005606; Hashimoto K, 1998, J PHYSIOL-LONDON, V506, P391, DOI 10.1111/j.1469-7793.1998.391bw.x; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HERRINGTON J, 1995, PULSE CONTROL V4 5 I; Ito M, 1984, CEREBELLUM NEURAL CO; JENKINSON DH, 1957, J PHYSIOL-LONDON, V138, P434, DOI 10.1113/jphysiol.1957.sp005860; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Kreitzer AC, 2000, NEURON, V27, P25, DOI 10.1016/S0896-6273(00)00006-4; KUSANO K, 1975, J PHYSIOL-LONDON, V245, P13, DOI 10.1113/jphysiol.1975.sp010832; LILEY AW, 1953, J NEUROPHYSIOL, V16, P509, DOI 10.1152/jn.1953.16.5.509; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; Matthews G, 1996, ANNU REV NEUROSCI, V19, P219; MINTZ IM, 1995, NEURON, V15, P675, DOI 10.1016/0896-6273(95)90155-8; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; REGEHR WG, 1994, NEURON, V12, P605, DOI 10.1016/0896-6273(94)90216-X; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; Schwarz C, 2001, J NEUROPHYSIOL, V86, P2489, DOI 10.1152/jn.2001.86.5.2489; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; SIMON SM, 1985, BIOPHYS J, V48, P485, DOI 10.1016/S0006-3495(85)83804-2; SMITH PD, 1984, ANAL BIOCHEM, V143, P188, DOI 10.1016/0003-2697(84)90575-X; Stevens CF, 1998, NEURON, V21, P415, DOI 10.1016/S0896-6273(00)80550-4; Tank DW, 1995, J NEUROSCI, V15, P7940; Taschenberger H, 2000, J NEUROSCI, V20, P9162; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; Watkins J C, 1990, Adv Exp Med Biol, V268, P49; Xu-Friedman MA, 2001, J NEUROSCI, V21, P6666, DOI 10.1523/JNEUROSCI.21-17-06666.2001; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	51	92	92	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 19	2002	36	6					1115	1126		10.1016/S0896-6273(02)01106-6	http://dx.doi.org/10.1016/S0896-6273(02)01106-6			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	628TA	12495626	Bronze, Green Published			2022-12-24	WOS:000180011600014
J	Stowers, RS; Megeath, LJ; Gorska-Andrzejak, J; Meinertzhagen, IA; Schwarz, TL				Stowers, RS; Megeath, LJ; Gorska-Andrzejak, J; Meinertzhagen, IA; Schwarz, TL			Axonal transport of mitochondria to synapses depends on Milton, a novel Drosophila protein	NEURON			English	Article							HUNTINGTIN-ASSOCIATED PROTEIN-1; MOTOR PROTEIN; KINESIN; MELANOGASTER; ORGANIZATION; EXPRESSION; MEMBRANE; RECEPTOR; NEURONS; ADULT	A protein required to localize mitochondria to Drosophila nerve terminals has been identified genetically. Photoreceptors mutant for milton show aberrant synaptic transmission despite normal phototransduction. Without Milton, synaptic terminals and axons lack mitochondria, although mitochondria are numerous in neuronal cell bodies. In contrast, synaptic vesicles continue to be transported to and concentrated at synapses. Milton protein is associated with mitochondria and is present primarily in axons and synapses. A likely explanation of the apparent trafficking defect is offered by the coimmunoprecipitation of Milton and kinesin heavy chain. Transfected into HEK293T cells, Milton induces a redistribution of mitochondria within the cell. We propose that Milton is a mitochondria-associated protein required for kinesin-mediated transport of mitochondria to nerve terminals.	Childrens Hosp, Div Neurosci, Boston, MA 02115 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Dalhousie Univ, Life Sci Ctr, Halifax, NS B3H 4J1, Canada; Stanford Sch Med, Beckman Ctr, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA	Harvard University; Boston Children's Hospital; University of California System; University of California Berkeley; Dalhousie University; Stanford University	Schwarz, TL (corresponding author), Childrens Hosp, Div Neurosci, Enders 208,300 Longwood Ave, Boston, MA 02115 USA.		Górska-Andrzejak, Jolanta/ABF-7770-2020	Meinertzhagen, Ian/0000-0002-6578-4526	NEI NIH HHS [EY03592] Funding Source: Medline; NIMH NIH HHS [MH48108] Funding Source: Medline; NINDS NIH HHS [NS07473, NS41062, NS10561] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY003592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH048108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041062] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; BlockGalarza J, 1997, NEUROREPORT, V8, P2247, DOI 10.1097/00001756-199707070-00031; Bowman AB, 2000, CELL, V103, P583, DOI 10.1016/S0092-8674(00)00162-8; BRAND AH, 1993, DEVELOPMENT, V118, P401; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; COOMBE PE, 1986, J NEUROGENET, V3, P135, DOI 10.3109/01677068609106845; ENGELFRIET J, 1997, HDB GRAPH GRAMMARS C, V1, P1, DOI [10.1142/9789812384720_0001, DOI 10.1142/9789812384720_0001, DOI 10.1142/9789812384720_]; FUJITA SC, 1982, P NATL ACAD SCI-BIOL, V79, P7929, DOI 10.1073/pnas.79.24.7929; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; Gutekunst CA, 1998, J NEUROSCI, V18, P7674, DOI 10.1523/jneurosci.18-19-07674.1998; HEISENBERG M, 1971, J EXP BIOL, V55, P85; Hermann GJ, 1997, J CELL BIOL, V137, P141, DOI 10.1083/jcb.137.1.141; Hollenbeck Peter J., 1996, Frontiers in Bioscience (online), V1, pD91; Hurd DD, 1996, GENETICS, V144, P1075; Kikuno R, 1999, DNA Res, V6, P197, DOI 10.1093/dnares/6.3.197; Klopfenstein DR, 2002, CELL, V109, P347, DOI 10.1016/S0092-8674(02)00708-0; LANGFORD GM, 1995, CURR OPIN CELL BIOL, V7, P82, DOI 10.1016/0955-0674(95)80048-4; Li SH, 1998, J NEUROSCI, V18, P1261, DOI 10.1523/jneurosci.18-04-01261.1998; Li SH, 2000, MOL CELL NEUROSCI, V16, P168, DOI 10.1006/mcne.2000.0858; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; Ligon LA, 2000, J COMP NEUROL, V427, P340, DOI 10.1002/1096-9861(20001120)427:3<340::AID-CNE2>3.0.CO;2-Y; LIPPINCOTTSCHWARTZ J, 1995, J CELL BIOL, V128, P293, DOI 10.1083/jcb.128.3.293; LITTLETON JT, 1993, DEVELOPMENT, V118, P1077; Meinertzhagen I A, 2001, Prog Brain Res, V131, P53; MEINERTZHAGEN IA, 1991, J COMP NEUROL, V305, P232, DOI 10.1002/cne.903050206; Meinertzhagen IA, 2000, EUR J NEUROSCI, V12, P1342, DOI 10.1046/j.1460-9568.2000.00033.x; Meinertzhagen Ian A., 1993, P1363; MORRIS RL, 1993, J CELL SCI, V104, P917; Morrow G, 2000, J BIOL CHEM, V275, P31204, DOI 10.1074/jbc.M002960200; Nagase T, 1998, DNA Res, V5, P31, DOI 10.1093/dnares/5.1.31; Nakagawa T, 2000, CELL, V103, P569, DOI 10.1016/S0092-8674(00)00161-6; NANGAKU M, 1994, CELL, V79, P1209, DOI 10.1016/0092-8674(94)90012-4; Pereira AJ, 1997, J CELL BIOL, V136, P1081, DOI 10.1083/jcb.136.5.1081; Peters A., 1991, FINE STRUCTURE NERVO; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Simon VR, 1997, CELL MOTIL CYTOSKEL, V37, P199, DOI 10.1002/(SICI)1097-0169(1997)37:3<199::AID-CM2>3.0.CO;2-2; Stowers RS, 1999, GENETICS, V152, P1631; STURMER K, 1995, J CELL SCI, V108, P2273; TAMKUN JW, 1991, P NATL ACAD SCI USA, V88, P3120, DOI 10.1073/pnas.88.8.3120; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; Vallee RB, 1996, SCIENCE, V271, P1539, DOI 10.1126/science.271.5255.1539; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; WERTH JL, 1994, J NEUROSCI, V14, P348; WONGRILEY MTT, 1980, P NATL ACAD SCI-BIOL, V77, P2333, DOI 10.1073/pnas.77.4.2333; XU T, 1993, DEVELOPMENT, V117, P1223; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	47	465	475	0	22	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 19	2002	36	6					1063	1077		10.1016/S0896-6273(02)01094-2	http://dx.doi.org/10.1016/S0896-6273(02)01094-2			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	628TA	12495622	Bronze			2022-12-24	WOS:000180011600010
J	Misgeld, T; Burgess, RW; Lewis, RM; Cunningham, JM; Lichtman, JW; Sanes, JR				Misgeld, T; Burgess, RW; Lewis, RM; Cunningham, JM; Lichtman, JW; Sanes, JR			Roles of neurotransmitter in synapse formation: Development of neuromuscular junctions lacking choline acetyltransferase	NEURON			English	Article							RAPSYN-DEFICIENT MICE; SKELETAL-MUSCLES; CELL-DEATH; ACETYLCHOLINE-RECEPTORS; MOTONEURON SURVIVAL; NEURAL REGULATION; GENE-EXPRESSION; NEURONAL DEATH; TROPHIC FACTOR; CHICK-EMBRYO	Activity-dependent and -independent signals collaborate to regulate synaptogenesis, but their relative contributions are unclear. Here, we describe the formation of neuromuscular synapses at which neurotransmission is completely and specifically blocked by mutation of the neurotransmitter-synthesizing enzyme choline acetyltransferase. Nerve terminals differentiate extensively in the absence of neurotransmitter, but neurotransmission plays multiple roles in synaptic differentiation. These include influences on the numbers of pre- and postsynaptic partners, the distribution of synapses in the target field, the number of synaptic sites per target cell, and the number of axons per synaptic site. Neurotransmission also regulates the formation or stability of transient acetylcholine receptor-rich processes (myopodia) that may initiate nerve-muscle contact. At subsequent stages, neurotransmission delays some steps in synaptic maturation but accelerates others. Thus, neurotransmission affects synaptogenesis from early stages and coordinates rather than drives synaptic maturation.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Lichtman, JW (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.	jeff@pcg.wustil.edu; sanesj@pcg.wustl.edu		Burgess, Robert/0000-0002-9229-3407				Akaaboune M, 1999, SCIENCE, V286, P503, DOI 10.1126/science.286.5439.503; Banks GB, 2001, J COMP NEUROL, V429, P156, DOI 10.1002/1096-9861(20000101)429:1<156::AID-CNE12>3.0.CO;2-3; BENNETT MR, 1974, J PHYSIOL-LONDON, V241, P515, DOI 10.1113/jphysiol.1974.sp010670; BETZ H, 1980, J PHYSIOL-LONDON, V302, P197; BROADIE K, 1993, NEURON, V11, P607, DOI 10.1016/0896-6273(93)90073-Z; BROWN MC, 1981, ANNU REV NEUROSCI, V4, P17, DOI 10.1146/annurev.ne.04.030181.000313; BUNGE RP, 1987, J EXP BIOL, V132, P21; Burgess RW, 1999, NEURON, V23, P33, DOI 10.1016/S0896-6273(00)80751-5; CARBINI LA, 1993, J NEUROCHEM, V61, P247, DOI 10.1111/j.1471-4159.1993.tb03561.x; CHIU AY, 1984, DEV BIOL, V103, P456, DOI 10.1016/0012-1606(84)90333-6; CHOW I, 1985, J NEUROSCI, V5, P1076; DAHM LM, 1991, J NEUROSCI, V11, P238; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; Deitcher DL, 1998, J NEUROSCI, V18, P2028; DiAntonio A, 1999, J NEUROSCI, V19, P3023; DING R, 1983, J NEUROCYTOL, V12, P887, DOI 10.1007/BF01153341; DUXSON MJ, 1982, J NEUROCYTOL, V11, P395, DOI 10.1007/BF01257985; Eiden LE, 1998, J NEUROCHEM, V70, P2227; ENTWISTLE A, 1988, J CELL BIOL, V106, P1703, DOI 10.1083/jcb.106.5.1703; Featherstone DE, 2002, NAT NEUROSCI, V5, P141, DOI 10.1038/nn789; FONNUM F, 1975, J NEUROCHEM, V24, P407, DOI 10.1111/j.1471-4159.1975.tb11895.x; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; GAUTAM M, 1995, NATURE, V377, P232, DOI 10.1038/377232a0; Georgiou J, 1999, J NEUROSCI, V19, P3836; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; GORDON T, 1974, CELL TISSUE RES, V155, P13; Grando SA, 1997, JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, VOL 2, NO 1, AUGUST 1997, P41, DOI 10.1038/jidsymp.1997.10; Greer JJ, 2000, PEDIATR PULM, V29, P394, DOI 10.1002/(SICI)1099-0496(200005)29:5<394::AID-PPUL9>3.0.CO;2-2; Greer JJ, 1999, J APPL PHYSIOL, V86, P779, DOI 10.1152/jappl.1999.86.3.779; HARRIS A J, 1981, Philosophical Transactions of the Royal Society of London B Biological Sciences, V293, P287, DOI 10.1098/rstb.1981.0078; HARRIS AJ, 1981, PHILOS T ROY SOC B, V293, P257, DOI 10.1098/rstb.1981.0076; HOUENOU LJ, 1990, J NEUROBIOL, V21, P1249, DOI 10.1002/neu.480210809; HUME RI, 1983, NATURE, V305, P632, DOI 10.1038/305632a0; JANSEN JKS, 1973, SCIENCE, V181, P559, DOI 10.1126/science.181.4099.559; KARNOVSKY MJ, 1964, J HISTOCHEM CYTOCHEM, V12, P219, DOI 10.1177/12.3.219; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Krause RM, 1995, J PHYSIOL-LONDON, V489, P779, DOI 10.1113/jphysiol.1995.sp021091; Lewandoski M, 1997, NAT GENET, V17, P223, DOI 10.1038/ng1097-223; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; LOMO T, 1980, J PHYSIOL-LONDON, V303, P191, DOI 10.1113/jphysiol.1980.sp013280; Marques MJ, 2000, J NEUROSCI, V20, P3663, DOI 10.1523/JNEUROSCI.20-10-03663.2000; MCARDLE JJ, 1981, J NEUROSCI METH, V4, P109, DOI 10.1016/0165-0270(81)90044-3; MICHEL RN, 1994, J CELL BIOL, V127, P1061, DOI 10.1083/jcb.127.4.1061; MISAWA H, 1992, J BIOL CHEM, V267, P20392; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; OPPENHEIM RW, 1989, DEVELOPMENT, V107, P331; Parsons RL, 1999, J NEUROPHYSIOL, V81, P2696, DOI 10.1152/jn.1999.81.6.2696; Patton BL, 2001, NAT NEUROSCI, V4, P597, DOI 10.1038/88414; Pun S, 2002, NEURON, V34, P357, DOI 10.1016/S0896-6273(02)00670-0; Ritzenthaler S, 2000, NAT NEUROSCI, V3, P1012, DOI 10.1038/79833; RUBIN LL, 1980, NATURE, V283, P264, DOI 10.1038/283264a0; Saitoe M, 2001, SCIENCE, V293, P514, DOI 10.1126/science.1061270; Sandri M, 1999, INT J BIOCHEM CELL B, V31, P1373, DOI 10.1016/S1357-2725(99)00063-1; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Sepich DS, 1998, GENETICS, V148, P361; Skorpen J, 1999, MOL CELL NEUROSCI, V13, P192, DOI 10.1006/mcne.1999.0743; SLATER CR, 1982, DEV BIOL, V94, P11, DOI 10.1016/0012-1606(82)90063-X; Spitzer NC, 2002, J PHYSIOLOGY-PARIS, V96, P73, DOI 10.1016/S0928-4257(01)00082-1; Sudhof TC, 2001, ANNU REV NEUROSCI, V24, P933, DOI 10.1146/annurev.neuro.24.1.933; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Terrado J, 2001, J NEUROSCI, V21, P3144, DOI 10.1523/JNEUROSCI.21-09-03144.2001; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Uhm CS, 2001, J NEUROSCI, V21, P9678, DOI 10.1523/JNEUROSCI.21-24-09678.2001; Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Washbourne P, 2002, NAT NEUROSCI, V5, P19, DOI 10.1038/nn783; White FA, 1998, J NEUROSCI, V18, P1428; Wong WT, 2000, J NEUROSCI, V20, P5024; Yamamoto Y, 1999, DEV BIOL, V214, P60, DOI 10.1006/dbio.1999.9413; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	76	246	249	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 14	2002	36	4					635	648		10.1016/S0896-6273(02)01020-6	http://dx.doi.org/10.1016/S0896-6273(02)01020-6			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	616PX	12441053	Bronze			2022-12-24	WOS:000179313100011
J	Padoa-Schioppa, C; Li, CSR; Bizzi, E				Padoa-Schioppa, C; Li, CSR; Bizzi, E			Neuronal correlates of kinematics-to-dynamics transformation in the supplementary motor area	NEURON			English	Article							ADJACENT CINGULATE CORTEX; MEDIAL PREMOTOR CORTEX; CORTICOSPINAL PROJECTIONS; TOPOGRAPHIC ORGANIZATION; NEURAL REPRESENTATIONS; INTERNAL-MODELS; MESIAL AREA-6; FRONTAL-LOBE; MOVEMENT; FORCE	It is widely acknowledged that movements are planned at the level of the kinematics. However, the central nervous system must ultimately transform kinematic plans into dynamics-related commands. How, when, and where the kinematics-to-dynamics (KD) transformation is processed represent fundamental and unanswered questions. We recorded from the supplementary motor area (SMA) of two monkeys as they executed visually instructed reaching movements. We specifically analyzed a delay period following the instruction but prior to the go signal (motor planning). During the delay, a group of neurons in the SMA progressively came to reflect the dynamics rather than the desired kinematics of the upcoming movement. This finding suggests that some neurons in the SMA participate in the KD transformation.	MIT, McGovern Inst Brain Res, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Padoa-Schioppa, C (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, WAB 224,200 Longwood Ave, Boston, MA 02115 USA.	camillo@alum.mit.edu	Li, Chiang-Shan Ray/J-2813-2016	Li, Chiang-Shan Ray/0000-0002-9393-1212; /0000-0002-7644-4498; Padoa-Schioppa, Camillo/0000-0002-7519-8790				ALEXANDER GE, 1990, J NEUROPHYSIOL, V64, P133, DOI 10.1152/jn.1990.64.1.133; ALEXANDER GE, 1990, J NEUROPHYSIOL, V64, P164, DOI 10.1152/jn.1990.64.1.164; Andersen R A, 1993, Curr Opin Neurobiol, V3, P171, DOI 10.1016/0959-4388(93)90206-E; Battaglia-Mayer A, 2000, J NEUROPHYSIOL, V83, P2374, DOI 10.1152/jn.2000.83.4.2374; Bhushan N, 1999, BIOL CYBERN, V81, P39, DOI 10.1007/s004220050543; BIZZI E, 1984, J NEUROSCI, V4, P2738; BIZZI E, 1992, BEHAV BRAIN SCI, V15, P603, DOI 10.1017/S0140525X00072538; Bizzi E, 2000, NAT REV NEUROSCI, V1, P101, DOI 10.1038/35039000; CHEN YC, 1995, EXP BRAIN RES, V102, P461; Cisek P, 1999, NEUROSCI LETT, V272, P1, DOI 10.1016/S0304-3940(99)00338-9; Colby CL, 1998, NEURON, V20, P15, DOI 10.1016/S0896-6273(00)80429-8; Crammond DJ, 1996, EXP BRAIN RES, V108, P45; CRUTCHER MD, 1990, J NEUROPHYSIOL, V64, P151, DOI 10.1152/jn.1990.64.1.151; Duhamel JR, 1997, NATURE, V389, P845, DOI 10.1038/39865; EVARTS EV, 1968, J NEUROPHYSIOL, V31, P14, DOI 10.1152/jn.1968.31.1.14; Fisher NI, 1995, STAT ANAL CIRCULAR D; Flanagan JR, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-20-j0005.1999; GEORGOPOULOS AP, 1989, SCIENCE, V243, P234, DOI 10.1126/science.2911737; GISZTER SF, 1993, J NEUROSCI, V13, P467; Gold JI, 2000, NATURE, V404, P390, DOI 10.1038/35006062; GRAZIANO MSA, 1994, SCIENCE, V266, P1054, DOI 10.1126/science.7973661; HE SQ, 1995, J NEUROSCI, V15, P3284; HE SQ, 1993, J NEUROSCI, V13, P952; HEPPREYMOND MC, 1994, CAN J PHYSIOL PHARM, V72, P571, DOI 10.1139/y94-081; Hernandez A, 2002, NEURON, V33, P959, DOI 10.1016/S0896-6273(02)00613-X; HIKOSAKA O, 2000, NEW COGNITIVE NEUROS; Imamizu H, 2000, NATURE, V403, P192, DOI 10.1038/35003194; Johnson MTV, 1999, J NEUROPHYSIOL, V81, P875, DOI 10.1152/jn.1999.81.2.875; KALASKA JF, 1990, EXP BRAIN RES, V80, P351; KALASKA JF, 1992, SCIENCE, V255, P1517, DOI 10.1126/science.1549781; KALASKA JF, 1989, J NEUROSCI, V9, P2080; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; Krakauer JW, 1999, NAT NEUROSCI, V2, P1026, DOI 10.1038/14826; KURATA K, 1988, EXP BRAIN RES, V72, P237; Li CSR, 2001, NEURON, V30, P593, DOI 10.1016/S0896-6273(01)00301-4; LUPPINO G, 1991, J COMP NEUROL, V311, P463, DOI 10.1002/cne.903110403; MATELLI M, 1991, J COMP NEUROL, V311, P445, DOI 10.1002/cne.903110402; MATSUZAKA Y, 1992, J NEUROPHYSIOL, V68, P653, DOI 10.1152/jn.1992.68.3.653; Mussa-Ivaldi FA, 2000, PHILOS T R SOC B, V355, P1755, DOI 10.1098/rstb.2000.0733; MUSSAIVALDI FA, 1994, P NATL ACAD SCI USA, V91, P7534, DOI 10.1073/pnas.91.16.7534; Neter J, 1985, APPL LINEAR REGRESSI; Newsome WT, 1997, J COMP PHYSIOL A, V181, P5, DOI 10.1007/s003590050087; OLSON CR, 1995, SCIENCE, V269, P985, DOI 10.1126/science.7638625; PENFIELD W, 1951, AMA ARCH NEUROL PSY, V66, P289, DOI 10.1001/archneurpsyc.1951.02320090038004; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; Prut Y, 1999, NATURE, V401, P590, DOI 10.1038/44145; RIEHLE A, 1993, BEHAV BRAIN RES, V53, P35, DOI 10.1016/S0166-4328(05)80264-5; SALTZMAN E, 1979, J MATH PSYCHOL, V20, P91, DOI 10.1016/0022-2496(79)90020-8; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shadmehr R, 1997, SCIENCE, V277, P821, DOI 10.1126/science.277.5327.821; Shen LM, 1997, J NEUROPHYSIOL, V77, P1195, DOI 10.1152/jn.1997.77.3.1195; SHIDARA M, 1993, NATURE, V365, P50, DOI 10.1038/365050a0; Shima K, 2000, J NEUROPHYSIOL, V84, P2148, DOI 10.1152/jn.2000.84.4.2148; TANJI J, 1994, NEUROSCI RES, V19, P251, DOI 10.1016/0168-0102(94)90038-8; TANJI J, 1985, EXP BRAIN RES, V60, P423; THACH WT, 1978, J NEUROPHYSIOL, V41, P654, DOI 10.1152/jn.1978.41.3.654; THALER D, 1995, EXP BRAIN RES, V102, P445; Thoroughman KA, 1999, J NEUROSCI, V19, P8573; WERNER W, 1991, EXP BRAIN RES, V86, P293; WISE SP, 1992, J NEUROPHYSIOL, V68, P969, DOI 10.1152/jn.1992.68.3.969; Wise SP, 1997, ANNU REV NEUROSCI, V20, P25, DOI 10.1146/annurev.neuro.20.1.25; Wise SP, 1996, ADV NEUROL, V70, P57; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; WOOLSEY CN, 1952, RES PUBL ASS NERV ME, V30, P231	65	64	65	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 14	2002	36	4					751	765		10.1016/S0896-6273(02)01028-0	http://dx.doi.org/10.1016/S0896-6273(02)01028-0			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	616PX	12441062	Bronze			2022-12-24	WOS:000179313100020
J	Todorov, E; Jordan, MI				Todorov, E; Jordan, MI			Optimal feedback control as a theory of motor coordination	NATURE NEUROSCIENCE			English	Article							INERTIAL ANISOTROPY; ARM MOVEMENTS; MODEL; TASK; ACCURACY; SPEECH; GRASP	A central problem in motor control is understanding how the many biomechanical degrees of freedom are coordinated to achieve a common goal. An especially puzzling aspect of coordination is that behavioral goals are achieved reliably and repeatedly with movements rarely reproducible in their detail. Existing theoretical frameworks emphasize either goal achievement or the richness of motor variability, but fail to reconcile the two. Here we propose an alternative theory based on stochastic optimal feedback control. We show that the optimal strategy in the face of uncertainty is to allow variability in redundant (task-irrelevant) dimensions. This strategy does not enforce a desired trajectory, but uses feedback more intelligently, correcting only those deviations that interfere with task goals. From this framework, task-constrained variability, goal-directed corrections, motor synergies, controlled parameters, simplifying rules and discrete coordination modes emerge naturally. We present experimental results from a range of motor tasks to support this theory.	Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92093 USA; Univ Calif Berkeley, Div Comp Sci, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA	University of California System; University of California San Diego; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Todorov, E (corresponding author), Univ Calif San Diego, Dept Cognit Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA.		Jordan, Michael I/C-5253-2013					Balasubramaniam R, 2000, GAIT POSTURE, V11, P12, DOI 10.1016/S0966-6362(99)00051-X; Bernstein N.A., 1967, COORDINATION REGULAT; BIZZI E, 1984, J NEUROSCI, V4, P2738; COLE KJ, 1987, J NEUROPHYSIOL, V57, P1498, DOI 10.1152/jn.1987.57.5.1498; COLE KJ, 1986, J NEUROPHYSIOL, V55, P1407, DOI 10.1152/jn.1986.55.6.1407; d'Avella A, 1998, P NATL ACAD SCI USA, V95, P7711, DOI 10.1073/pnas.95.13.7711; Davis M., 1985, STOCHASTIC MODELLING; Domkin D, 2002, EXP BRAIN RES, V143, P11, DOI 10.1007/s00221-001-0944-1; Flanagan JR, 2001, J NEUROSCI, V21, P1361; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Gel'fand IM., 1971, MODELS STRUCTURAL FU; GORDON J, 1994, EXP BRAIN RES, V99, P112, DOI 10.1007/BF00241416; Gottlieb GL, 1996, J NEUROPHYSIOL, V76, P3207, DOI 10.1152/jn.1996.76.5.3207; GRACCO VL, 1986, EXP BRAIN RES, V65, P156; GRACCO VL, 1985, J NEUROPHYSIOL, V54, P418, DOI 10.1152/jn.1985.54.2.418; Haggard P, 1995, EXP BRAIN RES, V107, P254; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; HINTON G, 1984, J MOTOR BEHAV, V16, P171; Hoff B., 1992, THESIS U SO CALIFORN; JORDAN MI, 1990, ATTENTION PERFORM, V13, P796; Kawagoe A, 1999, IEEE T APPL SUPERCON, V9, P727, DOI 10.1109/77.783398; Kelso S., 1995, DYNAMIC PATTERNS SEL; KOMILIS E, 1993, J MOTOR BEHAV, V25, P299, DOI 10.1080/00222895.1993.9941651; KUO AD, 1995, IEEE T BIO-MED ENG, V42, P87, DOI 10.1109/10.362914; Li ZM, 1998, EXP BRAIN RES, V119, P276, DOI 10.1007/s002210050343; LOEB GE, 1990, COLD SH Q B, V55, P791; Marr D., 1982, VISION; MEYER DE, 1988, PSYCHOL REV, V95, P340, DOI 10.1037/0033-295X.95.3.340; NELSON WL, 1983, BIOL CYBERN, V46, P135, DOI 10.1007/BF00339982; Newell KM, 2001, HUM MOVEMENT SCI, V20, P695, DOI 10.1016/S0167-9457(01)00073-2; Robertson EM, 1997, EXP BRAIN RES, V117, P148, DOI 10.1007/s002210050208; Sabes PN, 1998, J NEUROSCI, V18, P5948; Santello M, 2000, EXP BRAIN RES, V133, P457, DOI 10.1007/s002210000420; SCHMIDT RA, 1979, PSYCHOL REV, V86, P415, DOI 10.1037//0033-295X.86.5.415; Scholz JP, 2000, EXP BRAIN RES, V135, P382, DOI 10.1007/s002210000540; Scholz JP, 1999, EXP BRAIN RES, V126, P289, DOI 10.1007/s002210050738; SPORNS O, 1993, CHILD DEV, V64, P960, DOI 10.2307/1131321; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588; Todorov E, 1997, J MOTOR BEHAV, V29, P147, DOI 10.1080/00222899709600829; Todorov E, 2002, NEURAL COMPUT, V14, P1233, DOI 10.1162/089976602753712918; Todorov E, 1998, J NEUROPHYSIOL, V80, P696, DOI 10.1152/jn.1998.80.2.696; Todorov EV, 1998, THESIS MIT; Tseng YW, 2002, MOTOR CONTROL, V6, P183, DOI 10.1123/mcj.6.2.183; TURVEY MT, 1990, AM PSYCHOL, V45, P938, DOI 10.1037/0003-066X.45.8.938; UNO Y, 1989, BIOL CYBERN, V61, P89, DOI 10.1007/BF00204593; VEREIJKEN B, 1992, J MOTOR BEHAV, V24, P133, DOI 10.1080/00222895.1992.9941608; WINTER DA, 1989, PERSPECTIVES COORDIN, P329; WOLPERT DM, 1995, EXP BRAIN RES, V103, P460; WRIGHT CE, 1990, ATTENTION PERFORM, V13, P294	50	1843	1855	10	194	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1226	1235		10.1038/nn963	http://dx.doi.org/10.1038/nn963			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	609CG	12404008				2022-12-24	WOS:000178884600027
J	Debiec, J; LeDoux, JE; Nader, K				Debiec, J; LeDoux, JE; Nader, K			Cellular and systems reconsolidation in the hippocampus	NEURON			English	Article							LONG-TERM-MEMORY; RETROGRADE-AMNESIA; PROTEIN-SYNTHESIS; CONTEXTUAL FEAR; CONSOLIDATION; RETRIEVAL; EXTINCTION; AMYGDALA; CORTEX; ACTIVATION	Cellular theories of memory consolidation posit that new memories require new protein synthesis in order to be stored. Systems consolidation theories posit that the hippocampus has a time-limited role in memory storage, after which the memory is independent of the hippocampus. Here, we show that intra-hippocampal infusions of the protein synthesis inhibitor anisomycin caused amnesia for a consolidated hippocampal-dependent contextual fear memory, but only if the memory was reactivated prior to infusion. The effect occurred even if reactivation was delayed for 45 days after training, a time when contextual memory is independent of the hippocampus. Indeed, reactivation of a hippocampus-independent memory caused the trace to again become hippocampus dependent, but only for 2 days rather than for weeks. Thus, hippocampal memories can undergo reconsolidation at both the cellular and systems levels.	McGill Univ, Dept Psychol, Montreal, PQ H3A 1B1, Canada; NYU, Ctr Neural Sci, WM Keck Fdn Lab Neurobiol, New York, NY 10003 USA; Jagiellonian Univ, Coll Med, Dept Psychiat, PL-31501 Krakow, Poland	McGill University; New York University; Jagiellonian University; Collegium Medicum Jagiellonian University	Nader, K (corresponding author), McGill Univ, Dept Psychol, 1205 Dr Penfield Ave, Montreal, PQ H3A 1B1, Canada.		Debiec, Jacek/B-6820-2008	Debiec, Jacek/0000-0002-8473-1534	NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH000956, P50MH058911, R37MH038774] Funding Source: NIH RePORTER; NIMH NIH HHS [K02 MH00956, P50 MH 58911, R37 MH38774] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Anagnostaras SG, 2001, HIPPOCAMPUS, V11, P8; Anagnostaras SG, 1999, J NEUROSCI, V19, P1106; Bartlett F. C., 1932, REMEMBERING; Berman DE, 2001, SCIENCE, V291, P2417, DOI 10.1126/science.1058165; Bontempi B, 1999, NATURE, V400, P671, DOI 10.1038/23270; BOUTON ME, 1993, PSYCHOL BULL, V114, P80, DOI 10.1037/0033-2909.114.1.80; CHERKIN A, 1972, PHYSIOL BEHAV, V8, P949, DOI 10.1016/0031-9384(72)90309-5; Cipolotti L, 2001, NEUROPSYCHOLOGIA, V39, P151, DOI 10.1016/S0028-3932(00)00103-2; Corkin S, 2002, NAT REV NEUROSCI, V3, P153, DOI 10.1038/nrn726; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; DAVIS HP, 1978, PHARMACOL BIOCHEM BE, V8, P701, DOI 10.1016/0091-3057(78)90269-1; Dudai Y, 2000, BRAIN, PERCEPTION, MEMORY, P149; DUNCAN CP, 1949, J COMP PHYSIOL PSYCH, V42, P32, DOI 10.1037/h0058173; Ebbinghaus M, 1885, GEDACHTNIS; EICHENBAUM H, 1994, BEHAV BRAIN SCI, V17, P449, DOI 10.1017/S0140525X00035391; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; FLEXNER LB, 1965, EXP NEUROL, V13, P264, DOI 10.1016/0014-4886(65)90114-7; Frankland PW, 2001, NATURE, V411, P309, DOI 10.1038/35077089; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Frohardt RJ, 2000, BEHAV NEUROSCI, V114, P227, DOI 10.1037/0735-7044.114.2.227; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; GOLD PE, 1974, PSYCHOL REV, V81, P465, DOI 10.1037/h0036949; GOLD PE, 1973, SCIENCE, V180, P1199, DOI 10.1126/science.180.4091.1199; Guzowski JF, 1997, P NATL ACAD SCI USA, V94, P2693, DOI 10.1073/pnas.94.6.2693; Hall J, 2001, J NEUROSCI, V21, P2186, DOI 10.1523/JNEUROSCI.21-06-02186.2001; Hebb Donald O., 1949, ORG BEHAV; Kida S, 2002, NAT NEUROSCI, V5, P348, DOI 10.1038/nn819; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Land C, 2000, PSYCHOBIOLOGY, V28, P476; Lattal KM, 2001, J NEUROSCI, V21, P5773, DOI 10.1523/JNEUROSCI.21-15-05773.2001; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LEWIS DJ, 1979, PSYCHOL BULL, V86, P1054, DOI 10.1037/0033-2909.86.5.1054; LOFTUS EF, 1984, MEMORY CONSOLIDATION, P163; MACTUTUS CF, 1979, SCIENCE, V204, P1319, DOI 10.1126/science.572083; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Mayes AR, 2001, PHILOS T ROY SOC B, V356, P1395, DOI 10.1098/rstb.2001.0941; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; MCGAUGH JL, 1966, SCIENCE, V153, P1351, DOI 10.1126/science.153.3742.1351; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; McNish KA, 1997, J NEUROSCI, V17, P9353; MILLER RR, 1974, PSYCHOL REV, V81, P470, DOI 10.1037/h0036951; Miller RR, 2000, NAT REV NEUROSCI, V1, P214, DOI 10.1038/35044578; Millin PM, 2001, NAT REV NEUROSCI, V2, P68, DOI 10.1038/35049075; Misanin JR, 1968, SCIENCE, V160, P203; MONAGHAN DT, 1985, J NEUROSCI, V5, P2909; MULLER GE, 1900, Z PSYCHOL S, V1; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; Nader K, 2000, NAT REV NEUROSCI, V1, P216, DOI 10.1038/35044580; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; Przybyslawski J, 1997, BEHAV BRAIN RES, V84, P241, DOI 10.1016/S0166-4328(96)00153-2; Przybyslawski J, 1999, J NEUROSCI, V19, P6623; QUARTERM.D, 1970, NATURE, V228, P677, DOI 10.1038/228677a0; Quevedo J, 1999, LEARN MEMORY, V6, P600, DOI 10.1101/lm.6.6.600; Rolls E.T., 1989, NEURAL MODELS PLASTI, P240; Rosenblum K, 1997, J NEUROSCI, V17, P5129; Ryan L, 2001, HIPPOCAMPUS, V11, P707, DOI 10.1002/hipo.1086; Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73; Schacter DL, 1999, AM PSYCHOL, V54, P182, DOI 10.1037/0003-066X.54.3.182; Schafe GE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-18-j0003.2000; Schafe GE, 2000, J NEUROSCI, V20, P8177; SCHNEIDER AM, 1968, SCIENCE, V159, P219, DOI 10.1126/science.159.3811.219; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; Squire LR, 2001, HIPPOCAMPUS, V11, P50, DOI 10.1002/1098-1063(2001)11:1<50::AID-HIPO1019>3.0.CO;2-G; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; SUZUKI WA, 1994, J NEUROSCI, V14, P1856, DOI 10.1523/JNEUROSCI.14-03-01856.1994; Taubenfeld SM, 2001, NAT NEUROSCI, V4, P813, DOI 10.1038/90520; Vianna MRM, 2001, P NATL ACAD SCI USA, V98, P12251, DOI 10.1073/pnas.211433298; ZINKIN S, 1967, SCIENCE, V155, P102, DOI 10.1126/science.155.3758.102	73	546	556	1	64	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 24	2002	36	3					527	538		10.1016/S0896-6273(02)01001-2	http://dx.doi.org/10.1016/S0896-6273(02)01001-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	608ZE	12408854	Bronze			2022-12-24	WOS:000178877700020
J	Krylova, O; Herreros, J; Cleverley, KE; Ehler, E; Henriquez, JP; Hughes, SM; Salinas, PC				Krylova, O; Herreros, J; Cleverley, KE; Ehler, E; Henriquez, JP; Hughes, SM; Salinas, PC			WNT-3, expressed by motoneurons, regulates terminal arborization of neurotrophin-3-responsive spinal sensory neurons	NEURON			English	Article							NERVE GROWTH-FACTOR; DORSAL-ROOT AXONS; SEMAPHORIN-III; SYNAPSIN-I; FAMILY; GUIDANCE; CORD; NEUROTROPHINS; COLLAPSIN; PROTEINS	Sensory axons from dorsal root ganglia neurons are guided to spinal targets by molecules differentially expressed along the dorso-ventral axis of the neural tube. NT-3-responsive muscle afferents; project ventrally, cease extending, and branch upon contact with motoneurons (MNs), their synaptic partners. We have identified WNT-3 as a candidate molecule that regulates this process. Wnt-3 is expressed by MNs of the lateral motor column at the time when MNs form synapses with sensory neurons. WNT-3 increases branching and growth cone size while inhibiting axonal extension in NT-3- but not NGF-responsive axons. Ventral spinal cord secretes factors with axonal remodeling activity for NT-3-responsive neurons. This activity is present at limb levels and is blocked by a WNT antagonist. We propose that WNT-3, expressed by MNs, acts as a retrograde signal that controls terminal arborization of muscle afferents.	Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SW7 AY, England; Kings Coll London, MRC, Ctr Dev Neurobiol, London SE1 1UL, England	Imperial College London; University of London; King's College London	Salinas, PC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SW7 AY, England.	p.salinas@ic.ac.uk	Herreros, Judit/B-5809-2009; Hughes, Simon M/S-1073-2016	Herreros, Judit/0000-0003-4200-0853; Hughes, Simon M/0000-0001-8227-9225; Salinas, Patricia C./0000-0002-5748-083X; Ehler, Elisabeth/0000-0001-5646-5964				ALTMAN J, 1984, ADV ANAT EMBRYOL CEL, V85, P1; Augsburger A, 1999, NEURON, V24, P127, DOI 10.1016/S0896-6273(00)80827-2; BRADLEY RS, 1993, J CELL BIOL, V123, P1857, DOI 10.1083/jcb.123.6.1857; Brose K, 2000, CURR OPIN NEUROBIOL, V10, P95, DOI 10.1016/S0959-4388(99)00066-5; Brown AG, 1981, ORG SPINAL CORD; Chen HH, 1999, CURR OPIN NEUROBIOL, V9, P405, DOI 10.1016/S0959-4388(99)80061-0; Chen SQ, 2001, J CELL BIOL, V152, P87, DOI 10.1083/jcb.152.1.87; CHIN LS, 1995, P NATL ACAD SCI USA, V92, P9230, DOI 10.1073/pnas.92.20.9230; Cook G, 1998, CURR OPIN NEUROBIOL, V8, P64, DOI 10.1016/S0959-4388(98)80009-3; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; Davenport RW, 1999, NAT NEUROSCI, V2, P254, DOI 10.1038/6360; Eide AL, 1997, ANAT EMBRYOL, V195, P237, DOI 10.1007/s004290050043; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; FAN JH, 1995, NEURON, V14, P263, DOI 10.1016/0896-6273(95)90284-8; FARINAS I, 1994, NATURE, V369, P658, DOI 10.1038/369658a0; Finch PW, 1997, P NATL ACAD SCI USA, V94, P6770, DOI 10.1073/pnas.94.13.6770; Giger RJ, 1996, J COMP NEUROL, V375, P378, DOI 10.1002/(SICI)1096-9861(19961118)375:3<378::AID-CNE3>3.0.CO;2-#; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; HORYLEE F, 1993, P NATL ACAD SCI USA, V90, P2613, DOI 10.1073/pnas.90.7.2613; Hughes SM, 1999, CURR OPIN NEUROBIOL, V9, P54, DOI 10.1016/S0959-4388(99)80007-5; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; KANDEL ER, 1991, PRINCIPLES NEURONAL; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; KLEIN R, 1994, NATURE, V368, P249, DOI 10.1038/368249a0; KLEITMAN N, 1991, CULTURING NERVE CELL, P351; KUDO N, 1987, J PHYSIOL-LONDON, V389, P441, DOI 10.1113/jphysiol.1987.sp016665; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P371, DOI 10.1113/jphysiol.1978.sp012545; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P391, DOI 10.1113/jphysiol.1978.sp012546; LAWSON SN, 1984, J COMP NEUROL, V228, P263, DOI 10.1002/cne.902280211; Lentz SI, 1999, J NEUROSCI, V19, P1038; LIGHT AR, 1979, J COMP NEUROL, V186, P117, DOI 10.1002/cne.901860202; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Lucas FR, 1997, DEV BIOL, V192, P31, DOI 10.1006/dbio.1997.8734; LUO YL, 1995, NEURON, V14, P1131, DOI 10.1016/0896-6273(95)90261-9; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; MIMICS K, 1995, J COMP NEUROL, V355, P601; MU XJ, 1993, J NEUROSCI, V13, P4029; Mueller BK, 1999, ANNU REV NEUROSCI, V22, P351, DOI 10.1146/annurev.neuro.22.1.351; O'Leary DDM, 1999, CURR OPIN NEUROBIOL, V9, P65, DOI 10.1016/S0959-4388(99)80008-7; Ozaki S, 1997, J COMP NEUROL, V380, P215; Perrin JM, 2001, AMBUL PEDIATR, V1, P1; PERRY MJ, 1991, J NEUROCYTOL, V20, P746, DOI 10.1007/BF01187848; Pfaff S, 1998, CURR OPIN NEUROBIOL, V8, P27, DOI 10.1016/S0959-4388(98)80005-6; Price SR, 2002, CELL, V109, P205, DOI 10.1016/S0092-8674(02)00695-5; PUSCHEL AW, 1995, NEURON, V14, P941, DOI 10.1016/0896-6273(95)90332-1; Rattner A, 1997, P NATL ACAD SCI USA, V94, P2859, DOI 10.1073/pnas.94.7.2859; ROELINK H, 1991, GENE DEV, V5, P381, DOI 10.1101/gad.5.3.381; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; RUIT KG, 1992, NEURON, V8, P573, DOI 10.1016/0896-6273(92)90284-K; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Sharma K, 1998, DEVELOPMENT, V125, P635; Shepherd IT, 1997, DEVELOPMENT, V124, P1377; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; Snider WD, 1996, NEURON, V16, P229, DOI 10.1016/S0896-6273(00)80039-2; SNIDER WD, 1992, J NEUROSCI, V12, P3494; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; Szebenyi G, 2001, J NEUROSCI, V21, P3932, DOI 10.1523/JNEUROSCI.21-11-03932.2001; Tao HZW, 2001, P NATL ACAD SCI USA, V98, P11009, DOI 10.1073/pnas.191351698; TESSAROLLO L, 1994, P NATL ACAD SCI USA, V91, P11844, DOI 10.1073/pnas.91.25.11844; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Windle WF, 1936, J COMP NEUROL, V63, P189, DOI 10.1002/cne.900630203; Wright DE, 1997, NEURON, V19, P503, DOI 10.1016/S0896-6273(00)80367-0; WRIGHT DE, 1995, J COMP NEUROL, V361, P321, DOI 10.1002/cne.903610209; Yagi T, 2000, GENE DEV, V14, P1169; ZHANG L, 1994, J NEUROSCI, V14, P5187	68	157	163	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 12	2002	35	6					1043	1056		10.1016/S0896-6273(02)00860-7	http://dx.doi.org/10.1016/S0896-6273(02)00860-7			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	594GC	12354395	Bronze			2022-12-24	WOS:000178040000006
J	Raoul, C; Estevez, AG; Nishimune, H; Cleveland, DW; deLapeyriere, O; Henderson, CE; Haase, G; Pettmann, B				Raoul, C; Estevez, AG; Nishimune, H; Cleveland, DW; deLapeyriere, O; Henderson, CE; Haase, G; Pettmann, B			Motoneuron death triggered by a specific pathway downstream of Fas: Potentiation by ALS-linked SOD1 mutations	NEURON			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; NITRIC-OXIDE SYNTHASE; SIGNAL-REGULATING KINASE; TRANSGENIC MOUSE MODEL; CU/ZN SUPEROXIDE-DISMUTASE; TROPHIC FACTOR DEPRIVATION; NEURONAL CELL-DEATH; IN-VITRO; NECROSIS-FACTOR; C-JUN	Death pathways restricted to specific neuronal classes could potentially allow for precise control of developmental neuronal death and also underlie the selectivity of neuronal loss in neurodegenerative disease. We show that Fas-triggered death of normal embryonic motoneurons requires transcriptional upregulation of neuronal NOS and involves Daxx, ASK1, and p38 together with the classical FADD/caspase-8 cascade. No evidence for involvement of this pathway was found in cells other than motoneurons. Motoneurons from transgenic mice overexpressing ALS-linked SOD1 mutants (G37R, G85R, or G93A) displayed increased susceptibility to activation of this pathway: they were more sensitive to Fas- or NO-triggered cell death but not to trophic deprivation or excitotoxic stimulation. Thus, triggering of a motoneuron-restricted cell death pathway by neighboring cells might contribute to motoneuron loss in ALS.	Univ Mediterranee, Dev Biol Inst Marseille, CNRS, INSERM,U382, F-13288 Marseille 09, France; Univ Alabama Birmingham, Ctr Free Rad Biol, Dept Physiol & Biophys, Birmingham, AL 35294 USA; Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of Alabama System; University of Alabama Birmingham; Ludwig Institute for Cancer Research; University of California System; University of California San Diego	Henderson, CE (corresponding author), Univ Mediterranee, Dev Biol Inst Marseille, CNRS, INSERM,U382, Campus Luminy,Case 907, F-13288 Marseille 09, France.	chris@ibdm.univ-mrs.fr	Cleveland, Don/AAN-9783-2021; Raoul, Cedric/H-6517-2016; Nishimune, Hiroshi/B-7226-2013	Raoul, Cedric/0000-0003-0561-6851; Cleveland, Don/0000-0002-1934-3682; Henderson, Christopher/0000-0002-9936-3279				ADACHI M, 1995, NAT GENET, V11, P294, DOI 10.1038/ng1195-294; Almer G, 1999, J NEUROCHEM, V72, P2415, DOI 10.1046/j.1471-4159.1999.0722415.x; Anneser JMH, 2001, EXP NEUROL, V171, P418, DOI 10.1006/exnr.2001.7756; Arce V, 1999, J NEUROSCI RES, V55, P119, DOI 10.1002/(SICI)1097-4547(19990101)55:1<119::AID-JNR13>3.3.CO;2-Y; Babu BR, 1998, CURR OPIN CHEM BIOL, V2, P491, DOI 10.1016/S1367-5931(98)80125-7; Barker V, 2001, NAT NEUROSCI, V4, P1194, DOI 10.1038/nn755; Beckman JS, 2001, TRENDS NEUROSCI, V24, pS15, DOI 10.1016/S0166-2236(00)01981-0; BECKMANN JS, 1994, BIOL CHEM H-S, V375, P81, DOI 10.1515/bchm3.1994.375.2.81; Bonny C, 2001, DIABETES, V50, P77, DOI 10.2337/diabetes.50.1.77; Borasio GD, 1998, NEUROREPORT, V9, P1435, DOI 10.1097/00001756-199805110-00034; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Catania MV, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-11-j0002.2001; Chang HY, 1998, SCIENCE, V281, P1860, DOI 10.1126/science.281.5384.1860; Cheema ZF, 1999, J NEUROSCI, V19, P1754; Ciesielski-Treska J, 2001, J BIOL CHEM, V276, P13113, DOI 10.1074/jbc.M009711200; Ciriolo MR, 2000, J BIOL CHEM, V275, P5065, DOI 10.1074/jbc.275.7.5065; Cisterni C, 2001, NEUROBIOL DIS, V8, P240, DOI 10.1006/nbdi.2000.0374; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; DaSilva J, 1997, J BIOL CHEM, V272, P28373, DOI 10.1074/jbc.272.45.28373; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; Durham HD, 1997, J NEUROPATH EXP NEUR, V56, P523, DOI 10.1097/00005072-199705000-00008; Estevez AG, 1998, PROG BRAIN RES, V118, P269; Estevez AG, 1998, J NEUROSCI, V18, P923; Estevez AG, 1999, SCIENCE, V286, P2498, DOI 10.1126/science.286.5449.2498; Facchinetti F, 1999, NEUROSCIENCE, V90, P1483, DOI 10.1016/S0306-4522(98)00492-8; FAULKNER KM, 1994, J BIOL CHEM, V269, P23471; Fisher GH, 1996, CELL IMMUNOL, V169, P99, DOI 10.1006/cimm.1996.0096; Frade JM, 1998, NEURON, V20, P35, DOI 10.1016/S0896-6273(00)80432-8; Frey D, 2000, J NEUROSCI, V20, P2534; Ghadge GD, 1997, J NEUROSCI, V17, P8756; Gong YH, 2000, J NEUROSCI, V20, P660, DOI 10.1523/JNEUROSCI.20-02-00660.2000; Green D, 1998, TRENDS CELL BIOL, V8, P267, DOI 10.1016/S0962-8924(98)01273-2; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; HANDY RLC, 1995, BRIT J PHARMACOL, V116, P2349, DOI 10.1111/j.1476-5381.1995.tb15078.x; Harper SJ, 2001, CELL SIGNAL, V13, P299, DOI 10.1016/S0898-6568(01)00148-6; Henderson C.E., 1995, NERVE CELL CULTURE P, P69; Herdegen T, 1998, J NEUROSCI, V18, P5124, DOI 10.1523/JNEUROSCI.18-14-05124.1998; Julien JP, 2001, CELL, V104, P581, DOI 10.1016/S0092-8674(01)00244-6; Kanamoto T, 2000, MOL CELL BIOL, V20, P196, DOI 10.1128/MCB.20.1.196-204.2000; Kennel PF, 1996, NEUROREPORT, V7, P1427, DOI 10.1097/00001756-199605310-00021; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Kostic V, 1997, SCIENCE, V277, P559, DOI 10.1126/science.277.5325.559; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Le-Niculescu H, 1999, MOL CELL BIOL, V19, P751; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li MW, 2000, SCIENCE, V288, P335, DOI 10.1126/science.288.5464.335; Lino MM, 2002, J NEUROSCI, V22, P4825, DOI 10.1523/JNEUROSCI.22-12-04825.2002; Lowry KS, 2001, AMYOTROPH LATERAL SC, V2, P127, DOI 10.1080/146608201753275463; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; MANTHORPE M, 1986, DEV BRAIN RES, V25, P191, DOI 10.1016/0165-3806(86)90208-7; Maroney AC, 1998, J NEUROSCI, V18, P104; Martin-Villalba A, 1999, J NEUROSCI, V19, P3809; Matsushita K, 2000, J NEUROSCI, V20, P6879, DOI 10.1523/JNEUROSCI.20-18-06879.2000; MATSUYAMA T, 1995, MOL BRAIN RES, V34, P166, DOI 10.1016/0169-328X(95)00162-L; Michaelson JS, 1999, GENE DEV, V13, P1918, DOI 10.1101/gad.13.15.1918; Mielke K, 2000, PROG NEUROBIOL, V61, P45, DOI 10.1016/S0301-0082(99)00042-8; Migheli A, 1999, NAT MED, V5, P966, DOI 10.1038/12381; MIGHELI A, 1994, J NEUROPATH EXP NEUR, V53, P606, DOI 10.1097/00005072-199411000-00008; Morishima Y, 2001, J NEUROSCI, V21, P7551, DOI 10.1523/JNEUROSCI.21-19-07551.2001; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Northington FJ, 2001, J NEUROSCI, V21, P1931, DOI 10.1523/JNEUROSCI.21-06-01931.2001; OGASAWARA J, 1995, J EXP MED, V181, P485, DOI 10.1084/jem.181.2.485; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Pasinelli P, 2000, P NATL ACAD SCI USA, V97, P13901, DOI 10.1073/pnas.240305897; Paul A, 1997, CELL SIGNAL, V9, P403, DOI 10.1016/S0898-6568(97)00042-9; Pettmann B, 1991, Growth Factors, V5, P209, DOI 10.3109/08977199109000285; Pettmann B, 1998, NEURON, V20, P633, DOI 10.1016/S0896-6273(00)81004-1; Pramatarova A, 2001, J NEUROSCI, V21, P3369, DOI 10.1523/JNEUROSCI.21-10-03369.2001; RABIZADEH S, 1995, P NATL ACAD SCI USA, V92, P3024, DOI 10.1073/pnas.92.7.3024; Raoul C, 1999, J CELL BIOL, V147, P1049, DOI 10.1083/jcb.147.5.1049; Raoul C, 2000, CURR OPIN NEUROBIOL, V10, P111, DOI 10.1016/S0959-4388(99)00055-0; Reiter CD, 2000, J BIOL CHEM, V275, P32460, DOI 10.1074/jbc.M910433199; Robertson J, 2001, J CELL BIOL, V155, P217, DOI 10.1083/jcb.200107058; ROTHSTEIN JD, 1995, ADV NEUROL, V68, P7; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Sasaki M, 2000, P NATL ACAD SCI USA, V97, P8617, DOI 10.1073/pnas.97.15.8617; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Scaffidi C, 1999, J BIOL CHEM, V274, P22532, DOI 10.1074/jbc.274.32.22532; Shaw PJ, 2000, J NEUROL, V247, P17; Srinivasan A, 1998, CELL DEATH DIFFER, V5, P1004, DOI 10.1038/sj.cdd.4400449; Srinivasan A, 1998, J BIOL CHEM, V273, P4523, DOI 10.1074/jbc.273.8.4523; Tan Y, 1996, EMBO J, V15, P4629, DOI 10.1002/j.1460-2075.1996.tb00840.x; Terrado J, 2000, EUR J NEUROSCI, V12, P3443, DOI 10.1046/j.1460-9568.2000.00240.x; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Upton-Rice MN, 1999, ANN NEUROL, V45, P413, DOI 10.1002/1531-8249(199903)45:3<413::AID-ANA24>3.0.CO;2-5; VARON S, 1981, DEV BRAIN RES, V1, P73, DOI 10.1016/0165-3806(81)90095-X; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Yang XL, 1997, CELL, V89, P1067, DOI 10.1016/S0092-8674(00)80294-9; Yi FH, 2000, J NEUROIMMUNOL, V109, P211, DOI 10.1016/S0165-5728(00)00288-5; Zhang HQ, 1997, J MED CHEM, V40, P3869, DOI 10.1021/jm970550g	92	340	360	2	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 12	2002	35	6					1067	1083		10.1016/S0896-6273(02)00905-4	http://dx.doi.org/10.1016/S0896-6273(02)00905-4			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	594GC	12354397	Bronze			2022-12-24	WOS:000178040000008
J	Pirvola, U; Ylikoski, J; Trokovic, R; Hebert, JM; McConnell, SK; Partanen, J				Pirvola, U; Ylikoski, J; Trokovic, R; Hebert, JM; McConnell, SK; Partanen, J			FGFR1 is required for the development of the auditory sensory epithelium	NEURON			English	Article							FIBROBLAST-GROWTH-FACTOR; NEURAL STEM-CELLS; INNER-EAR; HAIR-CELLS; PROLIFERATION; GENE; MORPHOGENESIS; RECOMBINATION; TELENCEPHALON; DROSOPHILA	The mammalian auditory sensory epithelium, the organ of Corti, comprises the hair cells and supporting cells that are pivotal for hearing function. The origin and development of their precursors are poorly understood. Here we show that loss-of-function mutations in mouse fibroblast growth factor receptor 1 (Fgfr1) cause a dose-dependent disruption of the organ of Corti. Full inactivation of Fgfr1 in the inner ear epithelium by Foxg1-Cre-mediated deletion leads to an 85% reduction in the number of auditory hair cells. The primary cause appears to be reduced precursor cell proliferation in the early cochlear duct. Thus, during development, FGFR1 is required for the generation of the precursor pool, which gives rise to the auditory sensory epithelium. Our data also suggest that FGFR1 might have a distinct later role in intercellular signaling within the differentiating auditory sensory epithelium.	Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland; Univ Helsinki, Dept Otolaryngol, FIN-00014 Helsinki, Finland; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	University of Helsinki; University of Helsinki; Stanford University	Pirvola, U (corresponding author), Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland.	ulla.pirvola@helsinki.fi	Trokovic, Ras/AAC-7309-2022	Trokovic, Ras/0000-0002-3065-6663; Partanen, Juha/0000-0001-8850-4825				Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Chen P, 1999, DEVELOPMENT, V126, P1581; Colvin JS, 1996, NAT GENET, V12, P390, DOI 10.1038/ng0496-390; DENG CX, 1994, GENE DEV, V8, P3045, DOI 10.1101/gad.8.24.3045; Doetsch F, 2002, J NEUROSCI, V22, P2255, DOI 10.1523/JNEUROSCI.22-06-02255.2002; Eddison M, 2000, P NATL ACAD SCI USA, V97, P11692, DOI 10.1073/pnas.97.22.11692; Fekete DM, 1998, J NEUROSCI, V18, P7811; Freeman M, 1997, DEVELOPMENT, V124, P261; Fritzsch B, 1997, J NEUROSCI, V17, P6213; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Hadjantonakis AK, 1998, NAT GENET, V19, P220, DOI 10.1038/896; Hebert JM, 2000, DEV BIOL, V222, P296, DOI 10.1006/dbio.2000.9732; Igarashi M, 1998, J BIOL CHEM, V273, P13230, DOI 10.1074/jbc.273.21.13230; Ladher RK, 2000, SCIENCE, V290, P1965, DOI 10.1126/science.290.5498.1965; LIM DJ, 1985, ACTA OTO-LARYNGOL, P1; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Lowenheim H, 1999, P NATL ACAD SCI USA, V96, P4084, DOI 10.1073/pnas.96.7.4084; Lu WQ, 1999, J BIOL CHEM, V274, P12827, DOI 10.1074/jbc.274.18.12827; Ma QF, 2000, JARO-J ASSOC RES OTO, V1, P129, DOI 10.1007/s101620010017; MANSOUR SL, 1993, DEVELOPMENT, V117, P13; Martens DJ, 2000, J NEUROSCI, V20, P1085, DOI 10.1523/JNEUROSCI.20-03-01085.2000; Partanen J, 1998, GENE DEV, V12, P2332, DOI 10.1101/gad.12.15.2332; PETERS K, 1993, DEV BIOL, V155, P423, DOI 10.1006/dbio.1993.1040; Phillips BT, 2001, DEV BIOL, V235, P351, DOI 10.1006/dbio.2001.0297; Pirvola U, 2000, J NEUROSCI, V20, P6125, DOI 10.1523/JNEUROSCI.20-16-06125.2000; PIRVOLA U, 1992, P NATL ACAD SCI USA, V89, P9915, DOI 10.1073/pnas.89.20.9915; Ruben R.J., 1967, ACTA OTO-LARYNGOL, DOI DOI 10.3109/00016486709127790; TAN SS, 1993, NAT GENET, V3, P170, DOI 10.1038/ng0293-170; Tropepe V, 2000, SCIENCE, V287, P2032, DOI 10.1126/science.287.5460.2032; Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192; Vaccarino FM, 1999, NAT NEUROSCI, V2, P246, DOI 10.1038/6350; Vendrell V, 2000, DEVELOPMENT, V127, P2011; VONBARTHELD CS, 1991, DEVELOPMENT, V113, P455; WERNER S, 1992, MOL CELL BIOL, V12, P82, DOI 10.1128/MCB.12.1.82; Wilkinson D. G., 1990, POSTIMPLANTATION MAM, P155; YAMAGUCHI TP, 1994, GENE DEV, V8, P3032, DOI 10.1101/gad.8.24.3032	36	217	227	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 15	2002	35	4					671	680		10.1016/S0896-6273(02)00824-3	http://dx.doi.org/10.1016/S0896-6273(02)00824-3			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	585JE	12194867	Green Submitted, Bronze			2022-12-24	WOS:000177521000008
J	Carlson, G; Wang, Y; Alger, BE				Carlson, G; Wang, Y; Alger, BE			Endocannabinoids facilitate the induction of LTP in the hippocampus	NATURE NEUROSCIENCE			English	Article							DEPOLARIZATION-INDUCED SUPPRESSION; PYRAMIDAL CELLS; CANNABINOIDS; INHIBITION; GABA; POTENTIATION; TERMINALS; NEURONS		Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Alger, BE (corresponding author), Univ Maryland, Sch Med, Dept Physiol, 655 W Baltimore St, Baltimore, MD 21201 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036612, R01NS030219] Funding Source: NIH RePORTER; NINDS NIH HHS [NS30219, NS36612] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Di Marzo V, 1998, TRENDS NEUROSCI, V21, P521, DOI 10.1016/S0166-2236(98)01283-1; Ekstrom AD, 2001, NEURON, V31, P631, DOI 10.1016/S0896-6273(01)00401-9; Hajos N, 2001, NEUROSCIENCE, V106, P1, DOI 10.1016/S0306-4522(01)00287-1; KANDEL ER, 1961, J NEUROPHYSIOL, V24, P243, DOI 10.1152/jn.1961.24.3.243; Katona I, 1999, J NEUROSCI, V19, P4544; Le Beau FEN, 1998, J NEUROPHYSIOL, V79, P659, DOI 10.1152/jn.1998.79.2.659; Lenz RA, 1999, J PHYSIOL-LONDON, V521, P147, DOI 10.1111/j.1469-7793.1999.00147.x; LLANO I, 1991, NEURON, V6, P565, DOI 10.1016/0896-6273(91)90059-9; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; PITLER TA, 1992, J NEUROSCI, V12, P4122; Sullivan JM, 2000, LEARN MEMORY, V7, P132, DOI 10.1101/lm.7.3.132; Wagner JJ, 1996, J PHYSIOL-LONDON, V495, P107, DOI 10.1113/jphysiol.1996.sp021577; WIGSTROM H, 1985, ACTA PHYSIOL SCAND, V125, P159, DOI 10.1111/j.1748-1716.1985.tb07703.x; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076	15	240	247	0	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2002	5	8					723	724		10.1038/nn879	http://dx.doi.org/10.1038/nn879			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	577XT	12080342				2022-12-24	WOS:000177088900011
J	Murase, S; Mosser, E; Schuman, EM				Murase, S; Mosser, E; Schuman, EM			Depolarization drives beta-catenin into neuronal spines promoting changes in synaptic structure and function	NEURON			English	Article							CELL-CELL-ADHESION; PROTEIN-TYROSINE-PHOSPHATASE; LONG-TERM POTENTIATION; TUMOR-SUPPRESSOR PROTEIN; N-CADHERIN; ALPHA-CATENIN; POSTSYNAPTIC DENSITIES; COMPLEX-FORMATION; DENDRITIC SPINES; SILENT SYNAPSES	Activity-induced changes in adhesion molecules may coordinate presynaptic and postsynaptic plasticity. Here, we demonstrate that beta-catenin, which mediates interactions between cadherins and the actin cytoskeleton, moves from dendritic shafts into spines upon depolarization, increasing its association with cadherins. beta-catenin's redistribution was mimicked or prevented by a tyrosine kinase or phosphatase inhibitor, respectively. Point mutations of beta-catenin's tyrosine 654 altered the shaft/spine distribution: Y654F-beta-catenin-GFP (phosphorylation-prevented) was concentrated in spines, whereas Y654E-beta-catenin-GFP (phosphorylation-mimic) accumulated in dendritic shafts. In Y654F-expressing neurons, the PSD-95 or associated synapsin-I clusters were larger than those observed in either wild-type-beta-catenin or also Y654E-expressing neurons. Y654F-expressing neurons exhibited a higher minifrequency. Thus, neural activity induces beta-catenin's redistribution into spines, where it interacts with cadherin to influence synaptic size and strength.	CALTECH, Howard Hughes Med Inst, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute	Schuman, EM (corresponding author), CALTECH, Howard Hughes Med Inst, Div Biol, 216-76,1200 E Calif Blvd, Pasadena, CA 91125 USA.		Murase, Sachiko/AAC-5496-2022; Schuman, Erin M/D-6204-2011	Murase, Sachiko/0000-0002-9078-0471; 				Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Adams CL, 1996, J CELL BIOL, V135, P1899, DOI 10.1083/jcb.135.6.1899; Antonova I, 2001, SCIENCE, V294, P1547, DOI 10.1126/science.1066273; Balsamo J, 1998, J CELL BIOL, V143, P523, DOI 10.1083/jcb.143.2.523; Barth AIM, 1997, J CELL BIOL, V136, P693, DOI 10.1083/jcb.136.3.693; BEESLEY PW, 1995, J NEUROCHEM, V64, P2288; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; BEHRENS J, 1993, J CELL BIOL, V120, P757, DOI 10.1083/jcb.120.3.757; Bonvini P, 2001, CANCER RES, V61, P1671; Bozdagi O, 2000, NEURON, V28, P245, DOI 10.1016/S0896-6273(00)00100-8; Chavis P, 2001, NATURE, V411, P317, DOI 10.1038/35077101; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Choi S, 2000, NAT NEUROSCI, V3, P330, DOI 10.1038/73895; COHEN RS, 1977, J CELL BIOL, V74, P181, DOI 10.1083/jcb.74.1.181; DECAMILLI P, 1983, J CELL BIOL, V96, P1355, DOI 10.1083/jcb.96.5.1355; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; FATT P, 1952, J PHYSIOL-LONDON, V117, P109; Fuchs M, 1996, J BIOL CHEM, V271, P16712, DOI 10.1074/jbc.271.28.16712; Gasparini S, 2000, P NATL ACAD SCI USA, V97, P9741, DOI 10.1073/pnas.170032297; HAMAGUCHI M, 1993, EMBO J, V12, P307, DOI 10.1002/j.1460-2075.1993.tb05658.x; HARRIS KM, 1989, J NEUROSCI, V9, P2982; HARRIS KM, 1988, J NEUROSCI, V8, P4455; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Hazan RB, 1998, J BIOL CHEM, V273, P9078, DOI 10.1074/jbc.273.15.9078; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; HIRANO S, 1992, CELL, V70, P293, DOI 10.1016/0092-8674(92)90103-J; Honjo Y, 2000, GENES CELLS, V5, P309, DOI 10.1046/j.1365-2443.2000.00327.x; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Kaufmann N, 2002, NEURON, V34, P27, DOI 10.1016/S0896-6273(02)00643-8; Kypta RM, 1996, J CELL BIOL, V134, P1519, DOI 10.1083/jcb.134.6.1519; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; Manabe T, 2000, MOL CELL NEUROSCI, V15, P534, DOI 10.1006/mcne.2000.0849; MATSUYOSHI N, 1992, J CELL BIOL, V118, P703, DOI 10.1083/jcb.118.3.703; MEFFERT MK, 1994, NEURON, V12, P1235, DOI 10.1016/0896-6273(94)90440-5; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Montgomery JM, 2001, NEURON, V29, P691, DOI 10.1016/S0896-6273(01)00244-6; Muller T, 1999, J BIOL CHEM, V274, P10173, DOI 10.1074/jbc.274.15.10173; Munemitsu S, 1996, MOL CELL BIOL, V16, P4088; Murase S, 1999, CURR OPIN CELL BIOL, V11, P549, DOI 10.1016/S0955-0674(99)00019-8; NAGAFUCHI A, 1994, J CELL BIOL, V127, P235, DOI 10.1083/jcb.127.1.235; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; Ozawa M, 1998, J BIOL CHEM, V273, P6166, DOI 10.1074/jbc.273.11.6166; OZAWA M, 1990, P NATL ACAD SCI USA, V87, P4246, DOI 10.1073/pnas.87.11.4246; Pathre P, 2001, J NEUROSCI RES, V63, P143, DOI 10.1002/1097-4547(20010115)63:2<143::AID-JNR1006>3.0.CO;2-1; Phillips GR, 2001, NEURON, V32, P63, DOI 10.1016/S0896-6273(01)00450-0; Renger JJ, 2001, NEURON, V29, P469, DOI 10.1016/S0896-6273(01)00219-7; Roura S, 1999, J BIOL CHEM, V274, P36734, DOI 10.1074/jbc.274.51.36734; Ryan TA, 1997, NATURE, V388, P478, DOI 10.1038/41335; Schikorski T, 1999, P NATL ACAD SCI USA, V96, P4107, DOI 10.1073/pnas.96.7.4107; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; SOMMERS CL, 1994, CANCER RES, V54, P3544; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237; Tamura K, 1998, NEURON, V20, P1153, DOI 10.1016/S0896-6273(00)80496-1; Tang LX, 1998, NEURON, V20, P1165, DOI 10.1016/S0896-6273(00)80497-3; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; Wyszynski M, 2002, NEURON, V34, P39, DOI 10.1016/S0896-6273(02)00640-2	60	282	289	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 3	2002	35	1					91	105		10.1016/S0896-6273(02)00764-X	http://dx.doi.org/10.1016/S0896-6273(02)00764-X			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	569KP	12123611	Bronze			2022-12-24	WOS:000176601800013
J	Giasson, BI; Duda, JE; Quinn, SM; Zhang, B; Trojanowski, JQ; Lee, VMY				Giasson, BI; Duda, JE; Quinn, SM; Zhang, B; Trojanowski, JQ; Lee, VMY			Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein	NEURON			English	Article							MULTIPLE SYSTEM ATROPHY; PERIPHERAL NERVOUS-SYSTEM; CORTICAL LEWY BODIES; PARKINSONS-DISEASE; TRANSGENIC MICE; ALZHEIMERS-DISEASE; PROTEIN DOMAINS; MOUSE MODEL; WILD-TYPE; NEUROPATHOLOGY	alpha-Synucleinopathies are neurodegenerative disorders that range pathologically from the demise of select groups of nuclei to pervasive degeneration throughout the neuraxis. Although mounting evidence suggests that alpha-synuclein lesions lead to neurodegeneration, this remains controversial. To explore this issue, we generated transgenic mice expressing wild-type and A53T human alpha-synuclein in CNS neurons. Mice expressing mutant, but not wild-type, alpha-synuclein developed a severe and complex motor impairment leading to paralysis and death. These animals developed age-dependent intracytoplasmic neuronal alpha-synuclein inclusions paralleling disease onset, and the alpha-synuclein inclusions recapitulated features of human counterparts. Moreover, immunoelectron microscopy revealed that the alpha-synuclein inclusions contained 10-16 nm wide fibrils similar to human pathological inclusions. These mice demonstrate that A53T alpha-synuclein leads to the formation of toxic filamentous alpha-synuclein neuronal inclusions that cause neurodegeneration.	Univ Penn, Sch Med, Dept Pathol & Lab Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA; Philadelphia Vet Adm Hosp, Parkinsons Dis Res Educ & Clin Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Lee, VMY (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Ctr Neurodegenerat Dis Res, 3600 Spruce St, Philadelphia, PA 19104 USA.							Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Baba M, 1998, AM J PATHOL, V152, P879; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; COTE F, 1993, CELL, V73, P35, DOI 10.1016/0092-8674(93)90158-M; deRijk MC, 1997, J NEUROL NEUROSUR PS, V62, P10, DOI 10.1136/jnnp.62.1.10; Dickson DW, 1999, AM J PATHOL, V155, P1241, DOI 10.1016/S0002-9440(10)65226-1; Duda JE, 2000, J NEUROPATH EXP NEUR, V59, P830, DOI 10.1093/jnen/59.9.830; DUDA JE, 2002, IN PRESS ANN NEUROL; DUDA JE, 2002, IN PRESS ACTA NEUROP; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Forno LS, 1996, J NEUROPATH EXP NEUR, V55, P259, DOI 10.1097/00005072-199603000-00001; Galvin JE, 2000, AM J PATHOL, V157, P361, DOI 10.1016/S0002-9440(10)64548-8; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Giasson BI, 2000, J NEUROSCI RES, V59, P528, DOI 10.1002/(SICI)1097-4547(20000215)59:4<528::AID-JNR8>3.0.CO;2-0; Giasson BI, 1999, J BIOL CHEM, V274, P7619, DOI 10.1074/jbc.274.12.7619; Giasson BI, 2001, EXP NEUROL, V172, P354, DOI 10.1006/exnr.2001.7805; Golbe LI, 1999, MOVEMENT DISORD, V14, P6, DOI 10.1002/1531-8257(199901)14:1<6::AID-MDS1004>3.0.CO;2-L; Golbe LI, 1996, ANN NEUROL, V40, P767, DOI 10.1002/ana.410400513; Hsu LJ, 1998, J NEUROCHEM, V71, P338; Hurtig HI, 2000, NEUROLOGY, V54, P1916, DOI 10.1212/WNL.54.10.1916; Ishihara T, 1999, NEURON, V24, P751, DOI 10.1016/S0896-6273(00)81127-7; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Kahle PJ, 2000, J NEUROSCI, V20, P6365, DOI 10.1523/JNEUROSCI.20-17-06365.2000; LEE MK, 1994, NEURON, V13, P975, DOI 10.1016/0896-6273(94)90263-1; Lee MK, 1996, ANNU REV NEUROSCI, V19, P187, DOI 10.1146/annurev.ne.19.030196.001155; LOVE S, 1992, NEUROPATH APPL NEURO, V18, P585, DOI 10.1111/j.1365-2990.1992.tb00830.x; Masliah E, 2001, P NATL ACAD SCI USA, V98, P12245, DOI 10.1073/pnas.211412398; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Matsuoka Y, 2001, NEUROBIOL DIS, V8, P535, DOI 10.1006/nbdi.2001.0392; Mattila PM, 2000, ACTA NEUROPATHOL, V100, P285, DOI 10.1007/s004019900168; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Paxinou E, 2001, J NEUROSCI, V21, P8053, DOI 10.1523/JNEUROSCI.21-20-08053.2001; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; RODRIGUEZ EM, 1984, HISTOCHEMISTRY, V81, P253, DOI 10.1007/BF00495636; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; SCHMIDT ML, 1991, AM J PATHOL, V139, P53; Shoji M, 2000, J NEUROL NEUROSUR PS, V68, P605, DOI 10.1136/jnnp.68.5.605; SIMUNI T, 2000, NEURODEGENERATIVE DE, P193; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Spira PJ, 2001, ANN NEUROL, V49, P313, DOI 10.1002/ana.67; TROJANOWSKI JQ, 1989, J HISTOCHEM CYTOCHEM, V37, P209, DOI 10.1177/37.2.2492045; Tu PH, 1998, ANN NEUROL, V44, P415, DOI 10.1002/ana.410440324; van der Putten H, 2000, J NEUROSCI, V20, P6021, DOI 10.1523/JNEUROSCI.20-16-06021.2000; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6	49	875	911	1	42	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 16	2002	34	4					521	533		10.1016/S0896-6273(02)00682-7	http://dx.doi.org/10.1016/S0896-6273(02)00682-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	553FT	12062037	Bronze			2022-12-24	WOS:000175665700007
J	Jackson, GR; Wiedau-Pazos, M; Sang, TK; Wagle, N; Brown, CA; Massachi, S; Geschwind, DH				Jackson, GR; Wiedau-Pazos, M; Sang, TK; Wagle, N; Brown, CA; Massachi, S; Geschwind, DH			Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila	NEURON			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; PAIRED HELICAL FILAMENTS; DISEASE-LIKE PHOSPHORYLATION; NUCLEAR LAMIN ISOFORMS; HUMAN BRAIN-TAU; ALZHEIMERS-DISEASE; BETA-CATENIN; NEURONAL APOPTOSIS; PROTEIN-KINASE; NEURODEGENERATIVE DISEASES	Pathologic alterations in the microtubule-associated protein tau have been implicated in a number of neurodegenerative disorders, including Alzheimer's disease (AD), progressive supranuclear palsy (PSP), and frontotemporal dementia (FTD). Here, we show that tau overexpression, in combination with phosphorylation by the Drosophila glycogen synthase kinase-3 (GSK-3) homolog and wingless pathway component (Shaggy), exacerbated neurodegeneration induced by tau overexpression alone, leading to neurofibrillary pathology in the fly. Furthermore, manipulation of other wingless signaling molecules downstream from shaggy demonstrated that components of the Wnt signaling pathway modulate neurodegeneration induced by tau pathology in vivo but suggested that tau phosphorylation by GSK-3beta differs from canonical Wnt effects on beta-catenin stability and TCF activity. The genetic system we have established provides a powerful reagent for identification of novel modifiers of tau-induced neurodegeneration that may serve as future therapeutic targets.	Univ Calif Los Angeles, Sch Med, Dept Neurol, Neurogenet Program, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Jackson, GR (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Neurol, Neurogenet Program, 710 Westwood Plaza, Los Angeles, CA 90095 USA.	grjackson@mednet.ucla.edu	Wagle, Nikhil/Q-7428-2019	Sang, Tzu-Kang/0000-0001-7924-9359				Ahmed Y, 1998, CELL, V93, P1171, DOI 10.1016/S0092-8674(00)81461-0; Anderton BH, 2000, MOL MED TODAY, V6, P54, DOI 10.1016/S1357-4310(99)01640-8; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; BRAAK H, 1994, NEUROBIOL AGING, V15, P355, DOI 10.1016/0197-4580(94)90032-9; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brion JP, 2001, BIOCHEM SOC SYMP, V67, P81; BRUNNER D, 1994, NATURE, V370, P386, DOI 10.1038/370386a0; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Clark LN, 1998, P NATL ACAD SCI USA, V95, P13103, DOI 10.1073/pnas.95.22.13103; CROWTHER RA, 1991, P NATL ACAD SCI USA, V88, P2288, DOI 10.1073/pnas.88.6.2288; CROWTHER RA, 1992, FEBS LETT, V309, P199, DOI 10.1016/0014-5793(92)81094-3; Dale TC, 1998, BIOCHEM J, V329, P209; Elyaman W, 2002, EUR J NEUROSCI, V15, P651, DOI 10.1046/j.1460-9568.2002.01899.x; Fan SS, 1997, DEVELOPMENT, V124, P1497; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Fortini ME, 2000, TRENDS GENET, V16, P161, DOI 10.1016/S0168-9525(99)01939-3; Freeman M, 2001, EMBO REP, V2, P157, DOI 10.1093/embo-reports/kve019; Furukawa K, 2000, NEUROREPORT, V11, P57, DOI 10.1097/00001756-200001170-00011; Geschwind DH, 2001, AM J MED GENET, V101, P370; Geschwind DH, 2001, ANN NEUROL, V50, P741, DOI 10.1002/ana.10024; Godemann R, 1999, FEBS LETT, V454, P157, DOI 10.1016/S0014-5793(99)00741-3; Goedert M, 1998, NEURON, V21, P955, DOI 10.1016/S0896-6273(00)80615-7; Goedert M, 2000, ANN NY ACAD SCI, V920, P74; GOEDERT M, 1992, NEURON, V8, P159, DOI 10.1016/0896-6273(92)90117-V; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Greaves S, 1999, GENETICS, V153, P1753; HANGER DP, 1992, NEUROSCI LETT, V147, P58, DOI 10.1016/0304-3940(92)90774-2; Hasegawa S, 2002, P NATL ACAD SCI USA, V99, P297, DOI 10.1073/pnas.012264999; Hay BA, 1995, CELL, V83, P1253, DOI 10.1016/0092-8674(95)90150-7; HAY BA, 1994, DEVELOPMENT, V120, P2121; Heidary G, 2001, MECH DEVELOP, V108, P171, DOI 10.1016/S0925-4773(01)00487-7; Hetman M, 2000, J NEUROSCI, V20, P2567; Hoffmann R, 1997, BIOCHEMISTRY-US, V36, P8114, DOI 10.1021/bi970380+; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Houlden H, 1999, ANN NEUROL, V46, P243, DOI 10.1002/1531-8249(199908)46:2<243::AID-ANA14>3.0.CO;2-L; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; ISHIGURO K, 1993, FEBS LETT, V325, P167, DOI 10.1016/0014-5793(93)81066-9; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; JACKSON GR, 2000, MOL MECH NEURODEGENE, P373; JUDD BH, 1972, GENETICS, V71, P139; Killick R, 2001, J BIOL CHEM, V276, P48554, DOI 10.1074/jbc.M108332200; Kirschenbaum F, 2001, J BIOL CHEM, V276, P30701, DOI 10.1074/jbc.M102849200; KOSIK KS, 1988, NEURON, V1, P817, DOI 10.1016/0896-6273(88)90129-8; LAZEBNIK YA, 1995, P NATL ACAD SCI USA, V92, P9042, DOI 10.1073/pnas.92.20.9042; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; LOVESTONE S, 1994, CURR BIOL, V4, P1077, DOI 10.1016/S0960-9822(00)00246-3; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; MA CY, 1995, DEVELOPMENT, V121, P2279; MANDELKOW EM, 1992, FEBS LETT, V314, P315, DOI 10.1016/0014-5793(92)81496-9; MATSUO ES, 1994, NEURON, V13, P989, DOI 10.1016/0896-6273(94)90264-X; McCall K, 1998, SCIENCE, V279, P230, DOI 10.1126/science.279.5348.230; Morris HR, 2001, ARCH NEUROL-CHICAGO, V58, P1813, DOI 10.1001/archneur.58.11.1813; Mudher A, 2001, J NEUROSCI, V21, P4987, DOI 10.1523/JNEUROSCI.21-14-04987.2001; MULOT SFC, 1994, FEBS LETT, V349, P359, DOI 10.1016/0014-5793(94)00702-0; Muqit MMK, 2002, NAT REV NEUROSCI, V3, P237, DOI 10.1038/nrn751; OBERHAMMER FA, 1994, J CELL BIOL, V126, P827, DOI 10.1083/jcb.126.4.827; Ollmann M, 2000, CELL, V101, P91, DOI 10.1016/S0092-8674(00)80626-1; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; Pai LM, 1997, DEVELOPMENT, V124, P2255; Palacino JJ, 2001, J BIOL CHEM, V276, P38563, DOI 10.1074/jbc.M105376200; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; PERRIMON N, 1987, DEV BIOL, V119, P587, DOI 10.1016/0012-1606(87)90061-3; RIGGLEMAN B, 1989, GENE DEV, V3, P96, DOI 10.1101/gad.3.1.96; ROBINOW S, 1988, DEV BIOL, V126, P294, DOI 10.1016/0012-1606(88)90139-X; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Sang TK, 2002, DEVELOPMENT, V129, P143; Sanson B, 1996, NATURE, V383, P627, DOI 10.1038/383627a0; SMITH DE, 1989, J CELL BIOL, V108, P255, DOI 10.1083/jcb.108.2.255; SMITH DE, 1987, J CELL BIOL, V105, P771, DOI 10.1083/jcb.105.2.771; SPERBER BR, 1995, NEUROSCI LETT, V197, P149, DOI 10.1016/0304-3940(95)11902-9; Spittaels K, 2000, J BIOL CHEM, V275, P41340, DOI 10.1074/jbc.M006219200; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Steitz MC, 1998, DEV BIOL, V197, P218, DOI 10.1006/dbio.1998.8884; Su JH, 2000, EXP NEUROL, V163, P9, DOI 10.1006/exnr.2000.7340; Sun W, 2002, J BIOL CHEM, V277, P11933, DOI 10.1074/jbc.M107182200; Therrien M, 1999, P NATL ACAD SCI USA, V96, P13259, DOI 10.1073/pnas.96.23.13259; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; WIESCHAUS E, 1987, CELL, V49, P177, DOI 10.1016/0092-8674(87)90558-7; WILLE H, 1992, J CELL BIOL, V118, P573, DOI 10.1083/jcb.118.3.573; Willert K, 1998, CURR OPIN GENET DEV, V8, P95, DOI 10.1016/S0959-437X(98)80068-3; Williams DW, 2000, J COMP NEUROL, V428, P630, DOI 10.1002/1096-9861(20001225)428:4<630::AID-CNE4>3.0.CO;2-X; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; Zheng-Fischhofer QY, 1998, EUR J BIOCHEM, V252, P542, DOI 10.1046/j.1432-1327.1998.2520542.x	89	386	398	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 16	2002	34	4					509	519		10.1016/S0896-6273(02)00706-7	http://dx.doi.org/10.1016/S0896-6273(02)00706-7			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	553FT	12062036	Bronze			2022-12-24	WOS:000175665700006
J	Chklovskii, DB; Schikorski, T; Stevens, CF				Chklovskii, DB; Schikorski, T; Stevens, CF			Wiring optimization in cortical circuits	NEURON			English	Article							COMPONENT PLACEMENT; ORIENTATION; PATTERNS; NEURONS; ARBORS	Wiring a brain presents a formidable problem because neural circuits require an enormous number of fast and durable connections. We propose that evolution was likely to have optimized neural circuits to minimize conduction delays in axons, passive cable attenuation in dendrites, and the length of "wire" used to construct circuits, and to have maximized the density of synapses. Here we ask the question: "What fraction of the volume should be taken up by axons and dendrites (i.e., wire) when these variables are at their optimal values?" The biophysical properties of axons and dendrites dictate that wire should occupy 3/5 of the volume in an optimally wired gray matter. We have measured the fraction of the volume occupied by each cellular component and find that the volume of wire is close to the predicted optimal value.	Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Howard Hughes Medical Institute; Salk Institute; Cold Spring Harbor Laboratory	Stevens, CF (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	stevens@salk.edu		Schikorski, Thomas/0000-0003-3902-2461				ALLMAN JM, 1974, BRAIN RES, V76, P247, DOI 10.1016/0006-8993(74)90458-2; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; BEKKERS JM, 1990, PROG BRAIN RES, V83, P37; Braitenberg V, 1998, CORTEX STAT GEOMETRY; CHERNIAK C, 1994, J NEUROSCI, V14, P2418; CHERNIAK C, 1995, TRENDS NEUROSCI, V18, P522, DOI 10.1016/0166-2236(95)98373-7; CHERNIAK C, 1992, BIOL CYBERN, V66, P503, DOI 10.1007/BF00204115; Chklovskii DB, 2000, VISION RES, V40, P1765, DOI 10.1016/S0042-6989(00)00023-7; Chklovskii DB, 2000, J NEUROPHYSIOL, V83, P2113, DOI 10.1152/jn.2000.83.4.2113; COWEY A, 1979, Q J EXP PSYCHOL, V31, P1, DOI 10.1080/14640747908400703; DURBIN R, 1990, NATURE, V343, P644, DOI 10.1038/343644a0; HANAICHI T, 1986, J ELECTRON MICROSC, V35, P304; IKARI K, 1981, FOLIA PSYCHIAT NEU J, V35, P477; Koulakov AA, 2001, NEURON, V29, P519, DOI 10.1016/S0896-6273(01)00223-9; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; MITCHISON G, 1991, P ROY SOC B-BIOL SCI, V245, P151, DOI 10.1098/rspb.1991.0102; RALL W, 1992, PHYSIOL REV, V72, pS159, DOI 10.1152/physrev.1992.72.suppl_4.S159; Ramon y Cajal S., 1995, HISTOLOGY NERVOUS SY, V1; Reyes A, 2001, ANNU REV NEUROSCI, V24, P653, DOI 10.1146/annurev.neuro.24.1.653; RUPPIN E, 1993, BIOL CYBERN, V70, P89, DOI 10.1007/BF00202570; RUSHTON WAH, 1951, J PHYSIOL-LONDON, V115, P101, DOI 10.1113/jphysiol.1951.sp004655	21	316	318	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 25	2002	34	3					341	347		10.1016/S0896-6273(02)00679-7	http://dx.doi.org/10.1016/S0896-6273(02)00679-7			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	545JW	11988166	Bronze			2022-12-24	WOS:000175214700006
J	Fiala, JC; Allwardt, B; Harris, KM				Fiala, JC; Allwardt, B; Harris, KM			Dendritic spines do not split during hippocampal LTP or maturation	NATURE NEUROSCIENCE			English	Article							3-DIMENSIONAL STRUCTURE; SYNAPSES; FILOPODIA; CA1		Boston Univ, Dept Biol, Program Neurosci, Boston, MA 02215 USA	Boston University	Harris, KM (corresponding author), Boston Univ, Dept Biol, Program Neurosci, 5 Cummington St, Boston, MA 02215 USA.	harrisk@bu.edu		Harris, Kristen/0000-0002-1943-4744	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033574] Funding Source: NIH RePORTER; NIMH NIH HHS [MH/DA57351] Funding Source: Medline; NINDS NIH HHS [NS33574] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		CARLIN RK, 1983, P NATL ACAD SCI-BIOL, V80, P3517, DOI 10.1073/pnas.80.11.3517; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fiala JC, 1998, J NEUROSCI, V18, P8900; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; JONES DG, 1995, REV NEUROSCIENCE, V6, P177; Jontes JD, 2000, NEURON, V27, P11, DOI 10.1016/S0896-6273(00)00003-9; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Sorra KE, 1998, J COMP NEUROL, V398, P225; SORRA KE, 1993, J NEUROSCI, V13, P3736; Sorra KE, 1998, J NEUROSCI, V18, P658; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Toni N, 2001, J NEUROSCI, V21, P6245, DOI 10.1523/JNEUROSCI.21-16-06245.2001; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071	15	97	97	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2002	5	4					297	298		10.1038/nn830	http://dx.doi.org/10.1038/nn830			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	534UQ	11896399				2022-12-24	WOS:000174606900007
J	Sokolov, M; Lyubarsky, AL; Strissel, KJ; Savchenko, AB; Govardovskii, VI; Pugh, EN; Arshavsky, VY				Sokolov, M; Lyubarsky, AL; Strissel, KJ; Savchenko, AB; Govardovskii, VI; Pugh, EN; Arshavsky, VY			Massive light-driven translocation of transducin between the two major compartments of rod cells: A novel mechanism of light adaptation	NEURON			English	Article							DARK-ADAPTATION; OUTER SEGMENTS; A-WAVE; CRAYFISH PHOTORECEPTORS; RETINAL RODS; CYCLIC-GMP; RAT RETINA; G-PROTEIN; PHOTOTRANSDUCTION; ELECTRORETINOGRAM	We report a new cellular mechanism of rod photoreceptor adaptation in vivo, which is triggered by daylight levels of illumination. The mechanism involves a massive light-dependent translocation of the photoreceptor-specific G protein, transducin, between the functional compartments of rods. To characterize the mechanism, we developed a novel technique that combines serial tangential cryodissection of the rat retina with Western blot analysis of protein distribution in the sections. Up to 90% of transducin translocates from rod outer segments to other cellular compartments on the time scale of tens of minutes. The reduction in the transducin content of the rod outer segments is accompanied by a corresponding reduction in the amplification of the rod photoresponse, allowing rods to operate in illumination up to 10-fold higher than would otherwise be possible.	Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02114 USA; Univ Penn, Sch Med, Dept Ophthalmol, Philadelphia, PA 19104 USA	Harvard University; Harvard Medical School; University of Pennsylvania	Arshavsky, VY (corresponding author), Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02114 USA.		Govardovskii, Victor I/K-2655-2018		NEI NIH HHS [EY-02660, EY 10336] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010336, R01EY002660] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; BLAZYNSKI C, 1986, J BIOL CHEM, V261, P14142; BRANN MR, 1987, SCIENCE, V235, P585, DOI 10.1126/science.3101175; Burns ME, 2001, ANNU REV NEUROSCI, V24, P779, DOI 10.1146/annurev.neuro.24.1.779; DEAZEREDO FAM, 1981, J BIOL CHEM, V256, P2731; Fain GL, 1996, TRENDS NEUROSCI, V19, P502, DOI 10.1016/S0166-2236(96)10056-4; Fain GL, 2001, PHYSIOL REV, V81, P117, DOI 10.1152/physrev.2001.81.1.117; GOVARDOVSKII VI, 1981, BIOPHYS STRUCT MECH, V7, P125, DOI 10.1007/BF00539174; GrayKeller MP, 1996, NEURON, V17, P323, DOI 10.1016/S0896-6273(00)80163-4; HAGINS WA, 1970, BIOPHYS J, V10, P380, DOI 10.1016/S0006-3495(70)86308-1; Heck M, 2001, J BIOL CHEM, V276, P10000, DOI 10.1074/jbc.M009475200; HOOD DC, 1993, VISION RES, V33, P1605, DOI 10.1016/0042-6989(93)90027-T; JONES GJ, 1995, J PHYSIOL-LONDON, V487, P441, DOI 10.1113/jphysiol.1995.sp020891; Kennedy MJ, 2001, NEURON, V31, P87, DOI 10.1016/S0896-6273(01)00340-3; KUHN H, 1981, CURR TOP MEMBR TRANS, V15, P171; LAGNADO L, 1994, NATURE, V367, P273, DOI 10.1038/367273a0; LAMB TD, 1992, J PHYSIOL-LONDON, V449, P719, DOI 10.1113/jphysiol.1992.sp019111; Leibrock CS, 1998, EYE, V12, P511, DOI 10.1038/eye.1998.139; Leskov IB, 2000, NEURON, V27, P525, DOI 10.1016/S0896-6273(00)00063-5; LOLLEY RN, 1975, EXP EYE RES, V20, P585, DOI 10.1016/0014-4835(75)90225-0; Lyubarsky AL, 1996, J NEUROSCI, V16, P563, DOI 10.1523/jneurosci.16-02-00563.1996; Lyubarsky AL, 1999, J NEUROSCI, V19, P442, DOI 10.1523/JNEUROSCI.19-01-00442.1999; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; Nikonov S, 2000, J GEN PHYSIOL, V116, P795, DOI 10.1085/jgp.116.6.795; ORGANISCIAK DT, 1991, EXP EYE RES, V53, P773, DOI 10.1016/0014-4835(91)90113-S; ORR HT, 1976, P NATL ACAD SCI USA, V73, P4442, DOI 10.1073/pnas.73.12.4442; Pennesi ME, 1998, INVEST OPHTH VIS SCI, V39, P2148; PHILP NJ, 1987, FEBS LETT, V225, P127, DOI 10.1016/0014-5793(87)81144-4; Pugh E.N., 2000, HDB BIOL PHYS, V3, P183, DOI DOI 10.1016/S1383-8121(00)80008-1; Pugh EN, 1999, CURR OPIN NEUROBIOL, V9, P410, DOI 10.1016/S0959-4388(99)80062-2; Rodieck R.W., 1998, 1 STEPS SEEING; ROOF DJ, 1988, SCIENCE, V241, P845, DOI 10.1126/science.3136548; Smith NP, 1997, VISION RES, V37, P2943, DOI 10.1016/S0042-6989(97)00094-1; Tai AW, 1999, CELL, V97, P877, DOI 10.1016/S0092-8674(00)80800-4; Tam BM, 2000, J CELL BIOL, V151, P1369, DOI 10.1083/jcb.151.7.1369; Terakita A, 1996, VISUAL NEUROSCI, V13, P539, DOI 10.1017/S095252380000821X; Terakita A, 1998, J COMP PHYSIOL A, V183, P411, DOI 10.1007/s003590050267; Thomas MM, 1999, J PHYSIOL-LONDON, V518, P479, DOI 10.1111/j.1469-7793.1999.0479p.x; Tsang SH, 1998, SCIENCE, V282, P117, DOI 10.1126/science.282.5386.117; WHELAN JP, 1988, J NEUROSCI RES, V20, P263, DOI 10.1002/jnr.490200216	40	287	295	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 28	2002	34	1					95	106		10.1016/S0896-6273(02)00636-0	http://dx.doi.org/10.1016/S0896-6273(02)00636-0			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536HR	11931744	Bronze			2022-12-24	WOS:000174695100012
J	Lei, SB; McBain, CJ				Lei, SB; McBain, CJ			Distinct NMDA receptors provide differential modes of transmission at mossy fiber-interneuron synapses	NEURON			English	Article							LONG-TERM POTENTIATION; CA2+-PERMEABLE AMPA RECEPTORS; CALCIUM-PERMEABLE AMPA; D-ASPARTATE RECEPTOR; PYRAMIDAL CELLS; SILENT SYNAPSES; HIPPOCAMPAL CA3; INWARD RECTIFICATION; DENTATE GYRUS; NR2A SUBUNIT	Dentate gyrus granule cells innervate inhibitory interneurons via a continuum of synapses comprised of either Ca2+-impermeable (CI) or Ca2+-permeable (CP) AMPA receptors. Synapses at the extreme ends of this continuum engage distinct postsynaptic responses, with activity at CI synapses being strongly influenced by NMDA receptor activation. NMDARs at CI synapses have a lower NR2B subunit composition and a higher open probability, which generate larger amplitude and more rapid EPSCs than their CP counterparts. A novel form of NMDAR-dependent long-term depression (iLTD) is associated with CI-mossy fiber synapses, whereas iLTD at CP synapses is dependent on Ca2+-permeable AMPA receptor activation. Induction of both forms of iLTD required elevation of postsynaptic calcium. Thus mossy fibers engage CA3 interneurons via multiple synapse types that will act to expand the computational repertoire of the mossy fiber-CA3 network.	NICHHD, Lab Cellular & Mol Neurophysiol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	McBain, CJ (corresponding author), NICHHD, Lab Cellular & Mol Neurophysiol, NIH, 49 Convent Dr, Bethesda, MD 20892 USA.	chrismcb@codon.nih.gov			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001205] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001205] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Acsady L, 1998, J NEUROSCI, V18, P3386; AMARAL DG, 1981, J COMP NEUROL, V195, P51, DOI 10.1002/cne.901950106; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; BLASCHKE M, 1993, P NATL ACAD SCI USA, V90, P6528, DOI 10.1073/pnas.90.14.6528; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; BRAGIN A, 1995, J NEUROSCI, V15, P47; BRAGIN A, 1995, J NEUROPHYSIOL, V73, P1691, DOI 10.1152/jn.1995.73.4.1691; Cathala L, 2000, J NEUROSCI, V20, P5899, DOI 10.1523/JNEUROSCI.20-16-05899.2000; CHATTARJI S, 1989, BRAIN RES, V495, P145, DOI 10.1016/0006-8993(89)91228-6; Dingledine R, 1999, PHARMACOL REV, V51, P7; DONEVAN SD, 1995, P NATL ACAD SCI USA, V92, P9298, DOI 10.1073/pnas.92.20.9298; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Flint AC, 1997, J NEUROSCI, V17, P2469; Fricker D, 2000, NEURON, V28, P559, DOI 10.1016/S0896-6273(00)00133-1; He Y, 1998, EXP NEUROL, V150, P1, DOI 10.1006/exnr.1997.6720; HERLITZE S, 1993, NEURON, V10, P1131, DOI 10.1016/0896-6273(93)90061-U; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; HUETTNER JE, 1988, P NATL ACAD SCI USA, V85, P1307, DOI 10.1073/pnas.85.4.1307; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; JAHR CE, 1992, SCIENCE, V255, P470, DOI 10.1126/science.1346477; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; KAMBOJ SK, 1995, J PHYSIOL-LONDON, V486, P297, DOI 10.1113/jphysiol.1995.sp020812; Kamiya H, 1996, J PHYSIOL-LONDON, V493, P447, DOI 10.1113/jphysiol.1996.sp021395; KOH DS, 1995, J PHYSIOL-LONDON, V486, P305, DOI 10.1113/jphysiol.1995.sp020813; Laezza F, 1999, SCIENCE, V285, P1411, DOI 10.1126/science.285.5432.1411; LANGDON RB, 1995, J NEUROBIOL, V26, P370, DOI 10.1002/neu.480260309; Leranth C, 1996, NEUROSCIENCE, V70, P631, DOI 10.1016/S0306-4522(96)83003-X; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Maccaferri G, 1998, SCIENCE, V279, P1368, DOI 10.1126/science.279.5355.1368; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; MCBAIN CJ, 1994, PHYSIOL REV, V74, P723, DOI 10.1152/physrev.1994.74.3.723; McMahon LL, 1997, NEURON, V18, P295, DOI 10.1016/S0896-6273(00)80269-X; Mellor J, 2001, NAT NEUROSCI, V4, P125, DOI 10.1038/83941; MONAGHAN DT, 1985, J NEUROSCI, V5, P2909; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Penttonen M, 1997, HIPPOCAMPUS, V7, P437, DOI 10.1002/(SICI)1098-1063(1997)7:4<437::AID-HIPO9>3.0.CO;2-F; Pickard L, 2000, J NEUROSCI, V20, P7922; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; ROBINSON HPC, 1991, BIOPHYS J, V59, P295, DOI 10.1016/S0006-3495(91)82223-8; Rohrbough J, 1999, J NEUROSCI, V19, P8528; ROSENMUND C, 1995, J NEUROSCI, V15, P2788; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; SIEGEL SJ, 1994, P NATL ACAD SCI USA, V91, P564, DOI 10.1073/pnas.91.2.564; SPRUSTON N, 1995, J PHYSIOL-LONDON, V482, P325, DOI 10.1113/jphysiol.1995.sp020521; Stocca G, 1998, J PHYSIOL-LONDON, V507, P13, DOI 10.1111/j.1469-7793.1998.013bu.x; Toth K, 1998, NAT NEUROSCI, V1, P572, DOI 10.1038/2807; Toth K, 2000, J NEUROSCI, V20, P8279, DOI 10.1523/JNEUROSCI.20-22-08279.2000; Traynelis SF, 1998, TRENDS NEUROSCI, V21, P137, DOI 10.1016/S0166-2236(98)01238-7; TRAYNELIS SF, 1993, NEURON, V11, P279, DOI 10.1016/0896-6273(93)90184-S; Washburn MS, 1996, J PHARMACOL EXP THER, V278, P669; Watanabe M, 1998, EUR J NEUROSCI, V10, P478, DOI 10.1046/j.1460-9568.1998.00063.x; WEISSKOPF MG, 1995, NATURE, V376, P256, DOI 10.1038/376256a0; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; Yeckel MF, 1999, NAT NEUROSCI, V2, P625, DOI 10.1038/10180; ZALUTSKY RA, 1992, NEUROSCI LETT, V138, P193, DOI 10.1016/0304-3940(92)90503-Y; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614	58	124	126	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 14	2002	33	6					921	933		10.1016/S0896-6273(02)00608-6	http://dx.doi.org/10.1016/S0896-6273(02)00608-6			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	530ZK	11906698	Bronze			2022-12-24	WOS:000174389600009
J	Thiagarajan, TC; Piedras-Renteria, ES; Tsien, RW				Thiagarajan, TC; Piedras-Renteria, ES; Tsien, RW			alpha- and beta CaMKII: Inverse regulation by neuronal activity and opposing effects on synaptic strength	NEURON			English	Article							PROTEIN-KINASE-II; LONG-TERM POTENTIATION; HIPPOCAMPAL-NEURONS; RAT-BRAIN; POSTSYNAPTIC DENSITY; GLUTAMATE RECEPTORS; AMPA RECEPTORS; MUTANT MICE; IN-VIVO; CALMODULIN	We show that a and betaCaMKII are inversely regulated by activity in hippocampal neurons in culture: the alpha/beta ratio shifts toward alpha during increased activity and beta during decreased activity. The swing in ratio is similar to5-fold and may help tune the CaMKII holoenzyme to changing intensities of Ca2+ signaling. The regulation of CaMKII levels uses distinguishable pathways, one responsive to NMDA receptor blockade that controls alphaCaMKII alone, the other responsive to AMPA receptor blockade and involving betaCaMKII and possibly further downstream effects of betaCaMKII on alphaCaMKII. Overexpression of alphaCaMKII or betaCaMKII resulted in opposing effects on unitary synaptic strength as well as mEPSC frequency that could account in part for activity-dependent effects observed with chronic blockade of AMPA receptors. Regulation of CaMKII subunit composition may be important for both activity-dependent synaptic homeostasis and plasticity.	Stanford Univ, Sch Med, Beckman Ctr, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA; Loyola Univ, Stritch Sch Med, Dept Cellular & Mol Physiol, Maywood, IL 60153 USA	Stanford University; Loyola University Chicago	Tsien, RW (corresponding author), Stanford Univ, Sch Med, Beckman Ctr, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA.			Piedras-Renteria, Erika/0000-0001-7983-585X				Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; BEAR MF, 1995, NEURON, V15, P1, DOI 10.1016/0896-6273(95)90056-X; BENNETT MK, 1983, J BIOL CHEM, V258, P2735; Brocke L, 1999, J BIOL CHEM, V274, P22713, DOI 10.1074/jbc.274.32.22713; Broughton SJ, 1996, J CELL BIOCHEM, V62, P484, DOI 10.1002/(SICI)1097-4644(19960915)62:4<484::AID-JCB6>3.3.CO;2-Z; BURGIN KE, 1990, J NEUROSCI, V10, P1788; Davis GW, 1998, NATURE, V392, P82, DOI 10.1038/32176; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Deisseroth K, 1995, CURR BIOL, V5, P1334, DOI 10.1016/S0960-9822(95)00262-4; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Dosemeci A, 2001, P NATL ACAD SCI USA, V98, P10428, DOI 10.1073/pnas.181336998; ERONDU NE, 1985, J NEUROSCI, V5, P3270; Eshete F, 2001, J NEUROSCI, V21, P6694, DOI 10.1523/JNEUROSCI.21-17-06694.2001; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; KANASEKI T, 1991, J CELL BIOL, V115, P1049, DOI 10.1083/jcb.115.4.1049; Kolodziej SJ, 2000, J BIOL CHEM, V275, P14354, DOI 10.1074/jbc.275.19.14354; KURET J, 1985, J BIOL CHEM, V260, P6427; LAI Y, 1986, P NATL ACAD SCI USA, V83, P4253, DOI 10.1073/pnas.83.12.4253; Liao DZ, 2001, J NEUROSCI, V21, P6008, DOI 10.1523/JNEUROSCI.21-16-06008.2001; Lisman JE, 2001, NEURON, V31, P191, DOI 10.1016/S0896-6273(01)00364-6; MALINOW R, 1988, NATURE, V335, P820, DOI 10.1038/335820a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MAYFORD M, 1995, CELL, V81, P891, DOI 10.1016/0092-8674(95)90009-8; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; MILLER SG, 1985, J BIOL CHEM, V260, P9039; MUKHERJI S, 1994, J BIOL CHEM, V269, P13744; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Ouyang Y, 1999, J NEUROSCI, V19, P7823; Rich RC, 1998, J BIOL CHEM, V273, P28424, DOI 10.1074/jbc.273.43.28424; Rongo C, 1999, NATURE, V402, P195, DOI 10.1038/46065; ROSTAS JAP, 1988, J NEUROCHEM, V50, P945, DOI 10.1111/j.1471-4159.1988.tb03003.x; SCHULMAN H, 1992, CELL CALCIUM, V13, P401, DOI 10.1016/0143-4160(92)90053-U; SCHWORER CM, 1988, J BIOL CHEM, V263, P13486; SCHWORER CM, 1986, J BIOL CHEM, V261, P8581; Shen K, 1998, NEURON, V21, P593, DOI 10.1016/S0896-6273(00)80569-3; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Sik A, 1998, P NATL ACAD SCI USA, V95, P3245, DOI 10.1073/pnas.95.6.3245; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; SILVA AJ, 1992, COLD SPRING HARB SYM, V57, P527, DOI 10.1101/SQB.1992.057.01.058; SPRUSTON N, 1993, J NEUROPHYSIOL, V70, P781, DOI 10.1152/jn.1993.70.2.781; SUGIURA H, 1992, BRAIN RES, V593, P97, DOI 10.1016/0006-8993(92)91269-K; Tao-Cheng JH, 2001, NEUROSCIENCE, V106, P69, DOI 10.1016/S0306-4522(01)00262-7; THIEL G, 1988, P NATL ACAD SCI USA, V85, P6337, DOI 10.1073/pnas.85.17.6337; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Walikonis RS, 2001, J NEUROSCI, V21, P423, DOI 10.1523/JNEUROSCI.21-02-00423.2001; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976; WYLLIE DJA, 1994, NEURON, V13, P635, DOI 10.1016/0896-6273(94)90031-0; Zou DJ, 1999, J NEUROSCI, V19, P8909, DOI 10.1523/JNEUROSCI.19-20-08909.1999	55	224	233	1	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 19	2002	36	6					1103	1114		10.1016/S0896-6273(02)01049-8	http://dx.doi.org/10.1016/S0896-6273(02)01049-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	628TA	12495625	Bronze			2022-12-24	WOS:000180011600013
J	Sakai, KL; Noguchi, Y; Takeuchi, T; Watanabe, E				Sakai, KL; Noguchi, Y; Takeuchi, T; Watanabe, E			Selective priming of syntactic processing by event-related transcranial magnetic stimulation of Broca's area	NEURON			English	Article							SENTENCE COMPREHENSION; COGNITIVE NEUROSCIENCE; BRAIN; SPEECH; CORTEX; INHIBITION; SAFETY; FORM; FLOW	It remains controversial whether Brocals aphasia is an articulatory deficit, a lexical-access problem, or agrammatism. In spite of recent neuroimaging studies, the causal link between cortical activity and linguistic sub-components has not been elucidated. Here we report an experiment with event-related transcranial magnetic stimulation (TMS) to clarify the role of Brocals area, more specifically, the left inferior frontal gyrus (F3op/F3t), in syntactic processing. An experimental paradigm contrasted sentences requiring syntactic decisions with those requiring semantic decisions. We found selective priming effects on syntactic decisions when TMS was administered to the left F3op/F3t at a specific timing, but not to the left middle frontal gyrus (F2). Our results provide direct evidence of the involvement of the left F3op/F3t in syntactic processing.	Univ Tokyo, Grad Sch Arts & Sci, Dept Cognit & Behav Sci, Meguro Ku, Tokyo 1538902, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi 3320012, Japan; Tokyo Metropolitan Police Hosp, Dept Neurosurg, Tokyo 1028161, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Sakai, KL (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Cognit & Behav Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.							Caplan D, 1999, BEHAV BRAIN SCI, V22, P77; Dapretto M, 1999, NEURON, V24, P427, DOI 10.1016/S0896-6273(00)80855-7; Dronkers NF, 1996, NATURE, V384, P159, DOI 10.1038/384159a0; Embick D, 2000, P NATL ACAD SCI USA, V97, P6150, DOI 10.1073/pnas.100098897; Epstein CM, 1996, NEUROLOGY, V47, P1590, DOI 10.1212/WNL.47.6.1590; GOODMAN GO, 1981, MEM COGNITION, V9, P580, DOI 10.3758/BF03202352; Hallett M, 2000, NATURE, V406, P147, DOI 10.1038/35018000; Indefrey P, 2001, NEUROIMAGE, V14, P546, DOI 10.1006/nimg.2001.0867; Just MA, 1996, SCIENCE, V274, P114, DOI 10.1126/science.274.5284.114; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; MOHR JP, 1976, STUDIES NEUROLINGUIS, V1, P201; Moro A, 2001, NEUROIMAGE, V13, P110, DOI 10.1006/nimg.2000.0668; Mottaghy FM, 1999, NEUROLOGY, V53, P1806, DOI 10.1212/WNL.53.8.1806; Ni W, 2000, J COGNITIVE NEUROSCI, V12, P120, DOI 10.1162/08989290051137648; Noguchi Y, 2002, HUM BRAIN MAPP, V17, P89, DOI 10.1002/hbm.10050; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pascual-Leone A, 2000, CURR OPIN NEUROBIOL, V10, P232, DOI 10.1016/S0959-4388(00)00081-7; PASCUALLEONE A, 1991, NEUROLOGY, V41, P697, DOI 10.1212/WNL.41.5.697; PASCUALLEONE A, 1993, ELECTROEN CLIN NEURO, V89, P120, DOI 10.1016/0168-5597(93)90094-6; Sakai KL, 2001, NEUROSCI RES, V39, P1, DOI 10.1016/S0168-0102(00)00205-4; Shapiro KA, 2001, J COGNITIVE NEUROSCI, V13, P713, DOI 10.1162/08989290152541386; Smith N., 1979, MODERN LINGUISTICS R; Stewart L, 2001, NEUROIMAGE, V13, P472, DOI 10.1006/nimg.2000.0701; Stromswold K, 1996, BRAIN LANG, V52, P452, DOI 10.1006/brln.1996.0024; Terao Y, 1998, J NEUROPHYSIOL, V80, P936, DOI 10.1152/jn.1998.80.2.936; Trompetto C, 1999, CLIN NEUROPHYSIOL, V110, P1106, DOI 10.1016/S1388-2457(99)00043-7; Walsh V, 1998, P ROY SOC B-BIOL SCI, V265, P537, DOI 10.1098/rspb.1998.0328; Walsh V, 2000, NAT REV NEUROSCI, V1, P73, DOI 10.1038/35036239; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8	29	63	65	0	21	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 12	2002	35	6					1177	1182		10.1016/S0896-6273(02)00873-5	http://dx.doi.org/10.1016/S0896-6273(02)00873-5			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	594GC	12354406	Bronze, Green Published			2022-12-24	WOS:000178040000017
J	Wang, YP; Dakubo, G; Howley, P; Campsall, KD; Mazarolle, CJ; Shiga, SA; Lewis, PM; McMahon, AP; Wallace, VA				Wang, YP; Dakubo, G; Howley, P; Campsall, KD; Mazarolle, CJ; Shiga, SA; Lewis, PM; McMahon, AP; Wallace, VA			Development of normal retinal organization depends on Sonic hedgehog signaling from ganglion cells	NATURE NEUROSCIENCE			English	Article							OPTIC-NERVE; DIFFERENTIATION; EXPRESSION; GENE		Ottawa Hlth Res Inst, Program Mol Med, Ottawa, ON K1H 8L6, Canada; Univ Ottawa, Inst Eye, Ctr Neuromuscular Dis, Ottawa, ON K1H 8M5, Canada; Univ Ottawa, Inst Eye, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada; Harvard Univ, Biolabs, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; Harvard University	Wallace, VA (corresponding author), Ottawa Hlth Res Inst, Program Mol Med, 501 Smyth Rd, Ottawa, ON K1H 8L6, Canada.		McMahon, Andrew P/ABE-7520-2020		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033642, R37NS033642] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 33642] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Brown NL, 2001, DEVELOPMENT, V128, P2497; Campsall KD, 2002, DEV DYNAM, V224, P135, DOI 10.1002/dvdy.10092; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Goodrich LV, 1998, NEURON, V21, P1243, DOI 10.1016/S0896-6273(00)80645-5; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; Jensen AM, 1997, DEVELOPMENT, V124, P363; Lewis PM, 2001, CELL, V105, P599, DOI 10.1016/S0092-8674(01)00369-5; LILLIEN L, 1992, DEVELOPMENT, V115, P253; Neumann CJ, 2000, SCIENCE, V289, P2137, DOI 10.1126/science.289.5487.2137; RAYMOND SM, 1995, CURR BIOL, V5, P1286, DOI 10.1016/S0960-9822(95)00255-7; Wallace VA, 1999, DEVELOPMENT, V126, P2901; Willbold E, 1998, HISTOL HISTOPATHOL, V13, P531, DOI 10.14670/HH-13.531; Zhang XM, 2001, CELL, V105, P781, DOI 10.1016/S0092-8674(01)00385-3	15	112	116	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2002	5	9					831	832		10.1038/nn911	http://dx.doi.org/10.1038/nn911			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587RL	12195432				2022-12-24	WOS:000177656300007
J	Bixby, S; Kruger, GM; Mosher, JT; Joseph, NM; Morrison, SJ				Bixby, S; Kruger, GM; Mosher, JT; Joseph, NM; Morrison, SJ			Cell-intrinsic differences between stem cells from different regions of the peripheral nervous system regulate the generation of neural diversity	NEURON			English	Article							BONE MORPHOGENETIC PROTEINS; ZONE PROGENITOR CELLS; IN-VIVO; NEURONAL DIFFERENTIATION; CREST CELLS; SYMPATHETIC NEURONS; MOUSE DEVELOPMENT; SELF-RENEWAL; SPINAL-CORD; TRANSPLANTATION	Stem cells in different regions of the nervous system give rise to different types of mature cells. This diversity is assumed to arise in response to local environmental differences, but the contribution of cell-intrinsic differences between stem cells has been unclear. At embryonic day (E)14, neural crest stem cells (NCSCs) undergo primarily neurogenesis in the gut but gliogenesis in nerves. Yet gliogenic and neurogenic factors are expressed in both locations. NCSCs isolated by flow-cytometry from E14 sciatic nerve and gut exhibited heritable, cell-intrinsic differences in their responsiveness to lineage determination factors. Gut NCSCs were more responsive to neurogenic factors, while sciatic nerve NCSCs were more responsive to gliogenic factors. Upon transplantation of uncultured NCSCs into developing peripheral nerves in vivo, sciatic nerve NCSCs gave rise only to glia, while gut NCSCs gave rise primarily to neurons. Thus, cell fate in the nerve was stem cell determined.	Univ Michigan, Howard Hughes Med Inst, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Morrison, SJ (corresponding author), Univ Michigan, Howard Hughes Med Inst, Dept Internal Med, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	seanjm@umich.edu	Morrison, Sean/ABD-5326-2021; Crane, Genevieve M/AAK-9224-2020	Crane, Genevieve M/0000-0001-9274-0214; Morrison, Sean/0000-0003-1587-8329	NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048310, P60AR020557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040750] Funding Source: NIH RePORTER; NCI NIH HHS [CA46592] Funding Source: Medline; NIAMS NIH HHS [AR20557, P30 AR48310] Funding Source: Medline; NIDDK NIH HHS [5P60-DK20572] Funding Source: Medline; NINDS NIH HHS [R01 NS40750-01, R01 NS040750-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON DJ, 1985, CELL, V42, P649, DOI 10.1016/0092-8674(85)90122-9; Anderson DJ, 2001, NEURON, V30, P19, DOI 10.1016/S0896-6273(01)00260-4; BARTHEL LK, 1993, J NEUROSCI METH, V50, P145, DOI 10.1016/0165-0270(93)90002-9; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Brustle O, 1997, P NATL ACAD SCI USA, V94, P14809, DOI 10.1073/pnas.94.26.14809; Campbell K, 1995, NEURON, V15, P1259, DOI 10.1016/0896-6273(95)90006-3; Couly G, 2002, DEVELOPMENT, V129, P1061; DONG Z, 1995, NEURON, V15, P585, DOI 10.1016/0896-6273(95)90147-7; Fricker RA, 1999, J NEUROSCI, V19, P5990, DOI 10.1523/JNEUROSCI.19-14-05990.1999; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gage FH, 1998, CURR OPIN NEUROBIOL, V8, P671, DOI 10.1016/S0959-4388(98)80098-6; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; Hagedorn L, 1999, DEVELOPMENT, V126, P3781; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; He WL, 2001, J NEUROSCI, V21, P8854, DOI 10.1523/JNEUROSCI.21-22-08854.2001; Hitoshi S, 2002, DEVELOPMENT, V129, P233; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; JESSEN KR, 1994, NEURON, V12, P509, DOI 10.1016/0896-6273(94)90209-7; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kawaguchi A, 2001, MOL CELL NEUROSCI, V17, P259, DOI 10.1006/mcne.2000.0925; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Kruger GM, 2002, NEURON, V35, P657, DOI 10.1016/S0896-6273(02)00827-9; Kubu CJ, 2002, DEV BIOL, V244, P199, DOI 10.1006/dbio.2002.0568; LELIEVRE CS, 1980, DEV BIOL, V77, P362, DOI 10.1016/0012-1606(80)90481-9; LEMKE G, 1988, NEURON, V1, P73, DOI 10.1016/0896-6273(88)90211-5; Lillien L, 1997, CURR BIOL, V7, pR168, DOI 10.1016/S0960-9822(97)70080-0; LO LC, 1995, NEURON, V15, P527, DOI 10.1016/0896-6273(95)90142-6; Lo LC, 1997, CURR BIOL, V7, P440, DOI 10.1016/S0960-9822(06)00191-6; MCCONNELL SK, 1991, ANNU REV NEUROSCI, V14, P269, DOI 10.1146/annurev.ne.14.030191.001413; MCKAY RDG, 1989, CELL, V58, P815, DOI 10.1016/0092-8674(89)90934-3; MEYER D, 1994, P NATL ACAD SCI USA, V91, P1064, DOI 10.1073/pnas.91.3.1064; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; Morrison SJ, 2000, J NEUROSCI, V20, P7370; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; Na E, 1998, CURR BIOL, V8, P987, DOI 10.1016/S0960-9822(98)70403-8; Olsson M, 1997, NEURON, V19, P761, DOI 10.1016/S0896-6273(00)80959-9; Palmer TD, 1999, J NEUROSCI, V19, P8487; Panchision D, 1998, CURR OPIN CELL BIOL, V10, P727, DOI 10.1016/S0955-0674(98)80114-2; PHAM TD, 1991, J COMP NEUROL, V314, P789, DOI 10.1002/cne.903140411; Pisano JM, 2000, DEV BIOL, V227, P1, DOI 10.1006/dbio.2000.9876; Power J, 2002, DEV BIOL, V245, P362, DOI 10.1006/dbio.2002.0610; Puelles L, 2000, J COMP NEUROL, V424, P409, DOI 10.1002/1096-9861(20000828)424:3<409::AID-CNE3>3.0.CO;2-7; Reissmann E, 1996, DEVELOPMENT, V122, P2079; Riethmacher D, 1997, NATURE, V389, P725, DOI 10.1038/39593; Rietze RL, 2001, NATURE, V412, P736, DOI 10.1038/35089085; Schneider C, 1999, NEURON, V24, P861, DOI 10.1016/S0896-6273(00)81033-8; SHAH NM, 1994, CELL, V77, P349, DOI 10.1016/0092-8674(94)90150-3; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; Shihabuddin LS, 2000, J NEUROSCI, V20, P8727; Shimamura K, 1995, DEVELOPMENT, V121, P3923; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; Takahashi M, 1998, MOL CELL NEUROSCI, V12, P340, DOI 10.1006/mcne.1998.0721; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Trainor PA, 2002, SCIENCE, V295, P1288, DOI 10.1126/science.1064540; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; WEINMASTER G, 1991, DEVELOPMENT, V113, P199; White PM, 1999, DEVELOPMENT, V126, P4351; White PM, 2001, NEURON, V29, P57, DOI 10.1016/S0896-6273(01)00180-5; Williams BP, 1997, NEURON, V18, P553, DOI 10.1016/S0896-6273(00)80297-4; WILLIAMS R, 1995, MECH DEVELOP, V53, P357, DOI 10.1016/0925-4773(95)00451-3; Wilson SW, 2000, NEURON, V28, P641, DOI 10.1016/S0896-6273(00)00171-9; Zappone MV, 2000, DEVELOPMENT, V127, P2367	65	226	233	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 15	2002	35	4					643	656		10.1016/S0896-6273(02)00825-5	http://dx.doi.org/10.1016/S0896-6273(02)00825-5			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	585JE	12194865	Bronze			2022-12-24	WOS:000177521000006
J	Sundstrom-Poromaa, I; Smith, DH; Gong, QH; Sabado, TN; Li, XS; Light, A; Wiedmann, M; Williams, K; Smith, SS				Sundstrom-Poromaa, I; Smith, DH; Gong, QH; Sabado, TN; Li, XS; Light, A; Wiedmann, M; Williams, K; Smith, SS			Hormonally regulated alpha(4)beta(2)delta GABA(A) receptors are a target for alcohol	NATURE NEUROSCIENCE			English	Article							PREMENSTRUAL-SYNDROME; ETHANOL		SUNY Downstate Med Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA; Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, New York, NY 10021 USA; MCP Hahnemann Univ, Dept Neurobiol & Anat, Philadelphia, PA 19129 USA; Univ Chicago, Dept Neurol, Chicago, IL 60637 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Memorial Sloan Kettering Cancer Center; Drexel University; University of Chicago	Smith, SS (corresponding author), SUNY Downstate Med Ctr, Dept Physiol & Pharmacol, 450 Clarkson Ave, Brooklyn, NY 11203 USA.			Sundstrom Poromaa, Inger/0000-0002-2491-2042; Smith, Sheryl/0000-0003-4308-3267	NIAAA NIH HHS [R01 AA012958-02, R01 AA012958, R01 AA012958-01, AA12958] Funding Source: Medline; NIDA NIH HHS [R01 DA009618-04, DA09618, R01 DA009618, R01 DA009618-05A2] Funding Source: Medline; NINDS NIH HHS [R01 NS035047, NS35047] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA009618] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Adkins CE, 2001, J BIOL CHEM, V276, P38934, DOI 10.1074/jbc.M104318200; Brickley SG, 2001, NATURE, V409, P88, DOI 10.1038/35051086; COHEN HL, 1993, ELECTROEN CLIN NEURO, V86, P368, DOI 10.1016/0013-4694(93)90132-F; HOLFORD NHG, 1987, CLIN PHARMACOKINET, V13, P273, DOI 10.2165/00003088-198713050-00001; KALANT H, 1975, CAN MED ASSOC J, V112, P953; KOOB GF, 1988, ALCOHOL, V5, P437, DOI 10.1016/0741-8329(88)90079-1; Mahmoudi M, 1997, J NEUROCHEM, V68, P2485; MCLEOD DR, 1994, ALCOHOL CLIN EXP RES, V18, P664, DOI 10.1111/j.1530-0277.1994.tb00928.x; Mihalek RM, 2001, ALCOHOL CLIN EXP RES, V25, P1708, DOI 10.1111/j.1530-0277.2001.tb02179.x; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; Nusser Z, 1998, J NEUROSCI, V18, P1693; Smith SS, 1998, NATURE, V392, P926, DOI 10.1038/31948; Sundstrom I, 1998, NEUROENDOCRINOLOGY, V67, P126, DOI 10.1159/000054307; Ueno S, 2001, ALCOHOL CLIN EXP RES, V25, p76S, DOI 10.1097/00000374-200105051-00014; Wan FJ, 1996, P NATL ACAD SCI USA, V93, P5049, DOI 10.1073/pnas.93.10.5049	15	267	272	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2002	5	8					721	722		10.1038/nn888	http://dx.doi.org/10.1038/nn888			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	577XT	12118257	Green Accepted			2022-12-24	WOS:000177088900010
J	Field, GD; Rieke, F				Field, GD; Rieke, F			Nonlinear signal transfer from mouse rods to bipolar cells and implications for visual sensitivity	NEURON			English	Article							TEMPORAL CONTRAST ADAPTATION; TIGER SALAMANDER RETINA; SINGLE-PHOTON DETECTION; MAMMALIAN RETINA; GANGLION-CELLS; ALTERNATIVE PATHWAY; TRANSMITTER RELEASE; SYNAPTIC TRANSFER; LIGHT ADAPTATION; OUTER SEGMENTS	We investigated the impact of rod-bipolar signal transfer on visual sensitivity. Two observations indicate that rod-rod bipolar signal transfer is nonlinear. First, responses of rods increased linearly with flash strength, while those of rod bipolars increased supralinearly. Second, fluctuations in the responses of rod bipolars were larger than expected from linear summation of the rod inputs. Rod-OFF bipolar signal transfer did not share this strong nonlinearity. Surprisingly, nonlinear rod-rod bipolar signal transfer eliminated many of the rod's single-photon responses. The impact on sensitivity, however, was more than compensated for by rejection of noise from rods that did not absorb photons. As a consequence, rod bipolars provide a near-optimal readout of rod signals at light levels near visual threshold.	Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Rieke, F (corresponding author), Univ Washington, Dept Physiol & Biophys, Box 357290, Seattle, WA 98195 USA.		Field, Greg/AAI-1428-2021	Field, Greg/0000-0001-5942-2679	NEI NIH HHS [EY-11850] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011850] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ASHMORE JF, 1980, J PHYSIOL-LONDON, V300, P151, DOI 10.1113/jphysiol.1980.sp013156; BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P589; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; BAYLOR DA, 1980, J PHYSIOL-LONDON, V309, P591, DOI 10.1113/jphysiol.1980.sp013529; BELGUM JH, 1988, J PHYSIOL-LONDON, V396, P225, DOI 10.1113/jphysiol.1988.sp016960; BIALEK W, 1990, BIOPHYS J, V58, P1227, DOI 10.1016/S0006-3495(90)82463-2; DACHEUX RF, 1986, J NEUROSCI, V6, P331; DEVRIES H, 1961, PRINCIPLES SENSORY C, P159; DEVRIES SH, 1995, P NATL ACAD SCI USA, V92, P10658, DOI 10.1073/pnas.92.23.10658; Euler T, 2000, J NEUROPHYSIOL, V83, P1817, DOI 10.1152/jn.2000.83.4.1817; Hack I, 1999, P NATL ACAD SCI USA, V96, P14130, DOI 10.1073/pnas.96.24.14130; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Kim KJ, 2001, J NEUROSCI, V21, P287, DOI 10.1523/JNEUROSCI.21-01-00287.2001; NAKATANI K, 1991, J GEN PHYSIOL, V97, P413, DOI 10.1085/jgp.97.3.413; RAO R, 1994, BIOPHYS J, V67, P57, DOI 10.1016/S0006-3495(94)80454-0; RAOMIROTZNIK R, 1995, NEURON, V14, P561, DOI 10.1016/0896-6273(95)90312-7; Rieke F, 1996, J PHYSIOL-LONDON, V493, P1; Rieke F, 1996, BIOPHYS J, V71, P2553, DOI 10.1016/S0006-3495(96)79448-1; Rieke F, 1998, REV MOD PHYS, V70, P1027, DOI 10.1103/RevModPhys.70.1027; Rieke F, 2001, J NEUROSCI, V21, P9445, DOI 10.1523/JNEUROSCI.21-23-09445.2001; Rieke F, 2000, METHOD ENZYMOL, V316, P186; ROBSON JG, 1995, VISUAL NEUROSCI, V12, P837, DOI 10.1017/S0952523800009408; SCHNEEWEIS DM, 1995, SCIENCE, V268, P1053, DOI 10.1126/science.7754386; Schneeweis DM, 2000, VISUAL NEUROSCI, V17, P659, DOI 10.1017/S0952523800175017; SMITH RG, 1986, J NEUROSCI, V6, P3505; Soucy E, 1998, NEURON, V21, P481, DOI 10.1016/S0896-6273(00)80560-7; STERLING P, 1988, J NEUROSCI, V8, P623; Tsukamoto Y, 2001, J NEUROSCI, V21, P8616, DOI 10.1523/JNEUROSCI.21-21-08616.2001; van Rossum MCW, 1998, VISUAL NEUROSCI, V15, P809, DOI 10.1017/S0952523898155037; Walraven J, 1990, VISUAL PERCEPTION NE, P53; WERBLIN FS, 1978, J PHYSIOL-LONDON, V280, P449, DOI 10.1113/jphysiol.1978.sp012394; Witkovsky P, 1997, J NEUROSCI, V17, P7297; WU SMS, 1987, J NEUROSCI METH, V20, P139, DOI 10.1016/0165-0270(87)90046-X	34	215	217	0	16	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 30	2002	34	5					773	785		10.1016/S0896-6273(02)00700-6	http://dx.doi.org/10.1016/S0896-6273(02)00700-6			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	558DV	12062023	Bronze, Green Submitted			2022-12-24	WOS:000175951800011
J	Greger, IH; Khatri, L; Ziff, EB				Greger, IH; Khatri, L; Ziff, EB			RNA editing at Arg607 controls AMPA receptor exit from the endoplasmic reticulum	NEURON			English	Article							DOMAIN-CONTAINING PROTEIN; ER RETENTION SIGNAL; KINASE-C-ALPHA; HIPPOCAMPAL-NEURONS; GLUTAMATE RECEPTORS; BINDING-PROTEIN; SUBUNIT STOICHIOMETRY; MOLECULAR MECHANISMS; SECRETORY PATHWAY; SPLICE VARIANTS	AMPA-receptor (AMPAR) transport to synapses plays a critical role in the modulation of synaptic strength. We show that the functionally critical GluR2 subunit stably resides in an intracellular pool in the endoplasmic reticulum (ER). GluR2 in this pool is extensively complexed with GluR3 but not with GluR1, which is mainly confined to the cell surface. Mutagenesis revealed that elements in the C terminus including the PDZ motif are required for GluR2 forward-transport from the ER. Surprisingly, ER retention of GluR2 is controlled by Arg607 at the Q/R-editing site. Reversion to Gln (R607Q) resulted in rapid release from the pool and elevated surface expression of GluR2 in neurons. Therefore, Arg607 is a central regulator. In addition to channel gating, it also controls ER exit and may thereby ensure the availability of GluR2 for assembly into AMPARs.	NYU, Sch Med, Howard Hughes Med Inst, Dept Biochem, New York, NY 10016 USA	Howard Hughes Medical Institute; New York University	Ziff, EB (corresponding author), NYU, Sch Med, Howard Hughes Med Inst, Dept Biochem, New York, NY 10016 USA.			Ziff, Edward/0000-0001-7389-8649	NIA NIH HHS [AG13620] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG013620, R37AG013620] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BAEUERLE PA, 1987, J CELL BIOL, V105, P2655, DOI 10.1083/jcb.105.6.2655; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; BONIFACINO JS, 1991, EMBO J, V10, P2783, DOI 10.1002/j.1460-2075.1991.tb07827.x; Brodsky JL, 1999, SEMIN CELL DEV BIOL, V10, P507, DOI 10.1006/scdb.1999.0321; BRUSA R, 1995, SCIENCE, V270, P1677, DOI 10.1126/science.270.5242.1677; Chang XB, 1999, MOL CELL, V4, P137, DOI 10.1016/S1097-2765(00)80196-3; COSSON P, 1991, NATURE, V351, P414, DOI 10.1038/351414a0; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; Dev KK, 1999, NEUROPHARMACOLOGY, V38, P635, DOI 10.1016/S0028-3908(98)00230-5; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Dong HL, 1999, J NEUROSCI, V19, P6930, DOI 10.1523/JNEUROSCI.19-16-06930.1999; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Feldmeyer D, 1999, NAT NEUROSCI, V2, P57, DOI 10.1038/4561; Fernandez-Larrea J, 1999, MOL CELL, V3, P423, DOI 10.1016/S1097-2765(00)80470-0; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Hall RA, 1997, NEUROSCIENCE, V78, P361, DOI 10.1016/S0306-4522(96)00525-8; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Huh KH, 1999, J BIOL CHEM, V274, P151, DOI 10.1074/jbc.274.1.151; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; JONAS P, 1995, NEURON, V15, P987, DOI 10.1016/0896-6273(95)90087-X; Kopito Ron R., 1999, Physiological Reviews, V79, pS167; Lee SH, 2001, NEUROPHARMACOLOGY, V41, P680, DOI 10.1016/S0028-3908(01)00124-1; Li P, 1999, NAT NEUROSCI, V2, P972, DOI 10.1038/14771; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; MALLABIABARRENA A, 1995, EMBO J, V14, P2257, DOI 10.1002/j.1460-2075.1995.tb07220.x; Mammen AL, 1997, J NEUROSCI, V17, P7351; Manganas LN, 2001, P NATL ACAD SCI USA, V98, P14055, DOI 10.1073/pnas.241403898; Mansour M, 2001, NEURON, V32, P841, DOI 10.1016/S0896-6273(01)00520-7; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Perez JL, 2001, J NEUROSCI, V21, P5417, DOI 10.1523/JNEUROSCI.21-15-05417.2001; Rao A, 1998, J NEUROSCI, V18, P1217; Rubio ME, 1999, J NEUROSCI, V19, P5549; Rubio ME, 1999, J NEUROCHEM, V73, P942, DOI 10.1046/j.1471-4159.1999.0730942.x; Sans N, 2001, J NEUROSCI, V21, P7506, DOI 10.1523/JNEUROSCI.21-19-07506.2001; Scott DB, 2001, J NEUROSCI, V21, P3063, DOI 10.1523/JNEUROSCI.21-09-03063.2001; Seeburg PH, 1998, BRAIN RES REV, V26, P217, DOI 10.1016/S0165-0173(97)00062-3; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; Sprengel R, 2001, TRENDS PHARMACOL SCI, V22, P7, DOI 10.1016/S0165-6147(00)01588-1; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; STAUDINGER J, 1995, J CELL BIOL, V128, P263, DOI 10.1083/jcb.128.3.263; TERASAKI M, 1994, P NATL ACAD SCI USA, V91, P7510, DOI 10.1073/pnas.91.16.7510; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; WO ZG, 1995, TRENDS NEUROSCI, V18, P161; Wyszynski M, 1999, J NEUROSCI, V19, P6528; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	59	268	281	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 30	2002	34	5					759	772		10.1016/S0896-6273(02)00693-1	http://dx.doi.org/10.1016/S0896-6273(02)00693-1			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	558DV	12062022	Bronze			2022-12-24	WOS:000175951800010
J	Gurevich, I; Tamir, H; Arango, V; Dwork, AJ; Mann, JJ; Schmauss, C				Gurevich, I; Tamir, H; Arango, V; Dwork, AJ; Mann, JJ; Schmauss, C			Altered editing of serotonin 2C receptor pre-mRNA in the prefrontal cortex of depressed suicide victims	NEURON			English	Article							MESSENGER-RNA; 5-HT2C RECEPTOR; DEAMINASE ADAR1; GENE; 5-HYDROXYTRYPTAMINE(2C); SCHIZOPHRENIA; CLONING; VARIANT; BRAIN	Five adenosines within the coding sequence of the serotonin 2C receptor (5-HT2C) pre-mRNA are converted to inosines by RNA editing (named A, B, C' (E), C, and D sites). In human prefrontal cortex (PFC), the most abundant 5-HT2C mRNA sequences result from editing at the A site, or from the editing combinations AC'C, ABCD, and ABD. In suicide victims with a history of major depression, C' site editing is significantly increased, D site editing is significantly decreased, and the C site shows a trend toward increased editing. Treatment of mice with the antidepressant drug fluoxetine (Prozac(TM)) causes changes in C', C, and D site editing that are exactly opposite to those seen in suicide victims. Thus, one outcome of fluoxetine treatment may be to reverse the abnormalities in 5-HT2C pre-mRNA editing seen in depressed suicide victims.	Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Div Neurosci, New York, NY 10032 USA; Mt Sinai Grad Sch Biol Sci, New York, NY 10029 USA	Columbia University; Columbia University	Schmauss, C (corresponding author), Columbia Univ Coll Phys & Surg, Dept Psychiat, 630 W 168th St, New York, NY 10032 USA.		Arango, Victoria/K-9377-2015	Arango, Victoria/0000-0001-8811-400X	NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH046745, R56MH061906, P50MH046745, R01MH061906] Funding Source: NIH RePORTER; NIMH NIH HHS [MH 46745, MH 61906] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; Canton H, 1996, MOL PHARMACOL, V50, P799; Fitzgerald LW, 1999, NEUROPSYCHOPHARMACOL, V21, pS82, DOI 10.1038/sj.npp.1395328; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Huntsman MM, 1998, P NATL ACAD SCI USA, V95, P15066, DOI 10.1073/pnas.95.25.15066; JULIUS D, 1988, SCIENCE, V241, P558, DOI 10.1126/science.3399891; Liu Y, 1999, J BIOL CHEM, V274, P18351, DOI 10.1074/jbc.274.26.18351; Mann JJ, 2000, ARCH GEN PSYCHIAT, V57, P729, DOI 10.1001/archpsyc.57.8.729; Mann JJ, 1998, NAT MED, V4, P25, DOI 10.1038/nm0198-025; MOLINEAUX SM, 1989, P NATL ACAD SCI USA, V86, P6793, DOI 10.1073/pnas.86.17.6793; MORO O, 1993, J BIOL CHEM, V268, P22273; Niswender CM, 1999, J BIOL CHEM, V274, P9472, DOI 10.1074/jbc.274.14.9472; Niswender CM, 2001, NEUROPSYCHOPHARMACOL, V24, P478, DOI 10.1016/S0893-133X(00)00223-2; Roth BL, 1998, PHARMACOL THERAPEUT, V79, P231, DOI 10.1016/S0163-7258(98)00019-9; SALTZMAN AG, 1991, BIOCHEM BIOPH RES CO, V181, P1469, DOI 10.1016/0006-291X(91)92105-S; Schmauss C, 1996, J NEUROSCI, V16, P7902; SCHONEBERG T, 1995, J BIOL CHEM, V270, P18000; Seeburg PH, 2000, NEURON, V25, P261, DOI 10.1016/S0896-6273(00)80891-0; Sodhi MS, 2001, MOL PSYCHIATR, V6, P373, DOI 10.1038/sj.mp.4000920; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Wang Q, 2000, SCIENCE, V290, P1765, DOI 10.1126/science.290.5497.1765; Wang QD, 2000, J NEUROCHEM, V74, P1290	22	307	321	3	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 25	2002	34	3					349	356		10.1016/S0896-6273(02)00660-8	http://dx.doi.org/10.1016/S0896-6273(02)00660-8			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	545JW	11988167	Bronze			2022-12-24	WOS:000175214700007
J	Gauthier, I; Hayward, WG; Tarr, MJ; Anderson, AW; Skudlarski, P; Gore, JC				Gauthier, I; Hayward, WG; Tarr, MJ; Anderson, AW; Skudlarski, P; Gore, JC			BOLD activity during mental rotation and viewpoint-dependent object recognition	NEURON			English	Article							3-DIMENSIONAL OBJECTS; FUNCTIONAL ACTIVATION; SHAPE-RECOGNITION; NETWORK; FACES; TIME; FMRI; PERFORMANCE; INVARIANCE; ATTENTION	We measured brain activity during mental rotation and object recognition with objects rotated around three different axes. Activity in the superior parietal lobe (SPL) increased proportionally to viewpoint disparity during mental rotation, but not during object recognition. In contrast, the fusiform gyrus was preferentially recruited in a viewpoint-dependent manner in recognition as compared to mental rotation. In addition, independent of the effect of viewpoint, object recognition was associated with ventral areas and mental rotation with dorsal areas. These results indicate that the similar behavioral effects of viewpoint obtained in these two tasks are based on different neural substrates. Such findings call into question the hypothesis that mental rotation is used to compensate for changes in viewpoint during object recognition.	Vanderbilt Univ, Dept Psychol, Vanderbilt Vis Res Ctr, Nashville, TN 37203 USA; Chinese Univ Hong Kong, Dept Psychol, Shatin, Hong Kong, Peoples R China; Brown Univ, Dept Cognit & Linguist Sci, Providence, RI 02912 USA; Yale Univ, Sch Med, Dept Radiol, New Haven, CT 06510 USA	Vanderbilt University; Chinese University of Hong Kong; Brown University; Yale University	Gauthier, I (corresponding author), Vanderbilt Univ, Dept Psychol, Vanderbilt Vis Res Ctr, 502 Wilson Hall, Nashville, TN 37203 USA.	isabel.gauthier@vanderbilt.edu	Hayward, William G/C-2369-2009; Hayward, William Gordon/D-4911-2009	Hayward, William/0000-0002-7248-0301; Gauthier, Isabel/0000-0002-6249-4769	NINDS NIH HHS [NS 33332] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033332] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alivisatos B, 1997, NEUROPSYCHOLOGIA, V35, P111, DOI 10.1016/S0028-3932(96)00083-8; BIEDERMAN I, 1995, J EXP PSYCHOL HUMAN, V21, P1506, DOI 10.1037/0096-1523.21.6.1506; BIEDERMAN I, 1993, J EXP PSYCHOL HUMAN, V19, P1162, DOI 10.1037/0096-1523.19.6.1162; BULTHOFF HH, 1992, P NATL ACAD SCI USA, V89, P60, DOI 10.1073/pnas.89.1.60; Carpenter PA, 1999, J COGNITIVE NEUROSCI, V11, P9, DOI 10.1162/089892999563210; Cohen MS, 1996, BRAIN, V119, P89, DOI 10.1093/brain/119.1.89; CORBALLIS MC, 1984, J EXP PSYCHOL HUMAN, V10, P318, DOI 10.1037/0096-1523.10.2.318; CORBALLIS MC, 1982, SPATIAL ABILITIES DE, P173; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Coull JT, 1998, J NEUROSCI, V18, P7426; FOLK MD, 1987, J EXP PSYCHOL HUMAN, V13, P395, DOI 10.1037/0096-1523.13.3.395; Gauthier I, 2000, J COGNITIVE NEUROSCI, V12, P495, DOI 10.1162/089892900562165; GEORGOPOULOS AP, 1989, SCIENCE, V243, P234, DOI 10.1126/science.2911737; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Hayward WG, 2000, PSYCHOL SCI, V11, P7, DOI 10.1111/1467-9280.00207; Hayward WG, 1997, J EXP PSYCHOL HUMAN, V23, P1511, DOI 10.1037/0096-1523.23.5.1511; Hinton G., 1981, ATTENTION PERFORM, P261; HOCHBERG J, 1977, MEM COGNITION, V5, P23, DOI 10.3758/BF03209187; HUMMEL JE, 1992, PSYCHOL REV, V99, P480, DOI 10.1037/0033-295X.99.3.480; HUMPHREY GK, 1992, CAN J PSYCHOL, V46, P170, DOI 10.1037/h0084320; JOLICOEUR P, 1985, MEM COGNITION, V13, P289, DOI 10.3758/BF03202498; Jolicoeur P., 1990, MIND LANG, V5, P387, DOI [10.1111/j.1468-0017.1990.tb00170.x, DOI 10.1111/J.1468-0017.1990.TB00170.X]; JUST MA, 1976, COGNITIVE PSYCHOL, V8, P441, DOI 10.1016/0010-0285(76)90015-3; LAWSON R, 1994, PERCEPTION, V23, P595, DOI 10.1068/p230595; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; LOGOTHETIS NK, 1994, CURR BIOL, V4, P401, DOI 10.1016/S0960-9822(00)00089-0; Luna B, 1998, CEREB CORTEX, V8, P40, DOI 10.1093/cercor/8.1.40; Milner A. D., 1995, VISUAL BRAIN ACTION; Perrett DI, 1998, COGNITION, V67, P111, DOI 10.1016/S0010-0277(98)00015-8; PERRETT DI, 1987, TRENDS NEUROSCI, V10, P358, DOI 10.1016/0166-2236(87)90071-3; POGGIO T, 1990, NATURE, V343, P263, DOI 10.1038/343263a0; Richter W, 1997, NEUROREPORT, V8, P3697, DOI 10.1097/00001756-199712010-00008; ROCK I, 1989, COGNITIVE PSYCHOL, V21, P185, DOI 10.1016/0010-0285(89)90007-8; SHEPARD RN, 1971, SCIENCE, V171, P701, DOI 10.1126/science.171.3972.701; Shepard RN., 1982, J HIST BEHAV SCI, V19, P301, DOI 10.2307/1422825; Skudlarski P, 1999, NEUROIMAGE, V9, P311, DOI 10.1006/nimg.1999.0402; SUZUKI S, 1997, 4 ANN M COGN NEUR SO; Tagaris GA, 1996, NEUROREPORT, V7, P773, DOI 10.1097/00001756-199602290-00022; Tagaris GA, 1997, J COGNITIVE NEUROSCI, V9, P419, DOI 10.1162/jocn.1997.9.4.419; Talairach J., 1988, COPLANAR STEREOTAXIC; TARR MJ, 1989, COGNITIVE PSYCHOL, V21, P233, DOI 10.1016/0010-0285(89)90009-1; TARR MJ, 1995, J EXP PSYCHOL HUMAN, V21, P1494, DOI 10.1037/0096-1523.21.6.1494; Tarr MJ, 1998, COGNITION, V67, P1, DOI 10.1016/S0010-0277(98)00026-2; TARR MJ, 1995, PSYCHON B REV, V2, P55, DOI 10.3758/BF03214412; Tarr MJ, 2001, VISION RES, V41, P1981, DOI 10.1016/S0042-6989(01)00024-4; Tarr MJ, 1998, COGNITION, V67, P73, DOI 10.1016/S0010-0277(98)00023-7; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; WILSON KD, 1999, SOC NEUR ABSTR; YUILLE JC, 1982, PERCEPT PSYCHOPHYS, V31, P201, DOI 10.3758/BF03202524	49	150	154	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 28	2002	34	1					161	171		10.1016/S0896-6273(02)00622-0	http://dx.doi.org/10.1016/S0896-6273(02)00622-0			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536HR	11931750	Bronze			2022-12-24	WOS:000174695100018
J	Wyszynski, M; Kim, E; Dunah, AW; Passafaro, M; Valtschanoff, JG; Serra-Pages, C; Streuli, M; Weinberg, RJ; Sheng, M				Wyszynski, M; Kim, E; Dunah, AW; Passafaro, M; Valtschanoff, JG; Serra-Pages, C; Streuli, M; Weinberg, RJ; Sheng, M			Interaction between GRIP and liprin-alpha/SYD2 is required for AMPA receptor targeting	NEURON			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; FAMILY; LAR; SUBUNIT; BINDING; EXPRESSION; CLUSTER; DLAR	Interaction with the multi-PDZ protein GRIP is required for the synaptic targeting of AMPA receptors, but the underlying mechanism is unknown. We show that GRIP binds to the liprin-alpha/SYD2 family of proteins that interact with LAR receptor protein tyrosine phosphatases (LAR-RPTPs) and that are implicated in presynaptic development. In neurons, liprin-alpha and LAR-RPTP are enriched at synapses and coimmunoprecipitate with GRIP and AMPA receptors. Dominant-negative constructs that interfere with the GRIP-liprin interaction disrupt the surface expression and dendritic clustering of AMPA receptors in cultured neurons. Thus, by mediating the targeting of liprin/GRIP-associated proteins, liprin-alpha is important for postsynaptic as well as presynaptic maturation.	Massachusetts Gen Hosp, Dept Neurobiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA; MIT, Ctr Learning & Memory, RIKEN MIT Neurosci Res Ctr, Cambridge, MA 02139 USA; MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; Univ N Carolina, Dept Cell Biol & Anat, Chapel Hill, NC 27599 USA; Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); RIKEN; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Korea Advanced Institute of Science & Technology (KAIST); University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Sheng, M (corresponding author), Massachusetts Gen Hosp, Dept Neurobiol, Boston, MA 02114 USA.	msheng@mit.edu	Weinberg, Richard/AAC-1898-2020; Kim, Eunjoon/C-1566-2011	Sheng, Morgan/0000-0002-8703-5366; Weinberg, Richard/0000-0001-9689-7278	NCI NIH HHS [CA 55547] Funding Source: Medline; NINDS NIH HHS [NS35050] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA055547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035050] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Banker G., 1991, CULTURING NERVE CELL; Bateman J, 2000, NEURON, V26, P93, DOI 10.1016/S0896-6273(00)81141-1; Bruckner K, 1999, NEURON, V22, P511, DOI 10.1016/S0896-6273(00)80706-0; Dai ZS, 1998, J CELL BIOL, V141, P1613, DOI 10.1083/jcb.141.7.1613; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Dong HL, 1999, J NEUROSCI, V19, P6930, DOI 10.1523/JNEUROSCI.19-16-06930.1999; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Krueger NX, 1996, CELL, V84, P611, DOI 10.1016/S0092-8674(00)81036-3; Lin D, 1999, J BIOL CHEM, V274, P3726, DOI 10.1074/jbc.274.6.3726; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; NIETHAMMER M, 1999, METHOD ENZYMOL, P104; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; PHEND KD, 1995, J HISTOCHEM CYTOCHEM, V43, P283, DOI 10.1177/43.3.7532656; PHEND KD, 1992, J HISTOCHEM CYTOCHEM, V40, P1011, DOI 10.1177/40.7.1376741; PULIDO R, 1995, P NATL ACAD SCI USA, V92, P11686, DOI 10.1073/pnas.92.25.11686; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Serra-Pages C, 1998, J BIOL CHEM, V273, P15611, DOI 10.1074/jbc.273.25.15611; SERRAPAGES C, 1995, EMBO J, V14, P2827, DOI 10.1002/j.1460-2075.1995.tb07282.x; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; STREULI M, 1992, EMBO J, V11, P897, DOI 10.1002/j.1460-2075.1992.tb05128.x; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; Turrigiano GG, 2000, NEURON, V26, P5, DOI 10.1016/S0896-6273(00)81131-9; Valtschanoff JG, 1999, J COMP NEUROL, V410, P599; Van Vactor D, 1998, CURR OPIN CELL BIOL, V10, P174, DOI 10.1016/S0955-0674(98)80139-7; Wills Z, 1999, NEURON, V22, P301, DOI 10.1016/S0896-6273(00)81091-0; Wyszynski M, 1999, J NEUROSCI, V19, P6528; Wyszynski M, 1998, NEUROPHARMACOLOGY, V37, P1335, DOI 10.1016/S0028-3908(98)00120-8; WYSZYNSKI M, 1999, METHOD ENZYMOL, P371; Ye B, 2000, NEURON, V26, P603, DOI 10.1016/S0896-6273(00)81198-8; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886	34	195	209	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 28	2002	34	1					39	52		10.1016/S0896-6273(02)00640-2	http://dx.doi.org/10.1016/S0896-6273(02)00640-2			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536HR	11931740	Bronze, Green Published			2022-12-24	WOS:000174695100008
J	Baranauskas, G; Tkatch, T; Nagata, K; Yeh, JZ; Surmeier, DJ				Baranauskas, G; Tkatch, T; Nagata, K; Yeh, JZ; Surmeier, DJ			Kv3.4 subunits enhance the repolarizing efficiency of Kv3.1 channels in fast-spiking neurons	NATURE NEUROSCIENCE			English	Article							GATED K+ CHANNELS; NEOSTRIATAL CHOLINERGIC INTERNEURONS; POTASSIUM-CHANNEL; SUBTHALAMIC NUCLEUS; RAT HIPPOCAMPUS; A-TYPE; CURRENTS; BRAIN; EXPRESSION; PARKINSONISM	Neurons with the capacity to discharge at high rates-'fast-spiking' (FS) neurons-are critical participants in central motor and sensory circuits. It is widely accepted that K+ channels with Kv3.1 or Kv3.2 subunits underlie fast, delayed-rectifier (DR) currents that endow neurons with this FS ability. Expression of these subunits in heterologous systems, however, yields channels that open at more depolarized potentials than do native Kv3 family channels, suggesting that they differ. One possibility is that native channels incorporate a subunit that modifies gating. Molecular, electrophysiological and pharmacological studies reported here suggest that a splice variant of the Kv3.4 subunit coassembles with Kv3.1 subunits in rat brain FS neurons. Coassembly enhances the spike repolarizing efficiency of the channels, thereby reducing spike duration and enabling higher repetitive spike rates. These results suggest that manipulation of K3.4 subunit expression could be a useful means of controlling the dynamic range of FS neurons.	Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Biol Chem, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Surmeier, DJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Physiol, 303 E Chicago Ave, Chicago, IL 60611 USA.			Tkatch, Tatiana/0000-0001-6626-7435	NINDS NIH HHS [NS26473, NS34696] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034696, R37NS034696] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott GW, 2001, CELL, V104, P217, DOI 10.1016/S0092-8674(01)00207-0; Baranauskas G, 1999, J NEUROSCI, V19, P6394; BERGMAN H, 1994, J NEUROPHYSIOL, V72, P507, DOI 10.1152/jn.1994.72.2.507; Brew HM, 1995, J NEUROSCI, V15, P8011; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; DeLong MR, 2001, ANN NEUROL, V49, P142, DOI 10.1002/1531-8249(20010201)49:2<142::AID-ANA32>3.0.CO;2-O; DEMIERA EV, 1994, HDB MEMBRANE CHANNEL, P41; Diochot S, 1998, J BIOL CHEM, V273, P6744, DOI 10.1074/jbc.273.12.6744; Du J, 1996, J NEUROSCI, V16, P506; Erisir A, 1999, J NEUROPHYSIOL, V82, P2476, DOI 10.1152/jn.1999.82.5.2476; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P449, DOI 10.1113/jphysiol.1952.sp004717; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P473, DOI 10.1113/jphysiol.1952.sp004718; KOFUJI P, 1995, P NATL ACAD SCI USA, V92, P6542, DOI 10.1073/pnas.92.14.6542; LENZ S, 1994, SYNAPSE, V18, P55, DOI 10.1002/syn.890180108; Macica CM, 2001, J NEUROSCI, V21, P1160; Martina M, 1998, J NEUROSCI, V18, P8111; Murakoshi H, 1997, MOL PHARMACOL, V52, P821, DOI 10.1124/mol.52.5.821; Raz A, 2000, J NEUROSCI, V20, P8559, DOI 10.1523/JNEUROSCI.20-22-08559.2000; RETTIG J, 1992, EMBO J, V11, P2473, DOI 10.1002/j.1460-2075.1992.tb05312.x; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; Rhodes KJ, 1997, J NEUROSCI, V17, P8246; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; SCHROTER KH, 1991, FEBS LETT, V278, P211, DOI 10.1016/0014-5793(91)80119-N; SHENG M, 1993, NATURE, V365, P72, DOI 10.1038/365072a0; Song WJ, 1998, J NEUROSCI, V18, P3124; SURMEIER DJ, 1995, NEURON, V14, P385, DOI 10.1016/0896-6273(95)90294-5; THOMPSON S, 1982, J GEN PHYSIOL, V80, P1, DOI 10.1085/jgp.80.1.1; Tkatch T, 1998, NEUROREPORT, V9, P1935, DOI 10.1097/00001756-199806220-00004; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; WEISER M, 1995, J NEUROSCI, V15, P4298; WEISER M, 1994, J NEUROSCI, V14, P949, DOI 10.1523/JNEUROSCI.14-03-00949.1994; Wigmore MA, 2000, J PHYSIOL-LONDON, V527, P493, DOI 10.1111/j.1469-7793.2000.t01-1-00493.x; Yan Z, 1996, J NEUROSCI, V16, P2592	34	114	122	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2003	6	3					258	266		10.1038/nn1019	http://dx.doi.org/10.1038/nn1019			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	648YB	12592408				2022-12-24	WOS:000181178300014
J	Sankaranarayanan, S; Atluri, PP; Ryan, TA				Sankaranarayanan, S; Atluri, PP; Ryan, TA			Actin has a molecular scaffolding, not propulsive, role in presynaptic function	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; BRAIN MYOSIN-V; SYNAPTIC VESICLES; NEUROTRANSMITTER RELEASE; CELLS; SYNAPSES; PROTEIN; POLYMERIZATION; ARCHITECTURE; CYTOSKELETON	We used actin tagged with enhanced green fluorescent protein (EGFP-actin) to characterize the distribution and dynamics of actin in living presynaptic terminals in rat CNS neurons. Actin was preferentially concentrated around-and appeared to surround-the presynaptic vesicle cluster. In resting terminals, similar to30% of actin was found to be in a polymerized but dynamic state, with a remodeling time scale of similar to20 s. During electrical activity, actin was further polymerized and recruited from nearby axonal regions to the regions surrounding vesicles. Treatment of terminals with the actin monomer-sequestering agent latrunculin-A completely dispersed the actin network and abolished activity-dependent actin dynamics. We used a variety of methods to examine the role of actin in the presynaptic vesicle cycle. These data rule out a propulsive role for actin, either in maintaining the vesicle cluster or in guiding vesicle recycling. Instead, we propose that actin acts as a scaffolding system for regulatory molecules in the nerve terminal.	Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA	Cornell University	Ryan, TA (corresponding author), Cornell Univ, Weill Med Coll, Dept Biochem, 1300 York Ave, New York, NY 10021 USA.	taryan@med.cornell.edu	Ryan, Timothy/AAO-8286-2020	Ryan, Timothy/0000-0003-2533-9548; Atluri, Pradeep/0000-0002-0871-8311	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM061925] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM61925] Funding Source: Medline; NINDS NIH HHS [NS24692] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allison DW, 1998, J NEUROSCI, V18, P2423; Ballestrem C, 1998, J CELL SCI, V111, P1649; Benfenati F, 1999, PHILOS T R SOC B, V354, P243, DOI 10.1098/rstb.1999.0376; Bernstein BW, 1998, MOL BRAIN RES, V53, P236, DOI 10.1016/S0169-328X(97)00319-7; Betz WJ, 1998, ANNU REV PHYSIOL, V60, P347, DOI 10.1146/annurev.physiol.60.1.347; CANO M, 1995, J CELL BIOL, V115, P677; Chan AY, 2000, J CELL BIOL, V148, P531, DOI 10.1083/jcb.148.3.531; Chi P, 2001, NAT NEUROSCI, V4, P1187, DOI 10.1038/nn756; Cole JC, 2000, J PHYSIOL-LONDON, V525, P579, DOI 10.1111/j.1469-7793.2000.t01-2-00579.x; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2; Dresbach T, 2001, CELL MOL LIFE SCI, V58, P94, DOI 10.1007/PL00000781; Evans LL, 1998, J CELL SCI, V111, P2055; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Gautier I, 2001, BIOPHYS J, V80, P3000, DOI 10.1016/S0006-3495(01)76265-0; Goldberg MB, 2001, MICROBIOL MOL BIOL R, V65, P595, DOI 10.1128/MMBR.65.4.595-626.2001; GOTOW T, 1991, NEUROSCIENCE, V40, P587, DOI 10.1016/0306-4522(91)90143-C; HIROKAWA N, 1989, J CELL BIOL, V108, P111, DOI 10.1083/jcb.108.1.111; Holzinger A, 2001, METH MOL B, V161, P109; Job C, 1998, J CELL BIOL, V143, P1661, DOI 10.1083/jcb.143.6.1661; Kuromi H, 1998, NEURON, V20, P917, DOI 10.1016/S0896-6273(00)80473-0; LANDIS DMD, 1988, NEURON, V1, P201, DOI 10.1016/0896-6273(88)90140-7; Lee E, 2002, P NATL ACAD SCI USA, V99, P161, DOI 10.1073/pnas.012607799; May RC, 2001, J CELL SCI, V114, P1061; Merrifield CJ, 1999, NAT CELL BIOL, V1, P72, DOI 10.1038/9048; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Morales M, 2000, NEURON, V27, P539, DOI 10.1016/S0896-6273(00)00064-7; Mounier N, 1997, J CELL SCI, V110, P839; Prekeris R, 1997, J CELL BIOL, V137, P1589, DOI 10.1083/jcb.137.7.1589; Qualmann B, 1999, MOL BIOL CELL, V10, P501, DOI 10.1091/mbc.10.2.501; Roos J, 1999, CURR BIOL, V9, P1411, DOI 10.1016/S0960-9822(00)80087-1; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Schafer DA, 2002, CURR OPIN CELL BIOL, V14, P76, DOI 10.1016/S0955-0674(01)00297-6; Shupliakov O, 2002, P NATL ACAD SCI USA, V99, P14476, DOI 10.1073/pnas.212381799; SPECTOR I, 1989, CELL MOTIL CYTOSKEL, V13, P127, DOI 10.1002/cm.970130302; VITALE ML, 1995, NEURON, V14, P353, DOI 10.1016/0896-6273(95)90291-0; Wang XH, 1996, J PHYSIOL-LONDON, V491, P187, DOI 10.1113/jphysiol.1996.sp021206; Zhang WD, 2001, J NEUROSCI, V21, P5169, DOI 10.1523/JNEUROSCI.21-14-05169.2001	40	245	250	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2003	6	2					127	135		10.1038/nn1002	http://dx.doi.org/10.1038/nn1002			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	640CL	12536209				2022-12-24	WOS:000180669100012
J	Zwiers, MP; Van Opstal, AJ; Paige, GD				Zwiers, MP; Van Opstal, AJ; Paige, GD			Plasticity in human sound localization induced by compressed spatial vision	NATURE NEUROSCIENCE			English	Article							AUDITORY LOCALIZATION; SUPERIOR COLLICULUS; SPACE; REPRESENTATION; ORGANIZATION; ADAPTATION; ADJUSTMENT; NUCLEUS; GUIDES; CUES	Auditory and visual target locations are encoded differently in the brain, but must be co-calibrated to maintain cross-sensory concordance. Mechanisms that adjust spatial calibration across modalities have been described (for example, prism adaptation in owls), though rudimentarily in humans. We quantified the adaptation of human sound localization in response to spatially compressed vision (0.5x lenses for 2-3 days). This induced a corresponding compression of auditory localization that was most pronounced for azimuth (minimal for elevation) and was restricted to the visual field of the lenses. Sound localization was also affected outside the field of visual-auditory interaction (shifted centrally, not compressed). These results suggest that spatially modified vision induces adaptive changes in adult human sound localization, including novel mechanisms that account for spatial compression. Findings are consistent with a model in which the central processing of sound location is encoded by recruitment rather than by a place code.	Univ Rochester, Med Ctr, Dept Neurobiol & Anat, Rochester, NY 14642 USA; Univ Nijmegen, Dept Biophys, NL-6525 EZ Nijmegen, Netherlands	University of Rochester; Radboud University Nijmegen	Paige, GD (corresponding author), Univ Rochester, Med Ctr, Dept Neurobiol & Anat, 601 Elmwood Ave,Box 603, Rochester, NY 14642 USA.	gary_paige@urmc.rochester.edu	Zwiers, Marcel P/D-2968-2009; van Opstal, John/D-1907-2010	Zwiers, Marcel P/0000-0001-5483-2935; van Opstal, John/0000-0001-5957-5712	NATIONAL INSTITUTE ON AGING [R01AG016319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001935] Funding Source: NIH RePORTER; NCRR NIH HHS [RR09283] Funding Source: Medline; NIA NIH HHS [AG16319] Funding Source: Medline; NIDCD NIH HHS [DC01935] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BERTHOZ A, 1985, REV OCULOMOTOR RES, V1; Blauert J., 1997, SPATIAL HEARING PSYC; BRAINARD MS, 1995, J NEUROPHYSIOL, V73, P595, DOI 10.1152/jn.1995.73.2.595; CARR CE, 1993, J COMP NEUROL, V334, P337, DOI 10.1002/cne.903340302; FRENS MA, 1994, EXP BRAIN RES, V100, P293, DOI 10.1007/BF00227199; Good MD, 1996, J ACOUST SOC AM, V99, P1108, DOI 10.1121/1.415233; Goossens HHLM, 1999, J NEUROPHYSIOL, V81, P2720, DOI 10.1152/jn.1999.81.6.2720; Hofman PM, 1998, J ACOUST SOC AM, V103, P2634, DOI 10.1121/1.422784; Hofman PM, 1998, NAT NEUROSCI, V1, P417, DOI 10.1038/1633; Hyde PS, 2001, J NEUROSCI, V21, P8586, DOI 10.1523/JNEUROSCI.21-21-08586.2001; Irvine DRF, 1986, PROGR SENSORY PHYSL; KING AJ, 1991, TRENDS NEUROSCI, V14, P31, DOI 10.1016/0166-2236(91)90181-S; KING AJ, 1988, NATURE, V332, P73, DOI 10.1038/332073a0; Knudsen EI, 1998, SCIENCE, V279, P1531, DOI 10.1126/science.279.5356.1531; KNUDSEN EI, 1995, ANNU REV NEUROSCI, V18, P19, DOI 10.1146/annurev.ne.18.030195.000315; KNUDSEN EI, 1986, J NEUROSCI, V6, P1918; KNUDSEN EI, 1985, SCIENCE, V230, P545, DOI 10.1126/science.4048948; Lackner J R, 1976, Environ Biol Med, V2, P137; Lessard N, 1998, NATURE, V395, P278, DOI 10.1038/26228; MIDDLEBROOKS JC, 1992, J ACOUST SOC AM, V92, P2607, DOI 10.1121/1.404400; MIDDLEBROOKS JC, 1984, J NEUROSCI, V4, P2621; OLDFIELD SR, 1986, PERCEPTION, V15, P67, DOI 10.1068/p150067; Paige GD, 1998, J NEUROPHYSIOL, V80, P2391, DOI 10.1152/jn.1998.80.5.2391; RAUSCHECKER JP, 1995, TRENDS NEUROSCI, V18, P36, DOI 10.1016/0166-2236(95)93948-W; Roder B, 1999, NATURE, V400, P162, DOI 10.1038/22106; Shinn-Cunningham B, 2000, PERCEPT PSYCHOPHYS, V62, P33, DOI 10.3758/BF03212059; Shinn-Cunningham BG, 1998, J ACOUST SOC AM, V103, P3667, DOI 10.1121/1.423107; SMITH PH, 1993, J COMP NEUROL, V331, P245, DOI 10.1002/cne.903310208; Wallace MT, 1998, J NEUROPHYSIOL, V80, P1006, DOI 10.1152/jn.1998.80.2.1006; Wightman FL, 1997, J ACOUST SOC AM, V101, P1050, DOI 10.1121/1.418029; WIGHTMAN FL, 1989, J ACOUST SOC AM, V85, P858, DOI 10.1121/1.397557; WISE LZ, 1985, J NEUROPHYSIOL, V54, P185, DOI 10.1152/jn.1985.54.2.185; Zwiers MP, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-09-j0002.2001; Zwiers MP, 2001, EXP BRAIN RES, V140, P206, DOI 10.1007/s002210100800	34	106	106	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2003	6	2					175	181		10.1038/nn999	http://dx.doi.org/10.1038/nn999			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	640CL	12524547				2022-12-24	WOS:000180669100018
J	Zlatic, M; Landgraf, M; Bate, M				Zlatic, M; Landgraf, M; Bate, M			Genetic specification of axonal arbors: atonal regulates robo3 to position terminal branches in the Drosophila nervous system	NEURON			English	Article							SENSORY ORGAN IDENTITY; LONG-RANGE GUIDANCE; PRONEURAL GENE; CENTRAL PROJECTIONS; ECTOPIC EXPRESSION; COMBINATORIAL CODE; DISTINCT ROLES; NEURONS; SLIT; ROUNDABOUT	Drosophila sensory neurons form distinctive terminal branch patterns in the developing neuropile of the embryonic central nervous system. In this paper we make a genetic analysis of factors regulating arbor position. We show that mediolateral position is determined in a binary fashion by expression (chordotonal neurons) or nonexpression (multidendritic neurons) of the Robo3 receptor for the midline repellent Slit. Robo3 expression is one of a suite of chordotonal neuron properties that depend on expression of the proneural gene atonal. Different features of terminal branches are separately regulated: an arbor can be shifted mediolaterally without affecting its dorsoventral location, and the distinctive remodeling of one arbor continues as normal despite this arbor shifting to an abnormal position in the neuropile.	Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Cambridge	Bate, M (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	cmb16@cus.cam.ac.uk		Zlatic, Marta/0000-0002-3149-2250				Baines RA, 1998, J NEUROSCI, V18, P4673; Battye R, 1999, DEVELOPMENT, V126, P2475; BLOCHLINGER K, 1991, GENE DEV, V5, P1124, DOI 10.1101/gad.5.7.1124; BLOCHLINGER K, 1988, NATURE, V333, P629, DOI 10.1038/333629a0; BOYAN GS, 1993, PROG NEUROBIOL, V41, P657, DOI 10.1016/0301-0082(93)90030-V; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brewster R, 2001, MECH DEVELOP, V105, P57, DOI 10.1016/S0925-4773(01)00375-6; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; Casso D, 2000, MECH DEVELOP, V91, P449; Godenschwege TA, 2002, J NEUROSCI, V22, P3117, DOI 10.1523/JNEUROSCI.22-08-03117.2002; Goulding SE, 2000, NEURON, V25, P69, DOI 10.1016/S0896-6273(00)80872-7; Grillenzoni N, 1998, DEVELOPMENT, V125, P3563; HARTENSTEIN V, 1988, DEVELOPMENT, V102, P869; Hassan BA, 2000, GENE DEV, V14, P1852; Hassan BA, 2000, NEURON, V25, P549, DOI 10.1016/S0896-6273(00)81059-4; Huang ML, 2000, NEURON, V25, P57, DOI 10.1016/S0896-6273(00)80871-5; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; JARMAN AP, 1995, DEVELOPMENT, V121, P2019; JARMAN AP, 1993, CELL, V73, P1307, DOI 10.1016/0092-8674(93)90358-W; Jarman AP, 1998, MECH DEVELOP, V76, P117, DOI 10.1016/S0925-4773(98)00116-6; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kidd T, 1998, NEURON, V20, P25, DOI 10.1016/S0896-6273(00)80431-6; KIMMEL CB, 1979, P NATL ACAD SCI USA, V76, P4691, DOI 10.1073/pnas.76.9.4691; Landgraf M, 1997, J NEUROSCI, V17, P9642; LIN DM, 1994, NEURON, V13, P1055, DOI 10.1016/0896-6273(94)90045-0; Marie B, 2002, J NEUROSCI, V22, P832, DOI 10.1523/JNEUROSCI.22-03-00832.2002; MERRITT DJ, 1995, J NEUROSCI, V15, P1755, DOI 10.1523/JNEUROSCI.15-03-01755.1995; MLODZIK M, 1990, GENE DEV, V4, P1848, DOI 10.1101/gad.4.11.1848; PATTEL NH, 1994, DROSPHILIA MELANOGAS, P445; Prokop A, 1998, J CELL BIOL, V143, P1283, DOI 10.1083/jcb.143.5.1283; Rajagopalan S, 2000, CELL, V103, P1033, DOI 10.1016/S0092-8674(00)00207-5; Schrader S, 2000, J COMP NEUROL, V425, P34; Simpson JH, 2000, CELL, V103, P1019, DOI 10.1016/S0092-8674(00)00206-3; Simpson JH, 2000, NEURON, V28, P753, DOI 10.1016/S0896-6273(00)00151-3; Thor S, 1999, NATURE, V397, P76, DOI 10.1038/16275; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; Wong K, 2002, CURR OPIN GENET DEV, V12, P583, DOI 10.1016/S0959-437X(02)00343-X	38	64	64	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 9	2003	37	1					41	51		10.1016/S0896-6273(02)01131-5	http://dx.doi.org/10.1016/S0896-6273(02)01131-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	646UV	12526771	Bronze			2022-12-24	WOS:000181054700008
J	Fujiwara, M; Sengupta, P; McIntire, SL				Fujiwara, M; Sengupta, P; McIntire, SL			Regulation of body size and behavioral state of C-elegans by sensory perception and the EGL-4 cGMP-dependent protein kinase	NEURON			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; NUCLEOTIDE-GATED CHANNEL; LONG-TERM POTENTIATION; CHEMOSENSORY RECEPTORS; GUANYLYL CYCLASE; SEROTONIN; PATHWAY; HOMOLOG; NEURONS; ACTS	The growth and behavior of higher organisms depend on the accurate perception and integration of sensory stimuli by the nervous system. We show that defects in sensory perception in C. elegans result in abnormalities in the growth of the animal and in the expression of alternative behavioral states. Our analysis suggests that sensory neurons modulate neural or neuroendocrine functions, regulating both bodily growth and behavioral state. We identify genes likely to be required for these functions downstream of sensory inputs. Here, we characterize one of these genes as egl-4, which we show encodes a cGMP-dependent protein kinase. We demonstrate that this cGMP-dependent kinase functions in neurons of C. elegans to regulate multiple developmental and behavioral processes including the orchestrated growth of the animal and the expression of particular behavioral states.	Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Emeryville, CA 94608 USA; Univ Calif San Francisco, Dept Neurol, Program Neurosci, Emeryville, CA 94608 USA; Univ Calif San Francisco, Dept Neurol, Dept Biomed Sci, Emeryville, CA 94608 USA; Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02454 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Brandeis University; Brandeis University	McIntire, SL (corresponding author), Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, 5858 Horton St,Suite 200, Emeryville, CA 94608 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS044232] Funding Source: NIH RePORTER; NINDS NIH HHS [P01 NS044232] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ailion M, 2000, GENETICS, V156, P1047; BRENNER S, 1974, GENETICS, V77, P71; Brundage L, 1996, NEURON, V16, P999, DOI 10.1016/S0896-6273(00)80123-3; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; Daniels SA, 2000, GENETICS, V156, P123; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; Fujiwara M, 1999, DEVELOPMENT, V126, P4839; Hardaker LA, 2001, J NEUROBIOL, V49, P303, DOI 10.1002/neu.10014; Kleppisch T, 1999, J NEUROSCI, V19, P48, DOI 10.1523/JNEUROSCI.19-01-00048.1999; Klyachko VA, 2001, NEURON, V31, P1015, DOI 10.1016/S0896-6273(01)00449-4; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; L'Etoile ND, 2002, NEURON, V36, P1079, DOI 10.1016/S0896-6273(02)01066-8; Lanjuin A, 2002, NEURON, V33, P369, DOI 10.1016/S0896-6273(02)00572-X; LevRam V, 1997, NEURON, V18, P1025, DOI 10.1016/S0896-6273(00)80340-2; LEWIS JA, 1977, J COMP NEUROL, V172, P489, DOI 10.1002/cne.901720306; McLellan RA, 1998, NEUROREPORT, V9, P3919, DOI 10.1097/00001756-199812010-00028; Miller KG, 1999, NEURON, V24, P323, DOI 10.1016/S0896-6273(00)80847-8; Morita K, 2002, EMBO J, V21, P1063, DOI 10.1093/emboj/21.5.1063; Morita K, 1999, DEVELOPMENT, V126, P1337; Osborne KA, 2001, CHEM SENSES, V26, P223, DOI 10.1093/chemse/26.2.223; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; Patterson GI, 1997, GENE DEV, V11, P2679, DOI 10.1101/gad.11.20.2679; Patterson GI, 2000, TRENDS GENET, V16, P27, DOI 10.1016/S0168-9525(99)01916-2; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Pfeifer A, 1999, Rev Physiol Biochem Pharmacol, V135, P105, DOI 10.1007/BFb0033671; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Qin HM, 2001, CURR BIOL, V11, P457, DOI 10.1016/S0960-9822(01)00122-1; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; Sokolowski MB, 1998, NEURON, V21, P463, DOI 10.1016/S0896-6273(00)80556-5; Stansberry J, 2001, J NEUROCHEM, V76, P1177, DOI 10.1046/j.1471-4159.2001.00131.x; Suzuki Y, 1999, DEVELOPMENT, V126, P241; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; TRENT C, 1983, GENETICS, V104, P619; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Waggoner LE, 1998, NEURON, V21, P203, DOI 10.1016/S0896-6273(00)80527-9; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Yoshida S, 2001, DEV BIOL, V240, P32, DOI 10.1006/dbio.2001.0443; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384; ZHUO M, 1994, NATURE, V368, P635, DOI 10.1038/368635a0; Zwaal RR, 1997, GENETICS, V145, P715	44	235	245	2	36	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 19	2002	36	6					1091	1102		10.1016/S0896-6273(02)01093-0	http://dx.doi.org/10.1016/S0896-6273(02)01093-0			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	628TA	12495624	Bronze			2022-12-24	WOS:000180011600012
J	Lee, AK; Wilson, MA				Lee, AK; Wilson, MA			Memory of sequential experience in the hippocampus during slow wave sleep	NEURON			English	Article							SPATIOTEMPORAL FIRING PATTERNS; PHASE PRECESSION; SPATIAL MAP; REPLAY; COMPRESSION; SEQUENCES; DYNAMICS; NEURONS; MODEL; RAT	Rats repeatedly ran through a sequence of spatial receptive fields of hippocampal CA1 place cells in a fixed temporal order. A novel combinatorial decoding method reveals that these neurons repeatedly fired in precisely this order in long sequences involving four or more cells during slow wave sleep (SWS) immediately following, but not preceding, the experience. The SWS sequences occurred intermittently in brief (similar to100 ms) bursts, each compressing the behavioral sequence in time by approximately 20-fold. This rapid encoding of sequential experience is consistent with evidence that the hippocampus is crucial for spatial learning in rodents and the formation of long-term memories of events in time in humans.	MIT, Picower Ctr Learning & Memory, RIKEN,Neurosci Res Ctr, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); RIKEN	Lee, AK (corresponding author), MIT, Picower Ctr Learning & Memory, RIKEN,Neurosci Res Ctr, Dept Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	albert@cortical.mit.edu; wilson@ai.mit.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH058880] Funding Source: NIH RePORTER; NIMH NIH HHS [MH-58880] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ABELES M, 1988, J NEUROPHYSIOL, V60, P909, DOI 10.1152/jn.1988.60.3.909; ABELES M, 1993, J NEUROPHYSIOL, V70, P1629, DOI 10.1152/jn.1993.70.4.1629; Abeles M, 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; August DA, 1999, J COMPUT NEUROSCI, V6, P71, DOI 10.1023/A:1008861001091; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Blum KI, 1996, NEURAL COMPUT, V8, P85, DOI 10.1162/neco.1996.8.1.85; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; Frank MG, 2001, NEURON, V30, P275, DOI 10.1016/S0896-6273(01)00279-3; GUSTAFSSON B, 1987, J NEUROSCI, V7, P774; Kesner RP, 2002, BEHAV NEUROSCI, V116, P286, DOI 10.1037//0735-7044.116.2.286; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; LEVY WB, 1983, NEUROSCIENCE, V8, P791, DOI 10.1016/0306-4522(83)90010-6; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; Mehta MR, 1997, P NATL ACAD SCI USA, V94, P8918, DOI 10.1073/pnas.94.16.8918; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; Milner B., 1966, AMNESIA, P109; Mishkin M, 1998, HIPPOCAMPUS, V8, P212; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; PAVLIDES C, 1989, J NEUROSCI, V9, P2907; Quirk MC, 1999, J NEUROSCI METH, V94, P41, DOI 10.1016/S0165-0270(99)00124-7; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Stickgold R, 2000, J COGNITIVE NEUROSCI, V12, P246, DOI 10.1162/089892900562075; Wallenstein GV, 1997, J NEUROPHYSIOL, V78, P393, DOI 10.1152/jn.1997.78.1.393; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950	42	790	802	4	80	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 19	2002	36	6					1183	1194		10.1016/S0896-6273(02)01096-6	http://dx.doi.org/10.1016/S0896-6273(02)01096-6			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	628TA	12495631	Bronze			2022-12-24	WOS:000180011600019
J	Hernandez, PJ; Sadeghian, K; Kelley, AE				Hernandez, PJ; Sadeghian, K; Kelley, AE			Early consolidation of instrumental learning requires protein synthesis in the nucleus accumbens	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; MEMORY; DOPAMINE; ACQUISITION; EXTINCTION; RECEPTORS; NMDA; RAT; NEUROSCIENCE; ACTIVATION	It is widely held that long-term memories are established by consolidation of newly acquired information into stable neural representations, a process that requires protein synthesis and synaptic plasticity. Plasticity within the nucleus accumbens (NAc), a major component of the ventral striatum, is thought to mediate instrumental learning processes and many aspects of drug addiction. Here we show that the inhibition of protein synthesis within the NAc disrupts consolidation of an appetitive instrumental learning task (lever-pressing for food) in rats. Post-trial infusions of anisomycin immediately after the first several training sessions prevented consolidation, whereas infusions delayed by 2 or 4 hours had no effect. However, if the rats were allowed to learn the task, the behavior was not sensitive to disruption by intra-accumbens anisomycin. Control infusions into the medial NAc shell or the dorsolateral striatum did not impair learning; in fact, an enhancement was observed in the latter case. These results show that de novo protein synthesis within the NAc is necessary for the consolidation, but not reconsolidation, of appetitive instrumental memories.	Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA; Univ Wisconsin, Sch Med, Dept Psychiat, Madison, WI 53719 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Hernandez, PJ (corresponding author), Univ Wisconsin, Neurosci Training Program, 7226 Med Sci Ctr,1300 Univ Ave, Madison, WI 53706 USA.	phernand@wisc.edu			NIDA NIH HHS [DA04788] Funding Source: Medline; NIGMS NIH HHS [GM07507] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA004788, R01DA004788, R29DA004788] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Abel T, 2001, CURR OPIN NEUROBIOL, V11, P180, DOI 10.1016/S0959-4388(00)00194-X; AGRANOFF BW, 1967, SCI AM, V216, P115, DOI 10.1038/scientificamerican0667-115; Baldwin AE, 2000, BEHAV NEUROSCI, V114, P84, DOI 10.1037/0735-7044.114.1.84; Berman DE, 2001, SCIENCE, V291, P2417, DOI 10.1126/science.1058165; Bracha V, 1998, BRAIN RES, V788, P169, DOI 10.1016/S0006-8993(97)01535-7; CARLI M, 1985, NATURE, V313, P679, DOI 10.1038/313679a0; Corbit LH, 2001, J NEUROSCI, V21, P3251, DOI 10.1523/JNEUROSCI.21-09-03251.2001; Crofts HS, 2001, CEREB CORTEX, V11, P1015, DOI 10.1093/cercor/11.11.1015; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; DICKINSON A, 1994, ANIM LEARN BEHAV, V22, P1, DOI 10.3758/BF03199951; Dudai Y, 1996, NEURON, V17, P367, DOI 10.1016/S0896-6273(00)80168-3; FAIRLEY P, 1986, BEHAV NEUROSCI, V100, P652, DOI 10.1037/0735-7044.100.5.652; FLEXNER LB, 1965, EXP NEUROL, V13, P264, DOI 10.1016/0014-4886(65)90114-7; FLOOD JF, 1973, PHYSIOL BEHAV, V10, P555, DOI 10.1016/0031-9384(73)90221-7; Gurden H, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0003.2000; Haber SN, 2000, J NEUROSCI, V20, P2369; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kelley AE, 1997, P NATL ACAD SCI USA, V94, P12174, DOI 10.1073/pnas.94.22.12174; KELLEY AE, 1982, NEUROSCIENCE, V7, P615, DOI 10.1016/0306-4522(82)90067-7; Lattal KM, 2001, J NEUROSCI, V21, P5773, DOI 10.1523/JNEUROSCI.21-15-05773.2001; MARSHALL JF, 1980, J COMP PHYSIOL PSYCH, V94, P833, DOI 10.1037/h0077825; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Meiri N, 1998, BRAIN RES, V789, P48, DOI 10.1016/S0006-8993(97)01528-X; MOGENSON GJ, 1980, PROG NEUROBIOL, V14, P69, DOI 10.1016/0301-0082(80)90018-0; Nader K, 2000, NAT REV NEUROSCI, V1, P216, DOI 10.1038/35044580; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Parkinson JA, 2000, PROG BRAIN RES, V126, P263; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Petri HL, 1984, NEUROPSYCHOLOGY MEMO, P287; RESCORLA RA, 1991, Q J EXP PSYCHOL-B, V43, P1; ROSENBLUM K, 1993, BEHAV NEURAL BIOL, V59, P49, DOI 10.1016/0163-1047(93)91145-D; Scharf MT, 2002, J NEUROPHYSIOL, V87, P2770, DOI 10.1152/jn.2002.87.6.2770; Skinner B. F., 1953, SCI HUMAN BEHAV; Smith-Roe SL, 2000, J NEUROSCI, V20, P7737; SPRINGER AD, 1976, BEHAV BIOL, V17, P547, DOI 10.1016/S0091-6773(76)90973-1; Thorndike EL., 1911, ANIMAL INTELLIGENCE, DOI DOI 10.4324/9781351321044; Vianna MRM, 2001, P NATL ACAD SCI USA, V98, P12251, DOI 10.1073/pnas.211433298; Wang J, 2001, CEREB CORTEX, V11, P452, DOI 10.1093/cercor/11.5.452; Zahm DS, 2000, NEUROSCI BIOBEHAV R, V24, P85, DOI 10.1016/S0149-7634(99)00065-2	40	135	138	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2002	5	12					1327	1331		10.1038/nn973	http://dx.doi.org/10.1038/nn973			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	618ZE	12426572				2022-12-24	WOS:000179447500016
J	Wong, ST; Henley, JR; Kanning, KC; Huang, KH; Bothwell, M; Poo, M				Wong, ST; Henley, JR; Kanning, KC; Huang, KH; Bothwell, M; Poo, M			A p75(NTR) and Nogo receptor complex mediates repulsive signaling by myelin-associated glycoprotein	NATURE NEUROSCIENCE			English	Article							GROWTH CONE GUIDANCE; NERVE GROWTH; AXONAL REGENERATION; DIFFUSIBLE FACTORS; NEURITE OUTGROWTH; RHO GTPASES; INHIBITOR; COLLAPSE; IDENTIFICATION; NEUROTROPHINS	Myelin-associated glycoprotein (MAG), an inhibitor of axon regeneration, binds with high affinity to the Nogo-66 receptor (NgR). Here we report that the p75 neurotrophin receptor (p75(NTR)) is a co-receptor of NgR for MAG signaling. In cultured human embryonic kidney (HEK) cells expressing NgR, p75(NTR) was required for MAG-induced intracellular Ca2+ elevation. Co-immunoprecipitation showed an association of NgR with p75NTR that can be disrupted by an antibody against p75(NTR) (NGFR5), and extensive coexpression was observed in the developing rat nervous system. Furthermore, NGFR5 abolished MAG-induced repulsive turning of Xenopus axonal growth cones and Ca2+ elevation, both in neurons and in NgR/p75(NTR)-expressing HEK cells. Thus we conclude that p75(NTR) is a co-receptor of NgR for MAG signaling and a potential therapeutic target for promoting nerve regeneration.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA; Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of California System; University of California Berkeley; University of Washington; University of Washington Seattle	Poo, M (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA.		Huang, Kuo-Hua/AAA-4107-2021; Henley, John/D-7171-2011	Huang, Kuo-Hua/0000-0001-6232-296X; Henley, John/0000-0003-1846-5941; Bothwell, Mark/0000-0001-5423-2702				BANDTLOW CE, 1993, SCIENCE, V259, P80, DOI 10.1126/science.8418499; Cai DM, 1999, NEURON, V22, P89, DOI 10.1016/S0896-6273(00)80681-9; CARONI P, 1988, NEURON, V1, P85, DOI 10.1016/0896-6273(88)90212-7; Casaccia-Bonnefil P, 1998, CELL DEATH DIFFER, V5, P357, DOI 10.1038/sj.cdd.4400377; CHAO MV, 1986, SCIENCE, V232, P518, DOI 10.1126/science.3008331; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; DeBellard ME, 1996, MOL CELL NEUROSCI, V7, P89, DOI 10.1006/mcne.1996.0007; Dickson BJ, 2001, CURR OPIN NEUROBIOL, V11, P103, DOI 10.1016/S0959-4388(00)00180-X; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; Fournier AE, 2001, CURR OPIN NEUROBIOL, V11, P89, DOI 10.1016/S0959-4388(00)00178-1; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hempstead BL, 2002, CURR OPIN NEUROBIOL, V12, P260, DOI 10.1016/S0959-4388(02)00321-5; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Hutson LD, 2001, J NEUROBIOL, V49, P79, DOI 10.1002/neu.1067; Jiang H, 1997, J BIOL CHEM, V272, P6835, DOI 10.1074/jbc.272.11.6835; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; LEE KF, 1994, SCIENCE, V263, P1447, DOI 10.1126/science.8128229; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; LOHOF AM, 1992, J NEUROSCI, V12, P1253; MARANO N, 1987, J NEUROCHEM, V48, P225, DOI 10.1111/j.1471-4159.1987.tb13151.x; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; McQuillen PS, 2002, J NEUROSCI, V22, P3580; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; Ming GL, 2001, NEURON, V29, P441, DOI 10.1016/S0896-6273(01)00217-3; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X; PHAMDINH D, 1994, J NEUROCHEM, V63, P2353; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; Schwab ME, 2002, SCIENCE, V295, P1029, DOI 10.1126/science.1067840; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Song HJ, 1999, CURR OPIN NEUROBIOL, V9, P355, DOI 10.1016/S0959-4388(99)80052-X; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; SPITZER NC, 1976, P NATL ACAD SCI USA, V73, P1641, DOI 10.1073/pnas.73.5.1641; Tabti N, 1998, CULTURING NERVE CELL, P237; Turnley AM, 1998, NEUROREPORT, V9, P1987, DOI 10.1097/00001756-199806220-00013; Wahl S, 2000, J CELL BIOL, V149, P263, DOI 10.1083/jcb.149.2.263; Walsh GS, 1999, J NEUROSCI, V19, P258, DOI 10.1523/JNEUROSCI.19-01-00258.1999; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Wang Q, 1998, J NEUROSCI, V18, P4973; Wang XX, 2002, J NEUROSCI, V22, P5505; Yamashita T, 2002, J CELL BIOL, V157, P565, DOI 10.1083/jcb.200202010; Yamashita T, 1999, NEURON, V24, P585, DOI 10.1016/S0896-6273(00)81114-9; YAN Q, 1988, J NEUROSCI, V8, P3481; ZHENG JQ, 1994, NATURE, V368, P140, DOI 10.1038/368140a0	50	359	387	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2002	5	12					1302	1308		10.1038/nn975	http://dx.doi.org/10.1038/nn975			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	618ZE	12426574				2022-12-24	WOS:000179447500013
J	Hardie, RC; Martin, F; Cochrane, GW; Juusola, M; Georgiev, P; Raghu, P				Hardie, RC; Martin, F; Cochrane, GW; Juusola, M; Georgiev, P; Raghu, P			Molecular basis of amplification in Drosophila phototransduction: Roles for G protein, phospholipase C, and diacylglycerol kinase	NEURON			English	Article							LIGHT-SENSITIVE CHANNELS; IN-VIVO; RETINAL DEGENERATION; VISUAL TRANSDUCTION; SIGNALING COMPLEX; INSP(3) RECEPTOR; CA2+ CHANNEL; TRP; PHOTORECEPTORS; MUTANT	In Drosophila photoreceptors, the amplification responsible for generating quantum bumps in response to photoisomerization of single rhodopsin molecules has been thought to be mediated downstream of phospholipase C (PLC), since bump amplitudes were reportedly unaffected in mutants with greatly reduced levels of either G protein or PLC. We now find that quantum bumps in such mutants are reduced similar to3- to 5-fold but are restored to near wild-type values by mutations in the rdgA gene encoding diacylglycerol kinase (DGK) and also by depleting intracellular ATP. The results demonstrate that amplification requires activation of multiple G protein and PLC molecules, identify DGK as a key enzyme regulating amplification, and implicate diacylglycerol as a messenger of excitation in Drosophila phototransduction.	Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England; Univ Cambridge, Dept Physiol, Cambridge CB2 3DY, England	University of Cambridge; University of Cambridge	Hardie, RC (corresponding author), Univ Cambridge, Dept Anat, Downing St, Cambridge CB2 3DY, England.	rch14@hermes.cam.ac.uk	Padinjat, Raghu/Z-5578-2019; Martin, Fernando/AAZ-1300-2020; Juusola, Mikko/E-6948-2011	Hardie, Roger/0000-0001-5531-3264; Martin, Fernando/0000-0003-4380-567X; Juusola, Mikko/0000-0002-4428-5330; Cochrane, Guy/0000-0001-7954-7057				Acharya JK, 1997, NEURON, V18, P881, DOI 10.1016/S0896-6273(00)80328-1; Agam K, 2000, J NEUROSCI, V20, P5748, DOI 10.1523/JNEUROSCI.20-15-05748.2000; BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; BRAND AH, 1993, DEVELOPMENT, V118, P401; BRAZITIKOS PD, 1991, BRAIN RES, V567, P33, DOI 10.1016/0006-8993(91)91432-Z; Chyb S, 1999, NATURE, V397, P255, DOI 10.1038/16703; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Cook B, 2000, NAT CELL BIOL, V2, P296, DOI 10.1038/35010571; Cook B, 1999, CELL CALCIUM, V25, P161, DOI 10.1054/ceca.1998.0018; DELAND MC, 1973, NATURE-NEW BIOL, V244, P184, DOI 10.1038/newbio244184a0; DOLPH PJ, 1994, NATURE, V370, P59, DOI 10.1038/370059a0; Estacion M, 2001, J PHYSIOL-LONDON, V530, P1, DOI 10.1111/j.1469-7793.2001.0001m.x; Hardie RC, 1996, J NEUROSCI, V16, P2924; HARDIE RC, 1991, P ROY SOC B-BIOL SCI, V245, P203, DOI 10.1098/rspb.1991.0110; HARDIE RC, 1994, J GEN PHYSIOL, V103, P389, DOI 10.1085/jgp.103.3.389; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; Hardie RC, 2001, NEURON, V30, P149, DOI 10.1016/S0896-6273(01)00269-0; HARRIS WA, 1977, J GEN PHYSIOL, V69, P261, DOI 10.1085/jgp.69.3.261; HOWARD J, 1987, PROC R SOC SER B-BIO, V231, P415, DOI 10.1098/rspb.1987.0053; Huber A, 1996, EMBO J, V15, P7036, DOI 10.1002/j.1460-2075.1996.tb01095.x; Kalidas S, 2002, NEURON, V33, P177, DOI 10.1016/S0896-6273(02)00560-3; KIRKWOOD A, 1994, J GEN PHYSIOL, V103, P679, DOI 10.1085/jgp.103.4.679; MASAI I, 1993, P NATL ACAD SCI USA, V90, P11157, DOI 10.1073/pnas.90.23.11157; MINKE B, 1985, J COMP PHYSIOL A, V156, P339, DOI 10.1007/BF00610727; Minke B, 2000, HDB BIOL PHYSICS, V3; Montell C, 1999, ANNU REV CELL DEV BI, V15, P231, DOI 10.1146/annurev.cellbio.15.1.231; Montell C, 2001, Sci STKE, V2001, pre1, DOI 10.1126/stke.2001.90.re1; Niemeyer BA, 1996, CELL, V85, P651, DOI 10.1016/S0092-8674(00)81232-5; Oberwinkler J, 2000, J NEUROSCI, V20, P1701; PAK WL, 1976, SCIENCE, V194, P956, DOI 10.1126/science.824732; Pearn MT, 1996, J BIOL CHEM, V271, P4937; Pugh EN, 1999, CURR OPIN NEUROBIOL, V9, P410, DOI 10.1016/S0959-4388(99)80062-2; Raghu P, 2000, NEURON, V26, P169, DOI 10.1016/S0896-6273(00)81147-2; Raghu P, 2000, MOL CELL NEUROSCI, V15, P429, DOI 10.1006/mcne.2000.0846; Reuss H, 1997, NEURON, V19, P1249, DOI 10.1016/S0896-6273(00)80416-X; Rieke F, 1996, BIOPHYS J, V71, P2553, DOI 10.1016/S0006-3495(96)79448-1; Scott K, 1998, NATURE, V395, P805, DOI 10.1038/27448; SCOTT K, 1995, NEURON, V15, P919, DOI 10.1016/0896-6273(95)90182-5; Shieh BH, 1997, P NATL ACAD SCI USA, V94, P12682, DOI 10.1073/pnas.94.23.12682; WU L, 1995, NATURE, V373, P216, DOI 10.1038/373216a0	45	93	93	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 14	2002	36	4					689	701		10.1016/S0896-6273(02)01048-6	http://dx.doi.org/10.1016/S0896-6273(02)01048-6			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	616PX	12441057	Bronze			2022-12-24	WOS:000179313100015
J	Chance, FS; Abbott, LF; Reyes, AD				Chance, FS; Abbott, LF; Reyes, AD			Gain modulation from background synaptic input	NEURON			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; VISUAL-CORTEX; PARIETAL CORTEX; IN-VIVO; INTEGRATIVE PROPERTIES; SHUNTING INHIBITION; ATTENTION; CELLS; CONDUCTANCES; RESPONSES	Gain modulation is a prominent feature of neuronal activity recorded in behaving animals, but the mechanism by which it occurs is unknown. By introducing a barrage of excitatory and inhibitory synaptic conductances that mimics conditions encountered in vivo into pyramidal neurons in slices of rat somatosensory cortex, we show that the gain of a neuronal response to excitatory drive can be modulated by varying the level of "background" synaptic input. Simultaneously increasing both excitatory and inhibitory background firing rates in a balanced manner results in a divisive gain modulation of the neuronal response without appreciable signal-independent increases in firing rate or spike-train variability. These results suggest that, within active cortical circuits, the overall level of synaptic input to a neuron acts as a gain control signal that modulates responsiveness to excitatory drive.	NYU, Ctr Neural Sci, New York, NY 10003 USA; Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02454 USA	New York University; Brandeis University; Brandeis University	Chance, FS (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.			Chance, Frances/0000-0003-1420-4664	NEI NIH HHS [T32-EY-7136] Funding Source: Medline; NATIONAL EYE INSTITUTE [T32EY007136] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ANDERSEN RA, 1983, J NEUROSCI, V3, P532; ANDERSEN RA, 1985, SCIENCE, V230, P450; Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; BASTIAN J, 1986, J NEUROSCI, V6, P553; BERNANDER O, 1991, P NATL ACAD SCI USA, V88, P11569, DOI 10.1073/pnas.88.24.11569; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; DAYAN P, 2001, THEORETICAL NEUROSCI, P164; Destexhe A, 1999, J NEUROPHYSIOL, V81, P1531, DOI 10.1152/jn.1999.81.4.1531; Destexhe A, 2001, NEUROSCIENCE, V107, P13, DOI 10.1016/S0306-4522(01)00344-X; Doiron B, 2001, NEURAL COMPUT, V13, P227, DOI 10.1162/089976601300014691; Hahnloser RHR, 2000, NATURE, V405, P947, DOI 10.1038/35016072; Hansel D, 2002, J NEUROSCI, V22, P5118, DOI 10.1523/JNEUROSCI.22-12-05118.2002; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Hirsch JA, 1998, J NEUROSCI, V18, P9517; Ho N, 2000, J NEUROPHYSIOL, V84, P1488, DOI 10.1152/jn.2000.84.3.1488; Holt GR, 1997, NEURAL COMPUT, V9, P1001, DOI 10.1162/neco.1997.9.5.1001; Holt GR, 1996, J NEUROPHYSIOL, V75, P1806, DOI 10.1152/jn.1996.75.5.1806; Hupe JM, 1998, NATURE, V394, P784, DOI 10.1038/29537; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Koch C., 1992, SINGLE NEURON COMPUT, P315; McAdams CJ, 1999, NEURON, V23, P765, DOI 10.1016/S0896-6273(01)80034-9; MEL BW, 1993, J NEUROPHYSIOL, V70, P1086, DOI 10.1152/jn.1993.70.3.1086; Miller KD, 2002, J NEUROPHYSIOL, V87, P653, DOI 10.1152/jn.00425.2001; Pena JL, 2001, SCIENCE, V292, P249, DOI 10.1126/science.1059201; Pouget A, 1997, J COGNITIVE NEUROSCI, V9, P222, DOI 10.1162/jocn.1997.9.2.222; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; RAPP M, 1992, NEURAL COMPUT, V4, P518, DOI 10.1162/neco.1992.4.4.518; Reyes A, 1999, J NEUROSCI, V19, P3827; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; Ricciardi L.M., 1977, DIFFUSION PROCESSES, V14; ROBINSON HPC, 1993, J NEUROSCI METH, V49, P157, DOI 10.1016/0165-0270(93)90119-C; Salinas E, 1997, J NEUROPHYSIOL, V77, P3267, DOI 10.1152/jn.1997.77.6.3267; Salinas E, 1996, P NATL ACAD SCI USA, V93, P11956, DOI 10.1073/pnas.93.21.11956; SALINAS E, 1995, J NEUROSCI, V15, P6461; Salinas Emilio, 2000, Neuron, V27, P15, DOI 10.1016/S0896-6273(00)00004-0; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; SHARP AA, 1993, TRENDS NEUROSCI, V16, P389, DOI 10.1016/0166-2236(93)90004-6; Sherman SM, 1998, P NATL ACAD SCI USA, V95, P7121, DOI 10.1073/pnas.95.12.7121; Smith MR, 2002, J NEUROPHYSIOL, V87, P2031, DOI 10.1152/jn.00821.2001; SOFTKY WR, 1993, J NEUROSCI, V13, P334; SRINIVASAN MV, 1976, BIOL CYBERN, V21, P227, DOI 10.1007/BF00344168; Stevens CF, 1998, NAT NEUROSCI, V1, P210, DOI 10.1038/659; TIESINGA PHE, 2001, TOPICS, V62, P8413; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Troyer TW, 1997, NEURAL COMPUT, V9, P971, DOI 10.1162/neco.1997.9.5.971; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0	46	706	722	0	30	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 15	2002	35	4					773	782		10.1016/S0896-6273(02)00820-6	http://dx.doi.org/10.1016/S0896-6273(02)00820-6			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	585JE	12194875	Bronze			2022-12-24	WOS:000177521000016
J	Simmons, PJ				Simmons, PJ			Presynaptic depolarization rate controls transmission at an invertebrate synapse	NEURON			English	Article							LARGE 2ND-ORDER NEURONS; AMPA RECEPTOR DESENSITIZATION; RETINAL BIPOLAR; CALCIUM CURRENT; TRANSMITTER RELEASE; LOCAL INTERNEURONS; 3RD-ORDER NEURONS; GRADED POTENTIALS; GLUTAMATE RELEASE; CLIMBING FIBER	Second-order neurons L1-3 of the locust ocellar pathway make inhibitory synapses with each other. Although the synapses transmit graded potentials, transmission depresses rapidly and completely so that a synapse only transmits when the presynaptic terminal depolarizes rapidly. The rate at which a presynaptic neuron depolarizes determines the rate at which a postsynaptic neuron hyperpolarizes, and neurotransmitter is only released during a fixed 2 ms long period. Consequently, the amplitude of a postsynaptic potential depends on the rate rather than the amplitude of a presynaptic depolarization. Following a postsynaptic potential, a synapse recovers from depression over about a second. The synapse recovers from depression even if the presynaptic terminal is held depolarized.	Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Newcastle Univ, Sch Neurosci & Psychiat, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Simmons, PJ (corresponding author), Newcastle Univ, Sch Biol, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	p.j.simmons@ncl.ac.uk		Simmons, Peter/0000-0002-1630-5082				AMAR M, 1995, NEUROSCI LETT, V199, P107, DOI 10.1016/0304-3940(95)12033-Z; AMMERMULLER J, 1986, J COMP PHYSIOL A, V159, P363, DOI 10.1007/BF00603982; BLIGHT A R, 1980, Philosophical Transactions of the Royal Society of London B Biological Sciences, V290, P219, DOI 10.1098/rstb.1980.0092; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; Burrone J, 2000, J NEUROSCI, V20, P568, DOI 10.1523/JNEUROSCI.20-02-00568.2000; BURROWS M, 1992, J NEUROSCI, V12, P1477; BURROWS M, 1978, J PHYSIOL-LONDON, V285, P231, DOI 10.1113/jphysiol.1978.sp012569; Dittman JS, 1998, J NEUROSCI, V18, P6147; Eliasof S, 1997, VISUAL NEUROSCI, V14, P13, DOI 10.1017/S0952523800008713; Forsythe ID, 1998, NEURON, V20, P797, DOI 10.1016/S0896-6273(00)81017-X; Fortune ES, 2001, TRENDS NEUROSCI, V24, P381, DOI 10.1016/S0166-2236(00)01835-X; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; GOODMAN C, 1974, J COMP PHYSIOL, V95, P185, DOI 10.1007/BF00625443; HAYASHI JH, 1985, J PHYSIOL-LONDON, V368, P179, DOI 10.1113/jphysiol.1985.sp015852; ISAACSON JS, 1995, NEURON, V15, P875, DOI 10.1016/0896-6273(95)90178-7; JUUSOLA M, 1995, J GEN PHYSIOL, V105, P117, DOI 10.1085/jgp.105.1.117; KATZ B, 1967, J PHYSIOL-LONDON, V192, P407, DOI 10.1113/jphysiol.1967.sp008307; KLEIN M, 1980, P NATL ACAD SCI-BIOL, V77, P6912, DOI 10.1073/pnas.77.11.6912; LAUGHLIN SB, 1987, PROC R SOC SER B-BIO, V231, P437, DOI 10.1098/rspb.1987.0054; LAUGHLIN SB, 1978, J COMP PHYSIOL, V128, P319, DOI 10.1007/BF00657606; Leitinger G, 2000, J COMP NEUROL, V416, P345; Leitinger G, 2002, J NEUROBIOL, V50, P93, DOI 10.1002/neu.10018; LIN JW, 1993, J GEN PHYSIOL, V101, P45, DOI 10.1085/jgp.101.1.45; LITTLEWOOD PMH, 1992, J COMP NEUROL, V325, P493, DOI 10.1002/cne.903250404; LLINAS R, 1981, BIOPHYS J, V33, P323, DOI 10.1016/S0006-3495(81)84899-0; Lu T, 1998, NEUROSCI RES, V31, P123, DOI 10.1016/S0168-0102(98)00031-5; Maguire G, 1999, EUR J NEUROSCI, V11, P353, DOI 10.1046/j.1460-9568.1999.00439.x; Manor Y, 1997, J NEUROSCI, V17, P5610; MAYNARD DM, 1975, J COMP PHYSIOL, V97, P215, DOI 10.1007/BF00617544; Msghina M, 1999, J NEUROSCI, V19, P8419; Otis T, 1996, J NEUROSCI, V16, P7496; PARKER D, 1995, J NEUROPHYSIOL, V74, P529, DOI 10.1152/jn.1995.74.2.529; ROWELL CHF, 1983, J EXP BIOL, V103, P265; Sabatini BL, 1997, J NEUROSCI, V17, P3425; SHAW SR, 1975, NATURE, V255, P480, DOI 10.1038/255480a0; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; SIMMONS P, 1980, J EXP BIOL, V85, P281; SIMMONS PJ, 1985, J EXP BIOL, V117, P193; SIMMONS PJ, 1993, J COMP PHYSIOL A, V173, P635, DOI 10.1007/BF00197771; Simmons PJ, 2002, MICROSC RES TECHNIQ, V56, P270, DOI 10.1002/jemt.10030; SIMMONS PJ, 1981, J COMP PHYSIOL, V145, P265, DOI 10.1007/BF00605039; SIMMONS PJ, 1995, J EXP BIOL, V198, P537; SIMMONS PJ, 1989, J COMP NEUROL, V283, P129, DOI 10.1002/cne.902830111; SIMMONS PJ, 1982, J COMP PHYSIOL, V149, P389, DOI 10.1007/BF00619154; SIMMONS PJ, 1982, J COMP PHYSIOL, V147, P401, DOI 10.1007/BF00609674; SIMMONS PJ, 1986, J COMP PHYSIOL A, V159, P97, DOI 10.1007/BF00612500; Simmons PJ, 1999, J NEUROSCI, V19, P10584; Trussell LO, 1997, CURR OPIN NEUROBIOL, V7, P487, DOI 10.1016/S0959-4388(97)80027-X; Trussell LO, 1999, ANNU REV PHYSIOL, V61, P477, DOI 10.1146/annurev.physiol.61.1.477; van den Beukel I, 1998, BRAIN RES, V789, P263, DOI 10.1016/S0006-8993(98)00007-9; von Gersdorff H, 1998, NEURON, V21, P1177, DOI 10.1016/S0896-6273(00)80634-0; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; vonGersdorff H, 1996, J NEUROSCI, V16, P115; vonGersdorff H, 1997, J NEUROSCI, V17, P8137; Waldeck RF, 2000, J NEUROSCI, V20, P5312, DOI 10.1523/JNEUROSCI.20-14-05312.2000; WECKSTROM M, 1991, J PHYSIOL-LONDON, V440, P635, DOI 10.1113/jphysiol.1991.sp018729; WILSON M, 1978, J COMP PHYSIOL, V124, P297, DOI 10.1007/BF00661380; WILSON M, 1978, J COMP PHYSIOL, V124, P317, DOI 10.1007/BF00661381	58	14	14	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 15	2002	35	4					749	758		10.1016/S0896-6273(02)00791-2	http://dx.doi.org/10.1016/S0896-6273(02)00791-2			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	585JE	12194873	Bronze			2022-12-24	WOS:000177521000014
J	Zhu, Y; Yu, T; Zhang, XC; Nagasawa, T; Wu, JY; Rao, Y				Zhu, Y; Yu, T; Zhang, XC; Nagasawa, T; Wu, JY; Rao, Y			Role of the chemokine SDF-1 as the meningeal attractant for embryonic cerebellar neurons	NATURE NEUROSCIENCE			English	Article							RECEPTOR CXCR4; LYMPHOPOIESIS; MYELOPOIESIS; MIGRATION; PROTEIN; MICE; SLIT; CNS		Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Osaka Med Ctr Maternal & Child Hlth, Res Inst, Dept Mol & Cellular Immunol, Osaka 5901101, Japan	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Wu, JY (corresponding author), Washington Univ, Sch Med, Dept Pediat, Box 8108,660 S Euclid Ave, St Louis, MO 63110 USA.			Nagasawa, Takashi/0000-0002-1085-0960	NATIONAL CANCER INSTITUTE [R01CA114197] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY014576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070967] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA114197-01A2, R01 CA114197] Funding Source: Medline; NEI NIH HHS [R01 EY014576, R01 EY014576-03] Funding Source: Medline; NIGMS NIH HHS [R01 GM070967-02, R01 GM070967] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Asensio VC, 1999, TRENDS NEUROSCI, V22, P504, DOI 10.1016/S0166-2236(99)01453-8; Jazin EE, 1997, J NEUROIMMUNOL, V79, P148, DOI 10.1016/S0165-5728(97)00117-3; Lu Q, 2001, CELL, V105, P69, DOI 10.1016/S0092-8674(01)00297-5; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Mennicken F, 1999, TRENDS PHARMACOL SCI, V20, P73, DOI 10.1016/S0165-6147(99)01308-5; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Poznansky MC, 2000, NAT MED, V6, P543, DOI 10.1038/75022; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023; Wu JY, 2001, NATURE, V410, P948, DOI 10.1038/35073616; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	13	193	201	1	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2002	5	8					719	720		10.1038/nn881	http://dx.doi.org/10.1038/nn881			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	577XT	12080344	Green Accepted			2022-12-24	WOS:000177088900009
J	Shin, OH; Rizo, J; Sudhof, TC				Shin, OH; Rizo, J; Sudhof, TC			Synaptotagmin function in dense core vesicle exocytosis studied in cracked PC12 cells	NATURE NEUROSCIENCE			English	Article							INTRACELLULAR CALCIUM-DEPENDENCE; REGULATED EXOCYTOSIS; C2 DOMAIN; TRANSMITTER RELEASE; PHOSPHOLIPASE A(2); SYNAPTIC VESICLES; BINDING DOMAIN; CA2+ SENSOR; PROTEIN; MEMBRANES	Ca2+-triggered dense-core vesicle exocytosis in PC12 cells does not require vesicular synaptotagmins 1 and 2, but may use plasma membrane synaptotagmins 3 and 7 as Ca2+ sensors. In support of this hypothesis, C-2 domains from the plasma membrane but not vesicular synaptotagmins inhibit PC12 cell exocytosis. Ca2+ induces binding of both plasma membrane and vesicular synaptotagmins to phospholipids and SNAREs (soluble N-ethylmaleimide-sensitive attachment protein receptors), although with distinct apparent Ca2+ affinities. Here we used gain-of-function C-2-domain mutants of synaptotagmin 1 and loss-of-function C-2-domain mutants of synaptotagmin 7 to examine how synaptotagmins function in dense-core vesicle exocytosis. Our data indicate that phospholipid- but not SNARE-binding by plasma membrane synaptotagmins is the primary determinant of Ca2+ triggered dense-core vesicle exocytosis. These results support a general lipid-based mechanism of action of synaptotagmins in exocytosis, with the specificity of various synaptotagmins for different types of fusion governed by their differential localizations and Ca2+ affinities.	Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dept Mol Genet, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Sudhof, TC (corresponding author), Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dept Mol Genet, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.	thomas.sudhof@utsouthwestern.edu			NINDS NIH HHS [NS37200, NS40944] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037200, R01NS040944] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AHNERTHILGER G, 1987, BIOCHEMISTRY-US, V26, P7842, DOI 10.1021/bi00398a046; Avery J, 2000, J CELL BIOL, V148, P317, DOI 10.1083/jcb.148.2.317; Banerjee A, 1996, J BIOL CHEM, V271, P20227, DOI 10.1074/jbc.271.34.20227; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; Butz S, 1999, J BIOL CHEM, V274, P18290, DOI 10.1074/jbc.274.26.18290; CHAMBERLAIN LH, 1995, J CELL BIOL, V130, P1063, DOI 10.1083/jcb.130.5.1063; CHAPMAN ER, 1994, J BIOL CHEM, V269, P5735; Chapman ER, 1996, J BIOL CHEM, V271, P5844, DOI 10.1074/jbc.271.10.5844; Chapman ER, 1998, J BIOL CHEM, V273, P13995, DOI 10.1074/jbc.273.22.13995; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; Davletov B, 1998, J BIOL CHEM, V273, P19093, DOI 10.1074/jbc.273.30.19093; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; Earles CA, 2001, J CELL BIOL, V154, P1117, DOI 10.1083/jcb.200105020; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Gennis R. B., 1989, BIOMEMBRANES MOL STR, DOI [10.1007/978-1-4757-2065-5, DOI 10.1007/978-1-4757-2065-5]; GEPPERT M, 1991, J BIOL CHEM, V266, P13548; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Gerber SH, 2002, DIABETES, V51, pS12, DOI 10.2337/diabetes.51.2007.S12; Gerber SH, 2001, J BIOL CHEM, V276, P32288, DOI 10.1074/jbc.C100108200; Gerona RRL, 2000, J BIOL CHEM, V275, P6328, DOI 10.1074/jbc.275.9.6328; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; JOHNSTON PA, 1989, J BIOL CHEM, V264, P1268; Kee Y, 1996, J NEUROSCI, V16, P1975; Klenchin VA, 1998, METHODS, V16, P204, DOI 10.1006/meth.1998.0668; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; MATTHEW WD, 1981, J CELL BIOL, V91, P257, DOI 10.1083/jcb.91.1.257; MIZUTA M, 1994, J BIOL CHEM, V269, P11675; Nalefski EA, 1998, J BIOL CHEM, V273, P1365, DOI 10.1074/jbc.273.3.1365; PERIN MS, 1991, J BIOL CHEM, V266, P623; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; SHAO X, 2001, SCIENCE, V273, P248; SHOJIKASAI Y, 1992, SCIENCE, V256, P1820, DOI 10.1126/science.256.5065.1820; Sudhof TC, 2002, J BIOL CHEM, V277, P7629, DOI 10.1074/jbc.R100052200; Sugita S, 2002, EMBO J, V21, P270, DOI 10.1093/emboj/21.3.270; Sugita S, 2001, NEURON, V30, P459, DOI 10.1016/S0896-6273(01)00290-2; Sugita S, 1996, J BIOL CHEM, V271, P1262, DOI 10.1074/jbc.271.3.1262; Ubach J, 2001, BIOCHEMISTRY-US, V40, P5854, DOI 10.1021/bi010340c; Voets T, 2000, NEURON, V28, P537, DOI 10.1016/S0896-6273(00)00131-8; Voets T, 2001, P NATL ACAD SCI USA, V98, P11680, DOI 10.1073/pnas.201398798; WALENT JH, 1992, CELL, V70, P765, DOI 10.1016/0092-8674(92)90310-9; Wang CT, 2001, SCIENCE, V294, P1111, DOI 10.1126/science.1064002; Zhang XY, 1998, BIOCHEMISTRY-US, V37, P12395, DOI 10.1021/bi9807512; Zhong PY, 1997, BIOCHEMISTRY-US, V36, P4317, DOI 10.1021/bi9625408	46	71	73	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2002	5	7					649	656		10.1038/nn869	http://dx.doi.org/10.1038/nn869			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	566EP	12055633				2022-12-24	WOS:000176414300014
J	Rosenthal, JJC; Bezanilla, F				Rosenthal, JJC; Bezanilla, F			Extensive editing of mRNAs for the squid delayed rectifier K+ channel regulates subunit tetramerization	NEURON			English	Article							DOUBLE-STRANDED-RNA; SHAKER POTASSIUM CHANNEL; MESSENGER-RNA; ADENOSINE-DEAMINASE; GIANT-AXON; T1 DOMAIN; KINETIC-PROPERTIES; RECEPTOR CHANNELS; SODIUM-CHANNELS; SINGLE-CHANNEL	We report the extensive editing of mRNAs that encode the classical delayed rectifier K+ channel (SqK(v)1.1A) in the squid giant axon. Using a quantitative RNA editing assay, 14 adenosine to guanine transitions were identified, and editing efficiency varied tremendously between positions. Interestingly, half of the sites are targeted to the T1 domain, important for subunit assembly. Other sites occur in the channel's transmembrane spans. The effects of editing on K+ channel function are elaborate. Edited codons affect channel gating, and several T1 sites regulate functional expression as well. In particular, the edit R87G, a phylogenetically conserved position, reduces expression close to 50-fold by regulating the channel's ability to form tetramers. These data suggest that RNA editing plays a dynamic role in regulating action potential repolarization in the giant axon.	Univ Calif Los Angeles, Sch Med, Dept Physiol & Anesthesiol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Bezanilla, F (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Physiol & Anesthesiol, Los Angeles, CA 90024 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030376, R01GM030376] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM20314, GM30376] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARMSTRONG CM, 1973, NATURE, V242, P459, DOI 10.1038/242459a0; BASS BL, 1988, CELL, V55, P1089, DOI 10.1016/0092-8674(88)90253-X; BASS BL, 1987, CELL, V48, P607, DOI 10.1016/0092-8674(87)90239-X; BASS BL, 1989, CELL, V56, P331, DOI 10.1016/0092-8674(89)90234-1; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; BEZANILLA F, 1970, J PHYSIOL-LONDON, V207, P151, DOI 10.1113/jphysiol.1970.sp009054; BEZANILLA F, 1970, J PHYSIOL-LONDON, V211, P729, DOI 10.1113/jphysiol.1970.sp009301; Bixby KA, 1999, NAT STRUCT BIOL, V6, P38; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; Cushman SJ, 2000, NAT STRUCT BIOL, V7, P403; DEAL KK, 1994, J NEUROSCI, V14, P1666, DOI 10.1523/JNEUROSCI.14-03-01666.1994; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Fields PA, 1998, P NATL ACAD SCI USA, V95, P11476, DOI 10.1073/pnas.95.19.11476; Hanrahan CJ, 2000, GENETICS, V155, P1149; Hanrahan CJ, 1999, ANN NY ACAD SCI, V868, P51, DOI 10.1111/j.1749-6632.1999.tb11273.x; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Holland LZ, 1997, BIOCHEMISTRY-US, V36, P3207, DOI 10.1021/bi962664k; Hong KH, 2000, J GEN PHYSIOL, V115, P51, DOI 10.1085/jgp.115.1.51; KIM U, 1994, P NATL ACAD SCI USA, V91, P11457, DOI 10.1073/pnas.91.24.11457; Kobertz WR, 1999, NAT STRUCT BIOL, V6, P1122; KOHLER M, 1993, NEURON, V10, P491, DOI 10.1016/0896-6273(93)90336-P; Kreusch A, 1998, NATURE, V392, P945, DOI 10.1038/31978; LI M, 1993, ANN NY ACAD SCI, V707, P51, DOI 10.1111/j.1749-6632.1993.tb38041.x; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; Li-Smerin YY, 2000, J GEN PHYSIOL, V115, P33, DOI 10.1085/jgp.115.1.33; Liu TI, 2001, J NEUROPHYSIOL, V85, P61, DOI 10.1152/jn.2001.85.1.61; LLANO I, 1988, J GEN PHYSIOL, V92, P179, DOI 10.1085/jgp.92.2.179; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; Manganas LN, 2000, J BIOL CHEM, V275, P29685, DOI 10.1074/jbc.M005010200; Melcher T, 1996, J BIOL CHEM, V271, P31795, DOI 10.1074/jbc.271.50.31795; Melcher T, 1996, NATURE, V379, P460, DOI 10.1038/379460a0; Minor DL, 2000, CELL, V102, P657, DOI 10.1016/S0092-8674(00)00088-X; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; OCONNELL MA, 1995, MOL CELL BIOL, V15, P1389; OConnell MA, 1997, J BIOL CHEM, V272, P473; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.bi.55.070186.005351; Panyi G, 1996, J GEN PHYSIOL, V107, P409, DOI 10.1085/jgp.107.3.409; Patton DE, 1997, NEURON, V19, P711, DOI 10.1016/S0896-6273(00)80383-9; Paul MS, 1998, EMBO J, V17, P1120, DOI 10.1093/emboj/17.4.1120; Petschek JP, 1996, J MOL BIOL, V259, P885, DOI 10.1006/jmbi.1996.0365; Petschek JP, 1997, GENE, V204, P267, DOI 10.1016/S0378-1119(97)00465-4; PFAFFINGER PJ, 1995, J BIOL CHEM, V270, P28595, DOI 10.1074/jbc.270.48.28595; Polson AG, 1996, NATURE, V380, P454; POLSON AG, 1991, BIOCHEMISTRY-US, V30, P11507, DOI 10.1021/bi00113a004; Pongs O, 1999, FEBS LETT, V452, P31, DOI 10.1016/S0014-5793(99)00535-9; Rosenthal JC, 1996, J GEN PHYSIOL, V108, P207, DOI 10.1085/jgp.108.3.207; ROSENTHAL JJC, 1993, P NATL ACAD SCI USA, V90, P10026, DOI 10.1073/pnas.90.21.10026; Rosenthal JJC, 1997, J NEUROSCI, V17, P5070; Sambrook J., 2002, MOL CLONING LAB MANU; Schulteis CT, 1998, J BIOL CHEM, V273, P26210, DOI 10.1074/jbc.273.40.26210; Semenov EP, 1999, J NEUROCHEM, V72, P66, DOI 10.1046/j.1471-4159.1999.0720066.x; SHEN NV, 1993, NEURON, V11, P67; Sheng ZF, 1997, BIOCHEMISTRY-US, V36, P15501; Smith L A, 1998, J Neurogenet, V12, P227; Smith LA, 1996, J NEUROSCI, V16, P7868; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Stefani E, 1998, METHOD ENZYMOL, V293, P300; Strang C, 2001, J BIOL CHEM, V276, P28493, DOI 10.1074/jbc.M010540200; TRIGLIA T, 1988, NUCLEIC ACIDS RES, V16, P8186, DOI 10.1093/nar/16.16.8186; Tu LW, 1996, J BIOL CHEM, V271, P18904, DOI 10.1074/jbc.271.31.18904; TU LW, 1995, BIOPHYS J, V68, P147, DOI 10.1016/S0006-3495(95)80169-4; VANDENBERG CA, 1991, BIOPHYS J, V60, P1499, DOI 10.1016/S0006-3495(91)82185-3; Xu J, 1998, METHOD ENZYMOL, V293, P3; XU J, 1995, J BIOL CHEM, V270, P24761, DOI 10.1074/jbc.270.42.24761	65	61	65	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 30	2002	34	5					743	757		10.1016/S0896-6273(02)00701-8	http://dx.doi.org/10.1016/S0896-6273(02)00701-8			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	558DV	12062021	Bronze			2022-12-24	WOS:000175951800009
J	Spors, H; Grinvald, A				Spors, H; Grinvald, A			Spatio-temporal dynamics of odor representations in the mammalian olfactory bulb	NEURON			English	Article							VOLTAGE-SENSITIVE DYES; OSCILLATING NEURAL ASSEMBLIES; FUNCTIONAL ARCHITECTURE; SYNAPTIC INHIBITION; UNIT-ACTIVITY; RAT; PATTERNS; RESPONSES; STIMULATION; INFORMATION	We explored the spatio-temporal dynamics of odor-evoked activity in the rat and mouse main olfactory bulb (MOB) using voltage-sensitive dye imaging (VSDI) with a new probe. The high temporal resolution of VSDI revealed odor-specific sequences of glomerular activation. Increasing odor concentrations reduced response latencies, increased response amplitudes, and recruited new glomerular units. However, the sequence of glomerular activation was maintained. Furthermore, we found distributed MOB activity locked to the nasal respiration cycle. The spatial distribution of its amplitude and phase was heterogeneous and changed by sensory input in an odor-specific manner. Our data show that in the mammalian olfactory bulb, odor identity and concentration are represented by spatio-temporal patterns, rather than spatial patterns alone.	Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; Max Planck Inst Med Res, Zellphysiol Abt, D-69120 Heidelberg, Germany	Weizmann Institute of Science; Max Planck Society	Spors, H (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.			Spors, Hartwig/0000-0003-3153-9001				Adrian ED, 1942, J PHYSIOL-LONDON, V100, P459, DOI 10.1113/jphysiol.1942.sp003955; ADRIAN ED, 1950, ELECTROEN CLIN NEURO, V2, P377, DOI 10.1016/0013-4694(50)90075-7; ARIELI A, 1995, J NEUROPHYSIOL, V73, P2072, DOI 10.1152/jn.1995.73.5.2072; Belluscio L, 2001, J NEUROSCI, V21, P2113, DOI 10.1523/JNEUROSCI.21-06-02113.2001; Buck LB, 2000, CELL, V100, P611, DOI 10.1016/S0092-8674(00)80698-4; Carlson GC, 2000, J NEUROSCI, V20, P2011; CHAPUT M, 1979, J PHYSIOL-PARIS, V75, P939; CHAPUT MA, 1992, EUR J NEUROSCI, V4, P813, DOI 10.1111/j.1460-9568.1992.tb00191.x; Charpak S, 2001, P NATL ACAD SCI USA, V98, P1230, DOI 10.1073/pnas.021422798; CINELLI AR, 1995, J NEUROPHYSIOL, V73, P2053, DOI 10.1152/jn.1995.73.5.2053; COOPERSMITH R, 1984, SCIENCE, V225, P849, DOI 10.1126/science.6474157; DOTY RL, 1986, EXPERIENTIA, V42, P257, DOI 10.1007/BF01942506; EZEH PI, 1995, J NEUROPHYSIOL, V73, P2207, DOI 10.1152/jn.1995.73.6.2207; FREEMAN WJ, 1986, BEHAV NEUROSCI, V100, P753, DOI 10.1037/0735-7044.100.5.753; FREEMAN WJ, 1987, BEHAV NEUROSCI, V101, P393, DOI 10.1037/0735-7044.101.3.393; Friedrich RW, 1998, J NEUROSCI, V18, P9977; Friedrich RW, 2001, CURR OPIN NEUROBIOL, V11, P468, DOI 10.1016/S0959-4388(00)00236-1; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; Galizia CG, 2000, J INSECT PHYSIOL, V46, P877, DOI 10.1016/S0022-1910(99)00194-8; GRINVALD A, 1984, NATURE, V308, P848, DOI 10.1038/308848a0; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; Grinvald A, 1999, MODERN TECHNIQUES NE, P893, DOI 10.1007/978-3-642-58552-4_34; GUTHRIE KM, 1993, P NATL ACAD SCI USA, V90, P3329, DOI 10.1073/pnas.90.8.3329; HARRISON TA, 1986, J NEUROPHYSIOL, V56, P1571, DOI 10.1152/jn.1986.56.6.1571; Hopfield JJ, 1999, P NATL ACAD SCI USA, V96, P12506, DOI 10.1073/pnas.96.22.12506; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; Isaacson JS, 1999, NEURON, V23, P377, DOI 10.1016/S0896-6273(00)80787-4; JOURDAN F, 1980, BRAIN RES, V188, P139, DOI 10.1016/0006-8993(80)90563-6; Kauer JS, 2001, ANNU REV NEUROSCI, V24, P963, DOI 10.1146/annurev.neuro.24.1.963; Kent PF, 1996, J NEUROSCI, V16, P345; KONNERTH A, 1986, NEUROSCI LETT, V66, P49, DOI 10.1016/0304-3940(86)90164-3; Lam YW, 2000, J NEUROSCI, V20, P749, DOI 10.1523/JNEUROSCI.20-02-00749.2000; Laurent G, 1999, SCIENCE, V286, P723, DOI 10.1126/science.286.5440.723; Laurent G, 2001, ANNU REV NEUROSCI, V24, P263, DOI 10.1146/annurev.neuro.24.1.263; LAURENT G, 1994, SCIENCE, V265, P1872, DOI 10.1126/science.265.5180.1872; LEVETEAU J, 1966, SCIENCE, V175, P170; MacLeod K, 1998, NATURE, V395, P693, DOI 10.1038/27201; MACRIDES F, 1972, SCIENCE, V175, P84, DOI 10.1126/science.175.4017.84; Margrie TW, 2001, P NATL ACAD SCI USA, V98, P319, DOI 10.1073/pnas.011523098; MATHEWS DF, 1972, BRAIN RES, V47, P389, DOI 10.1016/0006-8993(72)90647-6; MEISAMI E, 1993, DEV BRAIN RES, V71, P253, DOI 10.1016/0165-3806(93)90177-C; Meister M, 2001, J NEUROSCI, V21, P1351; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mombaerts P, 1999, SCIENCE, V286, P707, DOI 10.1126/science.286.5440.707; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; NOWYCKY MC, 1981, J NEUROPHYSIOL, V46, P649, DOI 10.1152/jn.1981.46.3.649; ONODA N, 1980, J NEUROPHYSIOL, V44, P29, DOI 10.1152/jn.1980.44.1.29; ORBACH HS, 1983, J NEUROSCI, V3, P2251; PAGER J, 1985, BEHAV BRAIN RES, V16, P81, DOI 10.1016/0166-4328(85)90084-1; Pelosi P, 1996, J NEUROBIOL, V30, P3; Philpot BD, 1997, J NEUROBIOL, V33, P374, DOI 10.1002/(SICI)1097-4695(199710)33:4<374::AID-NEU3>3.0.CO;2-7; Reisert J, 1999, J PHYSIOL-LONDON, V519, P801, DOI 10.1111/j.1469-7793.1999.0801n.x; Reisert J, 2001, J PHYSIOL-LONDON, V530, P113, DOI 10.1111/j.1469-7793.2001.0113m.x; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; ROSS WN, 1979, J MEMBRANE BIOL, V48, P343, DOI 10.1007/BF01869445; ROYET JP, 1987, BRAIN RES, V417, P1, DOI 10.1016/0006-8993(87)90173-9; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Schoppa NE, 2001, NEURON, V31, P639, DOI 10.1016/S0896-6273(01)00389-0; Shepherd G.M., 1998, SYNAPTIC ORG BRAIN, P159; Shoham D, 1999, NEURON, V24, P791, DOI 10.1016/S0896-6273(00)81027-2; SOBEL EC, 1993, J NEUROPHYSIOL, V69, P1331, DOI 10.1152/jn.1993.69.4.1331; STEWART WB, 1979, J COMP NEUROL, V185, P715, DOI 10.1002/cne.901850407; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Stopfer M, 1999, NATURE, V402, P664, DOI 10.1038/45244; Teyke T, 1999, NEUROREPORT, V10, P1061, DOI 10.1097/00001756-199904060-00030; Tsodyks M, 1999, SCIENCE, V286, P1943, DOI 10.1126/science.286.5446.1943; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Wachowiak M, 1999, J NEUROSCI, V19, P8808, DOI 10.1523/JNEUROSCI.19-20-08808.1999; Wachowiak M, 2001, NEURON, V32, P723, DOI 10.1016/S0896-6273(01)00506-2; WALSH RR, 1956, AM J PHYSIOL, V186, P255, DOI 10.1152/ajplegacy.1956.186.2.255; Wehr M, 1996, NATURE, V384, P162, DOI 10.1038/384162a0; WELLIS DP, 1990, J NEUROPHYSIOL, V64, P932, DOI 10.1152/jn.1990.64.3.932; WELLIS DP, 1989, J NEUROPHYSIOL, V61, P1161, DOI 10.1152/jn.1989.61.6.1161; Wilson DA, 1998, J NEUROPHYSIOL, V79, P1425, DOI 10.1152/jn.1998.79.3.1425; Xu FQ, 2000, J COMP NEUROL, V422, P489, DOI 10.1002/1096-9861(20000710)422:4<489::AID-CNE1>3.0.CO;2-#; Yang XJ, 1998, P NATL ACAD SCI USA, V95, P7715, DOI 10.1073/pnas.95.13.7715; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371	78	253	256	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 11	2002	34	2					301	315		10.1016/S0896-6273(02)00644-X	http://dx.doi.org/10.1016/S0896-6273(02)00644-X			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	541GE	11970871	Bronze			2022-12-24	WOS:000174976200015
J	London, M; Schreibman, A; Hausser, M; Larkum, ME; Segev, I				London, M; Schreibman, A; Hausser, M; Larkum, ME; Segev, I			The information efficacy of a synapse	NATURE NEUROSCIENCE			English	Article							INPUTS; CONDUCTANCES; COINCIDENCE; VARIABILITY; INHIBITION; DENDRITES; TRANSIENT; RESPONSES; AMPLITUDE; LOCATION	We provide a functional measure, the synaptic information efficacy (SIE), to assess the impact of synaptic input on spike output. SIE is the mutual information shared by the presynaptic input and postsynaptic output spike trains. To estimate SIE we used a method based on compression algorithms. This method detects the effect of a single synaptic input on the postsynaptic spike output in the presence of massive background synaptic activity in neuron models of progressively increasing realism. SIE increased with increases either in time locking between the input synapse activity and the output spike or in the average number of output spikes. SIE depended on the context in which the synapse operates. We also measured SIE experimentally. Systematic exploration of the effect of synaptic and dendritic parameters on the SIE offers a fresh look at the synapse as a communication device and a quantitative measure of how much the dendritic synapse informs the axon.	Hebrew Univ Jerusalem, Inst Life Sci, Dept Neurobiol, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Ctr Neural Computat, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Dept Comp Sci, IL-91904 Jerusalem, Israel; UCL, Dept Physiol, London WC1E 6BT, England; Max Planck Inst Med Res, Zellphysiol Abt, D-69120 Heidelberg, Germany	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; University of London; University College London; Max Planck Society	Segev, I (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Dept Neurobiol, IL-91904 Jerusalem, Israel.	idan@lobster.ls.huji.ac.il	Hausser, Michael/AAW-6827-2020; London, Michael/B-4175-2010	Hausser, Michael/0000-0002-2673-8957; London, Michael/0000-0001-5137-1707; Segev, Idan/0000-0001-7279-9630; Larkum, Matthew/0000-0001-9799-2656				Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Abeles M., 1991, CORTICONICS; BERNANDER O, 1991, P NATL ACAD SCI USA, V88, P11569, DOI 10.1073/pnas.88.24.11569; BERNANDER O, 1994, NEURAL COMPUT, V6, P622, DOI 10.1162/neco.1994.6.4.622; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; CARNEVALE NT, 1982, J NEUROPHYSIOL, V47, P606, DOI 10.1152/jn.1982.47.4.606; Contreras D, 1997, J NEUROPHYSIOL, V78, P335, DOI 10.1152/jn.1997.78.1.335; Cook EP, 1999, J NEUROPHYSIOL, V81, P535, DOI 10.1152/jn.1999.81.2.535; Cover T.M., 2006, ELEMENTS INFORM THEO, DOI [10.1002/047174882X, DOI 10.1002/047174882X]; De Schutter E, 1998, J NEUROPHYSIOL, V80, P504; Destexhe A, 1999, J NEUROPHYSIOL, V81, P1531, DOI 10.1152/jn.1999.81.4.1531; FETZ EE, 1983, J PHYSIOL-LONDON, P387; Fricker D, 2000, NEURON, V28, P559, DOI 10.1016/S0896-6273(00)00133-1; Fuhrmann G, 2002, J NEUROPHYSIOL, V87, P140, DOI 10.1152/jn.00258.2001; Gil Z, 1999, NEURON, V23, P385, DOI 10.1016/S0896-6273(00)80788-6; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; Hebb Donald O., 1949, ORG BEHAV; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; IANSEK R, 1973, J PHYSIOL-LONDON, V234, P665, DOI 10.1113/jphysiol.1973.sp010366; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; London M, 2001, NAT NEUROSCI, V4, P853, DOI 10.1038/nn0901-853; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; Manwani A, 2001, NEURAL COMPUT, V13, P1, DOI 10.1162/089976601300014619; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MURTHY VN, 1994, NEURAL COMPUT, V6, P1111, DOI 10.1162/neco.1994.6.6.1111; NICOLL A, 1993, J PHYSIOL-LONDON, V468, P693, DOI 10.1113/jphysiol.1993.sp019795; OERTEL D, 1983, J NEUROSCI, V3, P2043; PINSKY PF, 1995, J COMPUT NEUROSCI, V2, P275, DOI 10.1007/BF00961439; RALL W, 1967, J NEUROPHYSIOL, V30, P1138, DOI 10.1152/jn.1967.30.5.1138; Rall W, 1964, NEURAL THEORY MODELI, P73; Reinagel P, 1999, J NEUROPHYSIOL, V81, P2558, DOI 10.1152/jn.1999.81.5.2558; Reyes A, 2001, ANNU REV NEUROSCI, V24, P653, DOI 10.1146/annurev.neuro.24.1.653; Rieke F., 1997, SPIKES EXPLORING NEU; RINZEL J, 1974, BIOPHYS J, V14, P759, DOI 10.1016/S0006-3495(74)85948-5; Schultz SR, 2001, PHYS REV LETT, V86, P5823, DOI 10.1103/PhysRevLett.86.5823; Segev I, 2000, SCIENCE, V290, P744, DOI 10.1126/science.290.5492.744; SHRRINGTON CS, 1897, TXB PHYSL, V3; STRATFORD RD, 1989, COMPUTING NEURON; Strong SP, 1998, PHYS REV LETT, V80, P197, DOI 10.1103/PhysRevLett.80.197; Stuart GJ, 2001, NAT NEUROSCI, V4, P63, DOI 10.1038/82910; TREVES A, 1995, NEURAL COMPUT, V7, P399, DOI 10.1162/neco.1995.7.2.399; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; WILLEMS FMJ, 1995, IEEE T INFORM THEORY, V41, P653, DOI 10.1109/18.382012; YAMADA S, 1993, BIOL CYBERN, V68, P215, DOI 10.1007/BF00224854	50	105	108	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2002	5	4					332	340		10.1038/nn826	http://dx.doi.org/10.1038/nn826			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	534UQ	11896396				2022-12-24	WOS:000174606900013
J	Kim, EY; Bae, K; Ng, FS; Glossop, NRJ; Hardin, PE; Edery, I				Kim, EY; Bae, K; Ng, FS; Glossop, NRJ; Hardin, PE; Edery, I			Drosophila CLOCK protein is under posttranscriptional control and influences light-induced activity	NEURON			English	Article							PER-TIM COMPLEX; CIRCADIAN CLOCK; FEEDBACK LOOPS; NUCLEAR ENTRY; DARK CYCLES; GENE; TIMELESS; TRANSCRIPTION; RHYTHMS; MUTANTS	In the Drosophila circadian clock, daily cycles in the RNA levels of dclock (dClk) are antiphase to those of period (per). We altered the timing/levels of dClk expression by generating transgenic flies whereby per circadian regulatory sequences were used to drive rhythmic transcription of dClk. The results indicate that posttranscriptional mechanisms make substantial contributions to the temporal changes in the abundance of the dCLK protein. Circadian regulation is largely unaffected in the transgenic per-dClk flies despite higher mean levels of dCLK. However, in per-dClk flies the duration of morning activity is lengthened in light-dark cycles and light pulses evoke longer lasting bouts of activity. Our findings suggest that, in addition to a role in generating circadian rhythms, dCLK modulates the direct effects of light on locomotion.	Rutgers State Univ, Ctr Adv Biotechnol & Med, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA	Rutgers State University New Brunswick; University of Houston System; University of Houston	Edery, I (corresponding author), Rutgers State Univ, Ctr Adv Biotechnol & Med, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA.			Hardin, Paul/0000-0002-3370-9011				Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Bae K, 2000, J NEUROSCI, V20, P1746; Bae K, 1998, MOL CELL BIOL, V18, P6142, DOI 10.1128/MCB.18.10.6142; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Cheng P, 2001, P NATL ACAD SCI USA, V98, P7408, DOI 10.1073/pnas.121170298; Cheng YZ, 1998, MOL CELL BIOL, V18, P6505, DOI 10.1128/MCB.18.11.6505; CITRI Y, 1987, NATURE, V326, P42, DOI 10.1038/326042a0; CURTIN KD, 1995, NEURON, V14, P365, DOI 10.1016/0896-6273(95)90292-9; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Edery I, 1999, CHRONOBIOL INT, V16, P377, DOI 10.3109/07420529908998716; Edery I, 2000, PHYSIOL GENOMICS, V3, P59, DOI 10.1152/physiolgenomics.2000.3.2.59; EDERY I, 1994, P NATL ACAD SCI USA, V91, P2260, DOI 10.1073/pnas.91.6.2260; Glossop NRJ, 1999, SCIENCE, V286, P766, DOI 10.1126/science.286.5440.766; HAMBLENCOYLE MJ, 1992, J INSECT BEHAV, V5, P417, DOI 10.1007/BF01058189; Hao HP, 1999, J NEUROSCI, V19, P987; Hao HP, 1997, MOL CELL BIOL, V17, P3687, DOI 10.1128/MCB.17.7.3687; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; Hastings J.W., 1991, NEURAL INTEGRATIVE A, P435; Helfrich-Forster C, 2000, J BIOL RHYTHM, V15, P135, DOI 10.1177/074873040001500208; Helfrich-Forster C, 2001, J INSECT PHYSIOL, V47, P877, DOI 10.1016/S0022-1910(01)00060-9; Helfrich-Forster C, 2001, NEURON, V30, P249, DOI 10.1016/S0896-6273(01)00277-X; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Hendricks JC, 2000, PROG NEUROBIOL, V61, P339, DOI 10.1016/S0301-0082(99)00048-9; HunterEnsor M, 1996, CELL, V84, P677, DOI 10.1016/S0092-8674(00)81046-6; KARESS RE, 1984, CELL, V38, P135, DOI 10.1016/0092-8674(84)90534-8; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Lee C, 1999, MOL CELL BIOL, V19, P5316; Lee CG, 1996, SCIENCE, V271, P1740, DOI 10.1126/science.271.5256.1740; Lee CG, 1998, NEURON, V21, P857, DOI 10.1016/S0896-6273(00)80601-7; Lee K, 2000, SCIENCE, V289, P107, DOI 10.1126/science.289.5476.107; Martinek S, 2001, CELL, V105, P769, DOI 10.1016/S0092-8674(01)00383-X; Mrosovsky N, 1999, CHRONOBIOL INT, V16, P415, DOI 10.3109/07420529908998717; Myers MP, 1996, SCIENCE, V271, P1736, DOI 10.1126/science.271.5256.1736; Naylor E, 2000, J NEUROSCI, V20, P8138; Ousley A, 1998, GENETICS, V148, P815; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; Saez L, 1996, NEURON, V17, P911, DOI 10.1016/S0896-6273(00)80222-6; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Sidote D, 1998, MOL CELL BIOL, V18, P2004, DOI 10.1128/MCB.18.4.2004; So WV, 1997, EMBO J, V16, P7146, DOI 10.1093/emboj/16.23.7146; VOSSHALL LB, 1994, SCIENCE, V263, P1606, DOI 10.1126/science.8128247; WHEELER DA, 1993, J BIOL RHYTHM, V8, P67, DOI 10.1177/074873049300800106; Williams JA, 2001, ANNU REV PHYSIOL, V63, P729, DOI 10.1146/annurev.physiol.63.1.729; Yang ZH, 2001, NEURON, V29, P453, DOI 10.1016/S0896-6273(01)00218-5; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0; ZENG HK, 1994, EMBO J, V13, P3590, DOI 10.1002/j.1460-2075.1994.tb06666.x	51	109	109	0	46	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 28	2002	34	1					69	81		10.1016/S0896-6273(02)00639-6	http://dx.doi.org/10.1016/S0896-6273(02)00639-6			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536HR	11931742	Bronze			2022-12-24	WOS:000174695100010
J	Akten, B; Jauch, E; Genova, GK; Kim, EY; Edery, I; Raabe, T; Jackson, FR				Akten, B; Jauch, E; Genova, GK; Kim, EY; Edery, I; Raabe, T; Jackson, FR			A role for CK2 in the Drosophila circadian oscillator	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE CK2; GENE-EXPRESSION; PERIOD PROTEIN; REGULATORY SUBUNIT; CRYSTAL-STRUCTURE; CLOCK PROTEINS; DOUBLE-TIME; RHYTHMS; MELANOGASTER; LIGHT	The posttranslational modification of clock proteins is critical for the function of circadian oscillators. By genetic analysis of a Drosophila melanogaster circadian clock mutant known as Andante, which has abnormally long circadian periods, we show that casein kinase 2 (CK2) has a role in determining period length. Andante is a mutation of the gene encoding the beta subunit of CK2 and is predicted to perturb CK2beta subunit dimerization. It is associated with reduced beta subunit levels, indicative of a defect in alpha:beta association and production of the tetrameric alpha2:beta2 holoenzyme. Consistent with a direct action on the clock mechanism, we show that CK2beta is localized within clock neurons and that the clock proteins Period (Per) and Timeless (Tim) accumulate to abnormally high levels in the Andante mutant. Furthermore, the nuclear translocation of Per and Tim is delayed in Andante, and this defect accounts for the long-period phenotype of the mutant. These results suggest a function for CK2-dependent phosphorylation in the molecular oscillator.	Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 01211 USA; Univ Wurzburg, Inst Med Strahlenkunde & Zellforsch, D-97078 Wurzburg, Germany; Rutgers State Univ, Dept Mol Biol & Biochem, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA	Tufts University; University of Wurzburg; Rutgers State University New Brunswick	Jackson, FR (corresponding author), Tufts Univ, Sch Med, Dept Neurosci, 136 Harrison Ave, Boston, MA 01211 USA.			Jauch, Edward/0000-0002-3533-4364				Bidwai A P, 1999, Mol Cell Biol Res Commun, V1, P21, DOI 10.1006/mcbr.1999.0103; BIDWAI AP, 1993, ARCH BIOCHEM BIOPHYS, V300, P265, DOI 10.1006/abbi.1993.1037; Chantalat L, 1999, EMBO J, V18, P2930, DOI 10.1093/emboj/18.11.2930; Claridge-Chang A, 2001, NEURON, V32, P657, DOI 10.1016/S0896-6273(01)00515-3; CURTIN KD, 1995, NEURON, V14, P365, DOI 10.1016/0896-6273(95)90292-9; DiBartolomeis SM, 2002, MOL GENET GENOMICS, V267, P564, DOI 10.1007/s00438-002-0700-7; EDERY I, 1994, P NATL ACAD SCI USA, V91, P2260, DOI 10.1073/pnas.91.6.2260; Helfrich-Forster C, 2000, J NEUROSCI, V20, P3339, DOI 10.1523/JNEUROSCI.20-09-03339.2000; HELFRICHFORSTER C, 1995, P NATL ACAD SCI USA, V92, P612, DOI 10.1073/pnas.92.2.612; HunterEnsor M, 1996, CELL, V84, P677, DOI 10.1016/S0092-8674(00)81046-6; Jauch E, 2002, GENE, V298, P29, DOI 10.1016/S0378-1119(02)00921-6; Kloss B, 2001, NEURON, V30, P699, DOI 10.1016/S0896-6273(01)00320-8; KONOPKA RJ, 1991, J NEUROGENET, V7, P103, DOI 10.3109/01677069109066214; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lee CG, 1996, SCIENCE, V271, P1740, DOI 10.1126/science.271.5256.1740; LEVINE JD, 1994, NEURON, V13, P967, DOI 10.1016/0896-6273(94)90262-3; Lin Y, 2002, P NATL ACAD SCI USA, V99, P9562, DOI 10.1073/pnas.132269699; LUSCHER B, 1994, EUR J BIOCHEM, V220, P521, DOI 10.1111/j.1432-1033.1994.tb18651.x; Martinek S, 2001, CELL, V105, P769, DOI 10.1016/S0092-8674(01)00383-X; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Myers MP, 1996, SCIENCE, V271, P1736, DOI 10.1126/science.271.5256.1736; NEWBY LM, 1995, DEV GENET, V16, P85, DOI 10.1002/dvg.1020160112; NEWBY LM, 1991, GENETICS, V128, P571; Niefind K, 2001, EMBO J, V20, P5320, DOI 10.1093/emboj/20.19.5320; ORR D, 1982, THESIS CALTECH; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; Shafer OT, 2002, J NEUROSCI, V22, P5946; Sidote D, 1998, MOL CELL BIOL, V18, P2004, DOI 10.1128/MCB.18.4.2004; Sugano S, 1999, P NATL ACAD SCI USA, V96, P12362, DOI 10.1073/pnas.96.22.12362; Ueda HR, 2002, J BIOL CHEM, V277, P14048, DOI 10.1074/jbc.C100765200; Yang YH, 2002, GENE DEV, V16, P994, DOI 10.1101/gad.965102; Yang ZH, 2001, NEURON, V29, P453, DOI 10.1016/S0896-6273(01)00218-5; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0	35	228	232	0	27	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2003	6	3					251	257		10.1038/nn1007	http://dx.doi.org/10.1038/nn1007			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	648YB	12563262				2022-12-24	WOS:000181178300013
J	Lee, HS; Nelms, JL; Nguyen, M; Silver, R; Lehman, MN				Lee, HS; Nelms, JL; Nguyen, M; Silver, R; Lehman, MN			The eye is necessary for a circadian rhythm in the suprachiasmatic nucleus	NATURE NEUROSCIENCE			English	Article							CALBINDIN-D-28K CELLS; PROTEIN-KINASE; MAP KINASE; HAMSTER; ACTIVATION; LIGHT		Univ Cincinnati, Coll Med, Dept Cell Biol Neurobiol & Anat, Cincinnati, OH 45267 USA; Univ Cincinnati, Coll Med, Program Neurosci, Cincinnati, OH 45267 USA; Univ Cincinnati, Coll Med, Phys Sci Training Program, Cincinnati, OH 45267 USA; Columbia Univ, New York, NY 10027 USA; Barnard Coll, Dept Psychol, New York, NY 10027 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Columbia University	Lehman, MN (corresponding author), Univ Cincinnati, Coll Med, Dept Cell Biol Neurobiol & Anat, Cincinnati, OH 45267 USA.	michael.lehman@uc.edu	Jansen, Heiko T./A-5770-2008; Lehman, Michael/ABC-9076-2020	Jansen, Heiko T./0000-0003-0178-396X; Silver, Rae/0000-0001-8633-739X; Lehman, Michael/0000-0002-9076-5108				Bryant DN, 2000, J BIOL RHYTHM, V15, P103, DOI 10.1177/074873040001500204; Butcher GQ, 2002, J BIOL CHEM, V277, P29519, DOI 10.1074/jbc.M203301200; CARD JP, 1984, NEUROSCIENCE, V13, P415, DOI 10.1016/0306-4522(84)90240-9; Hastings MH, 1997, TRENDS NEUROSCI, V20, P459, DOI 10.1016/S0166-2236(97)01087-4; Ko GYP, 2001, NEURON, V29, P255, DOI 10.1016/S0896-6273(01)00195-7; LEHMAN MN, 1987, J NEUROSCI, V7, P1626; Lupi D, 1999, NEUROSCIENCE, V89, P363, DOI 10.1016/S0306-4522(98)00353-4; Matsumoto S, 1996, J BIOL RHYTHM, V11, P145, DOI 10.1177/074873049601100207; Obrietan K, 1998, NAT NEUROSCI, V1, P693, DOI 10.1038/3695; Sanada K, 2000, J NEUROSCI, V20, P986, DOI 10.1523/JNEUROSCI.20-03-00986.2000; Silver R, 1996, NEUROREPORT, V7, P1224, DOI 10.1097/00001756-199604260-00026; Tosini G, 1996, SCIENCE, V272, P419, DOI 10.1126/science.272.5260.419; Williams JA, 2001, SCIENCE, V293, P2251, DOI 10.1126/science.1063097; Yamazaki S, 2002, J BIOL RHYTHM, V17, P315, DOI 10.1177/074873040201700405	14	119	120	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2003	6	2					111	112		10.1038/nn1006	http://dx.doi.org/10.1038/nn1006			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	640CL	12536213				2022-12-24	WOS:000180669100007
J	Penzes, P; Beeser, A; Chernoff, J; Schiller, MR; Eipper, BA; Mains, RE; Huganir, RL				Penzes, P; Beeser, A; Chernoff, J; Schiller, MR; Eipper, BA; Mains, RE; Huganir, RL			Rapid induction of dendritic spine morphogenesis by trans-synaptic EphrinB-EphB receptor activation of the Rho-GEF kalirin	NEURON			English	Article							GDP/GTP EXCHANGE FACTOR; HIPPOCAMPAL-NEURONS; SMALL GTPASES; PLASTICITY; MORPHOLOGY; ROLES; PROTEINS; DENSITY; DOMAIN; BRAIN	The morphogenesis of dendritic spines, the major sites of excitatory synaptic transmission in the brain, is important in synaptic development and plasticity. We have identified an ephrinB-EphB receptor trans-synaptic signaling pathway which regulates the morphogenesis and maturation of dendritic spines in hippocampal neurons. Activation of the EphB receptor induces translocation of the Rho-GEF kalirin to synapses and activation of Rac1 and its effector PAK. Overexpression of dominant-negative EphB receptor, catalytically inactive kalirin, or dominant-negative Rac1, or inhibition of PAK eliminates ephrin-induced spine development. This novel signal transduction pathway may be critical for the regulation of the actin cytoskeleton controlling spine morphogenesis during development and plasticity.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; Univ Connecticut, Ctr Hlth, Dept Neurosci, Farmington, CT 06030 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Fox Chase Cancer Center; University of Connecticut	Huganir, RL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.		Chernoff, Jonathan/I-7631-2014; Penzes, Peter/L-3987-2016	Chernoff, Jonathan/0000-0002-4803-7836; Penzes, Peter/0000-0001-5449-1640; Schiller, Martin R/0000-0003-1671-6823	NIDA NIH HHS [DA 00266] Funding Source: Medline; NIMH NIH HHS [MH 61873] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH061873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA000266] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Bagrodia S, 1999, TRENDS CELL BIOL, V9, P350, DOI 10.1016/S0962-8924(99)01618-9; Binns KL, 2000, MOL CELL BIOL, V20, P4791, DOI 10.1128/MCB.20.13.4791-4805.2000; Buchert M, 1999, J CELL BIOL, V144, P361, DOI 10.1083/jcb.144.2.361; Comery TA, 1996, NEUROBIOL LEARN MEM, V66, P93, DOI 10.1006/nlme.1996.0049; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; El-Hussein AE, 2000, SCIENCE, V290, P1364; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Ethell IM, 2001, NEURON, V31, P1001, DOI 10.1016/S0896-6273(01)00440-8; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; GEINISMAN Y, 1992, HIPPOCAMPUS, V2, P437, DOI 10.1002/hipo.450020411; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; Hayashi K, 1999, J NEUROSCI, V19, P3918; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Michiels F, 1997, J CELL BIOL, V137, P387, DOI 10.1083/jcb.137.2.387; Murphy DD, 1998, P NATL ACAD SCI USA, V95, P11412, DOI 10.1073/pnas.95.19.11412; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Newsome TP, 2000, CELL, V101, P283, DOI 10.1016/S0092-8674(00)80838-7; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; PAPA M, 1995, J NEUROSCI, V15, P1; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Penzes P, 2001, J NEUROSCI, V21, P8426, DOI 10.1523/JNEUROSCI.21-21-08426.2001; Penzes P, 2000, J BIOL CHEM, V275, P6395, DOI 10.1074/jbc.275.9.6395; PURPURA DP, 1974, SCIENCE, V186, P1126, DOI 10.1126/science.186.4169.1126; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Sells MA, 2000, J CELL BIOL, V151, P1449, DOI 10.1083/jcb.151.7.1449; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Shimada A, 1998, J NEUROSCI, V18, P8559; Sorra KE, 2000, HIPPOCAMPUS, V10, P501, DOI 10.1002/1098-1063(2000)10:5<501::AID-HIPO1>3.0.CO;2-T; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; van Rossum D, 1999, TRENDS NEUROSCI, V22, P290, DOI 10.1016/S0166-2236(99)01404-6; Vocero-Akbani A, 2001, METHOD ENZYMOL, V332, P36; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zhao ZS, 1998, MOL CELL BIOL, V18, P2153, DOI 10.1128/MCB.18.4.2153; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	43	364	376	1	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 23	2003	37	2					263	274		10.1016/S0896-6273(02)01168-6	http://dx.doi.org/10.1016/S0896-6273(02)01168-6			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	646UX	12546821	Bronze			2022-12-24	WOS:000181054900011
J	Ruan, WJ; Long, H; Vuong, DH; Rao, Y				Ruan, WJ; Long, H; Vuong, DH; Rao, Y			Bifocal is a downstream target of the Ste20-like serine/threonine kinase misshapen in regulating photoreceptor growth cone targeting in Drosophila	NEURON			English	Article							SH2/SH3 ADAPTER PROTEIN; N-TERMINAL KINASE; VISUAL-SYSTEM; AXON GUIDANCE; STE20-RELATED KINASE; DORSAL CLOSURE; LIM-KINASE; ACTIN; ACTIVATION; COLLAPSE	Misshapen (Msn) has been proposed to shut down Drosophila photoreceptor (R cell) growth cone motility in response to targeting signals linked by the SH2/SH3 adaptor protein Dock. Here, we show that Bifocal (Bif), a putative cytoskeletal regulator, is a component of the Msn pathway for regulating R cell growth cone targeting. bif displays strong genetic interaction with msn. Phenotypic analysis indicates a specific role for Bif to terminate R1-R6 growth cones. Biochemical studies show that Msn associates directly with Bif and phosphorylates Bif in vitro. Cell culture studies demonstrate that Msn interacts with Bif to regulate F-actin structure and filopodium formation. We propose that Bif functions downstream of Msn to reorganize actin cytoskeleton in decelerating R cell growth cone motility at the target region.	McGill Univ, Ctr Hlth, McGill Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada; McGill Univ, Ctr Hlth, Dept Neurol & Neurosci, Montreal, PQ H3G 1A4, Canada	McGill University; McGill University	Rao, Y (corresponding author), McGill Univ, Ctr Hlth, McGill Ctr Res Neurosci, 1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.							Ambach A, 2000, EUR J IMMUNOL, V30, P3422, DOI 10.1002/1521-4141(2000012)30:12<3422::AID-IMMU3422>3.0.CO;2-J; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bahri SM, 1997, MOL CELL BIOL, V17, P5521, DOI 10.1128/MCB.17.9.5521; Becker E, 2000, MOL CELL BIOL, V20, P1537, DOI 10.1128/MCB.20.5.1537-1545.2000; Bolz J, 1996, PROG BRAIN RES, V108, P41, DOI 10.1016/S0079-6123(08)62531-5; Clandinin TR, 2000, NEURON, V28, P427, DOI 10.1016/S0896-6273(00)00122-7; COX EC, 1990, NEURON, V4, P31, DOI 10.1016/0896-6273(90)90441-H; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Eichinger L, 1998, J BIOL CHEM, V273, P12952, DOI 10.1074/jbc.273.21.12952; FAN JH, 1993, J CELL BIOL, V121, P867, DOI 10.1083/jcb.121.4.867; Fu CA, 1999, J BIOL CHEM, V274, P30729, DOI 10.1074/jbc.274.43.30729; Garrity PA, 1996, CELL, V85, P639, DOI 10.1016/S0092-8674(00)81231-3; Garrity PA, 1999, NEURON, V22, P707, DOI 10.1016/S0896-6273(00)80730-8; GARRITY PA, 1995, CELL, V83, P177, DOI 10.1016/0092-8674(95)90159-0; Helps NR, 2001, MOL CELL BIOL, V21, P2154, DOI 10.1128/MCB.21.6.2154-2164.2001; Hing H, 1999, CELL, V97, P853, DOI 10.1016/S0092-8674(00)80798-9; Inoue A, 1997, SCIENCE, V276, P1428, DOI 10.1126/science.276.5317.1428; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; LI CL, 1995, J NEUROBIOL, V28, P363, DOI 10.1002/neu.480280309; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Meinertzhagen Ian A., 1993, P1363; Newsome TP, 2000, CELL, V101, P283, DOI 10.1016/S0092-8674(00)80838-7; Perez SE, 1996, MECH DEVELOP, V59, P11, DOI 10.1016/0925-4773(96)00556-4; Poeck B, 2001, NEURON, V29, P99, DOI 10.1016/S0896-6273(01)00183-0; Rao Y, 2000, P NATL ACAD SCI USA, V97, P5966, DOI 10.1073/pnas.110135297; Ruan WJ, 1999, NEURON, V24, P595, DOI 10.1016/S0896-6273(00)81115-0; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Sells MA, 1997, TRENDS CELL BIOL, V7, P162, DOI 10.1016/S0962-8924(97)01003-9; Senti KA, 2000, DEVELOPMENT, V127, P2291; Sisson JC, 2000, J CELL BIOL, V151, P905, DOI 10.1083/jcb.151.4.905; Stein E, 1998, J BIOL CHEM, V273, P1303, DOI 10.1074/jbc.273.3.1303; Su YC, 1998, GENE DEV, V12, P2371, DOI 10.1101/gad.12.15.2371; Su YC, 1997, EMBO J, V16, P1279, DOI 10.1093/emboj/16.6.1279; Su YC, 2000, MOL CELL BIOL, V20, P4736, DOI 10.1128/MCB.20.13.4736-4744.2000; TANAKA E, 1995, CELL, V83, P171, DOI 10.1016/0092-8674(95)90158-2; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Treisman JE, 1997, GENE, V186, P119, DOI 10.1016/S0378-1119(96)00694-4; Zhou FQ, 2001, J CELL BIOL, V153, P1071, DOI 10.1083/jcb.153.5.1071	39	27	27	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 5	2002	36	5					831	842		10.1016/S0896-6273(02)01027-9	http://dx.doi.org/10.1016/S0896-6273(02)01027-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	622VL	12467587	Bronze			2022-12-24	WOS:000179667800008
J	Yue, ZY; Horton, A; Bravin, M; DeJager, PL; Selimi, F; Heintz, N				Yue, ZY; Horton, A; Bravin, M; DeJager, PL; Selimi, F; Heintz, N			A novel protein complex linking the delta 2 glutamate receptor and autophagy: Implications for neurodegeneration in Lurcher mice	NEURON			English	Article							ENDOSOMAL-LYSOSOMAL SYSTEM; DOMAIN-CONTAINING PROTEIN; CELL-DEATH; AMPA RECEPTORS; PURKINJE-CELL; POSTSYNAPTIC DENSITY; CEREBELLUM; NEURONS; LOCALIZATION; SUBUNITS	Autophagy is a pathway for bulk degradation of subcellular constituents that is hyperactivated in many neurodegenerative conditions. It has been considered a second form of programmed cell death. Death of cerebellar Purkinje cells in lurcher animals is due to a mutation in GluRdelta2 that results in its constitutive activation. Here we have identified protein interactions between GluRdelta2, a novel isoform of a PDZ domain-containing protein (nPIST) that binds to this receptor, and Beclin1. nPIST and Beclin1 can synergize to induce autophagy. GluRdelta2(Lc), but not GluRdelta2(wt), can also induce autophagy. Furthermore, dying lurcher Purkinje cells contain morphological hallmarks of autophagic death in vivo. These results provide strong evidence that a direct link exists between GluRdelta2(Lc) receptor and stimulation of the autophagic pathway in dying lurcher Purkinje cells.	Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Rockefeller Univ, Mol Biol Lab, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University	Heintz, N (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10021 USA.	heintz@rockefeller.edu		Horton, Antony/0000-0003-4513-3088	Fondazione Telethon Funding Source: Custom	Fondazione Telethon(Fondazione Telethon)		Anglade P, 1997, HISTOL HISTOPATHOL, V12, P25; Bursch W, 2001, CELL DEATH DIFFER, V8, P569, DOI 10.1038/sj.cdd.4400852; CADDY KWT, 1979, PHILOS T ROY SOC B, V287, P167, DOI 10.1098/rstb.1979.0055; CADDY KWT, 1975, BRAIN RES, V91, P276, DOI 10.1016/0006-8993(75)90548-X; CADDY KWT, 1991, J COMP NEUROL, V305, P421, DOI 10.1002/cne.903050306; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Cataldo AM, 1996, J NEUROSCI, V16, P186; Cheng J, 2002, J BIOL CHEM, V277, P3520, DOI 10.1074/jbc.M110177200; Cutler NS, 2001, MOL BIOL CELL, V12, P4103, DOI 10.1091/mbc.12.12.4103; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Doughty ML, 2000, J NEUROSCI, V20, P3687; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; DUMESNILBOUSEZ N, 1992, J NEUROCYTOL, V21, P506, DOI 10.1007/BF01186954; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Grant SGN, 2001, CURR OPIN NEUROBIOL, V11, P363, DOI 10.1016/S0959-4388(00)00220-8; HAMPSON DR, 1992, NEUROSCIENCE, V50, P11, DOI 10.1016/0306-4522(92)90378-F; Heintz N, 2000, ANNU REV PHYSIOL, V62, P779, DOI 10.1146/annurev.physiol.62.1.779; Kametaka S, 1998, J BIOL CHEM, V273, P22284, DOI 10.1074/jbc.273.35.22284; KASHIWABUCHI N, 1995, CELL, V81, P245, DOI 10.1016/0092-8674(95)90334-8; Kegel KB, 2000, J NEUROSCI, V20, P7268, DOI 10.1523/jneurosci.20-19-07268.2000; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Klionsky DT, 1999, ANNU REV CELL DEV BI, V15, P1, DOI 10.1146/annurev.cellbio.15.1.1; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Landsend AS, 1997, J NEUROSCI, V17, P834, DOI 10.1523/jneurosci.17-02-00834.1997; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; LOMELI H, 1993, FEBS LETT, V315, P318, DOI 10.1016/0014-5793(93)81186-4; Miura M, 2000, METHOD ENZYMOL, V322, P480; Muller BM, 1996, NEURON, V17, P255, DOI 10.1016/S0896-6273(00)80157-9; Neudauer CL, 2001, BIOCHEM BIOPH RES CO, V280, P541, DOI 10.1006/bbrc.2000.4160; Niethammer M, 1996, J NEUROSCI, V16, P2157; Nixon RA, 2000, NEUROCHEM RES, V25, P1161, DOI 10.1023/A:1007675508413; NORMAN DJ, 1995, DEVELOPMENT, V121, P1183; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Petersen A, 2001, HUM MOL GENET, V10, P1243, DOI 10.1093/hmg/10.12.1243; PHILLIPS RITA J. S., 1960, JOUR GENET, V57, P35, DOI 10.1007/BF02985337; REME CE, 1977, A GRAEF ARCH KLIN EX, V203, P261, DOI 10.1007/BF00409832; Sapp E, 1997, ANN NEUROL, V42, P604, DOI 10.1002/ana.410420411; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; SCHWARTZ LM, 1993, P NATL ACAD SCI USA, V90, P980, DOI 10.1073/pnas.90.3.980; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Selimi F, 2000, J NEUROSCI, V20, P992, DOI 10.1523/JNEUROSCI.20-03-00992.2000; Selimi F, 2000, J NEUROSCI, V20, P5339, DOI 10.1523/JNEUROSCI.20-14-05339.2000; Sheng M, 2001, P NATL ACAD SCI USA, V98, P7058, DOI 10.1073/pnas.111146298; Skinner PJ, 2001, AM J PATHOL, V159, P905, DOI 10.1016/S0002-9440(10)61766-X; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; Stromhaug PE, 2001, TRAFFIC, V2, P524, DOI 10.1034/j.1600-0854.2001.20802.x; TAKAYAMA C, 1995, NEUROSCI LETT, V188, P89, DOI 10.1016/0304-3940(95)11403-J; Thumm M, 2001, MOL GENET GENOMICS, V266, P657, DOI 10.1007/s004380100585; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; WETTS R, 1982, BRAIN RES, V250, P358, DOI 10.1016/0006-8993(82)90431-0; WILSON DB, 1975, EXPERIENTIA, V31, P220, DOI 10.1007/BF01990715; WULLNER U, 1995, NEUROSCI LETT, V200, P109, DOI 10.1016/0304-3940(95)12090-Q; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Xue LZ, 1999, MOL CELL NEUROSCI, V14, P180, DOI 10.1006/mcne.1999.0780; YAMAZAKI M, 1992, BIOCHEM BIOPH RES CO, V183, P886, DOI 10.1016/0006-291X(92)90566-4; Zuo J, 1997, NATURE, V388, P769, DOI 10.1038/42009	60	262	278	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 29	2002	35	5					921	933		10.1016/S0896-6273(02)00861-9	http://dx.doi.org/10.1016/S0896-6273(02)00861-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	589UY	12372286	Bronze			2022-12-24	WOS:000177779800014
J	Martinez-Trujillo, JC; Treue, S				Martinez-Trujillo, JC; Treue, S			Attentional modulation strength in cortical area MT depends on stimulus contrast	NEURON			English	Article							STRIATE CORTEX; MOTION; NEURONS; V4; RESPONSES; MONKEY; CAT	The attentional modulation of sensory information processing in the visual system is the result of top-down influences, which can cause a multiplicative modulation of the firing rate of sensory neurons in extrastriate visual cortex, an effect reminiscent of the bottom-up effect of changes in stimulus contrast. This similarity could simply reflect the multiplicity of both effects. But, here we show that in direction-selective neurons in monkey visual cortical area MT, stimulus and attentional effects share a nonlinearity. These neurons show higher response gain for both contrast and attentional changes for intermediate contrast stimuli and smaller gain for low- and high-contrast stimuli. This finding suggests a close relationship between the neural encoding of stimulus contrast and the modulating effect of the behavioral relevance of stimuli.	German Primate Ctr, Cognit Neurosci Lab, D-37077 Gottingen, Germany; York Univ, Ctr Vis Res, Toronto, ON M3J 1P3, Canada	Deutsches Primatenzentrum (DPZ); York University - Canada	Treue, S (corresponding author), German Primate Ctr, Cognit Neurosci Lab, Kellnerweg 4, D-37077 Gottingen, Germany.		Martinez-Trujillo, Julio C/M-2146-2015	Martinez-Trujillo, Julio C/0000-0003-3338-578X				ALBRECHT DG, 1982, J NEUROPHYSIOL, V48, P217, DOI 10.1152/jn.1982.48.1.217; BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; DEAN AF, 1981, EXP BRAIN RES, V44, P437; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; KUKKONEN H, 1993, VISION RES, V33, P1431, DOI 10.1016/0042-6989(93)90049-3; McAdams CJ, 2000, J NEUROPHYSIOL, V83, P1751, DOI 10.1152/jn.2000.83.3.1751; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MOULDEN B, 1990, PERCEPTION, V19, P79, DOI 10.1068/p190079; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; SCLAR G, 1990, VISION RES, V30, P1, DOI 10.1016/0042-6989(90)90123-3; SCLAR G, 1982, EXP BRAIN RES, V46, P457; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; TOLHURST DJ, 1973, J PHYSIOL-LONDON, V231, P385, DOI 10.1113/jphysiol.1973.sp010239; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Treue S, 1999, J NEUROSCI, V19, P7591, DOI 10.1523/JNEUROSCI.19-17-07591.1999; Treue S, 2000, NAT NEUROSCI, V3, P270, DOI 10.1038/72985	19	277	281	1	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 18	2002	35	2					365	370		10.1016/S0896-6273(02)00778-X	http://dx.doi.org/10.1016/S0896-6273(02)00778-X			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	576YF	12160753	Bronze			2022-12-24	WOS:000177034200015
J	Burbea, M; Dreier, L; Dittman, JS; Grunwald, ME; Kaplan, JM				Burbea, M; Dreier, L; Dittman, JS; Grunwald, ME; Kaplan, JM			Ubiquitin and AP180 regulate the abundance of GLR-1 glutamate receptors at postsynaptic elements in C-elegans	NEURON			English	Article							LONG-TERM FACILITATION; AMPA RECEPTORS; DEUBIQUITINATING ENZYME; CAENORHABDITIS-ELEGANS; SYNAPTIC-TRANSMISSION; NERVOUS-SYSTEM; MECHANISMS; EXPRESSION; SYNAPSES; PROTEINS	Regulated delivery and removal of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) glutamate receptors (GluRs) from postsynaptic elements has been proposed as a mechanism for regulating synaptic strength. Here we test the role of ubiquitin in regulating synapses that contain a C. elegans GluR, GLR-1. GLR-1 receptors were ubiquitinated in vivo. Mutations that decreased ubiquitination of GLR-1 increased the abundance of GLR-1 at synapses and altered locomotion behavior in a manner that is consistent with increased synaptic strength. By contrast, overexpression of ubiquitin decreased the abundance of GLR-1 at synapses and decreased the density of GLR-1-containing synapses, and these effects were prevented by mutations in the unc-11 gene, which encodes a clathrin adaptin protein (AP180). These results suggest that ubiquitination of GLR-1 receptors regulates synaptic strength and the formation or stability of GLR-1 -containing synapses.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Kaplan, JM (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Wellman 8, Boston, MA 02114 USA.	joshkap@socrates.berkeley.edu		Dittman, Jeremy S./0000-0002-3850-9078	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032196, R37NS032196, F32NS041705] Funding Source: NIH RePORTER; NINDS NIH HHS [F32 NS41705, NS32196] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Bellocchio EE, 2000, SCIENCE, V289, P957, DOI 10.1126/science.289.5481.957; BRENNER S, 1974, GENETICS, V77, P71; Brockie PJ, 2001, J NEUROSCI, V21, P1510, DOI 10.1523/JNEUROSCI.21-05-01510.2001; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Chain DG, 1999, NEURON, V22, P147, DOI 10.1016/S0896-6273(00)80686-8; CHALFIE M, 1985, J NEUROSCI, V5, P956; Craig AM, 1998, NEURON, V21, P459, DOI 10.1016/S0896-6273(00)80555-3; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hegde AN, 1997, CELL, V89, P115, DOI 10.1016/S0092-8674(00)80188-9; Helliwell SB, 2001, J CELL BIOL, V153, P649, DOI 10.1083/jcb.153.4.649; Hicke L, 1999, TRENDS CELL BIOL, V9, P107, DOI 10.1016/S0962-8924(98)01491-3; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Kirchhausen T, 1999, ANNU REV CELL DEV BI, V15, P705, DOI 10.1146/annurev.cellbio.15.1.705; Lee RYN, 1999, J NEUROSCI, V19, P159, DOI 10.1523/JNEUROSCI.19-01-00159.1999; Liang F, 2001, J NEUROCHEM, V77, P1626, DOI 10.1046/j.1471-4159.2001.00377.x; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Nonet ML, 1999, MOL BIOL CELL, V10, P2343, DOI 10.1091/mbc.10.7.2343; PAPA FR, 1993, NATURE, V366, P313, DOI 10.1038/366313a0; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Reggiori F, 2001, EMBO J, V20, P5176, DOI 10.1093/emboj/20.18.5176; Rongo C, 1999, NATURE, V402, P195, DOI 10.1038/46065; Rongo C, 1998, CELL, V94, P751, DOI 10.1016/S0092-8674(00)81734-1; Seedorf M, 1999, MOL CELL BIOL, V19, P1547; Shamu CE, 1999, J CELL BIOL, V147, P45, DOI 10.1083/jcb.147.1.45; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Swaminathan S, 1999, MOL BIOL CELL, V10, P2583, DOI 10.1091/mbc.10.8.2583; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Urbanowski JL, 2001, TRAFFIC, V2, P622, DOI 10.1034/j.1600-0854.2001.20905.x; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WICKS SR, 1995, J NEUROSCI, V15, P2434, DOI 10.1523/JNEUROSCI.15-03-02434.1995; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9; Zheng Y, 1999, NEURON, V24, P347, DOI 10.1016/S0896-6273(00)80849-1	52	219	231	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 3	2002	35	1					107	120		10.1016/S0896-6273(02)00749-3	http://dx.doi.org/10.1016/S0896-6273(02)00749-3			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	569KP	12123612	Bronze			2022-12-24	WOS:000176601800014
J	Kleinschmidt, A; Buchel, C; Hutton, C; Friston, KJ; Frackowiak, RSJ				Kleinschmidt, A; Buchel, C; Hutton, C; Friston, KJ; Frackowiak, RSJ			The neural structures expressing perceptual hysteresis in visual letter recognition	NEURON			English	Article							PERIRHINAL CORTEX; MEMORY; ACTIVATION; MECHANISMS; AWARENESS; ATTENTION; RIVALRY; OBJECTS; SIGNAL; MODEL	Perception can change nonlinearly with stimulus contrast, and perceptual threshold may depend on the direction of contrast change. Such hysteresis effects in neurometric functions provide a signature of perceptual awareness. We recorded brain activity with functional neuroimaging in observers exposed to gradual contrast changes of initially hidden visual stimuli. Lateral occipital, frontal, and parietal regions all displayed both transient activations and hysteresis that correlated with change and maintenance of a percept, respectively. Medial temporal activity did not follow perception but increased during hysteresis and showed transient deactivations during perceptual transitions. These findings identify a set of brain regions sensitive to visual awareness and suggest that medial temporal structures may provide backward signals that account for neural and, thereby, perceptual hysteresis.	Goethe Univ Frankfurt, Dept Neurol, D-60590 Frankfurt, Germany; Univ Hamburg, Dept Neurol, D-20246 Hamburg, Germany; UCL, Wellcome Dept Imaging Neurosci, London WC1N 3BG, England	Goethe University Frankfurt; University of Hamburg; University of London; University College London	Kleinschmidt, A (corresponding author), Goethe Univ Frankfurt, Dept Neurol, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	akleins@em.uni-frankfurt.de	Frackowiak, Richard/H-4383-2011; Frackowiak, Richard S/I-1809-2013; Friston, Karl/D-9230-2011	Frackowiak, Richard/0000-0002-3151-822X; Friston, Karl/0000-0001-7984-8909				Bar M, 2001, NEURON, V29, P529, DOI 10.1016/S0896-6273(01)00224-0; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Brown MW, 1998, PROG NEUROBIOL, V55, P149, DOI 10.1016/S0301-0082(98)00002-1; Buchel C, 1999, SCIENCE, V283, P1538, DOI 10.1126/science.283.5407.1538; Buckley MJ, 1998, J NEUROSCI, V18, P2268; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; CARPENTER GA, 1993, TRENDS NEUROSCI, V16, P131, DOI 10.1016/0166-2236(93)90118-6; Courtney SM, 1997, NATURE, V386, P608, DOI 10.1038/386608a0; Desimone R, 1996, P NATL ACAD SCI USA, V93, P13494, DOI 10.1073/pnas.93.24.13494; Farah MJ, 1997, SEMIN NEUROL, V17, P145, DOI 10.1055/s-2008-1040924; Gauthier I, 2000, J COGNITIVE NEUROSCI, V12, P495, DOI 10.1162/089892900562165; GLUCK MA, 1993, HIPPOCAMPUS, V3, P491, DOI 10.1002/hipo.450030410; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 1998, NEURON, V21, P191, DOI 10.1016/S0896-6273(00)80526-7; Grill-Spector K, 2000, NAT NEUROSCI, V3, P837, DOI 10.1038/77754; Henson R, 2000, SCIENCE, V287, P1269, DOI 10.1126/science.287.5456.1269; Hinton GE, 1997, PHILOS T ROY SOC B, V352, P1177, DOI 10.1098/rstb.1997.0101; James TW, 2000, CURR BIOL, V10, P1017, DOI 10.1016/S0960-9822(00)00655-2; Kelso J.A.S., 1995, DYNAMIC PATTERNS; Kleinschmidt A, 1998, P ROY SOC B-BIOL SCI, V265, P2427, DOI 10.1098/rspb.1998.0594; Kourtzi Z, 2000, J NEUROSCI, V20, P3310, DOI 10.1523/JNEUROSCI.20-09-03310.2000; Logothetis N, 1998, CURR OPIN NEUROBIOL, V8, P536; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Miyashita Y, 1996, COGNITIVE BRAIN RES, V5, P81, DOI 10.1016/S0926-6410(96)00043-2; Murray EA, 1999, TRENDS COGN SCI, V3, P142, DOI 10.1016/S1364-6613(99)01303-0; Naya Y, 2001, SCIENCE, V291, P661, DOI 10.1126/science.291.5504.661; Polk TA, 2002, J COGNITIVE NEUROSCI, V14, P145, DOI 10.1162/089892902317236803; Polk TA, 1998, P NATL ACAD SCI USA, V95, P847, DOI 10.1073/pnas.95.3.847; Portas CM, 2000, P ROY SOC B-BIOL SCI, V267, P845, DOI 10.1098/rspb.2000.1080; Ranganath C, 2001, NEURON, V31, P865, DOI 10.1016/S0896-6273(01)00411-1; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Rees G, 1997, SCIENCE, V275, P835, DOI 10.1126/science.275.5301.835; Rees G, 2001, CURR OPIN NEUROBIOL, V11, P150, DOI 10.1016/S0959-4388(00)00190-2; Rees G, 2001, NEUROPSYCHOLOGIA, V39, P1343, DOI 10.1016/S0028-3932(01)00122-1; Samuel AG, 2001, J EXP PSYCHOL HUMAN, V27, P1433, DOI 10.1037/0096-1523.27.6.1433; Scoville WB, 2000, J NEUROPSYCH CLIN N, V12, P103; Sekuler R, 1996, PERCEPTION, V25, P1243, DOI 10.1068/p251243; SOLOMON JA, 1994, NATURE, V369, P395, DOI 10.1038/369395a0; Tanaka K, 1997, CURR OPIN NEUROBIOL, V7, P523, DOI 10.1016/S0959-4388(97)80032-3; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; Treisman AM, 1998, CURR OPIN NEUROBIOL, V8, P218, DOI 10.1016/S0959-4388(98)80143-8; ULLMAN S, 1995, CEREB CORTEX, V5, P1, DOI 10.1093/cercor/5.1.1; ZOLAMORGAN S, 1994, HIPPOCAMPUS, V4, P483, DOI 10.1002/hipo.450040410	44	82	83	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 16	2002	34	4					659	666		10.1016/S0896-6273(02)00694-3	http://dx.doi.org/10.1016/S0896-6273(02)00694-3			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	553FT	12062048	Bronze			2022-12-24	WOS:000175665700018
J	Zhang, XD; Kim-Miller, MJ; Fukuda, M; Kowalchyk, JA; Martin, TFJ				Zhang, XD; Kim-Miller, MJ; Fukuda, M; Kowalchyk, JA; Martin, TFJ			Ca2+-dependent synaptotagmin binding to SNAP-25 is essential for Ca2+-triggered exocytosis	NEURON			English	Article							MEMBRANE-FUSION COMPLEX; SNARE COMPLEX; NEUROTRANSMITTER RELEASE; SYNAPTIC TRANSMISSION; PC12 CELLS; KINETIC COMPONENTS; BOTULINUM TOXIN; CA2+ SENSOR; C2B DOMAIN; IN-VIVO	Synaptotagmin is a proposed Ca2+ sensor on the vesicle for regulated exocytosis and exhibits Ca2+-dependent binding to phospholipids, syntaxin, and SNAP-25 in vitro, but the mechanism by which Call triggers membrane fusion is uncertain. Previous studies suggested that SNAP-25 plays a role in the Ca2+ regulation of secretion. We found that synaptotagmins I and IX associate with SNAP-25 during Ca2+-dependent exocytosis in PC12 cells, and we identified C-terminal amino acids in SNAP-25 (Asp179, Asp186, Asp193) that are required for Ca2+-dependent synaptotagmin binding. Replacement of SNAP-25 in PC12 cells with SNAP-25 containing C-terminal Asp mutations led to a loss-of-function in regulated exocytosis at the Ca2+-dependent fusion step. These results indicate that the Ca2+-dependent interaction of synaptotagmin with SNAP-25 is essential for the Ca2+-dependent triggering of membrane fusion.	Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA; RIKEN, Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama 3510198, Japan	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; RIKEN	Martin, TFJ (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.		Fukuda, MItsunori/I-1511-2015	Fukuda, MItsunori/0000-0002-8620-5853	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK025861, R37DK025861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007507] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK25861] Funding Source: Medline; NIGMS NIH HHS [T32 GM07507] Funding Source: Medline; NIMH NIH HHS [MH12694] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BANERJEE A, 1996, J BIOL CHEM, V271; Bean AJ, 1997, NATURE, V385, P826, DOI 10.1038/385826a0; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; BROADIE K, 1995, NEURON, V15, P663, DOI 10.1016/0896-6273(95)90154-X; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; Budker V, 1996, GENE THER, V3, P593; Capogna M, 1997, J NEUROSCI, V17, P7190; Chapman ER, 1996, J BIOL CHEM, V271, P5844, DOI 10.1074/jbc.271.10.5844; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; Chen YA, 2001, J BIOL CHEM, V276, P26680, DOI 10.1074/jbc.M103522200; Chin LS, 2000, J BIOL CHEM, V275, P1191, DOI 10.1074/jbc.275.2.1191; Davis AF, 1999, NEURON, V24, P363, DOI 10.1016/S0896-6273(00)80850-8; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; Desai RC, 2000, J CELL BIOL, V150, P1125, DOI 10.1083/jcb.150.5.1125; DIANTONIO A, 1993, CELL, V73, P1281, DOI 10.1016/0092-8674(93)90356-U; DOUGLAS WW, 1968, BRIT J PHARMACOL, V34, P453, DOI DOI 10.1111/J.1476-5381.1968.TB08474.X; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fasshauer D, 1997, J BIOL CHEM, V272, P28036, DOI 10.1074/jbc.272.44.28036; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Fiebig KM, 1999, NAT STRUCT BIOL, V6, P117; Fukuda M, 1999, J BIOL CHEM, V274, P31421, DOI 10.1074/jbc.274.44.31421; Fukuda M, 1999, J BIOL CHEM, V274, P31428, DOI 10.1074/jbc.274.44.31428; Fukuda M, 2002, J BIOL CHEM, V277, P4601, DOI 10.1074/jbc.C100588200; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Gerona RRL, 2000, J BIOL CHEM, V275, P6328, DOI 10.1074/jbc.275.9.6328; Hanson PI, 1997, CURR OPIN NEUROBIOL, V7, P310, DOI 10.1016/S0959-4388(97)80057-8; HAY JC, 1995, NATURE, V374, P173, DOI 10.1038/374173a0; HAY JC, 1992, J CELL BIOL, V119, P131; HAYASHI T, 1995, EMBO J, V14, P2317, DOI 10.1002/j.1460-2075.1995.tb07226.x; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Ibata K, 2000, J NEUROCHEM, V74, P518, DOI 10.1046/j.1471-4159.2000.740518.x; Ilardi JM, 1999, NAT NEUROSCI, V2, P119, DOI 10.1038/5673; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; KATZ B, 1967, J PHYSIOL-LONDON, V189, P535, DOI 10.1113/jphysiol.1967.sp008183; Kee Y, 1996, J NEUROSCI, V16, P1975; Kida Y, 2000, J CELL BIOL, V150, P719, DOI 10.1083/jcb.150.4.719; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; Lin RC, 1997, NEURON, V19, P1087, DOI 10.1016/S0896-6273(00)80399-2; Littleton JT, 2001, J NEUROSCI, V21, P1421, DOI 10.1523/JNEUROSCI.21-05-01421.2001; LITTLETON JT, 1994, P NATL ACAD SCI USA, V91, P1088; LUNDH H, 1977, J NEUROL SCI, V32, P29, DOI 10.1016/0022-510X(77)90037-5; Marqueze B, 2000, BIOCHIMIE, V82, P409, DOI 10.1016/S0300-9084(00)00220-0; Martin TFJ, 1997, J BIOL CHEM, V272, P14447, DOI 10.1074/jbc.272.22.14447; Martin Thomas F. J., 1994, Current Opinion in Neurobiology, V4, P626, DOI 10.1016/0959-4388(94)90002-7; Masuda ES, 1998, NEURON, V21, P479, DOI 10.1016/S0896-6273(00)80559-0; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; Okamoto M, 1999, J BIOL CHEM, V274, P18446, DOI 10.1074/jbc.274.26.18446; Poirier MA, 1998, J BIOL CHEM, V273, P11370, DOI 10.1074/jbc.273.18.11370; Poirier MA, 1998, NAT STRUCT BIOL, V5, P765, DOI 10.1038/1799; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; ROOF DM, 1992, J CELL BIOL, V118, P95, DOI 10.1083/jcb.118.1.95; Schiavo G, 1997, P NATL ACAD SCI USA, V94, P997, DOI 10.1073/pnas.94.3.997; SHOJIKASAI Y, 1992, SCIENCE, V256, P1820, DOI 10.1126/science.256.5065.1820; SIMPSON LL, 1978, J PHARMACOL EXP THER, V206, P661; Sudhof TC, 1996, NEURON, V17, P379, DOI 10.1016/S0896-6273(00)80171-3; Sugita S, 2001, NEURON, V30, P459, DOI 10.1016/S0896-6273(01)00290-2; Sugita S, 1996, J BIOL CHEM, V271, P1262, DOI 10.1074/jbc.271.3.1262; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Vaidyanathan VV, 1999, J NEUROCHEM, V72, P327, DOI 10.1046/j.1471-4159.1999.0720327.x; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; WICK PF, 1993, J BIOL CHEM, V268, P10983; Wu MN, 1999, NEURON, V23, P593, DOI 10.1016/S0896-6273(00)80811-9; Xu T, 1999, CELL, V99, P713, DOI 10.1016/S0092-8674(00)81669-4; Xu T, 1998, NAT NEUROSCI, V1, P192, DOI 10.1038/642	68	195	205	1	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 16	2002	34	4					599	611		10.1016/S0896-6273(02)00671-2	http://dx.doi.org/10.1016/S0896-6273(02)00671-2			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	553FT	12062043	Bronze			2022-12-24	WOS:000175665700013
J	Deneve, S; Pouget, A				Deneve, S; Pouget, A			Basis functions for object-centered representations	NEURON			English	Article							PARIETAL CORTEX; VISUAL-FIELD; NEGLECT; ATTENTION; RESPONSES; RECOGNITION; INTEGRATION; INHIBITION; NEURONS; FRAMES	In an object-centered representation, the position of the subparts of an object are encoded with respect to a set of axes and an origin centered on the object. Several physiological and neuropsychological results support the existence of such representations in humans and monkeys. An explicit representation would involve neurons with invariant response properties in object-centered coordinates. We consider an alternative scheme using basis functions in which the cells have retinotopic receptive fields modulated by the orientation of the object and task-related signals. We show that this alternative is consistent with single-cell data, is computationally efficient, and accounts for object-centered hemineglect, a syndrome observed in humans after fronto-parietal lesions.	Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA; Gatsby Computat Neurosci Unit, London WC1N 3AR, England	University of Rochester; University of London; University College London	Pouget, A (corresponding author), Univ Rochester, Dept Brain & Cognit Sci, 601 Elmwood Ave, Rochester, NY 14627 USA.	alex@bcs.rochester.edu		Pouget, Alexandre/0000-0003-3054-6365	NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH057823] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANDERSEN RA, 1990, J NEUROSCI, V10, P1176; Behrmann M, 1999, J EXP PSYCHOL HUMAN, V25, P83, DOI 10.1037/0096-1523.25.1.83; Ben Hamed S, 2001, EXP BRAIN RES, V140, P127, DOI 10.1007/s002210100785; Bishop C. M., 1995, NEURAL NETWORKS PATT; BOUSSAOUD D, 1993, EXP BRAIN RES, V93, P423; Deneve S, 2001, NAT NEUROSCI, V4, P826, DOI 10.1038/90541; DENEVE S, 1998, ADV NEURAL INFORMATI; Drain M, 1997, NEUROPSYCHOLOGIA, V35, P445, DOI 10.1016/S0028-3932(96)00097-8; DRIVER J, 1994, NEUROPSYCHOLOGIA, V32, P1353, DOI 10.1016/0028-3932(94)00068-9; Driver J, 2000, J COGNITIVE NEUROSCI, V12, P542, DOI 10.1162/089892900562192; Duhamel JR, 1997, NATURE, V389, P845, DOI 10.1038/39865; DUNCAN J, 1984, J EXP PSYCHOL GEN, V113, P501, DOI 10.1037/0096-3445.113.4.501; FARAH MJ, 1990, NEUROPSYCHOLOGIA, V28, P335, DOI 10.1016/0028-3932(90)90060-2; GALLETTI C, 1993, EXP BRAIN RES, V96, P221; Gershon ED, 1998, J NEUROPHYSIOL, V79, P1135, DOI 10.1152/jn.1998.79.3.1135; GIBSON BS, 1994, PERCEPT PSYCHOPHYS, V55, P323, DOI 10.3758/BF03207603; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; KAHNEMAN D, 1992, COGNITIVE PSYCHOL, V24, P175, DOI 10.1016/0010-0285(92)90007-O; LAGAE L, 1994, J NEUROPHYSIOL, V71, P1597, DOI 10.1152/jn.1994.71.5.1597; LOGOTHETIS NK, 1995, CEREB CORTEX, V5, P270, DOI 10.1093/cercor/5.3.270; LOGOTHETIS NK, 1995, CURR OPIN NEUROBIOL, V5, P522; Marr D., 1982, VISION; MARSHALL JC, 1993, J NEUROL, V240, P37, DOI 10.1007/BF00838444; Moody J, 1989, NEURAL COMPUT, V1, P281, DOI 10.1162/neco.1989.1.2.281; MOSCOVITCH M, 1994, J COGNITIVE NEUROSCI, V6, P151, DOI 10.1162/jocn.1994.6.2.151; Mozer M C, 1999, Prog Brain Res, V121, P99; OLSHAUSEN BA, 1995, J COMPUT NEUROSCI, V2, P45, DOI 10.1007/BF00962707; OLSON CR, 1995, SCIENCE, V269, P985, DOI 10.1126/science.7638625; POGGIO T, 1990, COLD SPRING HARB SYM, V55, P899; Pouget A, 1997, J COGNITIVE NEUROSCI, V9, P222, DOI 10.1162/jocn.1997.9.2.222; Pouget A, 2001, PSYCHOL REV, V108, P653, DOI 10.1037//0033-295X.108.3.653; Pouget A, 1999, Prog Brain Res, V121, P81; Pouget A, 2000, NAT NEUROSCI, V3, P1192, DOI 10.1038/81469; ReuterLorenz PA, 1996, J COGNITIVE NEUROSCI, V8, P540, DOI 10.1162/jocn.1996.8.6.540; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Sabes PN, 2002, J NEUROPHYSIOL, V88, P1815, DOI 10.1152/jn.2002.88.4.1815; Sakata H, 1998, PHILOS T ROY SOC B, V353, P1363, DOI 10.1098/rstb.1998.0290; SALINAS E, 1995, J NEUROSCI, V15, P6461; SCHLAG J, 1987, J NEUROPHYSIOL, V57, P179, DOI 10.1152/jn.1987.57.1.179; TIPPER SP, 1994, J EXP PSYCHOL HUMAN, V20, P478, DOI 10.1037/0096-1523.20.3.478; Tipper SP, 1996, J EXP PSYCHOL HUMAN, V22, P1261, DOI 10.1037/0096-1523.22.5.1261; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P818, DOI 10.1073/pnas.95.3.818; WACHSMUTH E, 1994, CEREB CORTEX, V4, P509, DOI 10.1093/cercor/4.5.509; Zhou H, 2000, J NEUROSCI, V20, P6594, DOI 10.1523/JNEUROSCI.20-17-06594.2000	45	61	61	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 23	2003	37	2					347	359		10.1016/S0896-6273(02)01184-4	http://dx.doi.org/10.1016/S0896-6273(02)01184-4			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	646UX	12546828	Bronze			2022-12-24	WOS:000181054900018
J	Bao, L; Jin, SX; Zhang, C; Wang, LH; Xu, ZZ; Zhang, FX; Wang, LC; Ning, FS; Cai, HJ; Guan, JS; Xiao, HS; Xu, ZQD; He, C; Hokfelt, T; Zhou, Z; Zhang, X				Bao, L; Jin, SX; Zhang, C; Wang, LH; Xu, ZZ; Zhang, FX; Wang, LC; Ning, FS; Cai, HJ; Guan, JS; Xiao, HS; Xu, ZQD; He, C; Hokfelt, T; Zhou, Z; Zhang, X			Activation of delta opioid receptors induces receptor insertion and neuropeptide secretion	NEURON			English	Article							GENE-RELATED PEPTIDE; DORSAL-ROOT GANGLIA; SPINAL-CORD; SUBSTANCE-P; CA2+-DEPENDENT EXOCYTOSIS; PLASMA-MEMBRANE; SENSORY NEURONS; AMPA RECEPTORS; RAT; RELEASE	Here we describe a novel mechanism for plasma membrane insertion of the delta opioid receptor (DOR). In small dorsal root ganglion neurons, only low levels of DORs are present on the cell surface, in contrast to high levels of intracellular DORs mainly associated with vesicles containing calcitonin gene-related peptide (CGRP). Activation of surface DORs caused Ca2+ release from lP(3)-sensitive stores and Ca2+ entry, resulting in a slow and long-lasting exocytosis, DOR insertion, and CGRP release. In contrast, membrane depolarization or activation of vanilloid and P2Y, receptors induced a rapid DOR insertion. Thus, DOR activation induces a Ca2+-dependent insertion of DORs that is coupled to a release of excitatory neuropeptides, suggesting that treatment of inflammatory pain should include blockade of DORs.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Lab Sensory Syst, Shanghai, Peoples R China; Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Lab Sensory Syst, Shanghai, Peoples R China; Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Lab Cellular Biophys, Shanghai, Peoples R China; Karolinska Inst, Dept Neurosci, Stockholm, Sweden	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Karolinska Institutet	Zhou, Z (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Lab Sensory Syst, Shanghai, Peoples R China.	zzhou@ion.ac.cn; xu.zhang@ion.ac.cn	zhou, zhuan/A-8285-2011; Xu, Zhi-Qing David/H-9757-2013	Xu, Zhi-Qing David/0000-0002-0387-7559; Guan, Ji-Song/0000-0001-5219-0289; Xu, Zhen-Zhong/0000-0001-6578-211X				AUGUSTINE GJ, 1992, J PHYSIOL-LONDON, V450, P247, DOI 10.1113/jphysiol.1992.sp019126; Cahill CM, 2001, J NEUROSCI, V21, P7598, DOI 10.1523/JNEUROSCI.21-19-07598.2001; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; CHENG PY, 1995, J NEUROSCI, V15, P5976; COLLIN E, 1993, BRAIN RES, V609, P211, DOI 10.1016/0006-8993(93)90875-N; DECAMILLI P, 1990, ANNU REV PHYSIOL, V52, P625, DOI 10.1146/annurev.ph.52.030190.003205; Engisch KL, 1996, J NEUROSCI, V16, P1359; ERSPAMER V, 1989, P NATL ACAD SCI USA, V86, P5188, DOI 10.1073/pnas.86.13.5188; EVANS CJ, 1992, SCIENCE, V258, P1952, DOI 10.1126/science.1335167; FIELDS HL, 1980, NATURE, V284, P351, DOI 10.1038/284351a0; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; Gaudriault G, 1997, J BIOL CHEM, V272, P2880, DOI 10.1074/jbc.272.5.2880; Gillis Kevin D., 1995, P155; HOKFELT T, 1977, P NATL ACAD SCI USA, V74, P3081, DOI 10.1073/pnas.74.7.3081; Huang LYM, 1996, NEURON, V17, P135, DOI 10.1016/S0896-6273(00)80287-1; JESSELL TM, 1977, NATURE, V268, P549, DOI 10.1038/268549a0; JUNG LJ, 1991, SCIENCE, V251, P1330, DOI 10.1126/science.2003219; Kasai H, 1999, TRENDS NEUROSCI, V22, P88, DOI 10.1016/S0166-2236(98)01293-4; KIEFFER BL, 1992, P NATL ACAD SCI USA, V89, P12048, DOI 10.1073/pnas.89.24.12048; LAMOTTE C, 1976, BRAIN RES, V112, P407, DOI 10.1016/0006-8993(76)90296-1; Lissin DV, 1999, J NEUROSCI, V19, P1263; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; MANTYH PW, 1995, SCIENCE, V268, P1629, DOI 10.1126/science.7539937; MERIGHI A, 1988, CELL TISSUE RES, V254, P101; Meyer-Franke A, 1998, NEURON, V21, P681, DOI 10.1016/S0896-6273(00)80586-3; Moran-Jimenez MJ, 2000, MOL BRAIN RES, V78, P50, DOI 10.1016/S0169-328X(00)00067-X; MORTON CR, 1990, NEUROSCI LETT, V117, P319, DOI 10.1016/0304-3940(90)90684-2; Nakatsuka T, 2001, NEUROSCIENCE, V107, P293, DOI 10.1016/S0306-4522(01)00342-6; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; PEI G, 1995, MOL PHARMACOL, V48, P173; POHL M, 1989, NEUROPEPTIDES, V14, P151, DOI 10.1016/0143-4179(89)90039-5; Putney JW, 1999, P NATL ACAD SCI USA, V96, P14669, DOI 10.1073/pnas.96.26.14669; RINK TJ, 1990, FEBS LETT, V268, P381, DOI 10.1016/0014-5793(90)81290-5; Schiller PW, 1999, J MED CHEM, V42, P3520, DOI 10.1021/jm980724+; SCROGGS RS, 1992, J NEUROSCI, V12, P1789; Sheng M, 2001, CELL, V105, P825, DOI 10.1016/S0092-8674(01)00406-8; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; SMITH RE, 1966, J CELL BIOL, V31, P319, DOI 10.1083/jcb.31.2.319; SUAREZROCA H, 1992, BRAIN RES, V579, P195, DOI 10.1016/0006-8993(92)90051-A; SWANDULLA D, 1991, NEURON, V7, P915, DOI 10.1016/0896-6273(91)90337-Y; Trapaidze N, 2000, DNA CELL BIOL, V19, P195, DOI 10.1089/104454900314465; Tsao PI, 2000, J BIOL CHEM, V275, P11130, DOI 10.1074/jbc.275.15.11130; Usachev YM, 2002, NEURON, V33, P113, DOI 10.1016/S0896-6273(01)00557-8; Whim MD, 2001, NEURON, V30, P37, DOI 10.1016/S0896-6273(01)00261-6; Whistler JL, 2002, SCIENCE, V297, P615, DOI 10.1126/science.1073308; YAKSH TL, 1980, NATURE, V286, P155, DOI 10.1038/286155a0; YAKSH TL, 1988, PROG BRAIN RES, V77, P371; Zhang X, 1998, NEUROSCIENCE, V82, P1225; ZHOU ZA, 1993, J PHYSIOL-LONDON, V469, P245, DOI 10.1113/jphysiol.1993.sp019813	50	146	166	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 9	2003	37	1					121	133		10.1016/S0896-6273(02)01103-0	http://dx.doi.org/10.1016/S0896-6273(02)01103-0			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	646UV	12526778	Bronze			2022-12-24	WOS:000181054700015
J	Levkowitz, G; Zeller, J; Sirotkin, HI; French, D; Schilbach, S; Hashimoto, H; Hibi, M; Talbot, WS; Rosenthal, A				Levkowitz, G; Zeller, J; Sirotkin, HI; French, D; Schilbach, S; Hashimoto, H; Hibi, M; Talbot, WS; Rosenthal, A			Zinc finger protein too few controls the development of monoaminergic neurons	NATURE NEUROSCIENCE			English	Article							MIDBRAIN DOPAMINERGIC-NEURONS; ZEBRAFISH FOREBRAIN; GENE; EXPRESSION; DROSOPHILA; DIFFERENTIATION; SPECIFICATION; INDUCTION; SIGNALS; EMBRYOS	The mechanism controlling the development of dopaminergic (DA) and serotonergic (5HT) neurons in vertebrates is not well understood. Here we characterized a zebrafish mutant-too few (too-that develops hindbrain 5HT and noradrenergic neurons, but does not develop hypothalamic DA and 5HT neurons. tof encodes a forebrain-specific zinc finger transcription repressor that is homologous to the mammalian Fezl (forebrain embryonic zinc finger-like protein). Mosaic and co-staining analyses showed that fezi was not expressed in DA or 5HT neurons and instead controlled development of these neurons non-cell-autonomously. Both the eh1-related repressor motif and the second zinc finger domain were necessary for tof function. Our results indicate that tof/fezi is a key component in regulating the development of monoaminergic neurons in the vertebrate brain.	Rinat Neurosci Corp, Palo Alto, CA 94304 USA; Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; Osaka Univ, Biomed Res Ctr, Div Mol Oncol, Suita, Osaka 5650871, Japan; RIKEN, Ctr Dev Biol, Lab Vertebrate Axis Format, Chuoh Ku, Kobe, Hyogo 6500047, Japan	Stanford University; Roche Holding; Genentech; Osaka University; RIKEN	Levkowitz, G (corresponding author), Rinat Neurosci Corp, 3155 Porter Dr, Palo Alto, CA 94304 USA.		Levkowitz, Gil/AAB-9441-2019; Hibi, Masahiko/I-6215-2014	Levkowitz, Gil/0000-0002-3896-1881; Hibi, Masahiko/0000-0002-9142-4444	NCRR NIH HHS [RR12349] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR012349] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		AKIMENKO MA, 1994, J NEUROSCI, V14, P3475; BARTH KA, 1995, DEVELOPMENT, V121, P1755; Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Chen WB, 2001, DEVELOPMENT, V128, P2385; Dittrich R, 1997, DEVELOPMENT, V124, P2515; Geisler R, 1999, NAT GENET, V23, P86, DOI 10.1038/12692; Guo S, 2000, NATURE, V408, P366, DOI 10.1038/35042590; Guo S, 1999, DEV BIOL, V208, P473, DOI 10.1006/dbio.1999.9204; Guo S, 1999, NEURON, V24, P555, DOI 10.1016/S0896-6273(00)81112-5; Hashimoto H, 2000, MECH DEVELOP, V97, P191, DOI 10.1016/S0925-4773(00)00418-4; HYNES M, 1995, CELL, V80, P95, DOI 10.1016/0092-8674(95)90454-9; Iuchi S, 2001, CELL MOL LIFE SCI, V58, P625, DOI 10.1007/PL00000885; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kandel ER, 1991, PRINCIPLES NEURAL SC, P1135; Lawrence PA, 1996, CELL, V85, P951, DOI 10.1016/S0092-8674(00)81297-0; Lundell MJ, 1998, DEVELOPMENT, V125, P463; Matsuo-Takasaki M, 2000, MECH DEVELOP, V93, P201, DOI 10.1016/S0925-4773(00)00264-1; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Quint E, 2000, J EXP ZOOL, V288, P235, DOI 10.1002/1097-010X(20001015)288:3&lt;235::AID-JEZ4&gt;3.0.CO;2-J; Saucedo-Cardenas O, 1998, P NATL ACAD SCI USA, V95, P4013, DOI 10.1073/pnas.95.7.4013; Shimoda N, 1999, GENOMICS, V58, P219, DOI 10.1006/geno.1999.5824; Simon HH, 2001, J NEUROSCI, V21, P3126, DOI 10.1523/JNEUROSCI.21-09-03126.2001; Smidt MP, 2000, NAT NEUROSCI, V3, P337, DOI 10.1038/73902; STRAHLE U, 1993, GENE DEV, V7, P1436, DOI 10.1101/gad.7.7b.1436; Wullimann MF, 2001, DEV BRAIN RES, V131, P173, DOI 10.1016/S0165-3806(01)00270-X; Yang ZG, 2001, DEV BIOL, V231, P138, DOI 10.1006/dbio.2000.0139; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3; Ye WL, 2001, NAT NEUROSCI, V4, P1175, DOI 10.1038/nn761; Zeller J, 1999, DEVELOPMENT, V126, P3461; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	30	79	81	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2003	6	1					28	33		10.1038/nn979	http://dx.doi.org/10.1038/nn979			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	630CE	12469125				2022-12-24	WOS:000180089300012
J	Wang, XJ				Wang, XJ			Probabilistic decision making by slow reverberation in cortical circuits	NEURON			English	Article							SPATIAL WORKING-MEMORY; NEURONAL RESPONSES; PARIETAL CORTEX; NEURAL BASIS; TIME-COURSE; MACAQUE MT; AREA MT; MOTION; MODEL; NETWORK	Recent physiological studies of alert primates have revealed cortical neural correlates of key steps in a perceptual decision-making process. To elucidate synaptic mechanisms of decision making, I investigated a biophysically realistic cortical network model for a visual discrimination experiment. In the model, slow recurrent excitation and feedback inhibition produce attractor dynamics that amplify the difference between conflicting inputs and generates a binary choice. The model is shown to account for salient characteristics of the observed decision-correlated neural activity, as well as the animal's psychometric function and reaction times. These results suggest that recurrent excitation mediated by NMDA receptors provides a candidate cellular mechanism for the slow time integration of sensory stimuli and the formation of categorical choices in a decision-making neocortical network.	Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02254 USA	Brandeis University	Wang, XJ (corresponding author), Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02254 USA.	xjwang@brandeis.edu	Wang, Xiao-Jing/D-2722-2009		NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062349] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; AMIT DJ, 1995, BEHAV BRAIN SCI, V18, P617, DOI 10.1017/S0140525X00040164; Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; Bisley JW, 2001, J NEUROPHYSIOL, V85, P187, DOI 10.1152/jn.2001.85.1.187; Braitenberg V, 1991, ANATOMY CORTEX; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Brunel N, 2001, J COMPUT NEUROSCI, V11, P63, DOI 10.1023/A:1011204814320; CARPENTER RHS, 1995, NATURE, V377, P59, DOI 10.1038/377059a0; Carpenter RHS, 1981, EYE MOVEMENTS COGNIT, P237; Chafee MV, 1998, J NEUROPHYSIOL, V79, P2919, DOI 10.1152/jn.1998.79.6.2919; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; Compte A, 2000, CEREB CORTEX, V10, P910, DOI 10.1093/cercor/10.9.910; Cook EP, 2002, NAT NEUROSCI, V5, P985, DOI 10.1038/nn924; DITTERICH J, 2001, SOC NEUR ABSTR, V27; Dodd JV, 2001, J NEUROSCI, V21, P4809, DOI 10.1523/JNEUROSCI.21-13-04809.2001; GNADT JW, 1988, EXP BRAIN RES, V70, P216; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Hansel D, 1998, NEURAL COMPUT, V10, P467, DOI 10.1162/089976698300017845; Hastie R, 2001, ANNU REV PSYCHOL, V52, P653, DOI 10.1146/annurev.psych.52.1.653; Hernandez A, 2002, NEURON, V33, P959, DOI 10.1016/S0896-6273(02)00613-X; Hertz JA, 2018, INTRO THEORY NEURAL; HESTRIN S, 1990, NEURON, V5, P247, DOI 10.1016/0896-6273(90)90162-9; JAHR CE, 1990, J NEUROSCI, V10, P3178; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Krauzlis RJ, 2002, NEURON, V35, P355, DOI 10.1016/S0896-6273(02)00756-0; LUCE RD, 1986, RESPONSE TIME THEIR; Mainen T.J., 1998, METHODS NEURONAL MOD, V2, P1; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Platt ML, 2002, CURR OPIN NEUROBIOL, V12, P141, DOI 10.1016/S0959-4388(02)00302-1; QUINTANA J, 1992, NEUROREPORT, V3, P721, DOI 10.1097/00001756-199208000-00018; Quintana J, 1999, CEREB CORTEX, V9, P213, DOI 10.1093/cercor/9.3.213; Ratcliff R, 1999, PSYCHOL REV, V106, P261, DOI 10.1037/0033-295X.106.2.261; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Reddi BAJ, 2000, NAT NEUROSCI, V3, P827, DOI 10.1038/77739; Roitman JD, 2002, J NEUROSCI, V22, P9475; Romo R, 2001, ANNU REV NEUROSCI, V24, P107, DOI 10.1146/annurev.neuro.24.1.107; Romo R, 1997, CEREB CORTEX, V7, P317, DOI 10.1093/cercor/7.4.317; Salin PA, 1996, J NEUROPHYSIOL, V75, P1573, DOI 10.1152/jn.1996.75.4.1573; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; SCHALL JD, 1995, J NEUROSCI, V15, P6905; Schall JD, 2001, NAT REV NEUROSCI, V2, P33, DOI 10.1038/35049054; Scherzer CR, 1998, J COMP NEUROL, V390, P75, DOI 10.1002/(SICI)1096-9861(19980105)390:1<75::AID-CNE7>3.0.CO;2-N; Seung HS, 1996, P NATL ACAD SCI USA, V93, P13339, DOI 10.1073/pnas.93.23.13339; Seung HS, 2000, NEURON, V26, P259, DOI 10.1016/S0896-6273(00)81155-1; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Shelley MJ, 2001, J COMPUT NEUROSCI, V11, P111, DOI 10.1023/A:1012885314187; Simoncelli EP, 1998, VISION RES, V38, P743, DOI 10.1016/S0042-6989(97)00183-1; SPRUSTON N, 1995, J PHYSIOL-LONDON, V482, P325, DOI 10.1113/jphysiol.1995.sp020521; TSODYKS MV, 1995, NETWORK-COMP NEURAL, V6, P111, DOI 10.1088/0954-898X/6/2/001; Tuckwell H.C., 1988, INTRO THEORETICAL NE, DOI [10.1017/CBO9780511623202, DOI 10.1017/CBO9780511623202]; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; van Vreeswijk C, 1998, NEURAL COMPUT, V10, P1321, DOI 10.1162/089976698300017214; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; Wang XJ, 1999, J NEUROSCI, V19, P9587; Xiang ZX, 1998, J PHYSIOL-LONDON, V506, P715, DOI 10.1111/j.1469-7793.1998.715bv.x; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0; [No title captured]	64	744	748	2	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 5	2002	36	5					955	968		10.1016/S0896-6273(02)01092-9	http://dx.doi.org/10.1016/S0896-6273(02)01092-9			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	622VL	12467598	Bronze			2022-12-24	WOS:000179667800019
J	Carruth, LL; Reisert, I; Arnold, AP				Carruth, LL; Reisert, I; Arnold, AP			Sex chromosome genes directly affect brain sexual differentiation	NATURE NEUROSCIENCE			English	Article							DOPAMINERGIC-NEURONS; MOUSE-BRAIN; TESTOSTERONE; INVITRO		Univ Calif Los Angeles, Dept Physiol Sci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Neuroendocrinol Lab, Inst Brain Res, Los Angeles, CA 90095 USA; Univ Ulm, Anat & Zellbiol Abt, D-89081 Ulm, Germany	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Ulm University	Arnold, AP (corresponding author), Univ Calif Los Angeles, Dept Physiol Sci, Los Angeles, CA 90095 USA.			Arnold, Arthur/0000-0002-9908-9767	NIMH NIH HHS [MH59268] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059268] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Arnold AP., 2002, HORMONES BRAIN BEHAV, P105, DOI 10.1016/B978-012532104-4/50065-2; Becker JB, 1999, PHARMACOL BIOCHEM BE, V64, P803, DOI 10.1016/S0091-3057(99)00168-9; BEYER C, 1992, CELL TISSUE RES, V270, P547, DOI 10.1007/BF00645057; DEVRIES GJ, IN PRESS J NEUROSCI; Dluzen D E, 2000, J Gend Specif Med, V3, P36; Lahr Georgia, 1995, Molecular Brain Research, V33, P179, DOI 10.1016/0169-328X(95)00136-G; LOVELLBADGE R, 1990, DEVELOPMENT, V109, P635; Mahadevaiah SK, 1998, HUM MOL GENET, V7, P715, DOI 10.1093/hmg/7.4.715; PICON R, 1976, J ENDOCRINOL, V71, P231, DOI 10.1677/joe.0.0710231; PILGRIM C, 1992, HORM METAB RES, V24, P353, DOI 10.1055/s-2007-1003334; REISERT I, 1991, TRENDS NEUROSCI, V14, P467; Sibug R, 1996, DEV BRAIN RES, V93, P136, DOI 10.1016/0165-3806(96)00024-7; WEISZ J, 1980, ENDOCRINOLOGY, V106, P306, DOI 10.1210/endo-106-1-306; Xu J, 2002, HUM MOL GENET, V11, P1409, DOI 10.1093/hmg/11.12.1409	14	220	224	0	20	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2002	5	10					933	934		10.1038/nn922	http://dx.doi.org/10.1038/nn922			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	597VV	12244322				2022-12-24	WOS:000178242200009
J	Yantis, S; Schwarzbach, J; Serences, JT; Carlson, RL; Steinmetz, MA; Pekar, JJ; Courtney, SM				Yantis, S; Schwarzbach, J; Serences, JT; Carlson, RL; Steinmetz, MA; Pekar, JJ; Courtney, SM			Transient neural activity in human parietal cortex during spatial attention shifts	NATURE NEUROSCIENCE			English	Article							MULTIPLE-STIMULUS DISPLAYS; VISUAL-ATTENTION; BRAIN ACTIVITY; AREA 7A; SELECTIVE ATTENTION; NEURONAL RESPONSES; DIRECTED ATTENTION; MECHANISMS; MODULATION; SYSTEMS	Observers viewing a complex visual scene selectively attend to relevant locations or objects and ignore irrelevant ones. Selective attention to an object enhances its neural representation in extrastriate cortex, compared with those of unattended objects, via top-down attentional control signals. The posterior parietal cortex is centrally involved in this control of spatial attention. We examined brain activity during attention shifts using rapid, event-related fMRI of human observers as they covertly shifted attention between two peripheral spatial locations. Activation in extrastriate cortex increased after a shift of attention to the contralateral visual field and remained high during sustained contralateral attention. The time course of activity was substantially different in posterior parietal cortex, where transient increases in activation accompanied shifts of attention in either direction. This result suggests that activation of the parietal cortex is associated with a discrete signal to shift spatial attention, and is not the source of a signal to continuously maintain the current attentive state.	Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD 21218 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Zanvyl Krieger Mind Brain Inst, Baltimore, MD 21218 USA; Kennedy Krieger Inst, FM Kirby Res Ctr Funct Brain Imaging, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Radiol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Kennedy Krieger Institute; Johns Hopkins University	Yantis, S (corresponding author), Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD 21218 USA.	yantis@jhu.edu	Yantis, Steven/A-7488-2009; Schwarzbach, Jens/D-1776-2010	Pekar, James/0000-0002-9830-0655	NCRR NIH HHS [P41-RR15241] Funding Source: Medline; NIDA NIH HHS [R01-DA13165] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013165] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; Burock MA, 1998, NEUROREPORT, V9, P3735, DOI 10.1097/00001756-199811160-00030; BUSHNELL MC, 1981, J NEUROPHYSIOL, V46, P755, DOI 10.1152/jn.1981.46.4.755; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; Conner CE, 1997, J NEUROSCI, V17, P3201; Constantinidis C, 1996, J NEUROPHYSIOL, V76, P1352, DOI 10.1152/jn.1996.76.2.1352; Constantinidis C, 2001, CEREB CORTEX, V11, P581, DOI 10.1093/cercor/11.7.581; Constantinidis C, 2001, CEREB CORTEX, V11, P592, DOI 10.1093/cercor/11.7.592; CORBETTA M, 1990, SCIENCE, V248, P1556, DOI 10.1126/science.2360050; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; CORBETTA M, 1993, J NEUROSCI, V13, P1202; Coull JT, 1998, J NEUROSCI, V18, P7426; Culham JC, 1998, J NEUROPHYSIOL, V80, P2657, DOI 10.1152/jn.1998.80.5.2657; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; DESIMONE R, 1990, COLD SPRING HARB SYM, V55, P963; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; Goebel R, 1993, ADV NEURAL INFORMATI, V5, P903; HEINZE HJ, 1994, NATURE, V372, P543, DOI 10.1038/372543a0; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Kanwisher N, 2000, NAT REV NEUROSCI, V1, P91, DOI 10.1038/35039043; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; LABERGE D, 1990, J NEUROSCI, V10, P613; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; MOTTER BC, 1994, J NEUROSCI, V14, P2190; Nobre AC, 1997, BRAIN, V120, P515, DOI 10.1093/brain/120.3.515; OCraven KM, 1997, NEURON, V18, P591, DOI 10.1016/S0896-6273(00)80300-1; OLSHAUSEN BA, 1993, J NEUROSCI, V13, P4700; PETERSEN SE, 1987, NEUROPSYCHOLOGIA, V25, P97, DOI 10.1016/0028-3932(87)90046-7; POSNER MI, 1984, J NEUROSCI, V4, P1863; REEVES A, 1986, PSYCHOL REV, V93, P180, DOI 10.1037/0033-295X.93.2.180; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Rushworth MFS, 2001, J NEUROSCI, V21, P5262, DOI 10.1523/JNEUROSCI.21-14-05262.2001; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Sperling G., 1980, ATTENTION PERFORM, P347; Talairach J., 1988, COPLANAR STEREOTAXIC; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Wojciulik E, 1999, NEURON, V23, P747, DOI 10.1016/S0896-6273(01)80033-7; Yantis S., 1998, ATTENTION, V1, P223, DOI DOI 10.1037/0096-1523.16.4.812	46	539	548	1	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2002	5	10					995	1002		10.1038/nn921	http://dx.doi.org/10.1038/nn921			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	597VV	12219097				2022-12-24	WOS:000178242200019
J	Birder, LA; Nakamura, Y; Kiss, S; Nealen, ML; Barrick, S; Kanai, AJ; Wang, E; Ruiz, G; de Groat, WC; Apodaca, G; Watkins, S; Caterina, MJ				Birder, LA; Nakamura, Y; Kiss, S; Nealen, ML; Barrick, S; Kanai, AJ; Wang, E; Ruiz, G; de Groat, WC; Apodaca, G; Watkins, S; Caterina, MJ			Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1	NATURE NEUROSCIENCE			English	Article							INTRAVESICAL CAPSAICIN; PAIN; RESINIFERATOXIN; RELEASE; CHANNEL; REFLEX; CELLS; ATP	In the urinary bladder, the capsaicin-gated ion channel TRPV1 is expressed both within afferent nerve terminals and within the epithelial cells that line the bladder lumen. To determine the significance of this expression pattern, we analyzed bladder function in mice lacking TRPV1. Compared with wild-type littermates, trpv1(-/-) mice had a higher frequency of low-amplitude, nonvoiding bladder contractions. This alteration was accompanied by reductions in both spinal cord signaling and reflex voiding during bladder filling (under anesthesia). In vitro, stretch-evoked ATP release and membrane capacitance changes were diminished in bladders excised from trpv1(-/-) mice, as was hypoosmolality-evoked ATP release from cultured trpv1(-/-) urothelial cells. These findings indicate that TRPV1 participates in normal bladder function and is essential for normal mechanically evoked purinergic signaling by the urothelium.	Univ Pittsburgh, Sch Med, Dept Med, Renal Electrolyte Div,Lab Epithelial Cell Biol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Pharmacol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15213 USA; Kanazawa Univ, Sch Med, Dept Urol, Kanazawa, Ishikawa 9208641, Japan; Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Kanazawa University; Johns Hopkins University; Johns Hopkins University	Birder, LA (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Renal Electrolyte Div,Lab Epithelial Cell Biol, Pittsburgh, PA 15213 USA.	lbirder@pitt.edu	Barrick, Stacey/J-1595-2015; Watkins, Simon/ABG-2590-2021; Apodaca, Gerard/HCJ-0048-2022; Barrick, Stacey/E-7130-2010	Watkins, Simon/0000-0003-4092-1552; Barrick, Stacey/0000-0002-4837-3741	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054824, R01DK057284, R01DK054425] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL57985] Funding Source: Medline; NIDDK NIH HHS [R01 DK54824, R01 DK57284, R01 DK54425] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Avelino A, 2002, NEUROSCIENCE, V109, P787, DOI 10.1016/S0306-4522(01)00496-1; Birder LA, 1998, AM J PHYSIOL-RENAL, V275, pF226, DOI 10.1152/ajprenal.1998.275.2.F226; Birder LA, 2001, P NATL ACAD SCI USA, V98, P13396, DOI 10.1073/pnas.231243698; Bodin P, 2001, NEUROCHEM RES, V26, P959, DOI 10.1023/A:1012388618693; Bodin P, 2001, J CARDIOVASC PHARM, V38, P900, DOI 10.1097/00005344-200112000-00012; Burnstock G, 2001, TRENDS PHARMACOL SCI, V22, P182, DOI 10.1016/S0165-6147(00)01643-6; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1999, CURR OPIN NEUROBIOL, V9, P525, DOI 10.1016/S0959-4388(99)00009-4; Chancellor MB, 2000, UROLOGY, V55, P65, DOI 10.1016/S0090-4295(99)00499-9; Cheng CL, 1999, AM J PHYSIOL-REG I, V277, pR786, DOI 10.1152/ajpregu.1999.277.3.R786; Chuang YC, 2001, AM J PHYSIOL-REG I, V281, pR1302, DOI 10.1152/ajpregu.2001.281.4.R1302; Cockayne DA, 2000, NATURE, V407, P1011, DOI 10.1038/35039519; de Groat WC, 2001, ANNU REV PHARMACOL, V41, P691, DOI 10.1146/annurev.pharmtox.41.1.691; Ferguson DR, 1997, J PHYSIOL-LONDON, V505, P503, DOI 10.1111/j.1469-7793.1997.503bb.x; Fovaeus M, 1998, ACTA PHYSIOL SCAND, V162, P115; Fowler CJ, 2000, UROLOGY, V55, P60, DOI 10.1016/S0090-4295(99)00498-7; Lazzeri M, 1996, J UROLOGY, V156, P947, DOI 10.1016/S0022-5347(01)65669-6; Lecci A, 2001, AUTON NEUROSCI-BASIC, V91, P37, DOI 10.1016/S1566-0702(01)00303-4; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; MAGGI CA, 1984, EUR J PHARMACOL, V103, P41, DOI 10.1016/0014-2999(84)90187-0; MAGGI CA, 1986, J UROLOGY, V136, P696, DOI 10.1016/S0022-5347(17)45030-0; Namasivayam S, 1999, BJU INT, V84, P854; SANTICIOLI P, 1985, J UROLOGY, V133, P700, DOI 10.1016/S0022-5347(17)49164-6; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Truschel ST, 2002, MOL BIOL CELL, V13, P830, DOI 10.1091/mbc.01-09-0435; Vlaskovska M, 2001, J NEUROSCI, V21, P5670, DOI 10.1523/JNEUROSCI.21-15-05670.2001	26	512	553	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2002	5	9					856	860		10.1038/nn902	http://dx.doi.org/10.1038/nn902			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587RL	12161756				2022-12-24	WOS:000177656300015
J	Bosking, WH; Crowley, JC; Fitzpatrick, D				Bosking, WH; Crowley, JC; Fitzpatrick, D			Spatial coding of position and orientation in primary visual cortex	NATURE NEUROSCIENCE			English	Article							MONKEY STRIATE CORTEX; OCULAR DOMINANCE; MACAQUE MONKEY; SUPERIOR COLLICULUS; CAT AREA-17; MAPS; ORGANIZATION; FIELD; SELECTIVITY; REPRESENTATION	We examined the spatial distribution of population activity in primary visual cortex (V1) of tree shrews with optical imaging and electrophysiology. A line stimulus, thinner than the average V1 receptive field, evoked a broad strip of neural activity of nearly constant size for all stimulus locations tested within the central 10degrees of visual space. Stimuli in adjacent positions activated highly overlapping populations of neurons; nevertheless, small changes in stimulus position produced orderly changes in the location of the peak of the population response. Statistically significant shifts in the population response were found for stimulus displacements an order of magnitude smaller than receptive field width, down to the limit of optical imaging resolution. Based on the pattern of population activity, we conclude that the map of visual space in V1 is orderly at a fine scale and has uniform coverage of position and orientation without local relationships in the mapping of these features.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University	Fitzpatrick, D (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Box 3209, Durham, NC 27710 USA.				NEI NIH HHS [EY06821] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALBUS K, 1975, EXP BRAIN RES, V24, P159, DOI 10.1007/BF00234061; [Anonymous], 1941, AM J OPHTHALMOL, DOI [10.1016/S0002-9394(41)91363-6, DOI 10.1016/S0002-9394(41)91363-6]; BALDI P, 1988, BIOL CYBERN, V59, P313, DOI 10.1007/BF00332921; Blasdel G, 2001, J NEUROSCI, V21, P8286, DOI 10.1523/JNEUROSCI.21-20-08286.2001; BLASDEL GG, 1984, J NEUROSCI, V4, P880; BLASDEL GG, 1986, NATURE, V321, P579, DOI 10.1038/321579a0; BLASDEL GG, 1992, J NEUROSCI, V12, P3139, DOI 10.1523/JNEUROSCI.12-08-03139.1992; BLASDEL GG, 1992, J NEUROSCI, V12, P3115, DOI 10.1523/JNEUROSCI.12-08-03115.1992; BONHOEFFER T, 1993, J NEUROSCI, V13, P4157; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Bonhoeffer Tobias, 1996, P55; Bosking WH, 1997, J NEUROSCI, V17, P2112; Bosking WH, 2000, J NEUROSCI, V20, P2346; Crair MC, 1997, NEURON, V19, P307, DOI 10.1016/S0896-6273(00)80941-1; Crair MC, 1997, J NEUROPHYSIOL, V77, P3381, DOI 10.1152/jn.1997.77.6.3381; CREUTZFELDT OD, 1974, EXP BRAIN RES, V21, P251; DANIEL PM, 1961, J PHYSIOL-LONDON, V159, P203, DOI 10.1113/jphysiol.1961.sp006803; Das A, 1997, NATURE, V387, P594, DOI 10.1038/42461; Das A, 1999, NATURE, V399, P655, DOI 10.1038/21371; DURBIN R, 1990, NATURE, V343, P644, DOI 10.1038/343644a0; GRINVALD A, 1994, J NEUROSCI, V14, P2545; GRINVALD A, 1988, PHYSIOL REV, V68, P1285, DOI 10.1152/physrev.1988.68.4.1285; Grinvald A, 1999, MODERN TECHNIQUES NE, P893, DOI 10.1007/978-3-642-58552-4_34; Groh JM, 1997, J NEUROSCI, V17, P4312; Hetherington PA, 1999, VISUAL NEUROSCI, V16, P637, DOI 10.1017/S0952523899164046; Hinton G. E., 1986, FOUNDATIONS, V1, P77; HUBEL DH, 1974, J COMP NEUROL, V158, P295, DOI 10.1002/cne.901580305; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; HUBEL DH, 1974, J COMP NEUROL, V158, P267, DOI 10.1002/cne.901580304; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Hubener M, 1997, J NEUROSCI, V17, P9270; Jancke D, 1999, J NEUROSCI, V19, P9016, DOI 10.1523/JNEUROSCI.19-20-09016.1999; KAAS JH, 1972, BRAIN RES, V42, P491, DOI 10.1016/0006-8993(72)90548-3; Kim DS, 1999, NEUROREPORT, V10, P2515, DOI 10.1097/00001756-199908200-00015; McIlwain J T, 2001, Prog Brain Res, V130, P3; MCILWAIN JT, 1991, VISUAL NEUROSCI, V6, P3, DOI 10.1017/S0952523800000857; OBERMAYER K, 1990, P NATL ACAD SCI USA, V87, P8345, DOI 10.1073/pnas.87.21.8345; OBERMAYER K, 1993, J NEUROSCI, V13, P4114; Shmuel A, 1996, J NEUROSCI, V16, P6945; SPARKS DL, 1976, BRAIN RES, V113, P21, DOI 10.1016/0006-8993(76)90003-2; SWINDALE NV, 1991, BIOL CYBERN, V65, P415, DOI 10.1007/BF00204654; Swindale NV, 2000, NAT NEUROSCI, V3, P822, DOI 10.1038/77731; TOOTELL RBH, 1988, J NEUROSCI, V8, P1531; Treue S, 2000, NAT NEUROSCI, V3, P270, DOI 10.1038/72985; VANESSEN DC, 1984, VISION RES, V24, P429, DOI 10.1016/0042-6989(84)90041-5; Weliky M, 1996, NATURE, V379, P725, DOI 10.1038/379725a0	46	98	101	1	20	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2002	5	9					874	882		10.1038/nn908	http://dx.doi.org/10.1038/nn908			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587RL	12195429				2022-12-24	WOS:000177656300018
J	Washbourne, P; Bennett, JE; McAllister, AK				Washbourne, P; Bennett, JE; McAllister, AK			Rapid recruitment of NMDA receptor transport packets to nascent synapses	NATURE NEUROSCIENCE			English	Article							INDIVIDUAL EXCITATORY SYNAPSES; CULTURED HIPPOCAMPAL-NEURONS; LONG-TERM POTENTIATION; AMPA RECEPTORS; GLUTAMATE RECEPTORS; SILENT SYNAPSES; SPINE FORMATION; SYNAPTOGENESIS; DYNAMICS; VESICLE	Although many of the molecules involved in synaptogenesis have been identified, the sequence and kinetics of synapse assembly in the central nervous system (CNS) remain largely unknown. We used simultaneous time-lapse imaging of fluorescent glutamate receptor subunits and presynaptic proteins in rat cortical neurons in vitro to determine the dynamics and time course of N-methyl-D-aspartate receptor (NMDAR) recruitment to nascent synapses. We found that both NMDA and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) subunits are present in mobile transport packets in neurons before and during synaptogenesis. NMDAR transport packets are more mobile than AMPAR subunits, moving along microtubules at about 4 mum/min, and are recruited to sites of axodendritic contact within minutes. Whereas NMDAR recruitment to new synapses can be either concurrent with or independent of the protein PSD-95, AMPARs are recruited with a slower time course. Thus, glutamatergic synapses can form rapidly by the sequential delivery of modular transport packets containing glutamate receptors.	Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA	University of California System; University of California Davis	McAllister, AK (corresponding author), Univ Calif Davis, Ctr Neurosci, 1544 Newton Ct, Davis, CA 95616 USA.			McAllister, A. Kimberley/0000-0001-9177-9889	NEI NIH HHS [R01 EY13584] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY013584] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aarts LHJ, 1998, MOL BIOL CELL, V9, P1279, DOI 10.1091/mbc.9.6.1279; Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Allison DW, 2000, J NEUROSCI, V20, P4545, DOI 10.1523/JNEUROSCI.20-12-04545.2000; Arnold DB, 1999, NEURON, V23, P149, DOI 10.1016/S0896-6273(00)80761-8; BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; Benson DL, 1998, J NEUROSCI, V18, P6892; Benson DL, 1996, J NEUROSCI, V16, P6424; Bresler T, 2001, MOL CELL NEUROSCI, V18, P149, DOI 10.1006/mcne.2001.1012; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; COOPER MW, 1992, J NEUROBIOL, V23, P814, DOI 10.1002/neu.480230704; Cottrell JR, 2000, J NEUROPHYSIOL, V84, P1573, DOI 10.1152/jn.2000.84.3.1573; CRAIG AM, 1993, NEURON, V10, P1055, DOI 10.1016/0896-6273(93)90054-U; CRAIG AM, 1994, P NATL ACAD SCI USA, V91, P12373, DOI 10.1073/pnas.91.26.12373; Dai ZS, 1996, MOL CELL NEUROSCI, V7, P443, DOI 10.1006/mcne.1996.0032; Dailey ME, 1996, J NEUROSCI, V16, P2983; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; KRASZEWSKI K, 1995, J NEUROSCI, V15, P4328; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; Mammen AL, 1997, J NEUROSCI, V17, P7351; Marrs GS, 2001, NAT NEUROSCI, V4, P1006, DOI 10.1038/nn717; MARSHALL J, 1995, NEURON, V14, P211, DOI 10.1016/0896-6273(95)90279-1; McAllister AK, 2000, P NATL ACAD SCI USA, V97, P6173, DOI 10.1073/pnas.100126497; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Niethammer M, 1996, J NEUROSCI, V16, P2157; OBrien RJ, 1997, J NEUROSCI, V17, P7339; Okabe S, 1999, NAT NEUROSCI, V2, P804, DOI 10.1038/12175; Okabe S, 2001, J NEUROSCI, V21, P6105, DOI 10.1523/JNEUROSCI.21-16-06105.2001; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Prange O, 2001, J NEUROSCI, V21, P9325, DOI 10.1523/JNEUROSCI.21-23-09325.2001; Rao A, 1998, J NEUROSCI, V18, P1217; Rumpel S, 1998, J NEUROSCI, V18, P8863; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Sheng M, 2001, CELL, V105, P825, DOI 10.1016/S0092-8674(01)00406-8; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; VERDERIO C, 1994, J CELL BIOL, V126, P1527, DOI 10.1083/jcb.126.6.1527; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Washbourne P, 2002, NAT NEUROSCI, V5, P19, DOI 10.1038/nn783; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4; Ziv NE, 2001, CURR OPIN NEUROBIOL, V11, P536, DOI 10.1016/S0959-4388(00)00246-4	50	192	204	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2002	5	8					751	759		10.1038/nn883	http://dx.doi.org/10.1038/nn883			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	577XT	12089529				2022-12-24	WOS:000177088900018
J	Krauzlis, RJ; Dill, N				Krauzlis, RJ; Dill, N			Neural correlates of target choice for pursuit and saccades in the primate superior colliculus	NEURON			English	Article							FRONTAL EYE FIELD; COUNTERMANDING SACCADES; NEURONAL-ACTIVITY; VISUAL-MOTION; REACTION-TIME; AREAS MT; MOVEMENTS; SELECTION; MONKEY; RESPONSES	We have examined the role of the superior colliculus (SC) in choosing targets for pursuit and saccades by comparing neuronal activity at sites representing the possible choices. After recording during a two-alternative forced-choice paradigm, we measured the difference in activity of the populations representing the two choices by computing receiver operating characteristic (ROC) curves on a millisecond timescale. A signal indicating the correct choice emerged from noise over time, forming a tradeoff between speed and accuracy. The observed performance corresponded to particular points along the predicted speed-accuracy curves-pursuit emphasizing speed and saccades emphasizing accuracy. These results show that activity from the same set of neurons in the superior colliculus can predict target choices for both pursuit and saccades.	Salk Inst Biol Studies, Syst Neurobiol Lab, La Jolla, CA 92037 USA	Salk Institute	Krauzlis, RJ (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.			Richard, Krauzlis/0000-0002-1826-0447	NATIONAL EYE INSTITUTE [R01EY012212] Funding Source: NIH RePORTER; NEI NIH HHS [EY12212] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Basso MA, 1997, NATURE, V389, P66, DOI 10.1038/37975; Basso MA, 1998, J NEUROSCI, V18, P7519; Basso MA, 2000, J NEUROPHYSIOL, V84, P892, DOI 10.1152/jn.2000.84.2.892; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; DURSTELER MR, 1988, J NEUROPHYSIOL, V60, P940, DOI 10.1152/jn.1988.60.3.940; Ferrera VP, 1997, J NEUROPHYSIOL, V78, P1433, DOI 10.1152/jn.1997.78.3.1433; Gandhi NJ, 1999, J NEUROPHYSIOL, V82, P3236, DOI 10.1152/jn.1999.82.6.3236; GLIMCHER PW, 1992, NATURE, V355, P542, DOI 10.1038/355542a0; GLIMCHER PW, 1993, J NEUROPHYSIOL, V69, P953, DOI 10.1152/jn.1993.69.3.953; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; GRICE GR, 1968, PSYCHOL REV, V75, P359, DOI 10.1037/h0026287; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; HANES DP, 1995, VISUAL NEUROSCI, V12, P929, DOI 10.1017/S0952523800009482; Hanes DP, 1998, J NEUROPHYSIOL, V79, P817, DOI 10.1152/jn.1998.79.2.817; Hanes DP, 1999, VISION RES, V39, P2777, DOI 10.1016/S0042-6989(99)00011-5; Horwitz GD, 1999, SCIENCE, V284, P1158, DOI 10.1126/science.284.5417.1158; Horwitz GD, 2001, J NEUROPHYSIOL, V86, P2527, DOI 10.1152/jn.2001.86.5.2527; Horwitz GD, 2001, J NEUROPHYSIOL, V86, P2543, DOI 10.1152/jn.2001.86.5.2543; KELLER EL, 1991, NEUROSCI RES, V11, P79, DOI 10.1016/0168-0102(91)90048-4; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Krauzlis RJ, 1999, TRENDS NEUROSCI, V22, P544, DOI 10.1016/S0166-2236(99)01464-2; Krauzlis RJ, 1998, J NEUROPHYSIOL, V80, P2046, DOI 10.1152/jn.1998.80.4.2046; Krauzlis RJ, 1997, SCIENCE, V276, P1693, DOI 10.1126/science.276.5319.1693; Krauzlis RJ, 1999, J COGNITIVE NEUROSCI, V11, P641, DOI 10.1162/089892999563706; Krauzlis RJ, 2000, J NEUROPHYSIOL, V84, P876, DOI 10.1152/jn.2000.84.2.876; Kustov AA, 1996, NATURE, V384, P74, DOI 10.1038/384074a0; LEE CK, 1988, NATURE, V332, P357, DOI 10.1038/332357a0; LINK SW, 1975, PSYCHOMETRIKA, V40, P77, DOI 10.1007/BF02291481; LISBERGER SG, 1987, ANNU REV NEUROSCI, V10, P97, DOI 10.1146/annurev.ne.10.030187.000525; LOGAN GD, 1984, J EXP PSYCHOL HUMAN, V10, P276, DOI 10.1037/0096-1523.10.2.276; Miyashita N, 1996, EXP BRAIN RES, V112, P187; MORDKOFF JT, 1993, J EXP PSYCHOL HUMAN, V19, P981, DOI 10.1037/0096-1523.19.5.981; Munoz DP, 1998, J NEUROPHYSIOL, V79, P1193, DOI 10.1152/jn.1998.79.3.1193; MUNOZ DP, 1995, J NEUROPHYSIOL, V73, P2313, DOI 10.1152/jn.1995.73.6.2313; MUNOZ DP, 1993, J NEUROPHYSIOL, V70, P559, DOI 10.1152/jn.1993.70.2.559; NAZIR TA, 1991, PSYCHOL RES-PSYCH FO, V53, P281, DOI 10.1007/BF00920481; NEWSOME WT, 1985, J NEUROSCI, V5, P825; OSMAN A, 1986, J EXP PSYCHOL HUMAN, V12, P243, DOI 10.1037/0096-1523.12.3.243; Platt ML, 1997, J NEUROPHYSIOL, V78, P1574, DOI 10.1152/jn.1997.78.3.1574; RASHBASS C, 1961, J PHYSIOL-LONDON, V159, P326, DOI 10.1113/jphysiol.1961.sp006811; Ratcliff R, 1999, PSYCHOL REV, V106, P261, DOI 10.1037/0033-295X.106.2.261; Recanzone GH, 1997, J NEUROPHYSIOL, V78, P2904, DOI 10.1152/jn.1997.78.6.2904; Recanzone GH, 2000, J NEUROPHYSIOL, V83, P777, DOI 10.1152/jn.2000.83.2.777; ROBINSON DA, 1972, VISION RES, V12, P1795, DOI 10.1016/0042-6989(72)90070-3; Ross J, 2001, TRENDS NEUROSCI, V24, P113, DOI 10.1016/S0166-2236(00)01685-4; SCHALL JD, 1993, NATURE, V366, P467, DOI 10.1038/366467a0; SCHALL JD, 1995, J NEUROSCI, V15, P6905; Schall JD, 1999, ANNU REV NEUROSCI, V22, P241, DOI 10.1146/annurev.neuro.22.1.241; Schall JD, 2001, NAT REV NEUROSCI, V2, P33, DOI 10.1038/35049054; SCHWARZ W, 1993, PSYCHOL RES-PSYCH FO, V55, P200, DOI 10.1007/BF00419607; SPARKS DL, 1990, ANNU REV NEUROSCI, V13, P309, DOI 10.1146/annurev.ne.13.030190.001521; Sparks DL, 1999, CURR OPIN NEUROBIOL, V9, P698, DOI 10.1016/S0959-4388(99)00039-2; Tanaka M, 2001, NATURE, V409, P191, DOI 10.1038/35051582; Thompson KG, 1996, J NEUROPHYSIOL, V76, P4040, DOI 10.1152/jn.1996.76.6.4040; WURTZ RH, 1980, ANNU REV NEUROSCI, V3, P189, DOI 10.1146/annurev.ne.03.030180.001201; Zee DS., 1999, NEUROLOGY EYE MOVEME	57	93	93	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 18	2002	35	2					355	363		10.1016/S0896-6273(02)00756-0	http://dx.doi.org/10.1016/S0896-6273(02)00756-0			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	576YF	12160752	Bronze			2022-12-24	WOS:000177034200014
J	Nordstrom, U; Jessell, TM; Edlund, T				Nordstrom, U; Jessell, TM; Edlund, T			Progressive induction of caudal neural character by graded Wnt signaling	NATURE NEUROSCIENCE			English	Article							POSTERIOR NONAXIAL MESODERM; CENTRAL-NERVOUS-SYSTEM; CHICK-EMBRYO; ANTERIOR NEUROECTODERM; DYNAMIC EXPRESSION; PARAXIAL MESODERM; MOUSE EMBRYO; SPINAL-CORD; ZEBRAFISH; XENOPUS	Early in differentiation, all neural cells have a rostral character. Only later do posteriorly positioned neural cells acquire characteristics of caudal forebrain, midbrain and hindbrain cells. Caudalization of neural tissue in the chick embryo apparently involves the convergent actions of (i) fibroblast growth factor (FGF) signaling and (ii) signaling from the caudal paraxial mesoderm, or 'PMC activity', which has not yet been defined molecularly. Here we report evidence that Wnt signaling underlies PMC activity, and show that Wnt signals act directly and in a graded manner on anterior neural cells to induce their progressive differentiation into caudal forebrain, midbrain and hindbrain cells.	Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden; Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Umea University; Columbia University; Howard Hughes Medical Institute	Edlund, T (corresponding author), Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden.	Thomas.Edlund@molbiol.umu.se						Bang AG, 1997, DEVELOPMENT, V124, P2075; Bang AG, 1999, DEV BIOL, V212, P366, DOI 10.1006/dbio.1999.9319; Baranski M, 2000, DEV BIOL, V217, P25, DOI 10.1006/dbio.1999.9516; Bell E, 2001, DEV BIOL, V236, P76, DOI 10.1006/dbio.2001.0301; DAVIS CA, 1988, GENE DEV, V2, P1736, DOI 10.1101/gad.2.12b.1736; Domingos PM, 2001, DEV BIOL, V239, P148, DOI 10.1006/dbio.2001.0431; Eisenberg CA, 1997, DEVELOPMENT, V124, P525; Erter CE, 2001, DEVELOPMENT, V128, P3571; Fekany-Lee K, 2000, DEVELOPMENT, V127, P2333; Foley AC, 2000, DEVELOPMENT, V127, P3839; Foley AC, 1997, DEVELOPMENT, V124, P2983; Fredieu JR, 1997, DEV BIOL, V186, P100, DOI 10.1006/dbio.1997.8566; Gould A, 1998, NEURON, V21, P39, DOI 10.1016/S0896-6273(00)80513-9; Greco TL, 1996, GENE DEV, V10, P313, DOI 10.1101/gad.10.3.313; Heisenberg CP, 2001, GENE DEV, V15, P1427, DOI 10.1101/gad.194301; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Huelsken J, 2000, J CELL BIOL, V148, P567, DOI 10.1083/jcb.148.3.567; HUME CR, 1993, DEVELOPMENT, V119, P1147; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kiecker C, 2001, DEVELOPMENT, V128, P4189; Lekven AC, 2001, DEV CELL, V1, P103, DOI 10.1016/S1534-5807(01)00007-7; Liu JP, 2001, NEURON, V32, P997, DOI 10.1016/S0896-6273(01)00544-X; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; Maden M, 1999, BIOESSAYS, V21, P809, DOI 10.1002/(SICI)1521-1878(199910)21:10<809::AID-BIES2>3.0.CO;2-0; Mallamaci A, 1996, MECH DEVELOP, V58, P165, DOI 10.1016/S0925-4773(96)00571-0; Matsunaga E, 2000, DEVELOPMENT, V127, P2357; McGrew LL, 1997, MECH DEVELOP, V69, P105, DOI 10.1016/S0925-4773(97)00160-3; Muhr J, 1999, NEURON, V23, P689, DOI 10.1016/S0896-6273(01)80028-3; Muhr J, 1997, NEURON, V19, P487, DOI 10.1016/S0896-6273(00)80366-9; Mukhopadhyay M, 2001, DEV CELL, V1, P423, DOI 10.1016/S1534-5807(01)00041-7; NEW DAT, 1955, J EMBRYOL EXP MORPH, V3, P320; Niederreither K, 2000, DEVELOPMENT, V127, P75; Niehrs C, 1999, TRENDS GENET, V15, P314, DOI 10.1016/S0168-9525(99)01767-9; NIETO MA, 1991, DEVELOPMENT, P59; NIEUWKOOP PD, 1952, J EXP ZOOL, V120, P1, DOI 10.1002/jez.1401200102; Popperl H, 1997, DEVELOPMENT, V124, P2997; Rex M, 1997, DEV DYNAM, V209, P323, DOI 10.1002/(SICI)1097-0177(199707)209:3<323::AID-AJA7>3.3.CO;2-B; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Shamim H, 1998, MECH DEVELOP, V76, P157, DOI 10.1016/S0925-4773(98)00102-6; Shibamoto S, 1998, GENES CELLS, V3, P659; Stern CD, 2001, NAT REV NEUROSCI, V2, P92, DOI 10.1038/35053563; Storey KG, 1998, DEVELOPMENT, V125, P473; TAKADA S, 1994, GENE DEV, V8, P174, DOI 10.1101/gad.8.2.174; van de Water S, 2001, DEVELOPMENT, V128, P3877; Wilson SI, 2001, NATURE, V411, P325, DOI 10.1038/35077115; Woo K, 1997, SCIENCE, V277, P254, DOI 10.1126/science.277.5323.254; YAMADA T, 1991, CELL, V64, P635, DOI 10.1016/0092-8674(91)90247-V; Yamaguchi TP, 2001, CURR BIOL, V11, pR713, DOI 10.1016/S0960-9822(01)00417-1; Yoshikawa Y, 1997, DEV BIOL, V183, P234, DOI 10.1006/dbio.1997.8502	50	205	208	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2002	5	6					525	532		10.1038/nn854	http://dx.doi.org/10.1038/nn854			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	556XQ	12006981				2022-12-24	WOS:000175874600011
J	LaMonte, BH; Wallace, KE; Holloway, BA; Shelly, SS; Ascano, J; Tokito, M; Van Winkle, T; Howland, DS; Holzbaur, ELF				LaMonte, BH; Wallace, KE; Holloway, BA; Shelly, SS; Ascano, J; Tokito, M; Van Winkle, T; Howland, DS; Holzbaur, ELF			Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration	NEURON			English	Article							CYTOPLASMIC DYNEIN; DYNACTIN COMPLEX; P150(GLUED) COMPONENT; NEUROFILAMENT SUBUNIT; TRANSGENIC MICE; PROTEIN; SOD1; SPECTRIN; REVEALS; DISEASE	To test the hypothesis that inhibition of axonal transport is sufficient to cause motor neuron degeneration such as that observed in amyotrophic lateral sclerosis (ALS), we engineered a targeted disruption of the dynein-dynactin complex in postnatal motor neurons of transgenic mice. Dynamitin overexpression was found to disassemble dynactin, a required activator of cytoplasmic dynein, resulting in an inhibition of retrograde axonal transport. Mice overexpressing dynamitin demonstrate a late-onset progressive motor neuron degenerative disease characterized by decreased strength and endurance, motor neuron degeneration and loss, and denervation of muscle. Previous transgenic mouse models of ALS have shown abnormalities in microtubule-based axonal transport. In this report, we describe a mouse model that confirms the critical role of disrupted axonal transport in the pathogenesis of motor neuron degenerative disease.	Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; Univ Penn, Dept Biol Anim, Philadelphia, PA 19104 USA; Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; Wyeth Ayerst Res, Princeton, NJ 08543 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pfizer	Holzbaur, ELF (corresponding author), Univ Penn, Sch Med, Dept Physiol, 3700 Hamilton Walk, Philadelphia, PA 19104 USA.	holzbaur@mail.med.upenn.edu			NIGMS NIH HHS [GM56707, GM48661] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048661, R01GM056707] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmad FJ, 1998, J CELL BIOL, V140, P391, DOI 10.1083/jcb.140.2.391; Borchelt DR, 1998, BRAIN PATHOL, V8, P735, DOI 10.1111/j.1750-3639.1998.tb00198.x; BRADY ST, 1990, P NATL ACAD SCI USA, V87, P1061, DOI 10.1073/pnas.87.3.1061; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Caroni P, 1997, J NEUROSCI METH, V71, P3, DOI 10.1016/S0165-0270(96)00121-5; Cleveland DW, 1999, NEURON, V24, P515, DOI 10.1016/S0896-6273(00)81108-3; COLLARD JF, 1995, NATURE, V375, P61, DOI 10.1038/375061a0; Dillman JF, 1996, J NEUROSCI, V16, P6742; Echeverri CJ, 1996, J CELL BIOL, V132, P617, DOI 10.1083/jcb.132.4.617; Eckley DM, 1999, J CELL BIOL, V147, P307, DOI 10.1083/jcb.147.2.307; Elder GA, 1998, J CELL BIOL, V141, P727, DOI 10.1083/jcb.141.3.727; Elder GA, 1998, J CELL BIOL, V143, P195, DOI 10.1083/jcb.143.1.195; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Harada A, 1998, J CELL BIOL, V141, P51, DOI 10.1083/jcb.141.1.51; HIROKAWA N, 1990, J CELL BIOL, V111, P1027, DOI 10.1083/jcb.111.3.1027; Holleran EA, 2001, J BIOL CHEM, V276, P36598, DOI 10.1074/jbc.M104838200; Holleran EA, 1996, J CELL BIOL, V135, P1815, DOI 10.1083/jcb.135.6.1815; Julien JP, 2001, CELL, V104, P581, DOI 10.1016/S0092-8674(01)00244-6; Julien JP, 1997, TRENDS CELL BIOL, V7, P243, DOI 10.1016/S0962-8924(97)01049-0; KARKI S, 1995, J BIOL CHEM, V270, P28806, DOI 10.1074/jbc.270.48.28806; Karki S, 1998, J CELL BIOL, V142, P1023, DOI 10.1083/jcb.142.4.1023; Karki S, 2000, J BIOL CHEM, V275, P4834, DOI 10.1074/jbc.275.7.4834; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; Li JY, 2000, J NEUROSCI RES, V61, P151, DOI 10.1002/1097-4547(20000715)61:2<151::AID-JNR6>3.3.CO;2-E; Martin M, 1999, MOL BIOL CELL, V10, P3717, DOI 10.1091/mbc.10.11.3717; MELLONI RH, 1995, J COMP NEUROL, V357, P15, DOI 10.1002/cne.903570103; Meyer O A, 1979, Neurobehav Toxicol, V1, P233; Muresan V, 2001, MOL CELL, V7, P173, DOI 10.1016/S1097-2765(01)00165-4; Murphey RK, 1999, DEV BIOL, V209, P86, DOI 10.1006/dbio.1999.9217; NAVONE F, 1986, J CELL BIOL, V103, P2511, DOI 10.1083/jcb.103.6.2511; Pagala MK, 1998, MUSCLE NERVE, V21, P1729, DOI 10.1002/(SICI)1097-4598(199812)21:12<1729::AID-MUS16>3.0.CO;2-V; PASCHAL BM, 1987, NATURE, V330, P181, DOI 10.1038/330181a0; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Reddy S, 1997, J NEUROBIOL, V33, P711, DOI 10.1002/(SICI)1097-4695(19971120)33:6<711::AID-NEU1>3.0.CO;2-C; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; SCHMUED L, 1994, ELSEVIERS NEUROSCIEN, V50, P1; Shah JV, 2000, MOL BIOL CELL, V11, P3495, DOI 10.1091/mbc.11.10.3495; Starr DA, 1998, J CELL BIOL, V142, P763, DOI 10.1083/jcb.142.3.763; Tokito MK, 1996, MOL BIOL CELL, V7, P1167, DOI 10.1091/mbc.7.8.1167; Wang L, 2000, NAT CELL BIOL, V2, P137, DOI 10.1038/35004008; WATERMANSTORER CM, 1995, P NATL ACAD SCI USA, V92, P1634, DOI 10.1073/pnas.92.5.1634; WatermanStorer CM, 1997, P NATL ACAD SCI USA, V94, P12180, DOI 10.1073/pnas.94.22.12180; Williamson TL, 1999, NAT NEUROSCI, V2, P50, DOI 10.1038/4553; Xu ZS, 1996, J CELL BIOL, V133, P1061, DOI 10.1083/jcb.133.5.1061; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160; Zhang B, 1997, J CELL BIOL, V139, P1307, DOI 10.1083/jcb.139.5.1307; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4	48	413	432	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 30	2002	34	5					715	727		10.1016/S0896-6273(02)00696-7	http://dx.doi.org/10.1016/S0896-6273(02)00696-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	558DV	12062019	Bronze			2022-12-24	WOS:000175951800007
J	Kennerley, SW; Diedrichsen, J; Hazeltine, E; Semjen, A; Ivry, RB				Kennerley, SW; Diedrichsen, J; Hazeltine, E; Semjen, A; Ivry, RB			Callosotomy patients exhibit temporal uncoupling during continuous bimanual movements	NATURE NEUROSCIENCE			English	Article							COORDINATION; DIRECTION; DYNAMICS	Rhythmic bimanual movements are highly constrained in the temporal domain, with the gestures of the two hands tightly synchronized. Previous studies have implicated a subcortical locus for temporal coupling based on the observation that these constraints persist in callosotomy patients. We now report that such coupling is restricted to movements entailing a discrete event (such as a movement onset). Three callosotomy patients exhibited a striking lack of temporal coupling during continuous movements, with the two hands oscillating at non-identical frequencies. We propose a subcortical locus of temporal coupling for movements involving discrete events. In contrast, synchronization between the hands during continuous movements depends on interhemispheric transmission across the corpus callosum.	Univ Calif Berkeley, Berkeley, CA 94720 USA; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; CNRS, Ctr Rech Neurosci Cognit, F-13402 Marseille, France	University of California System; University of California Berkeley; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Centre National de la Recherche Scientifique (CNRS)	Ivry, RB (corresponding author), Univ Calif Berkeley, 3210 Tolman Hall 1650, Berkeley, CA 94720 USA.		Diedrichsen, Jörn/AAQ-2242-2020; Kennerley, Steven W/E-3330-2018; Diedrichsen, Jörn/A-7789-2010	Diedrichsen, Jörn/0000-0003-0264-8532; Kennerley, Steven W/0000-0002-5696-7507; Diedrichsen, Jörn/0000-0003-0264-8532; Hazeltine, Richard/0000-0002-0893-5789	NINDS NIH HHS [R01 NS30256, P50 NS17778] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS017778, R01NS030256] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BULLOCK D, 1988, PSYCHOL REV, V95, P49, DOI 10.1037/0033-295X.95.1.49; Carson RG, 1997, Q J EXP PSYCHOL-A, V50, P664, DOI 10.1080/027249897392062; Cattaert D, 1999, BIOL CYBERN, V81, P343, DOI 10.1007/s004220050567; Corballis PM, 2001, NEUROLOGY, V57, P1345, DOI 10.1212/WNL.57.7.1345; Eliassen JC, 1999, EXP BRAIN RES, V128, P573, DOI 10.1007/s002210050884; Eliassen JC, 2000, BRAIN, V123, P2501, DOI 10.1093/brain/123.12.2501; Fisher NI, 1995, STAT ANAL CIRCULAR D; Franz EA, 1996, PSYCHOL SCI, V7, P306, DOI 10.1111/j.1467-9280.1996.tb00379.x; Franz EA, 1997, Q J EXP PSYCHOL-A, V50, P684, DOI 10.1080/027249897392071; FRANZ EA, 1991, ACTA PSYCHOL, V77, P137, DOI 10.1016/0001-6918(91)90028-X; GAZZANIGA MS, 1985, NEUROLOGY, V35, P1763, DOI 10.1212/WNL.35.12.1763; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; HOLLERBACH JM, 1981, BIOL CYBERN, V39, P139, DOI 10.1007/BF00336740; Ivry RB, 1999, HUM MOVEMENT SCI, V18, P345, DOI 10.1016/S0167-9457(99)00014-7; Ivry RB, 1998, J EXP PSYCHOL HUMAN, V24, P463, DOI 10.1037/0096-1523.24.2.463; IVRY RB, IN PRESS BRAIN COGN; Kakei S, 1999, SCIENCE, V285, P2136, DOI 10.1126/science.285.5436.2136; Kalaska JF, 1997, CURR OPIN NEUROBIOL, V7, P849, DOI 10.1016/S0959-4388(97)80146-8; KELSO JAS, 1979, J EXP PSYCHOL HUMAN, V5, P229, DOI 10.1037/0096-1523.5.2.229; KELSO JAS, 1983, Q J EXP PSYCHOL-A, V35, P347; Kelso S., 1995, DYNAMIC PATTERNS SEL; MARTENIUK RG, 1984, Q J EXP PSYCHOL-A, V36, P335, DOI 10.1080/14640748408402163; Porter R, 1993, CORTICOSPINAL FUNCTI; PREILOWSKI BF, 1972, NEUROPSYCHOLOGIA, V10, P267, DOI 10.1016/0028-3932(72)90018-8; Robertson SD, 1999, J EXP PSYCHOL HUMAN, V25, P1316, DOI 10.1037/0096-1523.25.5.1316; SEMJEN A, 1995, J EXP PSYCHOL HUMAN, V21, P1139, DOI 10.1037/0096-1523.21.5.1139; Serrien DJ, 2001, NEUROREPORT, V12, P2721, DOI 10.1097/00001756-200108280-00026; SIDTIS JJ, 1981, J NEUROSCI, V1, P323; TULLER B, 1989, EXP BRAIN RES, V75, P306; Verschueren SMP, 1999, EXP BRAIN RES, V127, P182, DOI 10.1007/s002210050788; ZAIDEL D, 1977, NEUROPSYCHOLOGIA, V15, P193, DOI 10.1016/0028-3932(77)90028-8; Zelaznik HN, 2000, J MOTOR BEHAV, V32, P193, DOI 10.1080/00222890009601370	32	151	153	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2002	5	4					376	381		10.1038/nn822	http://dx.doi.org/10.1038/nn822			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	534UQ	11914724				2022-12-24	WOS:000174606900019
